septembre 2011

Acupuncture,
MTC & Foie
bibliographie

Acupuncture,
TCM & Liver
bibliography
groupe d’é
d’études
tudes et de recherches
en acupuncture
192 chemin des cè
cèdres
F-83130 La garde
France

centre.doc@gera.fr
 référence type
titre de l'article ou du document,
(en langue originale ou traduction si entre crochets).

numéro d'ordre relatif dans

la bibliographie sélective.
numéro de référence gera.
Indiquer ce numéro pour toute demande de
copie.
disponibilité du document
di: disponible,
nd: non disponible,
rd: résumé seul disponible,
type de document.
ra: revue d'acupuncture
re: revue extérieure
cg: congrès,
co: cours
tt: traité
th: thèse
me: mémoire,
tp: tiré-à-part.
el: extrait de livre

1 -gera:6785/di/ra
ACUPUNCTURE ANAESTHESIA: A REVIEW.
SMALL TJ. american journal of acupuncture.1974,2(3), 147-3.
(eng). réf:33

titre de la revue ou éditeur.

première et
éventuellement
nombre de références dernière page d'un
bibliographiques du article, ou nombre
document. de pages d'un traité,
auteur, année de publication. thèse ou mémoire.
premier auteur si suivi de et al.

langue de publication et résumé: volume et/ou

* indique un résumé en anglais (pour les documents non en anglais)
(fra) français, (eng) anglais, (deu) allemand, (ita) italien, (esp) espagnol,
numéro.

(por) portugais, (ned) hollandais, (rus) russe, (pol) polonais, (cze)

tchèque, (rou) roumain, (chi) chinois, (jap) japonais, (cor) coréen, (vie)
vietnamien.

Les résumés correspondent soit à la reproduction du résumé ou présentation de l'auteur, soit à

un résumé assuré par le CD GERA

1- gera: 21408/di/ra
L'HERPES, ZONA ET L'HEPATITE INFECTIEUSE.
GERNIERS W. bulletin de la societe d'acupuncture.
1962;44:57-8 (fra).
2- gera: 11034/di/ra
L'ELECTRO-ACUPUNCTURE SELON VOLL DANS
LES AFFECTIONS HEPATIQUES. RUFFING E. cahiers
de biotherapie. 1968;17:39 (fra).
3- gera: 11035/nd/ra
QUELQUES POINTS PRATIQUES EN
ACUPUNCTURE DANS LES AFFECTIONS
HEPATIQUES. FLAMENT M. cahiers de biotherapie.
1968;17:49 (fra).
4- gera: 11036/nd/ra
ACUPUNCTURE ET AFFECTIONS HEPATO-
BILIAIRES : LE COUPLE BOIS. DE TYMOWSKI.
cahiers de biotherapie. 1970;26:132 (fra).
5- gera: 26100/di/el
INFECTIOUS HEPATITIS. X. in the manual of china's
current acupuncture therapy,medecine and health
publishing. 1975;:190. (eng).
6- gera: 11047/nd/me
APPROCHE DE L'INSUFFISANCE HEPATIQUE
DISCRETE. BASMAN A. memoire d'acupuncture,afa.
1976;9: (fra).
7- gera: 5545/di/ra
[RAPPORT D'UN CAS MONTRANT LES LIMITES DE
LA MEDECINE ORIENTALE, EFFETS NOCIFS DES
CORTICOIDES]. NAGAYAMA K. journal of the kyoto
pain control institute. 1977;10(1):5-9 (eng).
Le traitement par corticoïde entrave le traitement par
acupuncture. Rapport d'un cas d'ascite cirrhotique.
8- gera: 10983/di/th
ESSAI DE TRAITEMENT PAR ACUPUNCTURE
DANS CERTAINES AFFECTIONS HEPATIQUES.
RAT P. these medecine,marseille. 1977;:135P (fra).
Le but de notre travail a été d'évaluer le plus objectivement
possible les résultats obtenus par l'acupuncture dans le
traitement de certaines affections hépatiques. Toutes nos
études portent sur le traitement des hépatites virales
d'évolution bénigne. Ce choix a été déterminé par la
fréquence de cette maladie et le peu d'efficacité des
traitements occidentaux proposés. Ainsi nous n'avons pas
risqué de priver les malades de thérapeutiques efficaces.
L'étude des données de la littérature semble montrer une
recrudescence actuelle des cas d'hépatites virales, en
particulier celles du type B qui pourrait être liée à la
multiplication des centres de transfusion sanguine et
d'hémodialyse. Pendant six mois, dans le service de monsieur
le professeur André, à l'hopital militaire Laveran, nous avons
traité dix-huit cas d'hépatites virales. Ces cas ont été répartis
au hasard en deux groupes : un groupe témoin, composé de
six malades, qui nous avons traité à l'aide de points
volontairement différents de ceux indiqués classiquement ;
un groupe d'expérimentation, composé de douze malades,
pour lequel l'acupuncture a été utilisée suivant les règles de la
tradition. La durée du traitement a été de dix jours à raison
d'une séance par jour. Chaque patient avait des aiguilles
personnelles. Celles-ci étaient stérilisées, à la fin de chaque
séance, à 180° pendant deux heures, afin d'éviter tout
accident iatrogène. Les critères biologiques qui nous ont
permis d'apprécier les résultats ont été le dosage des
transaminases et de la bilirubine. Un contrôle biologique était
1
effectué en moyenne tous les trois jours. Les résultats on fait
l'objet d'une étude statistique (professeur Fondaray). Aucune
différence significative n'a pu être mise en évidence en
comparant le groupe placebo et celui traité par l'acupuncture.
Dans le cadre de notre expérimentation, nous pouvons
conclure que l'acupuncture ne représente pas une
thérapeutique efficace de l'hépatite virale ; de plus, si les
conditions très strictes d'asepsie que nous avons observées ne
sont pas respectées, elle constitue un risque de dissémination
de
9- gera: 11020/di/ra
[EFFETS DE FRUCTUS GARDENIA SUR LA
FONCTION HEPATIQUE]. KONG YC ET AL.
comparative medicine east and west. 1977;5(3-4):241-55
(eng).
10- gera: 11048/di/el
[ASCITE]. X. in barefoot doctor's manual. 1977;:260-2
(eng).
11- gera: 11049/di/el
[HEPATO-SPLENOMEGALIE]. X. in barefoot doctor's
manual. 1977;:267-9 (eng).
12- gera: 11050/di/el
[HEPATITE INFECTIEUSE]. X. in barefoot doctor's
manual. 1977;:314-7 (eng).
13- gera: 11051/di/el
[CIRRHOSE DU FOIE]. X. in barefoot doctor's manual.
1977;:367-71 (eng).
14- gera: 11052/di/el
[HEPATITE INFECTIEUSE]. X. in treatment of 100
common diseases by new acupuncture. 1977;:10 (eng).
15- gera: 11054/di/el
[HEPATITE]. X. in a research into acupuncture and its
clinical practice,commercial press,hong kong. 1977;:82-6
(eng).
16- gera: 21535/di/ra
IRIDOLOGIA SPERIMENTALE : CONTRIBUTO
STATISTICO ALLA TOPOGRAFIA IRIDEA EPATO-
BILIARE (RICERA PRELIMINARE). MONFARDINI A.
rivista italiana di agopuntura. 1977;29:37-42 (ita).
17- gera: 1413/di/ra
[TRAITEMENT COMBINE MTC-MO DANS
L'HEPATITE VIRALE NECROTIQUE SUBAIGUE :
ETUDE CLINIQUE]. FIRST HOSPITAL FOR
INFECTIONS DISEASES. chinese medical journal.
1978;4(4):261 (eng).
18- gera: 1414/di/cg
HEPATITE VIRALE. REQUENA Y. conferences
d'acupuncture,gera,toulon. 1978;3:99 (fra).
19- gera: 1415/di/ra
[OBSERVATIONS CLINIQUES SUR PLUSIEURS
POINTS D'ACUPUNCTURE CHEZ DES PATIENTS
AVEC HEPATITE CHRONIQUE ET CIRRHOSE
COMPARES A CEUX *]. ARICHI ET AL. american
journal of chinese medicine. 1979;7(2):157-70 (eng).
20- gera: 4040/nd/th
ASPECTS PHYSIOPATHOLOGIQUES DU FOIE ET
APERCUS SUR LA RESPIRATION EN MEDECINE
TRADITIONNELLE CHINOISE. PERSPECTIVE
gera 2011

D'APPROCHE *. DUBOIS JC. these medecine,besancon.
1979;: (fra).
21- gera: 11033/di/ra
SOBRE LA EFECTIVIDAD DE UN PUNTO NUEVO
PARA EL TRATAMIENTO Y EL DIAGNOSTICO DE
LAS AFECCIONES HEPATICAS (RESUMEN). X.
sociedad espanola de medicos acupuntores sema.
1979;0:12-3 (esp).
22- gera: 11037/di/ra
[VALEUR DU DIAGNOSTIC DU SYNDROME DANS
LE TRAITEMENT DE L'HEPATITE]. ARICHI ET AL.
bulletin of the oriental healing arts institute. 1979;4(2):1-9
(eng).
23- gera: 11038/di/ra
[L'HEPATITE CHRONIQUE : JONCTION DES
MEDECINES CHINOISES ET OCCIDENTALES].
ARICHI S. bulletin of the oriental healing arts institute.
1979;4(2):10-18 (eng).
24- gera: 11039/di/ra
[TRAITEMENT PAR PLANTES MEDICINALES
CHINOISES DE LA CIRRHOSE]. NAKATA K ET AL.
bulletin of the oriental healing arts institute. 1979;4(2):19-
26 (eng).
25- gera: 11040/di/ra
[CIRRHOSE DU FOIE]. HONG-YEN HSU. bulletin of
the oriental healing arts institute. 1979;4(2):27-33 (eng).
26- gera: 11042/di/ra
[EFFICACITE DES AGENTS DE LEVEE DE STASE
DANS LE TRAITEMENT DE L'HEPATITE
CHRONIQUE]. ARICHI S. bulletin of the oriental healing
arts institute. 1979;4(3):7-16 (eng).
27- gera: 11043/di/ra
[CAS CLINIQUES D'HEPATITE PERSISTANTE
TRAITES PAR COMBINAISON DE BUPLEURUM ET
TITANG WAN (FORMULE DE RHUBARBE ET
SANGSUE)]. ARICHI ET AL. bulletin of the oriental
healing arts institute. 1979;4(3):17-24 (eng).
28- gera: 11044/di/ra
[HEPATITE CHRONIQUE]. HONG-YEN HSU. bulletin
of the oriental healing arts institute. 1979;4(3):25-32 (eng).
29- gera: 18169/di/ra
TRAITEMENT DE L'HEPATITE VIRALE PAR
ACUPUNCTURE. REQUENA Y. mensuel du medecin
acupuncteur. 1979;56:219-29 (fra).
30- gera: 19454/di/ra
HOW CHRONIC HEPATITIS AFFECTS THE
DEVELOPMENT OF STAGNANT BLOOD AND
VEGETATIVE (AUTONOMIC) NEUROSIS. ARICHI S.
bulletin of the oriental healing arts institute. 1979;4(3):1-6
(eng).
31- gera: 900/di/ra
RAPPORTS ENTRE LES VISCERES ET LA SURFACE
DU CORPS. REACTIONS OBSERVEES AU NIVEAU
DES POINTS D'ACUPUNCTURE DANS 150 CAS DE *.
WU XIUJIN. mensuel du medecin acupuncteur.
1980;70:384-5 (fra).
32- gera: 1406/di/ra
HEPATITE VIRALE. ZHEN JIU XUE. mensuel du
2
medecin acupuncteur. 1980;71:30-2 (fra).
33- gera: 1407/di/ra
TRAITEMENT PAR ACUPUNCTURE DE 212 CAS
D'HEPATITE VIRALE ICTERIQUE AIGUE (20).
COLLEGE DE MTC DE HUBEI. mensuel du medecin
acupuncteur. 1980;70:373-4 (fra).
34- gera: 1408/di/ra
EFFETS CLINIQUES DE L'ACUPUNCTURE DANS LE
TRAITEMENT DE L'HEPATITE ICTERIQUE AIGUE
(21). WANG TIEJUN ET AL. mensuel du medecin
acupuncteur. 1980;70:374 (fra).
35- gera: 5047/di/cg
[OBSERVATION SUR LES CONNEXIONS ENTRE
LES VISCERES ET LA SUPERFICIE, REACTIONS
PONCTUELLES DANS 150 CAS D'AFFECTIONS DE
L'ESTOMAC*]. WU XIUJIN ET AL. advances in
acupuncture and acupuncture anaesthesia,beijing.
1980;:296-7 (eng).
Etude des réactions ponctuelles chez 105 patients avec
pathologie gastrique (dont 99 cas de lésion organique) et chez
45 cas de pathologie hépatique. Un groupe de 10 sujets sains
sert de contrôle. 1) Les réactions ponctuelles sont de deux
ordres : hypersensibilité ou modification morphologique
comme la présence de cupule, de nodule ou de corde. Les
cordes apparaissent le plus souvent aux points 20V, 21V,
18V et 3F. Les réactions sont observées dans 149 cas sur 150
et dans aucun cas du groupe de contrôle. 2) En cas de
maladie gastrique les réactions apparaissent au niveau du
36E, 21V, 12VC et 34VB, en cas de maladie hépatique
34VB, 36E, 18V, 3F et 8F. Les autres points étudiés
réagissent peu. 3) L'intensité de la réaction est
proportionnelle à la sévérité de l'affection ; elle est maximum
en cas de cancer et minimum en cas de petit trouble
fonctionnel. 4) Il y a une
36- gera: 10989/di/cg
[TRAITEMENT PAR ACUPUNCTURE DE
L'HEPATITE VIRALE AIGUE ICTERIQUE.
RAPPORT DE 212 CAS]. HUBEI COLLEGE OF TCM.
advances in acupuncture and acupuncture
anaesthesia,beijing. 1980;:41 (eng).
37- gera: 10990/di/cg
[EFFET THERAPEUTIQUE DE L'ACUPUNCTURE
DANS L'HEPATITE AIGUE ICTERIQUE]. WANG
TIEJUN ET AL. advances in acupuncture and
acupuncture anaesthesia,beijing. 1980;:43 (eng).
38- gera: 11021/di/ra
EFFECTS OF ACUPUNCTURE ON THE CITRATE
AND GLUCOSE METABOLISM IN THE LIVER
UNDER VARIOUS TYPES OF STRESS. LIAO YY ET
AL. american journal of chinese medicine. 1980;8(4):354-
66 (eng).
A study was made of the effect of acupuncture on citrate and
glucose metabolism in the liver in terms of incorporation of
14C-1, 5-citric acid and 14C-u-glucose in some metabolites.
The effect of acupuncture on citrate metabolism in the liver
under control conditions was such as to increase production
of G and reduce that of KB, FC and FFA. No effect of
acupuncture on glucose metabolism in the liver under such
conditions was observed. Both citrate and glucose
metabolism were affected to a marked extent by
immobilization stress or exposure to heat or cold. The
deleterious effect of these types of stress was less prominent
in animals receiving acupuncture at the Tsu-San-Li locus
than in those treated otherwise or receiving no treatment.
gera 2011

39- gera: 11022/di/ra
[TRAITEMENT PAR MTC DE 182 CAS D'HEPATITE
B DE L'ENFANT]. CHEN RONGXIAN. journal of new
chinese medicine. 1980;16(6):25 (chi).
40- gera: 18338/di/ra
HEPATIC CANCER IN CHINESE : A CHAPTER IN
"GEOGRAPHIC PATHOLOGY". WELLMANN KF ET
AL. american journal of chinese medicine. 1980;8(1-2):1-
16 (eng).
41- gera: 313/di/ra
[VALEUR DIAGNOSTIC DE LA PROTUSION DU
POINT AURICULAIRE DANS LE CANCER DU FOIE
ET D'AUTRES AFFECTIONS]. HE CHENGJIAN ET AL.
shanghai journal of traditional chinese medicine.
1981;9:26 (chi).
42- gera: 442/di/ra
[SWERTIA MILEEUSIS DANS LE TRAITEMENT DE
L'HEPATITE VIRALE AIGUE (ANALYSE DE 422
CAS)]. DU GUANGMING. revue de mtc du yunnan.
1981;2(3):35-7 (chi).
43- gera: 443/di/ra
[TRAITEMENT DE LA CIRRHOSE PAR
DECOCTION]. LI GENGHE. shanghai journal of
traditional chinese medicine. 1981;12:27 (chi).
44- gera: 809/di/ra
[INVESTIGATION SUR LES RELATIONS ENTRE LE
SYSTEME DES MERIDIENS ET LES VISCERES PAR
L'OBSERVATION DE BANDES HEMORRAGIQUES
SOUS-CUTANEES]. LI ZINGZYNG ET AL. chinese
acupuncture and moxibustion. 1981;1(1):2-7 (chi*).
Présentation d'un cas d'apparition de bandes hémorragiques
sous-cutanées visibles à l'oeil nu. Une bande suit le trajet de
la vésicule biliaire (du 30VB au 40VB), une autre le trajet des
reins (du 3Rn au 9Rn). Parallèlement sont notées des
affections du foie et des reins, diagnostiquées cliniquement et
par des examens de laboratoire. Les bandes ont disparues
avec la guérison de ces affections. Les auteurs suggèrent qu'il
y a des connexions entre les méridiens et le système neuro-
humoral.
45- gera: 10998/di/ra
[EFFETS DU BIPHENYL DICARBOSYLATE ET DE
LA PILULE DE SYLYBUM MARIANUM (L) GAERTN
SUR L'HEPATITE VIRALE CHRONIQUE]. CHANG
YUXUAN ET AL. chinese journal of modern
developments in traditional medicine. 1981;1(1):24 (chi*).
Biphenyl Dicarbosylate entraîne dans 90,32 % une
diminution des SGPT contre seulement 21,43 % pour
Silybum Marianum, mais l'effet n'est pas stable.
46- gera: 11056/di/ra
[TRAITEMENT EFFICACE PAR PLANTES
CHINOISES DE L'HEPATITE CHRONIQUE ET LA
CIRRHOSE DU FOIE (résumé)]. HIROSHI SAKAGUSHI
ET AL. acupuncture research quarterly. 1981;17:25-6
(eng).
47- gera: 11057/di/ra
[DIAGNOSTIC ET TRAITEMENT DES GROS FOIES
A PARTIR D'UN POINT NOUVEAU (résumé)]. KIM
YM. acupuncture research quarterly. 1981;17:31-2 (eng).
48- gera: 11060/di/el
[CIRRHOSE HEPATIQUE]. X. in doctor's manual of
3
chinese medical diet. 1981;:8 (eng).
49- gera: 11061/di/el
[COMA HEPATIQUE]. X. in doctor's manual of chinese
medical diet. 1981;:31 (eng).
Formes cliniques et principes thérapeutiques.
50- gera: 11062/di/el
[HEPATITE AIGUE ET CHRONIQUE]. X. in doctor's
manual of chinese medical diet. 1981;:31 (eng).
51- gera: 438/di/ra
[DISCUSSION SUR LE TRAITEMENT DU CANCER
DU FOIE BASE SUR LA THEORIE RATE-
ESTOMAC]. YU ERXING. shanghai journal of
traditional chinese medicine. 1982;1: (chi).
52- gera: 439/di/ra
[RECHERCHE CLINIQUE SUR LE TRAITEMENT DE
L'ECHINOCOCCOSE PAR LA METHODE
COMBINEE MTC-MO, ANALYSE DE 14 CAS]. JIANG
CIPENG ET AL. journal of traditional chinese medicine.
1982;23(1):28 (eng).
53- gera: 440/di/ra
[AMELIORATION DE L'ELECTROPHORESE
SERIQUE DANS L'HEPATITE CHRONIQUE ET LA
CIRRHOSE PAR LA METHODE "AIDER L'ENERGIE
VITALE A *. YU HUIQIN ET AL. journal of traditional
chinese medicine. 1982;23(1):43 (eng).
54- gera: 441/di/ra
[PREVENTION ET TRAITEMENT DES MALADIES
HEPATIQUES EXPERIMENTALES PAR LES
DROGUES "ACTIVATION DU SANG" ET
"SUPPRESSION DE LA STASE"]. WANG ZHENLING
ET AL. journal of traditional chinese medicine.
1982;23(1):67 (eng).
55- gera: 1019/di/ra
[MODIFICATION DU TAUX DE CHOLESTEROL
HEPATIQUE ET VESICULAIRE DURANT LA PHASE
DES EXERCICES DE RESPIRATION PROFONDE].
WANG JIANLING ET AL. shanghai journal of traditional
chinese medicine. 1982;12:42 (chi).
56- gera: 1035/di/ra
[TRAITEMENT DIETETIQUE DE L'HEPATITE].
ZHAO LICHEN. journal of new chinese medicine.
1982;14(8):43 (chi).
57- gera: 1396/di/ra
[BASES BIOCHIMIQUES ET IMMUNOLOGIQUES
DE LA CLASSIFICATION DE LA MTC DES
HEPATITES CHRONIQUES]. BAO XUN. journal of
traditional chinese medicine. 1982;23(7):36 (eng).
58- gera: 1397/di/ra
[ETUDE EXPERIMENTALE SUR DES LESIONS
CHRONIQUES HEPATIQUES TRAITEES PAR DES
PRESCRIPTIONS "TONIFIER L'ENERGIE VITALE
ET *]. HAN XANGLING ET AL. journal of traditional
chinese medicine. 1982;23(7):77 (eng).
59- gera: 1398/di/ra
[TRAITEMENT DE 73 CAS D'HEPATITE VIRALE
CHRONIQUE]. HAO PU. journal of traditional chinese
medicine. 1982;23(8):29 (eng).
Traduction GERA disponible.
gera 2011

60- gera: 1399/di/ra
[LA MTC DANS LE TRAITEMENT DES HEPATITES
SEVERES]. MEN XIANYI. shanghai journal of
traditional chinese medicine. 1982;9:9 (chi).
61- gera: 1400/di/ra
[ANALYSE DE L'EFFET THERAPEUTIQUE DE LA
MTC CHEZ 7 ENFANTS AVEC DEGENERESCENCE
HEPATO- LENTICULAIRE]. ZHAO ZHENG ET AL.
journal of traditional chinese medicine. 1982;23(9):9
(eng).
62- gera: 1401/di/ra
LA INFLUENCIA DE LA MOXIBUSTION EN EL
DANO HEPATICO CAUSADO POR LA
ADMINISTRACION DE TETRACLORURO DE
CARBONO EN RATAS. MATSUYAMA Y ET AL.
revista uruguaya de acupuntura. 1982;23:36-7 (esp).
63- gera: 1402/di/ra
[OBSERVATIONS SUR 74 CAS DE CANCER
PRIMITIF DU FOIE AU STADE II TRAITES PAR
PLANTES TRADITIONNELLES]. LAI YUNGCHUNG
ET AL. revue de mtc du yunnan. 1982;3(1):16 (chi).
64- gera: 1403/di/ra
[TRAITEMENT DE L'HEPATITE B]. TIAN NAIGENG.
journal of new chinese medicine. 1982;14(7):18 (chi).
65- gera: 1404/di/ra
[CLASSIFICATION DES FORMES CLINIQUES DE
L'HEPATITE VIRALE ET LEURS TRAITEMENTS].
FU DAIMING. journal of new chinese medicine.
1982;14(8):1 (chi).
66- gera: 1409/di/ra
[EXPERIENCE DANS LE TRAITEMENT DES
AFFECTIONS HEPATIQUES CHRONIQUES]. HU
JIAN HUA. journal of traditional chinese medicine.
1982;23(10):20 (eng).
67- gera: 1410/di/ra
[ETUDE CLINIQUE ET EXPERIMENTALE SUR LES
EFFETS THERAPEUTIQUES DU GLYCYRRHIZIN
SUR L'HEPATITE VIRALE AIGUE ET CHRONIQUE].
SU XIANSHI ET AL. journal of traditional chinese
medicine. 1982;23(11):23 (eng).
68- gera: 1411/di/ra
[ETUDE SUR L'ACTION PREVENTIVE DE L'ACIDE
OLEANIQUE SUR LA CIRRHOSE
EXPERIMENTALE]. HAN DEWU ET AL. journal of
traditional chinese medicine. 1982;2(2):83 (eng).
69- gera: 1412/di/ra
[EXPERIENCE DU MEDECIN VETERAN YAN
ERLING DANS LE TRAITEMENT DES MALADIES
DU FOIE]. LEI YONGZHENG ET AL. shanghai journal
of traditional chinese medicine. 1982;4:9 (chi).
70- gera: 1416/di/ra
[DIAGNOSTIC DIFFERENTIEL ET TRAITEMENT
DE L'ASCITE DANS LA CIRRHOSE DU FOIE]. CHEN
JIMING. journal of traditional chinese medicine.
1982;23(12):8 (eng).
71- gera: 1417/di/ra
[TRAITEMENT DE L'HEPATITE B SELON LES
FORMES CLINIQUES D'APRES LES METHODES
DECRITES DANS "DES MALADIES FEBRILES" ET
4
*]. LIN HEHE. journal of traditional chinese medicine.
1982;23(12):18 (eng).
72- gera: 2857/di/ra
[EXPERIENCE DU PROFESSEUR DENG TIE TAO
DANS LE TRAITEMENT DE LA DISTOMIASE
HEPATIQUE]. DENG ZHONGYAN ET AL. journal of
traditional chinese medicine. 1982;2(2):131 (eng).
L'infestation par le parasite entraîne une dépression de
l'énergie du Foie et une asthénie de la Rate.
73- gera: 5135/di/ra
[EPUISEMENT DU YIN DU FOIE ET DES REINS ET
ACCUMULATION INTERNE D'HUMIDITE-
CHALEUR (CIRRHOSE POST-HEPATIQUE ET
SYNDROME HEPATO-*)]. CHEN ZELIN ET AL.
journal of traditional chinese medicine. 1982;2(3):227
(eng).
74- gera: 10958/nd/ra
[EFFETS PROTECTEURS DE L'ACUPUNCTURE SUR
LES LESIONS HEPATIQUES PROVOQUEES PAR
L'ADMINISTRATION DE TETRACHLORURE DE
CARBONE CHEZ*]. WATARI N. japan society of
acupuncture journal. 1982;4:315 (jap).
260 souris sont divisées en 5 groupes traités par acupuncture
(6 séances) et en deux groupes de contrôle. L'acupuncture a
un effet protecteur certain non seulement sur l'effet léthal,
mais également sur les lésions histologiques. Le stimulus
acupunctural doit être conduit au niveau du système nerveux
central où il va induire la production de substances comme
les endorphines ou les enképhalines qui ont une action
stimulante ou régularisante du système nerveux autonome.
Les fonctions viscérales sont stimulées permettant une
réparation
75- gera: 10999/di/ra
[ETUDE PRELIMINAIRE SUR LA REDUCTION DES
GPT DANS L'HEPATITE CHRONIQUE PAR BIAN
ZHEN LUN ZHI]. WANG CHENGBO. chinese journal of
modern developments in traditional medicine.
1982;2(4):201 (chi*).
76- gera: 11018/rd/ra
[EFFETS DE L'ACUPUNCTURE ET DE LA
MOXIBUSTION SUR LES MALADIES HEPATIQUES
CHRONIQUES]. IGARI ET AL. journal of the japan
society of acupuncture. 1982;32(2):34-9 (jap*).
Suivi de 8 patients atteints de maladies hépatiques chroniques
sur 1 an avec traitement par acupuncture associé à des
plantes. Le traitement comporte deux séances par semaine :
14F droit, 3F, 20V, 17V, 6Rte, 36E, 9VG et 13VC. On
observe une amélioration subjective des symptômes et une
amélioration des GOT, GPT et gamma
77- gera: 11055/di/ra
[EPUISEMENT DU YIN DU FOIE ET DES REINS ET
ACCUMULATION INTERNE D'HUMIDITE-
CHALEUR (CIRRHOSE POST-HEPATIQUE ET
SYNDROME HEPATO-RE*]. CHEN ZELIN ET AL.
journal of traditional chinese medicine. 1982;2(3):227
(eng).
78- gera: 19269/di/ra
[LA METHODE "AIDER LE COEUR ET CALMER
L'ESPRIT" DANS LE TRAITEMENT DE L'HEPATITE
CHRONIQUE PERSISTANTE. A PROPOS DE 34 CAS].
XI CALKUN. shanghai journal of tcm. 1982;5:8 (chi).
79- gera: 19270/di/ra
gera 2011

[EXPERIENCE DANS LE TRAITEMENT DE
L'HEPATITE FULMINANTE PAR MTC]. QI YINGJE.
journal of new tcm. 1982;5:23 (chi).
80- gera: 19493/di/ra
TREATMENT OF CHRONIC HEPATITIS BY
CHINESE HERBAL FORMULAS. SEIKOEN HOSONO
CLINIC ET AL. bulletin of the oriental healing arts
institute. 1982;7(6):5-17 (eng).
81- gera: 1422/di/ra
[L'EXPERIENCE DU MEDECIN VETERAN CHEN
JIMING DANS LES PRESCRIPTIONS POUR LE
TRAITEMENT DES MALADIES DU FOIE]. SHAO
XIAOMING. shanghai journal of traditional chinese
medicine. 1983;2:17 (chi).
82- gera: 5062/di/th
ETUDE SEMEIOLOGIQUE LA REACTION A LA
PRESSION EN 6 POINTS D'ACUPUNCTURE DANS
DES AFFECTIONS GASTRIQUES, COLIQUES ET
HEPATIQUES. ROCH FX. these medecine,bordeaux 2.
1983;250:42P (fra).
Etude des réactions à la pression au niveau du 4GI, 6MC,
25E, 18V et 21V comparées à la pression d'une surface
cutanée quelconque chez 60 patients porteurs d'affections
gastriques coliques et hépatiques et chez 27 sujets témoins
indemnes de toute pathologie digestive. Etude statistique des
résultats.
83- gera: 10330/di/ra
[REMARQUES SUR LE TRAITEMENT PAR QIGONG
DES MALADIES DU FOIE]. LI YUYIN. journal of
qigong and science. 1983;4:13 (chi).
84- gera: 10352/di/ra
[EXERCICES STATIQUES ET DYNAMIQUES POUR
LES MALADIES DU FOIE]. TANG YUNLONG. journal
of qigong and science. 1983;5: (chi).
85- gera: 10353/di/ra
[OBSERVATIONS SUR L'EFFET THERAPEUTIQUE
DES EXERCICES TAI JI WUXI DANS L'HEPATITE
CHRONIQUE]. CHEN HONGXUN ET AL. journal of
qigong and science. 1983;5:29 (chi).
86- gera: 10959/di/ra
[L'EXPERIENCE DE JIANG CHUNHUA DANS LE
TRAITEMENT DE LA CIRRHOSE DU FOIE]. BEI
RUNPU. journal of traditional chinese medicine.
1983;24(2):12 (eng).
87- gera: 10960/di/ra
[TRAITEMENT DE L'HEPATITE PAR LA METHODE
DE REGULATION, ELIMINATION ET
TONIFICATION]. CHEN LI-HUA. zhejiang journal of
traditional chinese medicine. 1983;18(3):99 (chi).
88- gera: 10961/di/ra
[APERCU SUR LE TRAITEMENT DU FOIE]. WANG
SHAO-HUA. zhejiang journal of traditional chinese
medicine. 1983;24(3):128 (chi).
89- gera: 10962/di/ra
[OBSERVATIONS CLINIQUES SUR LE
TRAITEMENT DE 194 CAS D'HEPATITES AIGUES
ET CHRONIQUES PAR ACUPUNCTURE]. ZHAO
JIMIN. chinese acupuncture and moxibustion.
1983;5(2):14 (chi*).
L'acupuncture est efficace pour le traitement de l'hépatite
5
aigue et chronique en régulisant les fonctions
immunologiques de l'organisme.
90- gera: 10963/di/ra
[OBSERVATIONS CLINIQUES SUR 55 CAS
D'HEPATITE VIRALE AIGUE TRAITES PAR
ACUPUNCTURE]. GAO GUOXUN ET AL. chinese
acupuncture and moxibustion. 1983;5(2):14 (chi*).
91- gera: 10964/di/ra
[INTRODUCTION A L'EXPERIENCE DE JIANG
CHUNHAU DANS LA CIRRHOSE DU FOIE]. ZHANG
CHUNGYUU. fujian journal of traditional chinese
medicine. 1983;97:27 (chi).
92- gera: 10965/di/ra
[L'EXPERIENCE DU CELEBRE MEDECIN VETERAN
HAN SHEXIAN DANS LE TRAITEMENT DES
MALADIES DU FOIE]. TAO YUFENG. shanghai journal
of traditional chinese medicine. 1983;5:7 (chi).
93- gera: 10966/di/ra
[TRAITEMENT DE BASE DE L'HEPATITE SEVERE
PAR MTC ET PLANTES MEDICINALES. ANALYSE
DE 12 CAS]. XIA DEXING ET AL. shanghai journal of
traditional chinese medicine. 1983;5:12 (chi).
94- gera: 10967/di/ra
[EFFETS DU BIPHENYL DICARBOSYLATE DANS
LE TRAITEMENT DE QUELQUES ANOMALIES
BIOLOGIQUES CHEZ DES PATIENTS AVEC
HEPATITE CHRONIQUE *]. YU HUIQIN ET AL.
chinese journal of integrated traditional and western
medicine. 1983;3(3):1980 (chi*).
Etude comparée avec un groupe traité par protecteurs
hépatiques occidentaux. Le Biphényl dicarbosylate diminue
le taux de GPT mais également normalise l'électrophorèse
protéines, les XFP et la bilirubine. On obtient ainsi non
seulement une inhibition de l'élevation de GPT, mais
également une action protectrice sur les fonctions hépatiques
et une réparation des lésions cellulaires.
95- gera: 10968/di/ra
[EFFETS DE SALVIA MILTIORRHIZA SUR LA
REGENERATION HEPATIQUE EXPERIMENTALE].
MA HUEHUI ET AL. chinese journal of integrated
traditional and western medicine. 1983;3(3):1980 (chi*).
Les hépatites chroniques et aigues répondent
expérimentalement et cliniquement aux drogues "activation
de la circulation sanguine et levée de la stase". Une étude
expérimentale est menée sur le mécanisme d'action de
certaines drogues (Salvia Miltiorrhiza, Carthamus Tinctotius,
Angelica Sinensiis, Prunus Persica). Des rats albinos après
ablation du lobe droit du foie sont divisés en 5 groupes : un
groupe de contrôle et 4 groupes traités par chacune des
plantes. Le résultat est apprécié sur la régénération du tissu
hépatique et du taux de mitose cellulaire. Salvia Miltiorrhiza
a un effet net. De même à un certain degrè Carthamus
Tinctorius et Angelica
96- gera: 10969/di/ra
[EXPERIENCE DANS LE TRAITEMENT DE
L'HEPATITE VIRALE CHRONIQUE]. CHEN JIMING
ET AL. journal of traditional chinese medicine.
1983;24(6):13 (eng).
97- gera: 10970/di/ra
[PROGRES DANS LA RECHERCHE DE L'ACTION
DE COMPOSANTS ISOLES DE FRUCTUS
SCHIZANDRAE CHINENSIS SUR LE FOIE ANIMAL].
gera 2011

LIU GENGTAO ET AL. chinese journal of integrated
traditional and western medicine. 1983;3(3):1980 (chi*).
98- gera: 10971/di/ra
[RAPPORT DE 21 CAS D'HEPATITE VIRALE
CHRONIQUE]. CHEN NINGSHENG. journal of new
chinese medicine. 1983;15(5):30 (chi).
99- gera: 10972/di/ra
[L'ACUPUNCTURE DANS LE TRAITEMENT DE
L'HEPATITE VIRALE AIGUE. ANALYSE CLINIQUE
DE 111 CAS]. QIU MAOLIANG ET AL. shanghai journal
of acupuncture and moxibustion. 1983;2:1 (chi).
100- gera: 10973/di/ra
[ETUDE CONTROLEE SUR LE TRAITEMENT DU
SYNDROME HEPATIQUE NEONATAL PAR MTC ET
MO]. SHI YUMIN ET AL. shanghai journal of traditional
chinese medicine. 1983;6:21 (chi).
101- gera: 10974/di/ra
[ANALYSE CLINIQUE DE 63 CAS D'HEPATITE
ANICTERIQUE INFANTILE]. LIANG HUILANG ET
AL. journal of new chinese medicine. 1983;15(6):23 (chi).
102- gera: 10975/di/ra
[HEPATITE CHOLOSTATIQUE TRAITEE PAR
DROGUES REFRIGERANTES DU SANG ET
ACTIVATRICES DU SANG AVEC FORTE DOSE DE
RADIX PAEONIAE *]. WANG CHENGBO ET AL.
journal of traditional chinese medicine. 1983;24(6):30
(eng).
103- gera: 10976/di/ra
[REMARQUES SUR LE TRAITEMENT PAR QIGONG
DANS LES MALADIES DU FOIE]. LI YUYIN. journal
of qigong and science. 1983;4:13 (chi).
104- gera: 10977/di/ra
[LES DIX METHODES DE DING GAREN POUR LE
TRAITEMENT DES MALADIES DU FOIE]. GAI
BAIRONG. journal of new chinese medicine.
1983;15(7):14 (chi).
105- gera: 10979/di/ra
[EFFET PROTECTEUR DE SWERTIA MUSSOTII
SUR LES LESIONS HEPATIQUES PROVOQUEES
PAR L'HYPOXIE]. DU JIZENG ET AL. acta
pharmaceutica sinica. 1983;18(3):174 (chi).
Etude chez le rat d'une plante médicinal tibétaine.
106- gera: 10980/di/ra
[HEPATITE AIGUE ICTERIQUE TRAITEE PAR YIN
LAN TANG]. XU CHENRU. fujian journal of traditional
chinese medicine. 1983;99:61 (chi).
107- gera: 10981/di/ra
[INJECTION DE RADIX NOTOGINSENG DANS LE
TRAITEMENT DE L'HEPATITE CHRONIQUE DE
TYPE STASE DU SANG ET OBSERVATIONS
HEMORHEOLOGIQUES]. WU SHANMING ET AL.
shanghai journal of traditional chinese medicine.
1983;8:12 (chi).
108- gera: 10982/di/ra
[OBSERVATIONS SUR 105 CAS DE CIRRHOSE
HEPATIQUE AU STADE PRECOCE TRAITES PAR
DECOCTION DE RADIX ASTRAGALI, RADIX
SALVIAE *]. JIANG SEN. journal of new chinese
medicine. 1983;15(8):24 (chi).
6
109- gera: 10984/di/ra
[L'EXPERIENCE DE XIA DEXIN DANS LE
TRAITEMENT DES MALADIES DU FOIE]. CHEN
JIANJIE ET AL. journal of traditional chinese medicine.
1983;24(9):12 (eng).
110- gera: 10985/di/ra
[HEPATITE CHRONIQUE ACTIVE TRAITEE PAR
RENFORCEMENT DE LA RESISTANCE DE
L'ORGANISME ET DE L'ENERGIE ESSENTIELLE.
OBSERVATION SUR *]. XU JIQUN ET AL. journal of
traditional chinese medicine. 1983;24(8):32 (eng).
111- gera: 10986/di/ra
[OBSERVATIONS CLINIQUES SUR 3 TRAITEMENTS
PAR MATERIA MEDICA CHINOISE DANS
L'HEPATITE AIGUE ICTERIQUE]. XIAO XINHUA.
journal of traditional chinese medicine. 1983;24(8):38
(eng).
112- gera: 10987/di/ra
[TUMEURS ET HYPERPLASIES COMME
COMPLICATION DES HEPATITES CHRONIQUES
ET LEUR TRAITEMENT PAR MTC]. SHI JIZHAO.
chinese medical journal. 1983;96(9):655 (eng).
Une étude sur 1512 membres du personnel hospitalier montre
que les manifestations tumorales ou hyperplastiques (goître,
kyste du sein, kiste de l'ovaire, lipome, polype cervical,
colique, fibrome ...) sont plus fréquent chez les patients avec
hépatite chronique. La symptomatologie de l'hépatite
chronique peut être groupée en deux syndromes : foie
(distention du thorax, douleur hépatique ou splénique,
irritabilité, langue bleutée et pouls tendu lié à la stagnation de
l'énergie vitale) ou syndrome rate (inapétence, distention
abdominale, selles molles, perte de poids, fatigue générale,
oèdeme, langue pâle, pouls fin lié au vide de l'énergie vitale
de la rate). Selon la MTC, les formations tumorales sont dues
à la stagnation de l'énergie dans le foie et la rate. Quand il y a
une stagnation de l'énergie du foie (hyperfonction) cela
entraîne un vide de l'énergie de la rate (hypofonction). La
constatation de tumeurs associées à une hépatite chronique
est conforme aux
113- gera: 10988/di/ra
[L'EXPERIENCE DU CELEBRE MEDECIN VETERAN
FANG YAOZHONG DANS LE TRAITEMENT DE
L'HEPATITE CHRONIQUE PERSISTANTE]. CHEN
LIHUA. shanghai journal of traditional chinese medicine.
1983;:10 (chi).
114- gera: 10991/di/ra
[TRAITEMENT DE 156 CAS D'ASCITES
CIRRHOTIQUES SELON LES FORMES CLINIQUES].
ZHU TIANZHONG ET AL. zhejiang journal of traditional
chinese medicine. 1983;18(10):443 (chi).
115- gera: 10992/di/ra
[DIAGNOSTIC ET TRAITEMENT DE L'HEPATITE
CHRONIQUE SELON LES FORMES CLINIQUES].
YUE ZHEMIN. zhejiang journal of traditional chinese
medicine. 1983;18(10):443 (chi).
116- gera: 10993/di/ra
[TRAITEMENT DE 35 CAS D'HEPATITE TOXIQUE
AU CHLOROETHYLENE PAR LA METHODE DE
PROMOTION DE LA CIRCULATION SANGUINE ET
LEVEE DE LA *]. YANG QIWEI. zhejiang journal of
traditional chinese medicine. 1983;18(10):446 (chi).
gera 2011

117- gera: 10994/di/ra
[DEVELOPPEMENTS RECENTS DANS LE
TRAITEMENT DE L'HEPATITE B PAR MTC]. LU
JINGJANG ET AL. zhejiang journal of traditional chinese
medicine. 1983;18(10):476 (chi).
118- gera: 10995/di/ra
[RECHERCHE SUR LE TRAITEMENT DE
L'HEPATITE VIRALE CHRONIQUE ACTIVE PAR
LE PRINCIPE DE DIFFERENCIATION DES
SYMPTOMES( ANALYSE DE *)]. FAN JIAHUA ET AL.
fujian journal of traditional chinese medicine. 1983;100:9
(chi).
119- gera: 10996/di/ra
[OBSERVATIONS SUR L'EFFET THERAPEUTIQUE
DES EXERCICES TAIJI WUXI DANS L'HEPATITE
CHRONIQUE]. SHEN HONGXUN. journal of qigong and
science. 1983;:5 (chi).
120- gera: 10997/di/ra
[ANALYSE PRELIMINAIRE DE 21 CAS D'HEPATITE
CHRONIQUE TRAITES PAR QIGONG]. CHEN
SHUYUAN ET AL. journal of qigong and science.
1983;5:30 (chi).
121- gera: 11000/di/ra
[CIRRHOSE DU FOIE AVEC ASCITE TRAITEE PAR
COMBINAISON MTC-MO]. HU XIYING. journal of
new chinese medicine. 1983;15(10):25 (chi).
122- gera: 11001/di/ra
[EFFETS DES SAPONINES ISOLEES DE LA TIGE ET
DES FEUILLES DE GINSENG SUR LES LESIONS
HEPATIQUES EXPERIMENTALES]. WANG
BENXIANG ET AL. acta pharmaceutica sinica.
1983;18(10):731 (chi).
123- gera: 11002/di/ra
[ETUDES SUR LE TRAITEMENT DES LESIONS
CHRONIQUES EXPERIMENTALES DU FOIE PAR
"MANGAN N°3" (DECOCTION DE TONIFICATION
DU FOIE ET *)]. HAN KANGLING. chinese traditional
and herbal drugs. 1983;14(11):22 (chi).
124- gera: 11007/di/ra
[TRAITEMENT DE L'HEPATITE B CHRONIQUE
ACTIVE PAR DUHANG ZHECHONG WAN ET
WUREN CHUN]. SHU CHANGJIE. chinese journal of
integrated traditional and western medicine.
1983;3(5):277 (chi*).
125- gera: 11008/di/ra
[MON EXPERIENCE DANS LE TRAITEMENT DES
TYMPANITES DES AFFECTIONS CHRONIQUES DU
FOIE PAR MTC]. XIA DECHENG. journal of new
chinese medicine. 1983;15(2):4 (chi).
126- gera: 11012/di/ra
[ETUDE BIOCHIMIQUE PRELIMINAIRE DES
EFFETS PROTECTEURS DE L'INJECTION QING
KAILING SUR L'HEPATITE EXPERIMENTALE
(CCL4)]. QI ZHIJIA ET AL. journal of traditional chinese
medicine. 1983;3(1):27 (eng).
Les pilules Angongniuhuang sont une des trois plus efficaces
prescriptions dans les cas de maladies fébriles sévères. Il
s'agit d'une préparation antipyrétique, détoxifiante, sédative
et hypnotique, comportant principalement Calculus Bovi,
Moschus, Cornu Rhinoceri et Margarita. Nous avons
transformé la préparation traditionnelle en forme injectable
7
appelée Qing Kailing n°1. Des études précédentes ont montré
l'efficacité de l'injection dans les cas d'hépatite virale
chronique sévère avec ictère et ascite. Le présent travail a
pour but l'analyse du mécanisme d'action dans l'hépatite
expérimentale au tétrachlorure de carbone chez la souris.
127- gera: 11017/di/ra
[L'ELECTRO-ACUPUNCTURE ET SES EFFETS SUR
LES FONCTIONS HEPATIQUES DU RAT].
CHAKRABARTI AK ET AL. acupuncture and
electrotherapeutics research. 1983;8(2):111-126 (eng).
Effets de l'électro-acupuncture en traitement aigu (7
impulsions/sec, 0,75 volt) ou chronique (4
impulsions/sec,0,75 volt) chez le rat. Une séance par jour de
30 minutes aux points 23V, 25V et 36E durant 21 jours.
Etude au niveau cellulaire et subcellulaire. Les résultats
montrent en cas de traitement chronique : 1) augmentation du
taux de protéines, RNA, phospholipides et cholestérol au
niveau du foie total ou de la fraction microsomique, 2)
augmentation significative de l'activité de la G6-Pase au
niveau microsomique, 3) diminution de la peroxidation
lipidique, 4) augmentation de l'activité de la lipase. En cas de
traitement aigu : 1) augmentation des phospholipides et
cholestérol 2) augmentation de la G6-Pase 3) diminution de
la
128- gera: 11045/di/ra
[TRAITEMENT DE L'HEPATITE CHRONIQUE PAR
PRESCRIPTIONS MEDICINALES CHINOISES].
NAKATA KEIGO ET AL. bulletin of the oriental healing
arts institute. 1983;8(3):18-24 (eng).
129- gera: 11046/di/ra
[TRAITEMENT DE L'HEPATITE CHRONIQUE
ACTIVE PAR UNE PRESCRIPTION CONTENANT
BUPLERUM]. ARICHI SHIGERU ET AL. bulletin of the
oriental healing arts institute. 1983;8(5):42-8 (eng).
130- gera: 11058/di/ra
[ANALYSE DE L'EFFET CLINIQUE DE
L'ACUPUNCTURE ET MEDECINE CHINOISE DANS
L'HEPATITE VIRALE]. TSAY CHING HUNG.
acupuncture research quarterly. 1983;26:35 (eng).
131- gera: 11059/di/ra
[ABAISSEMENT DES SGPT PAR LA MTC]. LIU
CHANG SHI ET AL. journal of the american college of
traditional chinese medicine. 1983;1:31-5 (eng).
132- gera: 11114/di/ra
[TRAITEMENT DE L'HEPATITE CHRONIQUE PAR
LES PRESCRIPTIONS DE POSTERITE]. HOSONO
HACHIRO. bulletin of the oriental healing arts institute.
1983;8(3):8-17 (eng).
133- gera: 21672/di/ra
IL TRATTAMENTO DEL MORBO DI DUPLAY
MEDIANTE AGOPUNTURA. ROSENHOLZ U. rivista
italiana di agopuntura. 1983;48:77-80 (ita).
134- gera: 83711/nd/re
INTERFERON INDUCTION AND CLINICAL
EFFICACY ON CHRONIC HEPATITIS SUBJECTS BY
SHOSAIKO-TO. NAKAJIMA O ET AL. j med pharm sci.
1983;10:687-93 (eng).
135- gera: 3126/di/ra
[METHODES DE SUPPORT DE VITALITE ET DE
L'ESSENCE VITALE DANS LE TRAITEMENT DU
CANCER PRIMITIF DU FOIE A UN STADE AVANCE
gera 2011

31 CAS]. LIN ZONGGUANG. shanghai journal of
traditional chinese medicine. 1984;2:7 (chi).
136- gera: 4642/di/cg
[RECHERCHE SUR LES CORRELATIONS ENTRE
LES ACTIVITES FONCTIONNELLES VISCERO-
MERIDIENNE ET LA PERIODE DU JOUR]. CHEN
KEQIN ET AL. second national symposium on
acupuncture and moxibustion,beijing. 1984;:121 (eng).
Etude des corrélations entre mortalité et évolution des
affections et moment de la journée : 1) Une aggravation des
symptômes est observée à la période Xu, une aggravation
minimum à la période Chou. 2) Une amélioration maximum
est observée à Si et minimum à Chou. 3) La mortalité
maximum est observée à la période Chen et You, minimum à
Zi. 4) On observe une relation entre moment de la mort et
viscère : Coeur (Zi, Mao, Wu et You), Poumon (You), Rate,
Estomac et Reins (Si), Intestin grêle (Shen), Vésicule Biliaire
(Wu), vessie (Mao), Cerveau (You) pour les coronopathies et
Mao pour les coeurs pulmonaires, Chen pour la cirrhose,
mais Chou et Yin pour
137- gera: 4823/di/ra
[ANALYSE DES MODIFICATIONS LINGUALES
DANS 213 CAS DE CARCINOME]. XU FEI ET AL.
chinese journal of integrated traditional and western
medicine. 1984;4(1):28 (chi*).
1) Etude sur 90 sujets normaux. On n'observe pas de
dilatation veineuse, de stase ou de pétéchie sur les faces
ventrale ou dorsale de la langue. 2) Dans les 213 cas de
cancer on observe une langue livide ou pourpre, il y a une
dilatation, stase ou varicosité de la face ventrale, la face
dorsale ou le corps est légèrement enflé avec pétéchies. Ceci
est particulièrement marqué chez les sujets avec cancer du
foie qui présentent pigmentation et pétéchies le long du bord
de la langue (une ligne angioïde noire, la ligne du cancer du
foie). Dans les cas de cancer de l'estomac, de l'oesophage ou
de la région cardiale on observe également stase veineuse ou
pétéchies le long du bord ou à l'apex de la langue. Les
patientes avec cancer du col présentent une pointe de la
langue rouge ou framboisée. 3) Le pH de la surface de la
langue est de 4,5 à 5,8 en cas de cancer du foie et de 5,4 à 6,5
en cas de cancer de l'estomac. 4) La microcirculation est
observée dans 15 cas de cancer du foie : il existe une
stagnation du sang dans 11 cas. Dans les cas ou
l'hémoglobine descend à 7 g %, la microcirculation devient
plus rapide et la langue devient rouge, au-dessous de 5 g % la
langue devien pâle. Dans ce dernier cas la ligne
138- gera: 11003/di/ra
[83 CAS D'HEPATITE CHRONIQUE ACTIVE
TRAITES PAR MEDECINE INTEGREE MTC-MO].
WANG GUANTING ET AL. shanghai journal of
traditional chinese medicine. 1984;2:8 (chi).
139- gera: 11004/di/ra
[DISTENSION DE L'ABDOMEN (ASCITE DANS LA
CIRRHOSE EN PHASE TERMINALE)]. ZHANG QI.
journal of new chinese medicine. 1984;16(1):22 (chi).
140- gera: 11005/di/ra
[REVUE DE 68 CAS DE CIRRHOSE DU FOIE
DECOMPENSEE TRAITES PAR MATERIA MEDICA
CHINOISE AFIN D'ELIMINER L'EXCES DE
LIQUIDE ORGANIQUE]. YIN DESUI. journal of
traditional chinese medicine. 1984;25(3):32 (eng).
141- gera: 11006/di/ra
[EXPERIENCE DU CELEBRE MEDECIN VETERAN
HAN ZHEXIAN DANS LE TRAITEMENT DE
8
L'ASCITE CIRRHOTIQUE]. WANG GUOSHENG.
shanghai journal of traditional chinese medicine. 1984;4:9
(chi).
142- gera: 11010/di/ra
[EFFETS D'ANGELICA SINENSIS SUR LA
SYNTHESE PROTIDIQUE DE LA CELLULE
HEPATIQUE IN VITRO]. X. chinese pharmaceutical
bulletin. 1984;19(2):53 (chi).
143- gera: 11013/di/ra
[RECHERCHES CLINIQUES ET EXPERIMENTALES
SUR LE TRAITEMENT PAR ACUPUNCTURE DE
L'HEPATITE]. WANG YU JING. zhejiang journal of
traditional chinese medicine. 1984;19(4):154 (chi).
144- gera: 11014/di/ra
[TRAITEMENT DES AFFECTIONS HEPATO-
BILIAIRES CHRONIQUES PAR LA DECOCTION
"XIESHU" (REGULARISER LA CHARNIERE)]. JIAO
SHUDE. journal of traditional chinese medicine.
1984;25(4):16 (eng).
145- gera: 11015/di/ra
[DIAGNOSTIC DIFFERENTIEL DE L'ENDUIT GRAS
ET EPAIS DANS L'HEPATITE CHRONIQUE :
ANALYSE DE 39 CAS D'HEPATITE CHRONIQUE B].
WANG CHENGBO. journal of traditional chinese
medicine. 1984;25(4):26 (eng).
146- gera: 11016/di/ra
[TRAITEMENT DES SYMPTOMES AIGUS A TOUS
LES STADES DES AFFECTIONS HEPATIQUES]. XIA
DEQING. journal of new chinese medicine. 1984;16(4):13
(chi).
147- gera: 11023/di/ra
[EFFETS DE "DANGGUI BUXUE TANG" SUR LES
LESIONS HEPATIQUES INDUITES PAR
L'HYDROCORTISONE CHEZ LE RAT]. NIU
JIANZHAO. journal of traditional chinese medicine.
1984;25(5):72 (eng).
148- gera: 11024/di/ra
[TRAITEMENT DE 108 CAS D'ASCITE
CIRRHOTIQUE SELON LA DIFFERENCTIATION DU
ZHENG]. CHEN LINGCAI. zhejiang journal of
traditional chinese medicine. 1984;19(5):202 (chi).
149- gera: 11025/di/ra
[TRAITEMENT DE 68 CAS D'HEPATITE B
PRINCIPALEMENT PAR TONIFICATION DE LA
FONCTION DE LA RATE]. LI ZHIFANG. zhejiang
journal of traditional chinese medicine. 1984;19(5):205
(chi).
150- gera: 11026/di/ra
[TRAITEMENT DE 302 CAS D'HEPATITE
CHRONIQUE PAR RENFORCEMENT DE LA
RESISTANCE DU PATIENT]. YIAN GUOREI. zhejiang
journal of traditional chinese medicine. 1984;19(5):207
(chi).
151- gera: 11027/di/ra
[TRAITEMENT DE 38 CAS D'HEPATITE AIGUE PAR
LA POUDRE JIA WEI DAI FAN SAN]. WANG LING ET
AL. zhejiang journal of traditional chinese medicine.
1984;19(5):212 (chi).
152- gera: 11028/di/ra
gera 2011

[ETUDE PRELIMINAIRE SUR LE TRAITEMENT DE
L'HEPATITE VIRALE PAR ACTIVATION DU SANG
POUR LEVER LA STASE]. RAO XIANYI ET AL. revue
de mtc du yunnan. 1984;5(2):1 (chi).
153- gera: 11029/di/ra
[L'HYPERTENSION PORTALE DU CIRRHOTIQUE :
ANALYSE DU TRAITEMENT DE 113 CAS]. ZHANG
WEIJIE. journal of new chinese medicine. 1984;16(7):21
(chi).
154- gera: 11030/di/cg
CLINICAL OBSERVATION AND EXPERIMENTAL
RESEARCH ON THE EFFECT OF ACUPUNCTURE
IN 151 CASES OF ACUTE ICTERIC VIRAL
HEPATITIS. QIU MAOLIANG ET AL. second national
symposium on acupuncture and moxibustion,beijing.
1984;:61 (eng).
155- gera: 11031/di/cg
THE CLINICAL OBSERVATION OF 32 CASES OF
ANICTERIC VIRUS HEPATITIS CURED BY
ACUPUNCTURE. COMPILED BY WEI LIFU. second
national symposium on acupuncture and
moxibustion,beijing. 1984;:63 (eng).
156- gera: 11032/di/cg
OBSERVATIONS ON CONNECTION BETWEEN
ACUPOINT AND VISCERA THROUGH SKIN
TEMPERATURE-POINT TEMPERATURE OF
TAICHONG AND GANSHU IN 60 *. LIU HUILAN ET
AL. second national symposium on acupuncture and
moxibustion,beijing. 1984;:293 (eng).
157- gera: 11053/di/el
HEPATITE VIRALE. X. in roustan,traite
d'acupuncture,masson,paris. 1984;:268-9 (fra).
158- gera: 11063/di/ra
[HEPATITE VIRALE TRAITEE PAR LA DECOCTION
DE CORTEX MAGNOLIAE OFFICINALIS POUR
RECHAUFFER LE RECHAUFFEUR MOYEN]. SHEN
SHUWEN. journal of chinese medicine. 1984;8:20 (eng).
159- gera: 11064/di/ra
[NOUVELLE APPLICATION CLINIQUE DE LA
DECOCTION DE RADIX GENTIANAE DANS LA
PURGATION DU FOIE]. YAO GENGMING ET AL.
journal of new chinese medicine. 1984;9:46 (chi).
160- gera: 11065/di/ra
[APPLICATION DU PRINCIPE DE NUTRITION DANS
L'HEPATITE CHRONIQUE]. WEI BEIHAI. journal of
traditional chinese medicine. 1984;25(10):29 (eng).
161- gera: 11066/di/ra
[TRAITEMENT DE L'HEPATITE CHRONIQUE AVEC
TESTS DE FLOCULATION ANORMAUX SELON LA
DIFFERENCIATION DU ZHENG]. CHEN ZHENGTAN.
journal of traditional chinese medicine. 1984;25(10):32
(eng).
162- gera: 11067/di/ra
[EFFET THERAPEUTIQUE DE "CHAICHU SHUGAN
SAN" (POUDRE DE RACINE DE BUPLEURUM POUR
CALMER L'ENERGIE DU FOIE) DANS 80 CAS
D'HEPATITE*]. PAN YUREN. revue de mtc du yunnan.
1984;5(5):19 (chi).
163- gera: 11068/di/ra
9
[RAPPORT DE CAS D'HEPATITE CHRONIQUE
TRAITES SELON LA DIFFERENCIATION DES
FORMES CLINIQUES]. GU HUIMIN ET AL. shanghai
journal of traditional chinese medicine. 1984;10:20 (chi).
164- gera: 11069/di/ra
[PROBLEMES SUR LA RECHERCHE
EXPERIMENTALE DANS LE TRAITEMENT DANS
L'HEPATITE PAR METHODE COMBINEE]. WANG
BAOEN. chinese journal of integrated traditional and
western medicine. 1984;4(6):376 (chi*).
165- gera: 11070/di/ra
[LA DECOCTION DE HALENIA ELLIPTICA DANS
LE TRAITEMENT DE L'HEPATITE ICTERIQUE
AIGUE DE L'ENFANT]. CHEN DAXUN. chinese
traditional and herbal drugs. 1984;15(11):29 (chi).
166- gera: 11071/di/ra
[OBSERVATIONS SUR L'EXCRETION DE CUIVRE
DANS 37 CAS DE MALADIE DE WILSON TRAITES
PAR LA DECOCTION "ANTI DEGENERESCENCE
HEPATO-L *]. YANG RENMIN ET AL. chinese journal
of integrated traditional and western medicine.
1984;4(8):462 (chi*).
L'élimination de cuivre est augmentée dans 35 cas sur 37.
L'effet thérapeutique est élevé avec des effets secondaires
mineurs.
167- gera: 11072/di/ra
[EFFETS PROTECTEURS DE L'INJECTION "QI
XUE" SUR LES LESIONS HEPATIQUES INDUITES
PAR L'ACETATE DE CORTISONE]. NIU JIANZHAO
ET AL. chinese journal of integrated traditional and
western medicine. 1984;4(10):618 (chi*).
168- gera: 11073/di/ra
[INTRODUCTION AU TRAITEMENT EXTERNE DU
CANCER DU FOIE]. ZHOU DANHAN. zhejiang journal
of traditional chinese medicine. 1984;19(10):462 (chi).
169- gera: 11074/di/ra
[EXPLORATION PERSONNELLE SUR LE
TRAITEMENT DE L'HEPATITE CHRONIQUE AVEC
HbS Ag POSITIF]. JIANG CHUNHUA. journal of
traditional chinese medicine. 1984;25(12):6 (eng).
170- gera: 11075/di/ra
[HEPATITE CHRONIQUE DE TYPE STAGNATION
DU SANG TRAITEE SELON LA DIFFERENCIATION
DU ZHENG]. GUAN MAOHUI. journal of traditional
chinese medicine. 1984;25(12):20 (eng).
171- gera: 11076/di/ra
[DEUX METHODES DE GUERISON DE L'HEPATITE
PAR QIGONG]. ZHU BIANZHU. qigong and science.
1984;11:3 (chi).
172- gera: 11077/di/ra
[EXPLORATION DU MECANISME DE GUERISON
DES MALADIES HEPATIQUES]. LI YUYIN. qigong
and science. 1984;11:4 (chi).
173- gera: 11078/di/ra
[RECHERCHE CLINIQUE SUR L'HEPATITE
AIGUE]. KIKUTANI TOYOHIKO. bulletin of the oriental
healing arts institute. 1984;9(2):51-7 (eng).
174- gera: 11079/di/ra
[APPLICATION PRATIQUE ET DISCUSSION SUR LA
gera 2011

METHODE DE WANG XUGAO DE TRAITEMENT DU
FOIE]. YU SHEN CHU. fujian journal of traditional
chinese medicine. 1984;15(6):5 (chi).
175- gera: 11080/di/el
[ANALYSE CLINIQUE DE 111 CAS D'HEPATITE
VIRALE AIGUE TRAITEES PAR ACUPUNCTURE].
QIU MAOLIANG ET AL. selections from shanghai
journal of acupuncture and moxibustion 1982-84.
1984;:15-23 (eng).
176- gera: 11081/di/ra
[OBSERVATION CLINIQUE ET PARACLINIQUE
SUR L'EFFET DE GLYCYRRHIZINE SUR
L'HEPATITE AIGUE ET CHRONIQUE]. SU XIANSHI
ET AL. journal of traditional chinese medicine.
1984;4(2):127-132 (eng).
177- gera: 11082/di/ra
[PLANTES MEDICINALES CHINOISES UTILISEES
CONTRE L'HEPATITE (résumé)]. HIROSHI HIKINO.
international journal of chinese medicine. 1984;1(3):49
(eng).
178- gera: 11083/di/ra
[PLANTES CHINOISES DANS LES AFFECTIONS
HEPATIQUES (résumé)]. CHANG HM ET AL.
international journal of chinese medicine. 1984;1(3):49
(eng).
179- gera: 11084/di/ra
[ETUDES SUR L'ACTION PREVENTIVE ET
THERAPEUTIQUE DE RADIX SALUBIAE
MILTIORRHIZAE SUR LA CIRRHOSE
EXPERIMENTALE (résumé)]. HAN DE WU ET AL.
international journal of chinese medicine. 1984;1(3):49
(eng).
180- gera: 11085/di/ra
[DROGUES A ACTION HEPATIQUE ISSUES DE
SILYBUM MARIANUM (résumé)]. WAGNER M.
international journal of chinese medicine. 1984;1(3):49-50
(eng).
181- gera: 11086/di/ra
[HEPATOPHARMACOLOGIE DE FRUCTUS
SCHIZANDRAE CHINENSIS (résumé)]. LIU GT.
international journal of chinese medicine. 1984;1(3):50
(eng ).
182- gera: 11087/di/ra
[PLANTES A ACTION HEPATOPROTECTRICE :
PHARMACOLOGIE ET TOXICITE DE AUCUBIN
(résumé)]. CHANG IM ET AL. international journal of
chinese medicine. 1984;1(3):50 (eng).
183- gera: 11088/di/ra
[LA MICROCIRCULATION DANS L'HEPATITE
VIRALE CHRONIQUE : OBSERVATION ET
TRAITEMENT PAR MEDECINE CHINOISE (résumé)].
QING-BO ZHANG ET AL. international journal of
chinese medicine. 1984;1(3):55 (eng).
184- gera: 11089/di/ra
[TRAITEMENT DIETETIQUE DE L'HEPATITE].
ZHAO LICHEN ET AL. journal of the american college of
traditional chinese medicine. 1984;2:18-21 (eng).
185- gera: 11637/di/ra
[TRAITEMENT PAR QIGONG DE LA CIRRHOSE
10
HEPATIQUE ET DES SEQUELLE DE
GASTRECTOMIE]. XU FEI. qigong. 1984;5(2):72 (chi).
186- gera: 13218/di/ra
[MANIFESTATIONS OCULAIRES DE L'HEPATITE
VIRALE ET L'ORIFICE DU FOIE EST AUX YEUX
(ANALYSE DE 1OO CAS)]. YAOYONG. shanghai
journal of tcm. 1984;11:20 (chi).
187- gera: 15073/di/ra
[RECHERCHE SUR LE TRAITEMENT DE
L'HEPATOME PAR LE LUXIANCAO B]. BAI SHU
XUN ET AL. revue de mtc du yunnan. 1984;5(3):53 (chi).
188- gera: 15074/di/ra
L'ACUPUNCTURE ET LE CANCER. LIU ZHUOYOU.
mtc et acupuncture. 1984;7(2):17-8 (fra).
1) L'examen de l'oreille permet un diagnostic du cancer,
notamment quant au cancer du foie. 2) Une douleur au point
Hxing Dashih (à mi-distance entre 36V et 40V) est
significative de néoplasie, la palpation des points Shu permet
la localisation. 3) Les modifications radiologiques induites
par la puncture du 36E permettent de différencier l'ulcère
gastroduodénal du cancer. 4) L'acupuncture permet de
diminuer les effets secondaires de la radiothérapie (36E,
12VC, 6Rte et 3F) ou de la chimiothérapie. 5) La technique
d'incision (ablation du tissu graisseux sous-cutané) permet,
sauf dans les cas d'obstruction complète d'améliorer le transit
oesophagien en cas de cancer. 7) L'acupuncture améliore les
index immunologiques.
189- gera: 17373/di/ra
YIGIHUOXUE AND IMPROVEMENT OF
ELECTROPHORETIC ABNORMALITIES OF
PROTEIN IN CHRONIC HEPATITIS AND
CIRRHOSIS OF LIVER. YU HUIQIN ET AL. journal of
tcm. 1984;1:39-44 (eng).
190- gera: 3046/di/re
ACUPUNCTURE ET DEFENSES IMMUNITAIRES.
CONFORTI M ET AL. lyon mediterranee medical.
1985;21(15):10153-5 (fra).
Revue de la littérature chinoise concernant l'action de
l'acupuncture sur les maladies infectieuses. Cette action
s'exerce essentiellement sur les défenses immunitaires
humorales chez les patients présentant : paludisme, diphtérie,
hépatite virale, dysenterie bacillaire.
191- gera: 4161/di/ra
[LES MALADIES DU FOIE SELON LA THEORIE DES
5 ELEMENTS]. BING HENG LEE. pacific journal of
oriental medicine. 1985;2(2):49-55 (eng).
192- gera: 5010/di/ra
IRIDOLOGIE ET INSUFFISANCE HEPATIQUE.
LIBOTTE R. officiel des medecines naturelles. 1985;18:5
(fra).
193- gera: 6313/di/ra
[COMPARAISON DE MTC ET DE L'HOMEOPATHIE
CLASSIQUE DANS LE DIAGNOSTIC DES
PROBLEMES HEPATIQUES]. MARTIN RW.
international journal of chinese medicine. 1985;2(2):5-12
(eng).
194- gera: 11091/di/ra
MISE AU POINT SUR L'HEPATITE VIRALE.
BOUVILLE L ET AL. officiel des medecines naturelles.
1985;18:6 (fra).
gera 2011

195- gera: 11092/di/ra
[DISCUSSION SUR L'EXPERIENCE DU DR JIANG
CHUN HUA DANS LE TRAITEMENT DES
MALADIES DU FOIE]. DOU DING GUO. zhejiang
journal of traditional chinese medicine. 1985;20(1):2 (chi).
196- gera: 11093/di/ra
[6O CAS D'HEPATITE B AVEC HBS AG POSITIF
TRAITES PRINCIPALEMENT PAR LE PRINCIPE DE
RECHAUFFEMENT DES REINS]. WANG LINGTAI ET
AL. journal of traditional chinese medicine. 1985;26(1):24
(eng).
197- gera: 11094/di/ra
[RELATION ENTRE LES FORMES CLINIQUES
TRADITIONNELLES DE L'HEPATITE B
CHRONIQUE ET CERTAINS EXAMENS DE
LABORATOIRE]. XIA DEXIN ET AL. shanghai journal
of traditional chinese medicine. 1985;1:11 (chi).
198- gera: 11095/di/ra
[TRAITEMENT DE L'HEPATITE ICTERIQUE AIGUE
PAR LE DR SHAN BAITU]. CHEN WEI PING ET AL.
zhejiang journal of traditional chinese medicine.
1985;20(5):54 (chi).
199- gera: 11096/di/ra
[SIX METHODES DE TRAITEMENT DU COMA
HEPATIQUE]. DENG YILING. zhejiang journal of
traditional chinese medicine. 1985;20(2):56 (chi).
200- gera: 11097/di/ra
[TRAITEMENT DE 166 CAS D'HEPATITE VIRALE
AIGUE PAR "WU JIU HEJI" (DECOCTION DE
SEENOLOMA CHUSAUM ET DIVERS)]. YE ZAI-SHI.
zhejiang journal of traditional chinese medicine.
1985;20(2):61 (chi).
201- gera: 11098/di/ra
[TRAITEMENT DE 100 CAS D'HEPATITE VIRALE
AIGUE PAR COMMELINE COMMUNIS]. JIANG
SHUTAN. zhejiang journal of traditional chinese
medicine. 1985;20(2):61 (chi).
202- gera: 11099/di/ra
[TRAITEMENT DE 31 CAS D'ABCES AMIBIEN DU
FOIE PAR "CHAI HU QING GAN TANG"
DECOCTION DE BUPLEURUM ET DIVERS]. LI
MINJIE. zhejiang journal of traditional chinese medicine.
1985;20(2):63 (chi).
203- gera: 11100/di/ra
[TRAITEMENT PAR MTC DE 31 CAS D'HEPATITE
FULMINANTE]. WANG GUOSHEN ET AL. shanghai
journal of traditional chinese medicine. 1985;2:7 (chi).
204- gera: 11101/di/ra
[L'EXPERIENCE DU DR JIANG SHIXING DANS LE
TRAITEMENT DE L'HEPATITE CHRONIQUE]. SU
YUNFANG ET AL. shanghai journal of traditional
chinese medicine. 1985;2:9 (chi).
205- gera: 11102/di/ra
[ETUDE CLINIQUE SUR L'HEPATITE
CHRONIQUE]. KIKUTANI TOYOHIKO. bulletin of the
oriental healing arts institute. 1985;10(3):112-26 (eng).
206- gera: 11103/di/ra
[PROGRES DANS LE TRAITEMENT DES MALADIES
DU FOIE PAR MTC]. CHEN LIHUA ET AL. journal of
11
traditional chinese medicine. 1985;26(2):68 (eng).
207- gera: 11104/di/ra
[MODULATION DE L'ACTION DE LA MTC DANS LE
TRAITEMENT DE L'HEPATITE VIRALE]. YU
SENSHAN. journal of traditional chinese medicine.
1985;26(2):72 (eng).
208- gera: 11105/di/ra
[ORDINATEUR DANS L'AIDE AU DIAGNOSTIC ET
AU TRAITEMENT DE L'HEPATITE VIRALE]. CHEN
YONG ET AL. liaoning journal of traditional chinese
medicine. 1985;9(2):18 (chi).
209- gera: 11106/di/ra
[UTILISATION DU TACHOGRAMME HEPATIQUE
POUR EVALUER LE TRAITEMENT DE L'HEPATITE
AIGUE ET CHRONIQUE DE L'ENFANT PAR LA
METHODE DE *]. SHI BINGPEI ET AL. liaoning journal
of traditional chinese medicine. 1985;9(2):40 (chi).
210- gera: 11107/di/ra
[ETUDE DE QUELQUES PROBLEMES SUR LE
TRAITEMENT PAR MTC DE L'HEPATITE
CHRONIQUE]. ZHENG XHONGXING. journal of new
chinese medicine. 1985;17(3):10 (chi).
211- gera: 11108/di/ra
[DIAGNOSTIC ET TRAITEMENT DE L'HEPATITE
B]. WANG MONGSHI ET AL. journal of traditional
chinese medicine. 1985;26(4):10 (eng).
212- gera: 11109/di/ra
[TRAITEMENT DE L'HEPATITE CHRONIQUE PAR
DISPERSION DE LA CHALEUR INTERNE ET
ACTIVATION DE LA CIRCULATION SANGUINE].
ZHU BINGBING ET AL. shanghai journal of traditional
chinese medicine. 1985;5(2):9 (chi).
213- gera: 11110/di/ra
[DIAGNOSTIC ET TRAITEMENT DE LA CIRRHOSE
HEPATIQUE ET ASCITE DANS LA
SCHISTOSOMIASE EVOLUEE]. ZHENG XIANMING.
revue de mtc du yunnan. 1985;6(1):12 (chi).
214- gera: 11111/di/ra
[EXPERIMENTAL STUDIES ON THE TREATMENT
FOR ACUTE TOXICOPATHIC HEPATITIS IN
RABBITS WITH VARIOUSLY PROCESSED DAN-
SHEN.]. CHEN YONG XIANG ET AL. bulletin of chinese
materia medica. 1985;10(4):17 (chi).
215- gera: 11112/di/ra
[EFFETS DE PANAX GINSENG SUR
L'INCORPORATION DE 3H-THYMIDINE DANS UNE
CULTURE DE CELLULES HEPATIQUES]. XU CHI-
HUA ET AL. bulletin of chinese materia medica.
1985;10(5):46 (chi).
216- gera: 11113/di/ra
[REVUE ET PERSPECTIVE DU TRAITEMENT PAR
MTC DE LA SCHISTOSOMIASE AU STADE DE LA
CIRRHOSE]. WANG WUREN. shanghai journal of
traditional chinese medicine. 1985;6:7 (chi).
217- gera: 11115/di/ra
[TRAITEMENT DE L'ASCITE CIRRHOTIQUE BASE
SUR LA DIFFERENCIATION DU ZHENG]. GUAN
YOUBO ET AL. journal of traditional chinese medicine.
1985;26(5):4 (eng).
gera 2011

218- gera: 11116/di/ra
[ETUDE PRELIMINAIRE SUR LES DROGUES ANTI-
HEPATITES VIRALE B. OBSERVATION CLINIQUE
SUR 88 CAS D'HEPATITE B PERSISTANTE]. JIANG
JIAN ET AL. journal of traditional chinese medicine.
1985;26(6):26 (eng).
219- gera: 11117/di/ra
[DIFFERENCIATION DES SIGNES ET TRAITEMENT
DE 3OO CAS D'HEPATITE CHRONIQUE]. ZHU
BINBIN. shanghai journal of traditional chinese medicine.
1985;6:12 (chi).
220- gera: 11118/di/ra
[OBSERVATION CLINIQUE SUR 400 CAS
D'HEPATITE AIGUE TRAITES PAR
ACUPUNCTURE]. ZHAO JIMIN. chinese acupuncture
and moxibustion. 1985;5(3):4 (chi*).
Etude comparée acupuncture - Herba Artemensia Scopariae .
Guérison dans 98,5 % des cas. L'acupuncture régule les
fonctions immunitaires.
221- gera: 11119/di/ra
[A STUDY OF THE PLASMA THROMBOXANE B2
CHANGES IN SEVERE ICTERIC HEPATITES
TREATED BY DISPELLING THE PATHOGENIC
HEAT FROM BLOOD, *]. WANG CHENGBO ET AL.
chinese journal of integrated traditional and western
medicine. 1985;5(6): (chi*).
222- gera: 11120/di/ra
[CLINICAL AND LABORATORY OBSERVATION
TRADITIONAL CHINESE MEDICINAL
COMPOSITIONS ON THE TREATMENT OF
PATIENTS WITH SUBACUTE SEVERE*]. WANG
GUOSHEN ET AL. chinese journal of integrated
traditional and western medicine. 1985;5(6):329 (chi*).
223- gera: 11121/di/ra
[A CLINICAL STUDY OF TREATMENT WITH MAN
GAN NING IN CHRONIC VIRUS HEPATITIS]. WU
WANFEN ET AL. chinese journal of integrated
traditional and western medicine. 1985;5(6):347 (chi*).
224- gera: 11122/di/ra
[CLINICAL OBSERVATION ON 4O CASES OF GAN
YU PI XU TYPE CHRONIC HEPATITS]. PAN QIMING,
LI XINGQUN ET AL. chinese journal of integrated
traditional and western medicine. 1985;5(6):350 (chi*).
225- gera: 11123/di/ra
[CLINICAL ANALYSIS OF 115 CASES OF CHRONIC
HEPATITIS WITH CIRCULATING IMMUNE
COMPLEXES POSITIVE TREATED BY TCM]. CHEN
ZENTAN ET AL. chinese journal of integrated traditional
and western medicine. 1985;5(6):332 (chi*).
226- gera: 11124/di/ra
[ANALYSE CLINIQUE DE 22 CAS DE CANCER DU
FOIE TRAITES PAR LIANHUAPIAN AVEC SURVIE
SUPERIEURE A 1 AN]. ZHOU DAIHAN ET AL. journal
of new chinese medicine. 1985;17(6):21 (chi).
227- gera: 11125/di/ra
[RELATION ENTRE YUXUE (STAGNATION DU
SANG) ET LES TROUBLES DE LA
MICROCIRCULATION DANS L'HEPATITE
VIRALE]. RAO XIANYI. revue de mtc du yunnan.
1985;6(3):1 (chi).
12
228- gera: 11126/di/ra
[EFFET THERAPEUTIQUE DE LA RECETTE
"YIGUAN JIAN" SUR LES MALADIES HEPATIQUES
AVEC VIDE DE YIN . ANALYSE]. ZHANG ZHENRU.
journal of traditional chinese medicine. 1985;25(8):26
(eng).
229- gera: 11127/di/ra
[INTRODUCTION A L'EXPERIENCE DU PR
DENGTIETAO DANS LE TRAITEMENT DES
AFFECTIONS CHRONIQUES DU FOIE]. YANG
WENHUI ET AL. journal of new chinese medicine.
1985;17(7):3 (chi).
230- gera: 11128/di/ra
[THIRTEEN CASES OF MULTIPLE PYOGENIC
HEPATIC ABSCESS TREATED WITH TCM AND WM
COMBINED]. HUANG ZIPING. chinese journal of
integrated traditional and western medicine.
1985;5(9):534 (chi*).
231- gera: 11129/di/ra
[LA MICROCIRCULATION DANS L'HEPATITE
VIRALE CHRONIQUE : OBSERVATIONS
CLINIQUES ET TRAITEMENT PAR MTC]. ZHANG
QINGBO ET AL. chinese journal of infectious diseases.
1985;3(1):4 (chi).
232- gera: 11130/di/ra
[TRAITEMENT DE 148 CAS D'HEPATITE VIRALE
PAR LA METHODE DE RENFORCEMENT DE LA
RATE ET DISPERSION DE L'HUMIDITE
PERVERSE]. CHEN LIULIN. shanghai journal of
traditional chinese medicine. 1985;7:14 (chi).
233- gera: 11132/di/ra
[A PRELIMINARY CLINICAL STUDY OF THE
EFFECT OF COMPLEX TCM PILLS (848) ON
CHRONIC HBV CARRIERS]. ZHUO HUANCI, WANG
BAOEN ET AL. chinese journal of integrated traditional
and western medicine. 1985;5(10):606 (chi*).
234- gera: 11133/di/ra
[SELECTION DE PRESCRIPTIONS D'ACTIVATION
DE LA CIRCULATION SANGUINE ET LEVEE DE
STASE POUR LE TRAITEMENT DE L'HEPATITE].
WANG CHENBO. journal of traditional chinese medicine.
1985;26(10):29 (eng).
235- gera: 11134/di/ra
[EFFECT OF DISODIUM CANTHARIDATE AND
INJECTIO HERBAE SARCANDRAE ON ENERGY
AND CYCLIC NUCLEOTIDE METABOLISM IN
HEPATOMA 22 CELLS*]. ZHANG YINGHUA CHEN
XING ET AL. chinese journal of integrated traditional
and western medicine. 1985;5(11):686 (chi*).
236- gera: 11135/di/ra
[OBSERVATIONS CLINIQUES SUR LE
TRAITEMENT DE 60 CAS DE CANCER PRIMITIF
DU FOIE]. PAN MINQIU ET AL. shanghai journal of
traditional chinese medicine. 1985;11:13 (chi).
237- gera: 11136/di/ra
[TRAITEMENT DE 53 CAS D'HEPATITE
CHRONIQUE PAR LES GRANULES ANTIHEPATITE
N° 3]. CHANG YUYING ET AL. journal of zhejiang
traditional chinese medicine college. 1985;9(4):19 (chi).
gera 2011

238- gera: 11137/di/ra
[TRAITEMENT DE L'ASCITE CIRRHOTIQUE
SELON LA DIFFERENCIATION DU ZHENG .
ANALYSE DE 102 CAS]. JIANG SEN. journal of
traditional chinese medicine. 1985;26(11):23 (eng).
239- gera: 11138/di/ra
[INTRODUCTION AU TRAITEMENT DE
L'HEPATITE]. ZHENG JIANPING ET AL. journal of
new chinese medicine. 1985;17(11):16 (chi).
240- gera: 11139/di/ra
[18 METHODES DE TRAITEMENT DE L'ASCITE
CIRRHOTIQUE]. SHU SHIJIAN. zhejiang journal of
traditional chinese medicine. 1985;20(11-12:498 (chi).
241- gera: 11140/di/ra
[TRAITEMENT DE 73 CAS DE CANCER PRIMITIF
DU FOIE AU STADE 3]. TANG XINMIN. shanghai
journal of traditional chinese medicine. 1985;12:11 (chi).
242- gera: 12125/di/ra
[EFFETS DE SEMEN PERSICAE SUR LA
MICROCIRCULATION HEPATIQUE ET LE FLUX
BILIAIRE]. ZHANG QINGBO ET AL. shanghai journal
of traditional chinese medicine. 1985;7:45 (chi).
243- gera: 16736/di/ra
[ETUDE DES ACTIONS PREVENTIVE ET
THERAPEUTIQUE DE RADIX SALVIAE
MILTIORRHIZAE DANS LA CIRRHOSE
EXPERIMENTALE]. HAN DEWU ET AL. journal of
tcm. 1985;5(4):279-84 (eng).
244- gera: 16737/di/ra
[APERCU DES PRESCRIPTIONS POUR LES
MALADIES DU FOIE]. WANG WENZHING. journal of
shandong college of tcm. 1985;9(4):16 (chi).
245- gera: 27679/di/ra
EFFECTS OF WU-LING-SAN ON ALCOHOL
METABOLISM AND ALCOHOLIC LIVER. RURIKO
HARANAKA ET AL. journal of traditional chinese
medicine. 1985;5(3):171-8 (eng).
The effects of traditional Chinese medicine (Wu-ling-san) on
alcohol metabolism in the liver were investigated in patients
and experimental animals. Five patients with alcoholic liver
were treated with Wu-ling·san in addition to Western therapy,
and liver function tests showed improved results in all the
five cases. Then, the active mechanisms of Wu-ling-san were
investigated in relation to alcohol metabolism in the liver
using mice given a high fat diet (55% fat as total calories)
with 15 g/kg ethanol for 4 weeks. The lipid levels in the liver
were then determined. The lipid peroxide (LPO), triglyceride
(TG), phosphoIipid (PL) and total cholesterol (T-cho) levels
were increased in the alcoholic liver given a high fat diet with
ethanol. These lipid levels were decreased in the Wu- ling-
san treated group. These results suggested an anti-fatty liver
effect of Wu-Ling-San. The reduced glutathione (GSH)
levels in the liver were decreased following the
administration of ethanol. However, the Wu-ling-san treated
groups showed relatively high levels. The activities of
enzymes concerned in glutathione metabolism (G-R, G-Px,
G-6PD, 6-PGD, G-ST, gamma-GTP) were also determined.
It is concluded that Wu-ling-san may exhibit a preventive
action against GSH depletion following ethanol ingestion,
and may protect against liver cell damage. The alcohol
dehydrogenase (ADH) and aldehyde dehydrogenase (AIDH)
in the liver were decreased in the alcoholic liver given a high
fat diet. However, these activities were elevated by the
13
administration of Wu·ling-san. Wu-ling-san may thus
increase the ethanol oxidation through the elevation of these
enzymes.
246- gera: 30474/di/ra
[TREATMENT OF HEPATIC CARCINOMA ON THE
BASIS OF ZHENG DIFFERENTIATION]. QIAN
BOWEN ET AL. journal of tcm. 1985;26(12):4-7 (chi).
247- gera: 31142/di/ra
[TREATMENT OF 148 HEPATITIS CASES WITH
METHOD OF STRENGTHENING SPLEEN AND
DEPRIVING EVIL WETNESS IN MAIN]. GU
HUIMING ET AL. shanghai journal of tcm. 1985;7:14
(chi).
248- gera: 31143/di/ra
[TCM TERMINOLOGY AND ANALYSIS OF MAIN
SYMPTOMS OF HEPATITIS]. HU ZHIJIAN. shanghai
journal of tcm. 1985;7:16 (chi).
249- gera: 32833/di/ra
[EIGHT METHODS FOR TREATING CIRRHOSIS
HYDROPERITONEAM]. SHU SHI-JIAN. zhejiang
journal of traditional chinese medicine. 1985;20(12):498
(chi).
250- gera: 40276/nd/re
[TREATMENT OF CHRONIC VIRAL HEPATITIS B
AND HBSAG CARRIERS WITH POLYSACCHARIDES
OF LENTINUS EDODES]. ZHU XIAN BAO ET AL.
jiangxi zhongyiyao. 1985;5:20-5 (chi*).
Résumé Acme (870613). ACME:870613
251- gera: 40310/rd/ra
[TREATMENT OF 53 CASES OF CHRONIC
HEPATITIS WITH HEPATITIS NO. 3 GRANULES].
CHANG YU YING ET AL. journal of zhejiang traditional
chinese medicine. 1985;9(4):19-20 (chi*).
Résumé Acme (870647). ACME:870647
252- gera: 40332/rd/ra
[TREATMENT OF 200 CASES OF VIRAL HEPATITIS
WITH YINCHEN SHIXIAO POWDER]. ZHAO NAI
XIN. hubei journal of traditional chinese medicine.
1985;5:17. (chi*).
253- gera: 40337/nd/re
[TREATMENT OF 22 CASES OF HEPATOMA BY
LIANHUA TABLET]. ZHOU DAI HAN ET AL. journal
of new chinese medicine. 1985;17(6):21-3 (chi*).
254- gera: 40338/nd/re
[TREATMENT OF 12 CASES OF LIVER
TREMATODIASIS]. DENG ZHONG YAN ET AL.
journal of new chinese medicine. 1985;17(7):22-3 (chi*).
255- gera: 40339/nd/re
[TREATMENT OF 30 CASES OF CHRONIC ICTERIC
HEPATITIS WITH DANFU YINYUERCAO
DECOCTION]. MA XIAN ZAO. journal of new chinese
medicine. 1985;17(7):24-5 (chi*).
256- gera: 40836/rd/ra
[TREATMENT OF 172 CASES OF CHRONIC
HEPATITIS B WITH HUANGQI JIANGHUANG
DECOCTION]. WANG GUI ZHEN ET AL. jiangsu
journal of traditional chinese medicine. 1985;6(10):439-40
(chi*).
gera 2011

257- gera: 40837/rd/ra
[TREATMENT OF 81 CASES OF CHRONIC
HEPATITIS B WITH MAN'GANFUFANG]. SUN JING
ZHEN ET AL. jiangsu journal of traditional chinese
medicine. 1985;6(10):442-44 (chi*).
258- gera: 40867/rd/ra
[TREATMENT OF 93 CASES OF HEPATITIS WITH
BAIJIN CHEQIAN DECOCTION]. LI GUO YONG.
zhejiang journal of traditional chinese medicine.
1985;20(11-2):491-92 (chi*).
259- gera: 40879/di/ra
[TREATMENT OF 96 CASES OF HEPATITIS B WITH
POSITIVE HBsAG TEST]. WANG JIAN ZHONG.
journal of traditional chinese medicine. 1985;26(11):813.
(eng*).
260- gera: 40880/di/ra
[TREATMENT OF 102 CASES OF ASCITES DUE TO
CIRRHOSIS]. JIANG SEN. journal of traditional chinese
medicine. 1985;26(11):823-25 (eng*).
261- gera: 40927/rd/ra
[TREATMENT OF 60 CASES OF PRIMARY
HEPATOMA]. PAN MIN QIU ET AL. shanghai journal
of traditional chinese medicine. 1985;11:13-4 (chi*).
262- gera: 40929/rd/ra
[TREATMENT OF 73 CASES OF THIRD STAGE
PRIMARY HEPATOMA]. TANG XIN MIN ET AL.
shanghai journal of traditional chinese medicine.
1985;12:11-2 (chi*).
263- gera: 40989/nd/re
[ANTIHEPATOTOXIC CONSTITUENTS OF
CHINESE DRUGS]. HIKINO H. chinese pharmaceutical
bulletin. 1985;20(7):415-17 (chi*).
Résumé Acme (870318). ACME:870318
264- gera: 517/di/ra
MICROCIRCULATION IN CHRONIC VIRAL
HEPATITIS, CLINICAL OBSERVATION AND
TREATMENT WITH TRADITIONAL CHINESE
MEDICINE. ZHANG QINGBO ET AL. chinese medical
journal. 1986;99(8):660-4 (eng).
265- gera: 16738/di/ra
[TRAITEMENT DE L'HEPATITE B PAR
RECHAUFFEMENT ET RENFORCEMENT DU
YANG]. CHEN LIHUA ET AL. journal of tcm.
1986;27(1):27 (chi).
266- gera: 16739/di/ra
[PRELIMINARY REPORT OF OBSERVATION ON
THERAPEUTIC EFFECT IN CHRONIC ACTIVE
HEPATITIS TREATED WITH SHORT WAVE
INFRARED *]. QU YAO,ET AL. chinese journal of
integrated traditional and western medicine.
1986;86(2):90 (chi*).
267- gera: 16740/di/ra
[A COMPARATIVE STUDY ON TREATING
INFANTILE HEPATITIS SYNDROME WITH TCM-
WM COMBINED AND TCM EXCLUSIVELY]. SHI
YUMIN,DUAN SHUCHENG ET AL. chinese journal of
integrated traditional and western medicine. 1986;6(1):23
(chi*).
268- gera: 16741/di/ra
14
[TREATMENT OF EXPERIMENTAL LIVER INJURY
WITH CHINESE HERBAL MEDICINE QUEEN
TABLET]. CHA LIANGYI ET AL. chinese journal of
integrated traditional and western medicine. 1986;6(1):36
(chi*).
269- gera: 16742/di/ra
[EXPERIMENTAL STUDY OF RHEUM OFFICINALE
BAILL IN TREATING SEVERE HEPATITIS AND
HEPATIC COMA]. HU LINHUA ET AL. chinese journal
of integrated traditional and western medicine.
1986;6(1):41 (chi*).
270- gera: 16743/di/ra
[CLINICAL ANALYSIS OF THE TONGUE PICTURE
IN 130 PATIENTS WITH PRIMARY LIVER
CARCINOMA]. LI NAIMIN. chinese journal of
integrated traditional and western medicine.
1986;6(3):143 (chi*).
271- gera: 16744/di/ra
[AN ANALYSIS ON THE TREATMENT OF SEVERE
VIRAL HEPATITIS WITH TCM-WM]. XIANG
JUZHENG ET AL. chinese journal of integrated
traditional and western medicine. 1986;6(6):345 (chi*).
272- gera: 20259/di/me
ETUDE BIBLIOGRAPHIQUE DU TRAITEMENT DES
HEPATITES VIRALES AIGUES PAR
ACUPUNCTURE. GASSIES P. memoire
d'acupuncture,bordeaux 2. 1986;:32P (fra).
Ce mémoire porte sur le traitement par acupuncture des
hépatites virales aiguës à partir de prescriptions théoriques et
de prescriptions thérapeutiques issues d'études cliniques.
L'acupuncture semble montrer une certaine efficacité dans le
traitement de ces hépatites aiguës ; cela est d'autant plus
intéressant que la médecine occidentale classique ne propose
actuellement aucune thérapeutique efficace.
273- gera: 20618/di/ra
[AN ANALYSIS ON THE TREATMENT OF SEVERE
VIRAL HEPATITIS WITH TCM-WM]. XIANG
JUZHENG ET AL. chinese journal of integrated
traditional and western medicine. 1986;6(6):345 (chi*).
274- gera: 21695/di/ra
L'ASTENIA NEUROPSICHICA E LA
SOMATIZZAZIONE GASTROEPATICA IN PAZIENTI
CON NEVRALGIA DEL TRIGEMINO. SCUTARI R ET
AL. rivista italiana di agopuntura. 1986;55:43. (ita).
275- gera: 22253/di/ra
MICROCIRCULATION IN CHRONIC VIRAL
HEPATITIS. ZHANG QING-BO ET AL. chinese medical
journal. 1986;99(8):660-4 (eng).
276- gera: 22452/di/ra
[SYMPATHETIC INNERVATION OF RABBIT LIVER
PARENCHYMA AND THEIR EFFECT OF
ACUPUNCTURE DURING HEMORRHAGIC SHOCK].
WEN SHEN ET AL. acupuncture research.
1986;11(4):252-7 (chi*).
277- gera: 22453/di/ra
[THE EFFECT OF ACUPUNCTURE AT
"RENZHONG" ON HEPATIC PHOSPHORYLASE OF
RABBIT DURING HAEMORRHAGIC SHOCK.
HISTOCHEMICAL OBSERVATION]. WEN SHEN ET
AL. acupuncture research. 1986;11(4):258-62 (chi*).
gera 2011

278- gera: 22454/di/ra
[THE EFFECT OF ACUPUNCTURE AT
"RENZHONG" ON HEPATIC GLYCOGEN OF
RABBITS DURING HEMORRHAGIC SHOCK. A
HISTOCHEMICAL STUDY]. WAN SHEN ET AL.
acupuncture research. 1986;11(4):263-7 (chi*).
279- gera: 23406/di/ra
[CLINICAL AND PATHOLOGICAL OBSERVATION
IN TREATMENT OF CHRONIC ACTIVE HEPATITIS
B WITH GAN FU EXTRACT*]. SHI YOUXIN ET AL.
chinese journal of integrated traditional and western
medicine. 1986;6(9):522 (chi).
280- gera: 23407/di/ra
[OBSERVATION ON THE THERAPEUTIC EFFECT
OF QIANG GAN TANG N°1 AND N°2 IN TREATING
358 CASES OF CHRONIC HEPATITIS*]. HAN
JINGHUAN ET AL. chinese journal of integrated
traditional and western medicine. 1986;6(9):526 (chi).
281- gera: 23408/di/ra
[A PRELIMINARY CLINICAL OBSERVATION ON
THE EFFECT OF KANG DU WAN ON CHRONIC
HBV INFECTION*]. YANG JIANYING ET AL. chinese
journal of integrated traditional and western medicine.
1986;6(9):530 (chi).
282- gera: 30077/di/ra
[THE VETERAN PHYSICIAN HU XISHU'S
EXPERIENCE IN TREATING HEPATITIS]. FENG
SHILUN. beijing journal of traditional chinese medicine.
1986;(4):2-3 (chi).
283- gera: 30085/di/ra
[A STUDY OF THE RULE OF EVIDENCE-
DIFFERENTIATION OF ASCITES DUE TO
CIRRHOSIS OF LIVER]. SHEN NINGSHENG. beijing
journal of traditional chinese medicine. 1986;(4):26-27
(chi).
284- gera: 30254/di/ra
[THE COMPARAISON OF THERAPEUTIC EFFECT
OF 1367 CASES OF ACUTE VIRAL HEPATITIS
(ICTERIC TYPE) TREATED BY CHINESE HERBAL
MEDICINE]. LIN SHOUQUAN. fujian journal of
traditional chinese medicine. 1986;17(1):31-41 (chi).
285- gera: 30255/di/ra
[CLINICAL APPLICATION OF WU JUTONG'S
METHOD USING PUNGENT AND BITTER DRUGS IN
THE DEPARTEMENT OF INTERNAL MEDICINE].
LIN SHOUQUAN. fujian journal of traditional chinese
medicine. 1986;17(1):31-41 (chi).
286- gera: 30273/di/ra
[THE TREATMENT OF CHRONIC HEPATITIS
BASED ON THE TYPE OF DIFFERENTIATING
SYMPTOMS AND SIGNS OF TCM]. WANG
RONGGUO. fujian journal of traditional chinese
medicine. 1986;17(3):8-9 (chi).
287- gera: 30274/di/ra
[OBSERVATION OF 7 SURVIVOR WITH ADVANCED
PRIMARY HEPATOCARCINIMA TREATED WITH
ELIMINATING THE STAGNANT AND ACTIVATING
THE BLOOD *]. ZHANG KEPING. fujian journal of
traditional chinese medicine. 1986;17(3):10-11 (chi).
288- gera: 30307/di/ra
15
[THERAPEUTIC EFFECT OF 66 CASES OF
PRIMARY LIVER CANCER TREATED WITH XIAO
ZHENG YI GAN PIAN]. COOPERATIVE GROUP OF
FUZHOU. fujian journal of traditional chinese medicine.
1986;17(6):16-7 (chi).
289- gera: 30497/di/ra
[TCM TREATMENT OF CHRONIC HEPATITIS
WITH POSITIVE HBSAG . ANALYSIS OF 74 CASES].
PENG YINGCAI. journal of tcm. 1986;27(2):32-7 (chi).
290- gera: 30505/di/ra
[TREATMENT OF CHRONIC HEPATITIS BASED ON
SYNDROME DIFFERENTIATION]. CHEN JIMING.
journal of tcm. 1986;27(3):13-20 (chi).
291- gera: 30522/di/ra
[TREATMENT OF SEVERE ICTERIC HEPATITIS BY
DISPELLING HEAT FROM BLOOD. ACTIVATING
CIRCULATION AND ELIMINATING BLOOD
STASIS*]. WANG CHENGBO. journal of tcm.
1986;27(4):30-2 (chi).
292- gera: 30552/di/ra
[TREATMENT OF LIVER CIRRHOSIS DUE TO
SCHISTOSOMIASIS WITH SEMEN PERSICAE]. YU
GUANGSHENG ET AL. journal of tcm. 1986;27(6):24-5
(chi).
293- gera: 30572/di/ra
[TCM TREATMENT OF HEPATOLENTICULAR
DEGENERATION]. LU ZAISHENG. journal of tcm.
1986;27(7):36-47 (chi).
294- gera: 30608/di/ra
[PRESENT STATUS ON TREATMENT OF
ABNORMALITY OF TURBIDITY AND
FLOCCULATION TEST IN HEPATIC DISORDER].
MENG LINSHENG. journal of traditional chinese
medicine. 1986;27(4):62 (eng).
295- gera: 30644/di/ra
[FOUR CASES OF LIVER CANCER TREATED ON
THE BASIS OF SYNDROME-DIFF. CAO YONGKANG.
journal of traditional chinese medicine. 1986;27(12):16-20
(eng).
296- gera: 30646/di/ra
[EXPERIENCE IN TREATING REVERSED A/G
RATIO IN PATIENTS WITH CHRONIC HEPATITIS].
YANG FENMING. journal of traditional chinese
medicine. 1986;27(12):33-4 (eng).
297- gera: 31174/di/ra
[COMPARISON BETWEEN CHINESE AND
WESTERN MEDICINES IN TREATMENT OF 87
CASES OF HEPATIC DAMAGE IN GESTATION].
MAM NAIJUE. shanghai journal of tcm. 1986;12:12 (chi).
298- gera: 31175/di/ra
[TREATMENT OF INFANTILE ACUTE ICTERIC
HEPATITIS WITH 8 METHODS OF PROMOTING
BLOOD CIRCULATION]. ZHAO WEIQIANG. shanghai
journal of tcm. 1986;12:14 (chi).
299- gera: 31390/di/ra
[INTRODUCTION TO EXPERIENCE OF GUAN
MAOHUI IN TREATING HEPATITIS]. ZHANG
DECHAO. shaanxi journal of tcm. 1986;7(1):16 (chi).
gera 2011

300- gera: 31421/di/ra
[CHINESE MATERIA MEDICA FOR 33 CASES OF
CHRONIC ACTIVE HEPATITIS]. LI YIFANG. shaanxi
journal of tcm. 1986;7(3):105 (chi).
301- gera: 31422/di/ra
[THE TREAMENT OF CHRONIC HEPATITIS B BY
BIAN ZHENG LUN ZHI : OBSERVATION OF
THERAPEUTIC EFFECT OF 100 CASE]. LIU
DONGSHENG. shaanxi journal of tcm. 1986;7(3):107
(chi).
302- gera: 31429/di/ra
[FEATURES OF TACHOGRAM OF THE LIVER IN
103 CASES OF CHRONIC HEPATITIS]. ZHANG
YUELIN ET AL. shaanxi journal of tcm. 1986;7(3):131
(chi).
303- gera: 31432/di/ra
[TCM TREATMENT OF HEPATITIS B]. FAN
CANGZHEN ET AL. shaanxi journal of tcm.
1986;7(3):137 (chi).
304- gera: 31458/di/ra
["GAN YAN MIXTURE" FOR TREATMENT OF 126
CHILDREN OF JAUDICE HEPATITIS]. SHA
YANRONG ET AL. shaanxi journal of tcm. 1986;7(5):205
(chi).
305- gera: 31486/di/ra
["DAMP HEAT STAGNATE TOXIN" AND SERIOUS
HEPATITIS]. XUE TAO. shaanxi journal of tcm.
1986;7(7):291 (chi).
306- gera: 31490/di/ra
[CASES OF HEPATOPATHY TREATED BY "QIANG
GAN TANG" COMBINED WITH WESTERN
MEDICINE]. ZHANG YUFANG. shaanxi journal of tcm.
1986;7(7):300 (chi).
307- gera: 31491/di/ra
[CASES OF CHRONIC ACTIVE HEPATITIS BY
TREATED WITH "DAI HUANG ZHE CHONG WAN"].
LIU GUANGHAN. shaanxi journal of tcm. 1986;7(7):301
(chi).
308- gera: 31496/di/ra
[SUCCESSFUL TREATMENT FOR 2 CASES OF
LIVER ABSCESS]. ZHANG ZHENXING. shaanxi
journal of tcm. 1986;7(7):312 (chi).
309- gera: 31866/di/ra
[TREATMENT OF VIRAL HEPATITIS (VIRUS B)
WITH TABLET CORNU BUDALI COMPLEX]. CHEN
ZHISHUI ET AL. liaoning journal of traditional chinese
medicine. 1986;10(8):28 (chi).
310- gera: 31872/di/ra
[OBSERVATIONS ON THE RELATION BETWEEN
DEFICIENCY SYNDROMES OF HEPATOCIRRHOSIS
AND THE CONTENTS OF SERUM ZINC, COPPER
AND IRON *]. LIU CHENG ET AL. liaoning journal of
traditional chinese medicine. 1986;10(10):22 (chi).
311- gera: 32178/di/ra
[TREATMENT OF CHRONIC HEPATITIS TYPE B
WITH GAN FU KANG IN 360 CASES]. WANG YUMEI
ET AL. journal of tcm and chinese materia medica of
jilin. 1986;5:10 (chi).
16
312- gera: 32317/di/ra
[THE SYNDROME OF YIN-TYPE JAUNDICE IN
ICTERIC HEPATITIS]. HU JINQUAN. journal of new
chinese medicine. 1986;3:13 (chi).
313- gera: 32357/di/ra
[THE PRESCRIPTION WITH THE EFFECT OF
EXPELLING WIND AS A THERAPY FOR CHRONIC
HEPATITIS]. HAI CHONGXI. journal of new chinese
medicine. 1986;18(6):16 (chi).
314- gera: 32390/di/ra
[TREATMENT OF GASTRITIS AND HEPATITIS IN
ACCORDANCE WITH THE THROAT STATUS : AN
EXPERIENCE OF ASSOCIATE-PROFESSOR HE
RUZHAN]. LI YICHANG ET AL. journal of new chinese
medicine. 1986;18(10):6 (chi).
315- gera: 32682/di/ra
[TREATMENT VIRUS CHRONIC HEPATITIS WITH
YAN GANTAN (NOURISHING LIVER DECOCTION)].
ZHOU DAOZHONG. yunnan journal of tcm. 1986;7(4):23
(chi).
316- gera: 32896/di/ra
[MY OPINION ON DIAGNOSIS AND TREATMENT
OF HEPATITIS]. WEI CHANG-CHEN. zhejiang journal
of traditional chinese medicine. 1986;21(5):193 (chi).
317- gera: 32899/di/ra
[TREATMENT OF 1 CASES OF GRAVE HEPATITIS
WITH THE METHOD OF CHINESE TRADITIONAL
AND WESTERN MEDICINE COMBINED]. PAN
CHEN-LIAN ET AL. zhejiang journal of traditional
chinese medicine. 1986;21(5):198 (chi).
318- gera: 32900/di/ra
[TREATMENT OF SUBACUTE HEPATIC
NECROSIS]. YAO GONG-SHU. zhejiang journal of
traditional chinese medicine. 1986;21(5):200 (chi).
319- gera: 32901/di/ra
[EFFECTIVE ANALYSIS OF 65 CASES OF CHRONIC
HEPATITIS BASED ON DIFFERENTING SYMPTOMS
AND SIGNS]. WEI BEI-HUAN ET AL. zhejiang journal
of traditional chinese medicine. 1986;21(5):202 (chi).
320- gera: 32903/di/ra
[DR XIA YU-TIAN'S EXPERIENCE IN TREATING
HEPATOPATHY IN GYNECOLOGY]. LI TIAN-ER.
zhejiang journal of traditional chinese medicine.
1986;21(5):206 (chi).
321- gera: 32905/di/ra
[DISCUSSION ON SOME QUESTIONS OF
TREATMENT OF CHRONIC HEPATITIS]. SHU SHI-
JIAN. zhejiang journal of traditional chinese medicine.
1986;21(5):222 (chi).
322- gera: 32908/di/ra
[RECENT DEVELOPMENTS IN TREATMENT OF
GRAVE HEPATITIS WITH TCM]. LIAO ZHEN-QIU.
zhejiang journal of traditional chinese medicine.
1986;21(5):234 (chi).
323- gera: 33117/di/ra
[RESEARCH ON RELATION BETWEEN TRACE
ELEMENT AND THE DIFFERENTIATION OF THE
SYMPTOMS AND SIGNS OF VIRAL HEPATITIS].
CHEN LIAN-QI ET AL. zhejiang journal of traditional
gera 2011

chinese medicine. 1986;21(10):466 (chi).
324- gera: 33162/di/ra
[DR : ZHU SHIMO'S EXPERIENCE IN TREATING
CHRONIC ACTIVE HEPATITIS]. CHEN ZEMI. hubei
journal of traditional chinese medicine. 1986;4:8 (chi).
325- gera: 40224/nd/re
[ANTIHEPATITIS AND HYPOGLYCEMIC EFFECTS
OF CANNA FLACCIDA]. HUANG RAY LING ET AL.
journal of the taiwan pharmaceutical association.
1986;38(2):96-101 (chi*).
Résumé Acme (870561). ACME:870561
326- gera: 40244/nd/re
[EFFECT OF PROPYL GALLATE ON SWELLING
AND LIPID PEROXIDATION OF RAT LIVER
MITOCHONDRIA]. WANG JI FENG ET AL. acta
pharmaceutica sinica. 1986;21(11):857-60 (chi*).
Résumé Acme (870581). ACME:870581
327- gera: 40286/rd/ra
[DIFFERENTIAL TREATMENT OF 120 CASES OF
CHRONIC HEPATITIS BY TRADITIONAL CHINESE
MEDICINE]. WANG RONG GUO. fujian journal of
traditional chinese medicine. 1986;17(3):8-9 (chi*).
328- gera: 40287/rd/ra
[SURVIVAL OF SEVEN CASES OF ADVANCED
PRIMARY HEPATOMA TREATED BY
ELIMINATING STASIS, ACTIVATING BLOOD,
DISSIPATING HEAT AND DETOXIFICATION].
ZHANG KE PING. fujian journal of traditional chinese
medicine. 1986;17(3):10-1 (chi*).
329- gera: 40295/rd/ra
[TREATMENT OF 33 CASES OF CHRONIC ACTIVE
HEPATITIS WITH CHINESE MEDICINES]. LI YI
FANG. shaanxi traditional chinese medicine.
1986;7(3):105-06 (chi*).
Résumé Acme (870632). ACME:870632
330- gera: 40389/nd/re
[EFFECT OF -INTERFERON COMBINED WITH
COMPOUND SILYBUM MARIANUM PILL IN
TREATMENT OF CHRONIC HEPATITIS B]. LI YI
FANG ET AL. journal of xi'an medical university.
1986;7(3):265-67 (chi*).
Résumé Acme (870729). ACME:870729
331- gera: 40496/nd/re
[EFFECTS OF 10-HYDROXYCAMPTOTHECINE ON
CHROMATIN PROTEIN SYNTHESIS IN MOUSE
HEPATOMA CELLS]. LING YI HE ET AL. acta
pharmacologica sinica. 1986;7(3):285-88 (chi*).
Résumé Acme (870886). ACME:870886
332- gera: 40509/nd/re
[EFFECTS OF CLOFIBRATE, SILYBIN, SAFFLOWER
OIL AND LAMINDRAN ON LIVER PEROXISOME
PROLIFERATION AND ENZYME ACTIVITIES IN
RATS]. WU SHU GUANG ET AL. acta pharmacologica
sinica. 1986;7(3):283-84 (chi*).
Résumé Acme (870899). ACME:870899
333- gera: 40528/nd/re
[EFFECTS OF SOME FUNGAL POLYSACCHARIDES
ON EXPERIMENTAL HEPATITIS INMICE]. ZHANG
XIAO PING ET AL. journal of northeast normal
university. 1986;4:101-08 (chi*).
17
Résumé Acme (870918). ACME:870918
334- gera: 40842/rd/ra
[THE COMPARISON OF THERAPEUTIC EFFECTS
OF 1307 CASES OF ACUTE ICTERIC VIRAL
HEPATITIS TREATED WITH CHINESE HERBAL
MEDICINES]. LIN SHOU QUAN ET AL. fujian journal
of traditional chinese medicine. 1986;17(1):31-3 (chi*).
335- gera: 51247/di/ra
[EXPERIMENTAL ACUTE LIVER INJURY MODEL
INDUCED BY -NAPHTHYL ISOTHIOCYANATE].
WEN QIZHEN ET AL. chinese traditional and herbal
drugs. 1986;17(7):19-21 (chi*).
336- gera: 19888/di/el
[HEPATITE NON-ICTERIQUE]. X. in patent
medicine,harmonious sunshine cultural center,san
francisco. 1987;2:152-6 (eng).
Formes cliniques et phytothérapie.
337- gera: 20118/di/ra
LES PHYSIOLOGIES DU FOIE ET DE LA VESICULE
BILIAIRE EN MEDECINE OCCIDENTALE ET
CHINOISE. REQUENA Y. acupuncture. 1987;91:25-38
(fra).
Ce que nous savons de la physiologie chinoise du foie n'est
pas développé dans un chapitre particulier de telle ou telle
oeuvre, mais nécessite l'exégèse de divers chapitres des
classiques comme le Nei Jing Su Wen et Ling Shou, le Zhen
Jiu Da Cheng et le Nan Jing, ainsi que divers passages
d'explications physiologiques au hasard de développements
séméiologiques, pathologiques ou thérapeutiques, dans ces
mêmes textes ou dans des textes postérieurs. Au total, il se
dégage des grands axes, comme le Jing de ce viscère et celui
de la vésicule biliaire, cette dernière figurant parmi les
entrailles à part, irrégulières, curieuses; ou encore, la fonction
de conservation du sang par le foie, enrichie de celle de
drainage et de décongestion. Cette exégèse amorcée par les
auteurs chinois eux-mêmes, a donné lieu à des synthèses
successives reprises et enrichies ensuite par les chercheurs
occidentaux. Nous avons tenté, dans cet article, une
confrontation des données de la physiologie traditionnelle
chinoise concernant gan (le foie), avec les connaissances
modernes sur la physiologie hépatique, et, à chaque étape,
nous avons indiqué les plantes occidentales qui paraissent les
plus aptes à traiter le secteur considéré.
338- gera: 20360/di/ra
[USE OF "SRRS" RECIPE ON TREATMENT OF
LATE STAGE LIVER CANCER PATIENTS AND
THEIR EXPERIMENTAL INVESTIGATIONS]. QIU
JIAXIN ET AL. chinese journal of integrated traditional
and western medicine. 1987;7(5):275 (eng).
339- gera: 20515/di/ra
A COMPARATIVE STUDY ON THE
PYRROLIZIDINE ALKALOID CONTENT AND THE
PATTERN OF HEPATIC PYRROLIC METABOLITE
ACCUMULATION IN MICE*. XIANG-LAN ZHAO ET
AL. american journal of chinese medicine. 1987;15(1-
2):59-67 (eng).
340- gera: 20528/di/ra
[EFFECT OF LONG KUI INJECTION CO ON
HEPATOMA H22 ASCITES TUMOUR CELLS IN
MICE]. LÜ GUIZHI ET AL. chinese journal of integrated
traditional and western medicine. 1987;7(2):97 (chi*).
341- gera: 20665/di/ra
gera 2011

[EFFECT OF SHENG MAI LIQUOR ON HEPATIC
HISTOCHEMISTRY IN AGED RATS]. ZHANG GUOXI
ET AL. chinese journal of integrated traditional and
western medicine. 1987;7(8):481 (chi*).
342- gera: 20686/di/ra
[SURVEY OF THE TREATMENT OF SEVERE
HEPATITIS WITH TRADITIONAL CHINESE
MEDECINE AS THE MAIN APPROACH]. GONG
WEIXING ET AL. chinese journal of integrated
traditional and western medicine. 1987;7(7):442 (chi*).
343- gera: 20695/di/ra
[A PRELIMINARY STUDY ON RELATIONSHIP
BETWEEN "LINE OF GANYIN" AND
HEMORHEOLOGY OF PRIMARY LIVER CANCER
PATIENTS]. WANG RONGPING. chinese journal of
integrated traditional and western medicine.
1987;7(12):734 (chi*).
344- gera: 20848/di/ra
THE THERAPEUTIC EFFECT OF BIPHENYL-
DIMETHIL-DICARBOXYLATE (DDB) ON CERTAIN
ABNORMAL LABORATORY PARAMETRES IN
CHRONC HEPATITIS. ZHANG YUXUAN. journal of
tcm. 1987;7(2):137 (eng).
345- gera: 21033/di/ra
THE JAUNDICE-SUPPRESSING EFFECT OF BLOOD-
COOLING CIRCULATION-INVIGORATING,
VISCERA- DREDGING AND CHOLAGOGIC
CHINESE HERBS IN THE*. WANG CHENGBAI ET AL.
journal of tmc. 1987;7(4):248-50 (eng).
346- gera: 21078/di/cg
THE INVESTIGATION OF REDUCING HBSAG
POSITIVE RATE BY ACUPUNCTURE TECHNIQUE.
ZHANG XIAOBIN ET AL. in compilation of the abstracts
of acupuncture and moxibustion papers, beijing.
1987;:112 (eng).
347- gera: 21150/di/cg
THE EFFECT OF ACUPUNCTURE AT DIFFERENT
TIME ON CONCENTRATION OF REDUCED
GLUTATHIONE IN LIVERS OF MICE POISONED BY
ACONITINE. SONG KAIYUAN ET AL. in compilation of
the abstracts of acupuncture and moxibustion papers,
beijing. 1987;:176 (eng).
348- gera: 21898/di/el
HEPATITE INFECTIEUSE AIGUE DE TYPE
ICTERIQUE. SUN XUE-QUAN. in recueil d'experiences
clinques en acupuncture-moxa. 1987;:114-6 (fra).
349- gera: 21899/di/el
CIRRHOSE HEPATIQUE. SUN XUE-QUAN. in recueil
d'experiences clinques en acupuncture-moxa. 1987;:116-9
(fra).
350- gera: 22041/di/cg
THE INVESTIGATION OF REDUCING HBSAG
POSITIVE RATE BY ACUPUNCTURE TECHNIQUE.
ZHANG XIAOBIN ET AL. in selections from article
abstracts on acupuncture and moxiibustion, beijing.
1987;:181 (eng).
4069 sujets sont étudiés. 243 (6%) sont HBSAg (+). 1502
sujets ont eu dans le passé un traitement par acupuncture,
parmi eux, 2,5% sont HBSAg. 2567 cas n'ont jamais eu un
traitement par acupuncture, 8% sont HBSAg (+). Un
traitement par acupuncture semble réduire la prévalence. Cela
18
peut être lié à une action immunostimulante de l'acupuncture
ou alors à un "effet de vaccination" possible.
351- gera: 22042/di/cg
PRELIMINARY CLINICAL AND EXPERIMENTAL
OBSERVATION ON ASYMPTOMATIC HBSAG
CARRIER (asc) TREATED WITH ACUPUNCTURE
AND MOXIBUSTION. TAO MINGZHONG ET AL. in
selections from article abstracts on acupuncture and
moxiibustion, beijing. 1987;:183 (eng).
352- gera: 22043/di/cg
CLINICAL OBSERVATION ON TREATMENT OF
ACUTE VIRAL ICTEROHEPATITIS WITH
ACUPUNCTURE. LIU HANCHENG ET AL. in selections
from article abstracts on acupuncture and moxiibustion,
beijing. 1987;:184 (eng).
[Hépatite virale aigue traitée par acupuncture]. Les malades
sont répartis en 2 groupes : traitement par acupuncture et
traitement par acupuncture et chimiopuncture. Traitement par
acupuncture (84 cas) : soit points principaux seuls (49 cas)
soit points principaux avec Dazhui (14VG) et Taichong (3F).
Les points principaux choisis : au stade ictérique : goupe I :
36E, 9VG, 19V. Groupe 2 : 34VB, 5F, 18V. Au stade de
résolution : Groupe 1 : 36E, 6Rte, 18V. Goupe 2 : 6 Rte,
34VB, 20V. Des points secondaires peuvent être ajoutés en
focntion des symptômes. Les aiguilles sont laissés en place
30 minutes, une séance par jour en alternant les groupes de
points. Traitements de 7 à 10 jours, puis arrêt de 3 jours.
Traitement par chimiopuncture : Injection de vit B12 au
niveau du 6Rte à 1-1,5 cm de profondeur (51 cas) Résultats :
l'hospitalisation est de 22,5 jours en moyenne pour le groupe
traité par chimiopuncture, 24,5 jours pour le groupe
acupuncture et 32,5 jours pour le groupe témoin. Les points
14VG et 3F favorisent la disparition de l'ictère. L'association
acupuncture et chimiopuncture permet
353- gera: 22044/di/cg
OBSERVATION ON 40 CASES OF ACUTE
ICTEROHEPATITIS TREATED WITH EMBEDING
CATGUT AT ACUPUNCTURE POINT. HUANG
AIHUA. in selections from article abstracts on
acupuncture and moxiibustion, beijing. 1987;:186 (eng).
[Observation de 40 cas d'hépatite aigue traités par pose de fils
de catgut au niveau de points d'acupuncture]. L'étude porte
sur 40 cas d'hépatite aigue traités au ambulatoire par pose de
fils catgut au niveau de points d'acupuncture. Les points
choisis : Chengman (20E), Zhanguien (13F) du côté droit et
Ganshu (18V), Yishe (49V) bilatéralement. On insère le fil
catgut 1-1,5 cm au dessus de chengman (20E), on le fait
ressortir 1-1,5 cm au delà de Zhangnien (13F), on coupe les
deux extrémités et on laisse en place. Idem au niveau de
Ganshu et Yishe. Résultats : 28 cas (70 %) de guérisons en
15 jours, 10 cas (25 %) de récupération en 1 mois, 2 cas (5
%) d'échec. La récupération est plus rapide et meilleure que
dans le groupe témoin : 19,2 jours pour 40,2 jours. La
méthode combine l'utilisation du fil de catgut et de la
technique shu/mu.
354- gera: 22407/di/ra
[EFFECT OF ACUPUNCTURE ON
ULTRASTRUCTURE OF LIVER IN RATS]. YUAN
DEXIA ET AL. acupuncture research. 1987;12(1):52-7
(chi*).
We selected 10 adult male rats (weight 165-250g) , which
were divided into control group and experimental group and
were used in this studies for electron microscopic
observation. In control group. The hepatocyte contains large
amount of rough endoplasmic reticulum (RER) and smooth
endoplasmic reticulum (SER) in the central and intermediate
gera 2011

area of classic lobules. The glycogen alpha-particles mainly
accumulated in periphery area of classic lobules. The hepatic
cell possessed abundant mitochondria which was always
closely surrounded by flat cisternae of RER. After the
acupuncture experiment. The hepatical cell body and nucleus
was hypertrophy and nucleolus were predominant. Ip the
hepatocyte the number of RER, free ribosome and polysome
were increased, the end of cisternae of RER appeared dilated
and the associated ribosome were decreased. So that it was
called degranules phenomenon. Cisternaes and tubules of
SER were dilated and anastomosed one another to form the
irregular meshwork that distributed throughout in the
cytoplasma. The swelled mitochondria were with tubule
cristae which was transformed from the plate cristae. The
glycogen alpha, beta-particles filled the cytoplasma of
hepatocytes in three areas of the classic. The Golgi complex
well developed and seted near the dilated bile canaliculi
(B.C) that was with more longer microvilli projected into the
lumen. The junction complex in periphery of B.C. was not
changed. Dissess space was distended and filled numerous
microvilli which branched and anastomosed with each other
formed loose meshwork. The fat-storing cell extend the
plasmic processes. Some of which arrenged along endothelial
lining. In the cytoplasm of this cell, there were abundant
RER, free ribosome and polysome. The cisternae of RER
possessed flocculent material of low electron density. It is
appeared that the synthesis of fatstoring cell was increased. In
addition, there were a number of large lipid droplete in the
cytoplasm of this cell. The phagocytosic activity of Kupffer's
cells was predominantly increased. At last, the relationship
between the control group and the acupuncture experimental
group was discussed in this article too,
355- gera: 22555/di/el
PRESCRIPTIONS ET OBSERVATIONS DES
AFFECTATIONS HEPATIQUES. MINGWU ZHANG ET
AL. in methode therapeutique par qi gong chinois,edition
scientifique du shandong,jinan. 1987;:254-56 (fra).
356- gera: 23296/di/ra
ULTRASTRUCTURAL OBSERVATION AND
GLUCOSE-6-PHOSPHATASE DETERMINATION ON
THE REPAIR OF RAT EXPERIMENTAL HEPATIC
LESION BY QING KAI *. DEWEN W ET AL. journal of
traditional chinese medicine. 1987;7(1):46-52 (eng).
357- gera: 23492/di/ra
HUANG DAN : JAUNISSE. APPROCHE CHINOISE
DES ICTERES. AUTEROCHE B ET AL. actes du iième
congres d'acupuncture afera, nimes. 1987;:31-78 (fra).
La maladie Huang Dan se caractérise par une coloration
jaune des conjonctivites, de la peau et des urines. Elle
correspond en Occident aux hépatites et aux ictères. Les
divers aspects de la maladie Huang Dan se retrouvent à
travers les théories de la médecine chinoise, démontrant ainsi
l'unité et la cohérence de cette dernière. Après un rappel
historique, la symptômatologie est étudiée, d'abord en suivant
la division Yin Yang, puis d'une manière plus élaborée en se
basant sur l'étiopathogénie. La thérapeutique découle d'un
principe variant avec le cadre clinique théorique envisagé. Le
traitement fait appel à une ou plusieurs associations de points,
le choix des points est toujours justifié soit par les lois de
l'acupuncture, soit par la fonction des points retenus. Afin
d'appréhender les similitudes entre la fonction des points et
l'action des composants médicamenteux, un traitement par
pharmacopée mentionnant la justification de la prescription
choisie a été décrit pour chaque cadre clinique théorique. En
fonction des dominantes sémiologiques, une adaptation du
traitement a été explicitée pour
19
358- gera: 24059/di/ra
A STUDY ON THE EFFECT OF EXTRACTUM
SEMEN PERSICAE (ESP) IN RESISTING CIRRHOSIS.
WANG YURUN. international conference on tcm and
pharmacology,shanghai. 1987;:10-3 (eng).
359- gera: 24145/di/ra
TREATMENT OF SIX KINDS OF EMERGENCY AND
HYPERLIPIDEMIA SOLELY WITH ALCOHOL
EXTRACT OF RHUBARB. JIAO DONGHAI ET AL.
international conference on tcm and
pharmacology,shanghai. 1987;:248-9 (eng).
360- gera: 24148/di/ra
CLINICAL AND PATHOLOGICAL OBSERVATIONS
ON THE TREATMENT OF CHRONIC ACTIVE
HEPATITIS B WITH EFFICACIOUS EXTRACT FOR
LIVER*. SHI YOUXING ET AL. international conference
on tcm and pharmacology,shanghai. 1987;:254-5 (eng).
361- gera: 24149/di/ra
MOISTENING LIVER AND SUPPORTING KIDNEY
RECIPE N°3 IN THE TREATMENT OF CHRONIC
ACTIVE HEPATITIS. ZHANG JUNFU ET AL.
international conference on tcm and
pharmacology,shanghai. 1987;:256-7 (eng).
362- gera: 24154/di/ra
BIOCHEMICAL AND ELECTRONMICROSCOPIC
STUDIES IN THE EFFECTS OF SAENGGANGONBI-
TANG ON METABOLISM AND REGENERATIVE
FUNCTION OF LIVER. BYUNG WOON KIM.
international conference on tcm and
pharmacology,shanghai. 1987;:267-9 (eng).
363- gera: 24155/di/ra
STUDIES IN THE EFFECTS OF SAENG KAN TANG
ON LIVER PROTECTION, PLATELET
AGGREGATION AND GENERAL IMMUNE
FUNCTION. SEO YOUNG CHOI. international
conference on tcm and pharmacology,shanghai.
1987;:270-2 (eng).
364- gera: 24156/di/ra
PRELIMINARY OBSERVATION OF THE CURATIVE
EFFECT OF SUPPORTING AND INVIGORATING
YANG AND DETOXIFYING THERAPY ON HBV
INFECTION INDEX. CHEN LIHUA. international
conference on tcm and pharmacology,shanghai.
1987;:273-5 (eng).
365- gera: 24157/di/ra
EFFECTS OF TRADITIONAL CHINESE MEDICINAL
PLANTS ON CHRONIC HEPATITIS AND
HYPERLIPIDEMIA. YAMAMOTO M. international
conference on tcm and pharmacology,shanghai.
1987;:276-7 (eng).
366- gera: 24158/di/ra
TREATMENT OF ASCITES CAUSED BY POST-
HEPATITIS CIRRHOSIS ACCORDING TO
DIFFERENTIATION OF PATTERN OF IMBALANCE.
ZHU BINGBING ET AL. international conference on tcm
and pharmacology,shanghai. 1987;:278-80 (eng).
367- gera: 24159/di/ra
SUBLINGUAL VEINS AND HEPATIC FIBROSIS. YU
GUANGSHEN ET AL. international conference on tcm
and pharmacology,shanghai. 1987;:281-3 (eng).
gera 2011

368- gera: 24160/di/ra
TCM PATHOGENIC MECHANISM AND
THERAPEUTIC PRINCIPLES OF
HEPATOCIRRHOSIS. HAN JINGHUAN. international
conference on tcm and pharmacology,shanghai.
1987;:284-5 (eng).
369- gera: 24161/di/ra
EFFECT OF "BO GAN INJECTION" ON THE LIVER
OF MICE GIVEN PARENTERAL
HYDROCORTISONE. XU MING. international
conference on tcm and pharmacology,shanghai.
1987;:286-7 (eng).
370- gera: 24162/di/ra
PEACH KERNEL PURGATIVE, DECOCTION FOR
TREATING HEPATIC PORPHYRIA. YOU KAIHONG
ET AL. international conference on tcm and
pharmacology,shanghai. 1987;:288-9 (eng).
371- gera: 24244/di/ra
SPLEEN-STENGTHENING AND QI-REGULATING
PRINCIPLE IN TREATING PRIMARY LIVER
CANCER. YU ERXIN ET AL. international conference
on tcm and pharmacology,shanghai. 1987;:441-2 (eng).
372- gera: 24245/di/ra
TREATMENT OF PRIMARY HEPATIC CANCER OF
THE II AND III STAGES WITH CHINESE
MEDICINAL HERBS. PAN MINQUI ET AL.
international conference on tcm and
pharmacology,shanghai. 1987;:443-4 (eng).
373- gera: 24246/di/ra
TREATMENT OF PRIMARY HEPATIC CARCINOMA
WITH TCM. LEI YOUNZHONG ET AL. international
conference on tcm and pharmacology,shanghai.
1987;:445-6 (eng).
374- gera: 24431/di/ra
EFFECT OF RADIX POLYGONI MULTIFLORI ON
(CH3 - 3H) THIMIDINE (5-3H))-URACIL3, 3H-
LEUCINE INCORPORATING INTO CULTURED
LIVER CELL IN *. XU CUIHUA ET AL. international
conference on tcm and pharmacology,shanghai.
1987;:872-3 (eng).
375- gera: 24452/di/ra
EFFECT OF CHINESE MEDICINE ON HISTOLOGY
AND HISTOCHEMISTRY OF LIVER IN
HYDROCORTISONE MICE MODELS. SHI YUHUA ET
AL. international conference on tcm and
pharmacology,shanghai. 1987;:914-6 (eng).
376- gera: 24478/di/ra
[ON CHRONIC DYSFUNCTION OF THE LIVER].
SINGERU HORI. journal of the japan society of
acupuncture. 1987;37(4):259 (jap*).
377- gera: 24595/di/ra
EFFECT OF PSORALEA CORYLIFOLIA INJECTION
ON HISTOLOGY AND HISTOCHEMISTRY OF
LIVER IN HYDROCORTISONE MICE MODELS. MA
ZHENLI ET AL. international conference on tcm and
pharmacology,shanghai. 1987;:973-5 (eng).
378- gera: 24610/di/ra
EFFECTS OF "EXTERNAL QI" OF QIGONG ON
HUMAN LIVER CANCER CELLS (BEL-7402). CHEN
YUANFENG ET AL. international conference on tcm and
20
pharmacology,shanghai. 1987;:1010-1 (eng).
379- gera: 24651/di/ra
CLINICAL OBSERVATION AND RESEARCH OF
MECHANISM OF TREATING CHRONIC ACTIVE
HEPATITIS BY ACUPUNCTURE POINT
IRRADIATION WITH NEAR *. QIAN CUNZE ET AL.
international conference on tcm and
pharmacology,shanghai. 1987;:1107-8 (eng).
380- gera: 24654/di/ra
THE APPLICATION OF B ULTRASONICS IN TCM
CLINIC. WANG XIMING. international conference on
tcm and pharmacology,shanghai. 1987;:1114-5 (eng).
381- gera: 24769/di/el
PAIN IN HYPOCHONDRIAC REGION. CHENG
XINNONG. in chinese acupuncture and moxibustion,
foreign languages press, *. 1987;:435 (eng).
382- gera: 30037/di/ra
[RESEARCH ON HYSTOCHEMISTRY AND
BIOCHEMISTRY OF THE LIVER OF RAT WITH
HEMOLYTIC ANEMIA BY THE ADMINISTRATION
OF STEROID *]. ZHANG YING ET AL. acta medica
sinica. 1987;2(4):25-92 (chi).
383- gera: 30040/di/ra
[TREATMENT IN TCM OF NEPHRITIS RELATED
TO HEPATITIS B]. LUO GUOJUN. acta medica sinica.
1987;2(4):35-7 (chi).
384- gera: 30051/di/ra
[EXPERIMENTAL STUDY OF THE EFFECT OF THE
STEROID GLYCOSID IN CYNANCHUM BUNGEI
DECNE ON THE OXYGEN METABOLISM OF THE
HEART AND LIVER]. ZHANG XIAORONG ET AL. acta
medica sinica. 1987;2(5):23-24 (chi).
385- gera: 30134/di/ra
[THERAPEUTIC EXPERIENCE OF CTM FOR
CHRONIC HEPATITIS BY STAGES]. WANG XU-
ZHAI. beijing journal of traditional chinese medicine.
1987;(1):5-7 (chi).
386- gera: 30142/di/ra
[HERB TREATMENT FOR CIRRHOSIS OF LIVER
WITH ASCITES AND REVERSED A/G RATIO : AN
ANALYSIS OF 40 CASES]. HAN QI-XUN. beijing
journal of traditional chinese medicine. 1987;(1):29-30
(chi).
387- gera: 30184/di/ra
[COMPARATIVE THERAPEUTIC EFFICACY OF
CHINESE TRADITIONAL LIVER COMPOSITUS,
RADIOTHERAPY, AND CHEMOTHERAPY FOR 112
CASES OF MODERA*]. LI YUEHENG. beijing journal
of traditional chinese medicine. 1987;(3):36-38 (chi).
388- gera: 30190/di/ra
[AN EXPERIENCE ON THERAPY OF LIVER
DISEASES]. QU PUQUAN. beijing journal of traditional
chinese medicine. 1987;(4):4-5 (chi).
389- gera: 30197/di/ra
[A PRIVATE OPINION ON DIFFERENTIAL
TREATMENT FOR HEPATITIS B]. XIE ZHENQIANG.
beijing journal of traditional chinese medicine.
1987;(4):21 (chi).
gera 2011

390- gera: 30334/di/ra
[THERAPEUTIC EFFECT OF ACUTE ICTERIC
HEPATITIS TREATED BY GRANULE
PREPARARION OF FRUCTUS CHAENOMELIS].
ZHENG ZHIMING ET AL. fujian journal of traditional
chinese medicine. 1987;18(2):24-8 (chi).
391- gera: 30342/di/ra
[SYMPTOM AND TREATMENT OF 40 CASES OF
CHRONIC HEPATITIS]. WU SHUZHONG. fujian
journal of traditional chinese medicine. 1987;18(3):13-5
(chi).
392- gera: 30343/di/ra
[DOUBLE-BLIND TEST ON CHRONIC HEPATITIS
TREATED WITH POLYSACCHARIDE INJECTION
OF XIANGGU MUSHROOM]. WU BICHENG ET AL.
fujian journal of traditional chinese medicine.
1987;18(3):16-8 (chi*).
393- gera: 30367/di/ra
[100 CASES OF ASCITES OF LIVER CIRRHOSIS
TRETED BY COMBINATION OF TCM AND WM].
ZHUANG JINFU. fujian journal of traditional chinese
medicine. 1987;18(6):25-6 (chi).
394- gera: 30369/di/ra
[AN ADVANCED CASES OF LIVER CANCER
TREATED BY SLOW ATTEMPT TO NOURISH YIN].
YAN WANGGUI. fujian journal of traditional chinese
medicine. 1987;18(6):33-44 (chi).
395- gera: 30454/di/ra
[PREVENTIVE AND CURATIVE EFFECT OF "GAN
FU KANG" ON EXPERIMENTAL
HEPATOCIRRHOSIS IN RATS]. GUO XIANGYUN ET
AL. henan traditional chinese medicine. 1987;7(2):28--32
(chi).
396- gera: 30675/di/ra
[EFFECT OF NANTONG ANTI-VENIN DRUG ON
IMMUNOLOGICAL INDICES OF CHRONIC ACTIVE
HEPATITIS B PATHOGEN]. XU JIQUN ET AL. journal
of traditional chinese medicine. 1987;28(2):32-5 (eng).
397- gera: 30689/di/ra
[TREATMENT OF CHRONIC HEPATITIS B BY
APPLYING DIFFERENT PRINCIPLES ACCORDING
TO THEIR TYPES]. CHEN ZENGTAN ET AL. journal of
traditional chinese medicine. 1987;28(4):23-5 (eng).
398- gera: 30708/di/ra
[35 CASES OF PORPHYRIA HEPATICA TREATED
WITH TAOHECHENGQI DECOCTION]. YOU
KAIHONG. journal of traditional chinese medicine.
1987;28(5):36-7 (eng).
399- gera: 30722/di/ra
[CLINICAL OBSERVATION ON TREATMENT OF
SEVERE JAUNDICE OF CHRONIC ACTIVE
HEPATITIS WITH COOLING-AND ACTIVATING
BLOOD RECIPE]. WANG CHENGBO ET AL. journal of
traditional chinese medicine. 1987;28(6):38-40 (eng).
400- gera: 30723/di/ra
[100 CASES OF CHRONIC HEPATITIS B TREATED
BY REINFORCING YANG AND REMOVING
OBSTRUCTION IN THE FLOW OF VITAL ENERGY].
CHEN LIHUA ET AL. journal of traditional chinese
medicine. 1987;28(6):41-3 (eng).
21
401- gera: 30738/di/ra
[CLINICAL STUDY AND MECHANISM ON
TREATMENT OF PRIMARY LIVER CANCER BY
INVIGORATING SPLEEN AND REGULATING QI].
YU ERXIN ET AL. journal of traditional chinese
medicine. 1987;28(7):28-30 (eng).
402- gera: 30793/di/ra
[DETERMINATION OF TRACE ELEMENTS IN
MEDICINAL HERBS FOR TREATING CHRONIC
HEPATOPATHY]. WANG GUANTING ET AL. journal
of traditional chinese medicine. 1987;28(12):22-6 (eng).
403- gera: 30838/di/ra
[OBSERVATION ON CURATIVE EFFECTS OF
CHRONIC B-TYPE HEPATITIS TREATED BY "YI
GAN TANG"]. LUO GUO JUN. journal of traditional
chinese medicine. 1987;3(4):17. (eng).
404- gera: 30862/di/ra
[CLINICAL OBSERVATION ON EFFECTS OF 120
CASES B-TYPE HEPATITIS TREATED WITH"YI
XING HE JI"]. KANG LIANG-SHI ET AL. journal of
traditional chinese medicine. 1987;3(6):16-7 (eng).
405- gera: 30938/di/ra
[TREATING BLOOD STAGNANCY TYPE OF
HEPATITIS BY ACTIVITING BLOOD AND
DISSOLVING STAGNANCY]. GONG WEIXING.
shandong journal of traditional chinese medicine.
1987;3:40 (chi).
406- gera: 31117/di/ra
[EXPERIENCE IN TREATMENT OF THE SERIOUS
HEPATITIS BY TCM]. ZHANG RONGBI. journal of
zhejiang tcm college. 1987;5(11):16 (chi).
407- gera: 31120/di/ra
[206 CASES OF TYPE B-HEPATITIS WITH
CONTINUED POSTIVE OF HBsAG TREATED BY "YI
GAN TANG"]. YE XINMIAO. journal of zhejiang tcm
college. 1987;5(11):31 (chi).
408- gera: 31228/di/ra
[TREATMENT OF 342 CASES OF INFANTILE
HEPATITIS SYNDROME WITH MIXTURE OF
ARTEMISIA CAPILLARIS]. TANG XIHUA. shanghai
journal of tcm. 1987;3:27 (chi).
409- gera: 31233/di/ra
[A TRIAL DISCUSSION ON ETIOLOGY AND
MECHANISM OF CHRONIC HEPATITIS. AN
ANALYSIS OF 257 CASES]. GU HUIMIN. shanghai
journal of tcm. 1987;4:2 (chi).
410- gera: 31234/di/ra
["370 COMPOUND" FOR TREATMENT OF 100
CASES OF VIRAL HEPATITIS]. WANG XIANGLIN.
shanghai journal of tcm. 1987;4:5 (chi).
411- gera: 31288/di/ra
[PRELIMINARY OBSERVATION ON CLINICAL
EFFECT OF ASSISTING YANG, REMOVING
OBSTRUCTION OF YANG AND DETOXICATION
METHOD UPON ANTI-HBV*]. CHEN LIHUA ET AL.
shanghai journal of tcm. 1987;7:2 (chi).
412- gera: 31364/di/ra
[SUMMARY ON EFFECTS OF LIVER FUNCTION
gera 2011

RESTORING CAPSULES FOR 58 CASES OF
CHRONIC HEPATITIS-B]. ZHANG WUYI. shanghai
journal of tcm. 1987;11:26 (chi).
413- gera: 31654/di/ra
[CLINICAL RESEARCH OF HEPATITIS B]. ZHI
JUNHON ET AL. shaanxi journal of tcm. 1987;8(5):193
(chi).
414- gera: 31655/di/ra
[BI YUN SHA YI GAN LING FOR HEPATITIS B].
YANG ZHEN ET AL. shaanxi journal of tcm.
1987;8(5):204 (chi).
415- gera: 31656/di/ra
[JUE CHUANG DECOCTION FOR CHRONIC
ACTIVE HEPATITIS]. YU KEYONG. shaanxi journal of
tcm. 1987;8(5):205 (chi).
416- gera: 31657/di/ra
[DIFFERENTIATION OF SYMPTOMS AND SIGNS IN
TREATING HEPATOCIRRHOSIS WITH ASCITES].
CHEN NINGSHENG ET AL. shaanxi journal of tcm.
1987;8(5):207 (chi).
417- gera: 31658/di/ra
[DIFFERENTIATION OF SYMPTOMS AND SIGNS IN
TREATING CHRONIC HEPATITIS AND
HEPATOCIRRHOSIS]. LIU YICHUN. shaanxi journal of
tcm. 1987;8(5):209 (chi).
418- gera: 31659/di/ra
[CLINICAL OBSERVATION ON
HEPATOCIRRHOSIS WITH ASCITES TREATED BY
TCM]. ZHANG MINGCHANG ET AL. shaanxi journal of
tcm. 1987;8(5):210 (chi).
419- gera: 31660/di/ra
[ICTERIC HEPATITIS TREATED BY CLEARING UP
AND REMOVING HEATTOXIC]. TONG YINGJIE.
shaanxi journal of tcm. 1987;8(5):212 (chi).
420- gera: 31661/di/ra
[YIN CHEN CHI HU DECOCTION FOR ICTERIC
HEPATITIS IN CHILDREN]. WANG XIZHOU. shaanxi
journal of tcm. 1987;8(5):214 (chi).
421- gera: 31662/di/ra
[YIE JINWEN'S EXPEREINCE WITH HEPATITIS].
ZHOU HUIDING. shaanxi journal of tcm. 1987;8(5):217
(chi).
422- gera: 31664/di/ra
[FULMINANT JAUNDICE HEALED]. GAO
ZHONGSHAN ET AL. shaanxi journal of tcm.
1987;8(5):223 (chi).
423- gera: 31665/di/ra
[RECENT DEVELOPMENTS OF RESEARCH OF
CHINESE MATERIA MEDICA FOR VIRUS
HEPATITIS]. LU LANXUN. shaanxi journal of tcm.
1987;8(5):228 (chi).
424- gera: 31666/di/ra
[SEROLOGICAL SIGNS OF HEPATITIS B AND
DIFFERENTIATION OF SYMPTOMS AND SIGNS OF
TCM]. WEI BEIHAI ET AL. shaanxi journal of tcm.
1987;8(5):234 (chi).
425- gera: 31667/di/ra
22
[PATHOLOGICAL RESEARCH OF COMMON
SYNDROMES OF CHRONIC HEPATITIS]. QIAO
FUQU. shaanxi journal of tcm. 1987;8(5):236 (chi).
426- gera: 31752/di/ra
[MI BORANG'S EXPERIENCE WITH DISEASES OF
THE LIVER]. MI LIEHAN. shaanxi journal of tcm.
1987;8(12):529 (chi).
427- gera: 31756/di/ra
[DIFFERENTIATION OF SYNDROMES AND THE
TREATMENT FOR CHRONIC HEPATITIS]. LI
JIABIN. shaanxi journal of tcm. 1987;8(12):538 (chi).
428- gera: 31757/di/ra
[ACUTE ICTERIC HEPATITIS TREATED BY HUANG
QI FU GAN DECOCTION]. WANG XINXIANG. shaanxi
journal of tcm. 1987;8(12):539 (chi).
429- gera: 31947/di/ra
[CLINICAL SUMMARY ON 32 CASES OF HEPATIC
CARCINOMA TREATED WITH TRADITIONAL
CHINESE MEDICINE]. QIAN BOWEN. liaoning journal
of tcm. 1987;11(4):13 (chi).
430- gera: 31956/di/ra
[CLINICAL OBSERVATION ON THE THOUGHT OF
COSMETOLOGY IN (VIRUS B HEPATITIS) WITH
POSITIVE HBS AG WITH "HUSHE TANG"
DECOCTION]. ZHANG XIAOPING. liaoning journal of
tcm. 1987;11(5):15 (chi).
431- gera: 31978/di/ra
[PRELIMINARY OBSERVATION ON THE
RELATION BETWEEN THE CONCENTRATION OFF
IBRONECTIN AND THE DEFICIENCY SYNDROME
IN HEPATIC CIRRHOSIS*. LIU CHENG. liaoning
journal of tcm. 1987;11(7):23 (chi).
432- gera: 32087/di/ra
[THE CHANGE OF NAIL WRINKLES CIRCULATION
IN ACTIVE CHRONIC HEPATITIS AND THE
THERAPEUTIC EFFECT OF DIAGNOSIS AND
TREATMENT*]. HUAN LIJUAN. fujian journal of
traditional chinese medicine. 1987;18(6):12 (chi).
433- gera: 32213/di/ra
[CLINICAL OBSERVATION ON TREATMENT OF
HEPATOCIRRHOSIS FULL OF ASCITIES WITH
XIAO ZHONG WAN YING TANG PLUS SOME
OTHERS]. LI SHU-WEN. journal of tcm and chinese
materia medica of jilin. 1987;2:13 (chi).
434- gera: 32216/di/ra
[AFFECTION OF MILK VETEH ON CULTURING
HEPATIC CELLS OUTSIDE THE BODY MIXING
WITH URACIL NUCLEOSIDE]. XU CUI-HUA ET AL.
journal of tcm and chinese materia medica of jilin.
1987;2:31 (chi).
435- gera: 32231/di/ra
[APPLICATION OF THE DRUG RHUBARB TO
SERIOUS HEPATITIS]. XUE YUN-FENG. journal of
tcm and chinese materia medica of jilin. 1987;4:11 (chi).
436- gera: 32232/di/ra
[TWO CASES OF HEPATITIS B IN CHILDREN
FOLLOWED BY MYOCARDITIS]. JING YU-ZHEN ET
AL. journal of tcm and chinese materia medica of jilin.
1987;4:15 (chi).
gera 2011

437- gera: 32456/di/ra
[VETERAN PHYSICIAN SHEN YANNAN'S
THERAPEUTIC EXPERIENCE IN NON-ICTERIC
HEPATITIS]. LIU SHAOHUI. journal of new chinese
medicine. 1987;19(3):8 (chi).
438- gera: 32526/di/ra
[EFFECTIVE THERAPY FOR LIVER DISORDER :
THREE CASES REPORT]. XU DIHUA. journal of new
chinese medicine. 1987;19(8):21 (chi).
439- gera: 32544/di/ra
[VETERAN PHYSICIAN WANG LIXUN'S
EXPERIENCE IN THE TREATMENT OF CIRRHOTIC
ASCITES]. WANG JUNYI. journal of new chinese
medicine. 1987;19(10):3 (chi).
440- gera: 32655/di/ra
[REVIEW OF THE RESEARCH ON HEPATIC
DISEASE (VIRUS HEPATITIS)]. QIAN YING. journal
of beijing tcm college. 1987;5:1 (chi).
441- gera: 32722/di/ra
[QI GONG TREATING POLYCYSTIC LIVER AND
POLYCYSTIC KIDNEY. CLINICAL OBSERVATION
OF 18 CASES]. YANG YUAN-JING ET AL. breath
exercice (an exercice for health and longevity).
1987;8(7):317 (chi).
442- gera: 32942/di/ra
[FIVE METHODS OF DIFFERENCIATION AND
TREATMENT OF BACTERIAL LIVER ABSCESS].
YAO GONG-SHU. zhejiang journal of traditional chinese
medicine. 1987;22(9):389 (chi).
443- gera: 32943/di/ra
[TREATING 100 CASES OF HEPATITIS B WITH
"QING GAN TANG"]. XU JIA-XIN. zhejiang journal of
traditional chinese medicine. 1987;22(9):390 (chi).
444- gera: 33001/di/ra
[EXPERIENCE IN TREATING HYDROPERITONEUM
OF CIRRHOSIS]. ZHANG MING-CHANG. zhejiang
journal of traditional chinese medicine. 1987;22(3):101
(chi).
445- gera: 33009/di/ra
[TREATING CHRONIC VIRAL HEPATITIS]. KE GAN.
zhejiang journal of traditional chinese medicine.
1987;22(3):124 (chi).
446- gera: 33227/di/ra
[ON TREATMENT OF ASCITES CAUSED BY
HEPATIC CIRRHOSIS IN 40 CASES OF LATE
SCHISTOSOMIASIS]. XIE ZHIFU. hubei journal of
traditional chinese medicine. 1987;6:15 (chi).
447- gera: 40549/nd/re
[INDUCTION OF HEPATIC MICROSOMAL ENZYME
IN MICE BY OXYMATRINE]. YUAN CAI ET AL.
journal of capital institute of medicine. 1987;8(1):23-6
(chi*).
Résumé Acme (870939). ACME:870939
448- gera: 41115/nd/re
[EFFECTS OF SAFFLOR YELLOW FROM
SAFFLOWER ON THE SERUM LIPIDS AND LIVER
FUNCTION OF RABBITS]. QI WEN XUAN ET AL.
journal of lanzhou medical college. 1987;3:57-60 (chi*).
23
Résumé Acme (880108). ACME:880108
449- gera: 41130/nd/re
[PROTECTIVE EFFECTS OF PROPYL GALLATE ON
ACUTE LIVER INJURY INDUCED BY ETHANOL IN
MICE AND RATS]. LU XUE YA ET AL. acta
pharmaceutica sinica. 1987;22(8):586-90 (chi*).
Résumé Acme (880123). ACME:880123
450- gera: 41210/nd/re
[TREATMENT OF EARLY HEPATOMA WITH
COMPOUND MUJI GRANULE]. HAN XUE HUA ET
AL. chinese journal of cancer. 1987;6(1):46-8 (chi*).
Résumé Acme (880203). ACME:880203
451- gera: 41213/rd/ra
[A BRIEF SUMMARY ON THE TREATMENT OF 73
CASES SHOWN POSITIVE IN HBsAG TEST]. AI
SHAO BO. jiangxi journal of traditional chinese medicine
and pharmacology. 1987;18(2):28-9 (chi*).
Résumé Acme (880206). ACME:880206
452- gera: 41279/nd/re
[EFFECT OF DANSHEN INJECTION ON HEPATIC
REGENERATION IN RATS WITH PARTIAL
HEPATECTOMY]. LI XIAO HUA ET AL. journal of
capital institute of medicine. 1987;8(4):286-90 (chi*).
Résumé Acme (880367). ACME:880367
453- gera: 41374/nd/re
[EFFECT OF TETRANDRINE ON EXPERIMENTAL
PORTAL HYPERTENSION IN PIGS]. LU XIN SHENG
ET AL. chinese journal of experimental surgery.
1987;4(3):124-25 (chi*).
Résumé Acme (880462). ACME:880462
454- gera: 41375/nd/re
[PROTECTION BY SCHISANDRA AGAINST
ACETAMINOPHEN HEPATOTOXICITY IN MICE].
LIU GENG TAO ET AL. acta pharmaceutica sinica.
1987;22(9):650-54 (chi*).
Résumé Acme (880463). ACME:880463
455- gera: 41395/nd/re
[EFFECTS OF COMPOUND BUSHEN DECOCTION
ON DRUG METABOLIZING LIVER ENZYMES].
WANG ZHEN YUE ET AL. zhongchengyao yanjiu.
1987;5:28. (chi*).
Résumé Acme (880483). ACME:880483
456- gera: 41403/nd/re
[TREATMENT OF CHRONIC HEPATITIS B WITH
WULINGDAN PILL]. YAN RONG ET AL. journal of the
fourth military medical college. 1987;8(6):380-83 (chi*).
Résumé Acme (880491). ACME:880491
457- gera: 41444/nd/re
[A BRIEF REPORT ON THE TREATMENT OF 85
HBsAg CARRIERS WITH MODIFIED QIANGGAN
DECOCTION]. LUO XIU FU. hunan zhongyizazhi.
1987;3(1):7-8 (chi*).
Résumé Acme (880532). ACME:880532
458- gera: 41485/nd/re
[TREATMENT OF 464 CASES OF HEPATITIS WITH
YANHUANGLIAN INJECTION]. LI JUN YU ET AL.
zhongchengyao yanjiu. 1987;6:19. (chi*).
Résumé Acme (880573). ACME:880573
459- gera: 41486/rd/ra
gera 2011

[TREATMENT OF 112 CASES OF PRIMARY
HEPATOMA, A COMPARISON BETWEEN HERBAL
DECOCTIONS, CHEMOTHERAPY AND
RADIOTHERAPY]. PAN MIN QIU ET AL. beijing
journal of traditional chinese medicine. 1987;3:36-8 (chi*).
460- gera: 41621/nd/re
[PROTECTIVE ACTION OF LENTINAN AGAINST
EXPERIMENTAL LIVER INJURIES]. LIN ZHI BIN ET
AL. journal of beijing medical university. 1987;19(2):93-5
(chi*).
Résumé Acme (880709). ACME:880709
461- gera: 41635/nd/re
[EFFECTS OF HYPECOUM CHINENSIS ON LIVER
FUNCTIONS]. KE JUN ET AL. journal of henan medical
university. 1987;22(3):204-06 (chi*).
Résumé Acme (880723). ACME:880723
462- gera: 41656/nd/re
[LIVER PROTECTIVE ACTION OF SWERTIA
MACROSPERMA (I). EFFECTS ON LIVER INJURY
CAUSED BY CHEMICALS]. LIU YA PING ET AL.
pharmacology and clinics of chinese materia medica.
1987;3(1):34-7 (chi*).
Résumé Acme (880744). ACME:880744
463- gera: 41664/nd/re
[EFFECTS OF INCARVILLEA ARGUTA ON
EXPERIMENTAL LIVER INJURY]. WEN ZHI JIAN ET
AL. pharmacology and clinics of chinese materia medica.
1987;3(1):38-41 (chi*).
Résumé Acme (880752). ACME:880752
464- gera: 41749/nd/re
[TREATMENT OF 47 HEPATOCARCINOMA WITH
LIANHUA TABLET]. ZHENG RU QI ET AL. guangzhou
medical journal. 1987;18(2):48-50 (chi*).
Résumé Acme (880837). ACME:880837
465- gera: 41753/nd/re
[A DOUBLE-BLIND TREATMENT OF 72 CASES OF
CHRONIC HEPATITIS WITH LENTINAN
INJECTION]. LIN YUN FANG ET AL. new drugs and
clinical remedies. 1987;6(6):362-63 (chi*).
Résumé Acme (880841). ACME:880841
466- gera: 41757/nd/re
[TREATMENT OF HBsAg CARRIERS WITH
XIAOCHAIHU DECOCTION]. LI FU SHAN ET AL.
pharmacology and clinics of chiense materia medica.
1987;3(2):42-3 (chi*).
467- gera: 41786/nd/re
[TREATMENT OF 140 CASES OF CHRONIC ACTIVE
HEPATITIS B WITH BLOOD ACTIVATING HERBS].
LIAO KONG YU ET AL. sichuanzhongyi. 1987;5(12):18-9
(chi*).
468- gera: 51289/di/ra
[OBSERVATIONS OF INHIBITORY EFFECT OF 100
CHINESE MEDICINAL HERBS ON HBsAG]. ZHENG
MINSHI ET AL. chinese traditional and herbal drugs.
1987;18(10):27-9 (chi*).
469- gera: 52120/di/ra
[THE EFFECT OF PANAXADIOL-SAPONINS FROM
GINSENG FLOWER AND LEAVES ON DNA
SYNTHESIS IN MOUSE ASCITIC RETICULOCYTIC
*]. SUN WEI ET AL. bulletin of chinese materia medica.
24
1987;12(10):45. (chi).
470- gera: 52212/di/ra
[THE PRELIMINARY STUDIES ON EFFECT OF THE
FRUIT JUICE OF ACTINIDIA CHINENSIS PLANCH
ON EXPERIMENTAL LIVER LESIONS IN *]. HUANG
ZHUO WEI ET AL. bulletin of chinese materia medica.
1987;12(3):52-4 (chi).
471- gera: 52610/di/ra
[OBSERVATIONS OF INHIBITORY EFFECT OF 100
CHINESE MEDICINAL HERBS ON HBsAG]. ZHENG
MINSHI ET AL. chinese traditional and herbal drugs.
1987;18(10):27-9 (chi).
472- gera: 52679/di/ra
[OBSERVATION ON THE EFFECT OF POLLEN ON
EXPERIMENTAL LIVER INJURY]. WANG
MAOSHAN ET AL. chinese traditional and herbal drugs.
1987;18(5):24-6 (chi).
473- gera: 52919/di/ra
[ON THE RELATION BETWEEN PATHOLOGIC
CHANGE OF LIVER AND ZHEN DIFFERENTIATION
CLASSIFICATION OF CHRONIC HEPATITIS B *].
WU CHUNRONG ET AL. hubei journal of traditional
chinese medicine. 1987;2:13-9 (chi).
474- gera: 80215/di/ra
CASE STUDY ON CURING SERUM HEPATITIS AND
ELIMINATING THE SIDE EFFECTS OF
PREDNISOLONE (III). SHIGERU ARICHI. oriental
healing arts international bulletin. 1987;12(6):314-325
(eng).
475- gera: 22912/di/ra
ULTRASTRUCTURAL STUDIES ON THE EFFECT
OF "GAN FU KANG" IN PREVENTING
EXPERIMENTAL LIVER DAMAGE IN MICE. DAN
LIANKAI ET AL. journal of traditional chinese medicine.
1988;8(2):151-4 (eng).
476- gera: 23033/di/ra
[CLINICAL AND EXPERIMENTAL RESEARCH ON
POLYPORUS UMBELLATUS POLYSACCHARIDE IN
TREATING CHRONIC VIRAL HEPATITIS]. YAN
SHUCHANG ET AL. chinese journal of integrated
traditional and western medicine. 1988;8(3):141 (chi*).
477- gera: 23034/di/ra
[CLINICAL DISAGREEMENT OF TCM DOCTORS IN
TREATING PATIENTS ACCORDING TO
SYNDROME DIFFERENTIATION FOR CHRONIC
PERSISTENT HEPATITIS]. CHEN QINGQUAN ET AL.
chinese journal of integrated traditional and western
medicine. 1988;8(3):144 (chi*).
80 cases of patients with chronic persistent hepatitis were
examined and diagnosed by two TCM doctors blindly and
separately for measuring the clinical disagreement between
observers. Same patients were examined and diagnosed twice
by each of the two doctors blindly for measuring
intraobserver agreement i. e. agreement between two exams
by the same physician on different occasions. Clinical data
including tongue and pulse conditions, and other symptoms
were assessed by scoring. Zheng (syndrome) were
categorized into Yin and Yang. Therapeutic principles were
divided into reinforcement and elimination methods. The
amount of agreement was expressed by the value of kappa
(K), the relation between Po and Pc or Po-Pc/1-Pc, where Po
was the observed proportion of agreement, and Pc was the
gera 2011

chance-expected proportion of agreement calculated with a
2X2 contingency tabla. The resets were as follows : K for
intraobserver agreement on symptoms, tongue and pulse
pictures, diagnosis and therapeutic principles were 0,80, 1.00,
0.89, 1.00, 1.00 respectively, indicating that the
°intraobserver agreement was moderately or perfectly reliable
(K > 0.60). K for interobserver agreement of pulse
examination is 0.65. K for other symptoms, diagnosis and
therapeutic principles were all less than 0.60. However, by
using U-test (significance test for K), it showed that the
agreement was also moderately reliable, but not as that for
intraobserver agreement. Therefore the conclusion is : it is
advisable to make diagnosis and treatment by two or more
than two TCM doctors.
478- gera: 23035/di/ra
[COMPARISON OF THE PATHOLOGY-IMPROVING
AND JAUNDICE-REDUCING EFFECTS OF
DIFFERENT PRESCRIPTIONS OF BLOOD-
COOLING AND CIRCULATION *]. HE JIANGPING ET
AL. chinese journal of integrated traditional and western
medicine. 1988;8(3):147 (chi*).
479- gera: 23036/di/ra
[CLINICAL OBSERVATION ON THE EFFECT OF
ARA-A WITH GLYCYRRHIZIN IN TREATING
CHRONIC ACTIVE HEPATITIS]. ZHANG
ZHENGHUA ET AL. chinese journal of integrated
traditional and western medicine. 1988;8(3):150 (chi*).
480- gera: 23037/di/ra
[ADDING SCOPOLAMINES IN TREATING 647
CASES OF SEVERE HEPATITIS]. MIAO ZHENGQIU.
chinese journal of integrated traditional and western
medicine. 1988;8(3):152 (chi*).
481- gera: 23039/di/ra
[STUDY ON REPAIRING EFFECTS OF BIPHENYL
DIMETHYL DICARBOXYLATE ON
EXPERIMENTAL LIVER INJURY IN RATS WITH
HISTOCHEMICAL AND ELECTR*]. WANG
GENGXIN ET AL. chinese journal of integrated
traditional and western medicine. 1988;8(3):158 (chi*).
482- gera: 23040/di/ra
[STUDIES ON COLLAGEN FIBERS OF LIVER
REABSORPTIVE ACTION OF SALVIA
MILTIORRHIZA ON EXPERIMENTAL CIRRHOSIS].
MA SUEHUI ET AL. chinese journal of integrated
traditional and western medicine. 1988;8(3):161 (chi*).
483- gera: 23084/di/ra
[PRELIMINARY CLINICAL AND EXPERIMENTAL
OBSERVATION ON ASYMPTOMATIC CARRIERS
OF ANTI- HEPATITIS B SURFACE ANTIGEN]. TAO
MINGZHONG ET AL. chinese acupuncture and
moxibustion. 1988;8(1):28 (chi*).
This paper deals with the observation of asymptomatic
HBsAg carrier (ASC) 62 cases. There are 32 cases in
acupuncture and moxibustion group (AMG), points selected
Zusanli, Dazhui and Qihai, treat 3 times weekly and 3 months
made a course. Another 30 cases in control group (CG),
Method : P.0. Xiang yuen tablet, 3~5 tablets each time, 2
times daily and 3 months made a course. The recent effective
rate of AMG was 70% and CG was 30%. HBsAg change into
negative rate of AMG was 25% and CG was 3.33% HBeAg.
HBV-DNA change into negative rate and HBeAb change into
positive rate of AMG all was higher Than CG. It shows
acupuncture and moxibustion can improve serum indication.
Before and after treatment 62 cases were made with skin-
25
slow reacting sentizing test, result shows before treatment
most of carriers' cell immunity function were low. After
treatment patients 59.09% in AMG id 50.0% in CG from
negative or subpositive change into positive. It shows
acupuncture and
484- gera: 23279/di/ra
[ANALYSIS OF CURATIVE EFFECT OF
SHUGANHUOXUE DECOCTION IN 84 CASES OF
CHRONIC VIRAL HEPATOSIS]. SHIYI L ET AL. acta
medica sinica. 1988;3(2):39-40 (chi).
485- gera: 23600/di/ra
[THE STUDY ON THE ACTION AND MECHANISM
OF EAR-PRESSURE THERAPY FOR
STRENGTHENING THE CONTRACTION OF
GALLBLADDER AND EVACUATING*]. WANG
HONGYE ET AL. chinese acupuncture and moxibustion.
1988;8(4):35-7 (chi*).
Under the B-type ultrasonic image apparatus, the authors
performed ear-pressure therapy to observe the change of
gallbladder. It was found that the ear-pressure can enable the
gallbladder remarkably to contract, make the hyperplastic
gallbladder wall thinner and the tunica intima even, change
the arrangement of stones and promote the diseased
gallbladder to restore to normal. Therefore, this therapy is
beneficial to cholecystitis for antiinflammation, analgesia, the
evacuation of stones, and preventing the formation of stones.
486- gera: 23838/di/ra
TREATMENT OF HEPATIC ABSCESSES
SUPPLEMENTED BY T.C.M. A COMPARATIVE
OBSERVATION OF THERAPEUTIC EFFECTS ON 64
PATIENTS. ZENG QINGHUA. journal of traditional
chinese medicine. 1988;8(3):187-9 (eng).
487- gera: 23858/di/ra
[INVESTIGATION ON EFFECT OF QIFEN DRUGS
ON ENERGY CHARGE IN RAT LIVER CELLS].
ZHANG JIAJUN ET AL. chinese journal of integrated
traditional and western medicine. 1988;8(8):475-7 (chi*).
488- gera: 23865/di/ra
[EXPLORATION ON RELATIONSHIP BETWEEN
PULSE, TONGUE PICTURE AND BIOCHEMICAL,
IMMUNOLOGICAL CHANGES OF PRIMARY
HEPATIC CARCINOMA]. TAO XIAOCHEN ET AL.
chinese journal of integrated traditional and western
medicine. 1988;8(7):405-7 (chi*).
489- gera: 23867/di/ra
[A COMPARATIVE STUDY OF THERAPEUTIC
EFFECT BETWEEN WM AND TCM-WM OF 517
CASES OF LIVER CIRRHOSIS]. GU WEIXIU ET AL.
chinese journal of integrated traditional and western
medicine. 1988;8(7):407-10 (chi*).
490- gera: 23869/di/ra
[MORPHOLOGICAL STUDY OF CCI-INDUCED
LIVER NECROSIS OF RATS AND ITS TREATMENT
WITH "HEPATITIS NO.III" DECOCTION]. SHU
ZHIJUN ET AL. chinese journal of integrated traditional
and western medicine. 1988;8(7):414-6 (chi*).
491- gera: 25328/di/ra
[PROTECTIVE EFFECT OF DAHUANG ZHECHONG
PILL ON EXPERIMENTAL HEPATIC INJURY]. QIU
PEILUN ET AL. chinese journal of integrated traditional
and western medicine. 1988;8(11):646 (chi*).
gera 2011

492- gera: 25375/di/ra
[CURATIVE EVALUATION OF ACUPUNCTURE IN
TREATMENT OF 70 CASES OF ASYMPTOMATIC
PATIENTS INFECTED BY VIRUS OF HEPATITIS B].
TAO MINGZHONG ET AL. acta medica sinica.
1988;3(6):18 (chi*).
The paper reports comparative observation of acupuncture
treatment in 70 cases of asymptomatic patients infected by
the virus of Hepatitis B (ASC). The result shows that the
curative effect in the acupuncture group is obviously higher
than that of the control group. When compared, there is quite
a disparity in the curative effect of the two groups (p<0.01),
whether in short or long periods. When the successful rate is
estimated to be 95% and 99%, reliability of the percentage of
the effective rate is higher in the acupuncture group than in
the control, the acupuncture group being above 50% and the
control below 50%. All of that shows that the curative effect
of acupuncture in the treatment of ASIC is authentic and
steady over long periods,.
493- gera: 25677/di/ra
THE PHARMACOLOGICAL AND PATHOLOGICAL
STUDIES ON SEVERAL HEPATIC PROTECTIVE
CRUDE DRUGS FROM TAIWAN. HUI-FEN CHUI ET
AL. american journal of chinese medicine. 1988;16(3-
4):127-138 (eng).
494- gera: 27753/di/ra
BUPLEURUM TREATS LIVER DISHARMONIES BY
REGULATING CELLULAR CALCIUM
METABOLISM. PACKER M ET AL. oriental healing arts
international bulletin. 1988;13(1):30-5 (eng).
495- gera: 33269/di/ra
[CLINICAL OBSERVATION OF 245 CASES OF
CHRONIC HEPATITIS B TREATED WITH
DONGWUHUA TABLETS]. WANG BAOYI ET AL. acta
medica sinica. 1988;3(4):17 (chi).
496- gera: 33272/di/ra
[OBSERVATION ON HEPATOPROTECTION
ACTION OF CYNANCHUM BUNGEI DECNE IN
RATS WITH HYPERLIPEMIA]. NIU JIANZHAO ET
AL. acta medica sinica. 1988;3(4):26 (chi).
497- gera: 33277/di/ra
[CLINICAL OBSERVATION OF 109 CASES OF
ASCITES CAUSED BY HEPATOCIRRHOSIS
TREATED WITH HUAYUSAN MIXTURE]. HUANG
HAIXIAO. acta medica sinica. 1988;3(4):39 (chi).
498- gera: 33442/di/ra
[SIDELIGHTS OF VETERAN PHYSICIAN HU
HENGFU'S EXPERIENCE IN THE TREATMENT OF
HEPATITIS]. HU YONG. journal of new chinese
medicine. 1988;20(3):9 (chi).
499- gera: 33646/di/ra
[ON THE ETIOLOGY AND PATHOLOGY OF
HEPATITIS B IN TCM]. ZHAO QINGJUN. hubei
journal of traditional chinese medicine. 1988;1:4 (chi).
500- gera: 33662/di/ra
[132 CASES OF CHRONIC PERSISTENT HEPATITIS
B TREATED BY KANG YUAN DECOCTION]. ZHONG
LEI. hubei journal of traditional chinese medicine.
1988;3:21 (chi).
501- gera: 33674/di/ra
[DR WANG ZHENGLIANG'S EXPERIENCE FOR
26
TREATING ASCITES CAUSED BY LIVER
CIRRHOSIS]. LI ZHONGNAN. hubei journal of
traditional chinese medicine. 1988;4:14 (chi).
502- gera: 33678/di/ra
[83 CASES OF LIVER CIRRHOSIS CAUSED BY
SCHISTOSOMIASIS TREATED WITH
"INVIGORATING SPLEEN AND CLEARING LIVER
DRINK"]. ZHU MINGLIE. hubei journal of traditional
chinese medicine. 1988;4:27 (chi*).
503- gera: 33679/di/ra
[CLINICAL OBSERVATION ON THE EFFECTS OF
"DANSHEN QINGGAN DRINK" FOR TREATING
ACUTE INFECTIONS ICTERIC HEPATITIS IN
CHILDREN]. PAN ZIHAN. hubei journal of traditional
chinese medicine. 1988;4:28 (chi).
504- gera: 33680/di/ra
[DICTARY THERAPY FOR PATIENTS OF VIRUS
HEPATITS]. LIN JINGHUA. hubei journal of traditional
chinese medicine. 1988;4:29 (chi).
505- gera: 33709/di/ra
[THE OBSERVATION OF 105 CASES OF VIRAL
HEPATITIS TREATED WITH CHAI PING
DECOCTION WITH ADDITION OR DELETION].
CHEN FULAI ET AL. jiangsu journal of tcm. 1988;9(1):12
(chi).
506- gera: 33718/di/ra
[CLINICAL OBSERVATIONS ON 20 CASES OF
CHRONIC ACTIVE HEPATITIS IN THE
DEFICIENCY COLD TYPE TREATED WITH "YIN
CHEN SHU FU" *]. XU QIAN ET AL. jiangsu journal of
tcm. 1988;9(2):8 (chi).
507- gera: 33738/di/ra
[RECENT PROGRESS AND PROSPECTIVE STUDY
IN THE TREATMENT OF CHRONIC HEPATITIS
WITH TCM]. WEI JUXIAN. jiangsu journal of tcm.
1988;9(3):43 (chi).
508- gera: 33765/di/ra
[TREATMENT OF 50 CASES OF CIRRHOSIS OF THE
LIVER AFTER HEPATITIS BY SUPPORTING THE
HEALTHY ENERGY TO ELIMINATE BLOOD
STASIS]. ZHAO XINMIN. jiangsu journal of tcm.
1988;9(6):4 (chi).
509- gera: 33779/di/ra
[CLINICAL OBSERVATIONS OF 136 CASES OF
CHRONIC VIRAL HEPATITIS B TREATED WITH
SOLUBLE POWDER AGAINST HEPATITIS]. HAO PO.
jiangsu journal of tcm. 1988;9(7):5 (chi*).
510- gera: 33814/di/ra
[SOME EXAMPLES OF EXPERIENCE WITH THE
TREATMENT OF CHRONIC HEPATITIS WITH
TURBIDITY TESTS POSITIVE]. PU YAOKUN. jiangsu
journal of tcm. 1988;9(10):11 (chi).
511- gera: 33837/di/ra
[CLINICAL EXPERIENCE WITH SYMPTOM-SIGN
DIFFERENTIATION AND TREATMENT OF
CIRRHOTIC LIVER WITH ASCITES]. QIAN YUSHOU
ET AL. jiangsu journal of tcm. 1988;9(12):9 (chi).
512- gera: 33842/di/ra
[AN INVESTIGATION ON THE RELATION
gera 2011

BETWEEN TYPE-DIFFERENTIATION OF CHRONIC
HEPATITIS B AND ITS BIOCHEMICAL AND
IMMUNOGICAL INDEXES]. GUI XIUXIONG. jiangsu
journal of tcm. 1988;9(12):32 (chi).
513- gera: 33857/di/ra
[UNDERSTANDING ON THE APPLICATION OF
ZHONG-JING'S THEORY B-HEPATITIS]. LIN HE-
HUO. jiangxi journal of tcm. 1988;19(2):22 (chi).
514- gera: 33858/di/ra
[OBSERVATION ON THE THERAPEUTIC
EFFECTIVESS OF "REN GAN NING" FOR
TREATMENT OF 78 CASES OF INFECTIVE
HEPATITIS (JAUNDICE) *]. SHI WEN-FENG. jiangxi
journal of tcm. 1988;19(2):25 (chi).
515- gera: 33874/di/ra
[ADVANCE ON THE TREATMENT OF SERIOUS
HEPATITIS BY TCM]. HUANG CUN-YUAN. jiangxi
journal of tcm. 1988;19(4):58 (chi).
516- gera: 34517/di/ra
[YIN CHEN HUANG QI DECOCTION FOR VIRAL
HEPATITIS]. ZENGJIE Z. shaanxi traditional chinese
medicine. 1988;9(12):538. (chi).
517- gera: 34518/di/ra
[INVIGORATE THE KIDNEY FOR CHRONIC
HEPATITIS]. SHENGLI Z. shaanxi traditional chinese
medicine. 1988;9(12):539-540 (chi).
518- gera: 41599/nd/re
[CONSTITUENTS OF FORSYTHIA SUSPENSA
ACTIVE FOR EXPERIMENTAL LIVER INJURIES].
LIU ZHENG GUANG ET AL. journal of shanxi medical
college. 1988;19(1):18-20 (chi*).
Résumé Acme (880687). ACME:880687
519- gera: 41709/nd/re
[PRELIMINARY OBSERVATIONS ON THE EFFECTS
OF PATRINIA SCABRA ON THE GROWTH OF
ASCITIC S-180 IN MICE]. WANG YIN TANG ET AL.
journal of lanzhou medical college. 1988;1:11-4 (chi*).
Résumé Acme (880797). ACME:880797
520- gera: 41805/nd/re
[TREATMENT OF ADVANCED
HEPATOCARCINOMA BY INTRAHEPATIC
INJECTION OF COMPOUND CHINESE HERBAL
DRUGS]. ZHANG LI BIN ET AL. guizhou medical
journal. 1988;12(2):69-70 (chi*).
521- gera: 41979/di/ra
[MORPHOLOGICAL STUDY ON THE EFFECT OF
GANYAN NO. 3 ON CCl4. INDUCED LIVER INJURY
IN RATS]. SHU ZHI JUN ET AL. chinese journal of
integrated traditional and western medicine.
1988;8(7):416-18 (chi*).
522- gera: 41988/rd/ra
[EFFECTS OF GINSENG ON INCORPORATION OF (7
3H). CHOLESTEROL INTO CULTURED
HEPATOCYTES]. XU CUI HUA ET AL. shanxi medical
journal. 1988;17(3):148-49 (chi*).
523- gera: 42006/nd/re
[TREATMENT OF 84 CASES OF ACUTE ICTERIC
HEPATITIS WITH DANSHAO HUSHEN
DECOCTION]. QIU SU LAN ET AL. sichuanzhongyi.
27
1988;6(7):21. (chi*).
524- gera: 42012/nd/re
[TREATMENT OF CHRONIC VIRAL HEPATITIS IN
CHILDREN WITH COMPOUND DANSHEN
INJECTION]. WANG YI LI ET AL. guangdong medical
journal. 1988;9(2):31-3 (chi*).
525- gera: 42013/nd/re
[TREATMENT OF 25 CASES OF CHRONIC ACTIVE
HEPATITIS WITH WENSHEN HUOXUE JIEDU
DECOCTION]. LI DI XIN. sichuanzhongyi. 1988;6(7):19.
(chi*).
526- gera: 42054/nd/re
[DETERMINATION OF TRACE ELEMENTS IN 100
CHINESE CRUDE DRUGS COMMONLY
PRESCRIBED FOR HEPATITIS]. CHEN GUO LIN ET
AL. trace elements. 1988;2:43-4 (chi*).
527- gera: 42145/nd/re
[EFFECTS OF ANEMARRHENA ASPHODELOIDES
SAPONIN ON HUMAN HEPATOCARCINOMA
MODEL IN NUDE RATS]. YE SHENG LONG ET AL.
tumor. 1988;8(5):259-60 (chi*).
528- gera: 42157/nd/re
[EFFECT OF SALVIA MILTIORRHIZA ON THE
INCORPORATION OF TRITIATED URIDINE AND
LEUCINE IN CULTURED HEPATOCYTES]. XU CUI
HUA ET AL. bulletin of chinese materia medica.
1988;13(9):557-58 (chi*).
529- gera: 42167/nd/re
[SCREENING OF 60 CHINESE HERBS FOR
HEPATITIS B VIRUS ANTAGONISTIC ACTIVITY].
ZHANG ZHENG ET AL. journal of beijing medical
university. 1988;20(3):211-13 (chi*).
530- gera: 42210/nd/re
[TREATMENT OF 114 CASES OF FULMINANT
VIRAL HEPATITIS WITH ANISODAMINE AND
OTHER DRUGS]. LIU JIAN SHENG ET AL. fujian
medical journal. 1988;10(6):1-3 (chi*).
531- gera: 48475/di/ra
[THE EXPLORATION FOR CURING CHRONIC
HEPATITIS THROUGH THE TREATMENT FOR THE
SYMPTOM OF VITAL ENERGY AND BLOOD
FLOWING DIFFICULTY]. LIU GUANG HONG.
liaoning journal of traditional chinese medicine.
1988;12(11):4 (chi).
532- gera: 48477/di/ra
[THE CLINICAL KNOWLEDGE OF TREATING THE
CHRONIC HEPATIC DISEASE BY MEANS OF
STRENGHTENING THE BODY RESISTANCE TO
DISSIPATE BLOOD]. HUANG XING KAI. liaoning
journal of traditional chinese medicine. 1988;12(11):12
(chi).
533- gera: 48490/di/ra
[THE REPORT ON TREATING HEPATITIS FOR 74
ABNORMAL CASES BY USING SELF-MADE HERB
"JIANG ZHUO XU"]. WANG MIN CHONG. liaoning
journal of traditional chinese medicine. 1988;12(12):22
(chi).
534- gera: 50212/di/ra
[YIN CHEN HUANG QI DECOCTION FOR VIRAL
gera 2011

HEPATITIS]. ZHANG ZENGJIE. shaanxi traditional
chinese medicine. 1988;9(12):538. (chi).
535- gera: 50213/di/ra
[INVIGORATE THE KIDNEY FOR CHRONIC
HEPATITIS]. ZHANG SHENGLI. shaanxi traditional
chinese medicine. 1988;9(12):539-0 (chi).
536- gera: 51120/di/ra
[STUDIES ON AN ANTI-HEPATITIS COMPONENT
FROM COTINUS COGGYGRIA SCOP]. ZHANG
ZHENGCHEN ET AL. bulletin of chinese materia medica.
1988;13(3):34. (chi*).
537- gera: 51480/di/ra
[CHANGE OF sLDH AND OF sLDH5 IN COMMON
PEONY (PAEONIA LACTIFLORA) PREVENTS
HEPATIC DAMAGE OF AFLATOXIN B1)]. HUANG
HANMING ET AL. chinese traditional and herbal drugs.
1988;19(6):23-5 (chi*).
538- gera: 51550/di/ra
[OBSERVATION ON EFFECTS IN 330 CASES OF
INFANTILE ACUTE VIRAL HEPATITIS. JIN YI.
shanghai journal of traditional chinese medicine.
1988;6:7. (chi*).
539- gera: 51613/di/ra
[XIE SHAONONG'S TREATMENT FOR HEPATIC
ANGIOMA. WANG YAOPING. shanghai journal of
traditional chinese medicine. 1988;10:10. (chi).
540- gera: 51618/di/ra
[METHOD OF QI-BENEFITING, SALIVA-
PRODUCING, YIN-NURSING THAT IS
APPROPRIATE FOR HEPATITIS A OF
CONVALESCENCE STAGE. WANG QIAOCHU.
shanghai journal of traditional chinese medicine.
1988;10:17. (chi).
541- gera: 51623/di/ra
[CLINICAL OBSERVATION ON TREATMENT OF
CHRONIC HEPATITIS B USING METHOD OF
SOFTENING LIVER, STRENGTHENING SPLEEN,
NURSING KIDNEY AND. ZHANG QING ET AL.
shanghai journal of traditional chinese medicine.
1988;10:27-9 (chi).
542- gera: 51624/di/ra
[REGIME AND CONVALESCENCE OF LIVER
DISEASE. HUANG JUN. shanghai journal of traditional
chinese medicine. 1988;10:30-7 (chi).
543- gera: 51642/di/ra
[OBSERVATION ON EFFECT OF TREATING 40
CASES OF HEPATIC CYST. YUAN MAOYUN.
shanghai journal of traditional chinese medicine.
1988;12:5. (chi*).
544- gera: 51662/di/ra
[THE SYMPTOM-SIGN DIFFERENTIATION AND
TREATMENT FOR 21 CASES OF LIVER DAMAGE
BY ANTIPSYCHOTICS. WANG YANHENG ET AL.
tianjin journal of traditional chinese medicine. 1988;1:11-
2 (chi).
545- gera: 51747/di/ra
[DR. SHEN YAN NAN TREATING CHRONIC
HEPATITIS IN EIGHT WAYS. DU TONG FANG.
zhejiang journal of traditional chinese medicine.
28
1988;23(2):61-3 (chi).
546- gera: 51757/di/ra
[ANALYSIS OF DEATH TIME IN 454 CASES OF
PRIMARY HEPATIC CANCER. WANG RONG PING.
zhejiang journal of traditional chinese medicine.
1988;23(3):126-32 (chi).
547- gera: 51775/di/ra
[TREATMENT OF ABDOMINAL TYMPANITES
WITH "ER GANG TANG". REPORT OF 33 CASES.
TAO SHOU PENG. zhejiang journal of traditional chinese
medicine. 1988;23(5):200-03 (chi).
548- gera: 51862/nd/re
[DETERMINATION OF TRACE ELEMENTS IN
DECOCTION, PILL AND CRUDE DRUG OF 12
COMMON PRESCRIPTIONS IN TREATING
HEPATITIS]. TANG QING MING ET AL. trace elements.
1988;4:53-6 (chi*).
549- gera: 51903/nd/re
[STUDIES ON ANTISHOCK ACTION OF
ANISODAMINE. EFFECT ON LIVER LYSOSOME
STABILITY]. ZHU YU ET AL. national medical journal
of china. 1988;4(5):258-61 (chi*).
550- gera: 51907/nd/re
[THE EFFECTS OF THE TAN SHI HSIAO YAO SAN
ON EXPERIMENTAL HEPATOTOXICITY IN RATS].
HSIEH MING TSUEN ET AL. journal of the taiwan
pharmaceutical association. 1988;39(4):223-33 (chi*).
551- gera: 51919/nd/re
[EFFECTS OF TIANXIAN PILL ON THE DNA
CONTENT OF ASCITIC HEPATOMA CELLS AND
HELA CELLS]. QU BAO XI ET AL. chinese journal of
clinical oncology. 1988;15(6):341-44 (chi*).
552- gera: 52960/di/ra
[DIAGNOSIS AND TREATMENT OF 22 CASES OF
SEVERE CHOLESTATIC HEPATITIS]. WANG
CHENGBO ET AL. journal of traditional chinese
medicine. 1988;29(8):27-32 (eng).
553- gera: 52974/di/ra
[TREATMENT OF ASYMPTOMATIC HEPATITIS B
VIRUS CARRIER WITH ANTI-HBV MEDICINAL
GRANULES]. DONG ZHENXIANG ET AL. journal of
traditional chinese medicine. 1988;29(9):31-4 (eng).
554- gera: 52989/di/ra
[ACUPUNCTURE TREATMENT OF
ASYMPTOMATIC HBsAG CARRIER ON THE BASIS
OF SYNDROME- DIFFERENTIATION]. TAO
MINGZHONG ET AL. journal of traditional chinese
medicine. 1988;29(10):38-41 (eng).
555- gera: 53003/di/ra
[COMPARATIVE STUDY ON CURATIVE EFFECTS
OF THREE THERAPEUTIC METHODS IN
TREATING ACUTE HEPATITIS]. LI SAIMEI. journal
of traditional chinese medicine. 1988;29(11):37-9 (eng*).
556- gera: 53005/di/ra
[COMPARATIVE STUDY ON THERAPEUTIC
EFFECT OF LI DAN MIXTURE IN TREATING
INFANTILE POSTHEPATITIC SYNDROME]. SHI
YUMIN ET AL. journal of traditional chinese medicine.
1988;29(11):41-3 (eng).
gera 2011

557- gera: 53080/di/ra
[PROFESSOR ZHU GUTING'S EXPERIENCE IN
TREATMENT OF LIVER-COMPLAINT]. ZHANG GE.
journal of zhejiang traditional chinese medical college.
1988;12(1):30-3 (chi).
558- gera: 53130/di/ra
[TREATMENT OF CHRONICAL LIVER BY MEANS
OF THE CHINESE PHARMACOLOGY CONJOINTLY
WITH THE CHEMICALS]. LIU LU MING. liaoning
journal of traditional chinese medicine. 1988;12(1):18-20
(chi).
559- gera: 53138/di/ra
[ADAPTTION ON THE TRADITIONAL CHINESE
MEDICINE ON VIRULENT HEPATITIS]. ZHAO CHIN
JIUN. liaoning journal of traditional chinese medicine.
1988;12(2):10-3 (chi).
560- gera: 53146/di/ra
[HOW A DOCTOR OF THE TRADITIONAL CHINESE
MEDICINE WANG XUE YI, BY EIGHT KINDS OF
DIFFERENT METHODS, CURED HEPATIC *].
HOSPITAL OF THE CHINESE TRADITIONAL MEDI.
liaoning journal of traditional chinese medicine.
1988;12(3):14-5 (chi).
561- gera: 53226/di/ra
[THE EXPLORATION FOR CURING CHRONIC
HEPATITIS THROUGH THE TREATMENT FOR THE
SYMPTOM OF VITAL ENERGY AND BLOOD
FLOWING*]. LIU GUANG HONG. liaoning journal of
traditional chinese medicine. 1988;12(11):4-6 (chi).
562- gera: 53228/di/ra
[THE CLINICAL KNOWLEDGE OF TREATING THE
CHRONIC HEPATIC DISEASE BY MEANS OF
STRENGTHENING THE BODY RESISTANCE TO *].
HUANG XING KAI. liaoning journal of traditional
chinese medicine. 1988;12(11):12-3 (chi).
563- gera: 53241/di/ra
[THE REPORT ON TREATING HEPATITIS FOR 74
ABNORMAL CASES BY USING SELF-MADE HERB"
JIANG ZHUO XU"]. WANG MIN CHONG. liaoning
journal of traditional chinese medicine. 1988;12(12):22-5
(chi).
564- gera: 53301/di/ra
[COMBINATION OF TCM WITH WM FOR THE
TREATMENT OF HEPATORENAL SYNDROME].
DENG DUZHONG ET AL. shaanxi traditional chinese
medicine. 1988;9(3):103. (chi).
565- gera: 53304/di/ra
[WU DAN DECOCTION FOR CHRONIC HEPATITIS].
WANG JIAJUN. shaanxi traditional chinese medicine.
1988;9(3):106. (chi).
566- gera: 53305/di/ra
[QING GAN HE WEI DECOCTION WITH ADDITION
AND DELETION FOR ACUTE ICTERIC HEPATITIS].
SUN YUANQIN. shaanxi traditional chinese medicine.
1988;9(3):107-08 (chi).
567- gera: 53335/di/ra
[COMBINED TREATMENT OF ASCITES DUE TO
LIVER CIRRHOSIS]. LU YUNZHAO ET AL. shaanxi
traditional chinese medicine. 1988;9(2):58-9 (chi).
29
568- gera: 53368/di/ra
[ACUTE VIRAL HEPATITIS TREATED MAINLY BY
PROMOTING BLOOD]. GUO YONGLE. shaanxi
traditional chinese medicine. 1988;9(6):247. (chi).
569- gera: 53370/di/ra
[CHRONIC ACTIVE HEPATITIS B TREATED BY
REINFORCING VITAL ENERGY, PROMOTING
BLOOD CIRCULATION AND REMOVING
HEATTOXIC]. HAO PU. shaanxi traditional chinese
medicine. 1988;9(6):249-50 (chi*).
570- gera: 53375/di/ra
[ANTIGEN OF CHRONIC CARRIER BECOMING
NEGATIVE THROUGH STRENGTHENING
RESISTANCE AND DISPELLING PATHOGENIC
FACTORS]. WANG XINYAO. shaanxi traditional
chinese medicine. 1988;9(6):263-64 (chi).
571- gera: 53399/di/ra
[REGULATING QI AND ACTIVATING BLOOD FOR
ASCITES CAUSED BY HEPATOCIRRHOSIS]. YANG
SHANDONG. shaanxi traditional chinese medicine.
1988;9(8):345-48 (chi).
572- gera: 53408/di/ra
[BRIEF INTRODUCTION OF ZHANG XICHUN'S
EXPERIENCE IN APPLYING THE DRUGS FOR
LIVER DISEASES]. LIANG FENGMING. shaanxi
traditional chinese medicine. 1988;9(8):375. (chi).
573- gera: 53430/di/ra
[CHRONIC ACTIVE HEPATITIS OF BLOOD STASIS
TYPE TREATED BY HUA GAN DECOCTION]. YIN
YICAI ET AL. shaanxi traditional chinese medicine.
1988;9(10):438. (chi).
574- gera: 53431/di/ra
[ZHI SHU HE WEI DECOCTION FOR CHRONIC
GASTRITIS]. BAI YANLONG. shaanxi traditional
chinese medicine. 1988;9(10):439-40 (chi).
575- gera: 53432/di/ra
[ACUTE EPIGASTRIC PAIN TREATED BY SI NI
POWDER WITH ADDITIONS AND DELETIONS]. HE
LIXUAN. shaanxi traditional chinese medicine.
1988;9(10):441. (chi).
576- gera: 53456/di/ra
[THEORY AND CLINIC OF TREATMENT AND
DIFFERENTIATION OF HEPATITIS]. CHEN LIHUA.
shandong journal of traditional chinese medicine.
1988;1:8-12 (chi).
577- gera: 53495/di/ra
[ACTIVITING BLOOD AND NOURISHING LIVER
TANG FOR CHRONIC HEPATITIS B-61 CASES].
CHAI JICAI ET AL. shandong journal of traditional
chinese medicine. 1988;5:12-27 (chi).
578- gera: 53517/di/ra
[BRIEF CLINICAL SUMMARY OF 262 CASES OF
ACUTE CHILDREN HEPATITIS TREATED WITH
"BAN LAN GEN JIE DU TANG"]. JIANG SEN. shanxi
journal of traditional chinese medicine. 1988;4(1):22-44
(chi).
579- gera: 53570/di/ra
[CLINICAL STUDY ON MOXIBUSTION FOR
gera 2011

TREATMENT OF CHRONIC VIRAL HEPATITIS B].
XIA WEI JIANG ET AL. shanghai journal of acupuncture
and moxibustion. 1988;1:3-5 (chi).
580- gera: 53602/di/ra
[ANALYSIS ON CURATIVE EFFECTS OF 32 CASES
OF HEPATITIS DUE TO STASIS IN GALL
BLADDER]. XIA XIANG ET AL. shanghai journal of
traditional chinese medicine. 1988;1:2-4 (chi).
581- gera: 53603/di/ra
[OBSERVATION ON CURATIVE EFFECTS OF 61
CHRONIC HEPATITIS CASES]. HU YONGZHEN.
shanghai journal of traditional chinese medicine.
1988;1:5. (chi).
582- gera: 53626/di/ra
[SYMPTOM-SIGN DIFFERENTIATION AND
TREATMENT OF EXCRETIVE TYMPANITIS. 30
CASES]. ZHANG QING ET AL. shanghai journal of
traditional chinese medicine. 1988;2:18-20 (chi).
583- gera: 53649/di/ra
[SYMPTOM-SIGN DIFFERENTIATION AND
TREATMENT OF CHRONIC VIRAL HEPATITIS. 50
CASES]. ZHANG BOYING. shanghai journal of
traditional chinese medicine. 1988;4:4. (chi).
584- gera: 53650/di/ra
[OBSERVATION OF SHORT-TERM EFFECT FOR
BILIRUBIN INCREASE DUE TO ACUTE
HEPATITIS]. PANG JUNQUN. shanghai journal of
traditional chinese medicine. 1988;4:5. (chi).
585- gera: 53658/di/ra
[GREEN VITRIOL AND SNATEHEAD FOR CURE OF
DETERIORATIVE CIRRHOSIS. 1 CASE]. WU
YAOSHENG. shanghai journal of traditional chinese
medicine. 1988;4:30-28 (chi).
586- gera: 80513/di/ra
AN OBSERVATION ON ACUPUNCTURE THERAPY
ON 400 CASES WITH ACUTE JAUNDICE
HEPATITIS. ZHAO JIMIN. chinese journal of
acupuncture and moxibustion. 1988;1(1-2):15-8 (eng).
Si Ag HBS (+) : 14VG, glandes lymphatiques de l'aine
(points principaux). 18V, 19V, 20V à droite (points
secondaires), 36E et 6Rte (si perte d'appétit et urines
colorées). Si Ag HBS (-) : 17V, 19V, 20V (points
principaux), 36E et 6Rte (points secondaires). Puncture du
14VG : d'abord perpendiculaire, puis léger retrait et enfoncer
à droite et à gauche sur 3,5 cm, retirer l'aiguille après
irradiation du Deqi aux épaules. Glandes lymphatiques :
maintenir le ganglion entre deux doigts de la main gauche.
Puncture rapide avec la main droite, retirer l'aiguille après
irradiation de la sensation le long du membre inférieur
(puncture à droite ou bilatérale). Points de la vessie :
puncture oblique à 45°, technique d'enfoncement-retrait.
Retirer l'aiguille quand une sensation irradiée au foie est
obtenue. Une séance / jour. Sur 400 cas, guérison clinique et
biologique dans 98,5% en 32,4 jours. Aucun cas d'hépatite
sévère. Négativisation de Ag HBS dans 132 cas sur 141.
Seulement 6 cas d'hépatite chronique observés.
587- gera: 81414/di/ra
CHINESE MEDICINES FOR THE PREVENTION AND
TREATMENT OF VIRAL HEPATITIS. HAN DE WU
ET AL. abstracts of chinese medicine. 1988;2(1):105-34
(eng).
30
588- gera: 82676/di/el
HYPOCHONDRIAC PAIN. NANJING COLLEGE OF
TCM. in acupuncture treatment of common diseases
based upon differentiation of syndrome. 1988;:96-104
(eng).
589- gera: 110875/di/ra
[EFFECT OF MOXIBUSTION ON IMMUNO-
FUNCTION OF CHRONIC HEPATITIS B]. XIA WEI-
JIANG ET AL. shanghai journal of acupuncture and
moxibustion. 1988;7(3):1 (chi).
590- gera: 110883/di/ra
[THE MORPHOLOGIC STUDY ON INHIBITORY
EFFECT OF MOXIBUSTION UPON LIVER LESIONS
OF MICE CAUSED BY HYDROCORTISONE]. GUI
JIN-SHUI ET AL. shanghai journal of acupuncture and
moxibustion. 1988;7(3):23 (chi).
591- gera: 25712/di/ra
[COMBINATION WITH AUTONOMIC FUNCTION
TEST TO INCREASE EFFECTIVENESS OF
TREATING ACCORDING TO SYMDROM
DIFFERENTATION IN TCM FOR CPVH]. MA CUIYU
ET AL. chinese journal of integrated traditional and
western medicine. 1989;8(12):717-719 (chi*).
592- gera: 25717/di/ra
[THE EFFECTS OF SRRS RECIPE ON THE
FORMATION OF RAT LIVER CANCER]. QIU JIAXIN
ET AL. chinese journal of integrated traditional and
western medicine. 1989;8(12):735-736 (chi*).
593- gera: 25767/di/ra
[APPLICATION OF VITAMIN K3 POINT INJECTION
IN THE TREATMENT OF UPPER GI BLEEDING
CAUSED BY HEPATOMA]. LIU LUMING. chinese
acupuncture and moxibustion. 1989;9(1):9-12 (chi*).
594- gera: 26213/di/el
GONFLEMENT DE L'ABDOMEN. INSTITUT DE MTC
DE TIANJIN. in seca et al, acupuncture en medecine
clinique, decarie, montreal. 1989;:151-153 (fra).
595- gera: 26651/di/ra
[RECENT DEVELOPMENTS IN TCM TREATMENT
OF CHRONIC ACTIVE HEPATITS]. GUO PENG.
journal of shandong tcm college. 1989;13(2):49-52 (chi).
596- gera: 26885/di/ra
[OBSERVATION OF CURATIVE EFFECT OF TCM IN
289 CASES OF CHRONIC ACTIVE HEPATITIS B]. PEI
ZHENGXUE ET AL. acta medica sinica. 1989;2(4):14-20
(chi*).
597- gera: 26916/di/ra
[PRELIMINARY STUDY OF TCM-WM TREATMENT
FOR PATIENTS WITH PRIMARY LIVER
CARCINOMA]. LING HONGYING ET AL. chinese
journal of integrated traditional and western medicine.
1989;9(6):348-350 (chi*).
598- gera: 26933/di/ra
[CLINICAL OBSERVATION ON HEPATITIS
TREATED BY EAR-POINTS]. ZHU YUEWEI. chinese
acupuncture and moxibustion. 1989;9(3):11-13 (chi*).
599- gera: 27210/di/ra
TREATMENT OF CHRONIC HEPATITIS IN
ELDERLY PATIENTS. AKIHARU WATANABE ET AL.
gera 2011

international journal of oriental medicine. 1989;14(1):57-
62 (eng).
600- gera: 27267/di/ra
[EXPERIMENTAL STUDY OF THE ANTI-HBV
EFFECT OF THE ORDINARY ANTI-HEPATITIS
CHINESE MEDICINAL HERBS]. YANG JIANYING ET
AL. chinese journal of integrated traditional and western
medicine. 1989;9(8):494-507 (chi*).
601- gera: 27315/di/ra
[FANG YAOZHONG'S ESPERIENCE IN TREATING
HEPATOSIS ASCITES]. ZHAO CHONGXUE. acta
medica sinica. 1989;4(4):45-66 (chi).
602- gera: 27453/di/ra
BILAN EXPERIMENTAL CLINIQUE ET
OBSERVATION DU QI GONG DANS LES MALADIES
DE L'APPAREIL DIGESTIF. REQUENA Y.
acupuncture. 1989;101:37-46 (fra).
Sont présentées dans cet article les observations préliminaires
de validation clinique du Qi Gong en gastro- entérologie ainsi
que des témoignages auto-biographiques propres à introduire
le sujet et à sensibiliser le milieu médical sur cette technique
thérapeutique.
603- gera: 27459/di/ra
CAS CLINIQUE : DOULEUR HYPOCONDRE.
HEINDRYCKX J ET AL. folia sinotherapeutica.
1989;3:27-30 (fra).
604- gera: 27493/di/ra
THE PHARMACOLOGICAL AND PATHOLOGICAL
STUDIES ON SEVERAL HEPATIC PROTECTIVE
CRUDE DRUGS FROM TAIWAN (II). CHIU H ET AL.
american journal of chinese medicine. 1989;17(1-2):17-23
(eng).
605- gera: 27550/di/ra
[EXPERIMENTAL STUDY OF THE ANTI-HBV
EFFECT OF THE ORDINARY ANTI-HEPATITIS
CHINESE MEDICINAL HERBS]. JIANYING Y ET AL.
chinese journal of integrated traditional and western
medicine. 1989;9(8):494-507 (chi).
606- gera: 27889/di/el
BLOODLETTING THERAPY AND SELECTING
POINTS. YANG JIEBIN. essentials of contemporary
chinese acupuncturists' clinical experiences, foreign lang.
1989;:226-32 (eng).
607- gera: 29704/di/cg
THERAPEUTIC EFFECT OF AURICULAR POINT
THERAPY ON HEPATITIS. ZHU YUWEI ET AL.
international symposium on diagnosis and treatment with
auricular points, beijing. 1989;:97-8 (eng).
608- gera: 29728/di/cg
AURICULAR DIAGNOSIS OF 64 CASES OF
CANCERS AND 49 CASES OF HEPATITIS. LI
YANHEN ET AL. international symposium on diagnosis
and treatment with auricular points, beijing. 1989;:125-6
(eng).
609- gera: 34199/nd/re
[SIXTY CASES OF PROFOUND ICTERIC HEPATITIS
TREATED BY CHI HUANG DECOCTION]. XIANFU J
ET AL. fujian journal of tcm. 1989;19(2):29-41 (chi).
610- gera: 34255/di/ra
31
[ANALYSIS OF THE EFFECT OF "HEPATITIS B NO :
6 SYRUP" FOR TREATING 124 CASES OF CHRONIC
HEPATITIS B]. QINGJUN Z ET AL. hubei journal of
traditional chinese medicine. 1989;3:8-12 (chi).
611- gera: 34256/di/ra
[ON THE TREATMENT OF POSTHEPATITIC
SYNDROME WITH THE METHOD OF REMOVING
BLOOD STASIS AND REGULATING THE FLOW OF
QI-AN ANALYSIS OF*]. FENMING Y. hubei journal of
traditional chinese medicine. 1989;3:13. (chi).
612- gera: 34257/di/ra
[ON THE EFFECT OF CHRONIC PERSISTANT
HEPATITIS B TREATED WITH "HEPATITIS B
DECOCTION". REPORT OF 40 CASES]. LINSHENG
K. hubei journal of traditional chinese medicine.
1989;3:14-6 (chi).
613- gera: 34265/di/ra
[TREATMENT OF CHRONIC HEPATITIS B BY
REINFORCING THE SPLEEN. CLINICAL ANALYSIS
OF 60 CASES]. XINLA L ET AL. hubei journal of
traditional chinese medicine. 1989;4:8-9 (chi).
614- gera: 34308/di/ra
[APPLICATIONS OF MEDICINAL HERBS WITH
REPLENISHING EFFECTS FOR COMBINED
TREATMENT OF PRIMARY HEPATOCARCINOMA].
FANG L. journal of traditional chinese medicine.
1989;30(5):27-9 (eng).
615- gera: 34370/di/ra
[THE OBSERVATION OF 122 CASES OF CIRRHOSIS
OF THE LIVER WITH ASCITES TREATED MAINLY
WITH COMBINATIONS OF MEDICINAL HERBS].
JINGZHEN S. jiansu journal of traditional chinese
medicine. 1989;10(4):7-9 (chi).
616- gera: 34390/di/ra
[PRELIMINARY OBSERVATION ON THE
THERAPEUTIC EFFECT OF "ZHUAN YIN" No. II ON
HBV SERUM MARKERS]. PO H ET AL. jiansu journal
of traditional chinese medicine. 1989;10(4):36-7 (chi).
617- gera: 34405/nd/re
[TREATMENT OF CARCINOMA OF DIGESTIVE
TRACT IN THE MIDDLE AND LATER STAGES
WITH CHINESE HERBAL DRUGS : A REPORT OF 48
CASES]. FAN D. jiangsu journal of tcm. 1989;10(8):5-7
(chi).
618- gera: 34416/nd/re
[TREATMENT OF HEPATITIS B AND DISEASES OF
THE THREE YANG MERIDIANS BY "SUPPORTING
THE HEALTHY ENERGY AND ELIMINATING THE
EVIL*]. XUDONG L. jiangsu journal of tcm.
1989;10(9):4. (chi).
619- gera: 34418/nd/re
[TREATMENT OF CHRONIC HEPATITIS WITH
DECOCTION "FU ZHENG HUO XUE" : A REPORT
OF 110 CASES]. XUEYIN Z. jiangsu journal of tcm.
1989;10(9):7-14 (chi).
620- gera: 34438/di/ra
[A SUCESSFUL EXPERIENCE FOR TREATMENT OF
1 CASE WITH ACUTE INFECTIVE HEPATITIS
(JAUNDICE) COMPLICATED WITH INTESTINAL
OBSTRUCTION]. ZHE-SHEN W. jiangxi journal of
gera 2011

traditional chinese medicine. 1989;20(2):8-9 (chi).
621- gera: 34500/di/ra
[COMBINATION OF TCM WITH WM FOR THE
TREATMENT OF ASCITES OF PORTAL CIRRHOSIS
OF THE LIVER]. SHUYUAN Z ET AL. shaanxi
traditional chinese medicine. 1989;10(7):292-3 (chi).
622- gera: 34501/di/ra
[XIAO ZHANG PAI SHUI DECOCTION FOR
ASCITES OF PORTAL CIRRHOSIS OF THE LIVER].
HAIRONG K. shaanxi traditional chinese medicine.
1989;10(7):293-4 (chi).
623- gera: 34502/di/ra
[CHINESE MATERIA MEDICA MAINLY IN ASCITES
OF CIRRHOSIS OF THE LIVER]. JUSAN G. shaanxi
traditional chinese medicine. 1989;10(7):295. (chi).
624- gera: 34503/di/ra
[COMBINATION OF TCM WITH WM FOR THE
TREATMENT OF ASCITES OF CIRRHOSIS OF THE
LIVER]. YUNZHAO L ET AL. shaanxi traditional
chinese medicine. 1989;10(7):296-7 (chi).
625- gera: 34531/di/ra
[CHINESE MATERIA MEDICA FOR CHRONIC
ACTIVE HEPATITIS B]. XIZHOU W. shaanxi
traditional chinese medicine. 1989;10(3):102. (chi).
626- gera: 34532/di/ra
[ACUTE ICTERO-HEPATITIS TREATED BY
DIFFERENTIATION OF SYMPTOMS AND SIGNS].
ZHENFENG Z. shaanxi traditional chinese medicine.
1989;10(3):103. (chi).
627- gera: 34533/di/ra
[CHRONIC HEPATITIS AND EARLY CIRRHOSIS
TREATED BY COMBINATION OF WM AND TCM].
YAN L. shaanxi traditional chinese medicine.
1989;10(3):104. (chi).
628- gera: 34551/di/ra
[CHRONIC VIRAL HEPATITIS TREATED BY
REINFORCING VITAL ENERGY, INVIGORATING
THE SPLEEN AND PROMOTING BLOOD
CIRCULATION]. YAPING Y. shaanxi traditional chinese
medicine. 1989;10(4):151-2 (chi).
629- gera: 34552/di/ra
[CHRONIC VIRAL HEPATITIS TREATED BY
NUTRISHING LIVER DECOCTION]. ZHANJIE C.
shaanxi traditional chinese medicine. 1989;10(4):153.
(chi).
630- gera: 34603/nd/re
[WANG WENZHENG AND HIS RESEARCH OF
LIVER DISEASES]. XUSHAN X ET AL. shandong
journal of tcm. 1989;1:57. (chi).
631- gera: 34639/nd/re
[ABNORMAL SERUM PROTEIN OF 90 CASES
CIRRHOSIS TREATED BY JIANGAN TANG].
BINGGONG L ET AL. shandong journal of tcm.
1989;4:24-7 (chi).
632- gera: 34708/nd/re
[QUANTITATIVE OBSERVATION OF AFP IN
PATIENTS OF II STAGE PRIMARY LIVER CANCER
TREATED WITH HERBAL CHINESE MEDICINE].
32
LIYING Z ET AL. shanghai journal of tcm. 1989;3:16.
(chi).
633- gera: 34735/nd/re
[OBSERVATION ON THERAPEUTIC EFFECT ON 45
CASES OF CHRONIC VIRAL HEPATITIS].
KEZHUANG L. shanghai journal of tcm. 1989;5:12. (chi).
634- gera: 34745/nd/re
[CLINICAL OBSERVATION ON EFFECT OF PEONY
AND LICORICE DECOCTION FOR 148 CASES OF
VIRAL HEPATITIS]. BINGYIN L ET AL. shanghai
journal of tcm. 1989;6:4-6 (chi).
635- gera: 34746/nd/re
[SYMPTOM-SIGN DIFFERENTIATION AND
TREATMENT OF TCM FOR CONVALESCENT
HEPATITIS A]. XIANG X. shanghai journal of tcm.
1989;6:7. (chi).
636- gera: 34747/nd/re
[CLINICAL ANALYSES ON 147 CASES OF ACUTE
HEPATITIS A]. YING T ET AL. shanghai journal of tcm.
1989;6:8. (chi).
637- gera: 34748/nd/re
[PRESSURE OF EAR POINTS FOR 40 CASES OF
ICTERIC HEPATITIS]. GUIFANG C ET AL. shanghai
journal of tcm. 1989;6:9. (chi).
638- gera: 34766/nd/re
[OBSERVATION ON THERAPEUTICS EFFECTS IN
112 CASES OF HEPATITIS A TREATED WITH
LIVER SOOTHING, VENTILATION AND
EXCRETION FORMULAE]. JINGXIANG W ET AL.
shanghai journal of tcm. 1989;7:13-4 (chi).
639- gera: 34770/nd/re
[SUMMARY IN DIFFERENTIATING AND TREATING
35 CASES OF ACUTE ICTERIC HEPATITIS].
GUIMAN L. shanghai journal of tcm. 1989;7:22. (chi).
640- gera: 34784/nd/re
[DING JIMIN'S EXPERIENCE FOR LIVER DISEASE].
ZHANGZHONG Z. shanghai journal of tcm. 1989;8:19-25
(chi).
641- gera: 34805/nd/re
[PREVENTION AND TREATMENT OF TCM FOR
FULMINANT PREVALENCE OF VIRAL HEPATITIS
A IN SHANGHAI AREA 1988]. XIANYI M. shanghai
journal of tcm. 1989;10:2-9 (chi).
642- gera: 34837/di/ra
[CIRRHOSIS OF LIVER WITH ASCITES TREATED
BY JIJIAOLOHUANGWAN AND LUTEOSTERONE :
A REPORT OF 22 CASES]. ZHAOYANG C. beijing
journal of traditional chinese medicine. 1989;2:20-3 (chi).
643- gera: 34839/di/ra
[TREATMENT OF ACUTE ICTEROHEPATITIS
WITH RHEUM INJECTION]. JINGHUA C ET AL.
beijing journal of traditional chinese medicine. 1989;2:25-
9 (chi).
644- gera: 34845/di/ra
[EXAMPLES OF DIFFERENT TREATMENTS FOR
SAME DISEASE : ASCITES]. PUQUAN Q. beijing
journal of traditional chinese medicine. 1989;3:3-4 (chi).
gera 2011

645- gera: 34856/di/ra
[A SURVEY OF CLINICAL APPLICATION AND
LABORATORY RESEARCH ABOUT PREVENTION
OR TREATMENT OF HEPATITIS WITH RADIX
GLYCYRRHIZAE]. YUNYAN G ET AL. beijing journal
of traditional chinese medicine. 1989;3:54-5 (chi).
646- gera: 34861/di/ra
[CLINICAL OBSERVATION ON CASES OF
CHRONIC HEPATITIS B TREATED BY
"PRESCRIPTION TO CURE HEPATITIS" (YU GAN
TANG)]. MING-HUI S. zhejiang journal of tcm.
1989;24(9):389-0 (chi).
647- gera: 34862/di/ra
[TREATING 86 CASES OF VIRUS HEPATITIS WITH
"KU JIAO TANG"]. BO-TANG L. zhejiang journal of
tcm. 1989;24(9):391-2 (chi).
648- gera: 34863/di/ra
[TO TREAT POSTHEPATITIC SYNDROME. 128
CASES WITH "MINOR BUPLEURUM
COMBINAITON" (XIAO CHAI HU TANG)
MODIFIED]. DE-MING Y. zhejiang journal of tcm.
1989;24(9):393. (chi).
649- gera: 34864/di/ra
[PRELIMINARY SUMMARY ON THE
EFFECTIVENESS OF PREVENTING HEPATITIS A
WITH CHINESE MATERIA MEDICA]. GENG-XIAN Q.
zhejiang journal of tcm. 1989;24(9):394-400 (chi).
650- gera: 34866/di/ra
[PRIMARY EXPLORATION OF TREATING VIRUS
HEPATITIS IN WAY OF REGULATING SANJIAO].
DONG-DU H. zhejiang journal of tcm. 1989;24(9):413-6
(chi).
651- gera: 35018/di/ra
[A SUMMARY OF THE DIAGNOSIS AND
TREATMENT OF PRIMARY CARCINOMA OF
LIVER]. YI HUANG-SHAN ET AL. zhejiang journal of
tcm. 1989;24(12):562. (chi).
652- gera: 35043/di/ra
[THE ANALYSIS ON THE PATHOLOGY AND
CLINICAL DIAGNOSIS OF CHRONIC HEPATITIS
AS WELL AS THE CHINESE MEDICAL TYPING].
ZUO SHU YAN. liaoning journal of traditional chinese
medicine. 1989;13(3):30-45 (chi).
653- gera: 35098/di/ra
[THE APPLICATION OF "BU ZHONG YI QI TANG"
TO TREATING PATIENTS WITH HEPATITIS B
SURFACE ANTIGEN RIDIOIMMUOASSAY FOR 80
CASE]. WANG CHUN SHENG. liaoning journal of
traditional chinese medicine. 1989;13(9):23-32 (chi).
654- gera: 35154/di/ra
[TREATMENT OF CHRONIC PERSISTENT
HEPATITIS BY ACUPUNCTURE : AN
OBSERVATION OF 21 CASES]. XU QUAN ET AL. new
journal of traditional chinese medicine. 1989;21(2):30-1
(chi).
655- gera: 35178/di/ra
[CLINICAL APPLICATION OF THE THERAPY FOR
PROMOTING BLOOD CIRCULATION TO REMOVE
BLOOD STASIS IN LIVER DISEASE]. LIU CHANGSHI.
new journal of traditional chinese medicine.
33
1989;21(4):25-33 (chi).
656- gera: 35251/di/ra
[A DISCUSSION ON THE CHARACTERISTICS OF
THE SHANHANLUN IN THE TREATMENT OF
LIVER DISORDERS]. CHEN BAOMING. new journal of
traditional chinese medicine. 1989;21(10):16-8 (chi).
657- gera: 35299/di/ra
[AN EXPERIMENTAL STUDY ON 1, 000 KINDS OF
CHINESE MEDICINAL HERBS FOR INHIBITING
SURFACE ANTIGEN OF HEPATITIS B VIRUS].
ZHENG MINSHI ET AL. journal of traditional chinese
medicine. 1989;30(11):47. (eng).
658- gera: 35305/di/ra
[TREATMENT OF SUBACUTE SEVERE HEPATITIS
COMPLICATED BY DIABETES]. WU HANMIN.
journal of traditional chinese medicine. 1989;30(12):21-2
(eng).
659- gera: 35307/di/ra
[A PRELIMINARY STUDY ON THE RELATIONSHIP
BETWEEN TYPING OF TCM DIFFERENTIATION OF
SYMPTOMS OF CHRONIC HEPATITIS B AND*].
ZHANG JUNFU ET AL. journal of traditional chinese
medicine. 1989;30(12):25-6 (eng).
660- gera: 35313/di/ra
[A STUDY ON IL-2R ACTIVITY AND EFFECTS OF
CHINESE MEDICINAL HERBS ON IT IN PATIENTS
OF VIRAL CHRONIC PERSISTENT HEPATITIS
WITH*]. CHEN HUAXIE ET AL. journal of traditional
chinese medicine. 1989;30(12):41-2 (eng).
661- gera: 35351/di/ra
[TREATMENT OF CHRONIC VIRAL HEPATITIS
WITH SHENMI BREATHING EXERCISE IN 20
CASES]. YU LU-PING. journal of traditional chinese
medicine and chinese materia medica of jilin. 1989;5:14-5
(chi).
662- gera: 35352/di/ra
[CLINICAL OBSERVATIONS ON TREATMENT OF
CHRONIC HEPATITIS-B WITH MIEAOLING IN 278
CASES]. ZHANG BO. journal of traditional chinese
medicine and chinese materia medica of jilin. 1989;5:16-
27 (chi).
663- gera: 35380/di/ra
[CLINICAL REPORT OF 31 CASES OF ASCITES DUE
TO CIRRHOSIS TREATED BY THE COMBINED
METHOD OF TCM AND WM]. ZHANG SHANCHUAN
ET AL. jiangsu journal of traditional chinese medicine.
1989;10(11):4-5 (chi).
664- gera: 35468/di/ra
[EFFECT OBSERVATION ON 50 CASES OF
SYMPTOMLESS HBsAg CARRIER TREATED BY
"HEPATITIS PASTE"]. LI DI-XIN. shanxi journal of
traditional chinese medicine. 1989;5(6):22-20 (chi).
665- gera: 35478/di/ra
[CLINICAL OBSERVATION ON CASES OF
CHRONIC HEPATITIS B TREATED BY
"PRESCRIPTION TO CURE HEPATITIS" (YU GAN
TANG)]. SUN MING-HUI. zhejiang journal of traditional
chinese medicine. 1989;24(9):389-390 (chi).
666- gera: 35479/di/ra
gera 2011

[TREATING 86 CASES OF VIRUS HEPATITIS WITH
"KU JIAO TANG"]. LI BO-TANG. zhejiang journal of
traditional chinese medicine. 1989;24(9):391-2 (chi).
667- gera: 35480/di/ra
[TO TREAT POSTHEPATITIC SYNDROME. 128
CASES WITH "MINOR BUPLEURUM
COMBINATION" (XIAO CHAI HU TANG)
MODIFIED]. YANG DE-MING. zhejiang journal of
traditional chinese medicine. 1989;24(9):393. (chi).
668- gera: 35481/di/ra
[PRELIMINARY SUMMARY ON THE
EFFECTIVENESS OF PREVENTING HEPATITIS A
WITH CHINESE MATERIA MEDICA]. HUANG
DONG-DU. zhejiang journal of traditional chinese
medicine. 1989;24(9):413-6 (chi).
669- gera: 35483/di/ra
[PRIMARY EXPLORATION OF TREATING VIRUS
HEPATITIS IN WAY OF REGULATING SANJIAO].
HUANG DONG-DU. zhejiang journal of traditional
chinese medicine. 1989;24(9):413-6 (chi).
670- gera: 35541/di/ra
[ALL DISEASES TREATED ONESELF WITH
QIGONG. HEPATOCIRRHOSIS]. YU XIAO. qi-gong
(an exercice for health and longevity). 1989;10(9):402-4
(chi).
671- gera: 42110/nd/re
[PROTECTIVE ACTION OF KOPSININE AGAINST
EXPERIMENTAL LIVER INJURIES IN MICE].
HUANG WAN YUN ET AL. acta pharmacologica sinica.
1989;10(1):65-8 (chi*).
672- gera: 42292/nd/re
[IMMUNOLOGICAL EFFECTS OF THE VOLATILE
OIL OF CURCUMA AROMATICA IN MICE WITH
TOXIPATHIC HEPATITIS]. JIA KUAN ET AL. chinese
journal of immunology. 1989;5(2):121-22 (chi*).
673- gera: 42304/nd/re
[EFFECTS OF OENANTHE JAVANICA ON
JAUNDICE AND GPT IN ANIT-POISONED RATS].
HUANG ZHENG MING ET AL. chinese pharmaceutical
journal. 1989;24(2):84-5 (chi*).
674- gera: 42318/nd/re
[EFFECTS OF POLYSTICTUS VERSICOLOR
POLYSACCHARIDE ON APLATOXIN B1. INDUCED
HEPATIC CARCINOMA IN RATS]. XU BING DONG
ET AL. jiangsu medical journal. 1989;15(3):195-97 (chi*).
675- gera: 42323/nd/re
[PROTECTIVE ACTION OF KOPSININE F AGAINST
EXPERIMENTAL LIVER INJURY IN MICE]. ZHANG
JIE ET AL. acta pharmaceutica sinica. 1989;24(3):165-69
(chi*).
676- gera: 42339/nd/re
[LIVER PROTECTIVE AND MICRONUCLEUS
INHIBITING EFFECTS OF THE POLYSACCHARIDE
OF TREMELLA FUCIFORMIS AND AURICULARIA
*]. ZHOU HUI PING ET AL. journal of china
pharmaceutical university. 1989;20(1):51-3 (chi*).
677- gera: 42349/nd/re
[TREATMENT OF 152 CASES OF CHRONIC
ATROPHIC GASTRITIS BY HEAT CLEARING AND
34
STASIS REMOVING THERAPY]. HUANG DAO FU ET
AL. xinjiang zhongyiyao. 1989;1:16-7 (chi*).
678- gera: 42472/nd/re
[EFFECTS OF CHINESE DRUGS WHICH NOURISH
YIN AND INVIGORATE KIDNEY ON HEPATIC
FIBROSIS]. FAN ZONG PANG ET AL. jiangsu medical
journal. 1989;15(5):234-35 (chi*).
679- gera: 42499/nd/re
[LIVER-PROTECTIVE EFFECT OF FUGANKANG
INFUSION]. CHU ZHENG YUN ET AL. journal of
shenyang college of pharmacy. 1989;6(1):61-4 (chi*).
680- gera: 42522/nd/re
[TREATMENT OF SEVERE ACUTE ICTERIC
HEPATITIS A BY TRADITIONAL CHINENSE
MEDICINE]. WANG GUO SHEN ET AL. shanghai
medical journal. 1989;12(2):102. (chi*).
681- gera: 42523/nd/re
[TREATMENT OF 244 CASES OF ACUTE HEPATITIS
A WITH SHAOYAO DAHUANG DECOCTION]. LI SU
JUAN ET AL. shanghai medical journal. 1989;12(2):103.
(chi*).
682- gera: 42663/nd/re
[EFFECTS OF CHINESE DRUGS WHICH NOURISH
YIN AND INVIGORATE KIDNEY ON HEPATIC
FIBROSIS]. FAN ZONG PANG ET AL. jiangsu medical
journal. 1989;15(5):234-35 (chi*).
683- gera: 42676/di/ra
[A PRELIMINARY STUDY ON THE MECHANISM OF
ACTION OF DAHUANG INJECTION IN
TREATMENT OF ACUTE ICTERIC HEPATITIS].
CHENG JING HUA ET AL. china journal of chinese
materia medica. 1989;14(10):622-23 (chi*).
684- gera: 42699/nd/re
[LIVER-PROTECTIVE EFFECT OF FUGANKANG
INFUSION]. CHU ZHENG YUN ET AL. journal of
shenyang college of pharmacy. 1989;6(1):61-4 (chi*).
685- gera: 50070/di/ra
[PROTECTIVE EFFECT OF EXTRACTS FROM
ALOE VERA L. VAR. CHINENSIS (HAW) BERG. ON
EXPERIMENTAL HEPATIC LESIONS AND
PRIMARY CLINICAL*]. FAN YIJUN ET AL. china
journal of chinese materia medica. 1989;14(12):42-3
(chi*).
686- gera: 50072/di/ra
[INFLUENCE OF RADIX ASTRAGALI ON THE
NOISE-CAUSED CHANGE IN HEPATIC GLUCOGEN
CONTENT OF RATS]. HAN GUOZHU ET AL. china
journal of chinese materia medica. 1989;14(12):46-8
(chi*).
687- gera: 50101/di/ra
[DISTINGUISHING FEATURE OF DR. ZHANG PEI-
MEI FOR TREATMENT OF CHRONIC HEPATITIS].
FANG JIE. jiangxi journal of traditional chinese medicine.
1989;20(5):2-6 (chi).
688- gera: 50105/di/ra
[CLINICAL INVESTIGATION ON THE TREATMENT
OF 68 CASES OF CHRONIC HEPATITIS B BY THE
METHOD OF "HUOXUE HAOYU" (INNIGORATE
THE*]. RAO HAN-XIONG. jiangxi journal of traditional
gera 2011

chinese medicine. 1989;20(5):31-5 (chi*).
689- gera: 50256/di/ra
[CLINICAL ANALYSIS ON EFFECT OF GOLDEN
ORANGE DAYLILY SYRUP FOR 36 CASES OF
JAUNDICE HEPATITIS]. WANG YAOCHU ET AL.
shanghai journal of traditional chinese medicine.
1989;12:8-0 (chi).
690- gera: 50265/di/ra
[SELF-FORMULATED CLEARING LIVER
DECOCTION FOR 60 CASES OF ACUTE HEPATITIS-
A]. WANG LILING ET AL. shanghai journal of
traditional chinese medicine. 1989;12:26-8 (chi).
691- gera: 50266/di/ra
[RADIX BUPLEURI LIVER DREDGING POWDER
FOR INNER IMPAIRMENT OF CHEST AND
FLANKS]. JIANG XINGLIANG. shanghai journal of
traditional chinese medicine. 1989;12:29-28 (chi).
692- gera: 50342/di/ra
[EXPERIENCE ON TREATMENT OF CIRRHOTIC
ASCITES]. RAO WANGFU. yunnan journal of
traditional chinese medicine. 1989;10(4):8-24 (chi).
693- gera: 50361/di/ra
[CIRRHOSIS OF LIVER WITH ASCITES TREATED
BY JIJIAOJIHUANGWAN AND LUTEOSTERONE : A
REPORT OF 22 CASES]. CHEN ZHAOYANG. beijing
journal of traditional chinese medicine. 1989;2:20-3 (chi).
694- gera: 50363/di/ra
[TREATMENT OF ACUTE ICTEROHEPATITIS
WITH RHEUM INJECTION]. CHENG JINGHUA ET
AL. beijing journal of traditional chinese medicine.
1989;2:25-9 (chi).
695- gera: 50369/di/ra
[EXAMPLES OF DIFFERENT TREATMENTS FOR
SAME DISEASE : ASCITES]. QU PUQUAN. beijing
journal of traditional chinese medicine. 1989;3:3-4 (chi).
696- gera: 50380/di/ra
[A SURVEY OF CLINICAL APPLICATION AND
LABORATORY RESEARCH ABOUT PREVENTION
OR TREATMENT OF HEPATITIS WITH RADIX
GLYCYRRHIZAE]. GAO YUNYAN ET AL. beijing
journal of traditional chinese medicine. 1989;3:54-5 (chi).
697- gera: 50514/di/ra
[CLINICAL EXPERIENCE ON 46 CASES OF
CHRONIC AND PERSISTING HEPATITIS TREATED
WITH ZHANG YU LI LAO DECOCTION]. DENG
QIYUAN. fujian journal of traditional chinese medicine.
1989;20(5):21-2 (chi).
698- gera: 50535/di/ra
[CLINIC APPLICATION OF THERAPY FOR THE
METHODS OF INVIGORATION THE KIDNEY IN
HEPATITIS (BV)]. GAOYA. henan traditional chinese
medicine. 1989;9(6):32-6 (chi).
699- gera: 50578/di/ra
[CLINICAL OBSERVATION OF 240 CASES OF
VIRAL HEPATITIS TREATED WITH METHOD OF
PROMOTING BLOOD CIRCULATION AND
REMOVING BLOOD STASIS]. ZHANG YUNPENG ET
AL. acta medica sinica. 1989;4(5):37-9 (chi).
35
700- gera: 50636/di/ra
[TREATMENT OF CHRONIC HEPATITIS WITH
LONG-TERM ABNORMALITY OF TRANSAMINASE
ACTIVITY]. YU RONGQING. journal of traditional
chinese medicine. 1989;30(10):14-5 (eng).
701- gera: 50736/di/ra
[CHRONIC HEPATITIS AND EARLY LIVER
CIRRHOSIS TREATED BY WM-TCM]. CUO
PINGQING. fujian journal of traditional chinese
medicine. 1989;20(6):20-9 (chi).
702- gera: 51893/nd/re
[EVALUATION OF EFFICACY OF YUNZHIGANTAI
AND FUGANNING IN TREATMENT OF HEPATITIS
B BY DOUBLE BLIND METHOD]. WANG MEI XIA ET
AL. journal of henan medical university. 1989;24(3):213-
16 (chi*).
703- gera: 51894/nd/re
[ANTINEOPLASTIC EFFECT OF VINCRISTINE-IgG
CONJUGATE AGAINST HEPATOMA]. YU ZHU
YUAN ET AL. tumor. 1989;9(4):154-56 (chi*).
704- gera: 51895/nd/re
[PROTECTIVE EFFECT OF WURENCHUN ON
CHRONIC HEPATIC INJURY]. WANG MEI NA ET AL.
journal of xi'an medical university. 1989;10(3):221-24
(chi*).
705- gera: 51936/nd/re
[BLOCKADE OF PRE-HEPATIC CARCINOMA IN
RATS WITH SPLEEN-STRENGTHENING AND
VITAL ENERGY- REGULATING HEBS]. TU HUA
CHENG ET AL. tumor. 1989;9(1):31-2 (chi*).
706- gera: 70082/di/re
TONGUE AND SKIN MICROCIRCULATION
CHANGES IN HEPATIC CIRRHOSIS. TIAN N ET AL.
journal of gastroenterology and hepatology.
1989;4(1):103-7 (eng).
707- gera: 80685/di/ra
THE EFFECT OF "JIANG ZHI YI GAN TANG" IN
THE TREATMENT OF FATTY LIVER. JIANG SEN.
journal of traditional chinese medicine. 1989;9(4):275-76
(eng).
708- gera: 80686/di/ra
TREATMENT OF PAIN ACCORDING TO
SYNDROME DIFFERENTIATION IN 169 CASES OF
LIVER CANCER. LIU LUMING ET AL. journal of
traditional chinese medicine. 1989;9(4):277-80 (eng).
In 169 cases with liver cancer pain the therapeutic effects of
TCM and the authors' "analgesic therapy of four steps" were
analysed. The results were that most patients with advanced
liver cancer had mild pain, and only a small number of
patients (14. 2%) had moderate or severe pain. By the first
step analgesic therapy 46. 1% of the patients were relieved
and with the second or third step of analgesic therapy, 93. 5%
of the patients were relieved. Only 6. 5% of the patients with
grade III pain needed the fourth step therapy. With TCM
treatment alone, the remission rate of grade I and , grade II
pain was 100% and 76. 9% respectively. Analgesic therapy
of four steps produced less
709- gera: 80724/di/ra
THE THERAPEUTIC EFFICACY OF THE
CHOLERETIC MIXTURE AGAINST THE
INFANTILE HEPATITIS SYNDROME. SHI YUMIN ET
gera 2011

AL. journal of traditional chinese medicine.
1989;9(2):103-05 (eng).
710- gera: 83705/nd/re
A MULTI CENTER RANDOMIZED CONTROLLED
CLINICAL TRIAL OF SHOSAIKO-TO IN CHRONIC
ACTIVE HEPATITIS. HIRAYAMA C ET AL. gastroent
japonica. 1989;24:715-9 (eng).
711- gera: 27700/di/ra
CAS CLINIQUE. DOULEUR HYPOCHONDRE. SUN
FEI LIN ET AL. folia sinotherapeutica. 1990;4:29-0 (fra).
712- gera: 29030/di/cg
CLINICAL OBSERVATION AND EXPERIMENTAL
RESEARCH IN THE TREATMENT OF ADVANCED
HEPATOMA BY CHINESE HERBS. JIA XIN QIU.
proceedings of the fifth international congress of chinese
medicine,berkeley. 1990;:28. (eng).
713- gera: 29363/di/ra
HEMORRHEOLOGICAL CHANGES IN CHRONIC
HEPATITIS AND LIVER CIRRHOSIS AND THEIR
RELATIONS TO THE SYNDROMES
DIFFERENTIATED BY TRADITIONAL CHINESE
MEDICINE. WANG QING-MIN ET AL. chinese medical
journal. 1990;103(11):939-44 (eng).
Blood and plasma viscosity, hematocrit and erythrocyte
sedimentation rate were examined in 146 cases of chronic
hepatitis and liver cirrhosis. In addition, blood fibrinogen and
blood flow of the tongue and skin were studied in 123 and 46
of them respectively. The same indices were observed in 39
cases before and after treatment. The results showed definite
hemorrheological patterns in different syndromes and
therapeutic efficacy was also correlated with the changes in
the mentioned indices. Thus it is believed that these indices
of hemorrheology may serve as supplementary means for the
differentiation of syndromes, evaluation of therapeutic effect
and prognosis
714- gera: 29534/di/el
HYPOCHONDRIAC PAIN. SHANG XIANMIN ET AL.
in clinical experiences, new world press, beijing.
1990;:192-5 (eng).
715- gera: 29907/di/el
CIRRHOSIS OF LIVER WITH ASCITES. SHAO NIAN-
FANG. the treatment of knotty diseases, shandong science
and technology press. 1990;:273-82 (eng).
716- gera: 29938/di/re
HEPATOPROTECTIVE COMPOUNDS FROM
CANARIUM ALBUM AND EUPHORBIA
NEMATOCYPHA. ITO M ET AL. chem pharm bull.
1990;38(8):2201-3 (eng).
Successive purification of the extract from Canarium album
and Euphorbia nematocypha, guided by antihepatotoxic
activity in primary cultured rat hepatocytes, led to the
isolation of brevifolin (1), hyperin (2), ellagic acid (3) and
3,3'-di-O-methylellagic acid (4) as hepatoprotective
compounds. Compounds 1,3 and 4 also reduced carbon
tetrachloride (CCl4)-induced liver damage in mice. The
hepatoprotective activities of 1, 2, 3 and 4 in vitro and in vivo
are apparently due to their antioxidative effects, which were
exhibited by further studies using 1,1- diphenyl-2-
picrylhydrazyl (DPPH) radicals and CCl4-induced lipid
peroxidation systems.
717- gera: 60025/di/ra
[FOUR SUCCESSFUL CASES IN TREATMENT OF
36
SEVERE HEPATITIS]. YU SENSHAN. journal of
traditional chinese medicine. 1990;31(1):20-2 (eng).
718- gera: 60032/di/ra
[AN OBSERVATION ON THE CURATIVE EFFECT
OF N° 865 CHONG JI IN TREATING SYMPTOMLESS
CARRIERS OF HBsAg]. DONG ZHENXIANG ET AL.
journal of traditional chinese medicine. 1990;31(1):41-3
(eng).
719- gera: 60048/di/ra
[SELECTIVE ANALYSIS ON HUI ERYIN'S MEDICAL
RECORDS ABOUT TREATMENT OF LIVER
DISEASE]. YU HUIMIN. hubei journal of traditional
chinese medicine. 1990;1:X (chi).
720- gera: 60069/di/ra
[CONTENT DETERMINATION OF BILIRUBIN WITH
INFRA-RED DERIVATIVE SPECTROMETRY]. DAI
JING ET AL. chinese traditional patent medicine.
1990;12(1):35. (chi).
721- gera: 60111/di/ra
[THE RELATION BETWEEN TCM TYPE-
DIFFERENTIATION OF CHRONIC HEPATITIS AND
ITS PATHOLOGIC DIAGNOSIS]. WU DEFU. jiangsu
journal of traditional chinese medicine. 1990;11(8):17-8
(chi).
722- gera: 60112/di/ra
[CLINICAL OBSERVATIONS ON 100 CASES OF
CHRONIC HEPATITIS TREATED BY ARTEMISIA
KEISKEANA MIQ]. JI XINLIANG. jiangsu journal of
traditional chinese medicine. 1990;11(8):19-24 (chi).
723- gera: 60134/di/ra
[THE RELATION OF PATHOLOGY OF CHRONIC
HEPATITIS AND CLINICAL DIAGNOSIS TO TCM
TYPE- DIFFERENTIATION : AN ANALYSIS OF 120
CASES]. ZUO SHUYAN. jiangsu journal of traditional
chinese medicine. 1990;11(6):13-8 (chi).
724- gera: 60142/di/ra
[CLINICAL SUMMERY OF 33 CASES OF SEVERE
HEPATITIS TREATED BY INTEGRATION OF WM
AND TCM]. CHEN NINGSHENG. jiangsu journal of
traditional chinese medicine. 1990;11(5):5-6 (chi).
725- gera: 60165/di/ra
[RECUPERATING ACTIONS OF RADIX SALVIAE
MILTIORRHIZA ON PATIENTS WITH
HEPATOPATHY]. DAI YUN ET AL. jiangsu journal of
traditional chinese medicine. 1990;11(4):39. (chi).
726- gera: 60213/di/ra
[45 CASES OF CHRONIC VIRUS HEPATITIS B
TREATED BY THE METHOD OF INVIGORATING
THE SPLEEN AND REGULATING THE LIVER]. WU
YU. hubei journal of traditional chinese medicine.
1990;4:18-9 (chi).
727- gera: 60299/di/ra
[DYNAMIC DETECTION OF BLOOD RHEOLOGY,
RHEOHEPATOGRAM TO SEARCH PATHOLOGY
OF BLOOD STASIS IN ACUTE HEPATITIS]. LI
SAIMEI ET AL. fujian journal of traditional chinese
medicine. 1990;21(2):39-40 (chi).
728- gera: 60340/di/ra
[TREATMENT FOR 51 CASES OF CIRRHOSIS
gera 2011

COMPLICATED WITH HEMORRHAGE OF UPPER
DIGESTIVE TRACT]. MENG DINGSHUI ET AL. beijing
journal of traditional chinese medicine. 1990;2:30-6 (chi).
729- gera: 60362/di/ra
[CHRONIC HEPATITIS B TREATED WITH JIEDU
YANGGAN GAO BY DOUBLE-BLIND METHOD.
CLINICAL ANALYSIS OF 96 CASES]. BEIJING
HOSPITAL OF TRADITIONAL CHINESE. beijing journal
of traditional chinese medicine. 1990;1:54. (chi).
730- gera: 60471/di/ra
[ACUTE TOXICITIES OF FLESH OIL OF
HIPPOPHAE RHAMNOIDES L. AND ITS
PROTECTION AGAINST EXPERIMENTAL HEPATIC
INJURY]. CHENG TIJUAN ET AL. china journal of
chinese materia medica. 1990;15(1):45-6 (chi*).
731- gera: 60474/di/ra
[OBSERVATION ON SHORT-TERM CURATIVE
EFFECT OF CULTURED CORDYCEPS SINENSIS
(BERK.) SACC. MYCELIA FOR CHRONIC
HEPATITIS B]. ZHOU LIANGMEI ET AL. china journal
of chinese materia medica. 1990;15(1):53. (chi*).
732- gera: 60511/di/ra
[CLINICAL APPLICATION OF SIMPLE RHIZOMA
RHEI FOR TREATMENT OF ACUTE ICTERIC
VIRAL HEPATITIS]. JIAO DONG HAI ET AL. chinese
traditional patent medicine. 1990;12(4):25-6 (chi).
733- gera: 60512/di/ra
[PHARMACOLOGICAL STUDIES ON ANTI-
HEPATITIS OF SHUIQIN COMPOUND INJECTION
(OENANTHE JAVANICA (BL.) DC.)]. HUANG ZHENG
MING ET AL. chinese traditional patent medicine.
1990;12(4):27-26 (chi).
734- gera: 60618/di/ra
[THERAPEUTIC EFFECT OF "BLOOD
INVIGORATING DECOCTION" ON
EXPERIMENTAL LIVER FIBROSIS]. WANG BAO EN
ET AL. chinese traditional and herbal drugs.
1990;21(4):23-5 (chi).
735- gera: 60681/di/ra
[RECENT INFORMATION OF STUDIES ON THE
DRUGS OF LOWERING BLOOD LIPIDS AND LIVER
LIPIDS IN EXPERIMENTAL ANIMALS]. ZHANG SHI
JIE ET AL. chinese traditional and herbal drugs.
1990;21(8):39-41 (chi).
736- gera: 60686/di/ra
[EXPERIENCE ON TREATING TYMPANITIS BASED
ON THE LUNG CONDITIONS]. LI SHULIANG. journal
of traditional chinese medicine. 1990;31(2):16-22 (eng).
737- gera: 60747/di/ra
[TREATMENT OF CHRONIC HEPATITIS B
PRIMARILY BASED ON THE DEPRESSION OF
LIVER-ENERGY CLINICAL ANALYSIS OF 584
CASES]. JIANG BENYOU. journal of traditional chinese
medicine. 1990;31(6):30-2 (eng).
738- gera: 60759/di/ra
[CLINICAL OBSERVATION ON THE TREATMENT
OF EARLY HEPATOCIRRHOSIS WITH "HUANG QI
E ZHU DECOCTION"]. GAO RONGHUI. journal of
traditional chinese medicine. 1990;31(7):31-2 (eng).
37
739- gera: 60776/di/ra
[OBSERVATION OF THERAPEUTIC EFFECT OF
SYMPTOMLESS CARRIER OF HBsAG TREATED
WITH 875 CHONG JI]. DONG ZHENXIANG ET AL.
journal of traditional chinese medicine. 1990;31(8):32-7
(eng).
740- gera: 60858/di/ra
[INTRODUCTION OF ACUPOINT TREATMENT OF
VIRUS HEPATITIS]. LIAN WEIZHEN ET AL. chinese
acupuncture and moxibustion. 1990;10(1):38-41 (chi*).
This article reviews that treatment of virus hepatitis by means
of acupuncture, Moxibustion, combination of both, injection,
blink, laser irradiance, pressing, catgut implantation,
vesiculation at the paint. It's claimed that these treating
methods can improve function of the hepaty, raise or reduce
the immunity, clear away virus. We consider that acupoint
injection vesiculation have great potentialities.
741- gera: 60929/di/ra
[DISCUSSION OF THE MECHANISMS FOR
TREATING LATE HEPATOCARCINOMA BY
NOURISHING YIN AND REMOVING HEAT]. CHEN
PEIFENG. journal of zhejiang college of traditional
chinese medicine. 1990;14(3):28-32 (chi).
742- gera: 60966/di/ra
[EXPERIENCE OF TREATMENT OF CHRONIC
HEPATITIS WITH DIFFERENTIATION OF
SYMPTOMS AND SIGNS]. SHAN SHOU XIAN ET AL.
journal of traditional chinese medicine and chinese
materia medica of jilin. 1990;2:5-6 (chi).
743- gera: 60967/di/ra
[THREE METHODS FOR TREATMENT OF
CHRONIC ACTIVE HEPATITIS]. WANG YU MEI ET
AL. journal of traditional chinese medicine and chinese
materia medica of jilin. 1990;2:7-8 (chi).
744- gera: 60968/di/ra
[CLINICAL OBSERVATION ON TREATMENT OF
ACUTE ICTEROHEPATITIS WITH THREE STEPS
AND NINE THERAPEUTIC METHODS IN 52 CASES].
LIU LI CANG. journal of traditional chinese medicine
and chinese materia medica of jilin. 1990;2:9-11 (chi).
745- gera: 61000/di/ra
[GENERAL SITUATION ON THE TREATMENT OF
LIVER CIRRHOSIS BY TCM]. ZHENG PING. jiangxi
journal of traditional chinese medicine. 1990;21(2):60.
(chi).
746- gera: 61042/di/ra
[TREATING 47 CASES OF CHRONIC LIVER
DISEASES WITH REGIMEN OF ACTIVATING
BLOOD AND DISSOLVING STASIS]. SUN FANJUN.
journal of shandong college of traditional chinese
medicine. 1990;14(1):33-48 (chi*).
747- gera: 61176/di/ra
[PRELIMINARY REPORT ON VARIOUS SYMPTOMS
OF CHRONIC HEPATITIS TREATED WITH RADIX
ASTRAGALI AND ITS REGULATIVE EFFECT TO
LEVELS OF SER*]. LIU KEZHOU ET AL. chinese
journal of integrated traditional and western medicine.
1990;10(6):330-33 (chi*).
748- gera: 61218/di/ra
[CLINICAL ANALYSIS OF 418 PATIENTS WITH
WILSON'S DISEASE IN TCM-WM TREATMENT].
gera 2011

YANG RENMIN ET AL. chinese journal of integrated
traditional and western medicine. 1990;10(3):134-36
(chi*).
749- gera: 61220/di/ra
[A STUDY ON RELATION BETWEEN CHANGES OF
PLASMA TXB PGF AND DIFFERENTIATION OF
SYMPTOMS AND SIGNS OF TCM IN SEVERE
ICTERIC HEPATITIS]. WANG CHENBAI ET AL.
chinese journal of integrated traditional and western
medicine. 1990;10(3):141-43 (chi*).
750- gera: 61222/di/ra
[VEGETATIVE NERVOUS FUNCTION AND IL 2
RECEPTOR IN PATIENTS WITH VERTIGO]. LUO
ZHIQIANG ET AL. chinese journal of integrated
traditional and western medicine. 1990;10(3):147-49
(chi*).
The authors used Wenger's vegetative nervous balance factor
analysis to measure vegetative nervous function of 75
patients with vertigo revealing enhancement of sympathetic
nervous function. The proliferation activity of IL-2 receptor
was determined by the amount of 3H-TdR incorporated cpm
in the peripheral blood lymphocyte after exogenous IL-2
stimulation (Lymphocult-T). The authors used this
techniques to measure the activity of IL-2 receptor in 49
patients with hepatitis and vertigo. The results showed that
the activity of IL-2 receptor in patients with or without
vertigo was lower than the controls (P<0,001). And patients
with vertigo showed lower activity of IL-2 receptor than that
without (P<0,01). In these patients with asthenia-syndrome
the activity of IL-2 receptor was lower than those with
sthenia syndrome. The activity of IL-2 receptor in these
patients with long course was lower than those with short
course. The difference of sex and age was not significant.
The above results suggest that "Wind" in TCM might be
related to the enhancement of sympathetic nervous function
and the activity of IL-2 receptor.
751- gera: 61232/di/ra
[CLINICAL STUDY OF 96 CASES WITH CHRONIC
HEPATITIS B TREATED WITH JIEDU YANGGAN
GAO BY A DOUBLE-BLIND METHOD]. CHEN
ZENGTAN ET AL. chinese journal of integrated
traditional and western medicine. 1990;10(2):71-4 (chi*).
752- gera: 61233/di/ra
[STUDY ON THE RELATION BETWEEN CHANGES
OF PLASMA CAMP, CGMP AND THE CLINICAL
CONDITIONS, PATHOLOGY AND TCM-TYPE IN 50
CASES OF CHRONIC SEVERE ICTERIC
HEPATITIS]. HE JIANGPING ET AL. chinese journal of
integrated traditional and western medicine.
1990;10(2):75-7 (chi*).
Plasma of cAMP and cGMP in 30 cases of chronic active
hepatitis (group of cholestatic patients) as well as in 20 cases
of chronic hepatitis with submassive or massive necrosis
(group of chronic severe hepatitis patients) were studied with
125I-marked radioimmunoassay. 50 cases with their serum
bilirubin levels higher than 171 mumol/L were selected as
subjects for this study. Among them, 42 were diagnosed as
hepatitis B, 6 as coinfection of hepatitis A and B. According
to differentiation of symptoms and signs of TCM, 24 were
diagnosed as simple hepatitis due to blood stasis and blood
heat, 17 as hepatitis due to blood stasis and blood heat
accompanying symptoms of Yang deficiency of the Spleen
and Kidney. 20 healthy persons were selected as controls.
The results were as follows: cAMP was 56. 82 ± 25. 54 ng/L
and 80. 32 ± 20. 73 ng/L, and cGMP was 9. 07 ± 6. 56 ng/L
and 19. 49 ± 9. 34 ng/L in the group of cholestatic patients
38
and in the group of chronic severe hepatitis patients
respectively. Both were higher than those in the control group
whose cAMP was 14. 12 ± 3. 25 ng/L and cGMP was
753- gera: 61244/di/ra
[DISCUSSION ON SOME ASPECTS OF CLINICAL
OBSERVATION ON TCM-WM TREATMENT OF
VIRAL HEPATITIS]. ZHANG YUXUAN ET AL. chinese
journal of integrated traditional and western medicine.
1990;10(2):116-122 (chi).
754- gera: 61259/di/ra
[EMPHASIZING THE EFFECT OF SPACE-TIME ON
THE STUDY OF TCM-WM. A HYPOTHESIS BASED
ON THE APPLICATION OF ZI-WU-LIU-ZHU IN THE
TREATMENT]. LIU LUMING ET AL. chinese journal of
integrated traditional and western medicine.
1990;10(1):50-8 (chi).
755- gera: 61352/di/ra
[RESEARCH OF CHINESE MATERIA MEDICA
ANTI-HBsAG HERBS EMPLOYING ELISA
TECHNIQUE]. ZHENG MIN SHI ET AL. chinese journal
of integrated traditional and western medicine.
1990;10(9):560-69 (chi).
756- gera: 61458/di/ra
[STUDIES ON THE TREATMENT OF ACUTE VIRAL
HEPATITIS WITH TABLETS OF REFINED RADIX
ET RHIZOMA RHEI]. JIAO DONGHAI ET AL. journal
of traditional chinese medicine. 1990;31(9):35-7 (eng).
757- gera: 61459/di/ra
[TREATMENT OF CHRONIC HEPATITIS B BY
INJECTION OF LIQUID MEDICINE INTO
ACUPOINT]. LIAN WEIZHEN. journal of traditional
chinese medicine. 1990;31(9):38-41 (eng).
758- gera: 61479/di/ra
[TALKING ABOUT THE MULTIPLE INFECTIONS
OF HEPATIC VIRUS AND ITS TREATMENT]. CHEN
LIHUA. journal of traditional chinese medicine.
1990;31(10):50-1 (eng).
759- gera: 61513/di/ra
[A DISCUSSION ON THE RELATIONSHIP BETWEEN
THE LIVER DISEASE IN TCM AND LIVER AND
GALLBLADDER DISORDERS IN WESTERN
MEDICINE]. CHEN ZEQI ET AL. new journal of
traditional chinese medicine. 1990;22(9):12-3 (chi).
760- gera: 61525/di/ra
[DISEASE DIFFERENTIATION, SYMPTOM-SIGN
DIFFERENTIATION AND TREATMENT OF
CHRONIC VIRAL HEPATITIS. BRIEF ANALYSIS ON
MME SHI YOUXIN'S]. GUO JIA. shanghai journal of
traditional chinese medicine. 1990;9:6-8 (chi).
761- gera: 61545/di/ra
[EFFECT OF OUR DESIGNED "ZHU BIE POWDER"
ON INVERTED PLASMA A/G IN 32 CASES OF
HEPATIC DISEASES]. KANG DIAN HONG. shanxi
journal of traditional chinese medicine. 1990;6(5):24-42
(chi).
762- gera: 61567/di/ra
[YI ZHUAN LING IN CHRONIC HEPATITIS B].
ZHANG RUIXIA ET AL. shaanxi traditional chinese
medicine. 1990;11(10):440-41 (chi).
gera 2011

763- gera: 61572/di/ra
[INVIGORATE THE SPLEEN AND REMOVE BLOOD
STASIS FOR MIDDLE AND LATER PERIOD
CANCER OF LIVER]. XIE YUANMING. shaanxi
traditional chinese medicine. 1990;11(10):448-49 (chi).
764- gera: 61606/di/ra
[PRELIMINARY EVALUATION OF PSYCHIATRIC
TREATMENT IN PATIENTS OF LIVER DISEASES,
REPORT OF 300 CASES]. WU ZONGLIN ET AL. tianjin
journal of traditional chinese medicine. 1990;4:15-6 (chi).
765- gera: 61609/di/ra
[EFFECT OF LIPID PEROXIDE AND MYOCARDIAL
LIPIFUSCIN CONTENT IN RAT LIVER]. WANG
XUEMEI ET AL. tianjin journal of traditional chinese
medicine. 1990;4:34-5 (chi).
766- gera: 61750/nd/re
[EFFECTS OF DANSHEN AND CHISHAO ON
PLASMA FIBRONECTIN IN RATS WITH
EXPERIMENTAL LIVER DAMAGE]. QI XIN GUANG.
chinese pharmaceutical journal. 1990;19(3):161-165
(chi*).
767- gera: 61807/di/ra
[A DISCUSSION ON THE TREATMENT OF
HEPATITIS B BY TCM AND ITS GENERAL
SITUATION]. SHEN ZHONGHOU. new journal of
traditional chinese medicine. 1990;22(5):10-1 (chi).
768- gera: 61817/di/ra
[EXEMPLIFICATIONS OF LI PEIYING'S
EXPERIENCE IN THE TREATMENT OF VIRAL
HEPATITIS]. LI SAIGENG. new journal of traditional
chinese medicine. 1990;22(4):7-9 (chi).
769- gera: 61844/di/ra
[RELATIONSHIP BETWEEN BLOOD STASIS AND
CHRONIC VIRAL HEPATITIS B]. PENG
SHENGQUAN ET AL. new journal of traditional chinese
medicine. 1990;22(2):10-2 (chi).
770- gera: 61921/di/ra
[ON TREATMENT OF CHRONIC HEPATITIS WITH
QI GONG]. LI DA BIN. qi gong. 1990;11(3):106. (chi).
771- gera: 61971/di/ra
[THE SHORT TERM EFFECT OF HERBAL
APPLICATION METHOD TO TREAT HEPATO-
CIRRHOSIS WITH PORTAL HYPERTENSION].
HUANG QIN FENG ET AL. shanghai journal of
acupuncture and moxibustion. 1990;3:4-7 (chi).
772- gera: 61993/di/ra
[EFFECT OF POINT INJECTION ON HEPATIC
HEMODROMOGRAM OF LIVER CANCER
PATIENTS]. LIU LUMING. shanghai journal of
acupuncture and moxibustion. 1990;1:4-5 (chi).
773- gera: 61994/di/ra
[EFFECT OF POINT APPLICATION METHOD WITH
CHINESE HERBS FOR TREATMENT OF 40 CASES
OF HEPATITIS B]. LEE DIXING. shanghai journal of
acupuncture and moxibustion. 1990;1:6-7 (chi).
774- gera: 62035/di/ra
[ON THE METHOD OF REPLENISHING QI AND
PROMOTING BLOOD FLOW FOR TREATMENT OF
ASCITES OF HEPATOCIRRHOSIS]. WANG
39
ZHAOTENG ET AL. liaoning journal of traditional
chinese medicine. 1990;14(6):5-6 (chi).
775- gera: 62107/di/ra
[COMBINING TREATMENT OF TCM WITH
WESTERN MEDICINE TO 20 CASES OF SERIOUS
SUBACUTE HEPATITIS]. SONG ZHENG ET AL.
shandong journal of traditional chinese medicine.
1990;2:29. (chi).
776- gera: 62118/di/ra
[EFFECT OF EXTREMITY EFFICACIOUS
CAPSULES ON IMMUNO FUNCTION OF PATIENTS
WITH B TYPE CHRONIC PERSISTENT HEPATITIS].
WANG XINMING ET AL. shanghai journal of traditional
chinese medicine. 1990;7:29-28 (chi).
777- gera: 62119/di/ra
[ALCOHOL EXTRACTED RHUBARB TABLETS FOR
POST-HEPATITIS PERSISTENT JAUNDICE]. TANG
MENGGUANG. shanghai journal of traditional chinese
medicine. 1990;7:28-30 (chi).
778- gera: 62127/di/ra
[INJECTION OF AT AGENT (VB17 SIMILARITY)
FOR 324 CASES OF PRIMARY LIVER CANCER]. LEI
YONGZHONG ET AL. shanghai journal of traditional
chinese medicine. 1990;8:9-10 (chi).
779- gera: 62141/di/ra
[EXPERIMENTAL STUDY ON EFFECT TO
TONIFYING KIDNEY PRESCRIPTIONS FOR ANTI
HEPATIC CELL NECROSIS]. CHEN JIANJIE ET AL.
shanghai journal of traditional chinese medicine.
1990;6:7-8 (chi).
780- gera: 62147/di/ra
[REFINED RHUBARB TABLETS FOR INFANTILE
HEPATITIC SYNDROME]. SHI YU'MIN ET AL.
shanghai journal of traditional chinese medicine.
1990;6:19-35 (chi).
781- gera: 62163/di/ra
[TREATING 33 PATIENTS OF POSITIVE HBsAG
USING PERIPATETIC POWDER WITH ADDITIVES].
ZHANG YUANZHI. shanghai journal of traditional
chinese medicine. 1990;5:26-7 (chi).
782- gera: 62169/di/ra
[MECHANISM OF LIVER (WOOD) DISORDER
CAUSED BY BLOOD STASIS DUE TO
MYELOPROLIFERATIVE DISEASE AND ITS
THERAPY]. HUANG ZHENQIAO. shanghai journal of
traditional chinese medicine. 1990;4:1-2 (chi).
783- gera: 62170/di/ra
[DIFFERENTIATION AND TREATMENT OF POST-
HEPATITIS SYNDROME]. WANG GUOPING. shanghai
journal of traditional chinese medicine. 1990;4:4-5 (chi).
784- gera: 62180/di/ra
[GENERAL SITUATION OF PHARMACOLOGICAL
STUDY ON CHINESE MATERIA MEDICA FOR
PRIMARY LIVER CANCER]. NING ZEPO. shanghai
journal of traditional chinese medicine. 1990;4:30-2 (chi).
785- gera: 62181/di/ra
[EFFECT OF SPLEEN STRENGTHENING AND QI
REGULATING DRUGS ON RAT'S LIVER TUMOUR
INDUCED BY ETHYLENE ESTROGENIC PHENOL].
gera 2011

ZHANG QINRONG ET AL. shanghai journal of
traditional chinese medicine. 1990;4:33-6 (chi).
786- gera: 62183/di/ra
[TREATING 386 CASES OF SERIOUS ACUTE
ICTERIC HEPATITIS A WITH HERBAL CHINESE
MEDICINE]. WANG GUOSHENG ET AL. shanghai
journal of traditional chinese medicine. 1990;3:1-2 (chi).
787- gera: 62199/di/ra
[OBSERVATION ON EFFECTS OF TREATING 37
CASES OF ACUTE VIRAL HEPATITIS A OF
GALLBLADDER OBSTRUCTION TYPE]. WANG
YUQUN ET AL. shanghai journal of traditional chinese
medicine. 1990;2:6-5 (chi).
788- gera: 62208/di/ra
[SUPPORTING VITAL ESSENCE IN PREVENTION
AND TREATMENT FOR LIVER CANCER]. WANG
XIWEN. shanghai journal of traditional chinese medicine.
1990;2:26-33 (chi).
789- gera: 62249/di/ra
[TRIAL DISCUSSION ON CLASSIFICATION OF
HEPATITIS B BASED ON DIFFERENTIATION OF
SYMPTOMS AND SIGNS OF TCM]. LUO GUOJUN ET
AL. shanxi journal of traditional chinese medicine.
1990;6(1):13-6 (chi).
790- gera: 62277/di/ra
[TREATING 30 CASES OF SEVERE VIRAL
HEPATITIS WITH TCM WM]. CHEN AIPING ET AL.
yunnan journal of traditional chinese medicine.
1990;11(2):17-44 (chi).
791- gera: 62622/di/ra
[EFFECTS OF COMPOUND HUANGQI EXTRACT ON
EXPERIMENTAL HEPATIC INJURY IN RATS].
ZHANG YUNHAN ET AL. traditional chinese medicinal
research. 1990;3(3):24-5 (chi*).
The experimental study was carried out on experimental
hepatic injury in rats by Chinese Herbs "Compound Huangqi
Extract" (CHQE). The results showed that SGPT and hepatic
histological changes in the control group induced by
tetrachlirmethane (CCl4) were abnormal obviously. CHQE
decreased SGPT level and had a marked protection to hepatic
tissue. It might be concluded that CHQE had remarkable
liver-protective action.
792- gera: 62636/di/ra
[STUDIES ON THE PREVENTIVE AND
THERAPEUTIC ACTIONS OF "XIAOYAO" PULVIS
ON EXPERIMENTAL CIRRHOSIS]. MA XUE HUI ET
AL. chinese traditional and herbal drugs. 1990;21(11):28-
30 (chi).
793- gera: 62643/di/ra
[HAVING AN EFFECT NEUTROPHIL OF CARRIER
OF HBsAg BY "XIAN DAI XIAO ZHOU TIAN GONG"
(A TYPE OF QIGONG)]. YANG LIN GUAN ET AL. qi
gong. 1990;11(12):535-36 (chi).
794- gera: 62733/di/ra
[THE 6TH NATIONAL CONFERENCE OF VIRAL
HEPATITIS. SUMMARY OF TCM-WM PART]. WANG
HUI JI. chinese journal of integrated traditional and
western medicine. 1990;10(11):702. (chi).
795- gera: 62759/di/ra
[A RESEARCH ON THE ACTION OF TRADITIONAL
40
CHINESE MEDICINES ON DNA REPRODUCTION IN
LIVER CELLS IN VITRO]. XU CUIHUA ET AL. china
journal of chinese materia medica. 1990;15(11):51. (chi*).
796- gera: 62795/di/ra
[CLINICAL SIGNIFICANCE OF WINTER SWEAT
SYNDROME IN VIRUS HEPATITIS]. ZHU YOUCAI ET
AL. journal of traditional chinese medicine.
1990;31(11):27-8 (eng).
797- gera: 62798/di/ra
[OBSERVATION ON THE CURATIVE EFFECT OF
CHI SHAO YU JIN PILL TREATING BILIRUBIN
INCREASE]. LI QIUGUI ET AL. journal of traditional
chinese medicine. 1990;31(11):37-8 (eng).
798- gera: 62846/di/ra
[THE TREATMENT OF CHRONIC VIRUS
HEPATITIS BASED ON DIFFERENTIATION OF
SYNDROMES OF SPLEEN : A REPORT OF 100
CASES]. LI HUAMIN. jiangsu journal of traditional
chinese medicine. 1990;11(11):7-9 (chi).
799- gera: 62848/di/ra
[A CASE REPORT ON THE TREATMENT OF
MULTIPLE ANGIOMA OF THE LIVER]. HUANG
TING ET AL. jiangsu journal of traditional chinese
medicine. 1990;11(11):16-21 (chi).
800- gera: 62967/di/ra
[EXPERIMENTAL OBSERVATION ON SUBMUCOUS
VENOUS CONGESTION OF TONGUE ROOT OF
RABBIT AFTER INCOMPLETE BLOCKING OF
HEPATIC VEINS]. LI XINGGUO ET AL. yunnan journal
of traditional chinese medicine. 1990;11(6):35-41 (chi).
801- gera: 62975/di/ra
[ANALYSIS OF EFFECT ON TREATMENT OF 115
CASES OF ACUTE HEPATITIS A WITH
PINGBUQINGXIA METHOD]. SU YONGQING. beijing
journal of traditional chinese medicine. 1990;6:18-9 (chi).
802- gera: 62976/di/ra
[EXPERIENCE OF TREATMENT OF HEPATITIS B
VIRUS MARKER POSITIVE WITH WAIDAFUQI
METHOD : A REPORT OF 203 CASES]. SHI
ZHONGSHUN ET AL. beijing journal of traditional
chinese medicine. 1990;6:20-3 (chi).
803- gera: 62977/di/ra
[SEVERE HEPATITIS TREATED BY COMBINATION
OF TCM AND WESTERN MEDICINE : A REPORT OF
101 CASES]. ZHANG XUDONG. beijing journal of
traditional chinese medicine. 1990;6:24-37 (chi).
804- gera: 62982/di/ra
[STUDY AND PROSPECT FOR TREATMENT OF
HEPATOPATHY WITH TCM]. YU SHOUSHAN ET AL.
beijing journal of traditional chinese medicine. 1990;6:50.
(chi).
805- gera: 63012/di/ra
[PROTECTIVE EFFECT OF CHINESE HERBAL
MEDICINE "YI GAN" ON EXPERIMENTAL LIVER
DAMAGE]. LUO GUO JUN ET AL. shanxi journal of
traditional chinese medicine. 1990;6(6):25-31 (chi).
806- gera: 63024/di/ra
[AN OBSERVATION ON THE CURATIVE EFFECT
OF 100 CASES OF INFANTILE ACUTE
gera 2011

ICTEROHEPATITIS]. GAO BINGE ET AL. shanxi
journal of traditional chinese medicine. 1990;6(3):32.
(chi).
807- gera: 63040/di/ra
[ANALYSIS OF THE PATHOGENESIS AND
DIFFERENTIATION OF 56 CASES OF
TYMPANITES]. YANG JINXIANG ET AL. journal of
beijing college of traditional chinese medicine. 1990;5:28-
9 (chi).
808- gera: 63325/di/ra
[ANALYSIS OF 70 CASES OF PRIMARY LIVER
CARCINOMA TREATED BY PU TUO PLASTER AND
HERBS]. WANG DE LONG. chinese journal of integrated
traditional and western medicine. 1990;10(12):723-25
(chi*).
This paper deals with 70 cases of primary liver cancer treated
by externally applying Putuo Plaster and internally taking
oral Chinese herbal medicine. In term of the statistics, of all
the cases applied the plaster, 96.7%. has proved to be
effective in alleviating the pain and 83.5% was remarkable. It
has significantly improved the quality of the patients' later
lifes. Applying Putuo Plaster with taking oral Chinese herbal
medicine, the patients could survive longer. On average, after
the treatment, the patient could live ten and half months,
44.8% of the II-stage liver cancer patients applied the plaster
could live as long as one year, the longest one has been living
more than
809- gera: 63778/di/ra
[TREATING 30 CASES OF ASCITES DUE TO
CIRRHOSIS WITH "HUANG GOU DAN WAN" (PILL
OF DOG'S GALLBLADDER)]. CAO SHU-HE ET AL.
zhejiang journal of traditional chinese medicine.
1990;25(7):294 (chi).
810- gera: 63780/di/ra
[TREATING 120 CASES OF INFANTILE VIRUS
HEPATITIS WITH "BAI YIN QI JIN TANG"]. ZHAO
HENG. zhejiang journal of traditional chinese medicine.
1990;25(7):303 (chi).
811- gera: 63801/di/ra
[TREATING ASCITES DUE TO CIRRHOSIS WITH
CHINESE MATERIA MEDICA]. QIAN JUN-DA ET AL.
zhejiang journal of traditional chinese medicine.
1990;25(9):403 (chi).
812- gera: 63830/di/ra
[WANG XUZHAI'S EXPERIENCE FOR CHRONIC
HEPATITIS]. LI XIUHUI. shaanxi traditional chinese
medicine. 1990;11(2):50 (chi).
813- gera: 63831/di/ra
[CHINESE MATERIA MEDICA FOR CHRONIC
HEPATITIS]. HUANG QINGYUN ET AL. shaanxi
traditional chinese medicine. 1990;11(2):52 (chi).
814- gera: 63832/di/ra
[REINFORCING (KIDNEY AND STRENGTHENING)
SPLEEN THERAPY FOR CHRONIC HEPATITIS]. LU
WENLIN ET AL. shaanxi traditional chinese medicine.
1990;11(2):53 (chi).
815- gera: 63833/di/ra
[DAN JU QING GAN DECOCTION FOR HEPATITIS
B]. ZHU JIUZI. shaanxi traditional chinese medicine.
1990;11(2):54 (chi).
41
816- gera: 63834/di/ra
[ASTRAGALUS MEMBRANACEUS AND GAN YAN
DECOCTION FOR VIRAL HEPATITIS]. HAO
SHUWEN. shaanxi traditional chinese medicine.
1990;11(2):57 (chi).
817- gera: 63835/di/ra
[CHINESE MATERIA MEDICA FOR VIRAL
HEPATITIS]. YU MING. shaanxi traditional chinese
medicine. 1990;11(2):60 (chi).
818- gera: 63844/di/ra
[STUDIES OF PATHOLOGY-MORPHOLOGY ON
MEI FAN SHI PREVENTING RAT'S LIVER DAMAGE
BY ALCOHOL]. REN CHANGQING ET AL. shaanxi
traditional chinese medicine. 1990;11(2):87 (chi).
819- gera: 63879/di/ra
[QIANG LI NING FOR THE VIRAL HEPATITIS]. LIU
GUANGHAN. shaanxi traditional chinese medicine.
1990;11(5):197 (chi).
820- gera: 63884/di/ra
[YIN LING CHAI JIN DECOCTION FOR THE VIRAL
HEPATITIS]. ZHANG SHUANGBIN. shaanxi traditional
chinese medicine. 1990;11(5):206 (chi).
821- gera: 63885/di/ra
[YU GAN DECOCTION FOR THE ACUTE VIRAL
HEPATITIS]. LIU QINGRONG. shaanxi traditional
chinese medicine. 1990;11(5):207 (chi).
822- gera: 80755/di/ra
EFFECTS OF NEEDLING AT RENZHONG
ACUPOINT ON HISTOCHEMISTRY,HISTOLOGY
AND ULTRASTRUCTURE OF THE LIVER IN
RABBITS WITH HEMORRHAGIC SHOCK. ZHAI LI
ET AL. journal of traditional chinese medicine.
1990;10(1):42-8 (eng).
823- gera: 80757/di/ra
APPLICATION OF TRADITIONAL CHINESE DRUGS
IN COMPREHENSIVE TREATMENT OF PRIMARY
LIVER CANCER. LIU FANG. journal of traditional
chinese medicine. 1990;10(1):54-60 (eng).
The present paper is a summary for treating 50 cases of Stage
II primary liver cancer by the Integrated method of traditional
Chinese and Western medicine.It was found by comparative
observation that the average survival time of the Spleen-
Deficiency (SD) type patients was markedly longer than that
of Phlegm-Dampness-Stagnancy (PDS), Qi- and Blood-
Stagnancy (QBS) and Liver-Kidney-Yin-Deficiency (LKYD)
types, indicating that the SD type patients might have a better
prognosis, and that the Chinese herbal medicine was an
alternative for treating
824- gera: 80762/di/ra
THERAPEUTIC EFFECTS OF GINSENG AND
MITOMYCIN C ON EXPERIMENTAL LIVER
TUMORS. DOU MONG HAU ET AL. international
journal of oriental medicine. 1990;15(1):10-4 (eng).
825- gera: 80887/di/ra
[ACUPUNCTURE THERAPY FOR VIRAL
HEPATITIS]. X. journal of the japan society of
acupuncture. 1990;40(1):36. (jap).
826- gera: 81004/di/ra
[ACUPUNCTURE THERAPY ON CHRONIC
HEPATITIS]. X. journal of the japan society of
gera 2011

acupuncture. 1990;40(1):169. (jap).
827- gera: 81324/di/ra
MEDICINAL PLANTS USED FOR THE TREATMENT
OF HEPATITIS IN TAIWAN. CHUN CHING LIN ET
AL. american journal of chinese medicine. 1990;18(1-
2):35-44 (eng).
828- gera: 81730/di/el
CIRRHOSIS. BI YONGSHENG ET AL. chinese qigong,
publishing house of shanghai college of tcm, shanghai.
1990;:306-11 (eng).
829- gera: 81768/di/el
CIRRHOSIS. ZHENG WENGAO ET AL. in chinese
medicated diet, publishing house of shanghai college of
tcm, shanghai. 1990;:252-66 (eng).
830- gera: 81806/di/el
VIRAL HEPATITIS. ZHENG WENGAO ET AL. in
chinese medicated diet, publishing house of shanghai
college of tcm, shanghai. 1990;:568-81 (eng).
831- gera: 81811/di/el
VIRAL HEPATITIS. LU JIANPING ET AL. in chinese
acupuncture and moxibustion, publishing house of
shanghai college of tcm,. 1990;:462-65 (eng).
832- gera: 81860/di/ra
VIRAL HEPATITIS. ZHANG ENQIN ET AL. in clinic of
tcm (1), publishing house of shanghai college of tcm,
shanghai. 1990;:10-23 (eng).
833- gera: 81874/di/ra
HEPATOCIRRHOSIS. ZHANG ENQIN ET AL. in clinic
of tcm (1), publishing house of shanghai college of tcm,
shanghai. 1990;:132-41 (eng).
834- gera: 82175/di/cg
THERAPEUTIC EFFECT ON HEPATITIS A WITH
THE AURICULAR-POINT THERAPY. ZHU YUWEI ET
AL. 2eme congres mondial d'acupuncture et moxibustion,
paris. 1990;:111. (eng).
835- gera: 82280/di/cg
THE EFFECTS OF ACUPUNCTURE AND ITS
REINFORCING AND REDUCING MANIPULATIONS
ON IMMUNOSURVEILLANCE AND T-CELLS
SUBSETS IN THE PATIENTS WITH PRIMARY
BRONCHOGENIC CARCINOMA AND PRIMARY
CARCINOMA OF LIVER. YU YAOCAI ET AL. 2eme
congres mondial d'acupuncture et moxibustion, paris.
1990;:184. (eng).
. medicine and pharmacology. 1991;1:42. (chi).
836- gera: 82641/di/ra
APPLICAZIONE DELLA FARMACOLOGIA
TRADIZIONALE CINESE NEL TRATTAMENTO
GLOBALE DEL CANCRO DEL FEGATO. LIU FANG.
rivista italiana di medicina tradizionale cinese. 1990;4:37-
41 (ita).
837- gera: 83204/di/ra
ACUPUNCTURE AND ACUPOINT INJECTION FOR
LATE STAGE PRIMARY LIVER CANCER. CHEN
YUFEN. american journal of acupuncture.
1990;18(4):355-57 (eng).
This paper reports on the result of the treatment with
acupuncture and acupoint injection combined with traditional
and general medicine (excluding chemotherapy and
42
radiotherapy) in 34 cases of late stage primary liver cancer.
After treatment, the tumor disappeared in two patients who
recovered their health and were able to work 3 years, 3
months and 4 years, 2 months respectively. Another three
patients lived comfortably with their tumor 2-4 years and
were able to do regular housework. Median survival after
treatment of the 34 cases was 7. 84 months. Pain in all
838- gera: 83958/di/ra
APLICACION DE LA FARMACOPEA TRADICIONAL
CHINA (FTC) EN EL TRATAMIENTO COMBINADO
DEL CANCER PRIMARIO DE HIGADO. LIU FANG.
revista de la medicina tradicional china. 1990;1(1):60
(esp).
839- gera: 29219/di/ra
[SUMMARIZATION OF CHRONIC HEPATIC
DYSFUNCTION RESEARCH GROUP. X. journal of the
japan society of acupuncture. 1991;41(1):11. (jap).
840- gera: 29250/di/ra
[ACUPUNCTURE TREATMENTS FOR CHRONIC
HEPATITIS AND EARLY LIVER CIRRHOSIS. WITH
SPECIAL REFERENCE TO THE REGULATION OF
SERUM TRANSAMINASE, A FETOPROTEIN (AFP)
AND R15ICG. X. journal of the japan society of
acupuncture. 1991;41(1):90. (jap).
841- gera: 37309/di/ra
DIE WIRKUNG VON PANAX GINSENG AUF DAS
DURCH DIATHYLNITROSAMIN AUSGELOSTE
LEBERKARZINOM DER RATTE EINEGEHENDE
STUDIE. LI X ET AL. journal of tongji medical
university. 1991;11(2):73-80 (deu*).
The curative effects of Panax ginseng on hepatocellular
carcinoma (HCC) in rats induced by diethylnitrosamine
(DEN) were further studied. The size of cancerous nodes was
quantitatively measured by image analysis instrument. The
hepatocellular hyperplastic foci were quantitatively analysed
with gamma-GT stain under microspectrophotometer.
Pathological changes of hepatocytes were observed under
light and electron microscope. The results of the investigation
indicated that ginseng had significant inhibitory effect on
HCC in rats induced by DEN and prolonged the survival time
of the rats with HCC. The mechanism of inhibition of the
development of HCC by ginseng was also preliminarily
approached.
842- gera: 62372/di/ra
[TREATING 54 CASES OF ASCITES DUE TO LIVER
CIRRHOSIS AFTER HEPATITIS B WITH
"REINFORCING LIVER AND ELIMINATING DAMP
DECOCTION"]. YANG SHIZHONG ET AL. acta chinese
843- gera: 62482/di/ra
[OBSERVATION ON CURATIVE EFFECTS OF
HEPATITIS B TREATED WITH TCM-WM ON 240
CASES]. WANG MINCONG. the practical journal of
integrating chinese with modern medicine. 1991;4(2):95-9
(chi).
844- gera: 62493/di/ra
[RESEARCH ON CHRONIC ACTIVE HEPATITIS B
TREATED WITH HUO XUE HUA YU]. MENG JIAN ET
AL. the practical journal of integrating chinese with
modern medicine. 1991;4(3):154-55 (chi).
English translation in Abstract & Review of clinical TCM,
1991(1),13-16.
gera 2011

845- gera: 62508/di/ra
[STUDY ON PROTECTIVE MECHANISM OF SALVIA
MILTIORRHIZA AND PAEONIA LACTIFLORA FOR
EXPERIMENTAL LIVER DAMAGE]. QI XIN GUAN
ET AL. chinese journal of integrated traditional and
western medicine. 1991;11(2):102-04 (chi*).
The results showed that Salvia Miltiorrhiza (SM) and Paeonia
Lactiflora (PL) could increase plasma fibronectin levels in
rats, and improve the reticuloendothelial system function and
plasma opsonic activity. Aggregation of microaggregated
albumin, collagen fragment and immune complexes were
markedly reduced. Liver immune damage and
microcirculation disorder were avoided. Meanwhile, PFN
could cause increase of phagocytosis of Kupffer cell to
endotoxin. It is concluded that SM and PL play an important
role in protective hepatocyte.
846- gera: 62511/di/ra
[PREVENTIVE EFFECT OF RE DU QING ON
HEPATOCYTES AND MITOCHONDRIA DAMAGED
BY LIPID PEROXIDATION IN EXPERIMENTAL
RABBITS WITH ENDOTOXIN-INDUCED DIC]. DENG
ZE MING ET AL. chinese journal of integrated traditional
and western medicine. 1991;11(2):110-15 (chi*).
847- gera: 62521/di/ra
[STUDY ON THE TONGUE PICTURE OF BLOOD
STASIS SYMPTOM-COMPLEX]. LI NAI MIN ET AL.
chinese journal of integrated traditional and western
medicine. 1991;11(1):28-30 (chi*).
The objective indices of tongue picture of blood stasis
symptom-complex in 400 patients with portal hypertension,
primary hepatic carcinoma, coronary heart disease,
pulmonary heart disease, intermediate and advanced gastric
carcinoma were observed during the period of past 6 years.
Pale purplish tongue, purplish tongue, bluish purplish tongue,
deep-red purplish tongue, dark tongue, yellow purplish
tongue etc. were found in these patients. All these were the
tongue colour of blood stasis. Ecchymosis, patechiae, streaks,
the width of sublingual vein, the appearance of veins and
prominences, B mode ultrasonic examination displaying the
width of intralingual vein and tissue sound transmission of
the tongue body, the blood stasis changes of tongue tip
microcirculation, the wave form changes of tongue rheogram
had an important significance for diagnosis of blood stasis.
There were significant differences in these variables between
the subject group and the healthy group or the subject group
and
848- gera: 62552/di/ra
[APPROACH TO SYNDROME TYPES AND LONG-
TERM INVESTIGATION ON PERSISTENTLY
INFECTED PERSONS OF HEPATITIS B VIRUS]. LI
FUSHAN ET AL. journal of traditional chinese medicine.
1991;32(2):33-4 (eng).
849- gera: 62553/di/ra
[A STUDY ON REMOVING JAUNDICE IN SEVERE
ICTEROHEPATITIS BY A SERIES OF
PRESCRIPTIONS]. HE JIANGPING ET AL. journal of
traditional chinese medicine. 1991;32(2):35-40 (eng).
850- gera: 63142/di/ra
[50 CASES OF CHRONIC ACTIVE HEPATITIS
TREATED BY ROOT RADIX SOPHORAE
TONKINENSIS OF INJECTION]. SONG ZHENG ET
AL. shandong journal of traditional chinese medicine.
1991;1:20-3 (chi).
851- gera: 63146/di/ra
43
[PREVENTION AND TREATMENT FOR SEVERAL
KINDS OF UNCOMMON HEPATIC DISEASES].
WANG SHAOHUA. journal of traditional chinese
medicine. 1991;32:13-4 (eng).
852- gera: 63147/di/ra
[SELECTIVE RECOMMENDATION OF WANG
WENZHENG'S EXPERIENCE IN TREATMENT OF
HEPATIC DISEASES]. YIN CHANGJIAN. journal of
traditional chinese medicine. 1991;32:15-7 (eng).
853- gera: 63150/di/ra
[STUDY ON TREATMENT OF SEVERE HEPATITIS
BY THE METHOD OF TONIFIYING PATIENT'S
VISCERA WITH ANIMAL VISCERA]. LIN HONG ET
AL. journal of traditional chinese medicine. 1991;32:23-6
(eng).
854- gera: 63151/di/ra
[OBSERVATION ON CONTROL TREATMENT OF
TCM AND WESTERN MEDICINE FOR NON-A NON-
B HEPATITIS]. ZHANG FUXIU ET AL. journal of
traditional chinese medicine. 1991;32:23-6 (eng).
855- gera: 63258/di/ra
[EXPERIENCE IN CURE OF 4 CASES OF LIVER
DISEASE]. XIE ZHAOFENG. jiangsu journal of
traditional chinese medicine. 1991;12(1):14-5 (chi).
856- gera: 63265/di/ra
[THE RELATIONSHIP BETWEEN CLINICAL
STAGES OF PRIMARY HEPATOMA AND PICTURES
OF THE TONGUE : AN ANALYSIS OF 128 CASES].
FENG XIAOLING ET AL. jiangsu journal of traditional
chinese medicine. 1991;12(1):41-5 (chi).
857- gera: 63497/di/ra
[OBSERVATION ON TREATMENT OF
POSTHEPATITIC CIRRHOSIS BY EXTRACT OF
SEMEN PERSICAE PLUS CORDYCEPS MYCELIA].
LIU CHENG ET AL. journal of traditional chinese
medicine. 1991;32(7):15 (eng).
858- gera: 63528/di/ra
[STUDY ON BLOOD RHEOLOGY OF CIRRHOSIS].
HOU LIUIA ET AL. traditional chinese medicinal
research. 1991;4(2):21 (chi*).
The indexes of blood rheology in 39 cirrhosis patients were
observed in this paper. The results showed that : (1). In the
non-ascites group, blood was ropy, the value of specific
viscosity of whole blood and plasma were high, packed cell
volume was increased, (2). In the ascites group, blood was
dilute, the value of specific viscosity of whole blood and
sympexis exponent were low, packed cell volume was
decreased. These findings suggested that the changes of
blood rheology in cirrhosis patients might reflect the
pathological state of blood stasis and blood deficiency of
859- gera: 63647/di/ra
[TREATING PRINCIPLE FOR MISTREATMENT OF
LIVER DISEASE]. CHANG CHUNTAO. shanghai
journal of traditional chinese medicine. 1991;6:14 (chi).
860- gera: 63648/di/ra
[CLINICAL OBSERVATION ON EFFECT ON
INFANTILE HEPATITIS SYNDROME, 28 CASES].
CHEN JIANNING. shanghai journal of traditional chinese
medicine. 1991;6:18 (chi).
861- gera: 63675/di/ra
gera 2011

[EXPERIMENTAL STUDY ON THE EFFECT OF
"WUJI BAIFENG WAN" IN TREATING CIRRHOSIS].
HU YI-YANG ET AL. zhejiang journal of traditional
chinese medicine. 1991;26(5):231 (chi).
862- gera: 63677/di/ra
[PROF. DU YUMOU'S EXPERIENCE IN CHRONIC
ACTIVE HEPATITIS B FOR DEALING WITH
INDICES ABNORMAL BIOCHEMISTRY]. ZHANG
XIKUI. new jounal of traditional chinese medicine.
1991;23(5):2 (chi).
863- gera: 63970/di/ra
[BRIEFLY DISCUSSION ON THE TREATMENT AND
CARE AFTER THE EXTINCTION OF ASCITES DUE
TO CIRRHOSIS]. ZHU JIANHUA. journal of beijing
college of traditional chinese medicine. 1991;2:33 (chi).
864- gera: 64167/di/ra
[EFFECT OF POLYPORUS UMBELLATUS
POLYSACCHARIDE ON FUNCTION OF
MACROPHAGES IN THE PERITONEAL CAVITIES
OF MICE WITH LIVER LESIONS]. ZHANG YING-
HUA ET AL. chinese journal of integrated traditional and
western medicine. 1991;11(4):225 (chi*).
865- gera: 64174/di/ra
[COMBINATION OF PHENTALAMINE AND
ANGELICINI IN CHOLESTASIS AND SEVERE TYPE
OF CHRONIC ACTIVE HEPATITIS B]. YU DI-XIA ET
AL. chinese journal of integrated traditional and western
medicine. 1991;11(3):135 (chi*).
866- gera: 64178/di/ra
[STUDY ON THE RELATIONSHIP BETWEEN
CHRONIC HEPATITIS AND CIRRHOSIS IN THE
TYPE OF DIFFERENTIATION OF SYMPTOMS AND
SIGNS AND ENDOCRINE HORMONE]. ZHANG JUN-
FU ET AL. chinese journal of integrated traditional and
western medicine. 1991;11(3):147 (chi*).
In order to investigate the objective index of the type of
differentiation of symptoms and signs between chronic
hepatitis and cirrhosis, the levels of serum Tes, ALD, HCT,
INS, GR, gastrin, T3, T4, TSH were tested in the chronic
hepatitis and cirrhosis of 27 cases of sthenia-syndrome and
61 cases of asthenia-syndrome. Meanwhile, 30 cases of
healthy people were taken as the control. The results
indicated that the levels of serum Tes, T3, T4, gastrin in the
group of asthenia-syndrome (P < 0. 01, P < 0. 05). The levels
of serum T4 and gastrin were increased in the group of
sthenia-syndrome than in the groups of asthenia-syndrome
and control (P < 0. 01). The levels of serum ALT, HCT, INS,
and GR were significantly different between the group of
asthenia-syndrome and that of sthenia- syndrome. This
suggests that clinic symptoms were concerned with the level
of serum endocrine on chronic hepatitis and cirrhosis, such as
the function of genital, thyroid, adrenal gland and pancreas.
The observation of the levels of serum Tes, T3, T4, ALT,
INS, GR and gastrin may be an objective index to
differentiate the chronic
867- gera: 64211/di/ra
[CLINICAL OBSERVATION ON 203 CASES OF
VIRULENT HEPATITIS TREATED WITH ACUPOINT
METHOD]. LIN HANCHENG ET AL. chinese
acupuncture and moxibustion. 1991;11(3):9 (chi*).
The article summarizes the clinical observation on 203 cases
of virulent hepatitis who were treated with several methods at
acupoints. The methods included acupuncture, acupuncture in
combination with ear-acu-pressure, ear- acu-pressure
44
combined with medication acupuncture combined with
acupoint injection and at the same time 60 cases with
medication therapy were observed as the controlled group.
The result exhibits that all the methods have fairly
satisfactory therapeutical effect in treating virulent hepatitis,
but the methods of acupuncture combined with acu-point-
injection and acupuncture combined with ear-acu-pressure
are the best effective, and X2 test proved that they are
superior to the controlled group (P<0.05) and the difference
is remarkable.
868- gera: 64281/di/ra
[STUDY ON CURING RAT LIVER INJURED BY CCL4
AND INSUFFICIENCY OF THE SPLEEN BY "HE
GAN ZHU PI YIN". EXPERIMENTAL RESEARCH ON
QUANTITATIVE HISTOLOGY, QUANTITATIVE
HISTOCHEMISTRY AND SERUM BIOCHEMISTRY].
XU WENZHONG ET AL. journal of beijing college of
traditional chinese medicine. 1991;1:46 (chi*).
This article discusses the mechanism of the function of "He
Gan Zhu Pi Yin". According to the indexes of quantitative
histology, quantitative histochemistry and serum
biochemistry, the author proved that the injury level of
hepatic injury model of insufficiency of the spleen is more
severe than that of simple hepatic injury model. Suggestion:
to avoid causing new iatrogenic diseases, it should not over
use the drugs of bitter flavour and cold
869- gera: 64413/di/ra
[CHRONIC HEPATITIS B TREATED BY
DECOCTION OF PARIS POLYPHILLA SMITH :
THERAPEUTIC EFFECT OF 112 CASES]. YOU
KAIHONG ET AL. fujian journal of traditional chinese
medicine. 1991;22(5):11 (chi).
870- gera: 64439/di/ra
[THE EFFECT OF DA HUANG SHU CHONG WAN IN
THE TREATMENT OF LIVER DISEASES]. LI
SHONGHUA. new journal of traditional chinese
medicine. 1991;23(11):13 (chi).
871- gera: 64452/di/ra
[ONE CASE OF HEPATOLENTICULAR
DEGENERATION WAS CURED BY CHINESE
DRUGS]. DENG ZHENMING. journal of traditional
chinese medicine. 1991;32(11):17 (eng).
872- gera: 64457/di/ra
[THERAPY OF MOTHER-INFANT VERTICAL
TRANSMISSION OF HEPATITIS B BY CHINESE
DRUGS]. LI GUI ET AL. journal of traditional chinese
medicine. 1991;32(11):32 (eng).
873- gera: 64571/di/ra
[A SUCCESSFUL CASE OF HEPATOLENTICULAR
DEGENERATION]. ZHAI WEILI. liaoning journal of
traditional chinese medicine. 1991;18(6):31 (chi).
874- gera: 64657/di/ra
[ANALYSIS OF CLINICAL EFFECTS IN TREATING
47 PREGNANCIES COMPLICATED WITH
HEPATITIS A]. FENG CHONGHUAN. shanghai journal
of traditional chinese medicine. 1991;12:11 (chi).
875- gera: 64759/di/ra
[ON THE EXPERIENCE FOR TREATING
POSTHEPATITIC CIRRHOSIS]. SHEN ZHONGYUAN.
hubei journal of traditional chinese medicine. 1991;6:31
(chi).
gera 2011

876- gera: 64818/di/ra
[DIFFERENTIATION OF SYNDROME IN THE
TREATMENT FOR ADVANCED STAGE CANCER OF
THE LIVER]. CUI KOUSHI. shaanxi traditional chinese
medicine. 1991;12(7):484 (chi).
877- gera: 64868/di/ra
[EXPERIENCE OF CHEN MAOWU FOR
TREATMENT OF HEPATITIS B]. GENG YUN ET AL.
jiangxi journal of traditional chinese medicine.
1991;22(6):11 (chi).
878- gera: 64885/di/ra
[PHARMACOLOGICAL STUDY ON ANTI-
HEPATITIS EFFECT OF COTINUS COGGYGRIA
SCOP. SYRUP]. SHEN QINGLIANG ET AL. china
journal of chinese materia medica. 1991;16(12):746 (chi*).
This paper shows that the Cotinus coggygria syrup has the
effect of protecting the liver from chemical damages,
reducing tension of the choledochal sphincter, increasing the
bile flow and raising the body immunity. The anti- hepatitis
effect may be carried out through decreasing transaminase,
normalizing functioning of the gallbladder, reducing icterus
and enhancing the immunity of the body.
879- gera: 64931/di/ra
[A CLINICAL RESEARCH ON CHRONIC HEPATITIS
TREATED WITH HEGAN ZHUPI DECOCTION]. XU
WENZHONG ET AL. acta medica sinica. 1991;6(3):16
(chi*).
This article reported that a short-term curative observation of
chronic hepatitis had been treated with Hegan Zhupi
Decoction by a method of qualitative response restricted
sequential trial. The results showed that the marked effective
rate of the group of Hegan Zhupi Decoction was 53.84%,
which was obviously superior to the control group. The
results also showed that the most patients with chronic
hepatitis had the symptom of spleen deficiency syndrome, so,
the bitter drugs in taste and cold drugs in nature should be
careful applied.
880- gera: 64933/di/ra
[AN EXPERIMENTAL ANALYSIS OF 75 CASES OF
CHRONIC ATROPHIC GASTRITIS TREATED WITH
A SERIES OF GRANULES OF CHINESE MATERIA
MEDICA]. WANG CHUIJIE ET AL. acta medica sinica.
1991;6(3):24 (chi*).
This article reported that a short-term curative observation of
chronic hepatitis had been treated with Hegan Zhupi
Decoction by a method of qualitative response restricted
sequential trial. The results showed that the marked effective
rate of the group of Hegan Zhupi Decoction was 53.84%,
which was obviously superior to the control group. The
results also showed that the most patients with chronic
hepatitis had the symptom of spleen deficiency syndrome, so,
the bitter drugs in taste and cold drugs in nature should be
careful applied.
881- gera: 64935/di/ra
[THE INHIBITORY EFFECT OF 400 KINDS OF
CHINESE HERBS ON HBSAG]. ZHENG MINSHI ET
AL. acta medica sinica. 1991;6(3):30 (chi).
882- gera: 64943/di/ra
[A SURVEY OF RESEARCH ON PRIMARY LIVER
CANCER TREATED WITH CHINESE HERBS]. WANG
XIMING. acta medica sinica. 1991;6(3):59 (chi).
883- gera: 65103/di/ra
[21 CASES OF HEPATIC ASCITES OF YANG
45
DEFICIENCY TYPE TREATED WITH THE METHOD
OF STRENGTHENING THE SPLEEN]. ZHONG
JANPING. liaoning journal of traditional chinese
medicine. 1991;18(3):22 (chi).
884- gera: 65112/di/ra
[THE TREATMENT OF INFANTILE
CYTOMEGALOVIRAL HEPATITIS WITH TCM]. YU
MINGYAN ET AL. journal of traditional chinese
medicine. 1991;32(3):31 (eng).
885- gera: 65178/di/ra
[CLINICAL STUDY ON POINT PLASTERING WITH
HERBAL DRUGS FOR POST-HEPATITIS
CIRRHOSIS]. HUANG JINGFENG ET AL. shanghai
journal of traditional chinese medicine. 1991;3:17 (chi).
886- gera: 65221/di/ra
[OBSERVATION ON CURATIVE EFFECT OF
JINGZHIDAHUANG TABLETS (RADIX ET
RHIZOMA RHEI) FOR ICTERUS HEPATITIS]. WU
WANFEN ET AL. chinese traditional patent medicine.
1991;13(10):18 (chi).
887- gera: 65240/di/ra
[STUDY ON THE RELATIONSHIP BETWEEN
PLASMA THROMBOXANE A2-PROSTACYCLIN
DESIQUILIBRIUM WITH DAMPNESS AND STASIS
OF VIRUS HEPATITIS PATIENTS]. YAN RUNMIN ET
AL. practical journal of integrating chinese with modern
medicine. 1991;4(8):453 (chi).
888- gera: 65241/di/ra
[EFFECTIVE OBSERVATION ON 45 CASES OF
PATIENTS OF ASCITES DUE TO CIRRHOSIS
TREATED WITH PROMOTING FLOW OF QI BY
REMOVING BLOOD STASIS]. XIA JUNHONG.
practical journal of integrating chinese with modern
medicine. 1991;4(8):455 (chi).
889- gera: 65242/di/ra
[CLINICAL ANALYSIS OF POSTHEPATITIS
ASCITES DUE TO CIRRHOSIS ON 36 CASES]. ZHOU
HONG. practical journal of integrating chinese with
modern medicine. 1991;4(8):456 (chi).
890- gera: 65243/di/ra
[OBSERVATION OF TREATING CIRRHOSIS WITH
XIAO SHI FAN SHI WANG ON 18 CASES]. GUO
WEIZHENG ET AL. practical journal of integrating
chinese with modern medicine. 1991;4(8):457 (chi).
891- gera: 65253/di/ra
[PROGRESS ON THE STUDY OF
HEPATOLENTICULAR DEGENERATION TREATED
WITH TCM-WM]. YANG RENMIN. practical journal of
integrating chinese with modern medicine. 1991;4(8):506
(chi).
892- gera: 65294/di/ra
[TREATMENT OF LATE STAGE OF PRIMARY
LIVER CANCER BY CHINESE DRUGS : A CLINICAL
OBSERVATION OF 35 CASES]. WU YUSHENG. new
journal of traditional chinese medicine. 1991;23(10):21
(chi).
893- gera: 65306/di/ra
[TREATMENT OF HEPATOLENTICULAR
DEGENERATION BY USE OF PULVIS OF SEMEN
STRYCHNI]. ZHONG YU-MING ET AL. jiangxi journal
gera 2011

of traditional chinese medicine. 1991;22(5):28 (chi).
894- gera: 65343/di/ra
[CHEMICAL THERAPY INDUCED LIVER INJURY
TREATED BY "INVIGORATING THE SPLEEN AND
DISPERSING THE DEPRESSED LIVER-ENERGY" : A
REPORT OF 31 CASES]. ZHU XUDONG. jiangsu
journal of traditional chinese medicine. 1991;12(9):6 (chi).
895- gera: 65384/di/ra
[APPROACH TO DIAGNOSIS AND TREATMENT OF
CHRONIC HEPATITIS B WITH TCM]. SHAO
RONGSHI. journal of traditional chinese medicine.
1991;32(6):39 (eng).
896- gera: 65392/di/ra
[A DISCUSSION ON THE COMPOSITION OF THE
PRESCRIPTIONS FOR THE TREATMENT OF
CHRONIC HEPATITIS B]. HAN SHENYING. new
journal of traditional chinese medicine. 1991;23(6):11
(chi).
897- gera: 65546/di/ra
[100 CASES OF CHRONIC HEPATITIS B TREATED
BY TCM-WM]. ZEN YAQING. fujian journal of
traditional chinese medicine. 1991;22(3):32 (chi).
898- gera: 65656/di/ra
[SITTING STILL : GOOD METHOD FOR
HEPATITIS]. LIU XIAO-PENG. qigong. 1991;12(8):346
(chi).
899- gera: 65664/di/ra
[DIAGNOSIS AND TREATMENT OF VIRAL
HEPATITIS WITH EPIDEMIC FEBRILE DISEASES
THEORY]. SHI DINGWEN ET AL. henan traditional
chinese medicine. 1991;11(4):4 (chi).
900- gera: 65794/di/ra
[POLYCYSTIC LIVER TREATED BY TCM-WM :
CLINICAL REPORT OF 30 CASES]. HE YAORONG.
fujian journal of traditional chinese medicine.
1991;22(6):30 (chi).
901- gera: 65841/di/ra
[THE EXPERIENCE IN TREATING PRIMARY
HEPATIC WITH TCM]. PAN CHEN-LIAN. zhejiang
journal of traditional chinese medicine. 1991;26(4):147
(chi).
902- gera: 65842/di/ra
[TREATMENT OF 108 CASES OF ASCITES DUE TO
CIRRHOSIS WITH "ZI DOU GUI QI TANG"]. LIU
JIA-LEI. zhejiang journal of traditional chinese medicine.
1991;26(4):148 (chi).
903- gera: 65843/di/ra
[TREATING 200 CASES OF ACUTE
ICTEROHEPATITIS WITH "GAN YAN JIE DU
TANG"]. LUO FEI. zhejiang journal of traditional
chinese medicine. 1991;26(4):150 (chi).
904- gera: 65853/di/ra
[FROM THEORY OF "MUTATION CAUSED BY
BITTER COLD" TO DISCUSS THE LEADING
SIGNIFICANCE OF SPLEEN STRENGTHENING AND
AROMATIZATION IN TREATING EARLY STAGE
HEPATITIS]. TANG TIECHENG. shanghai journal of
traditional chinese medicine. 1991;4:5 (chi).
46
905- gera: 65865/di/ra
[DISCUSSION ON MECHANISM OF IN GPT OF
DUCK MODELS WITH HEPATITIS B]. GUO JIA ET
AL. shanghai journal of traditional chinese medicine.
1991;4:47 (chi).
906- gera: 65869/di/ra
[RELATION BETWEEN EXAMINATION OF NAIL
FOLD MICROCIRCULATION AND TCM
SYNDROME TYPE OF 60 CASES OF CHRONIC
PERSISTING HEPATITIS]. PENG HANGUANG ET AL.
liaoning journal of traditional chinese medicine.
1991;18(4):11 (chi).
907- gera: 65879/di/ra
[ANALYSIS ON THE PICTURE OF THE TONGUE BY
OBSERVING 582 CASES OF HEPATITIS B]. LIU JIAN.
hubei journal of traditional chinese medicine. 1991;2:7
(chi).
908- gera: 65908/di/ra
[TREATMENT OF LATE PRIMARY LIVER CANCER
WITH HEPATIC ARTERY CATHETER PERFUSION
OF DMF DESIGN TOGETHER WITH TCM]. SHEN
MINGHE ET AL. journal of zhejiang college of traditional
chinese medicine. 1991;15(2):31 (chi).
909- gera: 65941/di/ra
[RECENT PROGRESS IN THE TREATMENT OF
VIRAL HEPATITIS BY THE METHOD OF TCM].
YANG WEI. jiangsu journal of traditional chinese
medicine. 1991;12(4):47 (chi).
910- gera: 65996/di/ra
[RELATION OF DOSAGE TO CURATIVE EFFECT IN
RADIX ET RHIZOMA RHEI TREATING ACUTE
ICTEROHEPATITIS]. ZHAO CANXIN. journal of
traditional chinese medicine. 1991;32(4):32 (eng).
911- gera: 65999/di/ra
[OBSERVATION ON THE CURATIVE EFFECT OF 33
CASES WITH HYPERBILIRUBINEMIA OF VIRUS
HEPATITIS TREATED BY CHI HU DECOCTION].
LUO YUANCHAO. journal of traditional chinese
medicine. 1991;32(4):39 (eng).
912- gera: 66006/di/ra
[A STUDY ON THE RELATIONSHIP BETWEEN TCM
DIAGNOSTIC TREATMENT CLASSIFICATION AND
LABORATORY DATA IN CHRONIC HEPATITIS B].
YANG XING-ZHONG ET AL. shanxi journal of
traditional chinese medicine. 1991;7(2):9 (chi).
913- gera: 66009/di/ra
[A STUDY OF 120 CASES CHRONIC PROGRESSIVE
HEPATITIS TREATED WITH "CAPSULES
HEPATITIS"]. JIANG SHENG. shanxi journal of
traditional chinese medicine. 1991;7(2):19 (chi).
914- gera: 66080/di/ra
[EXAMPLES OF ZHANG YUNPENG'S EXPERIENCE
FOR HEPATITIS B]. ZHOU QINHUA. shanghai journal
of traditional chinese medicine. 1991;9:24 (chi).
915- gera: 66091/di/ra
[CLINICAL OBSERVATION ON THE THERAPEUTIC
EFFECT OF 107 CASES OF CHRONIC HEPATITIS B].
WU DINGLIAN. hubei journal of traditional chinese
medicine. 1991;4:13 (chi).
gera 2011

916- gera: 66130/di/ra
[KU SHEN JIAN FOR CHRONIC HEPATITIS B]. LU
JINGYUN. shaanxi traditional chinese medicine.
1991;12(9):389 (chi).
917- gera: 66131/di/ra
[CAO GUO REN ZHONG HUANG TANG
DECOCTION FOR HEPATITIS B]. ZHOU SHIMING.
shaanxi traditional chinese medicine. 1991;12(9):391 (chi).
918- gera: 66132/di/ra
[JIANG XU ZHUO TANG DECOCTION FOR XU
ZHUO DU ABNORMALITY OF VIRAL HEPATITIS].
ZHU YUN. shaanxi traditional chinese medicine.
1991;12(9):394 (chi).
919- gera: 66133/di/ra
[SAN CAO TANG DECOCTION FOR CHRONIC
HEPATITIS]. PENG HANGUANG. shaanxi traditional
chinese medicine. 1991;12(9):395 (chi).
920- gera: 66134/di/ra
[FU GAN JIANG ZHI TANG DECOCTION FOR
CHRONIC HEPATITIS COMPANY WITH FATTY
LIVER]. YANG HUAN. shaanxi traditional chinese
medicine. 1991;12(9):396 (chi).
921- gera: 66135/di/ra
[COMBINATION OF TCM AND WM FOR ASCITES
OF CIRRHOSIS]. TANG SHANLING. shaanxi
traditional chinese medicine. 1991;12(9):397 (chi).
922- gera: 66151/di/ra
[A PRELIMINARY APPROACH TO CORRELATIVE
FACTORS IN DEAD CASES OF HEPATOSIS]. LI
SAIMEI. journal of traditional chinese medicine.
1991;32(9):22 (eng).
923- gera: 66153/di/ra
[AN APPROACH TO THE RELATIONSHIP
BETWEEN GPT CHANGES AND PRESCRIPTIONS
AND MEDICINES IN CHRONIC HEPATITIS]. CHEN
LIHUA. journal of traditional chinese medicine.
1991;32(9):30 (eng).
924- gera: 66185/di/ra
[EFFECT ON 461 CASES OF VIRUS HEPATITIS
TREATED WITH JIN YIN SYRUP]. ZHU YIUCAI ET
AL. practical journal of integrating chinese with modern
medicine. 1991;4(9):548 (chi).
925- gera: 66200/di/ra
[TALK ABOUT THE EMOTIONAL NURSING OF
PATIENTS WITH HEPATOPATHY]. HE YU-YING ET
AL. journal of traditional chinese medicine and chinese
materia medica of jilin. 1991;5:20 (chi).
926- gera: 66201/di/ra
[CLINICAL TREATMENT OF IRREGULAR
MENSTRUATION OF PATIENTS WITH CHRONIC
HEPATITIS B WITH DIFFERENTIATION OF
SYMPTOMS AND SIGNS]. YAO SHIAN. journal of
traditional chinese medicine and chinese materia medica
of jilin. 1991;5:23 (chi).
927- gera: 66208/di/ra
[TREATING 150 CASES OF ASCITES DUE TO
CIRRHOSIS WITH "YU YIN XIAO SHUI YIN"]. YAO
WEI ET AL. zhejiang journal of traditional chinese
medicine. 1991;26(9):394 (chi).
47
928- gera: 66214/di/ra
[RECENT DEVELOPMENTS ON TREATMENT AND
STUDY OF HEPATIC COMA WITH TCM]. YANG JIN-
XIANG. zhejiang journal of traditional chinese medicine.
1991;26(9):423 (chi).
929- gera: 66245/di/ra
[A THEORETICAL EXPLORATION ON THE
TREATMENT OF CHRONIC HEPATITIS B BY
BENEFITING THE KIDNEY]. YANG LING. journal of
traditional chinese medicine. 1991;23(9):12 (eng).
930- gera: 66257/di/ra
[PRELIMINARY OBSERVATION ON LIVER
ABSCESS TREATED BY GANYUTONG]. XU
ZHENGANG ET AL. tianjin journal of traditional chinese
medicine. 1991;2:11 (chi).
931- gera: 66324/di/ra
[TREATMENT OF TYMPANITIS WITH QIGONG].
YU YUN. qigong. 1991;12(9):403 (chi).
932- gera: 66339/di/ra
[CLINICAL RESEARCH ON THE TREATMENT OF
"XIAO GU LING" FOR LIVER CIRRHOSIS]. LI
ZHENG ET AL. henan traditional chinese medicine.
1991;11(5):18 (chi).
933- gera: 66406/di/ra
[476 CASES OF CIRRHOSIS TREATED BY
COMBINATION OF TCM AND WESTERN
MEDICINE]. JIN QINGFENG. beijing journal of
traditional chinese medicine. 1991;3:25 (chi).
934- gera: 66407/di/ra
[EXAMPLES OF SUCCESSFUL EXPERIENCE IN
TREATING TYMPANITES]. MO JINMING. beijing
journal of traditional chinese medicine. 1991;3:30 (chi).
935- gera: 66436/di/ra
[QIANG TIAN JIE DU DECOCTION FOR THE
HEPATITIS B]. YUAN ZHENJIA. shaanxi traditional
chinese medicine. 1991;12(3):100 (chi).
936- gera: 66437/di/ra
[DAN QING YIN DECOCTION FOR THE HEPATITIS
B]. MA FENGYOU. shaanxi traditional chinese medicine.
1991;12(3):101 (chi).
937- gera: 66438/di/ra
[CAI LIAN DA HUANG NING GAN DECOCTION FOR
THE VIRUS HEPATITIS]. WEI JINRONG. shaanxi
traditional chinese medicine. 1991;12(3):102 (chi).
938- gera: 66439/di/ra
[CHINESE MATERIA MEDICA FOR THE FATTY
LIVER]. SONG FUYIN. shaanxi traditional chinese
medicine. 1991;12(3):103 (chi).
939- gera: 66440/di/ra
[ASCITES OF THE LIVER CIRRHOSIS TREATED BY
THE COMBINATION OF TCM AND WM]. WANG
MINCONG. shaanxi traditional chinese medicine.
1991;12(3):104 (chi).
940- gera: 66441/di/ra
[STRENGTHENING THE SPLEEN WARMING THE
KIDNEY AND INCREASING URINE THERAPY FOR
ASCITES OF THE LIVER CIRRHOSIS]. LI ZHILONG.
gera 2011

shaanxi traditional chinese medicine. 1991;12(3):105 (chi).
941- gera: 70132/nd/re
EFFICACY OF PHYLLANTHUS AMARUS FOR
ERADICATION OF HEPATITIS B VIRUS IN
CHRONIC CARRIERS. THAMLIKIKUL V ET AL. j med
assoc thai. 1991;74(9):381-5 (eng).
Sixty-five adult asymptomatic chronic carriers of hepatitis B
virus were enrolled to the randomized controlled efficacy
study of Phyllanthus amarus. Thirty-four received
Phyllanthus amarus 600 mg per day for 30 days and 31
received placebo in identical capsules. The conversion rate of
HBsAg was 6 per cent in the study group at day 30. When 20
subjects in the Phyllanthus amarus group were given a further
30-day treatment and 22 placebo recipients given Phyllanthus
amarus 1,200 mg per day for 30 days, the conversion was
observed in 1 (5%) in the higher dose group. Adverse effects
were not observed in all patients receiving the plant. The
results indicated that Phyllanthus amarus, whole plant except
root, grown in the central part of Thailand, given at the
studied dosage and duration, had a very minimal effect on
eradication of HBsAg from Thai adult asymptomatic chronic
carriers.
942- gera: 70145/nd/re
EVALUATION OF ROOT QUALITY OF
BUPLEURUM SPECIES BY TLC SCANNER AND THE
LIVER PROTECTIVE EFFECTS OF "XIAO-CHAI-
HU-TANG- PREPARED USING THREE DIFFERENT
BUPLEURUM SPECIES. YEN MN ET AL. journal of
ethnopharmacology. 1991;34(2-3):155-65 (eng).
A simple and quick quantitative analysis of saikosaponins a,
c and d, the major bioactive principles contained in
Bupleurum species, by TLC scanner is described. Results
with Bupleurum kaoi, the species native to Taiwan, showed
that the roots, rhizomes and aerial parts (leaves and stem)
have greater quantities of saikosaponins than cultivated B.
falcatum var. komarowi and imported B. chinense. The liver
protective effects of water extracts of "Xiao-Chai-Hu-Tang"
(XCHT), a mixture of seven crude drugs, prepared using
roots of the three different Bupleurum species and aerial parts
of B. kaoi and B. falcatum var. komarowi, were evaluated
using CCl4-induced toxicity in rats. The acute increase of
serum transaminase (SGOT and SGPT) levels caused by
CCl4 administration (3. 0 ml/kg, s. c. ) was dramatically
reduced when treated with XCHT prepared with the roots of
B. kaoi. The histological metamorphoses such as fatty
changes, ballooning degeneration, cell necrosis and
lymphocyte and Kupffer cell increases around the central
vein, were clearly decreased by XCHT prepared with B. kaoi.
Furthermore, water extracts of aerial parts of both B. kaoi and
cultivated B. falcatum var. komarowi decreased SGOT and
SGPT
943- gera: 70166/nd/re
COMPARISON OF ANTI-LIPID PEROXIDATIVE
EFFECTS OF THE UNDERGROUND PARTS OF
NOTOPTERYGIUM INCISUM AND N. FORBESII IN
MICE. YANG XW ET AL. planta med. 1991;57(5):399-
402 (eng).
Intraperitoneal administration of CCl4 to mice led to
significant increases of thiobarbituric acid-reactive
substances (TBA-RS), free malondialdehyde (MDA), lipid
conjugated dienes and fluorescent lipid peroxidation products
in the liver. However, subchronic pretreatment with oral
doses of the MeOH extract of either the underground part of
Notopterygium incisum or that of N. forbesii appreciably
suppressed the formation of CCl4-induced lipid peroxidation
products. The suppressing potency was more remarkable in
the former.
48
944- gera: 70192/nd/re
[THE DIFFERENTIATED USE OF MUD THERAPY
AND ACUPUNCTURE IN THE EARLY
CONVALESCENT PERIOD OF VIRAL HEPATITIS].
SEREBRINA LA ET AL. voprosy kurortologii. 1991;3:41-
3 (rus*).
Two new techniques of migratory pelotherapy using mud
applications to the paravertebral area and acupuncture were
compared in 152 viral hepatitis convalescents. The efficacy
of the treatment was shown by a wide spectrum of hepatic
function and immunologic reactiviry indicators.
945- gera: 82617/di/ra
CHRONIC HEPATIC HYPERTENSION AND
APPLICATION OF CINNAMON AND HOELEN
FORMULA (gui zhi fu ling wan). TSUNEO KINOSHITA.
international journal of oriental medicine. 1991;16(1):24-
33 (eng).
946- gera: 82861/di/el
FROM FRUCTUS SCHIZANDRAE TO BIPHENYL
DIMETHYL DICARBOXYLATE (DDB),A NEW
HEPATOPROTECTOR FOR HEPATITIS. LIU
GENGTAO. recent advances in chinese herbal
drugs,science press,beijing. 1991;:112-25 (eng).
DDB is a new hepatoprotective drug. The mechanism of its
action may be the result of inhibition of lipid peroxidatio n
and covalent binding of CCl, metabolites to the lipids of
microsomes. In addition, DDB is capable of inducing of
hepatic cytochrome P-450 in rats and mice, which results in
the enhancement of the metabolism of xenobiotics by liver
microsomes. The mutagenicity of aflatoxin B and
benzo(a)pyrine in the Ames test on T. Salmonella was
partially antagonized by DDB. On the other hand, DDB
signilicantly reduced cardiac necrosis and the area of calcium
deposition in hereditary muscular dystrophic hamster. It was
found recently that DDB markedly inhibited the biosynthesis
of DNA, RNA and protein of ascitic hepatoma in mice.
Clinical trials on chronic viral hepatitis B showed that DDB
markedly improved the impaired liver function and reduced
the main symptoms of patients. It should be especially noted
that the elevated SGPT of about 80% of the patients was
reduced to the normal limit after treatment. The high serum
bilirubin and alpha-fetal protein levels were also lowered.
Lower serum albumin measured by electrophoresis increased
in about 50% of the patients. So far, no apparent side effect
has been observed. However, it should be pointed out that the
normalized SGPT level of some patients rebounds after
withdrawal of DDB treatment, although readministration of
DDB is still effective. To reduce the rate of rebound, longer
courses of treatment (say, 6 to 12 months or even more than
one year) might be beneficial. For patients with chronic
active hepatitis B or those with hepatitis accompanied by
cirrhosis, further prolongation of the course of therapy may
be necessary. The dose, however, should be reduced from tid
to bid after three to six months treatment. Since 1983, DDB
pilules have been widely used in the treatment of chronic
viral hepatitis B and drug induced hepatitis in China. Side
effects are rare and not serious. The pharmacology of DDB is
still being studied, and new findings will be reported as they
occur.
947- gera: 82973/di/ra
AN OBSERVATION ON ACUPUNCTURE THERAPY
ON 400 CASES WITH ACUTE JAUNDICE
HEPATITIS. ZAO JIMIN. chinese journal of acupuncture
and moxibustion. 1991;4(1):9-15 (eng).
This paper has summarized the clinic analysis of treating 400
cases with acute jaundice hepatitis by acupuncture in our
gera 2011

department in recent 5 years. Meanwhile, we set up 28 cases
who accepted Chinese herb treatment as a control group.
From initial results, it is concluded that acupuncture
treatment has a certain therapeutic effect in treating acute
jaundice hepatitis. Because facilities in our hospital were not
complete and the item of observation was fewer. Also, there
were not enough indexes of etiology, pathology and
immunology. Thus, all of these needs improving.
948- gera: 83534/di/ra
L'EPATITE : INQUADRAMENTO
EZIOPATOGENETICO E TERAPIA
FARMACOLOGICA ED IN AGOPUNTURA. SOTTE L
ET AL. rivista italiana di medicina tradizionale cinese.
1991;3:26-37 (ita).
949- gera: 83644/di/ra
EFFECT OF OLEAN-9 (11),12-DIENE-3B,30-DIOL
3B,O-HEMISUCCINATE NA SALT,A
GLYCYRRHETINIC ACID DERIVATIVE,ON
PEROXIDATION IN CCL4 INDUCED MOUSE ACUTE
HEPATITIS. WEN-TSAN HUANG. american journal of
chinese medicine. 1991;19(2):115-20 (eng).
Anti-hepatitis effect of the olean-9(11), 12-diene-3 b, 30- diol
3 b, o-hemisuccinate Na Salt (III b), a glycyrrhetinic acid
derivative, was studied in CCl4 induced mouse. The mouse
was administered i. p. with 0. 1 mole/kg or 0. 2 mole/kg of
IIIb, then followed by 31. 4 µl/kg of CCl4. IIIb was shown to
promote the activity of the glucose-6- phosphatase, lower the
content of malondialdehyde, and prevent the activity from the
soluble enzyme (i. e. GPT, GOT, LDH) from flowing out in
the serum enzyme and liver homogenate. III b had the similar
anti-peroxidation
950- gera: 83645/di/ra
EFFECT OF SHO-SAIKO-TO (XIAO-CHAI-HU-
TANG) ON HBEAG CLEARANCE IN CHILDREN
WITH CHRONIC HEPATITIS B VIRUS INFECTION
AND WITH SUSTAINED LIVER DISEASE. TAJIRI H
ET AL. american journal of chinese medicine.
1991;19(2):121-9 (eng).
We studied the effect of Sho-saiko-to (Xiao-Chai-Hu-Tang)
on HBeAg clearance rate (SN rate) in fourteen children with
chronic hepatitis B virus (HBV) infection and with sustained
liver disease. Seven of fourteen patients (50. 0%) became
HBeAg negative in the average observation period of 0. 47
years(0. 2-0. 9 years). Four of those seven patients developed
anti-HBe. The annual SN rate in the She-saiko-to treated
group was apparently higher than the natural annual SN rate
(22. 7%) of 22 untreated patients retrospectively reviewed
from the onset of hepatitis. Sho- saiko-to seemed to promote
clearance of HBeAg in children with chronic HBV infection
and with sustained liver disease. Sho-saiko-to may be an
useful drug for such patients.
951- gera: 84106/di/ra
TRATAMIENTO DEL DOLOR SEGUN EL
DIAGNOSTICO DIFERENCIAL EN 169 CASOS DE
CANCER HEPATICO. LIU LUMING ET AL. revista de
la medicina tradicional china. 1991;1(4):49-53 (esp).
Se analizan los efectos terapéuticos de la MTC y de la
"terapia analgésica en cuatro fases" de los autores en 169
casos de dolor debido a cáncer hepático. Los resultados
fueron que la mayoría de los pacientes con cáncer hepático
avanzado tenían dolores ligeros y sólo un pequeño número de
pacientes (14,2%) presentaban un dolor severo o marcado. El
46,1% de los pacientes se aliviaron con la primera fase de la
terapia analgésica, el 93,5% de los pacientes se aliviaron con
la segunda o tercera fase de la terapia analgésica, sólo el
6,5% de los pacientes con dolor de grado lll requirieron la
49
cuarta fase de la terapia. Solamente con el tratamiento de la
MTC el porcentaje de remisión del dolor de grado l y del de
grado ll fue del 100 y 76,9%, respectivamente. La "terapia
analgésica en cuatro fases" producía menos efectos
colaterales y menor adicción a los narcóticos.
952- gera: 84122/di/ra
VBDE THERAPY IN CHRONIC ACTIVE HEPATITIS
B (CAHB). CHEUNG CS. abstract and review of clinical
traditional chinese medicine. 1991;1:13-6 (eng).
Abstract from Meng Jian et al, Practical Journal of Chinese
Medicine, 1991, 3, 154.
953- gera: 84200/di/ra
ACUPUNCTURE AND MOXIBUSTION IN THE
TREATMENT OF ASYMPTOMATIC HEPATITIS B
VIRUS CARRIERS BY STRENGTHENING THE
BODY RESISTANCE TO ELIMINATE PATHOGENIC
FACTORS : A CLINICAL AND EXPERIMENTAL
STUDY. WANG XINYAO ET AL. international journal
of clinical acupuncture. 1991;2(2):117-25 (eng).
36E, 4 ou 6VC, 14VG, 6Rte (points principaux). 2F, 9Rte
(Humidité, Dispersion). 3Rn (Tonification, Vide de Yin).
Séance de 20 à 30mn, manipulation intermittente des
aiguilles. Moxas 5 à 10mn (36E, 4 - 6VC). 3 séances /
semaine sur 3 mois. Amélioration significative des bilans
sérologiques à court et moyen terme par rapport au
954- gera: 84224/di/ra
INFLUENCE OF ACUPUNCTURE ON THE
INDUCTION OF INTERFERON BY PERIPHERAL
LEUKOCYTES OF ASYMPTOMATIC HEPATITIS B
VIRUS CARRIERS (ASC). CHOU YUFENG ET AL.
international journal of clinical acupuncture.
1991;2(3):255-60 (eng).
Traitement de 9 sujets HbsAg positifs. 36E, 6VC, 4VC,
14VG et 6Rte. Tonification au 36E. Manipulation des
aiguilles toutes les 10mn. Séance de 30mn. Moxibustion au
36E et 6VC 10mn. Une séance tous les 2 jours pendant 3
mois. Elévation du titre d'Interféron à 6 semaines et 3 mois.
Diminution de HbsAg dans 7 cas sur 9 (négativisation dans 4
cas). Dans 3 cas sur 9, négativisation de HBeAb.
L'acupuncture a une action sur la
955- gera: 35805/di/ra
[ACUPUNCTURE THERAPY ON CHRONIC
HEPATITIS]. X. journal of the japan society of
acupuncture. 1992;42(1):12. (jap).
956- gera: 35925/di/ra
VIRAL HEPATITIS CONTROL IN CHINA. A BRIEF
REVIEW ON THE PRESENT STATUS OF VIRAL
HEPATITIS IN CHINA. LI ZHI-HONG. chinese medical
journal. 1992;105(3):179-82 (eng).
957- gera: 36037/di/ra
THE PHARMACOLOGICAL AND PATHOLOGICAL
STUDIES ON TAIWAN FOLK MEDICINE (VII) : THE
ANTI- INFLAMMATORY EFFECT OF ECHINOPS
GRJIISII. CHUN-CHING LIN ET AL. american journal
of chinese medicine. 1992;20(2):127-34 (eng ).
The hepatotoxic-protective effects of "San-fang-feng" (the
root of E. grijisii) and "Lou-lu" (the root of E. latifolius) on
CCl4 induced hepatotoxicity have been proposed in our
previous paper (Lin et al, 1990). The anti-inflammatory
effects of these two crude drugs were investigated in this
experiment. The results indicated that both of them displayed
pronounced anti-inflammatory activities against carrageenan-
induced edema. Furthermore, in order to isolated the main
active components of E. grijisii, fractions obtained from the
gera 2011

methanolic extract of E. grijisii were investigated in mice for
their 24-h LD50 and 95% confidence limits, which could be
used as a guiding for further animal experiments. Our
findings demonstrated that n-hexane (100,300 mg/kg),
chloroform (30,100, 300 mg/kg) and ethyl acetate (30,100,
300 mg/kg) fractions could markedly inhibit the carrageenan-
induced inflammation, and the main active principle was
found to be concentrated in the chloroform fraction, which
possessed significant inhibitory activities even more than
does indomethacin.
958- gera: 36038/di/ra
THE PHARMACOLOGICAL AND PATHOLOGICAL
STUDIES ON TAIWAN FOLK MEDICINE (VIII) :
THE ANTI- INFLAMMATORY AND LIVER
PROTECTIVE EFFECTS OF "MU-MIEN". CHUN-
CHING LIN ET AL. american journal of chinese
medicine. 1992;20(2):135-46 (eng).
The bark, xylem of stem, and root of (1) Bombax malabarica
DC. and (2) Ceiba pentandra GAERTN. are marked as "Mu-
mien" in Taiwan. In order to clarify the pharmacological
effects of these three parts, anti-inflammatory and liver
protective effect were evaluated with carrageenan-induced
paw edema and CCl4-induced hepatotoxicity in rats. The
statistical analysis (ANOVA) shows that all of the treatment
used exhibited significant anti-inflammatory activity against
carrageenan-induced edema. Furthermore, the administration
of root and xylem of stem of B. malabarica showed the
activity even better than indomethacin group did. However,
only three used parts of B. malabarica significantly alleviated
liver injury induced by CCl4. Meanwhile, the histological
changes in rat hepatic tissues such as fatty change, ballooning
degeneration, cell necrosis, lymphocytes and Kupffer cells
were also observed.
959- gera: 36126/di/ra
[ACUPUNCTURE THERAPY IMPROVES MUSCLE
SPASMS IN PATIENTS WITH LIVER CIRRHOSIS]. X.
journal of the japan society of acupuncture.
1992;42(1):59. (jap).
960- gera: 36249/di/ra
LE REFLEXE AURICULO-CARDIAQUE COMME
MOYEN DE DIAGNOSTIC DANS LA PATHOLOGIE
ABDOMINALE. BANOS A. annales de la societe
d'acupuncture d'aquitaine. 1992;13:37-42 (fra).
961- gera: 36283/di/ra
STUDIES ON FOLK MEDICINE "THANG-KAU-TIN"
FROM TAIWAN (1) THE ANTI-INFLAMMATORY
AND LIVER- PROTECTIVE EFFECT. CHUN-CHING
LIN ET AL. american journal of chinese medicine.
1992;20(1):37-50 (eng ).
Five species of crude drugs are used as "Thang-kau-tin" on
Taiwan market : (1) the stem of Mallotus repandus (Wild.)
Muell, - Arg, the stem and root of M. repandus (Wild.)
Muel.- Arg, (3) the stem of Bauhinia championii Benth, (4)
the stem with hooks of Uncaria hirsuta Haviland and (5) the
stem with hooks of U. rhynchophylla Miquel. To clarify the
effect of these crude drugs as antiinflammatory and liver-
protective agents, studies were conducted on water extracts
of these five crude drugs. The statistical analysis (ANOVA)
indicated that the stem of M. repandus showed the best
antiinflammatory activity against the paw oedema induced by
carrageenan. Nevertheless, the acute increase of GOT and Gfl
levels caused by CCI4 were markedly decreased by the
treatment of M. repandus (stem), B. campionii and u. hirsuta
as a recipe group. The pathological changes around the
central vein including fatty change, ballooning degeneration,
cell necrosis, the increase in lymphocytes and Kupffer cells
50
were improved by
962- gera: 36286/di/ra
LIVER AND GALLBLADDER DAMP HEAT
SYNDROME : A CASE STUDY ON BENIGN
NONSPECIFIC LIVER DYSFUNCTION WITH
ABNORMAL ENZYME PROFILE. WILLIAMS J.
american journal of acupuncture. 1992;20(3):205-11
(eng).
This paper illustrates that Chinese Traditional medicine, as
treatment, may be effectively used along with Western
methods of evaluation. In this case a 42-year-old female with
elevated ALT (SGPT), GGTP, and alkaline phosphatase was
treated for undiagnosable liver disease using Chinese herbs
and acupuncture over an eight- month period. A liver panel
was taken every 60 days, with a ten-month follow-up.
Normalization of the enzyme profile was apparent by the
second month. The patient was symptom free with
normalised liver profile at the end of treatment and remained
so up to the time of the last follow-up visit. These results
suggest that Chinese medicine is highly effective for cases of
benign liver disease of non-specific origin.
963- gera: 36304/di/ra
EXPERIMENTAL STUDIES ON THE INHIBITION
EFFECTS OF 1000 CHINESE MEDICINAL HERBS ON
THE SURFACE ANTIGEN OF HEPATITIS B VIRUS.
ZHENG MINSHI. journal of traditional chinese medicine.
1992;12(3):193-5 (eng ).
The reverse passive hemagglutination inhibition test was
used in the screening of 1000 Chinese materia medica for
inhibitors of hepatitis B virus surface antigen. The herbal
drugs were commercially available and the surface antigen
was from sera of hepatitis B patients. 127 effective drugs
were obtained from the survey of which 28 were highly
inhibitory (8:1), 35 were moderately effective (4:1), and 64
mildly effective (2:1). Further experiments with varying
dosages of the drug, dosages of HBsAg and duration of
contact showed 10 drugs to be of optimal effect.
964- gera: 36383/di/ra
PHARMACOLOGICAL AND PATHOLOGICAL
STUDIES ON HEPATIC PROTECTIVE CRUDE
DRUGS FROM TAIWAN (V) : THE EFFECTS OF
BOMBAX MALABARICA AND SCUTELLARIA
RIVULARIS. HUI-FEN CHIU ET AL. american journal
of chinese medicine. 1992;20(3-4):257-64 (eng).
965- gera: 36729/di/ra
A CASE OF VIRAL HEPATITIS WITH THREATENED
ABORTION. CHEUNG CS. abstract and review of
clinical traditional chinese medicine. 1992;4:15 (eng).
Abstract from Dr Chen Li Gao, Zhong San Clinic, City of
Long Gang, Da Zu County 10-1989, Si Chuan Zhong Yi,
966- gera: 37273/nd/re
[TREATMENT OF SEVERE VIRAL HEPATITIS].
DONG XJ ET AL. chung hua nei ko tsa chih.
1992;30(10):637-59 (chi*).
Combined treatment of thymosin, amino acid, blood products
and glucagon-insulin (G-I) for severe viral hepatitis reduced
the death rate to 42. 11-54. 54% in the years from 1983 to
1985. Since 1986, 207 patients with severe viral hepatitis
have been treated in our department, 80 of them died (38.
6%). All of the patients were divided into 6 groups receiving
different therapeutic measures. Group 1 and 2 received
different combinations of the above- mentioned drugs; group
3,4,5 and 6 were given fetal liver cell suspension, hepatocyte
growth factor (HGF), Chinese traditional medicine and
prostaglandin E1 (PGE1) either alone or in combination with
gera 2011

other medications. Therapeutic results were better in group
3,4,5 and 6 than in group 1 and 2. Determination of the
activity of tumor necrosis factor (TNF) showed that it was
higher in the patients than in the control subjects. TNF
activity was increased in rats with experimental liver failure;
HGF and PGE1 can protect experimental liver necrosis and
reduce the serum TNF activity.
967- gera: 37301/nd/re
PROTECTIVE EFFECT OF SCHISANHENOL
AGAINST OXYGEN RADICAL INDUCED
MITOCHONDRIAL TOXICITY ON RAT HEART AND
LIVER. LIN T ET AL. biomed environ sci. 1992;5(1):57-
64 (eng).
Schisandra (SAL) had been shown to have potent antioxidant
activities. The protective effects of SAL against oxygen
radical induced mitochondrial injuries of rat heart and liver
were investigated in the present study. The ferrous-cysteine
induced mitochondrial lipid peroxidation was significantly
inhibited by SAL, while the loss of ATPase activity induced
by the lipid peroxidation was prevented. The rigidification of
mitochondrial membrane, as well as swelling, lysis and
disintegration of the mitochondria induced by ferrous-
cysteine were all significantly inhibited by SAL. These
results further confirm that SAL possesses antioxidant
activity.
968- gera: 37325/nd/re
[EFFECT OF VARIOUS METHANOL EXTRACTS OF
CRUDE DRUGS ON EXPERIMENTAL SUBACUTE
AND CHRONIC HEPATIC INJURY]. ISHIZUKA O ET
AL. yakugaku zasshi. 1992;112(3):174-82 (jap*).
The effects of 5 crude drugs (Myricae Cortex, Polygoni
Avicularis Herba, Hyperici Erecti Herba, Forsythiae Fructus,
Desmodii Herba) on subacute and chronic hepatic injuries
induced by carbon tetrachloride (CCl4) or alpha-
naphthylisothiocyanate (ANIT) were investigated in rats. All
of these crude drugs suppressed significantly the increase of
several biochemical parameters with CCl4-injection twice per
week for 4 weeks. Polygoni Avicularis Herba and Desmodii
Herba among 5 crude drugs also protected the subacute
hepatic injury induced by ANIT- injection for 4 weeks. In
addition, the therapeutic effect of Desmodii Herba on the
chronic hepatic injury induced by CCl4-injection for 9 weeks
was recognized. Desmodii Herba has protective effects on the
acute and subacute hepatic injuries induced by CCl4 or ANIT
and an improving effect on the chronic injury induced by
CCl4. Though the increase of hydroxylproline content in the
liver began 4 weeks after the CCl4 or ANIT treatment, every
crude drug had no significant effect against the liver fibrosis
in these study.
969- gera: 37490/nd/re
[PROTECTIVE EFFECTS OF THE BARK OF
MYRICA RUBRA SIEB. ET ZUCC. ON
EXPERIMENTAL LIVER INJURIES]. OHTA S ET AL.
yakugaku zasshi. 1992;112(4):244-52 (jap*).
The methanol extract from the bark of Myrica rubra SIEB. et
ZUCC. showed protective effects on liver injuries induced by
carbon tetrachloride (CCl4) and alpha-aphthylisothiocyanate
(ANIT) in rats. In this study, the fractions and some
compounds from the bark of M. rubra were investigated for
the protection against CCl4 inducing liver injuries in rats.
The active principles for the protection were recognized in
two fractions (M-3 and M-5 Fr. 1) obtained from the
methanol extract, and one of the active principles in the
fraction (M-3) was found to be myricanol 5-O-beta-D-(6'-O-
galloyl)-g lucopyranoside. In addition, these fractions
protecting liver injuries induced by CCl4 showed significant
protective effects against cholestasis induced by ANIT.
51
970- gera: 37511/nd/re
PROTECTIVE EFFECTS OF DIMETHYL-4, 4'-
DIMETHOXY-5, 6, 5', 6'-DIMETHYLENE
DIOXYBIPHENYL-2, 2'- DICARBOXYLATE ON
DAMAGES OF ISOLATED RAT HEPATOCYTES
INDUCED BY CARBON TETRACHLORIDE AND D-
GALACTOSAMINE. FU T ET AL. biomed environ sci.
1992;5(3):185-94 (eng).
971- gera: 37541/nd/re
EFFECT OF GOMISIN A (TJN-101) ON LIVER
REGENERATION. KUBO S ET AL. planta med.
1992;58(6):489-92 (eng).
972- gera: 37544/nd/re
[PHARMACOLOGICAL STUDY ON PANAX
GINSENG C.A.MEYER XIV. EFFECT OF 70 %
METHANOLIC EXTRACT FROM RED GINSENG ON
THE CYTOCIDAL EFFECT OF MITOMYCIN C
AGAINST RAT ASCITES HEPATOMA AH 130].
MATSUDA H ET AL. yakugaku zasshi. 1992;112(11):846-
55 (jap*).
973- gera: 37567/nd/re
[PROTECTIVE EFFECT OF SHO-SAIKO-TO (TJ-9) IN
EXPERIMENTAL LIVER INJURY]. EYBL V ET AL.
cesk farm. 1992;41-(7-8):243-5 (slo).
974- gera: 38925/di/ra
[EXPLORATION AND STUDY ON METHODS OF
TREATING HEPATITIS B]. LU LIANGWEI. journal of
zhejiang college of traditional chinese medicine.
1992;16(1):9 (chi).
975- gera: 38926/di/ra
[OBSERVATION ON CURATIVE EFFECT OF
HEART-LIVER TREASURE CAPSULE FOR 125
CASES OF CHRONIC VIRUS HEPATITIS B]. HE
JIANJUN ET AL. journal of zhejiang college of traditional
chinese medicine. 1992;16(1):12 (chi).
976- gera: 38953/di/ra
[TREATMENT OF ASCITES DUE TO CIRRHOSIS
WITH YANGYIN LISHUI TANG]. WU HAN-BING.
journal of traditional chinese medicine and chinese
materia medica of jilin. 1992;1:32 (chi).
977- gera: 38963/di/ra
[CHRONIC HEPATITIS B TREATED ACCORDING
TO DIFFERENT TYPES AND DIFFERENTIATION OF
SYMPTOM- COMPLEX]. CHEN NINGSHENG. china
journal of traditional chinese medicine and pharmacy.
1992;7(1):29 (chi).
978- gera: 38969/di/ra
[STUDY ON THE RELATIONSHIP BETWEEN TCM
DIFFERENTIATION OF SYNDROMES AND HBV
ANTIGEN, HBV DNA IN SERUM AND LIVER
TISSUES AND PATHOLOGICAL CHANGES IN
CHRONIC HEPATITIS B]. LIU KE-ZHOU ET AL.
chinese journal of integrated traditional and western
medicine. 1992;12(1):11 (chi*).
TCM differentiation of syndrome in 131 cases of chronic
hepatitis B has been studied with molecular-biological and
immuno-histological techniques. The results showed that 94.
6% cases of Gan-Yu Pi-Xu (stagnancy in the liver leading to
diminished function of the spleen) type belonged to chronic
persistent hepatitis (CPH), whose coincidence rate of
pathology of the liver biopsies with CPH was 69. 2%; the
gera 2011

positive rate of HBeAg and/or HBV DNA in sera was 61.
5%, and the positive rates of HBsAg and HBV DNA in liver
tissues were 69. 2% (of which 44. 4% appeared diffuse
pattern morphologically) and 33. 3% respectively. 75. 5%
cases of Gan-Shen Yin-Xu (deficiency of Yin of the liver and
kidney) type belonged to chronic active hepatitis (CAH) and
88. 5% of the cases were pathologically described as CAH,
the positive rates of HBeAg and/or HBV DNA in serum and
HBsAg in liver tissues were all 80. 8%, among which the
diffuse pattern of HBsAg accounted for 85. 7%, which was
higher than that in Gan-Yu Pi-Xu type (P < 0. 05), the
positive rates of HBcAg and HBV DNA in liver tissues were
34. 6% (of which 55. 6% appeared cytoplasmic pattern) and
63. 2% respectively, which was higher than that in Gan-Yu
Pi-Xu type (P < 0. 05). 75. 0% cases of Qi-Zhi Xue-Yu
(stagnation of vital energy and stasis of blood) type belonged
to CAH with early state cirrhosis, its pathological changes in
liver tissues were obvious, replication levels of HBV
corresponded to the cases of Gan-Yu. Pi-Xu type.
979- gera: 38974/di/ra
[STUDY ON THE TREATMENT OF INFANTILE
HEPATITIS SYNDROME WITH INJECTION OF YIN
ZHI HUANG]. DONG YONG-SUI ET AL. chinese journal
of integrated traditional and western medicine.
1992;12(1):26 (chi*).
The infantile hepatitis syndrome is defined as a liver disease
which occurs during the infantile period with the clinical
manifestation of jaundice, hepatomegaly and hepatic
dysfunction. The cause of disease is complex and the
treatment is difficult. From March 1987 to June 1988, 55
patients (treatment group) were treated with injection of yin
zhi huang, and 15 cases (control group) with injection of
Inosine, vitamin C and glucose. The course of treatment
lasted 15 days. At the beginning and the end of the treatment,
serum bilirubin level, sALT level, duodenal juice bilirubin
level, liver size and T cell subsets in peripheral blood had
been detected separately. The results showed that among the
treatment group, serum bilirubin level was significantly lower
at the end of the treatment than that of the control group. The
sALT, and hepatomegaly were also reduced or lessened,
while the duodenal juice bilirubin level was increased. But
there was no difference in T cell subsets between the two
groups.
980- gera: 39024/di/ra
[CARCINOMA OF LIVER TREATED WITH
TOPICAL PLASTER]. LI HUIGANG ET AL. journal of
traditional chinese medicine. 1992;33(1):37 (eng).
981- gera: 39031/di/ra
[CHINESE MATERIA MEDICA FOR CHRONIC
ACTIVE HEPATITIS]. YU GURAN ET AL. shaanxi
traditional chinese medicine. 1992;13(1):1 (chi).
982- gera: 39032/di/ra
[SECONDARY SYNDROMES OF VIRAL HEPATITIS
TREATED WITH TCM]. LIU QINGRONG. shaanxi
traditional chinese medicine. 1992;13(1):2 (chi).
983- gera: 39039/di/ra
[BRIEF DISCUSSION OF LIVER CIRRHOSIS
TREATED WITH TCM]. WU SHENGCHANG. shaanxi
traditional chinese medicine. 1992;13(1):17 (chi).
984- gera: 39042/di/ra
[FOUR METHODS ON SYNDROMES AND
TREATMENTS OF LIVER CIRRHOSIS]. SU HEPING.
shaanxi traditional chinese medicine. 1992;13(1):26 (chi).
52
985- gera: 39048/di/ra
[OBSERVATION ON EFFECTS OF TCM AND
HERBAL MEDICINE IN MAIN FOR 57 CASES OF
VIRAL HEPATITIS A WITH SEVERE ICTERUS].
CHEN LIRONG ET AL. shanghai journal of traditional
chinese medicine. 1992;1:3 (chi).
986- gera: 39089/di/ra
[OBSERVATION ON THE THERAPEUTIC
EFFECTIVENESS ON TREATMENT OF 42 CASES OF
HEAVY HEPATITIS BY INTEGRATION OF
TRADITIONAL CHINESE MEDICINE AND
WESTERN MEDICINE]. LI ZHANGLIN ET AL. jiangxi
journal of traditional chinese medicine. 1992;23(1):43
(chi).
987- gera: 39127/di/ra
[EFFECT OF RHUBARB AND RED PEONY TANG ON
VIRUS HEPATITIS WITH DEEP JAUNDICE]. HUA
YUYING ET AL. shandong journal of traditional chinese
medicine. 1992;1:20 (chi).
988- gera: 39163/di/ra
[CLINICAL AND EXPERIMENTAL RESEARCH ON
TREATMENT OF CHRONIC HEPATITIS WITH
YIGANQINGREJIEYAO CHONGJI (HEAT-
CLEARING AND DETOXIFYING ELECTUARY FOR
B HEPATITIS) : A REPORT OF 356 CASES]. QAN
YING ET AL. beijing journal of traditional chinese
medicine. 1992;1:31 (chi).
989- gera: 39185/di/ra
[CLINICAL OBSERVATION ON THE ORAL GANG
FU SHU THERAPY IN CONVALESCENT PERIOD OF
HEPATITIS]. XIE ZHON-JIAN ET AL. shanxi journal of
traditional chinese medicine. 1992;8(1)):29 (chi).
990- gera: 39227/di/ra
[STUDY ON SPHYGMOGRAM OF 717 CASES OF
ACUTE ICTERIC VIRAL HEPATITIS A]. ZHOU
JINCHENG ET AL. liaoning journal of traditional chinese
medicine. 1992;19(2):4 (chi).
991- gera: 39241/di/ra
[OBSERVATION ON THE ACTION OF CHINESE
MATERIA MEDICA IN LOWERING THE REBOUND
OF GLUTAMIC- PYRUVIC TRANSAMINASE AFTER
INTERRUPTION OF DIPHENYL-DIESTER]. CHENG
WENQIAN. journal of traditional chinese medicine.
1992;33(2):25 (eng).
992- gera: 39426/di/ra
[RESEARCH ON INFECTION OF MYELOID CELL IN
PATIENTS' WITH VARIOUS TYPES OF HEPATITIS
HBV BY TCM]. BAI LIN ET AL. journal of traditional
chinese medicine and chinese materia medica of jilin.
1992;2:10 (chi).
993- gera: 39427/di/ra
[TREATMENT OF BACTERIAL LIVER ABSCESS BY
COMBINED METHODS OF TCM WITH WESTERN
MEDICINE]. CHENG GUANG-LI. journal of traditional
chinese medicine and chinese materia medica of jilin.
1992;2:12 (chi).
994- gera: 39428/di/ra
[TREATMENT OF SEVERE ICTEROHEPATITIS IN
50 CASES WITH TUIHUANG TANG]. JIANG SEN ET
AL. journal of traditional chinese medicine and chinese
materia medica of jilin. 1992;2:16 (chi).
gera 2011

995- gera: 39432/di/ra
[EFFECTS OF COMPOUND GINSENG SU ON
PREVENTION AND TREATMENT OF
EXPERIMENTAL HEPATIC INJURY]. LIU SHU-XIAN
ET AL. journal of traditional chinese medicine and
chinese materia medica of jilin. 1992;2:35 (chi).
996- gera: 39447/di/ra
[ANALYSIS OF THE RELATION BETWEEN
SYNDROME DIFFERENTIATION OF CHRONIC
HEPATITIS B AND ITS CURATIVE EFFECT]. LI
XIUYU ET AL. journal of beijing college of traditional
chinese medicine. 1992;15(1):49 (chi).
997- gera: 39456/di/ra
[THE EFFECTS OF TCM DECOCTION
HEGANZHUPIYIN ON THE BODY WEIGHT AND
GASTROENTERIC MUCOSA FO THE SPLEEN
DEFICIENT RAT WITH LIVER INJURY BY CCI4].
XU WENZHONG. journal of beijing college of traditional
chinese medicine. 1992;15(2):27 (chi*).
The rat spleen-deficiency and liver-injury model was
produced by Rhubarb and CCL4, and the mechanism of liver
protection of TCM decoction Heganzhupiyin was further
studied with the model. As far as the body weight change and
gastroenteric mucosa injury are concerned, the condition with
spleen-deficiency and liver-injury model was obviously
worse than that with simple liver injury model. After the
treatment of Heganzhupiyin, the conditions with both models
were improved, but better condition was found with simple
liver injury model.
998- gera: 39520/di/ra
[ANALYSIS OF 179 CASES OF HEPATITIS B
TREATED BY YIGAN TANG (PILLS)]. LÜ LANKAI ET
AL. shandong journal of traditional chinese medicine.
1992;2:15 (chi).
999- gera: 39576/di/ra
[STUDIES ON THE PROPHYLACTIC AND
THERAPEUTIC ACTIONS OF COCHINCHINA
PASSIFLOWER (PASSIFLORA COCHINCHINENSIS)
ON EXPERIMENTAL HEPATIC INJURY]. MA XUE-
HUI ET AL. chinese traditional and herbal drugs.
1992;23(2):78 (chi*).
Results of the study indicate that an aqueous extracts of
Passiflora cochinchinsis could alleviate degeneration and
necrosis of hepatic cells induced by CCL4 in rats with acute
hepatic injury, promote glycogen storage and prevent
cirrhosis moreover, aqueous extracts of P. cochinchinsis exert
some effects on collagenolytic activity and collagen
resorbsion in cirrhotic rats. Ethanolic precipitate of the
aqueous extract was partially effective, but ethanolic extracts
of P. cochinchins was without.
1000- gera: 39624/di/ra
[STUDIES ON MECHANISMS OF PROTECTIVE
ACTION OF RADIX SALVIAE MILTIORRHIZAE
(RSM) AGAINST EXPERIMENTAL HEPATIC
INJURY IN RATS]. DENG HEJUN ET AL. china journal
of chinese materia medica. 1992;17(4):233 (chi*).
The results indicated that RSM could significantly inhibit the
lipid peroxidation of normal livers and cultured hepatocytes
of rats, induce liver microsomal cytochrome P450 in normal
rats, increase nucleic acids, proteins, urea and cerolloplasmin
of damaged cultured hepatocytes of rats, relieve
ultrastructural damage of cultured hepatocytes induced by
CCl4. The pharmacological actions mentioned above should
be considered as important
53
1001- gera: 39673/di/ra
[OBSERVATION ON 65 CASES OF ASCITES DUE TO
CIRRHOSIS OF THE LIVER TREATED WITH "FU
ZHENG XIAO GU" DECOCTION]. JIN SHI ET AL.
jiangsu journal of traditional chinese medicine.
1992;13(4):9 (chi).
1002- gera: 39728/di/ra
[TREATMENT OF SEVERE CHRONIC HEPATITIS B
BY COMBINATION OF TCM AND WM THERAPY
WITH AN ANALYSIS OF 122 CASES]. WANG CHEN-
BAI ET AL. chinese journal of integrated traditional and
western medicine. 1992;12(4):203 (chi*).
This paper is a summary report of treatment of 122 cases of
severe chronic hepatitis by combination of TCM and WM
therapy. Among them, 44 cases were in their early stage of
disease, 66 in their intermediate stage, and 12 in their
advanced stage. They were treated by basic therapy with
hepatic cell growth factor (HGF) added to some of them. The
patients were divided into two groups, one receiving
treatment of blood-cooling and detoxifying Chinese herbs,
the other receiving treatment of heat-clearing and detoxifying
Chinese herbs. The treatment was effective for 52 cases, and
ineffective in 70 cases. Values of serum bilirubin (SB) and
prothrombin activity (PA) and the time of initial consultation
had marked influence on their prognoses. No difference was
found in total mortality between the two groups, also no
difference was found in mortality between the former and
latter group with or without the addition of HGF at the early
stage of disease. The survival rate of the former group was
significantly higher than that of the latter one with HGF
added at their intermediate stage of disease, which were 60%
and 14. 7% respectively, P < 0. 01. The conclusion is that as
diagnosis and treatment were based on the Syndrome
Differentiation of patients at intermediate stage of disease,
Chinese herbs will be effective in many ways such as
lowering and eliminating jaundice, improving symptoms and
signs, preventing and curing complications, curing coexisting
diseases, and repairing pathological lesions.
1003- gera: 39729/di/ra
[MODULATING EFFECTS OF EXTRACTUM SEMEN
PERSICAE AND CULTIVATED CORDYCEPS
HYPHAE ON IMMUNODYSFUNCTION OF
INPATIENTS WITH POSTHEPATITIC CIRRHOSIS].
ZHU JIAN-LIANG ET AL. chinese journal of integrated
traditional and western medicine. 1992;12(4):207 (chi*).
The treatment of 65 cases (with 20 cases in the control group)
of patients with post-hepatic cirrhosis by Extractum Semen
Persicae (ESP) and cultivated Cordyceps Hyphae (CH) was
reported, and the adjustment of the disorders of both cellular
and humoral immune functions was nvestigated. The results
indicated apparently that the restrained cellular immune
function, among which the rate of lymphocyte
transformation, the NK cell's function, CD8+ and CD4+ cells
in the patients' group were lower than those in the healthy
group. The CD8+ cell count was positively correlated with
lymphocyte transformation rate and the humoral immune
hyperfunction revealing that the levels of IgG, IgA, ssIgA
and CIC of the patients were abnormally higher than those of
healthy subjects, while level of C3 was negatively correlated
with that of CIC. After the treatment, rate of transformation,
function of NK cell, CD8+, CD4+ cells and the ratio of
CD4+/CD8+ improved; levels of IgG, IgA, ssIgA and CIC
reduced, while those of C4 and C3 rose. These results
revealed the ESP and cultivated CH could modulate the
cellular immune function, inhibit the humoral immune
hyperfunction and increase serum complement level in
patients with post-hepatitic cirrhosis, which were correlated
gera 2011

to the improvement of hepatic function. Disorder of immune
function was one of the important causes of liver cell
necrosis, inflammatory cell infiltration and fibroplastic
proliferation. The results showed that the drugs are of some
value in the treatment of patients with post-hepatitic
cirrhosis.
1004- gera: 39731/di/ra
[A STUDY OF DIAGNOSIS ON BLOOD STASIS IN
VIRAL HEPATITIS BY COMPUTER MULTI-
CRITERIAL ANALYSIS-AN ANALYSIS OF 63
CASES]. LIU JIAN-SHENG ET AL. chinese journal of
integrated traditional and western medicine.
1992;12(4):213 (chi*).
This study is based on the criteria for diagnosis of Blood
Stasis formulated by the international conference held in
Beijing in 1988. The patient that has one, two, three, and over
four items could be diagnosed as I-, II-, III-, IV- degree
hepatic Blood Stasis respectively. The data of pathologic
findings from liver biopsy, nail-fold microcirculation, blood
rheology, hepatogram, B-ultrasonography and blood
biochemical examination were stored in computer to carry on
single and multiple factor analysis in order to evaluate these
indexes in the diagnostic value of hepatic Blood Stasis.
Stepwise regression analysis formula was used to determine
the severity of Blood Stasis. By substitute related data into
the formula, mathematical model of hepatic Blood Stasis was
compared with clinical Syndrome Differentiation, it revealed
that 59 cases were coincided with each other (93. 6%).
According to numerical value, the increase and decrease of
the pre-and posttherapy, the curative effect of promoting
blood circulation to remove Blood Stasis could be determined
to provide some references for diagnosis and treatment of
1005- gera: 39735/di/ra
[THE ANTAGONISTIC EFFECT OF RE DU QING ON
DAMAGE OF HEPATOCYTIC MICROSOMES IN
RABBITS WITH ENDOTOXIN-INDUCED DIC]. TU
SHENG-HAO ET AL. chinese journal of integrated
traditional and western medicine. 1992;12(4):226 (chi*).
In this study, the generalized Shwartzman reaction of rabbit
induced by endotoxin of Escherichia Coli was built as DIC
models. The experiment showed that the levels of lipid
peroxide (LPO) in the hepatocytic microsomes of model
group were increased significantly, whereas the cytochrome
P-450 (Cyto. P-450) contents and aniline hydroxylase
activities were obviously decreased. In the Re Du Qing
(RDQ) group and dexamethasone group the decrease of LPO
in hepatocytic microsomes as well as the reduction of Cyto.
P-450 contents and aniline hydroxylase activities were
alleviated. Furthermore, the correlation analysis indicated a
significant negative correlation between levels of LPO in
microsomes and the Cyto. P-450 contents as well as aniline
hydroxylase activities. This study indicates the LPO may
play an important role in the damage of hepatocytic
microsomes and RDQ could prevent hepatocytic microsomes
from injury of rabbits with endotoxin-
1006- gera: 39736/di/ra
[EXPERIMENTAL STUDY ON YIQI-XUOXUE
THERAPY OF LIVER FIBROSIS]. FU I-LI ET AL.
chinese journal of integrated traditional and western
medicine. 1992;12(4):228 (chi*).
The experimental hepatic fibrosis was treated with YiQi
(reinforcing Qi, YQ) Huoxue (activating blood circulation,
HX) principle which was consisted of astragalus
membranaceus, Ligusticum wallichii, paeonia lactiflora, etc.
After stimulation with CCl4 over four months, the Wistar rat
developed liver fibrosis. Rats were divided into the normal
control, the toxifying control, YQHX group and HX group.
54
The experimental period lasted over four months. Results: (1)
Mortality of animal: Both toxifying control and HX group
reached 50%, while YQHX group was 16% only. These
results suggest that YQHX agents could strengthen the body
resistance; (2) The determination of serum SGPT: The mean
levels in toxifying control were 39. 3 ± 39, in HX group 43. 7
± 12. 9, while in YQHX group 29. 0 ± 7. 6 (units/Lserum).
These results indicated that YQHX agents had the function of
protecting the liver and lowering the activity of SGPT (P < 0.
01); (3) Measuring the contents of hepatic collages: The
mean levels in toxifying control was 38. 9 ± 3. 3 (mg/g liver),
while in HX group and YQHX group 28. 7 ± 2. 2 and 22. 7 ±
1. 1 (mg/g liver) respectively. The results indicated that the
YQHX agents had the best results in treating hepatic fibrosis;
(4) Observation with hepatic histopathology: The degree of
hepatocyte degeneration and necrosis in YQHX group was
milder than that in toxifying and HX group. These
observations revealed that YQHX agents possessed the
function of protecting liver.
1007- gera: 39756/di/ra
[THE EFFECTS OF ACUPUNCTURE'S
REINFORCING-REDUCING MANIPULATION ON
NK AND LAK CELL ACTIVITIES AND T CELL
SUBGROUPS IN PATIENTS WITH MALIGNANT
TUMOUR]. SUN HUA ET AL. chinese acupuncture and
moxibustion. 1992;12(2):39 (chi*).
In this paper, we investigated that the effects of acupuncture's
reinforcing-reducing manipulations on NK and LAK cell
activities and the percentages of T cell subgroups in patients
with primary bronchogenic carcinoma (PBC) and primary
carcinoma of liver (PCL) by 3HTdr release assay and SPA-Ig
assay. The result showed that both reinforcing and reducing
played the same roles to increase the lower NK and LAK
activities and percentages of OKT3 and OKT4 cells in
patients, but chinese herb treatment controls had no such
effects. Reinforcing made the percentage of OKT8 cells
decrease to normal level, while reducing had no effects on
normal OKT3 percentage. In raising NK activities and the
percentage of OKT4 cells, reinforcing is better than reducing.
1008- gera: 39806/di/ra
[CLINICAL SIGNIFICANCE OF DIAGNOSING
BLOOD STASIS DUE TO PORTAL HYPERTENSION
BY OBSERVATION OF TONGUE AND PULSE].
WANG SHUYING ET AL. acta chinese medicine and
pharmacology. 1992;2:22 (chi).
1009- gera: 39807/di/ra
[ACTION OF RECOVERING HEPATIC FUNCTION
WITH RADIX SALVIAE MILTIORRHIZAE]. HUANG
DABIN. acta chinese medicine and pharmacology.
1992;2:25 (chi).
1010- gera: 39847/di/ra
[EIGHT HEALING METHODS TO TREAT
HEPATOCIRRHOSIS BY TCM]. PAN CHENG-LIAN.
zhejiang journal of traditional chinese medicine.
1992;27(4):146 (chi).
1011- gera: 39849/di/ra
[TREATMENT OF 93 CASES OF ACUTE HEPATITIS
WITH "SAN CAO JIAN JI"]. ZENG QING-PEI. zhejiang
journal of traditional chinese medicine. 1992;27(4):151
(chi).
1012- gera: 39850/di/ra
[TREATING 21 CASES OF HEPATIC HEMANGIOMA
WITH "SHU GAN XIAO JI SAN"]. CHEN HONG-
SHENG. zhejiang journal of traditional chinese medicine.
gera 2011

1992;27(4):152 (chi).
1013- gera: 39862/di/ra
[100 CASES OF VIRUS CARRIER OF
ASYMPTOMATIC HEPATITIS B TREATED WITH
HEPATITIS B NEGATIVE TRANSFERRING
TABLET]. WANG WENZHENG ET AL. journal of
shandong college of traditional chinese medicine.
1992;16(2):37 (chi).
1014- gera: 42730/di/ra
[PROF. DONG JIANHUA'S CLINICAL EXPERIENCE
IN THE TREATMENT OF HEPATITIS B]. TIAN
HAIHE. new journal of traditional chinese medicine.
1992;24(1):1 (chi).
1015- gera: 42745/di/ra
[EXPLORATION ON THE LAW OF THE
TREATMENT FOR CHRONIC HEPATITIS BY
DIFFERENTIATION OF SYNDROMES AND
DISEASES]. ZHAN NINGSHENG ET AL. new journal of
traditional chinese medicine. 1992;24(2):7 (chi).
1016- gera: 42749/di/ra
[BRIEF INTRODUCTION TO PROF. LIU
SHICHANG'S EXPERIENCE IN THE TREATMENT
OF LIVER CANCER]. ZHONQ JIAXI ET AL. new
journal of traditional chinese medicine. 1992;24(2):15
(chi).
1017- gera: 42768/di/ra
[TREATMENT OF CHRONIC HEPATITIS BY BA ZI
YANG GAN TANG: A STUDY OF 100 CASES]. ZHAO
XUEYIN. new journal of traditional chinese medicine.
1992;24(3):42 (chi).
1018- gera: 42870/di/ra
[HOW TO TREAT PATIENTS WITH VIRUS OF
CHRONIC TYPE B HEPATITIS BUT WITHOUT ANY
CLINICAL SYMPTOM BY TCM]. LIU LICANG ET AL.
journal of traditional chinese medicine and chinese
materia medica of jilin. 1992;4:27 (chi).
1019- gera: 42897/di/ra
[TREATING HEPATIC DYSFUNCTION DUE TO
CHEMOTHERAPY OF PULMONARY
TUBERCULOSIS WITH MINOR DECOCTION OF
BUPLEURUM]. ZHANG YONG-HUA ET AL. zhejiang
journal of traditional chinese medicine. 1992;27(7):319
(chi).
1020- gera: 42929/di/ra
[TREATMENT OF ASCITIS DUE TO CIRRHOSIS
MAINLY BY BIE JIA JIAN WAN WITH
MODIFICATIONS: A STUDY OF 30 CASES]. HUANG
JUN. new journal of traditional chinese medicine.
1992;24(7):23 (chi).
1021- gera: 43014/di/ra
[EFFECTS OF ASTRAGALUS SAPONINS (ASI, SK)
ON EXPERIMENTAL LIVER INJURY]. YD ZHANG
ET AL. acta pharmaceutica sinica. 1992;27(6):405 (chi*).
The saponins (ASI, SK ) used in this study was extracted
from the root of Astragalus membranaceus Bge and
Astragalus sieversianus Pull. ASI and SK were found to
protect liver from chemical injury induced by CCI4, D-
galactosamine and acetaminophen in mice. The two saponins
were shown to impede the elevation of SGPT level, decrease
the MDA content and increase the GSH concentration in
mouse liver. Obvious improvement of histological changes
55
were also observed. The protective action of ASI and SK
against the hepatotoxicity was also shown in experiments
using primary cultured rat hepatocytes. The average value of
GPT in the medium treated with different concentration of
ASI and SK (0.00075-0.18 mmol/L was lower than that in
control. Analysing through multiple linear correlation, we
showed that the lowering of SGPT was negatively related to
the increase of GSH, positively related to the decrease of
MDA in mice given CCl4, or acetaminophen in combination
with ASI or SK. These results indicate that the hepato -
protective effects of ASI and SK may be due to their
antioxidation activities, since the content of liver protein in
mice given ASI or SK was more than that in the controls .
Moreover , the level of hepatic microsomal cytochrome P -
450 in all mice given the two saponins were significantly
increased, the liver metabolism and immunoregulating action
produced by ASI and SK may be also involved in their
hepato-protective effects. Through multiple linear
correlation, we showed that the lowering of SGPT was
negatively related to the increase of GSH, positively related
to the decrease of MDA in mice given CCI4, or
acetaminophen in combination with ASI or SK. These results
indicate that the hepato-protective effects of ASI and SK may
be due to their antioxidation activities, since the content of
liver protein in mice given ASI or SK was more than that in
the controls. Moreover, the level of hepatic microsomal
cytochrome P-450 in all mice given the two saponins were
significantly increased, the liver metabolism and
immunoregulating action produced by ASI and SK may be
also involved in their hepato- protective effects .
1022- gera: 43027/di/ra
[TREATMENT OF HEPATOSPLENOMEGALY IN
CHILDREN BY ZHI SHU HUA ZHENG SAN]. BAI
JUNFENG. new journal of traditional chinese medicine.
1992;24(6):20 (chi).
1023- gera: 43091/di/ra
[AN EXPLORATION ON THE TRAIN OF THOUGHTS
IN COMBINED TCM AND WESTERN MEDICAL
TREATMENT FOR CHRONIC HEPATITIS B]. JIANG
SEN ET AL. shanxi journal of traditional chinese
medicine. 1992;8(3):8 (chi).
1024- gera: 43092/di/ra
[CLINICAL OBSERVATION ON HEBAG POSITIVE
CHRONIC HEPATITIS TREATED WITH "YI-QI
YANG-YIN TANG", REPORT OF 40 CASES]. YU
GUAN-YA. shanxi journal of traditional chinese
medicine. 1992;8(3):16 (chi).
1025- gera: 43109/di/ra
[30 CASES OF DECOMPENSATED
HEPATOCIRRHOSIS TREATED WITH MIAN YI
RUANJIAN DECOCTION]. ZHANG ZHAN-MIN ET AL.
the practical journal of integrating chinese with modern
medicine. 1992;5(5):274 (chi).
1026- gera: 43140/di/ra
[A PROBE OF CLASSIFICATION OF CLINICAL
SYNDROME IN HEPATOCIRRHOSIS]. ZHU FANG
SHI. liaoning journal of traditional chinese medicine.
1992;19(6):13 (chi).
1027- gera: 43270/di/ra
[TCM TREATMENT OF HIGH SERUM GLUTAMIC
PYRUVIC TRANSAMINASE]. LIU XINWU. new
journal of traditional chinese medicine. 1992;24(8):9 (chi).
1028- gera: 43279/di/ra
gera 2011

[FIVE THERAPEUTIC PRINCIPLES FOR ICTERIC
HEPATITIS]. LI WENXUE. new journal of traditional
chinese medicine. 1992;24(8):44 (chi).
1029- gera: 43336/di/ra
[EXPLORATION ON THE THINKING FOR
TREATMENT OF CHRONIC HEPATITIS B BY
INTEGRATION OF TCM AND WESTERN
MEDICINE]. JIAN SEN. jiangxi journal of traditional
chinese medicine. 1992;23(4):52 (chi).
1030- gera: 43385/di/ra
[APPLICATION OF DHBV POLYMERASE AND
REVERSE TRANSCRIPTASE IN THE EVALUATION
OF ANTI-HBV DRUGS*]. GUO JU-TAO ET AL. chinese
journal of integrated traditional and western medicine.
1992;12(8):480 (chi*).
The method of DHBV replication complexes (RCs)
purification was modified. In order to screen anti-HBV drugs
from Chinese medicinal herbs, the inhibitory effects of the
extracts of 14 Chinese recipes and herbs, 30 compounds
isolated from Chinese herbs on bHBV DNA polymerase
(DNAP) and reverse transcriptase (RT) have been studied.
The results showed that extracts of Xiao Chai Hu Tang (small
Bupleurum decoction, inhibited DHBV DNAP and RT in less
extent. Of the 7 herbs, the components of Xiao Chai Hu
Tang, the extracts of S. baicalensis and P. ternata potentially
inhibited DHBV RT, their concentration of reducing enzyme
activity by 50 % (IC50) was 1.25 and 1. 6 mg/ml
respectively. Furthermore, it has been proved that S.
baicalensis inhibited DHBV DNA replication in ducklings. It
also was found the extract of P. cuspidatum inhibited DPIBV
RT with IC50 of 1.76 mg/ml. Nine of thirty isolated
compounds inhibited both DHBV DNAP and RT in less
extent under high concentration, while others
1031- gera: 43468/di/ra
[THE PRESENT SITUATION IN RESEARCH ON
SHORT TERM TURN TO THE NEGATIVE OF
SERIAL SIGNS OF HBVM BY TCM]. WANG QIN-MIN
ET AL. chinese journal of integrated traditional and
western medicine. 1992;12(5):316 (chi).
1032- gera: 43543/di/ra
[AN EXPERIMENTAL STUDY ON PREVENTING
THE LIVER CIRRHOSIS BY USING FOUR CHINESE
HERBS*]. WANG ZHENG-LIN ET AL. chinese journal of
integrated traditional and western medicine.
1992;12(6):357 (chi*).
55 rats were divided into six groups ; (1) normal control, (2)
cirrhosis control, (3-6) chinese hers groups 2-6 group were
liver cirrhosis model caused by combined factor dorminated
by CCI4, and 3-6 groups were given chinese herbs
silmultaneously untill the end of sixth week. Radix salviae
miltiorrhizae (TSM) were used in group 3, flos carthami (FC)
in group 4, Radix Angelicae sinensis (RAS) in group 5,
semen persicae (SP) in group 6. The results : in group 2,7 out
of 9 rats developed into cirrhosis, the degree of fibrosis was
2.55+ and collagen protein content was 35.3mg/g liver SGPT
387U. In group 3(RSM) no cirrhosis was found the degree of
the fibrosis was 0.43+(compared with group 2,P<0.01,
collagen protein content was 16.7/g liver (P<0.01), SGPT
132u (P<0.01). In group 4 (FC), 8 out of 9 rats did not
develope into cirrhosis, collagen content 21.1mg/g liver,
compared with group 2,P<0.05. In the group of 5 and 6, some
rats were developed into cirrhosis. The result showed that
RSM and FC possessed an inhibitory effect on fibrogenesis.
The effect of RSM was remarkable. It could prevent
experimental cirrhosis. The effect of RAS and SP were
incertain. This experiment predicted that RAM would
56
become the promising drug to restrain chronic hepatic disease
from developing into cirrhosis clinically.
1033- gera: 43554/di/ra
[CLINICAL OBSERVATION OF 24 CASES OF LATE
PRIMARY LIVER CANCER TREATED BY TCM
THERAPY FO PROMOTING BLOOD FLOW TO
REMOVE STASIS]. WANG XIAO ET AL. journal of
beijing college of traditional chinese medicine.
1992;15(3):31 (chi*).
24 Cases of late primary liver cancer were treated by TCM
therapy of promoting blood flow to remove stasis. The results
showed that after the treatment, the median survival period
was 5 months, the rate of surviving over 1 year was 25 %,
and the rates of improvement and tumor shrinkage were
60.96 % and 26.67 %, respectively.
1034- gera: 43572/di/ra
[TREATING 46 CASES OF CHRONIC ACTIVE
HEPATITIS WITH DECOCTION FOR LOWERING
THE TURBIDITY]. SHEN PENG ET AL. practical
journal of integrating chinese with modern medicine.
1992;5(7):393 (chi).
1035- gera: 43576/di/ra
[EFFECTIVE OBSERVATION ON 80 CASES OF
HEPATIC DECOMPENSATORY PERIOD DUE TO
CIRRHOSIS TREATED WITH DECOCTION FOR
NOURISHING THE LIVER AND SOFTENING HARD
MASSES]. HU SHI-SHAO ET AL. practical journal of
integrating chinese with modern medicine. 1992;5(7):402
(chi).
1036- gera: 43577/di/ra
[CLINICAL AND EFFECTIVE OBSERVATION ON
INTERMEDIATE AND LATE PRIMARY
CARCINOMA OF THE LIVER TREATED BY
INTEGRATING CHINESE WITH WESTERN
MEDICINE ON 19 CASES]. PENG DA-WEI ET AL.
practical journal of integrating chinese with modern
medicine. 1992;5(7):406 (chi).
1037- gera: 43591/di/ra
[EXPERIMENTAL STUDY OF REINFORCING THE
SPLEEN TO CURE OF PATHOLOGICAL CHANGES
OF THE LIVER IN CHINESE MEDICINE]. HUANG
XIAO-YU ET AL. practical journal of integrating chinese
with modern medicine. 1992;5(6):349 (chi).
1038- gera: 43604/di/ra
[BEAR-BILE INJECTION FOR CHRONIC LIVER
DISEASES]. CHENG DONGSHENG ET AL. shaanxi
traditional chinese medicine. 1992;13(8):349 (chi).
1039- gera: 43605/di/ra
[MIE AO TANG DECOCTION FOR CHRONIC
HEPATITIS B]. LUO RISHENG. shaanxi traditional
chinese medicine. 1992;13(8):352 (chi).
1040- gera: 43606/di/ra
[DISCUSS ON THE SYNDROMES AND
TREATMENTS OF LIVER CIRRHOSIS]. ZHU
FANGSHI. shaanxi traditional chinese medicine.
1992;13(8):354 (chi).
1041- gera: 43609/di/ra
[APPROACH ON ETIOLOGICAL-FACTORS AND
PATHOGENESIS OF CHRONIC HEPATITIS]. CUAN
JIKE. shaanxi traditional chinese medicine.
1992;13(8):362 (chi).
gera 2011

1042- gera: 43614/di/ra
[CLINICAL OBSERVATION ON EFFECT OF
KIDNEY TONIFYING SYRUP FOR 104 CASES OF
CHRONIC ACTIVE HEPATITIS B]. WANG LINGTAI
ET AL. shanghai journal of traditional chinese medicine.
1992;8:1 (chi).
1043- gera: 43615/di/ra
[EXPERIENCE IN SYMPTOM SIGN
DIFFERENTIATION AND TREATMENT OF ACUTE
SEVERE HEPATITIS]. CHENG JINGGUO. shanghai
journal of traditional chinese medicine. 1992;8:5 (chi).
1044- gera: 43772/di/ra
[WAN WENMO'S EXPERIENCE OF DRUG
COMPATIBILITY FOR TREATING LIVER
DISEASES]. MA ZHAOYU. hubei journal of traditional
chinese medicine. 1992;5:2 (chi).
1045- gera: 43822/di/ra
[EFFECTIVE OBSERVATION ON 56 CASES OF
CHRONIC VIRUS HEPATITIS DUE TO STAGNANCY
OF QI AND BLOOD STASIS TREATED BY
EXTERNAL COUNTERPULSATION AND DAN
SHEN]. JI QING ET AL. practical journal of integrating
chinese with modern medicine. 1992;5(8):457 (chi).
1046- gera: 43826/di/ra
[TREATING 56 CASES OF ASCITES DUE TO
CIRRHOSIS BY INTEGRATING CHINESE WITH
WESTERN MEDICINE]. PU YONG-RI ET AL. practical
journal of integrating chinese with modern medicine.
1992;5(8):483 (chi).
1047- gera: 43869/di/ra
[OBSERVATION ON SERUM THYROID HORMONE
IN 124 CASES OF LIVER DISEASES IN TCM
CONTEXT]. HUANG HUI. journal of traditional chinese
medicine. 1992;33(10):40 (eng).
1048- gera: 43944/di/ra
[CLINICAL OBSERVATION ON PRIMARY LIVER
CARCINOMA TREATED BY COMBINING
QINGKAILING INJECTION WITH DIFFERENTIAL
DIAGNOSIS OF SYNDROMES : REPORT OF 74
CASES]. DONG HAITAO. journal of traditional chinese
medicine. 1992;33(9):27 (eng).
1049- gera: 43950/di/ra
[THE RELATION BETWEEN TCM SYNDROME
TYPING AND INTRACELLULAR INFECTION OF
HEPATIC CELLS BY HEPATITIS B VIRUS IN LIVER
DISEASES]. WANG BAOYI ET AL. journal of
traditional chinese medicine. 1992;33(9):45 (eng).
1050- gera: 44025/di/ra
[PHARMACOLOGICAL STUDIES ON ERZHI PILLS].
DING ANWEI ET AL. china journal of chinese materia
medica. 1992;17(9):531 (chi*).
The experimental results show that Erzhi Pills can markedly
increase the weights of immunological organs in mice and
antagonize the immunosuppressive action of prednisolone.
The diameter of SRID precipitating ring, the haemolytic
ability of PFC and the clearance rate of iv char coal particles
in mice can all be increased by the pills. Erzhi Pills also
protect mice from CCL4 intoxication. Steamed Ligustitrum
lucidum has the same action as Erzhi
1051- gera: 44127/di/ra
57
[CHANGES OF CONTENT OF SEVERAL CHEMICAL
ELEMENTS IN BODY AND STAINING ON
AURICULAR POINTS ON TOXIC HEPATITIS OF
RABBITS]. ZHAO QIN ET AL. yunnan journal of
traditional chinese medicine. 1992;13(5):37 (chi).
1052- gera: 44154/di/ra
[CLINICAL OBSERVATION ON EFFECT OF PIAN-
ZAI-HUANG FOR ACUTE AND CHRONIC VIRAL
HEPATITIS]. ZHANG CHUNTAO ET AL. shanghai
journal of traditional chinese medicine. 1992;9:33 (chi).
1053- gera: 44175/di/ra
[AN ANALYSIS OF THE ASCITES TREATMENT IN
"FU QIN-ZHU'S ANDROLOGY "]. REN GUANG-
RONG. shanxi journal of traditional chinese medicine.
1992;8(5):7 (chi).
1054- gera: 44216/di/ra
[REGULATIVE EFFECT OF ENDOCRINOPATHY
WITH HEPATOCIRRHOSIS ON FUZHENG HUAYU
FORMULA]. HU YIYANG ET AL. acta medica sinica.
1992;7(5):27 (chi).
1055- gera: 44235/di/ra
[SEVERAL KEY POINTS IN DIFFERENTIAL
DIAGNOSIS AND TREATMENT OF CIRRHOSIS].
XUE YUNFENG. jiangsu journal of traditional chinese
medicine. 1992;13(10):34 (chi).
1056- gera: 44238/di/ra
[TCM TREATMMENT FOR DEGENERATION OF
HEPATIC LENTICULAR NUCLEUS]. CUI SHILIN.
shanghai journal of traditional chinese medicine.
1992;10:7 (chi).
1057- gera: 44239/di/ra
[PRELIMINARY OBSERVATION ON CLEARANCE
EFFECT OF TOXIN-REMOVING, LIVER-
PROTECTING DECOCTION IN HEPATITIS-B
VIRUS]. SHEN LONGZHU ET AL. shanghai journal of
traditional chinese medicine. 1992;10:10 (chi).
1058- gera: 44304/di/ra
[TREATMENT OF SERIOUS LIVER DISEASES]. LING
ZHENGQIANG. new journal of traditional chinese
medicine. 1992;24(11):20 (chi).
1059- gera: 44339/di/ra
[EFFECT OF THE ROOT OF POLYGONUM
MULTIFLORUM THUNB. AND ITS PROCESSED
PRODUCTS ON FAT ACCUMULATION IN THE
LIVER OF MICE]. LIU CHENGJI ET AL. china journal
of chinese materia medica. 1992;17(10):595 (chi*).
Experiments have shown that the root of Polygonum
multiflorum exhibits inhibitory effect on triglyceride (TG)
accumulation the liver of mice induced by CCI4 cortisone
acetate and thio acetamide (TAA). Its processed products(I,
II) were found to be effective in lowering the accumulated
TG induced by cortisone acetate. The rook of Polygonum
multiflorum and its processed products also reduced the
enlargement of liver by CCI4.
1060- gera: 44351/di/ra
[36 CASES OF CAVERNOUS HEMANGIOMA OF
LIVER WITH TCM]. YANG LIN. zhejiang journal of
traditional chinese medicine. 1992;27(10):440 (chi).
1061- gera: 44418/di/ra
[EXPERIENCE ON TREATING 2 CASES OF
gera 2011

HEPATIC HYDROTHORAX]. HUANG SHUIYUAN.
fujian journal of traditional chinese medicine.
1992;23(5):27 (chi).
1062- gera: 44476/di/ra
[ANTIOXIDANT AND PREVENTIVE EFFECT OF
TANNIN AND TANNIC ACID ON ACUTE LIVER
INJURY INDUCED BY AMINOPYRIN AND SODIUM
NITRITE]. FU NAI-WU ET AL. chinese traditional and
herbal drugs. 1992;23(11):585 (chi*).
Tannin was extracted from Terminalia chebula Retz. and
tannic acid from Rhus chinensis Mill. oral administration of
tannin 25-50mg/kg and tannic acid 75 mg/kg effectively
prevented mouse SGPT elevation induced by aminopyrin
(AP) and sodium nitrite. There was no effect by ip Injection.
These two drugs could not prevent the acute liver injury of
mouse induced by CCI4 at 5µg/ml, the in vitro NO2
production was prevented by these two compounds. Tannin
10-20µg/ml markedly inhibited VC/FeSO4 induced lipid
peroxidation of mouse liver mitochondria, inhibited
hemolysis induced by H2O2, and HPD plus light. At 2.5µg/
m1 tannin prevented O2 production. Tannic acid 20µg/ml
effectively inhibited OH Production, these was no effect of
tinnin at this dose.
1063- gera: 44505/di/ra
[SOME IMPORTANT PROBLEMS IN THE
TREATMENT BASED ON DIFFERENTIAL
DIAGNOSIS OF SYNDROMES IN HEPATITIS]. CHEN
LIHUA. journal of traditional chinese medicine.
1992;33(11):51 (eng).
1064- gera: 44642/di/ra
[EFFECTS OF SALVIA MILTIORRHIZA BUNGE ON
ISOLATED PERFUSED LIVER AND PORTAL VEIN
OF RATS]. YU ZEPU ET AL. china journal of chinese
materia medica. 1992;17(12):749 (chi*).
The experiment results showed that Salviae Miltiorrhiza
(SMB) had a protective effect on the isolated perfused liver
injured by CCI4, of rats, made the activity of GPT in
perfusate of SMB group lower than that of intoxicated group.
and relieve the hepato-pathohistologic lesions of SMB group
as compared to the intoxicated group. SMB had no
significant effects on both the activities of SGPT in vitro and
the portal vein of rats.
1065- gera: 44664/di/ra
[TREATMENT OF SENILE CIRRHOSIS OF LIVER
BY COMBINED TCM AND WM (REPORT OF 43
CASES)]. LUO GUO-JUN. shanxi journal of traditional
chinese medicine. 1992;8(6):4 (chi).
1066- gera: 44673/di/ra
[A CASE OF CURED INTRAHEPATIC
MACROCAVERNOMA]. WANG XI-PEI. shanxi journal
of traditional chinese medicine. 1992;8(6):48 (chi).
1067- gera: 44685/di/ra
[RECENT DEVELOPMENTS IN THE TREATMENT
OF HBSAG CARRIER WITH TCM]. ZENG YUANHUA
ET AL. traditional chinese medicinal research.
1992;5(2):45 (chi).
1068- gera: 44786/di/ra
[ANALYSIS OF PULSE PICTURES IN 190 CASES OF
CHRONIC PERSISTENT AND VIRAL HEPATITIS].
ZHOU JINGCHENG ET AL. shanghai journal of
traditional chinese medicine. 1992;11:4 (chi).
1069- gera: 44940/di/ra
58
[CLINICAL SUMMATION FOR 18 CASES OF VIRAL
HEPATITIS WITH HYPERICTERUS TREATED BY
BLOOD- ACTIVATING AND STASIS-REDUCING
METHOD MAINLY]. XING LIANJUN ET AL. shanghai
journal of traditional chinese medicine. 1992;12:8 (chi).
1070- gera: 44972/di/ra
[APPLICATION OF MIXTURE OF REINFORCING QI
AND PROMOTING BLOOD CIRCULATION TO
PREVENT HEPATIC FIBROSIS DUE TO BSA
IMMUNOLOGIC INJURY]. FANG BU-WU ET AL.
chinese journal of integrated traditional and western
medicine. 1992;12(12):738 (chi*).
44 Wistar female rats were divided randomly into 4 groups-
normal control (I), case control (II), reinforcing Qi and
promoting blood circulation (III) and nourishing Yin and
promoting blood circulation (IV). After 4 times of bovine
serum albumin (BSA) shock injection, the group III and the
group IV were medicated through gastric intubation for 40
days respectively with 300 % mixture of reinforcing Qi and
promoting blood circulation and 300 % mixture of nourishing
Yin and promoting blood circulation. The results suggest the
mixture of reinforcing Qi and promoting blood circulation
has the function of alleviating pathological changes of liver,
reducing the content of liver collagen, improving erythrocytic
function of clearing away immune complexes and regulating
humoral immune
1071- gera: 44976/di/ra
[PROGRESS OF STUDY ON CHINESE HERBAL
DRUGS IN TREATING FATTY LIVER]. ZHANG SHI-
JIE ET AL. chinese journal of integrated traditional and
western medicine. 1992;12(12):758 (chi).
1072- gera: 45022/di/ra
[FIVE METHODS FOR DISSOLVING EDEMA OF
ZHOU BINGWEN FOR TREATMENT OF
TYMPANITES]. GU RONGFANG. jiangxi journal of
traditional chinese medicine. 1992;23(6):3 (chi).
1073- gera: 45038/di/ra
[REGULATIVE EFFECT OF ENDOCRINOPATHY
WITH HEPATOCIRRHOSIS ON FUZHENG HUAYU
FORMULA]. HU YIYANG ET AL. china journal of
traditional chinese medicine and pharmacy. 1992;7(5):27
(chi).
1074- gera: 45061/di/ra
[DISCUSSION ON TREATMENT OF HEPATITIS B.].
ZHU HONGMING ET AL. journal of shandong college of
traditional chinese medicine. 1992;16(6):14 (chi*).
The cause of hepatitis B are considered two kinds such as
internal cause and external cause. Insufficiency of the spleen-
qi is the internal cause, and pathogenic factor of damp-heat is
the external cause. The pathology of hepatitis B is a
complicated one, and the treatment for it must depend upon
several aspects as stagnation of qi, damp-heat, insufficiency
of the spleen and kidney and blood stasis. Eliminating the
pathogenic factor is the important method during the whole
course of the disease. Hepatitis B is classified into four types
as : stagnation of the liver to damp-heat, insufficiency of the
liver yin and kidney yin, stagnation of the liver and
incubative pathogen, stagnancy of qi and blood stasis, Giant
knotweed rhizome, forsythia fruit, oldenlandia, hornet nest
are
1075- gera: 45592/nd/re
EFFICACY OF A HERBAL MEDICINE "SHO-SAIKO-
TO" ON THE IMPROVEMENT OF IMPAIRED
CYTOKINE PRODUCTION OF PERIPHERAL
gera 2011

BLOOD MONONUCLEAR CELLS IN PATIENTS
WITH CHRONIC VIRAL HEPATITIS. . YAMASHIKI
M ET AL. j clin lab immunol. 1992;37(3):111-21 (eng).
Peripheral blood samples were collected from normal
subjects and chronic viral hepatitis patients, and the in vitro
capability of the peripheral blood mononuclear cells to
produce various cytokine (interleukin-1 beta, interleukin-6,
interferon-gamma, and granulocyte-macrophage colony-
stimulating factor) were analyzed by adding pokeweed
mitogen. We then investigated the effects of a herbal
medicine "Sho-saiko-to" on the levels of cytokine production.
The production levels of the 4 cytokines were significantly
lower in the peripheral blood mononuclear cells of the
patients (Patient Group) than in those of normal subjects
(Control Group). The addition of Sho-saiko-to to the Patient
Group resulted in improved productions of those cytokines,
as well as an remarkable improvement of interleukin-1 beta
production. The results demonstrated that Sho-saiko-to acts
to improve such immunological abnormalities as decreased
cytokine productions. Administration of Sho-saiko-to to
chronic viral hepatitis patients is
1076- gera: 45819/nd/re
[A RESEARCH FOR SCREENING ANTI-HEPATITIS
B VIRUS DRUGS WITH THE 2.2.15 CELL LINE]. MI S
. national medical journal of china. 1992;72(10):612-5, 6
(chi*).
In this paper, 43 drugs have been screened and evaluated for
their ability of anti-hepatitis B virus by way of detecting in
the cell culture medium the HBsAG and HBeAG secreted
from the 2. 2. 15 cell line--a cell line derived from the Hep-
G2 transfected with cloned HBV DNA. In addition, the MTT
colorimetric assay is used in the process for monitoring the
cytotoxic effects. The result showed that five drugs, including
anti-HBV-I, anti-HBV-II, Radix Astragali Co. , Rhizoma
Curculiginis Co. and 518BII-A-6 are promising anti-HBV
drugs.
1077- gera: 45860/di/ra
INDUCTION OF LIVER MICROSOMAL
CYTOCHROME P-450 2B1 BY DIMETHYL
DIPHENYL BICARBOXYLATE IN RATS. . LI Y ET
AL. acta pharmacologica sinica. 1992;13(6):485-90 (eng).
Dimethyl diphenyl bicarboxylate (dimethyl-4,4'-
dimethyloxy- 5,6,5',6'-dimethylene-dioxy-di phe nyl-2,2'-
bicarboxylate, DDB), a synthetic mimic of the natural
product schizandrin C, is used in China as a hepatoprotective
agent to improve the liver functions of patients with hepatitis
or under cancer chemotherapy. In this study, we investigated
the effects of DDB on liver microsomal drug-metabolizing
enzymes. When male Sprague-Dawley rats were treated with
a daily intragastric dose of DDB (200 mg. kg-1) for 3 d, the
microsomal pentoxyresorufin dealkylase activity and P-450
2B1 protein levels were markedly increased. The fold
increase was lower than that by phenobarbital (75 mg. kg-1,
ip once daily x 3 d). The level of P-450 2B1 mRNA was
elevated by DDB but the magnitude of the elevation was
much less than that caused by phenobarbital. DDB also
increased the rates of testosterone hydroxylation at positions
16 beta, 16 alpha, 6 beta, and 2 beta as well as the rate of
ethoxyresorufin dealkylation, suggesting moderate increases
in the levels of P-450 3A and P-450 1A1 in addition to the
huge increase in P-450 2B1. The level of glutathione S-
transferase was also slightly increased, but the levels of P-
450 2E1 and NAD(P)H: quinone oxidoreductase were not
changed. The results indicate that DDB is an inducer of P-
450 2B1.
1078- gera: 45966/di/ra
[PROGRESS OF STUDY ON CHINESE HERBAL
59
DRUGS IN TREATING FATTY LIVER]. ZHANG SJ .
chinese journal of integrated traditional and western
medicine. 1992;12(12):758-9 (chi).
1079- gera: 45969/di/ra
[REINFORCING QI AND PROMOTING BLOOD
CIRCULATION TO PREVENT HEPATIC FIBROSIS
DUE TO BOVINE SERUM ALBUMIN
IMMUNOLOGIC INJURY]. FANG BW ET AL. chinese
journal of integrated traditional and western medicine.
1992;12(12):738-40, (chi*).
44 Wistar female rats were divided randomly into 4 groups--
normal control(I), case control (II), reinforcing Qi and
promoting blood circulation(III) and nourishing Yin and
promoting blood circulation(IV). After 4 times of bovine
serum albumin (BSA) shock injection, the group III and the
group IV were medicated through gastric intubation for 40
days respectively with 300% mixture of reinforcing Qi and
promoting blood circulation and 300% mixture of nourishing
Yin and promoting blood circulation. The results suggest the
mixture of reinforcing Qi and promoting blood circulation
has the function of alleviating pathological changes of liver,
reducing the content of liver collagen, improving erythrocytic
function of clearing away immune complexes and regulating
humoral immune
1080- gera: 45978/di/ra
[EFFECTS OF SALVIA MILTIORRHIZA BUNGE ON
ISOLATED PERFUSED LIVER AND PORTAL VEIN
OF RATS]. YU ZP ET AL. china journal of chinese
materia medica. 1992;17(12):749-51, (chi*).
The experiment results showed that Salvia miltiorrhiza
(SMB) had a protective effect on the isolated perfused liver
injured by CCl4 of rats, made the activity of GPT in perfusate
of SMB group lower than that of intoxicated groups and
relieved the hepato-pathohistologic lesions of SMB group as
compared to the intoxicated group. SMB had no significant
effects on both the activities of SGPT in vitro and the portal
vein of rats.
1081- gera: 48988/nd/ra
[EFFECT OF TCM BLOOD-ACTIVATING AND
STASIS-ELIMINATING RESIPE ON
HEMORRHEOLOGY IN PRIMARY LIVER
CARCINOMA-A REPORT OF 65 CASES]. LI
ZUOQING. guang xi journal of traditional chinese
medicine. 1992;15(5):4-6 (chi).
Thirty-nine cases were prescribed with the recipe consisting
of roasted Squama Manitis, Carapax Trionycis, Rhizoma
Zedoariae, Radix Notoginseng, Radix Paeoniae Rubra,
Eupolyphaga seu Stelepphaga, Herba Agrimoniae, Radix
Salviae Miltiororhizae ; decocted all the ingredients with
water for oral administration. The 26 cases of the control
group were treated with adriamycin, fluorouracil. Results :
The effective rates in the tested group and control groups
were respectively as follows : markedly effective 24, 2 cases
; effective, 10, 4 cases; failed 5, 20 cases. All the
hemorrheological indices were markedly lowered after the
treatment in the tested group (P<0.001-0.05). For the control
group, except the weight of the wet thrombus in vitro
revealing marked changes after treatment (P < 0.05), all the
other indices showed no significant difference (P>0.05).
1082- gera: 70196/nd/re
[EFFECTS OF SINO-JAPANESE HERBS IN THE
FAMILY UMBELLIFERAE ON THE HEPATIC DRUG
METABOLIZING ENZYMES AND LIPID
PEROXIDATION IN RATS]. MAYANAGI M ET AL.
nippon yakurigaku zasshi. 1992;99(2):115-21 (jap*).
Eight kinds of hot water extracts (HWE) and 2 kinds of
gera 2011

distanninized fractions (DTF) from Umbelliferae herbs were
prepared. The effects of HWE and DTF on rat hepatic lipid
peroxidation (LPO), aminopyrine N-demethylase (APD) and
aniline hydroxylase (ANH) activities were examined in vitro.
The APD activity was inhibited by HWE, DTF from
Byakushi and HWE from Uikyo, Zenko, Toki, Senkyu, Bofu
and Saiko, respectively, whereas DTF from Uikyo caused no
significant effect. The ANH activity was inhibited by HWE,
DTF from Byakushi, Uikyo and HWE from Bofu, Zenko,
Hokushajin and Toki, respectively. LPO was inhibited by
HWE from Zenko, Byakushi and Senkyu, but increased by
Saiko, Uikyo, Bofu and Hokushajin. The results of Uikyo
DTF suggests that the components of Uikyo that altered the
activity of APD and ANH are different respectively. Marked
inhibitions on the activity of APD and ANH caused by
Byakushi indicate that Byakushi might affect the activity of
hepatic drug metabolizing enzymes in
1083- gera: 3899/di/cg
ACUPUNCTURE FOR THE TREATMENT OF
HEPATITIS C. HORI S ET AL. third world conference
on acupuncture. 1993;:146. (eng).
1084- gera: 5737/di/cg
ULTRASTRUCTURAL STUDY OF THE EFFECTS OF
ACUPUNCTURE ON AGE-RELATED CHANGES IN
PANCREATIC AND HEPATIC TISSUE. KARINO Y ET
AL. third world conference on acupuncture. 1993;:249.
(eng).
1085- gera: 7799/di/cg
VARIATION IN MERIDIAN POINTS FOR
MOXIBUSTION. OCHI H. third world conference on
acupuncture. 1993;:330. (eng).
1086- gera: 19718/di/ra
TCM MANAGEMENT OF HEPATITIS. X. abstract and
review of clinical tcm. 1993;3:1-68 (eng).
1087- gera: 19721/di/ra
LIVER FAILURE IN A LABRADOR RETRIEVER.
RIDGWAY KJ. international journal of veterinary
acupuncture. 1993;4(1):8-10 (eng).
1088- gera: 37855/di/ra
[REVIEW ON THE STUDIES OF PREVENTION AND
TREATMENT OF EXPERIMENTAL LIVER DAMAGE
AND PROLIFERATION OF FIBROUS TISSUE IN THE
LIVER BY TCM]. ZHANG MENGREN ET AL. journal of
traditional chinese medicine. 1993;34(2):114 (eng).
1089- gera: 37873/di/ra
[CLINICAL INVESTIGATION ON TREATMENT OF
42 CASES OF VIRAL HEPATITIS B ACCORDING TO
DIFFERENTIATION OF THE SYMPTOMS]. ZHONG
SONGCAI. jiangxi journal of traditional chinese
medicine. 1993;24(2):13 (chi).
1090- gera: 37880/di/ra
[DR CHEN JI MING'S SEVERN METHODS OF
TREATING CHRONIC HEPATITIS]. JIANG JIAN.
zhejiang journal of traditional chinese medicine.
1993;28(4):145 (chi).
1091- gera: 37881/di/ra
[TREATING 100 CASES OF ASCITES DUE TO
CIRRHOSIS WITH "XIN DING XIAO YAO SAN"].
LIU JIN-SHU. zhejiang journal of traditional chinese
medicine. 1993;28(4):151 (chi).
60
1092- gera: 37896/di/ra
[SECRURINEGA SUFFRRUNCA COMPOUND
TABLETS OF BITTER TASTE FOR
ASYMPTOMATIC HEPATITIS B VIRUS CARRIERS].
MA FUXING ET AL. shanghai journal of traditional
chinese medicine. 1993;5:8 (chi).
1093- gera: 37932/di/ra
[TREATMENT OF HBSAG POSITIVE WITH
YIGUANJIAN JIAWEI : REPORT OF 83 CASES].
DONG MINGQIANG. beijing journal of traditional
chinese medicine. 1993;2:17 (chi).
1094- gera: 37940/di/ra
[CLINICAL OBSERVATION ON TREATMENT FOR
100 CASES OF CHRONIC HEPATITIS B WITH
YIGAN JIANPI HEWEI CHONGJI]. CHE NIANCONG
ET AL. beijing journal of traditional chinese medicine.
1993;2:37 (chi).
1095- gera: 37942/di/ra
[ONE CURED CASE OF MASSIVE
HEPATOCARCINOMA BY CHINESE HERBS IN
COOPERATION WITH LIGATION OF PATENT
ARTERIAL DUCT]. WU JUNYU ET AL. beijing journal
of traditional chinese medicine. 1993;2:48 (chi).
1096- gera: 37943/di/ra
[TCM'S THERAPEUTIC SURVEY ON ALL TYPES OF
HEPATITIS]. JING BINRONG ET AL. beijing journal of
traditional chinese medicine. 1993;2:52 (chi).
1097- gera: 37967/di/ra
[EFFECT OF BACTERIAL LIVER ABSCESS BY
INTEGRATING CHINESE WITH MODERN
MEDICINE ON 53 CASES]. YIE LONG-YU ET AL.
practical journal of integrating chinese with modern
medicine. 1993;6(4):199 (chi).
1098- gera: 37971/di/ra
[RELATIONSHIP BETWEEN CHRONIC HEPATITIS
AND DIFFERENTIATION OF SYMPTOMS AND
SIGNS IN TRADITIONAL CHINESE MEDICINE].
JIANG CHENG-HUI ET AL. practical journal of
integrating chinese with modern medicine. 1993;6(4):215
(chi).
1099- gera: 38002/di/ra
[PRIMARY LIVER CARCINOMA TREATED BY THE
PRINCIPLES OF SPLEEN-INVIGORATING AND QI-
REGULATING, STASISDISPELLING AND LUMP-
SOFTENING, HEAT-CLEARING AND
DETOXIFYING]. PAN MINQIU ET AL. journal of
traditional chinese medicine. 1993;34(4):239 (eng).
1100- gera: 38098/di/ra
[EXAMPLES OF PROFESS YU SHENCHU'S
CLINICAL EXPERIENCE IN TREATING THE
LIVER]. LIU DERONG. liaoning journal of traditional
chinese medicine. 1993;20(5):9 (chi).
1101- gera: 38128/di/ra
[TREATMENT OF CHRONIC VIRAL HEPATITIS B
BY YI GAN TANG ADDING WITH POLYINOSINIC
ACID : A CONTROL TRIAL REPORT]. ZHU
CHENGLAN ET AL. new journal of traditional chinese
medicine. 1993;25(3):21 (chi).
1102- gera: 38135/di/ra
[CLINICAL OBSERVATION OF CHRONIC ACTIVE
gera 2011

HEPATITIS B TREATED WITH THE PRINCIPLE OF
RUAN JIANB HUO XUE ON 36 CASES]. XU YOU-QI.
practical journal of integrating chinese with modern
medicine. 1993;6(1):5 (chi*).
According to the traditional Chinese medicine theory, 36
cases of the chronic active hepatitis B were treated by the
decoction of RJHX which the main function was softening
hard masses and promoting blood circulation. The results
showed that 9 cases were basically cured, 22 cases were
improved and 5 cases remains ineffectived, and the total
effective rate was 80, 1%. It also indicated that the decoction
of RJHX could improve the liver function, and restraine the
reproduce of hepatitis virus B. Therefore, this paper
presented that the principle of RJHX will be effective to treat
this disease.
1103- gera: 38144/di/ra
[CLINICAL AND EXPERIMENTAL STUDY ON THE
TREATMENT OF PRIMARY HEPATIC CARCINOMA
WITH REN KANG CAPSULAE]. ZHOU JIAN-HUA ET
AL. practical journal of integrating chinese with modern
medicine. 1993;6(1):37 (chi).
1104- gera: 38151/di/ra
[EFFECTIVE OBSERVATION OF PRESCRIPTION
FOR TONIFYING THE KIDNEY ON CHRONIC
CARRIERS OF HEPATITIS B VIRUS]. LU MIN.
practical journal of integrating chinese with modern
medicine. 1993;6(3):137 (chi).
1105- gera: 38152/di/ra
[CLINICAL ANALYSIS ON HEPATO-RENAL
SYNDROME AFTER SEVERE VIRUS HEPATITIS BY
INTEGRATING CHINESE WITH MODERN
MEDICINE]. CHENG YU-LIN. practical journal of
integrating chinese with modern medicine. 1993;6(3):148
(chi).
1106- gera: 38192/di/ra
[OBSERVATION ON 120 CASES OF HEPATITIS B
VIRUS CARRIER TREATED WITH CHINESE
MEDICINE]. CHEN MUTAO. hubei journal of
traditional medicine. 1993;1:29 (chi).
1107- gera: 38237/di/ra
[OBSERVATION ON THE THERAPEUTIC EFFECT
OF MAYI YIGANNING ON THE TRANSFORMATION
OF HBV-M : REPORT OF 480 CASES]. WU
ZHICHENG ET AL. journal of traditional chinese
medicine. 1993;34(1):40 (eng*).
1108- gera: 38242/di/ra
[PRESENT STATUS AND PROSPECTS OF VIRAL
HEPATITIS TREATED BY TCM]. WEI BEIHAI ET AL.
journal of traditional chinese medicine. 1993;34(1):52
(eng).
1109- gera: 38297/di/ra
[INFLUENCE OF ACUPUNCTURE AT ZUSANLI
(ST36) POINT ON IMMUNE FUNCTIONS OF HBSAG
CARRIERS]. CHEN YONG-KANG ET AL. chinese
acupuncture and moxibustion. 1993;13(2):33 (chi*).
One hundred twelve HBsAg carriers were divided into two
groups : the treatment (82 cases) and control (30 cases)
group. In the treatment group Zusanli (ST36) point was
punctured once every other day (42 cases) or received
indirect moxibustion with ginger (40 cases) 3 times a week.
Various indices espressing immune function were reexamed
after 18 treatments, and compared with thoses in the control
group. Each index was tested before starting the treatment
61
and after half a year of treatments respectively. It was found
that in the treatment group IgG and IgA values were
obviously attenuated (P<0.05), complement C3 and PHA
values were markedly elevated (P<0.01), but the IgM value
showed no noticeable changes. The difference in the values
mentioned above
1110- gera: 38316/di/ra
[MORPHOLOGICAL AND BIOCHEMICAL STUDY
ON THE CURATIVE EFFECT OF CHINESE
MEDICINAL PREPARATION 863 ON THE INJURED
RAT LIVER BY D-GALACTOSAMINE]. ZHANG YING
ET AL. chinese traditional patent medicine. 1993;15(2):55
(chi*).
1111- gera: 38390/di/ra
[A RESEARCH ON HEPATIC AND GALLSTONE
TREATED WITH XIAO RONG GAN DAN JIE SHI
TABLET]. XIE SHIFANG ET AL. china journal of
traditional chinese medicine and pharmacy. 1993;8(1):19
(chi*).
1112- gera: 38430/di/ra
[RECENT SURVEY ON TCM AND TCM PLUS WM
THERAPIES AND THEIR EXPERIMENTAL STUDY
OF INFANTILE HEPATITIC SYNDROME]. YU JIAN
ET AL. shanghai journal of traditional chinese medicine.
1993;1:26 (chi).
1113- gera: 38432/di/ra
[OBSERVATION ON CLINICAL EFFECT OF RE INES
SINGLE DOSE RHUBARB TABLETS FOR RECIPES
VIRAL HEPATITIS]. GAO GUIYING ET AL. shanghai
journal of traditional chinese medicine. 1993;1:32 (chi).
1114- gera: 38599/di/ra
[EXPERIENCE ON TREATMENT OF EARLY
CIRRHOSIS]. ZHONG SHENQING. journal of shandong
college of traditional chinese medicine. 1993;17(2):51
(chi).
1115- gera: 38736/di/ra
[CLINICAL OBSERVATION ON ANTIFIBROSIS
COMPOUND PRESCRIPTION IN TREATING POST-
HEPATITIS CIRRHOSIS]. XIA DEYING ET AL.
shanghai journal of traditional chinese medicine.
1993;9:15 (chi).
1116- gera: 38775/di/ra
STUDI SPERIMENTALI SULL'AZIONE INIBITRICE
DI 1OOO FARMACI CINESI SULL'ANTIGENE DI
SUPERFICIE DELL'EPATITE B. ZHENG MINSHI ET
AL. rivista italiana di medicina tradizionale cinese.
1993;50(2):62-4 (ita).
1117- gera: 38798/di/ra
HEPATITIS-THERAPIE IN DER TCM. SCHULLER B
ET AL. akupunktur theorie und praxis. 1993;1(93):57-9
(deu).
1118- gera: 38897/di/ra
PHARMACOLOGICAL AND PATHOLOGICAL
STUDIES ON TAIWAN FOLK MEDICINE (IX) : THE
HEPATOPROTECTIVE EFFECT OF THE
METHANOLIC EXTRACT FROM ECHINOPS
GRIJISII. CHUN-CHING LIN ET AL. american journal
of chinese medicine. 1993;21(1):33-44 (eng).
1119- gera: 38898/di/ra
ANTIHEPATOTOXIC ACTIVITY OF PHENOLIC
gera 2011

FLAVAN-3-OLS AND THEIR DERIVATIVES. FENG-
LIN HSU ET AL. american journal of chinese medicine.
1993;21(1):45-50 (eng).
1120- gera: 38899/di/ra
COMBINED THERAPY OF MITOMYCIN C AND
CHINESE MEDICAL HERBS ON EXPERIMENTAL
LIVER CANCER. DOU-MONG HAU ET AL. american
journal of chinese medicine. 1993;21(1):51-8 (eng).
1121- gera: 38900/di/ra
EVALUATION OF THE ANTI-INFLAMMATORY
AND LIVER-PROTECTIVE EFFECTS OF
ANOECTOCHILUS FORMOSANUS, GANODERMA
LUCIDUM AND GYNOSTEMMA PENTAPHYLLUM
IN RATS. JUR-MIN LIN ET AL. american journal of
chinese medicine. 1993;21(1):59-69 (eng).
1122- gera: 45480/nd/re
PREVENTIVE EFFECT OF GOMISIN A, A LIGNAN
COMPONENT OF SHIZANDRA FRUITS, ON
ACETAMINOPHEN- INDUCED HEPATOTOXICITY
IN RATS. YAMADA S ET AL. biochem pharmacol.
1993;46(6):1081-5 (eng).
The preventive effect of gomisin A, a lignan component of
shizandra fruits, on acetaminophen-induced hepatotoxicity in
rats was examined by histological and biochemical analysis.
Acetaminophen at a dose of 750 mg/kg was administered to
male Wistar rats with or without pretreatment with 50 mg/kg
of gomisin A. Gomisin A inhibited not only the elevation of
serum aminotransferase activity and hepatic lipoperoxides
content, characteristic of acetaminophen administration, but
also the appearance of histological changes such as
degeneration and necrosis of hepatocytes. However, gomisin
A did not affect the decrease in liver glutathione content.
These results suggest that gomisin A protects the liver from
injury after administration of acetaminophen
1123- gera: 45600/ /ra
[PROTECTIVE ACTION OF BLUMEATIN AGAINST
EXPERIMENTAL LIVER INJURIES]. XU SB ET AL.
acta pharmacologica sinica. 1993;14(4):376-8 (chi*).
Blumeatin (Blu, 5,3',5'-trihydroxy-7-methoxy-dihydro-flavo
ne) was first isolated from Blumea balsamifera DC by
Department of Chemistry, Sunyatsen University of China.
Blu ip inhibited the increase of serum alanine
aminotransferase (AAT) and liver triglyceride and increased
serum triglyceride, beta-lipoprotein, and liver glycogen
content in CCl4-intoxicated rats. Histological lesions of liver
were less severe than those of hepatic injury control. Blu ip 0.
65 and 3. 25 mg. kg-1 inhibited the increase of serum AAT
and hepatic TG in thioacetamide (TAA)- intoxicated mice.
Blu ip shortened the pentobarbital sleeping time in CCl4-
intoxicated mice. It suggested that Blu could protect liver
against injury induced by CCl4 and TAA.
1124- gera: 45633/nd/re
PREVENTIVE EFFECTS OF DIPHENYL DIMETHYL
DICARBOXYLATE ON THE IMMUNOTOXICITY OF
CARBON TETRACHLORIDE IN ICR MICE. . AHN YK
ET AL. j toxicol sci. 1993;18(3):185-95 (eng).
To investigate the preventive effects of diphenyl dimethyl
dicarboxylate (PMC) on the immunotoxicity of carbon
tetrachloride (CCl4) in ICR mice, PMC (3 and 6 mg/kg,
respectively) were orally administered to mice through a
zonde once a day for 28 consecutive days. CCl4 solution was
also administered at 1 ml/kg (25%) p. o. 2 hr later the
administration of PMC twice a week. Mice were immunized
and challenged with sheep red blood cells (SRBC). Immune
function were evaluated by humoral, cell-mediated and non-
62
specific immune responses. The results of this study were
summarized as follows; 1. The body weight gains and the
relative spleen and thymus weights were significantly
increased by PMC treatment as compared with treatment of
CCl4 alone. However, the relative liver weights were
significantly decreased. These values were similar to those of
control mice. 2. Hemagglutination (HA) titers were
significantly enhanced by PMC treatment as compared with
treatment of CCl4 alone. Plaque forming cells (PFC) were
also greatly increased by PMC treatment, especially at a dose
of 6 mg/kg of it. 3. Delayed-type hypersensitivity (DTH)
response was significantly decreased in mice treated with
CCl4 and PMC along with the increase of PMC doses, as
compared with those in the mice treated with CCl4 alone,
while rosette forming cells (RFC) were significantly
increased. These results were similar to those of control mice.
4. In PMC treatment as compared with treatment of CCl4
alone, there were significant increases in activities of natural
killer (NK) cells and phagocytes along with circulating
leukocytes. These results suggest that PMC has significant
preventive effect on CCl4-induced immunotoxic status.
1125- gera: 45637/nd/re
HEPATOTOXICITE DES PLANTES MEDICINALES
ET DES PREPARATIONS à BASE DE PLANTES.
PAUWELS A ET AL. gastroenterol clin biol. 1993;17(5 PT
:H79-85 (fra).
1126- gera: 45669/di/ra
[EFFECTS OF MAGNESIUM LITHOSPERMATE B
ON D-GALACTOSAMINE INDUCED RAT LIVER
INJURY]. LIU P ET AL. chinese journal of integrated
traditional and western medicine. 1993;13(6):352-3, 3
(chi).
To investigate the effective ingredients of Salvia
miltiorrhizae on anti-liver injury, the water soluble
component of the above drug, magnesium lithosperamate B,
was used to conduct the experimental treatment of acute liver
injury by D-galactosamine (10 mg/kg body weight, orally).
The results showed that the component could obviously
attenuate the necrosis of liver tissues, lower the activities of
serum alanine amino transferase (ALT) and aspartate amino
transferase (AST), P < 0. 05. Compared with those of the
normal rats, the levels of the products of cyclo- oxygenase
(6-keto-prostaglandin F1 alpha, prostaglandin D2 and total
prostaglandins) in the metabolism of arachidonic acid in non-
parenchymal cells of acute liver-injured rats were markedly
decreased (P < 0. 05). These data revealed that magnesium
lithosperamate B might be one of the main components of
Salvia miltiorrhizae in anti-liver injury, while increasing the
levels of total prostaglandins in liver non-parenchymal cells
was perhaps one
1127- gera: 45676/di/ra
[CLINICAL AND EXPERIMENTAL OBSERVATIONS
OF BUZHONG YIQI DECOCTION IN THE
TREATMENT OF CHRONIC HEPATITIS B]. DU FB
ET AL. chinese journal of integrated traditional and
western medicine. 1993;13(6):333-5, 3 (chi).
A clinical observation of Buzhong Yiqi decoction (BZYQD)
and Western medicine was used on a matched control in
treating chronic hepatitis B. The result showed that BZYQD
was significantly better than the Western medicine in
improving clinical symptoms and signs, the liver function
and serological test of hepatitis B antigen-antibody system
(HBAg-Ab system), P < 0. 05. In order to explore the
therapeutical mechanism of BZYQD, the study of the effects
of which on synthesis of hepatic DNA, RNA and protein in
mice were performed too. The results showed that BZYQD
had marked promotive effects on the synthesis of hepatic
gera 2011

DNA, RNA and protein. It was considered that the
mechanism of anti-hepatitis effects might related to the
enhancing protein synthesis in liver, promoting the repairs of
the damaged liver tissue and improving the defense function
of organism as a whole.
1128- gera: 45677/di/ra
[CLINICAL EFFECTS OF PERFUSING DRUGS INTO
HEPATIC ARTERY TO PROMOTE BLOOD
CIRCULATION IN LATE STAGE OF
HEPATOCARCINOMA]. PENG ZS ET AL. chinese
journal of integrated traditional and western medicine.
1993;13(6):330-2, 3 (chi).
The sophisticated technology of hepatic artery catheterization
was used since 1990 in treating exacerbated patient after
chemotherapy, 4-8 ml Salvia miltiorrhizae composita
injection with 20 ml of 10% glucose was used. The same
Chinese herbal drug based on Syndrome Differentiation as
well as Western drug to relieve the symptoms was used in
both treated and control groups. After two treatment courses,
the symptom of treated group was relieved, the tumor mass
shrunk and the biochemical parameters improved, the total
effective rate was 65%, while that of control group was 25%,
the difference between two groups was very significant, P <
0. 01. This result suggests that is one of effective methods
which worth further investigation.
1129- gera: 45762/nd/re
[PROTECTIVE EFFECTS OF TAIWAN CRUDE
DRUGS ON EXPERIMENTAL LIVER INJURIES].
OHTA S ET AL. yakugaku zasshi. 1993;113(12):870-80
(jap*).
Protective effects of 41 Taiwan crude drugs on rat hepatic
injuries caused by carbon tetrachloride (CCl4) and alpha-
naphthylisothiocyanate (ANIT) were investigated. The
methanol extracts of Elephantopi Herba and Lonicerae Flos
inhibited the release of intrahepatic enzymes and histological
changes by CCl4. The methanol extracts of Canarii Radix,
Arecae Pericarpium, Cynomorii Caulis, Polygoni Cuspidati
Radix, Phyllodii Herba, Junci Caulis Medulla, Rubiae Herba
and Rhinacanthi Herba protected the hepatic injury by ANIT.
Among them, the water extracts of Cymorii Caulis and Junci
Caulis Medulla showed higher protective potency than the
methanol extracts. And them this two crude drugs also
protected the cholestasis by ANIT.
1130- gera: 45788/di/ra
[CLINICAL AND EXPERIMENTAL STUDY ON YI-
GAN-NING GRANULE IN TREATING CHRONIC
HEPATITIS B]. ZHANG BZ ET AL. chinese journal of
integrated traditional and western medicine.
1993;13(10):597-9, 5 (chi).
This paper reports that 320 patients with chronic hepatitis B
(CHB) were treated with Yi-ganning Granule (YGNG) and
the pharmacodynamics of YGNG in the animal study. As
control, another 70 patients with CHB receiving oleanolic
acid granule (OAG) were compared to 68 patients in YGNG
group. YGNG is consisted of Astragalus membranaceus ,
Artemisia capillaris, Codonopsis pilosula, et al. Each patient
has taken YGNG or OAG for 3 months. The result showed
YGNG was effective on recovering the liver function and
OAG had similar effect. The sero-negative conversion rates
of HBsAg, HBeAg, HBcAb and positive conversion rate of
HBeAb in the YGNG group were 33. 1%, 40. 5%, 10. 5%
and 15. 5% respectively, which were much better than that in
OAG group (P < 0. 05-0. 001). The result of 6 months follow
up showed that 60 of 62 patients receiving YGNG were in
stabilized state. The result in the animal study demonstrated
that YGNG had significant protection from the liver damage
caused by CCl4. YGNG could decrease serum ALT level and
63
protect the liver function of carbohydrate, fat, protein
metabolism and detoxication. YGNG could induce interferon
in vivo and play an important role in seroconversion
1131- gera: 45804/nd/re
ANTI-GROWTH EFFECTS WITH COMPONENTS OF
SHO-SAIKO-TO (TJ-9) ON CULTURED HUMAN
HEPATOMA CELLS. . OKITA K ET AL. eur j cancer
prev. 1993;2(2):169-75 (eng).
The present study was undertaken to investigate the effects
and the mechanism of the components of Sho-saiko-to
(baicalein, baicalin, saikosaponin-a, saikosaponin-c,
ginsenoside Rb1, ginsenoside Rg1) on cultured human
hepatoma cells (HuH-7). Cell cycle analysis was carried out
with flow cytometry and the bromodeoxyuridine (BrdU)-
labelling method. The results showed that baicalein, baicalin
and saikosaponin-a inhibited cell proliferation dose-
dependently but independently of the cell cycle. Furthermore,
it was found that saikosaponin-a possesses a strong cell-
killing effect. On the other hand, saikosaponin-c, ginsenoside
Rb1 and ginsenoside Rg1 had no effect on cell
1132- gera: 46001/ /ra
EVALUATION OF THE ANTI-INFLAMMATORY
AND LIVER-PROTECTIVE EFFECTS OF
ANOECTOCHILUS FORMOSANUS, GANODERMA
LUCIDUM AND GYNOSTEMMA PENTAPHYLLUM
IN RATS. LIN JM ET AL. american journal of chinese
medicine. 1993;21(1):59-69 (eng).
The pharmacological effects of Anoectochilus formosanus,
Ganoderma lucidum and Gynostemma pentaphyllum were
studied against carrageenan-induced paw edema and CC1(4)-
induced hepatotoxicity in rats. The water extracts of G.
pentaphyllum and G. lucidum were found to possess
significant anti-inflammatory activity against carrageenan
induced edema. The administration of Gynostemma
pentaphyllum displayed an activity even more potent than
indomethacin. In contrast, Anoectochilus formosanus showed
a delayed onset of anti-inflammatory activity starting from 4
hrs post carrageenan administration. However, A.
formosanus significantly decreased the acute increase in
serum GOT and GPT level caused by CC1(4). Histological
changes such as necrosis, fatty change, ballooning
degeneration, inflammatory infiltration of lymphocytes and
Kupffer cells around the central vein were simultaneously
improved by the treatment of A. formosanus.
1133- gera: 46003/ /ra
PHARMACOLOGICAL AND PATHOLOGICAL
STUDIES ON TAIWAN FOLK MEDICINE (IX) : THE
HEPATOPROTECTIVE EFFECT OF THE
METHANOLIC EXTRACT FROM ECHINOPS
GRIJISII. . LIN CC ET AL. american journal of chinese
medicine. 1993;21(1):33-44 (eng).
In order to isolate the main hepatoprotective component of
Echinops grijisii, the crude drug was extracted with methanol
and subjected to continuous extractions using n-hexane
chloroform, ethyl acetate and n-butanol. The hepatoprotective
studies of each fraction from the methanol extract of E.
grijisii was conducted in Wistar albino rats with CC(1)4-
induced liver damage. Hepatoprotective activity was
evaluated in terms of the modification of serum transaminase
values such as SGOT and SGPT, and histopathological
changes of liver biopsy. The results indicated that the main
hepatoprotective component was concentrated in n-butanol
and aqueous fractions.
1134- gera: 46051/nd/re
[EFFECTS OF SINO-JAPANESE HERBS IN THE
FAMILY LABIATAE ON THE HEPATIC DRUG
gera 2011

METABOLIZING ENZYMES AND LIPID
PEROXIDATION IN RATS]. NAKAYAMA S ET AL.
nippon yakurigaku zasshi. 1993;101(5):327-36 (jap*).
The effects of hot water extracts (HWEs) and distanninized
fractions (DTFs) from 9 kinds of Labiatae herbs on rat
hepatic lipid peroxidation (LPO) and the activities of
aminopyrine N-demethylase (APD) and aniline hydroxylase
(ANH) were examined in vitro. The APD activity was
inhibited by the HWEs from 6 herbs, of which the effect of
HWE from Ogon was remarkable. The APD activity was
increased by HWE from Shisoshi. The inhibitory effect of the
HWE from Ogon was not different compared that of the DTF
from Ogon, whereas the APD activity was decreased in the
DTF from Shisoshi in comparison with that of the HWE. The
ANH activity was inhibited by the HWEs from 7 herbs.
Except in the case of Kakko and Shisoyo, the inhibitory
effects of the HWEs were enhanced by these of the DTFs
from the 7 herbs, of which the effect of DTF from Ogon was
remarkable. LPO was inhibited by the HWEs from 8 herbs.
Especially, HWE from Ogon strikingly inhibited LPO, and
this effect was retained by the DTF from Ogon. The present
results suggested that Ogon, which showed remarkable
effects on LPO, and the
1135- gera: 46059/nd/re
[CLINICAL SIGNIFICANCE OF TUMOR CELL DNA
ANALYSIS IN PATIENTS WITH LARGE
HEPATOCELLULAR CARCINOMA TREATED WITH
IRRADIATION COMBINED WITH TRADITIONAL
CHINESE MEDICINE]. LIU LM . chung hua chung liu
tsa chih. 1993;15(1):26-9 (chi*).
There has not been reported that DNA ploidy status of
hepatocellular carcinoma may be used to predict the
prognosis of patients with large liver cancer treated with
radiotherapy combined with Chinese traditional medicine. In
this series, the ploidy of DNA pattern in 28 cases were
analyzed. Of them, the diploid accounts for 57. 14% and
aneuploid for 42. 86%. Correlative analysis indicated that the
clinical course of the disease in diploid cases was less severe
than those in aneuploid ones (P < 0. 05) and the response to
treatment of patients with diploid DNA pattern was better
than that of aneuploid ones (P < 0. 01). However, there was
no significant correlation between ploidy of DNA pattern and
tumor size, AFP level or degree of differentiation of cancer
cells (P > 0. 05), which indicated that the ploidy pattern may
be of significance in the treatment outcome of large liver
cancer by
1136- gera: 46131/nd/re
EFFECTS OF DIAOXINXUEKANG ON ASCITES IN
BROILERS. . WANG JY ET AL. poult sci.
1993;72(8):1467-72 (eng).
To investigate whether Diaoxinxuekang (a Chinese medicine
that is reported to improve blood circulation) plays a role in
preventing ascites in broilers, day-old male broilers were
divided randomly into four groups, each with seven
replicates, and reared for 40 days. The birds were housed in a
brooder room from Day 1 to 21 and then reared in an
environmental chamber room under low temperatures.
Diaoxinxuekang was added to rations at the rate of 0, 500,
1,500, and 3,500 mg/kg as Treatments 1 to 4. When
Diaoxinxuekang was added to rations, body weight in the
first 3 wk was increased significantly, but feed consumption
remained unchanged. Heart weight was not significantly
different between control and treatments, but liver weight in
the control and 500 mg/kg group was heavier than in
Treatments 3 and 4. Within treatment, heart weight of the
normal broiler was less than that of the broiler with ascites.
Treatment 4 showed significantly (P < . 05) less ascites than
Treatments 1, 2, and 3 in the processing examination. The
64
results present evidence that 3,500 mg/kg Diaoxinxuekang
reduces the incidence of
1137- gera: 46167/nd/re
ANTIHEPATOTOXIC EFFECTS OF MAJOR
DITERPENOID CONSTITUENTS OF
ANDROGRAPHIS PANICULATA. . KAPIL A ET AL.
biochem pharmacol. 1993;46(1):182-5 (eng).
The diterpenes andrographolide (I), andrographiside (II) and
neoandrographolide (III) isolated from Andrographis
paniculata were investigated for their protective effects on
hepatotoxicity induced in mice by carbon tetrachloride or
tert-butylhydroperoxide (tBHP) intoxication. Pretreatment of
mice with the diterpenes (I, II & III; 100 mg/kg, i. p. ) for 3
consecutive days produced significant reduction in
malondialdehyde formation, reduced glutathione (GSH)
depletion and enzymatic leakage of glutamic-pyruvate
transaminase (GPT) and alkaline phosphatase (AP) in either
group of the toxin-treated animals. A comparison with the
known hepatoprotective agent silymarin revealed that I
exhibited a lower protective potential than II and III, which
were as effective as silymarin with respect to their effects on
the formation of the degradation products of lipid
peroxidation and release of GPT and AP in the serum. GSH
status was returned to normal only by III. The greater
protective activity of II and III could be due to their
1138- gera: 46236/di/ra
[TREATMENT OF HEPATITIS B BY YI CAN JING
SYRUP AND YI GAN QING MIXTURE : A CLINICAL
OBSERVATION OF 150 CASES]. SHEN ZHONGYUAN.
new journal of traditional chinese medicine. 1993;25(9):22
(chi).
1139- gera: 46255/di/ra
[THERAPEUTIC EFFECT OF COMBINED THERAPY
OF SALVIA MILTIOZZHIZA AND POLYPORUS
UMBELLATUS POLYSACCHARIDE IN TREATING
CHRONIC HEPATITIS B]. XIONG LI-LAN ET AL.
chinese journal of integrated traditional and western
medicine. 1993;13(9):533 (chi*).
1140- gera: 46302/di/ra
[CHRONIC ACTIVE B-HEPATITIS TREATED BY
ACTIVATING - BLOOD ELIMINATING - WIND
PRINCIPLE]. ZHANG CHANGFA ET AL. journal of
traditional chinese medicine. 1993;34(9):547 (eng*).
1141- gera: 46318/di/ra
[THE RELATIONSHIP BETWEEN SERUM
ADENOSINE DEAMINASE OF THE
HEPATOCIRRHOSIS CASES AND THE TREATMENT
BASED ON SYNDROME DIFFERENTIATION]. DENG
YINQUAN ET AL. china journal of tcm and pharmacy.
1993;8(4):27 (chi).
1142- gera: 46329/di/ra
[52 CASES OF ASCITES DUE TO CIRRHOSIS
TREATED WITH SELF-DRAFTED YANG GAN QU
SHUI TANG]. ZHANG JIDONG ET AL. henan traditional
chinese medicine. 1993;13(5):215 (chi).
1143- gera: 46350/di/ra
["SUPPORTING HEALTHY ENERGY AND
REMOVING BLOOD STASIS" IN TREATMENT OF
ACUTE LIVER DAMAGE CAUSED BY
CHEMOTHERAPY OF TUMORS, ANALYSIS OF 30
CASES]. ZHOU JU-YING ET AL. shanxi journal of
traditional chinese medicine. 1993;9(3):18 (chi).
gera 2011

1144- gera: 46412/di/ra
[ANALYSIS OF TREATMENT AND SYMPTOMS OF
ALCOHOLIC HEPATIC DISEASE]. YANG HUIMIN.
journal of beijing college of traditional chinese medicine.
1993;16(3):60 (chi).
1145- gera: 46414/di/ra
[TREATMENT OF 565 CASES OF VIRAL HEPATITIS
WITH XIAOFAN PILL]. WANG ZHENQUAN. jiangsu
journal of traditional chinese medicine. 1993;14(5):5 (chi).
1146- gera: 46443/di/ra
[THE CLINICAL ANALYSIS AND EXPERIENCE OF
DIAGNOSIS AND TREATMENT OF 66 CASES WITH
INFANTILE ACUTE HEPATITIS]. SONG JU ET AL.
liaoning journal of traditional chinese medicine.
1993;20(7):34 (chi).
1147- gera: 46551/di/ra
[EFFECT OF OUTGOING QI OF QIGONG ON
HEMODYNAMICS IN PATIENTS WITH HEPATITIS].
ZHU MEI-LUN ET AL. practical journal of integrating
chinese with modern medicine. 1993;6(5):285 (chi).
1148- gera: 46575/di/ra
[CLINICAL STUDY ON CINOBUFOTALIN IN
TREATING CHRONIC HEPATITIS B VIRUS
CARRIERS]. XU CIANG-TIAN ET AL. chinese journal
of integrated traditional and western medicine.
1993;13(8):473 (chi*).
1149- gera: 46576/di/ra
[INFLUENCE OF ANGELICA SINENSIS ON BLOOD
VISCOSITY AND WEDGE PRESSURE OF HEPATIC
VEIN IN PORTAL HYPERTENSION OF LIVER
CIRRHOSIS PATIENTS]. CHENG BIN ET AL. chinese
journal of integrated traditional and western medicine.
1993;13(8):476 (chi).
1150- gera: 46579/di/ra
[EXPERIENCE OF PROF ZENG QING-HUA IN
USING FUYUAN HUOXUE TANG IN TREATING
LIVER ABSCESS]. YANG XIANG-SHENG ET AL.
chinese journal of integrated traditional and western
medicine. 1993;13(8):491 (chi).
1151- gera: 46585/di/ra
[CHINESE MATERIAL MEDICA COMBINED WITH
CISPLATIN AND LIPIODOL THROUGH
TRANSCATHETER ARTERIAL EMBOLIZATION IN
TREATING PRIMARY HEPATOMA]. YU ZHI-JIAN ET
AL. chinese journal of integrated traditional and western
medicine. 1993;13(6):327 (chi*).
1152- gera: 46586/di/ra
[CLINICAL EFFECTS OF PERFUSING PROMOTING
BLOOD CIRCULATION DRUG THROUGH HEPATIC
ARTERY ON LATE STAGE OF
HEPATOCARCINOMA]. PENG ZHENG-SHUN ET AL.
chinese journal of integrated traditional and western
medicine. 1993;13(6):330 (chi*).
1153- gera: 46587/di/ra
[CLINICAL AND EXPERIMENTAL OBSERVATIONS
OF BUZHONG YIQI DECOCTION IN TREATING
CHRONIC HEPATITIS B]. DU FA-BIN ET AL. chinese
journal of integrated traditional and western medicine.
1993;13(6):333 (chi*).
1154- gera: 46594/di/ra
65
[EFFECTS OF MAGNESIUM LITHOSPERAMATE B
ON D-GALACTOSAMINE INDUCED RAT LIVER
INJURY]. LIU PING ET AL. chinese journal of integrated
traditional and western medicine. 1993;13(6):352 (chi*).
1155- gera: 46603/di/ra
[TREATMENT OF 45 CASES OF CHOLESTATIC
HEPATITIS WITH DECOCTION OF HERBA
ARTEMISIAE CAPILLARIS, FRUCTUS GARDENIAE
AND RADIX ASTRAGALI SEU HEDYSARI]. LIN
DEXIN. jiangsu journal of traditional chinese medicine.
1993;14(8):10 (chi).
1156- gera: 46618/di/ra
[CLINICAL VERIFICATION ON TREATING VIRAL
HEPATITIS A WITH PRESCRIPTIONS OF PURGING
LIVER AND BENEFITING GALLBLADDER]. YAO
YUKBN. shanghai journal of traditional chinese
medicine. 1993;6:12 (chi).
1157- gera: 46619/di/ra
[TREATING 100 CASES OF HEPATITIS OF
GALLBLADDER STASIS TYPE WITH
INTEGRATION OF CHINESE MATERIA MEDICA
AND WESTERN MEDICINE]. XU BOZHONG. shanghai
journal of traditional chinese medicine. 1993;6:13 (chi).
1158- gera: 46658/di/ra
[BU GAN HUO XUE JIE DU TANG DECOCTION FOR
CHRONIC HEPATITIS B]. YU SHUILUO ET AL.
shaanxi traditional chinese medicine. 1993;14(7):291 (chi).
1159- gera: 46659/di/ra
[BENEFITING KIDNEY AND STRENGTHENING
SPLEEN THERAPY FOR HAPATITIS B VIRUS
CARRIERS]. SHE WANXIAN ET AL. shaanxi traditional
chinese medicine. 1993;14(7):292 (chi).
1160- gera: 46660/di/ra
[SHEN QI BIE JIA TANG DECOCTION FOR
HEPATOCIRRHOSIS]. BIAN HUIQIN. shaanxi
traditional chinese medicine. 1993;14(7):293 (chi).
1161- gera: 46666/di/ra
[BRIEF KNOWLEDGE ON TREATMENT OF
CHRONIC NO-SYMPTOM HBSAG CARRIER]. SHI
ZHONGSHUN. shaanxi traditional chinese medicine.
1993;14(7):303 (chi).
1162- gera: 46673/di/ra
[RECENT SITUATION OF TREATMENT ABOUT
HEPATOCIRRHOSIS AFTER HEPATITIS]. ZHAO
XINXIU ET AL. shaanxi traditional chinese medicine.
1993;14(7):330 (chi).
1163- gera: 46684/di/ra
[BRIEF APPROACH ON THE RELATION BETWEEN
KIDNEY YANG DEFFICIENCY AND CHRONIC
HEPATITIS B]. HE ZHONGHUA. shaanxi traditional
chinese medicine. 1993;14(9):409 (chi).
1164- gera: 46737/di/ra
[EXPERIMENTAL STUDY ON EFFECT OF YIN-
NURSING PRESCRIPTION FOR BLOCKING PRE-
CANCEROUS AFFECTION OF LIVER IN RATS]. ZOU
KUICHANG ET AL. shanghai journal of traditional
chinese medicine. 1993;7:45 (chi).
1165- gera: 46780/di/ra
[ACUPUNCTURE CAN PREVENT DYSFUNCTIONS
gera 2011

AND DESTRUCTIONS OF THE LIVER AND KIDNEY
DUE TO CYCLOPHOSPHAMIDE IN RATS]. YANG
JINHONG ET AL. chinese acupuncture and moxibustion.
1993;13(4):32 (chi*).
1166- gera: 46813/di/ra
[INFLUENCE OF YIGANKANG ON SERUM MARKS
OF HBV]. XIAO CAISONG ET AL. journal of traditional
chinese medicine. 1993;34(6):355 (eng).
1167- gera: 46850/di/ra
[LIU XUEQIN'S EXPERIENCE IN TREATING OF
ASCITES DUE TO CIRRHOSIS]. ZHANG KELI. henan
traditional chinese medicine. 1993;13(4):168 (chi).
1168- gera: 46876/di/ra
[CLINICAL OBSERVATION ON 43 CASES OF
ASCITES DUE TO CIRRHOSIS BY INTEGRATING
CHINESE WITH MODERN MEDICINE]. GUO FANG-
QIN. practical journal of integrating chinese with modern
medicine. 1993;6(6):344 (chi).
1169- gera: 46883/di/ra
[DECOCTION FOR CURING OF CHRONIC
HEPATITIS AND EARLY STAGE OF CIRRHOSIS].
SUN YIE-NONG. practical journal of integrating chinese
with modern medicine. 1993;6(6):362 (chi).
1170- gera: 46903/di/ra
[EFFECT OF RUANGAN POWDER ON LIVER
CANCER DUE TO AFLATOXIN BRAIN MICE].
HUANG LI-MING ET AL. practical journal of integrating
chinese with modern medicine. 1993;6(7):0 (chi).
1171- gera: 46915/di/ra
[EFFECT OF ORAL SOLUTION 8868 ON SOME
INDICES OF SERU MARKERS OF B-HEPATITIS
VIRUS. YU SHENSHAN ET AL. journal of traditional
chinese medicine. 1993;34(5):283 (eng*).
1172- gera: 46928/di/ra
[CLINICAL OBSERVATION ON THE TREATMENT
OF CARCINOMA OF LIVER TREATED BY
DISPERSING LIVER AND NOURISHING KIDNEY].
XU JIPING ET AL. journal of traditional chinese
medicine. 1993;34(7):407 (eng).
1173- gera: 46929/di/ra
[COMPARATIVE STUDY ON 100 CASES OF
CHRONIC HEPATITIS B TREATED WITH CHINESE
TRADITIONAL AND WESTERN DRUGS]. ZHANG
JING ET AL. journal of traditional chinese medicine.
1993;34(7):409 (eng*).
1174- gera: 46930/di/ra
[PRELIMINARY EXPLORATION ON TREATING
GALLBLADDER FOR VIRAL HEPATITIS, CLINICAL
OBSERVATION ON 60 CASES]. SHEN QIMING ET AL.
journal of traditional chinese medicine. 1993;34(7):411
(eng*).
1175- gera: 46938/di/ra
[RECOGNITION OF TCM ETIOLOGY AND
PATHOGENESIS OF HEPATITIS B]. YIN CHANGJIAN
ET AL. journal of traditional chinese medicine.
1993;34(7):431 (eng).
1176- gera: 46972/di/ra
[VETERAN PHYSICIAN ZHANG ZHIQIU'S
EXPERIENCE IN THE TREATMENT OF ASCITES
66
DUE TO CIRRHOSIS]. ZHANG BAOLIANG ET AL. new
journal of traditional chinese medicine. 1993;25(5):7 (chi).
1177- gera: 46991/di/ra
[THE RELATIONSHIP BETWEEN THE
CLASSIFICATION OF HEPATITIS B IN CHINESE
MEDICINE AND WESTERN MEDICINE AND THE
ABO BLOOD TYPING]. HUANG ANAN ET AL. new
journal of traditional chinese medicine. 1993;25(7):21
(chi).
1178- gera: 47037/di/ra
[PROF. YU RONGQING'S EXPERIENCE IN
TREATING HYDROPERITONEUM DUE TO
CIRRHOSIS]. CHANG JIE. jiangsu journal of traditional
chinese medicine. 1993;14(9):3 (chi*).
1179- gera: 47071/di/ra
[BLOOD STASIS IN THE DISORDERS OF LIVER OF
TCM AND HEPATIC MICROCIRCULATORY
DISTURBANCE]. SHI MIN ET AL. hubei journal of
traditional chinese medicine. 1993;15(5):28 (chi).
1180- gera: 47092/di/ra
[SIMPLE ANALYSIS OF "TRADITIONAL DRUGS IN
PAIRS" USED IN TREATING LIVER DISEASES BY
PROFESSOR DONG GUO-LI]. GAO FENG-QIN. tianjin
journal of traditional chinese medicine. 1993;4:12 (chi).
1181- gera: 47106/di/ra
[ANALYSIS ON THE DETERMINATION OF THE
COLOURS OF TONGUES FOR 76 CASES OF VIRAL
HEPATITIS]. XU XING-GUO ET AL. tianjin journal of
traditional chinese medicine. 1993;3: (chi).
1182- gera: 47186/di/ra
[A TENTATIVE ANALYSIS OF LI HANG-QING'S
EXPERIENCE IN TREATMENT OF SEVERE LIVER
DISEASES]. PING QUAN-YI ET AL. shanxi journal of
traditional chinese medicine. 1993;9(5):4 (chi).
1183- gera: 47193/di/ra
[PROF HONG GUANGXIANG'S EXPERIENCES IN
TREATING CHRONIC HEPATITIS]. ZHAO FENGDA
ET AL. jiangxi journal of traditional chinese medicine.
1993;24(4):3 (chi).
1184- gera: 47201/di/ra
[TREATING CHRONIC HEPATITIS B WITH
ELECTURY "N° 1" : EFFECT OBSERVATION OF 30
CASES]. LI SHENQING ET AL. jiangxi journal of
traditional chinese medicine. 1993;24(4):30 (chi).
1185- gera: 47244/di/ra
[TREATMENT OF 30 CASES OF CHRONIC ACTIVE
HEPATITIS WITH LIGUSTRAZINE]. XUE QINGPEI
ET AL. jiangsu journal of traditional chinese medicine.
1993;14(7):17 (chi).
1186- gera: 47253/di/ra
[CLINICAL OBSERVATION ON THE EFFECTS OF
"WU LIN WAN" IN TREATMENT OF CHRONIC
HEPATITIS B, REPORT OF 30 CASES]. LUO GUO-
JUN ET AL. shanxi journal of traditional chinese
medicine. 1993;9(4):12 (chi).
1187- gera: 47268/di/ra
[COMBINATION OF TCM AND WM FOR BABY'S
HEPATIS SYNDROME]. WEI JUN. shaanxi traditional
chinese medicine. 1993;14(12):537 (chi).
gera 2011

1188- gera: 47312/di/ra
[PROGRESS OF TCM HERBS ON TREATING LIVER
CANCER PAIN]. ZHENG YULING. traditional chinese
medicinal research. 1993;6(3):39 (chi).
1189- gera: 47359/di/ra
[STUDY ON THE PROTECTIVE FUNCTION OF
GANYAOLING ON LIVER DAMAGE IN ANIMALS].
ZHANG QILAN. chinese traditional and herbal drugs.
1993;24(10):535 (chi*).
1190- gera: 47371/di/ra
[CLINICAL AND EXPERIMENTAL STUDY ON YI-
FAN-NING GRANULE IN TREATING CHRONIC
HEPATITIS B]. ZHANG BI-ZI ET AL. chinese journal of
integrated traditional and western medicine.
1993;13(10):597 (chi*).
1191- gera: 47382/di/ra
[CLINICAL EFFECTS OF CO-GANFULING ON
VIRAL HEPATITIS. QIN YI-ZHONG ET AL. practical
journal of integrating chinese with modern medicine.
1993;6(8):451 (chi*).
Seventy cases of viral hepatitis were treated with Co-
GANFULING since March 1991 to March 1993. There were
32 chronic persistent hepatic, 19 chronic active hepatitis and
19 cirrhosis, 65 patients were hepatitis B in the 70 cases. The
period of treatment was 3 months. The result was
satisfactory. The symptoms were improved soon after usage
of Co-GANFULING. Serum ALT lowered and recovered to
normal in 63. 6% cases after one month of treatment and in
87. 3% cases after the period of treatment. Serum albumin
increased and gbobulin decreased, Serum HBeAg transfer to
anti-HBE in 78. 4% cases after the treatment. The total
effective rate was 81. 4%.
1192- gera: 47390/di/ra
[ANALYSIS ON THE THREE STIPS BY TCMM-MM
ON INFANTILE ACUTE VIRUS HEPATITIS ON 23
CASES]. XING JIAN-KE. practical journal of integrating
chinese with modern medicine. 1993;6(8):468 (chi).
1193- gera: 47394/di/ra
[DEVELOPMENT ON ANTIVIRAL THERAPY ON
HEPATITIS B]. ZHANG DING-FENG. practical journal
of integrating chinese with modern medicine.
1993;6(8):494 (chi).
1194- gera: 47444/di/ra
[CLINICAL STUDY ON CHRONIC B - HEPATITIS
TREATED BY B - HEPATITIS N°1]. ZHANG JUNFU ET
AL. journal of traditional chinese medicine.
1993;34(11):673 (eng*).
1195- gera: 47456/di/ra
[THE OBSERVATION ON THE SUPER-MICRO
STRUCTURE CHANGE OF MARROW CELL FROM
VARIOUS TYPE OF CHINESE MEDICAL
HEPATOPATHY]. WANG BAOYI ET AL. journal of
traditional chinese medicine and chinese materia medica
of jilin. 1993;4:11 (chi).
1196- gera: 47479/di/ra
[OBSERVATION ON EFFECT OF SELF-
PRESCRIBED LIVER DISEASE RECIPE FOR
PRIMARY LIVER CANCER]. XU YIYU ET AL.
shanghai journal of traditional chinese medicine.
1993;12:3 (chi).
67
1197- gera: 47501/di/ra
[INVESTIGATION OF 236 CASES OF ALCOHOLIC
HEPATITIS IN GENHELIN DISTRICT OF INNER
MONGOLIA]. TIAN DELU ET AL. journal of beijing
college of traditional chinese medicine. 1993;16(6):31
(chi*).
1198- gera: 47626/di/ra
[TEN METHODS OF PROF YU SHENCHU'S
EXPERIENCE FOR TREATING LIVER DISEASES].
LIU DERONG. fujian journal of traditional chinese
medicine. 1993;24(2):1 (chi).
1199- gera: 47633/di/ra
[EFFECT OF YIGANLINGHEJI FOR HEPATITIS B
VIRUS CARRIER]. CHEN RUOPING ET AL. fujian
journal of traditional chinese medicine. 1993;24(2):20
(chi).
1200- gera: 47656/di/ra
[THE PROTECTIVE ACTION OF GLYCYRRHIZA
FLAVONOIDS AGAINST CARBON
TETRACHLORIDE HEPTOTOXICITY IN MICE].
WANG GS AND HAN ZW. acta pharmaceutica sinica.
1993;28(8):582 (chi*).
1201- gera: 47666/di/ra
[STUDY ON PREVENTIVE AND CURATIVE EFFECT
OF YIGANNING ON EXPERIMENTAL LIVER-
INJURY]. CHEN LIPING FAN XIANGHONG ET AL.
chinese traditional patent medicine. 1993;15(6):27 (chi*).
Yiganning can decrease the elevation of mice serum glutamic
pyruvic transaminase (SG-PT) induced by CCI4. It can make
the seralbumin content of rats rerise. The globulin content
decrease and the ration of serum albumin- globulin rise. It
can also directly induce the production of interferon.
1202- gera: 47681/di/ra
[EXPERIMENTAL STUDY ON CHEMICAL
COMPONENTS OF PROCESSED PRODUCTS OF
FRUCTUS LIGUSTRI LUCIDI AND ITS
PROTECTION ACTION FOR LIVER]. YIN
YUSHENGYU CHUANSU. chinese traditional patent
medicine. 1993;15(9):18 (chi*).
The qualitative and quantitative analyses of oleanolic acid in
the processed products of Fructus Ligustri I.ucidi and the
comparative study of its protection action for liver have been
carried out. As a result, the product steamed with wine
showed that the highest oleanolic acid contents. Its action of
depressing glutamic pyruvic transaminase was also the
strongest. These studies provide a base of rational clinical
application of the medicine.
1203- gera: 47910/di/ra
[CONTRAST STUDIES ON ACUTE ICTERO
HEPATITIS TREATED BY QINGKAILING]. LIU
CHANGKAI ET AL. journal of traditional chinese
medicine. 1993;34(12):736 (eng).
1204- gera: 47932/di/ra
[DETECTION OF NOXIOUS DAMPNESS AND
METABOLIC DISTURBANCE OF LIPOID
LIPOPROTEN ET AL ON HEPATITIS A]. HAN YIN
FANG ET AL. the practical journal of integrating chinese
with modern medicine. 1993;6(11):652 (chi).
1205- gera: 47946/di/ra
[REGULATION OF LIVER FUNCTION AND
PREVENTION OF DISEASE]. MI JUN. the practical
journal of integrating chinese with modern medicine.
gera 2011

1993;6(10):589 (chi).
1206- gera: 47966/di/ra
[OBSERVATION OF THE NEGATIVE-
TRANSFORMING EFFECT OF POINT INJECTION
ON HBsAg]. WAN MING TANG RONG. shanghai
journal of acupuncture and moxibustion. 1993;12(4):156
(chi).
1207- gera: 48056/di/ra
[USE OF REMOVING STAGNATION AND
PROMOTING DIGESTION DRUGS IN TREATING
LIVER CANCER]. LIN JUNHUA. shanghai journal of
traditional chinese medicine. 1993;11:29 (chi).
1208- gera: 48082/di/ra
[r-HYPERGLOBULINEMIA IN CHRONIC
HEPATITIS TREATED WITH MASSIVE DOSAGE OF
RADIX RUBIAE AND HERBA SIEGESBECKIAE]. LI
YUN. journal of traditional chinese medicine.
1993;34(10):603 (eng*).
On the basis of differentiation of syndromes, Radix Rubiae
and Herba Siegesbeckiae are applied in massive doses. 39
cases of chronic hepatitis with r - hyper-globulinemia with a
course of 2 - 4 months, the total effective rate being 56. 41%,
among them, 2/3 of the cases with r-globulin >30%, with
simultaneous decrease of TTT were counted as markedly
effective.
1209- gera: 48090/di/ra
[EXPERIMENTAL STUDY ON THE ACTION OF
TRADITIONAL COMPOUND RECIPE ON ANTI-B-
HEPATITIS VIRUS IN DUCK]. GONG HUIMIN. journal
of traditional chinese medicine. 1993;34(10):621 (eng).
1210- gera: 48269/di/ra
[SYNTHETICALLY TREATING 17 CASES OF
PRIMARY CARCINOMA OF LIVER]. WANG
XIAOXIAN. hubei journal of traditional chinese
medicine. 1993;15(6):22 (chi).
1211- gera: 48282/nd/ra
[32 CASES OF HEPATITIS B COMPLICATED WITH
CHOLECISTITIS BY MEANS OF TREATMENT
BASED ON SYNDROME DIFFERENTIATION].
ZHENG XIANG ET AL. acta medica sinica. 1993;8(6):26
(chi).
1212- gera: 48332/di/ra
[TREATMENT OF 30 CASES OF CHRONIC ACTIVE
HEPATITIS WITH CAH EQUIPMENT AND CHINESE
DRUGS]. YANG GONGYOU YING HUIYU. jiangsu
journal of traditional chinese medicine. 1993;14(11):16
(chi).
1213- gera: 48350/di/ra
[LI PEISHENG'S EXPERIENCE IN THE
TREATMENT OF HEPATITIS WITH DAMPNESS-
HEAT SYNDROME]. WANG JUNQUI. new journal of
traditional chinese medicine. 1993;25(12):1 (chi).
1214- gera: 48364/di/ra
[XIANGGU POLYSACCHARIDES INJECTION IN
THE TREATMENT OF TERTIARY CHRONIC VIRAL
HEPATITIS: CLINICAL SUMMARY OF 108 CASES].
WU BICHENG ET AL. fujian journal of traditional
chinese medicine. 1993;24(6):10 (chi).
1215- gera: 48386/di/ra
[ON THE RELATIONSHIPS BETWEEN THE
68
PATHOLOGICAL CHANGES OF LIVER DISEASES
AND TCM DIFFERENTIATION OF SYMPTOMS].
ZHENG XIOUYIN ET AL. jiangxi journal of traditional
chinese medicine. 1993;24(6):27 (chi).
1216- gera: 48577/di/ra
[CLINICAL OBSERVATION ON THE EFFECTS OF
"WU LIN WAN" IN TREATMENT OF CHRONIC
HEPATITIS B, REPORT OF 30 CASES]. LUO GUO-
JUN ET AL. shanxi journal of traditional chinese
medicine. 1993;9(4:12 (chi).
1217- gera: 48625/di/ra
[TREATING 100 CASES OF ASCITES DUE TO
CIRRHOSIS WITH "XIN DING XIAO YAO SAN"].
LIU JIN-SHU. zhejiang journal of traditional chinese
medicine. 1993;28(4):151 (chi).
1218- gera: 48974/di/ra
THE TREATMENT OF LIVER PATTERNS. MODERN
AND TRADITIONAL PRINCIPLES AND
METHODOLOGIES WITH CORRESPONDING
FORMULAS. WILLIAMS JE. journal of chinese
medicine. 1993;43:14-21 (eng).
Liver Qi stagnation, a common syndrome of modern patents
vith emotional stress, is a pattern or illness with diverse
symptoms ranging from headache to lower abdominal pain.
A comprehensive knowledge of Liver pathophysiology and
methodology is necessary in prescribing the correct formula.
Symptomatic prescribing is cautioned against, and systematic
follow-up is recommended in complex cases. According to
an old Eastern saying, "if the doctr does not find the right
prescription, the patient will find the right doctor."
1219- gera: 49112/di/ra
ACUPUNCTURE AND MOXIBUSTION IN
TREATMENT OF HBV CARRIERS : CLINICAL
OBSERVATION OF 67 CASES. WANG XINYUE.
international journal of clinical acupuncture.
1993;4(4):365-9 (eng).
1) 36E, 6VC ou 4VC ou 18V, 20V, 23V, 14F. 2F et 9Rte
(Humidité-Chaleur). 3Rn (Vide de Yin). 6MC (Stase).
Injection de RASH (Radix Astragali Seu Hedysari) 36E,
6Rte, 18V, 20V, 23V. 3) Injection d'Interféron 36E, 6Rte,
18V, 20V, 23V. 1) : Séance de 30mn, 3 séances / semaine, 3
mois. 2) : Injection de 2 points par séance, 1ml à chaque
point. 3) : Injection de 2 points par séance, 1,2ml à chaque
point. Différence significative dans les groupes
1220- gera: 49125/di/ra
[OBSERVATION ON THERAPEUTIC EFFECT OF
CHRONIC HEPATOPATHY ERUPT
SIMULTANEOUSLY PEPTIC ULCER TREATED BY
"YI QI HUO XUE JIE DU TANG"]. JI GUANG ET AL.
zhejiang journal of traditional chinese medicine.
1993;28(10):440 (chi).
1221- gera: 49923/nd/re
INDUCTION OF HEPATIC BILIRUBIN AND DRUG
METABOLIZING ENZYMES BY INDIVIDUAL
HERBS PRESENT IN THE TRADITIONAL CHINESE
MEDICINE, YIN ZHI HUANG. YIN J ET AL. dev
pharmacol ther. 1993;20(3-4):186-94 (eng).
Yin Zhi Huang (YZH) is a decoction of four plants which is
widely used in Asia to treat neonatal jaundice. This study
compares the ability of phenobarbital and the individual
herbs comprising YZH, Artemisia, Gardenia, Rheum, and
Scutellaria baicalensis, to induce hepatic drug and bilirubin
metabolizing enzymes in rats. Herbal decoctions (30
ml/kg/day) or phenobarbital (60 mg/kg/day) were
gera 2011

administered for 5 days. Only phenobarbital increased
cytochrome P-450 levels whereas Gardenia slightly
decreased levels. Artemisia, Rheum and phenobarbital
increased bilirubin glucuronyl transferase activity.
Glucuronidation of alpha-naphthol was increased by
Gardenia and phenobarbital, whereas Artemisia and Rheum
were ineffective inducers. Phenobarbital was the most
effective inducer of glutathione-S-transferase (GSHT)
activity. Phenobarbital and Gardenia both induced delta 5-3-
ketosteroid isomerase activity, a marker for the Ya subunit of
GSHT responsible for intracellular bilirubin transport in liver.
The selective patterns of enzyme induction suggest potential
value for using specific plant
1222- gera: 79855/di/ra
[CLINICAL OBSERVATION OF YINDANPINGGAN
CAPSULES (HERBA ARTEMISAE
SCOPARIAE,RADIX GENTIANAE,ETC.) ON 100
CASES OF VIRUS HEPATITIS]. HUANG XUEZHONG
ET AL. chinese traditional patent medicine. 1993;15(1):26
(chi).
1223- gera: 10515/di/ra
DIAGNOSTICO Y TRATAMIENTO DE LA
HEPATITIS VIRICA. HU DING BANG. el pulso de la
vida. 1994;2:16-49 (esp).
1224- gera: 17399/di/ra
BIBLIOGRAFIA INTERNACIONAL DE MTCH
HEPATOLOGIA 2. GERA. medicina holistica.
1994;36:17-25 (esp).
1225- gera: 17400/di/ra
BIBLIOGRAFIA INTERNACIONAL DE MTCH
HEPATOLOGIA 3. REFERENCIAS COMENTADAS.
GERA. medicina holistica. 1994;37:19-23 (esp).
1226- gera: 19232/di/ra
[QINGAO TANG IN THE TREATMENT OF 30 CASES
OF HEPATITIS B]. DINGMING H ET AL. fujian journal
of tcm. 1994;25(3):12 (chi).
1227- gera: 26898/di/ra
[HISTORY OF KNOWLEDGE ON HEPATITIS
VIRUS]. GUOQIANG H ET AL. chinese journal of
medical history. 1994;24(4):200 (chi).
1228- gera: 45077/nd/re
GOMISIN A, A LIGNAN COMPONENT OF
SCHIZANDORA FRUITS, INHIBITS DEVELOPMENT
OF PRENEOPLASTIC LESIONS IN RAT LIVER BY
3'-METHYL-4-DIMETHYLAMINO-AZOBENZENE.
NOMURA M ET AL. cancer lett. 1994;76(1):11-8 (eng).
The effects of gomisin A, a lignan component of Schizandra
fruits, on development of preneoplastic lesions in the liver
after a short-term (3 weeks) feeding of 3'-methyl-4-dimethyl-
aminoazobenzene (3'-MeDAB) to male Donryu rats were
investigated, and compared with the effects of phenobarbital.
Gomisin A inhibited both increases of the level of
glutathione-S-transferase placental form (GST-P) and the
number and size of GST-P positive foci in the liver increased
after treatment with 3'-MeDAB. Moreover, although the
population of diploid nuclei was increased and that of
tetraploid nuclei was decreased by pretreatment with 3'-
MeDAB, gomisin A returned this to near the normal ploidy
pattern. But phenobarbital increased the level of GST-P and
the number and size of GST-P positive foci with little affect
on the ploidy population changed by 3'-MeDAB. Thus, the
effect of gomisin A on hepatocarcinogenesis was inhibitory
in contrast with that of phenobarbital. This study suggests
69
that gomisin A is a candidate for a chemopreventive drug
inhibiting the promotion process in hepatocarcinogenesis.
1229- gera: 45131/di/re
INHIBITION BY SHI-QUAN-DA-BU-TANG (TJ-48) OF
EXPERIMENTAL HEPATOCARCINOGENESIS
INDUCED BY N- NITROSOMORPHOLINE IN
SPRAGUE-DAWLEY RATS. . TATSUTA MASAHARU
ET AL. european journal of cancer. 1994;30A(1):74-8
(eng).
The effect of Shi-Quan-Da-Bu-Tang (TJ-48) on
hepatocarcinogenesis induced by N-nitrosomorpholine
(NNM) was investigated in male Sprague-Dawley rats. Rats
were given drinking water containing NNM for 8 weeks, and
also from the start of the experiment, regular chow pellets
containing 2. 0 or 4. 0% TJ-48 until the end of the
experiment. Preneoplastic and neoplastic lesions staining for
the placental type of glutathione-S-transferase (GST- P) or
gamma-glutamyl transpeptidase (GGT) were examined
histochemically. In week 15, quantitative histological
analysis showed that prolonged administration of either 2. 0
or 4. 0% TJ-48 in the diet significantly reduced the size,
volume and/or number of GST-P-positive and GGT-positive
hepatic lesions. This treatment also caused a significant
increase in the proportion of interleukin-2 receptor-positive
lymphocytes among the lymphocytes infiltrating the tumours
as well as a significant decrease in the labelling index of
preneoplastic lesions. These findings indicate that TJ-48
inhibits the growth of hepatic enzyme-altered lesions, and
suggests that its effect may
1230- gera: 45181/nd/re
HEPATOPROTECTIVE EFFECTS OF ARTEMISIA
SCOPARIA AGAINST CARBON TETRACHLORIDE :
AN ENVIRONMENTAL CONTAMINANT. . GILANI
AH ET AL. jpma j pak med assoc. 1994;44(3):65-8 (eng).
The hepatoprotective activity of crude extract of artemisia
scoparia (aerial parts) was investigated against
experimentally produced hepatic damage using carbon
tetrachloride (CCl4) as a model hepatotoxin. CCl4 at the dose
of 1. 5 ml/kg, produced liver damage in rats as manifested by
the rise in serum levels of AST and ALT to 395 ± 110 and
258 ± 61 IU/l (mean ± SEM; n = 10) respectively, compared
to control values of 106 ± 15 and 26 ± 04. Pretreatment of
rats with plant extract (150 mg/kg) significantly lowered (P <
0. 01), the respective serum GOT and GPT levels to 93 ± 05
and 27 ± 03 IU/l, indicating hepatoprotective action.
Pentobarbital sodium (75 mg/kg)- induced sleeping time in
mice was found to be 140. 8 ± 1. 5 min (n = 10) which was
similar (P > 0. 05) to that obtained in the group of animals
pretreated with the plant extract (139. 9 ± 1. 8 min). CCl4
treatment extended the pentobarbital sleeping time to 212. 2
± 19. 1 min and pretreatment of animals with plant extract
reversed the CCl4-induced prolongation in pentobarbital
sleeping time to 143. 9 ± 5. 5 min (P < 0. 001) which further
confirms the protective action of the plant extract against
CCl4-induced liver damage. These data indicate that the plant
1231- gera: 45413/di/ra
PROTECTIVE AND THERAPEUTIC EFFECTS OF
BAN-ZHI-LIAN ON HEPATOTOXIN-INDUCED
LIVER INJURIES. . LIN SC ET AL. american journal of
chinese medicine. 1994;22(1):29-42 (eng).
The hepatoprotective effect of Ban-zhi-lian was investigated
in three kinds of experimental models. The animals were
treated with Ban-zhi-lian (300 mg/kg, p. o. ) at 2,4, and 10
hours after carbon tetrachloride (32 l/kg, i. p. ),
acetaminophen (600 mg/kg, i. p. ), and beta-D-galactosamine
(188 mg/kg, i. p. ) administration. Significant protective
effects from these hepatotoxins were expressed. This
gera 2011

protection was evidenced by comparing the serum glutamate
oxaloacetate transaminase (SGOT), serum glutamate
pyruvate transaminase (SGPT), and histopathologic
examination in animals treated and untreated with Ban-zhi-
lian. Serum enzyme activities were significantly lower in
Ban-zhi-lian-treated groups. In the histopathologic
observation, liver damage induced by three hepatotoxins was
markedly improved in Ban-zhi-lian treated animals. These
results demonstrated that Ban- zhi-lian has a protective effect
against experimental liver damage induced by various
hepatotoxins.
1232- gera: 45414/di/ra
COMBINED EFFECTS OF CHULING (POLYPORUS
UMBELLATUS) EXTRACT AND MITOMYCIN C ON
EXPERIMENTAL LIVER CANCER. . YOU JS ET AL.
american journal of chinese medicine. 1994;22(1):19-28
(eng).
Chuling (Polyporus umbellatus), one of the commonly used
Chinese medical herbs, was combined with mitomycin C and
then studied against intrahepatic implantation of sarcoma 180
tumor cells in mice. Oral administration of chuling extract,
intraperitoneal injection of mitomycin C and the combination
of both increased the life span of tumor-bearing mice 71. 6%,
70. 1% and 119. 9%, respectively. The same treatments were
found to be cytotoxic to Sarcoma-180-induced liver tumor
cells. The synthetic rates of DNA, RNA and protein were all
inhibited measurably by the combined treatment.
Histopathological studies showed that lymphocytes infiltrated
and surrounded the cancer cells, and there was some fibrosis
found in normal cells and cancer cells. These results indicate
the
1233- gera: 47763/di/ra
[CLINICAL ANALYSIS ON THE EFFECT OF 20
SEVERE HEPATITIS PATIENTS TREATED MAINLY
WITH JIE DU YI GAN TANG (DECOCTION OF
DETOXICATION AND BENEFITING THE LIVER)]..
ZHANG JUN FU ET AL. tianjin journal of traditional
chinese medicine. 1994;5:4 (chi).
1234- gera: 47771/di/ra
[APPLICATION OF YUANYEH POINT IN
DIAGNOSING LIVER AND GALLBLADDER
DISEASES]. YU RENZE ET AL. shanghai journal of
traditional chinese medicine. 1994;11:6 (chi).
1235- gera: 47800/di/ra
[COMBINATION OF TCM AND WM FOR
HEPATAPOSTEMA]. LIU JIALEI ET AL. shaanxi
traditional chinese medicine. 1994;15(11):502 (chi).
1236- gera: 47802/di/ra
[BRIEF STUDY OF HEPATOSIS TREATED USING
XIANG HUO LEARNING]. YANG ZHEN. shaanxi
traditional chinese medicine. 1994;15(11):506 (chi).
1237- gera: 47813/di/ra
[{THIRTY CASES OF LIVER HEMOTOPORPHYRIA
TREATED BY DIFFERENTIATION OF
SYNDROMS].]. CHEN QIAOYUAN. journal of
traditional chinese medicine. 1994;35(11):673 (eng).
1238- gera: 47835/di/ra
[TREATMENT ON HEPATITIS BY YI GAN JI KANG
WAN: A REPORT OF 42 CASES]. TANG GUANGYU.
new journal of traditional chinese medicine.
1994;26(10):48 (chi).
1239- gera: 47850/di/ra
70
[APPLICATION OF RADIX ASTRAQALI IN THE
TREATMENT OF ACUTE ICTERIC HEPATITIS]. CAI
LINGUANG. new journal of traditional chinese medicine.
1994;26(7):52 (chi).
1240- gera: 48136/di/ra
[COMPARISON OF PRE- AND POST-
TREATMENTAL HEPATOHISTOLOGY WITH
HEAVY DOSAGE OF PAEONIA RUBRA ON
CHRONIC ACTIVE HEPATITIS CAUSED LIVER
FIBROSIS]. YANG DA-GUO ET AL. chinese journal of
integrated traditional and western medicine.
1994;14(4):207 (chi*).
No report has been found on comparison of pre- and post-
treatmental liver biopsies for chronic active hepatitis (CAH)
caused liver fibrosis. The aim of this paper was to study the
effects of a heavy dosage of Radix Paeoniae rubra to the
reabsorptive action of liver collagen fibres. The patients were
suffering from CAH or CAH with liver cirrhosis confirmed
by liver biopsies. By the end of 3 months, the second liver
biopsy was carried out. The results showed that among 4
patients with liver cirrhosis, the false lobules disappeared;
and that 6 patients with CAH only, the interlobular collagen
fibres of 4 patients were completely reabsorbed. The effective
rate reached 77. 8%. It was concluded that a heavy dosage of
Paeonia rubra was effective in arresting the development of
liver fibrosis,
1241- gera: 48140/di/ra
[PROTECTION AGAINST EXPERIMENTAL
HEPATIC INJURY BY FENGXIANG YIGANKANG
CAPSULE]. CHENG TI-JUAN ET AL. chinese journal of
integrated traditional and western medicine.
1994;14(3):162 (chi*).
Protective effect of Fengxiang Yigankang (FXYGK) capsule
against hepatotoxicity induced by CCl4 and acetaminophen
(AAP) was studied. It was found that the FXYGK capsule
inhibited markedly malonic aldehyde (MDA) formation of
liver induced by CCl4 and AAP. It blocked also depletion of
reduced form of glutathione (GSH) of damaged liver induced
by AAP. In addition, FXYGK could decrease serum alanine
aminotransferase levels induced by CCl4 (P < 0. 05). The
results of histopathological examination showed that the
FXYGK capsule (0. 45, 0. 9 and 1. 8 g/kg) could also reduce
significantly fatty degeneration of liver (P < 0. 05).
1242- gera: 48150/di/ra
[AN PRELIMINARY STUDY ON HEPATO-
PROTECTIVE ACTION OF SEED OIL OF
HIPPOPHAE RHAMNOIDES L. (HR) AND
MECHANISM OF THE ACTION . CHENG TIJUAN ET
AL. china journal of chinese materia medica.
1994;19(6):367 (chi*).
The seed oil of Hippophae rhamnoides markedly inhibits the
rise of MDA in liver of mice and rats induced by CCl4, AAP
and ethyl alcohol, decreases significantly the activity of
SGPT and SGOT, and markedly checks the depletion of GSH
in liver of mice induced by AAP. The microscopic and
electron-microscopic examination has shown that the seed oil
can lighten liver injury.
1243- gera: 48161/di/ra
[EFFECTS OF WUZI YANZONG PILLS ON LIPID IN
RATS WITH ALCOHOL-INDUCED LIVER INJURY ].
LI YUHAO ET AL. china journal of chinese materia
medica. 1994;19(5):300 (chi*).
Experiments showed that in the rat model of alcohol-induced
liver injury, a dosage of the pills (1-2g/kg, ig) could increase
the cholesterol level, lower the triglyceride level, and
improve the fatty degeneration and necrosis of liver (P < 0.
gera 2011

05-0. 01). The results suggest that the important mechanism
of the pills in protecting and treating alcoholic fatty liver, lies
in the regulation of metabolism of the lipid, especially of the
triglyceride.
1244- gera: 48197/di/ra
[OBSERVATION ON THE ACTION OF EXTRACTUM
SEMEN PERSICAE ON ANTI-FIBROSIS OF LIVER].
XU LM ET AL. china journal of chinese materia medica.
1994;19(8):491 (chi*).
It was observed that Extractum Semen Persicae acted
obviously on hepatic fibrosis induced by CCl4. Through
promoting the degradation of collagens type I, II, IV, VI and
fibronectin, ESP has proved helpful in markedly reducing the
fibrous septa composed of both collagenous and reticular
fibers as well as in repairing the structure of
1245- gera: 48585/di/ra
[OBSERVATION ON THE COMBINED
MANAGEMENT OF 86 CASES OF CYRRHOSIS OF
LIVER BY TCM AND WESTERN MEDICINE]. FENG
GUANGYU ET AL. shanxi journal of traditional chinese
medicine. 1994;10(2):19 (chi).
1246- gera: 48596/di/ra
[PROGRESS IN MANAGEMENT OF CHRONIC
HEPATITIS BY COMBINED WESTERN AND
TRADITIONAL CHINESE MEDICAL TREATMENT].
LUO GUOJUN. shanxi journal of traditional chinese
medicine. 1994;10(3):52 (chi).
1247- gera: 48609/di/ra
[TREATMENT OF CHRONIC HEPATITIS AND
LIVER CIRRHOSIS BY "CAPSULAE JINER TANG
TAI". WANG NING. shanxi journal of traditional chinese
medicine. 1994;10(5):11 (chi).
1248- gera: 48887/nd/re
INHIBITION BY GOMISIN A, A LIGNAN
COMPOUND, OF HEPATOCARCINOGENESIS BY 3'-
METHYL-4- DIMETHYLAMINOAZOBENZENE IN
RATS. OHTAKI Y ET AL. biol pharm bull.
1994;17(6):808-14 (eng).
The effects of gomisin A, a lignan compound of Schizandra
fruits, on hepatocarcinogenesis induced by 3'-methyl- 4-
dimethylaminoazobenzene (3'-MeDAB) in rats were
investigated. Gomisin A inhibited both increases of the
number and size of glutathione S-transferase placental form
(GST-P)-positive foci, a marker enzyme of preneoplasm, and
the population of diploid nuclei, as a proliferative state of
hepatocytes, in the liver from rats simultaneously treated with
3'-MeDAB. Gomisin A increased GST activity in the liver,
by raising the level of GST 1 and 2 isozymes. 3'-MeDAB
increased GST activity and GST-P expression. This high
level of GST-P induced by 3'- MeDAB was suppressed by
additional treatment with gomisin A. In an experiment on
simultaneous treatment, gomisin A increased the biliary
excretion of 3'-MeDAB-related aminoazo dyes and decreased
the content in the liver of rats fed with 0. 06%-3'-MeDAB
containing diet. In an experiment on pretreatment with 3'-
MeDAB, even though no aminoazo dye was detectable in the
liver or bile 2-weeks after cessation of 3'-MeDAB-feeding,
gomisin A showed a tendency to reduce the preneoplastic
changes of increases in GST-P positive foci and diploid
nuclei in the liver. These results suggest that gomisin A
inhibits the hepatocarcinogenesis induced by 3'-MeDAB by
enhancing the excretion of the carcinogen from the liver and
by reversing the normal cytokinesis.
1249- gera: 48897/di/re
71
HERBAL MEDICINE AND TOXIC HEPATITIS. .
PILLANS PI ET AL. new zealand medical journal.
1994;107(988):432-3 (eng).
1250- gera: 48904/di/ra
THE APPLICATION OF TRADITIONAL CHINESE
MEDICINE TO THE MANAGEMENT OF HEPATIC
CANCEROUS PAIN. . WANG GUIMIAN ET AL. journal
of traditional chinese medicine. 1994;14(2):132-8 (eng).
The authors summarized the application of traditional
Chinese medicine to the management of hepatic cancerous
pain in Beijing and Shanghai, and in Jiangsu and Zhejiang
Provinces. The therapeutic principle was to invigorate blood
circulation and reduce stasis and to soothe the liver and
regulate Qi, so as to dredge the channels and collaterals. The
results were satisfactory.
1251- gera: 48916/nd/re
[THERAPY OF CHRONIC HEPATITIS OTHER THAN
INTERFERON THERAPY]. SAINOKAMI S ET AL.
nippon naika gakkai zasshi. 1994;83(2):235-9 (jap).
1252- gera: 48926/di/ra
HEPATOPROTECTIVE EFFECTS OF TAIWAN FOLK
MEDICINE : WEDELIA CHINENSIS ON THREE
HEPATOTOXIN- INDUCED HEPATOTOXICITY. .
LIN SC ET AL. american journal of chinese medicine.
1994;22(2):155-68 (eng).
The hepatoprotective effects of a Taiwanese crude herb,
Hwang-hua-mih-tsay (Wedelia chinensis (Osbeck) Merr. ),
were investigated. Acute hepatitis was induced by three
hepatotoxins: carbon tetrachloride and acetaminophen in
mice, and D(+)-galactosamine in rats. After treatment with
W. chinensis (300 mg/kg, p. o. ) at 2, 6 and 10 hours, a
reduction in the elevation of serum glutamate oxaloacetic
transaminase (SGOT) and glutamate pyruvic transaminase
(SGPT) levels was observed at 24 hrs after hepatotoxins were
administered. These serological observations were confirmed
by histopathological examinations. A microscopic
examination of the liver showed a marked improvement in
groups receiving W. chinensis. In order to further confirm the
hepatoprotective effect of W. chinensis, all pharmacological
and histopathological effects were compared with Bupleurum
chinense DC. (family Umbelliferae), a well documented
antihepatotoxicity herb. It was concluded that W. chinensis
has a definite
1253- gera: 49197/di/ra
[OBSERVATION ON TREATING THE CARRIER OF
HBV BY REGULATING SPLEEN AND STOMACH:
CLINICAL ANALYSIS OF 80 CASES]. SONG SONG-
WEN ET AL. zhejiang journal of traditional chinese
medicine. 1994;29(11):487 (chi).
1254- gera: 49198/di/ra
[OBSERVATION ON TREATING 105 CASES OF
POSTHEPATITIC CIRRHOSIS WITH "ZHI GAN FU
FANG"]. WANG SAN-HONG. zhejiang journal of
traditional chinese medicine. 1994;29(11):490 (chi).
1255- gera: 49199/di/ra
[TREATING 31 CASES OF ASCITES DUE TO
CIRRHOSIS WITH "HUA YU RUAN GAN JIAO
NAN"]. XU BO-LENG. zhejiang journal of traditional
chinese medicine. 1994;29(11):493 (chi).
1256- gera: 49200/di/ra
[TREATING 36 CASES OF INVERSION OF
ALBUMIN-GLOBULIN RATIO DUE TO CIRRHOSIS].
GE MAN-TIAN. zhejiang journal of traditional chinese
gera 2011

medicine. 1994;29(11):494 (chi).
1257- gera: 49201/di/ra
[TREATING 108 CASES OF ECLIPSED INFECTION
OF HEPATITIS A AND B WITH "YING CHEN CHI
SHAO TANG"]. TANG TIAN. zhejiang journal of
traditional chinese medicine. 1994;29(11):492 (chi).
1258- gera: 49237/di/ra
[EXAMPLE OF CHRONIC HEPATITIS TREATED BY
THERAPEUTIC METHOD OF PROMOTING BLOOD
CIRCULATION BY REMOVING BLOOD STASIS].
GUO HUI. yunnan journal of traditional chinese
medicine. 1994;15(5):39 (chi).
1259- gera: 49264/di/ra
[PROFESSOR DONG GUO-LI'S CLINICAL
EXPERIENCE IN THE TREATMENT OF LIVER
DISEASES]. GAO FENG-QIN. tianjin journal of
traditional chinese medicine. 1994;11(3):1 (chi).
1260- gera: 49281/di/ra
[CLINICAL OBSERVATION ON 154 CASES OF
CHRONIC ACTIVE HEPATITIS TREATED BY MAN
GAN NING CAPSULE (CURING CHRONIC
HEPATITIS)]. ZHANG JUN-FU ET AL. tianjin journal of
traditional chinese medicine. 1994;11(6):1 (chi).
1261- gera: 49282/di/ra
[THE TREATMENT OF HEPATITIS B BY ANTI-
FIBROSIS GRANULE PREPARATION (KANG XIAN
LING). LU FU-XING ET AL. tianjin journal of traditional
chinese medicine. 1994;11(6):3 (chi).
1262- gera: 49295/di/ra
[CLINICAL OBSERVATION ON ARTEMISIAE
SCOPARIAE-PACIFYING LIVER CAPSULES FOR
VIRAL HEPATITIS]. WANG YUQUN ET AL. shanghai
journal of traditional chinese medicine. 1994;5:29 (chi).
1263- gera: 49296/di/ra
[PRIMARY OBSERVATION ON EFFECT OF
ORIENTAL PORIA-GENODERMA ON PART OF
DUPLICATED INDEXES OF SERUM HBV OF
CHRONIC HEPATIS-B]. XU TIANXIONG ET AL.
shanghai journal of traditional chinese medicine.
1994;5:30 (chi).
1264- gera: 49305/di/ra
[MR. WANG LINGTAI'S FEATURE FOR
HEPATITIS]. CAO SHUNMING. shanghai journal of
traditional chinese medicine. 1994;6:15 (chi).
1265- gera: 49314/di/ra
[PRELIMINARY OBSERVATION ON CLINICAL
EFFECT OF LEI'S SIX DEITY PIAN-ZAI-HUANG
CAPSULES FOR CHRONIC HEPATITIS B]. WU
SHANMING JIANG JIA. shanghai journal of traditional
chinese medicine. 1994;7:5 (chi).
1266- gera: 49324/di/ra
[RECENT SURVEY OF TCM FOR INFANTILE VIRAL
HEPATITIS]. YU JIAN SHI YUMIN. shanghai journal of
traditional chinese medicine. 1994;7:43 (chi).
1267- gera: 49330/di/ra
[SUMMATION ON COMBINED TREATMENT OF
TCM AND WM FOR 15 CASES OF PREGNANCY
COMPLICATED WITH SEVERE HEPATITIS]. WENG
FULU ET AL. shanghai journal of traditional chinese
72
medicine. 1994;8:18 (chi).
1268- gera: 49357/di/ra
[SURVEY OF EXPERIMENTAL AND CLINICAL
STUDY ON CHINESE MATERIA MEDICA OF
SPLEEN- STRENGHTENING AND QI-BENEFITING
PROPERTY FOR MIDDLE AND LATER STAGE
PRIMARY LIVER CANCER]. WANG TING ET AL.
shanghai journal of traditional chinese medicine.
1994;8:40 (chi).
1269- gera: 49377/di/ra
[DIAGNOSTIC VALUE OF LIVER CANCER IN TCM
COMPUTER DIAGNOSTIC SYSTEM - ANALYSIS OF
138 CASES]. LIN JUNHUA ET AL. shanghai journal of
traditional chinese medicine. 1994;10:17 (chi).
1270- gera: 49388/di/ra
[CLINICAL ANALYSIS OF PIAN ZI HUANG
TREATMENT FOR 42 CASES OF INTERMEDIATE
AND ADVANCED HEPATIC CANCER]. XU YIYU ET
AL. shanghai journal of traditional chinese medicine.
1994;12:4 (chi).
1271- gera: 49485/di/ra
[QI ZHU SAN JIA TANG DECOCTION FOR ASCITES
OF HEPATOCIRRHOSIS]. LIU GUIYING. shaanxi
journal of traditional chinese medicine. 1994;15(7):301
(chi).
1272- gera: 49486/di/ra
[JI GAN TANG DECOCTION FOR HEPATITIS OF
JAUNDICE]. XUE LEBIN. shaanxi journal of traditional
chinese medicine. 1994;15(7):303 (chi).
1273- gera: 49530/di/ra
[A CLINICAL RESEARCH IN THE TREATMENT OF
HEPATIC CIRRHOSIS BY APPLICATION OF HERB
PASTE IN ACUPOINTS]. CAI YIMEI ET AL. shanghai
journal of acupuncture and moxibustion. 1994;13(3):99
(chi).
1274- gera: 49564/di/ra
[A SUMMARY OF EXPERIMENTAL STUDIES ON
PRIMARY LIVER CANCER WITH CHINESE
MEDICINE AND HERB]. NIE GUANG. traditional
chinese medicinal research. 1994;7(2): (chi).
1275- gera: 49606/di/ra
[STUDY ON PROTECTION EFFECT OF ORAL
LIQUID OF XINMAILING ON HEPATIC INJURY OF
ENDOTOXIC SHOCK MICE]. LI AIFANG ET AL. china
journal of traditional chinese medicine and pharmacy.
1994;9(2):11 (chi*).
The influence of oral liquid of Xinmailing on hepatic injury
of endotoxic shock mice was observed. The results showed
that mouse mortality of endotoxic shock group (ESG) in 6
hours was 90%, serum glutamic pyruvic transaminase (GPT),
glutamic oxalacetic transaminase ((GOT), lactic
dehydrogenase (LDH), plasma and hepatic lipid peroxide
(LPO) were increased obviously and the activity of hepatic
superoxide dismutase (SOD) was decreased notably.
Comparying with normal group , p<0. 01. All the above-
mentioned indexes were improved in the treatment group by
oral liquid of Xinmailing. Mouse mortaIity in 6 hours was 12.
5%, seroenzyme reaction, plasma and hepatic LPO were
decreased obviously, the activity of hepatic SOD was
increased notably.
1276- gera: 49624/di/ra
gera 2011

[CLINICAL RESEARCH ON VIRUS B HEPATITIS
TREATED WITH YI-HUANG ORAL LIQUID]. ZHANG
ZHIZHEN ET AL. china journal of traditional chinese
medicine and pharmacy. 1994;9(3):22 (chi*).
Yi-Huang oral liquid is a kind of immunopotentiator which is
compounded by means of taking Formica Sinae Emery being
rich in Luliang Mountains, as the main herb. Observating the
clinical treatment of 350 cases of virus B hepatitis and 90
cases of HBV carrier (setting up 78 cases as control group ) ,
it is found that this liquid has an obvious effect on treating
virus B hepatitis and clearing up HBV. The total effective
rate of clinical treatment for virus B hepatitis is 80%,
negative-transformation rate of HBsAg of patients suffering
from virus B hepatitis is 60. 2 % an negative transformation
rate of HBsAg of patients carrying HBV is 61. 1%. Such
treatment effect is notably higher than that of the same kind
of medecine applied in the present clinical practice.
1277- gera: 49641/di/ra
[INFLUENCE OF DIFFERENT SYNDROME TYPES
OF HEPATOCIRRHOSIS ON SUBGROUP OF T-
CELL]. ZHU FANGSHI ET AL. china journal of
traditional chinese medicine and pharmacy. 1994;9(5):25
(chi).
1278- gera: 49649/di/ra
[STUDY ON VIRUS HEPATITIS C TREATED BY
TCM AND ITS PROSPECT]. CHE NIANCONG ET AL.
china journal of traditional chinese medicine and
pharmacy. 1994;9(5):47 (chi).
1279- gera: 49652/di/ra
[ANALYSIS ON ACUTE FEBRILE DISEASES
TREATED WITH HEAT-CLEARING THERAPIES IN
"DIFFERENTIATION OF WARM DISEASES ITEM
BY ITEM"]. LIU YANRONG. china journal of traditional
chinese medicine and pharmacy. 1994;9(6):7 (chi*).
The heat-clearing therapies in "Differentiation of Warm
Diseases Item by Item" are the main treatment methods for
acute febrile diseases. On the basis of comprehensive study
of the heat-clearing therapies and by combining the clinical
practice, the heat-clearing therapies in "Differentiation of
Warm Diseases Item by Item" are summed up as the
following six aspects ; dispersing therapy with herbs of
pungent flavor and cool nature, heat-clearing therapy with
herbs of sweet flavor and cold nature, therapy of dispelling
heat by clearing the nutrient phase, heat-cIearing and blood-
cooling therapy, heat-purging therapy and yin-nourishing and
heat-clearing therapy. These therapies are extensively applied
to various acute diseases such as epidemic influenza,
meningitis, epidemic hemorrhagic fever, encephalitis B.
acute hepatitis, hemorrhage of digestive tract, etc.. But, the
curative mechanism should not be understood from the
angles of anti-inflammation, antisepsis, antivirus, cooling
temperature and sedation.
1280- gera: 49658/di/ra
[OBSERVATION ON THERAPEUTIC EFFECTS OF
ACUPUNCTURE IN THE TREATMENT OF ACTIVE
HEPATITIS B IN CHRONIC PATIENTS]. FU LANG-
LIN. chinese acupuncture and moxibustion. 1994;14(2):9
(chi*).
Eighty eight patients were randomly divided into acupuncture
group and medicine group (as the control) . After 3 months of
treatment, the ALT decreasing rate and SB decreasing rate in
the acupuncture group was 86.4% and 92.7%, respectively,
while those in the control group was 68.2% id 74.4%
respectively. In the acupuncture group the rate of
albumin/globulin increased in 78% of the patients, but only in
57. 1 % of the patients in the control. The HBSAg and
73
HBEAg values turned to be negative in 18.2% and 36,6% of
the patient respectively the acupuncture group, while only
4.5% and 16.3% in the control. The differences between the
two groups were of statistical signifiance. Therefore, we
suggest that acupuncture is one of the promising approaches
in treating CAH.
1281- gera: 49669/di/ra
[CLINICAL AND EXPERIMENTAL RESEARCH ON
CHRONIC HEPATIC DISEASE TREATED WITH
ROUGAN KANGXIAN DECOCTION]. JIN SHUGEN ET
AL. china journal of traditional chinese medicine and
pharmacy. 1994;9(4):12 (chi*).
Rougan Kangxian Decoction is a compound formula based
on therapies of reinforcing qi to nourish yin and activating
blood circulation to resolve stasis. It was applied to treat
different chronic hepatic diseases. It was found after
treatment of three months that the cIinical symptoms, liver
function and protein metabolism were improved, and the
level of serum hyaluronic acid wasdecreased in patients of
stable type of early hepatocirrhosis, while these changes were
not found in patients of active chronic hepatic diseases
(chronic active hepatitis and decompensated hepatocirrhosis
of late stage). By filling the extract of Rougan Kangxian
Decoction in rats with active hepatic fibrosis, it was found
that this decoction had effects of decreasing body weight,
improving liver function, rectifying protein metabolism,
decreasing the levels of serum hyaluronic acid and hepatic
xyproline hydroxyproline, and lightening hepatic
pathological changes (especially the fibrosis )of rats. The
curative effect of
1282- gera: 49811/nd/re
PROTECTIVE EFFECT OF TRIONYX CARAPAX ON
CCL4-INDUCED HEPATIC INJURY IS MEDIATED
BY URACIL. . KITAJIMA S ET AL. res commun chem
pathol pharmacol. 1994;84(2):203-22 (eng).
Oral administration of crude extracts of Trionyx carapax into
rats was found to protect the liver from its CCl4- induced
injury as judged by morphological and biochemical
observations. The active principle was purified from crude
extracts of Trionyx carapax by Sephadex G-75, Sephadex G-
25, DEAE-cellulose and silica gel column chromatographies.
The results of elemental analysis, infrared and mass
spectroscopy demonstrated the purified component to be
identical to uracil. Upon administration, authentic uracil
exhibited the protective effects on CCl4- induced hepatic
injury, a pattern identical to or very similar to that observed
with crude extracts of Trionyx carapax. Thus it is concluded
that uracil is the active component responsible for protection
from CCl4-induced hepatic
1283- gera: 49814/di/ra
COMBINED TRADITIONAL CHINESE MEDICINE
AND WESTERN MEDICINE. RELIEVING EFFECTS
OF CHINESE HERBS, EAR-ACUPUNCTURE AND
EPIDURAL MORPHINE ON POSTOPERATIVE PAIN
IN LIVER CANCER. LI QI-SONG ET AL. chinese
medical journal. 1994;107(4):289-94 (eng).
In the evaluation of Chinese herbs (A), ear-acupuncture (B)
and epidural morphine (C) to relieve postoperative pain and
abdominal distension, sixteen male patients with primary
liver cancer were observed. This study was conducted by
means of orthogonal experiment and double blind,
randomized design. The patients received various treatments
according to the display of the orthogonal table L16(2)15
which corresponds to 2(3) factorial experiment design. C+
(morphine 2 mg) was given before the peritoneum was
sutured. A+ (orally administered) and B+ were given 24
hours after operation. 50-100 mg of pethidine was given
gera 2011

when the pain intensity VAS (0- 100) exceeded 50-70. The
observation parameters included plasma leucine enkephalin
(LEK), postoperative total dosage of narcotics administered
for 5 days, VAS for pain and pain reliever, abdominal
distension, urinary retention, constipation, etc. The results
were as follows: a. Patients who had received A (A+B+C+,
A+B+C-, A+B-C-, A+B-C+); C (C+A+B+, C+A+B-, C+A-
B+, C+A-B-), or B (B+A+C+, B+A+C-, B+A-C+, B+A-C-)
produced better analgesic effects than those who had received
placebo. The A, B, and C reduced narcotics 650, 450 and 550
mg respectively when compared with placebo. The effects of
A and C were of statistical significance (P < 0. 05), while
AB, BC, and AC interactions were not found; b. A and B
minimized abdominal distension and urinary retention, while
C prolonged them. As compared with the placebo, A and B
accelerated restoration of bowel peristalsis (P <
1284- gera: 49867/nd/re
INHIBITION OF EARLY 3-METHYL-4-
DIMETHYLAMINOAZOBENZENE-IND UCED
HEPATOCARCINOGENESIS BY GOMISIN A IN
RATS. . NOMURA M ET AL. anticancer res.
1994;14(5A):1967-71 (eng).
The effects of gomisin A, a lignan component of Schizandra
fruits, on hepatocarcinogenesis caused by 3'-methyl- 4-
dimethylaminoazobenzene (3'-MeDAB) in male Donryu rats
were investigated. Gomisin A significantly inhibited the
appearance of foci stained for glutathione S-transferase
placental form (GST-P) in the liver of rats given feed with 0.
06% 3'-MeDAB. Gomisin A (30 mg/kg/daily, po) decreased
the concentration of 3'-MeDAB-related azo dyes in the liver,
and increased their excretion in the bile. The ratio of diploid
to tetraploid nuclei increased during ingestion of 3'-MeDAB,
but gomisin A delayed the increase. After the withdrawal of
3'-MeDAB, carcinogen-related azo dyes were not detected in
the liver or bile, but the proportion of diploid nuclei remained
high, although it decreased with a 0. 03% gomisin A diet.
The results suggested that the effects of gomisin A are related
to
1285- gera: 49922/nd/re
[EFFECTS OF BYAKUSHI AND OGON ON THE
HEPATIC DRUG METABOLIZING ENZYMES IN
RATS]. KOIZUMI K ET AL. nippon yakurigaku zasshi.
1994;104(5):413-9 (jap*).
The effect of single or daily oral administration of hot water
extracts (HWE) from Byakushi or Ogon on rat hepatic drug-
metabolizing enzymes were investigated in vivo. Enzymes
were measured for 3 to 72 hr after single oral administration
of HWE at the dose of 1. 0 g/kg or 5. 0 g/kg. Administration
of 1. 0 g/kg of Byakushi and 5. 0 g/kg of Ogon inhibited
aniline hydroxylase activity, while 5. 0 g/kg of Byakushi
inhibited it in the early phase, but increased it in the late
phase. Byakushi inhibited aminopyrine N-demethylase
activity, while 5. 0 g/kg of Ogon increased it. Byakushi and
Ogon decreased the amount of cytochrome P-450. Byakushi
and Ogon increased the amount of cytochrome b5. Byakushi
increased cytochrome c reductase activity 3 hr after
administration and decreased it 6 and 12 hr after
administration. In contrast, 1. 0 g/kg of Ogon decreased
cytochrome c reductase activity, and 5. 0 g/kg increased it 6
hr after administration and decreased it 12 hr after
administration. At 24 hr after the last administration to
animals treated with a regimen of once a day administration
of the HWE (0. 1 or 1. 0 g/kg) of Byakushi or Ogon for 14
days, the enzymes were measured. Byakushi decreased
aminopyrine N- demethylase activity, the amount of
cytochrome P-450, and cytochrome c reductase activity.
Ogon decreased cytochrome c reductase activity. Byakushi
altered the composition of cytochrome P-450 isozyme after
74
daily administration.
1286- gera: 49925/nd/re
EFFECT OF MOMORDICA CHARANTIA ON KEY
HEPATIC ENZYMES. . TENNEKOON KH ET AL. j
ethnopharmacol. 1994;44(2):93-7 (eng).
The effect of Momordica charantia on certain key hepatic
enzymes was investigated using male Sprague-Dawley rats as
the animal model. Fruit juice and seed extract of Momordica
charantia were administered orally at a daily dose of 1 ml/100
g body weight for 30 days under light ether anaesthesia while
the control group received equivalent amounts of distilled
water under identical conditions (n = 10 in each case). Serum
gamma-glutamyl transferase (P < 0. 001) and alkaline
phosphatase (P < 0. 01-0. 001) concentrations were found to
be significantly elevated following oral administration of
both the fruit juice and the seed extract. Consistent significant
histopathological changes in the liver were not observed in
either treatment group although the prevalence of dilatation
and/or congestion of the central vein sinusoidal system
appeared to be twice as high following fruit juice treatment
than in the other 2 groups. Thus, Momordica charantia may
either contain hepatotoxins capable of causing cellular
damage at the molecular level without causing significant
histopathological changes or the plant
1287- gera: 49952/di/ra
HEPATOPROTECTIVE EFFECTS OF TAIWAN FOLK
MEDICINE : IXERIS CHINENSIS (THUNB.) NAK. ON
EXPERIMENTAL LIVER INJURIES. . LIN SC ET AL.
american journal of chinese medicine. 1994;22(3-4):243-
54 (eng).
The hepatoprotective effects of Ixeris chinensis (Thunb. )
Nak. were studied on acute hepatitis induced in mice by a
single dose of carbon tetrachloride (31. 25 microliters/kg, ip)
or acetaminophen (600 mg/kg, ip), and in rats by a single
dose of beta-D-galactosamine (188 mg/kg, ip).
Hepatoprotective activity was monitored by estimating the
serum transaminases (SGOT and SGPT) levels and
histopathological changes in the livers of experimental
animals. The Ixeris chinensis (Thunb. ) Nak. extracts
significantly inhibited the acute elevation of serum
transaminases. Histopathologically, the crude I. chinensis
extract significantly ameliorated hepatotoxin-induced
histopathological changes in the livers of experimental
animals. All pharmacological and histopathological effects of
Ixeris chinensis (Thunb. ) Nak. were compared with
Bupleurum chinense DC. , which has been previously
1288- gera: 49966/nd/re
[A CLINICOPATHOLOGICAL ANALYSIS OF 70
CASES OF LIVER ALVEOLAR ECHINOCOCCOSIS
WITH A COMMENT OF THE PROGNOSTIC
FACTORS]. JIANG CP ET AL. chung hua nei ko tsa chih.
1994;33(7):452-4 (chi*).
As to the geographical distribution of the 70 cases of liver
alveolar echinococcosis in the present series, the highest
incidence was found in Gansu province (82. 8%), where most
of the patients came from Zhang county (65. 6%). Female
outnumbered slightly male. Most patients were young and in
robust years of their life (98. 8%). The most frequent
symptom was liver mass (56. 4%) and the next abdominal
pain (28. 2%). Imaging examination and immunological test
were helpful to the diagnosis. Under microscopic observation
the hyperplastic bud from germinal membrane of liver
alveococcus cyst wall comprised a few nuclei and showed
exogenous or endogenous budding. According to whether
alveococcus proliferation was present or not, pathological
types of regressive grade I and hyperplastic grade II were
discerned. Resection was not done in 34 cases during
gera 2011

exploratory laparotomy, but drainage was performed in 8
cases for alveococcus necrotic pseudocyst and
cholecstostomy was done in one case for jaundice.
Albendazole or/and traditional Chinese medicine were
administered in 35 cases. The prognosis of the patients in
relevant to some factors such as sex, age, pathology,
symptom and treatment was discussed.
1289- gera: 49967/nd/re
[EFFECT OF RADIX ANGELICAE SINENSIS ON
SERUM GASTRIN LEVELS IN PATIENTS WITH
CIRRHOSIS]. HUANG ZP ET AL. chung hua nei ko tsa
chih. 1994;33(6):373-5 (chi).
Acute and chronic effect of Radix Angelicae Sinensis (RAS)
on serum gastrin levels in patients with cirrhosis were
investigated. The results showed that after intravenous
perfusion of RAS, serum gastrin levels of inferior vana cava,
hepatic and peripheral veins were significantly decreased.
After long-term administration of the agent, the level fell
nearly to that of control subjects. It is suggested that the
effect of reducing serum gastrin level by RAS may improve
portal hemodynamics and be beneficial for portal
hypertensive gastroduodenal mucosal lesions in
1290- gera: 49983/nd/ra
EXPERIMENTAL STUDY ON ISCHEMIA AND
REPERFUSION INJURY OF RAT LIVER AND
EFFECTS OF LIGUSTRAZINE AND SALVIA
COMPOUND. . WU W ET AL. chinese medical sciences
journal. 1994;9(3):162-6 (eng).
The present study was to investigate changes of free radicals
in the whole rat liver, changes of ATP levels of hepatic cells,
ultrastructural changes in hepatic tissue during ischemia and
reperfusion in rats and the effects of ligustrazine and salvia
compound. The results indicated that: 1) the free radical
levels increased by 8. 3-fold and 9. 0-fold in the groups with
30 and 60 min ischemia after 40 min reperfusion, as
compared with the group with ischemia only (P < 0. 01, P <
0. 01, respectively). 2) The levels of ATP returned to normal
in the group with 30 min ischemia after reperfusion for 40
min and 3 d, remained low in the group with 90 min ischemia
and fell again after a mild increase in the group with 60 min
ischemia. 3) The hepatic and endothelial cell damage after
ischemia became more severe after reperfusion, as revealed
by electron microscopy. The present study also showed that
ligustrazine and salvia compound have protective effects
against reperfusion injury. They can be used to scavenge free
radicals, improve hepatic microcirculation and alleviate
hepatic and endothelial cell damage.
1291- gera: 53674/nd/re
[NONOPERATIVE TREATMENT FOR SIMPLE
HEPATIC INJURY : AN ANALYSIS OF 77 CASES].
TANG BS . chung hua wai ko tsa chih. 1994;32(8):477-9
(chi*).
In this study, 77 of 82 hepatic injury cases were selected for
conservative therapy. The hepatic injuries in all these 77
cases were originally graded as type I or Type II by
reviewing the history of trauma, abdominal paracentesis, B-
mode ultrasonography, peritoneoscopy, X-ray
pneumoperitoneography, and serum GPT measurement.
Patients were all resuscitated by fast volume expansion,
blood transfusion recovered from intraabdominal bleeding,
nasogastric tube decompression added by chinese herbs.
Three patients died of compound internal organ injuries,
respiratory failure and DIC, the remaining 74 (96. 1%) were
cured.
1292- gera: 53797/di/ra
[OBSERVATIONS ON THE EFFICACY OF
75
PHYLLANTHUS SPP. IN TREATING PATIENTS
WITH CHRONIC HEPATITIS B]. WANG MEIXIA ET
AL. china journal of chinese materia medica.
1994;19(12):750 (chi*).
The efficacy of Phyllanthus amarus produced in india, P.
niruri gathered from hainan province and P. urinaria from
henan province was assessed in a total of 88 cases of chronic
hepatitis B with 11. 42 and 35 each. It was shown that P.
urinaria had the effect of seroconversion on HBeAg from
positive to negative as well as on HBeAb from negative to
positive, while the other two herbs had not. In addition none
of these three herbs had similar
1293- gera: 53968/di/ra
[POSTOPERATIVE RESIDUALS AND RELAPSING
OF PRIMARY LIVER CARCINOMA TREATED BY
CHINESE DRUGS AND CHINESE DRUGS PLUS
CHEMOTHERAPY]. LIN JUNHUA ET AL. journal of
traditional chinese medicine. 1994;35(4):220 (eng*).
One hundred and ten cases of postoperative residuals,
relapsing and metastasis in primary liver carcinoma were
treated by traditional drugs and traditional drug plus
chemotherapy. The drugs were of strengthening spleen,
regulating Qi, dispersing Liver, relieving stagnation,
dissipating dampness, mediating the stomach and spleen,
invigorating Qi and replenishing blood. Results revealed that
the 1-year survival rate in 110 cases was 70,78 ± 8· 53 %, 3-
year survival rate was 33, 82 ± 9. 25%, 5-year survival rate
was 16 ± 7. 43% (by list of life-span method). Among them.
4 cases have survived for over 10 years, indicating that the
treating principles of supporting the body resistance and
strengthening the spleen is significant in prolonging the
survival rate of primary liver carcinoma
1294- gera: 53985/di/ra
[TWENTY CASES OF C-TYPE VIRAL HEPATITIS
TREATED MAINLY BY BLOOD-ACTIVATING AND
DETOXICATION METHODS]. XING LIANJUN ET AL.
journal of traditional chinese medicine. 1994;35(5):286
(eng).
1295- gera: 54015/di/ra
[TREATMENT OF LIVER FIBROSIS IN B-
HEPATITIS BY DIFFERENTIATION OF
SYNDROMES AND ITS RELATION WITH CHANGES
IN BIOCHEMICAL PARAMETERS]. WU JIAGENG ET
AL. journal of traditional chinese medicine.
1994;35(7):416 (eng*).
In fibrosis of liver due to its inflammatory lesions, the HA,
ADA, GST, are much higher than that of the normality. This
abnormality occurs with increasing severity in the order of
type of liver stagnation and spleen deficiency, type of Qi-
stagnation and blood stasis, type of accumulated heat and
blood-stasis and the differences are very significant among
these types. By treatment based on TCM differentiation of
syndromes, liver function was improved, with the first 2
indexes dropped down, demonstrating that TCM is effective
for liver fibrosis.
1296- gera: 54041/di/ra
[COMPARATIVE STUDY ON THE CLINICAL
MANIFESTATIONS AND ITS TCM DIAGNOSIS OF
CHRONIC HEPATITIS B AND C]. JIN SHI ET AL.
journal of traditional chinese medicine. 1994;35(9):538
(eng*).
Comparative analysis was made on 85 cases of hepatitis C
and 37 cases of hepatitis B, all diagnosed by liver biopsis and
virological indices. Results showed that cases in the hepatitis
C group were older in age, more cases with a history of
receiving transfusion and milder clinical symptoms. In
gera 2011

diagnosis. more eases revealed stagnant blood blocking the
collaterals. with less damp- heat in the interior. the Alb. T-
chol were all lower. P-111-p was higher and few eases had
GOT, GPT> 100u. It is recommended that the therapeutic
principles should be clearing the liver, cooling blood,
eliminating poisons hitting the a Ying-blood level. To
prevent relapse. emphasis should be laid on supporting
1297- gera: 54051/di/ra
[INTRODUCTION TO THERAPY FOR REDUCING
ENZYMES BY TCM IN CHRONIC HEPATITIS].
HONG HUIWEN. journal of traditional chinese medicine.
1994;35(9):561 (eng).
1298- gera: 54054/di/ra
[EXPERIENCE ON TREATMENT BASED ON
DIFFERENTIATION OF SYNDROMES IN ACUTE
REJECTION REACTION IN ORTHOPTIC
TRANSPLANTATION OF LIVER]. YU SHENSLAN ET
AL. journal of traditional chinese medicine.
1994;35(10):586 (eng*).
The experience on a case of human allogeneic orthotopic
transplantation of liver with acute rejection reaction treated
with differentiation of syndrome was reported. The principles
of clearing heat, eliminating dampness, detoxification and
eliminating filth, soothing and dredging liver and bile,
facilitating bile duct. Immune depressing method was also
used so that the primary rejection reaction was rapidly
brought under control and reversed. Then phlegm and blood
stasis were treated at the same time with facilitating the
flowing of bile, so that the remained jaundice can be also
cured and liver function
1299- gera: 54056/di/ra
[STUDIES ON ACTION OF ANTI-FIBROSIS OF
LIVER BY RECIPES OF SUPPORTING RESISTANCE
AND ELIMINATING BLOOD-STASIS]. LIU CHENG ET
AL. journal of traditional chinese medicine.
1994;35(10):602 (eng*).
Liver fibrosis induced by CC14 in rat models were prevented
and treated by recipes of supporting resistance and
eliminating blood stasis, Results showed that it decreased the
HyP contents in rat's liver and the severity of fibrotic
proliferation. For post hepatitic cirrhosis. it decreased the HA
and LM contents but no changes can be observed in control
group.
1300- gera: 54066/di/ra
[CHARACTERISTICS OF C HEPATITIS AND ITS
TCM THERAPY]. CHEN LIHUA. journal of traditional
chinese medicine. 1994;35(10):621 (eng).
1301- gera: 54075/di/ra
[BLOCKING THERAPY FOR PERSISTENT
POSITIVE LOW SERUM ALPHA-FETAL PROTEIN].
LIN ZONGGUANG. journal of traditional chinese
medicine. 1994;35(12):730 (eng*).
Primary liver carcinoma is closely related to persistent low
serum AFP. Patients from such community are highly
vulnerable to liver carcinoma, sometimes called precancerous
lesion of the liver. By applying blocking therapy based on
TCM diagnosis, 42 cases were treated with 92. 86 % (39
cases) AFP turned negative, 4. 76 % (2 cases) stable. Only 1
case evolved into cancer.This offersa basis for developing
new approach to tackle the problem.
1302- gera: 54078/di/ra
[IMMUNO-HISTO-CHEMICAL AND
PATHOLOGICAL STUDIES ON POST-HEPATITIC
LIVER CIRRHOSIS TREATED WITH PEACH-
76
KERNEL EXTRACT PLUS CORDICEPS HYPHA]. XU
LIEMING ET AL. journal of traditional chinese medicine.
1994;35(12):737 (eng*).
Based on the idea that the pathogenic-etiologic mechanism is
the " blockage of liver channels, blood stasis and Qi
stagnation resulting in malnutrition of liver due to lack of
blood supply" , the treating principle of " eliminating stasis
and supporting body resistance" was established with the
combined use of extracts from peach-kernel plus cordicep
hypha, 6 cases were thus treated. All of them received
laparoscopy , and liver biopsy before and after the treatment.
The gross appearance, histology and ultra - microscopic
structure and immuno - histo - chemistry were examined.
Results showed that most of the activated fat - storage cells
after treatment were silent the I, III types of col- lagen
deposited among the spaces of peri-sinusoid and liver cells
and FN, LM were decreased in part of the patient, resulting in
less intrahepatic fibrosis, degradation of collagen fibres
deposited in inter hepatic cellular spaces, inhibition and
reversion of capillarization of liver sinusoid, hence,
improvement of degeneration of liver cells in most cases. The
texture of the liver were turning normal with amelioration of
portal hypertension and decrease of varicose mesenteric
vessels. The liver turned red, swelling of falciform ligament
disappeared, and ascitis subsided.
1303- gera: 54082/di/ra
[RECENT PROGRESS IN THE STUDY OF
HEPATOPATHY IN TCM SOCIETY OF LIVER AND
GALLBLADDER DISEASES IN INTERNAL
MEDICINE, CHINA]. ASSOCIATON OF TCM AND
PHARMACY. journal of traditional chinese medicine.
1994;35(12):750 (eng).
1304- gera: 54091/di/ra
[INTRODUCTION OF XIE LINIE'S EXPERIENCE OF
TREATING LIVER-GALLBLADER DISEASES]. XIE
HUANRONG. shaanxi journal of traditional chinese
medicine. 1994;15(7):313 (chi).
1305- gera: 55709/di/ra
APLICACION DE LA MTC EN EL TRATAMIENTO
DEL DOLOR HEPATICO DE ORIGEN TUMORAL.
WANG GUIMIAN ET AL. revista de la medicina
tradicional china. 1994;4(3):42-7 (esp).
Los autores resumen la aplicacion de la MTC en el
tratamiento del dolor hepatico de origen tumoral en Pekin,
Shanghai, Jiangsu y Zhejiang. El principio terapeutico fue
activar la circulacion de la sangre y resolver la estasis y
suavizar el higado y regular el Qi para drenar los Canales.
Los resultados fueron satisfactorios.
1306- gera: 69265/di/ra
[THE EXPERIENCE OF QIAO LINCHENG
TREATING HEPATOLENTICULAR]. DU XINPING.
liaoning journal of traditional chinese medicine.
1994;21(6):251 (chi).
1307- gera: 69282/di/ra
[DISTINGUISHED RESEARCH OF CLINICAL
SYNDROMES OF CIRRHOSIS]. ZHU FANGSHI ET AL.
liaoning journal of traditional chinese medicine.
1994;21(8):340 (chi).
1308- gera: 79928/di/ra
[CLINICAL INVESTIGATION ON
XIANGGUDUOTANG TABLETS
(POLYSACCHARIDE OF LENTINUS EDODES) FOR
HEPATITIS B ON 60 CASES]. WANG JUNXIA. chinese
traditional patent medicine. 1994;16(5):23 (chi).
gera 2011

1309- gera: 84314/di/ra
[CLINICAL OBSERVATION ON 103 CASES OF
HEPATOCIRRHOSIS TREATED WITH XIAOGU
DECOCTION]. RONGCHUN L ET AL. journal of beijing
university of tcm. 1994;17(6):47 (chi).
1310- gera: 84510/di/ra
[THE ORIENTATION OF TCM STUDY ON VIRUS
HEPATITIS]. CHANGJIAN Y. journal of shandong
college of tcm. 1994;18(2):83 (chi*).
The orientation of the research on virus hepatitis in TCM is
removal of pathogen, improvement of prognosis and increase
of the resistance of the body to the disease. The research
include basis science, diagnosis, treatment and screening
prescriptions and drugs. On the basis of some data about the
studies on virus hepatitis, the author suggests that the
research on it include antivirus, improvement of the liver
function, antifibrosis, immuno regulation and removal of
symptoms and signs.
1311- gera: 84554/di/ra
[A CLINICAL STUDY ON CHRONIC ACTIVE
HEPATITIS TREATED ACCORDING TO
PRINCIPLES OF CLEARING UP THE YING SYSTEM
AND REMOVING DAMPNESS]. YUNDONG L. journal
of shandong college of tcm. 1994;18(3):151 (chi).
1312- gera: 84560/di/ra
[THE PRESENT SITUATION OF TREATMENT OF
THE LIVER CANCER WITH TCM AND COMBINED
WITH WESTERN MEDICINE IN CHINA]. XIMING W.
journal of shandong college of tcm. 1994;18(4):218 (chi).
1313- gera: 84810/di/ra
[ELEMENTARY INTRODUCTION ON TREATMENT
OF CHRONIC HEPATITIS B FROM SPLEEN
THESIS]. JUNSHENG W. beijing journal of tcm.
1994;2:15 (chi).
1314- gera: 84834/di/ra
[CLINICAL OBSERVATION ON TREATMENT OF
HEPATOPATHY WITH YI CUANJIAN]. NING Z.
beijing journal of tcm. 1994;3:45 (chi).
1315- gera: 84835/di/ra
[DIFFERENTIAL TREATMENT OF JAUNDICE IN
CHILDREN]. YIAN Z. beijing journal of tcm. 1994;3:51
(chi).
1316- gera: 84889/di/ra
[RECENT DEVELOPMENT OF TREATING
ABNORMAL SERUM PROTEIN DUE TO CHRONIC
HEPATOPATHY WITH TCM]. LI J ET AL. beijing
journal of tcm. 1994;6:60 (chi).
1317- gera: 84991/di/ra
[EFFECT OBSERVATION OF YIGAN TAI TANG FOR
TREATING PATIENTS WITH HEPATITIS B VIRUS].
HUAIZI ET AL. fujian journal of tcm. 1994;25(5):19 (chi).
1318- gera: 84994/di/ra
[HEPATOCIRRHOSIS COMPLICATED WITH
ASCITES TREATED WITH XIAOGU JIANGAN TANG
: A CLINICAL ANALYSIS OF 50 CASES].
CHAOLIANG Z ET AL. fujian journal of tcm.
1994;25(6):3 (chi).
1319- gera: 84995/di/ra
[BILIARY CALCULI WITH CHOLESTASIS
77
TREATED WITH NOURISH THE
LIVER,NORMALIZING GALLBLADDER AND
BLOOD STASIS : A REPORT OF 33 CASES]. ZHIZHI L
ET AL. fujian journal of tcm. 1994;25(6):5 (chi).
1320- gera: 85014/di/ra
[EXPERIMENT STUDY ON THE CHRONIC VIRUS
HEPATITIS EFFECT OF CONTRACEPTIVE
MEDICINAL WINE]. YU Z ET AL. henan traditional
chinese medicine. 1994;14(3):145 (chi).
1321- gera: 85015/di/ra
[CLINICAL STUDY ON THE CHRONIC VIRUS
HEPATITIS TREATED WITH MANGAN FUKANG
PILLS]. DONGHAI L ET AL. henan traditional chinese
medicine. 1994;14(3):152 (chi).
1322- gera: 85263/di/ra
[DECOCTION QIANGHUO QINGYI USED FOR
TREATING 300 CASES OF CHRONIC HEPATITIS B].
ZHU SHIFU. hubei journal of tcm. 1994;16(3):29 (chi).
1323- gera: 85264/di/ra
[OBSERVATION ON 80 CASES OF HEPATITIS WITH
HBeAg FROM POSITIVE TO NEGATIVE DUE TO
TREATMENT OF CHINESE HERBAL DRUGS].
LIANG LIN ET AL. hubei journal of tcm. 1994;16(3):31
(chi).
1324- gera: 85268/di/ra
[ANALYSIS ON RESULTS OF EXFOLIATIVE
CYTOLOGIC EXAMINATION OF TONGUE FUR
ATTAINED FROM 80 CASES OF VIRUS HEPATITIS].
XU XINGGUO. hubei journal of tcm. 1994;16(3):39 (chi).
1325- gera: 85283/di/ra
[ANALYSIS ON THE EFFECT OF KANGXIANLING
FOR TREATING SCHISTOSOMIAL HEPATIC
FIBROSIS]. YUAN ZHAOKAI. hubei journal of tcm.
1994;16(5):8 (chi).
1326- gera: 85351/di/ra
[VETERAN TCM DOCTOR JI HANYUAN'S
EXPERIENCE IN TREATING HEPATOPATHY].
WANG AIMIN. jiangsu journal of tcm. 1994;15(5):1 (chi).
1327- gera: 85392/di/ra
[TREATMENT OF 86 CASES OF POSTHEPATITIC
ASCITES DUE TO CIRRHOSIS BY
STRENGTHENING BODY RESISTANCE]. CAI
JINWEI. jiangsu journal of tcm. 1994;15(8):6 (chi).
1328- gera: 85399/di/ra
[FOUR CASES REPORTS ON USE OF RHUBARB IN
TREATMENT AND PREVENTION OF HEPATIC
COMA]. HU LINHUA. jiangsu journal of tcm.
1994;15(8):35 (chi).
1329- gera: 85407/di/ra
[TREATMENT OF 32 CASES OF ABNORMAL
DISTENSION DUE TO SEVERE HEPATITIS BY
ENEMA WITH DECOCTION OF RHUBARB]. CHEN
XIANGRONG. jiangsu journal of tcm. 1994;15(9):9 (chi).
1330- gera: 85456/di/ra
[THE EXPERIENCE OF ZENG QING HUA FOR
DIFFERENTIATION AND TREATMENT OF ACUTE
ICTEROHEPATITIS (CLINICAL ANALYSIS OF 233
CASES]. YANG XIANGSHENG. jiangxi journal of tcm.
1994;25(4):5 (chi).
gera 2011

1331- gera: 85458/di/ra
[OBSERVATION OF CURATIVE EFFECT OF 11
CASES OF SEVERE HEPATITIS TREATED WITH
LARGE DOSE NIU HUANG XING NAO JING]. MAO
DECHENG ET AL. jiangxi journal of tcm. 1994;25(4):13
(chi).
1332- gera: 85566/di/ra
[CLINICAL OBSERVATIONS FOR TREATING
CHRONIC HEPATITIS WITH TCMP]. FU MEIQING.
jiangxi journal of tcm. 1994;25(5):29 (chi).
1333- gera: 86091/di/ra
[EFFECT OF PRESSING OTOPOINT ON ACUTE
VIRUS HEPATITIS-WITH REPORT OF 95 CASES].
WANG FANG ET AL. journal of zhejiang college of tcm.
1994;18(3):51 (chi).
1334- gera: 86100/di/ra
[OBSERVATION OF EFFECT ON TREATMENT OF
53 CASES OF ASCITES DUE TO CIRRHOSIS WITH
XIAO GU TANG]. WANG JINGJIANG. journal of
zhejiang college of tcm. 1994;18(5):14 (chi*).
Author treated 53 cases of ascites due to cirrhosis with
modified Xiao Gu Tang (Kansui root, rhubarb, shell of areca
unt, Poria, eagle wood, Chinese-date, amomum fruit), the
results showed that cure was 30 cases, improvement 14,
inaction 9, a total effective rate 86.8%. The effective rate of
simple ascitic fluid was 95.8%. The effective rate of ascitic
fluid with complications was 72%. The effective rate of
stagnation of qi and retention of dampness was better than
that of retention of damp-heat in the interior, the effective
rate of the latter was better than that of insufficiency of both
the spleen and the kidney.
1335- gera: 86110/di/ra
[TREATMENT OF LIVER ABSCESS BY
COMBINATION OF CHINESE AND WESTERN
MEDICINE IN 62 CASES]. GUO XIN ET AL. journal of
tcm and chinese materia medica of jilin. 1994;4:13 (chi).
1336- gera: 86135/di/ra
[ESSENTIAL FACTOR OF EXPERIENCE OF
TREATMENT OF POSTHEPATITIC CIRRHOSIS BY
PROFESSOR LU ZHI QING]. CHENG ZHI QING.
journal of tcm and chinese materia medica of jilin.
1994;3:10 (chi).
1337- gera: 86158/di/ra
[BRIEF TALK ABOUT THE FORM OF CHINESE
MEDICINAL PRESCRIPTION OF HEPATITIS]. DENG
ZHENG PU. journal of tcm and chinese materia medica of
jilin. 1994;6:4 (chi).
1338- gera: 86530/di/ra
[DEVELOPMENT OF ANTI-FATTY LIVER BY TCM].
ZHANG JIAN JUN ET AL. acta chinese medicine and
pharmacology. 1994;2:50 (chi).
1339- gera: 86548/di/ra
[RELATIONSHIP BETWEEN THE METHOD OF
TONIFYING QI AND STRENGTHENING THE
SPLEEN AND CHRONIC HEPATITIS B]. ZHANG
GUIMING. acta chinese medicine and pharmacology.
1994;4:29 (chi).
1340- gera: 89963/di/ra
[A SURVEY OF STUDY ON TREATMENT OF VIRUS
HEPATITIS FOR CHINESE TRADITIONAL
78
MEDICINE AND ITS ACTIVE CONSTITUENTS]. NIE
KAN ET AL. chinese traditional and herbal drugs.
1994;25(7):381 (chi).
1341- gera: 90153/di/ra
[TREATMENT OF FULMINANT HEPATITIS BY TCM
COMBINED WITH WESTERN MEDICINE: A
REPORT OF 36 CASES]. LIU GUANGHAN. new journal
of tcm. 1994;26(3):48 (chi).
1342- gera: 90168/di/ra
[TREATMENT OF CHOLESTATIC HEPATITIS BY
JIN QIAM CAO QING DAI TANG: A STUDY OF 48
CASES]. HUANG CUANGRONG ET AL. new journal of
tcm. 1994;26(4):48 (chi).
1343- gera: 90183/di/ra
[THE SYNDROME PATTERNS,EFFECTIVENESS
AND HBV REPLICATION INDEXES OF CHRONIC
LINGERING HEPATITIS: AN ANALYSIS OF 40
CASES]. LI JUN. new journal of tcm. 1994;26(5):43 (chi).
1344- gera: 90191/di/ra
[TREATMENT OF CHRONIC HEPATITIS
COMPLICATED WITH LEUKOCYTOPENIA BY LIU
WEI DI HUANG TANG: A STUDY OF 30 CASES].
JIANG LELONG ET AL. new journal of tcm.
1994;26(6):22 (chi).
1345- gera: 90195/di/ra
[INTRODUCTION TO XU XINMEI'S EXPERIENCE
IN THE TREATEMENT OF CHRONIC GASTRITIS].
GUO SHUICHEN ET AL. new journal of tcm.
1994;26(6):42 (chi).
1346- gera: 90197/di/ra
[TREATMENT OF VIRAL HEPATITIS BY A LARGE
DOSE OF GAN YAN LING]. CHEN KAIHONG ET AL.
new journal of tcm. 1994;26(6):51 (chi).
1347- gera: 90212/di/ra
[TREATMENT OF SEVERE HEPATITIS BY DA
HUANG JIE DU TANG: A REPORT OF 10 CASES].
ZHU BOXING ET AL. new journal of tcm. 1994;26(8):50
(chi).
1348- gera: 90227/di/ra
[FOUR THERAPEUTIC METHODS FOR LOWERING
TRANSAMINASE]. JIANG JILIN. new journal of tcm.
1994;26(9):48 (chi).
1349- gera: 90228/di/ra
[FAMOUS VETERAN PHYSICIAN XU JINGFAN'S
EXPERIENCE ON THE TREATMENT OF GASTRITIS
AFTER OPERATION]. LIANG QIMING. new journal of
tcm. 1994;26(11):1 (chi).
1350- gera: 90257/di/ra
[TREATMENT OF HEPATITIS WITH SINGLE
RISING OF SGPT BY JIAN PI BU GAN TANG: A
REPORT OF 100 CASES]. FU MEIQING. new journal of
tcm. 1994;26(12):40 (chi).
1351- gera: 90518/di/ra
[EFFECT OF AMYGDALIN ON RDNA ACTIVITY
AND PHAGOCYTIC FUNCTION OF STELLATE
CELLS OF LIVER IN MICE]. LI CHUN-HUA ET AL.
practical journal of integrating chinese with modern
medicine. 1994;7(1):7 (chi).
gera 2011

1352- gera: 90534/di/ra
[EFFECT OF AMEBIC ABSCESS BY INTEGRATING
CHINESE WITH MODERN MEDICINE ON 30
CASES]. YAN ZHEN-DONG. practical journal of
integrating chinese with modern medicine. 1994;7(2):72
(chi).
1353- gera: 91012/di/ra
[CLINICAL OBSERVATION OF NIFEDIPINE ON
CHRONIC HEPATITIS AND CIRRHOSIS]. SUI YAN-
QING ET AL. practical journal of integrating chinese
with modern medicine. 1994;7(3):135 (chi).
1354- gera: 91015/di/ra
[EFFECTIVE OBSERVATION OF HIGH ICTERIC
VIRAL HEPATITIS TO CHRONIC ACTIVE
HEPATITIS BY COMBINING QIANGLINING AND
CHINESE MEDICINAL HERBS FOR REMOVING
HEAT FROM THE BLOOD AND PROMOTING
BLOOD CIRCULATI]. ZHU LIN. practical journal of
integrating chinese with modern medicine. 1994;7(3):141
(chi).
1355- gera: 91028/di/ra
[CLINICAL OBSERVATION OF PATIENT WITH
HBSAG'S TREATMENT BY INTEGRATE CHINESE
WITH MODERN MEDICINE]. LIANG MAN-HUA.
practical journal of integrating chinese with modern
medicine. 1994;7(4):210 (chi).
1356- gera: 91035/di/ra
[OBSERVATION OF ACUTE VIRUS HEPATITIS A'S
TREATMENT BY INTEGRATE CHINESE WITH
MODERN MEDICINE ON 73 CASES]. YU YI-QUAN.
practical journal of integrating chinese with modern
medicine. 1994;7(4):244 (chi).
1357- gera: 91039/di/ra
[PRELIMINARY OBSERVATION OF ZHULING
HOLOSIDE AND HEPATITIS B VACCINE ON
ACRATIVE EFFECT OF HEPATITIS B VIRUS]. ZHU
BEN-ZHONG ET AL. practical journal of integrating
chinese with modern medicine. 1994;7(5):264 (chi).
1358- gera: 91047/di/ra
[DIAGNOSTIC PROGNOSIS OF HEPATIC DISEASE
AND TONGUE PROPER IN TRADITIONAL CHINESE
MEDICINE]. ZHU LI-ZHUAN ET AL. practical journal
of integrating chinese with modern medicine.
1994;7(5):293 (chi).
1359- gera: 91068/di/ra
[ANALYSIS OF THE EFFECT OF THE VIRUS
HEPATITIS BY INTEGRATING CHINESE WITH
MODERN MEDICINE IN 100 CASES]. PEI YUE PING
ET AL. practical journal of integrating chinese with
modern medicine. 1994;7(7):387 (chi).
1360- gera: 91074/di/ra
[USING ICTEROHEPATITIS PHYLOGENETIC
METHOD CURE ICTEROHEPATITIS IN 220 CASES].
LI ZHI XIONG ET AL. practical journal of integrating
chinese with modern medicine. 1994;7(7):401 (chi).
1361- gera: 91075/di/ra
[OBSERVATION OF THE EFFECT OF CURING
HEPATIC CHOLESTASIS IN PREGNANCY BY
USING THE CHINESE DRUGS IN 22 CASES]. GAO
SHI MEI ET AL. practical journal of integrating chinese
with modern medicine. 1994;7(7):403 (chi).
79
1362- gera: 91080/di/ra
[PROBABLE SPEAK THE STUDING OF CURING
ACUTE HEPATITIS IN RESUMPTIVE TIME]. WANG
ZHEN BIAO ET AL. practical journal of integrating
chinese with modern medicine. 1994;7(7):425 (chi).
1363- gera: 91085/di/ra
[EFFECTIVE OBSERVATION ON TYPE-C
HEPATITIS TREATED BY ALPHA-INTERFERON
AND XIAO-CHAI-HU- TANG IN 32 CASES]. LIU SHU-
JIA ET AL. practical journal of integrating chinese with
modern medicine. 1994;7(8):452 (chi).
1364- gera: 91103/di/ra
[THE CLINICAL STUDY OF THE METAPHASE AND
LATE HEPATOCARCINOMA THAT IS CURED BY
COMBINATION OF TAI+TAE AND CHINESE
HERBS]. LIU ZHAO JUN ET AL. practical journal of
integrating chinese with modern medicine. 1994;7(9):534
(chi).
1365- gera: 91214/di/ra
[PCR USING IN INFECTION OF HEPATITIS B]. ZU
YAN-ZHEN ET AL. practical journal of integrating
chinese with modern medicine. 1994;7(12):730 (chi).
1366- gera: 91215/di/ra
[THE HEPATIC ABSCESS IS CURED BY CHINESE
WITH MODERN MEDICINE IN 73 CASES]. LIU JIA-
LEI ET AL. practical journal of integrating chinese with
modern medicine. 1994;7(12):736 (chi).
1367- gera: 153578/di/co
LES RENCONTRES DE MEDECINE CHINOISE-
HEPATITE C- DARTIGUES J-P,. rencontres de medecine
chinoise bon encontre. 1994;26 MARS:38-46 (fra).
1368- gera: 14944/di/ra
APPLICAZIONE DELLA MTC NEL TRATTARE IL
DOLORE DA CARCINOMA EPATICO. GUIMIAN W
ET AL. rivista italiana di medicina tradizionale cinese.
1995;60(2):64-8 (ita).
1369- gera: 22269/di/ra
[ACUPUNCTURE THERAPY ON CHRONIC
HEPATITIS]. X. journal of the japan society of
acupuncture. 1995;45(1):121. (jap).
1370- gera: 22428/di/ra
[EARLY LIVER CIRRHOSIS TREATED WITH SELF-
FORMULATED XIAOZHENG FUGAN (LUMP-
ELIMINATING AND LIVER-RECOVERING) PILLS].
ZHIJI Q. journal of tcm. 1995;36(4):224 (chi).
1371- gera: 23478/di/ra
[CLINICAL OBSERVATION OF 15 CASES OF
NEPHRITIS RELATED TO B-HEPATITIS VIRUS
TREATED BY DIFFERENTIAL DIAGNOSIS OF
SYNDROMES]. HONGWEI L ET AL. journal of tcm.
1995;36(7):415 (chi*).
15 cases of nephritis confirmedly diagnosed by kidney biopsy
to be related to B-hepatitis + virus, were treated by
systematic typing based on differentiation of syndromes.
Results revealed that 3 cases were remitted, 4 cases markedly
effective, the total effective cases being 13 cases, which is
favorably satisfactory.
1372- gera: 23573/di/ra
[THIRTY-TWO CASES OF CIRRHOTIC ASCITIS
gera 2011

TREATED BY INTEGRATED TCM AND WESTERN
MEDICINE]. SHUANGYIN W ET AL. journal of tcm.
1995;36(8):481 (chi*).
The therapeutic principle include elimination of ascitis first,
followed by nourishing and supporting the body resistance.
The basic recipe for the former was Wuling Powder. The
illness was grouped into five types with respective
modifications of drugs for each type, plus western diuretics,
with supporting therapy for severe cases. After ascitis was
expelled supporting body resistance was given, plus pathogen
eliminating remedies, liver protection drugs and vitamins.
The total effective rate was 87. 5 %
1373- gera: 23918/di/ra
[DR. LU JIDUAN'S EXPERIENCE OF TREATING
LIVER CARCINOMA]. CHIZHI Z. journal of tcm.
1995;36(9):531 (chi).
1374- gera: 23956/di/ra
[OBSERVATION ON T CELL SUBGROUP AND
CHRONIC B-HEPATITIS TREATED WITH SIWCE
(FOUR- INGREDIENTS) DECOCTION WITH RADIX
GINSENG AND RADIX ASTRAGALI SEU
HEDYSARI]. YONGLUO Z ET AL. journal of tcm.
1995;36(9):540 (chi).
1375- gera: 24909/di/ra
[PRELIMINARY STUDY ON REACTIONS OF
AURICULAR POINTS IN PATIENTS WITH
HEPATOLENTICULAR DEGENERATION]. HUIJUN
Z. chinese acupuncture and moxibustion. 1995;15(5):39
(chi).
1376- gera: 25690/di/ra
[CLINICAL RESEARCH ON CHRONIC HEPATITIS B
TREATED WITH 919 SYRUP]. JUN H ET AL. china
journal of traditional chinese medicine and pharmacy.
1995;10(1):17 (chi*).
89 cases of chronic hepatitis B were treated with 919 syrup
which was an experimental remedy. Results : It was superior
to the control group in the aspects of improving symptoms
and physical signs, lowering transaminase. The total effective
rate in the treatment group for chronic persisting hepatitis and
chronic active hepatitis were 89.5 % and 83.9 % respectively;
while they were 69.2 % and 50 % respectively in the control
group.
1377- gera: 26736/di/ra
[PHARMACEUTIC RESEARCH OF THE
TREATMENT OF CHRONIC HEPATITIS B BY
YIHUANG ORAL LIQUID]. SHENGRONG Y ET AL.
china journal of traditional chinese medicine and
pharmacy. 1995;10(3):24 (chi*).
The Yihuang oral liquid of different dosage has obvious
regulation effect on DHT pertaining to DNFB of the normal
mice and can antagonize the increase or decrease of DTH of
mice caused by Cy so as to recover to normal levels. It can
notably inhibit and lift the formation of PFC of mice increase
the formation and secretion of lymphocyte specific antibody,
promote the phagocytic function of peritoneal macrophage of
mice and increase the weight of thymus gland and spleen of
mice. When medicine is taken long with larger dosage, it
shows the protection effect on hepatic injury caused by
carbon tetrachloride, may decrease the activity of serum ALT
and AST, lighten the fatty degeneration and necrosis of
hepatic cells, promote the albumin formation in chronic
hepatic injury and lessen the fibrosis of hepatic tissues.
1378- gera: 50649/di/ra
[46 CASES OF FATTY LIVER TREATED BY MEANS
80
OF SYNDROME DIFFERENTIATION]. GUOKE Y ET
AL. china journal of traditional chinese medicine and
pharmacy. 1995;10(6):31 (chi).
1379- gera: 51406/di/ra
[A BRIEF COMMENT ON SINO-KOREA
SYMPOSIUM OF HEPATOBILIARY DISEASES].
NIANCONG C. china journal of traditional chinese
medicine and pharmacy. 1995;10(6):47 (chi).
1380- gera: 52415/di/ra
[ASSESSMENT OF THERAPEUTIC EFFECTIVENESS
OF TCM ON VIRAL HEPATITIS]. LIHUA C. journal of
traditional chinese medicine. 1995;36(10):621 (eng).
1381- gera: 53679/nd/re
HEPATITIS INDUCED BY TRADITIONAL CHINESE
HERBS; POSSIBLE TOXIC COMPONENTS. . KANE
JA ET AL. gut. 1995;36(1):146-7 (eng).
Traditional Chinese herbal remedies are widely available in
the United Kingdom for the treatment of chronic skin
disorders. Their benefits are considerable, but their use is
completely unregulated. Two patients are described here who
suffered an acute hepatitic illness related to taking traditional
Chinese herbs. Both recovered fully. The mixtures that they
took included two plant components also contained within
the mixture taken by a previously reported patient who
suffered fatal hepatic necrosis. These cases high-light the
need for greater awareness of both the therapeutic and toxic
potential of herbal remedies, as well as greater control of
their use.
1382- gera: 53836/nd/re
EFFECT OF A LIGNAN-ENRICHED FRUCTUS
SCHISANDRAE EXTRACT ON HEPATIC
GLUTATHIONE STATUS IN RATS : PROTECTION
AGAINST CARBON TETRACHLORIDE TOXICITY. .
KO KM ET AL. planta med. 1995;61(2):134-7 (eng).
The effect of a lignan-enriched extract of the fruits of
Schisandra chinensis (FS) on hepatic glutathione (GSH)
status was examined in both control and carbon tetrachloride
(CCl4)-treated rats. FS treatment caused a dose- dependent
enhancement in hepatic GSH status, as evidenced by
significant increases in hepatic GSH level and activities of
hepatic glucose-6-phosphate and glutathione reductase
(GRD), as well as a decreased susceptibility of hepatic tissue
homogenates to in vitro peroxide-induced GSH depletion.
The beneficial effect of FS treatment on hepatic GSH status
became more evident after CCl4 challenge. Pretreating rats
with FS extract at increasing daily doses ranged from 0. 2 to
3. 2 g/kg for 3 days caused a dose-dependent protection
against the CCl4-induced impairment in hepatic GSH status.
The enhancement in hepatic GSH status was associated with
corresponding decreases in tissue malondialdehyde levels and
plasma alanine aminotransferases activities, indicating a
significant reduction in the extent of oxidative hepatocellular
damage. Our results indicate that the molecular mechanism
of hepatoprotection afforded by FS pretreatment may involve
the facilitation of GSH regeneration via
1383- gera: 54146/di/ra
[OBSERVATION OF 1198 CASES OF CHRONIC
HEPATITIS B TREATED WITH SERIAL
KANGGYGAN CO.POWDER]. GOU SHENGLIANG ET
AL. journal of traditional chinese medicine. 1995;36(2):89
(eng).
1384- gera: 54159/nd/ra
EXPERIMENTELLE EMBOLISATION
UNTERSCHIEDLICHER HEPATISCHER GEFASSE
gera 2011

BEIM HUND MIT BLETILLA STRIATA. . FENG XS ET
AL. journal of tongji medical university. 1995;15(1):45-9
(deu*).
[Experimental studies of embolization of different
hepatotropic blood vessels using Bletilla striata in dogs].
1385- gera: 54251/di/ra
ANTI-INFLAMMATORY AND
HEPATOPROTECTIVE EFFECTS OF SOLANUM
ALATUM. . LIN CC ET AL. american journal of chinese
medicine. 1995;23(1):65-9 (eng).
Solanum alatum aqueous extract was investigated on
carrageenin-induced edema and on CCl4-induced liver
injury. The extract (100 or 200 mg/kg body weight) exhibited
both anti-inflammatory and hepatoprotective activities. The
effects were more prominent at the dose of 200 mg/kg.
Histological changes such as necrosis, fatty changes,
ballooning degeneration, and inflammatory infiltration of
lymphocytes and Kupffer cells around the central veins were
concurrently improved by treatment with the S. alatum
aqueous extract.
1386- gera: 54252/di/ra
PREVENTIVE EFFECT OF DAI-SAIKO-TO (DA-
CHAI-HU-TANG) EXTRACT ON DISRUPTED
HEPATIC ACTIVE OXYGEN METABOLISM IN
RATS WITH CARBON TETRACHLORIDE-INDUCED
LIVER INJURY. . OHTA Y ET AL. american journal of
chinese medicine. 1995;23(1):53-64 (eng).
In order to clarify the preventive action of Dai-Saiko-to (Da-
Chai-Hu-Tang) extract (TJ-8) on the progression of acute
liver injury in rats intoxicated with carbon tetrachloride
(CCl4), we examined the effect of post-oral TJ-8
administration on hepatic active oxygen metabolism
following the progression of this liver damage. When TJ-8
(1. 0 g/kg body weight) was administered orally to male
Wistar rats aged five weeks 2 hrs after i. p. injection of CCl4
(1. 0 ml/kg body weight), an apparent liver injury occurred.
Significant prevention against the progression of liver injury
was found at 24 hrs after injection, judging from the activities
of serum transaminases, indexes of liver cell damage. Liver
cytosolic superoxide dismutase (SOD) activity decreased 2
and 24 hrs after CCl4 injection, while liver cytosolic catalase
and glutathione reductase (GSSG-R) activities decreased 24
hrs after the injection. At 2 and 24 hrs after CCl4 treatment,
liver cytosolic Se-containing glutathione peroxidase (GSH-
px) activity did not change and liver cytosolic glucose-6-
phosphate dehydrogenase (G-6-PDH) activity increased.
Post-oral TJ-8 administration significantly ameliorated
decreases in liver SOD, catalase, and GSSG-R activities at 24
hrs after CCl4 injection, but did not affect liver Se-GSH-px
and increased liver G-6-PDH activities at 24 hrs after the
injection. Although increased liver lipid peroxide level and
decreased liver reduced glutathione and ascorbic acid levels
were observed 2 and 24 hrs after CCl4 injection, post-oral
TJ-8 administration significantly prevented these changes
found at 24 hrs after injection. These results indicate that
post-oral TJ-8 administration can prevent the progression of
acute liver injury in CCl4-injected rats by inhibiting
enhanced lipid peroxidation and by improving disrupted
active oxygen metabolism in the injured liver.
1387- gera: 54270/nd/re
[PROTECTIVE EFFECTS OF THE STEM OF
BERCHEMIA RACEMOSA SIEB. ET ZUCC. ON
EXPERIMENTAL LIVER INJURIES]. SATO N ET AL.
yakugaku zasshi. 1995;115(4):295-306 (jap*).
The methanol extract and water extract from the stem of
Berchemia racemosa (Rhamnaceae) showed protective
effects on liver injuries induced by carbon tetrachloride
81
(CCl4) and alpha-naphthylisothiocyanate (ANIT) in rats. The
acetone extract of B. racemosa protected the liver injury
induced by CCl4. One of the protective substances was
identified as carpusin. Some fractions showed significant
protective effects against the liver injury and
1388- gera: 54284/nd/re
SUPPRESSION OF LIVER CYTOCHROME P450 BY
ALPHA-HEDERIN : RELEVANCE TO
HEPATOPROTECTION. . LIU J ET AL. toxicol appl
pharmacol. 1995;134(1):124-31 (eng).
This study was designed to determine the protective effects
of alpha-hederin on chemical-induced liver injury in CF-1
mice and to evaluate cytochrome P450 suppression by alpha-
hederin as a means of protection. alpha- Hederin pretreatment
(30 mumol/kg, sc x 3 days) protected mice from
acetaminophen-, bromobenzene-, carbon tetrachloride-,
furosemide-, and thioacetamide-induced liver injury, without
affecting the hepatotoxicity of chloroform and
dimethylnitrosamine. To examine the role of P450 in
hepatoprotection by alpha-hederin, liver microsomes were
prepared 24 hr following the last dose of alpha-hederin
treatment (10 and 30 mumol/kg, sc x 3 days). Treatment of
mice with alpha-hederin produced a dose-dependent
suppression of liver cytochrome P450 (30-50%) and
cytochrome b5 (20-30%) levels, as well as NADPH-
cytochrome c reductase activity (15-25%). alpha- Hederin
treatment also decreased the activities of P450 enzymes, such
as 7-ethoxyresorufin O-dealkylation (65%), 7-
pentoxyresorufin O-dealkylation (50%), coumarin 7-
hydroxylation (40%), 7-ethoxycoumarin O-deethylation
(45%), caffeine N3-demethylation (30-50%), chlorzoxazone
6-hydroxylation (35-55%), and the oxidation of testosterone
to 2 alpha-, 6 alpha-, 15 alpha-, 15 beta-, 16 alpha-, 16 beta-,
and 18/12 alpha-hydroxyltestosterone, androstenedione, and
6-dehydroxytestosterone (25-60%). Consistent with these
observations, the levels of CYP1A, CYP2A, and CYP3A
enzymes were also suppressed, as determined by
immunoblotting with antibodies against rat P450 enzymes.
These results demonstrate that treatment of mice with alpha-
hederin decreases the levels and activities of several P450
enzymes. The suppression of P450 appears to be one of
mechanisms by which alpha- hederin protects mice from the
hepatotoxicity of some chemicals.
1389- gera: 54290/nd/re
REGULATION OF HEPATIC MACROPHAGE
FUNCTION BY ORAL ADMINISTRATION OF XIAO-
CHAI-HU-TANG (SHO-SAIKO-TO, TJ-9) IN RATS.
FUJIWARA K ET AL. j ethnopharmacol. 1995;46(2):107-
14 (eng).
The effect of Xiao-Chai-Hu-Tang (Sho-saiko-to, TJ-9), the
extract of a mixture of 7 herbs, on hepatic macrophage
function was studied using rats. Hepatic macrophages were
activated by injection of Corynebacterium parvum or 70%
partial hepatectomy. Oral administration of TJ-9 for 3 weeks
did not affect the ability of these macrophages to produce
superoxide anions evaluated in situ by liver perfusion with
nitro blue tetrazolium (NBT) and phorbol myristate acetate
(PMA). However, the similar administration of TJ-9
attenuated the blocking of the activation after partial
hepatectomy produced by pretreatment with gum arabic, a
polysaccharide of high molecular weight. When gum arabic
was added to the medium of rat hepatic macrophages
cultured with normal rat sera, their ability to produce
superoxide anions was reduced in a dose-related manner.
This reduction was attenuated by changing the sera to the
sera obtained from rats given oral doses of TJ-9 for 3 weeks.
These results suggest that TJ-9 may
gera 2011

1390- gera: 54308/di/ra
[EXPERIMENTAL STUDY ON ANTI-DUCK
HEPATITIS B VIRAL EFFECT OF PHYLLANTHUS
URINARIA OF DIFFERENT AREAS AND COMBINED
THERAPY WITH OTHER DRUGS]. CHEN YA-XI ET
AL. chinese journal of integrated traditional and western
medicine. 1995;15(4):225-7 (chi*).
The duck hepatitis B virus model was treated with
phyllanthus urinaria of different area and combined with
Sophora flavesceus as well as ciprofloxacin once a day for
one month, the results indicated: Guangxi and Yunnan
Phyllanthus could lower the serum DHBV DNA significantly
(P < 0. 05), but Chongqing Phyllanthus couldn't. And the
amount of serum DHBV DNA rose a week after stopping of
Yunnan Phyllanthus. The antiviral effect of Guangxi
Phyllanthus combined with ciprofloxacin seems to be
strengthened (P < 0. 05).
1391- gera: 54315/di/ra
[CLINICAL STUDY OF TCM-WM ON APLASTIC
ANEMIA COMPLICATED WITH HEPATITIS C]. LIU
QING-CHI ET AL. chinese journal of integrated
traditional and western medicine. 1995;15(4):198-201
(chi*).
The testing kit of second generation for serum anti-HCV was
used in 82 cases of aplastic anemia (AA). The results showed
that positive rate was 69. 4% (43/62) in the patients of AA
with transfusion, this was significantly higher than that in the
patients of AA without transfusion. There was no difference
of anti-HCV antibody positive rate between chronic AA and
acute AA (P > 0. 05), incidence rate of post-transfusion
hepatitis C (PTHC) in AA was 33. 9% (21/62), among which
the incidence rate in acute and chronic AA were 68. 8%
(11/16) and 21. 7% (10/46) respectively (P < 0. 01). The anti-
HCV positive patients were divided into two groups: PTHC
and non-PTHC, there was no statistical difference of their
transfusion volume, hemoglobin, white blood cell between
these groups. Response rate of AA was lower in anti-HCV
positive patients than that in negative patients (P < 0. 05).
Acute, icteric PTHC was predominant in patients with AA.
The patients with AA complicated with PTHC was liable to
bleed and be infected. PTHC has been an important
complication in patients with AA. The better response was
1392- gera: 54366/di/ra
[PROTECTIVE EFFECT OF THE
FULVOTOMENTOSIDES ON PARACETAMOL-
INDUCED HEPATOTOXICITY IN MICE]. SHI JZ ET
AL. acta pharmaceutica sinica. 1995;30(4):311-4 (chi*).
Fulvotomentoside alpha-hederin (H) and sapindoside B (S)
are two components of the fulvotomentosides reported to
decrease the toxicity of a number of hepatotoxins in mice.
We studied the effects of the mixture of alpha- hederin and
sapindoside B (HS) on paracetamol (Par)-induced liver
injury. HS (20 mg. kg-1 sc twice) was shown to decrease the
mortality produced by Par. The liver injury produced by Par
was remarkably decreased as indicated by decrease of sGPT
and by histopathological examination. Additionally, HS
mitigated the hepatic GSH depletion caused by Par. Par
excretion into urine was increased following HS.
1393- gera: 54448/di/ra
EFFECTS OF GINSENG ON THE BLOOD
CHEMISTRY PROFILE OF DEXAMETHASONE-
TREATED MALE RATS. . LIN JH ET AL. american
journal of chinese medicine. 1995;23(2):167-72 (eng).
Ginseng, a panacea in the Orient, has been widely
investigated in the last two decades and found to possess a
wide range of pharmacological activities including anti-
fatigue properties, a transient regulatory action on
82
metabolism and blood pressure, and an increase in the
hypothalamo-pituitary-adrenocortical activities. However, a
panoramic clinical chemistry study including adrenal and
thyroid functions has never been done before. Two
experiments with the same design but different
concentrations of dexamethasone were performed in this
study. The results obtained from the two experiments
indicated that ginseng administration at this regime did not
influence the blood chemistry profiles in normal rats, but
significantly decreased AST and ALT levels from those in
dexamethasone-treated ones. It implies that ginseng has a
liver-protective effect. Meanwhile, ginseng therapy restores
the adrenal and thyroid functions of rats inhibited by
dexamethasone treatment.
1394- gera: 54452/di/ra
ACUPUNCTURE PROTECTION AGAINST
EXPERIMENTAL HYPERBILIRUBINEMIA AND
CHOLANGITIS IN RATS. . LIN JG ET AL. american
journal of chinese medicine. 1995;23(2):131-7 (eng).
Effects of acupuncture on experimental hyperbilirubinemia
and cholangitis were studied in male rats (n = 33). The
experimental group were treated with acupuncture, 18, 12
and 6 hr prior to and 6, 12 and 18 hr after oral administration
of alpha-napthylisothiocyanate (ANIT, 100 mg per Kg). Rats
were sacrificed 48 hours after challenge. Serum and liver
samples were taken for biochemical and histological analysis,
respectively. Results of this study revealed that rats treated
with ANIT exhibited elevations in bilirubin, SGOT and
SGPT as well as cholangitis. In rats receiving acupuncture
and ANIT, biochemical and morphological parameters of
liver injury were significantly reduced. Acupuncture therapy
may be able to prevent ANIT-induced hyperbilirubinemia
and
1395- gera: 54475/nd/re
HERBS OF THE GENUS PHYLLANTHUS IN THE
TREATMENT OF CHRONIC HEPATITIS B :
OBSERVATIONS WITH THREE PREPARATIONS
FROM DIFFERENT GEOGRAPHIC SITES. . WANG M
ET AL. j lab clin med. 1995;126(4):350-2 (eng).
It has been suggested that herbs of the Phyllanthus family
may have antiviral activity. We therefore tested the effects of
three different Phyllanthus extracts on the serologic status of
123 patients with chronic hepatitis B. Eleven patients
received an extract of Phyllanthus amarus (L) provided by S.
P. Thyagarajan, Madras, India. Forty-two patients received
Phyllanthus niruri (L), gathered from Hainan Province in
China, and 35 patients received an extract of Phyllanthus
urinaria (L), which had been gathered in Henan Province.
Thirty-five control patients received no herbal therapy. The
patients receiving Phyllanthus urinaria (L) were both more
likely to lose detectable hepatitis B e-antigen from their
serum and more likely to seroconvert hepatitis B e-antibody
status from negative to positive than were patients given
either of the other two preparations. No patient changed
status with
1396- gera: 54543/nd/re
ACTIVE COMPOUNDS FROM SAUSSUREA LAPPA
CLARKS THAT SUPPRESS HEPATITIS B VIRUS
SURFACE ANTIGEN GENE EXPRESSION IN
HUMAN HEPATOMA CELLS. . CHEN HC ET AL.
antiviral res. 1995;27(1-2):99-109 (eng).
We have examined the antiviral activity of the crude extract
prepared from the root of Saussurea lappa Clarks, a Chinese
medicinal herb which is widely used for many illnesses
including cancer. Two active components, costunolide and
dehydrocostus lactone, were identified which show strong
suppressive effect on the expression of the hepatitis B surface
gera 2011

antigen (HBsAg) in human hepatoma Hep3B cells, but have
little effect on the viability of the cells. Both costunolide and
dehydrocostus lactone suppress the HBsAg production by
Hep3B cells in a dose- dependent manner with IC50s of 1. 0
and 2. 0 microM, respectively. Northern blotting analysis
shows that the suppression of HBsAg gene expression by
both costunolide and dehydrocostus lactone were mainly at
the mRNA level. Furthermore, the suppressive effect of
costunolide and dehydrocostus lactone on HBsAg and
hepatitis B e antigen (HBeAg), a marker for hepatitis B viral
genome replication in human liver cells, was also observed in
another human hepatoma cell line HepA2 which was derived
from HepG2 cells by transfecting a tandemly repeat hepatitis
B virus (HBV) DNA. Similarly, the mRNA of HBsAg in
HepA2 cells was also suppressed by these two compounds.
Our findings suggest that costunolide and dehydrocostus
lactone may have potential to develop as specific anti-HBV
drugs in the future.
1397- gera: 54556/nd/re
EFFECT OF SCHISANDRIN B ON HEPATIC
GLUTATHIONE ANTIOXIDANT SYSTEM IN MICE :
PROTECTION AGAINST CARBON
TETRACHLORIDE TOXICITY. . IP SP ET AL. planta
med. 1995;61(5):398-401 (eng).
Pretreating female Balb/c mice with schisandrin B (Sch B) at
increasing daily doses (1-4 mmol/kg) for 3 days caused dose-
dependent increases in hepatic glutathione S-transferase
(GST) and glutathione reductase (GRD) activities. However,
the activities of glucose-6-phosphate dehydrogenase
(G6PDH), Se-glutathione peroxidase (GPX), and gamma-
glutamylcysteine synthetase (GCS) were down-regulated to
varying degrees in a dose- dependent manner. While there
were biphasic changes in hepatic reduced glutathione (GSH)
level as well as susceptibility of hepatic tissue homogenates
to in vitro peroxide-induced GSH depletion, a gradual
decrease in hepatic malondialdehyde content was observed.
The beneficial effect of Sch B on the hepatic GSH anti-
oxidant system became more evident after CCl4 challenge.
The same Sch B pretreatment regimen caused a dose-
dependent protection against carbon tetrachloride (CCl4)-
induced hepatotoxicity. The hepatoprotection was associated
with significant enhancement in hepatic GSH status, as
indicated by the substantial increase in tissue GSH levels and
the corresponding decrease in susceptibility of tissue
homogenates to GSH depletion. Where the activities of GST
and GRD were increased linearly over non-CCl4 control
values, there was also a gradual elevation in G6PDH activity
upon administration of increasing doses of Sch B. In contrast,
GPX activity was moderately down-regulated. The ensemble
of results suggests that the hepatoprotection afforded by Sch
B pretreatment may mainly be attributed to the enhancement
in the functioning of the hepatic GSH anti-oxidant system,
possibly through stimulating the activities of GSH related
enzymes.
1398- gera: 54557/nd/re
FRUCTUS AURANTII REDUCED PORTAL
PRESSURE IN PORTAL HYPERTENSIVE RATS. .
HUANG YT ET AL. life sci. 1995;57(22):2011-20 (eng).
The purpose of this study was to investigate the effects of
Fructus Aurantii (the unripe fruits of Citrus aurantium L. ) on
portal hypertensive rats. Portal hypertension was induced by
partial portal vein ligation (PVL) in Sprague- Dawley rats.
Sham-operated (Sham) rats served as controls. Hemodynamic
and in vitro contractile studies were performed at 14 days
after surgery. Both the aqueous extract of Fructus Aurantii
and synephrine, one of its purified principles with pressor
activity, were infused into the conscious PVL and Sham rats
via a syringe pump. Fructus Aurantii (1. 25, 2. 5, & 5. 0
83
mg/kg/min) dose-dependently reduced portal pressure in PVL
and Sham rats, with the percentage change in portal pressure
more pronounced in PVL rats. Mean arterial pressure was
dose-dependently elevated by Fructus Aurantii. Synephrine
(0. 095, 0. 19, & 0. 38 mg/kg/min) also dose-dependently
reduced portal pressure and elevated mean arterial pressure in
PVL and Sham rats. Fructus Aurantii (2. 8-280 ¦gs/ml)
induced dose-dependent contractile responses mainly in aorta
and mesenteric artery, but little response in portal vein. The
results showed that Fructus Aurantii infusion reduced portal
pressure, possibly by way of arterial vasoconstriction.
1399- gera: 54558/nd/re
PHARMACOLOGICAL EFFECTS OF DAI-SAIKO-TO
ON LIPID BIOSYNTHESIS IN CULTURED HUMAN
HEPATOCYTE HEPG2 CELLS. . YAMAMOTO K ET
AL. j ethnopharmacol. 1995;46(1):49-54 (eng).
The pharmacological effects of Dai-saiko-to, a Japanese and
Chinese traditional medicinal mixture (Kampohozai), on lipid
biosynthesis were investigated in cultured human hepatocyte
HepG2 cells. The addition of Dai-saiko-to (0. 5 mg/ml),
which had no significant effect on cell proliferation, caused a
marked decrease in the intracellular triglyceride content with
no significant changes in the other lipid fraction. At the same
time, the incorporation of 14C-acetate or 3H-glycerol into the
triglyceride or diglyceride fractions also decreased
significantly. These results suggest that Dai-saiko-to
decreases hepatic triglyceride biosynthesis, which might
contribute to a reduction in
1400- gera: 54580/di/ra
[LIVER-PROTECTING AND ALT LOWERING
ACTIONS OF HONGNING GANTAI]. CHEN YI ET AL.
china journal of chinese materia medica. 1995;20(5):299-
300, (chi*).
Hongning Gantai has a remarkable counteraction on the
elevation of ALT activity of mice and rats induced by
chemical damages with CCl4 and D-Gal. It can decrease the
BSP-retention. The result of pathologic examination indicates
that Hongning Gantai can alleviate liver damages of mice and
rats and thus has liver-protecting and
1401- gera: 54627/nd/ra
PROTECTIVE AND THERAPEUTIC EFFECTS OF
CURCUMA XANTHORRHIZA ON HEPATOTOXIN-
INDUCED LIVER DAMAGE. . LIN SC ET AL. american
journal of chinese medicine. 1995;23(3-4):243-54 (eng).
Curcuma xanthorrhiza Roxb. (Zingiberaceae family,
commonly known as temu lawak or Javanese turmeric in
Indonesia), which is found both wild and cultivated in
Indonesia, has been traditionally used for medicinal purposes.
C. xanthorrhiza is also used as a tonic in Indonesia. The aim
of the present study is to clarify whether C. xanthorrhiza
treatment may prevent acute liver damage induced by
acetaminophen and carbon tetrachloride in mice. The results
clearly indicated that extract of C. xanthorrhiza could reduce
significantly the acute elevation of serum transaminases
levels induced by the two kinds of hepatotoxins, and
alleviated the degree of liver damage at 24 hours after the
intraperitoneal administration of two hepatotoxins. It may be
concluded that C. xanthorrhiza can protect the liver from
various hepatotoxins, hence C. xanthorrhiza could be useful
in the treatment of liver injuries and has promise as a kind of
broad spectrum hepatoprotective agent.
1402- gera: 54707/nd/re
PROSPECTIVE STUDY OF CHEMOPREVENTION
OF HEPATOCELLULAR CARCINOMA WITH SHO-
SAIKO-TO (TJ- 9). . OKA H ET AL. cancer.
1995;76(5):743-9 (eng).
gera 2011

BACKGROUND. Most hepatocellular carcinomas (HCC)
arise in patients with cirrhosis, in whom its incidence is high.
The prevention of HCC in patients with cirrhosis is
important. METHODS. A prospective, randomized, nonblind
controlled study was performed to evaluate the preventive
effect of Sho-saiko-to (TJ-9) on HCC development. TJ-9 is a
Chinese herbal medicine that contains crude extracts of seven
herbs; it has antitumor effects in experimental animals. Two
hundred sixty patients with cirrhosis were randomly assigned
to two groups, matched for age, sex, presence of hepatitis B
surface antigen, and the severity of liver damage. The
patients in the trial group were given TJ-9 at a daily oral dose
of 7. 5 g in addition to the conventional drugs given to the
control patients. The patients were prospectively monitored
for 60 months and the cumulative incidence of HCC and the
survival rate in the two groups were calculated. RESULTS.
The cumulative incidence curve for 5 years of the trial group
was lower than that of the control group (P = 0. 071). For the
patients without HBs antigen, the difference was significant
(P = 0. 024). The survival curve for 5 years of the trial group
was higher than that of the control group (P = 0. 053). For the
patients without HBs antigen, the difference was significant
(P = 0. 043). CONCLUSIONS. TJ-9 helped to prevent the
development of HCC in patients with cirrhosis, particularly
in patients without HBs antigen.
1403- gera: 54796/nd/re
[REVERSING EFFECT OF DIMETHYL-4, 4'-
DIMETHOXY-5, 6, 5'6'-DIMETH
YLENEDIOXYBIPHENYL-2, 2'-
DICARBOXYLATE(DDB) ON THE PHENOTYPES OF
HUMAN HEPATOCARCINOMA CELL LINE]. LIU Z
ET AL. chung hua i hsueh tsa chih. 1995;75(11):676-8, 7
(chi).
When human Bel-7402 hepatocarcinoma cell line grew in a
medium containing 10(-4)M DDB, the secretion of alpha-
fetoprotein (AFP) and the activity of gamma-glutamyl-
transpeptidase (gamma-GT) were significantly lower than the
control cells, whereas the albumin (ALB) secretion and the
activity of tyrosine-alpha-ketoglutarate transaminase (TAT)
were markedly increased. DDB at the concentration of 10(-
4)M could significantly increase the content of cAMP in Bel-
7402 cells, and also suppressed the expressions of oncogene
c-myc and hepatocarcinoma marker AFP gene and enhanced
the anti-oncogene p53 expression. The results of this paper
suggest that DDB has some reversing effects on the
phenotypes of human Bel-7402 hepatocarcinoma cell line.
1404- gera: 54824/di/ra
[PRELIMINARY STUDY ON EARLY FIBROSIS OF
CHRONIC HEPATITIS B TREATED WITH GINKGO
BILOBA COMPOSITA]. LI WEI ET AL. chinese journal
of integrated traditional and western medicine.
1995;15(10):593-5 (chi).
The purpose of this paper was to study the effect of Ginkgo
biloba Composita (GBC) on liver collagen fibrosis. The 86
patients were suffering from chronic persistent and active
hepatitis B with early fibrosis confirmed by liver biopsy.
Serum pro-collagen-III-peptide (PIIIP), laminin (LN),
superoxide dismutase (SOD), malonyldialdehyde (MDA)
were determined and some patients' biopsies examined with
light and electron microscope before and after treatment were
observed. By the end of 3 months, the results showed that
PIIIP, LN, SOD, MDA were significantly decreased after
GBC treatment (P < 0. 01) and liver fibrosis of patients was
partly reabsorbed and had remission. It was suggested that
GBC was effective in arresting the development of liver
fibrosis of chronic hepatitis.
1405- gera: 54844/di/ra
84
[PROTECTIVE EFFECTS OF LIU TEA ON CCL4
INJURED LIVER AND ITS WORKING
MECHANISM]. WANG XIAOLI ET AL. china journal of
chinese materia medica. 1995;20(12):746-8, 7 (chi).
Liu Tea can effectively prevent the elevation of SGPT and
SGOT induced by CCl4 in mice, reduce MDA and elevate
GSH and GSH-px levels. It also induces the anabolism of
microsomal protein and hepatocyte microsomal cytochrome
P-450. These results suggest that Liu Tea has protective
effects on the liver, which may be related to the clearing of
free radicals and inhibition of lipid peroxidation.
1406- gera: 56157/di/ra
INDUCTION OF GAMMA INTERFERON AND
INTERLEUKIN-2 BY ACUPUNCTURE IN
ASYMPTOMATIC HEPATITIS- B VIRUS CARRIERS.
WANG XIN-YAO. international journal of clinical
acupuncture. 1995;6(2):129-32 (eng).
1407- gera: 60947/di/ra
[PROBING THERAPEUTIC COUNTER-MEASURES
FOR C-HEPATITIS]. CHENGBO W. journal of
traditional chinese medicine. 1995;36(11):691 (eng).
1408- gera: 66739/di/ra
[OBSERVATION OF THE TONGUE PICTURE OF 295
CASES HEPATITIS B AND THE ASYMPTOMATIC
VIRUS CARRIERS]. XIA JUNQUAN. liaoning journal of
traditional chinese medicine. 1995;22(7):310 (chi).
1409- gera: 66755/di/ra
[RELATIONSHIP BETWEEN VARIABLE
IMPORTANCE OF SERUM HAGG OF CHRONIC
HEPATITIS B PATIENTS AND TYPOLOGY
ACCORDING TO DIFFERENTIATION OF
SYMPTOMS AND SIGNS]. ZHANG BUO ET AL.
liaoning journal of traditional chinese medicine.
1995;22(9):390 (chi).
1410- gera: 66837/di/ra
[CASE_CONTROL STUDY OF INTERMEDIATE &
LATE LIVER CANCER BY AT_2]. MA YONGYUAN
ET AL. fujian journal of traditional chinese medicine.
1995;26(4):10 (chi).
1411- gera: 66868/di/ra
[YAO YULAN'S EXPERIENCE IN TREATMENT OF
CHRONIC HEPATITIS]. ZHANG YASHENG. shanghai
journal of traditional chinese medicine. 1995;4:17 (chi).
1412- gera: 66872/di/ra
[DIFFERENTIATION AND TREATMENT IN TCM OF
28 CASES OF INFANTILE POSTHEPATITIC
SYNDROME]. NI JUXIOU. shanghai journal of
traditional chinese medicine. 1995;4:31 (chi).
1413- gera: 66886/di/ra
[CLINICAL OBSERVATION ON HUAI ER CHONG JI
IN TREATING 275 CASES OF PRIMARY HEPATIC
CANCER]. X. shanghai journal of traditional chinese
medicine. 1995;3:30 (chi).
1414- gera: 66889/di/ra
[A CLINICAL COMPARISON BETWEEN "QUDU
BAOGAN TANG" AND ACICLOVIRI TABLETS IN
THEIR EFFECT OF HBEAG NEGATIVE
TRANSFORMATION]. XU JIANZHONG ET AL.
shanghai journal of traditional chinese medicine. 1995;2:2
(chi).
gera 2011

1415- gera: 66890/di/ra
[THE EFFECT OF "BU SHEN FANG" ON MICE'S
HISTOCHEMISTRY AND ULTRASTRUCTURE OF
PRIMARY HEPATIC CELLS]. CHEH JIANJIE ET AL.
shanghai journal of traditional chinese medicine. 1995;2:4
(chi).
1416- gera: 66891/di/ra
[CLINICAL OBSERVATION ON ASCITES DUE TO
CIRRHOSIS TREATED WITH OVERDOSES OF
RHIZOMA ATRACTYLODIS MACROCEPHALAE].
JIANG SEN ET AL. shanghai journal of traditional
chinese medicine. 1995;2:6 (chi).
1417- gera: 66906/di/ra
[CLINICAL OBSERVATION ON 210 CASES OF
CHRONIC HEPATITIS B TREATED WITH "THREE
THERAPEUTIC METHODS FOR CHB"]. LU JI.
shanghai journal of traditional chinese medicine.
1995;1:15 (chi).
1418- gera: 66925/di/ra
[TREATMENT OF 30 CASES OF VIRUS HEPATITIS E
WITH THE METHOD OF CLEARING AWAY HEAT,
ELIMINATING DAMPNESS AND PROMOTING
BLOOD CIRCULATION TO REMOVE BLOOD
STASIS]. WANG YUNONG ET AL. shanghai journal of
traditional chinese medicine. 1995;5:9 (chi).
1419- gera: 66926/di/ra
[ZHANG JUNFU'S EXPERIENCE IN TREATING
SEVERE HEPATITIS AND JAUNDICE]. CUI LIAN.
shanghai journal of traditional chinese medicine.
1995;5:11 (chi).
1420- gera: 66927/di/ra
[CLINICAL AND EXPERIMENTAL STUDY OF
INFANTILE HEPATITIS SYNDROME TREATED
WITH THE MIXTURE OF NORMALIZING THE
FUNCTION OF THE GALLBLADDER TO PROTECT
THE LIVER]. YU JIAN ET AL. shanghai journal of
traditional chinese medicine. 1995;5:13 (chi).
1421- gera: 67051/di/ra
[APPLICATION OF THE METHOD OF
REINFORCEMENT AND ELIMINATION IN
COMBINATION TO TREATING RECURRENT AND
REFRACTORY ASCITES DUE TO CIRRHOSIS].
ZHANG CUNYI ET AL. shanghai journal of traditional
chinese medicine. 1995;12:6 (chi).
1422- gera: 67065/di/ra
[TREATMENT OF EMBOLISM-INVOLVED
HEPATOCARCINOMA SYNDROME WITH
COMBINED CHINESE AND WESTERN MEDICINES].
LIN JUNHUA ET AL. shanghai journal of traditional
chinese medicine. 1995;10:16 (chi).
1423- gera: 67066/di/ra
[A RESEARCH ON SEVERAL PROBLEMS ABOUT
ACUTE ICTEROHEPATITIS]. ZHANG PEIFENG.
shanghai journal of traditional chinese medicine.
1995;10:18 (chi).
1424- gera: 67080/di/ra
[OBSERVATION OF EFFECT OF YI GAN YI HAO ON
IMMUNOGLOBULIN AND COMPLEMENT C3 IN
CASES OF CHRONIC HEPATITIS]. LONG ZHIPING
ET AL. shanghai journal of traditional chinese medicine.
1995;7:22 (chi).
85
1425- gera: 67085/di/ra
[A SURVEY OF EXPERIMENTAL STUDY OF
PREVENTION AND TREATMENT OF FIBROSIS OF
THE LIVER WITH CHINESE MEDICINAL HERBS].
LI ZHAOJIAN. shanghai journal of traditional chinese
medicine. 1995;7:44 (chi).
1426- gera: 67093/di/ra
[RECENT DEVELOPMENT IN TREATING
CIRRHOSIS DUE TO HEPATITIS B WITH CHINESE
MEDICINE]. YAO ZHANGWEI. shanghai journal of
traditional chinese medicine. 1995;6:21 (chi).
1427- gera: 67101/di/ra
[CLINICAL AHD EXPERIMENTAL STUDY OF BILE
GASTRITIS SYNDROME TREATED WITH SELF-
DEVELOPED WEI KANG YIHAO CHONGJI]. NI
KEZHONG ET AL. shanghai journal of traditional
chinese medicine. 1995;11:8 (chi).
1428- gera: 67104/di/ra
[TREATING 30 CASES OF FATTY LIVER WITH
JIANG ZHI HUA ZHUO DECOCTION]. HUA GENMU
ET AL. shanghai journal of traditional chinese medicine.
1995;11:13 (chi).
1429- gera: 67106/di/ra
[EFFECT OF INGREDIENT-ADDED SI NI
DECOCTION UPON SERUM ADENOSINE
DEAMINASE OF HEPATOCIRRHOSIS CASES].
DENG YINQUAN ET AL. shanghai journal of traditional
chinese medicine. 1995;11:16 (chi).
1430- gera: 68960/di/ra
[THE INFLUENCE OF DIFFERENT SYNDROME OF
LIVER CIRRHOSIS ON THE CHANGE OF IG]. ZHU
FANGSHI ET AL. liaoning journal of traditional chinese
medicine. 1995;22(4):159-60 (chi*).
The detention of the seroimmunity globulin's of 79 cirrhotic
patients of 6 syndrome types shows that their IgG , lgA and
IgM rise higher in varying degrees than those of normal
persons. Liver qi depression and spleen qi deficiency type is
the lowest whereas spleen - kidney yang defiance type and
liver - kidney yin defiance types the highest. Our research
discovered that various syndrome types of cirrhosis are in
different conditions of body fluid immunity. Along with the
development of TCM pathological mechanism and the
change of syndrome types, the immunological reaction of
body fluid tends gradually to be active. Seroimmunity
globulin's seem to present progressive increase tendency
from liver qi depression and spleen qi deficiency type of
compensatory phase to water - fluid retention type. spleen -
kidney yang deficiency type and liver - kidney yin deficiency
type of decompensation phase. Therefore, we may consider
the detention indexes of IgG, lgA and IgM as one of the
objective bases for differentiation of symptoms and signs and
the classification of syndrome types of liver cirrhosis.
1431- gera: 68963/di/ra
[45 CASES OF WILSON'S DISEASE TREATED BY
TCM MAINLY]. LIU TIEXIN ET AL. liaoning journal of
traditional chinese medicine. 1995;22(4):168 (chi).
1432- gera: 78760/di/ra
[EFFECT OF KANGXIAN NING ON
CYTOCHEMISTRY IN TREATING SCHISTOSOMIAL
FIBROSIS OF LIVER]. GUO ZHENQIU ET AL. hunan
journal of tcm. 1995;11(6):6 (chi).
gera 2011

1433- gera: 78831/di/ra
[RECENT ACCOUNT OF CHINESE MEDICAL
RESEARCH OF HEPATOCIRRHOSIS]. ZHANG
YOUAN. jiangxi journal of tcm. 1995;26(5):59 (chi).
1434- gera: 78839/di/ra
[OBSERVATION OF CURATIVE EFFECT OF
KANGYUAN JIEDUTANG IN TREATING 92 CASES
OF HEPATITIS VIRUSES B]. ZHANG WEIMING ET
AL. jiangxi journal of tcm. 1995;26(4):22 (chi).
1435- gera: 78848/di/ra
[CLINICAL EXPERIENCE OF USING NOURISHING
YIN FLUID TO TREAT CHRONIC HEPATITIS].
ZANG YONG FENG ET AL. jiangxi journal of tcm.
1995;26(3):25 (chi).
1436- gera: 78894/di/ra
[DIRECTOR GU JI-SHENG'S EXPERIENCE IN THE
TREATMENT OF CHRONIC HEPATITIS B]. ZHANG
JUN-FU. tianjin journal of tcm. 1995;1:1 (chi).
1437- gera: 78927/di/ra
[A STUDY ON THE ACTIVITY OF NK CELLS IN
PATIENTS OF CHRONIC HEPATITIS]. XIE XUE-JUN.
zhejiang journal of tcm. 1995;30(1):38 (chi).
1438- gera: 78947/di/ra
[EXPERIENCE IN TREATMENT OF HEPATITIS BY
QIAO YANG-XIAN]. ZHAO WEI. zhejiang journal of
tcm. 1995;30(4):146 (chi).
1439- gera: 78948/di/ra
[TALKING ABOUT TREATING ASCITES DUE TO
CIRRHOSIS USING THE METHODS FOR
PURGATION AND INVIGORATION]. ZHANG FAN-
DING. zhejiang journal of tcm. 1995;30(4):150 (chi).
1440- gera: 78949/di/ra
[TREATMENT OF 25 CASES OF ALCOHOLIC
CIRRHOSIS WITH "RUAN GAN XIAO SHUI TANG"].
CHEN QUAN-SHOU ET AL. zhejiang journal of tcm.
1995;30(4):149 (chi).
1441- gera: 78950/di/ra
[TREATING 450 CASES OF ACUTE ICTERIC VIRAL
HEPATITIS WITH " PU HU TANG "]. CHEN SHOU-
SHAN. zhejiang journal of tcm. 1995;30(4):148 (chi).
1442- gera: 78960/di/ra
[TREATING 58 CASES OF VOMITUS OF
HEPATOCARCINOMA PATIENTS AFTER
ARTERIAL CATHETER CHEMOTHERAPY WITH
LOPHATHERUM AND GYPSUM DECOCTION]. JIN
PU-FANG. zhejiang journal of tcm. 1995;30(5):200 (chi).
1443- gera: 78970/di/ra
[TREATING 32 CASES OF CHRONIC HEPATITIS B
TOGETHER WITH SICCA SYNDROME WITH
CHINESE DRUGS]. SUN MING-HUI. zhejiang journal of
tcm. 1995;30(6):251 (chi).
1444- gera: 79017/di/ra
[INTRODUCTION ON CHENG QIAN-SHAN'S
EXPERIENCE FOR TREATMENT OF
HEPATOCIRRHOSIS]. CHENG ZAI-ZHI. zhejiang
journal of tcm. 1995;30(10):434 (chi).
1445- gera: 79114/di/ra
[APPROACH ON THE DIAGNOSISING DISEASES
86
THERAPY PASSING STAINING ON PALM]. WANG
JUNHUA. shaanxi journal of traditional chinese medicine.
1995;16(8):354 (chi).
1446- gera: 79115/di/ra
[EXAMPLE OF TREATING HEPATOCIRRHOSIS
ASCITES]. HUA GENCAI ET AL. shaanxi journal of
traditional chinese medicine. 1995;16(8):359 (chi).
1447- gera: 84320/di/ra
[TREATMENT EFFECT OF LIVER-HARMONIZING
AND SPLEEN REINFORCING DECOCTION ON
IMMUNOLOGICAL LIVER INJURY OF MOUSE].
ZHENGYE M ET AL. journal of beijing university of tcm.
1995;18(1):31 (chi).
1448- gera: 84411/di/ra
[PRELIMINARY RESEARCH ON TREATMENT OF
VIRAL HEPATITIS B ACCORDING TO TOXIN AND
DEFICIENCY]. FENGQIANG Z. journal of beijing
university of tcm. 1995;18(5):13 (chi).
1449- gera: 84662/di/ra
[TREATMENT OF 36 CASES OF CHOLESTATIC
HEPATITIS BY AURICULAR-PLASTER THERAPY].
JIEMIN G. shanghai journal of acupuncture and
moxibustion. 1995;14(5):197 (chi).
1450- gera: 84955/di/ra
[EFFECT OF TCM IN COMBINED WESTERN
MEDICINE AND TCM TREATMENT FOR PRIMARY
HEPATIC CARCINOMA]. JUNYU W ET AL. beijing
journal of tcm. 1995;1:16 (chi).
1451- gera: 84972/di/ra
[OBSERVATION ON LONG-TERM FOLLOW-UP
RESULT ON TREATMENT OF CHRONIC
HEPATITIS B WITH ZHI GAN TANG JIAJIAN : A
REPORT OF 188 CASES]. GUOJI H. beijing journal of
tcm. 1995;2:11 (chi).
1452- gera: 84983/di/ra
[LIVER-KIDNEY CORRELATION AND CHRONIC
HEPATOPATHY]. XIUWEN F. beijing journal of tcm.
1995;2:48 (chi).
1453- gera: 85524/di/ra
[TREATMENT OF 32 CASES CIRRHOSIS OF THE
LIVER ASCILES WITH THE METHOD OF
ENRICHING YIN,ANTIPYRETIC AND DIURESIS].
GUO TIE SHENG ET AL. journal of tcm and chinese
materia medica of jilin. 1995;5:6 (chi).
1454- gera: 85525/di/ra
[CLINIC OBSERVATION OF TREATMENT OF
FATTY LIVER BY DIFFERENTIATION OF
SYMPTOMS AND SIGNS]. LI FU ET AL. journal of tcm
and chinese materia medica of jilin. 1995;3:18 (chi).
1455- gera: 85938/di/ra
[PROTECTIVE ACTION OF POLYSACCHARIDE
LIPOSOME OF CORDYCEPS ON LIVER INJURY OF
MICE]. WU GANTONG ET AL. chinese traditional
patent medicine. 1995;17(2):26 (chi).
1456- gera: 85949/di/ra
[INVESTIGATION ON CLINICAL CURATIVE
EFFECT OF ORAL YINZHIHUANG PREPARATION
(HERBA ARTEMISIAE SCOPARIAE,FRUCTUS
GARDENIAE,ETC.) FOR ICTERUS HEPATITIS]. HE
gera 2011

JIE ET AL. chinese traditional patent medicine.
1995;17(7):23 (chi*).
1457- gera: 86035/di/ra
[TREATING ACUTE FATAL HEPATITIS BY
INTEGRATED TRADITIONAL AND WESTERN
MEDICINE]. GAO HAN. journal of zhejiang college of
tcm. 1995;19(5):34 (chi).
1458- gera: 86041/di/ra
[PROFESSOR LU ZHIQING'S EXPERIENCE IN
DIAGNOSIS AND TREATMENT OF HEPATITIS].
CHENG ZHIQING. journal of zhejiang college of tcm.
1995;19(6):30 (chi).
1459- gera: 86391/di/ra
[CLINICAL OBSERVATION ON EXT SALVIA
MILTIORRHIXWA CO AND LIVER CELL GROWTH
FACTOR IN TREATMENT OF CHRONIC HEPATITIS
B]. HUANG RUIJIE. shanxi journal of tcm. 1995;11(6):5
(chi).
1460- gera: 86402/di/ra
[NON-OPERATIVE TREATMENT OF BACTERIAL
LIVER ABSCESS BY COMBINATION OF TCM AND
WESTERN MEDICINE]. CHEN QINGCHUAN ET AL.
shanxi journal of tcm. 1995;11(5):25 (chi).
1461- gera: 86413/di/ra
[INFLUENCE OF QIN KAI LING INJECTION ON
CYTOCHROME P-450 AND LPO OF ISOLATED
LIVER CELLS]. LIANG LIYUN ET AL. shanxi journal
of tcm. 1995;11(4):44 (chi).
1462- gera: 86445/di/ra
[PRELIMINARY OPINION ABOUT VIRUS
HEPATITIS IS NAMED GANWEN (LIVER WARM) IN
TCM]. YU SENSHAN. beijing journal of tcm. 1995;6:12
(chi).
1463- gera: 86450/di/ra
[CLINICAL OBSERVATION OF FATTY LIVER
TREATED BY COMBINATION OF TCM AND
WESTERN MEDICINE: A REPORT OF 32 CASES]. LI
LIN ET AL. beijing journal of tcm. 1995;6:22 (chi).
1464- gera: 86473/di/ra
[DIFFERENTIAL TREATMENT OF TCM FOR 1056
CASES OF HEPATITIS B]. CHE NIANCONG ET AL.
beijing journal of tcm. 1995;5:50 (chi).
1465- gera: 86623/di/ra
[TREATMENT OF PORTAL HYPERTENSION DUE
TO CIRRHOSIS WITH TCM]. HUI XIULI. acta chinese
medicine and pharmacology. 1995;5:24 (chi).
1466- gera: 86649/di/ra
[ZHU MINGLIE'S EXPERIENCE ON TREATMENT
OF HEPATOCIRRHOSIS]. FU XUMEI. hubei journal of
tcm. 1995;17(6):7 (chi).
1467- gera: 86760/di/ra
[LECTURE ON BOTH DIAGNOSIS AND
TREATMENT OF HEPATIC DISEASE BY PROF
GUAN YOU-BO]. ZHAO TIAN-MIN. yunnan journal of
tcm and materia medica. 1995;16(5):4 (chi).
1468- gera: 86765/di/ra
[87 CASES OF CIRRHOSIS TREATED WITH
TRADITIONAL CHINESE MEDICINE FOR ORAL
87
AND EXTERNAL USE]. ZHOU QIN-HUA ET AL.
yunnan journal of tcm and materia medica. 1995;16(5):11
(chi).
1469- gera: 87365/di/ra
[MAN GAN TANG DECOCTION FOR CHRONIC
HEPATITIS]. GUO TAOMEI ET AL. shaanxi journal of
traditional chinese medicine. 1995;16(7):289 (chi).
1470- gera: 87366/di/ra
[SHU GAN LI QI TANG DECOCTION FOR CHRONIC
HEPATITIS B]. BO LIMIN. shaanxi journal of
traditional chinese medicine. 1995;16(7):290 (chi).
1471- gera: 87367/di/ra
[QIANG LI NING DECOCTION FOR CHRONIC
VIRAL HEPATITIS]. BO LIMIN. shaanxi journal of
traditional chinese medicine. 1995;16(7):291 (chi).
1472- gera: 87375/di/ra
[ON YU FU YING'S EXPERIENCE OF TREATING
HEPATITIS]. ZHANG WENJIN. shaanxi journal of
traditional chinese medicine. 1995;16(7):308 (chi).
1473- gera: 87378/di/ra
[ON THE CURRENT SITUATION OF
POLYSACCHAROSE OF CHINESE MATERIA
MEDICA RESISTING] VIRAL HEPATITIS. CAI YI ET
AL. shaanxi journal of traditional chinese medicine.
1995;16(7):330 (chi).
1474- gera: 87412/di/ra
[ON THE EXPERIMENT STUDY OF RECEDING
JAUNDICE AND REDUCING TRANSAMINASE
AFFECTION OF GAN FU XING INSTANT
GRANULES]. SUN XINMIN ET AL. shaanxi journal of
traditional chinese medicine. 1995;16(5):232 (chi).
1475- gera: 87448/di/ra
[KE YI GAN SAN DECOCTION FOR CHRONIC
HEPATITIS B]. WU TIANCAI. shaanxi journal of
traditional chinese medicine. 1995;16(1):1 (chi).
1476- gera: 87454/di/ra
[YI QI HUO XUE THERAPY FOR ASCITIC FLUID OF
HEPATHCIRRHOSIS]. LI FUSHENG ET AL. shaanxi
journal of traditional chinese medicine. 1995;16(1):8 (chi).
1477- gera: 87459/di/ra
[LI QIULI'S EXPERIENCE OF TREATING
HEPATITIS B]. ZHAO FUSHENG. shaanxi journal of
traditional chinese medicine. 1995;16(1):22 (chi).
1478- gera: 87460/di/ra
[BRIEF APPROACH ON CANCEROUS ASCITES
TREATED BY TCM]. MIAO WENHONG. shaanxi
journal of traditional chinese medicine. 1995;16(1):24
(chi).
1479- gera: 87508/di/ra
[INTRODUCTION ABOUT JIAO RUIXIANG
PROFESSOR'S LEARNING THOUGHT FOR LIVER
DISEASES]. XIE JIANGUO ET AL. shaanxi journal of
traditional chinese medicine. 1995;16(2):73 (chi).
1480- gera: 88304/di/ra
[41 CASES OF ISCHEMIC HEPATITIS TREATED BY
TCM COMBINED WITH WESTERN MEDICINE].
WANG ZONGZHAN ET AL. shandong journal of tcm.
1995;14(8):361 (chi).
gera 2011

1481- gera: 88308/di/ra
[AN ANALYSIS OF THE RELATIVE FACTORS OF
100 CASES OF CIRRHOSIS]. LIU YANLING ET AL.
shandong journal of tcm. 1995;14(9):393 (chi).
1482- gera: 88309/di/ra
[240 CASES OF ASCITES DUE TO CIRRHOSIS
TREATED ACCORDING TO THE RULE OF
SUPPLMENTING QI,SOFTENING HARD MASSES
AND INDUCING DIURESIS]. HUANG CHANGRONG.
shandong journal of tcm. 1995;14(9):394 (chi).
1483- gera: 88332/di/ra
[22 CASES OF CHOLESTATIC HEPATITIS
TREATED BY TCM COMBINED WITH WESTERN
MEDICINE]. JI CHANGXIAN. shandong journal of tcm.
1995;14(11):509 (chi).
1484- gera: 88334/di/ra
[THE MAIN POINTS OF DIFFERENTIATION AND
TREATMENT OF CIRRHOSIS]. XIE XUSHAN.
shandong journal of tcm. 1995;14(12):531 (chi).
1485- gera: 88337/di/ra
[THE EFFECTS OF RUAN GAN SUO PI POWDER ON
SERUM HYALURONIDASE IN PATIENTS WITH
CHRONIC LIVER DISEASE]. JIAO SHUANLIN ET AL.
shandong journal of tcm. 1995;14(12):540 (chi).
1486- gera: 88635/di/ra
[TREATMENT OF 36 CASES OF CHRONIC SEVERE
HEPATITIS]. SHEN XIANG. jiangsu journal of tcm.
1995;16(3):7 (chi).
1487- gera: 88647/di/ra
[TREATMENT OF 32 CASES OF VIRUS HEPATITIS E
BY REMOVING DAMPNESS AND ACTIVATING
BLOOD CIRCULATION]. LIU CHENGHAI ET AL.
jiangsu journal of tcm. 1995;16(4):4 (chi).
1488- gera: 88648/di/ra
[TREATMENT OF 750 CASES OF CHRONIC
HEPATITIS B WITH ANT YIGANNING]. WU
ZHICHENG ET AL. jiangsu journal of tcm. 1995;16(4):6
(chi).
1489- gera: 88659/di/ra
[YU RONGQING'S EXPERIENCE IN TREATING
CHRONIC VIRUS HEPATITIS B IN CHILDREN].
WANG QIANSHAN. jiangsu journal of tcm. 1995;16(5):3
(chi).
1490- gera: 88663/di/ra
["DECOCTION OF HERBA ARTEMISIAE AND
RADIX SCUTELLARIAE" USED IN TREATMENT OF
FEMALE POSITIVE ASAB]. XI JIA. jiangsu journal of
tcm. 1995;16(5):12 (chi).
1491- gera: 88673/di/ra
[TREATMENT OF 42 CASES OF CIRRHOSIS WITH
TRADITIONAL CHINESE MEDICINE AND
WESTERN MEDICINE COMBINED]. LI QIMING ET
AL. jiangsu journal of tcm. 1995;16(6):6 (chi).
1492- gera: 88677/di/ra
[ULTRASONIC DIAGNOSIS AND DIFFERENTIAL
DIAGNOSIS AND CLASSIFICATION OF FATTY
LIVER]. CHEN WEIMING ET AL. jiangsu journal of
tcm. 1995;16(6):16 (chi).
88
1493- gera: 88686/di/ra
[REPORT ON 8 CASES OF TOXIC HEPATITIS].
CHEN FANG. jiangsu journal of tcm. 1995;16(7):9 (chi).
1494- gera: 88712/di/ra
[TREATMENT OF 176 CASES OF CHRONIC
HEPATITIS B WITH MINOR DECOCTION OF
BUPLEURUMS AND HEPATITIS B VACCINE]. XIE
SHIDA. jiangsu journal of tcm. 1995;16(9):7 (chi).
1495- gera: 88739/di/ra
[TREATMENT OF ASCITES DUE TO CIRRHOSIS]. BI
SHIMIN ET AL. jiangsu journal of tcm. 1995;16(11):9
(chi).
1496- gera: 88776/di/ra
[THE EXPERIMENTAL STUDY OF THE DRUGS
SOUR PUNGENT SWEET AND PURE SOUR DRUGS
TREATMENT RAT'S ACUTE HEPATIC INJURY BY
D-AMINOGALACTOSE]. XU CHENGHE. henan
traditional chinese medicine. 1995;15(2): (chi).
1497- gera: 88796/di/ra
[PROFESSOR LU CHENGQUAN'S EXPERIENCE IN
TREATING HEPATITIS B]. PENG BO ET AL. henan
traditional chinese medicine. 1995;15(4):226 (chi).
1498- gera: 88818/di/ra
[REGULATING THE FUNCTION OF THE LIVER
AND STRENGTHENING THE SPLEEN AND THE
STOMACH IN CURING THE CHRONIC HEPATITIS].
DU TINGGUI. henan traditional chinese medicine.
1995;15(6):372 (chi).
1499- gera: 90272/di/ra
[TREATMENT OF HEPATITIS WITH
HYPERBILIRUBINEMIA BY JIE DU HUA YU TANG:
A REPORT OF 40 CASES]. HU JINMAN. new journal of
tcm. 1995;27(1):46 (chi).
1500- gera: 90287/di/ra
[TREATMENT ON HEPATITIS B BY JIEDU JIANPI
HUOXUE TANG: A REPORT OF 72 CASES]. YANG
XINGCHI. new journal of tcm. 1995;27(2):47 (chi).
1501- gera: 90288/di/ra
[PROF LI CHANGYUAN'S EXPERIENCE ON THE
TREATMENT OF LIVER BY REGULATING QI].
ZHOU DAOHONG. new journal of tcm. 1995;27(3):1 (chi).
1502- gera: 90293/di/ra
[PROF. LIU SHICHANG'S EXPERIENCE ON THE
TREATMENT OF HEPATOCIRRHOSI]. SHEN QIANG.
new journal of tcm. 1995;27(3):10 (chi).
1503- gera: 90302/di/ra
[TREATMENT OF SENILE CHRONIC HEPATITIS B
BY SANCAI FENGSUI PILL: A REPORT OF 58
CASES]. CHEN SHIJUN ET AL. new journal of tcm.
1995;27(3):48 (chi).
1504- gera: 90306/di/ra
[DIFFERENTIATION TREATMENT ON
REFRACTORY ASCITES DUE TO CIRRHOSIS].
ZHANG CHIZHI. new journal of tcm. 1995;27(4):8 (chi).
1505- gera: 90317/di/ra
[CLINICAL OBSERVATION ON THE TREATMENT
OF CHRONIC HEPATITIS B BY PRINCIPLE OF
gera 2011

DISPERSING THE DEPRESSED LIVER-QI AND
STRENGTHENING THE LIVER: A REPORT OF 69
CASES]. QIN CHUNHONG ET AL. new journal of tcm.
1995;27(4):47 (chi).
1506- gera: 90319/di/ra
[PROF. WANG BOXIANG'S EXPERIENCE ON THE
TREATMENT OF HEPATITIS B]. NIE GUANG. new
journal of tcm. 1995;27(5):3 (chi).
1507- gera: 90346/di/ra
[TREATMENT OF OBSTINATE CASES OF
HEPATITIS A BY HUSHENG SANJIE TANG: A
REPORT OF 30 CASES]. CAO HUIBO ET AL. new
journal of tcm. 1995;27(6):51 (chi).
1508- gera: 90370/di/ra
[PROF. LIU SHICHANG'S EXPERIENCE ON THE
TREATMENT OF VIRAL HEPATITIS]. ZHANG
CHAOXI. new journal of tcm. 1995;27(8):9 (chi).
1509- gera: 90377/di/ra
[TREATMENT ON POSITIVE E-ANTIGEN OF
HEPATITIS B BY YI GAN FANG: A REPORT OF 198
CASES]. XU ZHONGHONG. new journal of tcm.
1995;27(8):45 (chi).
1510- gera: 90471/di/ra
[TREATMENT OF ACUTE ICTERIC HEPATITIS A
BY QING GAN LI SHI JIE DU TANG: A REPORT OF
408 CASES]. SUI JIDONG. new journal of tcm.
1995;27(9):47 (chi).
1511- gera: 90486/di/ra
[TREATMENT ON THE CAUTE ICTEROHEPATITIS
BY SICAO DAHUANG TANG: A REPORT OF 102
CASES]. DAI FUHAI ET AL. new journal of tcm.
1995;27(10):51 (chi).
1512- gera: 90516/di/ra
[TREATMENT OF ACUTE ICTERIC HEPATITIS BY
YIN CHEN FU GAN TANG: A REPORT OF 158
CASES]. LI FANGYU. new journal of tcm. 1995;27(12):44
(chi).
1513- gera: 91114/di/ra
[OBSERVATION ON INHIBITION HBSAG WITH
PHYLLANTHUS URINARIAL AND DESMODIUM
STYRACIFOLIUM (OSB) MERR]. ZHOU SHIWENG ET
AL. practical journal of integrating chinese with modern
medicine. 1995;8(12):760 (chi).
1514- gera: 91233/di/ra
[THE SUPERFICIAL STUDY OF REFERENCE OF
BLOOD RHEOLOGY AND HEPATOPATHY]. JANG
SHAO LING ET AL. practical journal of integrating
chinese with modern medicine. 1995;8(1):37 (chi).
1515- gera: 91241/di/ra
[THE EFFECTIVE OBSERVATION THAT THE
CHRONIC HEPATITIS B IS CURED BY COMPOUND
PRESCRIPTION OF CHINESE DRUGS ZHU LING
POLYSACCHARIDE AND HEPATITIS B]. LI YOU
ZHANG. practical journal of integrating chinese with
modern medicine. 1995;8(2):71 (chi).
1516- gera: 91279/di/ra
[THE 23 REPORTMENT THAT CHRONIC
HEPATITIS HEPATICACHE IS CURED BY
LIGUSTICUM WALLICHII TAI ION LEADED IN].
89
LIU YONG-HONG ET AL. practical journal of
integrating chinese with modern medicine. 1995;8(4):241
(chi).
1517- gera: 91304/di/ra
[THE POSTHEPATITIC CIRRHOSIS ASCITES IS
CURED BY CHINESE WITH MODERN MEDICINE IN
53 CASES]. ZHANG JIA-XING. practical journal of
integrating chinese with modern medicine. 1995;8(6):329
(chi).
1518- gera: 91366/di/ra
[THE EFFECTIVE OBSERVATION THAT
CIRRHOSIS IS CURED BY AUTOBLOOD
PHOTOELECTRON WAY IN 28 CASES]. SHUN DE
RONG ET AL. practical journal of integrating chinese
with modern medicine. 1995;8(11):649 (chi).
1519- gera: 91368/di/ra
[CHRONIC HEPATITIS IS CURED BY IF AND
CHINESE WITH MODERN MEDICINE
DIFFERENTIATION OF SYMPTOMS AND SIGNS
TYPING WITH CLINICAL STUDING]. DAI GUAN
RONG ET AL. practical journal of integrating chinese
with modern medicine. 1995;8(11):662 (chi).
1520- gera: 91370/di/ra
[THE CLINICAL EXPERIMENT STUDING THAT
HEPATO-RENAL TWO CATHERETIC TYPE WITH
MINERAL SUBSTANCE CONTENT]. WU WEN-SHE
ET AL. practical journal of integrating chinese with
modern medicine. 1995;8(11):666 (chi).
1521- gera: 91376/di/ra
[THE EFFECTIVE OBSERVATION THAT LIVER
AND GALLBLADDER SYSTEM ILLS IS CURED BY
CHINESE WITH MODERN MEDICINE IN 88 CASES].
CHEN ZHI-XIANG. practical journal of integrating
chinese with modern medicine. 1995;8(11):692 (chi).
1522- gera: 103847/di/ra
A STUDY ON VARIOUS SYMPTOMS OF CHRONIC
HEPATITIS TREATED WITH RADIX ASTRAGALI
AND ITS REGULATIVE EFFECT TO LEVELS OF
SERUM HORMONE. LIU KE-ZHOU, TONG ZHONG-
HANG, ZHANG MING-TAI, E. chinese journal of
integrated traditional and western medicine (english
edition). 1995;1(2):118 (eng).
1523- gera: 103848/di/ra
A STUDY OF THE MECHANISM OF YINZHIHUANG
04*0) INJECTION IN THE TREATMENT OF
INFANTILE HEPATITIS SYNDROME. DONG YONG-
SUI, HUANG ZHI-HUA, WU LAN-FEN, ET AL. chinese
journal of integrated traditional and western medicine
(english edition). 1995;1(2):122 (eng).
1524- gera: 107167/di/ra
HYDROXYCAMPTOTHECINE AND CANTHARIDIN
COMBINED WITH CISPLATIN AND LIPIODOL
THROUGH TRANSCATHETER ARTERIAL
EMBOLIZATION IN HEPATOCELLULAR
CARCINOMA. YU ZHI-JIAN MENG XIAN-YONG, XU
KE-CHENG, ET AL. chinese journal of integrated
traditional and western medicine (english edition).
1995;1(3):175 (eng).
1525- gera: 107168/di/ra
THERAPEUTIC EFFECTS OF PERFUSING
COMPOUND SALVIA MILTIORRHIZA INJECTION
gera 2011

THROUGH THE HEPATIC ARTERY IN THE LATE
STAGE OF HEPATOCARCINOMA. PENG ZHENG-
SHUN, RAO RONG-SHENG, NI YONG-WEN, E. chinese
journal of integrated traditional and western medicine
(english edition). 1995;1(3):179 (eng).
1526- gera: 107179/di/ra
PROTECTIVE EFFECTS FOR HEPATOCYTES OF
SALVIAE MILTIORRHIZA AND PAEONIA
LACTIFLORA IN EXPERIMENTAL LIVER
DAMAGE. QI XIN-GUANG AND YUTAKA INAGAKI.
chinese journal of integrated traditional and western
medicine (english edition). 1995;1(3):227 (eng).
1527- gera: 107264/di/ra
EFFECT OF MAGNESIUM LITHOSPERAMATE B ON
D-GALACTOSAMINE INDUCED LIVER WARY RAT.
LIU PING, YASUHIRO MIZOGUZHI AND SEIJI
MORISAWA. chinese journal of integrated traditional
and western medicine (english edition). 1995;1(4):291
(eng).
1528- gera: 54696/nd/re
THE HERBAL MEDICINE INCHIN-KO-TO INHIBITS
LIVER CELL APOPTOSIS INDUCED BY
TRANSFORMING GROWTH FACTOR BETA 1. .
YAMAMOTO M ET AL. hepatology. 1996;23(3):552-9
(eng).
Transforming growth factor beta 1 (TGF-beta 1) is reported
to play an important role in the induction of liver cell
apoptosis. In this report, we demonstrate that TGF-beta 1
induces apoptosis in a rat Morris hepatoma McA-RH8994
cell line and rat primary cultured hepatocytes at similar doses
and in a similar manner. Using McA-RH8994 cells, we
screened a number of chemical reagents, aqueous extracts of
crude drugs, and herbal medicines for their inhibitory
activities on TGF-beta 1-induced apoptosis. The results
indicate that Artemisiae capillaris spica (ACS) and the ACS-
containing herbal medicine Inchin-ko-to, which are used for
treatment of various liver disorders, exhibited the most potent
anti-apoptotic activity. Various chemicals that were reported
as inhibitors of apoptosis in other experimental systems
showed no evident activity. By contrast, two of nine ACS
ingredients we tested, capillin and capillene, showed activity
at concentrations of sub¦g per milliliter. The inhibitory effects
of Inchin-ko-to, capillin and capillene were also confirmed
on TGF-beta 1-induced apoptosis of rat primary cultured
hepatocytes. Inhibition of undesired apoptosis induced by
TGF-beta 1 is expected to be beneficial for the treatment of
various inflammatory liver diseases. Our findings therefore
suggest the possibility that therapeutic effects of Inchin-ko-to
on liver diseases might be associated with its inhibitory
activity on TGF-beta 1-induced liver cell apoptosis.
1529- gera: 54708/nd/re
EFFECTS OF HEPATIC STIMULATOR SUBSTANCE,
HERBAL MEDICINE, SELENIUM/VITAMIN E, AND
CIPROFLOXACIN ON CIRRHOSIS IN THE RAT.
ZHANG M ET AL. gastroenterology. 1996;110(4):1150-5
(eng).
BACKGROUND & AIMS: Cirrhosis is a potentially lethal
condition for which there is no proven effective therapy. The
aim of this study was to compare the effects of hepatic
stimulator substance, traditional Chinese herbal medicine,
selenium plus vitamin E, and ciprofloxacin treatment on
biochemical and histological features of fibrosis in rats with
carbon tetrachloride (CCl4)/ethanol-induced cirrhosis.
METHODS: One hundred twenty adult Wistar rats were
divided into six study groups (20 rats/group): healthy
controls, CCl4/ethanol-injured rats left untreated, and
90
CCl4/ethanol-injured rats treated for 4 weeks with either
hepatic stimulator substance, traditional Chinese herbal
medicine, a combination of selenium plus vitamin E, or
ciprofloxacin. After the 4-week treatment, rats were killed
and the following parameters of hepatic fibrosis were
determined: hepatic hydroxyproline and proline levels, serum
hyaluronic acid concentrations, and histological staining of
hepatic tissue. RESULTS: Hepatic fibrosis was significantly
improved in all four treated groups compared with the
untreated CCl4/ethanol- injured controls. Improvements were
most striking in the groups treated with traditional Chinese
herbal medicine and ciprofloxacin. CONCLUSIONS: The
data indicate that hepatic stimulator substance, traditional
Chinese herbal medicine, selenium plus vitamin E, and
ciprofloxacin significantly decrease the amount of hepatic
fibrosis caused by CCl4/ethanol injury in rats.
1530- gera: 54742/nd/re
HERBAL MEDICINE 'SHO-SAIKO-TO' INDUCES
TUMOUR NECROSIS FACTOR-ALPHA AND
GRANULOCYTE COLONY-STIMULATING FACTOR
IN VITRO IN PERIPHERAL BLOOD
MONONUCLEAR CELLS OF PATIENTS WITH
HEPATOCELLULAR CARCINOMA. YAMASHIKI M
ET AL. j gastroenterol hepatol. 1996;11(2):137-42 (eng).
'Sho-saiko-to' (TJ-9) is a Japanese herbal medicine that is
commonly administered to patients with chronic viral liver
disease in order to improve their overall physical condition
and to prevent the development of liver cancer, The present
in vitro study demonstrated that, by adding TJ-9 to cell
cultures, there were dose-dependent increases in production
levels of tumour necrosis factor-alpha (TNF-alpha) and
granulocyte colony-stimulating factor (G-CSF) in peripheral
mononuclear cells of patients with hepatocellular carcinoma
accompanied by liver cirrhosis. Increases in the production of
TNF-alpha and G-CSF in control cell cultures exposed to
different herbal medicines were low, and this indicates the
specificity of the response increases in production of these
cytokines to TJ-9. TNF- alpha and G-CSF are known to play
important roles in the biological defence mechanism.
Administration of TJ-9 may, therefore, be beneficial for
patients afflicted with intractable liver diseases because it
could mildly induce
1531- gera: 54877/nd/re
HIBISCUS PROTOCATECHUIC ACID PROTECTS
AGAINST OXIDATIVE DAMAGE INDUCED BY
TERT- BUTYLHYDROPEROXIDE IN RAT PRIMARY
HEPATOCYTES. . TSENG TH ET AL. chem biol
interact. 1996;101(2):137-48 (eng).
Hibiscus protocatechuic acid (PCA), a simple phenolic
compound isolated from Hibiscus sabdariffa L. , was studied
for its protective effects against oxidative damage induced by
tert-butylhydroperoxide (t-BHP) in a primary culture of rat
hepatocytes. It had been reported that exposure of isolated
hepatocytes to t-BHP results in leakage of lactate
dehydrogenase (LDH) and alanine transaminase (ALT),
peroxidation of cellular lipids, and depolarization of
mitochondria. The present investigations showed that PCA at
concentrations of 0. 05 mg/ml and 0. 10 mg/ml significantly
decreased the leakage of LDH (P < 0. 01) and ALT (P < 0. 05
and P < 0. 01) and the formation of malondialdehyde (MDA;
P < 0. 05 and P < 0. 01) induced by 30-min treatment with t-
BHP (1. 5 mM) in primary cultured rat hepatocytes. PCA
also attenuated t-BHP (0. 10 mM) induced mitochondrial
depolarization as determined by a retention test of rhodamine
123 and DNA repair synthesis as evidenced by unscheduled
DNA synthesis (UDS). In addition, PCA exhibited an
effective ability to quench 1,1-diphenyl-2-picrylhydrazyl
radicals (DPPH). In conclusion, PCA demonstrated
gera 2011

protective effects against cytotoxicity and genotoxicity of
hepatocytes induced by t-BHP. One of mechanisms of PCA's
protective effect may be associated with its property of
scavenging free radicals.
1532- gera: 55006/nd/re
GINSENOSIDE-RG1 POSITIVELY REGULATES
CYCLIN E-DEPENDENT KINASE ACTIVITY IN
HUMAN HEPATOMA SK-HEP-1 CELLS. . LEE KY ET
AL. biochem mol biol int. 1996;39(3):539-46 (eng).
In the present study, we describe that ginsenoside-Rg1 (G-
Rg1) stimulates the proliferation of cultured human hepatoma
SK-HEP-1 cells. The incorporation of [3H] thymidine into
DNA was increased in the cells in response to G-Rg1. The
stimulatory effect of G-Rg1 on DNA synthesis in SK-HEP-1
cells require newly synthesized proteins, since cycloheximide
blocked the DNA synthetic activity stimulated with G-Rg1.
Thus, we examined whether G-Rg1 induces the intracellular
protein levels of regulatory proteins for cell cycle progression
using immunoblottings. The results from immunoblottings
showed that G-Rg1 induced the levels of cyclin E and cdk2
proteins in the cells. Furthermore, the results from immuno-
complex kinase assays for cyclin E-dependent kinase showed
that G-Rg1 up- regulates the kinase activity in a dose-
dependent manner. These results suggest that G-Rg1
stimulates cell-growth of SK-HEP-1 cells by inducing the
intracellular levels of cyclin E/cdk2 complex, which in turn
up-regulates cyclin E-
1533- gera: 55085/di/ra
INDUCTION OF CYTOCHROME P-450-LINKED
MONOOXYGENASE SYSTEM IN RAT LIVER
MICROSOMES BY XIAO-CHAIHU-TANG. . OBNISHI
T ET AL. american journal of chinese medicine.
1996;24(2):143-51 (eng).
The administration of Xiao-Chaihu-Tang (TJ-9) for 2 weeks
induced a 25% increase in the content of cytochrome P-450
in female rat liver microsomes, while the content in male rats
remained unchanged. The enzymatic activities toward
various xenobiotics were stimulated in female rats, the levels
being in the range of 125-250% of those in the control rats.
Among these xenobiotics, the metabolic rates for substrates
of cytochrome P-450 2E1 were significantly enhanced in
female rats. On the other hand, the activities toward various
xenobiotics in male rats were unchanged. When 3-
methylcholanthrene was given to rats for a week, the
augmentation of cytochrome P- 450 content and the
stimulation of xenobiotic metabolism were observed.
However, co-administration of TJ-9 did
1534- gera: 55093/nd/re
INHIBITION OF HEPATITIS B SURFACE ANTIGEN
SECRETION ON HUMAN HEPATOMA CELLS.
COMPONENTS FROM RUBIA CORDIFOLIA. . HO LK
ET AL. j nat prod. 1996;59(3):330-3 (eng).
The antiviral activity in the roots of Rubia cordifolia was
examined, and three naphthohydroquinones, furomollugin
(1), mollugin (2), and rubilactone (3), were isolated from it.
Compounds 1 and 2 strongly suppressed the secretion of
hepatitis B surface antigen (HBsAg), both with IC50 = 2. 0
Ágs/mL, in human hepatoma Hep3B cells while having little
effect on the viability of the cells. Evaluation of structurally
related derivatives of 1 and 2 revealed that a 6-hydroxy group
and a pyran or furan ring contribute to this suppressive effect.
1535- gera: 55323/di/ra
[ON THE RELATIONSHIP BETWEEN SYNDROME
OF ACCUMULATED BLOOD IN COLD DISEASES
AND ACUTE JAUNDICE AND SEVERE HEPATITIS].
JIANG SEN. journal of tcm. 1996;37(7):392 (chi).
91
1536- gera: 55324/di/ra
[GU PEIRONG'S EXPERIENCE IN APPLYING
LARGE DOSE OF RADIX GINSENG AND RHIZOMA
ATRATYLODIS MACROCEPHALAE IN
TREATMENT OF CIRRHOTIC ASCITIS]. ZHANG
JUN. journal of tcm. 1996;37(7):394 (chi).
1537- gera: 55450/di/ra
[PERSPIRATION ON THE HEAD, A SPECIAL
MANIFESTATION IN SEVERALY-ICTERIC
CHRONIC HEPATITIS, REPORT OF 124 CASES].
WANG CHENGBAI ET AL. journal of tcm.
1996;37(9):539 (chi*).
Of the 411 hepatitis with severe jaundice admitted, 124
(30,17%) had head perspiration. Based on Zhang Zhongjing's
etiologic-pathogenic conception, 102 cases of such patients
were treated by the principle of cooling and activating blood,
benefitting Qi and Yin. 89 cases had jaundice eliminated. 13
cases had residual jaundice. All 22 cases of chronic severe
hepatitis survived. Of them, 9 early stage cases were all
survived. 7 of the 8 cases of intermediate stage survived, only
1 out of 5 cases of late stage survived.
1538- gera: 55536/di/ra
[THE QUESTION OF INCUBATIVE PATHOGEN ON
CHRONIC HEPATITIS TREATMENT BASED ON
SYNDROME DIFFERENTIATION]. KUANG
CUIZHANG. china journal of tcm and pharmacy.
1996;11(3):42 (chi).
1539- gera: 55543/di/ra
[STUDY ON MODIFIED XIAOCHAIHU TANG ON
TREATING DYSIMMUNITY AND HEPATIC INJURY
OF PATIENTS WITH CHRONIC ACTIVE HEPATITIS
B]. CHEN ZEXIONG ET AL. china journal of tcm and
pharmacy. 1996;11(4):25 (chi).
1540- gera: 55658/di/ra
[CLINICAL STUDY ON C-HEPATITIS TREATED
WITH BINGGANLING ORAL LIQUID]. YOU
SONGXIN ET AL. journal of tcm. 1996;37(11):673 (chi).
1541- gera: 55765/di/ra
ALIMENTACION Y RECUPERACION DE
PACIENTES AFECTOS DE CANCER HEPATICO.
WANG YONG KUA. el pulso de la vida. 1996;9:11-2 (esp).
1542- gera: 55899/di/ra
THE HEPATOPROTECTIVE EFFECTS OF TAIWAN
FOLK MEDICINE HAM-HONG-CHHO IN RATS. .
CHIN HW ET AL. american journal of chinese medicine.
1996;24(3-4):231-40 (eng).
Bidens pilosa L. var minor (Blume) Sherff, B. pilosa L. and
B. chilensis DC (compositae), commonly known as "Ham-
hong-chho" in Taiwan, have been traditionally used for
medicinal purposes. To clarify and compare the
hepatoprotective effects of these three plants, we evaluated
their potential effectiveness on CCl4- and acetaminophen-
induced acute hepatic lesions in rats. The results indicated
that the increase in SGOT and SGPT activities caused by
CCl4 (3. 0 ml/kg, s. c. ) and acetaminophen administration
(600 mg/kg, i. p. ) could be significantly reduced by treating
with the extracts of all the three kinds of "Ham-hong-chho"
and the extract of B. chilensis exhibited the greatest
hepatoprotective effects. These phenomena were also
confirmed by histological observation. Liver damage induced
by CCl4 and acetaminophen was markedly improved in the
extract of B. chilensis treated groups, while groups treated
with the extracts of B. pilosa var minor and B. pilosa
gera 2011

demonstrated only moderate protective effects. The
pharmacological and pathological effects of these three crude
groups were compared with Bupleurum chinense, which has
been reported previously as a treatment criteria in the CCl4
model, and with silymarin as a standard reference medicine
in the acetaminophen model. The results suggest that B.
pilosa var minor, B. pilosa and B. chilensis can protect liver
injuries from various hepatotoxins and have potential as
broad spectrum antihepatic agents.
1543- gera: 55900/nd/ra
PROTECTIVE AND THERAPEUTIC EFFECTS OF
HUANGLIAN-JIE-DU-TANG ON HEPATOTOXIN-
INDUCED LIVER INJURIES. . LIN SC ET AL. american
journal of chinese medicine. 1996;24(3-4):219-29 (eng).
The hepatoprotective effect of Huanglian-Jie-Du-Tang
(HLJDT), a Chinese medicinal prescription, was investigated
in three kinds of experimental models. The animals were
treated with HLJDT (300 mg/kg, p. o. ) thrice at 2, 4 and 10
hours after administration with carbon tetrachloride (32
microliters/kg, i. p. ), acetaminophen (600 mg/kg, i. p. ) and
beta-D-galactosamine (188 mg/kg, i. p. ). Significant
hepatoprotective effects on carbon tetrachloride and
acetaminophen induced liver injuries were noted, but no
significant effect on beta-D- galactosamine induced liver
injury was observed. These hepatoprotective effects were
evidenced by comparing the serum glutamate oxaloacetate
transaminase (SGOT) and serum glutamate pyruvate
transaminase (SGPT) levels in HLJDT treated and untreated
groups. Serum enzyme activities in the carbon tetrachloride
and acetaminophen experiments were significantly lower in
the treated groups while the herbal prescription has no effect
on the beta-D-galactosamine experiment. These results
demonstrated that Huanglian-Jie-Du-Tang has a
hepatoprotective effect against experimental liver injuries
induced by specific hepatotoxins, and therefore may be
1544- gera: 55930/nd/re
WILSON DISEASE : ASYMPTOMATIC OR LATE-
ONSET TYPE.? (LETTER) . WANG XP . acta neurol
scand. 1996;94(6):421-2 (eng).
1545- gera: 56791/di/ra
[BASIC PRINCIPLE AND DRUG THERAPY OF
HEPATIC CANCER TREATED WITH TCM]. YANG
TONGLI. china journal of tcm and pharmacy.
1996;11(6):42 (chi).
1546- gera: 56843/di/ra
A REPORT OF 4 CASES OF LIVER CARCINOMIA
TREATED BY TOPICAL ADHESIVE METHOD. LI
HUIGANG ET AL. journal of tcm. 1996;16(4):243-6 (eng).
1547- gera: 56914/di/ra
[COMPLICATION OF POST-HEMORRHAGE OF
UPPER DIGESTIVE TRACT IN POSTHEPATITIC
CIRRHOSIS PREVENTED WITH RADIX ET
RHIZOMA RHEI : REPORT OF 14 CASES]. HE
JIANGPING ET AL. journal of tcm. 1996;37(12):728 (chi).
1548- gera: 56919/di/ra
[NEONATAL HEPATITIS SYNDROME TREATED BY
SOOTHING THE LIVER AND REMOVING BLOOD
STASIS : REPORT OF 46 CASES]. YANG WENYI ET
AL. journal of tcm. 1996;37(12):738 (chi).
1549- gera: 57007/di/ra
[A CLINICAL OBSERVATION ON 31 CASES OF
HEPATITIS C TREATED BY CHINESE DRUGS]. YIN
CHANGJIAN ET AL. journal of shandong college of tcm.
92
1996;20(3):176 (chi).
1550- gera: 57008/di/ra
[A CLINICAL APPLICATION OF RULE OF
SUPPLEMENTING QI AND NOURISHING YIN TO
LIVER CANCER]. MA LINGYUN. journal of shandong
college of tcm. 1996;20(3):178 (chi).
1551- gera: 57011/di/ra
[PROGRESS IN THE TREATMENT OF FIBROSIS OF
LIVER BY CHINESE MEDICINE]. GAO YANJING ET
AL. journal of shandong college of tcm. 1996;20(3):211
(chi).
1552- gera: 57044/di/ra
[REVIEW OF MODERN EXPERIMENTAL STUDIES
OF PHYSIOLOGY AND PATHOLOGY OF THE
LIVER IN TCM CONCEPTS]. YE BAIKUAN. journal of
beijing university of tcm. 1996;19(3):2 (chi*).
1553- gera: 57059/di/ra
[PROTECTIVE EFFECTS OF XINMAILING
SOLUTION ON LIVER INJURY OF ENDOTOXIN
SHOCK RATS]. LI AIFANG ET AL. journal of shandong
college of tcm. 1996;19(3):67 (chi*).
1554- gera: 57068/di/ra
[INFLUENCE OF QING KAI LING ON LIPID
PREOXIDATIVE INJURY BY ENDOTOXIN IN
ISOLATED HEPATOCYTES OF RATS]. ZHU
LINGQUN ET AL. journal of beijing university of tcm.
1996;19(4):32 (chi).
1555- gera: 57076/di/ra
[PRESENT SITUATION AND PROSPECTS OF THE
STUDIES OF TREATING HEPATIC FIBROSIS BY
TCM]. BEN CHANGEN. journal of beijing university of
tcm. 1996;19(5):2 (chi*).
1556- gera: 57085/di/ra
[SHORT INTRODUCTION TO PROF. LIU DUZHOU'S
CLINICAL EXPERIENCE IN TREATING CHRONIC
VIRUS HEPATITIS]. LIU YANHUA. journal of beijing
university of tcm. 1996;19(5):46 (chi).
1557- gera: 57126/di/ra
[SCREENING OF ANTI-HBsAg EFFECTS OF 270
CHINESE MEDICINAL HERBS BY USING ELISA
TECHNIQUE]. ZHENG MINSHI ET AL. traditional
chinese medicinal research. 1996;9(1):51 (chi).
1558- gera: 57321/di/ra
MODULATION OF MICROSOMAL CYTOCHROME
P450 BY SCUTELLARIAE RADIX AND GENTIANAE
SCABRAE RADIX IN RAT LIVER. . KANG JJ ET AL.
american journal of chinese medicine. 1996;24(1):19-29
(eng).
1559- gera: 57329/nd/re
EFFECTS OF THE MYCELIAL EXTRACT OF
CULTURED CORDYCEPS SINENSIS ON IN VIVO
HEPATIC ENERGY METABOLISM IN THE MOUSE. .
MANABE N ET AL. jpn j pharmacol. 1996;70(1):85-8
(eng).
1560- gera: 57702/di/ra
ALIMENTACION Y RECUPERACION DE
PACIENTES AFECTOS DE CANCER HEPATICO.
WANG YONG KUA. pulso de la vida. 1996;9:11-2 (esp ).
gera 2011

1561- gera: 58332/di/ra
PULSE SPECTRUM ANALYSIS OF HOSPITAL
PATIENTS WITH POSSIBLE LIVER PROBLEMS. LU
WA ET AL. american journal of chinese medicine.
1996;24(3-4):315-20 (eng ).
Pulse diagnosis were performed on 85 patients who came to
the hospital for liver and gallbladder problems. Correlation
between liver tests, which include T- Bil, D - Bil, SOOT,
SGPT, ZTT, Alp, Y- GT, Cho, Alb and ultra sound scanning,
and pulse diagnosis were analyzed. 77 out of 85 subjects
showed abnormal liver tests. We used the following 5 criteria
for pulse diagnosis as liver abnormality to test thecorrelation:
(1) C1>3+and CI +C4 > 4+or CI+C6 > 4 in intensity) ; (2) CI
<3 (in intensity) ; (3) C6 > 3 and C I + C6 > 4 (in intensity);
(4) C6 < -2 (in intensity) and C6 < -2 (in the phase) and (5) C
1 > 2 C3 < -2 (in intensity) or C3 < -2 (in the phase). For C I
(liver) every 5% above normal was given one "+," every 5%
below normal was given one "-." For C3 (spleen), C4 (lung),
C6 (gall- bladder), every 10% above normal was given one
"+," every 10% below normal was given one "-." For the
phase, every 10% delay in the traveling speed was given one
"-." When considering only the "+" and "-" states and
neglecting the quantity of "+" and "-," there are 21 l (from
intensity) x 21 l (from phase), which equal 2048 x 2048
possible states in the pulse analysis. We considered only 5
criteria for liver abnormality; the correlation was still very
high, p < 0.0002, Kappa = 0.64. It strongly suggests that
meridian theory and pulse diagnosis have physiological and
pathological importance.
1562- gera: 58338/di/ra
THE PROTECTIVE EFFECT OF ALSTONIA
SCHOLARIS R.BR.ON HEPATOTOXIN-INDUCED
ACUTE LIVER DAMAGE. LIN SONG-CHOW ET AL.
american journal of chinese medicine. 1996;24(2):153-64
(eng ).
The hepatoprotective effect of Alstonia scholaris R. Br. on
liver injuries induced by carbon tetrachloride (CC14), ß- D-
galactosamine, acetaminophen and ethanol were investigated
by means of serum-biochemical and histopathological
examinations. Post treatment of A scholaris reduced
dosedependently the elevation of serum transaminases level
and histopathological changes such as cell necrosis,
inflammatory cell infiltration, which were caused by the
single administration of 32 µ1/kg CC14 or 600 mg/kg
acetaminophen in mice. A. scholaris significantly lowered
288 mg/kg ß-D-galactosamine induced serum transaminases
elevation in the serum- biochemical analysis in rats. A
tendency was also shown to inhibit cell necrosis and
inflammatory cell infiltration caused by ß-D-galactosamine in
histopathological examination. All serological and
histopathological effects of A. scholaris were compared with
those of Bupleurum chinense, which has been reported
previously as a treatment
1563- gera: 58340/di/ra
PULSE SPECTRUM ANALYSIS OF CHEMICAL
FACTORY WORKERS WITH ABNORMAL BLOOD
TEST. WANG WEI KUNG ET AL. american journal of
chinese medicine. 1996;24(2):199-203 (eng ).
Double blind tests to check the correlation between pulse
diagnosis and liver function tests were performed. Blood tests
including T-Bil, D-Bil, SGOT and SGPT of 70 chemical
factory workers were compared with pulse analysis. Special
attention was paid to the indicators of liver and lung
meridians for pulse diagnosis. It was found that using the
criterion (1) C1 > or = 3+ and Cl + C4 > or = 4+
(hyperfunction) and (2) Cl < or = 3- (hypofunction) as
abnormal liver meridian (for Cl, every 5% above normal give
one +, every 5% below normal give one -; for C4 every 10%
93
above normal give one +, every 10% below normal give one -
). The correlation or agreement between the blood tests and
the pulse diagnosis was very high (noncorrelation chance
checked by X2-test, P < 0.001, degree of agreement checked
by Kappa test Ka = 0.61 which means a substantial
relationship). Suggestions such as more tests, more criteria
and precautions for future study are also proposed.
1564- gera: 58354/nd/ra
(COMPARATIVE STUDY ON THE LONG-TERM
EFFECT OF PERMANENT EMBOLIZATION OF
HEPATIC ARTERY WITH BLETILLA STRIATA IN
PATIENTS WITH PRIMARY LIVER CANCER). FENG
G ET AL. journal of tongji medical university.
1996;16(2):111-6 (deu*).
From May, l990 toSept., 1993, 106 cases of primary liver
cancer were treated by temporary or permanent hepatic
arterial embolization with Bletilla striata powders
(permanent, 56 cases) or gelfoam powders (temporary, 50
cases) under controlled technical conditions, in term of
degree of tumor necrosis, revascularization of tumor, and
long- term effect, the results of Bletilla striata group were
better as compared with those of gelfoam group.The 1, 2 and
3 year survival rates were 44.9%, 33.ó% and 33.ó% in
Beltilla striata group while the rates were 48.9%, 31.1% and
16.0% in gelfoam group, suggesting that Bletilla striata is
superior to gelfoam as an embolizing agent for hepatic
1565- gera: 66713/di/ra
[EFFECT OF MODIFICATION OF SINI SAN ON THE
CHANGE OF CIRRHOSIS EXPERIMENTAL INDEX].
DENG YINQUAN. liaoning journal of traditional chinese
medicine. 1996;23(2):49 (chi*).
To study the effect of traditional Chinese medicine on serum
adenosine deaminase (ADA) and peripheral T Iymphocyte
subsets in liver cirrhosis patients, the 32 cases (group A)
treated with jiaweisinisan and the 16 cases (group B) treated
by Gexiazhuyutang. The results showed that serum ADA and
the OKT8 of group A were significantly lower (P<0. 01),
serum albumen,the ratio of albumen/globulin and OKT4 /
OKT8 were significantly higher (P<0.05) than before
treatment. Whereas those of group B were not significnat
(P>0.05). The difference of ADA between the two groups
before treatment was not significnat (P>0.05) and after
treatment was significant( P<0.05). The results showed that
the therapy of adding dispersion the depressed Liver-energy,
supplement vital energy and invigoration the Spleen to
dispersion blood stasis and softening the hard lumps seemed
to be obviously superior to that of only promotion blood
circulation to disperse blood stasis and have immune
regulatory
1566- gera: 66950/di/ra
[COMBINATION OF CHINESE DRUGS AND
RADIOTHERAPY FOR TREATMENT OF 45 CASES
OF HEPATIC CANCER]. ZHANG LIANGMAO.
shanghai journal of traditional chinese medicine.
1996;6:16 (chi).
1567- gera: 66958/di/ra
[SHU GAN XIAO JI WAN'S EFFECT ON CERTAIN
SERUM INDEX OF CHRONIC HEPATITIS B VIRUS].
HE JIANCHENG ET AL. shanghai journal of traditional
chinese medicine. 1996;7:8 (chi).
1568- gera: 66959/di/ra
[CLINICAL OBSERVATION OF TREATMENT OF
CHRONIC VIRUS HEPATITIS AND
HEPATOCIRRHOSIS]. ZHOU XIAQIU ET AL. shanghai
journal of traditional chinese medicine. 1996;7:11 (chi).
gera 2011

1569- gera: 66966/di/ra
[A STUDY OF YANG YIN PRESCRIPTION AND QING
JIE PRESCRIPTION IN PREVENTING AND
TREATING ULTRASTRUCTURE OF MICES LIVER
CANCERATION]. ZOU KUICHANG ET AL. shanghai
journal of traditional chinese medicine. 1996;7:45 (chi).
1570- gera: 67019/di/ra
[TREATMENT OF 38 CASES OF VIRAL HEPATITIS
E WITH YIN CHEN HUI LING DECOCTION]. DAN
KAIRONG. shanghai journal of traditional chinese
medicine. 1996;10:15 (chi).
1571- gera: 67032/di/ra
[AN ANALYSIS OF CLINICAL EFFECT OF THE
METHOD OF ACTIVATING BLOOD CIRCULATION
TO DISSIPATE BLOOD STASIS IN TREATING 264
CASES OF CHRONIC HEPATITIS]. ZHANG JUNFU
ET AL. shanghai journal of traditional chinese medicine.
1996;12:15 (chi).
1572- gera: 67033/di/ra
[32 CASES OF ASCITES DUE TO CIRRHOSIS
TREATED MAINLY WITH THE METHOD OF
STRENGTHENING THE BODY RESISTANCE TO
ELIMINATE PATHOGENIC FACTORS]. WANG
XINGWEN ET AL. shanghai journal of traditional
chinese medicine. 1996;12:18 (chi).
1573- gera: 67041/di/ra
[A CLINICAL STUDY OF CHRONIC HEPATITIS B
VIRUS CARRIERS TREATED WITH YI XIA ZHU].
CAO WEIZU ET AL. shanghai journal of traditional
chinese medicine. 1996;5:8 (chi).
1574- gera: 67451/di/ra
[CLINICAL AND EXPERIMENTAL STUDY ON
EFFECT OF GANYAN IV IN TREATMENT OF
CHRONIC ACTIVE HEPATITIS COMPLICATED
WITH HYPERBILIRUBINEMIA]. HU YAO-HUA ET
AL. chinese journal of integrated traditional and western
medicine. 1996;16(4):210 (chi*).
Sixty chronic active hepatitis patients complicated with
hyperbilirubinemia (total bilirubin> 171,umol/L) were treated
with combined treatment of Ganyan IV and Western
medicine. The curative effect was compared with that treated
with Western medicine alone as control (56 cases). Result
showed that the effect of combined therapy group was much
better than that of the control in eliminating the jaundice,
descending the alanine transaminase (ALT) and improving
the reversed A/G ratio (P<0.05~0.001). In experimental
studies, Ganyan IV was app]ied to the mice with acute liver
damage formed by CC14, it also showed significant effect on
reducing total bilirubin and elevating the serum albumin
statistically as compared with control (P<0.05~0.01). In
addition Ganyan N could accellerating the bile excretion of
normal as well as of liver damaged rats significantly. It was
concluded that the Ganyan IV has the effects of treating
jaundice, descending transaminase, elevating serum albumin
and improving
1575- gera: 67453/di/ra
[RELATIONSHIP BETWEEN THE BLOOD STASIS
SYNDROME OF HEPATOPATHY AND
HEMODYNAMICS OF PORTAL VEIN]. TANG ZHI-
MIN ET AL. chinese journal of integrated traditional and
western medicine. 1996;16(4):216 (chi).
1576- gera: 67493/di/ra
94
[CLINICAL AND EXPERIMENTAL STUDIES ON
EFFECTS OF CHRONIC HEPATITIS B TREATED
WITH ASTRAGALI COMPOSITA]. LIU KE-ZHOU ET
AL. chinese journal of integrated traditional and western
medicine. 1996;16(7):394 (chi*).
Eighty-seven cases of chronic persistent hepatitis(CPH)and
29 cases of chronic active hepatitis (CAH)were treated with
Astragali Composita (AC), the clinical markedly effective
rates were 69.0% and 55.2%, the total effective rates were
90.8% and 89.7% respectively ; the sero-negative conversion
rates of HBeAg and HBV-DNA were 27.7% and 28.0%
respectively, they were higher than that of control
group(P<0.05~0.01). Eight ducks infected duck hepatitis B
virus were treated with AC, sero-negative conversion of
DHBV-DNA was seen in 3 ducks, DHBV-DNA levels of
duck sera were lower after treatment than that before
treatment(P <0.05); mild inflammatory changes in liver
tissues were seen in 3 ducks, its pathologic changes were
milder than that of control groups; DHBV-DNA in liver
tissues of 2 ducks was negative in situhybridization. The
results indicated that AC had obvious effects of protecting
liver tissues and some effects of inhibiting sera H BV and H
BV replication.
1577- gera: 67507/di/ra
[EFFECT OF FUZHENG HUAYU RECIPE IN
TREATING POSTHEPATITIC CIRRHOSIS]. LIU PING
ET AL. chinese journal of integrated traditional and
western medicine. 1996;16(8):459 (chi*).
This article deals with the effect of Fuzheng Huayu recipe
(FZHYR), composed of Semen Persicae, Cordyceps, Radix
Salviae Miltiorrhizae, Pollen pint, etc. in treating
posthepatitic cirrhosis. 40 patients treated with FZHYR were
observed, and another 40 patients in simile condition treated
with symptomatic therapy were taken as control. Results
showed that the FZHYR could (1) Increase the serum level of
albumin and decrease the y-globulin; (2) Elevate the lowered
plasma branchedchain amino acid/aromatic amino acid ratio;
(3) Reduce the raised level of laminin and hyaluronic acid in
serum; (4) Escalate the level of CD3+, CD4+, CD4+/CD8+
ratio, NK cells activity and complement C3, lowered the
raised level of IgG and IgM in serum. In addition, it could
also adjust the anormal change of hormonal secretion. These
results suggested that FZHYR has beneficial effect in treating
posthepatitic cirrhosis, it acts multifariously and plays
important role either in controlling the development of
1578- gera: 67551/di/ra
[EFFECT OF FUZHENG HUAYU 319 RECIPE ON
SEROLOGICAL PARAMETERS OF FIBROSIS IN
TREATING CHRONIC HEPATITIS B]. LIU PING ET
AL. chinese journal of integrated traditional and western
medicine. 1996;16(10):588 (chi*).
Fifty-six patients with chronic hepatitis B were treated with
Fuzheng Huayu 319 Recipe (319 Recipe) for supplementing
body resistance and removing blood stasis, the efficacy was
compared with that of 19 cases treated with Dahuang
Zhechong Pill as control. The effective rate of the two groups
were 87.5% and 68.4% respectively. Results showed that the
319 Recipe could not only improve the clinical symptoms
and liver functions, but also reduce the serum levels of
monoamine oxidase B activity, tissue inhibitor of
metalloproteinase I (TIMP), procollagen type III N-terminal
peptide, collagen type N, hyaluronic acid and laminin, as well
as increase the excretion of urohydroxyproline markedly. As
compared with control group, the difference between the two
groups were significant except the change of TIMP, the
improvement of 319 Recipe group were more obvious than
that of control group (P <0.001~0.05). These results
displayed the good effect of 319 Recipe in treating chronic
gera 2011

hepatitis
1579- gera: 67562/di/ra
[CURRENT STATUS OF PREVENTING HEPATIC
FIBROSIS BY CHINESE MEDICINES]. YAN ZHONG-
SHENG ET AL. chinese journal of integrated traditional
and western medicine. 1996;16(10):634 (chi).
1580- gera: 67604/di/ra
[INHIBITORY EFFECTS OF CO-CINOBUFOTALIN
ORAL LIQUOR ON HEPATITIS B IN VITRO]. LIU
ZHUANG ET AL. chinese journal of integrated
traditional and western medicine. 1996;16(12):738 (chi*).
Co-Cinobufotalin Oral Liquor (CCOL) was studied for its
ability to inhibit hepatitis B virus DNA replication, HBsAg
and HBeAg expression in a HBV-transfected cell line (2.2.15
cell). The result showed that ID50 (the drug concentration
that inhibits HBsAg or HBeAg secretion by 50%) was 0.08
mg/ml and 0.07 mg/ml on HBsAg and HBeAg respectively.
CD50 (the drug concentration that reduces cell growth by
50%) was 2.5 mg/ml. TI (therapeutic index) was 31.3 and
35.7 respectively. The present data suggest that CCOL could
exert a potent antiviral activity against HBV in vitro.
Southern blot showed that CCOL inhibited HBV-DNA
replication in a dose-dependent
1581- gera: 67954/di/ra
[YU ERXIN'S ORIGINAL EXPERIENCE IN
TREATING ADVANCED LIVER CANCER]. XU YIYU.
shanghai journal of traditional chinese medicine. 1996;1:9
(chi).
1582- gera: 84709/di/ra
[ANALYSIS OF TREATMENT OF 15 CASES OF
ASCITES DUE TO OOPHOROMA]. GUANGRONG L.
china journal of tcm and pharmacy. 1996;11(1):24 (chi).
1583- gera: 85478/di/ra
[INVESTIGATION ON CURATIVE EFFECT OF
FUGANKANG GRANULES (RADIX
BUPLEURI,RADIX SALVIAE
MILTIORRHIZAE,ETC.) FOR HEPATITIS B]. MU
KEHONG ET AL. chinese traditional patent medicine.
1996;18(1):24 (chi*).
1584- gera: 85487/di/ra
[INVESTIGATION ON CURATIVE EFFECT OF
KUHUANG INJECTION (RADIX SOPHORAE
FLAVESCENTIS,RADIX ET RHIZOMA RHEI,ETC.)
FOR ICTERIC VIRAL HEPATITIS]. WU CHAO ET AL.
chinese traditional patent medicine. 1996;18(3):21 (chi).
1585- gera: 85496/di/ra
[COMPARATIVE STUDY ON LIVER-PROTECTING
ACTION OF DIFFERENT PROCESSED PRODUCTS
OF FRUCTUS GARDENIAE]. ZHANG XUELAN ET AL.
chinese traditional patent medicine. 1996;18(2):18 (chi).
1586- gera: 85609/di/ra
[EFFECT OF POINT-INJECTION THERAPY ON
SERUM MARKERS IN CHRONIC CARRIER OF
HEPATITIS B VIRUS]. LIU SHULUAN ET AL. chinese
acupuncture and moxibustion. 1996;16(3):7 (chi).
1587- gera: 85634/di/ra
[RELATIONSHIP BETWEEN SYNDROME-TYPING
AND TOTAL SERUM CONTENTS OF T3,T4 IN
CHRONIC HEPATITIS]. GAO QING ET AL. journal of
tcm. 1996;37(1):44 (chi).
95
1588- gera: 85655/di/ra
[OBSERVATION ON PRIMARY LIVER CARCINOMA
TREATED WITH QINGLONG (GREEN DRAGON)
BOLUS]. CHEN CHANGHUAI ET AL. journal of tcm.
1996;37(3):165 (chi*).
Two hundred cases were treated, with 90 cases treated by
chemotherapy as control for comparison. In the treatment
group, 17 cases (8. 5%) were totally or partially ameliorated,
161 cases (80. 5%) stable. There was significant amelioration
in clinical symptoms and survival quality in the treatment
group as compared with that of
1589- gera: 85744/di/ra
[CHRONIC B-HEPATITIS COMPLICATED WITH
ABNORMAL MENSTRUATION TREATED WITH
LARGE DOSE OF RADIX RUBIAE]. MA LIEQING.
journal of tcm. 1996;37(4):227 (chi).
1590- gera: 85759/di/ra
[OBSERVATION ON THERAPEUTIC EFFECTS OF
COMBINATION OF ACUPUNCTURE WITH DRUGS
ON SEVERE ICTERIC HEPATITIS]. CHEN YANNAN
ET AL. chinese acupuncture and moxibustion.
1996;16(4):15 (chi).
1591- gera: 85770/di/ra
[APPLICATION OF THE PRINCIPLE,"SPLEEN
SHOULD BE TONIFIED FIRSTLY FOR TREATMENT
OF HEPATOPATHY" IN CLINIC OF ACUPUNCTURE
AND MOXIBUSTION]. CHEN HAO. chinese
acupuncture and moxibustion. 1996;16(4):47 (chi).
1592- gera: 85801/di/ra
[CORRELATION BETWEEN TCM TYPES OF
SYNDROMES AND SERUM A POA-1,APOB IN
PATIENTS WITH CHRONIC VIRAL HEPATITIS B].
WANG XIANBO ET AL. journal of beijing university of
tcm. 1996;19(2):57 (chi*).
1593- gera: 85831/di/ra
[THE QUESTION OF INCUBATIVE PATHOGEN ON
CHRONIC HEPATITIS TREATMENT BASED ON
SYNDROME DIFFERENTIATION]. KUANG
CUIZHANG. china journal of tcm and pharmacy.
1996;11(2):44 (chi).
1594- gera: 85904/di/ra
[INTRODUCTION TO PRIMARY LIVER
CARCINOMA TREATED BY TCM]. LI ZUOQING.
journal of tcm. 1996;37(5):308 (chi).
1595- gera: 86069/di/ra
[RELATIONSHIP BETWEEN PICTURE OF THE
TONGUE AND HEPATIC PATHOLOGIC CHANGE
OF PATIENTS WITH CHRONIC HEPATITIS B]. LUO
QUN ET AL. journal of zhejiang college of tcm.
1996;20(5):29 (chi).
1596- gera: 86980/di/ra
[PERSPECTIVE STUDY ON INTELLIGENCE
QUOTIENT OF 28 HEPATIC LENTICULAR
DEGENERATION PATIENTS WITH TREATMENT
COMBINING TRADITIONAL CHINESE AND
WESTERN MEDICINE.]. CAI YONG-LIANG ET AL.
chinese journal of integrated traditional and western
medicine. 1996;16(1):6 (chi*).
1597- gera: 87244/di/ra
[54 CASES OF PRIMARY CARCINOMA OF LIVER
TREATED BY THE TCM DIFFERENTIATION OF
gera 2011

SYMPTOMS AND SIGNS]. JU CHANGRUI ET AL.
liaoning journal of traditional chinese medicine.
1996;23(4):168 (chi).
1598- gera: 87272/di/ra
[THE DIAGNOSIS AND TREATMENT OF CHINESE
MEDICINE AND MICROSCOPIC STUDY OF
ALCOHOLIC HEPATITIS]. ZHANG MINGXUE.
liaoning journal of traditional chinese medicine.
1996;23(7):299 (chi).
1599- gera: 88346/di/ra
[ON DEATH TIME OF 411 CASES OF SEVERE
HEPATIC DISEASE]. ZHANG YONG ET AL. shandong
journal of tcm. 1996;15(1):11 (chi).
1600- gera: 91378/di/ra
[TREATMENT OF HEPATITIS C BASED ON
IMMUNOREGULATION AND ANTIVIRUS
COMBINED WITH CHINESE AND WESTERN
MEDICINE]. CAO FU-QUAN. practical journal of
integrating chinese with modern medicine. 1996;9(1):6
(chi*).
1601- gera: 91604/di/ra
[DETECTION ON THE RELATIONSHIP BETWEEN
OXYGEN FREE RADICAL LEVELS AND VIRUS
HEPATITIS]. ZHU YAN-ZHEN. practical journal of
integrating chinese with modern medicine. 1996;9(2):76
(chi).
1602- gera: 91605/di/ra
[SHORT EFFEOFINE OBSERVATION OF
DIGESTIVE ULCER WITH WEILE DECOCTION].
SHEN YING ET AL. practical journal of integrating
chinese with modern medicine. 1996;9(2):77 (chi*).
1603- gera: 91610/di/ra
[CLINICAL AND EFFECTIVE OBSERVATION OF
SERIOUS VIRUS HEPATITIS BY INTEGRATED
CHINESE WITH MODERN MEDICINE]. CHEN JING-
JIAN ET AL. practical journal of integrating chinese with
modern medicine. 1996;9(2):91 (chi).
1604- gera: 91624/di/ra
[EXPERIMENTAL RESEARCH OF WULIAN YIGAN
DECOCTION IN TREATMENT OF MOUSE WITH
CIRRHOSIS]. QING GUI-LUN ET AL. practical journal
of integrating chinese with modern medicine.
1996;9(3):157 (chi).
1605- gera: 107194/di/ra
CLINICAL STUDY ON TREATMENT OF
DECOMPENSATED LIVER CIRRHOSIS WITH
COMBINATION OF RADIX SALVIAE
MILTIORRHIZAE AND MAGNESIUM SULFATE.
XIONG LI-LAN, ZHU SHI-CAI, CAO GUO-MING.
chinese journal of integrated traditional and western
medicine (english edition). 1996;2(3):207 (eng).
1606- gera: 55908/nd/re
PREVENTIVE EFFECT OF LITHOSPERMATE B
FROM SALVIA MILTIORHIZA ON EXPERIMENTAL
HEPATITIS INDUCED BY CARBON
TETRACHLORIDE OR D-
GALACTOSAMINE/LIPOPOLYSACCHARIDE. .
HASE K ET AL. planta med. 1997;63(1):22-6 (eng).
The water extract from the root of Salvia miltiorhiza Bunge
showed a protective effect on cultured rat hepatocytes against
carbon tetrachloride (CCl4)-induced necrosis. A further study
96
was carried out to isolate the active constituent. Activity
guided fractionation of the extract and chemical analysis gave
us lithospermate B (a salt of lithospermic acid B), a tetramer
of caffeic acid. Lithospermate B was also found to have a
potent hepatoprotective activity in not only in vitro but also
in vivo experimental liver injuries induced by CCl4 or D-
galactosamine (D-
1607- gera: 55963/nd/re
EVALUATION OF FOUR PRESCRIPTIONS OF
TRADITIONAL CHINESE MEDICINE : SYH-MO-
YIIN, GUIZHI- FULING-WAN, SHIEH-QING-WAN
AND SYH-NIH-SANN ON EXPERIMENTAL ACUTE
LIVER DAMAGE IN RATS. TSAI CC ET AL. j
ethnopharmacol. 1997;55(3):213-22 (eng).
Syh-Mo-Yiin (SMY), Guizhi-Fuling-Wan (GFW), Shieh-
Qing-Wan (SQW) and Syh-Nih-Sann (SNS) are four
prescriptions of Traditional Chinese Medicine (TCM) used in
the remedy of liver trouble in various types. The
hepatoprotective effects of water extracts of these four
recipes against D-galactosamine (D-GalN) and carbon
tetrachloride (CCl4)-induced acute hepatic damage were
determined in rats. The results indicated that the serum
glutamate-oxalate-transaminase (sGOT) and the serum
glutamate-pyruvate-transaminase (sGPT) levels provoked by
D-GalN and CCl4 decreased after treatment with these
prescriptions of TCM. Histological changes around portal
area (D-GalN-induced hepatotoxicity) and central vein
(CCl4-induced hepatotoxicity) were simultaneously
1608- gera: 55965/nd/re
[BIOACTIVE CONSTITUENTS OF CHINESE
NATURAL MEDICINES. III. ABSOLUTE
STEREOSTRUCTURES OF NEW
DIHYDROFLAVONOLS, HOVENITINS I, II, AND III,
ISOLATED FROM HOVENIAE SEMEN SEU
FRUCTUS, THE SEED AND FRUIT OF YOSHIKAWA
M ET AL. yakugaku zasshi. 1997;117(2):108-18 (jap*).
The methanol-soluble fraction from a Chinese natural
medicine Hoveniae Semen Seu Fructus, the seed and fruit of
Hovenia dulcis THUNB. (Rhamnaceae) was found to show
an inhibitory effect on the alcohol-induced muscular
relaxation and a protective activity on the D-
galactosamine/lipopolysa ccharide or carbon tetrachloride-
induced liver injury. Through bioassay-guided separation
using a traction performance test, three new dihydrofravonols
named hovenitins I, II, and III were isolated from Hoveniae
Semen Seu Fructus together with four known flavonoids, (+)-
ampelopsin, laricetrin, myricetin, and (+)-gallocatechin. The
absolute stereostructures of hovenitins I, II, and III were
determined on the basis of chemical and physicochemical
evidence to be (2R, 3R)-5,7,4',5'- tetrahydroxy-3'-
methoxydihydroflavonol, (2R,3S)-5,7,4',5'-tetrahydroxy-3'-
methoxy-dihydroflavonol, and (2R, 3S)- 5,7,3',4',5'-
pentahydroxydihydro-flavonol, respectively. Hovenitin I and
(+)-ampelopsin, both of which were principal ingredients of
the active fractions from this natural medicine, were found to
show an inhibitory activity on the ethanol-induced muscle
relaxation in rats. In addition, hovenitin I showed a protective
activity on the liver
1609- gera: 55995/nd/re
INHIBITORY EFFECTS OF OREN-GEDOKU-TO AND
ITS COMPONENTS ON CHOLESTERYL ESTER
SYNTHESIS IN CULTURED HUMAN HEPATOCYTE
HEPG2 CELLS : EVIDENCE FROM THE CULTURED
HEPG2 CELLS AND IN VITRO ASSAY OF ACAT. .
YOTSUMOTO H ET AL. planta med. 1997;63(2):141-5
(eng).
The pharmacological effects of Oren-gedoku-to (OGT), a
gera 2011

Japanese-Chinese traditional herbal medicinal mixture on
lipid biosynthesis were investigated in cultured human
hepatocyte HepG2 cells. The addition of OGT (0. 5 and 4. 2
mg/ml), which had no effect on cell proliferation and cellular
protein content, caused a marked decrease in the cellular
cholesterol content, particularly cholesteryl ester content
following 24 h incubation. The incorporation of 14C-oleate
into cellular cholesteryl ester fraction was also reduced
remarkably during incubation for 6 and 24 h. The effects of
OGT, its components and its main active chemicals on acyl-
coenzyme A:cholesterol acyltransferase (ACAT) activity
were studied in vitro to explore the mechanism by which
OGT inhibits cholesteryl ester formation. The data confirmed
that OGT, in a dose-dependent manner, and its components
(Scutellaria baicalensis, Coptis japonica, Gardenia
jasminoides and Phellodendron amurense) remarkably inhibit
ACAT activity. Among the main active chemicals of OGT,
baicalein, a kind of flavonoid, decreased ACAT activity in a
dose-dependent fashion from the level of 10(-6)M. These
results strongly suggest that OGT reduces the cholesteryl
ester formation in human hepatocytes by inhibiting ACAT,
and that baicalein may, in part, be responsible for ACAT
inhibition.
1610- gera: 56001/nd/re
THE EFFECT OF DIPHENYL-DIMETHYL-
DICARBOXYLATE ON CYCLOSPORINE-A BLOOD
LEVEL IN KIDNEY TRANSPLANTS WITH CHRONIC
HEPATITIS. . KIM YS ET AL. korean j intern med.
1997;12(1):67-9 (eng).
An adequate blood level of cyclosporine-A (CsA) is essential
to keep graft function in kidney transplants. Due to a narrow
therapeutic index and highly variable pharmacokinetic
properties associated with CsA, drug interactions may have a
significant impact on the immunosuppressive efficacy or
toxicity of CsA. Numerous drug interactions of potential
clinical significance involving CsA have been reported.
Dephenyl-dimethyl-dicarboxylate (PMC), a hepatotonic drug,
is a substance derived from the synthesis of Schizandrae
fructus elements. We have experienced two cases of drug
interaction between CsA and PMC in kidney transplants with
chronic hepatitis. In both cases, CsA troughs decreased
markedly to a subtherapeutic level following administration
of PMC. We, therefore, suggest that PMC could decrease the
CsA trough level and thus a close monitoring of the CsA
trough level is necessary during
1611- gera: 56018/nd/re
HEPATOPROTECTIVE EFFECT OF HOVENIA
DULCIS THUNB. ON EXPERIMENTAL LIVER
INJURIES INDUCED BY CARBON
TETRACHLORIDE OR D-
GALACTOSAMINE/LIPOPOLYSACCHARIDE. .
HASE K ET AL. biol pharm bull. 1997;20(4):381-5 (eng).
The hepatoprotective effects of the fruits of Hovenia dulcis
THUNB. on chemically or immunologically induced
experimental liver injury models were examined. The
methanol extract showed significant hepatoprotective activity
against CCl4-toxicity in rats and D-galactosamine (D-
GalN)/lipopolysaccharide-induced liver injury in mice. The
methanol extract also significantly protected against CCl4-
toxicity in primary cultured rat hepatocytes. Hepatoprotective
activity-guided fractionation and chemical analysis led to the
isolation of an active constituent,
1612- gera: 56588/di/ra
[THE CLINIC OBSERVATION ON THE TREATMENT
OF 36 CASES OF HEPATITIS (HBV) BY
MOXIBUSTION AND PRICKING BLOOD THERAPY].
LIU XINMENG ET AL. acupuncture research.
97
1997;22(3):190 (chi*).
In this paper, authors treated the thirty-six cases of hepatitis
(HBV) by moxibustion and pricking blood therapy. Through
the observation of nine to twenty-four moiths, the full
recovery was seven cases (19,49%), the total effective rate
was 83,3%. The result showed that this method had better
effects to enhance the function of immunity; to promote the
disease-resistance ability; to eliminate the HBV; to induce the
production of the anti-
1613- gera: 56932/di/ra
[CLINICAL OBSERVATION ON 100 CASES OF E-
TYPE VIRAL HEPATITIS TREATED BY
DIFFERENTIATION OF SYNDROMS AND SIGNS
(BIAN ZHENG) : WITH COMPARATIVE
OBSERVATION ON 100 CASES OF A-TYPE VIRAL
HEPATITIS AS CT]. ZHANG WEI ET AL. journal of
tcm. 1997;38(1):37 (chi*).
1614- gera: 57149/di/ra
[CLINICAL AND CYTOLOGICAL STUDIES ON
CARCINOGENIC ASCITIS TREATED BY TOPICAL
APPLICATION OF CHINESE MEDICAMENTS]. TAN
HUANGYING. journal of tcm. 1997;38(3):165 (chi).
1615- gera: 57599/di/ra
PREVENTIVE EFFECT OF OREN-GEDOKU-TO
(HUANGLIAN-JIE-DU-TANG) EXTRACT ON
PROGRESSION OF CARBON TETRACHLORIDE-
INDUCED ACUTE LIVER INJURY IN RATS. OHTA Y
ET AL. american journal of chinese medicine.
1997;25(1):57-68 (eng ).
The effect of oral administration of Oren-gedoku-to
(Huanglian-Jie-Du-Tang) extract (TJ15) on the progression
of acute liver injury was examined in rats intoxicated with
carbon tetrachloride (CCl4). WhenTJ-15 at a close of 500
mg/kg body weight (b.w.)was administered to male Wistar
rats aged seven weeks 6 hours afteri.p. injection of CCl4 (1,0
ml/kg b.w.), an apparent liver injury occurred. Significant
prevention against the progression of liver injury was found
24 hours after the injection judging from the activities of
serum transaminases and other indices of liver cell damage.
An increase in lipid peroxide level and decreases in reduced
glutathione level and superoxide dismutase (SOD) activity
occurred in the liver at 6 and 24 hours after CC l4 injection.
Serum SOD activity increased 24 hours after CCl4 injection.
Post-oralTJ-15 administration significantly ameliorated all
these changes found at 24 hours after CCl4 injection. An
increase in liver triglyceride level and a decrease in serum
triglyceride level also occurred 6 and 24 hours after CCl4
injection. Post-oral TJ-15 administration prevented the
increase in liver triglyceride level at 24 hours after CC l4
injection. Although the activity of liver tryptophan 2,3-
dioxygenase (TDO), a marker of the inhibition of liver
protein synthesis by CCl4, decreased 6 and 24 hours after
injection of the toxicant, post-oral TJ- 15 administration had
no effect on this decrease in TDO activity at 24 hours after
the injection. These results indicate that oral TJ-15
administration can prevent the progression of acute liver
injury in CCl4-injected rats, and suggest that this prevention
could be due to the action of TJ- 15 to scavenge free radicals
formed in the liver and to inhibit triglyceride accumulation in
the liver.
1616- gera: 57605/di/ra
EFFECT OF NIUSCHE-SHEN-QI-WAN ON PAINFUL
MUSCLE CRAMPS IN PATIENTS WITH LIVER
CIRRHOSIS : A PRELIMINARY REPORT. MOTOO Y
ET AL. american journal of chinese medicine.
1997;25(1):97-02 (eng ).
gera 2011

Twelve patients with liver cirrhosis complaining of painful
muscle cramps were treated with Niuche-Shen-Qi-Wan (TJ-
107). Three patients were at the decompensated state. Muscle
cramps disappeared in 4 weeks on the average after oral
administration of TJ- 107 in all 12 patients. During the period
of TJ- 107 administration, there was no significant
improvement of hepatic function. One patient complained of
mild epigastric discomfort after taking TJ- 107, but there
were no other adverse effects. Our results indicate that TJ-
107 is useful for treatment of painful muscle cramps in
cirrhotic patients.
1617- gera: 57643/di/ra
EFFECT OF GEGEN-TANG ON PAINFUL
GYNECOMASTIA IN PATIENTS WITH LIVER
CIRRHOSIS: A BRIEF REPORT. MOTOO Y ET AL.
american journal of chinese medicine. 1997;25(3-4):317-
24 (eng ).
Four patients with liver cirrhosis and complaining of painful
gynecomastia were treated with oral administration of
Gegen-Tang (TJ- I ). Pain disappeared in 3 patients in one
week, and in one patient in 4 weeks. The size of
gynecomastia did not change significantly on mammography,
but palpable induration diminished or disappeared. The
patients had been treated with Chaihu (saiko) group drugs for
liver diseases, and TJ-1 was used in combination with these
drugs. Serum levels of oestrogen, progesterone, testosterone,
and other sex hormones did not change significantly after TJ-
I treatment. These results suggest that TJ- I could be used for
the painful
1618- gera: 57644/di/ra
THE HEPATOPROTECTIVE AND THERAPEUTIC
EFFECTS OF PROPOLIS ETHANOL EXTRACT ON
CHRONIC ALCOHOL-INDUCED LIVER INJURIES.
SONG-CHOW LIN ET AL. american journal of chinese
medicine. 1997;25(3-4):325-32 (eng ).
Propolis designates a mixture of gums, resins and balms, of
viscous consistency, which are gathered on certain parts
(buds and bark, mainly) of vegetables (especially coniferous
trees) by honeybees. They bring this back to the hive, where
it is modified and mixed with other substances (essentially
their own wax and salivary secretions). In this study, the
hepatoprotective and therapeutic effects of propolis ethanol
extract on chronic alcohol-induced liver injuries were
investigated in rats. 3.125 ml of 99.5% alcohol was added to
animal's daily diet for four weeks to induce chronic alcohol
liver injuries. After sacrifice, serum transaminases (GOT,
OPT), triacylglyceride and hepatic triacylglyceride (HTG)
concentration were assayed to observe liver injuries induced
by chronic alcohol abuse. In addition, the phenomenon of
alcohol induced fatty liver were also observed by
histopathological changes. Different doses of propolis
ethanol extract were p.o. administered three times per day for
three days, after four weeks' alcohol administration. It was
found that 10 mg/kg of propolis ethanol extract significantly
decreased the elevations of serum GOT, GPT TG and HTG.
In histopathological examination, 30 mg/kg of propolis
ethanol extract also remarkably decreased the hepatocellular
fatty degeneration, apparent as vacuolization, induced by
chronic alcohol abuse.
1619- gera: 57645/di/ra
COMPARATIVE STUDY OF ORAL AND
PARENTERAL ADMINISTRATION OF SHO-SAIKO-
TO (XIAO-CHAIHU-TANG) EXTRACT ON D-
GALACTOSAMINE-INDUCED LIVER INJURY IN
RATS. OHTA Y ET AL. american journal of chinese
medicine. 1997;25(3-4):333-42 (eng ).
The preventive effect of Sho-saiko-to (Xiao-Chaihu-Tang)
98
extract (TJ-9) on the progression of D-galactosamine (GalN)-
induced liver injury was examined in five week-old male
Wistar rats with oral (p.o.) or intraperitoneal (i.p.)
administration of the same dose of TJ-9. Rats treated once
with GalN (500 mg/kg body weight, i.p.) received TJ-9 at a
dose of 1.0 g/kg body weight (p.o. or i.p.) 2 hours after GalN
treatment at which time an apparent liver injury occurred.
Both p.o. and i.p administration of TJ-9 showed similar
significant prevention against the progression of liver injury
24 hours after GalN injection. Although total protein and
albumin concentrations in serum and protein concentration in
the liver decreased with the progression of GalN-induced
liver injury, oral or i.p. administration of TJ-9 prevented
these decreases in similar degree. However, decreases in
serum and liver triglyceride concentration with the
progression of liver injury were not attenuated after p.o. or
i.p. administration of TJ-9. The activities of liver 5'-
nucleotidase and glucose-6-phosphatase marker enzymes of
liver plasma and microsomal membranes, respectively,
decreased during the progression of liver injury. A similar
preventive effect on the decrease of both enzyme activities
was found after p.o. or i.p. administration of TJ-9. These
results indicate that the preventive effect on progression of
GalN-induced liver injury by oral or i.p. administration is
approximately equal, and that the effect may be through
improving the impaired liver protein synthesis and disrupted
liver plasma and microsomal membranes in a similar degree.
1620- gera: 57652/di/ra
EVALUATION OF THE ANTIOXIDANT AND
HEPATOPROTECTIVE ACTIVITY OF TERMINALIA
CATAPPA . CHUN-CHING LIN ET AL. american journal
of chinese medicine. 1997;25(2):153-61 (eng ).
The free radical scavenging and antihepatotoxic activity from
Terminalia catappa was studied. Treatment with T. catappa
water extracts showed antihepatotoxic activity against CCL4-
induced toxicity in the rat liver that was tested. The crude
drug also exhibited anti-oxidant effects in FeCl2-Ascorbic
acid induced lipid peroxidation in the rat liver homogenate.
Moreover, the superoxide radical scavenger effect of T.
catappa was demonstrated using electron spin resonance
(ESR) and spintrapping technique. The results indicate that T.
catappa possesses good antihepatotoxic activity and
superoxide radical scavenger activity.
1621- gera: 57657/di/ra
AMELIORATIVE EFFECT OF TRADITIONAL
CHINESE MEDECINE PRESCRIPTIONS ON ALPHA-
NAPHTHYLISOTHIOCYANATE AND CARBON-
TETRACHLORIDE INDUCED TOXICITY IN RATS.
CHIN-CHUAN TSAI ET AL. american journal of chinese
medicine. 1997;25(2): 185-96 (eng ).
Syh-Mo-Yin (SMY), Guizhi-Fuling-Wan (GFW), Shich-
Qing-Wan (SQW)and Syh-NihSan (SNS) are prescriptions of
Traditional Chinese Medicine (TCM) for liver disease. The
effects of these four prescriptions against experimental liver
injury induced by alpha-Naphthylisothiocyanate (ANIT) and
carbon tetrachloride (CCl4) were studded. Rats treated with
ANIT(IOO mg/kg) exhibited elevations of serum tote]
bilirubin (TBI), alkaline phosphatase (ALP), glutamate-
oxalatetransaminase (sGOT) and glutamate-pyruvate-
transaminase (sGPT) as well as cholestasis and
parenchymanecrosis. In rats receiving SMY, SQW and SNS
treatment after ANIT challenged, the biochemical and
morphological parameters of liver injury were significantly
reduce. Elevated lipid peroxidation (LPO) level in liver
tissue, associated with an increase in serum GOT and GPT
level, was observed in CCl4-treated rats. Treatment with
these four prescriptions on CCl4-induced liver injury rats
showed a remarkable hepatoprotective effect. A significant
gera 2011

decrease in peroxidative level suggested that these
prescriptions have anti free radical properties.
1622- gera: 58252/di/ra
[CLINICAL STUDY ON THE EFFECT OF
NOURISHING THE LIVER TO DOWN REGULATING
ENZYME ACTIVITY IN "SYNOPSIS OF THE
GOLDEN CHAMBER"). LU LIANGWEI. china journal
of traditional chinese medicine and pharmacy.
1997;12(4):27 (chi ).
1623- gera: 58262/di/ra
[(PRELIMINARY EXPLORATION ON HEPATIC
DISEASE INDUCED BY ALCOHOL VIEWED FROM
TCM).]. YIE YONGAN ET AL. china journal of
traditional chinese medicine and pharmacy. 1997;12(5):8
(chi*).
The name of TCM and features of its pathogenesis of hepatic
disease induced by alcohol was advanced based on review of
ancient literature and combination with the point of modern
clinical. Jinpi corresponding to the compensatory phase of
hepatic disease induced by alcohol was chosen as research
object, and 53 compound prescriptions which could be
treatment of Jinpi recorded in TCM literature were
comparative analyzed. The results showed that hepatic
disease induced by alcohol belonged to Shangjiu, Xietong,
Huangdan, Jinpi and Jingui of TCM, its locations were liver,
spleen and kidney, its main pathogenesis was spleen
deficiency with overabundance of dampness, deficiency of
liver-yin and kidney-yin, deficiency of spleen-yang and
kidney-yang, while congeital
1624- gera: 58280/di/ra
[(ANALYSIS ON TREATMENT AND CLINICAL
CHARACTERISTICS OF CHRONIC B AND C
HEPATITIS).]. HONG HUIWEN ET AL. journal of
traditional chinese medicine. 1997;38(12):732 (eng*).
Retrospective comparison was made on 100 cases of chronic
B - hepatitis and 50 cases of C chronic hepatitis. It was found
that their were several characteristics. including male
susceptibility. similar syndrome and fluctuating hepatic
functions. However. there were differences. such as more
ways of spreading with higher incidence in the age-range
from 18 - 42 mostly in active chronic condition in the former
group, whereas for the latter group the way of spreading was
simple. mostly persistent in its course. and occurred mostly in
elderly and middle--aged. due to differences in their
viralgene and pathogenesis. For the B-hepatitis group. most
patients were of damp- heat type. with high scoring for their
syndromes. whereas. for the C - hepatitis. the scoring for
syndromes was lower. and can be effectively treated with
blood-cooling. blood activating and detoxifying drugs. but
the total rate of relapse was
1625- gera: 58289/di/ra
[(ANALYSES OF THE TREATMENT OF
TYMPANITIES IN THE ANCIENT TIMES).]. YANG
BO. traditional chinese medicinal research. 1997;10(2):7
(chi ).
1626- gera: 58300/di/ra
[(REVIEW ON TREATMENT AND PREVENTION OF
EXPERIMENTAL FIBROSIS OF LIVER WITH
CHINESE MATERIA MEDICA).]. YANG LING.
traditional chinese medicinal research. 1997;10(1):46 (chi
).
1627- gera: 58421/nd/re
LACK OF DEAFNESS IN CRIGLER-NAJJAR
SYNDROME TYPE 1: A PATIENT SURVEY. SURESH
99
G ET AL. pediatrics. 1997;100(5):E9 (eng ).
We performed a questionnaire survey about 42 patients with
Crigler-Najjar syndrome type 1 who were currently alive.
Information was obtained on their age, sex, birth weight,
gestation, parental consanguinity, other family members
affected, age of onset of jaundice, neonatal and postneonatal
bilirubin values, neonatal and postneonatal therapy, problems
faced with phototherapy, liver transplantation, current growth
status, current neurologic status, and the status of hearing.
Patients were between 2 months and 21 years of age. There
were 18 males and 24 females. Thirty-nine patients had been
born at full term gestation and 3 had been preterm. Jaundice
was noted on postnatal day 1 in 34%, between days 2 and 4
in 55%, and after day 11 of life in 11% of patients. In the
neonatal period bilirubin values (mean +/- SD) were typically
19.8 +/- 4.5 mg/dL. Eighty-six percent of patients had
neonatal peak bilirubin values of >20 mg/dL. Parental
consanguinity was present in 44% and a history of Gilbert's
disease in one parent was present in 10% of patients. Causes
of exacerbations of jaundice reported were respiratory
infections, febrile illnesses, vaccinations, fasting, surgery,
emotional stress, and noncompliance with treatment.
Neonatal therapy consisted of exchange transfusion in 28%,
phototherapy in 79%, phenobarbitone in 20%, and
cholestyramine, albumin, infusions, and plasmapheresis in
one case each. The mainstay of postneonatal therapy was
home phototherapy for 10 to 16 hours, primarily at night
during sleep, using blue lights or a combination of blue and
fluorescent lights. Some patients used innovatively designed
phototherapy units. Problems reported with phototherapy
were decreased effectiveness with age, poor compliance,
restriction of activity and play, inability to travel or take
vacations, irritation from eye shades, difficulty keeping eye
protection on, difficulties in temperature maintenance,
tanning of the skin, embarrassment from the need to be
nearly nude during phototherapy, and difficulty in procuring
phototherapy lamps. Other therapies that had been tried
included oral agar, albumin infusions, antioxidants,
acupuncture, bilirubin oxidase, calcium infusions, clofibrate,
cruciferous vegetables, cholestyramine, chlorpromazine,
flumecinol, plasmapheresis, tin mesoporphyrin,
ursodeoxycholic acid, and urinary alkalinization. Fifteen
children had undergone liver transplantation (5 auxiliary and
10 orthotopic). All 42 patients are reportedly of normal
height and weight. Neurodevelopmental status is said to be
normal in 77% of patients. Two patients have kernicterus, 4
have cerebellar symptoms, and 1 each has developmental
delay, mild intention tremor, and mild speech delay. Hearing
was reported to be normal in 94% of patients. The 2 children
with hearing loss have conductive loss from otitis media.
With home phototherapy prolonged, survival free of
neurologic deficits is possible in Crigler-Najjar syndrome
type 1, but there are many problems associated with
phototherapy. Avoiding exacerbations of jaundice is an
important aspect of management. Liver transplantation offers
the prospect of cure but its risk versus benefit ratio is
undetermined.
1628- gera: 66975/di/ra
[THE EFFECT OF DIFFERENT TYPES OF
CIRRHOSIS ON AST, ALT AND THEIR RATIO]. ZHU
FANGSHI ET AL. liaoning journal of traditional chinese
medicine. 1997;24(8):339 (chi*).
The serum AST and ALT detection and AST/ALT stagnation
analysis on 89 liver cirrhosis patients of 6 syndrome types
show that AST ALT and AST/ALT stagnation are higher
than those o{ normal persons. Liver Qi depression and spleen
Qi deficiency type is the lowest whereas spleen-kidney Yang
deficiency type and Qi stgnancy and both blood type the
highest. There is marked difference (P<O. 05 and 0.
gera 2011

Ol)between the indexes of all the other syndrome types and
those of normal except liver Qi depression and spleen Qi
deficiency type and retention of dampheat type (P>O. 05).
The research suggests that the syndrome type of liver
cirrhosis raries as well as liver injury. Along with the
development of TCM pathological mechanism and the
change of syndrome types, AST ALT and AST/ALT
stagnation tend to rise gradually. They seem to present
progressive increase tendency from liver Qi depression and
spleen Qi deficiency type of compensatory phase to water-
fluid retention type , spleen-kidney Yang deficiency type and
liver-kidney Yin deficiency type of decompensation phase.
However,ALT rises step by step and seems irregular.
Therefore,we may consider AST and AST/ALT stgnation as
one of the objective indexes for differentiation of symptoms
and signs and the classification of syndrome types of liver
cirrhosis.
1629- gera: 67520/di/ra
[CLINICAL STUDY OF INTEGRATED
TRADITIONAL AND WESTERN MEDICINE
THERAPY ON HEPATOLENTICULAR
DEGENERATION]. REN MING-SHAN ET AL. chinese
journal of integrated traditional and western medicine.
1997;17(3):136 (chi*).
Objective: To investigate the curative effect of integrated
traditional and western medicine (TCM-WM) therapy on
hepatolenticular degeneration (HLD). Methods: Eighty
patients with HLD were divided randomly into two groups
(TCM-WM group and WM group) ,TCM-WM group (40
cases) were given orally dimercaptosuccinic acid (DMSA)
and Gandou decoction for 1 month. The efficacy was
compared with that of 40 cases treated with DMSA as the
control. The changes of urinary trace and macro-elements
before and after treatment were observed. Results: The total
effective rate of TCM-WM group was significantly higher
than that of WM group (P<0. 05), especially more patients
with hepatic type responded well to treatment with TCM-
WM than with only chelating agent DMSA. Urinary trace
and macro-elements were all obviously elevated in patients of
two groups after treatment (P<0. 01). Conclusion: TCM-WM
therapy appears extremely promising as new cupruretic
method for treatment of HLD. It is
1630- gera: 67527/di/ra
[CLINICAL AND EXPERIMENTAL STUDY ON
TREATMENT OF CHRONIC HEPATITIS B WITH
YANGGAN AOPING MIXTURE]. YU RONG-QING ET
AL. chinese journal of integrated traditional and western
medicine. 1997;17(3):155 (chi*).
Objective: To assess the efficacy of Yanggan Aoping
Mixture (YGAPM) in treating hepatitis B. Methods : Patients
suffered from chronic hepatitis B were treated with YGAPM.
Observe their short and long-term efficacy and the change of
serum hepatitis B virus marker. In experiment, the effect of
YGAPM in treating rat's liver injury as well as HBV-infected
tree shrew and duck HBV-infected ducks was observed.
Results: In 79 cases of chronic persistent hepatitis, the
markedly effective rate was 60. 76% , and follow-up studies
on 40 cases, the futher rasied to 70. 00%. In 73 cases of
chronic active hepatitis, the markedly effective rate was 60.
27% land further raised to 62. 50% in 32 follow-up cases. In
the treatment group, 85 (71. 43%) of the 119 cases with
HBeAg-positive turned to negative. Whereas in the control
group, only 40 (44. 94%) of 89 HBeAg-positive cases turned
to negative, P<0. 01. Results of experimental study showed
that negative conversion rate of tree shrew infected with
HBV marker was raised, while infected duck blood with duck
HBV DNA was inhibited. Those compared with the control
group separately, the difference was remarkably significant.
100
Conclusions: YGAPM is an effective drug in treating chronic
hepatitis B, and
1631- gera: 67532/di/ra
[SURVEY AND PROGRESS ON RESEARCH OF
CHINESE MEDICINAL HERBS INTERVENTION
THERAPY IN TREATING PRIMARY LIVER
CARCINOMA]. CHENG JIAN-HUA ET AL. chinese
journal of integrated traditional and western medicine.
1997;17(3):187 (chi).
1632- gera: 67568/di/ra
[CONTRAST ANALYSIS OF BRAINSTEM
AUDITORY EVOKED POTENTIAL IN UNTREATED
AND TREATED HEPATOLENTICULAR
DEGENERATION PATIENTS WITH TREATMENT
OF COMBINIG TRADITIONAL CHINESE AND
WESTERN MEDICINE]. XU SHENG-HONG ET AL.
chinese journal of integrated traditional and western
medicine. 1997;17(1):17 (chi*).
Objective: To observe the effect of combination therapy of
traditional and Western medicine (TCM-WM) on brainstem
auditory evoked potential (BAEP) in hepatolenticul ar
degenerati on patients. Methods: BAEP was recorded and
analysed in 65 patients with hepatolenticular degeneration
(HLD) before and after decoppered TCM- WM treatment.
Results: The peak latency (PL) and interpeak latency (IPL) of
BAEP in untreated patients were greatly increased compared
with those of control group, especially in the prolongations of
III, V, III- V and I - V. The PL and IPL improved as
improvement of clinical symptoms in HLD patients treated
with TCM-WM than that in untreated patients. The abnormal
rates of men and women in BAEP were decreased from 21.
97% and 19. 05% in untreated patients to 9.09% and 6.75%
in treated patients respectively. Conclusion: BAEP not only
has an complementary diagnosis but also judge the efficacy
of treatment on the HLD disease.
1633- gera: 67587/di/ra
[OBSERVATION ON SHORT-TERM EFFICACY OF
SHUGANMEI IN TREATING CHRONIC HEPATITIS
B AND POSTHEPATITIC CIRRHOSIS]. ZHENG
DONG-ZHEN ET AL. chinese journal of integrated
traditional and western medicine. 1997;17(2):84 (chi).
1634- gera: 67672/di/ra
[EFFECT OF JIAWEI DACHAIHU DECOCTION ON
BLOOD T LYMPHOCYTE SUBSTES AND TUMOR
NECROSIS FACTOR IN PATIENTS WITH
OBSTRUCTIVE JAUNDICE]. GONG TAO ET AL.
chinese journal of integrated traditional and western
medicine. 1997;17(11):660 (chi*).
Objective: To observe the effect of the preoperative Jiawei
Dachaihu decoction in improving cellular immune functions
in patients with obstructive jaundice. Methods: Forty patients
were randomly divided into two groups with (group B) and
without (group A) the herbal therapy. And their preoperative
T lymphocyte subsets, TNF and the postoperative dynamic
changes were measured. Results: CD3, CD4 and CD4/CD8
decreased and TNF increased in the patients. CD3, CD4 and
CD4/CD8 decreased much less and were lower than
preoperative levels 2 days after the operation. CD3 CD4 and
CD4/CD8 were higher and TNF lower than preoperative
levels in group A after 20 days of the operation (all of them
P<0.05). Conclusions: The operation could be helpful to
recover immune functions of T lymphocyte and decrease
TNF levels. The perioperative herbal therapy is an important
adjuvant
1635- gera: 67685/di/ra
gera 2011

[EFFECTS OF TETRAMETHYLPYRAZINE ON
PLATELET FUNCTIONS OF ADVANCED CASES OF
LUNG CARCINOMA]. CHEN SHAO-XIAN ET AL.
chinese journal of integrated traditional and western
medicine. 1997;17(9):531 (chi*).
Objective: To explore the role of hypercoagulation in the
metastasis of carcinoma. Methods: The effect of
Tetramethylpyrazine (TTMP) on platelet functions among the
25 advanced cases of lung carcinoma, and 26 matched
control subjects were investigated in the study. Their ages
varied from 31~86 years (mean 58.2) in lung carcinoma
group (13 male, 12 female) and 36 to 61 (mean 52. 9) in the
control group (16 male, 10 female). The pathologic types
were as follows :7 cases of squamous cell cancer, 12
adenocarcinoma, 2 small cell carcinoma and 4
undistinguished type. The TNM stage revealed 14 cases in
stage III a, 3 in stage III b and 8 in stage IV . The site of
metastasis metastasis included mediastinal lymph node,
pleura, supraclavicular lymph node, brain, spine, costa, skin
and pericardium. The levels of plasma TXB2, 6-keto-
PGF1alpha, VIII : C, vWF, AT- III: a, AT- III : Ag, Fg and
blood PAdT, PAgT were measured before and after the
intravenous infusion of 80 mg TTMP in patients with lung
carcinoma. Results: The levels of TXB2, 6-keto-PGF1alpha,
VIII: C, vWF and Fg in lung carcinoma group were
significantly elevated, while the levels of PAdT was greatly
decreased, compared with the control group, no significant
differences in levels of PAgT, AT -III: a and AT- III : Ag
were found between the two groups. After the infusion of
TTMP the levels of PAdT, PAgT, VIll : C, dWF and Fg were
decreased significantly, while TXB2, 6- keto-PGF1alpha,
AT- III: a and AT-III: Ag remained unchanged. Conclusions:
TTMP inhibits the adhesion and aggregatory functions of
blood platelet and the activity of coagulation factors. It might
be one of the mechanisms of TTMP's antimetastasis of lung
carcinoma.
1636- gera: 67688/di/ra
[TREATMENT OF SEVERE CHOLESTATIC
HEPATITIS BY INTEGRATED TRADITIONAL
CHINESE AND WESTERN MEDICINE]. HE JIANG-
PING ET AL. chinese journal of integrated traditional
and western medicine. 1997;17(9):540 (chi*).
Objective : To study the curative effect of Chinese medicine
in treating severe cholestatic hepatitis (SCH). Methods :
Three hundred and fifty patients of SCH with total bilirubin
level >ou=171µmol/L were treated with Chinese medicines.
For those with Blood Stasis Syndrome, treated with the
recipe mainly consisted of Radix Paeoniae Rubra, and for
which accompanied with blood Heat, fluid retention in
epigastric region, Dampness dissenubated in Sanjiao or both
Spleen and Kidney Yang-Deficiency Syndrome, the recipe
was used in modification according to the Syndrome.
Results: Treatment was markedly effective in 288 cases and
effective in 26 cases, the total effective rate being 89. 7% 0
Conclusion: It is difficult in treating severe cholestatic
hepatitis, especially the chronic cholestatic hepatitis, which
could develop to severe chronic hepatitis if the jaundice
lasted for a long time. This study showed a good effect of
Chinese herbal medicine in eliminating jaundice.
1637- gera: 67697/di/ra
[THE CLINICAL STUDY ON TREATMENT OF
HEPATIC FIBROSIS OF HEPATITIS B BY IFN-
ALPHA1 AND CHINESE MEDICAL PREPARATION].
CHENG MING-LIANG ET AL. chinese journal of
integrated traditional and western medicine.
1997;17(8):453 (chi*).
Objective: To find the effective method of curing hepatic
fibrosis of hepatitis B. Methods: Using interferon alpha1 and
101
Chinese medical preparation to treat patients with hepatic
fibrosis of hepatitis B and the comprehensive indexes,
including levels of laminin, precollagen type m and
hyaluronic acid, liver puncture, ultrasonographic and fiber-
gastroscopic examination were observed before and after
treatment. Results: After 3 months of treatment, the fibrotic
indexes lowered obviously, in comparing with those before
treatment, the difference was significant (P<0.001). Liver
biopsy, B-type ultrasonographic and fiber-gastroscopic
examination proved that the hepatofibrosis was improved.
The hepato fibrotic indexes, blood albumin and globulin level
were re-examined after 6 months, results showed that the
difference between the IFN-effective group and the IFN-
ineffective group was significant, P < 0.001. Conclusions:
Beneficial effect might be obtained by using IFN-alpha1 to
suppress the replication of hepatitis B virus and Chinese
medical preparation to treat hepatic fibrosis.
1638- gera: 67698/di/ra
[CLINICAL AND EXPERIMENTAL STUDY ON
TREATMENT OF FATTY LIVER OF PHLEGM-
DAMPNESS STAGNATION TYPE BY ZHIGANLE
CAPSULE]. ZHAO WEN-XIA ET AL. chinese journal of
integrated traditional and western medicine.
1997;17(8):456 (chi*).
Objective: To explore the mechanism of Zhiganle capsule
(ZGLC) in treating fatty liver of Phlegm-Dampness
Stagnation type. Methods: One hundred and forty-six patients
were treated with ZGLC, the effects were observed and
compared with those treated with Dongbao Gantai (DBGT)
tablets as control. The effect of ZGLC on ethionine induced
hyperlipemia model rats was also observed. Results: The
effect of ZGLC was obviously better than those of DBGT in
relieving or removing symptoms, normalizing the ultrasonic
abnormal findings, lowering the serum levels of lipid and
enzyme and improving hemorrheologic properties.
Experimental study showed that ZGLC could reduce the
blood lipids, inhibit the lipid deposition in liver. As compared
with the model group, level of triglyceride in the ZGLC
treatment group were much lowered (P<0.01) and the effect
was better than those in the control group. Conclusions:
ZGLC has the effect of reducing blood triglyceride level,
inhibiting lipid deposition in
1639- gera: 67699/di/ra
[CLINICAL OBSERVATION ON TREATMENT OF
INFANTILE CHOLESTATIC HEPATITIS
SYNDROME BY RHUBARB]. HUANG ZHI-HUA ET
AL. chinese journal of integrated traditional and western
medicine. 1997;17(8):459 (chi*).
Objective: To evaluate the role of Rhubarb in treating
infantile cholestatic hepatitis syndrome ( IHS) . Methods:
Forty-four patients of the treatment group were treated with
Rhubarb per os and /or duodenal infusion, 20 cases of the
control group were treated with general liver protecting
therapy such as inosine, vitamin C and glucose. Serum
bilirubin, alanine transaminase (ALT) and y-glutamyl
transferase (y-GT) level, bilirubin in duodenal juice and liver
size were observed before and after treatment. Results: In the
treatment group, 18 cases were markedly effective, 21
effective, 3 ineffective and 2 were deteriorated, while in the
control group, the respective number were 0, 4, 13 and 3.
Conclusions: Rhubarb was a markedly effective in
cholagoging and abating of jaundice, it could promote the
recovery of liver function, dredge the cholestasis in
cholangiole and micro-cholangiole so as to promote the
1640- gera: 67701/di/ra
[CLINICAL STUDY OF COMBINED CHINESE
HERBAL MEDICINE WITH MOVE STRIPE FIELD
gera 2011

RADIATION IN TREATING PRIMARY
HEPATOCELLULAR CARCINOMA]. HAN JUN-QING
ET AL. chinese journal of integrated traditional and
western medicine. 1997;17(8):465 (chi*).
Objective: To find a more effective treatment of primary
hepatocellular carcinoma by using combined therapy of
Chinese herbal medicine with radiotherapy. Methods:
Prospective study was conducted with double-blind method
on prognosis of patients treated with combined therapy of
Xuefu Zhuyu decoction and move stripe field radiation on
entire liver. A control group was established and treated with
placebo and radiotherapy. Results: The 1-, 3- and 5- year
survival rates of the test group were higher than those of the
control group by 20. 0 %, 23. 4 % and 16. 6 % respectively.
The remote metastatic rate of the two groups were not
different significantly. Conclusions: Xuefu Zhuyu Decoction
showed coordinative effect with radiotherapy on antitumor, it
could enhance the radiosensitivity of liver cancer cells,
increase the radiation tolerance of normal hepatocytes and
reduce the side effect of
1641- gera: 68313/di/ra
[ONE HUNDRED CASES OF SYMPTOMLESS HBSAG
CARRIER TREATED BY SEQUENTIAL THERAPY
WITH CHINESE HERBALS]. WAN CHUANGUI ET AL.
journal of traditional chinese medicine. 1997;38(10):609
(eng).
1642- gera: 68433/di/ra
[STUDY ON THE RELATIONSHIP BETWEEN THE
SYNDROME CLASSIFICATION OF CIRRHOSIS AND
THE HYPOFUNCTION OF LIVER CELL]. ZHU
FANGSHI ET AL. traditional chinese medicinal research.
1997;10(3):13 (chi).
1643- gera: 68510/di/ra
[CLINICAL AND EXPERIMENTAL STUDY ON
TREATMENT OF CHRONIC HEPATITIS B WITH
"YIGANSAN"]. CHENG MINGLIANG ET AL. china
journal of traditional chinese medicine and pharmacy.
1997;12(3):23 (chi*).
Using"clear away heat and toxic materials" with
"invigorating the spleen and eliminating wetness-evil" two
methods composed pure TCM preparation to treat 40 cases
suffered chronic hepatitis B, random compared with oleanolic
acid tablets, the results showed that not only the clinical
manifestation, physical sign, liver function and protein
metabolism in patients of treatment group were obviously
improved, but also the "Yigansan" has good function to turn
the patients HBeAg with hepatitis B into negative, it has
obvious differences compared with the control group (P< 0.
05). The in vitro test adopted 2. 2.15 cell line of transfected
HePGz of DNA's clone of hepatitis B virus, the expression
and inhibitor study has been made in HBsAg and HBeAg in
hepatitis B virus, the results revealed that "Yigansan" has the
apparent inhibited effect for HBeAg expression, IC50 is 656.
96±40.19 ug/ml, the therapeutic index is 5. 34+0. 23, it has
different effect in various dosage groups, which appear dose-
response
1644- gera: 68795/di/ra
[QUANTITATIVE MORPHOLOGICAL AND
IMMUNOHISTOCHEMICAL STUDY ON THE HEAT-
CLEARING-AWAY AND DAMP-EXCRETING
RECIPE USED TO TREAT HEPATIC FIBROSIS]. YU
SHIYING ET AL. journal of beijing university of
traditional chinese medicine. 1997;20(1):28 (chi*).
Rat hepatic fibrosis model was induced by porcine serum and
treated by a heat-clearing-away and damp-ex-creting recipe.
The morphological and immunohistochemical changes of the
102
model were observed. The results showed that the above-
mentioned recipe could protect hepatocytes, inhibit the
synthesis and secretion of some substances, such as collagen.
and promote the degradation and absorption of them, which
implies that the recipe can play a role in preventing and
treating hepatic fibrosis.
1645- gera: 68801/di/ra
[EFFECTS OF THE TCM PREPARATION
MANGANXIAO ON HEPATIC PATHOLOGY AND
HISTOCHEMISTRY OF THE RAT WITH HEPATIC
INJURY INDUCED BY ALCOHOL]. YE YONG'AN ET
AL. journal of beijing university of traditional chinese
medicine. 1997;20(1):43 (chi).
1646- gera: 68802/di/ra
[HISTOCHEMICAL AND BIOCHEMICAL STUDY ON
THE PROTECTIVE EFFECTS OF XIAOCHAIHU
DECOCTION ON RAT HEPATIC INJURY INDUCED
BY ALCOHOL]. HE FUJIN ET AL. journal of beijing
university of traditional chinese medicine. 1997;20(1):45
(chi).
1647- gera: 68807/di/ra
[RESEARCH ON TCM DIFFERENTIATING
DIAGNOSES OF 79 CASES OF DRUG-INDUCED
HEPATOPATHY]. YANG JINXIANG ET AL. journal of
beijing university of traditional chinese medicine.
1997;20(1):60 (chi).
1648- gera: 68831/di/ra
[LU CHENGQUAN'S EXPERIENCE IN TREATING
SUBACUTE SEVERE HEPATITIS]. PENG BO. journal
of beijing university of traditional chinese medicine.
1997;20(3):26 (chi).
1649- gera: 69392/di/ra
[THE TYPE OF BLOOD-STASIS SHOULD NOT BE
LISTED SINGLE IN THE TYPOLOGY OF
CIRRHOSIS DIFFERENTIATION]. JIAO YIMING ET
AL. liaoning journal of traditional chinese medicine.
1997;24(2):53 (chi).
1650- gera: 69421/di/ra
[ON THE RELATIONSHIP BETWEEN THE LIVER
FUNCTION CAPSULA FIBROSA AND BLOOD
STASIS OF HEPATOPATHY]. SHEN JIYUN ET AL.
liaoning journal of traditional chinese medicine.
1997;24(6):243 (chi*).
To measure the function of liver and serum PC 11 HAHN in
30 cases with blood stasis syndrome of hepatopathy , 32
cases with non-blood stasis syndrome of hepatopathy and 20
cases of healthy persons. The results showed both blood
stasis syndrome and non--blood stasis syndrome showed
higher positive rate of HBV infection and duplcation indexes,
it showed no difference each other. BIL in blood stasis
syndrome is significantly higher than that of non- blood stasis
syndrome, while A/G is lower than that of non-blood stasis
syndrome (P< 0. 05~0. 01). The content of HA LN in chronic
hepatopathy blood stasis syndrome was significantly higher
than that of non-blood stasis syndrome and normal
persons.There was no difference between non-blood stasis
syndrome and normal persons. PC also showed this tendency
, but no statistical difference. It is suggested that A/G
decrease or reverse and HA LN can be served as objective
indexes for hepatopathy blood stasis syndrome.
1651- gera: 69423/di/ra
[THE EXPERIENCE OF PROFESSOR LIU JIA XIANG
IN TREATING LIVER CANCER]. GAO HONG. liaoning
gera 2011

journal of traditional chinese medicine. 1997;24(6):248
(chi*).
Liver is fond of smoothing the flow of vital energy and blood
but intolerant of depress. According to the physiological
characteristic and pathologic changes of the liver cancer,
proof , Liu applys the rule of promoting the free movement of
qi and blood as the basic way in the treatment with Chinese
medicine. Since the occurrence of the liver cancer is the
outcome of disharmony between yin and yang, the methods
of the treatment should aim at harmonising to two.
Depending on symptoms and stages of the disease , some
methods often be used for reinforcing insufficiency and
redoing excessiveness such as strengthening the liver and
benefit vital energy, invigorating the spleen and regulating qi
, nourishing yin and softening liver , expelling the evil and
eliminating excessive humidity and liquefying the stasis and
breaking the mass.
1652- gera: 70510/di/ra
PROMISING RESULTS OF A PILOT TRIAL OF THE
KAMPO HERBAL REMEDY NIUCHE-SHEN-QI-WAN
FOR MUSCLE CRAMPS IN CIRRHOTIC PATIENTS.
ABSTRACT. RAND J. focus on alternative and
complementary therapies. 1997;2(4):157 (eng).
Résumé et commentaire de l'article: Motoo Y et al. Effect of
Niuche-Shen-Qi-Wan on painful muscle cramps in patients
with liver cirrhosis: a preliminary report. American Journal
of Chinese Medicine. 1997; 25: 97-102. Réf
1653- gera: 73886/di/ra
[96 CASES OF CHRONIC VIRUS HEPATITIS B
TREATED BY FU GAN CAPSULE]. ZHU SHENGHUA
ET AL. journal of shandong university of tcm.
1997;21(4):282 (chi*).
96 six cases of chronic virus hepatitis B were treated by Fu
(fan capsule. The capsules were made according to the
experienced prescription provided by famous director
physician of (Chinese medicine, Mr. Zhu Liangchun.
Compared with 80 hospital-based controls who were treated
by general drugs of protecting liver, the curing effect of the
capsule was significant on promoting liver function,
correcting A/G invert, decreasing gamma globulin and HA,
promoting microcirculation and making the markers of
Hepatitis B virus negative. The total curing effect was
1654- gera: 73887/di/ra
[32 CASES OF ASCITES DUE TO CIRRHOSIS
TREATED ACCORDING TO DIFFERENTIATION OF
TRIPLE WARMER]. GUO PENG ET AL. journal of
shandong university of tcm. 1997;21(4):284 (chi).
1655- gera: 73888/di/ra
[57 CASES OF CHRONIC VIRUS HEPATITIS B
TREATED ACCORDING TO THE RULE OF
DISCHARGING THE BILE AND REINFORCING THE
SPLEEN]. LIU ZHIYONG ET AL. journal of shandong
university of tcm. 1997;21(4):286 (chi).
1656- gera: 74282/di/ra
[EFFECT OF GANDOU TABLET N°1 FOR
BIOCHEMISTRY OF COPPER AND LIVER-KIDNEY
FUNCTIONS IN HEPATOLENTICULAR
DEGENERATION]. HU WENBIN ET AL. journal of tcm.
1997;38(7):414 (chi*).
Observation showed that the Tablet revealed no inhibition to
the peripheral blood picture and liver- kidney functions. It
also yielded no obvious effect on microelements,
copperoxidase. and hemoelectrolytes (P>0. 1). 34 cases of
HI,D were treated for 4 weeks. the total effective rate was 70.
6%. in which 8. 82% were markedly effective.
103
1657- gera: 74283/di/ra
[EFFECT OF METHODS OF NOURISHING LIVER-
KIDNEY ON INDEXES OF LIVER FUNCTION IN
CHRONIC B- HEPATITIS]. ZHOU YIQIANG ET AL.
journal of tcm. 1997;38(7):416 (chi).
1658- gera: 74399/di/ra
[ANALYSIS ON CAUSES OF DEATH OF LIVER
CARCINOMA TREATED BY TRADITIONAL
REMEDIES,REPORT OF 45 CASES]. YANG
ZONGYAN ET AL. journal of tcm. 1997;38(4):231 (chi).
1659- gera: 74424/di/ra
[NON-LIVER PARENCHYMA
NECROTIC,CHRONIC,SEVERE HEPATITIS
TREATED BY INTEGRATION OF CHINESE AND
WESTERN MEDICINE]. HE JIANGPING ET AL.
journal of tcm. 1997;38(8):477 (chi).
1660- gera: 74430/di/ra
[INFLUENCE OF SPLEEN-STRENGTHENING QI-
REGULATING RECIPE (SQR) ON LEVEL OF AFB1-
DNA ADDITION PRODUCTS IN LIVER OF MICE
WITH HBV TRANSVERSE GENE]. WU WANYIN ET
AL. journal of tcm. 1997;38(8):497 (chi).
1661- gera: 74436/di/ra
[CHRONIC HEPATITIS COMPLICATED WITH
ARTERIOVENOUS EMBOLISM TREATED WITH
YIQI-HUOXUE (QI- STRENGTHENING BLOOD-
ACTIVATING) DRUGS]. XU HUIYUAN ET AL. journal
of tcm. 1997;38(6):347 (chi).
1662- gera: 74442/di/ra
[CONTRAST STUDIES ON SEROLOGY AND
PATHOHISTOLOGY OF ANTI-FIBROSIS ACTION
ON LIVER WITH REMEDIES CONTAINING RADIX
STEPHENIAE TETRANDIAE AND RADIX SALVIAE
MILTIORRHIZA]. CHENG MINGLIANG ET AL.
journal of tcm. 1997;38(6):361 (chi).
1663- gera: 74535/di/ra
[CLINICAL OBSERVATION AND EXPERIMENTAL
RESEARCH OF LINGDANWANG CAPSULE IN
TREATMENT OF HEPATOCIRRHOSIS]. HUANG
YAPING ET AL. journal of zhejiang college of tcm.
1997;21(3):15 (chi*).
Authors treated 150 cases of hepatocirrhosis induced by
various causes with Lingdanwang capsule. The results
showed a total effective rate was 90%, the effective rate of
improving symptoms and liver function were 70% and 50%
respectively. The experimental research indicated that
Lingdanwang capsule could lower ALT. AST and y-
globulin, raise the radio of A/G, reduce collagen and fibrosis
of the liver in rats with hepatocirrhosis induced by
1664- gera: 74539/di/ra
[TREATMENT OF 80 CASES OF CHRONIC
HEPATITIS B WITH DEFICIENCY OF LIVER-YIN
AND KIDNEY-YIN WITH MODIFIED ERZHI PILL].
LOU XIAOWEI. journal of zhejiang college of tcm.
1997;21(3):35 (chi).
1665- gera: 75097/di/ra
[CLINICAL STUDY ON CHRONIC ACTIVE
HEPATITIS TREATED WITH FUFANG KU ZHI
GRANULES]. CHENG MINGLIANG ET AL. china
journal of traditional chinese medicine and pharmacy.
1997;12(6):17 (chi*).
gera 2011

94 cases of chronic active hepatitis treated with Fufang Ku
Zhi granules was observed, the results were significantly
better in improving clinical symptoms and signs as well as
reducing transaminase as compared with control group, the
total effective rate was 95.74% in the observed group, while
the latter was 80.00% in the control group.
1666- gera: 75639/di/ra
[PRELIMINARY DISCUSSION ON THE SUITABLE
LIFE AND DIET AND CONTRAINDICATION IN
HEPATITIS B PREMATURE HEPATOCIRRHOSIS].
QIU ZHIJI ET AL. liaoning journal of tcm.
1997;24(11):514 (chi).
1667- gera: 86053/di/ra
[EXPERIMENTAL STUDY ON DECOCTED TURTLE
SHELL PILL IN TREATING FIBROSIS OF LIVER].
YAO ZHENMIN ET AL. journal of zhejiang college of
tcm. 1997;21(1):45 (chi).
1668- gera: 86178/di/ra
[TREATING 38 CASES OF ASCITIC FLUID DUE TO
HEPATOCIRRHOSIS WITH SHEN QI ZE LING
TANG]. ZHENG ZHARONG. journal of zhejiang college
of tcm. 1997;21(4):11 (chi*).
38 cases of ascitic fluid due to hepatocirrhosis treated with
Shen Qi Ze Ling Tang (ingredient: pilose asiabell root, red
sage root, astragalus root, poria peel, Herba Lycopi, mulberry
bark, shell of areca nut, dodder seed, white atractylodes
rhizome, lotus seed, fresh-water turtle shell, lepidium seed,
morning glory seed). The results showed that cure was 20
cases, improvement was 15 cases, a total effective rate was
92.11%.
1669- gera: 87130/di/ra
[REPORT ON THE WORKSHOP OF CHRONIC
HEPATITIS RESEARCH GROUP]. HORI S. journal of
the japan society of acupuncture. 1997;47(3):154-55 (jap).
1670- gera: 87204/nd/re
[A CASE OF DRUG-INDUCED LIVER INJURY DUE
TO BUKURYO-IN-GO-HANGE-KOBOKU-TO].
YOSHIKUBO S ET AL. nippon shokakibyo gakkai zasshi.
1997;94(8):564-8 (jap).
1671- gera: 87212/nd/re
AMELIORATIVE EFFECT OF TRADITIONAL
CHINESE MEDICINE PRESCRIPTIONS ON ALPHA-
NAPHTHYLISOTHIOCYANATE AND CARBON-
TETRACHLORIDE INDUCED TOXICITY IN RATS. .
TSAI CC ET AL. american journal of chinese medicine.
1997;25(2):185-96 (eng).
Syh-Mo-Yin (SMY), Guizhi-Fuling-Wan (GFW), Shieh-
Qing-Wan (SQW) and Syh-Nih-San (SNS) are prescriptions
of Traditional Chinese Medicine (TCM) for liver disease.
The effects of these four prescriptions against experimental
liver injury induced by alpha-Naphthylisothiocyanate (ANIT)
and carbon tetrachloride (CCl4) were studied. Rats treated
with ANIT (100 mg/kg) exhibited elevations of serum total
bilirubin (TBI), alkaline phosphatase (ALP), glutamate-
oxalatetransaminase (sGOT) and glutamate-pyruvate-
transminase (sGPT) as well as cholestasis and
parenchymanecrosis. In rats receiving SMY, SQW and SNS
treatment after ANIT challenged, the biochemical and
morphological parameters of liver injury were significantly
reduce. Elevated lipid peroxidation (LPO) level in liver
tissue, associated with an increase in serum GOT and GPT
level, was observed in CCl4-treated rats. Treatment with
these four prescriptions on CCl4-induced liver injury rats
showed a remarkable hepatoprotective effect. A significant
104
decrease in peroxidative level suggested that these
prescriptions have anti free radical properties.
1672- gera: 87214/nd/re
EVALUATION OF THE ANTIOXIDANT AND
HEPATOPROTECTIVE ACTIVITY OF TERMINALIA
CATAPPA. . LIN CC ET AL. american journal of chinese
medicine. 1997;25(2):153-61 (eng).
The free radical scavenging and antihepatotoxic activity from
Terminalia catappa was studied. Treatment with T. catappa
water extracts showed antihepatotoxic activity against CCl4-
induced toxicity in the rat liver that was tested. The crude
drug also exhibited anti-oxidant effects in FeCl2-Ascorbic
acid induced lipid peroxidation in the rat liver homogenate.
Moreover, the superoxide radical scavenger effect of T.
catappa was demonstrated using electron spin resonance
(ESR) and spintrapping technique. The results indicate that T.
catappa possesses good antihepatotoxic activity and
superoxide radical scavenger activity.
1673- gera: 103883/di/ra
PROSPECTIVE STUDY ON INTELLIGENCE
QUOTIENT OF HEPATIC LENTICULAR
DEGENERATION PATIENTS TREATED WITH
COMBINED TRADITIONAL CHINESE AND
WESTERN MEDICINE. CAI YONG-LIANG, YANG
REN-MIN, XU SHENG-HONG, ET. chinese journal of
integrated traditional and western medicine (english
edition). 1997;3(1):35 (eng).
1674- gera: 107137/di/ra
COMBINED TREATMENT OF ADVANCED
PRIMARY HEPATOCELLULAR CARCINOMA WITH
TRADITIONAL CHINESE MEDICINE AND
WESTERN MEDICINE. YU ER-XIN. chinese journal of
integrated traditional and western medicine (english
edition). 1997;3(2):86 (eng).
1675- gera: 107147/di/ra
TRADITIONAL CHINESE MEDICINE COMBINED
WITH HEPATIC ARTERIAL CHEMOTHERAPY AND
EMBOLIZATION IN TREATING PRIMARY
HEPATOCELLULAR CAREINOMA. HE YONG-HE,
FANG JI-LIANG. chinese journal of integrated traditional
and western medicine (english edition). 1997;3(2):117
(eng).
1676- gera: 58078/di/ra
[PRELIMINARY STUDY ON THERAPEUTIC EFFECT
OF OXYMATRINE IN TREATING PATIENTS WITH
CHRONIC HEPATITIS C]. LI JIQIANG ET AL. chinese
journal of integrated traditional and western medicine.
1998; 18(4):227-9 (chi*).
Objective: To evaluate the efficacy of oxymatrine in treating
chronic hepatitis C and its mechanism. Methods: Forty-three
patient were divided randomly into the treated group (20
cases) and the control group (23 cases) . The treated group
was given oxymatrine 600 mg per day intramuscularly, and
the control group was given the general liver protective
agents such as vitamins. The therapeutic course of both
groups was 3 months. Results: HCVRNA of 8 in 17 cases
(47. 1% ) of the treated group converted to negative, while in
18 cases of the control group, the negative conversion only
took place in 1 patient ( 5 . 6 % ), the negative conversion
rate was significantly higher in the treated group than that in
the control group ( P < 0 . 05) . The normalization rates of
serum alanine transaminase (Al,T) of the treated group after 1
month and 2 months treatment was higher than that of the
control group, but after 3 months treatment, the normalization
rates of the two groups were not different significantly.
gera 2011

Plasma level of soluble interleukin-2 receptor and serum
level of collagen type IV in the treated group were lowered
significantly after treatment, but in the control group, there
were no significant change, the difference between the two
groups was significant (P<0.01, P<0.05) . Conclusion:
Oxymatrine is effective in inhibiting proliferation of HCV,
antagonising liver fibrosis and regulating immune reaction of
the host, so it could be a safe, effective durg in treating
chronic hepatitis C.
1677- gera: 58346/di/ra
CORDYCEPS SINENSIS INCREASES THE
EXPRESSION OF MAJOR HISTOCOMPATIBILITY
COMPLEX CLASS II ANTIGENS ON HUMAN
HEPATOMA CELL LINE HA22T/VGH CELLS. CHIU
JEN-HWEY ET AL. american journal of chinese
medicine. 1998;26(2):159-70 (eng ).
Previous studies suggest that down-regulation of the major
histocompatibility complex (MHC) antigens on the cell
surface of certain tumors results in an escape of immune
surveillance. Cordyceps sinensis is well known for its
modulatory effect on host immune system. To investigate the
modulatory effect of Cordyceps sinensis on MHC class II
antigen expression on hepatoma cells, immunostaining with
monoclonal antibody (MAb) L243, against the HLA DR
region of MHC class II antigens on human hepatoma cell line
HA22T/VGH was analyzed by using flow cytofluorimetry.
The degree of fluorescence intensity on L243 (+) cells was
expressed as relative mean fluorescence intensity (RMFI).
The extract of Cordyceps sinensis (VGH-CS-ME-82, 40
µg/ml) was found to increase the MHC class II antigen
expression on HA22T/VGH cells with the percentage of
L243 (+) cells 40.2 + or - 2.5 and RMFI 6.6 + or - 0.4;
whereas cells without treatment disclosed the percentage of
L243 (+) cells 17.2 + or - 1.4 and RMFI 5.4 + or - 0.3,
respectively (P<0.05). There was a dose-related increase in
the degree of fluorescence intensity in terms of RMFI on
VGH-CS-ME-82 induced cells. The RMFI in cells treated
with IFN-y 0, 0.2 and 5 ng/ml were 5.4 + or - 0 3, 8.2 + or -
0.4, and 24.9 + or - 1.5, respectively; whereas the RMFI in
cells co-incubated with VGH-CS-ME-82 (40 µg/ml) and
IFN-y0, 0.2 ng/ml and 5 ng/ml were 6.7 + or - 0.2 (P<0.05),
9.2 + or - 0.9 (p<O.I) and 29.5+ or - 1.2 (p<0.005),
respectively. We conclude that VGH-CS-ME-82, either alone
or with IFN-y induction, increases the MHC class II antigen
expression on hepatoma cell line HA22T/VGH, which will
shed light into the present immunotherapy, and make the host
immune surveillance more effective against tumor cells with
down-regulated MHC class II antigen expression.
1678- gera: 58375/di/re
THE LIVER IN TRADITIONAL CHINESE MEDICINE.
CHEN TS ET AL. j gastroenterol hepatol. 1998;13(4):437-
442 (eng ).
Medical thinkers in China visualized the liver in microcosmal
and macrocosmal terms. An anatomical tradition did not
exist, hence the liver was described grossly in broad outline.
It was recognized as being functionally important in the
movement of qi (vital energy) and storage of xue ('blood').
The liver corresponded to various phenomena in both the
natural and social orders, according to the scheme of yin
yang and five phases. These interrelationships provided the
basis for the diagnosis and treatment of liver dysfunctions.
The disorders fell into three general groups: (i) hepatic qi
stasis; (ii) hepatic yang excess with yin deficiency; and (iii)
hepatic yin insufficiency. The signs and symptoms
represented the logical outcomes of the disturbed physiology.
Acupuncture, moxibustion and herbal drugs were used to
redress the imbalance of hepatic qi and yin-yang. The impact
of Western medicine led traditional authors to recognize the
105
hepatobiliary role in bile secretion and in jaundice. The
exchange between the Western and Chinese medical
traditions revealed that active agents were included in the
Chinese formulary,
1679- gera: 58678/di/ra
COME TRATTARE L'ITTERO LATENTE IN CASO DI
EPATOCIRROSI. ZONGGUANG L. rivista italiana di
medicina tradizionale cinese. 1998;73(3):87-8 (ita ).
1680- gera: 66505/di/ra
[LONG-TERM OBSERVATION ON EFFECTS OF
METHODS OF KIDNEY-BENEFITTING, QI-
INVIGORATING, BLOOD-COOLING, AND
DETOXIFICATION ON LIVER FIBROSIS]. YANG
HONGZHI ET AL. journal of traditional chinese
medicine. 1998;39(6):343 (eng*).
Forty-eight cases of liver fibrosis due to B-hepatitis were
treated with this principle for over 2 years. It improved
symptoms remarkedly with normal ALT and recovery of
normal serum bilirubin in most cases. After a course of 1/2
year therapy. the mean values of HA, PC III and circulated
immunocomplex were all decreased as compared with that
before the treatment. and all recovered to normal after 2 years
of treatment. 82% of the cases revealed normal calibre of the
widened portal vessels. and there was a tendency of decrease
in size of the enlarged spleen.
1681- gera: 66517/di/ra
[WAY OF THINKING FOR TREATMENT OF
CHRONIC LIVER DISEASES COMPLICATED WITH
ENDOCRINE DISORDERS]. WANG QINGMIN ET AL.
journal of traditional chinese medicine. 1998;39(6):371
(eng).
1682- gera: 66536/di/ra
THE INTEGRATED TREATMENT OF
TRADITIONAL CHINESE MEDICINE AND MODERN
MEDICINE FOR HEPATITIS (PART II). LI ZHENG
YU. acupunctuur. 1998;21(5):4 (eng).
This is the second part of the article on TCM treatments of
hepatitis and has also been translated from the chinese by
mrs. Yang Yifan (OMD) with funding of the Ministry of
Health in an effort to promote and encourage the continuing
education and modernisation of Traditional Chinese
Medicine and Acupuncture in the West.
1683- gera: 66539/di/ra
[PRINCIPLE AND METHOD IN THE TREATMENT
OF LIVER DISEASE]. YIN CHANGJIAN. journal of
shandong university of traditional chinese medicine.
1998;22(4):251 (chi).
1684- gera: 66545/di/ra
[EXPERIMENTAL STUDY OF RONGGAN
DECOCTION FOR ANTI-LIVER FIBROSIS]. ZHANG
YONG ET AL. journal of shandong university of
traditional chinese medicine. 1998;22(4):309 (chi*).
We duplicated the animal pattern of the liver fibrosis by
injecting Ccl4 suspension to white Mice's abbominal cavity,
and take the content of ALT, HA, LN in blood serums and
the change of the hepatic tissue under the optical and the
electron microscope. After 4 weeks treatment with Rongan
decoction, compared with the control group ,the liver
function and the serum parameters of fibrosis were
significantly decreased (P<0.01). The results show that
Ronggan decoction has the effect of antifibrosis, and the
further improved study is needed.
1685- gera: 66547/di/ra
gera 2011

THE INTEGRATED TREATMENT OF
TRADITIONAL CHINESE MEDICINE AND MODERN
MEDICINE FOR HEPATITIS (PART I). LI ZHENG YU.
acupunctuur. 1998;21(4):7 (eng).
This article has been translated from the chinese by mrs.
Yang Yifan (OMD) with funding of the Ministry of Health in
an effort to promote and encourage the continuing education
and modernisation of Traditional Chinese Medicine and
Acupuncture in the West.
1686- gera: 66641/di/ra
[HISTOCHEMICAL AND SEROLOGICAL STUDY ON
THE TREATMENT OF RAT HEPATIC FIBROSIS
WITH DRUGS FOR PROMOTING BLOOD
CIRCULATION AND REMOVING STASIS]. CAO
XIANYING ET AL. journal of beijing university of
traditional chinese medicine. 1998;21(2):35 (chi*).
Rat immune hepatic fibrosis model was induced by using
porcine serum. The model was used to study the mechanism
of the preventing and treating effects on hepatic fibrosis of
drugs for promoting blood circulation and removing stasis.
Hepatic CCO activity and serious GPT content were chosen
as criteria in the study. The rats were divided into four
groups, namely control, model, preventing and treating. The
results show that drugs for promoting blood circulation and
removing stasis had comparatively marked hepatic fibrosis-
fighting effects, especially, the
1687- gera: 67282/di/ra
[SURVEY OF TREATMENT OF VIRUS HEPATITIS B
WITH ACUPOINT-INJECTION IN RECENT 10
YEARS]. XIONG YIFEI. chinese acupuncture and
moxibustion. 1998;18(3):179 (chi).
1688- gera: 67639/di/ra
[STUDY ON THERAPEUTICAL EFFECT OF
TREATING HEPATOLENTICULAR
DEGENERATION BY THE HLD- TABLET I]. HU
WENBIN ET AL. chinese journal of integrated traditional
and western medicine. 1998;18(1):12 (chi*).
Objective: To investigate the efficacy of HLD Tablet I in
treating hepatolenticular degeneration (HLD) and its effect
on urinary trace element in 24 hours. Methods: After 4 weeks
of treatment on 34 cases of HLD by oral taken HLD -Tablet
I, the clinical practice was closely observed on the patients'
change of symptoms, signs and daily life pattern, and
measured the level of urinary trace element in 24 hours
before the therapy and after that every week. Results: The
total effective rate reached 70. 59%, marked effective rate
was 8. 82% . The effect of treatment was better in the
infantile and mild patient. After treatment, the daily output of
urinary copper was obviously increased every week than that
before ( P < 0.01 ) . It was highly negative linear correlated
with the duration of treatment ( r = 0. 96, P < 0. 05) . But it
was insignificantly different between any two weekly
excretion of urinary copper per 24 hours after treatment by
the HLD-Tablet I (P>0.05), so its effect on urinary copper
excretion was not decreased. Conclusion: The HLD Tablet I
could increase the output of urinary copper, hence it was
effective in treating HLD D
1689- gera: 68285/di/ra
THE PROTECTIVE EFFECTS OF TRADITIONAL
CHINESE MEDICINE PRESCRIPTION, HAN-DAN-
GAN-LE, ON CC14-INDUCED LIVER FIBROSIS IN
RATS. CHENG-XIU LI ET AL. american journal of
chinese medicine. 1998;26(3-4):325-332 (eng).
Han-Dan-Gan-Le, a Chinese medicine preparation composed
of Salvia miltorrhiza, Radix paeoniae, Astragalus
membranaceus, Stephania tetrandra, and dried leaves of
106
Ginkgo biloba, has been used successfully to treat human
liver fibrosis and cirrhosis for years. This study was designed
to examine the mechanisms of the protection. Male Wistar
rats were given CC14 (1.2 ml/kg, 2 times/ week), 20% fat
diet, and 30% alcohol in drinking water (every other day) for
6 weeks. Han-Dan-Gan-Le (0.5 and 1.0 g/kg, p.o., daily for 6
weeks) was administered to rats simultaneously to examine
the protective effects against CC14-induced liver fibrosis.
The experimentally-induced liver fibrosis and other
morphological alterations were significantly ameliorated by
Han-Dan-Gan-Le. Han-Dan- Gan-Le treatments decreased
CC14-induced hepatic collagen accumulation by more than
50%, and significantly increased urinary excretion of
hydroxyproline. The CC14-induced lipid peroxidation in
liver and serum was ameliorated as a result of Han-Dan-Gan-
Le treatment, possibly by restoring the activity of superoxide
dismutase activity in liver and erythrocytes. In conclusion,
Han-Dan-Gan-Le is effective in protecting against liver
fibrosis. The mechanisms of the protection appear to be due
to its antioxidant properties and the modulation of hepatic
collagen metabolism.
1690- gera: 68286/di/ra
MECHANISM OF THE PROTECTIVE EFFECTS OF
SUMAC GALL EXTRACT AND GALLIC ACID ON
THE PROGRESSION OF CC14-INDUCED ACUTE
LIVER INJURY IN RATS. SHIGEYUKI KANAI ET AL.
american journal of chinese medicine. 1998;26(3-4):333-
41 (eng).
To examine the mechanism of the preventive effect of
tannins on the progression of carbon tetrachloride (CC14)-
induced acute liver injury in rats, sumac gall (SG) extract and
garlic acid (GA) were used as substitutes for crude tannins,
because SG is a kind of Chinese traditional medicinal herb
containing large amounts of various tannins, and GA is one
of the major constituents of SG. The protective effect of oral
(p.o.) and intraperitoneal (i.p.) administration of each
substance on progression of CC14-induced hepatitis was
investigated in rats. Speculating that the superoxide
dismutase (SOD)-like activities (O2 radical-scavenging
activities) and/or protective effects of these substances on cell
membranes might play a key role in the mechanism opposing
the progression of CC14- induced hepatitis, the O2 radical-
scavenging activities in liver cells and serum in rats were
monitored. Both substances significantly prevented the
progression of acute liver injury with both p.o. and i.p.
administration. These findings suggest that the mechanism
for this prevention might be due mainly to the protective
effect of these
1691- gera: 68287/di/ra
EFFECT OF PRETREATMENT OF RATS WITH AN
URINARY PREPARATION ON LIVER INJURIES
INDUCED BY CARBON TETRACHLORIDE AND
ALPHA-NAPHTHYLISOTHIOCYANATE. TUNG-
YUAN LAI ET AL. american journal of chinese medicine.
1998;26(3-4):343-51 (eng).
The effect of oral administration of a preparation of human
urine (PHU) on the progression of acute liver injury was
examined in rats intoxicated with carbon tetrachloride
(CC14) and anaphthylisothiocyanate (ANIT). PHU protected
the liver from CC14-induced injury as judged by
morphological and biochemical observations. In contrast,
PHU aggravated ANIT-induced injury as judged also by
morphological and biochemical observation. PHU prevented
the increase in hepatic glutathione (GSH) and lipid
peroxidation induced by CC14. But PHU enhanced the
increase in hepatic GSH caused by ANIT. These results
indicate that the effect of PHU on hepatic GSH
concentrations is through an indirect pathway. Clinical
gera 2011

application of PHU on hepatitis should be explored further.
1692- gera: 68302/di/ra
[EXPLORATION ON THE RELATIONSHIP
BETWEEN TCM ZHENG TYPING OF CHRONIC C-
HEPATITIS AND CLINICAL LABORATORY
INDICES]. JIN SHI ET AL. journal of traditional chinese
medicine. 1998;39(4):233 (eng).
1693- gera: 68329/di/ra
[ALCOHOLIC HEPATOPATHY TREATED WITH
QINGGAN JIE JIU YIN]. CUI MINLU. journal of
traditional chinese medicine. 1998;39(1):32 (eng).
1694- gera: 68340/di/ra
[EIGHTY CASES OF ACTIVE B-HEPATITIS
TREATED BY TCM DIFFERENTIATION OF
SYNDROME TYPES]. XUE HUANDE ET AL. journal of
traditional chinese medicine. 1998;39(8):476 (eng).
1695- gera: 68355/di/ra
[TWENTY CASES OF ACUTE
HEPATOENCEPHALOPATHY TREATED BY
WESTERN COMPREHENSIVE THERAPY
CONCERTED WITH TCM]. LIU SHIJING ET AL.
journal of traditional chinese medicine. 1998;39(12):728
(eng*).
Twenty cases of acute hepatoencephalopathy induced by
severe hepatitis were treated by western supportive therapy
combined with venous drip of Chinese materia medica,
enema, umbilical compress and point stimulation, with 12
cases clinically cured, 6 ameliorated, 2 died, the total
effective rate being 90%, When compared with western
treatment alone as control, the effect was obviously superior,
The improvement of the four indexes, VIZ, the graded
improvement of encephalopathy, blood ammonia, serum
bilirubin and activity of prothrombin, were superior with
statistical difference as compared with the control group.
1696- gera: 68376/di/ra
A CLINICAL STUDY ON BING GAN LING ORAL
LIQUID FOR TREATMENT OF HEPATITIS C. YOU
SONGXIN ET AL. journal of traditional chinese
medicine. 1998;18(3):209-14 (eng).
Based on the principles of cooling the blood to expel the
pathogenic toxins and regulating the function of liver and
activating the spleen in traditional Chinese medicine, 60
cases of chronic hepatitis C were treated with Bing Gan Ling
(BGL), an oral liquid, which is composed mainly of
Shuininjiso (Cornu Bubali), Huzhang (Rhizome Polygoni
Cuspidati), Chishao (Radix Paeoniae Rubra), and Huangqi
(Radix Astragali), etc. The total effective rate was 86.7%,
which is considerably better than that of the control group
(P< 0.01). The animal experiments and pathological studies
suggest that the above-mentioned prescription has marked
action of protecting the liver and lowering the activity of
enzymes; and that it can ameliorate the acute liver injury
induced by D-galactosamine.
1697- gera: 68387/di/ra
[CORRELATION STUDY ON TOTAL
CONCENTRATION OF SERUM T4, FT4 AND THE
TYPOLOGY OF LIVER DISEASES]. WANG QI ET AL.
liaoning journal of traditional chinese medicine.
1998;25(12):555 (chi).
1698- gera: 68445/di/ra
[TREATMENT OF ACUTE A-TYPE VIRAL
HEPATITIS BY GANNING POWDER]. LI WEI ET AL.
traditional chinese medicinal research. 1998;11(1):25
107
(chi).
1699- gera: 68529/di/ra
[CLINICAL AND EXPERIMENTAL STUDIES OF
INFANTILE VIRUS HEPATITIS TREATED WITH
NEBULIZATION MIXTURE OF CHINESE HERBS].
SHI JINGLI ET AL. china journal of traditional chinese
medicine and pharmacy. 1998;13(3):38 (chi).
1700- gera: 68533/di/ra
[ON THE TREATMENT OF HEPATIC
FIBROSCLEROSIS FROM TCM]. LU LIANGEWI.
china journal of traditional chinese medicine and
pharmacy. 1998;13(3):52 (chi).
1701- gera: 68558/di/ra
[ACUTE ICTERIC HEPATITIS TREATED WITH
CHINESE HERBS OF NOURISHING YANG-QI].
JIANG KAIPING. china journal of traditional chinese
medicine and pharmacy. 1998;13(2):46 (chi).
1702- gera: 68568/di/ra
[CLINICAL OBSERVATION OF HYPOPROTEIN DUE
TO CIRRHOSIS TREATED WITH "TAIYI" ORAL
SOLUTION]. TANG YI ET AL. china journal of
traditional chinese medicine and pharmacy. 1998;13(1):27
(chi).
1703- gera: 69115/di/ra
[OBSERVATION ON THERAPEUTIC EFFECTS OF
ACUPUNCTURE AND APPLICATION OF XIAO
ZHONG POWDER ON HEPATOGENIC ABDOMINAL
DISTENSION]. CHEN YANNAN ET AL. chinese
acupuncture and moxibustion. 1998;18(5):275 (chi).
1704- gera: 69116/di/ra
[TREATMENT OF 30 CASES OF HYPOCHONDRIUM
PAIN DUE TO HEPATITIS WITH COUPLING-
NEEDLING METHOD]. XU GUANGFU. chinese
acupuncture and moxibustion. 1998;18(5):277 (chi).
1705- gera: 69492/di/ra
[EXPERIMENTAL STUDY ON THE PREVENTION
OF LIVER FIBROSIS WITH SHUGAN LIPI TABLET].
WEI AILING. liaoning journal of traditional chinese
medicine. 1998;25(8):381 (chi*).
The effect of the Shu Gan Li Pi Pian on anti-liver-fibrosis
was observed on the animal model ,the Wistar rats with liver
fibrosis caused by complex factors. The results from this
experiment showed that the liver fibrosis of the rats in the
preventing group was marked slight,the content of liver
collagen was 19.11 ±1. 95mg/per gram of hepar siccatum.
Comparing with the negative model group,there was a
remarkable significance (P<0. 05). It indicates that the Shu
Can Li Pi Pian has the effect on preventing liver fibrosis
through the effect of anti-fibrosis that may works in the ways
of protecting liver cells.decreasing the liver cells
degeneration and necrosis,as well as increasing the ability of
phagocyte to phagocytize the degraded collagenous fiber.
1706- gera: 69590/di/ra
[100 CASES OF CHRONIC HEPATITIS B TREATED
BY USING A SELF-MADE PRESCRIPTION-JIANPI
YIGAN DECOCTION-WITH DIFFERENT
MODIFICATIONS]. LIU HUI ET AL. journal of beijing
university of traditional chinese medicine. 1998;21(1):63
(chi).
1707- gera: 69610/di/ra
[GANFULE CONCERTED WITH INTERVENTIONAL
gera 2011

THERAPY FOR LATE STAGE OF LIVER
CARCINOMA]. ZHANG YIQUN. journal of traditional
chinese medicine. 1998;39(10):601 (eng*).
Nine cases of large cancer of liver in its late stage. being
diagnosed by image examination and AFP test, during the
period of March 1996 ~ March 1997 were treated
interventionally with arterial catheter, concerted with oral
Ganfule before and after the operation. Of them, 6 cases
(67%) received simple perfusion of chemotherapy, the other
3 received chemotherapeutic embolus formation. Judging
from clinical symptoms, improvement of hepatic functions,
lowering of AFP and survival time, this concerted therapy
can effectively ameliorate the symptoms and abnormal
hepatic functions due to the cancer or liver cirrhosis, lower
AFP, thus improving the survival quality and
1708- gera: 69626/di/ra
[MASSIVE LIVER CANCER TREATED BY
INTEGRATED TRADITIONAL CHINESE AND
WESTERN MEDICINES IN TWO STEPS]. ZHENG
ZUOSHEN ET AL. journal of traditional chinese
medicine. 1998;39(11):668 (eng*).
In order to probe the new approach of two-step excision of
massive liver carcinoma. For the 1st step the che, thr
chemotherapy was modified as whole liver moving strip-field
radiation. miniature technique and segmental chemotherapy,
with a total radio amount of 50-60 G was applied. added with
TCM therapy for strengthening the spleen. 3-4 weeks after
the 1st step. the 2nd step began for operation. In 10 cases of
liver cancer receiving pre- operative chemotherapy plus
Chinese medicine the maximal diameter of the mass shrank
from 11-15 cm to 6-3 cm. with a 2-cm focus at the portal
lymph nodes under CT exam. and some satellite focus at the
portal lymph nodes under CT exam. and some satellite foci 1-
3 cm. each 1 case. After chemotherapy the lesion
disappeared. Another negative AFP case was found to have
survival-cancer-cells. There were no fated case due to
operation
1709- gera: 69631/di/ra
[INFLUENCE OF COLD-PURGATIVES ON INJURY
OF LIVER-CELL LYSOSOME AND MEMBRANOUS
FUNCTION IN MODS RAT MODELS]. ZHAO QI ET
AL. journal of traditional chinese medicine.
1998;39(11):683 (eng).
1710- gera: 69679/di/ra
[URGENT PROBLEMS TO BE RESOLVED IN TCM
FOR CHRONIC B-HEPATITIS AND ITS
PONDERATION]. XU SHOUCHANG ET AL. journal of
traditional chinese medicine. 1998;39(7):435 (eng).
1711- gera: 69681/di/ra
[PRELIMINARY DISCOURSE ON "INVOLVING THE
LUNG FOR TREATMENT OF LIVER-DISEASE"].
ZHANG ZHENGLI. journal of traditional chinese
medicine. 1998;39(2):73 (eng).
1712- gera: 69686/di/ra
[COMPARATIVE STUDY ON FOUR KINDS OF
INTEGRATED CHINESE AND WESTERN
THERAPIES ON 120 CASES OF MIDDLE AND LATE
STAGES OF PRIMARY LIVER CARCINOMA]. PAN
MINGJI ET AL. journal of traditional chinese medicine.
1998;39(2):95 (eng).
1713- gera: 69697/di/ra
[PRELIMINARY DISCUSSION ON THE TREATMENT
OF HEPATIC DISEASE BY THE COMBINATION OF
PNEUMOTHERAPY]. ZHANG ZHENGLI. traditional
108
chinese medicinal research. 1998;11(3):3 (chi).
1714- gera: 69820/di/ra
[CLINIC AND EXPERIMENTAL STUDY OF XIAOZHI
HUGAN CAPSULE ON THE TREATMENT OF FATTY
LIVER WITH HYPERLIPIDEMIA]. DUAN
RONGZHANG ET AL. china journal of traditional
chinese medicine and pharmacy. 1998;13(5):27 (chi*).
In order to explore the effect of Xiaozhi Hugan Capsule
(XZHGC) on the treatment of fatty liver with hyperlipidemia,
the patients in April 1994 to May 1996 were divided into
XZHGC treatment group and western medicine Dongbai
Gantai Tablet as control group. The results showed that both
TC and TG decreased, HDL - C increased in two groups; but
the effect of decreasing TC and TG in treatment group was
much better than that of control group ( P < 0 . 01 ), no
significant difference as increasing HDL - C in two groups (
P > 0. 05 ) . Animal experiment also showed that high and
low dosage treatment group could increase the serum HDL -
C, and decrease TC and TG, the decreasing level was better
than that of control group XZHGC could also decrease the
1715- gera: 69836/di/ra
[COMPARISON ON THREE TCM METHODS FOR
TREATMENT OF SEVERE HEPATITIS]. CHEN
NINGSHENG ET AL. journal of traditional chinese
medicine. 1998;39(3):165 (eng).
1716- gera: 71911/di/ra
CASE STUDIES ON THE TREATMENT OF CHRONIC
HEPATITIS C VIRUS: AN INTEGRATD APPROCH
USING TRADITIONAL CHINESE MEDICINE AND
ACUPUNCTURE. WILLIAMS JE. american journal of
acupuncture. 1998;26(4):241-50 (eng).
In recent years, hepatitis C virus has emerged as the most
important liver disease in the United States and Canada,
becoming a chronic condition in 85% of cases with cirrhosis
and hepatocellular carcinoma the most common outcome.
Though conventional drug treatment has shown some
success, in most patients side effects of therapy are extreme
and long term results are poor. Chinese medicine and
acupuncture have been used successfully to manage chronic
hepatitis. This paper outlines the methodology for the
treatment of chronic hepatitis C virus with Chinese herbal
medicine, acupuncture, and adjunctive nutritional therapies.
Two case studies are presented in support of the hypothesis
that integrated therapy may offer improved outcomes for thin
disease.
1717- gera: 72188/di/ra
THE INTEGRATED TREATMENT OF
TRADITIONAL CHINESE MEDICINE AND MODERN
MEDICINE FOR HEPETITIS, PART III. LI ZHENG
YU. acpunctuur. 1998;22(1):5-7 (eng).
1718- gera: 74071/di/ra
[THE PROTECTIVE EFFECTS OF PINELLIA AND
POWRIA DECOCTION ON EXPERIMENTAL LIVER
INJURY IN RATS]. SUI YANHUA ET AL. journal of
shandong university of tcm. 1998;22(5):388 (chi*).
To investigate the protective effects of pinellia and powria
Decoction (PPD) on experimental hepatic injury in mice and
compare it with in the dose-response relationships.
Biochemical indexes and histopathological examination of
hepatic injury in mice by toxicant chemicals and CCL4 were
determined. PPD obviously inhibited the rising of serum (Al.
l). (AST) caused byCCL4 and dramatically decreased liver
(MDA) in a dose-dependent manner. Histopathological
examination showed that PPD could evidently alleviate the
condition of the degeneration of hepatic cells and their
gera 2011

necrosis. The protective effects of PPD on experimental liver
injury in mice.
1719- gera: 74140/di/ra
[CLINIC STUDY ON THE TREATMENT OF
POSTHEPATIC CIRRHOSIS WITH RUANGANBAO].
WANG GUOBIN. traditional chinese medicinal research.
1998;11(5):4 (chi).
1720- gera: 74779/nd/re
PRELIMINARY REPORT OF A
RANDOMIZED,DOUBLE-BLIND PLACEBO-
CONTROLLED TRIAL OF A CHINESE HERBAL
MEDICINE PREPARATION CH-100 IN THE
TREATMENT OF CHRONIC HEPATITIS C. BATEY
RG ET AL. j gastroenterol hepatol. 1998;13:244-7 (eng).
1721- gera: 75118/di/ra
[TRAIN OF THOUGHT AND METHOD ON THE
RESEARCH OF HEPATIC FIBROSCLEROSIS
INDUCED BY ALCOHOL]. DING XIA ET AL. china
journal of traditional chinese medicine and pharmacy.
1998;13(6):62 (chi).
1722- gera: 75199/di/ra
[TREATMENT OF HEPATITIS B SHOULD BE TAKE
GOOD CARE OF KIDNEY]. WANG GUOBIN. china
journal of traditional chinese medicine and pharmacy.
1998;13(4):54 (chi).
1723- gera: 75599/di/ra
[EXAMPLES OF PROFESSOR YAN DEXIN'S
EXPERIENCE IN USING TOXIC DRUGS]. YAN XIN.
liaoning journal of tcm. 1998;25(2):53 (chi*).
According to Dr Yan's thoughts, toxic medicine has both
advantage and disadvantage. If one takes care of processing
and combination of toxic medicine, and controls dosage
strictly, he can produces unique effects for treating difficult
and dangerous illness. For instance, Hirudo not only has the
function of breaking stasis and dispers concretions, freeing
the channels and promoting diuretics, but also goes into
blood lever, so it can treat various complicated cases caused
by blood stagnation. Processed Rhizoma Pinelliae is
commonly used in clinic practice, but it seems not strong
enough for treating certain intractable diseases. Dr Yan
thinks: that Rhizoma Pinelliae is heavy, descending, pungent
in nature, and it has function of opening and regulating
movements of qi, drying the dampness and reducing phlegm,
it also has extict effect for orifice block, stagnation of qi,
accumulation of dampness and phlegm, water retention, etc.
Semen Strychnine has better functions than other herbs in
regulating blood stagnation and accelerating the network
vessels, ceasing pain, reducing swelling and medicine
penetrating to the joints. Imitating ancient TCM doctor's
formulations, Dr Yan invents Longmadingtongdan using
Semen Strychnine as a main composition in his prescription.
This formulation is a time-tested prescription in treating Bi
syndrome.
1724- gera: 75600/di/ra
[QIU ZHIJI'S EXPERIENCE IN ADMINISTRATING
IN THE TREATMENT OF INFANT HEPATIC
DISEASE]. XIU JIANGDONG. liaoning journal of tcm.
1998;25(2):55 (chi).
1725- gera: 75750/di/ra
[CURATIVE EFFECT OF TCM-WM THERAPY ON
WILSON DISEASE WITH DIFFERENT CLINICAL
PHENOTYPES AND POLYMORPHISMS OF ATP7B
GENE]. REN MINGSHAN ET AL. chinese journal of
109
integrated traditional and western medicine.
1998;18(11):652 (chi*).
1726- gera: 75907/di/ra
[CLINICAL OBSERVATION ON EFFECT OF
COMPREHENSIVE IMMUNOTHERAPY IN
TREATING HEPATIC CARCINOMA AFTER
EMBOLISM CHEMOTHERAPY]. WANG
HUAIZHANG. chinese journal of integrated traditional
and western medicine. 1998;18(7):411 (chi*).
1727- gera: 108757/di/ra
DEVELOPMENT IN THE INTERVENTIONAL
HERBAL TREATMENT OF PRIMARY LIVER
CANCER. CHENG JIANHUA AND LIU XINHONG.
chinese journal of integrated traditional and western
medicine. 1998;4(1):61 (eng).
1728- gera: 108783/di/ra
TREATMENT OF SEVERE CHOLESTATIC
HEPATITIS BY INTEGRATING TRADITIONAL
CHINESE AND WESTERN MEDICINE. HE
JIANGPING AND WANG CHENGBO. chinese journal of
integrated traditional and western medicine. 1998;4(1):18
(eng).
Objective : To reveal the central mechanism of acupuncture
on the central nervous system. Methods : Excitatory amino
acids (EAAs) were determined in cerebral cortex,
hippocampus and striate body of ,left side by Shimadzu LC-
6A ]HPLC. Results : Metabolic disorder existed in excitatory
amino acids - The content .of Glu, Gln, Asp and Asn in
hippocampus and striate body were generally increased (P <
0. 05, or P < 0. 01), the content of Asn in cerebral cortex was
also increased (P<O. 01). The changes of inhibited amino
acids (1- AAs) to certain extent also existed in the three
regions but without regularity. Xingnao Kaiqiao ( AI 0 )f Y~
) acupuncture method could obviously reduce the levels of
Glu, Asp, Gln and Asn in hippocampus and striate body and
the levels of Asn and Gln in cerebral cortex of senescence
accelerate mouse P/8 (SAM-P/8). The non-acu-point
acupuncture method did not exert obvious effects on Glu and
Asp which was quite different from Xingnao Kaiqiao
acupuncture effects. Conclusions : (1) The hypermetabolism
of EAAs existed in the brain of SAM-P/8, which could be
regarded as the important pathological mechanism of
disorder in study and memory and cerebral atrophy. (2)
Xingnao Kaiqiao acupuncture method could obviously
regulate the abnormal metabolism of cerebral improving
brain which could be regarded as one of the mechanisms of
acupuncture effects on improving brain in function.
Acupuncture effect has remarkable- specificity of acupoint.
1729- gera: 108784/di/ra
CLINICAL OBSERVATIONS ON TREATMENT OF
INFANTILE CHOLESTATIC HEPATITIS
SYNDROME BY RHUBARB. HUANG ZHIHUA, YE
SIYING, DONG YONGSUI, ET AL. chinese journal of
integrated traditional and western medicine. 1998;4(1):22
(eng).
1730- gera: 108832/di/ra
EFFECT OF LIUJUNZI DECOCTION
SUPPLEMENTED WITH RADIX ASTRAGALI TO
ENHANCE CELLULAR IMMUNE FUNCTION OF
HEPATOCARCINOMA PATIENTS AFTER
TRANSCATHETER ARTERIAL
CHEMOEMBOLIZATION. CHENG HUIHUA, ZHENG
LISHENG, CHEN ZHANGSHU, ET A. chinese journal of
integrated traditional and western medicine.
1998;4(3):209 (eng).
gera 2011

1731- gera: 108856/di/ra
EFFECT OF MUSHROOM POLYSACCHARIDE
INJECTION ON T-CELL SUBSET AND SOLUBLE
INTERLEUKIN-2 RECEPTOR IN PERIPHERAL
BLOOD IN PRIMARY HEPATOMA PATIENTS. CHEN
WEIQIANG, CHEN YANGSHU. chinese journal of
integrated traditional and western medicine.
1998;4(4):296 (eng).
1732- gera: 145373/di/ra
PROMPT HEPATITIS C VIRUS SUPPRESSION
FOLLOWING HEPATITIS B VIRUS
SUPERINFECTION IN CHRONIC UNTREATED
HEPATITIS C. GUIDO M, RUGGE M, COLOMBARI R,
CECCHETTO A, SCARPA A, CADROBBI P. ital j
gastroenterol hepatol. 1998;30(4):14-7 (eng).
The natural course of chronic hepatitis C virus infection after
hepatitis B virus superinfection is not clear since it is difficult
to determine the chronology of the double infections. We
report on a case of de novo hepatitis B virus infection in the
course of chronic untreated hepatitis C, in which the time of
hepatitis B virus infection is actually known. The patient
eliminated HCV-RNA, both from serum and from liver
tissue, soon after the clinical onset of the acute hepatitis B.
Liver histology featured hepatitis with severe portal
inflammation and high-grade periportal and intralobular
necro-inflammatory lesions. This observation demonstrates
that hepatitis C virus replication can be promptly and
spontaneously suppressed by acute hepatitis B virus
superinfection.
1733- gera: 58892/di/ra
[CLINICAL OBSERVATION ON 32 CASES OF
CIRRHOSIS TREATED WITH INTERNAL AND
EXTERNAL THERAPIES OF TCM]. LIU YIJIN. hunan
journal of traditional chinese medicine. 1999;15(2):17 (chi
).
1734- gera: 58896/di/ra
[JIN SHI'S EXPERIENCE IN TREATING CHRONIC
HEPATITIS B]. YANG LI. zhejiang journal of tcm.
1999;34(4):141 (chi ).
1735- gera: 58897/di/ra
[TREATMENT OF 34 CASES OF ASCITES DUE TO
CIRRHOSIS WITH "WEI LING TANG"]. LI
SHENGCAI. zhejiang journal of tcm. 1999;34(4):143 (chi
).
1736- gera: 58904/di/ra
[PROGRESS OF EXPERIMENTAL STUDY ON
TREATING POSTHEPATITIC FIBROSIS WITH
TRADITIONAL CHINESE MEDICINE]. GUO LAI.
zhejiang journal of tcm. 1999;34(4):173 (chi ).
1737- gera: 58948/di/ra
[EFFECTS OF TURMEROL EXTRACTS ON THE
LIPOMETABOLISM AND THE FUNCTIONS OF THE
LIVER AND THE KIDNEY IN THE PATIENTS WITH
HYPERLIPEMIA]. WO WINGDE ET AL. journal of
zhejiang college of tcm. 1999;23(1):20 (chi ).
1738- gera: 58960/di/ra
[ACUPUNCTURE OF YONGQUAN (KI 1) AND
SHUIGOU (GV 26) POINTS CONTROLING
CONVULSION DUE TO HEPATIC
ENCEPHALOPATHY]. DANG ZHONGQIN. chinese
acupuncture and moxibustion. 1999;19(4):211 (chi ).
110
1739- gera: 58963/di/ra
[CLINICAL STUDY ON TREATMENT OF THE
CHRONIC CARRIER OF HBSAG WITH POINT-
INJECTION OF HUANGQI INJECTIO]. WANG
XINYAO ET AL. chinese acupuncture and moxibustion.
1999;19(4):223 (chi*).
72 cases of chronic carriers of HBsAg were treated with
point-injection of Huang Qi Injectio, and 20 cases were
treated with intermuscular injection of Huang Qi Injectio and
19 cases received point-injection of saline which were used
as control group. Results indicated that the rate of HBsAg
returning negative was 27.69 % ~ 37. 5 % and the rate of
HBsAg returning negative was 70.00 % ~ 84 .21% in the
group of point-injection of Huang Qi, the therapeutic effect
being superior to those of the control groups (P < 0.01 or 0.
05) . The therapeutic effects in the treatment group were
superior to those in the control groups 6 months and 12
months after treatment. Comparision between short-term and
long-term therapeutic effects on various indexes of serology
of hepatitis virus in the treatment group did not find obvious
differences, indication that the therapeutic effect in the
treatment is more
1740- gera: 59271/di/ra
[WANG YUQUN'S EXPERIENCE OF 46 CASES OF
TREATMENT OVER TRANSAMINASE NOT
REDUCING OVER A LONG PERIOD OF TIME IN
HEPATITIS-B]. WU XIAOING. jiangxi journal of tcm.
1999;30(3):7 (chi ).
1741- gera: 59357/di/ra
[WHAT THE YI (SECOND) -TYPE "HEPATITIS
PATIENT SHOULD PAY ATTENTION TO WHILE
PRACTICING "YANG" QIGONG]. MA MENGCHANG.
qigong and physical training. 1999;6: (chi ).
1742- gera: 59446/di/ra
[TREATING 107 CASES OF CHRONIC HEPATITIS B
WITH YANGYIN HUOXUE TANG]. QIAN HAIQING.
zhejiang journal of tcm. 1999;34(7):290 (chi ).
1743- gera: 59470/di/ra
[TREATMENT OF LOW FEVER IN HEPATITIS B BY
CAN LU XIAO DU DAN: A REPORT OF 22 CASES].
XU HUIXIANG. new journal of tcm. 1999;31(7):47 (chi ).
1744- gera: 59503/di/ra
[THE HEMORRHEOLOGY ASSAY FOR PATIENTS
OF PRIMARY LIVER CANCER AND LIVER
CIRRHOSIS WITH BLOOD STASIS SYNDROME].
WANG RONGPING ET AL. fujian journal of tcm.
1999;30(3):2 (chi ).
1745- gera: 59519/di/ra
[CLINICAL OBSERVATION OF CIRRHOSIS
ASCITES TREATED MAINLY BY PATTERN
IDENTIFICATION]. XIA YI-GUO. shanghai journal of
tcm. 1999;6:20 (chi ).
1746- gera: 59644/di/ra
[EXPERIMENTAL STUDY ON PROTECTION OF
ANIMAL LIVER AND ENHANCEMENT ACTION OF
IMMUNE FUNCTION OF WEIKELIAN TABLET
(GEMMATIVE BARLEY, RADIX ASTRAGALI SEU
HEDYSARI, ETC.)]. JIAO XIAOLAN ET AL. chinese
traditional patent medicine. 1999;21(5):249 (chi*).
In order to confirm the antiillness, preventing senility and
many other beneficial effects of Weikejian Tablet, some
animal experiments were carried out. The results showed: (1)
Using the method of MDA with TBA we have proved that
gera 2011

Weikejian Tablet and gemmative barley both in 3 different
concentrations had a strong antiperoxydation effect on the
spontaneous lipid peroxydation of liver homogenate in vitro.
Only in higher concentration, the rest herb mixture besides
gemmative barley could show statistical signification in
inhibiting MDA formation. Q value of various concentration
groups were all larger than 0. 8, which suggested that
compound prescription could enhance the effect. (2) In the
liver MDA raising model of mice induced by CCI4.
Weikejian Tablet could obviously decrease MAD at larger
dose ( P< 0. 05 ), which suggested that it had also an effect of
antiperoxydation in viva. (3) Weikejian Tablet at larger dose
could obviously raise SOD activity in the blood and liver of
mice ( P < 0. 05 ) . At same time the GSH levels of blood and
liver were little affected by various doses of Weikejian
Tablet. (4) The various dose groups of Weikejian Tablet
could significantly activate the phargocytic function of
mouse celiac
1747- gera: 59667/di/ra
[SERAPHARMACOLOGICAL EFFECT OF FUZHENG
HUAYU 3I9 DECOCTION ON EXPRESSION OF TYPE
I COLLAGEN AND TRANSFORNING GROWTH
FACTOR ß1 IN HEPATIC STELLATE CELLS]. LIU
CHENGHAI ET AL. chinese journal of integrated and
western medicine. 1999;19(7):412-4 (chi*).
Objective: To investigate the main serapharmacological
mechanism of antifibrotic action of Fuzheng Huayu 319
Decoction (FHD) at cellular and molecular level Methods:
Hepatic stellate cells (HSC) were isolated from the normal
rats and subcultured. Normal rats were medicated with FHD
and their blood serum collected to prepare the medicated
serum, which was incubated with the subcultured HSC. Then,
the extra- and intracellular collagen synthetic rates were
assayed with collagenase digestion method, type I collagen
content in the medium measured with ELISA, transforming
growth factor ß (TGF,ß1 ) protein production semiquantified
by immunocytochemistry stain and image analysis system,
the gene expressions of type I procollagen and TGFß1
analyzed by RT-PCR. Results: FHD medicated serum could
obviously inhibit the extra- and intracellular collagen
synthetic rates, decreased type I procollagen rnRNA
expression and its secretion, downregulate TGFß1 rnRNA
and its protein expression Conclusion: FHD could inhibit
HSC activation markedly, the main mechanism of its
antifibrotic action may be the medicated serum inhibition on
type I procollagen and TGFß1 gene expression.
1748- gera: 59695/di/ra
[EXPERIMENTAL STUDY ABOUT HUOXUE
SHENSHI DECOCTION'S ANTI-FIBROSIS IN
LIVER]. LIU LIANGWEI ET AL. journal of zhejiang
college of tcm. 1999;23(4):47 (chi*).
Make a model with carbon tetrachloride and make a
pharmacodynamic test with huoxue shenshi decoction,
colchicine being the control. 6 weeks later choose serum
glutamic pyrovic transaminase (SGPT) activity, albumin
(Alb), the rate of Alb and globulin (A/G), hyaluronic acid
(HA) and the changes in histology as determination indexes.
The experimental result: 1) In the therapeutic group the
indexes of ALT activity and A/G are obviously higher, there
is a definite difference compared with colchicine. 2)
Histological changes In the therapeutic group, the
degeneration and necrosis are obviously less than that in the
control group and also the degree of fibrosis in liver. So it
shows that huoxue shenshi decoction can definitely improve
liver function, its HA index of anti-fibrosis in
1749- gera: 59709/di/ra
[TREATMENT OF HEPATITIS B UNDER THE
111
GUIDANCE OF TCM THEORY OF PATHOGEN-
BODY RESISTANCE (ZHENG XIE)]. JIANG SEN ET
AL. journal of tcm. 1999;40(7):439 (chi ).
1750- gera: 59713/di/ra
[OBSERVATION ON THERAPEUTIC EFFECT OF
ACUPOINT-EJECTION COMBINED WITH CHINESE
DRUG FOR 52 CASES OF SEVERE
ICTEROHEPATITIS]. WANG FAZHI. chinese
acupuncture and moxibustion. 1999;19(8):467 (chi ).
1751- gera: 59780/di/ra
THE ANTI-INFLAMMATORY AND
HEPATOPROTECTIVE EFFECTS OF FRACTIONS
FROM CUDRANIA COCHINCHINENSIS VAR.
GERONTOGEA. CHUN-CHING-LIN ET AL. american
journal of chinese medicine. 1999;27(2):227-39 (eng ).
Various fractions of the ethanol extract from the root wood of
Cudrania cochinchinensis var. gerontogea (Moraceae) were
evaluated for their anti-inflammatory effects on carrageenan-
induced edema and hepatoprotective activities on carbon
tetrachloride (CC14)-induced and D-galactosamine-(D-
Ga1N) induced acute hepatotoxicity in rats. The fractions (n-
hexane, CHC13, EtOAc, nBuOH, and H2O) displayed
significant inhibitory activity against carrageenan-induced
edema, and the active anti-inflammatory components were
further localized in the n-BuOH fraction, which exhibited the
greatest anti-inflammatory effect, an effect 5% greater than
indomethacin (which was used as a standard reference
substance). Each fraction exerted a significant
hepatoprotective effect by reducing enzymatic alteration
(sGOT and sGPT) and by improving hepatic lesions,
including liver centrilobular inflammation, cell necrosis, fatty
change, ballooning degeneration in CC14-induced acute
hepatitis; and necrosis of the portal area in D-GalN-induced
acute liver injury. The n-BuOH and EtOAc fractions had the
greatest hepatoprotective effects on CC14-induced liver
injury; in contrast, the CHC13 fraction
1752- gera: 59781/di/ra
EFFECT OF A URINARY PREPARATION ON LIVER
INJURY BY SHORT-TERM CARBON
TETRACHLORIDE TREATMENT IN RATS. TUNG-
YUAN LAI ET AL. american journal of chinese medicine.
1999;27(2):241-50 (eng ).
The hepatoprotective effect of a preparation of human urine
(PHU) was assessed against short-term carbon tetrachloride
(CC14) treatment in rats. Significant prevention of liver
injury by PHU was found after CC14 treatment, judging by
the changes of serum biochemical parameters, and hepatic
protein and triglyceride contents. The increased liver lipid
peroxidation, and decreased liver vitamin C concentrations
observed after CC14 treatment were significantly prevented
by PHU administration. The increase in liver glutathione
(GSH) contents observed after CC14 treatment was further
increased by PHU treatment. Liver catalase activity
decreased after CC14 treatment, while liver superoxide
dismutase and GSH-peroxidase activities did not change.
PHU administration further inhibited the decrease in liver
catalase activity after CC14 treatment. These results indicate
that PHU administration can prevent liver injury induced by
CC14 in rats by inhibiting enhanced lipid peroxidation
1753- gera: 59782/di/ra
ORALLY ADMINISTERED PANAX GINSENG
EXTRACT DECREASES PLATELET ADHESIVENESS
IN 66% HEPATECTOMIZED RATS. XING CUI ET AL.
american journal of chinese medicine. 1999;27(2):251-6
(eng ).
The effect of oral administration of Panax ginseng extract
gera 2011

(GE) on platelet adhesiveness was examined in 66%
hepatectomized rats. A significant decrease in platelet
adhesiveness was obtained when 125 mg/kg/day GE was
administered for 6 days before and after hepatectomy. The
total cholesterol concentration in the serum was also
decreased by GE administration. Food intake was unaffected
by GE administration. Serum parameters indicating liver and
kidney function were unchanged after GE administration
except for lipid metabolic parameters. Because enhanced
platelet adhesiveness and hyperlipidemia induces
atherosclerosis, these results suggest that orally administered
GE is capable of improving the atherosclerotic condition
associated with hepatectomy.
1754- gera: 59944/di/ra
[EFFECT OF ACUPUNCTURE ON FUNCTION OF
CONTRACTION OF BILIARY TRACT IN THE
PATIENT OF ACUTE ICTEROHEPATITIS]. CHEN
YANNAN ET AL. chinese acupuncture and moxibustion.
1999;19(10):626 (chi ).
1755- gera: 69515/di/ra
[TREATMENT OF PRIMARY CARCINOMA OF
LIVER ACCORDING TO THE METHOD OF
INVIGORATING THE SPLEEN AND REGULATING
THE FLOW OF QI]. ZHANG XIAOXIA ET AL. journal
of shandong university of traditional chinese medicine.
1999;23(1):18 (chi).
1756- gera: 69640/di/ra
[CLINICAL OBSERVATION ON HEPATITIS
TREATED WITH GANLU XIAO DU POWDER]. CHU
YUYI. journal of traditional chinese medicine.
1999;40(2):87 (eng).
1757- gera: 69646/di/ra
[ANALYSIS ON 19 CASES OF B-HEPATITIS
CORRELATED SKIN ERUPTIONS TREATED BY
CHINESE MATERIA MEDICA]. YAO CHANGHUI.
journal of traditional chinese medicine. 1999;40(2):102
(eng).
1758- gera: 69656/di/ra
[LUPUS HEPATITIS TREATED WITH PILL OF
RADIX GENTIANAE MACROPHAYLLAE WITH
ADDITIVES]. HUANG JUN. journal of traditional
chinese medicine. 1999;40(1):31 (eng).
1759- gera: 69746/di/ra
[VETRAN PHYSICIAN GU PIRONG'S EXPERIENCE
ON SYNDROME DIFFERENTIATION AND
TREATMENT OF LIVER CANCER]. ZHANG JUN. new
journal of traditional chinese medicine. 1999;31(1):8 (chi).
1760- gera: 69755/di/ra
[STUDIES ON THE TYPE DIFFERENTIATION OF
CHRONIC GASTRITIS BY ACTIVITY OF NAK-
ATPASE OF RED BLOOD CELL MEMBRANE]. QI
JIANSHENG ET AL. new journal of traditional chinese
medicine. 1999;31(1):34 (chi).
1761- gera: 69935/di/ra
[ANALYSIS OF THE THERAPEUTIC EFFECT OF
1126 CASES OF LIVER CIRRHOSIS TREATED BY
INTEGRATED THERAPY OF CHINESE AND
WESTERN MEDICINES]. SUN DIANXING ET AL.
shanghai journal of traditional chinese medicine.
1999;4:26 (chi*).
Based upon the routine therapies of western medicine, 1126
cases of liver cirrhosis were identified into the pattern of
112
yang deficiency in the spleen and kidney, pattern of yin
deficiency in the liver and kidney, pattern of qi stagnation
and blood stasis, pattern of mixture of qi and water and
pattern of accumulation of damp heat and were treated with
Chinese herbal medicine and Chinese patent medicine
accordingly. The results showed obvious effectiveness in 286
cases, improvement in 629 cases, no change or deterioration
in 137 cases and death in 74 cases, in the total effective rate
of 81.26% and in the death rate of 6.57%. Among them, the
effective rate was 61.59% and the death rate was 26.09% in
the cases complicated with the upper digestive hemorrhage.
The effective rate was 35.14% and death rate was 35.14% in
the cases complicated with hepatic encephalopathy. These
results indicated that the therapeutic effect in the treatment of
liver cirrhosis by the integrated therapy of
1762- gera: 69976/di/ra
AMELIORATIVE EFFECT OF AN URINARY
PREPARATION ON ACETAMINOPHEN AND D-
GALACTOSAMINE INDUCED HEPATOTOXICITY
IN RATS. TUNG-YUAN LAI ET AL. american journal of
chinese medicine. 1999;27(1):73-81 (eng).
The effect of oral administration of a preparation of human
urine (PHU) on acute liver injury was examined in rats
intoxicated with acetaminophen and D-galactosamine. The
results indicated that PHU protected the liver from
acetaminophen and D-galactosamine-induced injury as
judged by morphological and biochemical observation. An
increase in lipid peroxide concentrations and decrease in
protein concentrations occurred in the liver by D-
galactosamine injection, PHU administration significantly
prevented these changes.
1763- gera: 69977/di/ra
THE INFLUENCE OF PROPOLIS ETHANOL
EXTRACT ON LIVER MICROSOMAL ENZYMES
AND GLUTATHIONE AFTER CHRONIC ALCOHOL
ADMINISTRATION. SONG-CHOW LIN ET AL.
american journal of chinese medicine. 1999;27(1):83-93
(eng).
Propolis designates a series of gums, resins and balms of
viscous consistency, which are gathered by honeybees from
certain parts, mainly the buds and barks of plants, especially
those found on coniferous trees. Bees bring propolis back to
the hive, where it is modified and mixed with other
substances including the bees' own wax and salivary
secretions. In this study, the influences of propolis ethanol
extract on chronic alcohol induced liver microsomal enzyme
changes were investigated. three of alcohol was added to rats'
daily diet for four weeks to induce chronic alcohol liver
injuries, and two different doses of propolis ethanol extract
were p.o. administrated three times per day on the 28th, 29th,
and 30th day. During the period of propolis administration,
the ethanol diet was continued. After sacrifice, the rat livers
were excised for assay of microsomal enzymes activity,
glutathione (GS H) concentration, glutathione-S -transferase
(G STase) and Y-glutamylcysteine synthetase (Y-GCSase)
activity. It was found that 30 mg/kg of propolis ethanol
extract significantly prevented the elevations of total
cytochrome P- 450 enzymes, NADPH-dependent cytochrome
C reductase, aniline hydroxylation, 7-ethoxyresorufin
hydroxylation (7-ERH), 7-penthoxyresorufin hydroxylation
(7-PRH), and lipid peroxidation induced by chronic ethanol
administration. Additionally, propolis ethanol extract (100
mg/kg) also induced GSTase and y-GCSase activities and
decreased glutathione levels in the liver.
1764- gera: 69978/di/ra
EFFECT OF GARLIC ACTIVE PRINCIPLE, DIALLYL
DISULFIDE, ON CELL VIABILITY, LIPID
gera 2011

PEROXIDATION, GLUTATHIONE
CONCENTRATION AND ITS RELATED ENZYME
ACTIVITIES IN PRIMARY RAT HEPATOCYTES.
LEE-YAN SHEEN ET AL. american journal of chinese
medicine. 1999;27(1):95-105 (eng).
This study investigated the effects of various concentrations
and incubation time intervals of diallyl disulfide (DADS), the
active principle of garlic, on: 1. cell viability, 2. lipid
peroxidation. and 3. glutathione (GSH) concentration and its
related enzyme activities of rat hepatocytes. According to the
results of LDH leakage and microscopic examination, 0.5 and
I mM DADS did not significantly affect the viability of
hepatocytes. However, significant decrease in cell viability
according to increased LDH leakage and significant changes
in morphology of hepatocytes were observed at 2 mM DADS
(P<0.05). Lipid peroxidation was also detected when the
hepatocytes were treated with 2 mM DADS. At 0.5 mM
DADS, a higher GSH content was found in the hepatocytes
although not at a statistically significant level. 0.5 and I mM
DADS has little effect on the activities of glutathione-
Stransferase (UIST) and glutathione peroxidase (GPx);
however a significant decrease in UIST, GPx and glutathione
reductase (GRd) activities was observed at 2 mM DADS.
Once the media of 2 mM DADS was replaced with fresh
medium at 24 hr treatment, the activities of UIST, GRd and
GPx were recovered, although they were still lower than the
1765- gera: 70623/di/ap
HEPATITE A. LE FOIE A PLAT. X. medecine douce.
1999;SEP:1P1/2 (fra).
Mention du traitement par acupuncture. (Dr DERIS Colin).
1766- gera: 70814/di/ra
[DENG TIETAO'S EXPERIENCE IN TREATING
CHRONIC HEPATITIS-C]. XIAO HUIQUAN ET AL.
journal of tcm. 1999;40(9):524 (chi).
1767- gera: 70818/di/ra
[THERAPEUTIC EFFECT OF YANG-WARMING AND
FLUID-EXPELLING PRINCIPLE ON ASCITIS IN
LIVER CIRRHOSIS]. WANG LICHUN ET AL. journal
of tcm. 1999;40(9):541 (chi).
1768- gera: 70832/di/ra
[CLINICAL OBSERVATION OF TREATMENT OF
HEPATIC CARCINOMA IN METAPHASE OR
ADVANCED STAGE]. XIONG MONIAN. journal of
shandong university of tcm. 1999;23(5):347 (chi).
1769- gera: 70973/di/ra
[THE RELATION BETWEEN DIET AND LIVER
CANCER]. WANG YIQIN ET AL. shanghai journal of
tcm. 1999;3:43-45 (chi).
1770- gera: 71734/di/ra
DIFFERENTIALDIAGNOSIS OF ABDOINAL
DISEASE UTILISING BI-DIGITAL O-RING TEST
ORGAN REPRESENTATION POINT. ABSTRACT.
KAZUO YANAGI. acupuncture and electro-therapeutics
research. 1999;24(3-4):213-4 (eng).
1771- gera: 71980/di/ra
EXPEDIENCY OF APPLYING ACUPUNCTURE
TREATMENT(REFFLEXIVE THERAPEUTICS) TO
LIVER AND BILIARY TRACT DISEASES. BORIS D
ET AL. word journal of acupuncture-moxibustion.
1999;9(1):56 (eng).
1772- gera: 72264/di/ra
AN ANALYSIS FOR DEATH CAUSES IN 45 CASES
113
OF LIVER CANCER TREATED WITH
TRADITIONAL CHINESE DRUGS. YANG ZONGYAN
ET AL. journal of tcm. 1999;19(2):97-9 (eng).
Among the 165 cases of late-stage liver cancer treated in our
hospital, 65 (39.4%) died, with an average survival time of
8.1 months and a median survival time of 7 months. Among
the 65 dead patients, 45 were treated with traditional Chinese
drugs and 20 with western medicine. The average survival
time was 8.4 months in the former and 7.3 months in the
latter group. The direct causes of death for the 65 patients
were hepatic coma, severe haemorrhage of the upper
digestive tract, Heyd's syndrome, hepatorrhexis, respiratory
failure, cardiac failure, etc. The incidence rates of
haemorrhage of the upper digestive tract and hepatorrhexis in
the 45 patients treated with traditional Chinese drugs were
obviously lower than those treated with western medicine.
1773- gera: 72313/di/ra
DIE ERFAHRUNGEN DES ALTARZTES YAO YULAN
BEI DER BEHANDLUNG VON CHRONISCHER
HEPATITIS. ZHANG YASHENG. chinesische medizin.
1999;14(2):37-45 (deu*).
[Veteran physician Yao Yulan's experiences in treating
chronic hepatitis].This article describes veteran physician
Yao Yulan's experiences in treating chronic hepatitis with
Chinese herbs. In his opinion, during chronic hepatitis
accumulations of calor humidus ("damp-heat") and Epidemic
toxin (Yidu) are predominant. Mainly they can be found in
the hepatic orb. The different stages of hepatitis and their
pathomechanisms are demonstrated and explained. The
indicated prescriptions are given also for possible
complications. The author illustrates his
1774- gera: 72314/di/ra
DIE ERFAHRUNGEN DES ALTARZTES QIAO
YANGXIAN BEI DER BEHANDLUNG VON
HEPATITIS. ZHAO WEI. chinesische medizin.
1999;14(2):46-53 (deu*).
[Veteran physician Qiao yangxian's experiences in treating
hepatitis].This article describes veteran physician Qiao
Yangxian s experiences in treating hepatitis with Chinese
herbs. From his point of view, hepatitis can base on humor
("dampness"), toxin, stasis and depletio ("vacuity"). The
pathomechanism and treatments are described and
prescriptions are given. The author emphasizes the promotion
of the Xue-circulation as well as the using of Rhizoma Rhei
(Dahuang) and of the 4 herbs Herba Hedyotidis (Baihuashe
shecao), Herba Kummerowia striata (Jiyancao), Herba
Selaginella moellendorfii (Yanbaicao) and Radix Gentianae
(Longdancao). Finally the article
1775- gera: 72486/di/ra
ACUPUNCTURE FOR GASTROINTESTINAL AND
HEPATOBILIARY DISORDERS. DIEHL DL. journal of
alternative and complementary medicine. 1999;5(1):27-45
(eng).
Acupuncture has been used for various gastrointestinal (GI)
conditions. Voluminous data support the effect of
acupuncture on the physiology of the GI tract, including acid
secretion; motility, neurohormonal changes, and changes in
sensory thresholds. Much of the neuroanatomic pathway of
these effects has been identified in animal models. A large
body of clinical evidence supports the effectiveness of
acupuncture for suppressing nausea associated with
chemotherapy, postoperative state, and pregnancy.
Prospective randomized controlled trials have also shown the
efficacy of acupuncture for analgesia for endoscopic
procedures, including colonoscopy and upper endoscopy.
Acupuncture has also been used for a variety of other
conditions including postoperative ileum, achalasia, peptic
gera 2011

ulcer disease, functional bowel diseases (including irritable
bowel syndrome and nonulcer dyspepsia), diarrhea,
constipation, inflammatory bowel disease, expulsion of
gallstones and billiard ascariasis, and pain associated with
pancreatitis. Although there are few prospective randomized
clinical studies, the well- documented physiological basis of
acupuncture effects on the GI tract, and the extensive history
of successful
1776- gera: 72885/di/ra
EFFECTS OF ACUPUNCTURE ON THE
IMMUNOLOGICAL FUNCTIONS IN HEPATITIS B
VIRUS CARRIERS. CHEN JIAFU ET AL. journal of tcm.
1999;19(4):268-72 (eng).
1777- gera: 73071/di/ra
[(COMPARATIVE STUDY ON THERAPEUTIC
EFFECTS OF GANDOU TABLET AND
DIMERCAPTOSUCCINATE ACIDE IN TREATING
WILSON DISEASE).]. HAN YONGZHU ET AL. chinese
journal of integrated traditional and western medicine.
1999;19(2):69 (chi).
Objective: To compare the effects of Gandou I (GD, a
Chinese herbal preparation) and dimercaptosuccinate acid
(DMSA) in treating Wilson disease (WD). Methods: Ninety-
four patients with WD were divided into 2 groups, 32 cases
in the GD group and 62 in the DMSA group, they were
treated with GD and DMSA respectively. The therapeutic
course was 4 weeks for both groups. Modified Goldstein's
Degree was adopted to evaluate the clinical effect. Results:
The total effective rate of the GD group was 71. 9 %, which
was similar to that of the DMSA group (77. 4 %, P > 0. 05).
But the adverse reaction occurred in the latter group was
more than that in the former. Conclusion: GD is a low toxic
and highly effective drug for long-term treatment of WD.
1778- gera: 73387/di/ra
[RELATIONSHIP BETWEEN THE THERAPEUTIC
EFFECT AND CONTENTS OF HBV-DNA IN
COMBINED TREATMENT OF MEDICINAL
VESICULATION AND ACUPOINT-INJECTION FOR
CHRONIC HEPATITIS B]. CHEN HAIYING ET AL.
chinese acupuncture and moxibustion. 1999;19(12):729
(chi).
1779- gera: 73600/di/ra
CERTAIN PROGRESS OF CLINICAL RESEARCH ON
CHINESE INTEGRATIVE MEDICINE. CHEN KEJI.
chinese medical journal. 1999;112(10):934-37 (eng).
1780- gera: 73601/di/ra
PREVENTION AND THERAPY OF HEPATITIS B.
TAO QIMIN ET AL. chinese medical journal.
1999;112(10):942-46 (eng).
Purpose To review the achievements of the prevention and
therapy of hepatitis B (HB) in China during the thirty years
after the discovery of hepatitis B virus (HBV) in 1967. Data
source Data come from an English language literature search
using MEDLINE 1966 - 1999, especially 1982 - 1999, and
Chinese language literature, published and unpublished, from
the Chinese Health Administration. Study selection After
reviewing of the literature we select 14 articles to address our
statement. Data extraction Two observers independently
evaluated the quality of the data materials obtaining from
these articles. Results Investigation of HBV vaccine
development in China was almost simultaneously with the
same kind of work in the international. At least 200 million
people have accepted the vaccination of HBV vaccine. The
vaccination of the HBV vaccine in China has decreased the
prevalence of HBV infection no matter in urban cities or in
114
nural area. The protection against HBV infection can be
maintained at least for 9- 11 years. Conclusions Vaccination
of HBV vaccine in China is successful and has obtained great
1781- gera: 73618/di/ra
CASO CLINICO DI EPATITE CRONICA ATTIVA
HCV POSITIVA,DIAGNOSTICATA IN MTC COME
SINDROME DA STASI DEL QI DIFEGATO. DOGLIA
FIORELLO. rivista italiana di agopuntura.
1999;20(96):63-8 (ita*).
We have analized a c linical case of ACTIVE CHRONIC
HEPATITIS POSITIVE HCV recognized through MTC as
"Astheny-Depression by stasis of Liver Qi". It was faced with
Agopuncture, Pharmacology and Qi Gong Technics; it was
observed the complete normalization of SCOT and SGPT
values; it was not obteined that situation before the
intervention with the MTCP. With a manteniment therapy,
after three mounths, that values remain normal.
1782- gera: 73620/di/ra
SU DI UN CASO DI LICHEN RUBER PLANUS E
CIRROSI BILIARE PRIMITIVA,TRATTATO CON
AGOPUNCTURA. DI STANISLAO C. rivista italiana di
agopuntura. 1999;20(96):81-6 (ita*).
Lichen plan is a common dermatitis sometimes associated
with differents liver diseases. This article referred about a 57
years old women with biliary chirrosis and lichen, treated to
success with acupuncture.
1783- gera: 73670/di/ra
[(STUDY ON ESSENCE OF SYNDROME OF
TRADITIONAL CHINESE MEDICINE IN LIVER
CIRRHOTIC PATIENTS).]. WU JIAGENG ET AL.
chinese journal of integrated traditional and western
medicine. 1999;19(5):279 (chi).
To explore the essence of Syndrome of traditional Chinese
medicine (TCM) in cirrhotic patients. Methods: Eighty
patients of post-hepatitis-B cirrhosis were classified,
according to Syndrome Differentiation of TCM, into three
types: the Liver-Qi Stagnancy and Spleen-Deficiency type
(A), the Qi Stagnancy and blood stasis type (B) and the Heat
Stagnancy and blood stasis type (C), serum hyaluronic acid
(HA), adenosine deaminase (ADA), glutathione-s- epoxide
transferase (GST), N-acetyl-, ß-D-glucosaminidase (NAG),
hydroxyproline (HYP) and procollagen type III (PC III) of 52
patients were determined before and after treatment based on
Syndrome Differentiation. Results: Serum HA, ADA, GST
and PCIII of patients were significantly higher than those of
the healthy control (P < 0.01), and the change of these
parameters were closely associated with types of Syndrome,
which were, in turn, C > B > A > control, the difference
between groups was significant (P < 0. 05, P < 0. 01). After
treatment, the liver function and above-mentioned serologic
parameters were significantly improved (P < 0. 05, P < 0.
01). Conclusions: Syndrome of cirrhosis patients hat its
inherent essential content. Serum HA, ADA, GST and PCIII
could serve as objective indexes for establishing Syndrome
Differentiation and guiding treatment. TCM treatment of
cirrhosis based on Syndrome Differentiation has good effect
with beneficial anti-fibrotic action.
1784- gera: 73674/di/ra
[(STUDY ON PREVENTIVE AND THERAPEUTIC
EFFECT OF RADIX SALVIAE MILTIORRHIZAE ON
RECURENCE AND METASTASIS OF LIVER
CANCER).]. SUN JINGINGET AL. chinese journal of
integrated traditional and western medicine.
1999;19(5):292 (chi).
To study the inhibitory effect of Radix Salviae Miltiorrhizae
(RSM) on adhesive and invasive ability of SMMC-7721 liver
gera 2011

cancer cells, and on the metastasis and recurrence on post-
hepatectomy liver cancer in nude mice. Methods: Effect of
RSM on SMMC-7721 cell membrane intercellular adhesive
molecule-1 (ICAM-1) expression was observed by
immunofluorescence flow cytometry; effect on invasive
ability and of SMMC-7721 cell and the detachment of which
attached to fibronectin (FN) by cell migration experiment;
effect on adhesion of SMMC-7721 cell with FN by MTT
method and effect on adhesion between 7721-7721,
7721lymphocyte and 7721-endothelial cell by cell adhesion
experiment. LCI-D20 human liver cancer metastasis model,
after hepatectomy, was used to observe the effect of RSM on
recurrence and metastasis of liver carcinoma in nude mice.
Results: ICAM-1 expression in SMMC- 7721 cells incubated
with RSM was significantly lower than that in cells did not
treated with RSM. RSM could inhibit the invasive ability of
SMMC-7721 cell and made the cells already attached to FN
exfoliated. It could also inhibit the adhesion of 7721-7721,
7721-lymphocyte and 7721-endothelial cell. And RSM
showed preventive and therapeutic effect on intrahepatic and
remote metastasis/recurrence of early and late human post-
hepatectomy liver cacer in nude mice. Conclusion: RSM
could inhibit the invasion and adhesion of SMMC-7721 cell
and could also prevent and inhibit metastasis and recurrence
of human liver cancer after hepatectomy in nude mice.
1785- gera: 73739/di/ra
[INFLUENCE OF THE EXTRACT OF RADIX
SALVIAE MILTIORRHIZAE ON HEPATIC FIBROSIS
INDUCED BY CCL4 AND DMN IN RATS]. HU YI-
YANG ET AL. shanghai journal of tcm. 1999;10:7 (chi*).
In order to investigate the preventive and therapeutic actions
of the extract of Radix Salvia Miltiorrhizae (RSM) on liver
fibrosis and in related mechanisms, the liver fibrotic model
was induced with tetrachloride carbon (CCI4) and
dimethylnitrosamine (DMN) in rats and treated with the
extracts derived from RSM and colchicine as the control
drug. Then hepatohistopathological changes were evaluated,
type I and II collagens in liver were observed with
immunohistochemistric stain, hepatic hydoxyproline (Hyp)
and MDA, serum ALT and Alb activities were assayed. The
results showed taht the extract of RSM could improve the
injurious and fibrotic pathology and decrease serum ALT
activity and hepatic MDA and Hyp contents, etc…it is
concluded that the extract from RSM had a good action on
liver fibrosis, the mechanism of its action is mainly
associated with its actions against peroxidation and
regulation of collagen metabolism in liver, the extract of
RSM is one of the important effective components from
1786- gera: 73741/di/ra
[CLINICAL OBSERVATION OF TREATMENT OF
CHRONIC HEPATITIS BASED ON TCM SYNDROME
DIFFERENTIATION: A REPORT OF 80 CASES].
ZHANG JUN. shanghai journal of tcm. 1999;10:13 (chi).
1787- gera: 74076/di/ra
[EFFECTS OF DAIHUANG ZHECHONG PILLS ON
SERUM HYALURONIDASE,PORTAL
HYPERTENSION AND HYPERSPLENISM IN
PATIENTS WITH HEPATOCIRRHOSIS]. JIAO
SHUANLIN ET AL. journal of shandong university of
tcm. 1999;23(2):115 (chi).
1788- gera: 74105/di/ra
[CLINICAL AND EXPERIMENTAL STUDY ON
TREATMENT OF CHRONIC ACTIVE HEPATITIS B
WITH HUAYU RUANGAN DECOCTION]. QI
ZHONGXI. journal of shandong university of tcm.
1999;23(3):185 (chi).
115
1789- gera: 74158/di/ra
[RELATIONSHIP BETWEEN THE SYMPTOME AND
THE LEVELS OF TNFAS AND IL2R IN SERUM FOR
CHRONIC HEPATITIS B PATIENTS]. ZHU QINGJING
ET AL. traditional chinese medicinal research.
1999;12(2):7 (chi).
1790- gera: 74177/di/ra
[CLINICAL STUDY ON XUELONG GRANULES IN
TREATING CHRONIC HEPATITIS AND
CIRRHOSIS]. DAI CHUANGUI ET AL. shandong
journal of tcm. 1999;18(11):490 (chi).
1791- gera: 74182/di/ra
[TREATING 28 CASES OF INFANTILE HEPATITIC
SYNDROME WITH INTEGRATION OF
TRADITIONAL CHINESE AND WESTERN
MEDICINES]. SONG YUMEI ET AL. shandong journal
of tcm. 1999;18(11):506 (chi).
1792- gera: 74201/di/ra
[TREATMENT OF 68 CASES OF CHRONIC
HEPATITIS B WITH BAOGANLING].]. ZANG
QINGYUN ET AL. shandong journal of tcm.
1999;18(12):537 (chi).
1793- gera: 74215/di/ra
[THERAPEUTIC OBSERVATION ON 27 CASES OF
LATE LIVER CANCER TREATED BY
INTEGRATION OF TRADITIONAL CHINESE AND
WESTERN MEDICINES. ZHANG ZHI'AN ET AL.
shandong journal of tcm. 1999;18(3):125 (chi).
1794- gera: 74309/di/ra
[QIAN BOWEN'S EXPERIENCES IN TREATMENT
OF PRIMARY LIVER CARCINOMA]. WANG
CHANGJUN ET AL. journal of tcm. 1999;40(8):460 (chi).
1795- gera: 74319/di/ra
[RELATIONSHIP BETWEEN THE SERUM INDICES
OF LIVER FIBROSIS AND TCM SYNDROME TYPES
IN LIVER CIRRHOSIS DUE TO CHRONIC
HEPATITIS]. PAN ZHIHENG ET AL. journal of tcm.
1999;40(8):494 (chi*).
In order to probe into the relationship between the TCM
syndrome types and the five indices of fibrotic markers of
liver in serum, the HA, hPC III, IV -C in 160 of liver
cirrhosis patients induced by chronic hepatitis were
examined. Results showed that the 5 indices in all TCM
syndrome types were all higher than the control group. each
with its specificity. The increased amplitude in the group of
liver-stagnant, spleen-deficiency was the least one. It was
also found that the 3 indices of liver fibrosis in the group of
internal blockade of damp - heat were markedly increased; it
was mainly the increase of HA. hPC III in the group of yin-
deficiency of both liver-kidney and obstruction of collateral
by static blood: but it was mainly the increase of HA. B -C in
the group of Yang - deficiency of spleen and kidney. This
demonstrated that the above indices were of significance in
TCM syndrome typing for chronic hepatic victims. Lingering
of damp-heat may be the trigger factor for liver fibrosis in
which blood stasis we present
1796- gera: 74332/di/ra
[ANALYSIS ON SYNDROME AND TREATMENT OF
VIRAL HEPATITIC COMPLICATED WITH
MUCOSAL LESION OF DUODENUM]. XIAO
JIANZHEN ET AL. journal of tcm. 1999;40(5):295 (chi).
gera 2011

1797- gera: 74343/di/ra
[CLINICAL STUDY ON TREATMENT OF SIDE-
EFFECTS BY XIAO CHAI HU DECOCTION AFTER
INTERVENTIONAL TREATMENT FOR LIVER
CANCER]. YE ANNA ET AL. journal of tcm.
1999;40(12):734 (chi*).
Of the 300 inpatients who were diagnosed definitely as
primary liver cancer and excision could not be carried out on
them. The patient had fever vomit pain in the liver region
haemorrhage of digestive tract and other side effects after
interventional treatment. 150 cases were treated with Xiao
Chai Hu. Decoction and the other 150 cases were treated by
simple Western medicine as control. Results showed that
Xiao Chai Hu Decoction in therapeutic effects was superior
to the simple Western medicine.
1798- gera: 74373/di/ra
[CHRONIC HEPATITIS -C TREATED BY
PRINCIPLES OF COOLING-
BLOOD,DETOXIFYING,SOFTENING-LIVER AND
REGULATING-SPLEEN: OBSERVATION OF 45
CASES]. LIU MIN ET AL. journal of tcm. 1999;40(4):227
(chi).
1799- gera: 74377/di/ra
[EXPERIMENTAL STUDY ON MILD CHRONIC
LIVER INJURY TREATED BY VARIOUS DRUGS OF
ACTIVATING- BLOOD-REMOVING-STASIS IN
DIFFERENT DOSAGES]. XIE FENGYING ET AL.
journal of tcm. 1999;40(4):237 (chi).
1800- gera: 74474/di/ra
[CURRENT STATION OF STUDIES OF CHINESE
DRUGS IN ANTI-FIBROSIS OF LIVER]. DU BIN.
journal of tcm. 1999;40(10):629 (chi).
1801- gera: 74660/di/ra
[FURTHER STUDY ON ACUPOINT RELATIVE
SPECIFICITY OF ACUPOINT DRUG INJECTION].
ZHOU AILING ET AL. shanghai journal of acupuncture
and moxibustion. 1999;18(1):33 (chi*).
Objective To observe acupoint relative specificity of acupoint
drug injection. Methods and Results Gan Yan Ling. (GYL)
were used to prevent and treat mouse hepatitis caused by
CCI4. GYL was given to the mice by three different route
injections. Protective effect on hepatic cells was significantly
better in Zusanli (S36) group than that in intramuscular or
Neiguan (P6) injection group. Neostigmine methylsulfate
Zusanli (S36) injection of gave rise too much stronger
gastrointestinal peristaltic effect in mice than Neiguan (P6).
Weizhong (B40) and intramuscular injection of it. In healthy
volunteer study diuretic kaliuretic and natriuretic effects of
furosemide given by Sanyinjiao (Sp6) injection were similar
to those by i. v injection. These effects were statistically
higher than those in other groups receiving furosemide
respectively by Fuliu (K7) and beside Sanyinjiao injections.
Conclusion: The above mentioned results indicate that
acupoint drug injection produce a good effect in the proper
selection of
1802- gera: 74774/di/ra
PRELIMINARY EVIDENCE FOR THE
EFFECTIVENESS OF A CHINESE HERBAL
COMBINATION IN CHRONIC HEPATITIS C.
STEVINSON C. focus on alternative and complementary
therapies. 1999;4(4):191 (eng).
Analyse et commentaire de l'article: Batey RG et al.
Preliminary report of a randomized, double-blind placebo-
controlled trial of a chinese herbal medicine preparation CH-
100 in the treatment of chronic hepatitis C. J Gastroenterol
116
Hepatol, 1998; 13: 244-7. Réf gera: [74779].
1803- gera: 74915/di/ra
[EFFECTS OF OLEANOLIC ACID ON THE
ACTIVITY OF AMINOTRANSFERASES IN THE
SERUM OF LIVER INJURY MICE AND THE
CULTURE FLUID OF MICE'S DAMAGED LIVER
CELLS]. WANG XIAOFENG ET AL. chinese
pharmaceutical journal. 1999;34(6):377 (chi*).
1804- gera: 74976/di/ra
[THE SELECTION OF THERAPEUTIC METHOD OF
HEPATIC DISEASE]. LUO XINLA ET AL. hubei journal
of tcm. 1999;21(4):167 (chi).
1805- gera: 75038/di/ra
[CLINICAL OBSERVATION ON 63 CASES OF
HEPATIC DAMAGE TREATED BY JIAWEI SINI
SAN]. PENG HANGUANG ET AL. hubei journal of tcm.
1999;21(10):450 (chi).
1806- gera: 75068/di/ra
[TREATMENT OF 30 CASES OF CIRRHOSIS
COMPLICATED BY GASTROPATHY DUE TO
PORTAL HYPERTENSION WITH CHINESE
MEDICINE COMBINED WITH WESTERN
MEDICINE. CHANG JIE ET AL. jiangsu journal of tcm.
1999;20(9):15 (chi).
1807- gera: 75146/di/ra
[TRAIN OF THOUGHT ABOUT CHRONIC
HEPATITIS B TREATED FROM INCUBATIVE
PATHOGEN]. CHEN SANCAI. china journal of
traditional chinese medicine and pharmacy. 1999;14(5):55
(chi).
1808- gera: 75245/di/ra
[CLINICAL OBSERVATION OF "TCM II"
PRESCRIPTION ON CHRONIC HEPATITIS B
TREATMENT]. JIANG XUELIAN ET AL. journal of
beijing university of tcm. 1999;22(2):58 (chi).
1809- gera: 75260/di/ra
[EXPERIMENTAL STUDY ON THE PREVENTION
AND TREATMENT OF HEPATIC FIBROSIS WITH
THE TCM DECOCTION II]. JIANG XUELIAN ET AL.
journal of beijing university of tcm. 1999;22(3):36 (chi*).
1810- gera: 75318/di/ra
[EFFECTS OF MANGANXIAO ON SERUM
BIOCHEMISTRY OF ALCOHOLIC LIVER DAMAGE
IN RAT]. YE YONG'AN ET AL. journal of beijing
university of tcm. 1999;22(6):31 (chi*).
1811- gera: 75319/di/ra
[FLOW CYTOMETRIC ANALYSIS OF
SCHINIFOLINE'S INHIBITION ON RAT HEPATOMA
CELL INDUCED BY DEN. BAI JINWEN ET AL. journal
of beijing university of tcm. 1999;22(6):34 (chi*).
1812- gera: 75370/di/ra
[MY EXPERIENCE OF TREATING LIVER DISEASE].
ZHANG JINNAN. henan traditional chinese medicine.
1999;19(2):3 (chi).
1813- gera: 75674/di/ra
[EFFECT OF GLUCOSIDORUM PAEONIAE ALBA
ON EXZYMATIC ACTIVITY OF LYMPHOCYTES IN
EXPERIMENTAL LIVER CANCER]. CAI YUWEN ET
AL. liaoning journal of tcm. 1999;26(6):285 (chi*).
gera 2011

The effects of total glucosides of peony on enzyme activities
in Lymphocytes of the Lymph node around the cancer in Rat
liver during AFB1 were studied using electron enzyme
histochemical method. The results showed: 1) The activities
of Mg2+-ATPase. G-6-Pase and SDH in Lymphocytes of the
Lymph node around cancer become lower in group of
experimental liver carcinogenesis. ATOP could promote
enzyme activities in Lymphocytes on the Lymph node around
the cancer. which might be one of its immunomodulatory
mechanism. These results suggests that promoting enzyme
activities in Lymphocytes on the Lymph node constitutes part
of the pharmaceutical basis of the treatment of immunologic
inadequacy with malignant tumors, for which "TGP" is an
effective prescription.
1814- gera: 75681/di/ra
[CLINICAL STUDY ON DIAGNOSIS OF
HEPTOCARCINOM IN ZHUANG AND YAO
TRADITIONAL MEDICINE]. LI TONG ET AL. liaoning
journal of tcm. 1999;26(12):541 (chi*).
The rate of liver cancer in Guangxi Zhuang Autonomies
Kegion is higher than another region. There is much clinic
experience in treating liver cancer in Zhuang, Yao national
medical in ocular diagnosis. We hat observed 800 cases
which includes 4 groups treatment group and three
contrasting groups. Treatment group by 200 cases of liver
cancer, contrasting groups by 200 cases of tumor (no liver
cancer) and 200 cases of no tumor and 200 cases of normal.
With observation eyes, nails. Tongue, etc. There was
statistical of GRA results demonstrating that the 7 indice can
be served as a comprehesue index for diagnosis of liver
cancer.
1815- gera: 75698/di/ra
[ZHANG ZHIYUAN'S EXPERIENCE IN THE
TREATMENT OF THE LIVER AND GALLBLADDER
DISEASE WITH WIND-DRUG]. ZHENG GUOQING.
liaoning journal of tcm. 1999;26(2):51 (chi*).
This paper is the summary of Professor Zhang Zhiyuan's
experience in treatment of liver and gallbladder diseases with
drugs for evil-wind. He illustrates the mechanism of drugs for
evil-wind function on liver and gallbladder diseases and
describes in details about the application of drugs for evil-
wind on acute and chronic cholecystitis, cholelithiasis,
primary biliary cirrhosis and chronic hepatitis B on the basis
of patho-physiological correlation ship among the wind,
liver, qi and the blood. The paper has highly theoretic
meaning and clinical value.
1816- gera: 75703/di/ra
[RELATIONSHIP BETWEEN THE PICTURE OF
TONGUE AND THE DETECTION OF HBV AND DNA
WITH PCR]. HONG FANLI ET AL. liaoning journal of
tcm. 1999;26(2):58 (chi*).
To explore the relationship between picture of tongue in
TCM and PCR-HBV-DNA. Methods: To determine the
hepatitis B Virus DNA using the PCR in 116 patients and
Compared with the picture of tongue in TCM. Results: The
patients with sick picture of tongue have more possibility of
PCR-HBV-DNA Positive than that patients with normal
picture of tongue (P<0. 0l), but the patient with sick picture
of tongue mustn't have regular PCR-HBV-DNA positive. The
degree of P (, R-HBV-DNA in tongue Shapa were enlarged
and teeth marks tongue, delicate tongue, prickly tongue.
cracked tongue, Shrivelled tongue and normal tongue
respectively, that of enlarged and teeth marks tongue group
has the most possibility (P<O. 001). The degree of PCR-
HBV-DNA Positive in tongue Coating Were thick and
yellow fur, thick and white rur, thin and white fur, grey and
black fur respectively. Conclusions the picture of tongue in
117
TCM indicated the results of determination of PCR-HBV-
DNA
1817- gera: 75916/di/ra
[REVERSION OF HBV-RELATED LIVER FIBROSIS
AND EARLY CIRRHOSIS BY BAICAO ROUGAN
CAPSULE].]. XIANG YANG ET AL. chinese journal of
integrated traditional and western medicine.
1999;19(12):709 (chi*).
Objective : to observe the therapeutic effect of herbal
compound, Baicao Rougan Capsule on human liver fibrosis
and early cirrhosis associated with chronic hepatitis B.
Methods : forty-two patients with liver fibrosis and 10 cases
early cirrhosis were treated with a herbal compound for six
months. Two liver biopsies were performed before and after
treatment, their serum samples were collected before, in the
middle of and after the treatment, all samples were measured
at the same time. Results : improvement of clinical symptoms
and signs occured in 75% to 91% of the patients, serum ALT
lowered to normal level in 68%. The serum level of type IV
collagen, laminin and hyaluronic acid were significantly
reduced by the end of treatment (P<0.05). Grading score was
reduced from 7.79±6.15 to 5.36±3.95 after treatment
(P<0.05), while staging score was reduced from 7.39±5.55 to
5.26±4.36 (P<0.05). Conclusion : Chinese herbal compound
Baicao Rougan Capsule is effective in the treatment, and in
the
1818- gera: 76011/di/ra
[FIVE DIAGNOSTIC AND THERAPEUTIC METHODS
FOR INTRACTABLE HEPATIC DISEASES]. ZHANG
ZHIYIN. shanghai journal of tcm. 1999;1:26 (chi).
1819- gera: 76069/di/ra
[OBSERVATION OF THERAPEUTIC RESULTS OF
"TOXIN-EXPELLING AND LIVER-BENEFITING
FORMULA" TO NEGATIVE TRANSFORMATION OF
HBV SERUM MARKERS]. HU WEN-HAO. shanghai
journal of tcm. 1999;8:10 (chi*).
1820- gera: 76348/di/ra
[CURATIVE EFFECTS OF DIFFERENT DEGREES OF
BLOOD-QUICKENING STASIS-DISPELLING
MEDICINAL ON CHRONIC HEPATITIS MODEL
INDUCED BY CC14]. LIU JIE ET AL. chinese traditional
patent medicine. 1999;21(8):422 (chi*).
1821- gera: 76429/di/ra
[CLINICAL OBSERVATION REPORT ON
TREATMENT OF VIRUS HEPATITIS WITH
KOREAN MEDICINE,GANSSHENGJING CAPSULE
IN 360 CASES]. JIN HONG-DE. journal of tcm and
chinese materia medica of jilin. 1999;19(6):11 (chi).
1822- gera: 76505/di/ra
[CLINICAL STUDY ON TREATMENT OF HEPATITIS
B VIRUS-ASSOCIATED NEPHRITIS MAINLY BY
GLUIOSIDOUM TRIPTERYGIITOTRUM]. YE LIYAN.
fujian journal of tcm. 1999;30(4):6 (chi).
1823- gera: 76510/di/ra
[DOCTOR ZHANG ZHIHAO'S EXPERIENCES ON
THERAPY OF TYMPANITES]. SHUN WEIFENG ET
AL. fujian journal of tcm. 1999;30(4):14 (chi).
1824- gera: 76512/di/ra
[CLINICAL OBSERVATION ON DAHUANG SANQI
SAN TREATING VIRAL HEPATITIS]. QIU LIN'AN ET
AL. fujian journal of tcm. 1999;30(5):2 (chi).
gera 2011

1825- gera: 76595/di/ra
[TREATING 306 CASES OF POSITIVE REACTION
OF HEPATITIS B ANTIGEN-ANTIBODY SYSTEM
WITH WEISHI QINGGANG DECOCTION]. LI
GUANHUO. zhejiang journal of tcm. 1999;34(1):15 (chi).
1826- gera: 76655/di/ra
[TREATING 50 CASES OF ASCITES DUE TO
CIRRHOSIS WITH YING QI WEI TANG]. ZHENG
LIMING ET AL. zhejiang journal of tcm. 1999;34(12):517
(chi).
1827- gera: 76705/di/ra
[TREATING 168 CASES OF ACUTE AND CHRONIC
CHOLECYSTITIS WITH XIAOYAO SAN]. GU
XIAOXIA. jiangxi journal of tcm. 1999;30(1):27 (chi).
1828- gera: 76725/di/ra
[PRIMARY STUDY OF TREATMENT ACCORDING
TO DIFFERENTIATION OVER MALIGNANCY
LIVER HARM CAUSED BY CHEMICAL THERAPY].
WANG ZHAO-LIN. jiangxi journal of tcm. 1999;30(4):27
(chi).
1829- gera: 76738/di/ra
[CLINICAL OBSERVATION ON 30 CASES OF
TREATMENT OVER MIDDDLE AND LATER
PERIOD IDIOPATHY LIVER CANCER WITH
GIVING PRIORITY TO TRADITIONAL CHINESE
MEDICINE]. REN JIAN ET AL. jiangxi journal of tcm.
1999;30(5):21 (chi).
1830- gera: 76754/di/ra
[TREATMENT OF 50 CASES OF CHRONIC ACTIVE
HEPATITIS BY SHUGAN YIQI DECOCTION]. CHEN
ZHONGYI. shaanxi journal of traditional chinese
medicine. 1999;20(4):145 (chi).
1831- gera: 76755/di/ra
[TREATMENT OF 298 CASES OF CHRONIC
HEPATITIS B BY FUZHENG JIEDU PULVIS]. DI
CAIYUN. shaanxi journal of traditional chinese medicine.
1999;20(4):148 (chi).
1832- gera: 76757/di/ra
[TREATMENT OF 45 CASES OF SENILE CIRRHOSIS
BY INTEGRATED TCM AND WM]. LIU BIANLIN.
shaanxi journal of traditional chinese medicine.
1999;20(4):151 (chi).
1833- gera: 76758/di/ra
[TREATMENT OF 48 CASES OF PRIMARY
CIRRHOSIS BY TCM]. GUO JIAQIANG. shaanxi
journal of traditional chinese medicine. 1999;20(4):152
(chi).
1834- gera: 76759/di/ra
[TREATMENT OF 82 CASES OF HEPATITIS
COMPLICATED CIRRHOSIS WITH ASCITES BY
INTEGRATED TCM AND WM]. REN YINGQUAN.
shaanxi journal of traditional chinese medicine.
1999;20(4):154 (chi).
1835- gera: 76764/di/ra
[CLINICAL STUDY ON TREATED PRIMARY
HEPATIC CARCINOMA BY TCM]. ZHAO FUJIN.
shaanxi journal of traditional chinese medicine.
1999;20(4):191 (chi).
1836- gera: 76810/di/ra
118
[PROGRESS ON RESEARCH OF TREATMENT OF
FATTY LIVER WITH TCM]. CAO XIAOJU ET AL.
shaanxi journal of traditional chinese medicine.
1999;20(9):429 (chi).
1837- gera: 76840/di/ra
[THE TREATMENT OF CHRONIC HEPATITIS WITH
HUACHANSU AND UMBELLATE PORE FUNGUS
POLYSACCHARIDES,A REPORT OF 60 CASES]. MA
PING ET AL. shanxi journal of tcm. 1999;15(1):11 (chi).
1838- gera: 76842/di/ra
[THE EFFECTS OF ACUPUNCTURE ON SERUM
VIRUS SYMBOLS OF HEPATITIS B]. LIU YUNMEI ET
AL. shanxi journal of tcm. 1999;15(1):30 (chi*).
1839- gera: 76863/di/ra
[PROFESSOR WANG FUQIU'S EXPERIENCE IN
TREATING CHRONIC HEPATITIS]. ZHANG QIANDE.
jiangsu journal of tcm. 1999;20(8):9 (chi).
1840- gera: 76868/di/ra
[TREATMENT OF 94 CASES OF CIRRHOSIS WITH
SYNDROME OF YIN DEFICIENCY AND BLOOD
STASIS WITH N°3 KANGGAN TABLET]. HAO PU ET
AL. jiangsu journal of tcm. 1999;20(8):20 (chi).
1841- gera: 76885/di/ra
[TREATMENT OF 35 CASES OF SEVERE HEPATITIS
WITH TRADITIONAL CHINESE MEDICINE AND
WESTERN MEDICINE COMBINED]. SHEN JIANJUN.
jiangsu journal of tcm. 1999;20(2):23 (chi).
1842- gera: 76886/di/ra
[TREATMENT OF 10 CASES OF METASTATIC
CARCINOMA OF LIVER WITH TRADITIONAL
CHINESE MEDICINE AND WESTERN MEDICINE
COMBINED]. LI SU. jiangsu journal of tcm.
1999;20(2):25 (chi).
1843- gera: 76895/di/ra
[CLINICAL RESEARCH ON TREATMENT OF
CHRONIC INTRAHEPATIC CHOLESTASIS WITH
SIMEITAI AND KUHUANG INJECTION]. MIN XIAN
ET AL. jiangsu journal of tcm. 1999;20(1):9 (chi).
1844- gera: 76915/di/ra
[TREATMENT OF 30 CASES OF CHRONIC
HEPATITIS B WITH "GANSHU N°1"]. BAI HU ET AL.
jiangsu journal of tcm. 1999;20(5):16 (chi).
1845- gera: 76922/di/ra
[(PSYCHOLOGICAL APPROACH TO NURSING OF
PATIENTS WITH HEPATITIS].]. CHEN SHUFAN.
jiangsu journal of tcm. 1999;20(5):43 (chi).
1846- gera: 76932/di/ra
[TREATMENT OF 40 CASES OF SEVERE HEPATITIS
DURING EARLY STAGE WITH CRUDE RADIX ET
RHIZOMA]. SUN XIAOLONG. jiangsu journal of tcm.
1999;20(11):17 (chi).
1847- gera: 76939/di/ra
[ON USING MEDICATIONS YANG IN NATURE TO
TREAT LIVER WHICH IS YIN IN NATURE]. XU
ZHENGHAI. jiangsu journal of tcm. 1999;20(11):43 (chi).
1848- gera: 76949/di/ra
[TREATMENT OF 30 CASES OF CHRONIC
HEPATITIS B WITH HUGAN BADU PLASTER]. HUA
gera 2011

HAIQING ET AL. jiangsu journal of tcm. 1999;20(12):20
(chi).
1849- gera: 76991/di/ra
[A SURVEY OF THE METHOD OF PROMOTING
BLOOD FLOW TO RESOLVE THE STASIS IN
TREATING HEPATIC FIBROSIS]. SHEN JIYUN ET
AL. liaoning journal of tcm. 1999;26(11):529 (chi).
1850- gera: 78720/di/ra
[SEVERE VIRUS HEPATITIS TREATED BY TCM
AND WESTERN MEDICINE]. DU BIN. beijing journal
of tcm. 1999;4:59 (chi).
1851- gera: 86639/di/ra
[CLINICAL OBSERVATION ON INFANTILE
HEPATITIS SYNDROME TREATED BY HUZHI YI
MIXTURE]. PENG WENJUAN ET AL. hubei journal of
tcm. 1999;21(8):347 (chi).
1852- gera: 87754/di/ra
[PROPHYLAXIS AND TREATMENT OF
HEPATOCARCINOMA BY DAN-SHEN (SALVAI
MILTIORRHIZA)]. CHEN JIAN ET AL. chinese
traditional and herbal drugs. 1999;30(3):226 (chi).
1853- gera: 87913/di/ra
[TREATMENT OF CHRONIC ACTIVE HEPATITIS B
BY YU GANG FANG: A CLINICAL OBSERVATION
OF 48 CASES]. YE XIAOHAN. new journal of tcm.
1999;31(3):40 (chi).
1854- gera: 87914/di/ra
[VETERAN PHYSICIAN LI ZHIXIN'S EXPERIENCE
ON THE TREATMENT OF HEPATITIS B]. LIANG
GUOCHUAN. new journal of tcm. 1999;31(8):5 (chi).
1855- gera: 87920/di/ra
[THE CHARACTERISTICS OF LIVER CANCER IN
SOUTH CHINA AND ITS TREATMENT BASED ON
SYNDROME DIFFERENTIATION]. TAN KAIJI ET AL.
new journal of tcm. 1999;31(8):25 (chi).
1856- gera: 87927/di/ra
[TREATMENT OF HEPATITIS B BY SAN JIE TANG
WITH FOAMING THERAPY: A REPORT OF 84
CASES]. ZHOU YIHUA ET AL. new journal of tcm.
1999;31(8):40 (chi).
1857- gera: 87939/di/ra
[CLINICAL STUDY BETWEEN THE RELATIONSHIP
OF COAGULATION OF LIVER STAGNATED HEAT
AND FIBROSIS OF THE LIVER]. HUO QINGPING ET
AL. new journal of tcm. 1999;31(4):36 (chi).
1858- gera: 87942/di/ra
[TREATMENT OF CHRONIC HEPATITIS BY PILL
OF RADIX ET RHIZOMA RHEI AND
EUPOLYPHAGA SEU STELEOPHAGA: A CLINICAL
OBSERVATION OF 212 CASES]. TANG WENCHAN ET
AL. new journal of tcm. 1999;31(4):41 (chi).
1859- gera: 87957/di/ra
[AN INTRODUCTION OF PROF YANG JISUN'S
EXPERIENCE ON THE DIFFERENTIAL DIAGNOSIS
AND TREATMENT OF FATTY LIVER]. PAN ZHIMIN.
new journal of tcm. 1999;31(9):7 (chi).
1860- gera: 87982/di/ra
[SYNDROME DIFFERENTIATION AND
119
TREATMENT OF CHRONIC HEPATITIS B BY YI
GAN ZHUAN YIN SAN: A REPORT OF 371 CASES].
ZHOU DAOHONG ET AL. new journal of tcm.
1999;31(6):41 (chi).
1861- gera: 87996/di/ra
[TREATMENT OF CHOLESTATIC HEPATITIS BY
TCM COMBINED WITH WESTERN MEDICINE: A
REPORT OF 38 CASES]. LIU CHANGSHI. new journal
of tcm. 1999;31(12):36 (chi).
1862- gera: 87998/di/ra
[VETERAN PHYSICIAN HUANG BAOZHONG'S
EXPERIENCE ON THE APPLICATION OF HERBAL
DRUGS FOR HEPATOPATHY]. LI XIAOYAN ET AL.
new journal of tcm. 1999;31(11):6 (chi).
1863- gera: 88023/di/ra
[THE RELATIONSHIP BETWEEN SYNDROME OF
TCM AND THE SERUM INDEXES OF HEPATITIC
FIBROSIS AND THE LIVER PATHOLOGICAL
CHANGE IN HEPATITIS]. LI JUN ET AL. new journal
of tcm. 1999;31(2):36 (chi).
1864- gera: 88024/di/ra
[TREATMENT OF LUPOID HEPATITIS BY
ADDITIONAL PILL OF RADIX GENTINAE
MACROPHYLLAE]. HUANG JUN. new journal of tcm.
1999;31(2):40 (chi).
1865- gera: 88223/di/ra
[ADVANCES IN THE EXPERIMENTAL STUDY ON
ANTI-HBV BY CHINESE MEDICINAL HERB]. YE
REN. chinese traditional and herbal drugs. 1999;30(9):714
(chi).
1866- gera: 88228/di/ra
[THE HEPATOCYTE PROTECTIVE ROLE OF THE
POLYPEPTIDE EXTRACT FROM CAPILLARY
WORMWOOD (ARTEMISIA CAPILLARIS) IN MICE].
HU YIQIAO ET AL. chinese traditional and herbal drugs.
1999;30(12):894 (chi).
1867- gera: 90772/di/ra
[TREATING 306 CASES OF POSITIVE REACTION
OF HEPATITIS B ANTIGEN-ANTIBODY SYSTEM
WITH WEISHI QINGGANG DECOCTION]. LI
GUANHUO. zhejiang journal of tcm. 1999;34(1):15 (chi).
1868- gera: 70738/di/ra
[CLINICAL OBSERVATION ON CHRONIC VIRUS
HEPATITIS B TREATED BY HEPATITIS B III].
ZHENG XIAOYING ET AL. hubei journal of tcm.
2000;22(3):10 (chi).
1869- gera: 70750/di/ra
[DISCUSSION OF HEPATITIS B TREATED BY
PATTERN IDENTIFICATION FROM DOCTRINE OF
EPIDEMIC FEBRILE DISEASE]. BAI YINGCAI ET AL.
xinjiang journal of tcm. 2000;18(1):3 (chi).
1870- gera: 71090/di/ra
[EFFECT OF INACTIVATION ON LPO PRODUCING
OF LIVER TISSUE OF MICE INHIBITED BY DRUG
SERUM OF DANG GUI BU XUE DECOCTION]. YIN
CHENGHONG ET AL. chinese journal of information on
tcm. 2000;7(2):23 (chi).
1871- gera: 71126/di/ra
[THE EFFECTS OF THE SSCC EXTRACTS ON
gera 2011

PROLIFERATION AND MITOCHONDRIA
METABOLISM OF HUMAN HEPATOMA SMMC-7721
CELLS]. XIAO ZHENG-MING ET AL. journal of
shandong university of tcm. 2000;24(1):62 (chi*).
Objective: To dimonstrate the effects of the extracts from
Sophora Subprostrata chun et T chan (SSCC) on the
proliferation and mitochondria metabolism of human
hepatoma SMMC-7721 cells. Methods: After the test of dose
dependent experiment, human hepatoma cells were treated
with SSCC extracts at dose of 250 Mg/ml for 48 h and
mitochondria metabolism activity was detected by MTT
method. The experiments of effects of SSCC extracts on the
proliferation were performed with the treatments of SSCC
extracts at dose of 500 Mg/ml for 7 d and the proliferation of
human hepatoma cells were also examined after treated with
SSCC extracts for 24 h and then replaced by cultured in
normal media (containing 10% FCS) for 72 h.Result: (1)
SSCC extracts could significantly decrease the activity of
mitochondria metabolism, and the A570 absorption in the
treatment group was only 62. 1% of that in control group
after 48 h treatment and 9. 64% after 72 h treatment. (2) The
human hepatoma cell number in the treatment group was
much lower than that in control groups during the two groups
were treated for seven days. (3) Had been treated for 24 h
then cultured in normal media for 72 h,the human hepatoma
cells slowly increased in number; (4) After treated for 24
h,the mitosis index in the treatment group was only 50. 6% of
that in the control group. Conclusion: SSCC extracts could
effectively inhibit the proliferation and mitochondria
metabolism activty of human hepatoma cells.
1872- gera: 71142/di/ra
[CLINICAL STUDY ON JIANGHUANGSHU CAPSULE
IN TREATING ICTERIC HEPATITIS B]. SUN LIN ET
AL. hebei journal of tcm. 2000;22(2):95 (chi*).
Objective: To investigate the therapeutic effect of
Jianghuangshu capsule on icteric hepatitis B. Methods : One
hundred and twenty - four patients with icteric hepatitis B
were randomly allocated to receiving combination of
intravenous infusion of vitamin C 5g once a day and taking
liver - protecting agents (control group, n = 50) or
combination of intravenous infusion of vitamin C 5g once a
day and taking Jianghuangshu capsule 4 - 6 pills three times a
day (treatment group, n =74) respectively. with the 60-day
therapeutic duration in either group. In neither group
antivirus and immono - modulating agents were given.
Results: The basical cure rate and total efficiency rate in
treatment group werer much higher than those in control
group (P <0. 01). The improved degrees of parameters of
liver function. symptoms and signs, and the negative -
reversed rate of serum marker in treatment group after
treatment were all much higher than those in control group (P
<0. 01 or 0. 05) Conclusions:
1873- gera: 71154/di/ra
[MEDICAMENTOUS LIVER LESION OF TCM
DRUGS]. HUA BI-CHUN ET AL. journal of fujian college
of tcm. 2000;10(1):30 (chi*).
After the review of a vast amount of data in recent years, the
known TCM drugs which might cause liver lesion and the
clinical manifestationss are summed up, for studing the
mechanism of medicamentous liver lesion of TCM drugs.
The method for the prevention and treatment is introduced.
1874- gera: 71162/di/ra
CLINICAL STUDY ON TREATMENT OF
ALCOHOLIC HEPATOPATHY WITH QING GAN JIE
JIU YIN. CUI MINLU. journal of tcm. 2000;20(1):17
(eng).
Voir traduction italienne de réf gera: [94763].
120
1875- gera: 71257/di/ra
[OBSERVATION OF THERAPEUTIC EFFECT OF
"SPLEEN-NOURISHING AND QI-REGULATING
PRESCRIPTION" ON NEGATIVE EFFECTS AFTER
TACE IN PATIENT WITH HEPATOCARCINOMA].
REN HUA-PING ET AL. shanghai journal of tcm.
2000;34(3):24 (chi).
1876- gera: 71282/di/ra
[EVALUATION OF CURATIVE EFFECT OF
POLYSACCHARIDE LIPOPLAST OF CORDYCEPS
AND RADIX SALVIAE MILTIORRHIZAE
COMBINATION FOR FIBROSIS OF LIVER]. MEI
CUN-JIN ET AL. chinese traditional patent medicine.
2000;22(2):146 (chi*).
Objective: To find out the effective drug with antagonising
action on liver fibrosis. Methods: The patients suffering from
chronic active hepatitis and early hepatocirrhosis were treated
with polysaccharide lipoplast of Cordyceps and Radix
Salviae Miltiorrhizae combination on 68 cases. 3 items of
indexes of patients of serum liver fibrosis (HA, PCm, LN)
before and in 4 months after treatment were detected.
Results: 3 items of indexes more obviously decreased after
treatment than that before treatment. There was significant
between before and after treatment ( P < 0. 01 or P < 0. 05 ) .
Conclusions: The polysaccharide of Cordyceps and Radix
Salviae Miltiorrhizae combination with the functions of
strengthening the patients's resistance and dispersing blood
stasis possesses a
1877- gera: 71304/di/ra
[PROFESSOR YU RONGQING'S EXPERIENCE OF
TREATING COMPLICATION OF CHRONIC
HEPATITIS B]. CHEN JING. hubei journal of tcm.
2000;22(2):3 (chi).
1878- gera: 71321/di/ra
[THE NEW THEORY OF "TIRE DEU TO THE LIVER
PROBLEM"]. YANG WEIPENG. acta chinese medicine
and pharmacology. 2000;1:7 (chi).
1879- gera: 71325/di/ra
[APPLICATION OF COMPOUND TCM FORMULAS
IN TREATING CHRONIC HEPATITIS B WITHOUT
SYMPTOMS]. LI YINGSONG ET AL. acta chinese
medicine and pharmacology. 2000;1:29 (chi).
1880- gera: 71327/di/ra
[TREATMENT OF ASCITES DUE TO LIVER
CIRRHOSIS: 30 CASES REPORTED]. LIU YAN. acta
chinese medicine and pharmacology. 2000;1:34 (chi).
1881- gera: 71374/di/ra
[TREATMENT OF 66 CASES OF HEPATITIS B BY
YIGAN JIANG DECOCTION]. LIU DIJIA. shaanxi
journal of traditional chinese medicine. 2000;21(1):11
(chi).
1882- gera: 71375/di/ra
[TREATMENT OF 265 CASES OF CHRONIC
HEPATITIS B BY JINBAO CAPSULE]. WANG BINGLI
ET AL. shaanxi journal of traditional chinese medicine.
2000;21(1):14 (chi).
1883- gera: 71402/di/ra
[APPLYING WANG TAILIN'S THERAPEUTIC
METHODS FOR LIVER TO TREATMENT OF
CHRONIC HEPATITIS B]. LI DEMING. hubei journal
of tcm. 2000;22(1):29 (chi).
gera 2011

1884- gera: 71404/di/ra
[OBSERVATION OF DROPPING GPT AND GOT
CURATIVE EFFECT ON CHRONIC VIRUS
HEPATITIS TREATED BY SCHISANDRA FRUIT
POWDER]. FU YUANZHONG ET AL. hubei journal of
tcm. 2000;22(1):34 (chi).
1885- gera: 71407/di/ra
[GENERAL SITUATION OF CLINICAL AND
EXPERIMENTAL STUDY ON ALCOHOLIC
HEPATOPATHY TREATED WITH TCM]. CHEN
HONGCI ET AL. hubei journal of tcm. 2000;22(1):55
(chi).
1886- gera: 71445/di/ra
[TREATING 64 CASES OF OBESITY FATTY LIVER
WITH XIAOZHANG TIAOGANG DECOCTION-
COMPARED BY TREATING 30 CASES OF THE
SAME DISEASE WITH GANG DE JIANG (ONE KIND
OF WESTERN MEDICINE)]. HAN WEIFENG ET AL.
zhejiang journal of tcm. 2000;35(1):14 (chi).
1887- gera: 71449/di/ra
[TREATING 2 CASES OF CHRONIC HEPATITIS BY
REVERSE TREATMENT]. QIAN HAIQING ET AL.
zhejiang journal of tcm. 2000;35(1):43 (chi).
1888- gera: 71472/di/ra
[25 CASES OF PRIMARY LIVER CANCER TREATED
BY NORCANTHARIDIN-POLOXAMER 407 IN
INTRATUMORAL ADMINISTRATION]. CHEN JIAN
ET AL. journal of anhui traditional chinese medical
college. 2000;19(1):5 (chi).
1889- gera: 71490/di/ra
[EFFECTIVE OBSERVATION ON 116 CASES OF
PAIN CAUSED BY HEPATOCARCINOMA TREATED
BY ZHANG'S ANTI-TUMOR RECIPE]. GAO
SHAOQIU. hunan journal of tcm. 2000;16(1):14 (chi).
1890- gera: 71508/di/ra
[THERAPEUTIC EFFICE OF GUANZHE MIXTURE
ON EXPERIMENTAL LIVER FIBROSIS RATS].
WANG JIANYI ET AL. jiangsu journal of tcm.
2000;21(1):40 (chi).
1891- gera: 71513/di/ra
[CHANGES IN MICROCIRCULATION IN
PREGNANT PATIENTS WITH CHOLESTASIS IN
LIVER AND ITS TREATMENT]. SONG SAIFEN.
jiangsu journal of tcm. 2000;20(2):7 (chi).
1892- gera: 71529/di/ra
[34 CASES SUFFERING ASCITES CAUSED BY
HEPATOCIRRHOSIS TREATED BY WAY OF
SELECTION OF TREATMENTS BASED ON
DIFFERENT DIAGNOSIS OF TRADITIONAL
CHINESE MEDICINE]. NIU YAOLI ET AL. nei mongol
journal of tcm. 2000;19(1):12 (chi).
1893- gera: 71530/di/ra
[CLINICAL OBSERVATION ON BAIZE DECOCTION
USED IN TREATING HEPATOCIRRHOSIS
ASCITES]. YU BAOFENG. nei mongol journal of tcm.
2000;19(1):14 (chi).
1894- gera: 71591/di/ra
[ONE-HUNDRED NINETY-EIGHT CASES OF
ASCITIS IN LIVER CIRRHOSIS TREATED WITH
121
EQI DRINK]. LIU SHUCHANG ET AL. journal of tcm.
2000;41(2):92 (chi*).
All the cases were randomly assigned to two groups, the
treatment group and controll group. For the treatment group,
western remedies and Eqi drink (EQD) were given during the
ascitic stage, and with EQD alone after ascitis subsided.
while the control group was administered western remedies
in its whole course. Observation was made on both groups in
terms of manifestations before and after the treatment, first
appearance of effective time. time of cure, and long-term
effectiveness. Results showed that there was significant
difference in the above indices between the 2 groups (P<0. 05
or P<0.01), the treatment group being superior to the control
group. demonstrating that EQD is effective for the treatment
of cirrhotic ascitis with stable and rapid effect, and complete
eradication of ascitis, and with satisfactory both short-term
and long-term effectiveness.
1895- gera: 72327/di/ra
THE EFFECT OF GAN FU LE IN INTERVENTIONAL
TREATMENT OF HEPATOCARCINOMA. XU KAI ET
AL. journal of traditional chinese medicine.
2000;20(3):185-6 (eng).
1896- gera: 72334/di/ra
ADVANCES IN TCM TREATMENT OF PRIMARY
HEPATOCARCINOMA. GUAN DONGYUAN ET AL.
journal of traditional chinese medicine. 2000;20(3):223-6
(eng).
1897- gera: 72546/di/ra
[A STUDY ON THE ACTION OF FRUCTUS
PSORALEAE DECOCTION ON LIVER TISSUE]. OU
WEIPING ET AL. new journal of tcm. 2000;32(3):33 (chi).
1898- gera: 72567/di/ra
[TREATMENT EXPERIENCE OBTAINED IN THE
TREATMENT OF PAIN IN THE LIVER AREA
CAUSED BY CHRONIC HEPATITIS]. ZHANG
FUNAN. guang ming journal tcm. 2000;15(1):38 (chi).
1899- gera: 72588/di/ra
[TREATMENT OF 75 CASES OF CHRONIC
HEPATITIS WITH "HUANGJIN DECOCTION"].
ZHANG MINGHUA. jiangsu journal of tcm. 2000;21(3):18
(chi).
1900- gera: 72640/di/ra
[EFFECT OF SAPONINS OF STEMS AND LEAVIES
OF RADIX PANACIS QUINGNEFOLII ON
EXPERIMENTAL LIVER INJURY OF RATS]. ZHAO
YU-ZHEN ET AL. chinese traditional patent medicine.
2000;22(3):219 (chi*).
1901- gera: 72837/di/ra
MONITORING OF LIVER ENZIMES IN PATIENTS
ON CHINESE MEDICINE. AL-FHAFAJI MAZIN.
journal of chinese medicine. 2000;62:6-10 (eng).
1902- gera: 73487/di/ra
[CLINICAL STUDY ON TREATMENT OF HEPATIC
FIBROSIS DUE TO CHRONIC HEPATITIS BY
COMBINATION OF ACUPOINT-INJECTION OF
SMELL DOSE OF INTERFERON WITH CHINESE
DRUGS]. GUO JIANCHUN ET AL. chinese acupuncture
and moxibustion. 2000;20(1):9 (chi*).
72 cases of chronic hepatitis B were randomly assigned to
treatment group, large dose interferon treatment group and
routine treatment group. Control observation on symptoms,
signs, hepatic function, HHeAg, HBV-DNA, indexes of
gera 2011

hepatic fibrosis and biopsy of liver were carried out before
and after treatment of 2 months. Results indicated that the
therapy has a certain therapeutic effect in improving
symptoms and signs of chronic hepatitis, recovering hepatic
function, anti-virus, improving the indexes of hepatic fibrosis
and pathological changes of hepatic tissue, with significant
difference (P < 0.001) in anti-virus and improvement serum
globulin and the indexes of hepatic fibrosis as compared with
the routine treatment group, and similar therapeutic effects
with the large dose treatment
1903- gera: 73494/di/ra
[INVESTIGATION ON THERAPEUTIC EFFECTS OF
64 CASES OF CHRONIC HBV CARRIERS OF
VERTICAL INFECTION TREATED BY COOL-
INDUCING NEEDLING COMBINED WITH ANTI-
HEPATITIS B IMMUNE RIBONUCLEIC ACID].
YANG DEQUAN. chinese acupuncture and moxibustion.
2000;20(1):31 (chi).
1904- gera: 73758/di/ra
[AN APPROACH TO THE MECHANISM OF
TREATING PRIMARY CARCINOMA OF LIVER
WITH MONGOLIA MEDICINE]. CHEN LUHUA ET
AL. chinese journal of ethnomedicine and
ethnopharmacy. 2000;42:15 (chi).
1905- gera: 73761/di/ra
[OBSERVATION OF EFFECTS TREATING
HEPATITIS B 91 CASES WITH TIBETAN
MEDICINE]. GUO BA. chinese journal of ethnomedicine
and ethnopharmacy. 2000;42:20 (chi).
1906- gera: 73782/di/ra
[STUDY ON THE REGUALTION EFFECT OF
CHINESE HERBAL MEDICINE AC960 ON THE
EXPRESSION OF P21RAS,BAL -2 AND P53 IN
HUMAN HEPATOMA CELL LINE SMMC - 7721].
WANG CANG-JUN ET AL. chinese journal of traditional
medical science and technology. 2000;7(1):10 (chi*).
Objective:To study the effects of AC960 on the expression of
oncogene and tumor suppressor gene and investigate its anti -
cancerous mechanism. Methods: Drugcontending serum was
derived from rats orally pre - administered with AC960
through gastrogavage, and was added to subcultured humand
hepatoma cells (SMMC-7721)while the nominal rat serum
were as the control. Cell proliferation was measured with3H-
TdR incorporation .Cell apoptosis and expressions of P53,
bel - 2 and p21ras gene protein were analyzed with flow
cytometry. Results: After treating with AC960, the inhibitory
rate of 3 H - TdR was 33.4% for 48h. There were tipical
apoptotic peaks in DNA histigram, the apoptotic rate was 21.
25% for 24h ,27 .77% for 48h, AC960 arrested cell cycling at
S - phrase at early and at G0/G1 phrase at later stage .
Expression of p53 enhanced, bal - 2 and ras reduced .
Conclusion: The inhibition of proliferation, induction of
apoptosis via effect on the expression of oncogene and tumor
suppressor gene might be the main anti- hepatoma action
mechanism of AC960.
1907- gera: 73791/di/ra
[EXPERIMENTAL STUDY ON THE PROTECTIVE
EFFECT OF EMODIN ON RAT'S LIVER INJURY
INDUCED BY CCL4]. ZHAN YU-TAO ET AL. chinese
journal of traditional medical science and technology.
2000;7(1):30 (chi*).
To investigate the protective effect of emodin on liver injury
induced by CCL4, . Methods: The rat liver injury model was
induced by CCL4, the liver injury rats were bested with low -
dose, mediate - dose and high - dose emodin (20, 40 and
122
80mg/kg body weight) . Liver function in rats was measured
by routine method . The morphological changes of
hepatocytes were examined under electroscopy . Results: To
compare with model group, in all group rats treated with
emodin, serum glutamic pyruvic transaminase ( ALT) and
alkaline phosphates (AKP) was significantly reduced (P <
0.05 or 0.0l ) ,.serum total protein (TP) and albumin ( ALP,)
was significantly increased ( P <0.05 or0. 01 ), globulin (C)
was reduced (P> 0.05) . (2) Morphologic studies showed that
hepatocytes injury in emodin - treated rats were ameliorated
compared with those in model rats . Conclusions: Emodin has
1908- gera: 73835/di/ra
[HEPATITIS E (33 CASES) MAINLY TREATED WITH
POWDER OF BUPLEURUM AND CAPEJASMINE].
YU XINZHONG. journal of practical tcm. 2000;3(16):14
(chi).
1909- gera: 73867/di/ra
[CLINICAL RESEARCH ON THE TREATMENT OF
PRIMARY CARCINOMA OF LIVER WITH XIAOPI
KANGAI FORMULA]. GUO ZHENQIU ET AL. shanxi
journal of tcm. 2000;16(1):35 (chi*).
1910- gera: 73988/di/ra
ESTUDIO CLINICO SOBRE EL TRATAMIENTO DE
PORTADORES CRONICOS DEL VIRUS DE
ANTIGENO SUPERFICIAL DE LA HEPATITIS B
CON INYECCION DE TRAGACANTO EN LOS
PUNTOS ACUPUNTURALES. WANG XIYAO ET AL.
enerqi. 2000;9:52-7 (esp).
Se trataron 72 casos de portadores cronicos del virus de la
hepatitis B con inyeccion de tragacanto en los puntos de
acupuntura y se organizaron dos grupos de comparacion: uno
de inyeccion de tragacanto en los musculos, con 20 casos, y
otro de inyeccion de suero en los puntos de acupuntura, con
19 casos. Se dieron los siguientes resultados: el grupo de
inyeccion de tragacanto en los puntos de acupuntura arrojo
un porcentaje de 27,69%- 37,50% de alcanzar un resultado
negativo en HBsAG y 70,00%-84,21 % en HBEAG,
resultados éstos mejores que los del grupo de comparacion,
siendo las estadisticas: p<0,01 o p<0,05. Estos resultados se
mantienen inalterables después de un seguimiento de los
grupos de tratamiento y comparacion durante 6 y 12 meses,
respectivamente. La comparacion entre largo y corto plazo de
los distintos indicadores de suerologia del virus de la
hepatitis B del grupo de tratamiento no ha ostentado
diferencia notable (p>0,05), lo cual demuestra una estabilidad
en los
1911- gera: 74271/di/ra
[CLINICAL SUMMATION OF 84 CASES OF
CHRONIC VIRAL HEPATITIS TREATED BY
CHINESE DRUGS FOR SUPPLEMENTING QI AND
ACTIVATING BLOOD CIRCULATION]. XU RUIPING
ET AL. journal of tcm. 2000;41(1):36 (chi).
1912- gera: 74690/di/ra
[INFLUENCE OF CYTOKINES IN HEPATIC INJURY
MICE OF MACROPHAGE BY MICE'S SERUM
CONTAINING HUANG LIAN JIE DU DECOCTION
(MSHDD)]. KUANG ZAO-YUAN ET AL. journal of
liaoning college of tcm. 2000;2(1):63 (chi*).
1913- gera: 74725/di/ra
[THE STUDY OF CHINESE MEDICINE
COMPOUND/DPC INDUCED DIFFERENTIATION ON
HUMAN HEPTOCARCINOMA CELL LINES HCC-
9204 AND ITS MECHANISM]. HU BING ET AL. journal
of chengdu university of tcm. 2000;23(1):46 (chi*).
gera 2011

Objective: To investigate the effects and mechanism of
Chinese medicine compound/dragon power capsule (DPC)
induced differentiation on human hepatocarcinoma cell lines
Hcc-9240. Methods: The present study was carried out by
using technique of cell culture in vitro. The effect was
observed by monitoring cytomorphology, cloney- forming,
the secretion of AFP and ALB, y-GT activity' chromosome,
cell cycle and expression of oncogene. Results Morphology
of HCC-9204 became well-differentiated, growth became
slower, cloney-forming was inhibited, the secretion of AFP
and y-GT activity were reduced, the secretion of ALB
increased and expression of c-myc. C-H-ras oncogene
decreased, the main range of chromosome reduced, but cell
cycle did not change markedly. Conclusions: DPC had the
effect of induced differentiation on HCC-9204, the
mechanism might be related to chromosome and Down
Regulation of c-myc. c-H-ras oncogene.
1914- gera: 74945/di/ra
[TREATMENT OF 40 CASES OF
HYPERHYALURONEMIA DUE TO LIVER
CIRRHOSIS BY COMBINATION OF DRUGS HEAT -
REDUCING,PURGATION,RESOLVING AND
TONIFICATION]. YANG HONGZHI ET AL. journal of
traditional chinese medicine. 2000;41(9):543 (eng).
1915- gera: 75092/di/ra
[STUDY ON FEASIBILITY OF ACUPUNCTURE AND
MOXIBUSTION FOR ANTI-FIBROSIS OF LIVER].
ZHAO TIANPING ET AL. chinese acupuncture and
moxibustion. 2000;20(10):635 (chi).
1916- gera: 75221/di/ra
[IMMUNOHISTOCHEMISTRY AND IMAGE
ANALYSIS ON THE ANTI-ALCOHOLIC LIVER
FIBROSIS FUNCTION OF TIAOGANLIPIFANG IN
RAT]. ZHAO LIYUN ET AL. journal of beijing university
of tcm. 2000;23(2):25 (chi*).
1917- gera: 75344/di/ra
[CLINICAL STUDY OF TIAOGANLIPIFANG ON
ALCOHOLIC HEPATIC FIBROSIS]. DING XIA ET AL.
journal of beijing university of tcm. 2000;23(1):58 (chi*).
1918- gera: 75407/di/ra
[PROTECTION OF EXPERIMENTAL LIVER INJURY
BY BING GAN KANG]. PENG BO ET AL. henan
traditional chinese medicine. 2000;20(1):31 (chi*).
After Bing Gan Kang was applied in the liver injury in rats
induced by injecting thioacetamide and carbon tetrachloride,
it was discovered that Bing Gan Rang could reduce the level
of ALT in rats brought about by various factors, increase the
content of SOD in liver tissues, and inhibit the accumulation
of MDA induced by CCL4 as well as the damage it does to
the liver.
1919- gera: 75430/di/ra
[EXPERIMENTAL STUDY ON BIEJIAJIAN ORAL
LIQUID'S ANTI-FIBROSIS OF LIVER]. YAO
ZHENMIN. journal of zhejiang college of tcm.
2000;24(1):58 (chi*).
1920- gera: 75471/di/ra
[CLINICAL EFFECT ON QUZHI HUGAN GRANULES
IN TREATING FATTY LIVER]. WANG MENG ET AL.
shandong journal of tcm. 2000;19(1):9 (chi).
1921- gera: 75590/di/ra
[EFFECTS OF AIZHONGNING ON TUMOR
ERYTHROCYTE IMMUNE AND CELL CYCLE IN
123
HEPATOCARCINOMA 22-BEARING MICE]. YAN
ZHIYONG ET AL. chinese journal of integrated and
western medicine on gastro-spleen. 2000;8(1):17 (chi*).
1922- gera: 75596/di/ra
[STUDY ON THE ANTI-HBV ACTIVITY OF THE
GANSHU CAPSULE IN VITRO]. XIAO HUIQUAN ET
AL. chinese journal of integrated and western medicine
on gastro-spleen. 2000;8(1):32 (chi*).
1923- gera: 75733/di/ra
[COMPARISON ON EFFICACY IN TREATING
LIVER FIBROSIS OF CHRONIC HEPATITIS B
BETWEEN ASTRAGALUS POLYGONUM ANTI-
FIBROSIS DECOCTION AND JINSHUIBAO
CAPSULE]. CHEN HANCHENG ET AL. chinese journal
of integrated traditional and western medicine.
2000;20(4):255 (chi*).
1924- gera: 75739/di/ra
[EFFECT OF EMODIN ON DEVELOPMENT OF
HEPATIC FIBROSIS IN RATS]. ZHAN YUTAO ET AL.
chinese journal of integrated traditional and western
medicine. 2000;20(4):276 (chi*).
1925- gera: 75825/di/ra
[EFFECT OF GANDOU DECOCTION ON COPPER
METABOLISM OF SKIN FIBROBLAST OF
HEPATOLENTICULAR DEGENERATION MODEL].
TANG QIQIANG ET AL. chinese journal of integrated
traditional and western medicine. 2000;20(1):37 (chi*).
1926- gera: 75850/di/ra
[STUDY ON ROLE OF METALLOTHIONEIN IN
ANTICANCER EFFECT OF COPPER GREEN ON
TREATMENT OF EXPERIMENTAL
HEPATOCARCINOMA IN MICE]. HUANG GUOJIAN
ET AL. chinese journal of integrated traditional and
western medicine. 2000;20(5):368 (chi*).
1927- gera: 75861/di/ra
[INHIBITION OF TELOMERASE ACTIVITY BY
JIANPILIQI FORMULA IN LIVER CANCER]. MENG
ZHI-QIANG ET AL. chinese journal of basic medicine in
tcm. 2000;6(1):23 (chi*).
1928- gera: 75862/di/ra
[RESEARCH ON THE MODEL OF MICE HEPATOMA
(H22) AND APPLICATION OF THE MODEL TO
EXPERIMENTAL STUDY OF TCM]. LI HAI-YAN ET
AL. chinese journal of basic medicine in tcm. 2000;6(1):27
(chi*).
1929- gera: 75987/di/ra
[CLINICAL RESEARCH OF CHRONIC HEPATITIS C
TREATED MAINLY BY BLOOD-ACTIVATING AND
STASIS- RESOLVING THERAPY]. ZHANG WEI ET
AL. shanghai journal of tcm. 2000;34(2):24 (chi*).
1930- gera: 76268/di/ra
[GALLBLADDER STASIS TYPE HEPATITIS
TREATED BY COMBINATION OF TCM AND
WESTERN MEDICINE]. TAI HUILING. beijing journal
of tcm. 2000;5:15 (chi).
1931- gera: 76314/di/ra
[CORRELATION OF THE LEVEL OF SOD-LPO IN
LIVER TISSUE AND THE HEPATIC FFIBROSIS
MARKER IN SERUM]. HU XIAO-YU ET AL. journal of
chengdu university of tcm. 2000;23(3):40 (chi).
gera 2011

1932- gera: 77172/di/ra
[THE EFFECT OF RELIEVING ALCOHOLISM AND
PROTECTING LIVER DRINK ON THE BLOOD
SERUM,LIVER TISSUE ALT AND AST OF
ALCOHOLIC LIVER INJURY RAT]. YANG
MUXIANG ET AL. hebei journal of tcm. 2000;22(10):793
(chi).
1933- gera: 77177/di/ra
[CURRENT PROGRESS IN TREATING FATTY
LIVER WITH TCM]. ZHANG QI. guangxi journal of
tcm. 2000;23(5):61 (chi).
1934- gera: 77186/di/ra
[EFFECT OF THE CHINESE HERBS ANTI-
HEPATITIS B VIRUS IN VITRO]. WU SHU-KUN ET
AL. chinese journal of basic medicine in tcm.
2000;6(10):24 (chi*).
1935- gera: 77193/di/ra
[PONDER OVER CLINICAL ANALYSIS WITH
SYNDROME DIFFERENTIATION FOR 190 CANCER
PATIENTS]. GUO YONG. chinese journal of basic
medicine in tcm. 2000;6(10):44 (chi*).
To evaluate the clinical significance of syndrome-
classification in Traditional Chinese Medicine (TCM)
oncology. The syndrome characteristic of 190 patients with
malignant tumor had been analyzed by the four methods of
physical examination (inspection, listening and smelling,
inquiring, palpation). The result suggested: there are no
significance of the syndrome classification with clinical stage
and KPS (P>0. 05). The data indicated: the patients main
pathogenesis is asthenia-syndrome (include deficiency of QI,
YIN and both QI and YIM) (170/190 cases, 89.4%). It would
caused stasis heat and phlegm ect. . According to the
characteristic of difference syndromes of lung stomach and
liver cancer, benefiting QI and nourishing YIN, invigorating
spleen and supplementing QI and
1936- gera: 77204/di/ra
[EFFECT OF PRESCRIPTION FOR CLEARING
AWAY HEAT AND REMOVING BLOOD STASIS ON
CHRONIC HEPATIC FIBROSIS AND RELATED
INDEXES]. HUO QINGPING ET AL. jiangsu journal of
tcm. 2000;21(11):9 (chi).
1937- gera: 77211/di/ra
[EXPERIENCE IN TREATING PNEUMONIA AND
HYDROPERICARDIUM SECONDARY TO SEVERE
HEPATITIS]. WU HANMIN ET AL. jiangsu journal of
tcm. 2000;21(11):39 (chi).
1938- gera: 77215/di/ra
[INHIBITING EFFECT OF BINGGANKANG ON
HEPATIC FIBROSIS IN RATS AND ITS
MECHANISM]. REN ZHOUXIN ET AL. jiangsu journal
of tcm. 2000;21(11):48 (chi).
1939- gera: 77297/di/ra
[ULTRASRUCTURAL STUDY ON HEPATIC
FIBROSIS MOUSE PREVENTED AND TREATED
WITH ERSHENZEHU AND DANSHENTAOXIONG
DECOCTIONS]. YU ZHE FENG ET AL. chinese journal
of traditional medical science and technology.
2000;7(3):139 (chi*).
1940- gera: 77300/di/ra
[EXPERIMENTAL STUDY ON RAT' S CHRONIC
ALCOHOLIC LIVER INJURY PREVENTED WITH
124
CHAIKOU GRANULE]. LI DONG LIANG ET AL.
chinese journal of traditional medical science and
technology. 2000;7(3):141 (chi*).
1941- gera: 77310/di/ra
[EXPERIMENTAL STUDY ON THE EFFECT OF
BAOCHUNGANKANG CAPSULE ON ACUTE AND
CHRONIC HEPATITIS ANIMALS]. LONG ZI JIANG
ET AL. chinese journal of traditional medical science and
technology. 2000;7(3):159 (chi).
1942- gera: 77331/di/ra
[TREATMENT OF ASCITES DUE TO LIVER
CIRRHOSIS WITH COMBINED TCM AND WEST
MEDICINE: 34 CASES REPORTED]. WANG LILI ET
AL. information on tcm. 2000;17(2):11 (chi).
1943- gera: 77339/di/ra
[TREATMENT OF ASCITES DUE TO LIVER
CIRRHOSIS WITH THE METHODS OF
ACTIVATING BLOOD CIRCULATION AND
REMOVING STASIS: 18 CASES REPORTED]. ZHANG
JIANGMING ET AL. information on tcm. 2000;17(3):31
(chi).
1944- gera: 77357/di/ra
[CLINICAL OBSERVATION OF TREATING FATTY
LIVER WITH XIAO ZHI YIN]. SUN BINJIE ET AL.
information on tcm. 2000;17(4):34 (chi).
1945- gera: 77367/di/ra
[EFFECTS OF SCHINOFOLINE ON
CYTOSKELETON OF EXPERIMENTAL HEPATOMA
IN RATS OBSERVED BY WHOLE MOUNT CELL
TRANSMISSION ELECTRON MICROSCOPY]. BAI
JINWEN ET AL. journal of beijing university of tcm.
2000;23(4):27 (chi*).
1946- gera: 77413/di/ra
[EXPERIMENTAL STUDIES ON LOWERING THE
SERUM LEVEL OF SGPT AND LIVER
PROTECTION]. WANG LI ZHEN. henan journal of tcm
and pharmacy. 2000;15(2):15 (chi).
1947- gera: 77461/di/ra
[CLINICAL OBSERVATION OF TREATING
HEPATITIS B 56 CASES WITH DONG MEDICINE
YIGAN ZHUANYIN DECOCTION]. WU QINSHUN.
chinese journal of ethnomedicine and ethnopharmacy.
2000;44:136 (chi).
1948- gera: 77470/di/ra
[OBSERVATION OF EFFECTS ON TREATING
FATTY LIVER WITH ERSHIWUWEI SONGSHI
PILLS AND FUFANG DANSHEN TABLETS]. YANG
QING. chinese journal of ethnomedicine and
ethnopharmacy. 2000;45:203 (chi).
1949- gera: 77481/di/ra
[CLINICAL EXAMPLES FOR PROLONGING
SURVIVAL TIME OF HEPATOMA WITH RHIZOMA
SMILACIS CHINENSIS]. HUANG ZHAOQIAN ET AL.
chinese journal of ethnomedicine and ethnopharmacy.
2000;45:212 (chi).
1950- gera: 77533/di/ra
[THE EFFECTS OF THREE HEAT AND DAMPNESS
REMOVING FORMULAS IN RATS WITH IMMUNE
HEPATIC INJURIES]. ZHAO GUORONG ET AL.
journal of hunan college of tcm. 2000;20(2):18 (chi).
gera 2011

1951- gera: 77601/di/ra
[OBSERVATION ON THERAPEUTIC EFFECT OF
NEEDLE-RETAINING METHOD OF TRIPLE
PUNCTURE IN 80 CASES OF PAIN DUE TO
HEPATIC CANCER]. SUN YALIN ET AL. chinese
acupuncture and moxibustion. 2000;20(4):211 (chi).
1952- gera: 77650/di/ra
[SPECULATION ON OBJECTIVE RESEARCH INTO
TCM DIFFERENTIATION OF CHRONIC VIRAL
HEPATITIS]. CHANG JIE ET AL. jiangsu journal of tcm.
2000;21(5):38 (chi).
1953- gera: 77654/di/ra
[TREATMENT OF HYPERBILIRUBINEMIA IN
PATIENTS WITH ACUTE VIRAL HEPATITIS WITH
PRESCRIPTIONS FOR REMOVING TOXIN AND
COOLING BLOOD]. FENG LAN ET AL. jiangsu journal
of tcm. 2000;21(5):18 (chi).
1954- gera: 77658/di/ra
[AN EXPERIMENTAL STUDY OF TREATMENT OF
CHOLESTASIS IN LIVER OF PREGNANT WOMEN
WITH YINHUANG MIXTURE]. LIU XUEHUA ET AL.
jiangsu journal of tcm. 2000;21(7):39 (chi).
1955- gera: 77696/di/ra
[STUDY ON THE REGULATORY EFFECT OF
CHINESE HERBAL MEDICINE ON PERITONEAL
LYMPHATIC STOMATA AND IN ENHANCING
DRAINAGE OF ASCITES IN MICE WITH LIVER
FIBROSIS]. LI JICHENG ET AL. chinese journal of
integrated traditional and western medicine.
2000;20(10):753 (chi*).
1956- gera: 77709/di/ra
[OBSERVATION ON DYNAMIC CHANGES OF
SERUM PROCOLLAGEN III,HYALURONIC ACID
AND LAMININ IN RATS WITH HEPATIC FIBROSIS
TREATED WITH HUJIN PILL]. HUANG ZHAOSHENG
ET AL. chinese journal of integrated traditional and
western medicine. 2000;20(6):447 (chi*).
1957- gera: 77711/di/ra
[EXPERIMENTAL STUDY ON INHIBITORY EFFECT
OF CHINESE HERBAL COMPOUND ON
HEPATOCYTE CYTOCHROME P 450 II E1
EXPRESSION IN RAT MODEL OF NONALCOHOLIC
FATTY LIVER]. DAI NING ET AL. chinese journal of
integrated traditional and western medicine.
2000;20(6):453 (chi*).
1958- gera: 77734/di/ra
[EXPERIMENTAL STUDY OF SHUANGCAO
GRANULE NO 1 ON DUCK HEPATITIS B VIRUS IN
DUCKLINGS]. LIAN YUEXIANG ET AL. chinese
journal of integrated traditional and western medicine.
2000;20(7):530 (chi*).
1959- gera: 77792/di/ra
[CLINICAL AND EXPERIMENTAL STUDIES ON 120
CASES OF CARCINOUS ASCITES TREATED WITH
APPLICATION OF CHINESE DRUG XIAO SHUI
PLASTER]. LI PEIWEN ET AL. journal of tcm.
2000;41(6):358 (chi).
1960- gera: 77794/di/ra
[UNDERSTANDING AND CURRENT SITUATION
FOR TREATMENT OF FATTY LIVER IN TCM]. CAO
125
XIAJU. journal of tcm. 2000;41(6):373 (chi).
1961- gera: 77808/di/ra
[STUDIES ON ERIGERONTIS AGAINST
EXPERIMENTAL LIVER FIBROSIS OF RATS].
BAIND JUAN ET AL. chinese journal of information on
tcm. 2000;7(5):34 (chi).
1962- gera: 77848/di/ra
[STUDY ON PATHOLOGICAL TISSUE AND
ULTRASTRUCTURE OF IMMUNE LIVER FIBROSIS
OF RATS' TREATED BY GANDAN HUKANG
CAPSULE]. LI JIANGUO ET AL. chinese journal of
information on tcm. 2000;7(8):24 (chi).
1963- gera: 77881/di/ra
[TREATING 12 CASES OF ACUTE SEVERE
ICTEROHEPATITIS WITH CHINESE HERBS ORAL
ADMINISTRATION AND EXTERNAL
APPLICATION]. NI WUFENG. zhejiang journal of tcm.
2000;35(8):326 (chi).
1964- gera: 77885/di/ra
[BUDD CHIARI SYNDROME TREATED WITH
COMBINED TRADITIONAL CHINESE AND
WESTERN MEDICINE REPORT OF 8 CASES]. HE
RUIXING ET AL. zhejiang journal of tcm. 2000;35(9):371
(chi).
1965- gera: 77894/di/ra
[CLINICAL OBSERVATION ON 34 CASES OF
ADVERSE REACTION FOR USED INTERFERON
TREATED WITH CHAIDGE SOLUBLE GRANULES].
LI XIAOBIN ET AL. zhejiang journal of tcm.
2000;35(9):378 (chi).
1966- gera: 77921/di/ra
[STUDY ON THE RELATION OF THE SERUM ALT
AND THE LIVER TISSUE IN FLAMMATORY
ACTIVITY IN CHRONIC HEPATITIS B]. LIU WEI ET
AL. chinese journal of integrated traditional and western
medicine on liver diseases. 2000;10(3):17 (chi).
1967- gera: 77922/di/ra
[EXPERIMENTAL STUDY ON AGAINST DHBV
EFFECT OF GANTAI VIII PILL]. ZHANG BEIPING ET
AL. chinese journal of integrated traditional and western
medicine on liver diseases. 2000;10(3):24 (chi*).
1968- gera: 77923/di/ra
[CLINICAL EFFECT OF JIAMPI HUOXUE
DECOCTION ON 40 PATIENTS WITH FATTY
LIVER]. HE DONGYI ET AL. chinese journal of
integrated traditional and western medicine on liver
diseases. 2000;10(3):5 (chi*).
1969- gera: 77924/di/ra
[CLINICAL STUDY OF COMPREHENSIVE AND
SEQUENTIAL THERAPY OF MIDDLE AND
ADVANCED HEPATOCELLULAR CARCINOMA].
PAN XINGNAN ET AL. chinese journal of integrated
traditional and western medicine on liver diseases.
2000;10(3):7 (chi*).
1970- gera: 77925/di/ra
[INFLUENCE OF RESPIRATION ON CALIBER OF
PARTAL VASCULATURE AND ITS CORRELATION
WITH PORTAL HYPERTENSION]. QIN YOUJUAN.
chinese journal of integrated traditional and western
medicine on liver diseases. 2000;10(3):18 (chi).
gera 2011

1971- gera: 77926/di/ra
[EXPERIMENTAL STUDY ON THE THERAPEUTIC
EFFECT OF WANG' S ANIT FIBROSIS
DECOCTION]. YANG YANFANG ET AL. chinese
journal of integrated traditional and western medicine on
liver diseases. 2000;10(3):19 (chi*).
1972- gera: 77927/di/ra
[ISOLATION,CULTURE,DETECTION OF RAT
HEPATIC ENDOTHELIAL CELLS]. CHEN
SHIZHUANG ET AL. chinese journal of integrated
traditional and western medicine on liver diseases.
2000;10(3):22 (chi*).
1973- gera: 77928/di/ra
[CLINICAL OBSERVATION OF TREATING
PATIENTS WITH CHRONIC HEPATITIS B USING
GANDUQING CAPSULE]. DIAO SHIQUAN ET AL.
chinese journal of integrated traditional and western
medicine on liver diseases. 2000;10(3):15 (chi*).
1974- gera: 77929/di/ra
[STUDY ON THE LEVEL OF SIL - 2R,IFN- Y AN D IL-
1 IN SERA VARIOUS HEPATITIS B]. CHEN YAN ET
AL. chinese journal of integrated traditional and western
medicine on liver diseases. 2000;10(3):10 (chi*).
1975- gera: 77930/di/ra
[CLINICAL STUDY ON TRANSFUSION
TRANSMITTED VIRUS (TTV) SINGLE INFECTION
AND SUPERINFECTION WITH HBV]. WU YINWEI ET
AL. chinese journal of integrated traditional and western
medicine on liver diseases. 2000;10(3):13 (chi*).
1976- gera: 77931/di/ra
[COMPARISION OF THE LEVELS OF N TERMINAL
PROPEPTIDE OF COLLAGEN TYPE III AND
LAMININ IN SERUM AND LIVER PATHOLOGICAL
CHANGES WITH ACUTE AND CHRONIC
HEPATITIS B AND OTHER LIVER DISEASES]. LIN
XIAOTIAN ET AL. chinese journal of integrated
traditional and western medicine on liver diseases.
2000;10(3):3 (chi*).
1977- gera: 77932/di/ra
[EFFECT OF HUANGQI INJECTION ON IMMUNE
AND LIVER FUNCTION IN PATIENTS WITH
PRIMARY HEPATIC CARCINOMA AFTER HEPATIC
ARTERIAL CHEMOEMBOLIZATION]. SONG
HUAIYU ET AL. chinese journal of integrated traditional
and western medicine on liver diseases. 2000;10(4):5
(chi*).
1978- gera: 77933/di/ra
[CLINICAL STUDY OF COMBINED TREATMENT
WITH INTERFERON A 1 B AND RIBAVIRIN IN
HEPATITIS C]. ZHANG ZHENGANG ET AL. chinese
journal of integrated traditional and western medicine on
liver diseases. 2000;10(4):9 (chi*).
1979- gera: 77934/di/ra
[ENDOSCOPIC MANIFESTATIONS OF GASTRIC
MUCOSAL LESION IN VIRUS HEPATITIS]. XIANG
MEI ET AL. chinese journal of integrated traditional and
western medicine on liver diseases. 2000;10(4):12 (chi*).
1980- gera: 77935/di/ra
[INFLUENCE OF REPEATED TRANSCATHETER
HEPATIC ARTERIAL CHEMOEMBOLIZATION ON
126
HEPATIC FIBROSIS INDEXES OF PATIENTS WITH
HEPATOCARCINOMA]. REN QIUGUI ET AL. chinese
journal of integrated traditional and western medicine on
liver diseases. 2000;10(4):15 (chi*).
1981- gera: 77936/di/ra
[QUALITATIVE RESEARCH OF HUMAN FETAL
HEPATOCYTES INFECTED WITH HEPATITIS C
VIRUS IN VITRO]. TANG ZHIMIN ET AL. chinese
journal of integrated traditional and western medicine on
liver diseases. 2000;10(4):18 (chi*).
1982- gera: 77937/di/ra
[EXPERIMENTAL STUDY ON THE EFFECT OF
GANSHUKANG ON TREATING FIBERIZED LIVER
IN RATS LEADED BY DIMITHYLNITROSAMINE].
JIANG DEYOU ET AL. chinese journal of integrated
traditional and western medicine on liver diseases.
2000;10(4):21 (chi*).
1983- gera: 77938/di/ra
[INFLUENCE OF KEGAN CAPSULE ON
EXPERIMENTAL ACUTE HEPATIC DAMAGE IN
MICE]. XU YUFANG ET AL. chinese journal of
integrated traditional and western medicine on liver
diseases. 2000;10(4):23 (chi*).
1984- gera: 77939/di/ra
[CHANGES OF PORTAL VEIN PRESSURE IN RAT
FIBROSIS INDUCED WITH CCI 4]. HU PING ET AL.
chinese journal of integrated traditional and western
medicine on liver diseases. 2000;10(4):26 (chi*).
1985- gera: 77941/di/ra
[SIGNIFICANCE OF DETECTING ORGANIC
INTERNAL ENVIRONMENT PART INDEX IN
PATIENTS WITH PRIMARY HEPATOMA]. LUO
ZEMIN ET AL. chinese journal of integrated traditional
and western medicine on liver diseases. 2000;10(4):3
(chi*).
1986- gera: 77942/di/ra
[CLINICAL PHENOMENA AND TCM WM THERAPY
OF COMPLICATION WITH HEPATOLENTICULAR
DEGERATION ON CHILDREN]. YU JING ET AL.
chinese journal of integrated traditional and western
medicine on liver diseases. 2000;10(4):55 (chi).
1987- gera: 77943/di/ra
[CLINICAL ANALYSIS OF 183 CASES SPONTANEUS
BACTERIAL PERITONITIS WITH LIVER
CIRRHOSIS]. ZHAO HONGXIN ET AL. chinese journal
of integrated traditional and western medicine on liver
diseases. 2000;10(4):7 (chi*).
1988- gera: 77951/di/ra
[LASER CONFOCUS MICROSCOPE ANALYSIS FOR
THE PROTECTIVE FUNCTION OF JIEJIU ORAL
LIQUID TO ALCOHOLIC LIVER DAMAGE]. WANG
XING YUE ET AL. chinese journal of basic medicine in
tcm. 2000;6(3):34 (chi).
1989- gera: 77967/di/ra
[APPLICATION OF TREATING PRIMARY LIVER
CANCER WITH BIE JIA WAN]. CAO YANG. chinese
journal of basic medicine in tcm. 2000;6(7):30 (chi).
1990- gera: 77984/di/ra
[EFFECTS AND SIGNIFIANCE OF" BENEFIING QI
AND NOURISHING YIN" ON INDUCTION OF
gera 2011

HEPATOMA CELL DIFFERENTIATION]. LIU PING
ET AL. chinese journal of basic medicine in tcm.
2000;6(8):29 (chi*).
Objective to study the mechanism of the compound
preparation Yi-Sui-Ling to cure leukaemia. Method based on
the fact that Yi-Sui-Ling can induce the apoptosis of HL60,
by serologic pharmacological test, the author choose rabbit
serum samples with various density of Yi-Sui-Ling, cultured
them with HL60 cells during different time, observed the
effect of rabbit' serum with Yi-Sui-Ling on the apoptosis of
HL60, and explored primarily the mechanism of its
apoptosis. Results Yi-Sui-Ling has a marked effect of
inducing the apoptosis of HL60 cells. The best effect was
produced by rabbit' serum with 10 percent concentration of
Yi-Sui-Ling during 48 hours. The mechanism of its inducing
apoptosis is related to its inhibiting the expression of Bcl-2
gene. Conclusion Yi-Sui- Ling can induce the apoptosis of
leukaemia. cells even in animal's body, which is the key
mechanism of Yi-Sui-
1991- gera: 77997/di/ra
[STUDY ON BLOOD STASIS ON SPLEEN DAMP
HEAT SYNDROME OF CHRONIC HEPATITIS].
CHEN JIN FANG ET AL. journal of fujian college of tcm.
2000;10(3):3 (chi*).
For studding the pathogenic essence of blood stasis in spleen
damp-heat syndrome of chronic hepatitis, 41 cases of spleen
damp-heat syndrome and 39 cases of spleen damp-heat with
blood stasis have been selected. And the contents of plasma
TXB2, 6-K-PGF1 alpha and cAMP have been tested. The
result shows that there is the pathogenesis of blood stasis in
spleen dams-heat of chronic hepatitis regardless of the exist
of blood stasis
1992- gera: 78049/di/ra
[INTEGRATED THERAPY IN TREATING PRIMARY
LIVER CANCER: REPORT OF 31 CASES]. QIANG
YONG ET AL. journal of nanjing university tcm.
2000;16(2):86 (chi*).
OBJECTIVE To treat 31 cases of primary liver cancer of the
spleen deficiency type with the herbal medicine that can
invigorate the spleen and replenish qi together with hepatic
arterial intubation. METHOD The treatment group was
treated in the integrated way while the control was only
treated with the intubation. The results were compared.
RESULTS In the treatment group. The condition was
improved in 67.9% of the patient, and quality of life (KS
score) was improved in 80.7%, with statistical significance
compared with the control. CONCLUSION The integrated
method can prolong the life span and improve the quality of
life.
1993- gera: 78138/di/ra
[EXPERIENCE OBTAINED BY ZHAO GUANG USED
IN THE TREATMENT OF HEPATIC HEPATITIS B].
SHI XUEPING. guangming journal tcm. 2000;88(3):14
(chi).
1994- gera: 78150/di/ra
[COMBINATION OF WESTERN AND CHINESE
MEDICINE USED IN THE TREATMENT OF 64
CASES OF ASCITES DUE TO CIRRHOSIS]. DING
QINGXUE. guangming journal tcm. 2000;89(4):56 (chi).
1995- gera: 78162/di/ra
[OBSERVATION ON PATIENTS WITH HEPATITIS B
VIRUS REPLICATION TREATED BY DECOCTION"
FU GAN ZHUAN YIN]. GAO YAOHUA. journal of
practical tcm. 2000;16(4):8 (chi).
127
1996- gera: 78190/di/ra
[OBSERVATION ON INFLUENCE OF DRUG" MAN
GAN FU" IN INDEX OF LIVER FIBROSIS]. SHEN
JIXUAN ET AL. journal of practical tcm. 2000;16(6):3
(chi).
1997- gera: 78243/di/ra
[CLINICAL OBSERVATION OF DECREASING GPT
AND REDUCING ICT IN 380 CASES OF HEPATITIS
TREATED WITH APPLICATION MIXTURE OF
GALLIC AND OTHER HERBS]. CHEN LIXIN. journal
of external therapy of tcm. 2000;9(2):3 (chi).
1998- gera: 78300/di/ra
[SCHOOL OF REGULATING QI BY TCM AND
PSYCHOTERAPY OF HEPATOPATHY]. LIU TIE JUN
ET AL. journal of chang chun college of tcm. 2000;16(2):5
(chi).
1999- gera: 78313/di/ra
[CLINICAL STUDY ON PINGZHI CHONGJI
TREATING FATTY LIVER]. HUANG YI QI ET AL.
fujian journal of tcm. 2000;31(4):3 (chi).
2000- gera: 78318/di/ra
[THE INFLUENCE OF WENSHEN BAYANG
THERAPY ON T LYMPHOCYTE SUBGROUP IN
PERIPHERAL BLOOD OF CHRONIC HEPATITIS B].
LIU RUI HUA ET AL. fujian journal of tcm. 2000;31(4):14
(chi).
2001- gera: 78330/di/ra
[LIN HE HE' S EXPERIENCE OF TREATING FATTY
LIVER]. YANG JIAN HUI. jiangxi journal of tcm.
2000;31(3):1 (chi).
2002- gera: 78335/di/ra
[CURATIVE EFFECT OBSERVATION ON 46 CASES
OF TREATMENT OVER FATTY LIVER WITH
PROMOTING BLOOD CIRCULATION AND
DISPELLING TURBID]. SUN LING JUAN ET AL.
jiangxi journal of tcm. 2000;31(4):18 (chi).
2003- gera: 78341/di/ra
[147 CASES OF TREATMENT OVER CHRONIC
HEPATITIS B COMBINED WITH YUGANJING
CAPSULE AND ANTI HEPATITIS B IMMUNE RNA].
ZHANG BO ET AL. jiangxi journal of tcm. 2000;31(4):46
(chi).
2004- gera: 78348/di/ra
[LI ZE FAN 'S EXPERIENCE IN TREATMENT OF
CIRRHOSIS]. ZHANG DING GUO. journal of tcm and
chinese materia medica of jilin. 2000;20(2):7 (chi).
2005- gera: 78370/di/ra
[CLINICAL OBSEVATION ON TREATMENT OF
ASCITES DUE TO CIRRHOSIS BY COMBINED
METHOD OF CHINESE MEDICINE AND WESTERN
MEDICINE IN 28 CASES]. XU QIAN ET AL. journal of
tcm and chinese materia medica of jilin. 2000;20(5):46
(chi).
2006- gera: 78400/di/ra
[CLINICAL STUDY ON KANGXIAN RUANGAN
DECOCTION FOR TREATING CHRONIC
HEPATITIS AND THE HEPATITIS INDUCED LIVER
CIRRHOSIS]. ZHANG ZHAOQI ET AL. hebei journal of
tcm. 2000;22(3):165 (chi*).
gera 2011

2007- gera: 78419/di/ra
[CLINICAL OBSERVATION OF DETERMINATION
OF TREATMENT ACCORDING TO DIFFERENT
SIGNS AND SYMPTOMS ON LIVER CIRRHOSIS
WITH ASCITES]. SUN JIUGUANG ET AL. hebei journal
of tcm. 2000;22(5):325 (chi*).
2008- gera: 78420/di/ra
[OBSERVATION ON INTRAVASCULAR
IRRADIATION OF LOW ENERGY HE NE LASER
FOR THE TREATMENT OF CHRONIC B
HEPATITIS]. ZHOU YUQIN. hebei journal of tcm.
2000;22(5):330 (chi*).
2009- gera: 78428/di/ra
[OBSERVATION ON B HEPATITIS DETOXICATING
INFUSION COMBINED ROUTINE METHOD FOR
THE TREATMENT OF CHRONIC VIRUS B
HEPATITIS]. HAO ZHONGPIN. hebei journal of tcm.
2000;22(6):420 (chi*).
2010- gera: 78451/di/ra
[OBSERVATION OF WLGY 801 COMPUTER
CURATIVE EQUIPMENT FOR HEPATITIS ON THE
TREATMENT OF VIRUS HEPATITIS]. ZHANG BO ET
AL. hebei journal of tcm. 2000;22(9):656 (chi*).
2011- gera: 78461/di/ra
[EFFECTS OF RENSHENBIEJIA PILL ON TGF B1
TGF BII R EXPRESSION IN HEPATOCYTE
PROLIFERATION OF CIRRHOSIS RAT]. WANG YU
QUN ET AL. chinese journal of traditional medical
science and technology. 2000;7(4):215 (chi).
2012- gera: 78464/di/ra
[LABORATORY STUDY ON THE PROTECTIVE
EFFECT OF XIONGDANGANTAI ON
EXPERIMENTAL HEPATIC INJURY IN MICE]. XU
HUI BO ET AL. chinese journal of traditional medical
science and technology. 2000;7(4):221 (chi).
2013- gera: 78468/di/ra
[STUDY ON THE EXPERIMENTAL LIVER
METASTASIS FROM HCC CELL PREVENTED WITH
CHANGAIKANGFU DECOCTION]. LI HUA SHAN ET
AL. chinese journal of traditional medical science and
technology. 2000;7(4):208 (chi).
2014- gera: 78472/di/ra
[MORPHOLOGIC INFLUENCE OF XINZHIKANGAI
PRESCRIPTION ON TRANSPLANTED HEPATIC
CARCINOMA CELL IN NUDE MICE AND ITS
INHIBITION IN VIVO]. ZHU MEI JU ET AL. chinese
journal of traditional medical science and technology.
2000;7(4):219 (chi).
2015- gera: 78483/di/ra
[PROTECTIVE EFFECTS OF CAIHUYANGGAN
MIXTURE ON ACUTE LIVER INJURY CAUSED BY D
GALACTOSAMIN IN RAT]. SUN JIANG QIAO ET AL.
chinese journal of traditional medical science and
technology. 2000;7(5):314 (chi).
2016- gera: 78484/di/ra
[EXPERIMENTAL STUDY ON THE PROTECTIVE
EFFECT OF GANBAO CAPSULE ON RAT' S LIVER
FIBROSIS]. PAN XUE FEI ET AL. chinese journal of
traditional medical science and technology. 2000;7(5):293
(chi).
128
2017- gera: 78488/di/ra
[EXPERIMENTAL STUDY ON THE PROTECTIVE
EFFECT OF QIZUKELI ON LIVE FIBROSIS]. LIU
SHAO NENG ET AL. chinese journal of traditional
medical science and technology. 2000;7(5):303 (chi).
2018- gera: 78492/di/ra
[EXPERIMENTAL STUDY IN VITRO ON THE
EFFECT OF DAHURIAN PATRINIA ON KUPFFLER
CELL SECRETING TNF,IL 1 AND IL 6 PROMTED BY
LIPOPOLYSACCHARIDE]. ZHAO CHENG MEI ET AL.
chinese journal of traditional medical science and
technology. 2000;7(5):310 (chi).
2019- gera: 78498/di/ra
[WANG LINGTAI'S EXPERIENCE OF APPLYING
RHUBARB TO TREAT CHRONIC HEPATOPATY].
YAN YI JIAN ET AL. shanghai journal of tcm.
2000;34(5):12 (chi*).
2020- gera: 78544/di/ra
[OBSERVATION ON THE THERAPEUTIC EFFECT
OF GAMBI DECOCTION ON POST
ANTIBERCULOTIC LIVER INJURY]. GONG
XIANFENG ET AL. journal of tcm. 2000;41(3):157 (chi*).
2021- gera: 79238/di/ra
[EFFECT OF ACUPUNCTURE ON BLOOD FLOW OF
HEPATIC ARTERY]. SAI XIYA. chinese acupuncture
and moxibustion. 2000;20(5):307 (chi).
2022- gera: 79269/di/ra
[40 CASES OF SHISTOSOMAL HEPATIC FIBROSIS
TREATED BY INTERNAL INVIGORATION AND
EXTERNAL ELIMINATION THERAPY]. YE HAILING
ET AL. journal of anhui traditional chinese medical
college. 2000;19(3):12 (chi*).
2023- gera: 79288/di/ra
[PROF FEI KAIYANG' S EXPERIENCE ON THE
APPLICATION OF CHINESE HERBAL DRUGS IN
THE TREATMENT OF CIRRHOSIS]. LI PING. new
journal of tcm. 2000;32(5):11 (chi).
2024- gera: 79324/di/ra
[THE INFLUENCE OF SPLEEN STRENGTHENING
THERAPY ON IMMUNOLOGIC FUNCTION OF
LATE AND MIDDLE STAGES OF HEPATIC
CARCIOMA AFTER INTERVENTION THERAPY].
JIANG MEI. new journal of tcm. 2000;32(8):20 (chi).
2025- gera: 79341/di/ra
[ZHANG RUIXIA' S EXPERIENCE IN TREATING
FATTY LIVER AFTER HEPATITIS]. XUE JING
DONG. shaanxi journal of traditional chinese medicine.
2000;21(6):264 (chi).
2026- gera: 79394/di/ra
CLINICAL OBSERVATION ON THE LONG-TERM
THERAPEUTIC EFFECTS OF TRADITIONAL
CHINESE MEDICINE FOR TREATMENT OF LIVER
FIBROSIS. YANG HONGZHI ET AL. journal of tcm.
2000;20(4):247-50 (eng).
48 patients with liver fibrosis due to hepatitis B were treated
for 2 years with the drugs for tonifying the kidney,
supplementing qi, cooling and invigorating the blood and
detoxification. The symptoms were markedly improved, and
serum ALT and bilirubin were recovered and kept normal in
most of the cases. The mean levels of serum hyaluronic acid,
procollagen peptide III and circulating immune complex
gera 2011

were decreased and returned to normal after the treatment. B-
ultrasonography showed that the portal vein kept in normal
size in 82% of the patients, the enlarged portal vein
diminished in diameter, and the enlarged spleen reduced.
2027- gera: 79411/di/ra
THE THERAPEUTIC WAYS FOR CHRONIC LIVER
DISEASES ACCOMPANIED BY DISEASES OF THE
ENDOCRINE AND MAMMARY GLANDS. WANG
QINGMIN ET AL. journal of tcm. 2000;20(4):307-13 (eng).
2028- gera: 79452/di/ra
[EFFECT OBSERVATION OF TIBETAN MEDICINE
CAPSULE QIWEIHONGHUA SHUSHENG IN
TREATMENT OF CHOLESTATIC HEPATITIS
ATTACHING ON 11 CASES]. YANG QING. liaoning
journal of tcm. 2000;27(6):258 (chi*).
2029- gera: 79455/di/ra
[106 CASES OF CLINICAL OBSERVATION ON
EFFECT OF AOKANG ZHUANYIN TABLET ON
CHRONIC HEPATITIS B . ATTACHING 94 CASES OF
THE CONTROL GROUP]. DUAN LIAN YOU ET AL.
liaoning journal of tcm. 2000;27(7):302 (chi*).
2030- gera: 79482/di/ra
[COMPARATIVE OBSERVATION ON 116 CASES OF
HEPATITIS B TREATED BY YINGAN JIAN
DECOCTION AND CONCENTRACTED GRANULES].
LIU XING ET AL. hunan journal of tcm. 2000;16(2):20
(chi).
2031- gera: 79536/di/ra
[68 CASES OF SEVERE HEPATITIS TREATED WITH
INTEGRATION OF TRADITIONAL CHINESE AND
WESTERN MEDICINES]. LU XINWEI. hubei journal of
tcm. 2000;22(7):18 (chi).
2032- gera: 79538/di/ra
[CLINICAL STUDY OF RESISTING HEPATIC WITH
GANQIAN I GRANULE PREPARATION FIBROSIS].
ZUO JUNLING. hubei journal of tcm. 2000;22(7):16 (chi).
2033- gera: 79542/di/ra
[CLINICAL STUDY OF RESISTING HEPATIC WITH
GANQIAN I GRANULE PREPARATION FIBROSIS].
ZUO JUNLING. hubei journal of tcm. 2000;22(7):16 (chi).
2034- gera: 79549/di/ra
[35 CASES OF ICTERIC VIRAL HEPATITIS
TREATED WITH COMBINATION OF TRADITIONAL
CHINESE AND WESTERN MEDICINES]. WU QIKAI
ET AL. hubei journal of tcm. 2000;22(8):15 (chi).
2035- gera: 79586/di/ra
[CLINICAL OBSERVATION OF TREATMENT OF
TRANSAMINASE DUE TO CHRONIC ACTIVE
HEPATITIS WITH JIANG MEI DECOCTION]. MA
GUOQING ET AL. acta chinese medicine and
pharmacology. 2000;28(4):25 (chi).
2036- gera: 79627/di/ra
[56 CASES OF ASCITES DUE TO CIRRHOSIS
TREATED BY COMBINED WESTERN MEDICINE
WITH TCM]. FENG JINGKE ET AL. forum on tcm.
2000;15(4):38 (chi).
2037- gera: 79647/di/ra
[CLINICAL OBSERVATION ON 30 CASES OF
CHRONIC HEPATITIS B TREATED BY FU FANG
129
XIAN LING PI CHONG JI (COMPOUND HERBA
EPIMEDII GRANULE) AND ANTIHEPATITIS B
IRNA]. SHI BOAN ET AL. tianjin journal of tcm.
2000;17(4):7 (chi).
2038- gera: 79658/di/ra
[76 CASES WITH CHOLISTATIC HEPATITIS
TREATED BY INTEGRATION OF TCM AND WM].
LU JUNQING ET AL. inner mongolia journal of tcm.
2000;19(3):27 (chi).
2039- gera: 79671/di/ra
[CLINICAL STUDY ON MINOR BUPLEURUM
DECOCTION FOR LIVER DISEASE]. WANG YU ZHI.
chinese traditional patent medicine. 2000;22(4):296 (chi*).
2040- gera: 79715/di/ra
[CLINICAL STUDY OF JIANGZHI QINGGAN
DECOCTION IN TREATING HYPERLIPEMIA
FATTY LIVER]. WANG XIAOMING. journal of zhejiang
college of tcm. 2000;24(2):26 (chi).
2041- gera: 79762/di/ra
[REPORT OF 2 CASES OF IDIOPATHIC PORTAL
HYPERTENSION TREATED BY CHINESE HERBAL
MEDICINE]. WANG CHUNFANG. xinjiang journal of
tcm. 2000;18(2):23 (chi).
2042- gera: 86210/di/ra
[CLINICAL STUDY ON TREATMENT OF CHRONIC
ATROPHIC GASTRITIS WITH ACUPUNCTURE AT
JIAJI POINTS]. TAN QIWEN ET AL. chinese
acupuncture and moxibustion. 2000;20(3):133 (chi*).
Thirty-one patients of chronic atrophic gastritis were treated
with acupuncture at T7-T12 Jiaji points and fiften of the
patient were treated with routine points as control group. It
was proved from symptom and gastroscopic and pathological
observation before and after treatment that acupuncture could
not only improve the symptoms, and also change the
gastroscopic and pathological results to varying degrees, and
showed that the effect in the observation group was superior
to that in the control group. It is indicated that acupuncture
regulates the vegetative nervous system and improve gastric
secretion and motor functions, so as to promote gastric
secresion and regeneration of cells, protect gastric mucosa
and prevent malignant change.
2043- gera: 86226/di/ra
[EFFECT OF COMPOUND EPIMEDIUM
BREVICORNUM ON SERUM SOLUBLE
INTERLEUKIN-2 RECEPTOR (SIL- 2R) IN PATIENTS
WITH CHRONIC HEPATITIS B]. BI QING ET AL.
chinese journal of integrated traditional and western
medicine on liver diseases. 2000;10(1):14 (chi*).
Aim, slL-2R. CD4/CD8 in T Iymphcytes and HBeAg in the
blood were observed in patients with chronic hepatitis B
treated by Compound Epimedium Brevicornum (CEB).
Methods: slL-2R was determined by ELISA. T Iymphcyte
subpopulation in the blood was determined by
immunofluorescence and HBeAg was determined by ELISA.
Results It was found that slL-2R was evidently decreased in
patients treated by CEB compared with the contrast and there
was a significant difference (P<0.05), that T Iymphcyte
subpopulation was improved on a higher CD4/CD8 ratio than
the contrast and there was a specially significant differnce
(P<0.01) . and that there was a effect on antivirus of
improving HBeAg disappearing. Conclusion: These findings
indicate that CEB could affect slL-2R decreasing. CD4/CD8
ratio increasing and HBeAg disappearing.
gera 2011

2044- gera: 86227/di/ra
[STUDY OF HERBAL MEDICINE 960 MIXTURE
INDUCES HUMAN HEPATOMA CELL UNDERWENT
APOPTOSIS]. WANG CHANGJUN ET AL. chinese
journal of integrated traditional and western medicine on
liver diseases. 2000;10(1):19 (chi*).
Aim: To investigate the induction of apoptosis by herbal
medicine 960 mixture (960) in human hepatoma cells for
demonstration of its mechanism of treatment of primary finer
cancer. Methods: The drug serum was derived from rates at
Ihour after second administration with 8.0ml/kg of 960, and
added to cultured human hepatoma cell line SMMC-7721
while the normal rat serum as control. Cell apoptosis was
detected by acridine orange (AO) staining, DNA
electrophoresis. Cell cycling analysis (PI-FCM) and TdT
enzyme mediated deoxynucleotide nick end label:ng methot!
(TUNEL) by flow cytometry. Results: After treatment of the
drug-serum, SMMC-7721 ceils became small and
condensecl. and showed condensed and fragment nuclei
under the fluorescence microscope by AO staining. There
were characteristic DNA "ladder"on agarose gel
electrophoresis, and Sub-G1 peaks (apoptotic peak) in DNA
histogram. the positive labeling rates by TUNEL were among
64.12%-70.02%. Conclusion: 960 may induce apoptosis in
human hepatoma cells, which led the death of the cancer
cells.
2045- gera: 86228/di/ra
[EXPERIMENTAL STUDY ON EFFECT OF
DANSHEN TAO XIONG DECOCTION ON THE
PERITONEAL LYMPHATIC STOMATA AND
URINARY SODIUM IN HEPATIC FIBROSIS MICE].
LU ZHILIAN ET AL. chinese journal of integrated
traditional and western medicine on liver diseases.
2000;10(1):22 (chi*).
Aim: To find effective drug treating hepatic fibrosis ascites.
Methods: Danshen Tao Xiong Decoction (DSTXD)
Composed of Radix Salviae Miltiorrhizae has effect on the
regulation of the peritoneal Iymphatic stomata, Semen
Persicae and Rhizoma Ligustici Chuanxiong providing with
promoting blood circulation to remote blood stasis, was used
in the research of the peritoneal lymphatic stomata and
urinary sodium in hepatic fibrosis mice. The diameter r and
distributive density of the peritoneal lymphatic stomata were
quantitatively analysed by using scanning electron
microscope and computer image system. Results: The
diameter and distributive density were more obvious in
prevention and treatment groups than the control and model
groups. Urinary sodium in prevention group drain mort than
that in treatment groud. Conclusion: DSTXD is an effective
formula for the treatment of
2046- gera: 86229/di/ra
[EFFECT OF SALVIANOLIC ACID-A ON NIH/3T3
FIBROBLAST VIABILITY,PROLIFERATION AND
COLLAGEN SYNTHESIS]. WANG XIAOLING ET AL.
chinese journal of integrated traditional and western
medicine on liver diseases. 2000;10(1):24 (chi*).
Aim: To study effect of Salvianolic Acid-A (SA--A) on
NIH/3T3 fibroblast functions such as viability, proliferation
and collagen synthesis. Methods: NIH/3T3 fibroblasts were
cultured with regular method, and incubated with 10-4 - 10-
7mol/L SA-A for 22h. The cell viability was assayed by
[3H]-proline incorporation, cell proliferation by [3H] - TdR
incorporation, cell collagen synthesis rate was measured with
[3H] -proline incorporation collagenase digestion. Results:
10-4 - 10-6mol/L SA-A could inhibited fibroblast except 10-
4mol/l SA-A which decreased cell viability. and 10-6mol/l
had the best effect among three groups also 10-5 - 10-6mol/L
SA-A inhibited intracellular collagen synthesis, 10-6mol/L
130
showed a better effect, but both 10-5 - 10- 6mol/L SA-A had
no significant influence on extracelluar collagen secretion.
Conclusion: SA-A could inhibited fibroblast proliferation and
intracellular collagen synthesis, the best drug concentration
perhaps was 10-6mol/l in vitro.
2047- gera: 86230/di/ra
[INFLUENCE OF FUZHENG ANTI-CARCINOMA
PRESCRIPTION (FAP) ON RED BLOOD CELL
ADHERSIVE FUNCTIONS PROTECTIVE EFFECTS
OF AMPELOPSIS BREVIPEDUNCULATA ON MICE
LIVER INJURY INDUCED BY CONCANERALIN A
(CON A)]. ZHANG YABING ET AL. chinese journal of
integrated traditional and western medicine on liver
diseases. 2000;10(1):26 (chi*).
Aim: To investigate the protective effects of Ampelopsis
brevipedunculata on mice liver injury induced by ConA.
Methods: Liver injury models were induced by ConA in mice
in vivo anti treated with high, medium, low dosage
Ampelopsis Brevipedunculata or Dexamethasone. Serum
tumor necrosis factor-alpha (TNF-alpha) contents, serum
nitric oxide (NO) contents. Serum alanine aminotransferases
(ALT ) activities and histopathologic changes of the liver
samples were observed. Results: High and medium dosage
Ampelopsis Brevipeducalata alleviated the histopathologial
changes, decrasted TNF--alpha and NO contents and ALT
activities in the liver injured mice, and had no different from
Dexamethasone used as control. Conclusion: Ampelopsis
brevipedunculata has a good protective effects on liver injury
induceci by ConA.
2048- gera: 86282/di/ra
[OBSERVATION ON CHRONIC HEPATITIS B (40
CASES) TREATED WITH DECOCTION "ER-GEN-
ER-CAO"]. PENG BO ET AL. journal of practical tcm.
2000;16(1):11 (chi).
2049- gera: 86283/di/ra
[OBSERVATION ON POSTHEPATITIC CIRRHOSIS
TREATED BY TREATMENT OF STRENGTHENING
BODY RESISTANCE,REMOVING BLOOD STASIS
AND TOXIC SUBSTANCES]. GU ERLI. journal of
practical tcm. 2000;16(1):12 (chi).
2050- gera: 86351/di/ra
[CONTEMPLATION TO TREATMENT OVER
HEPATOCIRRHOSIS]. CHEN RUI-CHUN. jiangxi
journal of tcm. 2000;31(2):1 (chi).
2051- gera: 86357/di/ra
[THEORY THAT TASTE IS THE IMPORTANT OF
TREATING CHRONIC HEPATITIS-B]. YU GUAN-YA.
jiangxi journal of tcm. 2000;31(2):22 (chi).
2052- gera: 86818/di/ra
[EFFECTIVE OBSERVATION ON 30 CASES OF
XIAOZHI FUGAN MIXTURE IN TREATMENT OF
FATTY LIVER]. ZHOU YU-QIN. liaoning journal of tcm.
2000;27(12):549 (chi*).
2053- gera: 87348/di/ra
[60 CASES OF APPLYING JING ZHU GAN TAI SHU
CAPSULE FOR TREATMENT OF HEPATITIS B AND
CIRRHOSIS]. WANG WU HUA. journal of liaoning
college of tcm. 2000;2(2):125 (chi*).
2054- gera: 87521/di/ra
[CLINICAL OBSERVATION OF COMBINATION OF
TCM AND WESTERN MEDICINE ON SEVERE
HEPATITIS]. CHEN FANHAI ET AL. hebei journal of
gera 2011

tcm. 2000;22(12):931 (chi).
2055- gera: 87524/di/ra
[THE EFFECT OBSERVATION OF ALCOHOL-
DETOXIFICATION & LIVER-PROTECTION DRINK
ON PATHOLOGICAL HISTOLOY OF ALCOHOLIC
LIVER-INJURY RAT]. YAN MUXIN ET AL. hebei
journal of tcm. 2000;22(12):950 (chi).
2056- gera: 87552/di/ra
[CLINICAL OBSERVATION ON 30 CASES OF
FIBROSIS OF LIVER TREATED WITH THE
THERAPY OF TRADITIONAL CHINESE AND
WESTERN MEDICINE]. SHU PENG. hunan journal of
tcm. 2000;16(6):15 (chi).
2057- gera: 87613/di/ra
[PRODUCTION OF PHSA-RECEPTOR TARGETING
ALPHA-INTERFERON (PHSA-IFN) AND
THERAPEUTIC EFFECT ON VIRAL HEPATITIS].
LIU MINGXU ET AL. chinese journal of integrated
traditional and western medicine on liver diseases.
2000;10(6):3 (chi*).
2058- gera: 87614/di/ra
[THERAPEUTIC EFFECT OF HB-GRANULE-3 ON
HEPATIC FIBROSIS]. GAO HUI ET AL. chinese journal
of integrated traditional and western medicine on liver
diseases. 2000;10(6):5 (chi*).
2059- gera: 87615/di/ra
[STUDY OF THE SEPARATE COMPREHENSIVE
TREATMENT ON TRADITIONAL CHINESE AND
WESTERN MEDICINE FOR PATIENTS WITH
ADVANCED HEPATOMA]. LUO ZEMIN ET AL.
chinese journal of integrated traditional and western
medicine on liver diseases. 2000;10(6):7 (chi*).
2060- gera: 87616/di/ra
[MEASUREMENT AND SIGNIFICANCE OF
CALCITONIN GENE-RELATED
PEPTIDE,NEUROPEPTIDE Y AND ALDOSTERONE
IN PORTAL HYPERTENSION]. ZHANG LIJUAN ET
AL. chinese journal of integrated traditional and western
medicine on liver diseases. 2000;10(6):9 (chi).
2061- gera: 87617/di/ra
[ANALYSIS OF HBE SYSTEM AND PRECORE
MUTATION OF HBV DNA IN CHRONIC HEPATITIS
B]. WANG JIEFEI ET AL. chinese journal of integrated
traditional and western medicine on liver diseases.
2000;10(6):12 (chi*).
2062- gera: 87618/di/ra
[DETECTION OF SERUM IL-10 AND IFN-Y IN
PATIENTS WITH HEPATITIS B AND THEIR
SIGNIFICANCES]. HUANG MINGQING ET AL. chinese
journal of integrated traditional and western medicine on
liver diseases. 2000;10(6):15 (chi*).
2063- gera: 87619/di/ra
[DETECTION ON HEPATITIS C OR G VIRAL RNA IN
PLASMA AND IN PERIPHERAL BLOOD
MONONUCLEAR CELLS OF PATIENTS WITH
HEPATITIS C OR G]. LI SHULI ET AL. chinese journal
of integrated traditional and western medicine on liver
diseases. 2000;10(6):19 (chi).
2064- gera: 87620/di/ra
[INITIAL STUDY ON ANTIGEN-PRESENTING
131
FUNCTION OF DENDRITIC CELL FROM HBV
TRANSGENIC MICE]. LIU GUANGZE ET AL. chinese
journal of integrated traditional and western medicine on
liver diseases. 2000;10(6):21 (chi*).
2065- gera: 87621/di/ra
[SERAPHARMACOLOGICAL EFFECT OF TIDU
HUGAN RECIPE ON THE PRODUCTION OF TYPE I
COLLAGEN AND TRANSFORMING GROWTH
FACTOR ß1 IN HEPATIC STELLATE CELL]. ZHU
QINGJING ET AL. chinese journal of integrated
traditional and western medicine on liver diseases.
2000;10(6):25 (chi*).
2066- gera: 87623/di/ra
[EFFECT OF NORMAL HEPATOCYTES AND
HERBAL COMPOUND 861 (CPD 861) ON APOPTOSIS
OF HEPATIC STELLATE CELLS]. YOU HONG ET AL.
chinese journal of integrated traditional and western
medicine on liver diseases. 2000;10(6):32 (chi*).
2067- gera: 87624/di/ra
[PREVENTION AND TREATMENT OF SAFFRON ON
EXPERIMENTAL ALCOHOLIC AND CC14 LIVER
INJURY IN WISTAR RATS]. MA ANLIN ET AL.
chinese journal of integrated traditional and western
medicine on liver diseases. 2000;10(6):34 (chi*).
2068- gera: 87625/di/ra
[48 CASES OF HEPATIC CARCINOMA TREATED BY
DECOCTION RESOLVING TUMOR (XIAOLIU
TANG)]. LIU JIANGUO. chinese journal of integrated
traditional and western medicine on liver diseases.
2000;10(6):37 (chi).
2069- gera: 87675/di/ra
[PRELIMINARY STUDY OF DUCK WEPATIC
FIBROSIS MODELS INDUCED BY DHBV]. NIE
GUANG ET AL. chinese journal of integrated traditional
and western medicine on gastro-spleen. 2000;8(2):70
(chi*).
2070- gera: 87677/di/ra
[EFFECT OF JIANPILIQI FORMULA ON HAC
MOUSE HEPATIC CARCINOMA CELLS BY
INDUCING APOPTOSIS AND UP-REGULATING THE
PROTEIN EXPRESSION OF BAX GENE]. ZHOU
ZHENHUA ET AL. chinese journal of integrated
traditional and western medicine on gastro-spleen.
2000;8(2):78 (chi*).
2071- gera: 87699/di/ra
[STUDY ON IMPROVEMENT OF LIVER CIRRHOSIS
AND LIVER FUNCTION IN HEPATOLENTICULAR
DEGENERATION PATIENTS TREATED WITH
INTEGRATED TRADITIONAL AND WESTERN
MEDICINE]. HONG MINGFAN ET AL. chinese journal
of integrated traditional and western medicine.
2000;20(12):890 (chi*).
2072- gera: 87886/di/ra
EFFECTS OF YUKMI,AN HERBAL FORMULA,ON
THE LIVER OF SENESCENCE ACCELERATED
MICE (SAM) EXPOSED TO OXIDATIVE STRESS.
JEONG SANG KIM ET AL. american journal of chinese
medicine. 2000;28(3-4):343-50 (eng).
2073- gera: 87887/di/ra
CLINICAL AND PHARMACOLOGICAL STUDIES ON
LIVER DISEASES TREATED WITH KAMPO
gera 2011

HERBAL MEDICINE. JONG-CHOL CYONG ET AL.
american journal of chinese medicine. 2000;28(3-4):351-
60 (eng).
2074- gera: 87888/di/ra
THE EVALUATION OF THE THERAPEUTIC
EFFECT OF TAO-SHANG-TSAO ON ALPHA-
NAPHTHYLISOTHIOCYANATE AND CARBON
TETRACHLORIDE-INDUCED ACUTE LIVER
DAMAGE IN RATS. KUO-LIANG LU ET AL. american
journal of chinese medicine. 2000;28(3-4):361-70 (eng).
2075- gera: 88035/di/ra
[PHARMACOLOGIC STUDY OF GAN DU QING ON
THE PROTECTION OF LIVER DAMAGE IN MICE].
ZHANG XIAOSHAN ET AL. new journal of tcm.
2000;32(1):35 (chi).
2076- gera: 88038/di/ra
[TREATMENT OF CHRONIC HEPATITIS B BY
QIANG LI NING COMBINED WITH INJECTIO
SALVIA MILTIORRHIZA CO: A CLINICAL
OBSERVATION OF 32 CASES]. MA HANQIAN ET AL.
new journal of tcm. 2000;32(1):43 (chi).
2077- gera: 88921/di/ra
[BINGGANNING'S PROTECTIVE EFFECTS ON
EXPERIMENTAL HEPATIC INJURY IN ANIMALS].
FANG TAI-HUI, ET AL. journal of nanjing university
tcm. 2000;16(4):214 (chi*).
OBJECITVE: To study a complex prescription of Chinese
herbs Bingganning 's protective effects on liver. METHOD:
DGal was used to cause acute hepatic injury models while
CCI-4 was adopted to induce chronic hepatic injury models
in rats. RESULT Bingganning in two different dose groups
were proved to have obvious inhibitive effects on the
seroenzyme activity in both acute hepatic injury models and
chronic hepatic injury models (P < 0. 05, P < 0. 01). The
pathological examinations showed that Bingganning in the
different dose groups could remarkably improve the
pathological changes in these two injury models.
CONCLUSION: Bingganning has
2078- gera: 88945/di/ra
[YINZHI DECOCTION FOR TREATING
HYPERBILIRUBINEMIA OF VIRAL HEPATITIS:
ANALYSIS ON EFFECT OF 80 CASES]. LI SHU-QING
ET AL. fujian journal of tcm. 2000;31(6):8 (chi).
2079- gera: 89058/di/ra
[CLINICAL ANALYSIS ON "THE PHENOMENON OF
RECOVERING VITAL-QI PREVAILING OVER THE
PATHOGENIC FACTOR" IN HEPATITIS B]. JIANG
SEN. journal of tcm. 2000;41(12):730 (chi).
2080- gera: 89065/di/ra
[STUDY ON MECHANISM OF THE PROTECTIVE
ACTION OF JIE JIU ORAL LIQUID ON ALCOHOLIC
LIVER INJURY IN MICE]. WANG XINYUE ET AL.
journal of tcm. 2000;41(12):748 (chi).
2081- gera: 89124/di/ra
[PROTECTIVE EFFECT OF HPS ON INJURY OF
PARENCHYMATOUS LIVER (II)]. REN YUAN ET AL.
journal of gansu college of tcm. 2000;17(4):10 (chi).
2082- gera: 89197/di/ra
[EFFECTS OF A NEWLY-MADE ANTI-CANCER
RECIPE ON CANCER-RESTRAINED GENE OF
EXPERIMENTAL LIVER-CANCER]. GUO ZHENQIU
132
ET AL. journal of hunan college of tcm. 2000;20(4):1
(chi*).
Aim: To study the effects of newly - made anti - cancer
recipe Kangqianling in Prorenting and treating liver fibrosis.
Method: The experiment adopted human liver - cancer's cell
HepG2 cultivation, human liver - cancer cell rat - naked
replanted carcinoma and methods of serum pharmacology,
and analysed effect of anti - cancer recipe on human liver -
cancer's cell plant HepG2 cells, and analysed P53 with LSAB
method, expression of HepG2, cells P21 wafI/Cipl protein
with immunity - histochemistry method and observed its
varieties of cellular morphology and expression of P21
protein gene with optical microscope and electron
microscope in human liver cancer - cell rat - naked replanted
carcinoma. Results: Anti - cancer recipe could restrain
HepG2 growth in evidence and its half growth. restraint dose
( IC 50) was 1 mg/ml. With LSAB method we observed that
anti - cancer recipe was able to induce from very feeble to
very strong and thick karyon pigmentation in HepG2, cell
plants and its low concentration (0. 1 mg/ml) was stronger
than its high one (1 mg/ml) in P53 protein expression and
nearly 50% of cell show P53 high expression. HepG2,
P21wafl/Cipl of human liver's cancer cells in serums of all
groups of anti - cancer recipe had higher expression than
those of CTX group, and blank serum group (all P <0. 05).
HCPG2 P21wafl/Ciplof big dose group of anti - cancer recipe
was higher expression than one of its middle and small dose
groups (all P < 0. 05). HePG2 1>21wafl/Cipl of both CTX
serum and blank serum had no significant difference of its
expression (all P > 0. 05). After human liver cancer - cell rat -
naked replanted carcinoma were treated, replanted bodies
%um and weight of both anti - cancer recipe and CTX groups
were respectively smaller than that of blank model group (all
P < 0. 0 1), and their rate of restraining - cancer was 33 %.
and in the group of the anti - cancer recipe expression of
HePG2 and P21 of cancer tissue became strong and in the
groups of bland model and CTX their expression was terribly
low. With electron microscope we observed: in the group of
anti - cancer recipe cancer - cell was integrity, and karyon
chromatin was condense and gathering in sides, and cell
organ frame was clear. In the blank models group, cells
linked tightly; in the CTXs group cancer cell was no integrity
and cell organ became vacuole and function of its restrained
cancer was mainly cancer cell becoming putrescent; and
function in the anti - cancer recipes group was to induce
cancer cell apotosis. Conclusion: Newly - made anti - cancer
recipe indeed had effective ingredients restraining HepG2, of
human liver - cancer cells and taking orally in effect, and its
rate of restraining - cancer was same as one of CTX but it
had not as evident side - effect as CTX in lowing blood
leukocyte. Its mechanism restraining HepG2, growth in and
out of cell was related to inducing HepG2, of liver -
2083- gera: 89211/di/ra
[CLINICAL EFFICACY OF CHRONIC HEPATITIS
TREATED BY HD-91-II HEPATOPATHY
THERAPEUTIC EQUIPMENTS]. LI XIUHUI ET AL.
beijing journal of tcm. 2000;3:15 (chi).
2084- gera: 89224/di/ra
[THE TREATMENT TO ASCITES DUE TO LIVER
CIRRHOSIS WITH METHOD OF STRENGTHENING
THE SPLEEN AND TONIFYING BLOOD: 55 CASES
REPORTED]. WANG QICHI. acta chinese medicine and
pharmacology. 2000;28(6):15 (chi).
2085- gera: 89225/di/ra
[THE TREATMENT OF LIVER DISEASE: 2 SPECIAL
DISEASES REPORTED]. QIAN HAIQING. acta chinese
medicine and pharmacology. 2000;28(6):16 (chi).
gera 2011

2086- gera: 89246/di/ra
[EFFECT OF SHENMAI INJECTION ON
IMMUNOLOGIC FUNCTION OF PATIENTS WITH
PRIMARY HEPATOCARCINOMA]. SHI CHUN-LEI ET
AL. shandong journal of tcm. 2000;19(10):615 (chi).
2087- gera: 89350/di/ra
[40 CASES OF HEPATOPHYMA TREATED BY THE
COMBINED MEDICINE OF TCM AND WESTERN
MEDICINE]. ZHANG SHU-PING. journal of tianjin
college of tcm. 2000;19(3):8 (chi).
2088- gera: 89378/di/ra
[HELICOBACTER PYLORI INFECTING
INFORMATION OF CHRONIC GASTRITIS
PATIENTS]. WEI XUE-QIN ET AL. journal of chengdu
university of tcm. 2000;23(2):27 (chi).
2089- gera: 89380/di/ra
[EFFECT OF TRADITIONAL CHINESE HERB
PANAX NOTOROGENSENG (BURK) F.H. CHEN ON
DIMETHYLNITROSAMINE-INDUCED LIVER
INJURY IN RATS]. LI ZHAO-JIAN ET AL. journal of
chengdu university of tcm. 2000;23(2):33 (chi).
2090- gera: 89492/di/ra
[EFFECT OF JIANGANLING CAPSULES ON
IMMUROLOGICAL HEPATITIS IN MICE]. ZHANG
DAN ET AL. chinese traditional patent medicine.
2000;22(5):356 (chi*).
2091- gera: 89493/di/ra
[PROTECTIVE EFFECTS OF GANSHAO INJECTION
ON EXPERIMENTAL LIVER INJURY IN MICE]. LIU
TAO-SHI ET AL. chinese traditional patent medicine.
2000;22(5):358 (chi*).
2092- gera: 89525/di/ra
EFFETTI DELL'AGOPUNTURA SULLE FUNZIONI
IMMUNITARIE NEI PORTATORI DI VIRUS B
DELL'EPATITE. CHEN JIAFU ET AL. rivista italiana di
medicina tradizionale cinese. 2000;82(4):47-9 (ita).
Venne eseguito uno studio comparativo sugli effetti
dell'agopuntura manuale e dell'elettroagopuntura su 60
portatori di virus B dell'epatite. 1 risultati dimostrarono che le
funzioni immunitarie, sia cellulari che umorali, furono
significativamente regolarizzate come evidenziato dalla
percentuale di negativizzazione di HBsAg, HBeAg, anti-HBc
e HBcAg, e dalla percentuale di positivizzazione di anti-HBe.
2093- gera: 89545/di/ra
ANALISI DELLE CAUSE DI DECESSO IN 45 CASI DI
CARCINOMA DEL FEGATO TRATTATO CON
FARMACI TRADIZIONALI CINESI. YANG
ZONGYAN ET AL. rivista italiana di medicina
tradizionale cinese. 2000;80(2):40-1 (ita).
Tra i 165 casi di carcinoma del fegato allo stadio terminale
trattati nel nostro ospedale, vi furono 65 decessi (39.4%) con
una sopravvivenza media di 8.1 mesi e una sopravvivenza
mediana di 7 mesi. Dei i 65 pazienti deceduti, 45 furono
trattati con farmaci tradizionali cinesi e 20 con farmaci
occidentali. La sopravvivenza media fu di 8.4 mesi nel primo
gruppo e di 7.3 mesi nel secondo. Le cause dirette di decesso
nei 65 pazienti furono coma epatico, grave emorragia del
tratto digestivo superiore, sindrome di Heyd, rottura del
fegato, insufficienza respiratoria e insufficienza cardiaca.
L'incidenza di emorragia del tratto digestivo superiore e di
rottura del fegato nei 45 pazienti trattati con farmaci
tradizionali cinesi fu chiaramente inferiore rispetto a quelli
133
trattati con farmaci
2094- gera: 89826/di/ra
[EXPERIMENTAL STUDY ON THE EFFECTS OF
FORTIFIED XIAOSHIFANSHI POWDER ON
HEPATIC IMMUNE INJURY]. WANG FU ET AL.
journal of beijing university of tcm. 2000;23(5):39 (chi*).
2095- gera: 89830/di/ra
[THE COUNTERACTION OF TUOLIXIAODU
POWDER ON THE ADVERSE REACTIONS CAUSED
BY TRANSCATHETER HEPATIC ARTERIAL
CHEMOEMBOLIZATION IN TREATING PRIMARY
HEPATOCARCINOMA]. LIANG JUNXIONG ET AL.
journal of beijing university of tcm. 2000;23(5):56 (chi*).
2096- gera: 90402/di/ra
[SELF-CREATED KANGYI GANGFANG ON
THERAPY OF 100 CASES OF CHRONIC ACTIVE
HEPATITIS B]. CHEN HONG-LUE ET AL. fujian
journal of tcm. 2000;31(3):12 (chi).
2097- gera: 90633/di/ra
[EFFECT OF SHUANGCAO GRANULE-3 ON
EXPERIMENTAL HEPATIC FIBROSIS IN RATS].
LIAN YUEXIANG ET AL. chinese journal of integrated
traditional and western medicine on gastro-spleen.
2000;8(3):137 (chi*).
2098- gera: 90635/di/ra
[OBSERVATION ON THE CURATIVE EFFECT OF
LAMIVUDINE AND INTERFERON FOR CHRONIC
HEPATITIS B]. WANG SONG ET AL. chinese journal of
integrated traditional and western medicine on gastro-
spleen. 2000;8(3):142 (chi*).
2099- gera: 90636/di/ra
[THE SIGNIFICANCE AND EFFECT OF ERSHEN ZE
ZHU DECOCTION ON THE PERITONEAL
LYMPHATIC STOMATA IN HEPATIC FIBROSIS
MICE]. LU ZHILIAN ET AL. chinese journal of
integrated traditional and western medicine on gastro-
spleen. 2000;8(3):145 (chi*).
2100- gera: 90637/di/ra
[EXPERIMENTAL STUDY ON GANXINNING (GXN)
LIQUID EXTRACT IN TREATMENT OF HEPATIC
FIBROSIS]. HU XIAOYU ET AL. chinese journal of
integrated traditional and western medicine on gastro-
spleen. 2000;8(3):148 (chi*).
2101- gera: 90638/di/ra
[ANTIFIBROTIC MECHANISM OF COMPLEX
PRESCRIPTION HANFANGJI]. WANG YAOJUN ET
AL. chinese journal of integrated traditional and western
medicine on gastro-spleen. 2000;8(3):151 (chi*).
2102- gera: 90646/di/ra
[PROPHYLACTIC EFFECT OF GANZHENG
PERORAL SOLUTION ON PRECANCEROUS LESION
OF LIVER IN RATS]. YAO SHUKUN ET AL. chinese
journal of integrated traditional and western medicine on
gastro-spleen. 2000;8(5):268 (chi*).
2103- gera: 90649/di/ra
[CLINICAL SIGNIFICANCE AND RELATIONSHIP
WITH THE SYNDROME TYPE OF TCM OF THE
SERUM CONTENTS OF PA,TF AND CP IN LOSEING-
COMPENSATION STAGE OF CIRRHOSIS OF POST
HEPATITIS B]. LIN ZONGGUANG. chinese journal of
gera 2011

integrated traditional and western medicine on gastro-
spleen. 2000;8(5):275 (chi*).
Objective: To approach the clinical significance and
relationship with the syndrome type of TCM of the serum
contents of PA, Tf and CP in decompensation stage of
cirrhosis of post hepatitis B. Methods: The serum contents of
PA, Tf and CP between observation group including 30
patients and control group including 100 normal people were
compared. Results: The PA, Tf and CP contents of the former
and the later were (137.50±6-42) mg/I, and (249.50±7. 10)
mg/I, (1. 67± 0. 1 g/L and (2. 35 ± 0. 002) g/L, (614. 14 ± 36.
09) mg/1- and (411. 40± 3. 95) mg/l, respectively. It showed
that the contents of PA and Tf were decline and the content
of CP was ascension (P < 0. 01) remarkably in observation
group. Comparison of the decline level of PA and Tf of
deficiency of Yin in the liver and kidney and ascension level
deficiency of Qi in the spleen and stomach also showed a
remarkable difference. Conclusion: The contents of AP, Tf
and CP could be the reference index in diagnosis and judging
therapeutic effect of cirrhosis. To differentiate the syndrome
type of TCM has a useful value in judgement patient's
condition.
2104- gera: 90666/di/ra
[A TRIAL OF XIAOHUANGJIANGMEI GRANULE IN
THE TREATMENT OF CHRONIC VIRAL HEPATITIS
B]. SUN JIUGUANG ET AL. hebei journal of tcm.
2000;22(11):809 (chi).
2105- gera: 90750/di/ra
[TREATING 32 CASES OF HEPATITIS CAUSED BY
DRUG ALLERGY WITH JIAWEI TUOMIN
DECOCTION]. MAO GUORONG. zhejiang journal of
tcm. 2000;35(12):518 (chi).
2106- gera: 90751/di/ra
[TREATING 80 CASES OF CHRONIC HEPATITIS
WITH WUCHONG JIEDU DECOCTION-COMPARED
WITH TREATING 80 CASES OF THE SAME
DISEASE WITH WESTERN MEDICINE]. JIANG
HAIHUA. zhejiang journal of tcm. 2000;35(12):519 (chi).
2107- gera: 90911/di/ra
[ELEMENTARY INTRODUCTION TO LI XIUWU' S
EXPERIENCE OF DIAGNOSING AND TREATING
PRIMARY CARCINOMA OF LIVER]. LI YONG HONG
ET AL. journal of henan college of tcm. 2000;15(3):8 (chi).
2108- gera: 90918/di/ra
[CHATING ON DIFFERENTIATION OF SYMPTOMS
AND SIGNS OF ASCITES DUE TO CIRRHOSIS].
ZHAO SHOU YE ET AL. journal of henan college of tcm.
2000;15(3):3 (chi).
2109- gera: 90929/di/ra
[JIANG CHUNHUA' S EXPERIENCE ON THE
MANAGEMENT OF CHRONIC HEPATITIS]. DAI
KEMIN. shanxi journal of tcm. 2000;16(4):1 (chi).
2110- gera: 90945/di/ra
[OBSERVATION ON CURATIVE EFFECT OF
POSTHEPATITIC FIBROSIS TREATED BY
KANGGAN XIANFANG]. ZHANG YABING ET AL.
hubei journal of tcm. 2000;22(4):13 (chi).
2111- gera: 90947/di/ra
[CHRONIC VIRUS HEPATITIS B TREATED WITH
INTEGRATION OF TRADITIONAL CHINESE AND
WESTERN MEDICINES]. YUAN CHANGJIN. hubei
journal of tcm. 2000;22(4):16 (chi).
134
2112- gera: 90989/di/ra
[DIFFERENTIATION AND TREATMENT PLUS
QIGONG THERAPY FOR THE INTERMEDIATE AND
LATE STAGE OF 153 CASES OF PRIMARY
CARCINOMA OF THE LIVER]. FAN YAN LEI ET AL.
henan traditional chinese medicine. 2000;20(3):35 (chi*).
The 153 patients of primary carcinoma of liver include 30
cases of stagnation of qi and blood stasis, 52 imparirment of
yin due to blood stasis, 34 water retention due to
hypofunction of the spleen and 37 of weakened body
resistance. They are differentiated and treated in combination
with qigong and general chemotherapy. Observation of the
changes of tumor itself as well as those of the survival period
and weight post treatment has shown that best result is seen
in those who are treated by differentiating syndromes in
combination with qigong. Thus, it's believed this is an ideal
therapy for the intermediate and late stage of primary
carcinoma of liver.
2113- gera: 91181/di/ra
[COMPARISON OF 4 KINDS OF EXTRACT
SOLUTIONS FOR PREPARATION OF HEPATITIS B
GRANULES]. LU QING-TAO ET AL. chinese traditional
patent medicine. 2000;22(11):752 (chi*).
2114- gera: 91445/di/ra
[CLINICAL OBSERVATION OF SYNERGIC AND
ANTI-TOXIC EFFECT OF SHENGMAI INJECTION
ON PRIMARY LIVER CANCER WITH TREATMENT
OF TRANSCATHETER ARTERIAL
EMBOLIZATION]. CHEN ZHE ET AL. journal of anhui
traditional chinese medical college. 2000;19(5):15 (chi*).
2115- gera: 91538/di/ra
[APPLICATION OF THE TONIFYING METHOD IN
TREATING CHRONIC HEPATITIS B]. ZHANG JIAN-
GUO. shanghai journal of tcm. 2000;34(4):28 (chi*).
In coordination of TCM pattern identification (spleen qi
deficiency, yin deficiency of both spleen and kidney) and
modern research progress in treating chronic hepatitis B, the
author discusses the application of the tonifying method in
the diagnosis and treatment of this disease and also
introduces his experience in using herbal drugs to enhance
the therapeutic effect for Chinese medical therapy of hepatitis
B by the tonifying method prior to the clearing method and
simultaneous application of the tonifying method and
clearing method.
2116- gera: 91571/di/ra
[APPLICATION OF REAL-TIME B-MODE
ULTRASONOGRAPHY IN TREATMENT OF FATTY
LIVER]. LIU MING ET AL. jiangsu journal of tcm.
2000;21(10):15 (chi).
2117- gera: 91573/di/ra
[TREATMENT OF 107 CASES OF CHRONIC
HEPATITIS WITH "HUANGQI JIEDU HUOXUE
DECOCTION"]. XU LIMING. jiangsu journal of tcm.
2000;21(10):22 (chi).
2118- gera: 91722/di/ra
[RECOVERY THERAPY OF CIRRHOSIS]. YIN XIN
ET AL. journal of shaanxi college of tcm. 2000;23(2):19
(chi).
2119- gera: 91723/di/ra
[TREATMENT AND AFFECT OF DIRECT DEATH
FROM SEVERE HEPATITIS CAUSED BY
CEREBRAL HEMORRHAGE]. ZHAO LIANG ET AL.
gera 2011

journal of shaanxi college of tcm. 2000;23(2):34 (chi).
2120- gera: 91731/di/ra
[TREATMENT OF VIRUS HEPATITIS WITH
DECOCTION OF REMOVING TOXIC FROM LIVER:
A CLINICAL REPORT OF 800 CASES]. LI LI-JUAN ET
AL. journal of shaanxi college of tcm. 2000;23(4):15 (chi).
2121- gera: 91795/di/ra
[CLINICAL OBSERVATION ON 30 CASES OF
CHRONIC ACTIVE HEPATITIS TREATED WITH
QINGGAN DECOCTION]. SONG JIN-DUO ET AL.
shandong journal of tcm. 2000;19(8):470 (chi).
2122- gera: 91804/di/ra
[OBSERVATIONS ON THE RECENT THERAPEUTIC
EFFECT OF INTEGRATED WM AND TCM ON
ASCITES DUE TO CIRRHOSIS,A REPORT OF 100
CASES]. FU XINSHUN. shanxi journal of tcm.
2000;16(5):26 (chi*).
2123- gera: 91805/di/ra
[OBSERVATIONS ON THE THERAPEUTIC EFFECT
OF INTEGRATED TCM AND WM ON SEVERE
HEPATITIS]. WANG BING ET AL. shanxi journal of
tcm. 2000;16(5):28 (chi*).
2124- gera: 91814/di/ra
[OBSERVATION ON CHRONIC B-HEPATITIS
TREATED WITH SHUGAN JIEYU HUAYU
DECOCTION,A REPORT OF 86 CASES]. WEN
RUFENG. shanxi journal of tcm. 2000;16(3):16 (chi*).
2125- gera: 91833/di/ra
[TREATING 100 CASES OF FATTY LIVER WITH
GANZHIQING]. LI YONG ET AL. shandong journal of
tcm. 2000;19(6):343 (chi).
2126- gera: 91834/di/ra
[CLINICAL OBSERVATION ON SHENNONGYE
LOWERING CONTENT OF AFP OF CHRONIC
LIVER DISEASE]. XU WEN-GANG ET AL. shandong
journal of tcm. 2000;19(6):344 (chi).
2127- gera: 91900/di/ra
[TREATMENT OF CHRONIC TYPE II HEPATITIS BY
THE DIFFERENTIATION OF DISEASE AND
SYNDROME]. XU HAIQING ET AL. traditional chinese
medicinal research. 2000;13(6):50 (chi).
2128- gera: 91903/di/ra
[DISCUSSION ON COMMON TREATMENT OF
FATTY LIVER]. YIN CHANG-JIAN ET AL. shandong
journal of tcm. 2000;19(9):519 (chi*).
This article mainly discusses the study on the treatment of
fatty liver and summarises treatments as follows. a.
Eliminating phlegm and the wetness-evil, which is suitable
for hyperactivity of phlegm type. b. Activating vital energy,
which is suitable for stagnation of vital energy type. c.
Clearing away heat-damp, and promoting diuresis, which is
suitable for stagnation of damp-heat type. d. Activating blood
circulation to dredge the collateral, which is suitable for liver-
blood stasis type. It can improve curative effect by applying
selection of treatment based on the differential diagnosis and
using the medicine that can protecting liver-cell and weaking
the activities of ALT and reducing lipomicron. This article
also put forward six problems that should be paid attention to
during the
2129- gera: 91906/di/ra
135
[TREATMENT OF 86 CASES OF ASCITES DUE TO
CIRRHOSIS WITH JIANHUO LIGAN DECOCTION].
XUAN EN-YU ET AL. shandong journal of tcm.
2000;19(9):529 (chi).
2130- gera: 91909/di/ra
[CLINICAL OBSERVATION ON 92 CASES OF
CHRONIC HEPATITIS B TREATED WITH
SHUIHUANG CAPSULE]. YU FENG-CHUN ET AL.
shandong journal of tcm. 2000;19(9):535 (chi).
2131- gera: 91910/di/ra
[TREATMENT OF 72 CASES CHRONIC HEPATITIS
B WITH MINOR DECOCTION OF BUPLEURUM].
SUN PENG-QIANG ET AL. shandong journal of tcm.
2000;19(9):536 (chi).
2132- gera: 92000/di/ra
[OBSERVATION ON THE EFFECT OF TREATING
HEPATOCIRRHOSIS ACCOMPANIED WITH
HEMORRHAGE UPPER DIGESTIVE TRACT BY ZHI
XUE SAN (POWDER FOR STOPPING
BLEEDING,CHINESE HERBAL MEDICINE) AND
PITUITRIN]. GUO QINGJIE ET AL. tianjin journal of
tcm. 2000;17(5):7 (chi).
2133- gera: 92054/di/ra
[EFFECT OF QIHUANG GRANULE ON IMMUNITY
FUNCTION OF CHRONIC HEPATITIS B PATIENTS].
ZHANG WEI ET AL. chinese journal of integrated
traditional and western medicine on liver diseases.
2000;10(5):1 (chi*).
2134- gera: 92055/di/ra
[STUDY ON TRANSFUSION TRANSMITTED VIRUS
IN LIVER TISSUE BY IN SITU HYBRIDIZATION].
YAN HUIPING ET AL. chinese journal of integrated
traditional and western medicine on liver diseases.
2000;10(5):3 (chi*).
2135- gera: 92056/di/ra
[CLINIC STUDY OF SYNCHRONOUS DETECTION
THE HCV RNA IN PLASMA AND PBMC OF
HEPATITIS C]. YE JIN ET AL. chinese journal of
integrated traditional and western medicine on liver
diseases. 2000;10(5):5 (chi*).
2136- gera: 92057/di/ra
[INFLUENCE OF HEPATIC DISEASE IN
PREGNANCY ON THE NEWBORN]. WU SHANMING
ET AL. chinese journal of integrated traditional and
western medicine on liver diseases. 2000;10(5):7 (chi).
2137- gera: 92058/di/ra
[STUDY ON THE RELATION OF THE SERUM
CHOLINESTERASE AND THE LIVER TISSUE
FIBROSIS ACTIVITY IN CHRONIC HEPATITIS B].
LIU WEI ET AL. chinese journal of integrated traditional
and western medicine on liver diseases. 2000;10(5):10
(chi*).
2138- gera: 92059/di/ra
[EPIDEMIOLOGY AND CLINICAL ANALYSIS OF 28
PATIENTS WITH HEPATITIS C]. ZHANG JIANHUA
ET AL. chinese journal of integrated traditional and
western medicine on liver diseases. 2000;10(5):12 (chi*).
2139- gera: 92060/di/ra
[CLINICAL SIGNIFICANCE OF MEASUREMENT OF
IL-8 IN ASCITES OF SPONTANEOUS BACTERIAL
gera 2011

PERITONITIS]. CHEN KEN ET AL. chinese journal of
integrated traditional and western medicine on liver
diseases. 2000;10(5):14 (chi*).
2140- gera: 92061/di/ra
[INHIBITORY EFFECTS OF FUFANG HUANGQI
DECOCTION AND XIAO CHAIHU DECOCTION ON
HEPATITIS C VIRUS]. LI JIANRONG ET AL. chinese
journal of integrated traditional and western medicine on
liver diseases. 2000;10(5):18 (chi*).
2141- gera: 92062/di/ra
[PATHOGENESIS EXPLORATION OF ACUTE
SEVERE HEPATITIS WITH SERUM NITRIC OXIDE
IN MICE]. XIA QIN ET AL. chinese journal of integrated
traditional and western medicine on liver diseases.
2000;10(5):20 (chi).
2142- gera: 92063/di/ra
[EXPERIMENTAL INVESTIGATION OF APOPTOSIS
OF HEPATOMA MEDIATED BY ARTEMISININ].
CHEN ZHENGTU ET AL. chinese journal of integrated
traditional and western medicine on liver diseases.
2000;10(5):23 (chi*).
2143- gera: 92064/di/ra
[EFFECT OF FUZHENG HUAYU DECOCTION
(FZHYF) ON THE FUNCTION OF KUPFFER CELLS
FROM ACUTE INJURY LIVER INDUCED BY CCI4].
JIANG CHUNMENG ET AL. chinese journal of integrated
traditional and western medicine on liver diseases.
2000;10(5):26 (chi*).
2144- gera: 92065/di/ra
[EFFECTS OF ZHUZI GANTAI CAPSULE ON LIVER
FIBROSIS IN RAT]. LI CAIDONG ET AL. chinese
journal of integrated traditional and western medicine on
liver diseases. 2000;10(5):29 (chi*).
2145- gera: 92066/di/ra
[EFFECTS OF GANODERMA LUCIDUM SPORO-
POLLEN ON HEPATOMA INHIBITION AND LIVER
PROTECTION IN MOUSE]. LIU XIN ET AL. chinese
journal of integrated traditional and western medicine on
liver diseases. 2000;10(5):31 (chi).
2146- gera: 92067/di/ra
[STUDY OF XIAOZHI BAOGAN DECOCTION ON
TREATING FATTY LIVER IN RAT MODEL]. QI
PEIHONG ET AL. chinese journal of integrated
traditional and western medicine on liver diseases.
2000;10(5):33 (chi*).
2147- gera: 92068/di/ra
[OBSERVATION OF EFFICACY OF ALPHA-
INTERFERON COMBINED WITH THYMOSIN ON
PATIENTS WITH CHRONIC HEPATITIS B]. KONG
QINGFU ET AL. chinese journal of integrated traditional
and western medicine on liver diseases. 2000;10(5):36
(chi*).
2148- gera: 92069/di/ra
[EFFECT OF HEPATITIS C VIRUS INFECTION ON
HEPATITIS B VIRUS]. SHANG QINGHUA ET AL.
chinese journal of integrated traditional and western
medicine on liver diseases. 2000;10(5):48 (chi).
2149- gera: 92122/di/ra
[EXPERIMENTAL STUDY ON INHIBITORY EFFECT
OF XIAOCHAIHU DECOCTION ON DUCK
136
HEPATITIS B VIRUS]. LIU ZHONGJING ET AL.
chinese journal of integrated traditional and western
medicine. 2000;20(11):853 (chi*).
2150- gera: 92125/di/ra
[KNOWLEDGE FROM EXPERIENCE IN
TREATMENT OF LOW FEVER DUE TO CHRONIC
HEPATOPATHY BY DIFFERENTIATION OF
SYMPTOMS AND SIGNS]. SUN JIAN. journal of tcm
and chinese materia medica of jilin. 2000;20(6):1 (chi).
2151- gera: 92130/di/ra
[TREATMENT OF FATTY LIVER DUE TO HEPATIC
DYSFUNCTION WITH YANGGAN QU ZHI TANG]. BI
DE-ZHONG ET AL. journal of tcm and chinese materia
medica of jilin. 2000;20(6):22 (chi).
2152- gera: 92191/di/ra
[CURATIVE EFFECTS INVESTIGATORY OF
LIGANLING SYRUP WITH INTERFERON FOR
PEDIATRIC HEPATITIS]. GAN JING-ZHOU ET AL.
chinese traditional patent medicine. 2000;22(7):490 (chi*).
2153- gera: 92271/di/ra
[EXPERIENCES ON DIAGNOSIS AND TREATMENT
OF LIVER CIRRHOSIS]. ZHOU FAYANG. journal of
tcm. 2000;41(10):588 (chi).
2154- gera: 92283/di/ra
[A STUDY ON FU ZHENG HUA YU FANG AND ITS
INGREDIENTS ON PRODUCTION OF COLLAGEN
IN THE LIVER]. LIU CHENGHAI ET AL. journal of tcm.
2000;41(10):620 (chi*).
2155- gera: 92292/di/ra
[TREATMENT OF CHRONIC HEPATITIS B WITH
TIAO ZHI QU XIE LIAO GAN FANG IN 240 CASES].
ZHANG SHAOJIAN. journal of tcm. 2000;41(11):664
(chi*).
240 cases of chronic hepatitis B were treated with Tiao Zhi
Qu Xie Liao Gan Fang, a prescription of our own. The
prescription has the following actions: supplementing qi and
invigorating the spleen: tonifying the liver and kidney;
enriching the liver and blood: promoting the flow of qi by
soothing the liver; promoting the circulation of blood
circulation and removing stasis; detoxifying, expelling the
pathogenic dampness and heat. In the control group, 100
cases were treated with concentrated pills of Yi Gan Ling.
plus composite Shu She tablets. The total and markedly
effective rates of the treatment group were significantly
higher than the control group (P<0. 05 or P<0. 01). The
negative turnover rates of HBeAg and HBV-DNA were also
significantly higher (P<0. 01) than the control
2156- gera: 92314/di/ra
[CLINICAL OBSERVATION OF SELF-MADE
"TURBIDITY-MELTING AND LIPID-REDUCING
DECOCTION" IN TREATING FATTY LIVER]. LUO
LI-JUAN. shanghai journal of tcm. 2000;34(11):20 (chi*).
2157- gera: 92315/di/ra
[STRENGTHENING BODY AND DISPELLING
PATHOGEN THERAPY FOR HEPATOCARCINOMA].
ZHANG CUN-YI ET AL. shanghai journal of tcm.
2000;34(11):22 (chi*).
2158- gera: 92345/di/ra
[EFFECTS AND MECHANISM OF CORDYCEPS
POLYSACCHARIDE ON LIVER FIBROSIS INDUCED
BY IMMUNOLOGIC INJURY IN RATS]. FANG BU-
gera 2011

WU ET AL. shanghai journal of tcm. 2000;34(9):37 (chi*).
2159- gera: 92372/di/ra
[EXPERIMENTAL STUDY ON THE INFLUENCE OF
"CANCER-ELIMINATING INJECTION" ON HUMAN
HEPATOCARCINOMA CELLS]. SUN JUE ET AL.
shanghai journal of tcm. 2000;34(7):12 (chi*).
2160- gera: 92398/di/ra
[DISON DISPERSING METHOD WITH USING ACRID
DRUGS TO TREAT HEPATOPATHY DISEASE].
WANG YU-FANG. journal of shandong university of tcm.
2000;24(6):448 (chi*).
The basic theory in Emperor's Canon of Medicine (ECM)
"Liver wants to scatter, the acrid drug should be given at first
to disperse and to invigorate" and the theory was developed
by the later age's doctors. This study used the traditional way
to systematise and discuss hepatopathy disease (HD) and uses
the experimental study to demonstrate that the acrid drugs
belonged to different channel distribution can ameliorate the
objective indication of stagnation of liver-energy rats in
different levels. So it was proved that the acrid drugs have
efficiently effects to
2161- gera: 92401/di/ra
[EFFECTS OF HUANGQI INJECTION ON
IMMUNOLOGIC FUNCTION IN PATIENTS WITH
PRIMARY CARCINOMA OF LIVER]. SONG HUAI-YU
ET AL. journal of shandong university of tcm.
2000;24(6):459 (chi*).
2162- gera: 92402/di/ra
[IMMUNOLOGIC EFFECTS OF BINGGANKANG
ORAL LIQUID ON RATS WITH INJURED LIVER].
PENG BO ET AL. journal of shandong university of tcm.
2000;24(6):461 (chi*).
2163- gera: 92501/di/ra
[CLINICAL AND EXPERIMENTAL STUDY ON
ASCITES DUE TO CIRRHOSIS OF LIVER WITH
HUEXUE LISHUI RECIPE. YAN XIAO-YAN. journal of
shandong university of tcm. 2000;24(2):128 (chi*).
2164- gera: 92845/di/ra
[CORRELATION RESEARCH ON SERUM LEVEL OF
HA,TNF-ALPHA,IL-6 WITH LIVER AND
GALLBLADDER WETNESS-HEAT SYNDROME OF
HEPATITIS B]. JI GUANG ET AL. liaoning journal of
tcm. 2000;27(10):433 (chi*).
2165- gera: 92912/di/ra
[ZHANG JINGREN'S EXPERIENCES ON THE
TREATMENT OF CHRONIC ATROPHIC
GASTRITIS: REPORT OF FOUR CASES]. YE JIAN-
HUA. journal of traditional chinese medicinal literature.
2000;3:28 (chi).
2166- gera: 92925/di/ra
[CASE RECORDS OF WANG-XINGRAN'S IN
TREATING ASCITES DUE TO CIRRHOSIS]. CHEN
WUI-MING. journal of traditional chinese medicinal
literature. 2000;2:32 (chi).
2167- gera: 92958/di/ra
[RESEARCH ON INHIBITORY EFFECT OF VENIN
COMPLEX ENZYME ON HUMAN
HEPATOCELLULAR CARCINOMA BEL-7402]. ZOU
JING ET AL. liaoning journal of tcm. 2000;27(9):424
(chi*).
137
2168- gera: 92967/di/ra
[CLINICAL STUDY OF GRANULE-NOURISHING
LIVER OF TREATING CHRONIC HEPATITIS B]. QIN
QIU-HAO ET AL. liaoning journal of tcm. 2000;27(4):159
(chi*).
2169- gera: 92975/di/ra
[STUDY ON THE CORRELATIONS BETWEEN THE
INDEXES OF HEPATIC FIBROSIS AND THE
SYNDROME TYPES OF TCM OF LIVER
CIRRHOSIS]. ZHU FANG-SHI ET AL. liaoning journal
of tcm. 2000;27(11):481 (chi*).
The detection of the serum of 131 cirrhotic patients of 6
syndromes shows there HA, LN.P III P and NAG rise higher
than those of normal people. The indexes among all types
have significant differences from the normal people except
the LN index in the type of live qi depression and spleen qi
deficiency. The 4 indexes of liver qi depression and spleen qi
deficiency type are the lowest among all types. The indexes
of HA and LN are the highest in the types of spleen-kidney
yang deficiency and liver-kidney yin deficiency. And they
have obvious differences between types. The index of P III P
of the qi stagnancy and blood stasis type is the highest and
also has the significant difference from the other 5 types. The
index of NAG in the type of liver-kidney yin deficiency is the
highest. but it has not statistical meaning between types.
Since the varieties of HA, LN. P III P has regularity in the
types. We consider the 3 indexes as one of the objective
bases for differentiation of symptoms and signs and the
classification
2170- gera: 92978/di/ra
[OBSERVATION ON THE EFFECT OF SHEN QI ER
JIA POWDER IN TREATMENT OF LIVER
FIBROSIS]. LI GUO-AN ET AL. liaoning journal of tcm.
2000;27(11):495 (chi*).
2171- gera: 93106/di/ra
[THE ACADEMIC THINKING ON THE TREATMENT
OF HEPATIS B BY TCM COMBINED WITH
WESTERN MEDICINE]. SHEN ZHONGYUAN. new
journal of traditionnal chinese medicine. 2000;32(10):5
(chi).
2172- gera: 93116/di/ra
[A PATHOLOGICAL OBSERVATION ON THE
TREATMENT OF CHRONIC HEPATITIS B BY
FUFANG CHONGEAO ZHENZHU CAPSULE]. LEI
CHENGDUO. new journal of traditionnal chinese
medicine. 2000;32(10):32 (chi).
2173- gera: 93144/di/ra
[THAREPEUTIC EFFECT ANALYSIS OF TREATING
HEPATITIS - B WITH ACUPUNCTURE]. HAI RIHAN
ET AL. journal of clinical acupuncture and moxibustion.
2000;16(8):6 (chi).
2174- gera: 93174/di/ra
[THE CLINICAL OBSERVATION OF TREATING
HEPATITIS - B WITH ACUPUNCTURE AND
CHINESE HERBS: 58 CASES REPORTED]. HAN
YALAN ET AL. journal of clinical acupuncture and
moxibustion. 2000;16(9):12 (chi).
2175- gera: 93238/di/ra
[THE EFFECT OF JIANGHUANGSHU CAPSULE ON
ACUTE OR CHRONIC LIVER INJURY IN
EXPERIMENTAL ANIMALS]. REN AIDONG ET AL.
chinese journal of ethnomedicine and ethnopharmacy.
2000;47:354 (chi).
gera 2011

2176- gera: 93260/di/ra
[PROF. PENG SHENGQUAN' S EXPERIENCE ON
THE TREATMENT OF HEPATOPATHY]. WU
JIYONG. new journal of tcm. 2000;32(11):8 (chi).
2177- gera: 93262/di/ra
[TREATMENT OF ASCITES DUE TO CIRRHOSIS OF
QI AND DAMP STAGNATION TYPE BY HAN' S LI QI
XIAI?,ZHANG TANG: A CLINICAL OBSERVATION
OF 87 CASES]. ZHENG SONGMING. new journal of
tcm. 2000;32(11):20 (chi).
2178- gera: 93268/di/ra
[TREATMENT OF FATTY LIVER BY XIAO ZHI BAO
GAN TANG: A REPORT OF 60 CASES]. ZHANG
XIANYAO. new journal of tcm. 2000;32(11):32 (chi).
2179- gera: 93278/di/ra
[TREATMENT OF CHRONIC ATROPHIC
GASTRITIS BY FORMULA OF STRENGTHENING
SPLEEN,CLEARINGHEAT AND ACTIVATING
BLOOD CIRCULATION- A CLINICAL
OBSERVATION OF 60 CASES]. LI DONG ET AL. new
journal of tcm. 2000;32(4):20 (chi).
2180- gera: 93611/di/ra
[RELATIONSHIP BETWEEN SEVERE
HEPATITIS,HEPATOCIRRHOSIS AND MANY
ORGANA FUNCTION FAILURE]. WEI DAOWU ET
AL. journal of gansu college of tcm. 2000;17(3):22 (chi).
2181- gera: 93614/di/ra
[CLINICAL EFFICACY OF GANYANLING TABLET
IN THE TREATMENT OF CHRONIC HEPATITIS].
HOU SHIRONG ET AL. traditional chinese drug research
and clinical pharmacology. 2000;11(2):68 (chi*).
2182- gera: 93695/di/ra
[OBSERVATION ON LATE LIVER CANCER
TREATED BY WAY OF TCM IN COMBINATION
WITH CHEMOTHERAPY IN SMALL DOSE]. WANG
SHOUFENG ET AL. inner mongol journal of tcm.
2000;19(4):2 (chi).
2183- gera: 93809/di/ra
[INFLUENCE OF GANFULE TABLET ON MOUSE
HEPATIC INJURY BY D-AMINOGALACTOSE]. XU
LIN-BEN ET AL. traditional chinese drug research and
clinical pharmacology. 2000;11(6):343 (chi*).
2184- gera: 93864/di/ra
[THE RESEARCH DEVELOPMENT OF CHINESE
HERBS ON ANTI-CANCERATION OF LIVER CELL].
ZHOU JIANFENG ET AL. information on tcm.
2000;17(5):3 (chi).
2185- gera: 93874/di/ra
[THE TREATMENT OF ASCITES DUE TO LIVER
CIRRHOSIS WITH COMPOUND TCM
PRESCRIPTIONS 563 CASES REPORTED]. GENG
LANSHU ET AL. information on tcm. 2000;17(5):38 (chi).
2186- gera: 93883/di/ra
[CLINICAL STUDY OF JIA WEI GE XIA ZHU YU
CAPSULE IN RESISTING LIVER FIBROSIS]. TANG
NONG ET AL. guangxi journal of tcm. 2000;23(4):7
(chi*).
2187- gera: 93894/di/ra
138
[TREATING 50 CASES OF ACUTE VIRAL
CHOLESTATIC HEPATITIS WITH BOTH WESTERN
AND TRADITIONAL CHINESE MEDICINE]. LI
WEIDONG. guangxi journal of tcm. 2000;23(3):12 (chi).
2188- gera: 93907/di/ra
[GUO ZHIYUAN'S EXPERIENCE OF TREATMENT
OVER LIVER AND GALL DISEASES WITH
ACTIVATING BLOOD,NEUTRALIZING POISON
AND RESOLVING PHLEGM]. GUO YIMIN. jiangxi
journal of tcm. 2000;31(6):4 (chi).
2189- gera: 93945/di/ra
[ARCHEN'S PROTECTIVE ACTION ON THE
PRIMARY CULTURE HEPATOCYTES OF RATS
INJURED WITH CCL4]. JIAO HE-LING ET AL. henan
traditional chinese medicine. 2000;20(5):20 (chi*).
2190- gera: 94054/di/ra
[CLINICAL OBSERVATION ON 68 CASES OF
POSTHEPATITIC CIRRHOSIS TREATED WITH
SOFTING LIVER DECOCTION OF RADIX
ANGELICAE SINENSIS AND RADIX ASTRAGALI
SEU HEDYSARI]. ZHAO GEN. forum on tcm.
2000;15(5):24 (chi).
2191- gera: 94058/di/ra
[SCIENTIFIC STUDY ON ANTIEFFECTS OF
NEEDLE-EMBEDDING THERAPY IN ZUSANLI
POINT ON HEPATIC INJURY INDUCED BY CCL4].
ZHAO TIANPING ET AL. forum on tcm. 2000;15(5):47
(chi).
2192- gera: 94705/di/ra
[TREATMENT OF LIVER CANCER BY ELEMENE
EMULSION HEPATIC ARTERIAL INTERVENTION
THERAPY: A REPORT OF 32 CASES]. WU
ZHESHENG ET AL. new journal of tcm. 2000;32(9):30
(chi).
2193- gera: 95232/di/ra
[PROTECTIVE EFFECTS OF SODIUM FERULATE
AND ETHANOL SEDIMENTS FROM ANG-ELIA
SINENSIS ON IMMUNOLOGICAL LIVER INJURY].
LI YING ET AL. chinese traditional and herbal drugs.
2000;31(4):274 (chi*).
2194- gera: 95863/di/ra
[STRUCTURAL AND MORPHOMETRIC STUDIES OF
THE CURATIVE EFFECTS OF MOXIBUTION
TREATMENTS FOR DIABETIC HEPATIC INJURIED
FOLLOWING ADMINISTRATION OF
STREPTOZOTOCIN]. NAKAI SACHIKO ET AL.
journal of the japan society of acupuncture and
moxibustion. 2000;50(4):659 (jap*).
To analyze the curative effects of moxibustion for rat diabetic
hepatic injuries caused by the administration of steptozotocin
(STZ), the authors designed ultrastructural studies using light
microscopy, transmission electron microscopy and image
processing, Wistar male rats (44 animals) were divided into 4
groups. The first group (10 animals) was used as the control.
The second group (14 animals) was a diabetic group injected
I.P. with 50 mg/kg BW of STZ on the first experimental day,
The third and fourth groups (10 animals each) were the
curative groups, which were given moxibustion treatments of
5 half-rice grains of moxa, three times a week following STZ
administration. Used acupoints were Tian Men (3rd group)
and Tian Ping (4th group) according to the animal acupoint
chart. First, light and electron microscopices were used to
observe, the hepatic parenchymal cells, and light and electron
gera 2011

micrographs were obtained. The electron micrographs were
used to analyze the distribution of glycogen granules
including its glycogen areas, fat droplets and autophagic
vacuoles using an image processing method. The results were
as follows: Normal control hepatocytes contained moderate
volumes of glycogen areas and glycogen granules, but a few
hepatocytes were without fat droplets or autophagic vacuoles.
On the other hand, the hepatocytes, that had been treated with
only STZ, were injured, and contained a number of fat
droplets and autophagic vacuoles, but glycogen areas and
glycogen granules had decreased. The hepatocytes of the rats
treated with both STZ and moxibustion recovered to their
normal state, suggesting that moxibustion treatment had
curative effects for the rat hepatic dabetic injuries caused by
the administration of STZ.
2195- gera: 96019/di/cg
EFFICACITE DE L'ACUPUNCTURE APRES UNE
GREFFE HEPATIQUE. TORRACCA F. colloque
international d'acupuncture nguyen van nghi, marseille.
2000;18-19No:22 (fra).
2196- gera: 89089/di/ra
[CLINICAL APPLICATION AND REALIZATION OF
DISPERSING BLOOD-STASIS THERAPY FOR
HEPATOPATHY]. GUI MEI-HUA. shanghai journal of
tcm. 2001;35(1):21 (chi*).
Dispersing blood-stasis therapy coordinating with freeing
gallbladder, regulating conception and thoroughfare vessels,
cleansing fu-organ and eliminating phlegm was applied to
treat jaundice of hepatitis; hepatitis C, drug hepatitis and fatty
liver in 4 cases. Results showed dispersing blood-stasis
therapy had better clinical effects.
2197- gera: 89271/di/ra
[SPEEDY TREATMENT OF SERIOUS HEPATITIS].
CHEN NINGSHENG ET AL. new journal of tcm.
2001;33(1):3 (chi*).
It is considered that the chief etiology and pathogenesis of
serious hepatitis is the combination of blood stasis and toxic
substance, so speedy treatment is Its therapeutical principle.
Putting herbal drugs for removing toxic substance and
resolving blood stasis in an important position can control the
disease rapidly, so that the invasion of toxic substance into
ying - xue system and pericardium and deterioration of the
disease can be prevented.
2198- gera: 89281/di/ra
[TREATMENT OF HEPATIC TUMOR BY XIAO LIU
YE: A CLINICAL OBSERVATION OF 36 CASES]. QU
LIANGYI ET AL. new journal of tcm. 2001;33(1):53 (chi).
2199- gera: 89298/di/ra
[AN APPROACH TO PROVED MEDICAL RECORDS
IN PATHOLOGICAL CHANGES OF THE LIVER OF
TEACHER XU SHU FU]. XU JING SHI ET AL. forum on
tcm. 2001;16(1):16 (chi).
2200- gera: 89324/di/ra
[TREATMENT OF 34 CASES OF LIVER CIRRHOSIS
WITH ASCITES DUE TO NEPHRITIS
INTERRELATED HEPATITIS B BY
IDENTIFICATION OF TCM]. WANG FENG ET AL.
shaanxi journal of traditional chinese medicine.
2001;22(1):2 (chi).
2201- gera: 89325/di/ra
[TREATMENT OF 38 CASES OF LIVER CIRRHOSIS
WITH ASCITES BY TAOHECHENGQI COMBINED
WULINGSAN DECOCTION]. MA FUZHONG. shaanxi
139
journal of traditional chinese medicine. 2001;22(1):3 (chi).
2202- gera: 89326/di/ra
[TREATMENT OF 58 CASES OF LIVER CIRRHOSIS
WITH ASCITES BY CHINESE MEDICINAL HERBS].
TANG JIANWU ET AL. shaanxi journal of traditional
chinese medicine. 2001;22(1):5 (chi).
2203- gera: 89327/di/ra
[TREATMENT OF 50 CASES OF HEPATITIS B BY
CHINESE MEDICINAL HERBS]. HE RONGHUA.
shaanxi journal of traditional chinese medicine.
2001;22(1):10 (chi).
2204- gera: 89401/di/ra
[DISCUSSION ON HEMODYNAMICS
HYPERBILIRUBINEMIA DUE TO CHRONIC
HEPATITIS TREATED WITH CHIYIN MIXTURE].
ZHANG HUI-YUN ET AL. shandong journal of tcm.
2001;20(1):17 (chi).
2205- gera: 89583/di/ra
[EFFECTS OF 941 RECIPE ON LIVER
MITOCHONDRION ENZYME FROM AGED RATS].
YU CHAO-QIN ET AL. journal of anhui traditional
chinese medical college. 2001;20(1):35 (chi*).
2206- gera: 89589/di/ra
[A REVIEW ON EXPERIMENTAL STUDIES OF
COUNTERACTING HEPATITIS B VIRUS BY
CHINESE HERBAL DRUGS]. WANG BOXIANG. new
journal of traditional chinese medicine. 2001;33(2):3 (chi).
2207- gera: 89597/di/ra
[TREATMENT OF POSTHEPATITIC CIRRHOSIS BY
YIGAN ZHUANYIN POWDER COMBINED WITH
RUANJIAN DECOCTION: A REPORT OF 47 CASES].
ZHOU DAOHONG ET AL. new journal of traditional
chinese medicine. 2001;33(2):48 (chi).
2208- gera: 89612/di/ra
[EXPERIMENTAL STUDY OF THE TREATMENT OF
FATTY LIVER BY TIANJIU THERAPY IN RATS].
SUN XUAN ET AL. journal of beijing university of tcm.
2001;24(1):48 (chi*).
Rat fatty liver model was established by feeding high fat food
and intragastrically giving a Chinese spirit, and the effects of
the tianjiu therapy were observed in the model. The
parameters observed in this study included the body weight,
liver weight, and the ratio of liver weight and body weight,
liver lipid, blood lipid, transaminase, alkaline phosphates,
lactic dehydrogenase, gamma glutamyltransferase, and the
liver pathology changes. The results showed that the tianjiu
therapy could regulate the fat metabolism of the liver and the
whole body, reduce the fat deposit in the liver, inhibit fatty
degeneration of liver cells, and help liver cells to restore their
normal functions. Mie results also showed that the recovery
speed of the rat with fatty liver treated by the tianjiu therapy
was higher dm that of the rat with the same disease not
treated by the therapy.
2209- gera: 89619/di/ra
[THE SURVEY OF TREATING HEPATITIS B WITH
ETHNIC MEDICINE]. LI HONG. chinese journal of
ethnomedicine and ethnopharmacy. 2001;48:9 (chi).
2210- gera: 89622/di/ra
[OBSERVATION OF EFFECTS ON TREATING
HEPATITIS B 35 CASES WITH SELF-FORMULATED
SHUITAO SHIWEI DECOCTION]. PAN YONGHUA ET
gera 2011

AL. chinese journal of ethnomedicine and
ethnopharmacy. 2001;48:14 (chi).
2211- gera: 89647/di/ra
[EFFECT OF JIANPIHUOXUE FORMULA ON RAT'S
HEPATIC STEATOSIS INDUCED BY CC14 WITH
HIGH FAT AND LOW PROTEIN DIET]. HE DONG-YI
ET AL. chinese journal of traditional medical science and
technology. 2001;8(1):13 (chi*).
2212- gera: 89648/di/ra
[EXPERIMENTAL STUDY ON THE EFFECT OF
FUGAN VI ON RAT'S LIVER FIBROSIS INDUCED BY
DIMETHYLNITROSAMINE]. CHEN WEN-HUI ET AL.
chinese journal of traditional medical science and
technology. 2001;8(1):15 (chi*).
2213- gera: 89680/di/ra
[THE INFLUENCE OF HERBA ARTEMISIAE
CAPILLARIS ON THE UDPGT ACTIVITY IN RAT'S
HEPAT]. LI HAN-ZHONG ET AL. chinese traditional
patent medicine. 2001;23(1):45 (chi*).
2214- gera: 89735/di/ra
[EFFECT OF RELIEVING ALCOHOLISM AND
PROTECTING LIVER DRINK ON BLOOD SERUM
LIVER TISSUE IL-8 OF ALCOHOLIC LIVER INJURY
RAT]. YANG MU-XIANG ET AL. chinese journal of
basic medicine in tcm. 2001;7(1):30 (chi*).
2215- gera: 89793/di/ra
[LIVER CANCER OF LATE STAGE (31 CASES)
TREATED BY EXTERNAL APPLICATION OF
CHINESE DRUGS]. ZHU YINGLAI ET AL. journal of
practical tcm. 2001;17(2):36 (chi).
2216- gera: 89810/di/ra
[EXPERIMENTAL STUDY OF INHIBITORY EFFECT
OF KANGXIAN RECIPE ON TGF-ß1 INDUCED
HEPATOCYTE APOPTOSIS]. ZHENG LI-HUANG ET
AL. chinese journal of integrated and western medicine.
2001;21(1):37 (chi*).
2217- gera: 89862/di/ra
[CLINICAL OBSERVATION ON TREATMENT FOR
240 CASES OF CHRONIC HEPATITIS OF
SYNDROMELESS DIFFERENTIATION TYPE WITH
SELF-MADE WEN GAN TABLET]. WANG
HUAMENG. journal of tcm. 2001;42(1):28 (chi*).
In order to probe into change of syndrome types and the
necessity of treatment, 346 cases of chronic hepatitis of
syndromeless differentiation type were randomly divided into
two groups. 240 cases in the treatment group were treated
with Wen Gan Tablet and 106 cases in the control group
were treated with starch or did not receive any treatment.
Within 6 months, it was investigated whether the patient in
syndromeless differentiation type changed and the changed
syndrome types. Results showed that the syndrome type was
changed in 44 cases of the treatment group, and 62 cases in
the control group, accounting for 18. 33% and 58. 49%
respectively, with significant difference (P<0. 01). It is
indicated that intensive treatment can be used for chronic
hepatitis of syndromeless differentiation type to reduce attack
of chronic hepatitis.
2218- gera: 89922/di/ra
[STUDIES ON STANDARD FOR QUALITY CONTROL
OF BINGGANKANG GRANULE (A COMPOUND
HERBAL PREPARATION FOR TREATMENT OF
HEPATITIS C)]. PENG BO ET AL. chinese traditional
140
and herbal drugs. 2001;32(1):19 (chi*).
2219- gera: 90022/di/ra
[CLINICAL STUDY OF CHAIPING DECOCTION ON
GASTRIC MOTILITY AND ITS RELATIVITY OF
HEPATITIS PATIENTS]. PEI JUNQING ET AL. hebei
journal of tcm. 2001;23(1):5 (chi*).
2220- gera: 90026/di/ra
[REPORT OF PATIENTS WITH CHRONIC
HEPATITIS TREATED BY YUGAN DECOCTION].
CHEN DAOSHENG. hebei journal of tcm. 2001;23(1):15
(chi*).
2221- gera: 90607/di/ra
[EFFECTS OF SALVIANOLIC ACID-A ON
PROLIFERATION OF HSC]. LIU CHENG ET AL.
chinese journal of integrated traditional and western
medicine on digestion. 2001;9(1):15 (chi*).
2222- gera: 90609/di/ra
[THE STUDY ON INHIBITING EFFECT OF
FUZHENGHUAYUFANG ON HEPATOCARCINOMA
INDUCED BY DMN IN RAT]. JI GUANG ET AL. chinese
journal of integrated traditional and western medicine on
digestion. 2001;9(1):20 (chi*).
2223- gera: 90613/di/ra
[RELATIONSHIP BETWEEN ALCOHOLIC
HEPATOPATHY AND INSULIN RESISTANCE].
CHENG PENG ET AL. chinese journal of integrated
traditional and western medicine on digestion.
2001;9(1):30 (chi*).
2224- gera: 90615/di/ra
[CLINICAL STUDY ON TREATMENT OF FATTY
LIVER WITH JIANPI HUOXUE DECOCTION]. HE
DONGYI ET AL. chinese journal of integrated traditional
and western medicine on digestion. 2001;9(1):35 (chi*).
2225- gera: 90616/di/ra
[AN INVESTIGATION OF THE INFECTION
CONDITION IN I BLOOD RELATIONS AND
SPOUSES OF PATIENTS WITH HEPATITIS B]. HE
BINGFU. chinese journal of integrated traditional and
western medicine on digestion. 2001;9(1):38 (chi*).
2226- gera: 90689/di/ra
[48 CASES OF FATTY LIVER TREATED BY HEGAN
DECOCTION]. JIN QINGMING. hubei journal of tcm.
2001;23(1):26 (chi).
2227- gera: 90793/di/ra
[40 CASES OF CHRONIC HEPATITIS B WITH
HBEAG POSITIVE TYPE TREATED BY
QUDUFUGAN DECOCTION]. HU DA-QING ET AL.
liaoning journal of tcm. 2001;28(2):90 (chi*).
2228- gera: 91634/di/ra
[PATHOLOGY AND IMMUNOHISTOCHEMISTRY
RESEARCH ON EFFECTS OF FUZHENG-HUAYU
PRESCRIPTION ON HEPATOCYTE
PROLIFERATION OF CIRRHOSIS RATS]. JI GUANG
ET AL. chinese journal of basic medicine in tcm.
2001;7(2):29 (chi*).
2229- gera: 91653/di/ra
[THE TREATMENT OF INFANT LIVER CIRRHOSIS
WITH COMPREHENSIVE METHODS: 9 CASES
REPORTED]. LI YAN ET AL. acta chinese medicine and
gera 2011

pharmacology. 2001;29(1):7 (chi).
2230- gera: 91655/di/ra
[CLINICAL ANALYSIS ON TREATING ALCOHOLIC
HEPATITIS WITH GE-SHAO-JIU-GAN DECOCTION:
83 CASES REPORTED]. DONG QUANSHENG ET AL.
acta chinese medicine and pharmacology. 2001;29(1):9
(chi).
2231- gera: 91709/di/ra
[INHIBITION TO FIBROSIS OF LIVER AND
INFLUENCE TO ADRENAL CORTEX FUNCTION OF
RAT OF BINGGAN (HEPATITIS C) KANG]. PENG BO
ET AL. yunnan journal of tcm and materia medica.
2001;22(4):36 (chi*).
2232- gera: 91747/di/ra
[EXPERIENCE ON THE TREATMENT ON THE
CIRRHOSIS ASCITES DUE TO CIRRHOSIS]. LIU
FENG ET AL. guangming journal tcm. 2001;92(1):27
(chi).
2233- gera: 91748/di/ra
[A DISCUSSION ON THE TREATMENT ON
HEPATITIS B BY TRADITIONAL CHINESE
MEDICINE]. MA WUKAI. guangming journal tcm.
2001;92(1):30 (chi).
2234- gera: 91858/di/ra
[TREATMENT OF 80 CASES OF ASCITES DUE TO
CIRRHOSIS WITH YUSHUI POWDER AND
SHENGDANBA RUANGAN DECOCTION]. WANG KE-
XIAN ET AL. shandong journal of tcm. 2001;20(3):140
(chi).
2235- gera: 91863/di/ra
[CLINICAL OBSERVATION OF MANGAN ONE IN
TREATING VIRAL CHRONIC HEPATITIS B AND
HEPATITIS B CIRRHOSIS]. ZHANG ZHAOQI ET AL.
hebei journal of tcm. 2001;23(2):85 (chi*).
2236- gera: 91873/di/ra
[CLINICAL OBSERVATION ON ASCITES DUE TO
HEPATIC CANCER TREATED BY COMPOUND
DANSHEN INJECTION COMBINED WITH
DOPAMINE AND LASIX]. HUANG ZHIFEN ET AL.
chinese journal of integrated traditional and western
medicine on liver diseases. 2001;11(1):3 (chi*).
2237- gera: 91874/di/ra
[HEPATIC ARTERY INFUSION OF CINOBUFOTAIN
FOR TREATING ADVANCE HEPATOCELLULAR
CARCINOMA]. WANG CHANGJUN ET AL. chinese
journal of integrated traditional and western medicine on
liver diseases. 2001;11(1):5 (chi*).
2238- gera: 91875/di/ra
[CLINICAL VALUE OF DETECTING THE AFP AND
AFU IN THE PATIENT OF PRIMARY HEPATIC
CARCINOMA]. ZHANG HONGYU ET AL. chinese
journal of integrated traditional and western medicine on
liver diseases. 2001;11(1):8 (chi*).
2239- gera: 91877/di/ra
[CLINICAL STUDY ON THE RELATIONSHIP
BETWEEN BREAST FEEDING AND HBV
TRANSMISSION]. ZENG WENTING ET AL. chinese
journal of integrated traditional and western medicine on
liver diseases. 2001;11(1):13 (chi*).
141
2240- gera: 91879/di/ra
[INFLUENCE OF CHISHAOCHENGQI DECOCTION
ON APOPTOSIS OF ACUTE HEPATIC FAILURE IN
RATS]. WU QIKAI ET AL. chinese journal of integrated
traditional and western medicine on liver diseases.
2001;11(1):24 (chi*).
2241- gera: 91880/di/ra
[EXPERIMENTAL STUDY OF GANDAN SHUKANG
CAPSULE AGAINST IMMUNODAMAGED HEPATIC
FIBROSIS IN RATS]. ZHANG SHUWEN ET AL. chinese
journal of integrated traditional and western medicine on
liver diseases. 2001;11(1):27 (chi*).
2242- gera: 91881/di/ra
[THE EXPERIMENTAL RESEARCH OF THE
SUPPRESSION OF SHENTAO RUANGAN WAN ON
THE PROLIFERATION OF HUMAN HCC AND THE
IMPROVEMENT IN THE ANTICANCER ACTIVITY
OF LAK CELL]. SHI SHIDE ET AL. chinese journal of
integrated traditional and western medicine on liver
diseases. 2001;11(1):30 (chi*).
2243- gera: 91882/di/ra
[EFFECT OF CHITOSAN AND TRADITIONAL
CHINESE MEDICINES ON RATS FATTY LIVER].
JIANG LI ET AL. chinese journal of integrated traditional
and western medicine on liver diseases. 2001;11(1):33
(chi*).
2244- gera: 92015/di/ra
[THE PROTECTIVE AND THERAPEUTIC EFFECTS
OF CHITOSAN ON RATS FATTY LIVER]. JIANG LI
ET AL. chinese journal of marine drugs. 2001;20(1):28
(chi*).
2245- gera: 92203/di/ra
[PATHOGENESIS AND DIFFERENTIAL DIAGNOSIS
AND TREATMENT OF LIVER FIBROSIS]. XUE BO-
YU ET AL. journal of nanjing university tcm.
2001;17(2):76 (chi*).
In China the main cause of liver fibrosis is viral hepatitis,
especially hepatitis B, C and D. The etiology of the disease is
the invasion of damp-heat and deficiency of anti-pathogenic
factors. The key pathogenesis is accumulation of heat toxin
and damage to the Ever and spleen. The main method of
treatment should be cooling blood, removing blood stasis and
toxin, nourishing die liver and spleen, removing dampness,
etc. The disease can be differentiated into the following six
syndromes: syndrome of liver depression and deficiency of
die spleen, syndrome of damp - heat accumulation, syndrome
of stagnation of qi and blood, syndrome of accumulation of
heat toxin, syndrome of deficiency of qi and yin, and
syndrome of deficiency of yin in the Ever and kidney. The
syndrome of accumulation of heat toxin is the main
syndrome of liver fibrosis.
2246- gera: 92213/di/ra
[EXPERIMENTAL RESEARCH ON EFFECT OF
CHITOSAN IN TREATING HEPATIC ADIPOSE
INFILTRATION]. ZHANG SHAO-PING ET AL. journal
of nanjing university tcm. 2001;17(2):107 (chi*).
2247- gera: 92257/di/ra
[PRESENT SITUATIONS AND PROBLEMS OF NEW
TCD PHARMACEUTICS ON THE TREATMENT OF
CHRONIC LIVER DISEASES]. LI XUDONG. chinese
journal of information on tcm. 2001;8(2):8 (chi).
2248- gera: 92620/di/ra
gera 2011

[RECENT PROFILE CONCERNING THE PRIMARY
LIVER CANCER TREATED WITH TCM]. WANG LI-
LIN ET AL. journal of laoning college of traditional
chinese medicine. 2001;3(1):67 (chi).
2249- gera: 92683/di/ra
[EFFECT OF VARIOUS DRUGS AND THEIR
COMPATIBILITY OF STRENGTHENING HEALTHY
QI ON INDUCING SMMC-7721 CELL
DIFFERENTIATION]. ZHOU JIAN-FENG ET AL.
chinese journal of traditional medical science and
technology. 2001;8(2):75 (chi*).
Objective: To investigate the effect of various drugs for
strengthening healthy Qi and their compatibility on inducing
SMMC - 7721 hepatocarcinoma cell differentiation and the
mechanism. Methods: some herbs for strengthening healthy
Qi, which were often used to treat live cancer in clinic, such
as qi tonics, yang tories, tonics and yin tonics were selected
and divided into four complex groups according to the Yin -
Yang principle, then decocted, administrated the rats via
gavage and separated die phannacal sera for using on SMMC
- 7721 cells in vitro. Normal sera of rats and Retinal acid as
controls. HE stain method was applied to observe cell
morphosis; RIA, Albumin, measured AFP and cAMP by
ELISA. Results: Albumin secretion and cAMP of the cell
increased, AFP secretion decreased in each compatibility
group and the ratio of the cell nucleus to plasma decreased.
2250- gera: 92857/di/ra
[EXPERIMENTAL STUDY OF RESISTING FIBROSIS
OF LIVER WITH ACUPOINT INJECTION OF RADIX
SALVIAE MILTIORRHIZAE]. ZHOU HAIWANG ET
AL. xinjiang journal of tcm. 2001;19(1):9 (chi).
2251- gera: 92869/di/ra
[CLINICAL STUDY ON 23 CASES OF PORTAL
HYPERTENSION DUE TO CIRRHOSIS OF LIVER
AFTER HEPATITIS B TREATED WITH SHU GAN
DECOCTION]. SHANG JIANZHONG ET AL. journal of
tcm. 2001;42(3):167 (chi).
2252- gera: 92996/di/ra
[DEVELOPMENT OF RESEARCHING INTO
RESISTING THE FIBROSIS OF LIVER WITH TCM].
LI PING. hubei journal of tcm. 2001;23(3):52 (chi).
2253- gera: 93162/di/ra
[RESTRAINED ACTION OF HERBA ERGERONIS
LIQUID TO EXPERIMENTAL LIVER FIBROSIS
COLLAGEN SYNTHESIS]. BAI JUN. study journal of
tcm. 2001;19(1):79 (chi).
2254- gera: 93459/di/ra
[A CLINICAL OBSERVATION ON THE TREATMENT
OF FATTY LIVER BY TCM COMBINED WITH
WESTERN MEDICINE: A REPORT OF 44 CASES].
ZHAO XILIAN ET AL. new journal of tcm. 2001;33(3):42
(chi*).
2255- gera: 93462/di/ra
[TREATMENT OF STAGES II AND III OF PRIMARY
HEPATOCARCINOMA BY GAN HUO XI COMBINED
WITH TAE: A CLINICAL OBSERVATION OF 23
CASES]. SONG JIE ET AL. new journal of tcm.
2001;33(3):53 (chi*).
2256- gera: 93493/di/ra
[A PRELIMINARY PHARMACODYNAMIC STUDY
ON THE PREPARATION OF ARTIFICIAL FEL
SERPENTIS AND BULBUS FRITILIARIAE
142
CIRRHOSAE]. HU XIA-MIN ET AL. traditional chinese
drug research and clinical pharmacology. 2001;12(2):95
(chi*).
2257- gera: 93521/di/ra
[CLINICAL OBSERVATION ON 164 CASES OF
FATTY LIVER TREATED BY QUZHI DECOCTION].
FENG HUIMING ET AL. hunan journal of tcm.
2001;17(2):13 (chi).
2258- gera: 93522/di/ra
[EFFECTIVE OBSERVATION ON 58 CASES OF
ACUTE VIRAL HEPATITIS TREATED BY JIGAN
DECOCTION]. CHEN LANLING. hunan journal of tcm.
2001;17(2):15 (chi).
2259- gera: 93578/di/ra
[TREATING 67 CASES OF ASCITES DUE TO
CIRRHOSIS WITH INTEGRATION OF CHINESE
AND WESTERN MEDICINES]. XU JI-WEN. shandong
journal of tcm. 2001;20(4):228 (chi).
2260- gera: 93579/di/ra
[TREATMENT OF CIRRHOTIC ASCITES BY
THERAPIES OF DESPERSION,ELIMINATION AND
INVIGORATION]. CHEN NINGSHENG ET AL. new
journal of tcm. 2001;33(4):3 (chi*).
Cirrhotic ascites is attributed to the category of " tympanites"
in TCM. Its etiology and pathogenesis are complicated and
its manifestations are various. Its treatment are multiple and
can be summarized as dispersion, elimination and
invigoration. Dispersion aims at the liver, including qi and
blood, activating diuresis and distension relieving.
Elimination airm at the gastrointestinal, including fluid
purging, blood - stasis removing and mass softening.
Invigoration aims at the spleen and kidney, including qi
benefiting, spleen strengthening, qi and blood tonifying,
spleen and kidney warming, and liver and kidney nourishing.
However, these three methods should not be applied
individually for a long time, and usually used successively or
simultaneously. Moreover, elimination is advisable for excess
syndrome and supplemented by invigoration, and
invigoration is applicable to
2261- gera: 93694/di/ra
[RESEARCH ON THE TREATMENT OF HEPATICAL
FIBROSIS IN HEPATITIS B WITH JIASIWEINI
POWDER]. SUN SHOU-CAI ET AL. journal of shaanxi
college of tcm. 2001;24(1):46 (chi).
2262- gera: 93721/di/ra
[COMPARISON STUDY ON ANTI-FIBROSIS EFFECT
OF HEPATIZATION OF CARAPAX TRIONYCIS
FROM TWO DIFFERENT METHODS MAKE]. LI
XINMEI ET AL. primary journal of chinese materia
medica. 2001;15(2):19 (chi*).
2263- gera: 93739/di/ra
[58 CASES ABOUT TREATING CHRONIC
HEPATITIS B WITH CAPSULE OF
XIONGDANYIGAN]. LIANG XUIZHI ET AL.
heilongjiang journal of tcm. 2001;2:44 (chi).
2264- gera: 93851/di/ra
[PRELIMINARY EXPLORATION ON THE
UNDERSTANDING AND TREATMENT OF TCM FOR
FIBROSIS OF LIVER]. GENG LUFANG ET AL.
research of tcm. 2001;17(2):61 (chi).
2265- gera: 93922/di/ra
gera 2011

[INHIBITION AND MECHANISM STUDY ON DRUG
SERUM OF KANGXIANLING EFFECT ON HUMAN
HEPATOCARCINOMA CELL IN VITRO]. ZHU MEIJU
ET AL. chinese journal of information on tcm.
2001;8(3):23 (chi).
2266- gera: 93932/di/ra
[CLINICAL STUDY OF COMBINING INTRA-
PERITONEAL THERAPY AND TCM FOR
CARCINOMATOUS ASCITES]. WANG WEIPING ET
AL. hebei journal of tcm. 2001;23(3):167 (chi*).
2267- gera: 93939/di/ra
[CLINICAL EFFECT OF WESTERN MEDICINE
INTEGRATED WITH TRADITIONAL CHINESE
MEDICINE ON LIVER CIRRHOTIC ASCITES]. JIANG
LIANZHANG ET AL. hebei journal of tcm.
2001;23(3):214 (chi*).
2268- gera: 94301/di/ra
[SELECTION OF OPTIMAL INDICES
COMBINATION FOR DIAGNOSIS OF LIVER
CANCER]. HE QINGSI ET AL. chinese journal of surgery
of integrated traditional and western medicine.
2001;7(2):73 (chi*).
2269- gera: 94309/di/ra
[TREATMENT OF SEVERE CHRONIC HEPATITIS B
ACCORDING TO THE THEORY OF VITAL QI
WHICH COME BACK AND CONQUER THE
PATHOGENIC FACTOR]. JIA JIN-PENG ET AL. shanxi
journal of tcm. 2001;17(2):7 (chi*).
The pathogenesis of severe chronic hepatitis B mostly
includes a struggle between the vital qi and pathogenic factor,
body resistance weekend while pathogenic factors prevailing.
The major treatment should bc eliminating the pathogenic
factor, that is clearing away heat and toxic materials,
promoting blood circulation and cooling blood. The treatment
supporting the healthy energy also should bc taken, it
includes invigorating the spleen and kidney and sending up
the lucid yang. Then the Quxie Fuzheng Tuodu Decoction
was made. Mild reinforcing should bc taken and potent tonic
should bc avoided, so the vital qi was expected to come back
and conquer the pathogenic factor. The point of improving
clinic treatment is mastery of commonness and individuality.
2270- gera: 94325/di/ra
[30 CASES OF ASCITES DUE TO CIRRHOSIS
TREATED WITH RUAN GAN QING GU
DECOCTION]. QIN SIMING ET AL. guangxi journal of
tcm. 2001;24(2):23 (chi).
2271- gera: 94341/di/ra
[EXPERIENCE ON TREATMENT OF CIRRHOSIS
AFTER HEPATITIS B BASED ON
DIFFERENTIATION OF SYNDROMES AT
DIFFERENT STAGE]. JIANG SEN. journal of tcm.
2001;42(2):78 (chi).
2272- gera: 94346/di/ra
[EFFECTS OF GAN DOU PIAN ON
ULTRASONOGRAM AND FUNCTIONS OF LIVER IN
34 CASES OF HEPATOLENTICULAR
DEGENERATION]. HONG MINGFAN ET AL. journal of
tcm. 2001;42(2):93 (chi*).
2273- gera: 94407/di/ra
[OBSERVATION ON THE EFFECT OF FRESH JUICE
OF REHMANNIA ROOT TO THROMBOGEN TIME
AND ACCOMPANIED BLEEDING IN SEVERE TYPE
143
OF HEPATITIS]. JIA JIANWEI ET AL. tianjin journal of
tcm. 2001;18(2):4 (chi).
2274- gera: 94415/di/ra
[INFLUENCE OF MOUNTING ON POINTS WITH
KANGAI FUSHUI CREAM TO THE LEVEL OF SIL-
2R OF MOUSE ELLIS ASCITES CARCINOMA]. TIAN
JIANHUI ET AL. journal of external therapy of tcm.
2001;10(2):6 (chi).
2275- gera: 94488/di/ra
[CLINICAL EXPERIENCE OF THE TREATMENT OF
HEPATOCIRRHOSIS FOLLOWING HEPATITIS]. MU
QI-JIN ET AL. shanghai journal of tcm. 2001;35(4):21
(chi*).
Inh the treatment of hepatocirrhosis following hepatitis, it is
argued that its pathogenesis is health-qi deficiency, heat
toxin, blood stasis and qi-disorder, and the treatment
emphasis is to invigorate qi-blood, dispel toxin, melt blood-
stasis, and regulate oneself cautiously.
2276- gera: 94502/di/ra
[CLINICAL STUDY ON LIVER CANCER TREATED
BY CHINESE MEDICINE]. SONG DONG-JUAN.
shanghai journal of tcm. 2001;35(4):47 (chi*).
This paper presents the advances of the clinical treatment of
liver cancer by Chinese medicine in recent years. Previous
literature revealed that the treatment of liver cancer focused
on the whole body and local area, meanwhile, interventional
treatment by Chinese medicine is the hot spot in the future.
2277- gera: 94527/di/ra
[A CONTROLLED CLINICAL STUDY BETWEEN
HEPATIC ARTERIAL INFUSION WITH EMBOLIZED
CURCUMA AROMATIC OIL AND CHEMICAL
DRUGS IN TREATING PRIMARY LIVER CANCER].
CHENG JIAN-HUA ET AL. chinese journal of integrated
traditional and western medicine. 2001;21(3):165 (chi*).
2278- gera: 94528/di/ra
[CLINICAL STUDY ON TREATMENT OF MIDDLE-
ADVANCED STAGE LIVER CANCER BY
COMBINED TREATMENT OF HEPATIC ARTERY
CHEMOEMBOLIZATION WITH GAN'AI NO. I AND
NO. II]. SHAO ZHONG-XING ET AL. chinese journal of
integrated traditional and western medicine.
2001;21(3):168 (chi*).
2279- gera: 94580/di/ra
[CLINICAL OBSERVATION ON 30 CASES OF FATTY
LIVER TREATED WITH SHU GAN QU ZHI
PRESCRIPTION]. CHE NIANCONG. journal of tcm.
2001;42(4):228 (chi).
2280- gera: 94586/di/ra
[EFFECTS OF AMPELOPSIS BREVIPEDUNCULATA
TRAUTV ON FAS ANTIGEN EXPRESSION IN LIVER
TISSUE OF MICC LIVER INJURY MODELS
INDUCED BY CONCANAVALIN A (CONA)]. ZHANG
CHIZHI ET AL. chinese journal of integrated traditional
and western medicine on digestion. 2001;9(2):67 (chi*).
2281- gera: 94594/di/ra
[INHIBITORY EFFECT OF KADSURAE COCCINEA
ON EXPERIMENTAL HEPATIC FIBROSIS IN RATS].
QU KEYI ET AL. chinese journal of integrated traditional
and western medicine on digestion. 2001;9(2):86 (chi*).
2282- gera: 94597/di/ra
[CLINICAL STUDY ON THE HEJIE DECOCTION IN
gera 2011

KEEPING HBEAG NEGATIVE CONVERSION
STATES OF CHRONIC HEPATITIS B PATIENTS
AFTER HBEAG NEGATIVE CONVERSION]. ZHANG
SHIJUN ET AL. chinese journal of integrated traditional
and western medicine on digestion. 2001;9(2):92 (chi*).
2283- gera: 94599/di/ra
[CLINICAL STUDY ON COMBINED TREATMENT
OF TCM WITH POST HEPATOCELLULAR
CARCINOMA LP-TAE]. LI HAILIANG ET AL. chinese
journal of integrated traditional and western medicine on
digestion. 2001;9(2):97 (chi*).
2284- gera: 94635/di/ra
[CLINICAL INVESTIGATION ON SIX-INGREDIENT
REHMANUIA DECOCTION FOR AUTOIMMUNE
HEPATITIS]. CHEN JING. chinese traditional patent
medicine. 2001;23(3):188 (chi*).
2285- gera: 94724/di/ra
[ADVANCEMENT IN MODERN RESEARCH ON
METHOD OF CLEARING AWAY HEAT AND
REMOVING TOXIN AND ITS APPLICATION IN
TREATMENT OF LIVER CANCER]. LU. HENGXIN ET
AL. jiangsu journal of tcm. 2001;22(4):43 (chi).
2286- gera: 94763/di/ra
STUDIO CLINICO SUL TRATTAMENTO
DELL'EPATOPATIA ALCOLICA CON QING GAN
JIE JIU YIN. CUI MINLU. rivista italiana di medicina
tradizionale cinese. 2001;83(1):39-41 (ita*).
Traduction italienne de réf gera: [71162]. Recently, the
incidence of alcoholic hepatopathy is rising year by year
along with the increase of alcoholics. This paper reports the
application of Qing Gan Jie Jiu Yin (a decoction for
removing heat from liver and relieving alcoholism) as the
basic formula in 42 cases of alcoholic hepatopathy. Another
15 cases were patients treated by western drugs as the
controls. The following are details of the report.
2287- gera: 94948/di/ra
[VIRUS HEPATITIS B' TREATMENT OF TCM]. XIA
YONG-LIANG ET AL. liaoning journal of tcm.
2001;28(5):260 (chi*).
Prof Li has rich clinical experience in the Virus Hepatitis B'
treatment. He considers that tonifying the liver blood and
smoothing the liver function are the general rules of remedy
Hepatitis B. Diagnosis and treatment are based on an overall
analysis of the illness and the patient's condition. The
prescription stems from the remedy method. Being adjustable
to medicine adapts patients to syndrome, adopting flexible
measures, achieving significant
2288- gera: 95017/di/ra
EFFECT OF GAN FU LE ON 24 CASES OF PRIMARY
HEPATOCARCINOMA. ZHAO HONGTAO ET AL.
journal of tcm. 2001;21(2):134-5 (eng).
2289- gera: 95020/di/ra
PRESENT SITUATION IN PREVENTING AND
TREATING LIVER FIBROSIS WITH TCM DRUGS.
DU BIN ET AL. journal of tcm. 2001;21(2):147-52 (eng).
2290- gera: 95058/di/ra
[CLINICAL STUDY ON 33 CASES OF WILSON'S
DISEASE TREATED WITH INTEGRATION OF
CHINESE AND WESTERN MEDICINE]. CUI GUI-
XIANG ET AL. shandong journal of tcm. 2001;20(5):353
(chi).
144
2291- gera: 95355/di/ra
[OBSERVATION ON TREATMENT OF CHRONIC
HEPATITIS B WITH SELF-MADE CHINESE
MEDICINAL PRESCRIPTION IN COMBINATION
WITH QIANG LI NING IN 52 CASES]. LIN LI ET AL.
journal de mtc and chinese materia medica of jilin.
2001;21(3):52 (chi).
2292- gera: 95397/di/ra
[SHI KUIJUN'S EXPERIENCE OF TREATING
ASCITES DUE TO CIRRHOSIS]. WU MEIQIAN.
zhejiang journal of tcm. 2001;36(5):189 (chi).
2293- gera: 95420/di/ra
[STUDY ON CORRELATION BETWEEN
DIFFERENTIATION SYNDROMES AND IMMUNITY
INDEX IN PRIMARY LIVER CARCINOMA]. WANG
RONG-PING ET AL. fujian journal of tcm. 2001;32(2):4
(chi).
2294- gera: 95435/di/ra
[OBSERVATION ON SUBACUTE FATAL HEPATITIS
(30 CASES) TREATED BY TRADITIONAL CHINESE
MEDICINE INTEGRATED WITH WESTERN
MEDICINE]. ZHU AIJUN ET AL. journal of pratical
traditional chinese medicine. 2001;5(17):26 (chi).
2295- gera: 95457/di/ra
[EFFECTIVE OBSERVATION ON 23 CASES OF
CIRRHOSIS COMBINED TREATED BY CHINESE
PATENT DRUGS]. OU ZHONGBO. hunan journal of
traditional chinese medicine. 2001;17(3):12 (chi).
2296- gera: 95515/di/ra
[NEW EXPLANATION ABOUT TREATING
CHRONIC HEPATITIS B FROM YIN - DEFICIENCY
OF THE KIDNEY]. WU CHENG. study journal of
traditional chinese medicine. 2001;19(3):223 (chi).
2297- gera: 95522/di/ra
[OUTLINES OF ACADEMIC THOUGHT OF
TREATMENT OF HEPATOPATHY BY PROF LU TIE-
JUN]. JIA GUI-ZHI ET AL. academic periodical of
changchun college of t c m. 2001;17(2):8 (chi).
2298- gera: 95526/di/ra
[TREATMENT OF CHRONIC VIRAL HEPATITIS B
WITH MODIFIED YIGUANJIAN IN 100 CASES].
ZHOU JIN-GANG. academic periodical of changchun
college of t c m. 2001;17(2):24 (chi).
2299- gera: 95531/di/ra
[GENERAL SITUATION OF LABORATORY
RESEARCH ON ANTIHEPATIC FIBROSIS]. ZHANG
JING-YU ET AL. academic periodical of changchun
college of t c m. 2001;17(2):60 (chi).
2300- gera: 95655/di/ra
[OBSERVATION OF COMBINATION OF GANSHI
DECOCTION AND FUFANG DANSHEN INJECTION
ON LIVER CIRRHOTIC ASCITES]. YU CHMEN ET
AL. hebei journal of tcm. 2001;23(6):421 (chi).
2301- gera: 95657/di/ra
[OBSERVATION ON CHRONICAL HEPATITIS B (30
CASES) TREATED BY MODIFIED MINOR
DECOCTION OF BUPLEURUM AND RED SAGE
INJECTION]. MIAO WEIFENG ET AL. journal of
practical tcm. 2001;17(6):3 (chi*).
gera 2011

2302- gera: 95821/di/ra
[CHANGES OF SDHASE AND ATPASE IN
EXPERIMENTAL MODEL RATS WITH FATTY
LIVER AND THEIR BEING INTERFERED BY
GANZHIXIAO FORMULA (GZHXF)]. HE DONGYI ET
AL. chinese journal of integrated traditional and western
medicine on digestion. 2001;9(3):133 (chi*).
2303- gera: 95849/di/ra
[THE EFFECT OF AMYLOSE OF LOACH ON
PROTECTING CHEMICAL LIVER INJURY]. QIN
CHUANGUANG ET AL. acta chinese medicine and
pharmacology. 2001;29(4):31 (chi*).
2304- gera: 95884/di/ra
[TREATMENT OF 34 CASES OF CIRRHOSIS WITH
ASCITES BY FLUID-PURGING THERAPY]. CAI YALI
ET AL. shaanxi journal of traditional chinese medicine.
2001;22(7):385 (chi).
2305- gera: 95885/di/ra
[TREATMENT OF 45 CASES OF CIRRHOSIS WITH
ASCITES BY JIANPI LISHUI THERAPY]. LUO QIANG
ET AL. shaanxi journal of traditional chinese medicine.
2001;22(7):387 (chi).
2306- gera: 95944/di/ra
[TREATMENT OF HYPERSPLENISM DUE TO
CIRRHOSIS BY "LIVER-SOFTENING AND SPLEEN-
NOURISHING DECOCTION"]. LIU YAN ZHANG ET
AL. shanghai journal of tcm. 2001;35(7):22 (chi*).
2307- gera: 95946/di/ra
[TREATMENT OF ASCITES DUE TO CIRRHOSIS BY
"SPLEEN-NOURISHING,LIVER-SOFTENING AND
WATER- REMOVING DECOCTION" IN 108 CASES].
JI KUN6MING ET AL. shanghai journal of tcm.
2001;35(7):25 (chi*).
2308- gera: 95947/di/ra
[CLINICAL OBSERVATION OF "GANFUKANG
PILL" IN TREATING CHRONIC HEPATITIS B]. LOU
GUO-QIANG. shanghai journal of tcm. 2001;35(7):26
(chi).
2309- gera: 95987/di/ra
[TREATMENT OF 48 CASES OF CHRONIC
HEPATITIS B BY SOOTHING LIVER AND
INVIGORATING SPLEEN]. LU JUN. jiangsu journal of
tcm. 2001;22(10):27 (chi).
2310- gera: 95993/di/ra
[ADVANCEMENT IN RESEARCH AND TREATMENT
OF HEPATIC ADIPOSE INFILTRATION]. SHI
YAXIANG. jiangsu journal of tcm. 2001;22(10):51 (chi).
2311- gera: 96066/di/ra
[SERAPHARMALOCOGICAL EFFECT OF
KANGXIAN RUANGAN CHONGJI ON EXPRESSION
OF TYPE I PROCELLAGEN AND TRANSFORMING
GROWTH FACTOR B1 MRNA IN HEPATIC
STELLATE CELLS]. YANG LING, ZHU QING-JING,
ZHANG CHI-ZHI. chinese journal of basic medicine in
traditional chinese medicine. 2001;7(8):38 (chi).
2312- gera: 96070/di/ra
[OBSERVATION AND MORPHOMETRY OF
HEPATOCYTES ULTRASTRUCTURE IN MICE
PATTERN BETWEEN HEAT OF EXCESS TYPE AND
FEVER OF DEFICIENCY TYPE]. XU ZHI-WEI, CHEN
145
QUN, LIU YA-MEI, ET AL. chinese journal of basic
medicine in traditional chinese medicine. 2001;7(8):47
(chi).
2313- gera: 96077/di/ra
[TREATMENT ON SEVERE HEPATITIS BY TCM].
KANG JUN-JIE, KANG SU-QIONG. chinese journal of
basic medicine in traditional chinese medicine.
2001;7(8):64 (chi).
2314- gera: 96083/di/ra
[LUO KECONG'S EXPERIENCE ON TREATING
CIRRHOSIS HYDROPERITONEURN]. XIANG NAN.
journal of guiyang college of traditional chinese medicine.
2001;23(3):8 (chi).
2315- gera: 96084/di/ra
[WU ZHENSHI'S EXPERIENCE ON TREATING
VIRAL HEPATITIS]. WU GUOCHUN. journal of
guiyang college of traditional chinese medicine.
2001;23(3):9 (chi).
2316- gera: 96087/di/ra
[CLINICAL OBSERVATION ON CHRONIC
SUPERFICIAL GASTRITIS TREATED BY WEI FU
CHUN TABLET]. LI YAMIN ET AL. journal of guiyang
college of traditional chinese medicine. 2001;23(3):13
(chi).
2317- gera: 96095/di/ra
[ COMMON COMPLICATION OF CHRONIC
HEPATITIS B TREATED BY TCM]. ZHOU
DAOHONG. journal of guiyang college of traditional
chinese medicine. 2001;23(3):45 (chi).
2318- gera: 96102/di/ra
[63 CASES OF ALCOHOLIC FATTY LIVER
TREATED BY " LOWERING BLOOD - LIPID ARID
PROTECTING LIVER DECOCTION]. LI HUA ,
ZHANG WEI, ZENG BIN-FANG. xinjiang journal of
traditional chinese medicine. 2001;19(3):22 (chi).
2319- gera: 96109/di/ra
[ TREATING 42 CASES OF LATE LIVER CANCER
WITH FUZHENG YILIU DECOCTION]. FU LIQI.
zhejiang journal of traditional chinese medicine.
2001;36(9):375 (chi).
2320- gera: 96135/di/ra
[ CLINICAL OBSERVATION ON 64 CASES OF
HEPATIC GASTROINTESTINAL INSUFFICIENCY
TREATED ADJUVANTLY WITH BAO JI PING
DECOCTION]. SHI ZHONGSHUN. journal of traditional
chinese medicine. 2001;42(8):474 (eng).
2321- gera: 96140/di/ra
[ STUDY ON RELATION OF TCM SYNDROME
TYPES OF PRIMARY LIVER CANCER WITH
RELATIVE OBJECTIVE INDEXES]. LIN LIZHU, LAN
SHAOQING. journal of traditional chinese medicine.
2001;42(8):486 (eng*).
Relation of different TCM syndrome types of primary liver
cancer with some relative objective indexes, including a
fetoprotein (AFP), alkaline phosphatase (AKP), 7-
glutamyltranspeptidase (GGT), L - lactic dehydrogenase
(LDH), aspartate aminotransferase (AST), alanine
aminotransferase (ALT), albumin (ALB), globulin (GLO),
A/G, total bilirubin (TB), indexes of hepatic reserve (ICG),
prothrombin time (PT), natural killer (NK), lymphocyte
transformation rate (LBT) and T - lymphocye subgroups,
gera 2011

were analysed for probing into objective indexes of diagnosis
in TCM syndrome typing. Results indicated that there were
significant differences in AST, ALB, TB, PT, ICG, NK, CD4
among different syndrome types, and relative indexes for
syndrome typing of liver cancer are ALB,
2322- gera: 96161/di/ra
[CLINICAL OBSERVATION ON CHRONIC P-
HEPATITIS TREATED BY GELATINOUS YEXIAZHU
CAPSULE]. ZENG ZHENDONG WEI JINYU LI YAN.
inner mongol journal of traditional chinese medicine.
2001; 20(3):5 (chi).
2323- gera: 96166/di/ra
[CEA COMPARATIVE STUDY ON EFFICACY OF
QINGGAN GRANULE (;*FF;KPPJ) AND BUSHEN
GRANULE (*'N;13 ~OFL IN TREATING CHRONIC
HEPATITIS C*]. REN JIN-YU, WANG LING-TAI, LEI
CHENG-DUO, ET AL. chinese journal of integrated
traditional and western medicine. 2001;21(9):645 (chi*).
2324- gera: 96167/di/ra
[CLINICAL AND EXPERIMENTAL STUDY OF
SHUANGCAO TUIHUANG GRANULE-L 1 IN
TREATING SEVERE JAUNDICE OF ACUTE
ICTEROHEPATITIS]. LIAN YUE-XIANG, LONG
XIAO-YING, WU WAN-FEN, ET AL. chinese journal of
integrated traditional and western medicine.
2001;21(9):649 (chi*).
2325- gera: 96168/di/ra
[RELATIONSHIP BETWEEN LIVER FIBROSIS
CRITERIA AND SYNDROME-TYPE OF TCM IN
PATIENTS WITH NON- ALCOHOLIC FATTY
LIVER*]. DENG YIN-QUAN, FAN XIAO-FEN. chinese
journal of integrated traditional and western medicine.
2001;21(9):652 (chi*).
To explore the relationship between the liver fibrosis criteria
and TCM Syndrome type in the patients suffering from non-
alcoholic fatty liver. Methods : Seventy-nine patients with
non-alcoholic fatty liver diagnosed by B ultrasonography
were classified by TCM Syndrome Differentiation and their
liver fibrosis criteria was determined and compared with
those of the healthy subjects as control. Results : Levels of
procollagen III (PC III ) I hyaluronic acid (HA), collagen IV
(C IV) and laminin (LN) in the fatty liver group were
significantly higher than those in the control group (P < 0. 05,
P < 0. 0 1). In respect to the TCM Syndrome-types, PC III,
CIV and LN in patients of Phlegm-stasis combined type were
significantly higher than those in patients of other two
Syndrome-types (P < 0 05, P < 0. 01 ), while HA was
insignificantly different (P > 0. 05). Conclusion : There was
trend of liver fibrosis in fatty liver patients. It was indicated
that the Phlegm-stasis combined Syndrome-type possibly was
the main TCM
2326- gera: 96176/di/ra
[STUDY OF CHINESE HERBAL MEDICINE IN
TREATING ASCITES AND THEIR MECHANISM IN
REGULATING LYMPHATIC STOMATA]. WU YU, LL
JI-CHENG, MAO LIAN-GEN, ET AL. chinese journal of
integrated traditional and western medicine.
2001;21(9):677 (chi*).
2327- gera: 96178/di/ra
[EXPERIMENTAL STUDY ON XIAOLIU PINGYI
MIXTURE WITH MEDICATED SERUM IN
INDUCING APOPTOSIS OF HUMAN
HEPATOCELLULAR CARCINOMA CELL LINE H-
7402]. LI XIU-RONG, ZHANG DAN, QI YUAN-FU, ET
146
AL. chinese journal of integrated traditional and western
medicine. 2001;21(9):684 (chi*).
2328- gera: 96186/di/ra
[EXAMPLES OF YIN CHANGJIAN'S EXPERIENCE
IN TREATMENT OF HEPATIC DISEASES]. ZHANG
YUBO, WANG MIN, HU ZHENGXUE. journal of
traditional chinese medicine. 2001; 42(9):522 (eng).
2329- gera: 96206/di/ra
[TREATMENT OF HYPERGAMMAGLOBULINEMIA
OF CHRONIC HEPATITIS BY "JIAWEI SANJIA" : A
REPORT OF 48 CASES]. ZHANG ZHI-YIN. shanghai
journal of traditional chinese medicine. 2001; 35(9):18
(chi).
2330- gera: 96252/di/ra
[A SHORT-TERM CLINICAL OBSERVATION ON
LIVER FIBROSIS TREATED BY DIAMMONIUM
GLYCYRRHIZINATE]. WANG GUIRONG, ZHANG
HONGXIA, ZHANG RUILING. chinese journal of
integrated traditional and western medicine on digestion.
2001; 9(4):216 (chi*).
2331- gera: 96253/di/ra
[INFLUENCES OF CHINESE HERB RHIZOMA
ALISMATIS ON HEMODYNAMICS OF PORTAL
HYPERTENSION IN LIVER CIRRHOTIC RATS].
FENG ZHIJIE, YAO XIXIAN. chinese journal of
integrated traditional and western medicine on digestion.
2001; 9(4):218 (chi*).
2332- gera: 96256/di/ra
[EFFECT OF ZINC INCREASE AND IRON
REDUCTION THERAPY ON CHINESE MEDICINE'S
ACTION OF ANTI- DHBV]. XIA JINYU, LI
TIANWANG, ZHU XIAOHONG, ET AL. chinese journal
of integrated traditional and western medicine on
digestion. 2001; 9(4):225 (chi*).
2333- gera: 96258/di/ra
[CLINICAL STUDY OF CONSENSUS INTERFERON
COMBINED WITH RIBAVIRIN IN THE
TREATMENT OF CHRONIC HEPATITIS C]. LIU QIN,
CUIJIANG JUN, WANG SONG, ET AL. chinese journal of
integrated traditional and western medicine on digestion.
2001; 9(4):230 (chi*).
2334- gera: 96276/di/ra
[SURGICAL TREATMENT FOR HEPATIC
METASTASES FROM LARGE BOWEL
CARCINOMA]. CHEN JUNXIONG, REN DONGLIN ,
FAN XIAOHUA , ET AL. chinese journal of surgery of
integrated traditional chinese and western medicine.
2001;7(4):216 (chi*).
2335- gera: 96281/di/ra
[EFFECT OF TRIPTERYGIUM WIFORDDI HOOK.
F(TWHF) ON ORTHOTOPIC LIVER
TRANSPLANTATION (OLT) IN RATS]. TIAN WEIJUN
, WANG PENGZHI, ZHU LIWEI, ET AL. chinese journal
of surgery of integrated traditional chinese and western
medicine. 2001;7(4):257 (chi*).
2336- gera: 96342/di/ra
[EXPERIMENTAL STUDY ON EUPOLYPHAGA SEU
STELEOPHAGA TREATING HEPATIC FIBROSIS].
XI ZHUTING ET AL. research of tcm. 2001;17(4):38
(chi*).
gera 2011

2337- gera: 96356/di/ra
[CLINICAL OBSERVATION OF "LIVER-
SOFTENING GRANULE" IN FIGHTING HEPATIC
FIBROSIS]. WANG LING-TAI CHEN JIAN-JIE ZHANG
BIN, ET AL. shanghai journal of traditional chinese
medicine. 2001;35(10):7 (chi*).
2338- gera: 96363/di/ra
[CLINICAL OBSERVATION OF "BLOOD-
ACTIVATING AND LIVER- SOFTENING
DECOCTION" IN TREATING CIRRHOSIS FROM
HEPATITIS]. XING LIAN-JUN JI GUANG ZHANG WEI,
ET AL. shanghai journal of traditional chinese medicine.
2001;35(10):21 (chi*).
2339- gera: 96381/di/ra
[THE CLINICAL OBSERVATION OF 100 PATIENTS
OF CHRONIC VIRAL HEPATITIS B FREATED BY
TRADITIONAL CHINESE MEDICINE]. SUN
JIUGUANG XU HONGWEI. hebei journal of traditional
chinese medicine. 2001;23(7):488 (chi*).
2340- gera: 96393/di/ra
[TREATING HEPATITIS B BY TREATING LUNG].
HU XILIU, LI JIQIANG , CHANG XIUFENG. zhejiang
journal of traditional chinese medicine , (monthly).
2001;36(8):334 (chi).
2341- gera: 96394/di/ra
[TREATING 120 CASES OF EARLY OR
INTERMEDIATE HEPATOCIRRHOSIS WITH
JIAWEI XIA YUXUE DECOCTION]. DONG
CHANGJIANG, CHEN XIANGRONG. zhejiang journal of
traditional chinese medicine , (monthly). 2001;36(8):339
(chi).
2342- gera: 96441/di/ra
[THE PROTECTIVE ACTION OF DRUGS WITH THE
FUNCTIONS OF REINFORCING KIDNEY AND
PROMOTING BLOOD FLOW,DRUGS WITH
PURGATIVE FUNCTION AND DRUGS WITH THE
FUNCTIONS OF INDUCING RESUSCITATION AND
PROMOTING BL. LI JIAN-SHENG, LL JIAN-GUO,
GAO AI-SHE, ET AL. henan traditional chinese medicine.
2001;21(4):14 (chi*).
2343- gera: 96473/di/ra
[PROF TANG CHENLONG'S EXPERIENCE ON THE
SYNDROME DIFFERENTIATION AND TREATMENT
OF PRIMARY HEPATOCARCINOMA]. LI YONGJIAN,
SANG JIUHUA, DI RUOHONG, ET AL. new journal of
tcm. 2001;33(8):9 (chi*).
Prof. Tang' s experience and characterics for the treatment of
primary hepatocarcinoma was presented. Generally he
preferred the herbs of mild nature, applied purgation and
ramification slowly, supported the healthy qi and eliminated
pathogenic factor simultaneously with emphasis on the
former. In determining the severity of the disease, he paid
attention to the tongue inspection. Effective case records are
also attached.
2344- gera: 96521/di/ra
[CLINICAL STUDY ON THE PROTECTION AND
TREATMENT OF HEPATIC FIBROSIS WITH
RUANGAN GRANDULE]. LI WEI-QING, ZHOU DA-
QIAO, PENG LI-SHENG, ET AL. shanxi journal of
traditional chinese medicine. 2001;17(4):40 (chi*).
2345- gera: 96636/di/ra
[STUDY ON CLINICAL PRESENTATION AND
147
PATHOLOGICAL FEATURES OF DEFICIENCY OF
QI AND BLOOD STASIS AND STAGNANCY OF QI
AND BLOOD STASIS PATIENTS WITH
HEPATOCELLULAR CARCINOMA]. ZHOU XIAO-
ZHOU, GUO ZHEN-QIU, YANG ZHENG-WANG, ET.
chinese journal of basic medicine in traditional chinese
medicine. 2001;7(9):50 (chi*).
The prevalence of the putative etiologic factors of
hepatocellular carcinoma (HCC) and its clinical presentation,
gross pathological types, TNM classification grades and
laboratory features in group (69 patients) and group 2 (74
patients) seen from 1994 to 1997 were evaluated. Results,
prevalence of solitary type (58.5 % vs 35.2 %, P < 0. 05) , iv
stage of TNM classification grades( 17.4 % vs 6.8 %, P < 0.
05), concomitant cirrhosis (63.3 % vs; 21.6 %, P < 0. 05 not
smoking cigarette (65. 2 % vs 47. 3 %, P < 0. 05), the
hepatitis B VIRUS ANTIGEN ( HBSAg carriers (71. 0% vs-
54. 1 %, P < 0. 05) and AFP diagnostic ( > 400ng/ml) levels
(60. 87 % vs 27. 03 %, P < 0. 05) more common in group)
than in group 2 patients with HCC; and, prevalence of
younger than age 50 years (25.3 % ) vs 48.7 %, P < 0. 05),
diffuse and massive types (23. 0 % vs 5. 8 %; 14.9 % vs 2. 9
%, P < 0. 05) and AFP suspicious (20-200ng/ml) levels (24.3
% vs 7.35 %, P < 0. 01 ) were more common in group 2 than
in group I patients. Howerer, prevalence of multinodular type
(35.8% vs 27.0%) 1 - 11 and IV-stages of TNNM
classification grades(9.8% vs 17.6% 69.8% vs 75.7%),
hepatitis B virus infection both current and past (88.4% vs
78.4% )and AFP negative and diagnositic( < 20ng/ml and
200ng/ MI to 400ng/ml) level(24.64% vs 33.78%;7.3% vs
14.9%)did not differ significantly between the two groups.
Conclusion: suggested that HbsAg positivity, smoking habits,
underlying cirrhosis and so on, can influence the likelihood
of developing certain syndroms of HCC like deficiency of qi
and blood stasis and stagnancy of qi and blood stasis.
2346- gera: 96720/di/ra
[RELATIVE PROBLEMS ABOUT TCM IN TREATING
HBV CARRIERS]. YIN CHANG-JIAN, SUN JIAN-
GUANG, SHAN CHUN-MEI. shandong journal of
traditional chinese medicine. 2001;20(8):451 (chi*).
2347- gera: 96723/di/ra
[CLINICAL STUDY ON TREATMENT OF PRIMARY
HEPATOCARCINOMA BASED ON DEFICIENCY OF
SPLEEN]. DONG XIU-LI CHANG-HUA, LI WEI.
shandong journal of traditional chinese medicine.
2001;20(8):459 (chi*).
The relation between primary hepatocarcinoma WHO and the
deficiency of spleen is discussed. It suggests that the
deficiency of spleen is the basic cause of PHC, whether it is
external sensibility or internal injury. Its usual symptom,
especialy icterus, hydroperitoneum, tumor pain and fever,
which occur at advanced stage all can be analysed on spleen.
Modern medicine has proved that the treatment of
strengthening the spleen and regulating the flow of qi can
resist or detain the growing and transfering of the tumor,
improve the immunity of organism and prolong the survival
period, and, obviously better than the treatment of activating
the blood circulation and clearing away pathogenic heat and,
toxic material. The curative effect should be even better if it
is- used together with other treatment based on overall
analysis of symptoms and signs.
2348- gera: 96825/di/ra
[EFFECTS OF THE EXTRACTS FROM BCDC ON
HUMAN HEPATOMA SMMC-7721 CELLS AND MICE
IMPLANTED S-180 TUMOR]. SONG JING-GUI, XIAO
ZHENG-MING, LI SHI-PENG, ET AL. journal of
shandong university of traditional chinese medicine.
gera 2011

2001;25(4):299 (chi*).
2349- gera: 96833/di/ra
[EXPERIMENTAL STUDY ON THE EFFECT OF
XIHUANG PILL DRUG SREUM ON THE GROWTH
AND CELL CYCLE OF HUMAN HEPATIC
CARCINOMA CELLS]. XIONG YING, ET AL. chinese
journal of traditional medical science and technology (.
2001;8(4):217 (chi*).
2350- gera: 96838/di/ra
[THE INHIBITION EFFECT OF GANFUSHUILING
ORAL LIQUOR ON RAT'S HEPATIC FIBROSIS
INDUCED BY CCI4]. XU BING-QUAN, ET AL. chinese
journal of traditional medical science and technology (.
2001;8(4): (chi).
2351- gera: 96845/di/ra
[THE EFFECT OF MATRINE ON RAT'S
HEPATOCYTE APOPTOSIS INDUCED BY TNF - A
AND ACT D IN VITRO]. HU CONG, ET AL. chinese
journal of traditional medical science and technology (.
2001;8(4):242 (chi).
2352- gera: 96876/di/ra
[THE CLINICAL EXPERIENCE OF TREATING
VIRUS HEPATITIS 132 CASES WITH
SELFFORMULATED THREE HERBS DECOCTION].
FENG CHONG-LIAN. chinese journal of ethnomedicine
and ethnopharmacy. 2001;10(5):260 (chi*).
2353- gera: 96882/di/ra
[THE ANALYSIS OF TREATING HEPATITIS
SYNDROME OF INFANT 30 CASES WITH
SHUANGHUANGLIAN INJECTION]. XIE HUAI-PING,
ET AL. chinese journal of ethnomedicine and
ethnopharmacy. 2001;10(5):267 (chi).
2354- gera: 96906/di/ra
[XIAO CHAI HU TANG INHIBIT HBV IN VITRO AND
EXPERIMENTAL RESEARCH OF PRINCIPAL OF
FORMATION]. LIU ZHONG-JING, XIONG MANG-QI,
LI SAI-MEI, ET AL. chinese journal of basic medicine in
tcm. 2001;7(6):17 (chi*).
2355- gera: 96970/di/ra
[ROLE OF IL-18 IN ENDOTOXIN HEPATIC INJURY
IN RATS AND PROTECTIVE MECHANISM OF FU-
AN]. WANG LIANJIANG, FENG BINGAN, CHEN
JIANING, ET AL. chinese journal of surgery of integrated
traditional chinese and western medicine. 2001;7(5):331
(chi*).
2356- gera: 96971/di/ra
[EFFECTS OF INFLAMMATORY CYTOKINES ON
BILE ACID SECRETION OF HEPATOCYTES IN
RATS IN VITRO]. SUN BAIJUN, CUI NAIQIANG.
chinese journal of surgery of integrated traditional
chinese and western medicine. 2001;7(5):334 (chi*).
2357- gera: 96979/di/ra
[14 C AMINOPYRINE BREATH TEST.(14 C-ABT)
FOR MEASUREMENT OF LIVER RESERVE
FUNCTION IN CIRRHOTIC PATIENTS]. LUO ZIYI,
CHEN QUDING, GUAN LIJUAN, ET AL. chinese journal
of integrated traditional and western medicine on
digestion. 2001;9(5):277 (chi*).
2358- gera: 96981/di/ra
[STUDY ON CONTRACTIONS OF THE
148
GALLBLADDER IN PATIENTS WITH CHRONIC
HEPATITIS AND THE THERAPEUTIC EFFECT OF
MOTILIUM]. CHENG TIANMING, GAO FANG, ZHOU
HUA, ET AL. chinese journal of integrated traditional
and western medicine on digestion. 2001;9(5):281 (chi*).
2359- gera: 96989/di/ra
[EXPERIMENTAL STUDY OF THE INHIBITING
EFFECTS OF GENISTEIN ON THE EXPRESSION OF
NF-KB IN HUMAN HEPATIC CANCER CELL
STRAIN BEL 7402]. WANG JIFENG, DAI SHUJING, NIU
JIANZHAO, ET AL. journal of beijing university of
traditional chinese medicine. 2001;24(5):16 (chi*).
2360- gera: 97006/di/ra
[OBSERVATION OF PROTECTING THE LIVER
CURATIVE EFFECT ON PULMONARY
TUBERCULOSIS TREATED BY RADIX SALVIAE
MILTIORRHIZAE]. CHEN BIN, ET , AL. hubei journal
of traditional chinese medicine. 2001;23(10):23 (chi).
2361- gera: 97022/di/ra
[ESSENCE OF PROFESSOR WANG MIANZHI'S
EXPERIENCE ON TREATING LIVER FIBRATION].
YAN JUN, WANG XU. study journal of traditional
chinese medicine. 2001;19(5):410 (chi).
2362- gera: 97070/di/ra
[TREATMENT OF POSTHEPATITIC CIRRHOSIS BY
TONGLUO RUANJIAN CAPSULE: A CLINICAL
OBSERVATION OF 365 CASES]. GENG ZIXUAN, QI
ZHONGXI. new journal of traditional chinese medicine.
2001;33(10):26 (chi*).
2363- gera: 97105/di/ra
[A DYNAMIC OBSERVATION OF THE EFFECT OF
CARAPAS TRIONYCIS BOLUS ON HEPTIC
COLLAGEN AND SERUM PROCOLLAGEN III OF
AGED RATS IN THE PROCESS OF HEPATIC
FIBROSIS]. REN XIAO-QIAO, CHEN YONG-XU. henan
traditional chinese medicine. 2001;21(5):19 (chi*).
2364- gera: 97111/di/ra
[THE DIFFERENTIATION AND TREATMENT OF 168
CASES OF FATTY LIVER]. PEI DAO-LING, ZHOU YU-
QIN, ZHANG-XIAN. henan traditional chinese medicine.
2001;21(5):39 (chi).
2365- gera: 97116/di/ra
[CLINICAL OBSERVATION OF CHRONIC VIRUS
HEPATITIS B TREATED BY SHUGAN JIANPI FAN].
LI XIUHUI. beijing journal of traditional chinese
medicine. 2001;7(4):7 (chi).
2366- gera: 97123/di/ra
[EXPERIMENTAL STUDY OF –HUQI SAN IN
PRECANCEROSIS OF LIVER]. WANG XUEJIANG, ET
AL. beijing journal of traditional chinese medicine.
2001;7(4):42 (chi).
2367- gera: 97134/di/ra
[HERB COMPATIBLE ACTION OF FUZHENG
HUAYU 319 DECOCTION ON ALBUMIN
PRODUCTION IN HEPATOCYTES]. LIU CHENG-HAI,
WANG XIAO-LING, TAN YIN-ZI, ET AL. china journal
of basic medicine in tcm. 2001;7(4):36 (chi*).
2368- gera: 97155/di/ra
[CLINICAL STUDY ON EFFECT OF QIHUANG
ORAL LIQUID ('XJT 139RA) TO ENTERIC FLORA
gera 2011

DISTURBANCE AND SERUM ENDOTOXIN LEVEL
IN PATIENTS OF LIVER CIRRHOSIS*]. JIA DE-XING,
XU LEI, SU FEN, ET AL. chinese journal of integrated
traditional and western medicine. 2001;21(7):495 (chi*).
2369- gera: 97159/di/ra
[PERSPECTIVE STUDY ON EFFECT OF GANDOU
TABLET I ()FFTDT 14) ON BILIARY TRACE
ELEMENTS IN TREATING HEPATOLENTICULAR
DEGENERATION]. HU WEN-BIN, YANG REN-MIN.
chinese journal of integrated traditional and western
medicine. 2001;21(7):507 (chi*).
2370- gera: 97241/di/ra
[EFFECTS OF SHENLING BAIZHU GRANULE ON
MID-LATE LIVER-CANCER-ASSOCIATED
DIARRHEA]. LAI YI-QIN, JIN YUAN, HUANG PING,
ET AL. fujian journal of traditional chinese medicine.
2001;32(4):11 (chi).
2371- gera: 97242/di/ra
[POHUANG DECOCTION FOR TREATING 50 CASES
OF ACUTE VIRAL AND ICTERUS HEPATITIS]. SU
XUN-BO. fujian journal of traditional chinese medicine.
2001;32(4):12 (chi).
2372- gera: 97267/di/ra
[CLINICAL INVESTIGATION ON TREATMENT OF
CHRONIC HEPATITIS C WITH COMPOUND
CHINESE MEDICINE BINGGANNING]. ZHOU MIN,
XUE BO-YU, LL CHUN-TING, ET AL. journal of nanjing
university of traditional chinese medicine(natural
science). 2001;17(5):283 (chi*).
2373- gera: 97278/di/ra
[LIN HE-HE'S EXPERIENCE OF TREATMENT
OVERHEPATOCIRRHOSIS ASCITES]. YANG JIAN-
HU. jiangxi journal of traditional chinese medicine.
2001;32(5):8 (chi).
2374- gera: 97305/di/ra
[OBSERVATION OF THE EFFECTS OF DR. ZHANG
ZHONGJING'S THREE FORMULAS ON THE
LEVELS OF SERUM PROCOLLAGEN
III,HYALURONIC ACID AND LAMININ IN THE
RATS WITH HEPATIC FIBROSIS IN DIFFERENT
STAGES]. REN XIAOQIAO, LU YUEQING, CHEN
YONGXU ET AL. journal of beijing university of
traditional chinese medicine. 2001;24(3):35 (chi*).
2375- gera: 97308/di/ra
[EFFECTS OF HUOXUEHUAYU RECIPE ON THE
ACTIVATION OF RAT HEPATIC STELLATE
CELLS]. JIANG TAO, GUO SHUNGEN, MENG
YICHUN. journal of beijing university of traditional
chinese medicine. 2001;24(3):43 (chi*).
2376- gera: 97314/di/ra
[CLINICAL STUDY ON CHRONIC HEPATITIS B
TREATED BY CHINESE HERBA I GANTELING*].
GAO BIN, YUAN GUIYU, LIANG SHUREN, ET AL.
chinese journal of integrated traditional and western
medicine on liver diseases. 2001;11(2):67 (chi*).
2377- gera: 97315/di/ra
[CLINICAL EFFECT ON CHRONIC HEPATITIS B
TREATED BY HELUO SHUGAN CAPSULE*]. HUANG
JIAQUAN, WANG JUN GUO WEI, ET AL. chinese
journal of integrated traditional and western medicine on
liver diseases. 2001;11(2):69 (chi*).
149
2378- gera: 97316/di/ra
[CLINICAL OBSERVATION OF MARTINE FOR
ANTIFIBROSIS *]. LIU AIPING, PANG XIAOYING GU
YINAN, ET AL. chinese journal of integrated traditional
and western medicine on liver diseases. 2001;11(2):71
(chi*).
2379- gera: 97317/di/ra
[THERAPEUTIC EFFECTS OF FAMCICLOVIR TO
PATIENTS WITH HEPATITIS TTV *]. YAN
NANYING, SUN QIYAN. chinese journal of integrated
traditional and western medicine on liver diseases.
2001;11(2):73 (chi*).
2380- gera: 97318/di/ra
[CLINICAL EVALUATION FOR DIAGNOSING
EARLY LIVER CIRRHOSIS IN THE PATIENTS
WITH CHRONIC HEPATITIS B*]. LIN XIAOTIAN,
HOU JINLIN, CAI LILI, ET AL. chinese journal of
integrated traditional and western medicine on liver
diseases. 2001;11(2):75 (chi*).
2381- gera: 97319/di/ra
[CLINICOPATHOLOGIC FEATURES OF
HEPATOCELLULAR CARCINOMA PATIENTS
WITH DIFFERENT SYNDROMES]. LI JINGPING, SU
NANXIANG. chinese journal of integrated traditional
and western medicine on liver diseases. 2001;11(2):78
(chi).
2382- gera: 97320/di/ra
[DETECTING AND ANALYSIS TO HEPATITIS B & C
VIRUS AFTER INJECTING CRYOFIBRINOGEN TO
PATIENTS WITH HEMOPHILIA*]. YU ZHONGQING,
HU LIHUA, RAO SHENZONG. chinese journal of
integrated traditional and western medicine on liver
diseases. 2001;11(2):80 (chi*).
2383- gera: 97321/di/ra
[ANTIOXIDATION OF PRESCRIPTION NO. I FOR
ANTI-HEPATITIS B IN EXPERIMENTAL MICE
WITH CHRONIC IMMUNO-HEPATIC INJURY *].
QIAN YALIN, SUN PEIYI, SUN YUN, ET AL. chinese
journal of integrated traditional and western medicine on
liver diseases. 2001;11(2):86 (chi*).
2384- gera: 97323/di/ra
[EFFECT OF ANALGESIC POWDER FOR
TREATING HEPATOCARCINOMA ON
IMMUNOLOGIC FUNCTION IN MICE*]. LI
SHUIQING, LIU YANJU. chinese journal of integrated
traditional and western medicine on liver diseases.
2001;11(2):92 (chi).
2385- gera: 97324/di/ra
[EFFECT OF GOOSENECK BLOOD ON
PHAGOCYTIC FUNCTION IN ASCITES OF MOUSE
WITH HEPATOCARCINOMA]. YU PING. chinese
journal of integrated traditional and western medicine on
liver diseases. 2001;11(2):94 (chi).
2386- gera: 97325/di/ra
[31 CASES OF FATTY LIVER TREATED BY
DECOCTION ANTI-LIPOID AND SUPPLEMENTING
LIVER]. TAN XINGHUA, TAN JUN, YIN CHIBIAO, ET
AL. chinese journal of integrated traditional and western
medicine on liver diseases. 2001;11(2):110 (chi).
2387- gera: 97421/di/ra
gera 2011

[ON ORIGIN OF WANG XUGAO' S TREATMENT OF
HEPATOPATHY]. HU FANGLIN. jiangsu journal of
traditional chinese medicine. 2001;22(8):37 (chi).
2388- gera: 97424/di/ra
[ADVANCEMENT IN EXPERIMENTAL
INVESTIGATION ON TREATMENT OF FIBROSIS
WITH TRADITIONAL CHINESE MEDICINE]. SUN
LIXIA. jiangsu journal of traditional chinese medicine.
2001;22(8):46 (chi).
2389- gera: 97476/di/ra
[CLINICAL ANALYSIS ON HEPATIC INJURY
INDUCED BY CHINESE PROPRIETARY MEDICINE].
GUO LIZHU. chinese journal of information on
traditional chinese medicine. 2001;8(6):88 (chi).
2390- gera: 97491/di/ra
[TREATMENT OF 100 CASES OF CHRONIC
HEPATITIS B WITH"YUGAN DECOCTION]. LI
JISHENG. jiangsu journal of traditional chinese medicine.
2001;22(7):23 (chi).
2391- gera: 97510/di/ra
[TREATMENT AND STUDIES OF LIVER FIBROSIS].
LU LIANGWEI. journal of zhejiang college of traditional
chinese medicine. 2001;25(2):3 (chi).
2392- gera: 97531/di/ra
[EXPERIMENTAL STUDY ON PROMOTING
GROWTH FUNCTION OF HOVENA DULCIS THUNB
WATER EXTRACTION ON PRIMARY CULTURE
RAT'S HEPATIC CELL]. JI YANG, ET AL. chinese
journal of traditional medical science and technology.
2001;8(3):162 (chi).
2393- gera: 97547/di/ra
[CLINICAL AND EXPERIMENTAL STUDY ON
REDUCING ALT WITH NO. I JIANGMEI
DECOCTION]. FENG ZHI-PENG. journal of shandong
university of traditional chinese medicine. 2001;25(5):367
(chi*).
2394- gera: 97550/di/ra
[EFFECTS OF ACUPUNCTURE ON ACTIVITY OF
ANTIOXIDASE AND EXPRESSION OF GENE IN
LIVER OF SAM- P/10]. LIU YI-FAN, SHI XUE-MIN,
HAN JING-XIAN, ETAL. journal of shandong university
of traditional chinese medicine. 2001;25(5):382 (chi*).
Objective : To study the effects of acupuncture on the activity
of antioxidase and expression of gene in liver of SAM-P/10.
Methods: DNA content, SOD activity and SOD mRNA
levels were assayed by biochemical and Northern Blot
methods. Results : The level of MDA in liver of the acupoint
group was lower than that in the control group. The higher
defense defense capacity against oxygen free radical was
supported by the findings that the activitiy of SOD was
higher than that in the control group. The SOD mRNA level
demonstrated the same tendency as the enzyme changes.
Conclusion : Acupuncture can affect the activity of
antioxidase, the capacity to remove oxygen free radical and
up-regulation of SOD mRNA at the transcription level.
2395- gera: 97556/di/ra
[PROTECTIVE EFFECTS OF BINGGANNING
GRANULES ON IMMUNOLOGIC LIVER INJURY IN
MICE]. ZHOU LINGLING, ET AL. chinese journal of
information on traditional chinese medicine(ii).
2001;8(9):30 (chi).
150
2396- gera: 97562/di/ra
[CLINICAL AND EXPERIMENTAL STUDY ON
TREATMENT OF CHRONIC VIRUS HEPATITIS B
WITH HEPATITIS B MIXTURE(HBMII)]. QIAN
YALIN, ET AL. chinese journal of information on
traditional chinese medicine(ii). 2001;8(9):47 (chi).
2397- gera: 97563/di/ra
[EFFECTS OF YUGAN DECOCTION ON LIPID
PEROXYDATION IN PATIENTS OF CHRONIC
HEPATITIS B]. WANG XIANBO, ET AL. chinese journal
of information on traditional chinese medicine(ii).
2001;8(9):50 (chi).
2398- gera: 97570/di/ra
[STUDIES OF GINKGO BILOBA TESTA
POLYSACCHARIDES IN INHIBITING LIVER
CANCER AND INDUCING APOPTOSIS OF THE
LIVER CANCER CELL IN MICE]. XU AIHUA, JA
XIAOQIN, CHEN HUASHENG, ET AL. traditional
chinese drug research and clinical pharmacology.
2001;12(5):340 (chi).
2399- gera: 97577/di/ra
[DIFFERENTIATION OF SYMPTOM-COMPLEX AND
MEDICATION EXPERIENCE IN TREATING
CARBUNCLE OF THE HYPOCHONDRIUM DUE TO
LIVER AILMENT]. JIANG XINJUN. journal of chengdu
university of traditional chinese medicine. 2001;24(3):6
(chi).
2400- gera: 97628/di/ra
[INTERVENIENT TREATING PRIMARY
CARCINOMA OF LIVER WITH COMBINATION OF
FRUCTUS BRUCEAE OLEIC EMULSION AND
ABSOLUTE ALCOHOL]. YOU JIANLIANG, ET AL.
hubei journal of traditional chinese medicine.
2001;23(8):9 (chi).
2401- gera: 97631/di/ra
[CHRONIC VIRUS HEPATITIS B TREATED WITH
COMBINATION OF TRADITIONAL CHINESE AND
WESTERN MEDICINES]. PENG YAN, ET AL. hubei
journal of traditional chinese medicine. 2001;23(8):23
(chi).
2402- gera: 97635/di/ra
[32 CASES OF CHRONIC SUPERFICIAL GASTRITIS
TREATED BY RUIN SOFT EXTRACT]. LU
XUNCONG, ET AL. hubei journal of traditional chinese
medicine. 2001;23(8):28 (chi).
2403- gera: 97650/di/ra
[AFFECT OF PRESCRIPTIONS FOR
STRENGTHENING BODY RESISTANCE AND
DETOXICATING UPON CELLULAR IMMUNE
FUNCTION OF CHILDREN WITH HEPATITIS]. LU
SHEN ET AL. journal of traditional chinese medicine and
chinese materia medica of jilin. 2001;21(5):8 (chi).
2404- gera: 97654/di/ra
[TREATMENT OF CHRONIC PERSISTING
HEPATITIS B BY PROMOTING BLOOD
CIRCULATION AND DETOXICATING METHOD IN
60 CASES]. WU DE-PING. journal of traditional chinese
medicine and chinese materia medica of jilin.
2001;21(5):17 (chi).
2405- gera: 97726/di/ra
[EFFECT OF TUOLI XIAODU POWDER ON CELL-
gera 2011

MEDIATED MUNOFUNCTION IN LIVER
CARCINOMA PATIENTS BEFORE AND AFTER
SURGICAL OPERATION "]. LI HONG-HAO, LIANG
JUN-XIONG, CHEN JI-SHENG. chinese journal of
integrated traditional and western medicine.
2001;21(10):739 (chi*).
2406- gera: 97727/di/ra
[EFFECT OF RELIEVING BLOOD
STASIS,STRENGTHENING SPLEEN AND SOOTHING
LIVER THERAPY IN IMPROVING HEPATIC
FUNCTION IN PATIENTS AFTER LIVER-
CARCINOMECTOMY *]. XU BO-PING, ZHANG YA-
QI, LL SHENG-PING, ET AL. chinese journal of
integrated traditional and western medicine.
2001;21(10):742 (chi*).
2407- gera: 97811/di/ra
[CLINICAL OBSERVATION ON TREATMENT OF 38
CASES OF SEVERE VIRUS HEPATITIS WITH
FRESH SHENG DI JUICE COMBINED WITH
COMPREHENSIVE THERAPY OF CHINESE
TRADITIONAL AND WESTERN JIA JIANWEI, YANG
JIMING, YUAN GUIYU. journal of traditional chinese
medicine. 2001;42(10):611 (eng).
2408- gera: 97815/di/ra
[THINKING AND METHODS OF THE STUDY ON
TREATMENT OF ASCITES DUE TO
HEPATOCIRRHOSIS WITH COMBINED
TREATMENT OF CHINESE TRADITIONAL AND
WESTERN MEDICINE]. LIN ZONGGUANG. journal of
traditional chinese medicine. 2001;42(10):624 (eng).
2409- gera: 97821/di/ra
[CLINICAL OBSERVATION ON TREATMENT OF
HEPATITIS WITH MAO-XUE-QING-DU-YE: 183
CASES REPORTED]. CAO CHANG'EN, ET AL. acta
chinese medicine and pharmacology. 2001;29(5):12 (chi*).
2410- gera: 97823/di/ra
[THE TREATMENT OF CHRONIC HEPATITIS WITH
KURARINONE:40 CASES REPORTED]. SHI GANG,
ET AL. acta chinese medicine and pharmacology.
2001;29(5):17 (chi).
2411- gera: 97837/di/ra
[CLINICAL OBSERVATION ON GANLE MIXTURE
IN TREATING 32 PATIENTS WITH CHRONIC
HEPATITIS C]. YU WENJUN. hebei journal of
traditional chinese medicine. 2001;23(10):736 (chi).
2412- gera: 97841/di/ra
[EFFECT OF HB-GRANULE-3 ON TNF-A AND IL-6
OF CHRONIC HEPATITIS B PATIENTS*]. GAO HUI,
ZHOU DAQIAO, XIONG YIQUN, ET AL. chinese journal
of integrated traditional and western medicine on liver
diseases. 2001;11(5):259 (chi*).
2413- gera: 97842/di/ra
[STUDY ON THE RELATION BETWEEN-CHANGES
OF IL-2,TNF-A IN SERUM IN PATIENTS WITH
CHRONIC HEPATITIS B AND ACTION OF
'TREATMENT WITH FOSCARNET *]. DING
HONGFANG, TIAN DEYING, HUANG YUANCHENG,
ET AL. chinese journal of integrated traditional and
western medicine on liver diseases. 2001;11(5):262 (chi*).
2414- gera: 97843/di/ra
[STUDY ON THE RELATIONSHIP BETWEEN IN
151
STAGE OF HEPATIC FIBROSIS AND THE LEVELS
OF SERUM BIOCHEMISTRY]. XU GUOGUANG, LUO
CHENGYU, WU SHANGMING, ET AL. chinese journal
of integrated traditional and western medicine on liver
diseases. 2001;11(5):265 (chi*).
2415- gera: 97844/di/ra
[RELATIONSHIP BETWEEN HBV-PRE-C
MUTATION AND LIVER FUNCTION,TNF-A,SIL-
2R*]. HUANG YUHUA, SHENG GUOGUANG, ZHANG
JIANJUN. chinese journal of integrated traditional and
western medicine on liver diseases. 2001;11(5):267 (chi*).
2416- gera: 97845/di/ra
[DYNAMIC CHANGE AND CLINICAL
SIGNIFICANCE OF COAGULATION FACTOR V,VI,X
IN CHRONIC SEVERE HEPATITIS *]. WANG
CHUNLI, YU JINDONG, GAO TAO, ET AL. chinese
journal of integrated traditional and western medicine on
liver diseases. 2001;11(5):269 (chi*).
2417- gera: 97846/di/ra
[STUDY ON THE CHANGES OF INTESTINAL
MICROFLORA IN PERIOPERATIVE PATIENTS
WITH PRIMARY LIVER CANCER*]. CHEN
YANLING, YU FEIFEI, HUANG JIANFU, ET AL. chinese
journal of integrated traditional and western medicine on
liver diseases. 2001;11(5):272 (chi*).
2418- gera: 97847/di/ra
[DETECTION OF TTV INFECTION AND SEQUENCE
ANALYSIS IN PATIENTS WITH NON A-G
HEPATITIS]. ZHOU XIAOPING, LI XIANGXIA, LI
AIYUE, ET AL. chinese journal of integrated traditional
and western medicine on liver diseases. 2001;11(5):278
(chi).
2419- gera: 97848/di/ra
[EFFECT OF GINKGO BILOBA EXTRACT (GBE) ON
EXPRESSION OF TGF-B1 MRNA AND DEPOSIT ION
OF COLLAGEN IN CC14 RATS*]. ZHANG
CHUNQING, ZHU JUREN, SHI HENGMEI, ET AL.
chinese journal of integrated traditional and western
medicine on liver diseases. 2001;11(5):284 (chi*).
2420- gera: 97849/di/ra
[EFFECTS OF PAEONIFLORIN ON
PROLIFERATION OF HUMAN
HEPATOCARCINOMA CELL STRAIN BEL-7402*].
YAN XUESHEN, LI HANMIN, PENG YAQIN, ET AL.
chinese journal of integrated traditional and western
medicine on liver diseases. 2001;11(5):287 (chi*).
2421- gera: 97850/di/ra
[EFFECTS OF THE KANGGANHUN ENEMA ON
INTERLEUKIN-6 IN EXPERIMENTAL HEPATIC
ENCEPHALOPATHY*]. LI ZHIQING, YANG
WANGANG, XIONG YIQUN. chinese journal of
integrated traditional and western medicine on liver
diseases. 2001;11(5):289 (chi*).
2422- gera: 97857/di/ra
[THERAPEUTIC OBSERVATION ON 50 CASES OF
CHRONIC HEPATITIS B TREATED WITH
INTEGRATED CHINESE AND WESTERN
MEDICINE]. FU LU. forum on traditional chinese
medicine. 2001;16(6):34 (chi).
2423- gera: 97872/di/ra
[INHIBITORY EFFECT OF KANGXIANLING
gera 2011

CONTAINING SERUM ON EX-VIVO
PROLIFERATION OF HUMAN HEPATO
CARCINOMA CELL HEP G . I]. ZHU MEI-JU, GUO
ZHEN-QIU. chinese traditional and herbal drugs.
2001;32(10):905 (chi*).
2424- gera: 97905/di/ra
[THE INFORMATION ON THE TREATMENT OF
FATTY LIVER]. LI JI ET AL. information on traditional
chinese medicine. 2001;18(5):13 (chi*).
This paper presents the review and analysis on the general
situation of Fatty Liver treated by Chinese medicine in the
recent years mainly through the following three aspects: (1)
The cognition of the etiology and pathology of diseases in
traditional Chinese medicine that match fatty liver and find
that. the stagnation of Qi, stagnant, phlegm-damp, etc. are the
most common factors. (2) The treatment of fatty liver with
Chinese medicine mainly includes planning treatment
according to diagnosis. the special drug for it, etc. The
researching on the pharmacology of the Chinese material
medical for fatty liver. Meanwhile, the authors put forward
the
2425- gera: 97924/di/ra
[EFFECTIVE OBSERVATION ON 68 CASES OF HBV
POSITIVE REACTION TREATED BY CHINESE
HERB MEDICINE AND POINT-INJECTION
THERAPY]. SHU XIANGDE, ET AL. hunan journal of
traditional chinese medicine. 2001;17(5):11 (chi).
2426- gera: 97925/di/ra
[CLINICAL OBSERVATION ON 84 CASES OF
CHRONIC VIRAL HEPATITIS B TREATED BY
GANYAN JIEDU DECOCTION]. JIANG HUANPING,
ET AL. hunan journal of traditional chinese medicine.
2001;17(5):13 (chi).
2427- gera: 97930/di/ra
[CLINICAL OBSERVATION ON TREATMENT OF
HEPATITIS B WITH CHINESE DRUGS PLUS
INTERFERON IN 24 CASES]. BAI LIN ET AL. academic
periodical of changchun college of traditional chinese
medicine. 2001;17(3):17 (chi).
2428- gera: 97965/di/ra
[PREVENTIVE EFFECT OF GAN-FU-KANG 9-*)ON
ENDOTOXEMIA AND ANTI-FIBROSIS IN
EXPERIMENTAL LIVER CIRRHOSIS]. LIU ZHONG,
SHEN ZHONGYI, GUAN FENGLIN, ET AL. chinese
journal of surgery of integrated traditional chinese and
western medicine. 2001;7(3):148 (chi*).
2429- gera: 97998/di/ra
[ON THE TREATMENT OF HEPATITIS-B CASES
WITH LANCET AND MOXIBUSTION METHODS].
LIU XIN-MENG, XIAO WEI. journal of shaanxi college of
traditional chinese medicine. 2001;24(3):34 (chi).
2430- gera: 98006/di/ra
[FUZHENG GUBEN THERAPY FOR ASCITES DUE
TO POSTHEPATITIS CIRRHOSIS; A REPORT OF 92
CASES]. CAI JINWEI. beijing journal of traditional
chinese medicine. 2001;20(3):12 (chi).
2431- gera: 98014/di/ra
[THERAPEUTIC EFFICACY OF CHRONIC VIRUS
HEPATITIS B TREATED BY HUQI SAN: A REPORT
OF 30 CASES]. GAO LIANYIN, ET AL. beijing journal of
traditional chinese medicine. 2001;20(3):49 (chi).
152
2432- gera: 98025/di/ra
[CLINICAL OBSERVATION ON ATTENUATION
AND SYNERGY OF FUZHENG YILIU DECOCTION
ON CHEMOTHERAPY OF INTERMEDIATE AND
LATE PRIMARY CARCINOMA OF LIVER]. LI WEI,
ET AL. chinese journal of information on traditional
chinese medicine. 2001;8(5):52 (chi).
2433- gera: 98032/di/ra
[EFFECT OF MOUNTING POINTS ON THE
ACTIVITY OF TNF IN PERIPHERAL BLOOD OF
ASCITES CARCINOMA MICE]. LIU YUNXIA, GAO
HAISHENG, TIAN JIANHUI, ET AL. traditional chinese
medicinal research. 2001;14(3):9 (chi).
2434- gera: 98033/di/ra
[ANALYTICAL AND STATISTICAL STUDY ON THE
REFERENCES OF 2492 CASES OF TREATING
PRIMARY CARCINOMA OF LIVER]. MA JUN, LI
YONGJIAN. traditional chinese medicinal research.
2001;14(3):15 (chi).
2435- gera: 98065/di/ra
[CLINICAL STUDIES ON TREATING LIVER
CANCER WITH TRADITIONAL CHINESE HERBS
COMPANYING WITH INTERVENE TREATMENT].
TIAN HUA-QIN, LIANG GUI-WEN, TAO YIN, ET AL.
henan journal of traditional chinese medicine and
phrmacy. 2001;16(1):47 (chi).
2436- gera: 98108/di/ra
[ONE EXAMPLE OF THE EFFECTIVE TREATMENT
OF HEPATIC HEMANGIOMA]. QIN HUATAI. guang
ming journal traditional chinese medicine. 2001;6(3):2
(chi).
2437- gera: 98131/di/ra
[EXPERIMENTAL STUDY ON SHENTAO RUANGAN
WAN IN INHIBITING THE GROWTH OF
CARCINOMA IN MICE WITH HEPATOCARCINOMA
PROMOTING THE ACTIVITY OF IL-2 AND NK
CELLS]. SHI SHIDE, LI RENXIAN, ZHOU DAIHAN.
traditional chinese drug research and clinical
pharmacology. 2001;12(3):216 (chi).
2438- gera: 98145/di/ra
[PREVENTION AND TREATMENT CC14 INDUCED
LIVER INJURY AND SCLEROSIS MICE WITH YING
- GAN - FU - KANG]. WANG TIAN-RAN, ZENG
XIANG-YUAN, MA BU-REN. journal of chengdu
university of traditional chinese medicine. 2001;24(2):28
(chi).
2439- gera: 98172/di/ra
[A DISCUSSION ON PATHOGENESIS OF CHRONIC
HEPATITIS B]. HUA HAI-QING. journal of nanjing
university 0 traditional chinese medicine (natural
science). 2001;17(4):210 (chi*).
The pathogenesis of chronic hepatitis B is related to
dampness and heat, which are the causative factors for the
occurrence cf the disease. Dysfunction of the spleen is the
internal basis for the onset of the disease, stagnation of the
liver collaterals is an important factor for the development of
the disease and deficiency of the liver and kidney is the
inevitable outcome of the disease. The pathological features
of the disease is deficiency of the anti - pathogenic factors
with lingering of the pathogenic factors, which gives rise to
Ns chronic disease with changes and recurrence. Satisfactory
results can only be obtained by treating the disease according
to the condition of
gera 2011

2440- gera: 98189/di/ra
[EXPLORING AND DISCUSSING THE
PATHOGENESIS OF FIBROUS DEGENERATION OF
LIVER IN CHINESE MEDICINE]. LU LIANGWEI.
china journal of traditional chinese medicine and
pharmacy. 2001;16(3):39 (chi).
2441- gera: 98192/di/ra
[JINMIAOWEN' S EXPERIENCES ON DIAGNOSING
AND TREATING THE CHRONIC VIRAL HEPATITIS
TYPE B]. DU LIN, ET AL. china journal of traditional
chinese medicine and pharmacy. 2001;16(3):44 (chi).
2442- gera: 98196/di/ra
[APPLICATION OF THE DRUGS FOR REDUCING
PHLEGM AND RELIEVING MASSES IN
TREATMENT OF VIRUS HEPATITIS]. ZU WU.
journal of traditional chinese medicine. 2001;42(6):334
(eng).
2443- gera: 98201/di/ra
[OBSERVATION ON THERAPEUTIC EFFECT OF 236
CASE'S OF INTESTINE -INFECTIOUS VIRUS
HEPATITIS TREATED WITH CHINESE DRUGS]. LU
ZHIPING, YU FANGTING, YU SHOUYI, ET AL. journal
of traditional chinese medicine. 2001;42(6):350 (eng).
2444- gera: 98247/di/ra
[CLINICAL STUDY ON CHRONIC HEPATITIS C
TREATED WITH QINGGAN GRANULES*]. CHEN
JIANGIE, WANG LINGTAI, REN JINYU, ET AL. chinese
journal of integrated traditional and western medicine on
liver diseases. 2001;11(4):195 (chi*).
2445- gera: 98248/di/ra
[EFFECT OF FOSCARNET SODIUM INJECTION ON
CHRONIC HEPATITIS B*]. LEI CHUNLIANG, FAN
HUIMIN, YANG ZHANG, ET AL. chinese journal of
integrated traditional and western medicine on liver
diseases. 2001;11(4):198 (chi*).
2446- gera: 98249/di/ra
[EFFECT OF HEPATITIS B MIXTURE (HBM I) ON
ANTIOXIDATION DURING THE TREATMENT OF
CHRONIC VIRUS HEPATITIS B]. QIAN YALIN, CHEN
WEIMIN, SUN PEIYI. chinese journal of integrated
traditional and western medicine on liver diseases.
2001;11(4):200 (chi*).
2447- gera: 98250/di/ra
[CLINICAL SIGNIFICANCE OF DETERMINATION
SERUM CA19-9 IN PATIENTS WITH CHRONIC
LIVER DISEASE*]. CHEN HONGBIN, ZHANG
YADONG, LI JIANJUN, ET AL. chinese journal of
integrated traditional and western medicine on liver
diseases. 2001;11(4):202 (chi*).
2448- gera: 98251/di/ra
[OBSERVATION OF LONG-TERM CURATIVE
EFFECT OF THE CHRONIC HEPATITIS B TREATED
BY HEPATITIS B GUDING INTERFERON]. CUI
HUAFU. chinese journal of integrated traditional and
western medicine on liver diseases. 2001;11(4):204 (chi).
2449- gera: 98252/di/ra
[DETECTION OF PLASMA FIBRINOGEN LEVEL
AND FIBRIN MONOMER POLYMERIZE FUNCTION
IN PATIENTS WITH FATTY LIVER AND ITS
CLINICAL SIGNIFICANCE]. PENG YUNSHENG,
153
DONG LINJIANG, ZHOU LIHONG, ET AL. chinese
journal of integrated traditional and western medicine on
liver diseases. 2001;11(4):206 (chi).
2450- gera: 98253/di/ra
[EXPERIMENTAL RESEARCH OF THE VARIOUS
DOSES TREATMENT GROUPS OF SALVIA
MILTISRRHIZA TO PREVENT LIVER FIBROSIS
INDUCED WITH CC14 *]. HUANG XIANZHANG, SHE
SHIFENG, WANG GUOBIN. chinese journal of integrated
traditional and western medicine on liver diseases.
2001;11(4):210 (chi*).
2451- gera: 98254/di/ra
[EFFECT OF OXYMATRINE ON COLLAGEN
SYNTHESIS AND EXPRESSION OF TGF-B1 IN AN
IMMUNE HEPATIC FIBROSIS MODEL*]. CHENG
YANG, ZHANG MIN, LIU CHAZHEN, ET AL. chinese
journal of integrated traditional and western medicine on
liver diseases. 2001;11(4):213 (chi*).
2452- gera: 98255/di/ra
[DETECTING THE MUTATION OF HBV BY USING
PCR-SSCP AND SILVER STAINING TECHNIQUE*].
SHENG GUOGUANG, LI HANMIN, RAN RUIQIONG, ET
AL. chinese journal of integrated traditional and western
medicine on liver diseases. 2001;11(4):216 (chi*).
2453- gera: 98256/di/ra
[INFLUENCE OF JIAWEI WENDAN DECOCTION ON
THE ACTIVE GENE IN NUCLEUS OF LIVER*].
WANG PING, LIU LING, QIU XINGFAN, ET AL. chinese
journal of integrated traditional and western medicine on
liver diseases. 2001;11(4):218 (chi*).
2454- gera: 98257/di/ra
[EXPERIMENTAL STUDY ON APOPTOSIS OF
HEPG2 CELL INDUCED BY TIDU HUGAN FANG*].
MING ANPING, YAN XUESHENG, ZHU QINGJING, ET
AL. chinese journal of integrated traditional and western
medicine on liver diseases. 2001;11(4):220 (chi*).
2455- gera: 98258/di/ra
[INFLUENCE OF FUZHENG ANTI-CARCINOMA
PRESCRIPTION TAP) ON P53 AND NM23-
H,EXPRESSIONS IN RATS WITH IMPLANTED
HEPATOMA*]. HAN KEQI, ZHOU LITANG, HUANG
CHUANJI. chinese journal of integrated traditional and
western medicine on liver diseases. 2001;11(4):222 (chi*).
2456- gera: 98259/di/ra
[OBSERVATION OF THE CURATIVE EFFECT OF
GANSU CAPSULE ON CHRONIC HEPATITIS B].
TANG RONGZHEN. chinese journal of integrated
traditional and western medicine on liver diseases.
2001;11(4):225 (chi).
2457- gera: 98263/di/ra
[PROTECTIVE EFFECTS OF QIANG GAN SYRUPS
ON CHRONIC LIVER INJURY INDUCED BY CCL4
IN RATS]. DAI MIN, LIU QINGYUAN, ZI XIAOMEI, ET
AL. primary journal of chinese materia medica.
2001;15(4):12 (chi*).
2458- gera: 98335/di/ra
[CHEN RUI-CHUN'S EXPERIENCE OF TREATMENT
OVER LIVER CHIRRHOSIS]. LIN JIAN-HUI. jiangxi
journal of traditional chinese medicine. 2001;32(3):3 (chi).
2459- gera: 98340/di/ra
gera 2011

[CLINICAL ANALYSIS OF LIVER FIBROSIS
TREATED WITH DAHUANGZHECHONG-WAN].
LONG QINGHUA, YU XIAO-FENG, QU-YANG HONG.
jiangxi journal of traditional chinese medicine.
2001;32(3):21 (chi).
2460- gera: 98341/di/ra
[CLINICAL OBSERVATION ON TREATMENT OVER
FATTY LIVER BY THE METHOD OF ELIMINATING
DAMP AND REDUCING PHLEGM,REGULATING Q
AND INUIGORATING THE BLOOD]. CHEN LI-QUN,
WANG WEI-CHUN. jiangxi journal of traditional chinese
medicine. 2001;32(3):22 (chi).
2461- gera: 98357/di/ra
[RELATIONSHIP BETWEEN THE PRECORE
MUTATION IN PATIENTS WITH CHRONIC
HEPATITIS B AND SIL-2R]. YANG LING, ZHU
QINGJING, LL HANMIN, ET AL. chinese journal of
integrated traditional and western medicine on liver
diseases. 2001;11(3):131 (chi*).
2462- gera: 98358/di/ra
[THERAPEUTIC EFFECT OF GINKGOLIDES
COMBINED A-1B INTERFERON FOR TREATING
CHRONIC HEPATITIS B]. HE YUN, YUAN HONGBO,
YUAN FENGYI, ET AL. chinese journal of integrated
traditional and western medicine on liver diseases.
2001;11(3):134 (chi*).
2463- gera: 98359/di/ra
[CLINICAL STUDY ON CHINESE HERB BEIJIAJIAN
PILL FOR TREATING HEPATICE FIBROSIS]. ZI-IAO
ZHIYOU, YAO ZHENMIN, ZHONG QINGPING, ET AL.
chinese journal of integrated traditional and western
medicine on liver diseases. 2001;11(3):136 (chi*).
2464- gera: 98360/di/ra
[STUDY ON SYNDROME TYPES OF TCM IN LIVER
CIRRHOTIC JAUNDICE]. ZHANG QIN, LIU PING.
chinese journal of integrated traditional and western
medicine on liver diseases. 2001;11(3):139 (chi*).
Objective:, To explore syndrome types of TCM in liver
cirrhotic jaundice. Methods : 199 patients of cirrhotic
jaundice were classified, according to syndrome
differentiation of TCM into four types: liver-Qi stagnancy
and spleen deficiency type,Qi stagnancy and blood stasis
type, heat -stagnancy and damp-block,and both liver and
kidney deficiency type. Serum bilirubin, serum total bile
acid, the ratio of albumin to globulin; Serum hyaluronic acid,
procollagen type I , collagen type IV were detected; at the
same time detected the items relating to classification of
Child-Pugh. Result : I Among the four types, heat-stagnancy
and damp-block type and both liver and kidney deficiency
type's SB, TBA level were markedly higher than liver-Qi
stagnancy and spleen-def iciency type's, the difference
between groups was significant; heat-stagnancy and damp-
block type and both liver and kidney deficiency type's A/G
ratio were respectively lower than liver-Qi stagnancy and
spleen-damp type, the difference was significant 2 Qi-
stagnancy and blood stasis type and both liver and kidney
deficiency type's HA level was markedly higher than liver-Qi
stagnancy and spleen-def iciency type's; and in turn both liver
and kidney deficiency type> heat-stagnancy and damp-block
type >Qi-stagnancy and blood stasis type, the three types
compared with liver-Qi stagnancy and spleen-deficiency type
was significant difference; heatstagnancy and damp- block
type and both liver and Whey deficiency type was
significant; Qi-stagnancy and blood stasis type, heat-
stagnancy and damp-block type and both liver and kidney
154
deficiency type's IV C was higher than liver-Qi stagnancy
spleen -deficiency type's. The three types compared with
liver-Qi stagnancy and spleen -deficiency type was
significant difference respectively. 3 Liver-Qi stagnancy and
spleen-deficiency type's child A was the most in four groups,
73-68%; Qi-stagnancy and blood stasis type's child B was 45.
23%, both liver and kidney deficiency type's child C was 57-
45 %. Conclusion Serum SB, TBA, A/G; HA, PC I I , IV C;
and Child-Pugh classification could serve as objective
indexes for classifying syndrome type of TCM in cirrhotic
jaundice.
2465- gera: 98361/di/ra
[RELATIONSHIP AMONG HBV SERUM
MARKERS,PRE-C 1896 MUTANT AND VIRUS
LOADING]. PENG HUILI, GU SHIMIN, JIANG WEILUN,
ET AL. chinese journal of integrated traditional and
western medicine on liver diseases. 2001;11(3):142 (chi*).
2466- gera: 98362/di/ra
[STUDIES ON THE LINK OF ANTIGENS
EXPRESSION IN LIVER TISSUE AND FE,ZN,CU,MG
IN SERUM OF CHRONIC HEPATITIS B]. HUANG
YUEHUA, ZHU KELUN, GAO ZHILIANG. chinese
journal of integrated traditional and western medicine on
liver diseases. 2001;11(3):145 (chi*).
2467- gera: 98363/di/ra
[EFFECT OF RUANGAN SUOPI PILL TO THE
EXPRESSION OF I,I COLLAGEN MRNA AND
PROTEIN IN RAT WITH LIVER FIBROSIS]. WANG
QUANCHU, SHEN DELIN, ZHANG CHENGDAO, ET AL.
chinese journal of integrated traditional and western
medicine on liver diseases. 2001;11(3):152 (chi*).
2468- gera: 98364/di/ra
[EFFECT OF XIAOHUANG GRANULE ON
EXPERIMENTAL JAUNDICE IN RAT]. XIONG
YIQUN, ZHU HUIMIN, ZHANG CHIZHI, ET AL. chinese
journal of integrated traditional and western medicine on
liver diseases. 2001;11(3):154 (chi*).
2469- gera: 98365/di/ra
[EFFECT OF LIVER-NOURISHING CAPSULE
(LINGDAN WANG) ON THE ACTIVITY OF NK
CELLS IN MICE]. HUANG YAPING, RU QINGJING,
CHEN XIUGUI, ET AL. chinese journal of integrated
traditional and western medicine on liver diseases.
2001;11(3):157 (chi*).
2470- gera: 98366/di/ra
[EXPERIMENTAL STUDY ON TREATMENT OF
FATTY LIVER WITH HYPERLIPEMIA BY
QINGYUAN TIAOZHI (QYTZ) CAPSULE]. LI
WENBIAO, WANG YIREN. chinese journal of integrated
traditional and western medicine on liver diseases.
2001;11(3):159 (chi*).
2471- gera: 98367/di/ra
[EXPERIMENTAL STUDY ON THE EFFECT OF
GANSU ON ANTI-DUCK HEPATITIS B VIRUS].
CHEN YAXI, QI ZHENYUAN, GUO SHUHUA, ET AL.
chinese journal of integrated traditional and western
medicine on liver diseases. 2001;11(3):162 (chi*).
2472- gera: 98391/di/ra
[COMBINED CANTHARIDIN AND HYDROXY
CAMPTOTHECIN FOR TREATING LIVER CANCER
OF MID-LATE STAGE]. WU DAN-HONG, CHEN YUN-
YING. fujian journal of traditional chinese medicine.
gera 2011

2001;32(3):10 (chi).
2473- gera: 98404/di/ra
[EFFECT OF ANTI-FIBROSIS COMPOUND
PRESCRIPTION ON ULTRASTRUCTURE OF
PRIMARY CULTURED FIBROUS HEPATOCYTES].
ZHOU FEI, ZHANG BIN, WANG LING-TAI, ET AL.
liaoning journal of traditional chinese medicine.
2001;28(11):699 (chi*).
2474- gera: 98446/di/ra
[TREATING 39 CASES OF FATTY LIVER BY THE
MEANS OF INTEGRATION OF TRADITIONAL AND
WESTERN MEDICINE]. WANG DONGQING, WU
BUTAO, XIANG XIANG. henan journal of traditional
chinese medicine and phrmacy. 2001;16(6):49 (chi).
2475- gera: 98466/di/ra
[TREATMENT OF CHRONIC HEPATITIS B BY
FUFAN HUANGQI YIGAN TANG : A CLINICAL
OBSERVATION OF 39 CASES]. LI JUN, LIU SHIJING,
WANG XIAOMING, ET AL. new journal of traditional
chinese medicine. 2001;33(11):22 (chi*).
2476- gera: 98468/di/ra
[TREATMENT OF FATTY LIVER BASED ON
SYNDROME DIFFERENTIATION : A
CLINICALOBSERVATION OF 52 CASES]. ZHU
YAOQUN, CHEN JUNXIAN, LIN ZUHUI. new journal of
traditional chinese medicine. 2001;33(11):26 (chi*).
2477- gera: 98543/di/ra
[SERAPHARMACOLOGICAL STUDY OF
GANZHENG PERORAL SOLUTION ON
PROLIFERATION AND APOPTOSIS OF HUMAN
HEPATO CELLULAR CARCINOMA SMMC-7721
CELLS WITH TRANSFORMING GROWTH FACTOR
A]. YIN FEI', YAO SHUKUN, GAO HONGSHENG.
chinese journal of integrated traditional and western
medicine on digestion. 2001;9(6):328 (chi*).
2478- gera: 98545/di/ra
[CLINICAL STUDY ON CHRONIC HEPATITIS C
TREATED WITH KIDNEY-TONIFYING GRANULE].
REN JINYU, ET AL. chinese journal of integrated
traditional and western medicine on digestion.
2001;9(6):334 (chi*).
2479- gera: 98547/di/ra
[THERAPEUTIC ACTION OF QINGGAN GRANULE
FOR ACUTE LIVER INJURY]. ZHANG BIN, WANG
LINGTAI, CHEN JIANJIE, ET AL. chinese journal of
integrated traditional and western medicine on digestion.
2001;9(6):339 (chi*).
2480- gera: 98549/di/ra
[INHIBITORY EFFECT OF QUXIAN RUANGAN
CAPSULE (QXRGC) ON HEPATIC FIBROSIS IN
RATS]. YANG QING, ZI-IAO BING, YAN YINGCHUN.
chinese journal of integrated traditional and western
medicine on digestion. 2001;9(6):345 (chi*).
2481- gera: 98550/di/ra
[RELATIONSHIPS BETWEEN TCM TYPE OF
SYNDROMES OF CHRONIC LIVER DISEASES,AND
SERUM LEVELS OF HEPATIC
FIBROSIS,GLYCOCHOLIC ACID]. ZHANG JIAN, LL
NING, XING YONGNING, ET AL. chinese journal of
integrated traditional and western medicine on digestion.
2001;9(6):348 (chi*).
155
Objective: To inquire into the relationships of chronic liver
disease TCM type of syndromes and serum level of hepatic
fibrosis, glycocholic acid, and to deepen the connection of
traditional Chinese medicine and modern medical science.
Methods : The indexed of hepatic fibrosis and serum levels of
glycocholic acid were measured by RIA in 120 patients
which chronic liver diseases with include blood stasis vessel
obstruction syndromes or retention of dampness-heat in the
body, deficiency of liver-Yin and kidney-yin. The normal
control 40 were measured at the same time. Results : The
serum levels of hepatic fibrosis were higher in all the TCM
type of syndromes than in the normal control. The indexes of
glycocholic acid in all the TCM type of syndromes were
higher than in the normal control. It was most notable in the
retention of dampness-heat in the body. Conclusion : These
results suggest that the above-mentioned indexes have
guiding significance for differentiting the TCM types.
2482- gera: 98553/di/ra
[CLINICAL STUDY ON THE EFFECT OF COICIS
SEMEN INJECTION ON PRIMARY HEPATIC
CANCER]. GUAN CHUNSHOU, YI PING, LIN
YANJUAN, ET AL. chinese journal of integrated
traditional and western medicine on digestion.
2001;9(6):355 (chi*).
2483- gera: 98625/di/ra
[RECENT RESEARCH INTO THE TREATMENT OF
PRIMARY LIVER CANCER WITH TRADITIONAL
CHINESE MEDICINE]. FANG YUAN. zhejiang journal
of traditional chinese medicine. 2001;36(11):499 (chi).
2484- gera: 98646/di/ra
[ LI DEXIN'S EXPERIENCE ON TREATMENT OF
CHRONIC HEPATITIS]. JIN HONGSHU ET AL. journal
of traditional chinese medicine. 2001;42(11):652 (eng).
2485- gera: 98652/di/ra
[TREATMENT OF 60 CASES OF SECRETORY
TYMPANITIS BASED ON TCM SYNDROME
DIFFERENTIATION]. XUAN WEIJUN. journal of
traditional chinese medicine. 2001;42(11):670 (eng*).
2486- gera: 98685/di/ra
[EFFECT OF SORBARIA SORBIFOLIA EXTRACT
ON RADICAL RESIDUE RAT WITH LIVER DAMAGE
INDUCED BY CCI4]. ZHANG XUE-WU ET AL. chinese
journal of traditional medical science and technology.
2001;8(6):373 (chi).
2487- gera: 98703/di/ra
[PROBLEMS AND SOLUTIONS IN ANTIFIBROSIS
STUDY OF CHINESE HERBAL DRUGS]. SUN SHOU-
CAI. journal of shaanxi college of traditional chinese
medicine. 2001;24(5):3 (chi).
2488- gera: 98827/di/ra
[PRIMARY CARCINOMA OF LIVER TREATED
WITH TAIE AS WELL AS WITH MEDICINES TO
STRENGTHEN BODY RESISTANCE AND REMOVE
STAGNANCY AND TOXIC SUBSTANCE]. WANG
ZHAO-XIANG ET AL. henan traditional chinese
medicine. 2001;21(6):48 (chi).
2489- gera: 98828/di/ra
[THE ADVANCE IN THE CLINICAL STUDY OF
CHINESE MEDICINES IN THE TREATMENT OF
HEPATIC FIBROSIS]. WANG YING-FANG ET AL.
henan traditional chinese medicine. 2001;21(6):74 (chi).
gera 2011

2490- gera: 98846/di/ra
[PROFESSOR ZHOU MIN'S EXPERIENCE IN
TREATING CHRONIC HEPATITIS]. YANG ZHIJUN.
jiangsu journal of traditional chinese medicine.
2001;22(12):10 (chi).
2491- gera: 98851/di/ra
[TREATMENT OF 84 CASES OF CIRRHOSIS WITH
LOSS OF COMPENSATION WITH TRADITIONAL
CHINESE MEDICINE COMBINED WITH WESTERN
MEDICINE]. SUN SU. jiangsu journal of traditional
chinese medicine. 2001;22(12):22 (chi).
2492- gera: 98882/di/ra
[ANTIOCIDATION OF PRESCRIPTION NO II FOR
ANTI-HEPATITIS B IN EXPERIMENTAL MICE
WITH CHRONIC IMMUNO-HEPATIC INJURY].
QIAN YALIN ET AL. chinese journal of information on
traditional chinese medicine. 2001;8(10):23 (chi).
2493- gera: 98924/di/ra
[EFFECT OF JINFUKANG DECOCTION ON IL-10
AND IFN-Y OF HEPATOCARCINOMA]. SUN GANG
ET AL. shandong journal of traditional chinese medicine.
2001;20(12):721 (chi).
2494- gera: 98978/di/ra
[COMPENSATORY ASCITES DUE TO CIRRHOSIS
(160 CASES) TREATED BY INTEGRATED
TRADITIONAL CHINESE AND WESTERN
MEDICINE]. XU XIAOMEI ET AL. journal of practical
traditional chinese medicine. 2001;12(17):18 (chi*).
2495- gera: 98989/di/ra
[EFFECTIVE OBSERVATION ON 30 CASES OF
CHRONIC HEPATITIS B TREATED WITH THE
THERAPY OF STRENGTHENING - SPLEEN
ACTIVATING - BLOOD SOOTHING - LIVER]. TAN
YING ET AL. hunan journal of traditional chinese
medicine. 2001;17(6):17 (chi).
2496- gera: 99007/di/ra
[THE EFFECT OF STRENGTHENING RESISTANCE
AND SOLIDIFYING HEALTH QI METHOD TO
IMMUNE FUNCTION OF THE PATIENT SUFFERING
HEPATOCIRRHOSIS HYDROPERITONEUM AFTER
HEPATITIS]. CAI JINWEI. tianjin journal of traditional
chinese medicine. 2001;18(6):1 (chi).
2497- gera: 99049/di/ra
[EXPERIMENTAL STUDY OF KANGXIAN-I
CAPSULE ON HEPATIC FIBROSIS RATS]. ZHANG
YUE-YING ET AL. journal of fujian college of traditional
chinese medicine. 2001;11(4):42 (chi*).
2498- gera: 99115/di/ra
[EFFECTS OF TWO TCM DECOCTIONS ON SERUM
LEVELS OF NITROGEN OXIDE AND
INTERLEUKIN-2 IN HEPATIC FIBROSIS MICE]. XU
JIAN ET AL. chinese journal of basic medicine in
traditional chinese medicine. 2001;28(11):28 (chi*).
2499- gera: 99147/di/ra
[CORRELATION BETWEEN CHINESE MEDICAL
SYNDROME AND PATHOLOGICAL STAGE AND
GRADE OF LIVER TISSUE IN PATIENTS WITH
LIVER FIBROSIS FOLLOWING CHRONIC
HEPATITIS B]. WANG BAO-ZHEN. shanghai j0urnal 0f
tradtional chinese medicine. 2001;35(12):10 (chi*).
To investigate the correlation between the Chinese medical
156
syndrome and pathological stage and grade, 133 cases were
randomized into 5 types by syndrome differentiation: type I
(liverdepression and spleen asthenia) , type II (dampness-heat
accumulation) , type IIl (liver-kidney yin-deficiency) , type
IV (spleen-kidney yang deficiency) and type V (blood-stasis
in collateral) . There were striking differences between the
syndrome and the pathological stage and grade. SI and G2
increased in type I S2,G2 and G3 increasing in type II S3,G2
and G3 'increasing, S3, S4 and G4 increasing in type V . It is
indicated that the Chinese medical syndrome of liver fibrosis
has certain pathological basis; the fibrosis increasing with the
hepatitis.
2500- gera: 99182/di/ra
[EXPERIMENTAL STUDY ON THE ACTION OF SHU
GAN RUAN JIAN GRANULE TO PREVENT AND
CURE LIVER FIBROSIS IN RAT]. MA JI ET AL.
liaoning journal of traditional chinese medicine.
2001;28(12):707 (chi*).
2501- gera: 99183/di/ra
[PRIMARY STUDY ON RELATIONSHIP BETWEEN
TCM TYPE OF SYNDROMES AND REPLICATION
OF VIRUS IN PATIENTS WITH CHRONIC
HEPATITIS B]. XING LIAN-JUN ET AL. liaoning
journal of traditional chinese medicine. 2001;28(12):710
(chi*).
Objective: To investigate the relationship between TCM type
of syndromes and replication of virus in patients with chronic
Hepatitis B by the method of survey and study on large
samples. Method : The method of clinical epidemiologic
study-retrospective study was adapted. Result : The survey
materials of 282 cases with chronic hepatitis B were initial
selected by perfected data, normal diagnosis and standard
syndromes. The distribution of their TCM differentiation of
symptoms and signs: stagnation of the liver Qi and deficiency
of the spleen > damp- heat of liver and gall > blood stasis
vessel obstruction syndrome > deficiency of liver-Yin and
kidney-Yin> insufficiency of both the spleen and the kidney,
among all cases, the first and second groups were 84.75 % ;
among stagnation of the liver Qi and deficiency spleen the
HBsAg (+) ,HBeAg (+) are more, the virus are in lower level
replication (R1 = 0. 938, P < 0. 01) ; However, dump-heat of
liver and gall are seen in two types (R2 = 0. 799, P < 0. 0 1) ,
which are HBsAg (+) ,HBeAg (+) , HBcAg (+) , HBVDNA
(+) or HBsAg (+) , HBcAg (+) I above two suggested that the
replication of virus is very active. Conclusion: there was
significant correlation between dump-
2502- gera: 99196/di/ra
[EFFECT OF PELLE RHUBARB AND ZHECHONG
ON THE COLLAGEN OF LIVER AND
MUCOPROTEIN OF BLOOD SERUM IN THE RATS
WITH HEPATIC FIBROSIS IN DIFFERENT STAGES].
LU YUE-QING ET AL. liaoning journal of traditional
chinese medicine. 2001;28(12):762 (chi*).
2503- gera: 99205/di/ra
[EFFECT OF HERBS OF HUO - XUE - HUA - YU
JFTJ-B*,) ON HEPATIC LESION OF
EXPERIMENTAL SEVERE ACUTE PANCREATITIS
IN RATS]. LI GANG ET AL. chinese journal of surgery of
integrated traditional chinese and western medicine.
2001;7(6):393 (chi*).
2504- gera: 99221/di/ra
[TREATMENT OF LIVER FIBROSIS DUE TO
CHRONIC HEPATITIS B WITH TCM,A REPORT OF
50 CASES]. WANG RU-GAO ET AL. shanxi journal of
traditional chinese medicine. 2001;17(6):13 (chi*).
gera 2011

2505- gera: 99231/di/ra
[PROBE INTO CHEN RUI-CHUN'S EXPERIENCE OF
TREATMENT OVER LIVER DISEASES]. ZHOU JIN-
SHENG. jiangxi journal of traditional chinese medicine.
2001;32(6):5 (chi).
2506- gera: 99238/di/ra
[CURATIVE EFFECT ANALYSIS OF TREATMENT
OVER FAT LIVER WITH SHUGANJIANPIFA]. WU
GUO-FAN. jiangxi journal of traditional chinese
medicine. 2001;32(6):24 (chi).
2507- gera: 99248/di/ra
[CLINICAL RESEARCH OF GANYAN LINGWEI
CAPSULE COMLEX THERAPY FOR CHRONIC
HEPATITIS B]. WEN JIANCHUN ET AL. beijing journal
of traditional chinese medicine. 2001;20(6):21 (chi).
2508- gera: 99271/di/ra
[CLINICAL AND EXPERIMENTAL STUDY ON ANTI-
LIVER FIBROSIS EFFECT OF XUELONG
GRANULE]. ZHAO-ZHONG ET AL. journal of external
therapy of traditional chinese medicine. 2001;10(6):813
(chi*).
2509- gera: 99313/di/ra
[PRESENT SITUATION OF HEPATITIS B
RESEARCH IN TAIWAN]. LI QIANGOU. china journal
of traditional chinese medicine and pharmacy.
2001;16(5):67 (chi).
2510- gera: 99316/di/ra
[RESEARCH PROGRESS ON THE TREATMENT OF
LIVER PRIMARY CARCINOMA BY COMBINATION
OF TCD AND INTERVENTION THERAPY]. LI
DONGTAO, ET AL. chinese journal of information on
traditional chinese medicine. 2001;8(11):27 (chi).
2511- gera: 99323/di/ra
[38 CASES OF OBSTINATE CIRRHOSIS ASCITES
TREATED BY ASCITES ULTRAFILTRATION
CONCENTRATION- REINFUSION COMBINED
WITH TCM]. DUAN ZHENGFU ET AL. chinese journal
of information on traditional chinese medicine.
2001;8(11):63 (chi).
2512- gera: 99405/di/ra
[CLINICAL OBSERVATION ON NON -
COMPENSATORY HEPATO CIRRHOSES TREATED
BY LINGDANWANG GELATINE CAPSULE]. HUANG
YAPING ET AL. inner mongol journal of traditional
chinese medicine. 2001;20(4):1 (chi).
2513- gera: 99408/di/ra
[CLINICAL OBSERVATION ON 118 CASES
SUFFERED FROM ASCITES CAUSED BY HEPATIC
CIRRHOSIS TREATED BY SELECTION OF
TREATMENT BASED ON THE DIFFERENTIAL
DIAGNOSIS]. JIANG CHUNSHUI ET AL. inner mongol
journal of traditional chinese medicine. 2001;20(4):7 (chi).
2514- gera: 99412/di/ra
[UNDER GUIDANCE OF COLOR
ULTRASONOGRAPH,TRADITIONAL CHINESE
MEDICINE IN COMBINATION WITH PURE
ALCOHOL WAS APPLIED TO THE TREATMENT OF
PRIMARY HEPATIC CANCER]. YOU JIANLIANG ET
AL. inner mongol journal of traditional chinese medicine.
2001;20(4):27 (chi).
157
2515- gera: 99487/di/ra
OBSERVATION OF THE EFFECTS OF
ACUPUNCTURE THERAPY ON CHRONIC ACTIVE
HEPATITIS B. FU LANGLIN. international journal of
clinical acupuncture. 2001;12(3):281-84 (eng).
Up to now, there is no specific therapy to treat chronic active
Hepatitis B. Most antiviral drugs are too expensive to be
applied widely. A satisfactory curative effect for chronic
active Hepatitis B with acupuncture therapy was attained in
my clinic and the following is a report.
2516- gera: 99647/di/ra
[SERAPHARMACOLOGICAL STUDY OF
GANZHENG PERORAL SOLUTION ON
PROLIFERATION AND APOPTOSIS OF HUMAN
HEPATO CELLULAR CARCINOMA SMMC-7721
CELLS WITH TRANSFORMING GROWTH FACTOR
A]. YIN FEI', YAO SHUKUN, GAO HONGSHENG.
chinese journal of integrated traditional and western
medicine on digestion. 2001;9(6):328 (chi*).
2517- gera: 99649/di/ra
[CLINICAL STUDY ON CHRONIC HEPATITIS C
TREATED WITH KIDNEY-TONIFYING GRANULE].
REN JINYU, ET AL. chinese journal of integrated
traditional and western medicine on digestion.
2001;9(6):334 (chi*).
2518- gera: 99651/di/ra
[THERAPEUTIC ACTION OF QINGGAN GRANULE
FOR ACUTE LIVER INJURY]. ZHANG BIN, WANG
LINGTAI, CHEN JIANJIE, ET AL. chinese journal of
integrated traditional and western medicine on digestion.
2001;9(6):339 (chi*).
2519- gera: 99653/di/ra
[INHIBITORY EFFECT OF QUXIAN RUANGAN
CAPSULE (QXRGC) ON HEPATIC FIBROSIS IN
RATS]. YANG QING, ZI-IAO BING, YAN YINGCHUN.
chinese journal of integrated traditional and western
medicine on digestion. 2001;9(6):345 (chi*).
2520- gera: 99654/di/ra
[RELATIONSHIPS BETWEEN TCM TYPE OF
SYNDROMES OF CHRONIC LIVER DISEASES,AND
SERUM LEVELS OF HEPATIC
FIBROSIS,GLYCOCHOLIC ACID]. ZHANG JIAN, LL
NING, XING YONGNING, ET AL. chinese journal of
integrated traditional and western medicine on digestion.
2001;9(6):348 (chi*).
Objective: To inquire into the relationships of chronic liver
disease TCM type of syndromes and serum level of hepatic
fibrosis, glycocholic acid, and to deepen the connection of
traditional Chinese medicine and modern medical science.
Methods : The indexed of hepatic fibrosis and serum levels of
glycocholic acid were measured by RIA in 120 patients
which chronic liver diseases with include blood stasis vessel
obstruction syndromes or retention of dampness-heat in the
body, deficiency of liver-Yin and kidney-yin. The normal
control 40 were measured at the same time. Results : The
serum levels of hepatic fibrosis were higher in all the TCM
type of syndromes than in the normal control. The indexes of
glycocholic acid in all the TCM type of syndromes were
higher than in the normal control. It was most notable in the
retention of dampness-heat in the body. Conclusion : These
results suggest that the above-mentioned indexes have
guiding significance for differentiting the TCM types.
2521- gera: 99657/di/ra
gera 2011

[CLINICAL STUDY ON THE EFFECT OF COICIS
SEMEN INJECTION ON PRIMARY HEPATIC
CANCER]. GUAN CHUNSHOU, YI PING, LIN
YANJUAN, ET AL. chinese journal of integrated
traditional and western medicine on digestion.
2001;9(6):355 (chi*).
2522- gera: 99729/di/ra
[RECENT RESEARCH INTO THE TREATMENT OF
PRIMARY LIVER CANCER WITH TRADITIONAL
CHINESE MEDICINE]. FANG YUAN. zhejiang journal
of traditional chinese medicine. 2001;36(11):499 (chi).
2523- gera: 99750/di/ra
[ LI DEXIN'S EXPERIENCE ON TREATMENT OF
CHRONIC HEPATITIS]. JIN HONGSHU ET AL. journal
of traditional chinese medicine. 2001;42(11):652 (eng).
2524- gera: 99756/di/ra
[TREATMENT OF 60 CASES OF SECRETORY
TYMPANITIS BASED ON TCM SYNDROME
DIFFERENTIATION]. XUAN WEIJUN. journal of
traditional chinese medicine. 2001;42(11):670 (eng*).
2525- gera: 99789/di/ra
[EFFECT OF SORBARIA SORBIFOLIA EXTRACT
ON RADICAL RESIDUE RAT WITH LIVER DAMAGE
INDUCED BY CCI4]. ZHANG XUE-WU ET AL. chinese
journal of traditional medical science and technology.
2001;8(6):373 (chi).
2526- gera: 99807/di/ra
[PROBLEMS AND SOLUTIONS IN ANTIFIBROSIS
STUDY OF CHINESE HERBALDRUGS]. SUN SHOU-
CAI. journal of shaanxi college of traditional chinese
medicine. 2001;24(5):3 (chi).
2527- gera: 99931/di/ra
[PRIMARY CARCINOMA OF LIVER TREATED
WITH TAIE AS WELL AS WITH MEDICINES TO
STRENGTHEN BODY RESISTANCE AND REMOVE
STAGNANCY AND TOXIC SUBSTANCE]. WANG
ZHAO-XIANG ET AL. henan traditional chinese
medicine. 2001;21(6):48 (chi).
2528- gera: 99932/di/ra
[THE ADVANCE IN THE CLINICAL STUDY OF
CHINESE MEDICINES IN THE TREATMENT OF
HEPATIC FIBROSIS]. WANG YING-FANG ET AL.
henan traditional chinese medicine. 2001;21(6):74 (chi).
2529- gera: 99950/di/ra
[PROFESSOR ZHOU MIN'S EXPERIENCE IN
TREATING CHRONIC HEPATITIS]. YANG ZHIJUN.
jiangsu journal of traditional chinese medicine.
2001;22(12):10 (chi).
2530- gera: 99955/di/ra
[TREATMENT OF 84 CASES OF CIRRHOSIS WITH
LOSS OF COMPENSATION WITH TRADITIONAL
CHINESE MEDICINE COMBINED WITH WESTERN
MEDICINE]. SUN SU. jiangsu journal of traditional
chinese medicine. 2001;22(12):22 (chi).
2531- gera: 99986/di/ra
[ANTIOCIDATION OF PRESCRIPTION NO II FOR
ANTI-HEPATITIS B IN EXPERIMENTAL MICE
WITH CHRONIC IMMUNO-HEPATIC INJURY].
QIAN YALIN ET AL. chinese journal of information on
traditional chinese medicine. 2001;8(10):23 (chi).
158
2532- gera: 100028/di/ra
[EFFECT OF JINFUKANG DECOCTION ON IL-10
AND IFN-Y OF HEPATOCARCINOMA]. SUN GANG
ET AL. shandong journal of traditional chinese medicine.
2001;20(12):721 (chi).
2533- gera: 100082/di/ra
[COMPENSATORY ASCITES DUE TO CIRRHOSIS
(160 CASES) TREATED BY INTEGRATED
TRADITIONAL CHINESE AND WESTERN
MEDICINE]. XU XIAOMEI ET AL. journal of practical
traditional chinese medicine. 2001;12(17):18 (chi*).
2534- gera: 100093/di/ra
[EFFECTIVE OBSERVATION ON 30 CASES OF
CHRONIC HEPATITIS B TREATED WITH THE
THERAPY OF STRENGTHENING - SPLEEN
ACTIVATING - BLOOD SOOTHING - LIVER]. TAN
YING ET AL. hunan journal of traditional chinese
medicine. 2001;17(6):17 (chi).
2535- gera: 100111/di/ra
[THE EFFECT OF STRENGTHENING RESISTANCE
AND SOLIDIFYING HEALTH QI METHOD TO
IMMUNE FUNCTION OF THE PATIENT SUFFERING
HEPATOCIRRHOSIS HYDROPERITONEUM AFTER
HEPATITIS]. CAI JINWEI. tianjin journal of traditional
chinese medicine. 2001;18(6):1 (chi).
2536- gera: 100153/di/ra
[EXPERIMENTAL STUDY OF KANGXIAN-I
CAPSULE ON HEPATIC FIBROSIS RATS]. ZHANG
YUE-YING ET AL. journal of fujian college of traditional
chinese medicine. 2001;11(4):42 (chi*).
2537- gera: 100219/di/ra
[EFFECTS OF TWO TCM DECOCTIONS ON SERUM
LEVELS OF NITROGEN OXIDE AND
INTERLEUKIN-2 IN HEPATIC FIBROSIS MICE]. XU
JIAN ET AL. chinese journal of basic medicine in
traditional chinese medicine. 2001;28(11):28 (chi*).
2538- gera: 100251/di/ra
[CORRELATION BETWEEN CHINESE MEDICAL
SYNDROME AND PATHOLOGICAL STAGE AND
GRADE OF LIVER TISSUE IN PATIENTS WITH
LIVER FIBROSIS FOLLOWING CHRONIC
HEPATITIS B]. WANG BAO-ZHEN. shanghai j0urnal 0f
tradtional chinese medicine. 2001;35(12):10 (chi*).
To investigate the correlation between the Chinese medical
syndrome and pathological stage and grade, 133 cases were
randomized into 5 types by syndrome differentiation: type I(
liverdepression and spleen asthenia ), type II ( dampness-heat
accumulation) , type IIl ( liver-kidney yin-deficiency ) , type
IV (spleen-kidney yang deficiency) and type V ( blood-stasis
in collateral) . There were striking differences between the
syndrome and the pathological stage and grade. SI and G2
increased in type I S2,G2 and G3 increasing in type II S3,G2
and G3 'increasing, S3, S4 and G4 increasing in type V . It is
indicated that the Chinese medical syndrome of liver fibrosis
has certain pathological basis; the fibrosis increasing with the
hepatitis.
2539- gera: 100286/di/ra
[EXPERIMENTAL STUDY ON THE ACTION OF SHU
GAN RUAN JIAN GRANULE TO PREVENT AND
CURE LIVER FIBROSIS IN RAT]. MA JI ET AL.
liaoning journal of traditional chinese medicine.
2001;28(12):707 (chi*).
gera 2011

2540- gera: 100287/di/ra
[PRIMARY STUDY ON RELATIONSHIP BETWEEN
TCM TYPE OF SYNDROMES AND REPLICATION
OF VIRUS IN PATIENTS WITH CHRONIC
HEPATITIS B]. XING LIAN-JUN ET AL. liaoning
journal of traditional chinese medicine. 2001;28(12):710
(chi*).
Objective: To investigate the relationship between TCM type
of syndromes and replication of virus in patients with chronic
Hepatitis B by the method of survey and study on large
samples. Method : The method of clinical epidemiologic
study-retrospective study was adapted. Result : The survey
materials of 282 cases with chronic hepatitis B were initial
selected by perfected data, normal diagnosis and standard
syndromes. The distribution of their TCM differentiation of
symptoms and signs: stagnation of the liver Qi and deficiency
of the spleen > damp- heat of liver and gall > blood stasis
vessel obstruction syndrome > deficiency of liver-Yin and
kidney-Yin> insufficiency of both the spleen and the kidney,
among all cases, the first and second groups were 84.75 % ;
among stagnation of the liver Qi and deficiency spleen the
HBsAg( + ),HBeAg( + ) are more, the virus are in lower level
replication (R1 = 0. 938, P < 0. 01); However, dump-heat of
liver and gall are seen in two types(R2 = 0. 799, P < 0. 0 1),
which are HBsAg( + ),HBeAg( + ), HBcAg( + ), HBVDNA(
+ ) or HBsAg( + ), HBcAg( + ) I above two suggested that
the replication of virus is very active. Conclusion: there was
significant correlation between dump-
2541- gera: 100300/di/ra
[EFFECT OF PELLE RHUBARB AND ZHECHONG
ON THE COLLAGEN OF LIVER AND
MUCOPROTEIN OF BLOOD SERUM IN THE RATS
WITH HEPATIC FIBROSIS IN DIFFERENT STAGES].
LU YUE-QING ET AL. liaoning journal of traditional
chinese medicine. 2001;28(12):762 (chi*).
2542- gera: 100325/di/ra
[TREATMENT OF LIVER FIBROSIS DUE TO
CHRONIC HEPATITIS B WITH TCM, A REPORT OF
50 CASES]. WANG RU-GAO ET AL. shanxi journal of
traditional chinese medicine. 2001;17(6):13 (chi*).
2543- gera: 100335/di/ra
[PROBE INTO CHEN RUI-CHUN'S EXPERIENCE OF
TREATMENT OVER LIVER DISEASES]. ZHOU JIN-
SHENG. jiangxi journal of traditional chinese medicine.
2001;32(6):5 (chi).
2544- gera: 100342/di/ra
[CURATIVE EFFECT ANALYSIS OF TREATMENT
OVER FAT LIVER WITH SHUGANJIANPIFA]. WU
GUO-FAN. jiangxi journal of traditional chinese
medicine. 2001;32(6):24 (chi).
2545- gera: 100352/di/ra
[CLINICAL RESEARCH OF GANYAN LINGWEI
CAPSULE COMLEX THERAPY FOR CHRONIC
HEPATITIS B]. WEN JIANCHUN ET AL. beijing journal
of traditional chinese medicine. 2001;20(6):21 (chi).
2546- gera: 100375/di/ra
[CLINICAL AND EXPERIMENTAL STUDY ON ANTI-
LIVER FIBROSIS EFFECT OF XUELONG
GRANULE]. ZHAO-ZHONG ET AL. journal of external
therapy of traditional chinese medicine. 2001;10(6):813
(chi*).
2547- gera: 100417/di/ra
159
[PRESENT SITUATION OF HEPATITIS B
RESEARCH IN TAIWAN]. LI QIANGOU. china journal
of traditional chinese medicine and pharmacy.
2001;16(5):67 (chi).
2548- gera: 100420/di/ra
[RESEARCH PROGRESS ON THE TREATMENT OF
LIVER PRIMARY CARCINOMA BY COMBINATION
OF TCD AND INTERVENTION THERAPY]. LI
DONGTAO, ET AL. chinese journal of information on
traditional chinese medicine. 2001;8(11):27 (chi).
2549- gera: 100427/di/ra
[38 CASES OF OBSTINATE CIRRHOSIS ASCITES
TREATED BY ASCITES ULTRAFILTRATION
CONCENTRATION- REINFUSION COMBINED
WITH TCM]. DUAN ZHENGFU ET AL. chinese journal
of information on traditional chinese medicine.
2001;8(11):63 (chi).
2550- gera: 100509/di/ra
[CLINICAL OBSERVATION ON NON -
COMPENSATORY HEPATO CIRRHOSES TREATED
BY LINGDANWANG GELATINE CAPSULE]. HUANG
YAPING ET AL. inner mongol journal of traditional
chinese medicine. 2001;20(4):1 (chi).
2551- gera: 100512/di/ra
[CLINICAL OBSERVATION ON 118 CASES
SUFFERED FROM ASCITES CAUSED BY HEPATIC
CIRRHOSIS TREATED BY SELECTION OF
TREATMENT BASED ON THE DIFFERENTIAL
DIAGNOSIS]. JIANG CHUNSHUI ET AL. inner mongol
journal of traditional chinese medicine. 2001;20(4):7 (chi).
2552- gera: 100516/di/ra
[UNDER GUIDANCE OF COLOR
ULTRASONOGRAPH, TRADITIONAL CHINESE
MEDICINE IN COMBINATION WITH PURE
ALCOHOL WAS APPLIED TO THE TREATMENT OF
PRIMARY HEPATIC CANCER]. YOU JIANLIANG ET
AL. inner mongol journal of traditional chinese medicine.
2001;20(4):27 (chi).
2553- gera: 101177/di/ra
[ANALYSIS ON CHANGES OF ELECTRIC
FREQUENCY SPECTRUM OF THE COLON IN 163
CASES OF ABNORMAL DEFECATION OF
DIFFERENT SYNDROMES]. LIAN ZHICHENG ET AL.
journal of tcm. 2001;42(5):294 (chi).
Statistical analysis of TCM syndrome differentiation and
clinical symptoms were made in 163 cases of diseases of
digestive tract. It was found that the patients of abnormal
defecation or tendency of abnormal defecation with the
hyperactive liver-Qi attacking the spleen, stagnation of liver-
Qi due to hypofunction of the spleen, loose stool due to
deficiency of spleen, constipation due to Qi-deficiency,
constipation due to Qi-stagnation syndromes accounted for
60%-100%. Electric examination of colon on the body
surface and analysis of frequency spectrum found that
hyperelectroactivity of low-frequency and high-frequency
segment of colon and contractive complex myoelectric
hyperactivity in the patients of the hyperactive liver-Qi
attacking the spleen; hyperelectroactivity of high-frequency
segment of the ascending and descending colon and
contractive complex myoelectric hyperactivity and decrease
of electric activity of high-frequency segment of the sigmoid
colon in the patients of loose stool due to hypofunction of the
spleen; obvious decrease of electric activity of low-frequency
and high-frequency of the colon and contractive complex
gera 2011

myoelectric hyperactivity in the patients of constpation due to
deficiency of Qi or Qi- stagnation, but electric activity of the
high-frequency segment of the colon and contractive
complex myoelectric after meal in the patients of constipation
due to Qi-stagnation was stronger than that in the patients of
constipation due to Qi-deficiency. Electric frequency
spectrum of colon can indirectly reflect changes of colon
dynamics of different syndromes, and it can partially expain
the changes of stool and the mechanism of relative
2554- gera: 101207/di/ra
[RESEARCH INFORMATION ON THE PATHOLOGY
OF TCM OF LIVER FIBROSIS OF HEPATITIS-B]. LIU
SHAONENEG. information on tcm. 2001;18(6):10 (chi).
2555- gera: 101226/di/ra
[THE RESEARCH DEVELOPMENT OF CHINESE
HERBS WITH EFFECTS OF PROTECTING LIVER].
HAN JINGLAN ET AL. information on tcm. 2001;18(2):22
(chi).
2556- gera: 104376/di/ra
[CLINICAL STUDIES ON TREATING LIVER
CANCER WITH TRADITIONAL CHINESE HERBS
COMPANYING WITH INTERVENE TREATMENT].
TIAN HUANGAN, LIANG GUI-WEN, TAO YIN, ET AL.
henan journal of traditional chinese medicine and
pharmacy. 2001;16(1):47 (chi).
2557- gera: 104434/di/ra
[CLINICAL AND EXPERIMENTAL STUDIES ON
GAN BAO CHONG JI ANTAGONISING HEPATIC
FIBROSIS IN THE PATIENT OF HEPATITIS B]. PAN
XUEFEI, ZHANG CHANGFA, LIU YINGNA, ET AL.
journal of traditional chinese medicine. 2001;42(7):415
(eng*).
2558- gera: 104521/di/ra
[AN OBSERVATION OF THE EFFECT OF HEPATIC
FIBROSIS FROM CHRONIC HEPATITIS TREATED
WITH IMPROVEMENT PERCEPTION OF KANGSHI
COMBINED WITH GANLIXIN INJECTION]. RUAN
QINGFA. hebei journal of traditional chinese medicine.
2001;23(8):565 (chi*).
2559- gera: 104530/di/ra
[EFFECT OF GANLIXIN COMBINED WITH
LIGANLONG INSTANT POWDER ON CHRONIC
VIRAL HEPATITIS B]. MA HANQIAN, ZHOU LIPING.
hebei journal of traditional chinese medicine.
2001;23(8):631 (chi).
2560- gera: 104560/di/ra
[CLINICAL STUDY OF APPLICATION OF YINZHEN
TEA TO ICTEROHEPATITIS]. CAI YOE, GAO
KARMEN, QIU MEIHONG EL AL. hebei journal of
traditional chinese medicine. 2001;23(9):655 (chi*).
2561- gera: 104567/di/ra
[CLINICAL EFFECT OF FUFANG DANSHEN
INJECTION INTEGRATED WITH CF BY THORACIC
INJECTION ON MALIGNANT ASCITES]. SHI
ZHIYAN LUO YONG MENG JIAHUI. hebei journal of
traditional chinese medicine. 2001;23(4):248 (chi*).
2562- gera: 104585/di/ra
[INFLUENCE OF SALVIA MILTIORRHIZAE AND
ASTRAGALUS MEMBRANACEUS ON
HEMODYNAMICS AND LIVER FIBROSIS INDEXES
IN LIVER CIRRHOTIC PATIENTS WITH PORTAL
160
HYPERTENSION*]. TAN YOU-WEN YIN YU-MEI, YU
XUE-JUN, ET AL. chinese journal of integrated
traditional and western medicine. 2001;21(5):351 (chi*).
2563- gera: 104612/di/ra
[TREATMENT OF 50 CASES OF LATER LUNG
CANCER WITH WENYANG YIQI DECOCTION].
CHEN SHI-WEI, WANG XIN . shandong journal of
traditional chinese medicine. 2001;20(10):589 (chi).
2564- gera: 104673/di/ra
[EFFECTS OF CHINESE MEDICINALS WITH
RIGHT-SUPPORTING AND PHLEM-
TRANSFORMING ACTIONS ON ALBUMIN
SYNTHESIS AND SECRETION OF FIBROUS
HEPATIC CELLS OF RATS IN VITRO]. LI XU-DONG
WANG SHU-HUAI ET AL. chinese traditional patent
medicine. 2001;23(4):274 (chi*).
2565- gera: 104674/di/ra
[STUDY ON CHEMICAL CONSTITUENTS OF
VOLATILE OIL FROM ARTEMISIA ANNUA L. BY
GC-MS]. QIU QIN CUI ZHAO-JIE ET AL. chinese
traditional patent medicine. 2001;23(4):278 (chi*).
2566- gera: 104684/di/ra
[REGULATING AND PROTECTION ACTIONS OF
GUSHENCHANGAN CAPSULES ON DIGESTIVE
TRACT REACTION INDUCED BY RADIOTHERAPY
AND CHEMOTHERAPY]. HAN YU-XIA PING YU-
HUA. chinese traditional patent medicine. 2001;23(4):303
(chi*).
2567- gera: 105874/di/ra
[NEW PROGRESS IN EXPERIMENTAL STUDY OF
ANTI - LIVER - FIBROSIS DRUG]. ZHONG MING.
guangxi journal of traditional chinese medicine.
2001;24(5):7 (chi).
2568- gera: 107094/di/ra
CLINICAL STUDY ON REVERSING HEPATIC
FIBROSIS WITH HANDAN. GANLE CAPSULE.
CHENG MING-LIANG, LU YIN-YING, WU JUN, ET AL.
chinese journal of integrated traditional and western
medicine (english edition). 2001;7(1):16 (eng).
2569- gera: 107097/di/ra
COMPARISON ON EFFICACY BETWEEN
ASTRAGALUS POLYGONUM ANTI-FIBROSIS
DECOCTION AND JINSHUIBAO CAPSULE IN
TREATING LIVER FIBROSIS OF CHRONIC
HEPATITIS B. CHEN HAN-CHENG, WENG LUN-HUA.
chinese journal of integrated traditional and western
medicine (english edition). 2001;7(1):26 (eng).
2570- gera: 107119/di/ra
STUDY ON TREATMENT OF 313 PATIENTS WITH
MID-LATE PRIMARY HEPATOCARCINOMA BY
INTEGRATED TRADITIONAL CHINESE AND
WESTERN MEDICINE. LING CHANG-QUAN, CHEN
ZHE, ZHU DE-ZENG, ET AL. chinese journal of
integrated traditional and western medicine (english
edition). 2001;7(4):256 (eng).
2571- gera: 107120/di/ra
STUDY ON TREATMENT OF PRIMARY HEPATIC
CARCINOMA BY ARTERIAL PERFUSION
EMBOLIZATION WITH ZEDOARY TURMERIC OIL.
CHENG JIAN-HUA, CHANG GANG, WU WAN-YIN, ET
AL. chinese journal of integrated traditional and western
gera 2011

medicine (english edition). 2001;7(4):261 (eng).
2572- gera: 107127/di/ra
OBSERVATION ON THE EFFECT OF AIDI
INJECTION COMBINED WITH INTERVENTION
CHEMOTHERAPY IN TREATING MIDDLE-
ADVANCED HEPATOCARCINOMA. WANG XIAO-
HONG, AND LIU YU-MAO. chinese journal of integrated
traditional and western medicine (english edition).
2001;7(4):297 (eng).
2573- gera: 108895/di/ra
STUDY ON THE EFFECT OF CHINESE HERBAL
MEDICINE IN REGULATING PERITONEAL
LYMPHATIC STOMATA AND ENHANCING
DRAINAGE OF ASCITES IN MICE WITH LIVER
FIBROSIS. LI JI-CHENG, YUAN SHU-HUI, ZHAO JIAN-
PEI, ET AL. chinese journal of integrated traditional and
western medicine. 2001;7(2):121 (eng).
2574- gera: 111775/di/ra
[STATISTICAL ANALYSIS OF CLINICALLY
REPORTED SYNDROMES DIFFERENTIATION OF
2492 PHC CASES]. LI YONG-JIAN ET AL. chinese j
basic med tcm. 2001;7(6):71 (chi*).
2575- gera: 111824/di/ra
AN EXPERIMENTAL STUDY ON DRUGS FOR
IMPROVING BLOOD CIRCULATION AND
REMOVING BLOOD STASIS IN TREATING MILD
CHRONIC HEPATIC DAMAGE. ME FENGYING, LI
XIAOLIANG, SUN KEWEI ET AL. journal of tcm.
2001;21(3):225 (eng*).
2576- gera: 112490/di/ra
LIVER CLEARANCE AND EAV. KRAVCHENKO L.
deutsche zeitschrift fur akupunktur. 2001;44(2a):228
(deu).
2577- gera: 115481/di/ra
LIVER CLEARANCE AND EAV. KRAVCHENKO L.
deutsche zeitschrift fur akupunktur. 2001;44(2a):228
(deu).
Liver clearance and a number of its methods have been
known for a long time.. However, even nowadays some
opponents whether it is entitled to belong to medicine at all,
are raised the discussion about the effectiveness of the
process and a question, From the group of patients, who have
undergone the liver clearance using olive oil as a cholagoga,
10 women under 45. years old were chosen for EAV testing
before lore the liver clearance and a month after it. Three
patients were testing more than two times. The second testing
was carried out on the fifth day after liver clearance. We have
worked out a special algorithm of testing pathological liver
sufferers. All of them had subjective liver problems, while
six patients had clinically proved disorders of liver functions
(2 pac.- cholelithiasis, 2 pac.; steatosis, 2 pac.; hepatitis
chronica with icterus in anamnesis). Before the liver
clearance all 10 patients registrated increased liver meridian
indices up to 89. On the 5' day after the liver clearance the
liver meridian indices rose by 9 to 14 per cent, moreover,
spleen meridian indices, which were at normal level before
the liver clearance after it rose as well. After a month patients
had their indices back to normal level, while 4 patients tad
still their liver meridian indices above the normal level.
Dynamics of other meridian indices, e.g. gallbladder, was not
proved. Subjectively all the 10 patients characterised their
condition either as improved or dramatically improved. One
of the most typical subjective feelings was the feeling of
lightness and absence of tiredness, which the patients had not
161
enjoyed for a long time. Biochemical liver tests came to
normal after 2 months in three cases, and 3 patients registered
improved results. Resistant patients without objective
improvement signs, required as testified our further
experience, to carry out the liver clearance from 3 to 5 times
to achieve stable clinical effect. It is important to take into
account that after the liver clearance all the patients began to
keep at least partly a diet and follow a healthy life style,
which could have also contributed to their improved
condition. EAV can undoubtfully serve as an objective
criterion for the liver clearance effectiveness, especially
provided the tests are carried out twice before and after the
liver clearance with an interval of at least 30 to 40 days
between them. Therefore, the liver clearance must be
considered as a medical method, which, however, is not
panacea,
2578- gera: 100378/nd/re
EFFECT OF SALVIANOLIC ACID B ON COLLAGEN
PRODUCTION AND MITOGEN-ACTIVATED
PROTEIN KINASE ACTIVITY IN RAT HEPATIC
STELLATE CELLS. LIU P ET AL. acta pharmacol sin.
2002;23(8):733-738 (eng).
To investigate the mechanism of salvianolic acid-B (SA-B)
action against liver fibrosis relating to mediating hepatic
stellate cell (HSC) activation and transforming growth factor-
beta1(TGF-beta1) intracellular signal transduction.
METHODS: HSC was isolated from normal rat through in
situ perfusion of liver with pronase E and density-gradient
centrifugation with 11 % nycondenz, then cells were
subcultured. Cell proliferation was observed by [3H]TdR
uptake. Cellular collagen deposition was measured with
Ponceau S stain and semi-quantified with image analytic
system. Type I collagen secretion in the supernatant was
detected with ELISA. The gene expression of type I pro-
collagen was analyzed by RT-PCR. The supernatant was
acidified and active TGF-beta1 contents were assayed with
ELISA. Mitogen-activated protein kinase (MAPK) activity
was analyzed with immunoprecipitation and Western blot.
RESULTS: SA-B 0.1, 1, 10, and 100 &mgr;mol/L
suppressed HSC proliferation concentration-dependently as
determined by [3H]TdR uptake by 94.1 %, 82.4 %, 62.7 %,
and 4 % of the control respectively (P<0.05 or P<0.01). SA-B
1, 10, and 100 &mgr;mol/L inhibited soluble type I collagen
secretion by 75.3 %, 69.8 %, and 63.5 % of the control and
decreased the matrix collagen deposition to 86.2 %, 75.4 %,
and 73.4 % (P<0.05 or P<0.01). SA-B 1 and 10 &mgr;mol/L
decreased the cell active TGF-beta1 secretion by 63.3 % and
15.6 % of the control, down-regulated pro-collgen alpha1(I)
mRNA expression to 77.0 % and 51.8 % respectively
(P<0.05). SA-B 1 and 10 &mgr;mol/L also inhibited MAPK
activity by 1 to 2 fold respectively. CONCLUSION: SA-B
inhibited HSC proliferation and collagen production as well
as decreased the cells' TGF- beta1 autocrine and MAPK
activity, which might contribute to the mechanism of SA-B
action against hepatic
2579- gera: 101089/di/ra
[CLINICAL INVESTIGATION ON TREATMENT OF
CHRONIC HEPATITIS C WITH BINGGANNING
GRANULE]. YIN JIE ET AL. journal of nanjing
university tcm. 2002;18(1):21 (chi).
2580- gera: 101092/di/ra
[EFFECT OF COMBINED USE OF HERBA
SARGASSII AND RADIX GLYCYRRHIZOE
URALENSIS ON MICE'S DRUG METABOLIZING
ENZYME OF LIVER]. DING XUAN-SHENG ET AL.
journal of nanjing university tcm. 2002;18(1):33 (chi).
gera 2011

2581- gera: 101268/di/ra
[THE EFFECTS OF RHUBARB ON THE FUNCTION
OF MITOCHONDRIA OF HEPATIC CELL IN POST -
TRAUMA SEPSIS]. CHEN DE-CHANG ET AL. chinese
journal of integrated traditional and western medicine in
intensive and criti. 2002;9(1):9 (chi*).
2582- gera: 101283/di/ra
[SYNDROME DIFFERENTIATION OF SEVERE
HEPATITIS]. ZHOU ZHONGYING. new journal of
traditional chinese medicine. 2002;34(3):3 (chi*).
Severe hepatitis is a Critical disease with rapid
hepatonecrosis and serious damage of liver function, which is
marked by acute onset rapid progress, many complications,
difficult freatment and high mortality. Jaundice is the chief
manifestation. In TCM, the disease belongs to the category of
"acute jaundice" . The pathogenesis is considered as
overabundance of damp heat in middle -jiao and
accumulation of Pestilential toxin in the heart, liver and triple
- jiao. Exhaustion of yin - qi and collapse occur as a result of
retention of healthy qi, heat - toxin. Treatment should accord
with syndrome differentiation, and clearing heat, expelling
damp, remoring toxic substance, purging fu - organs, cooling
blood, removing blood - stasis, promoting diuretics and
preventing collapse
2583- gera: 101308/di/ra
[GENERAL SITUATION OF TCM RESEARCHES ON
FATTY LIVER]. TI GUIXIANG, ET AL. chinese journal
of information on traditional chinese medicine.
2002;9(2):83 (chi).
2584- gera: 101312/di/ra
[CLINICAL OBSERVATION ON MODIFIED LIUWEI
SIPING DECOCTION FOR TREATING CHRONIC
HEPATITIS B]. LI SHU-FEN ET AL. fujian journal of
traditional chinese medicine. 2002;33(1):6 (chi).
2585- gera: 101333/di/ra
[EXPERIMENTAL STUDY ON LIVER PROTECTIVE
EFFECT OF ARTEMISIA RUPESTRIS EXTRACT*].
ISRAPIL, ET AL . chinese journal of integrated
traditional and western medicine. 2002;22(2):126 (chi*).
2586- gera: 101336/di/ra
[OBSERVATION ON SHORT-TERM EFFECTS OF
HAIZHU YIGAN CAPSULE IN TREATING CHRONIC
HEPATITIS B]. SHENG GUO-GUANG. chinese journal
of integrated traditional and western medicine.
2002;22(2):136 (chi).
2587- gera: 101346/di/ra
[[STUDY ON CORRELATIVITY OF DEVELOPMENT
OF ILLNESS STATE WITH CHANGES OF
BIOCHEMICAL INDEXES IN THE CASES OF
HEPATITIS B AND E WITH OVERLAPPING
INFECTIONS E OF THE LIVER AND
GALLBLADDER DAMPNESS-HEAT WANG YUQUN
ET AL. journal of traditional chinese medicine.
2002;43(2):117 (chi*).
As the patient of hepatitis B and E overlapping infection of
liver and gallbladder damp - heat type compared with the
patient of simple hepatitis E of liver and gallbladder
dampheat type, attack was very rapid, jaundice exacerbated
progressively and hepatic function damaged severely. After
treatment the state of illness restored more slowly and the
duration of illness was obviously prolonged. At the same
time, it was found that the biochemical indexes (hyaluronic
acid, total bile acid) increased significantly at acute stage,
and the indexes in the patient of overlapping infection in the
162
time for recovering normality at restoration stage was longer
than that in the patient of simple hepatitis E, with a
significantly difference between the two groups. It is
indicated that lesion of the liver in the patient of overlapping
infection of hepatitis B and E was more severe than the
simple hepatitis
2588- gera: 101389/di/ra
[RESEARCH INTO METHYLATION OF Y-
GLUTAMYL-TRANSPEPTIDASE (GGT) GENE IN
THE HEPATOCELLULAR CARCINOMA *]. LU
DONGDONG ET AL. chinese journal of integrated
traditional and western medicine on liver diseases.
2002;12(1):4 (chi*).
2589- gera: 101390/di/ra
[THERAPEUTIC EFFECT OF COMPLEX
PRESCRIPTION-GANXIN ON HEPATIC FIBROSIS*].
SU LIWEN ET AL. chinese journal of integrated
traditional and western medicine on liver diseases.
2002;12(1):6 (chi*).
2590- gera: 101391/di/ra
[SERUM MDA, GSH-PX, SOD 'AND AFTER
TREATMENT OF REDUCED GLUTATHIONE FOR
PATIENTS WITH CHRONIC LIVER DISEASES*]. SHI
JUN ET AL. chinese journal of integrated traditional and
western medicine on liver diseases. 2002;12(1):8 (chi*).
2591- gera: 101392/di/ra
[INFLUENCE OF DECOCTION RENSHENG SIWU
ON LEVEL OF SERUM ELEMENT ZN AND LIVER
FUNCTION IN PATIENTS WITH CHRONIC VIRAL
HEPATITIS *]. WANG YUQIANG ET AL. chinese
journal of integrated traditional and western medicine on
liver diseases. 2002;12(1):11 (chi*).
2592- gera: 101393/di/ra
[STUDY OF HEPATITIS C VIRUS DIRECT
PATHOGENESIS ON SMMC 7721 IN VITRO*]. CHEN
RUILIE ET AL. chinese journal of integrated traditional
and western medicine on liver diseases. 2002;12(1):17
(chi*).
2593- gera: 101397/di/ra
[EFFECTS OF KANGXIAN RUANGAN GRANULE ON
PLATELET DERIVED GROWTH FACTOR (PDGF)
INDUCED CELL CYCLE AND INTRACELLULAR
CALCIUM CONCENTRATION OF HEPATIC
STELLATE CELLS*]. YANG LING ET AL. chinese
journal of integrated traditional and western medicine on
liver diseases. 2002;12(1):20 (chi*).
2594- gera: 101398/di/ra
[EXPERIMENTAL STUDY OF YIGANJIANPI FANG
ANTI-HEPATIC FIBROGENESIS IN RATS*]. LONG
AIHUA ET AL. chinese journal of integrated traditional
and western medicine on liver diseases. 2002;12(1):23
(chi*).
2595- gera: 101399/di/ra
[INHIBITORY EFFECT OF PENTHORUM CHINESE
PURSH ON HEPATITIS B VIRUS IN VITRO*]. ZHAO
JIANQIN ET AL. chinese journal of integrated traditional
and western medicine on liver diseases. 2002;12(1):26
(chi*).
2596- gera: 101400/di/ra
[EXPERIMENTAL STUDY OF §19 SYRUP ON DUCK
HEPATITIS B VIRUS IN DUCKLINGS*]. HUANG JUN
gera 2011

ET AL. chinese journal of integrated traditional and
western medicine on liver diseases. 2002;12(1):28 (chi*).
2597- gera: 101431/di/ra
[THE EFFECT OF QINGGAN HUOXUE DECOCTION
'ON THE EXPRESSION OF THE LIVER COLLAGEN
TYPE I OF WISTAR RATS WITH ALCOHOLIC
LIVER DISEASE]. JI GUANG ET AL. chinese journal of
integrated traditional and western medicine on digestion.
2002;10(1):24 (chi*).
2598- gera: 101432/di/ra
[THE EXPERIMENTAL STUDY OF PROTECTIVE
EFFECT OF HUOLUOSHUGAN CAPSULE ON
ACUTE HEPATIC INJURY]. WANG TIANCAI ET AL .
chinese journal of integrated traditional and western
medicine on digestion. 2002;10(1):27 (chi*).
2599- gera: 101433/di/ra
[EFFECT OF ANTIDOTIC DECOCTION FOR
TREATING HEPATITIS B (ADHB) ON
IMMUNOLOGICAL FUNCTION IN MICE]. MA
XUEYU . chinese journal of integrated traditional and
western medicine on digestion. 2002;10(1):29 (chi*).
2600- gera: 101434/di/ra
[CLINICAL STUDY ON THERAPEUTIC EFFECT OF
THYMOSIN-A1 COMBINED WITH HGF IN THE
CHRONIC SEVERE HEPATITIS]. QIU MEI ET AL .
chinese journal of integrated traditional and western
medicine on digestion. 2002;10(1):31 (chi*).
2601- gera: 101436/di/ra
[CLINICAL SIGNIFICANCE OF QUANTITATIVE
ASSAY OF HBV DNA IN E-ANTIGEN NEGATIVE
HEPATITIS B]. ZHU CHUNHUA ET AL. chinese journal
of integrated traditional and western medicine on
digestion. 2002;10(1):35 (chi*).
2602- gera: 101458/di/ra
[APPLICATION OF INCUBATIVE PATHOGEN
THEORY IN THE TREATMENT OF HEPATITIS B].
CAI CHUNJIANG ET AL . zhejiang journal of traditional
chinese medicine. 2002;37(2):51 (chi).
2603- gera: 101459/di/ra
[TREATING 32 CASES OF CHRONIC SERIOUS
HEPATITIS B WITH COMBINED TREATMENT OF
TRADITIONAL CHINESE MEDICINE AND
WESTERN MEDICINE]. YANG ZHENGWU. zhejiang
journal of traditional chinese medicine. 2002;37(2):53
(chi).
2604- gera: 101460/di/ra
[DIFFERENTIAL TREATMENT OF HEPATITIS -
ASSOCIATED NEPHRITIS]. WANG HONG . zhejiang
journal of traditional chinese medicine. 2002;37(2):54
(chi).
2605- gera: 101467/di/ra
[CLINICAL OBSERVATION ON OXYGEN FREE
RADICAL DAMAGE OF CIRRHOSIS RESISTED BY
RUANGAN ORAL LIQUID]. LIU PENG, ET AL. hubei
journal of traditional chinese medicine. 2002;24(2):5 (chi).
2606- gera: 101478/di/ra
[EFFECTIVE OBSERVATION ON 42 CASES- OF
CHRONIC HEPATITIS B TREATED BY MODIFIED
XIAOYAO DECOCTION]. CHEN LANLING . hunan
journal of traditional chinese medicine. 2002;18(1):5
163
(chi*).
2607- gera: 101590/di/ra
[118 CASES OF TREATMENT OVER ACUTE
CHOLESTASIA VIRUS HEPATITIS WITH
TRADITIONAL CHINESES MEDICINE]. LIU DAO-XI.
jiangxi journal of traditional chinese medicine.
2002;33(1):10 (chi).
2608- gera: 101593/di/ra
[60 CASES OF TREATMENT OVER PRIMARY LIVER
CANCER WITH HUAYANTANG]. SUI DAO-JING ET
AL. jiangxi journal of traditional chinese medicine.
2002;33(1):17 (chi).
2609- gera: 101611/di/ra
[APPLICATION OF INVIGORATING THE SPLEEN
AND TONIFYING THE KIDNEY TO TREATMENT
OF CHRONIC HEPATITIS B]. SONG SU-HUA ET AL.
academic periodical of changchun college of traditional
chinese medicine. 2002;18(1):10 (chi).
2610- gera: 101649/di/ra
[INFLUENCE OF SEASONAL CLIMATIC CHANGE
ON SYNDROME TYPE OF ATTACK AND INDEX OF
ALT IN VIRUS HEPATITIS]. WANG SHOUPENG .
hubei journal of traditional chinese medicine.
2002;24(3):9 (chi).
2611- gera: 101652/di/ra
[CLINICAL OBSERVATION ON CHRONIC VIRUS
HEPATITIS B TREATED WITH COMBINATION OF
TRADITIONAL CHINESE AND WESTERN
MEDICINES]. LI HANLIN, ET AL. hubei journal of
traditional chinese medicine. 2002;24(3):21 (chi).
2612- gera: 101674/di/ra
[APPLICATION OF INVIGORATING THE SPLEEN
IN TREATING HEPATOPATHY]. LU MING. xinjiang
journal of traditional chinese medicine. 2002;20(1):1 (chi).
2613- gera: 101712/di/ra
[TO STUDY THE EFFECT AND MECHANISM OF
THE MEDICINE OF REGULATING QI ON LIVER
CANCER]. NI HONG-MEI. shanxi journal of traditional
chinese medicine. 2002;18(1):47 (chi*).
2614- gera: 101720/di/ra
[GUANG YOUBO' S "PHLEGM STASIS" THEORY
ON APPLICATION OF TREATMENT OF CHRONIC
HEPATITIS]. LIU LIJUN ET AL. beijing journal of
traditional chinese medicine. 2002;21(1):16 (chi).
2615- gera: 101739/di/ra
[STUDY ON REGULATION OF CELLULAR
IMMUNITY OF MICE BEARING EHRLICH ASCITES
CARCINOMA BY ACUPOINT-APPLICATION OF
ASCITIS PLASTER]. TIAN JIAN-HUI ET AL. liaoning
journal of traditional chinese medicine. 2002;29(2):118
(chi*).
Objective : To investigate the mechanism of Ascitis Plaster
(AP) in mice bearing Ehrlich Ascites Careinoma (EAC) by
Acupoint sticking therapy. Method : 40 NIH mice were
randomly divided into 4 groups with different treatment and
TNF and sIL-2R were used as indexes. Result : AP can
prolong longevity of EAC mice (P < 0.05) ; markedly inhibit
the growth of ascitis (P < 0.05). Acupoint-Application is
better than local-application in all above indexes (P < 0.05).
It is revealed that the disorder of cellular immunity among
tumor-bearing mice featured by high serum level of sIL-2R
gera 2011

(P < 0.05) and lower killing activity of serum TNF (P <
0.05), comparing with that of normal mice. AP can
significantly reduce the sIL-2R level (P < 0.05) and enhance
the killing activity of serum TNF among tumor- bearing mice
(P < 0.05), comparing with that of control group. Conclusion
: The therapeutic effect of AP in mice bearing EAC was
definite. AP can regulate the disorder of sII_2R and TNF so
as to maintain the normal cellular
2616- gera: 101746/di/ra
[EFFECTS OF RHEIN ON ACUTE LIVER INJURY OF
MICE]. GUO MEIZI ET AL. research of traditional
chinese. 2002;18(1):37 (chi*).
2617- gera: 101799/di/ra
[STUDY ON PRIMARY BILIARY CIRRHOSIS OF
LIVER]. XIANG BAIKANG. journal of zhejiang college
of traditional chinese medicine. 2002;26(1):1 (chi*).
2618- gera: 101804/di/ra
[GANTAIBAO CAPSULE TREAT CHRONIC
HEPATITIS II]. GUO JIANCHUN ET AL. journal of
zhejiang college of traditional chinese medicine.
2002;10.1:26 (chi*).
2619- gera: 101807/di/ra
[THE PROTECTION OF YINCHENHAO TANG TO
RAT'S DAMAGED LIVER]. CAO YI ET AL. journal of
zhejiang college of traditional chinese medicine.
2002;26(1):41 (chi*).
2620- gera: 101939/di/ra
[STUDY ON RELATIONSHIP BETWEEN
ARG778LEU/GIN GENE MUTATION SPOT IN ATP7B
AND TCM SYNDROME TYPE IN CHINESE
PATIENTS WITH WILSON DISEASE]. YANG BIN, HU
JI-YUAN, HONG MING-FAN, ET AL. chinese journal of
integrated traditional and western medicine.
2002;22(4):280 (chi*).
Objective : To investigate the relationship between Arg 778
Leu/Gln gene mutation spot in ATP7B and TCM Syndrome
type in Chinese patients with Wilson disease (WD). Methods
: Exon 8 of ATP7B of 90 WD patients and 30 healthy
controls were amplified by PCR and analysed by restriction
enzyme Msp I, the TCM Syndrome type of the patients was
differentiated at the same time. Results : In the 90 WD
patients, 34 with Arg 778 Leu/ Gln of exon 8 were detected,
among them 20 cases belonged to the TCM Syndrome type
of endogenous LiverWind agitation. Conclusion : Onset age
of WD patients with Arg 778 Leu/Gln mutation is later than
that without this mutation. Arg 778 Leu/Gln mutation might
be related to the TCM Syndrome type of endogenous Liver-
Wind agitation
2621- gera: 101948/di/ra
[CLINICAL OBSERVATION ON TREATMENT OF
CHRONIC HEPATITIS B BY DOSE OF
RIBONUCLEIC ACID PLUS SALVIAE INJECTION].
GAO SHU-HUA, ZHANG TING-WEI, MA YONG-LIN.
chinese journal of integrated traditional and western
medicine. 2002;22(4):305 (chi).
2622- gera: 101951/di/ra
[STUDIES ON MOLECULAR MECHANISM OF TCM
IN PREVENTING AND TREATING HEPATOPATHY].
NIE GUANG. chinese journal of integrated traditional
and western medicine. 2002;22(4):318 (chi).
2623- gera: 101957/di/ra
[TREATMENT OF CHRONIC HEPATITIS B BY THE
164
COMBINATION OF TRADITIONAL CHINESE
MEDICINE WITH WESTERN MEDICINE]. PU
JIANYING. hebei journal of traditional chinese medicine.
2002;24(3):209 (chi*).
2624- gera: 101973/di/ra
[THE REALIZATION OF BIANZHENG LUNZHI IN
EARLY CIRRHOSIS CAUSED BY CHRONIC
HEPATITIS B]. WU YANGFEI, SUN JIANMIN. research
of traditional chinese medicine. 2002;18(2):18 (chi).
2625- gera: 102064/di/ra
[CLINICAL STUDY ON EFFECT OF SANJIA HUGAN
DECOCTION.IN TREATING ADVANCED LIVER
CARCINOMA]. ZHANG GUO-XI . liaoning journal of
traditional chinese medicine. 2002;29(5):267 (chi*).
2626- gera: 102065/di/ra
[CLINICAL AND EXPERIMENTAL RESEARCH ON
TWO GRANULES IN TREATMENT OF CHRONIC
VIRUS HEPATITIS B]. ZHANG WEI, WANG YU-QUN,
JI GUANG, ET AL. liaoning journal of traditional chinese
medicine. 2002;29(5):269 (chi*).
2627- gera: 102084/di/ra
[STUDY ON THE PHARMACOLOGICAL EFFECT OF
DANSHEN (SALVIA ROOT) ON THE LIVER]. PEI LEI,
REN YING. acta chinese medicine and pharmacology.
2002;30(1):57 (chi).
2628- gera: 102093/di/ra
[EXPLORATION OF TREATING HEPATOGENIC
DIABETES ON TRADITIONAL CHINESE
MEDICINE]. SUN JUN. china journal of tcm and
pharmacy. 2002;17(2):100 (chi).
2629- gera: 102109/di/ra
[TREATMENT OF CHRONIC HEPATITIS B BY
COMBINED METHOD OF CHINESE AND WESTERN
MEDICINE IN 100 CASES]. SONG MING-YUAN.
journal of traditional chinese medicine and chinese
materia medica of jilin. 2002;22(2):40 (chi).
2630- gera: 102201/di/ra
[EFFECTS OF RUANGANHUAZHENG PILLS ON
THE ACTIVATION OF HEPATIC SATELLITE
CELLS]. YANG YANFANG WANG MIANZHI WANG
XU ET AL. journal of beijing university of traditional
chinese medicine. 2002;25(2):38 (chi*).
2631- gera: 102209/di/ra
[ANALYSIS ON THE FREQUENCY OF HERBS USED
IN PRIMARY HEPATOCELLULAR CARCINOMA].
CHEN DE-SU, FANG ZHAO-QIN. liaoning journal of
traditional chinese medicine. 2002;29(4):187 (chi*).
Based on the theory of Ying and Wei, and combining with
clinical research, the author reports that the disharmony
between Ying and Wei is TCM's chief pathogenesis of
hypertension, which includes the functional disorder of the
activities of Ying and Wei as well as disturbance in Ying and
Wei transformation. Regulating Ying and Wei is taken as
TCM's general principle of hypertension's treatment.
2632- gera: 102225/di/ra
[TREATMENT OF HEPATOCIRRHOSIS WITH THE
METHOD OF DETOXICATING, PROMOTING
BLOOD AND STRENGTHENING THE BODY
RESISTANCE]. MA ZUO-FENG, JIANG RUI-XUE.
shanxi journal of traditional chinese medicine.
2002;18(2):13 (chi*).
gera 2011

2633- gera: 102229/di/ra
[CLINICAL STUDY OF TREATMENT OF HEPATITIS
WITH JIUGAN DECOCTION]. ZHANG WU, XU RU-
PING, ZHANG LING ET AL. shanxi journal of traditional
chinese medicine. 2002;18(2):45 (chi*).
2634- gera: 102243/di/ra
[CLINICAL OBSERVATION ON 24 CASES OF
CAROTID ATHEROMATOUS CIRRHOSIS TREATED
WITH YU YIN YU TANG]. ZHANG JUFU, WANG
YUEFEN, WU FAN ET AL. forum on traditional chinese
medicine. 2002;17(2):32 (chi).
2635- gera: 102249/di/ra
[EFFECTS OF QZRG ON THE HEPATIC FAT OF
THE EXPERIMENTAL FATTY LIVER]. LIN QING, ET
AL. chinese journal of information on traditional chinese
medicine. 2002;9(5):33 (chi*).
2636- gera: 102374/di/ra
[EXPERIMENTAL STUDY ON FATTY LIVER
TREATED WITH QUZHIRUANGAN PILL]. LIN QING,
ET AL. chinese journal of traditional medical science and
technology. 2002;19(3):140 (chi).
2637- gera: 102381/di/ra
[EXPERIMENTAL STUDY ON THE PROTECTIVE
EFFECT OF DIHYDROMYRIECTIN FROM
GUANGXI AMPELOPSIS GROSSEDENTATA ON
LIVER]. ZHONG ZHENG-XIAN, ET AL. chinese journal
of traditional medical science and technology.
2002;19(3):155 (chi).
2638- gera: 102417/di/ra
[OBSERVATION OF CURATIVE EFFECT ON
TREATING 56 CASES OF HEPAR ADIPOSUM WITH
SHUGAN JIANGZHI DECOCTION]. ZHANG XIAO-
IAN. chinese journal of ethnomedicine and
ethnopharmacy. 2002;6(3):147 (chi).
2639- gera: 102458/di/ra
[OBSERVATION ON SEVERE ASCITED DUE TO
CIRROHOSIS (37 CASES) TREATED BY
TRADITIONAL CHINESE DRUGS]. PAN XUDONG .
journal of practical tcm. 2002;5(18):6 (chi).
2640- gera: 102459/di/ra
[OBSERVATION ON HEPATOCARCINOMA IN
METAPHASE AND ADVANCED STAGE (24 CASES)
MAINLY TREATED BY QING KAI LING .]. GAO
JILIANG, SHEN ZHUANGHONG. journal of practical
tcm. 2002;5(18):8 (chi).
2641- gera: 102472/di/ra
[CLINICAL OBSERVATION OF THYMIC PEPTIDE
COMBINED WITH YIGAN NO. I ORAL LIQUID IN
TREATING 100 PATIENTS WITH CHRONIC
HEPATITIS B]. YANG YINGJIE,ZHENG YONGZHI, HU
WEI. hebei journa of tcm. 2002;24(4):295 (chi).
2642- gera: 102478/di/ra
[TREATING 38 CASES OF ATROPHIC GASTRITIS
WITH COMBINED TREATMENT OF TRADITIONAL
CHINESE MEDICINE AND WESTERN MEDICINE].
LIANG ZHILONG, ZHAO GUOREN. zhejiang journal of
traditional chinese medicine. 2002;37(5):194 (chi).
2643- gera: 102520/di/ra
[THINKING AND METHODS OF RESISTANCE OF
165
INTEGRATED CHINESE AND WESTERN MEDICINE
TO LIVER FIBROSIS]. LIN WENBO, GUO SUICHENG.
forum on traditional chinese medicine. 2002;17(3):14
(chi).
2644- gera: 102559/di/ra
[YANG JIN'S EXPERIENCE IN TREATING
CHRONIC HEPATITIS]. LIU RONGXI. jiangsu journal
of traditional chinese medicine. 2002;23(3):13 (chi).
2645- gera: 102630/di/ra
[ANTI-HEPATIC FIBROSIS AND ANTI-LIPID
PEROXIDATION EFFECTS OF PHELLINUS
IGNIARIUS ON RAT LIVER]. ZHANG WAN-GUO HU
JIN-HONG ET AL . chinese traditional patent medicine.
2002;24(4):281 (chi*).
2646- gera: 102632/di/ra
[OBSERVATION OF ACTION OF BUPLEURUM
CHINESE COMPABILITY WITH SCHISANDRA
CHINENSIS ON EXPERIMENTALHEPATIC
FIBROSIS IN RAT]. WANG SHENG-CHUN ZHAO HUI-
PING ET AL. chinese traditional patent medicine.
2002;24(4):286 (chi*).
2647- gera: 102636/di/ra
[THERAPEUTIC EFFECTS OF PHOSPHOLIPID ON
ALCOHOLIC LIVER DAMAGE]. MA JIN-LONG.
chinese traditional patent medicine. 2002;24(4):299 (chi).
2648- gera: 102645/di/ra
[CLINICAL OBSERVATION OF RUANGAN SUOPI
TABLET(VLFF IN TREATING CHRONIC HEPATITIS
B CAUSED LIVER CIRRHOSIS]. LI JIA-FU, ZHANG
HUI-QIN, SHI PENG-HUI, ET AL. chinese journal of
integrated traditional and western medicine.
2002;22(3):188 (chi*).
2649- gera: 102651/di/ra
[PROTECTIVE EFFECT OF HYDROPHILIC SALVIA
MONOMER ON LIVER ISCHEMIA/ REPERFUSION
INJURY INDUCED BY PRO- INFLAMMATORY
CYTOKINES*]. WANG HONG-CHAO, ZHANG HUA,
ZHOU TONG-LIANG, ET AL. chinese journal of
integrated traditional and western medicine.
2002;22(3):207 (chi).
2650- gera: 102652/di/ra
[CLINICAL OBSERVATION ON LARGE DOSAGE OF
SHENFU INJECTION IN SUPPLEMENTARY
TREATING LIVER CIRRHOSIS COMPLICATED
WITH ESOPHAGEAL VARIX RUPTURE BLEEDING].
SONG XIN-WEI, LUO YONG-ZHONG. chinese journal of
integrated traditional and western medicine.
2002;22(3):211 (chi).
2651- gera: 102661/di/ra
[MINUTE ON NATIONAL SYMPOSIUM ON LIVER
FIBROSIS]. LIU CHENG-HAI, HU YI-YANG, LIU PING.
chinese journal of integrated traditional and western
medicine. 2002;22(3):238 (chi).
2652- gera: 102668/di/ra
[TREATMENT OF 54 CASES OF CHRONIC
HEPATITIS B FIBROSIS WITH INTEGRATION OF
TRADITIONAL CHINESE AND WESTERN
MEDICINE]. ZHANG CAI-QING, LIANG TIE-JUN,
HUANG CHEN,ET AL. shandong journal of traditional
chinese medicine. 2002;21(4):225 (chi).
gera 2011

2653- gera: 102674/di/ra
[32 CASES OF LOW-GRADE JAUNDICE DUE TO
CHRONIC HEPATITIS AND HEPATOCIRRHOSIS
TREATED WITH WENYANG QUYU HUATAN
DECOCTION]. XU KUI, YAN ZHAO-HONG, WANG
HUI, ET AL. journal of anhui traditional chinese medical
college. 2002;21(2):15 (chi*).
2654- gera: 102686/di/ra
[VIRUS HEPATITIS B COMBINED MYOCARDITIS
TREATED BY ASTRAGALUS AND COMPOUND
INJECTION OF RED SAGE]. HUANG YUHONG, ET
AL. hubei journal of tcm. 2002;24(5):7 (chi).
2655- gera: 102750/di/ra
[EFFECT OF EXTRACT FROM POLYGONUM
MULTIFLORUM THUNB. AND PAEONIA
LACTIFLORA PALL. ON ASCITES, SYNDROMES IN
BROILER]. LI JIANXL, ZHANG SHIZHEN, YANG
ZHIQIANG ET AL. journal of traditional chinese
veterinary medicine. 2002;21(2):9 (chi).
2656- gera: 102767/di/ra
[DIAGNOSIS AND TREATMENT OF 80 CASES OF
ASCITES DUE TO CIRRHOSIS WITH TCM]. LIU
BING. hubei journal of traditional chinese medicine.
2002;24(4):31 (chi).
2657- gera: 102897/di/ra
[THE TREATMENT OF ASCITES DUE TO
CIRRHOSIS AT THE STAGE OF
DECOMPENSATION WITH AOMIKE CAPSULE].
WANG TAOHUA LIU YUCHEN, WANG HANDONG ET
AL. traditional chinese medicinal research. 2002;15(2):27
(chi).
2658- gera: 102910/di/ra
[GUO SHUSHEN' S EXPERIENCES ON DRUGS FOR
HEPATIC DISEASE]. GUO HAI-TAO, WANG GUAN-
MIN, HAO XIAO-JUN, ET AL. fujian journal of
traditional chinese medicine. 2002;33(2):14 (chi).
2659- gera: 102918/di/ra
EFFECT OF ACUPUNCTURE ON IL 2-IFN-NKC
IMMUNOREGULATORY NETWORK IN MICE WITH
TRANSPLANTED HEPATOCARCINOMA. MA
ZHENYA, ET AL. world journal of acupuncture-
moxibustion. 2002;12(1):31 (eng).
Objective : To study the effect of acupuncture on interleukin
2 (IL 2) -interferon ( IFN) -natural killer cells (NKC)
immunoregulatory network of mice with transplanted
hepatocarcinoma (HAC) in order to provide new evidence for
acupuncture treatment of hypofunction of immune system.
Methods : The 28 HAC-vaccinated BALB/C mice are
randomly divided into control group (n= 14) and acupuncture
group (n= 14). In the latter group bilateral" Dazhui" (BL 11)
and "Zusanli" (ST 36) which are located according to the
same positions indicated in Comparative Anatomy of
Macroanimals, are needled once every day, twelve sessions
altogether. Twenty-four hours after the needling treatment the
mice are killed and the spleen is taken out to be made into
cell suspension for assaying concentrations of IL2 (MTT
method) and NKC (colorimetric method) respectively. Obital
Serum IFN is determined by using (CPE microplate staining),
and the tumor mass is taken out and balanced with an
analytical balance (1/10000) to calculate the tumor inhibition
rate according to the formula. Results : The tumor weight of
the mice of acupuncture group is obviously decreased
(inhibition rate 43. 06 % ) while the activity of the IL2 and
NKC, and the IFN titer are increased greatly, which have
166
significant differences compared with those of control group
(P>0.01). Conclusion : The results of the study show that
acupuncture can strengthen the positive immunoregulatory
function of the IL2 -IFN-NKC network in immune
hypofunction mice bearing HAC.
2660- gera: 102958/di/ra
[A RESEARCH ON THE EFFECT OF CLEARING
DAMP-HEAT, STRENGTHENING RESISTANCE AND
ACTIVATING BLOOD CIRCULATION ON LIVER
FIBROSIS OF LABORATORY RATS]. NIE DANLI, ZHI
MIN, CUI DAJIANG. shaanxi journal of traditional
chinese medicine. 2002;23(6):568 (chi).
2661- gera: 102961/di/ra
[PRIMARY LIVER CANCER TREATED BY
MATRINE INJECTION WITH TAE OPERATION].
WAN XUYING ET AL. traditional chinese medicine.
2002;26(2):2 (chi).
2662- gera: 102972/di/ra
[EXPERIMENTAL STUDY OF ANTI-LIVER
FIBROSIS OF BLOOD-ACTIVATING AND
DAMPNESS-ELIMINATING DECOCTION (BDD)].
ZHANG YONGSHENG, LU LIANGWEI. traditional
chinese medicine. 2002;26(2):63 (chi*).
2663- gera: 102991/di/ra
[TREATMENT OF 53 CASES OF CHRONIC
HEPATITIS B WITH ACUPOINT-INJECTION[]. WU
PEITIAN. chinese acupuncture and moxibustion.
2002;22(6):377 (chi*).
Purpose : To observe the therapeutic effect of acupoint-
injection on chronic hepatitis B and to study on its
mechanisms. Methods : Treatment group (53 cases) and
control group (30 cases) were set up randomly, and different
drugs were injected alternately into same points, once every
other day or once every two days. Clinical symptoms,
HBeAg, HBV DNA marker and hepatic functions were
compared. Results : The total effective rate was 94.3% in the
treatment group and 76.6% in the control group, and the
treatment group in hepatic function and turning negative
effect of HBeAg and HBV-DNA was superior to the control
group (P<0.01).
2664- gera: 103016/di/ra
[PROF. WANG LING-TAI' S EXPERIENCE IN
DIAGNOSIS AND TREATMENT OF LIVER
CIRRHOSIS]. ZHANG YOU-XIANG, ZHANG JIA-FA.
acta universitatis traditionis medicalis sinensis
pharmacologiaeque shanghai. 2002;16(1):28 (chi*).
In his rich experience in the treatment of liver cirrhosis, Prof.
WANG LIng-tai believes that the key of pathogenesis is qi
stagnation and blood stasis and that the treatment should be
stressed to apply both die attacking and tonifying measures
upon the symptoms, and stresses that the treatment is mainly
given to soothe the liver, strengthen the spleen and promote
digestion in the early stage of liver cirrhosis ascites, and to
activate blood and soothe the liver in the middle stage and to
regulate and treat the liver, spleen and kidney and circulate
blood and remove water in the critical stage. Two proved
cases were attached.
2665- gera: 103020/di/ra
[MECHANISM STUDY ON COMBINATION OF
CHINESE HERBAL FORMULA TO SUPPORT ANTI-
PATHOGENIC ABILITY AND DISSIPATE BLOOD
STASIS IN PROMOTING REVERSION OF LIVER
FIBROSIS IN CCI4 RATS]. LIU PING, WU DING-
ZHONG, LIU CHENG-HAI, ET AL. acta universitatis
gera 2011

traditionis medicalis sinensis pharmacologiaeque
shanghai. 2002;16(1):37 (chi*).
2666- gera: 103021/di/ra
[COMPARATIVE STUDY ON FUNCTIONS OF
DIFFERENT THERAPIES ON LIVER CANCER IN
MICE]. FANG ZHAO-QIN, GUAN DONG-YUAN, LIANG
SHANG-HUA, ET. acta universitatis traditionis medicalis
sinensis pharmacologiaeque shanghai. 2002;16(1):42
(chi*).
2667- gera: 103086/di/ra
[STUDY OF DYNAMIC RELATIONSHIP BETWEEN
DIETARY COPPER LEVEL AND TRACE ELEMENTS
IN MICE LIVER]. WANG XUEZHI, YANG ZHIQIANG,
MA WEI ET AL. journal of traditional chinese veterinary
medicine. 2002;21(3):12 (chi).
2668- gera: 103159/di/ra
[CHANGES OF IL - 6 AND OFR IN ACUTE
PANCREATITIS WITH LIVER DAMAGE AND
THERAPEUTIC MECHANISMS OF IL-2 AND TMP].
LI YONG, NIE LIANBO, ZHANG XUEMING, ET AL.
chinese journal of surgery of integrated traditional
chinese and western medicine. 2002;8(2):121 (chi).
2669- gera: 103193/di/ra
[CLINICAL OBSERVATION OF " LIVER-
SOFTENING DECOCTION" IN TREATING LIVER
FIBROSIS FOLLOWING CHRONIC HEPATITIS]. LI
GANG. shanghai journal of tcm. 2002;36(5):15 (chi).
2670- gera: 103209/di/ra
[PREVENTION AND TREATMENT OF HERBA
SCUTELLARIAE BARBATAE COMPOUND ON
DIETHYLNITROSAMINE-INDUCED
HEPATOCARCINOMA OF RAT]. YE JIAN, XU
XIKUN, ZHOU JIANWEI, ET AL. chinese journal of
integrated traditional and western medicine on digestion.
2002;10(2):67 (chi*).
2671- gera: 103212/di/ra
[PROTECTIVE EFFECT OF YIGANKANG ON
HEPATOCYTES OF RATS WITH EXPERIMENTAL
HEPATIC FIBROSIS AND ULTRASTRUCTURAL
OBSERVATION]. TANG YOUWEI, YAO XIXIAN, YAO
HONGSEN. chinese journal of integrated traditional and
western medicine on digestion. 2002;10(2):76 (chi*).
2672- gera: 103215/di/ra
[EXPERIMENTAL STUDY ON CONCENTRATED
YIGAN DECOCTION IN THE TREATMENT OF
LIVER FIBROSIS]. SUN YUFENG, YAO XIXIAN, CUI
DONGLAI. chinese journal of integrated traditional and
western medicine on digestion. 2002;10(2):84 (chi*).
2673- gera: 103221/di/ra
[A TEN-YEAR FOLLOW-UP OF THE POST-
TRANSFUSION HCV-INFECTORS]. LIU RUIXIN, LI
FENGLAN, BA CUIZHEN, ET AL. chinese journal of
integrated traditional and western medicine on digestion.
2002;10(2):98 (chi*).
2674- gera: 103243/di/ra
[TREATING 132 CASES OF CHRONIC GASTRITIS
WITH TRADITIONAL CHINESE MEDICINE]. LIU
HECHEN . zhejiang journal of traditional chinese
medicine. 2002;37(6):255 (chi).
2675- gera: 103257/di/ra
167
[PROTECTIVE EFFECTS OF TOTAL GLUCOSIDES
OF PAEONY AND EXTRACT FROM ANGELICA
SINENSIS ON EXPERIMENTAL HEPATITIS]. CHEN
XIANG-QING, WANG QIN-MAO, FANG-HUA-WU, ET
AL. journal journal of anhui traditional chinese medical
college. 2002;21(3):44 (chi*).
2676- gera: 103261/di/ra
[ANTI-LIVER FIBROSIS WITH INTEGRATIVE
CHINESE AND WESTERN MEDICINE]. LIU PING,
ZENG MIN-DE, WANG JI-YAO, ET AL. chinese journal
of integrated traditional and western medicine.
2002;22(5):328 (chi).
2677- gera: 103262/di/ra
[CLINICAL STUDY ON TREATMENT OF LIVER
FIBROSIS IN PATIENTS OF HEPATITIS B BY
KANGXIAN BAOGAN DECOCTION]. LIANG TIE-JUN,
ZHANG WEI, ZHANG CAI-QING ET AL. chinese journal
of integrated traditional and western medicine.
2002;22(5):332 (chi*).
2678- gera: 103263/di/ra
[RELATIONSHIP BETWEEN SERUM LOAD OF HBV-
DNA AND THERAPEUTIC EFFECT OF
OXYMATRINE IN PATIENTS WITH CHRONIC
HEPATITIS B]. CHEN YAN-XI, MAO BAI-YUAN,
JIANG JIAN-HUA, ET AL. chinese journal of integrated
traditional and western medicine. 2002;22(5):335 (chi*).
2679- gera: 103271/di/ra
[EFFECT OF HERBAL COMPOUND 861 ON
EXPRESSION AND ACTIVITY OF NITRIC OXIDE
SYNTHASE IN HEPATIC STELLATE CELLS*]. DING
HUI-GUO, WANG BAO-EN, SHANG HONG-WEI, ET AL.
chinese journal of integrated traditional and western
medicine. 2002;22(5):362 (chi*).
2680- gera: 103277/di/ra
[EFFECT OF COMPOUND SALVIA PILL COMBINED
WITH PROPANOLOL ON LIVER FIBROSIS AND
PORTAL HYPERTENSION]. LIANG YU-GUO, CHU
XIU-JU. chinese journal of integrated traditional and
western medicine. 2002;22(5):382 (chi).
2681- gera: 103314/di/ra
[[EXPERIMENTAL STUDY OF THE EFFECTS OF
HYPERLIPIDEMIC SERUM ON THE CULTURE OF
MOUSE CELIAC MACROPHAGES IN VITRO AND
THE REGULATIVE EFFECTS OF TCM DRUGS FOR
RELIEVING HEPATIC DEPRESSION AND
REMOVING TU LU YIZHU, FAN YINGCHANG, LI
GUANGBIN. journal of beijing university of traditional
chinese medicine. 2002;25(3):42 (chi*).
2682- gera: 103383/di/ra
[TREATMENT OF CHRONIC HEPATITIS B WITH
ESSENTIAL PHOSPHOLIPID AND ZHIGANGLING
ORAL LIQUID]. ZHANG HUI-YUN, LI ZENG-KUI,
SONG XIU-GUANG, ET AL. shandong journal of
traditional chinese medicine. 2002;21(6):336 (chi).
2683- gera: 103419/di/ra
[CLINICAL OBSERVATION ON TREATMENT OF
200 CASES OF CHRONIC HEPATITIS B WITH JIE
DU TONG LUO TIAO GAN FANG COMBINED WITH
FOOT BATH METHOD]. WU PEITIAN . journal of
traditional chinese medicine. 2002;43(3):194 (chi).
2684- gera: 103478/di/ra
gera 2011

[ON PREVENTION AND TREATMENT OF IMMUNE
HEPATIC FIBROSIS IN RATS]. SUN SHOUCAI, LI
XIAOMIAO, ET AL. journal of shaanxi college of
traditional chinese medicine. 2002;25(2):43 (chi).
2685- gera: 103487/di/ra
[32 CASES OF TREATMENT OF FIBROSIS OF LIVER
WITH RUANGAN DECOCTION]. ZHENG LINING,
QIU JING. traditional chinese medicinal research.
2002;15(1):43 (chi).
2686- gera: 103488/di/ra
[EFFECT OF QINGHUARUANGAN DECOCTION ON
THE TREATMENT OF HEPATO-CIRRHOSIS].
WANG SHANGJIN. traditional chinese medicinal
research. 2002;15(1):50 (chi).
2687- gera: 103514/di/ra
[CLINICAL STUDY ON LAMIVUDINE WITH
KURARINONE IN TREATMENT OF CHRONIC
HEPATITIS B]. WANG JUN ET AL . journal of guiyang
college of traditional chinese medicine. 2002;24(1):50
(chi).
2688- gera: 103518/di/ra
[CLINICAL STUDY ON FATTY LIVER TREATED
WITH SHUANGQINGPIAN]. CHEN LI-XIA, ET AL.
chinese journal of traditional medical science and
technology. 2002;9(2):71 (chi).
2689- gera: 103520/di/ra
[EFFECT OF TIDUHUGANFANG ON THE
EXPRESSION OF TYPE I COLLAGEN AND
TRANSFORMING GROWTH FACTOR P, MRNA IN
HEPATIC STELLATE CELLS]. ZHU QING-JING, ET
AL. chinese journal of traditional medical science and
technology. 2002;9(2):76 (chi*).
2690- gera: 103522/di/ra
[EFFECT OF CANXIANLING ON SERUM CELL
FACTOR OF RAT WITH LIVER FIBROSIS]. MA
HONG-WEI, ET AL. chinese journal of traditional
medical science and technology. 2002;9(2):81 (chi*).
2691- gera: 103527/di/ra
[ANALYSIS ON THE EFFECTIVE COMPONENTS OF
YUICHENHAOTANG' S PROTECTING LIVER FROM
DAMAGE]. DONG ZHI-BO, ET AL. chinese journal of
traditional medical science and technology. 2002;9(2):91
(chi).
2692- gera: 103528/di/ra
[THE PROLIFERATION INHIBITION AND
DIFFERENTIATION INDUCTION OF 18P -
GLYCYRRHETINIC ACID AND GLYCYRRHIZIN OF
BEL - 7402 HUMAN HEPATOCARCINOMA CELLS].
HUANG WEI, ET AL. chinese journal of traditional
medical science and technology. 2002;9(2):92 (chi*).
2693- gera: 103558/di/ra
[VITAL HEPATITIS B TYPE AND DAMPNESS, HEAT,
AND PHLEGM, AND BLOOD STASIS]. GUI
XIANGPING CHEN YOUKUN. journal of traditional
chinese medicine. 2002;4(2):15 (eng).
2694- gera: 103588/di/ra
[EXPRESSION OF HBV PX AND BCL-2 IN PATIENTS
WITH HEPATOCELLULAR CARCINOMA]. JIANG
XIANGRONG, WANG XIAOZHONG, CHEN
XIAOCHUN, ET. chinese journal of integrated traditional
168
and western medicine on liver diseases. 2002;12(2):68
(chi*).
2695- gera: 103589/di/ra
[FATTY LIVER: CHANGS OF HEPATIC
HEMODYNAMICS AFTER TRANSCUTANEOUS
ELECTRIC PULSE STIMULATION ON ACUPOINTS
NEAR BY LIVER]. WANG LING, LI HONG, LI JUN, ET
AL. chinese journal of integrated traditional and western
medicine on liver diseases. 2002;12(2):71 (chi*).
Objective: To evaluate the effect of transcutaneous electric
pulse stimulation on hepatic blood flow and parenchymal
microcirculation in patients with fatty liver. Method : The
photos of color Doppler energy (CDE) before and after
transcutaneous electric pulse stimulation on local acupoints
near by liver were gained in 31 cases with fatty liver. Sum of
color pixel area (SCPA), average of color value (ACV) and
SCPA X ACV of the photos were got by photo processing
system with single blind, and were analysed in beforeand
after paired t-test. Results : After the stimulation, SCPA or
ACV increased in most of the cases (t= 2.71, P=O. 0109;
t=3.42, P=0.0018), and SCPA X ACV significantly increased
(t= 8. 15, P<0.0001). Conclusion : These results suggested
that the stimulation would improve hepatic blood flow and
parenchymal microcirculation in patients with fatty liver.
2696- gera: 103590/di/ra
[STUDY ON COMBINATION THERAPY OF JING
ZHU GAN TAI SHU CAPSULE AND LAMIVUDINE IN
TREATING HEPATITIS B]. LIU HONG, YANG
DAGUO, WANG DONG, ET AL. chinese journal of
integrated traditional and western medicine on liver
diseases. 2002;12(2):74 (chi*).
2697- gera: 103591/di/ra
[OBSERVATION OF SUCCESSIVE EFFECT ABOUT
THE CONSOLIDATING TREATMENT OF CHRONIC
HEPATITIS B BY DADINGFENGZHU]. LI WEILIN,
ZHAO XIANMING, XIANG YIQUN, ET AL. chinese
journal of integrated traditional and western medicine on
liver diseases. 2002;12(2):77 (chi*).
2698- gera: 103592/di/ra
[DETECTION OF SERUM HBV DNA IN PATIENTS
WITH HEPATITIS B BY QUANTITATIVE PCR AND
IT'S SIGNIFICANCE]. ZHAO JIANQIN, LIU LI, LEI
XUEZHONG, ET AL. chinese journal of integrated
traditional and western medicine on liver diseases.
2002;12(2):79 (chi*).
2699- gera: 103593/di/ra
[THERAPEUTICAL EFFECT OF ANFURON
(INTERFERON A-2B) ON PATIENTS WITH
CHRONIC HEPATITIS B*]. SONG JIANXIN, WANG
JUN, LU DINGBO, ET AL. chinese journal of integrated
traditional and western medicine on liver diseases.
2002;12(2):81 (chi*).
2700- gera: 103594/di/ra
[STUDY OF EFFECTS AND MECHANISMS AGAINST
EXPERIMENTAL HEPATIC FIBROSIS IN RATS
WITH CHINESE MEDICINE*]. WANG JIAN, HE
FUJING, NIU JIANZHAO, ET AL. chinese journal of
integrated traditional and western medicine on liver
diseases. 2002;12(2):86 (chi*).
2701- gera: 103595/di/ra
[EXPERIMENTAL REASEARCH OF HUOXUE
SHENSHI FANG TO PREVENT HEPATIC FIBROSIS
IN RATS*]. LU LIANGWEI, CAI WEIMIN, ZHANG
gera 2011

YONGSHENG, ET AL. chinese journal of integrated
traditional and western medicine on liver diseases.
2002;12(2):89 (chi*).
2702- gera: 103596/di/ra
[EFFECTS OF IL-10 ON EXPRESSION OF TGF-B1 AT
EXPERIMENTAL RAT LIVER FIBROSIS*]. CHEN
ZHIXIN, ZHANG LIJUAN, CHEN YUNXIN, ET AL.
chinese journal of integrated traditional and western
medicine on liver diseases. 2002;12(2):92 (chi*).
2703- gera: 103597/di/ra
[LIVER CIRRHOSIS INDUCED BONE LOSS IN MICE
AND THE PREVENTION EFFECT OF ASTRAGALUS
POLYSACCHARIDES]. ZOU LIYI, WU TIE, CUI LIAO.
chinese journal of integrated traditional and western
medicine on liver diseases. 2002;12(2):95 (chi*).
2704- gera: 103598/di/ra
[EFFECT OF HAIZHUYIGAN CAPSULE ON THE
HEPATIC DAMAGE OF IMMUNITY IN MICE*]. LI
WEIXING, TAN DAQI, LI QIUHUA, ET AL. chinese
journal of integrated traditional and western medicine on
liver diseases. 2002;12(2):99 (chi*).
2705- gera: 103620/di/ra
[EXAMPLES OF WANG ZHAOHAO TREATING
INTRACTABLE HYPOCHONDRIA]. HONG WEN.
journal of clinical acupuncture and moxibustion.
2002;18(3):8 (chi).
2706- gera: 103666/di/ra
[EXPERIMENTAL STUDY OF POINT -
APPLICATION WITH CHINESE MEDICINE
AGAINST A'S ASCITES CARCINOMA IN SMALL
RATS]. SANG FENG-MEI, SUN LIU-HE. henan
traditional chinese medicine. 2002;22(2):18 (chi*).
2707- gera: 103897/di/ra
[OBSERVATION OF THE CLINICAL THERAPEUTIC
EFFECT OF GANDOU TABLET I ON
HEPATOLENTICULAR DEGENERATION]. HU WEN-
BIN, YANG REN-MIN, REN MING-SHAN ET AL. chinese
journal of integrated traditional and western medicine
(english edition). 2002;8(1):7 (eng).
2708- gera: 103961/di/ra
THE CLINICAL AND BASIC RESEARCH PROGRESS
IN THE APPLICATION OF MINOR BUPLEURUM
DECOCTION (XIAO CHAI HU TANG) TO
TREATMENT OF CHRONIC HEPATITIS C IN
JAPAN. YA-XIN WANG. international journal of
oriental medicine. 2002;27(1):36 (eng).
2709- gera: 104061/di/ra
[CLINICAL AND EXPERIMENTAL STUDIES ON
TREATMENT OF VIRUS HEPATITIS WITHTIBETAN
MEDICINE]. SUN XUEHUA, ET AL. chinese journal of
ethnomedicine and ethnopharmacy. 2002;4(2):75 (chi).
2710- gera: 104075/di/ra
[TAKE CARE TREATING ASCITES CAUSED BY
HEPATOPATHY WITH SHIZAO DECOCTION]. XIA
BAOWEI. chinese journal of ethnomedicine and
ethnopharmacy. 2002;4(2):97 (chi).
2711- gera: 104078/di/ra
[EFFECT OF ZHANG YINCHEN ON HEPATIC
ISCHEMIA REPERFUSION INJURY NO CONTENT
AND MORPHOLOGICAL CHANGS IN
169
HEPATOCYTES IN RATS]. WANG FANG, ET AL.
chinese journal of ethnomedicine and ethnopharmacy.
2002;4(2):109 (chi).
2712- gera: 104176/di/ra
[THE EXPERIMENTAL RESEARCH & MECHANISM
EXPLORATION OF GIJ TO PREVENT AND CURE
ACUTE LIVER DAMAGE OF RATS]. LIU YAMING ET
AL . china journal of traditional chinese medicine and
pharmacy. 2002;17(5):280 (chi*).
2713- gera: 104185/di/ra
[CORRELATION AND MECHANISM RESEARCH
PROGRESS OF ANTI-SPERM IMMUNOSTERILITY
IMMUNOSTERILITY AND CHRONIC VAGINAL
ANTI-HEPAFIBROSIS EXPERIMENTAL RESEARCH
OF PILLS]. YAN JUN ET AL . china journal of
traditional chinese medicine and pharmacy.
2002;17(5):313 (chi).
2714- gera: 104210/di/ra
[INVESTIGATION ON THE TREATMENT OF
CHRONIC HEPATITIS B WITH INTEGRATED TCM
AND WM]. JIANG SEN, JIA JING-PENG, JIANG FANG-
LI. shanxi journal of traditional chinese medicine.
2002;18(3):43 (chi*).
2715- gera: 104211/di/ra
[EXPERIMENTAL RESEARCH ON THE EFFECT OF
HELUOSHUGAN CAPSULE ON LIVER INJURY].
YANG WEN-BIN, CHAI QIU-YAN, LI BAI-QIANG, ET
AL. shanxi journal of traditional chinese medicine.
2002;18(3):49 (chi).
2716- gera: 104232/di/ra
[THE EXPERIMENTAL RESEARCH ON
PROTECTING FUNCTION TO LIVER BY "QING JIE
LING" OF CHINESE HERB]. ZHAO CHENGME.
journal of tian in university of tianjin traditional chinese
medicine. 2002;21(2):10 (chi*).
2717- gera: 104254/di/ra
[CORRELATIVE STUDY BETWEEN CHINESE
MEDICAL SYNDROME AND LABORATORY INDEX
IN CHRONIC HEPATITIS B]. JIANG JIAN GAO YUE-
QIU WU XIAO, ET AL. shanghai journal of traditional
chinese medicine. 2002;36(6):15 (chi*).
To study the correlation between Chinese medical syndrome
and laboratory index in chronic hepatitis B, 256 cases were
randomized into five syndromes: liver-gallbladder dampness-
heat syndrome (A), liver-depression and spleen- asthenia
syndrome (B), liver-kidney Yin deficiency syndrome (C),
spleen-kidney Yang deficiency syndrome (D) and blood
stasis in collateral syndrome (E) . Results: ALT, AST, TBiL
and IgG were highest in syndrome A, second in syndrome B,
with significant differences as compared to other
syndromes(P < 0. 05), while the possibility of splenomegaly
was lower in syndrome A than any of other syndromes (P <
0. 05) ; the possibility of splenomegaly in syndrome B was
secondly lower; in syndrome E, the possibility of
splenomegaly and IgG were highest (P < 0. 05 positive rate
of HBeAg tended to be higher in excess syndrome than in n
deficiency syndrome. It is revealed that the different
pathological changes in the liver are the essential basis for the
syndrome differentiation of chronic
2718- gera: 104255/di/ra
[CLINICAL OBSERVATION OF "QI-
SUPPLEMENTING AND BLOOD-ACTIVATING
DECOCTION" PLUS KURARINONE FOR HEPATITIS
gera 2011

B VIRUS]. LIN SHU-HUA ZHANG WEI WANG YU-
QUN, ET AL. shanghai journal of traditional chinese
medicine. 2002;36(6):18 (chi).
To observe the action of " Qi-Supplementing and Blood-
Activating Decoction" phis kurarinone injection in the
removal of hepatitis B virus, 30 cases in treatment group
were heated with the Decoction and kurarinone, and another
30 cases in control group were treated with mere kurarinone.
They were all treated for 6 months. Results: In treatment
group, the negative-conversion rates of HBeAg and HBV-
DNA were 50.00% and 56.00% respectively; in the control
group, they were 40. 00% and 40.91 % respectively, with
great differences between the two groups (P < 0.05);
furthermore, the symptoms and signs improved more
obviously in treatment group than in control group
2719- gera: 104322/di/ra
[STUDIES ON MECHANISM OF SINISAN
ALLEVIATING LIVER INJURY INDUCED BY
CELLULAR IMMUNOLOGICAL REACTION]. ZHOU
CHUN-XIANG XU QIANG CAO JIN-SONG, ET AL.
chinese journal of basic medicine in traditional chinese
medicine. 2002;8(5):47 (chi).
2720- gera: 104549/di/ra
[49 CASES OF FATTY LIVER FROM
HYPERLIPOIDEMIA TREATED WITH "MODIFIED
FRUCTUS AURANTII- RHIZOMA ATRACTYLODIS
MACROCEPHALAE SOUP"]. ZHOU XIU-TONG .
liaoning journal of traditional chinese medicine.
2002;28(7):406 (chi*).
2721- gera: 104602/di/ra
[EFFECTS OF CHITOSAN ON HEPATIC LIPIDS AND
MITOCHONDRIA IN FATTY LIVER RATS]. QI XIAO-
HONG, JIANG LI, LI XIAO-YU ET AL. chinese journal of
marine drugs . 2002;20(2):32 (chi).
2722- gera: 104734/di/ra
[SOME QUESTIONS FOR TREATMENT OF
HEPATITIS-B]. LIU SHIJING ET AL . information on
traditional chinese medicine. 2002;18(4):3 (chi).
2723- gera: 104746/di/ra
[EXPERIMENTAL STUDY ON ANTI-LIVER
FIBROSIS WITH CHINESE HERBS]. CHEN HUIJING
ET AL. information on traditional chinese medicine.
2002;18(4):47 (chi*).
2724- gera: 104785/di/ra
[THE ANALYSIS OF TREATING LIVER CIRRHOSIS
WITH ASCITES 90 CASES WITH ZHUANG
NATIONALITY RECIPE FUGANLING DECOCTION].
WEI JIAQING, ET AL. chinese journal of ethnomedicine
and ethnopharmacy. 2002;6(3):141 (chi).
2725- gera: 104830/di/ra
[APPROACHES AND METHODS IN CLINICAL
RESEARCH OF VIRAL HEPATITIS]. XUE BOYU .
jiangsu journal of traditional chinese medicine.
2002;22(5):2 (chi).
2726- gera: 104834/di/ra
[LU JI ' S THREE METHODS IN TREATING
CHRONIC HEPATITIS B]. LU SHAOWU. jiangsu
journal of traditional chinese medicine. 2002;22(5):9 (chi).
2727- gera: 104857/di/ra
[RESEARCH ON FATTY LIVER TREATED BY
TRADITIONAL CHINESE MEDICINE]. ZHENG
170
XINYU . journal of traditional chinese medicinal
literature. 2002;69(2):41 (chi).
2728- gera: 104890/di/ra
[HERBAL MEDICATION 960 MIXTURE COMBINED
WITH TRANSCATHETER ARTERIAL
CHEMOEMBOLIZATION FOR ADVANCED LIVER
CANCER]. WANG CHANGJUN, LIAO ZIJUN, CHEN
QINGQIANG, ET A. chinese journal of integrated
traditional and western medicine on digestion.
2002;10(4):211 (chi*).
2729- gera: 104892/di/ra
[INFLUENCE OF GANWEISHU MIXTURE ON
PROTECTING LIVER AND IMMUNE FUNCTION
AFTER TRANSCATHETER ARTERIAL
CHEMOEMBOLIZATION FOR HEPATOCELLULAR
CARCINOMA]. LIU YINGKE, ZHANG YIPING, XU
ZHIDE, ET AL. chinese journal of integrated traditional
and western medicine on digestion. 2002;10(4):217 (chi*).
2730- gera: 104963/di/ra
[INFLUENCE OF GANFUJIAN GRANULE ON
COLLAGEN SEDIMENT IN RAT LIVER FIBROSIS].
QIAN YAN, LING CHANG-QUAN, JIN YAN. journal of
anhui traditional chinese medical college. 2002;21(4):36
(chi).
2731- gera: 104982/di/ra
[CLINICAL OBSERVATION OF YISHEN XIGAN
HUAZHI TANG IN THE TREATMENT OF 40 CASES
OF ALCOHOLIC FATTY LIVER]. DONG ZI-QIANG .
henan traditional chinese medicine. 2002;22(3):29 (chi*).
2732- gera: 104992/di/ra
[GUO SHU - SHENG ' S EXPERIENCE IN
FORMULATING PRESCRIPTIONS FOR LIVER
DISEASE IN LIGHT OF TONGUE DIAGNOSIS]. GUO
HAI-TAO. henan traditional chinese medicine.
2002;22(4):15 (chi).
2733- gera: 104994/di/ra
[GANLU XIAODUDAN WITH MODIFICATION FOR
TREATING 50 CASES OF POST - EMBOLISM
SYNDROME OF PRIMITIVE CARCINOMA OF
LIVER]. ZHONG YI, ZHOU HONG, CHEN CHUN-
YONG. henan traditional chinese medicine. 2002;22(4):20
(chi).
2734- gera: 105003/di/ra
[TREATMENT SEVERE HEPATITIS WITH
COMBINED TCM AND WM, A REPORT OF 32
CASES]. WEN LIU-RUI, LI QING-JIE, FAN TONG-XIN.
shanxi journal of traditional chinese medicine.
2002;18(4):27 (chi*).
2735- gera: 105009/di/ra
[PROTECTION OF ORAL KEBOLI-2 LIQUOR
AGAINST LIVER FIBROSIS INDUCED BY CARBON
TETRACHLORIDE IN RATS]. ZHAO SENG-LI, TAN
REN-BIN, ET AL. shanxi journal of traditional chinese
medicine. 2002;18(4):51 (chi*).
2736- gera: 105011/di/ra
[REVIEW AND PROSPECT OF CLINIC AND
EXPERIMENTAL STUDY OF TCM ON PRIMARY
HEPATOCARCINOMA]. PAN MINGQIU, ET AL. hunan
journal of traditional chinese medicine. 2002;18(4):1 (chi).
2737- gera: 105015/di/ra
gera 2011

[A SUMMARY ON 40 CASES OF SEVERE HEPATITIS
TREATED BY RETENTION - ENEMA WITH RHEUM
OFFICINALE DECOCTION]. LIAO SHUQI, ET AL.
hunan journal of traditional chinese medicine.
2002;18(4):9 (chi*).
2738- gera: 105033/di/ra
[CLINICAL OBSERVATION ON TREATING LIVER
FIBROSIS CAUSED BY CHRONIC HEPATITIS B
WITH GANPING CAPSULE]. WEN WEI-BO, ET AL.
chinese journal of ethnomedicine and ethnopharmacy.
2002;8(4):210 (chi).
2739- gera: 105042/di/ra
[MEDICINAL ANALYSIS ON TREATING 150 CASES
OF HEPATITIS B WITH TRADITIONAL CHINESE
MEDICINE]. LI CHONG-AN. chinese journal of
ethnomedicine and ethnopharmacy. 2002;8(4):226 (chi).
2740- gera: 105066/di/ra
[EFFECTS OF QIZHU GRANULES ON RAT MODELS
OF HEPATIC FIBROSIS]. LIU SHAONENG, YAO
NAILI, YIN HAIBO, ET AL. traditional chinese drug
research and clinical pharmacology. 2002;13(4):216
(chi*).
2741- gera: 105121/di/ra
[45 CASES OF LIVER CIRRHOTIC ASCITES
TREATED WITH FENGSHI DECOCTION]. GE WEN-
JING, LI GUO-HONG. liaoning journal of traditional
chinese medicine. 2002;29(8):466 (chi*).
2742- gera: 105196/di/ra
[CLINICAL OBSERVATION ON
QIANYANGFIANGYA CAPSULE TREATING
HYPERTENSION]. FENG PING, FU CANYUN, XIANG
YUANGENG. journal of emergency in traditional chinese
medicine. 2002;11(4):257 (chi).
2743- gera: 105282/di/ra
[CLINICAL OBSERVATION OF XIAOZHI HANGAN
DECOCTION TREATING 32 PATIENTS WITH
FATTY LIVER]. TAO JIHONG ET AL. acta chinese
medicine and pharmacology. 2002;30(4):27 (chi).
2744- gera: 105288/di/ra
[SUMMARY OF STUDY ON MECHANISM OF
CHINESE HERBS TREATING HEPATITIS B]. HE
JINYANG ET AL. acta chinese medicine and
pharmacology. 2002;30(4):64 (chi).
2745- gera: 105289/di/ra
[CLINICAL STUDY ON TREATMENT OF
ALCOHOLIC FAT LIVER WITH REMOVING LIVER
FAT PILL*]. JU LIJUN, MENG XINAGHUA, WANG
MENG. chinese journal of integrated traditional and
western medicine on liver diseases. 2002;12(4):196 (chi*).
2746- gera: 105290/di/ra
[CLINICAL STUDY ON THE TREATMENT OF GAN
DU QING GRANULE. OF 60 PATIENTS OF
ENDOTOXEMIA COMPLICATED BY CHRONIC
HEPATITIS B*]. WEI MEI, YANG HUAXIU, LIU PENG,
ET AL. chinese journal of integrated traditional and
western medicine on liver diseases. 2002;12(4):199 (chi*).
2747- gera: 105291/di/ra
[THERAPEUTIC EFFECT OF SHUGAN HUAYU
GRANULE ON CHRONIC HEPATITIS B AND
POSTHEPATITIC CIRRHOSIS*]. SUN YU. chinese
171
journal of integrated traditional and western medicine on
liver diseases. 2002;12(4):202 (chi*).
2748- gera: 105292/di/ra
[EFFECTS OF LAMIVUDINE ON MATRIX
METALLOPROTEINASE-1 AND TISSUE INHIBITOR
OF METALLOPROTEINASE-1 IN LIVERS OF
CHRONIC HEPATITIS B PATIENTS*]. GE YA, HU
TAIHONG, FONG LI, ET AL. chinese journal of
integrated traditional and western medicine on liver
diseases. 2002;12(4):205 (chi*).
2749- gera: 105293/di/ra
[CLINIC EFFECT ON CHRONIC HEPATITIS B
TREATED BY HELUO SHUGAN CAPSULE*]. ZHU
YUE, SUO AISHENG. chinese journal of integrated
traditional and western medicine on liver diseases.
2002;12(4):207 (chi*).
2750- gera: 105294/di/ra
[DETECTION OF SERUM IL-12, IFN- Y AND IL-10 IN
PATIENTS WITH VIRAL HEPATITIS AND THEIR
SIGNIFICANCE*]. LI YI, GUI XIEN, ZHANG YONGXI,
ET AL. chinese journal of integrated traditional and
western medicine on liver diseases. 2002;12(4):209 (chi*).
2751- gera: 105295/di/ra
[INFLUENCES OF KANGXIANFANG DECOCTION
ON THE PROLIFERATION AND APOPTOSIS OF
HEPATIC STELLATE CELLS AND THE
EXPRESSION OF MATRIX METALLOPROTEINASE-
1 AND TISSUE INHIBITOR OF
METALLOPROTEINASE- 1]. YIN JIDONG, TIAN
DEYING, HUANG QIAOXIN. chinese journal of
integrated traditional and western medicine on liver
diseases. 2002;12(4):211 (chi*).
2752- gera: 105296/di/ra
[EFFECT OF QINGGAN HUOXUE DECOCTION ON
GENE EXPRESSION OF KEY ENZYME ABOUT
ALCOHOL METABOLISM OF WISTAR RAT WITH
ALCOHOLIC LIVER DISEASE*]. JI GUANG, CAO
CHENGLOU, ZHANG WEI, ET AL. chinese journal of
integrated traditional and western medicine on liver
diseases. 2002;12(4):215 (chi*).
2753- gera: 105297/di/ra
[EXPRESSION OF FUSION PROTEIN OF HBV CORE
AND PRES1 GENE IN E. COLI. *]. CAI XIONGMAO,
CHEN XINCHUN, ZHOU BOPING, ET AL. chinese
journal of integrated traditional and western medicine on
liver diseases. 2002;12(4):218 (chi*).
2754- gera: 105298/di/ra
[ANTIVIRAL ACTIVITY OF HAMMERHEAD
RIBOZYME AGAINST HBV IN 2.2.15 CELLS*]. MENG
ZHONGJI, ZHANG QUANRONG, YANG LIHUA, ET AL.
chinese journal of integrated traditional and western
medicine on liver diseases. 2002;12(4):221 (chi*).
2755- gera: 105299/di/ra
[PHARMACODYNAMIC STUDY ON ANTI-
EXPERIMENTAL HEPATIC FIBROSIS OF SANCAO
HUGAN CAPSULE*]. ZHONG MING, YU SHENGMIN,
HUANG LINYUN, ET AL. chinese journal of integrated
traditional and western medicine on liver diseases.
2002;12(4):225 (chi*).
2756- gera: 105300/di/ra
[A STUDY OF INHIBITORY EFFECT OF
gera 2011

TETRANDRINE ON EXPERIMENTAL HEPATIC
FIBROSIS*]. WU GUODONG, LUO DUANDE. chinese
journal of integrated traditional and western medicine on
liver diseases. 2002;12(4):228 (chi*).
2757- gera: 105323/di/ra
[OBSERVATION OF CURATIVE EFFECT ON
FIBROSIS OF LIVER OF CHRONIC VIRUS
HEPATITIS B PREVENTED AND TREATED BY
DAHUANG ZHECHONG WAN]. SHEN ZHONGLIANG,
ET AL. hubei- journal of traditional chinese medicine.
2002;24(8):21 (chi).
2758- gera: 105347/di/ra
[CLINICAL RESEARCH OF RANDOM CONTRAST
ON TREATMENT OF ALCOHOLIC HEPATOPATHY
WITH QINGGAN HUOXIE FANG]. WANG YUQUN,
ET AL. beijing journal of traditional chinese medicine.
2002;21(4):195 (chi).
2759- gera: 105409/di/ra
[42 CASES OF TREATMENT OVER FATTY LIVER
COMBINED WITH ZHIZHUTANG AND
SHENGJIANGSAN .]. WANG JUE. jiangxi journal of
traditional chinese medicine. 2002;33(4):11 (chi).
2760- gera: 105469/di/ra
[ZHANG HAICEN ' S EXPERIENCE IN TREATING
TYMPANITES]. ZHANG GUOTAI . zhejiang journal of
traditional chinese medicine. 2002;37(8):328 (chi).
2761- gera: 105470/di/ra
[EXPLORATION INTO THE DYNAMIC CHANGE OF
TCM SYNDROME OF CHRONIC HEPATITIS]. YAN
QIN . zhejiang journal of traditional chinese medicine.
2002;37(8):329 (chi).
2762- gera: 105518/di/ra
[OBSERVATION ON CHRONICAL HEPATITIS B (120
CASES) TREATED BY TRADITIONAL CHINESE
DRUGS MIXED WITH WESTERN DRUGS .]. LIU
XIUZHEN. journal of practical traditional chinese
medicine. 2002;8(18):20 (chi*).
2763- gera: 105584/di/ra
[LABORATORY STUDY ON DIE
ANTIHEPATOCIRRHOSIS EFFECT OF
GUIJIAGANTAI TABLET]. ZHU ZHI-JUN. chinese
journal of traditional medical science and technology.
2002;9(4):202 (chi).
2764- gera: 105590/di/ra
[THE STUDY OF THE PREVENTION AND
TREATMENT OF THE LIVER CANCER TREATED
BY TRADITIONAL CHINESE MEDICINE AT THE
STANDARD OF MOLECULE AND GENE]. DONG LIN
ET AL. gansu journal of traditional chinese medicine.
2002;15(4):7 (chi).
2765- gera: 105615/di/ra
[MECHANISM OF PROTECTIVE EFFECT OF
TETRAMETHYLPYRAZINE ON HEPATIC
ISCHEMIA - REPERFUSION INJURY IN RABBITS].
WANG WAN-TIE XU ZHENG-JIE LIN LI-NA ET AL.
chinese journal of integrated traditional and western
medicine in intensive and criti. 2002;9(4):216 (chi*).
2766- gera: 105633/di/ra
[CLINICAL OBSERVATION ON CHINESE HERBS
COMBINED WITH INTERFERON - A IN TREATING
172
36 CASES OF CHRONIC HAPATITIS B]. XU XUEJUN.
hebei journal of traditional chinese medicine.
2002;24(7):491 (chi*).
2767- gera: 105715/di/ra
[EXPERIMENTAL STUDY ON THE ANTI-FIBROTIC
EFFECT OF YUTONGXIAO CAPSULE]. WEI AI-LING.
liaoning journal of traditional chinese medicine.
2002;29(7):446 (chi*).
2768- gera: 105753/di/ra
[EFFECTS OF COADMINISTRATION OF
BERBERINE HYDROCHLORIDE AND
CYCLOSPORINE A ON LIVER MICROSOMAL
DRUG METABOLIZING ENZYMES IN MICE]. WU
XIAO-CHUN, XIN HUA-WEN, LI QING ET AL. chinese
traditional and herbal drugs. 2002;33(6):528 (chi*).
2769- gera: 105767/di/ra
[CLINICAL OBSERVATION OF CURATIVE EFFECT
SELF - PREPARED FUZHENG YUGAN DECOCTION
ON 30 CASES OF CHRONIC HEPATITIS B]. HUANG
BIN WEI AILING. guangxi journal of traditional chinese
medicine. 2002;25(3):5 (chi).
2770- gera: 105784/di/ra
[126 CASES OF CHRONIC HEPATITIS B TREATED
WITH DECOCTION OF YI-QI-HUO-XUE-JIE-DU].
LUO ZHONG-MIN. journal of chengdu university of
traditional chinese medicine. 2002;25(2):11 (chi).
2771- gera: 105787/di/ra
[EFFECTS OF YING-GAN-FU-KANG ON MICE WITH
IMMUNOLOGICAL LIVER DAMAGE]. WANG TIAN-
RAN, ZENG XIANG-YUAN, MA BU-REN. journal of
chengdu university of traditional chinese medicine.
2002;25(2):18 (chi*).
2772- gera: 105827/di/ra
[CLINICAL STUDY ON PAIN FOLLOWING LIVER
CANCER TREATED BY EXTERNAL THERAPY.].
WANG KAI FAN XIAO-PENG LIN YA-JIE. shanghai
journal of traditional chinese medicine. 2002;36(7):19
(chi*).
2773- gera: 105828/di/ra
["LIVER-RESTORING AND TOXIN-RESOLVING
DECOCTION" FOR CHRONIC HEPATITIS B IN 36
CASES]. LE MIN. shanghai journal of traditional chinese
medicine. 2002;36(7):21 (chi*).
2774- gera: 105843/di/ra
[CLINICAL OBSERVATION OF WARMING YANG
TO PROMOTE DIURESIS THERAPY FOR ASCITES
DUE TO CIRRHOSIS: A REPORT OF 36 CASES]. LI
LIN ET AL. beijing journal of traditional chinese
medicine. 2002;21(3):131 (chi).
2775- gera: 105852/di/ra
[TREATMENT FOR 96 CASES OF CHRONIC
HEPATITIS B WITH FUZHENG SHUXIE METHOD].
WANG JINGQI, ET AL. beijing journal of traditional
chinese medicine. 2002;21(3):154 (chi).
2776- gera: 105853/di/ra
[CLINICAL OBSERVATION OF CHRONIC
HEPATITIS B TREATED BY SHUGAN JIANPI TANG:
A REPORT OF 287 CASES]. WANG GUOWEI, ET AL.
beijing journal of traditional chinese medicine.
2002;21(3):157 (chi).
gera 2011

2777- gera: 105869/di/ra
[THE CLINICAL RESEARCH OF 50 CASES FATTY
LIVER BY USING HUAZHIBIANGAN DECOCTION].
WANG FANG LU XINLIE. guang . 2002;3:31 (chi).
2778- gera: 106019/di/ra
[CHEN KUN-SHAN'S EXPERIENCE OF TREATMENT
OVER LIVER DISEASES]. YU JIAN-PING. jiangxi
journal of traditional chinese medicine. 2002;33(3):1 (chi).
2779- gera: 106065/di/ra
[DIAGNOSIS AND TREATMENT OF BACTERIAL
LIVER ABSCESS BY INTEGRATED TRADITIONAL
CHINESE AND WESTERN MEDICINE]. YIN
ZONGFU, HE QINGYU, LIU LIANG, ET AL. chinese
journal of surgery of integrated traditional chinese and
western medicine. 2002;8(3):139 (chi*).
2780- gera: 106105/di/ra
[THE EFFECT OF RHODIOLA SACHALINENSIS
COMPOUND ON THE EXPRESSION OF TGF-B1
MRNA IN RATS OF CCI4- INDUCED LIVER
FIBROSIS]. ZENG WEIZHENG, WU XIAOLING, JIANG
MINGDE, ET AL. chinese journal of integrated
traditional and western medicine on digestion.
2002;10(3):138 (chi*).
2781- gera: 106107/di/ra
[OBSERVATION ON THE METHOD OF CLEARING
HEAT AND REMOVING DAMPNESS IN TREATING
ALCOHOLIC HEPATITIS]. ZHANG SHIJUN CHEN
ZEXIONG HUANG BIJUN, ET AL. chinese journal of
integrated traditional and western medicine on digestion.
2002;10(3):145 (chi*).
2782- gera: 106112/di/ra
[CLINICAL EFFECT OF SHUANGJIA-WULING
CAPSULE ON HEPATIC FIBROSIS]. XU JIAPING BAI
XIANGUANG. chinese journal of integrated traditional
and western medicine on digestion. 2002;10(3):159 (chi*).
2783- gera: 106114/di/ra
[CLINICAL STUDY ON THE THERAPEUTIE
EFFECT OF QUZHI FUGAN DECOCTION ON THE
PATIENTS WITH FATTY LIVER]. GAO HUI ZHOU
DAQIAO XIONG YIQUN, ET AL. chinese journal of
integrated traditional and western medicine on digestion.
2002;10(3):165 (chi*).
2784- gera: 106115/di/ra
[EFFECT OF TIDU HUGAN PRESCRIPTION ON
BULBAR CONJUNCTIVAL MICROCIRCULA TION
AND BLOOD RHEOLOGY IN HEPATITIS B VIRUS-
INDUCED HEPATIC FIBROSIS DUCKS]. LUO XINLA
ZHU QINGJING LU DINGBO. chinese journal of
integrated traditional and western medicine on digestion.
2002;10(3):168 (chi*).
2785- gera: 106127/di/ra
[OBSERVATION ON FATTY LIVER (58 CASES)
TREATED BY TRADITIONAL CHINESE DRUGS
COMBINED WITH WEIGHT REDUCTION .]. HUANG
ZIXIA, ZHENG CHINUO, QIU CAIXIN. journal of
practical traditional chinese medicine. 2002;7(18):8 (chi).
2786- gera: 106128/di/ra
[HEPATITIS B FIBROCALCIFICATION (76 CASES)
TREATED BY POWDER FOR RESOLVING HARD
LUMPS.]. ZHANG LUGAO. journal of practical
173
traditional chinese medicine. 2002;7(18):11 (chi).
2787- gera: 106224/di/ra
[STUDY ON MECHANISM OF "LIVER-CLEANING
AND BLOOD-ACTIVATING FORMULA" IN
PREVENTION AND TREATMENT OF ALCOHOLIC
LIVER INJURY]. XING LIAN-JUN, JI GUANG, CHENG-
LOU, ET AL. acta universitatis traditionis medicalis
sinensis pharmacologiaeque shanghai. 2002;16(2):48
(chi*).
2788- gera: 106225/di/ra
[INTERFERENCE OF "RESISTANCE-
STRENGTHENING AND STASIS-DISPERSING
FORMULA" ON ACTIVATION CHANNEL OF PAM-
SECRETION AND AUTO-SECRETION IN HEPATIC
STALLATE CELLS]. JIANG CHUN-MEN, LIU CHENG.
acta universitatis traditionis medicalis sinensis
pharmacologiaeque shanghai. 2002;16(2):51 (chi*).
2789- gera: 106230/di/ra
[CLINICAL ANALYSIS OF ARTIFICIAL LIVER
SUPPORT SYSTEM IN TREATMENT OF 36
PATIENTS WITH SEVERE HEPATITIS]. GUO WEI,
TAO XINXUE, DING HONGFANG, ET AL. chinese
journal of integrated traditional and western medicine on
liver diseases. 2002;12(3):131 (chi*).
2790- gera: 106231/di/ra
[EFFICACY OF LAMIVUDINE IN TREATING
CHRONIC SERIOUS-TYPE HEPATITIS]. LI XIAOOU,
GUO JIANCHUN. chinese journal of integrated
traditional and western medicine on liver diseases.
2002;12(3):134 (chi*).
2791- gera: 106232/di/ra
[ANTIVIRAL EFFECTS OF HAIZHU YIGAN CAPSUL
ON HEPATITIS B VIRUS]. HUANG YUHUA, SHENG
GUOGUANG, ZHANG JIANJUN. chinese journal of
integrated traditional and western medicine on liver
diseases. 2002;12(3):136 (chi*).
2792- gera: 106233/di/ra
[PARTIAL SPLENIC EMBOLOTHERAPY
TREATMENT ON PORTAL HYPERTENSION AND
HYPERSPLENIA CAUSED BY CIRRHOSIS]. HUANG
YUE, CHEN HONGBIN, HUANG ZHONGWEN, ET AL.
chinese journal of integrated traditional and western
medicine on liver diseases. 2002;12(3):138 (chi*).
2793- gera: 106234/di/ra
[CLINICAL STUDY OF MARINE INJECTION
TREATMENT FOR DECOMPENSATED CIRRHOSIS
RELATED TO CHRONIC HEPATITIS B]. ZHANG
XUEWU, ZHOU MIN, HU GUOQI. chinese journal of
integrated traditional and western medicine on liver
diseases. 2002;12(3):141 (chi*).
2794- gera: 106235/di/ra
[ANTIVIRAL EFFICACY OF ORAL BIFENDATE FOR
A LONG TERM IN TREATMENT OF PATIENTS
WITH CHRONIC HEPATITIS B]. CUI SUNAN, WANG
ZHAOHONG, LI XINLI, ET AL. chinese journal of
integrated traditional and western medicine on liver
diseases. 2002;12(3):144 (chi*).
2795- gera: 106236/di/ra
[EFFECTS OF QINGGAN JIEDU INJECTION ON
IMMUNOLOGIC FUNCTION OF RATS WITH
LABORATORY ACUTE HEPATIC FAILURE *]. XUE
gera 2011

BOYU, ZHOU MIN, ZHOU ZHONGYING, ET AL. chinese
journal of integrated traditional and western medicine on
liver diseases. 2002;12(3):147 (chi*).
2796- gera: 106238/di/ra
[EFFECTS OF PRAZIQUANTEL ON THE SEROUS
NITRIC OXIDE AND INTRAHEPATIC INDUCED
NITRIC OXIDE SYNTHASE IN SCHISTOSOMIASIS
MICE WITH LIVER FIBROSIS]. XIONG LIJUAN, ZHU
JIANFANG, LUO DUANDE, ET AL. chinese journal of
integrated traditional and western medicine on liver
diseases. 2002;12(3):153 (chi*).
2797- gera: 106328/di/ra
[CHANGES AND CLINICAL MEANING OF THE
LEVELS OF PLASMA ET ANDTNF - A IN THE
ALCOHOLIC FATTY LIVER PATIENTS]. SHI
JUNPING, WU JUYING, PAN HONGYING ET AL.
journal of zhejiang college of traditional chinese
medicine. 2002;26(3):26 (chi*).
2798- gera: 106340/di/ra
[ANALYSIS ON RECENT THERAPEUTIC EFFECTS,
AND FEES OF MEDICINE ON DIFFERENT
CHEMOTHERAPY METHODS COMBINED WITH
TCM FOR TREATING LATE PRIMARY LIVER
CARCINOMA]. WANG YONG WANG RONG-PING.
fujian journal of traditional chinese medicine.
2002;33(3):6 (chi).
2799- gera: 106397/di/ra
[CLINICAL OBSERVATION ON TREATMENT OF 49
CASES OF CHOLESTASIA VIRAL HEPATITIS BY
INTEGRATIVE MEDICINE]. YANG BIN. chinese
journal of integrated traditional ional and western
medicine. 2002;22(6):459 (chi*).
2800- gera: 106459/di/ra
[COMBINED TCM AND WM TREATMENT FOR
SEVERE HEPATITIS AND HEPATOCIRRHOSIS
COMPLICATED BY ENDOTOXICEMIA]. MAYUPING
PENG JIE ZHAO LING. shaanxi journal of traditional
chinese medicine. 2002;23(7):579 (chi).
2801- gera: 106460/di/ra
[CHRONIC HEPATITIS B TREATED BY
DISSIPATING DAMPNESS]. ZHAO LING HUANG
XIAOZHENG SUN FANGXIA. shaanxi journal of
traditional chinese medicine. 2002;23(7):582 (chi).
2802- gera: 106461/di/ra
[DIFFERENTIATION OF SYNDROMES AND
DISEASES IN THE TREATMENT OF PRIMARY
LIVER CANCER OF LATE STAGE]. WEI LIN YANG
CHENGUANG. shaanxi journal of traditional chinese
medicine. 2002;23(7):587 (chi).
2803- gera: 106462/di/ra
[STASIS -DISSIPATING AND LIVER-SOFTENING
FOR HEPATIC FIBROSIS]. TANG SHILI LIU
QIZHENG WANG YANNI. shaanxi journal of traditional
chinese medicine. 2002;23(7):588 (chi).
2804- gera: 106475/di/ra
[INFLUENCE OF RANGANGAISENG GRAINS ON
THE INDEX SIGN OF CHRONIC HEPATIC
FIBROSIS]. PU JIANGYINA. inner mongol journal of
traditional chinese medicine. 2002;21(3):1 (chi).
2805- gera: 106477/di/ra
174
[HEARING FROM TREATING 270 CASES SUFFERED
FROM ACUTE ICTERIC HEPATITIS]. SHI GANG SHI
WENBIN, MA BAOLIN. inner mongol journal of
traditional chinese medicine. 2002;21(3):8 (chi).
2806- gera: 106544/di/ra
[TREATMENT OF 53 CASES OF ICTERIC VIRAL
HEPATITIS WITH ARMILLARISIN A]. CHEN QI.
jiangsu journal of traditional chinese medicine.
2002;23(9):16 (chi).
2807- gera: 106563/di/ra
[RECENT CONDITION OF TREATMENT OF
CHRONIC HEPATITIS B BY TCM AND CHINESE
MATERIA MEDICA]. YANG SHI-ZHONG ET AL.
academic periodical of changchun college of traditional
chinese medicine. 2002;18(3):57 (chi).
2808- gera: 106610/di/ra
[AN ANALYSIS OF TREATMENT WITH SYNDROME
DIFFERENTIATION ABOUT CHRONIC HEPATITIS].
SHI QIAOLING. guang ming journal traditional chinese
medicine. 2002;8(4):21 (chi).
2809- gera: 106737/di/ra
[EFFECT OF GANXIANTAI MIXTURE ON FOUR
INDEXES ABOUT BLOOD PATELET IN PATIENTS
WITH CIRRHOSIS]. CHEN YAN-NAN, ZHANG WEN-
CHAO, DONG CHANG-SONG,. journal of shandong
university of traditional chinese medicine. 2002;26(5):356
(chi).
2810- gera: 106778/di/ra
[CINICAL STUDY ON FATTY LIVER TREATED
WITH HUGAN TIAOZHI POWDER]. LIU YU, WANG
GUO-SHUN, TIAN LAN-JUN, ET AL AL. shandong
journal of traditional chinese medicine. 2002;21(8):464
(chi).
2811- gera: 106798/di/ra
[DEGRADATION EFFECT OF DECOCTION
EXTRACTED FROM PEACH SEEDS ON TYPE I, III
SERUM PROCOLLAGEN OF HEPATIC FIBROSIS
MICE]. ZHANG XIAO-PING, CHEN JIAN-MING,
QIANG SHI-PING. fujian journal of traditional chinese
medicine. 2002;33(4):36 (chi).
2812- gera: 106843/di/ra
[EFFECT OF HEJIE DECOCTION (*OJWA) ON T-
CELL RECEPTOR VB7 GENE EXPRESSION IN
PATIENTS OF CHRONIC HEPATITIS B*]. ZHANG
SHI-JUN, CHEN ZE-XIONG, HUANG BI-JUN, ET.
chinese journal of integrated traditional and western
medicine. 2002;22(7):499 (chi*).
2813- gera: 106844/di/ra
[OBSERVATION ON EFFECT OF YUGAN GRANULE
()* FF OFT ) IN TREATING PATIENTS OF CHRONIC
HEPATITIS B WITH BASIC CORE PROMOTER
MUTANT HEPATITIS B VIRUS*]. XIE CHAO-LIANG,
SHAO ZE-YONG. chinese journal of integrated
traditional and western medicine. 2002;22(7):502 (chi*).
2814- gera: 106857/di/ra
[CLINICAL OBSERVATION ON THE ANTI-LIVER
FIBROSIS TREATMENT BY DIAMMONIOM
CLYCYRRHIZINATE INJECTION COMBINED WITH
SALVIA]. ZHANG YI-FA, WANG LIN-LUN,YIN WEI-
HUA. chinese journal of integrated traditional and
western medicine. 2002;22(7):538 (chi).
gera 2011

2815- gera: 106860/di/ra
[COMPARATIVE STUDY ON TREATMENT OF
SEVERE HEPATITIS BY WESTERN MEDICINE AND
BY TCM]. YI LU-QIAN WANG XIAO-WANG. chinese
journal of integrated traditional and western medicine.
2002;22(7):543 (chi).
2816- gera: 106888/di/ra
[CLINICAL OBSERVATION ON 30 CASES OF
FIBROSIS OF LIVER TREATED BY DA DING FENG
ZHU]. LI WEILIN, WANG CAIDANG, ZHANG JUNLI.
journal of traditional chinese medicine. 2002;43(7):520
(chi*).
2817- gera: 106908/di/ra
[THE INFORMATION ON THE TREATMENT OF
LIVER DISORDERS CAUSED BY ALCOHOL]. SUN
JINHUI ET AL. acta chinese medicine and pharmacology.
2002;30(2):65 (chi).
2818- gera: 106952/di/ra
[THE EFFECT OF PROMOTING THE BLOOD FLOW
AND RESOLVING DAMPNESS RECIPE ON
SYNTHESIS AND DECOMPOSITION OF COLLAGEN
FIBER OF EXPERIMENTAL HEPATOFIBROSIS
RATS]. LULIANG WEI ET AL. china journal of
traditional chinese medicine and pharmacy.
2002;17(6):348 (chi).
2819- gera: 106980/di/ra
[ANALYSIS AND COUNTERMEASURES OF THE
RELATIVE FACTORS FORMING FATTY LIVER].
PAN HONGYING SHI JUNPING FU XIAOQIN ET AL.
journal of zhejiang college traditional chinese medicine.
2002;26(4):21 (chi).
2820- gera: 106988/di/ra
[DISCUSSION ABOUT DIFFERENTIAL DIAGNOSIS
BY THE ANALYSIS OF WEI, QI, YING AND XUE OF
CHRONIC HEPATITIS B]. LI WEI-LIN. chinese journal
of basic medicine in traditional chinese medicine.
2002;28(8):3 (chi).
2821- gera: 106998/di/ra
[PRELIMINARY MECHANISM OF ARTESUNATE
TREATING HEPATOCARCINOMA]. WU LI-MAO,
ZHAO YI, WANG QIN, ET AL. chinese journal of basic
medicine in traditional chinese medicine. 2002;28(8):33
(chi*).
2822- gera: 107030/di/ra
[SURVEY OF ACUPUNCTURE AND MOXIBUSTION
FOR PREVENTION AND TREATMENT OF LIVER
CANCER]. YANG YUNKUAN, DIAO CANYANG, HU
YOUPING, ET AL. chinese acupuncture and moxibustion.
2002;22(9):638 (chi*).
Review present situation of clinical and laboratory studies for
treatment arid prevention of liver cancer, pain of liver cancer,
and its complications with acupuncture, moxibustion ,
acupoint-injection and acupoint application in recent 20
years, and comment and study on its developing tendency
and direction, in order to provide reference for deep study on
prevention and treatment of liver cancer.
2823- gera: 107080/di/ra
[STUDY ON THE DIFFERENTIATION OF
SYNDROMES OF FIBROCALCIFICATION CAUSED
BY CHRONIC HEPATITIS-B]. LU SHAONENG ET AL.
information on traditional chinese medicine.
175
2002;19(5):15 (chi).
2824- gera: 107280/di/ra
[COMBINED TCM AND WEST MEDICINE IN
WHICH DAHUANGGANJUSAN AS MAIN
PRESCRIPTION FOR TREATING 30 CASES OF
ASCITIC FLUID RESULTING FROM HEPATITIS-
ASSOCIATED CIRRHOSIS.]. X. hunan guiding journal
of tcmp. 2002;8(4):163 (chi).
2825- gera: 107330/di/ra
[APPLYING JIANPIYIGANTANG TO TREATING
LIVER CIRRHOSIS WITH ASCITIC FLUID.]. X.
hunan guiding journal of tgmp. 2002;8(5):252 (chi).
2826- gera: 107331/di/ra
[APPLYING QISHAOZHIHUANGTANG TO
TREATING 56 CASES OF ACUTE VIRUS ICTERIC
HEPATITIS.]. X. hunan guiding journal of tgmp.
2002;8(5):254 (chi).
2827- gera: 107395/di/ra
[[]CORRELATION ANALYSIS ON TRADITIONAL
CHINESE MEDICINE TYPING OF CHRONIC
GASTRITIS AND TWO DETECTIONS OF HB
INFECTION]. CAI ZIHONG, ET AL. journal of
traditional chinese medicine hubei. 2002;24(9):7 (chi).
2828- gera: 107426/di/ra
[OBSERVATION ON THE THERAPEUTIC EFFECT
OF ACUPUNCTURE ON POST-EMBOLIC
SYNDROME AFTER ENDARTERIAL
CHEMOTHERAPY FOR LIVER CANCER]. MU
RONG, ZHENG QUBIN. chinese acupuncture and
moxibustion. 2002;22(1):21 (chi*).
Purpose : To observe the therapeutic effect of acupuncture on
post-embolic syndrome after endarterial chemotherapy for
liver cancer. Methods : Thirty-six cases with post-embolic
syndrome after endarterial chemotherapy for liver cancer
were treated with acupuncture at Neiguan ( PC 6) and Zusanli
( ST 36) , and treatment of Ondansetron was used as controls.
and the clinical results of the two groups were compared.
Results The effective rate was 97. 2% and 95. 2% in the
treatment group and the control group respectively, with no
significantly difference. But there was a significant difference
in the markedly effective rate between the two groups ( P<0.
05). Conclusion : The therapeutic effect in the treatment
group is superior to that in the control group.
2829- gera: 107495/di/ra
[EFFECT OF ACUPOINT APPLICATION OF KANG
AI FU SHUI PLASTER ON SIL-2R IN MICE OF
EHRLICH ASCITES CARCINOMA]. TIAN JIANHUI,
LIU YUNXIA, AU BAOGANG, ET AL. chinese
acupuncture and moxibustion. 2002;21(9):559 (chi*).
Purpose : To Approach to Effect of acupoint application of
Kangai Fushui Plaster on serum soluble IL-2 receptor( sIL-
2R) level in mice of Ehrlichascites carcinoma. Methods : The
mice of Ahrlich ascites carcinoma were randomly divided
into 4 groups, normal control group, model control group,
local application group and acupoint application group, and
the sIL-2R levels were determined with radioimmunoassay.
Results The sIL-2R in the tumor- bearing mice was higher
than that of the normal control group ( P<0. 01) , and external
application of Kangai Fushui Plaster could significantly
decrease the level of sIL-2R. Conclusion : There is
dysfunction of cellular factors network in mice of Ahrlich
ascites carcinoma, and Kangai Fushui Plaster can reduce sIL ,
2R level in peripheral blood, so as to regulate cellular factor
network and promote cellular immunological function.
gera 2011

2830- gera: 107500/di/ra
[OBSERVATION ON EFFECT OF TREATING FATTY
LIVER WITH FUGAN PILL FOR CLEARING UP
FATTY: A REPORT OF 71 CASES]. CHEN WEN-HUI,
ZHANG CHAO, LIN QING, ET AL. journal of yunnan
college of tcm. 2002;25(1):4 (chi*).
2831- gera: 107501/di/ra
[EFFECT OF CZYGW ON LTC AND LTS IN FATTY
LIVER MICE CAUSED BY TETRACYCLINE]. SUN
CHUANG-BIN, YU ZE-PU, LIN QING ET AL. journal of
yunnan college of tcm. 2002;25(1):8 (chi*).
2832- gera: 107537/di/ra
[OBSERVATION ON SHORT-TERM EFFECT AND
FOLLOW-UP OF INTEGRATIVE MEDICINE IN
TREATING 198 PATIENTS WITH
HEPATOLENTICULAR DEGENERATION*]. YANG
REN-MIN, CHENG NAN. chinese journal of integrated
traditional and western medicine. 2002;22(9):657 (chi*).
2833- gera: 107538/di/ra
[CLINICAL OBSERVATION ON TREATMENT OF
CHRONIC HEPATITIS B CAUSED LIVER FIBROSIS
BY COMPOUND PEACH KERNEL SOFTENING
LIVER CAPSULE*]. LI MING, WANG AI ZHEN, YANG
QI-YING, ET AL. chinese journal of integrated traditional
and western medicine. 2002;22(9):660 (chi*).
2834- gera: 107548/di/ra
[EFFECT OF ANTI-FIBROSIS COMPOUND ON
ACTIVITY OF HUMAN A1, PRECOLLAGEN GENE
PROMOTER*]. ZHAO GANG, ZHANG BIN, CHEN
JIAN-JIE, ET AL. chinese journal of integrated traditional
and western medicine. 2002;22(9):694 (chi*).
2835- gera: 107550/di/ra
[CLINICAL OBSERVATION ON ANTI-VIRUS
EFFECT OF COMBINED LAMIVUDINE AND
SOPHORAE SUBPROSTRATAE INJECTION IN
TREATING CHRONIC SEVERE HEPATITIS B].
ZHANG XIAO-HONG, YANG SHAO-JI, MEI YONG-YU,
ET. chinese journal of integrated traditional and western
medicine. 2002;22(9):701 (chi*).
2836- gera: 107551/di/ra
[CLINICAL OBSERVATION ON TREATMENT OF
CHRONIC HEPATITIS B BY INTEGRATED
TRADITIONAL CHINESE AND WESTERN
MEDICINE]. SHANG JIAN-ZHONG, MA LONG-FEI,
YAO XIN, ET AL. chinese journal of integrated
traditional and western medicine. 2002;22(9):703 (chi).
2837- gera: 107552/di/ra
[FOURTY-TWO PATIENTS WITH LIVER
CIRRHOSIS COMPLICATED WITH PROTRACTED
ASCITES TREATED WITH INTEGRATED
TRADITIONAL CHINESE AND WESTERN
MEDICINE]. QIAO GUO-MIN, CHEN CHUAN-MING.
chinese journal of integrated traditional and western
medicine. 2002;22(9):705 (chi).
2838- gera: 107592/di/ra
[TREATMENT OF FATLY LIVER WITH SHUGAN
HUATAN - TANG IN 80 CASES]. YUAN YI-HONG.
journal of traditional chinese medicine and chinese
materia medica of jilin. 2002;22(5):10 (chi).
2839- gera: 107593/di/ra
176
[TREATMENT OF PREGNANT HEPATIC INJURY
WITH MODIFIED XIAOYAO SAN IN 30 CASES]. CAO
LI-QIN. journal of traditional chinese medicine and
chinese materia medica of jilin. 2002;22(5):13 (chi).
2840- gera: 107623/di/ra
[TREATMENT OF FATLY LIVER WITH SHUGAN
HUATAN- TANG IN 80 CASES]. YUAN YI-HONG.
journal of traditional chinese medicine and chinese
materia medica of jilin. 2002;22(5):10 (chi).
2841- gera: 107624/di/ra
[TREATMENT OF PREGNANT HEPATIC INJURY
WITH MODIFIED XIAOYAO SAN IN 30 CASES]. CAO
LI-QIN. journal of traditional chinese medicine and
chinese materia medica of jilin. 2002;22(5):13 (chi).
2842- gera: 107717/di/ra
[STUDY ON DIFFERENT DOSE OF BAIZHU AND
DIURETIC FUNCTION IN PATIENTS OF HEPATIC
ASCITES]. ZHENG YU. journal of gansu college of
traditional chinese medicine. 2002;19(3):14 (chi).
2843- gera: 107725/di/ra
[CLINICAL STUDY ON EFFECT OF INTEGRATED
TRADITIONAL CHINESE AND WESTERN
MEDICINE IN TREATMENT OF MULTIPLE ORGAN
DYSFUNCTION SYNDROME AFTER LIVER
TRANSPLANTATION]. CAO SHU-HUA, GAO HONG-
MEI, WANG YONG-QIANG. chinese journal of
integrated traditional and western medicine in intensive
and criti. 2002;9(5):263 (chi*).
2844- gera: 107737/di/ra
[CLINICAL STUDY OF TAKING ORALLY AND
EXTERNAL TREATMENT FOR LIPAROID LIVER].
LIU YU, WANG GUO-SHUN, TIAN LAN-JUN, ET AL.
chinese journal of integrated traditional and western
medicine in intensive and criti. 2002;9(5):299 (chi*).
2845- gera: 107745/di/ra
[EXPERIMENTAL STUDY ON TREATMENT OF
LIVER FIBROSIS WITH GANXIANKANG
DECOCTION]. ZHENG SHU-GUO YAN SHUN-QIN,
FENG LIANG-YUAN. journal of anhui traditional
chinese medical college. 2002;21(5):37 (chi*).
2846- gera: 107761/di/ra
[A PRELIMINARY APPROACH TO TREATING
HEPATITIS A WITH GIANT KNOTWOOD
RHIZOME]. AI SHAO-ZUO. chinese journal of
ethnomedicine and ethnopharmacy. 2002;10(5):273 (chi).
2847- gera: 107768/di/ra
[EXPERIENCE OF TREATING 21 CASES OF ACUTE
ICTEROHEPATITIS]. ZHANG JIN-YUN. chinese
journal of ethnomedicine and ethnopharmacy.
2002;10(5):282 (chi).
2848- gera: 107792/di/ra
[EXPERIMENTAL STUDY ON THE INDUCTION AND
DIFFERENTIATION FUNCTION OF YEZIAZHU
DRUG SERUM ON HUMAN LIVER CANCER CELL
STRAIN]. ZHANG JIAN-JUN, ET AL. chinese journal of
traditional medical science and technology. 2002;9(5):289
(chi).
2849- gera: 107852/di/ra
[CLINICAL OBSERVATION ON 33 CASES OF
CHRONIC SERIOUS HEPATITIS TREATED BY SI
gera 2011

MEI TAI AND YIN ZHI HUAN INJECTION]. ZHANG
RUKUN ET AL. journal of guiyang college of traditional
chinese medicine. 2002;24(3):34 (chi).
2850- gera: 107883/di/ra
[EFFECTS OF ELECTROACUPUNCTURE
COMBINED WITH ACUPOINT-INJECTION ON
SERUM INDEXES OF FIBROSIS IN THE PATIENT
OF SENILE CHRONIC HEPATITIS B]. LIU YAN.
chinese acupuncture and moxibustion. 2002;22(10):697
(chi*).
Purpose : To approach to the mechanism of
electroacupuncture combined with acupoint-injection. for
treatment of senile chronic hepatitis B. Methods :
Electroacupuncture was applied at bilateral Ganshu ( BL 18) ,
Danshu ( BL 19) , Yanglingquan ( GB 34) , Sanyinjiao ( SP
6) and Taichong ( LR 3) with continuous wave, and at the
same time, Huangqi Injection was injected into 4 of the
above-mentioned points. The treatment was given 3 months.
Results : These indexes of fibrosis, hyaluronic acid, type Ill
procollagen and laminin. decreased significantly as compared
with those before treatment, P < 0. 05 or P < 0. 01.
Conclusion : Electroacupuncture combined with acupoint-
injection. can arrest formation and development of hepatic
fibrosis in the patient of chronic hepatitis B.
2851- gera: 107892/di/ra
[CLINICAL OBSERVATION OF " TIAOMIAN I
DECOCTION" IN TREATING AUTOIMMUE
HEPATITIS]. ZHANG WEI JI GUANG WANG YU-QUN,
ET AL. shanghai journal of tcm. 2002;36(10):13 (chi*).
2852- gera: 107979/di/ra
[PROF ZHOU DAIHAN'S EXPERIENCE ON THE
TREATMENT OF PRIMARY LIVER CANCER]. LIN
LIZHU. new journal of tcm. 2002;34(10):12 (chi).
2853- gera: 108020/di/ra
[INFLUENCE OF "QING KAI GRANULES" ON
MORPHOLOGY OF RAT LIVER WITH ACUTE
LIVER NECROSIS]. ZHUO YUN-HUI, CHEN JIAN-JIE,
WANG LING-TAI. acta universitatis traditionis medicalis
sinensis pharmacologiaeque shanghai. 2002;16(3):54
(chi*).
2854- gera: 108043/di/ra
[TREATMENT OF 31 CASES OF CHRONIC
HEPATITIS B WITH ALT LASTING ABNORMITY BY
YIGANNING]. CHEN YUEFEI GAO TIANSHU.
traditional chinese medicinal research. 2002;15(5):30
(chi).
2855- gera: 108044/di/ra
[REVIEWS ON THE TREATMENT OF FATTY LIVER
WITH THE METHODS OF TCM]. SUN JINFANG, YIN
ZHONGDONG. traditional chinese medicinal research.
2002;15(5):45 (chi).
2856- gera: 108125/di/ra
[CLINICAL OBSERVATION ON PROTECTIVE
EFFECT OF SHENMAI INJECTION TO LIVER
FUNCTION DAMAGED BY TACE THERAPY OF
LIVER CANCER]. CHEN HUA, YANG SHOUFENG,
YANG XUEQIN. journal of emergency in tcm.
2002;11(5):365 (chi).
2857- gera: 108137/di/ra
[IMMUNE RESPONSE OF MICE AFTER REPEATED
INOCULATED WITH HBV AND HCV MIXED DNA
VACCINE]. LIU YUE, WANG SONG, ZHOU TAOYOU,
177
ET AL. chinese journal of integrated traditional and
western medicine on digestion. 2002;10(5):267 (chi*).
Objective : To study the relationship of HBV DNA level of
chronic HBV infective patients and their sex, age, HBV-
marker ( HBV-M) , liver function and TCM syndrome type.
Methods : The subjects were collected with epidemiological
observation method and analyzed statistically. Results : HBV
DNA level was not related with sex, but was inversely related
with the increase of age ( P < 0. 05-0. 01) , ALT and AST ( P
< 0. 05) , and was positively related with HBeAg positive
rate. HBV DNA level was gradually decreased with TCM
syndrome type changing from evil retention in collateral to
stagnation of Ever qi and asthenia of spleen, to deficiency of
liver-yin and kidney-yin , to retention of damp-heat evil in
spleen and stomach, to deficiency of spleen-yang and kidney-
yang , to blood stasis in collateral. Conclusion : HBV DNA
level of chronic HBV infective patients was closely related
with their age,
2858- gera: 108138/di/ra
[CHANGES OF A-SMOOTH MUSCLE ACTIN AND
PORTAL VEIN PRESSURE DURING
DIMETHYLNITROSAMINE- INDUCED HEPATIC
FIBROSIS IN RATS]. LIU CHENG, XU GUANGFU, LU
XIONG, ET AL. chinese journal of integrated traditional
and western medicine on digestion. 2002;10(5):271 (chi*).
2859- gera: 108142/di/ra
[PREVENTION AND TREATMENT OF
EXPERIMENTAL LIVER FIBROSIS IN RATS BY
OXYMATRINE]. SONG JIAN, ZHONG HUIMIN, YAO
PING. chinese journal of integrated traditional and
western medicine on digestion. 2002;10(5):282 (chi*).
2860- gera: 108143/di/ra
[EFFECT OF GANZHIXIAO DECOCTION ON
MEMBRANE FLUIDITY, DTD AND MDA OF FATTY
LIVER RAT]. MA XIAOYAN, JI YALING, YANG
YANG, ET AL. chinese journal of integrated traditional
and western medicine on digestion. 2002;10(5):284 (chi*).
2861- gera: 108237/di/ra
[PROGRESS IN THE TREATMENT OF FATTY
LIVER WITH TCM]. ZHANG QI. journal of shaanxi
college of traditional chinese medicine. 2002;25(5):53
(chi).
2862- gera: 108238/di/ra
[A SUMMARY OF TREATMENT OF HEPATIC
TUMOR WITH MULTIPLE RADIO FREQUENCY].
YANG YI, YANG JIN. journal of shaanxi college of
traditional chinese medicine. 2002;25(5):56 (chi).
2863- gera: 108239/di/ra
[ON SURGICAL NURSING OF PORTAL
HYPERTENSION CASES]. ZHANG RUNLING, CHAO
DONGMEI, ET AL. journal of shaanxi college of
traditional chinese medicine. 2002;25(5):59 (chi).
2864- gera: 108243/di/ra
[CIRRHOSIS (42 CASES) TREATED BY DECOCTION
FOR PROMOTING BLOOD CIRCULATION AND
SOFTENING HARD MASSES]. ZHU JIANMING, XU
GUIYING PAN XIAOHONG ET AL. journal of practice
tcm. 2002;10(18):11 (chi).
2865- gera: 108267/di/ra
[THE INFLUENCE OF FUZHENG YUGAN FANG ON
IMMUNOLOGIC FUNCTION OF PATIENTS WITH
CHRONIC HEPATITIS B]. HUANG BIN WEI AILING.
gera 2011

new journal of traditional chinese medicine.
2002;34(11):28 (chi*).
2866- gera: 108308/di/ra
[TREATMENT OF 30 CASES OF FATTY LIVER
WITH QINGGAN XIAOZHI DECOCTION]. SUN JIAN-
GUAN. shandong journal of tcm. 2002;21(11):663 (chi).
2867- gera: 108310/di/ra
[EFFECTS OF ZHIGANTAI CAPSULE ON THE
CONTENTS OF GLUCAGON AND INSULIN IN
FATTY LIVER RATS WITH HYPERLIPIDEMIA].
YANG MU-XIANG WANG YI-XIN WANG ZHAN-BO,
ET AL. shandong journal of tcm. 2002;21(11):679 (chi*).
2868- gera: 108315/di/ra
[SURFACE GENE VARIABILITY OF HEPATITIS B
VIRUS IN SUNAN AREA*]. TONG FU FUYI, BAI
JINGYU TANG YONGHUANG, ET AL. chinese journal
of integrated traditional and western medicine on liver
diseases. 2002;12(5):260 (chi*).
2869- gera: 108316/di/ra
[CONSTRUCTION OF HEPATITIS B VIRUS PRES1
GENE EXPRESSION VECTOR AND ITS
EXPRESSION IN EUKARYOTIC CELLS*]. LI DAN,
WANG XIAOZHONG, CHEN ZHIXIN, ET AL. chinese
journal of integrated traditional and western medicine on
liver diseases. 2002;12(5):263 (chi*).
2870- gera: 108317/di/ra
[ALTERED THREE KINDS OF CYTOKINE IN
ALCOHOLIC LIVER DISEASE*]. LI GUOQIN, YE
BAOCHUN, GAO BIHUA, ET AL. chinese journal of
integrated traditional and western medicine on liver
diseases. 2002;12(5):266 (chi*).
2871- gera: 108318/di/ra
[CLINICAL STUDY OF QILING CHAIHU SOLUTION
FOR CHRONIC HEPATITIS B PATIENTS*]. JIN
WENJUN, YE XIAOGUANG TANG ZHENGYUN ET AL.
chinese journal of integrated traditional and western
medicine on liver diseases. 2002;12(5):268 (chi*).
2872- gera: 108319/di/ra
[THE EFFECTS AND SIDE EFFECTS OF
SUPPOSITORY GANKANG ON CHRONIC HBV
INFECTION*]. YANG DAOFENG TIAN DEYING SHEN
HANXIN. chinese journal of integrated traditional and
western medicine on liver diseases. 2002;12(5):270 (chi*).
2873- gera: 108320/di/ra
[ESTABLISHMENT OF NUDE MOUSE MODELS
WITH HCV INFECTION IN BODYS*]. TANG ZHIMIN,
ZHAN CHUNJIAO, JIN WENYIN, ET AL. chinese journal
of integrated traditional and western medicine on liver
diseases. 2002;12(5):276 (chi*).
2874- gera: 108321/di/ra
[THE PREVENTIONAL AND TREATMENT EFFECT
OF PINGZHI GRANULE ON EXPERIMENTAL
FATTY LIVER AND THE STUDY OF
PATHOMORPHOLOGICAL MEASUREMENT*].
HUANG YIQI YANG HUI NIE MING ET AL. chinese
journal of integrated traditional and western medicine on
liver diseases. 2002;12(5):279 (chi*).
2875- gera: 108322/di/ra
[THE ROLE OF EXPRESSION OF ET REGULATED
BY NUCLEAR FACTOR KAPPA B IN LIVER INJURY
178
INDUCED BY CON A*]. ZHU LI LI YUEHUA LL
XIAOYU, ET AL. chinese journal of integrated
traditional and western medicine on liver diseases.
2002;12(5):282 (chi*).
2876- gera: 108323/di/ra
[EFFECT OF COMPOUND 861 CONTAINED SERUM
ON COL-I TIMP1 GENE EXPRESSION OF HSC-T6
CELLS*]. YIN CHENGHONG MA HONG MA XUEMEI,
ET AL. chinese journal of integrated traditional and
western medicine on liver diseases. 2002;12(5):286 (chi*).
2877- gera: 108324/di/ra
[EFFECT OF CURCUMA ARAMATICA OIL (CAO)
ON CELLULAR APOPTOSIS OF HEPATOMA
CARRIED BY MICE*]. TAN MIN BIN XIAONONG WU
WANYIN, ET AL. chinese journal of integrated
traditional and western medicine on liver diseases.
2002;12(5):290 (chi*).
2878- gera: 108329/di/ra
[CLINICAL STUDY ON TREATMENT OF 25 CASES
OF HEPATIC FIBROSIS AFTER HEPATITIS B WITH
RUAN GAN MIXTURE COMBINED WITH
INTERFERON]. YAN ZHONGSHENG, SHEN JIYUN,
ZHAO SHUYUAN. journal of traditional chinese
medicine. 2002;43(10):753 (chi*).
2879- gera: 108338/di/ra
[EFFECT OF CHINESE DRUGS FOR REMOVING
DAMPNESS ON GENE EXPRESSION OF TCRVB7 IN
THE PATIENT OF CHRONIC HEPATITIS B
(DAMPNESS SYNDROME)]. ZHANG SHIJUN, CHEN
ZEXIONG, HUANG BIJUN. journal of traditional chinese
medicine. 2002;43(10):780 (chi).
2880- gera: 108375/di/ra
[AFFECT OF XIAOYAN SAN JIAJIAN FOR HEPATIC
FIBROSIS INDUCED VIRUS B HEPATITIS]. MA
LIEQING. beijing journal of tcm. 2002;21(5):285 (chi).
2881- gera: 108376/di/ra
[COMBINED TCM AND WESTERN MEDICINE
DIAGNOSIS-TREATMENT FOR BILIARY
CIRRHOSIS]. LI LIN, ET AL. beijing journal of tcm.
2002;21(5):287 (chi).
2882- gera: 108409/di/ra
[DTTD IN THE TREATING OF CBRONIC ACTIVE
HEPATITIS A CLINICAL OBSERVATION OF 46
CASES]. SHEN PENG, MA XIAO YING. acta chinese
medicine and pharmacology. 2002;30(5):33 (chi*).
2883- gera: 108484/di/ra
[TREATING 66 CASES OF CIRRHOSIS DUE TO
HEPATITIS B WITH COMBINED TREATMENT OF
TRADITIONAL CHINESE MEDICINE AND
WESTERN MEDICINE -COMPARED WITH
TREATMENT OF 52 CASES WITH WESTERN
MEDICINE]. LI CHAO. zhejiang journal of tcm.
2002;37(11):470 (chi).
2884- gera: 108500/di/ra
[PROTECTING EFFECT OF ZIQIRUANGAN ON
RATS WITH CHRONIC FIBROSIS CAUSED BY
CARBON TETRACHLORIDE]. YANG SHUN-MIN,
ZHANG LIANG, ZHOU LING-LING, ET. journal of
nanjing university of tcm (natural science).
2002;18(6):345 (chi).
gera 2011

2885- gera: 108521/di/ra
[SUMMARY OF WANG YU-QUN ' S EXPERIENCE
OF TREATMENT OVER CHRONIC HEPATITIS B].
JIANG YOU-LIN. jiangxi journal of tcm. 2002;33(5):3
(chi).
2886- gera: 108537/di/ra
[CLINICAL OBSERVATION ON ASCITES DUE TO
CIRRHOSIS TREATED WITH COMBINATION OF
TRADITIONAL CHINESE AND WESTERN
MEDICINES]. BAI DONGMEI, ET AL. hubei journal of
tcm. 2002;24(10):24 (chi).
2887- gera: 108538/di/ra
[TREATMENT OF ASCITES DUE TO CIRRHOSIS
WITH PROMOTING BLOOD CIRCULATION BY
REMOVING BLOOD STASIS MAINLY]. WANG
JIANGZHONG. hubei journal of tcm. 2002;24(10):25 (chi).
2888- gera: 108559/di/ra
[CLINICAL OBSERVATION ON ASCITES DUE TO
HEPATOCIRRHOSIS TREATED WITH
INTEGRATED TCM AND WM]. DING GUO-FENG, WU
JIN-LIAN. shanxi journal of tcm. 2002;18(5):28 (chi*).
2889- gera: 108644/di/ra
[DISCUSSION ON THE CURRENT STATUS OF THE
DIFFERENTIATION OF CHRONIC HEPATITIS B
AND THE METHOD OF DIFFERENTIATION]. LI
WEN-LIANG, LI QIANG, YAO NAI-LI, ET AL. chinese
journal of basic medicine in tcm. 2002;8(9):11 (chi).
2890- gera: 108646/di/ra
[TRAIN OF THOUGHT DISCUSSION OF HERBS
TREATMENT ON NO-SYMPTOM CHRONIC
HEPATITIS B VIRUS CARRIERS]. YE YONG-AN,
TIAN DE-LU, LI XIAO-LIN, ET AL. chinese journal of
basic medicine in tcm. 2002;8(9):15 (chi).
2891- gera: 108650/di/ra
[EFFECT OF CHINESE HERBAL OF PROFIT GAS
AND SOFTEN LIVER ON MMP-1/TIMP-1 ACTIVITY
AND THEIR DYNAMIC CHANGE IN IMMUNE
FIBROTIC LIVER OF RAT MODEL]. DUAN ZHI-JUN,
LI JI-YAN, CONG ZHEN-RI, ET AL. chinese journal of
basic medicine in tcm. 2002;8(9):32 (chi).
2892- gera: 108922/di/ra
CLINICAL PATHOLOGIC STUDY ON EFFECT OF
QIANGGAN CAPSULE (3K)FFVZ
) IN TREATING PATIENTS OF CHRONIC
HEPATITIS B WITH LIVER CIRRHOSIS. YANG LIU-
MING ZHAO-YAN LONG WU ZHI-RONG ET AL.
chinese journal of integrated traditional and western
medicine. 2002;8(2):85 (eng).
2893- gera: 108923/di/ra
CLINICAL STUDY ON TREATMENT OF LIVER
FIBROSIS OF CHRONIC HEPATITIS B PATIENTS
WITH GINKGO LEAF. HE YUN, YUAN FENG--YI
WANG JIAN BIN, ET AL. chinese journal of integrated
traditional and western medicine. 2002;8(2):90 (eng).
2894- gera: 108924/di/ra
CLINICAL OBSERVATION ON EFFECT OF
RUANGAN GRANULE '(TTFFFLWV-LPJ) IN
TREATING CHRONIC HEPATITIC LIVER
FIBROSIS. LIXIU-HUI, ZHAO CHUN-HUI, JIN RONG-
HUA ET AL. chinese journal of integrated traditional and
western medicine. 2002;8(2):95 (eng).
179
2895- gera: 108929/di/ra
STUDY ON THE ANTI-LIVER, FIBROSIS EFFECT
ON BENEFIT LIVER GRANULE AND ITS
MECHANISM IN RATS. YAO XI-XIAN CUI DONG-LAI
SUN YU-FENG, ET AL. chinese journal of integrated
traditional and western medicine. 2002;8(2):118 (eng).
2896- gera: 108930/di/ra
STUDY ON INTERVENIENT EFFECT OF ANGELICA
SINENSIS POLYSACCHARIDE ON
IMMUNOLOGICAL LIVER INJURY AND ITS
MECHANISM IN MICE. DING HONG AND HUANG
JIE-AN. chinese journal of integrated traditional and
western medicine. 2002;8(2):122 (eng).
2897- gera: 108931/di/ra
STUDY ON EFFECT OF IH764-3 , AN ACTIVE
PRINCIPLE OF SALVIAE MILTIORRHIZAE, IN
INDUCING HEPATIC STELLATE CELL APOPTOSIS.
ZHAO DONG-QIANG, JIANG HUI-QLNG, XIU HE-
MING ET. chinese journal of integrated traditional and
western medicine. 2002;8(2):126 (eng).
2898- gera: 108933/di/ra
OBSERVATION ON EFFECT OF TREATMENT OF
ALCOHOLIC FATTY LIVER BY TRADITIONAL
MEDICAL THERAPY OF LIVER-CLEARING ,
DAMPNESS-REMOVING AND COLLATERALS-
DREDGING. MANG SHI-JUN, CHEN ZE-XIONG, LAO
SHAO-XIAN, ET A. chinese journal of integrated
traditional and western medicine. 2002;8(2):134 (eng).
2899- gera: 108940/di/ra
RECENT STUDIES ON THE MOLECULAR
MECHANISM OF TREATMENT OF LIVER
DISEASES BY TRADITIONAL CHINESE MEDICINE.
NIE GUANG. chinese journal of integrated traditional
and western medicine. 2002;8(2):152 (eng).
2900- gera: 108941/di/ra
NEW EFFECTIVE TREATMENT OF LIVER
FIBROSIS BY CHINESE HERBAL MEDICINE.
ZHANG GUO-LIANG. chinese journal of integrated
traditional and western medicine. 2002;8(2):156 (eng).
2901- gera: 108979/di/ra
STUDIO SPERIMENTALE SUI FARMACI CHE
MIGLIORANO LA CIRCOLAZIONE DEL SANGUE E
NE RIMUOVONO LA STASI NELLA TERAPIA DEL
DANNO EPATICO CRONICO LIEVE. XIE FENGYING
ED ALTRI. rivista italiana di medicina tradizionale
cinese. 2002;89:69 (ita*).
2902- gera: 109000/di/ra
LIVER REGENERATION ENHANCED BY ORALLY
ADMINISTERED URSODESOXYCHOLIC ACID IS
MEDIATED BY IMMUNOSUPPRESSION IN
PARTIALLY HEPATECTOMIZED RATS. LIU L ET
AL. american journal of chinese medicine. 2002;30(1):119
(eng).
2903- gera: 109573/di/ra
[EFFECT OBSERVATION ON TREATING
CIRRHOSIS OF LIVER COMBINED WITH
HEMORRHAGE OF THE UPPER DIGESTIVE TRACT
WITH THE MEANS OF INTEGRATED TCM AND
WESTERN MEDICINE]. CAO SHAO-TING. henan
journal of tcm and phamacy. 2002;17(6):37 (chi).
gera 2011

2904- gera: 109582/di/ra
[THE UNDERSTANDING OF 80 CASES OF
HEPATOCIRRHOSIS TREATED BY INTEGRATED
CHINESE AND WESTERN MEDICINE ]. LIU
YANZHONG, ET AL. gansu journal of tcm. 2002;15(6):55
(chi).
2905- gera: 109592/di/ra
[EXPERIMENTAL RESEARCH ON PREVENTION.
AND TREATMENT OF FIBROSA HEPATITIS]. ZHU
GUANG-ZE ET AL. journal of tcm and chinese materia
medica of jilin. 2002;22(6):53 (chi).
2906- gera: 109599/di/ra
[CLINICAL STUDY ON TREATMENT OF 118 CASES
OF HEPATOCARCINOMA WITH TACE COMBINED
WITH CHINESE MEDICINES]. ZHOU XUEYI, WU
XIONG ZUO XIANG ET AL. jiangsu journal of tcm.
2002;23(11):15 (chi).
2907- gera: 109684/di/ra
[CLINICAL OBSERVATION ON THERAPEUTIC
EFFECT OF COMPLEX BIEJIA RUANGAN TABLET
ON 15 PATIENTS WITH HEPATIC CIRRHOTIC OF
CHRONIC HEPATITIS B]. LIN SHU-HUA WANG YU-
QUN, ZHANG WEI ET AL. liaoning journal of tcm.
2002;29(11):653 (chi*).
2908- gera: 109685/di/ra
[RUDIMENTAL INVESTIGATION ON FATTY LIVER
SYNDROME DIFFERENTIATION TYPING LAW].
WEI HUA-FENG, JI GUANG XING LIAN-JUN. liaoning
journal of tcm. 2002;29(11):655 (chi*).
2909- gera: 109686/di/ra
[SYSTEMATICAL REVIEW ON TREATING FATTY
LIVER WITH TCM BY DIFFERENTIATION OF
SYMPTOM ]. LI YU-HONG ZHANG BO-LI XU ZONG-
PEI, ET AL. liaoning journal of tcm. 2002;29(11):657
(chi*).
2910- gera: 109687/di/ra
[21 CASES OF TAKING PEIYUAN YIGAN
DECOCTION FOR TREATING CHRONIC
HEPATITIS B]. MA WEI-RONG. liaoning journal of tcm.
2002;29(11):659 (chi*).
2911- gera: 109711/di/ra
[CLINICAL OBSERVATION ON POSTHEPATITIC
FIBROSIS OF "LIVER" TREATED WITH GAN BAO
MEDICINE POWDER PREPARATION]. DU BIN PAN
XUEFEI, ZHANG CHANGFA. forum on tcm.
2002;17(6):21 (chi).
2912- gera: 109712/di/ra
[155 CASES ASCITES DUE TO CIRRHOSIS
TREATED WITH CHINESE DRUGS]. DUAN
QINGYIN. forum on tcm. 2002;17(6):23 (chi).
2913- gera: 109721/di/ra
[OBSERVATION OF CURATIVE EFFECT ON 30
CASES OF ACTIVE CIRRHOSIS TREATED WITH
INVIGORATING THE SPLEEN, PROMOTING
BLOOD CIRCULATION AND REMOVING TOXIC
SUBSTANCES]. ZHOU ZHENG ET AL. hubei journal of
tcm. 2002;24(11):10 (chi).
2914- gera: 109744/di/ra
['ANGANZHU CAPSULE" FOR CHRONIC VIRAL
HEPATITIS IN 200 CASES]. CUI LI-AN ZHANG JUN-
180
FU. shanghai journal of tcm. 2002;36(11):17 (chi).
2915- gera: 109745/di/ra
[BLOOD-COOLING AND TOXIN RELIEVING
THERAPY FOR ACUTE AND CHRONIC HEPATITIS
IN 1000 CASES ]. ZHANG GONG-XIANG. shanghai
journal of tcm. 2002;36(11):17 (chi).
2916- gera: 109746/di/ra
["PLANTAIN DECOCTION" FOR CHRONIC ACTIVE
HEPATITIS IN 232 CASES]. CHEN JIAN-PING YUAN
QI-XIA. shanghai journal of tcm. 2002;36(11):18 (chi).
2917- gera: 109747/di/ra
[BLOOD-COOLING, TOXIN-RELIEVING AND
HEALTH-SUPPORTING THERAPY FOR CHRONIC
SEVERE HEPATITIS IN 33 CASES]. WANG YI ZHANG
WEI XING LIAN-JUN, ET AL. shanghai journal of tcm.
2002;36(11):19 (chi).
2918- gera: 110022/di/ra
[EFFECT OF KANGXIAN RUANGAN GRANULE ON
PROLIFERATION OF HEPATIC STELLATE CELLS].
YANG LING, ZHANG CHIZHI, ZHU QINGJING, ET AL.
chinese journal of integrated traditional and western
medicine on digestion. 2002;10(5):323 (chi*).
2919- gera: 110031/di/ra
[PREVENTIVE AND THERAPEUTIC EFFECT OF
KANGXIAN MIXTURE ON HEPATIC FIBROSIS
CAUSED BY SCHISTOSOMIASIS IN RABBITS]. YIN
JIDONG, TIAN DEYING, HUANG QIAOXIN. chinese
journal of integrated traditional and western medicine on
digestion. 2002;10(5):348 (chi*).
2920- gera: 110032/di/ra
[EFFECT OF WUDAN WEIFU DECOCTION ON THE
LEVEL OF FREE RADICAL IN RATS MODEL OF
CHRONIC ATROPHIC GASTRITIS]. WEI GUOLUAN,
LIU XINSHENG, SHAO ZUYAN, ET AL. chinese journal
of integrated traditional and western medicine on
digestion. 2002;10(5):352 (chi*).
2921- gera: 110133/di/ra
[INFLUENCE OF THE FACTORS OF LIVER
DEPRESSION AND SPLEEN DEFICIENCY ON
IMMUNOLOGICAL FUNCTION IN THE RATS WITH
HEPATOCARCINOMA INDUCED BY
DIETHYLNITROSAMINE]. PENG GUIYING, GU
LIGANG, WANG QINGGUO, ET AL. journal of beijing
university of tcm. 2002;25(6):34 (chi*).
The influence of the factors of liver depression and spleen
deficiency (LDSD) on the occurrence of hepatocarcinoma
induced by diethylnitrosamine (DEN) and on the function of
T lymphocytes, and the treating and preventing effects of the
Shuganjianpi Formula (SF) were investigated in the model
rats. All rats in the experiment were stimulated with the
factors of LDSD for 19 weeks, and simultaneously, given by
gastric perfusion a dose of DEN, 70 mg/ kg, once a week for
8 weeks; the rats in the preventing and treating group were
given a dose of SF, 1.5 g/ kg; and then, the abilities of T
lymphocytic proliferation and IFN-Y and IL-2 production
were detected in the isolated spleen of the rats in the 9th, 14th
and 19th weeks respectively. The results showed that the
abilities of T lymphocytic proliferation and IFN- Y and IL-2
production were significantly lower in the rats stimulated
with both the factors of LDSD and DEN than those in the rats
stimulated only with DEN (P < 0. 05) ; but after the rats were
given SF, the abilities of T lymphocytic proliferation and
lFN-Y and IL-2 production were significantly restored. The
gera 2011

results suggest that SF can significantly improve
immunological function in the rats with DEN-induced
hepatocarcinoma plus the stimulation of the LDSD factors,
and at the same time, can relieve the severity of
hepatocarcinoma.
2922- gera: 110137/di/ra
[STUDY OF THE MECHANISM OF THE EFFECTS
OF 4 CHINESE HERBAL DRUG EXTRACTS ON
LIVER LIPID METABOLISM IN OVARIECTOMIZED
RATS]. DAI YU, DAI DAJIANG, HE FUJIN, ET AL.
journal of beijing university of tcm. 2002;25(6):45 (chi).
2923- gera: 110200/di/ra
[SUMMARY ON 60 CASES OF
HYPERBILIRUBINEMIA CAUSED BY VIRAL
HEPATITIS TREATED WITH THE THERAPY OF
REMOVING HEAT FROM THE BLOOD AND
PROMOTING BLOOD CIRCULATION]. YAN HANG.
hunan journal of tcm. 2002;18(6):12 (chi).
2924- gera: 110218/di/ra
[CLINICAL RESEARCH OF SUBSYMPTOMATIC
TYPE OF CHRONIC B HEPATITIS]. CUI HUAFU ET
AL. china journal of tcm and pharmacy. 2002;17(9):537
(chi).
2925- gera: 110306/di/ra
[CLINICAL OBSERVATION ON CHANGE OF
SERUM ALBUMIN OF CHRONIC HEPATITIS AND
CIRRHOSIS TREATED WITH REPLENISHING QI
TO INVIGORATE THE SPLEEN]. CHEN QINGSHAN.
hubei journal of tcm. 2002;24(12):11 (chi).
2926- gera: 110399/di/ra
[CLINICAL OBSERVATION ON 32 CASES OF
CHRONIC SERIOUS HEPATITIS TREATED BY DA
CHENG QI TANG ENEMA ]. SUN DI. journal of
guiyang college of tcm. 2002;24(4):14 (chi).
2927- gera: 110417/di/ra
[CLINICAL OBSERVATION ON TREATING LIVER
AND GALLBLADDER DISEASES WITH
YANXIAODINAER SYRUPUS WHICH IS A KIND OF
WEI NATIONALITY MEDICINE]. MAIHEFURETI, ET
AL. chinese journal of ethnomedicine and
ethnopharmacy. 2002;12(6):329 (chi).
2928- gera: 110441/di/ra
[EXPERIMENTAL STUDY OF JIA WEI SI SAN
(JWSNS) AGAINST IMMUNODAMAGED HEPATIC
FIBROSIS IN RATS ]. SUN SHOU-CAI LIU GUANG-
WEI, CENG FU-HAI ET AL. chinese journal of basic
medicine in tcm. 2002;8(11):30 (chi*).
2929- gera: 110445/di/ra
[EFFECTS OF EUPOLYPHAGA SEU STELEOPHAGA
ON IV. C, LN, HA IN RAT WITH HEPATIC
FIBROSIS]. XI ZHU-TING LUAN XI-YING LI KE-KE ET
AL. chinese journal of basic medicine in tcm.
2002;8(11):43 (chi*).
2930- gera: 110446/di/ra
[EXPERIMENTAL STUDY OF HISTOCHEMISTRY
AND IMMUNOHISTOCHEMISTRY ON
PREVENTION AND TREATMENT OF HEPATIC
FIBROSIS WITH THE SECOND DECOCTION]. JIANG
XUE-LIAN, JIN YAN-HUA, BEN CHANG-EN. chinese
journal of basic medicine in tcm. 2002;8(11):48 (chi*).
181
2931- gera: 110451/di/ra
[REVIEW ON MECHANISM OF TREATMENT OF
PRIMARY CARCINOMA OF LIVER WITH THE
TRADITIONAL CHINESE MEDICINE ]. LI DONG-
TAO SHOU GUI-ZHI YU ZHI-KUI. chinese journal of
basic medicine in tcm. 2002;8(11):72 (chi).
2932- gera: 110454/di/ra
[CLINICAL OBSERVATION ON TREATMENT OF
PRIMARY LIVER CANCER WITH GANJI GRANULE
COMBINED WITH TACE]. WANG RUI-PING, YANG
CHEN. journal of anhui traditional chinese medical
college. 2002;21(6):9 (chi*).
2933- gera: 110457/di/ra
[BAIYING DECOCTION IN THE TREATMENT OF 43
CASES OF CHRONIC HEPATITIS B]. CHEN HUA-
DONG HE HAO ZHANG YU-LIANG. journal of anhui
traditional chinese medical college. 2002;21(6):17 (chi*).
2934- gera: 110468/di/ra
[PROTECTIVE EFFECT OF SWERTIA PUNICEA ON
EXPERIMENTAL HEPATIC INJURY]. PENG FANG
LIU XIAOBAO, FANG CHUNSHENG. traditional chinese
drug research and clinical pharmacology. 2002;13(6):376
(chi*).
2935- gera: 110488/di/ra
[STUDY OF Q - T INTERVAL PROLONGATION AND
ITS TREATMENT BY COMPOSITE SALVIA
MILTIORRHIZA IN HEPATIC CIRRHOSIS]. ZHENG
YONG-PING YANG BI-HUI LIN YI-FEN,. chinese journal
of integrated traditional and western medicine in
intensive and criti. 2002;9(6):353 (chi*).
2936- gera: 110493/di/ra
[THE THERAPEUTIC COMPARISON OF WULING
PILLS AND BIFENDATE IN TREATING CHRONIC
HEPATITIS B ]. TIAN GUIZHEN. chinese journal of
information on tcm. 2002;9(11):6 (chi*).
2937- gera: 110625/di/ra
[THE EFFECT IN ZHIGANTAI CAPSULE ON THE
HEMORRHEOLOGY IN THE PATIENTS WITH
FATTY LIVER CAUSED BY HYPERLIPIDEMIA].
YANG MUXIANG, ZHANG YIXIN , LI PINGSHAN, ET
AL. hebei journal of tcm. 2002;24(11):803 (chi*).
2938- gera: 110627/di/ra
[CLINICAL AND EXPERIMENTAL STUDY ON THE
TREATMENT OF HEPATIC FIBROSIS WITH YIGAN
DECOCTION]. SUN YUFENG, YAO XIXIAN, CUI
DONGLAI. hebei journal of tcm. 2002;24(11):808 (chi*).
2939- gera: 110646/di/ra
[ADVANCES OF STUDY ON DIAGNOSIS AND
TREATMENT OF FATTY LIVER]. ZHAO XIAOWEI.
journal of tcm. 2002;43(12):943 (chi).
2940- gera: 110710/di/ra
[HISTOLOGICAL CHANGES OF LIVER WITH
CHRONIC HEPATITIS B PATIENTS TREATED BY
HEPATOPATHY THERAPEUTIC EQUIPMENT ]. XU
RUIPING, ET AL. beijing journal of tcm. 2002;21(6):363
(chi).
2941- gera: 110751/di/ra
[CLINICAL OBSERVATION ON
HEPATOCIRRHOSIS PATIENTS'
GLYCOMETABOLISM DISORDER AND
gera 2011

SYNDROME-DIFFERENTIATING OF TCM]. HU
JIAN-WEN, WU WEN-BIAO. liaoning journal of tcm.
2002;29(12):751 (chi).
2942- gera: 110753/di/ra
[THE EFFECT OF COMPOUND LEECH ORAL
LIQUOR ON INTRACEREBRAL HEMATOMA OF
RATS ]. ZHU DAN, CHI MING-YU, JIANG DIAN-XUN,
ET AL. liaoning journal of tcm. 2002;29(12):765 (chi).
2943- gera: 110754/di/ra
[THE RELATIONSHIP BETWEEN SERUM LEVELS
OF HYALURONIC ACID, PROCOLLAGEN IN
PEPTIDE, UNDULIN AND LIVER FUNCTION, B
ULTRASOUND IN PATIENTS WITH LIVER
DISEASES]. YAO DINGKANG, XIE WEIFEN, CHEN
WEIZHONG, ET AL. chinese journal of integrated
traditional and western medicine on liver diseases.
2002;12(6):323 (chi*).
2944- gera: 110755/di/ra
[CLINICAL STUDY OF YEXIAZHU CAPSULE ON
TREATING CHRONIC HEPATITIS B]. ZHANG
JIANJUN, SHENG GUOGUANG, ZHANG CHIZHI, ET A.
chinese journal of integrated traditional and western
medicine on liver diseases. 2002;12(6):326 (chi*).
2945- gera: 110756/di/ra
[TO EVALUATE THE REGULATION OF CLASSICAL
DIFFERENTIAL DIAGNOSIS OF TRADITIONAL
CHINESE MEDICINE IN PATIENTS WITH CHRONIC
B HEPATITIS IN TAIWAN]. HUANG SHENGTENG,
XU KUANGHUNG. chinese journal of integrated
traditional and western medicine on liver diseases.
2002;12(6):329 (chi*).
Objective : To study the relationship between biochemical
markers and classical differential diagnosis of traditional
Chinese medicine (CDDTCM) in patients with chronic B
hepatitis in Taiwan and evaluate the objective basis and
standard for CDDTCM. Methods : The 264 out - patients
with chronic B hepatitis by keeping a check on sero-
immunology were randomly assigned to this project. Males
and females were 194 versus 70 individually. The patients
with chronic B hepatitis were divided into five groups on the
basis of CDDTCM namely, retention of damp - heat in the
interior, stagnation of liver - Qi and deficiency of the spleen,
deficiency of liver - Yin and Kidney - Yin, blood stasis in the
collateral circulation and insufficiency of both the spleen and
kidney. Herein, the correlation of living custom and liver
function test (AST/ALT) were analyzed among five groups in
patients with chronic B hepatitis. Results : 1 Verified by
CDDTCM in patients with chronic B hepatitis, there were 90
cases (34 %) of deficiency of liver - Yin and kidney - Yin, 74
cases (28 %) of retention of damp - heat in the interior, 73
cases (28 %) of stagnation of liver - Qi and deficiency of the
spleen, 27 cases (10 % of blood stasis in the collateral
circulation and insufficiency of both the spleen and kidney. 2
The patients in the group of blood stasis in the collateral
circulation and insufficiency of both the spleen and kidney
were senior than the other four groups and followed
deficiency of liver - Yin and Kidney - Yin, stagnation of liver
- Qi and deficiency of the spleen and retention of damp - heat
in the interior in order. P = 0.016. 3 There was significant
difference in symptoms and signs among the four groups in
gastro- hepatobiliary system, especially high prevalence in
the groups of stagnation of liver - Qi and deficiency of the
spleen, deficiency of liver - Yin and kidney - Yin, P = 0. 021.
(@The value of AST/ALT was highest in the group of
retention of damp - heat in the interior. There was significant
change in ALT among the four groups, P = 0. 038.
182
Conclusion : (1) The patients of deficiency of liver - Yin and
kidney- Yin and kidney- Yin with chronic B hepatitis in
Taiwan were more than those of the other groups. 2 The
patients of blood stasis in the collateral circulation and
insufficiency of both the spleen and kidney were obdest in,
all of patients. It stated that chronic B hepatitis with long
term viral incubation will lead to the exacerbation of hepatic
lesion and result in liver cirrhosis and hepatocellular
carcinoma. 3 Clinical symptoms and signs of gastroentero
and hepatobiliary system were more prevalent in the patients
of stagnation of liver - Qi and deficiency of the spleen,
deficiency of liver - Yin and kidney - Yin. It demonstrated
that clinical symptoms and signs by CDDTCM are associated
with modem physiology, pathology and anatomy closely. 4
The values of AST/ALT were highest in the group of
retention of damp - heat in the interior. It seems that the liver
function is not necessary to up - regulate along with the calm
of chronic change. Meanwhile, the value of ALT presented
statistically significance among the groups. We predict that
ALT could be a good objective marker of CDDTCM in the
patients with chronic B
2946- gera: 110757/di/ra
[RNA ADMINISTRATION TO BENEFIT RECIPIENTS
RECOVERY AFTER LIVER TRANSPLANTATION].
GONG NIANQIAO, GUO HUI, YE QIFA. chinese journal
of integrated traditional and western medicine on liver
diseases. 2002;12(6):334 (chi*).
2947- gera: 110759/di/ra
[CLINICAL EFFICACY OF TIOPRONIN COMBINED
WITH XUEZHIKANG IN THE TREATMENT OF
STEATOHEPATITIS]. DENG BIN, LIU AIQIONG, YAN
SHAOLAN. chinese journal of integrated traditional and
western medicine on liver diseases. 2002;12(6):339 (chi*).
2948- gera: 110760/di/ra
[EFFECTS OF IL-10 AND PDGF ON EXPRESSION OF
TGF-B1 AT HEPATIC STELLATE CELLS]. CHEN
YUNXIN, WANG XIAOZHONG, WENG SHANGENG, ET
A. chinese journal of integrated traditional and western
medicine on liver diseases. 2002;12(6):343 (chi*).
2949- gera: 110761/di/ra
[EXPERIMENTAL STUDY OF EFFECT OF
CONCENTRATED YIGAN DECOCTION AND
QIANGAN CAPSULE ON HEPATIC FIBROSIS IN
RATS]. YAO XIN, YAO XIXIAN, FENG LIYING, ET AL.
chinese journal of integrated traditional and western
medicine on liver diseases. 2002;12(6):346 (chi*).
2950- gera: 110762/di/ra
[THERAPEUTIC EFFECT OF PHELLINUS
IGNIGARIUS ON HEPATIC FIBROSIS IN RATS].
ZHANG WANGUO, HU JINHONG, HUANG JIN. chinese
journal of integrated traditional and western medicine on
liver diseases. 2002;12(6):348 (chi*).
2951- gera: 110763/di/ra
[THE PROTECTIVE EFFECT OF TAURINE ON RAT
LIVER MITOCHONDRIA AFTER ISCHEMIA AND
REPERFUSION]. WANG ZHAOHUI, ZHANG
XIANKANG, MIAO MINGYONG, ET. chinese journal of
integrated traditional and western medicine on liver
diseases. 2002;12(6):351 (chi*).
2952- gera: 110803/di/ra
[CLINICAL SUMMARIZATION OF " CIDAN
CAPSULE" IN TREATING 325 CASES OF PRIMARY
LIVER CANCER ]. ZHENG WEI-DA ZHENG DONG-
gera 2011

HAI ZHENG WEI-HONG. shanghai journal of tcm.
2002;36(12):7 (chi*).
2953- gera: 110828/di/ra
[PRIMARY LIVER TREATED BY MATRINE
INJECTION WITH TACE OPERATION]. WAN
XUYING ET AL. journal of zhejiang college of tcm.
2002;26(2):22 (chi*).
2954- gera: 110924/di/ra
[APPLYING JIANPIYIGANTANG TO TREATING
LIVER CIRRHOSIS WITH ASCITIC FLUID]. X. hunan
guiding journal of tcmp. 2002;8(5):252 (chi).
2955- gera: 110925/di/ra
[APPLYING QISHAOZHIHUANGTANG TO
TREATING 56 CASES OF ACUTE VIRUS ICTERIC
HEPATITIS]. X. hunan guiding journal of tcmp.
2002;8(5):254 (chi).
2956- gera: 110980/di/ra
[EFFECT OF CHISHAO CHENGQI DECOCTION ON
ENDOTOXIN AND TNF-CC IN PATIENTS WITH
SEVERE HEPATIC DISEASES]. WU QI-KAI, YANG
DA-GUO, TAO YAN-YAN, ET AL. chinese journal of
integrated traditional and western medicine.
2002;8(4):271 (eng*).
2957- gera: 111017/di/ra
[TREAT THE 32 CASES OF THE ASCITES DUES TO
CIRRHOSIS BY THE COMBINATION OF CHINESE
TRADITIONAL AND WESTERN MEDICINE]. LIU
FENGJUN. guang ming journal traditional chinese
medicine. 2002;12(6):49 (chi).
2958- gera: 111046/di/ra
[TREATING HEPATITIS E OF 50 CASES BY SELF-
FORMULATED ANTI-HEPATITIS E MIXTURE].
CHEN WEI-PING. journal of laoning college of tcm.
2002;4(4):275 (chi).
2959- gera: 111073/di/ra
[INDUCTION OF INTERFERON - R PRODUCTION
BY PHELLINUS IGNIARIUS AND ITS EFFECT ON
HEPATIC FIBROSIS]. ZHANG WANGUO, HU
JINHONG, CAI QIN. acta chinese medicine and
pharmacology. 2002;30(6):22 (chi*).
2960- gera: 111126/di/ra
[AN EXPERIMENTAL STUDY ON THE
ANTAGONISTIC EFFECT OF DANGGUI ON THE
HEPATIC FIBROSIS OF RATS]. CHEN BIN, SUN
KEWEI, XIE FENGYING, ET AL. journal of hunan
college of tcm. 2002;22(4):1 (chi*).
2961- gera: 111130/di/ra
[THE EFFECTS OF RGG ON P21 MRNA
EXPRESSION IN THE EXPERIMENTAL CIRRHOSIS
INDUCED BY CARBON TETRACHLORIDE( CCL4)
AMONG RATS]. ZHOU XIAOZHOU, ZHOU DAQIAO,
QI YANPING, ET AL. journal of hunan college of tcm.
2002;22(4):13 (chi*).
2962- gera: 111137/di/ra
[CLINICAL OBSERVATION ON THE THERAPEUTIC
EFFECT OF BAIYING DECOCTION COMBINED
WITH INTERFERON ON CHRONIC HEPATITIS B ].
HE HAO, ZHANG YULIANG, YAN YIZHONG. journal of
hunan college of tcm. 2002;22(4):47 (chi*).
183
2963- gera: 111196/di/ra
[SELECTION AND EVALUATION FOR ANIMAL
MODEL OF HEPATIC FIBROSIS]. X. hunan guiding
journal of tcmp. 2002;8(12):785 (chi).
2964- gera: 111226/di/ra
SITUACION ACTUAL DE LA PREVENCION Y DEL
TRATAMIENTO DE LAFIBROSIS HEPATICA CON
DROGAS DE MTC. DU BIN ET AL. journal of tcm.
2002;28:37 (esp*).
La fibrosis hepática es un proceso progresivo de elevada
secreción y reducida degradación de materiales extracelulares
(ECM). La mayoría de los autores creen que el proceso se
inicia con el daño de las células hepáticas (HCs) que conduce
a la activación y secreción de factores celulares múltiples de
las células de Kupffer. Estos factores, junto con los factores
celulares segregados por los HCs dañados, los trombocitos y
las células endoteliales M sinusoide hepático, y algunos
mediadores quimicos, son los activadores de las células
hepáticas estrellares (HSCs). Al activarse, las HSCs se
diferencian en miofibroblastos, y, a través de la autosecreción
y parasecreción, proliferan y sintetizan una cantidad masiva
de materiales extracelulares que se van acumulando y
conducen a la formación de la fibrosis hepática'. Como la
fibrosis es un proceso común de una variedad de patologías
hepáticas crónicas, la prevención contra su desarrollo es de
suma importancia. A continuación se
2965- gera: 112025/di/ra
[EFFECT OF DAHUANGZHECHONG PILL ON
DIFFERENT LIVER FIBROSIS MODEL]. YU CHANG-
YUAN,CHEN ZHEN-GUI,TIAN YONG-LI,ET AL. chinese
journal of basic medicine in tcm. 2002;8(12):33 (chi).
2966- gera: 112026/di/ra
[EFFECTS OF ZHIGANTAI (ZHGO) CAPSULE ON
THE SOD AND CAT ACTIVITY AND THE MDA
CONTENTS IN THE BLOOD SERUM AND HEPATIC
TISSUE OF FATTY LIVER RAT WITH
HYPERLIPIDEMIA]. ZHANG YI-XIN,YANG MU-
XIANG,WANG ZHAN-BO, ET AL. chinese journal of
basic medicine in tcm. 2002;8(12):35 (chi*).
2967- gera: 112042/di/ra
[THERAPEUTIC EFFECT ON TREATING CHRONIC
HEPATITIS B BY THE THERAPY OF ELIMINATING
DAMPNESS AND HEAT]. LE ENSHI ET AL. tianjin
journal of tcm. 2002;19(1):25 (chi*).
2968- gera: 112361/di/ra
[CLINICAL OBSERVATION ON TREATMENT OF
LIVER FIBROSIS WITH ZHUANGGAN ZHUYU
DECOCTION]. LIN SHOUNING ET AL. guangxi journal
of tcm. 2002;25(1):19 (chi).
2969- gera: 112770/di/ra
[ANIMAL EXPERIMENT ON ANTI - HEPATIC
FIBROSIS OF "LIVER - SOFTENING GRANULES"].
WANG LIN-TAI CHEN JIAN-JIE ZHANG BIN ET AL.
acta universitatis traditionis medicalis sinensis
pharmacologiaeque shanghai. 2002;16(4):52 (chi*).
2970- gera: 112839/di/ra
[THE CLINICAL EXPERIENCE OF DENG TIE - TIAO
TREATING LIVER SCLEROSIS]. FENG CHONGLIAN.
china journal of tcm and pharmacy. 2002;17(11):692 (chi).
2971- gera: 115761/di/ra
[ANIMAL EXPERIMENT ON ANTI-HEPATIC
FIBROSIS OF "LIVER-SOFTENING GRANULES"].
gera 2011

WANG LIN-TAI CHEN JIAN-JIE ZHANG BIN ET AL.
acta universitatis traditionis medicalis sinensis
pharmacologiaeque shanghai. 2002;16(4):52 (chi*).
2972- gera: 120979/di/ra
[PROGRESS IN RESEARCH ON TCM AND CHINESE
MATERIA MEDICA FOR HEPATITIS C]. YANG SHI-
ZHONG ET AL. academic periodical of changchun college
of tcm. 2002;19(2):51 (chi).
2973- gera: 111271/di/ra
[CLINICAL STUDY ON THE TREATMENT OF
STUBBORN JAUNDICE FROM HEPATITIS AND
CIRRHOSIS' BY "GAN FU KANG"]. ZHANG JING
CHENG WEI-ZHONG LU MIN ET AL. shanghai journal
of tcm. 2003;37(1):12 (chi*).
2974- gera: 111272/di/ra
[PROFESSOR ZHANG JUNFU'S EXPERIENCE IN
TREATING LIVER DISEASES]. CHAI XIA. shanghai
journal of tcm. 2003;37(1):16 (chi*).
In the treatment of chronic hepatitis B and cirrhosis,
professor Zhang Junfu often combines syndrome
differentiation mid disease differentiation. It is believed that
the hepatitis is caused by dampness-heat and toxin in the
blood involving the liver as well as the spleen, stomach, qi,
blood, yin and yang; the treatment mainly aims to nourish the
liver, spleen and kidney, harmonize qi-blood, yinyang as well
as to clear dampness-heat, resolve twin, activate blood flow
and dissolve blood-stasis. Four case studies are listed.
2975- gera: 111273/di/ra
[TREATMENT OF CHRONIC HEPATITIS B BY
"ZHIGANLING ORAL LIQUID" IN 106 CASES].
ZHANG HUI-YUN REN QUAN-ZHONG ZHU XU-ZHI.
shanghai journal of tcm. 2003;37(1):19 (chi*).
2976- gera: 111443/di/ra
[BRIEF ON STUDY OF MODERN
PHYSIOPATHOLOGY OF HEPATIC FUNCTION]. XU
ZHIWEI. chinese archives of tcm. 2003;21(1):(15). (chi).
2977- gera: 111449/di/ra
[STUDY ON RELATIVITY BETWEEN SYNDROME
DIFFERENTIATION OF CHRONIC HEPATITIS B
AND IMMUNITY]. SUN XUEHUA , ET AL. chinese
archives of tcm. 2003;21(1):115 (chi).
2978- gera: 111463/di/ra
[RESEARCH ON THE IMPACT OF LIVER-
STAGNATION AND SPLEEN-DEFICIENCY ON
EXPERIMENTAL HEPATOCARCINOMA INDUCED
BY DEN IN RATS]. WANG JI , ET AL. chinese journal of
information on tcm. 2003;10(1):18 (chi*).
2979- gera: 111470/di/ra
[CLINICAL STUDY ON CIRRHOSIS DUE TO
SCHISTOSOMIASIS TREATED BY RUANGAN PILL].
FU CHA NGGE ET AL. hubei journal of tcm. 2003;25(1):6
(chi).
2980- gera: 111506/di/ra
[STUDY OF SERUM PROLIDASE CHANGE IN
HEPATIC FIBROSIS RATS AND EFFECT OF
VITAMIN E ON THOSE]. WANG YA-FAN , LI PING ,
LI QI-FEN , ET AL. modern journal of integrated
traditional chinese and western medicine. 2003;12(2):126
(chi*).
2981- gera: 111586/di/ra
184
[PROF. ZHANG XUE - WEN'S EXPERIENCE ON THE
TREATMENT OF FATTY LIVER BY LIVER -
CLEARING AND BLOOD - ACTIVATING THERAPY].
WANG XIAO-JUN. new journal of tcm. 2003;35(2):12
(chi*).
2982- gera: 111593/di/ra
[TREATMENT OF HEPATITIS B VIRUS RELATED
NEPHRITIS BY TCM COMBINED WITH WESTERN
MEDICINE: A CLINICAL OBSERVATION OF 29
CASES]. LI CHAO. new journal of tcm. 2003;35(2):41
(chi).
2983- gera: 111630/di/ra
[RECENT PROGRESS IN THE CLINICAL STUDY OF
CHINESE -WESTERN-COMBINED THERAPY FOR
THE TREATMENT OF ASCITES DUE TO
CIRRHOSIS]. WANG HUA-NING FENG NI. henan tcm.
2003;23(1):69 (chi).
2984- gera: 111680/di/ra
[EXPERIENCE OF TREATING LIVE CIRRHOSIS
WITH ASCITES BY TRADITIONAL CHINESE
MEDICINE]. LUO GUANG-JING. chinese journal of
ethnomedicine and ethnopharmacy. 2003;2(1):22 (chi).
2985- gera: 111687/di/ra
[CLINICAL EXPERIENCE OF TREATING 50 CASES
OF ACUTE VIRUS HEPATITIS WITH ORIENTAL
WORMWOOD DECOCTION]. TENG LI-MING. chinese
journal of ethnomedicine and ethnopharmacy.
2003;2(1):30 (chi).
2986- gera: 111708/di/ra
[CLINICAL OBSERVATION ON DANGGUIYUGAN
POWDER IN TREATMENT OF CHRONIC VIRUS
HEPATITIS B.]. MIAO XIANG-DONG. liaoning journal
of tcm. 2003;30(1):32 (chi*).
2987- gera: 111721/di/ra
[CLINICAL STUDY ON TREATMENT OF HEPATITIS
B WITH FUZHENG QINGDU HUOXUE
DECOCTION"]. ZHU JIANMING , WANG BI, XU
GUIYING, ET AL. jiangsu journal of tcm. 2003;24(1):13
(chi).
2988- gera: 111741/di/ra
[A SUMMARY ON 35 CASES OF HYPOHEMOGRARN
CAUSED BY CHRONIC HEPATITIS TREATED WITH
ZUOGUI HUOXUE DECOCTION]. WU SHUISHENG
ET AL. hunan journal of tcm. 2003;19(1):13 (chi).
2989- gera: 111759/di/ra
[TREATING 48 CASES OF FATTY LIVER WITH
TIAO ZHI HUA YU TANG -COMPARED WITH
TREATMENT OF 38 CASES WITH DONG BAO GAN
TAI PIAN]. CHEN JINHONG. zhéjiâng journal of tcm.
2003;38(2):56 (chi).
2990- gera: 111959/di/ra
[CLINICAL OBSERVATION OF COMBINATION OF
TIOPRONIN AND BAIYINGTANG ON CHRONIC
VIRAL HEPATITIS TYPE B]. HE HAO, ZHANG YU-
LIANG, YAN YI-ZHONG. modern journal of integrated
traditional chinese and western medicine . 2003;12(3):235
(chi*).
2991- gera: 111969/di/ra
[CLINICAL OBSERVATION OF AODUQING
POWDER ON CHRONIC HEPATITIS B]. YU
gera 2011

WENJUN, GENG CHANGE. hebei journal of tcm.
2003;25(1):15 (chi*).
2992- gera: 111987/di/ra
[EFFECT OF ANTI-FIBROSIS HERBS ON
EXPRESSION OF TYPE I , III COLLAGEN AND
TRANSFORMING GROWTH FACTOR P, MRNA IN
LIVER OF RAT WITH HEPATIC FIBROSIS]. ZHU
BING, LIU DIAN-WU, FANG WEN-LIANG, ET AL.
chinese journal of basic medicine in tcm. 2003;9(1):21
(chi).
2993- gera: 112096/di/ra
[DAHUANGHUSHAO DECOCTION FOR CHRONIC
HEPATITIS SEQUESTRANS]. DENG HAIPENG, TANG
JIANWU. shaanxi journal of tcm. 2003;24(1):27 (chi).
2994- gera: 112097/di/ra
[ANTI -HEPATICOFIBROSIS EFFECT OF CHINESE
MEDICINE]. HAO JIANMEI, GAO HONGMEI. shaanxi
journal of tcm. 2003;24(1):33 (chi).
2995- gera: 112115/di/ra
[DISCUSSION ON THE CORRELATION BETWEEN
ULTRASONIC EXAMINATION, TONGUE PROPER
OBSERVATION AND THE DEGREE OF LIVER
FIBROSIS]. SONG QIAN. zhejiang journal of tcm.
2003;38(1):30 (chi).
2996- gera: 112134/di/ra
[HEPATOCIRRHOSIS (50 CASES CASES
)>,TREATED BY "GAN-FU" DECOCTION]. LU
QIYUN. journal of practical tcm. 2003;19(1):19 (chi).
2997- gera: 112136/di/ra
[OBSERVATION ON CHRONIC HEPATITIS B (50
CASES) TREATED BY TRADITIONAL CHINESE
DRUGS, INTERFERON AND THYMIC FACTOR]. XU
JINBO , ZHOU YONGFANG. journal of practical tcm.
2003;19(1):26 (chi).
2998- gera: 112351/di/ra
[DR. WANG XUGAO' S EXPERIENCE IN TREATING
LIVER DISEASES]. YI FA-YIN HU FANG-LIN. shanghai
journal of tcm. 2003;37(2):42 (chi*).
2999- gera: 112644/di/ra
[RECENT PROGRESS OF ANTIVIROTIC
TREATMENT ON CHRONIC VIRAL HEPATITIS
TYPE B]. ZHANG GUANG-YE. modern journal of
integrated traditional chinese and western medicine .
2003;12(4):436 (chi).
3000- gera: 112646/di/ra
[CONSTRUCTION OF RECOMBINANT PLASMID
CONTAINING PRES2S GENE OF ADW HBV SERUM
AND ITS EXPRESSION IN THE EUKARYOTIC
CELLS]. SUN MEIQIN, ZHAO LIANSAN, WANG SONG,
ET AL. chinese journal of integrated traditional and
western medicine on digestion. 2003;11(1):3 (chi*).
3001- gera: 112653/di/ra
[CLINICAL EFFECTIVENESS OF PROSTAGLANDIN
E1 TREATING 108 PATIENTS WITH CHRONIC
HEPATITIS B]. HE YANZHUAN, HUANG ZHONGMIN,
QIN HOUJI. chinese journal of integrated traditional and
western medicine on digestion. 2003;11(1):25 (chi*).
3002- gera: 112654/di/ra
[CLINICAL STUDY OF JUANKUGANTAI IN THE
185
TREATMENT OF CHRONIC HEPATITIS B]. WANG
WEI, ZHOU XUEWEN, ZHUANG YAN, ET AL. chinese
journal of integrated traditional and western medicine on
digestion. 2003;11(1):27 (chi*).
3003- gera: 112657/di/ra
[STUDY ON RELATIONSHIP BETWEEN LIVER
HISTOLOGICAL ACTIVITY INDEX AND LIVER
FUNCTION OR HBVM IN THE PATIENTS WITH
CHRONIC HEPATITIS B]. ZHANG YONGDONG 9
XIONG JIADE, HOU GANZENG. chinese journal of
integrated traditional and western medicine on digestion.
2003;11(1):36 (chi*).
3004- gera: 112705/di/ra
[STUDY OF THE EFFECTS OF THE MEDICATED
SERUM PREPARED WITH HUOXUEHUAYU
FORMULA ON HEPATIC STELLATE CELLS IN
VITRO]. GUO SHUNGEN, ZHANG WEI, JIANG TAO,
ET AL. journal of beijing university oftcm. 2003;26(1):24
(chi*).
3005- gera: 112711/di/ra
[DYNAMIC CHANGES IN THE LEVELS OF
PROCOLLAGEN III , HYALURONIC ACID AND
LAMININ IN THE TREATMENT OF HEPATIC
FIBROSIS WITH GANJIE POWDER IN MICE]. YANG
GUOHAN, DAI YUGUANG, ZHONG YU. journal of
beijing university oftcm. 2003;26(1):42 (chi*).
3006- gera: 112719/di/ra
[CLINICAL OBSERVATION OF THE EFFICACY-
ENHANCING AND TOXICITY-REDUCING EFFECTS
OF HUGANRUANJIAN FORMULA ON PRIMARY
LIVER CARINOMA AT STAGE II AND III TREATED
BY LIVER TAE]. WU XIAODONG JIN XUEJUN LIU
SHUMEI, ET AL. journal of beijing university oftcm.
2003;26(1):67 (chi).
3007- gera: 112742/di/ra
[CLINICAL OBSERVATION ON CHRONIC
ATROPHIC GASTRITIS TREATED BY
DECOCTION"WEI-NING"]. SHAO RONGSHI,GU
QINGHUA,JI YANHAO ET AL. journal of practical tcm.
2003;19(2):59 (chi*).
3008- gera: 112777/di/ra
[OBSERVATIONS ON THE ANALGESIC EFFECT OF
ACUPUNCTURE ON CHOLECYSTAGIA]. WANG
P,WU YL, ZHANG YQ. shanghai journal of acupuncture
and moxibustion. 2003;22(2):16 (chi*).
3009- gera: 112923/di/ra
THE COMBINED USE OF TONIFICATION. AND
PURGATION IN TREATMENT OF FATTY LIVER.
WU PEITIAN. journal of tcm. 2003;23(1):7 (eng).
3010- gera: 112943/di/ra
PRELIMINARY INVESTIGATION ON REGULATING
EFFECTS OF DIFFERENT TCM TREATMENTS ON
TRANSCRIPTION OF THE CORRELATED GENES
OF LIVER CANCER IN RATS. GUAN DONGYUAN,
FANG ZHAOQIN, LU HENGXIN ET AL. journal of tcm.
2003;23(1):62 (eng).
3011- gera: 112948/di/ra
[KNOWLEDGE FOR HEPATIC FAILURE BY TCM].
MAO DEWEN,LI XINGGANG. hunan guiding journal of
tcmp. 2003;9(2):6 (chi).
gera 2011

3012- gera: 113009/di/ra
[TREATMENT OF SECONDARY
HEPATOCARCINOMA BY HEPATIC ARTERY
PERFUSION EMBOLISM OF OLEUM CURCUMAE:
A CLINICAL OBSERVATION OF 28 CASES]. CHEN
CHUN-YONG, XU KAI, ZHU DI-YING, ET AL. new
journal of tcm. 2003;35(3):23 (chi*).
3013- gera: 113045/di/ra
[ORIGIN AND DEVELOPMENT OF TREATING
LIVER FIBROSIS FROM PHLEGM]. LU WEIMIN ET
AL. china journal of tcm and pharmacy. 2003;18(1):21
(chi).
3014- gera: 113055/di/ra
[EXPERIMENTAL RESEARCH OF YUXIAN PILLS
FOR LIVER CANCER]. ZHOU HONG ET AL. china
journal of tcm and pharmacy. 2003;18(1):53 (chi).
3015- gera: 113066/di/ra
[EXAMPLE OF REGULATING THE FUNCTION OF
LIVER BY ACUPUNCTURE AND MOXIBUSTION].
WANG DE-JING. journal of tcm and chinese materia
medica of jilin. 2003;23(2):34 (chi).
3016- gera: 113076/di/ra
[CLINICAL STUDY ON THE TREATMENT OF
HEPATIC FIBROSIS BY "ANTIFIBROSIS-I
DECOCTION"]. WENG WEI-DONG. shanghai journal of
tcm. 2003;37(3):24 (chi*).
3017- gera: 113093/di/ra
[42 CASES SUFFERING FATTY LIVER TREATED
WITH ZHEZHU DECOCTION IN UNION WITH
SHENGJIANG POWDER]. WANG JUE. inner mongol
journal of tcm. 2003;22(1):1 (chi).
3018- gera: 113146/di/ra
[THE RELATION BETWEEN THERAPEUTIC
EFFECT OF MEDICINAL VESCULATION AND
POINT INJECTION ON CHB AND DIFFERENT
EXISTENT FORMS OF HBV IN PBMCS]. CHEN
HAIYING ET AL. journal of zhejiang college of tcm.
2003;27(1):55 (chi*).
3019- gera: 113177/di/ra
[CLINICAL OBSERVATION OF 124 CASES OF
CHRONIC HEPATITIS TREATED WITH CHAO -
DAO METHOD]. LIU GUOYING ZHANG JINYING.
journal of external therapy of tcm. 2003;12(1):18 (chi).
3020- gera: 113209/di/ra
[CLINICAL OBSERVATION ON TREATMENT OF
MID-ADVANCED PATIENTS WITH
HEPATOCARCINOMA BY XIAO'AIPING
COMBINED WITH ULTRASOUND GUIDED
PERCUTANEOUS RADIO-FREQUENCY*]. WANG
WEN-RONG, CUI SHENG-DA, ZENG LI-MING. chinese
journal of integrated traditional and western medicine.
2003;23(1):19 (chi*).
3021- gera: 113210/di/ra
[EFFECT OF CHINESE HERBAL MEDICINE FOR
CLEARING-HEAT REMOVING-DAMPNESS
SOOTHING-GAN AND INVIGORATING- PI ON
SERUM INTERLEUKIN-6, INTERLEUKIN-8 AND
TUMOR NECROSIS FACTOR A IN PATIENTS WITH
HEPATITIS B* QIU MEI, ZHOU DA-QIAO, ZHOU
XIAO-ZHOU, ET AL. chinese journal of integrated
traditional and western medicine. 2003;23(1):22 (chi*).
186
3022- gera: 113211/di/ra
[CLINICAL OBSERVATION ON TREATMENT OF
CHRONIC HEPATITIS B BY BAOGAN PILL*]. LIU
ZHAN-HAI, ZHANG XIAO-SHUANG, SHAO XIANG-
WEN. chinese journal of integrated traditional and
western medicine. 2003;23(1):25 (chi*).
3023- gera: 113212/di/ra
[CORRELATIVE STUDY ON PI DAMP-HEAT
STAGNANCY SYNDROME AND PI.WEI QI-
DEFICIENCY SYNDROME WITH TUMOR
NECROSIS FACTORA AND INTERLEUKIN-6 IN
PATIENTS WITH CHRONIC HEPATITIS B *]. CHEN
JIN-FANG, WU CHENG, LIU LI-JUAN. chinese journal of
integrated traditional and western medicine.
2003;23(1):28 (chi*).
3024- gera: 113218/di/ra
[PRELIMINARY STUDY ON APPLICATION OF
CHINESE DRUGS BY REFERRING TO THE
LABORATORY CRITERIA OF HEPATOPATHY]. LIU
YAN-LING, CHEN LI-HUA. chinese journal of integrated
traditional and western medicine. 2003;23(1):54 (chi).
3025- gera: 113226/di/ra
[MINUTE OF NATIONAL CONFERENCE ON
HEPATOPATHY OF INTEGRATED TRADITIONAL
CHINESE AND WESTERN MEDICINE]. LIU CHENG-
HAI, XU LIE-MING, LIU PING. chinese journal of
integrated traditional and western medicine.
2003;23(1):77 (chi).
3026- gera: 113230/di/ra
[CLINICAL OBSERVATION ON CHRONIC VIRUS
HEPATITIS B TREATED WITH COMBINATION OF
TRADITIONAL CHINESE AND WESTERN
MEDICINES]. LIU TIANMING. hubei journal of tcm.
2003;25(2):12 (chi).
3027- gera: 113232/di/ra
[96 CASES OF POSTHEPATITIC CIRRHOSIS
TREATED BY RUANGAN KANGXIAN RECIPE].
CHEN LAN. hubei journal of tcm. 2003;25(2):20 (chi).
3028- gera: 113233/di/ra
[41 CASES OF NON- ALCOHOLIC FATTY LIVER
TREATED BY CENZE LIGAN DECOCTION]. XU
WEIDAN , ET AL. hubei journal of tcm. 2003;25(2):21
(chi).
3029- gera: 113255/di/ra
PROBE INTO RELATIONSHIP BETWEEN THEORY
OF COLLATERAL DISEASE AND CLINICAL
HEPATIC FIBROSIS. LIU WEIMIN. journal of tcm.
2003;44(2):85 (eng).
3030- gera: 113263/di/ra
CLINICAL STUDY ON BU YANG HUAN WU
DECOCTION FOR ANTI-FIBROSIS OF LIVER IN 52
CASES. ZHU YING, YUAN WEIJIAN, YAO HONGYAN.
journal of tcm. 2003;44(2):117 (eng).
3031- gera: 113281/di/ra
HEPATOPROTECTIVE ACTIVITY OF
REDUOHANXIAO-TANG (YULDAHANSO-TANG) IS
RELATED TO THE INHIBITION OF P-
GLUCURONIDASE. HYUNG-SUP BAE, YOUNG-SUK
KIM, KI-HO CHO, KYUNG-SUP. american journal of
chinese medicine. 2003;31(1):111 (eng).
gera 2011

3032- gera: 113282/di/ra
TRADITIONAL CHINESE MEDICINE PREVENTS
INFLAMMATION IN CC14-RELATED LIVER
INJURY IN MICE. LI, P RYAN AND R G BATEY.
american journal of chinese medicine. 2003;31(1):119
(eng).
3033- gera: 113296/di/ra
[EFFECT OF RUANGAN GRANULE ON SERUM NO
AND ET OF HEPATIC CIRRHOSIS PATIENTS WITH
PORTAL HYPERTENSION*]. GAO HUI, ZHOU
DAQIAO, XIONG YIQUN, ET AL. chinese journal of
integrated traditional and western medicine on liver
diseases. 2003;13(1):3 (chi*).
3034- gera: 113297/di/ra
[STUDY ON IMMUNE HISTOCHEMISTRY OF
CHRONIC HEPATITIS B PATIENTS TREATED
WITH ZHUZI GANTAI *]. CHEN YI, CAI YANMEI,
WU BIN, ET AL. chinese journal of integrated traditional
and western medicine on liver diseases. 2003;13(1):6
(chi*).
3035- gera: 113298/di/ra
[CLINICAL STUDY ON NONALCOHOLIC
STEATOHEPATITIS TREATED BY
URSODESOXYCHOLIC ACID COMBINED WITH
HUGAN TABLET*]. ZHANG XUEWU, ZHOU MIN, HU
GUOQI. chinese journal of integrated traditional and
western medicine on liver diseases. 2003;13(1):8 (chi).
3036- gera: 113299/di/ra
[CLINIC STUDY ON 78 CASES OF AUTOIMMUNE
CHRONIC LIVER DISEASE*]. WANG RONGBING,
SUN FENGXIA, JIANG YUYONG, ET AL. chinese
journal of integrated traditional and western medicine on
liver diseases. 2003;13(1):10 (chi*).
3037- gera: 113300/di/ra
[CLINICAL OBSERVATION OF SEVERE HEPATITIS
AND CIRRHOSIS ACCOMPANIED WITH LIVER-
RENAL SYNDROME TREATED WITH LIPO-
PROSTAGLANDIN E1 *]. TONG QIAOXIA, CAI
SUQING. chinese journal of integrated traditional and
western medicine on liver diseases. 2003;13(1):13 (chi*).
3038- gera: 113301/di/ra
[THE ROLE AND MECHANISM OF QUERCETIN ON
HUMAN HEPTOCARCINOMA CELL LINE HEPG2 *].
ZENG WENTING, TANG WUBING, NI HONG, ET AL .
chinese journal of integrated traditional and western
medicine on liver diseases. 2003;13(1):17 (chi*).
3039- gera: 113302/di/ra
[STUDY ON SIDE-EFFECTS OF CURCUMA
ZEDOARIA IN TREATING RATS WITH CHRONIC
LIVER INJURY*]. CHEN BIN, SUN KEWEI, XIE
FENGYING, ET AL. chinese journal of integrated
traditional and western medicine on liver diseases.
2003;13(1):20 (chi*).
3040- gera: 113303/di/ra
[INHIBITORY EFFECT OF BAOGANKANG ON
HEPATOCELLULAR APOPTOSIS IN RATS WITH
ACUTE LIVER INJURY*]. ZHU QIGUI, HUANG QIAN,
ZHU JIANHONG. chinese journal of integrated
traditional and western medicine on liver diseases.
2003;13(1):22 (chi*).
187
3041- gera: 113304/di/ra
[EFFECTS OF RUANGAN GRANULE (RGG) ON P2L
EXPRESSION AND CELL CYCLE REGULATION OF
EXPERIMENTAL CIRRHOSIS IN SD RATS*]. ZHOU
XIAOZHOU, CIIEN JINGJUN, ZHOU DAQIAO, ET AL.
chinese journal of integrated traditional and western
medicine on liver diseases. 2003;13(1):25 (chi*).
3042- gera: 113305/di/ra
[EFFECT OF HEPATOCYTE GROWTH FACTOR ON
RAT LIVER REGENERATION AFTER
HEPATECTOMY*]. WU YABIN, GONG ZUOJIONG,
YANG LIHUA. chinese journal of integrated traditional
and western medicine on liver diseases. 2003;13(1):29
(chi*).
3043- gera: 113306/di/ra
[FUNCTIONAL GENOMICS, PROTEOMICS, AND
THE MECHANISM OF LIVER PROTECTION AND
ANTI-CANCER OF CORDYCEPS SINENSIS *]. PAN
TAILONG, LI YINGXIONG. chinese journal of integrated
traditional and western medicine on liver diseases.
2003;13(1):5 (chi*).
3044- gera: 113363/di/ra
[EFFECTS OF CURCUMIN PRIMARY CULTURED
RAT HEPATOCYTE INJURED BY CC14]. LIU YONG-
GANG CHEN HOU-CHANG ET AL. chinese traditional
patent medicine. 2003;25(3):222 (chi*).
3045- gera: 113387/di/ra
[EFFECT OF CHINESE HERBS ON GENES
EXPRESSION IN HEPATIC SATELLITE CELLS BY
FLUORESCENT MRAN DIFFERENTIAL DISPLAY].
ZHU BING,LIU DIAN-WU,CUI JUN-SHENG,ET AL.
shandong journal of tcm. 2003;22(2):110 (chi).
3046- gera: 113415/di/ra
[MEASUREMENT OF ELECTRIC RESISTANCE OF
THE WELL ACUPOINTS AND CLINICAL
DIAGNOSIS OF CHINESE MEDICINE IN CHRONIC
HEPATITIS B]. GONG QI-MING ET AL. shanghai
journal of acupuncture and moxibustion. 2003;22(3):32
(chi*).
3047- gera: 113460/di/ra
[OBSERVATION ON CHRONIC HEPATITIS B (40
CASES) TREATED BY YEXIAZHU COMPOUND
CAPSULES AND ANTI-HEPATITIS B TRANSFER
FACTOR]. WANG RONGGUO,LIN RUIJING. journal of
practical tcm. 2003;19(3):121 (chi*).
3048- gera: 113468/di/ra
[AN EXPERIMENTAL STUDY ON THE EFFECT OF
ZEDOARY ON THE MEMBRANE FUNCTION OF
HEPATOCYTES AMONG RATS WITH IMMUNE-
INJURING INDUCED HEPATIC FIBROSIS]. CHEN
BIN, SUN KE-WEI LIU MING-DE, ET AL. journal of tcm
university of hunan. 2003;23(1):7 (chi*).
3049- gera: 113476/di/ra
[OBSERVATION OF CURATIVE EFFECT ON
SEVERE TYPE HEPATITIS TREATED BY RHUBARB
MOUTAN DECOCTION]. ZHANG WENCAI ET AL.
hubei journal of tcm. 2003;25(3):10 (chi).
3050- gera: 113477/di/ra
[CLINICAL OBSERVATION ON FATTY LIVER
TREATED BY GANSU AND ZHIBITUO CAPSULE].
CHEN CHAOJUN,ET AL. hubei journal of tcm.
gera 2011

2003;25(3):11 (chi).
3051- gera: 113484/di/ra
[TREATMENT OF CHRONIC HEPATITIS B WITH 0
GANYAN]. XIAO TIANXIANG. hubei journal of tcm.
2003;25(3):25 (chi).
3052- gera: 113485/di/ra
[DISCUSSION ON DIFFERENTIATION OF
SYNDROMES AND TREATMENT OF CHRONIC
HEPATITIS B]. HE SONG-QI. shandong journal of tcm.
2003;22(3):131 (chi*).
3053- gera: 113508/di/ra
[CHINESE MEDICINE IN THE TREATMENT OF
CHRONIC HEPATITIS]. ZHOU JING. henan tcm.
2003;23(2):49 (chi).
3054- gera: 113519/di/ra
[RESEARCH PROGRESSION OF VIRUS RELATED
TO POSTTRANSFUSE HEPATITIS]. GAN XUE-TING,
BAI XIAN-GUANG. modern journal of integrated
traditional chinese and western medicine. 2003;12(6):667
(chi).
3055- gera: 113527/di/ra
[INHIBITION OF APITOXIC GENOME
ADENOVIRUS TO MULTIPLICATION OF HEP3B
CELLS OF HURRIAN LIVER CANCER]. LI BAI, ET
AL. chinese archives of tcm. 2003;21(3):357 (chi).
3056- gera: 113545/di/ra
[ETIOLOGY AND PATHOGENESIS CHRONIC -,VW
HEPATITIS B AND ITS TREATMENT]. LI
MINGZHAO, ZHAO LIFU. jiangsu journal of tcm.
2003;24(3):48 (chi).
3057- gera: 113593/di/ra
[THE THEORY OF COLLATERAL DISEASE AND
THE CLINIC OF HEPATIC FIBROSIS]. LIU WEIMIN,
YAO NAILI. acta chinese medicine and pharmacology.
2003;31(1):2 (chi).
3058- gera: 113630/di/ra
[PHARMACOLOGICAL RESEARCH OF EXTRACTS
OF NATIONAL HERB MATIJIN FOR D - GLAN, TAA
AND ANIT INDUCED CHEMICAL LIVER LESION OF
MICE]. QU LISHA ET AL. china journal of tcm and
pharmacy. 2003;18(2):84 (chi*).
3059- gera: 113647/di/ra
[INFLUENCE OF YI SHEN XI GAN HUA ZHI SOUP
ON BUA - TBA PATIENTS WITH ALCOHOLIC
FATTY LIVER]. DONG ZIQIANG,ZHAO
YONGJUN,SHI YUXIA. forum on tcm. 2003;18(2):20
(chi).
3060- gera: 113653/di/ra
[DISCUSSION ON THE RELATIONSHIP BETWEEN
THE DEGREE OF LIVER - BLOOD STASIS AND THE
PATHOLOGICAL STAGE OF FIBROSIS]. WANG
BAO-ZHEN, ET AL. chinese journal of traditional
medical science and technology. 2003;10(2):65 (chi*).
3061- gera: 113657/di/ra
[CLINICAL STUDY ON ASCITES DUE TO
CIRRHOSIS TREATED WITH JIANPIHUAYULISHUI
METHOD]. ZHANG PEI-QIN, ET AL. chinese journal of
traditional medical science and technology. 2003;10(2):74
(chi).
188
3062- gera: 113660/di/ra
[EFFECT OF EURYTOPICITY WAN'AIKANG ON
APOPTOPIC GENE EXPRESSION IN HUMAN
PRIMARY HEPATOMA CELLS]. MAO XIAO-LING,
ET AL. chinese journal of traditional medical science and
technology. 2003;10(2):81 (chi*).
3063- gera: 113663/di/ra
[EXPERIMENTAL STUDY ON THE
ANTIHEPATOCIRRHOSIS EFFECT OF GANPISHU
MIXTURE]. CHEN LI-XIA, ET AL. chinese journal of
traditional medical science and technology. 2003;10(2):86
(chi).
3064- gera: 113675/di/ra
[CLINICAL OBSERVATIONS ON 46 CASES WITH
CIRRHOSIS TREATED WITH HUOXUEXIAOZHENG
DECOCTION]. ZHU YAO-QUN, ET AL. chinese journal
of traditional medical science and technology.
2003;10(2):111 (chi).
3065- gera: 113688/di/ra
[CLINICAL OBSERVATION OF MANGANKANG
TREATING CHRONIC HEPATITIS B]. HU SHIPING.
hebei journal of tcm. 2003;25(3):167 (chi*).
3066- gera: 113712/di/ra
[CLINICAL OBSERVATION ON EFFECT OF JIANPI
XIAOJI ORAL LIQUID (FTJR)'0FR OBRA) IN
TREATING 40 PATIENTS WITH
HEPATOCARCINOMA STAGE 11 - III FOR
SUPPLEMENTARY TREATMENT *]. HUANG ZHI-
FEN, LL HAN-ZHONG, SHI ZHI-YAN, ET AL. chinese
journal of integrated traditional and western medicine.
2003;23(3):192 (chi*).
3067- gera: 113745/di/ra
[40 CASES OF TREATMENT OVER
HEPATOCIRRHOSIS ASCITES COMBINED WITH
TRADITIONAL CHINESE MEDICINE AND
WESTERN MEDICINE]. WU GUO-LI. jiangxi journal of
tcm. 2003;34(3):31 (chi).
3068- gera: 113751/di/ra
[CLINICAL CONTROLLED RESEARCH OF THE
TREATMENT OF SUPPORTING HEALTHY ENERGY
TO ELIMINATE EVILS AND CLEARING AWAY
HEAT AND TOXIC MATERIAL ON THE PRECORE
MUTATION IN PATIENTS WITH CHRONIC
HEPATITIS B]. YANG HONG-ZHI,WANG YONG-
ZE,DAI MIN,ET AL. chi j integrated traditional and
western medicine in intensive and critical care.
2003;10(2):74 (chi*).
3069- gera: 113877/di/ra
[THERAPEUTIC ANALYSIS ON TREATING VIRUS
HEPATITIS WITH MONGOLIAN DRUGS]. BU-REN-
DA-LAI, ET AL. chinese journal of ethnomedicine and
ethnopharmacy. 2003;4(2):90 (chi).
3070- gera: 113943/di/ra
[EFFECTS OF" QIANGGAN RUANJIAN
DECOCTION" ON LIVER FUNCTION, PORTAL
BLOOD FLOW AND FIBROSIS MARKERS IN
PATIENTS WITH LIVER CIRRHOSIS]. WANG XIAO-
SU LI YONG. shanghai journal of tcm. 2003;37(4):19
(chi*).
3071- gera: 114005/di/ra
gera 2011

[OBSERVATION OF HUAZHUO QINGGAN
DECOCTION ON THE TREAT MENT OF FATTY
LIVER]. DUAN LIFENG. hebei journal of tcm.
2003;25(4):247 (chi*).
3072- gera: 114024/di/ra
[EXPRESSION OF BCL-2 AND BAX PROTEINS IN
RAT HEPATIC FIBROSIS MODEL AND THE ROLE
OF HUOXUE SHENSHI FANG]. LU LIANGWEI, CHEN
QUNWEI, CHAI WEIMIN ET AL. journal of zhejiang
college of tcm. 2003;27(2):51 (chi*).
3073- gera: 114026/di/ra
[EXPERIMENTAL STUDY ON MECHANISM OF
GANFUJIAN GRANULE INHIBITING
HEPATOCARCINOGENESIS INDUCED WITH
DIETHYLNITROSAMINE IN RATS]. QIAN YAN, FIN
YAN, LI YUAN, ET AL. journal of zhejiang college of
tcm. 2003;27(2):56 (chi*).
3074- gera: 114126/di/ra
[A SUMMARY ON 48 CASES OF CHRONIC
HEPATITIS B TREATED MAINLY BY HUOXUE
SHUGAN DECOCTION]. HE ZHIQIANG,TANG
YANENG. hunan journal of tcm. 2003;19(2):9 (chi*).
3075- gera: 114127/di/ra
[A SUMMARY ON 24 CASES OF ASCITES DUE TO
CIRRHOSIS TREATED BY YUGAN DECOCTION].
HE XIANGYU. hunan journal of tcm. 2003;19(2):11 (chi).
3076- gera: 114169/di/ra
[TREATMENT OF CHRONIC HEPATITIS B BY TCM
COMBINED WITH WESTERN MEDICINE: A
CLINICAL OBSERVATION OF 42 CASES]. DING
GUO-FENG, CHENG ZHEN-IAN, LIU MING. new
journal of tcm. 2003;35(4):38 (chi).
3077- gera: 114172/di/ra
[FLOWING CYTOLOGICAL ANALYSIS ON
PREVENTION AND TREATMENT OF
EXPERIMENTAL HYPERLIPEMIA FATTY LIVER
BY ZHIGANSU CAPSULE]. ZHANG YI-XIN, YANG
MU-XIANG. new journal of tcm. 2003;35(4):76 (chi).
3078- gera: 114174/di/ra
[CLINICAL EFFECT AND MECHANISM OF JIAWEI
LANDOUFENGZHU DECOCTION IN TREATING
HEPATIC CIRRHOSIS]. JIN GUILAN, ET AL. chinese
journal of information on tcm. 2003;10(3):9 (chi).
3079- gera: 114180/di/ra
[INTERVENTIONAL STUDY OF DECOCTION FOR
REMOVING BLOOD STASIS (XIAYUXUE TANG) ON
EXPERIMENTAL HEPTIC CIRRHOSIS AND LIPID
PEROXIDATION]. QIN DANPING, ET AL. chinese
journal of information on tcm. 2003;10(3):25 (chi*).
3080- gera: 114215/di/ra
[CLINICAL ANALYSE 40 CASES ON TREATMENT
OF LIPID LIVER BY DECOCTION TAOHECHENGQI
COMBINATION BOLUS BAOHE]. LI
SHAOSONG,ZHANG YINGLI. helongjiang journal of
tcm. 2003;2:22 (chi).
3081- gera: 114229/di/ra
[OBSERVATION ON HISTOLOGICAL INFLUENCE
OF DANSHEN INJECTION TO ALCOHOLIC LIVER
INJURY OF GREAT GERBIL]. CHEN XIAONAN, ZHU
XI 9 HE JIAGAN, ET AL. zhejiang journal of tcm.
189
2003;38(4):172 (chi).
3082- gera: 114242/di/ra
[THE CLINICAL EXPERIENCE OF WEI
CHANGCHUN DOCTOR TREATING WITH LIVER
DISEASE]. PAN TAICHUAN. journal of tcm.
2003;104(1):46 (chi).
3083- gera: 114326/di/ra
[ANALYSIS OF 1010 ARTICLES ABOUT THE
CORRELATION OF BLOOD-STASIS SYNDROME
AND LIVER CANCER]. LIU QING, YUE XIAO-QIANG,
HOU FENG-GANG, ET AL. journal of shandong
university of tcm. 2003;27(2):92 (chi).
3084- gera: 114434/di/ra
[BRIEF ON STUDY OF MODERN
PHYSIOPATHOLOGY OF HEPATIC FUNCTION]. XU
ZHIWEI. chinese archives of tcm. 2003;21(1):(15). (chi).
3085- gera: 114440/di/ra
[STUDY ON RELATIVITY BETWEEN SYNDROME
DIFFERENTIATION OF CHRONIC HEPATITIS B
AND IMMUNITY]. SUN XUEHUA, ET AL. chinese
archives of tcm. 2003;21(1):115 (chi).
3086- gera: 114454/di/ra
[RESEARCH ON THE IMPACT OF LIVER-
STAGNATION AND SPLEEN-DEFICIENCY ON
EXPERIMENTAL HEPATOCARCINOMA INDUCED
BY DEN IN RATS]. WANG JI, ET AL. chinese journal of
information on tcm. 2003;10(1):18 (chi*).
Objective : To investigate the effect of liver-stagnation and
spleen-deficiency on the immune function of rats and the
contents of DNA in liver cells in rats of experimental
hepatocarcinoma induced by DEN. Methods : Rats were
stimulated with the factor of liver-stagnation and spleen-
deficiency for 18 weeks and simultaneously induced by DEN
70mg/kg once a week for 8 weeks. The pathological changes
of liver and contents of DNA in liver cells were detected; T-
lymphocyte transformation rate, B-lymphocyte
transformation rate of the spleen and phagocytic function of
peritoneal macrophage were tested. Results : Body weights of
the rats could be decreased, the contents of DNA in liver cells
could also be changed and the immune functions could be
impaired significantly by stimulation of liver-stagnation and
spleen deficiency. Conclusion : The factor of liver-stagnation
and spleen- deficiency could promote the development of
experimental hepatocarcinoma induced by DEN in rats.
3087- gera: 114461/di/ra
[CLINICAL STUDY ON CIRRHOSIS DUE TO
SCHISTOSOMIASIS TREATED BY RUANGAN PILL].
FU CHA NGGE ET AL. hubei journal of tcm. 2003;25(1):6
(chi).
3088- gera: 114497/di/ra
[STUDY OF SERUM PROLIDASE CHANGE IN
HEPATIC FIBROSIS RATS AND EFFECT OF
VITAMIN E ON THOSE]. WANG YA-FAN, LI PING, LI
QI-FEN, ET AL. modern journal of integrated traditional
chinese and western medicine. 2003;12(2):126 (chi*).
3089- gera: 114577/di/ra
[PROF. ZHANG XUE-WEN'S EXPERIENCE ON THE
TREATMENT OF FATTY LIVER BY LIVER-
CLEARING AND BLOOD-ACTIVATING THERAPY].
WANG XIAO-JUN. new journal of tcm. 2003;35(2):12
(chi*).
Prof. MANG considered that stagnation of heat in liver
gera 2011

meridian, stagnation of qi and blood and accumulation of
blood - stasis in the interior are the important pathogenesis of
fatty liver. The disease is located in the liver and its meridian
and the spleen and stomach were involved. Clearing of liver -
heat, dispersion of stagnated liver - qi and removal of blood -
stasis and masses were the main therapeutic principles, which
were modified according to the
3090- gera: 114584/di/ra
[TREATMENT OF HEPATITIS B VIRUS RELATED
NEPHRITIS BY TCM COMBINED WITH WESTERN
MEDICINE : A CLINICAL OBSERVATION OF 29
CASES]. LI CHAO. new journal of tcm. 2003;35(2):41
(chi).
3091- gera: 114621/di/ra
[RECENT PROGRESS IN THE CLINICAL STUDY OF
CHINESE -WESTERN-COMBINED THERAPY FOR
THE TREATMENT OF ASCITES DUE TO
CIRRHOSIS]. WANG HUA-NING FENG NI. henan tcm.
2003;23(1):69 (chi).
3092- gera: 114671/di/ra
[EXPERIENCE OF TREATING LIVER CIRRHOSIS
WITH ASCITES BY TRADITIONAL CHINESE
MEDICINE]. LUO GUANG-JING. chinese journal of
ethnomedicine and ethnopharmacy. 2003;2(1):22 (chi).
3093- gera: 114678/di/ra
[CLINICAL EXPERIENCE OF TREATING 50 CASES
OF ACUTE VIRUS HEPATITIS WITH ORIENTAL
WORMWOOD DECOCTION]. TENG LI-MING. chinese
journal of ethnomedicine and ethnopharmacy.
2003;2(1):30 (chi).
3094- gera: 114699/di/ra
[CLINICAL OBSERVATION ON DANGGUIYUGAN
POWDER IN TREATMENT OF CHRONIC VIRUS
HEPATITIS B. ]. MIAO XIANG-DONG. liaoning journal
of tcm. 2003;30(1):32 (chi*).
3095- gera: 114712/di/ra
[CLINICAL STUDY ON TREATMENT OF HEPATITIS
B WITH FUZHENG QINGDU HUOXUE
DECOCTION"]. ZHU JIANMING, WANG BI, XU
GUIYING, ET AL. jiangsu journal of tcm. 2003;24(1):13
(chi).
3096- gera: 114732/di/ra
[A SUMMARY ON 35 CASES OF HYPOHEMOGRAM
CAUSED BY CHRONIC HEPATITIS TREATED WITH
ZUOGUI HUOXUE DECOCTION]. WU SHUISHENG
ET AL. hunan journal of tcm. 2003;19(1):13 (chi).
3097- gera: 114750/di/ra
[TREATING 48 CASES OF FATTY LIVER WITH
TIAO ZHI HUA YU TANG -COMPARED WITH
TREATMENT OF 38 CASES WITH DONG BAO GAN
TAI PIAN]. CHEN JINHONG. zhejiang journal of tcm.
2003;38(2):56 (chi).
3098- gera: 114766/di/ra
[STATISTICAL ANALYSIS OF CLINICALLY
REPORTED SYNDROMES DIFFERENTIATION OF
2492 PHC CASES]. LI YONG-JIAN ET AL. chinese j
basic med tcm. 2003;7(6):71 (chi*).
Purpose :This article deals with a statistical analysis of
clinically reported primary hepatocellular Carcinoma (PHC)
cases in recent 20 years ,to investigate the objective rule of
TCM syndromes differentiation of PHC. Method: The
190
classified 9 groups of syndrome patterns is analyzed with
multiple-group X test. Result :The mostly reported patterns
am showed by frequency as following : (1) qi-stagnated
blood stasis; 2 hepatic stagnation and splenic asthenia; (3)
asthenic hepato-yin and nephroyin,4 hepato-qi stagnation; (5)
asthenic splenic qi and gastro qi. Moreover , hepatic and
cholic hygropyrexia along with hygropyretic retention is
reported to be seen comparatively
3099- gera: 114815/di/ra
AN EXPERIMENTAL STUDY ON DRUGS FOR
IMPROVING BLOOD CIRCULATION AND
REMOVING BLOOD STASIS IN TREATING MILD
CHRONIC HEPATIC DAMAGE. ME FENGYING, LI
XIAOLIANG, SUN KEWEI ET AL. journal of tcm.
2003;21(3):225 (eng*).
Large and small doses of drugs for improving blood
circulation and removing blood stasis were used in model rats
to treat mild chronic hepatic damage induced by carbon
tetrachloride (CCI4). The results show that large dose of
Dang Gui (Radix Angelicae Sinensis) and Dan Shen (Radix
Salviae Miltiorrhizae) (drugs for regulating blood flow) and
small dose of Yu Jin (Radix Curcumae) and Niu Xi (Radix A
chyranthis Bidentatae) (drugs for activating blood flow) can
significantly elevate the activity of SOD (P<0.05) and/or
lower the T/K ratio, markedly reduce the MDA content
(P<0.05 or P<0.01) and significantly decrease the activities of
ALT and AST (P<0.05 or P<0.01), demonstrating that these
drugs are effective in combating oxygen free radicals (OFR)
in chronic liver damage. On the contrary, large dose of Tu
Bie Chong Eupolyphaga seu Steleophaga) and E Zhu
(Rhizoma Curcumae) (drugs for removing blood stasis) tend
to increase the ALT and AST (P<0.05) activities. The results
suggest that the synergism of elevation of the SOD activity
and reduction of T/K ratio contributes to the action of drugs
for improving blood circulation and removing blood stasis in
combating the liver damage induced by CCI4.
3100- gera: 114950/di/ra
[CLINICAL OBSERVATION OF COMBINATION OF
TIOPRONIN AND BAIYINGTANG ON CHRONIC
VIRAL HEPATITIS TYPE B]. HE HAO, ZHANG YU-
LIANG, YAN YI-ZHONG. modern journal of integrated
traditional chinese and western medicine . 2003;12(3):235
(chi*).
3101- gera: 114960/di/ra
[CLINICAL OBSERVATION OF AODUQING
POWDER ON CHRONIC HEPATITIS B]. YU
WENJUN, GENG CHANGE. hebei journal of tcm.
2003;25(1):15 (chi*).
3102- gera: 114978/di/ra
[EFFECT OF ANTI-FIBROSIS HERBS ON
EXPRESSION OF TYPE I, III COLLAGEN AND
TRANSFORMING GROWTH FACTOR P, MRNA IN
LIVER OF RAT WITH HEPATIC FIBROSIS]. ZHU
BING, LIU DIAN-WU, FANG WEN-LIANG, ET AL.
chinese journal of basic medicine in tcm. 2003;9(1):21
(chi).
3103- gera: 115016/di/ra
[EFFECT OF DAHUANGZHECHONG PILL ON
DIFFERENT LIVER FIBROSIS MODEL]. YU CHANG-
YUAN,CHEN ZHEN-GUI,TIAN YONG-LI,ET AL. chinese
journal of basic medicine in tcm. 2003;8(12):33 (chi).
3104- gera: 115017/di/ra
[EFFECTS OF ZHIGANTAI (ZHGO) CAPSULE ON
THE SOD AND CAT ACTIVITY AND THE MDA
gera 2011

CONTENTS IN THE BLOOD SERUM AND HEPATIC
TISSUE OF FATTY LIVER RAT WITH
HYPERLIPIDEMIA]. ZHANG YI-XIN,YANG MU-
XIANG,WANG ZHAN-BO, ET AL. chinese journal of
basic medicine in tcm. 2003;8(12):35 (chi*).
3105- gera: 115033/di/ra
[THERAPEUTIC EFFECT ON TREATING CHRONIC
HEPATITIS B BY THE THERAPY OF ELIMINATING
DAMPNESS AND HEAT]. LE ENSHI ET AL. tianjin
journal of tcm. 2003;19(1):25 (chi*).
Objective : To observe the therapeutic effect of the therapy of
eliminating dampness and heat on chronic Hepatitis B, and
understand the feature of differentiation of symptoms and
signs deeply. Method : The patients were chose by the
method of randomness and control. There were three indexes:
the level of amintransferase, humoral immunity and length of
hospitalization. And these data were processed with the
method of statistics. Results: There was a difference of the
level of amintransferase and humoral immunity between
these two groups at the third or fourth week after treatment
and an influence on length of hospitalization. Conclusion :
The therapy of eliminating dampness and heat has an obvious
effect on treating chronic Hepatitis B, especially on reducing
humoral immune
3106- gera: 115087/di/ra
[DAHUANGHUSHAO DECOCTION FOR CHRONIC
HEPATITIS SEQUESTRANS]. DENG HAIPENG, TANG
JIANWU. shaanxi journal of tcm. 2003;24(1):27 (chi).
3107- gera: 115088/di/ra
[ANTI -HEPATICOFIBROSIS EFFECT OF CHINESE
MEDICINE]. HAO JIANMEI, GAO HONGMEI. shaanxi
journal of tcm. 2003;24(1):33 (chi).
3108- gera: 115106/di/ra
[DISCUSSION ON THE CORRELATION BETWEEN
ULTRASONIC EXAMINATION, TONGUE PROPER
OBSERVATION AND THE DEGREE OF LIVER
FIBROSIS]. SONG QIAN. zhejiang journal of tcm.
2003;38(1):30 (chi).
3109- gera: 115125/di/ra
[HEPATOCIRRHOSIS (50 CASES )>,TREATED BY
"GAN-FU" DECOCTION]. LU QIYUN. journal of
practical tcm. 2003;19(1):19 (chi).
3110- gera: 115127/di/ra
[OBSERVATION ON CHRONIC HEPATITIS B (50
CASES) TREATED BY TRADITIONAL CHINESE
DRUGS, INTERFERON AND THYMIC FACTOR]. XU
JINBO, ZHOU YONGFANG. journal of practical tcm.
2003;19(1):26 (chi).
3111- gera: 115342/di/ra
[DR. WANG XUGAO' S EXPERIENCE IN TREATING
LIVER DISEASES]. YI FA-YIN HU FANG-LIN. shanghai
journal of tcm. 2003;37(2):42 (chi*).
3112- gera: 115352/di/ra
[CLINICAL OBSERVATION ON TREATMENT OF
LIVER FIBROSIS WITH ZHUANGGAN ZHUYU
DECOCTION]. LIN SHOUNING ET AL. guangxi journal
of tcm. 2003;25(1):19 (chi).
3113- gera: 115635/di/ra
[RECENT PROGRESS OF ANTIVIROTIC
TREATMENT ON CHRONIC VIRAL HEPATITIS
TYPE B]. ZHANG GUANG-YE. modern journal of
191
integrated traditional chinese and western medicine .
2003;12(4):436 (chi).
3114- gera: 115637/di/ra
[CONSTRUCTION OF RECOMBINANT PLASMID
CONTAINING PRESS'S GENE OF ADW HBV SERUM
AND ITS EXPRESSION IN THE EUKARYOTIC
CELLS]. SUN MEIQIN, ZHAO LIANSAN, WANG SONG,
ET AL. chinese journal of integrated traditional and
western medicine on digestion. 2003;11(1):3 (chi*).
3115- gera: 115644/di/ra
[CLINICAL EFFECTIVENESS OF PROSTAGLANDIN
E1 TREATING 108 PATIENTS WITH CHRONIC
HEPATITIS B]. HE YANZHUAN, HUANG ZHONGMIN,
QIN HOUJI. chinese journal of integrated traditional and
western medicine on digestion. 2003;11(1):25 (chi*).
3116- gera: 115645/di/ra
[CLINICAL STUDY OF JUANKUGANTAI IN THE
TREATMENT OF CHRONIC HEPATITIS B]. WANG
WEI, ZHOU XUEWEN, ZHUANG YAN, ET AL. chinese
journal of integrated traditional and western medicine on
digestion. 2003;11(1):27 (chi*).
3117- gera: 115648/di/ra
[STUDY ON RELATIONSHIP BETWEEN LIVER
HISTOLOGICAL ACTIVITY INDEX AND LIVER
FUNCTION OR HBVM IN THE PATIENTS WITH
CHRONIC HEPATITIS B ]. ZHANG YONGDONG 9
XIONG JIADE, HOU GANZENG. chinese journal of
integrated traditional and western medicine on digestion.
2003;11(1):36 (chi*).
3118- gera: 115696/di/ra
[STUDY OF THE EFFECTS OF THE MEDICATED
SERUM PREPARED WITH HUOXUEHUAYU
FORMULA ON HEPATIC STELLATE CELLS IN
VITRO]. GUO SHUNGEN, ZHANG WEI, JIANG TAO,
ET AL. journal of beijing university of tcm. 2003;26(1):24
(chi*).
3119- gera: 115702/di/ra
[DYNAMIC CHANGES IN THE LEVELS OF
PROCOLLAGEN III, HYALURONIC ACID AND
LAMININ IN THE TREATMENT OF HEPATIC
FIBROSIS WITH GANJIE POWDER IN MICE ].
YANG GUOHAN, DAI YUGUANG, ZHONG YU. journal
of beijing university of tcm. 2003;26(1):42 (chi*).
3120- gera: 115710/di/ra
[CLINICAL OBSERVATION OF THE EFFICACY-
ENHANCING AND TOXICITY-REDUCING EFFECTS
OF HUGANRUANJIAN FORMULA ON PRIMARY
LIVER CARCINOMA AT STAGE II AND III
TREATED BY LIVER TAE]. WU XIAODONG JIN
XUEJUN LIU SHUMEI, ET AL. journal of beijing
university of tcm. 2003;26(1):67 (chi).
3121- gera: 115733/di/ra
[CLINICAL OBSERVATION ON CHRONIC
ATROPHIC GASTRITIS TREATED BY DECOCTION
"WEI-NING"]. SHAO RONGSHI,GU QINGHUA,JI
YANHAO ET AL. journal of practical tcm. 2003;19(2):59
(chi*).
3122- gera: 115768/di/ra
[OBSERVATIONS ON THE ANALGESIC EFFECT OF
ACUPUNCTURE ON CHOLECYSTAGIA]. WANG
P,WU YL, ZHANG YQ. shanghai journal of acupuncture
gera 2011

and moxibustion. 2003;22(2):16 (chi*).
Purpose : To observe the analgesic effect of acupuncture on
cholecystalgia. Method : The immediate effects were
compared between an acupuncture treatment group and a
control group receiving routine medication. Results : The
total effective rate was 84% and 37% in the treatment group
and the control group respectively. The course of treatment
was shorter and the effect quicker in the treatment group
(P<0. 01). Conclusion : The analgesic effect was better in the
treatment group than in the control group.
3123- gera: 115830/di/ra
[THE CLINICAL EXPERIENCE OF DENG TIE-TIAO
TREATING LIVER SCLEROSIS]. FENG CHONGLIAN.
china journal of tcm and pharmacy. 2003;17(11):692 (chi).
3124- gera: 115914/di/ra
THE COMBINED USE OF TONIFICATION. AND
PURGATION IN TREATMENT OF FATTY LIVER.
WU PEITIAN. journal of tcm. 2003;23(1):7 (eng).
3125- gera: 115934/di/ra
PRELIMINARY INVESTIGATION ON REGULATING
EFFECTS OF DIFFERENT TCM TREATMENTS ON
TRANSCRIPTION OF THE CORRELATED GENES
OF LIVER CANCER IN RATS. GUAN DONGYUAN,
FANG ZHAOQIN, LU HENGXIN ET AL. journal of tcm.
2003;23(1):62 (eng).
3126- gera: 115939/di/ra
[KNOWLEDGE FOR HEPATIC FAILURE BY TCM].
MAO DEWEN,LI XINGGANG. hunan guiding journal of
tcmp. 2003;9(2):6 (chi).
3127- gera: 116000/di/ra
[TREATMENT OF SECONDARY
HEPATOCARCINOMA BY HEPATIC ARTERY
PERFUSION EMBOLISM OF OLEUM CURCUMAE :
A CLINICAL OBSERVATION OF 28 CASES]. CHEN
CHUN-YONG, XU KAI, ZHU DI-YING, ET AL. new
journal of tcm. 2003;35(3):23 (chi*).
3128- gera: 116036/di/ra
[ORIGIN AND DEVELOPMENT OF TREATING
LIVER FIBROSIS FROM PHLEGM]. LU WEIMIN ET
AL. china journal of tcm and pharmacy. 2003;18(1):21
(chi).
3129- gera: 116046/di/ra
[EXPERIMENTAL RESEARCH OF YUXIAN PILLS
FOR LIVER CANCER]. ZHOU HONG ET AL. china
journal of tcm and pharmacy. 2003;18(1):53 (chi).
3130- gera: 116057/di/ra
[EXAMPLE OF REGULATING THE FUNCTION OF
LIVER BY ACUPUNCTURE AND MOXIBUSTION ].
WANG DE-JING. journal of tcm and chinese materia
medica of jilin. 2003;23(2):34 (chi).
3131- gera: 116067/di/ra
[CLINICAL STUDY ON THE TREATMENT OF
HEPATIC FIBROSIS BY "ANTIFIBROSIS-I
DECOCTION"]. WENG WEI-DONG. shanghai journal of
tcm. 2003;37(3):24 (chi*).
3132- gera: 116084/di/ra
[42 CASES SUFFERING FATTY LIVER TREATED
WITH ZHEZHU DECOCTION IN UNION WITH
SHENGJIANG POWDER]. WANG JUE. inner mongol
journal of tcm. 2003;22(1):1 (chi).
192
3133- gera: 116137/di/ra
[THE RELATION BETWEEN THERAPEUTIC
EFFECT OF MEDICINAL VESICULATION AND
POINT INJECTION ON CHB AND DIFFERENT
EXISTENT FORMS OF HBV IN PBMCS]. CHEN
HAIYING ET AL. journal of zhejiang college of tcm.
2003;27(1):55 (chi*).
3134- gera: 116168/di/ra
[CLINICAL OBSERVATION OF 124 CASES OF
CHRONIC HEPATITIS TREATED WITH CHAO-DAO
METHOD]. LIU GUOYING ZHANG JINYING. journal of
external therapy of tcm. 2003;12(1):18 (chi).
3135- gera: 116200/di/ra
[CLINICAL OBSERVATION ON TREATMENT OF
MID-ADVANCED PATIENTS WITH
HEPATOCARCINOMA BY XIAO'AIPING
COMBINED WITH ULTRASOUND GUIDED
PERCUTANEOUS RADIO-FREQUENCY*]. WANG
WEN-RONG, CUI SHENG-DA, ZENG LI-MING. chinese
journal of integrated traditional and western medicine.
2003;23(1):19 (chi*).
3136- gera: 116201/di/ra
[[EFFECT OF CHINESE HERBAL MEDICINE FOR
CLEARING-HEAT REMOVING-DAMPNESS
SOOTHING-GAN AND INVIGORATING- PI ON
SERUM INTERLEUKIN-6, INTERLEUKIN-8 AND
TUMOR NECROSIS FACTOR A IN PATIENTS WITH
HEPATITIS B QIU MEI, ZHOU DA-QIAO, ZHOU XIAO-
ZHOU, ET AL. chinese journal of integrated traditional
and western medicine. 2003;23(1):22 (chi*).
3137- gera: 116202/di/ra
[CLINICAL OBSERVATION ON TREATMENT OF
CHRONIC HEPATITIS B BY BAOGAN PILL*]. LIU
ZHAN-HAI, ZHANG XIAO-SHUANG, SHAO XIANG-
WEN. chinese journal of integrated traditional and
western medicine. 2003;23(1):25 (chi*).
3138- gera: 116203/di/ra
[CORRELATIVE STUDY ON PI DAMP-HEAT
STAGNANCY SYNDROME AND PI-WEI QI-
DEFICIENCY SYNDROME WITH TUMOR
NECROSIS FACTOR AND INTERLEUKIN-6 IN
PATIENTS WITH CHRONIC HEPATITIS B *]. CHEN
JIN-FANG, WU CHENG, LIU LI-JUAN. chinese journal of
integrated traditional and western medicine.
2003;23(1):28 (chi*).
Objective : To study the relationship of Pi Damp-Heat
stagnancy Syndrome (PDHS) and Pi-Wei Qi-deficiency
Syndrome with tumor necrosis factor a (TNF-a) and
interleukin-6 (IL-6) in patients with chronic hepatitis B
(CHB) - Methods : One hundred and twenty-four patients
with CHB were enrolled, among them 64 were typed as
PDHS and the other 60 typed as Pi-Wei Qi-deficiency
Syndrome (PWQDS) - They were randomly divided into the
control group (treated with conventional treatment) and the
treated group (treated with conventional treatment plus
Chinese herbal medicine), besides, a normal control group
consisting of 30 subjects was also set up. Their fasting
venous blood was drawn before and after treatment to
determine TNF-a and IL-6 by ELISA. Results : Levels of
TNF-a and IL-6 in all the patients were higher than those in
the normal control group significantly (P<0.01). After
treatment, levels of the two parameters were all obviously
decreased, as compared with those before treatment, the
difference was significant (P<0.01). As compared with the
gera 2011

control group, in the treated group, TNF-a level in patients
with PDHS, and TNF-a and IL-6 levels in patients with
PWQDS were lower significantly (P < 0. 05 or P < 0. 01).
Conclusion : In patients with CHB, the severity of patient
with PDHS was more serious than those with PWQDS.
Integrated conventional treatment with Chinese herbal
medicine depending on Syndrome Differentiation could
significantly improve the changes in TNF-a and IL-6 levels
in patients with CHB.
3139- gera: 116209/di/ra
[PRELIMINARY STUDY ON APPLICATION OF
CHINESE DRUGS BY REFERRING TO THE
LABORATORY CRITERIA OF HEPATOPATHY]. LIU
YAN-LING, CHEN LI-HUA. chinese journal of integrated
traditional and western medicine. 2003;23(1):54 (chi).
3140- gera: 116217/di/ra
[MINUTE OF NATIONAL CONFERENCE ON
HEPATOPATHY OF INTEGRATED TRADITIONAL
CHINESE AND WESTERN MEDICINE]. LIU CHENG-
HAI, XU LIE-MING, LIU PING. chinese journal of
integrated traditional and western medicine.
2003;23(1):77 (chi).
3141- gera: 116221/di/ra
[CLINICAL OBSERVATION ON CHRONIC VIRUS
HEPATITIS B TREATED WITH COMBINATION OF
TRADITIONAL CHINESE AND WESTERN
MEDICINES]. LIU TIANMING. hubei journal of tcm.
2003;25(2):12 (chi).
3142- gera: 116223/di/ra
[96 CASES OF POSTHEPATITIC CIRRHOSIS
TREATED BY RUANGAN KANGXIAN RECIPE].
CHEN LAN. hubei journal of tcm. 2003;25(2):20 (chi).
3143- gera: 116224/di/ra
[41 CASES OF NON- ALCOHOLIC FATTY LIVER
TREATED BY CENZE LIGAN DECOCTION]. XU
WEIDAN, ET AL. hubei journal of tcm. 2003;25(2):21
(chi).
3144- gera: 116246/di/ra
PROBE INTO RELATIONSHIP BETWEEN THEORY
OF COLLATERAL DISEASE AND CLINICAL
HEPATIC FIBROSIS. LIU WEIMIN. journal of tcm.
2003;44(2):85 (eng).
3145- gera: 116254/di/ra
CLINICAL STUDY ON BU YANG HUAN WU
DECOCTION FOR ANTI-FIBROSIS OF LIVER IN 52
CASES. ZHU YING, YUAN WEIJIAN, YAO HONGYAN.
journal of tcm. 2003;44(2):117 (eng).
3146- gera: 116272/di/ra
HEPATOPROTECTIVE ACTIVITY OF
REDUOHANXIAO-TANG (YULDAHANSO-TANG) IS
RELATED TO THE INHIBITION OF P-
GLUCURONIDASE. HYUNG-SUP BAE, YOUNG-SUK
KIM, KI-HO CHO, KYUNG-SUP. american journal of
chinese medicine. 2003;31(1):111 (eng).
3147- gera: 116273/di/ra
TRADITIONAL CHINESE MEDICINE PREVENTS
INFLAMMATION IN CC14-RELATED LIVER
INJURY IN MICE. LI, P RYAN AND R G BATEY.
american journal of chinese medicine. 2003;31(1):119
(eng).
193
3148- gera: 116287/di/ra
[EFFECT OF RUANGAN GRANULE ON SERUM NO
AND ET OF HEPATIC CIRRHOSIS PATIENTS WITH
PORTAL HYPERTENSION*]. GAO HUI, ZHOU
DAQIAO, XIONG YIQUN, ET AL. chinese journal of
integrated traditional and western medicine on liver
diseases. 2003;13(1):3 (chi*).
3149- gera: 116288/di/ra
[STUDY ON IMMUNE HISTOCHEMISTRY OF
CHRONIC HEPATITIS B PATIENTS TREATED
WITH ZHUZI GANTAI *]. CHEN YI, CAI YANMEI,
WU BIN, ET AL. chinese journal of integrated traditional
and western medicine on liver diseases. 2003;13(1):6
(chi*).
3150- gera: 116289/di/ra
[CLINICAL STUDY ON NONALCOHOLIC
STEATOHEPATITIS TREATED BY
URSODESOXYCHOLIC ACID COMBINED WITH
HUGAN TABLET*]. ZHANG XUEWU, ZHOU MIN, HU
GUOQI. chinese journal of integrated traditional and
western medicine on liver diseases. 2003;13(1):8 (chi).
3151- gera: 116290/di/ra
[CLINIC STUDY ON 78 CASES OF AUTOIMMUNE
CHRONIC LIVER DISEASE*]. WANG RONGBING,
SUN FENGXIA, JIANG YUYONG, ET AL. chinese
journal of integrated traditional and western medicine on
liver diseases. 2003;13(1):10 (chi*).
3152- gera: 116291/di/ra
[CLINICAL OBSERVATION OF SEVERE HEPATITIS
AND CIRRHOSIS ACCOMPANIED WITH LIVER-
RENAL SYNDROME TREATED WITH LIPO-
PROSTAGLANDIN E1 *]. TONG QIAOXIA, CAI
SUQING. chinese journal of integrated traditional and
western medicine on liver diseases. 2003;13(1):13 (chi*).
3153- gera: 116292/di/ra
[THE ROLE AND MECHANISM OF QUERCETIN ON
HUMAN HEPATOCARCINOMA CELL LINE HEPG2
*]. ZENG WENTING, TANG WUBING, NI HONG, ET AL
. chinese journal of integrated traditional and western
medicine on liver diseases. 2003;13(1):17 (chi*).
3154- gera: 116293/di/ra
[STUDY ON SIDE-EFFECTS OF CURCUMA
ZEDOARIA IN TREATING RATS WITH CHRONIC
LIVER INJURY*]. CHEN BIN, SUN KEWEI, XIE
FENGYING, ET AL. chinese journal of integrated
traditional and western medicine on liver diseases.
2003;13(1):20 (chi*).
3155- gera: 116294/di/ra
[INHIBITORY EFFECT OF BAOGANKANG ON
HEPATOCELLULAR APOPTOSIS IN RATS WITH
ACUTE LIVER INJURY*]. ZHU QIGUI, HUANG QIAN,
ZHU JIANHONG. chinese journal of integrated
traditional and western medicine on liver diseases.
2003;13(1):22 (chi*).
3156- gera: 116295/di/ra
[EFFECTS OF RUANGAN GRANULE (RGG) ON P2L
EXPRESSION AND CELL CYCLE REGULATION OF
EXPERIMENTAL CIRRHOSIS IN SD RATS*]. ZHOU
XIAOZHOU, CIIEN JINGJUN, ZHOU DAQIAO, ET AL.
chinese journal of integrated traditional and western
medicine on liver diseases. 2003;13(1):25 (chi*).
gera 2011

3157- gera: 116296/di/ra
[EFFECT OF HEPATOCYTE GROWTH FACTOR ON
RAT LIVER REGENERATION AFTER
HEPATECTOMY*]. WU YABIN, GONG ZUOJIONG,
YANG LIHUA. chinese journal of integrated traditional
and western medicine on liver diseases. 2003;13(1):29
(chi*).
3158- gera: 116297/di/ra
[FUNCTIONAL GENOMICS, PROTEOMICS, AND
THE MECHANISM OF LIVER PROTECTION AND
ANTI-CANCER OF CORDYCEPS SINENSIS *]. PAN
TAILONG, LI YINGXIONG. chinese journal of integrated
traditional and western medicine on liver diseases.
2003;13(1):5 (chi*).
3159- gera: 116354/di/ra
[EFFECTS OF CURCUMIN PRIMARY CULTURED
RAT HEPATOCYTE INJURED BY CCl4]. LIU YONG-
GANG CHEN HOU-CHANG ET AL. chinese traditional
patent medicine. 2003;25(3):222 (chi*).
3160- gera: 116378/di/ra
[EFFECT OF CHINESE HERBS ON GENES
EXPRESSION IN HEPATIC SATELLITE CELLS BY
FLUORESCENT MRAN DIFFERENTIAL DISPLAY].
ZHU BING,LIU DIAN-WU,CUI JUN-SHENG,ET AL.
shandong journal of tcm. 2003;22(2):110 (chi).
3161- gera: 116406/di/ra
[MEASUREMENT OF ELECTRIC RESISTANCE OF
THE WELL ACUPOINTS AND CLINICAL
DIAGNOSIS OF CHINESE MEDICINE IN CHRONIC
HEPATITIS B]. GONG QI-MING ET AL. shanghai
journal of acupuncture and moxibustion. 2003;22(3):32
(chi*).
Objective : To investigate the possibility of quantification of
chinese medicine's discriminative diagnosis in chronic
hepatitis B. Methods To detect and analysis the electric
resistance values of the well acupoints separately in the
chronic hepatitis B patients with normal or abnormal liver
function by the electric resistance measurement. Results :
The unbalanced rates of twelve channels were higher in the
abnormal liver function group than in the normal group,
particularly in four channels which links to liver and spleen
and etc. , to have to show the significance difference.
Conclusion : The electric resistance measurement of the well
acupoints is beneficial to the chinese
3162- gera: 116451/di/ra
[OBSERVATION ON CHRONIC HEPATITIS B (40
CASES) TREATED BY YEXIAZHU COMPOUND
CAPSULES AND ANTI-HEPATITIS B TRANSFER
FACTOR]. WANG RONGGUO,LIN RUIJING. journal of
practical tcm. 2003;19(3):121 (chi*).
3163- gera: 116459/di/ra
[AN EXPERIMENTAL STUDY ON THE EFFECT OF
ZEDOARY ON THE MEMBRANE FUNCTION OF
HEPATOCYTES AMONG RATS WITH IMMUNE-
INJURING INDUCED HEPATIC FIBROSIS]. CHEN
BIN, SUN KE-WEI LIU MING-DE, ET AL. journal of tcm
university of hunan. 2003;23(1):7 (chi*).
3164- gera: 116467/di/ra
[OBSERVATION OF CURATIVE EFFECT ON
SEVERE TYPE HEPATITIS TREATED BY RHUBARB
MOUTAN DECOCTION]. ZHANG WENCAI ET AL.
hubei journal of tcm. 2003;25(3):10 (chi).
194
3165- gera: 116468/di/ra
[CLINICAL OBSERVATION ON FATTY LIVER
TREATED BY GANSU AND ZHIBITUO CAPSULE].
CHEN CHAOJUN,ET AL. hubei journal of tcm.
2003;25(3):11 (chi).
3166- gera: 116475/di/ra
[TREATMENT OF CHRONIC HEPATITIS B WITH 0
GANYAN]. XIAO TIANXIANG. hubei journal of tcm.
2003;25(3):25 (chi).
3167- gera: 116476/di/ra
[DISCUSSION ON DIFFERENTIATION OF
SYNDROMES AND TREATMENT OF CHRONIC
HEPATITIS B]. HE SONG-QI. shandong journal of tcm.
2003;22(3):131 (chi*).
The pathogenesis of the chronic Hepatitis B is complicated
and varied. The external causes are attributed to the
pathogenic damp and the pestilent substance, while the
internal cause is the vital-Qi deficiency characterized by the
spleen deficiency. Its pathological essence is deficiency in
origin and excess in superficiality. Namely the liver depress
and the spleen deficiency are the causes while the stagnation
of the damp-heat and the pestilent substance are the
superficiality, and stagnation of Qi and blood stasis are varied
with the development of the disease course. In treatment, the
combination of macroscopic and microscopic should be
emphasized and also that of the differentiation of syndromes
and treatment. The prescription should be flexible according,
to the indices
3168- gera: 116499/di/ra
[CHINESE MEDICINE IN THE TREATMENT OF
CHRONIC HEPATITIS]. ZHOU JING. henan tcm.
2003;23(2):49 (chi).
3169- gera: 116510/di/ra
[RESEARCH PROGRESSION OF VIRUS RELATED
TO POSTTRANSFUSE HEPATITIS]. GAN XUE-TING,
BAI XIAN-GUANG. modern journal of integrated
traditional chinese and western medicine. 2003;12(6):667
(chi).
3170- gera: 116518/di/ra
[INHIBITION OF APITOXIC GENOME
ADENOVIRUS TO MULTIPLICATION OF HEP3B
CELLS OF HURRIAN LIVER CANCER]. LI BAI, ET
AL. chinese archives of tcm. 2003;21(3):357 (chi).
3171- gera: 116536/di/ra
[ETIOLOGY AND PATHOGENESIS CHRONIC -,VW
HEPATITIS B AND ITS TREATMENT]. LI
MINGZHAO, ZHAO LIFU. jiangsu journal of tcm.
2003;24(3):48 (chi).
3172- gera: 116584/di/ra
[THE THEORY OF COLLATERAL DISEASE AND
THE CLINIC OF HEPATIC FIBROSIS]. LIU WEIMIN,
YAO NAILI. acta chinese medicine and pharmacology.
2003;31(1):2 (chi).
3173- gera: 116621/di/ra
[PHARMACOLOGICAL RESEARCH OF EXTRACTS
OF NATIONAL HERB MATIJIN FOR D-GLAN, TAA
AND ANIT INDUCED CHEMICAL LIVER LESION OF
MICE]. QU LISHA ET AL. china journal of tcm and
pharmacy. 2003;18(2):84 (chi*).
3174- gera: 116638/di/ra
[INFLUENCE OF YI SHEN XI GAN HUA ZHI SOUP
gera 2011

ON BUA-TBA PATIENTS WITH ALCOHOLIC FATTY
LIVER]. DONG ZIQIANG,ZHAO YONGJUN,SHI
YUXIA. forum on tcm. 2003;18(2):20 (chi).
3175- gera: 116644/di/ra
[DISCUSSION ON THE RELATIONSHIP BETWEEN
THE DEGREE OF LIVER-BLOOD STASIS AND THE
PATHOLOGICAL STAGE OF FIBROSIS]. WANG
BAO-ZHEN, ET AL. chinese journal of traditional
medical science and technology. 2003;10(2):65 (chi*).
Objective : To explore initially the relationship between the
degree of liver - blood stasis and the pathological fibroc stage
in patients with chronic hepatitis B and liver fibrosis.Method
: 149 patients with chronic hepatitis B were chosen according
to pathology and serology diagnosis, and 135 patients were
accompany with liver fibrosis, the scores of the degree of
liver - blood stasis was counted according to clinical
symptoms and physical signs. Analyzing the relationship
between the degree of liver - blood stasis and the pathological
stage of fibrosis and serum fibrosis indexes. Result : There
existed significant difference between the degree of liver -
blood stasis and the pathological fibroc stage and the content
of HA P III P in serum. The histological fibroic stages
became severer with the progress of degree of liver - blood
stasis. Conclusion : Liver fibrosis is the fundamental
pathologic change
3176- gera: 116648/di/ra
[CLINICAL STUDY ON ASCITES DUE TO
CIRRHOSIS TREATED WITH JIANPIHUAYULISHUI
METHOD]. ZHANG PEI-QIN, ET AL. chinese journal of
traditional medical science and technology. 2003;10(2):74
(chi).
3177- gera: 116651/di/ra
[EFFECT OF EURYTOPICITY WAN'AIKANG ON
APOPTOPIC GENE EXPRESSION IN HUMAN
PRIMARY HEPATOMA CELLS]. MAO XIAO-LING,
ET AL. chinese journal of traditional medical science and
technology. 2003;10(2):81 (chi*).
3178- gera: 116654/di/ra
[EXPERIMENTAL STUDY ON THE
ANTIHEPATOCIRRHOSIS EFFECT OF GANPISHU
MIXTURE]. CHEN LI-XIA, ET AL. chinese journal of
traditional medical science and technology. 2003;10(2):86
(chi).
3179- gera: 116666/di/ra
[CLINICAL OBSERVATIONS ON 46 CASES WITH
CIRRHOSIS TREATED WITH HUOXUEXIAOZHENG
DECOCTION]. ZHU YAO-QUN, ET AL. chinese journal
of traditional medical science and technology.
2003;10(2):111 (chi).
3180- gera: 116679/di/ra
[CLINICAL OBSERVATION OF MANGANKANG
TREATING CHRONIC HEPATITIS B]. HU SHIPING.
hebei journal of tcm. 2003;25(3):167 (chi*).
3181- gera: 116703/di/ra
[CLINICAL OBSERVATION ON EFFECT OF JIANPI
XIAOJI ORAL LIQUID ( OBRA) IN TREATING 40
PATIENTS WITH HEPATOCARCINOMA STAGE 11-
III FOR SUPPLEMENTARY TREATMENT *]. HUANG
ZHI-FEN, LL HAN-ZHONG, SHI ZHI-YAN, ET AL.
chinese journal of integrated traditional and western
medicine. 2003;23(3):192 (chi*).
3182- gera: 116736/di/ra
195
[40 CASES OF TREATMENT OVER
HEPATOCIRRHOSIS ASCITES COMBINED WITH
TRADITIONAL CHINESE MEDICINE AND
WESTERN MEDICINE]. WU GUO-LI. jiangxi journal of
tcm. 2003;34(3):31 (chi).
3183- gera: 116742/di/ra
[CLINICAL CONTROLLED RESEARCH OF THE
TREATMENT OF SUPPORTING HEALTHY ENERGY
TO ELIMINATE EVILS AND CLEARING AWAY
HEAT AND TOXIC MATERIAL ON THE PRECORE
MUTATION IN PATIENTS WITH CHRONIC
HEPATITIS B]. YANG HONG-ZHI,WANG YONG-
ZE,DAI MIN,ET AL. chi j integrated traditional and
western medicine in intensive and critical care.
2003;10(2):74 (chi*).
3184- gera: 116868/di/ra
[THERAPEUTIC ANALYSIS ON TREATING VIRUS
HEPATITIS WITH MONGOLIAN DRUGS]. BU-REN-
DA-LAI, ET AL. chinese journal of ethnomedicine and
ethnopharmacy. 2003;4(2):90 (chi).
3185- gera: 116934/di/ra
[EFFECTS OF" QIANGGAN RUANJIAN
DECOCTION" ON LIVER FUNCTION, PORTAL
BLOOD FLOW AND FIBROSIS MARKERS IN
PATIENTS WITH LIVER CIRRHOSIS]. WANG XIAO-
SU LI YONG. shanghai journal of tcm. 2003;37(4):19
(chi*).
3186- gera: 116996/di/ra
[OBSERVATION OF HUAZHUO QINGGAN
DECOCTION ON THE TREATMENT OF FATTY
LIVER]. DUAN LIFENG. hebei journal of tcm.
2003;25(4):247 (chi*).
3187- gera: 117015/di/ra
[EXPRESSION OF BCL-2 AND BAX PROTEINS IN
RAT HEPATIC FIBROSIS MODEL AND THE ROLE
OF HUOXUE SHENSHI FANG]. LU LIANGWEI, CHEN
QUNWEI, CHAI WEIMIN ET AL. journal of zhejiang
college of tcm. 2003;27(2):51 (chi*).
3188- gera: 117017/di/ra
[EXPERIMENTAL STUDY ON MECHANISM OF
GANFUJIAN GRANULE INHIBITING
HEPATOCARCINOGENESIS INDUCED WITH
DIETHYLNITROSAMINE IN RATS]. QIAN YAN, FIN
YAN, LI YUAN, ET AL. journal of zhejiang college of
tcm. 2003;27(2):56 (chi*).
3189- gera: 117117/di/ra
[A SUMMARY ON 48 CASES OF CHRONIC
HEPATITIS B TREATED MAINLY BY HUOXUE
SHUGAN DECOCTION]. HE ZHIQIANG,TANG
YANENG. hunan journal of tcm. 2003;19(2):9 (chi*).
3190- gera: 117118/di/ra
[A SUMMARY ON 24 CASES OF ASCITES DUE TO
CIRRHOSIS TREATED BY YUGAN DECOCTION].
HE XIANGYU. hunan journal of tcm. 2003;19(2):11 (chi).
3191- gera: 117160/di/ra
[TREATMENT OF CHRONIC HEPATITIS B BY TCM
COMBINED WITH WESTERN MEDICINE : A
CLINICAL OBSERVATION OF 42 CASES]. DING
GUO-FENG, CHENG ZHEN-IAN, LIU MING. new
journal of tcm. 2003;35(4):38 (chi).
gera 2011

3192- gera: 117163/di/ra
[FLOWING CYTOLOGICAL ANALYSIS ON
PREVENTION AND TREATMENT OF
EXPERIMENTAL HYPERLIPEMIA FATTY LIVER
BY ZHIGANSU CAPSULE]. ZHANG YI-XIN, YANG
MU-XIANG. new journal of tcm. 2003;35(4):76 (chi).
3193- gera: 117165/di/ra
[CLINICAL EFFECT AND MECHANISM OF JIAWEI
LANDOUFENGZHU DECOCTION IN TREATING
HEPATIC CIRRHOSIS]. JIN GUILAN, ET AL. chinese
journal of information on tcm. 2003;10(3):9 (chi).
3194- gera: 117171/di/ra
[INTERVENTIONAL STUDY OF DECOCTION FOR
REMOVING BLOOD STASIS (XIAYUXUE TANG) ON
EXPERIMENTAL HEPATIC CIRRHOSIS AND LIPID
PEROXIDATION]. QIN DANPING, ET AL. chinese
journal of information on tcm. 2003;10(3):25 (chi*).
3195- gera: 117206/di/ra
[CLINICAL ANALYZE 40 CASES ON TREATMENT
OF LIPID LIVER BY DECOCTION TAOHECHENGQI
COMBINATION BOLUS BAOHE ]. LI
SHAOSONG,ZHANG YINGLI. helongjiang journal of
tcm. 2003;2:22 (chi).
3196- gera: 117220/di/ra
[OBSERVATION ON HISTOLOGICAL INFLUENCE
OF DANSHEN INJECTION TO ALCOHOLIC LIVER
INJURY OF GREAT GERBIL]. CHEN XIAONAN, ZHU
XI 9 HE JIAGAN, ET AL. zhejiang journal of tcm.
2003;38(4):172 (chi).
3197- gera: 117233/di/ra
[THE CLINICAL EXPERIENCE OF WEI
CHANGCHUN DOCTOR TREATING WITH LIVER
DISEASE]. PAN TAICHUAN. journal of tcm.
2003;104(1):46 (chi).
3198- gera: 117317/di/ra
[ANALYSIS OF 1010 ARTICLES ABOUT THE
CORRELATION OF BLOOD-STASIS SYNDROME
AND LIVER CANCER]. LIU QING, YUE XIAO-QIANG,
HOU FENG-GANG, ET AL. journal of shandong
university of tcm. 2003;27(2):92 (chi).
3199- gera: 117888/di/ra
[OBSERVATION OF FATTY LIVER TREATED BY
JIANGZHIMAIAN IN STANT DRINK ]. SUN
JIUGUANG, WU JIANFANG, YANG JU, ET AL. hebei
journal of tcm. 2003;25(7):494 (chi*).
3200- gera: 117911/di/ra
[EXPERIENCES IN TREATMENT OF CHRONIC
HEPATITIS B BY DIFFERENCE OF SYMPTOMS
AND SIGNS FROM PROFESSOR JIN SHI]. RUAN
GONGSHI ET AL. journal of tcm and chinese materia
medica of jilin. 2003;23(7):7 (chi).
3201- gera: 117912/di/ra
[CLINICAL RESEARCH ON ANTI - HEPATIC
FIBROSIS BY USING RUAN GANXIAOPI ORAL
LIQUIDE]. LI GUANGHUI. journal of tcm and chinese
materia medica of jilin. 2003;23(7):9 (chi).
3202- gera: 117996/di/ra
[EFFECTIVE OBSERVATION ON CHRONIC
HEPATITIS B TREATED BY HONGCHIQI
RUANGAN PREPARATION]. LIU JIANJUN. hunan
196
journal of tcm. 2003;19(4):6 (chi*).
3203- gera: 117997/di/ra
[SUMMARY ON 63 CASES OF CHRONIC HEPATITIS
B TREATED BY FIVE ESTER CAPSULES AND
QIANGGAN ORAL LIQUID]. YANG JUEMING,ET AL.
hunan journal of tcm. 2003;19(4):8 (chi*).
3204- gera: 117998/di/ra
[SUMMARY ON 52 CASES OF SCHISTOSOMIAL
CIRRHOSIS TREATED BY RUANGAN SANJIE
DECOCTION]. LU HUIHUI. hunan journal of tcm.
2003;19(4):10 (chi*).
3205- gera: 118047/di/ra
[A DISCUSSION ON THE CAUSE OF BABY' S
HEPATITIS SYNDROME WITH COMBINED TCM
AND WESTERN MEDICINE]. LU YAN ET AL. beijing
journal of tcm. 2003;22(4):58 (chi).
3206- gera: 118060/di/ra
[YINSHAO GRANULES FOR SYNDROME OF DAMP-
HEAT STAGNANCY SPLEEN IN CHRONIC
HEPATITIS B]. CHEN JIN-FANG,XIE RONG,ZHOU
XIAO-LING,ET AL. journal of fujian college of tcm.
2003;13(4):1 (chi*).
3207- gera: 118086/di/ra
[EFFECT OF THE COMBINATION USE OF
CURCUMIN AND AMILORIDE ON THE
PROLIFERATION OF RAT HEPATIC STELLATE
CELLS]. YANG WEIFENG, CHEN HOUCHANG, JIANG
YIPING. journal of beijing university of traditional
chinese medicine. 2003;26(3):53 (chi).
3208- gera: 118098/di/ra
[MANNITOL COMBINED FLUID INFUSION FOR
TREATING ACUTE VIRAL CHOLESTATIC
HEPATITIS*]. YANG SHANMAI, LIU SHUITENG, LI
LIXIONG. chinese journal of integrated traditional and
western medicine on liver diseases. 2003;13(4):205 (chi).
3209- gera: 118099/di/ra
[INHIBITORY EFFECT OF CHINESE HERBS XIAO
CHAI HU TANG, FU FANG HUANG QI AND BING
GAN LING ON TRANSCRIPTION OF HEPATITIS C
VIRUS STRUCTURAL GENES IN VITRO]. CHEN
QIAN, DOU JUN. chinese journal of integrated
traditional and western medicine on liver diseases.
2003;13(4):207 (chi).
3210- gera: 118100/di/ra
[EFFECTS OF SALIANIC-ACID B FOR CELLULAR
OXIDATION AND PCNA OF HEPATIC SETLLATE
CELLS IN RAT*]. CUI YUNHUA, WANG XIAOLING,
YAN ZHENGUO, ET AL. chinese journal of integrated
traditional and western medicine on liver diseases.
2003;13(4):210 (chi).
3211- gera: 118101/di/ra
[EFFECT OF HUGANYIN ON MORPHOLOGY OF
LIVER OF THE RATS FOLLOWING EXPOSURE TO
ETHANOL*]. TIAN CUISHI, BO AIHUA, LI
ZHONGPING, ET AL. chinese journal of integrated
traditional and western medicine on liver diseases.
2003;13(4):213 (chi).
3212- gera: 118102/di/ra
[INFLUENCE OF FUZHENG ANTI-CARCINOMA
PRESCRIPTION (FAP) ON PCNA EXPRESSION AND
gera 2011

AGNORS IN RATS WITH IMPLANTED HEPATOMA].
HAN KEQI, LING CHANGQUAN, HUANG CHUANJI, ET
AL. chinese journal of integrated traditional and western
medicine on liver diseases. 2003;13(4):215 (chi).
3213- gera: 118103/di/ra
[EFFECT OF HUANGQI INJECTION ON CONTENT
OF HYALURONIC ACID IN SERUM AND
HYDROXYPROLINE IN LIVER TISSUS OF
SCHISTOSOMIASIC LIVER FIBROSIS MICE].
HUANG MIN, BI JIN, FAN HONG, ET AL. chinese
journal of integrated traditional and western medicine on
liver diseases. 2003;13(4):217 (chi).
3214- gera: 118104/di/ra
[EFFECTS OF HUANGQI ON THE EXPRESSION OF
PBR IN LIVER OF SCHISTOSOMIASIS MICE WITH
LIVER FIBROSIS*]. CHEN SHENGDUO, LUO
JUNHUA, I YANG PEIMING, ET AL. chinese journal of
integrated traditional and western medicine on liver
diseases. 2003;13(4):219 (chi).
3215- gera: 118105/di/ra
[CLINICAL MEANING IN PREGNANT SERUM HBV-
DNA QUANTITATIVE DETERMINATION*]. YANG
HONG, ZHANG JIN, CUI DAN, ET AL. chinese journal of
integrated traditional and western medicine on liver
diseases. 2003;13(4):220 (chi).
3216- gera: 118106/di/ra
[CLINICAL SIGNIFICANCE OF DETECTION OF
BLOOD PROTEIN IN PATIENTS WITH
HEPATOCIRRHOSIS]. XU XUEQIN. chinese journal of
integrated traditional and western medicine on liver
diseases. 2003;13(4):225 (chi).
3217- gera: 118155/di/ra
[FIFTY CASES OF FATTY LIVER WITH SHUGAN
HUOXUE DECOCTION]. DU YING-HAN. shandong
journal of tcm. 2003;22(8):468 (chi).
3218- gera: 118237/di/ra
[DIAGNOSIS AND TREATMENT OF TYPE B VIRAL
HEPATITIS]. WU HANMIN. jiangsu journal of tcm.
2003;24(8):1 (chi).
3219- gera: 118240/di/ra
[CLINICAL INVESTIGATION ON TREATMENT OF
120 CASES OF CHRONIC HEPATITIS B WITH
"FUGAN NO. 1"]. WANG XINGTIAN, WANG
ZONGYING. jiangsu journal of tcm. 2003;24(8):12 (chi).
3220- gera: 118271/di/ra
[VARIATION OF FIBRONECTIN AND ITS
SIGNIFICANCE IN CHRONIC VIRUS HEPATITIS .].
CHEN YONG-PING, GAO TAO. modern journal of
integrated traditional chinese and western medicine .
2003;12(16):1692 (chi*).
3221- gera: 118285/di/ra
[CLINICAL RESEARCH ON CHRONIC HEPATITIS B
TREATED BY KURARINONE COMBINED WITH
ARABINOSY LADENOSINE MONOPHOSPHATE
(ARA-AMP)]. XIE BI-HONG. tianjin journal of tcm.
2003;20(4):36 (chi*).
3222- gera: 118425/di/ra
[CLINICAL OBSERVATIONS ON ANTI - FIBROSA
HEPATIS OF GANXIANRONG AND ITS
EXPERIMENT RESEARCH]. YANG SHI-ZHONG.
197
academic periodical of changchun college of tcm.
2003;19(3):68 (chi).
3223- gera: 118445/di/ra
[PROF. XU XINMEI'S EXPERIENCE ON THE
TREATMENT OF ASCITES DUE TO CIRRHOSIS].
KUANG WEI-HONG, YANG XIAO-JUN. new journal of
tcm. 2003;35(9):5 (chi*).
3224- gera: 118450/di/ra
[DIAGNOSIS AND TREATMENT OF HEPATIC
DISEASES]. HE REN. journal of zhejiang college of tcm.
2003;27(4):30 (chi).
3225- gera: 118451/di/ra
[STUDY ON RELATIONSHIP BETWEEN INSULIN
RESISTANCE AND SYNDROME DIFFERENTIATION
TYPING IN FATTY LIVER]. SHI JUNPING, W17NG
XINGUANG, LOU GUOQIANG ET AL. journal of
zhejiang college of tcm. 2003;27(4):32 (chi*).
3226- gera: 118479/di/ra
[AN EXPERIMENTAL STUDY ON THE
THERAPEUTIC EFFECTS OF GANFUKANG
GRANULE ON CHRONIC LIVER INJURY INDUCED
BY CC14 IN RATS ]. TAN FAJIN, YU RONG, WEI YON.
journal of traditional chinese medicine university of
hunan. 2003;23(4):13 (chi*).
3227- gera: 118484/di/ra
[METHODOLOGICAL EVALUATION OF CLINICAL
STUDY ON TRADITIONAL CHINESE MEDICINE
THERAPIES FOR PRIMARY LIVER CARCINOMA].
WANG XI, LIU QING, YUE XIAOQIANG, ET AL.
journal of traditional chinese medicine university of
hunan. 2003;23(4):50 (chi*).
3228- gera: 118491/di/ra
[CLEARING HEAT AND REMOVING DAMP,
STRENGTHENING SPLEEN AND DISSOLVING
PHLEGM FOR TREATING 18 CASES OBESE FATTY
LIVER ]. CAI HONG. fujian journal of tcm. 2003;34(4):10
(chi).
3229- gera: 118553/di/ra
[PROFESSOR LI DEXIN'S EXPERIENCE IN
TREATING ASCITES DUE TO LAVER CIRRHOSIS
THROUGH SPLEEN]. XIA YONG-LIANG. shanghai
journal of tcm. 2003;37(9):8 (chi*).
3230- gera: 118554/di/ra
[CLINICAL OBSERVATION OF "SHUGAN
JIANGZHI DECOCTION" IN TREATING FATTY
LAVER]. HUANG CHAO. shanghai journal of tcm.
2003;37(9):10 (chi*).
3231- gera: 118555/di/ra
[CLINICAL OBSERVATION OF "COMPOUND
DANSHEN PILL" IN TREATING SENILE FATTY
LAVER IN 60 PEI DAO-LING TANG SHENG-LONG.
shanghai journal of tcm. 2003;37(9):12 (chi*).
3232- gera: 118556/di/ra
[CLINICAL OBSERVATION OF
HEPATOLENTICULAR DEGENERATION TREATED
BY COMBINED CHINESE AND WESTERN
MEDICINE]. CAO LIANG LIU KANG-YONG ZHAO
LEI-LEI. shanghai journal of tcm. 2003;37(9):14 (chi*).
3233- gera: 118754/di/ra
gera 2011

[JIEDU HUOXUE DECOCTION IN THE
TREATMENT OF 34 CA OF POSTHEPATITIC
HYPERBILIRUBINEMIA]. LEI QISHAN. journal of
henan university of chinese medicine. 2003;18(107):56
(chi).
3234- gera: 118789/di/ra
[CONSTRUCTION OF EUKARYOTIC EXPRESSION
PLASMID ENCODING IFNA-8 AND HBV_S2S AND
ITS EXPRESSION IN EUKARYOTIC CELLS]. XU
CHENG, LIU ZHONGRONG, WANG SONG, ET AL.
chinese journal of integrated traditional and western
medicine on digestion. 2003;11(4):209 (chi*).
3235- gera: 118790/di/ra
[CLINICAL STUDY ON DAIHUANG ZHECHONG
PILL IN THE TREATMENT OF HEPATIC FIBROSIS].
PAN ZHIHENG, CHENG MUHUA, LI LIN, ET AL.
chinese journal of integrated traditional and western
medicine on digestion. 2003;11(4):212 (chi*).
3236- gera: 118791/di/ra
[CLINICAL OBSERVATION OF SPICA PRUNELLAE
AND NO. I ANTI-INFLAMMATION INJECTIONS IN
TREATING LATE PRIMARY LIVER CANCER BY I-
AVER ARTERIAL PERFUSION]. ZHANG HAI-BO
ZHOU RONG-YAO. shanghai journal of tcm.
2003;37(8):18 (chi*).
3237- gera: 118792/di/ra
[OBSERVATION OF CURATIVE EFFECT OF
FUFANG SANYE XIANGCHACAI TABLET ON
HEPATIC ABNORMALITY DUE TO CHRONIC
VIRUS B HEPATITIS ]. LI SHUPING LI QIANG.
guangxi journal of tcm. 2003;26(4):12 (chi).
3238- gera: 118793/di/ra
[IMMUNE EFFECT OF YAF AND HXF TO WISTAR
RAT HEPATICA]. LIANG SHANG-HUA, FANG ZHAO-
QIN, SHI XIAO-IAN ET AL. chinese journal of basic
medicine in tcm. 2003;9(8):10 (chi).
3239- gera: 118794/di/ra
[STUDY ON THE INVITRO MODEL OF HEPATIC
STELLATE CELL PROLIFERATION THE CAUSED
BY ACETALDEHYDE]. YE YONG-AN,TIAN DE-
LU,ZHU LING-QUN ET AL. chinese journal of basic
medicine in tcm. 2003;9(8):48 (chi).
3240- gera: 118795/di/ra
[CLINICAL EXPERIENCE OF PROFESSOR TIAN DE-
LU IN ALCOHOLIC HEPATOPATHY TREATING].
KIM YONG-HYUN,ZHANG HAO,TIAN DE-LU. chinese
journal of basic medicine in tcm. 2003;9(8):66 (chi*).
3241- gera: 118796/di/ra
[APPLICATION OF DIFFERENTIAL DIAGNOSIS
AND TREATMENT OF HEPATOCARCINOMA WITH
TRADITIONAL CHINESE MEDICINE COMBINED
WITH WESTERN MEDICINE ]. CUI YONGAN. jiangsu
journal of tcm. 2003;24(9):12 (chi).
3242- gera: 118797/di/ra
[CLINICAL STUDY ON TREATMENT OF 120 CASES
OF SEVERE ICTERIC HEPATITIS WITH
"TUIGAOHUNAG DECOCTION"]. WANG LUJUN,
ZHU YONGGEN, LI MIN, ET AL. jiangsu journal of tcm.
2003;24(9):15 (chi).
3243- gera: 118798/di/ra
198
[CLINICAL STUDY ON TREATMENT AND
PREVENTION OF ALCOHOLIC LIVER DISEASE
WITH "QINGGANHUOXUE PRESCRIPTION]. XU
YIBIN, JI GUANG. jiangsu journal of tcm. 2003;24(9):18
(chi).
3244- gera: 118799/di/ra
[ULTRASONIC OBSERVATION ON 300 CASES WITH
FATTY LIVER TREATED BY CHINESE HERBS OF
ZHIGAN XIAOWAN]. KONG YAN-MEI. journal of
tianjin university of tcm. 2003;22(3):24 (chi).
3245- gera: 118857/di/ra
CLINICAL AND HISTOLOGIC STUDY ON QIWEI
HUAXIAN DECOCTION AGAINST FIBROSIS FOR
THE PATIENT OF CHRONIC HEPATITIS B. TANG
JINMO, CHEN GUOLIANG. journal of tcm.
2003;44(7):514 (eng).
3246- gera: 118863/di/ra
STUDY ON CORRELATIVITY OF TCM PHLEGM
AND STASIS COEXISTENCE SYNDROME WITH
LIVER FIBROSIS IN THE PATIENT OF CHRONIC
VIRUS HEPATITIS. TAO CUILING, LI YAN, ZHAO
YANBO. journal of tcm. 2003;44(7):535 (eng*).
3247- gera: 118873/di/ra
[MY EXPERIENCE IN TREATING PATHOLOGICAL
CHANGES OF THE LIVER BY REINFORCING THE
SPLEEN]. HUANG YUANYUAN. zhejiang journal of
tcm. 2003;38(8):356 (chi).
3248- gera: 118876/di/ra
[STATUS QUO AND THINKING ON TREATING
FATTY LIVER WITH CHINESE TRADITIONAL
MEDICINE]. CAO JIANMEI, HU YIYANG. zhejiang
journal of tcm. 2003;38(8):363 (chi).
3249- gera: 119197/di/ra
[EFFECTS OF NEW ANTI-TUMOR FORMULARON
PROTECTING AGAINST SYNERGISTIC
HEPATOCARCINOGENESIS OF HEPATITIS B
VIRUS EXPRESSION AND AFLATOXIN B, AND
FREE RADICALS METABOLISM IN HBV LARGE
ENVELOPE TRANSGENIC ZHU MEI-JU, ZHANG
HONG, GAO SHUN-SHENG, ET AL. journal of laoning
college of tcm. 2003;5(3):263 (chi*).
3250- gera: 119310/di/ra
[CIRRHOTIC ASCITES TREATED BY APPLICATION
ON UMBILICUS WITH CHINESE DRUGS
ACCORDING TO DIFFERENTIATION SYMPTOM .].
CHEN SHUAI. journal of external therapy of tcm.
2003;12(4):21 (chi).
3251- gera: 119318/di/ra
[PROHIBITIVE EFFECT OF MARINE COMBINED
WITH COMPOUND SALVIA MILTIORRHIZA ON
HEPATIC FIBROSIS WITH CHRONIC HEPATITIS
B]. LI CAI-XIA,FENG YI-NONG,BI YONG. shanxi
journal of tcm. 2003;19(4):8 (chi*).
3252- gera: 119322/di/ra
[EFFECT OF COMBINED TCM AND WM ON
JAUNDICE WITH CHRONIC HEPATITIS, A REPORT
OF 42 CASES]. HA LI-YANG,LIU YU-IING. shanxi
journal of tcm. 2003;19(4):24 (chi*).
3253- gera: 119326/di/ra
[EFFECT OF XIAOCHAIHU DECOCTION W)RK) ON
gera 2011

THE IMMUNE FUNCTION OF EXPERIMENTAL
HEPATIC IN MICE]. WANG WEN-JIE,WANG JI. shanxi
journal of tcm. 2003;19(4):47 (chi*).
3254- gera: 119341/di/ra
[TREATMENT OF CHRONIC HEPATITIS B WITH
CAIHU YIN IN 193 CASES]. LI CHANG-QIN ET AL.
journal of traditional chinese medicine and chinese
materia medica of jilin. 2003;23(8):12 (chi).
3255- gera: 119344/di/ra
[TREATMENT OF CHRONIC HEPATITIS B BY
COMBINED METHOD OF WESTERN AND CHINESE
MEDICINE IN 109 CASES]. CHEN YAN. journal of
traditional chinese medicine and chinese materia medica
of jilin. 2003;23(8):32 (chi).
3256- gera: 119369/di/ra
[EFFECT OF N-ACETYLCYSTEIN ON SERUM
SOLUBLE INTERCELLULAR ADHESION
MOLECULE-1 IN PATIENTS WITH FULMINANT
HEPATIC FAILURE]. PAN HONGYING, YU XIULI,
LOU GUOQIANG, ET AL. chinese journal of integrated
traditional and western medicine on liver diseases.
2003;13(4):196 (chi).
3257- gera: 119370/di/ra
[SEN VIRUS INFECTION DURING PLASMA
EXCHANGE ON CHRONIC HEPATITIS GRAVIS*].
XU DONG, TIAN DEYING, GUO WEI, ET AL. chinese
journal of integrated traditional and western medicine on
liver diseases. 2003;13(4):198 (chi).
3258- gera: 119371/di/ra
[ACUPOINT-INJECTION WITH BLENDING BLOOD
AND ANTI-HB-IRNA IN TREATMENT OF CHRONIC
HEPATITIS B- AN OBSERVATION ON 54 CASES]. LI
YE, WANG XINHUA, LU MEISHENG, ET AL. chinese
journal of integrated traditional and western medicine on
liver diseases. 2003;13(4):200 (chi*).
3259- gera: 119372/di/ra
[EXPRESSION OF TYPE I COLLAGEN AND PDGF-1
MRNA AND TYPE I , TV COLLAGEN PROTEINS IN
THE PATIENTS WITH GRIEVOUS VIRAL
HEPATITIS*]. HUANG YUANCHENG, ZHANG ZHIAN,
SHI SHUXIAN, ET AL. chinese journal of integrated
traditional and western medicine on liver diseases.
2003;13(4):202 (chi).
3260- gera: 119405/di/ra
[CLINICAL OBSERVATION ON TREATMENT OF
CHRONIC HEPATITIS B WITH INJECTION OF
MATRINI AND IFNA- 1B ]. DENG CHU-SHU, LUO LI,
ZHU CHENG-QUAN, ET AL. journal of anhui traditional
chinese medical college. 2003;22(4):8 (chi*).
3261- gera: 119409/di/ra
[EXPERIMENTAL STUDY ON TREATMENT OF
HYPERLIPIDEMIC FATTY HEPATITIS WITH
FORMULA OF BLOOD ACTIVATING AND
PHLEGM- AND DAMPNESS- RELIEVING]. GAO HUI,
ZHOU DA-QIAO, XIONG YI-QUN, ET AL. journal of
anhui traditional chinese medical college. 2003;22(4):26
(chi*).
3262- gera: 119415/di/ra
[EFFECT OF MELITTIN ON APOPTOSIS OF
HEPATOCARCINOMA CELL LINE BEL-7402].
ZHANG CHEN, WAN XU-YING, LI BAI, ET AL. journal
199
of anhui traditional chinese medical college. 2003;22(4):44
(chi*).
3263- gera: 119416/di/ra
[EFFECT OF YIGAN GRANULE ON LIVER
FUNCTION IN MICE WITH ACUTE LIVER INJURY].
QI LA-MEI, ZHU QING-FENG. journal of anhui
traditional chinese medical college. 2003;22(4):46 (chi*).
3264- gera: 119458/di/ra
[JIANPI JIANGNI XIAOPI FANG FOR TOXIC AND
SIDE EFFECTS OF DIGESTIVE TRACT AFTER
CHEMOTHERAPY BY HEPATIC ARTERY
EMBOLISM: A CLINICAL OBSERVATION OF 32
CASES]. HE SONG-QI, WEN BIN, ZHENG HANG. new
journal of tcm. 2003;35(9):22 (chi).
3265- gera: 119459/di/ra
[THE INFLUENCE OF NORCANTHARIDIN AND
KANGLAITE ON LIVER FUNCTION AFTER
HEPATIC ARTERY CHEMOTHERAPY EMBOLISM
IN CASES OF LIVER CANCER]. WANG JING-QUAN,
CUI SHI-CHANG, WANG HAI-YAN,. new journal of tcm.
2003;35(9):24 (chi).
3266- gera: 119542/di/ra
[THE EFFECT OF QU SHI RUAN GAN FANG ON
THE EXPRESSION OF TGF-B1 IN LIVER FIBROSIS
IN RATS]. CUI DAJIANG ET AL. journal of guiyang
college of tcm. 2003;25(3):58 (chi).
3267- gera: 119549/di/ra
[EXPERIMENTAL STUDY ON GANLING GRANULE
RESTRAIN ON HEPATIC DAMAGE AND EFFECT
IMMUNE FUNCTION IN ANIMAL]. HUANG
CHAOYANG, ET AL. chinese journal of information on
tcm. 2003;10(9):19 (chi*).
3268- gera: 119550/di/ra
[THE EFFECT OF KANGXIAN RUANGAN GRANULE
ON THE SELF-SECRETION OF TRANSFORMING
GROWTH FACTOR B1 OF HEPATIC STELLATE
CELLS ]. ZHOU ZHENG, ET AL. chinese journal of
information on tcm. 2003;10(9):21 (chi*).
3269- gera: 119576/di/ra
[PROTECTIVE EFFECT OF SWERTIA PUNICEA
HMSL. ON CHRONIC HEPATIC INJURY]. PENG
FANG,FANG CHUNSHENG,LIU XIAOBO, ET AL.
traditional chinese drug research and clinical
pharmacology. 2003;14(5):304 (chi*).
3270- gera: 119579/di/ra
[THE EFFECT OF ZHIGANQING GRANULE ON
RATS' VARIOUS FATTY LIVER MODELS ]. SUN
RONG, ZHAO ZHIYUAN, WANG PING, ET AL.
traditional chinese drug research and clinical
pharmacology. 2003;14(5):313 (chi*).
3271- gera: 119596/di/ra
[NEW EXPLORATION ON BASIS OF TREATING
SEVERE HEPATITIS WITH METHOD OF COOLING
BLOOD TO REMOVE BLOOD STASIS]. CHEN
WEIPING. china journal of tcm and pharmacy.
2003;18(9):543 (chi).
3272- gera: 119638/di/ra
[EFFECTS OF SHEHUANGGAO APPLIED TO
UMBILLICAL REGION ON THE HEMODYNAMICS
AND CHANGES OF NO LEVEL IN PATIENTS WITH
gera 2011

REFRACTORY ASCITES DUE TO CIRRHOSIS].
TONG GUANG-DONG, ET AL. chinese journal of
traditional medical science and technology.
2003;10(5):259 (chi*).
3273- gera: 119642/di/ra
[EXPERIMENTAL STUDY ON MICE WITH IMMUNE
HEPATIC INJURY TREATED WITH YIGAN
CAPSULE 303]. TANG MING-ZHENG, ET AL. chinese
journal of traditional medical science and technology.
2003;10(5):269 (chi).
3274- gera: 119728/di/ra
[EFFECTS OF JIANPI HUOXUE TONGLUO
CAPSULES ON IMMUNOREGULATORY FUNCTION
AND SERUM MARKERS IN THE PATIENT OF
HEPATOCIRRHOSIS]. ZHENG YU, MA HONGBIN,
YANG SHAOJUN, ET AL. journal of tcm. 2003;44(4):277
(chi).
3275- gera: 119732/di/ra
[EFFECTS OF ZHIGANTAI CAPSULES ON
APOPTOSIS OF HEPATIC CELLS AND EXPRESSION
OF RELATIVE GENE PROTEINS IN
HYPERLIPEMIC FATTY LIVER RATS]. ZHANG
YIXIN, YANG MUXIANG. journal of tcm. 2003;44(4):293
(chi).
3276- gera: 119734/di/ra
[EXPERIMENTAL STUDY ON XUEFU ZHUYU
DECOCTION AGAINST HEPATIC FIBROSIS
INDUCED BY SCHISTOSOME IN RATS]. ZHANG
XIAOPING, CHEN JIANMING, QIANG SHIPING. journal
of tcm. 2003;44(4):299 (chi).
3277- gera: 119755/di/ra
[EFFECT OF TRIPTERYGIUM WILFORDII HOOK F.
(TII) ON ACUTE REJECTION OF RAT OTHOTOPIC
LIVER TRANSPLANTATION]. DU JIAWEN, HUANG
LINPING, ZHOU LEI, ET AL. chinese journal of surgery
of integrated traditional chinese and western medicine.
2003;9(2):74 (chi*).
3278- gera: 119871/di/ra
[EXPERIMENTAL STUDY ON THE EFFECT OF
QINGGAN HUOXUE DECOCTION ON RESISTING
FATTY LIVER RATS]. WANG XIAOJUN,ZHANG
XIAOGANG,ZHANG XUEWEN,ET AL. chinese journal
of integrated traditional and western medicine on
digestion. 2003;11(2):70 (chi*).
3279- gera: 119874/di/ra
[EFFECT OF CHAIQINPINGWEI CAPSULE ON
GASTROINTESTINAL HORMONES OF BILE
REFLUX GASTRITIS]. YANG HONG, HOU JIAYU,
TIAN DELU, ET AL. chinese journal of integrated
traditional and western medicine on digestion.
2003;11(2):78 (chi*).
3280- gera: 119878/di/ra
[CLINICAL OBSERVATION ON THERAPEUTIC
EFFECT OF ADJUSTED BUYANG HUANWU
DECOCTION ON 59 CASES WITH FATTY LIVER].
WANG CHANGMING , SHI YONGFEN , WANG
DANHUA. chinese journal of integrated traditional and
western medicine on digestion. 2003;11(2):88 (chi*).
3281- gera: 119879/di/ra
[ENDOTHELIUM-DEPENDENT RELAXATION
EFFECT OF RHIZOMA ALISMATIS IN AORTIC
200
RINGS OF LIVER CIRRHOTIC RATS]. FENG ZHIJIE,
ZHAI JUNXIA,SUN YUFENG, ET AL. chinese journal of
integrated traditional and western medicine on digestion.
2003;11(2):90 (chi*).
3282- gera: 119880/di/ra
[EFFECT OF RUANGAN GRANULE ON DNA
CONTENT IN CELLULAR CYCLE OF THE
EXPERIMENTAL LIVER CIRRHOTIC
PROGRESSION]. ZHOU XIAOZHOU, HE JINSONG, XU
WENJUN, ET AL. chinese journal of integrated
traditional and western medicine on digestion.
2003;11(2):93 (chi).
3283- gera: 119881/di/ra
[EFFECT OF PREGNANCY ON SERUM LEVELS OF
CYTOKINE IN THE PATIENTS WITH CHRONIC
HEPATITIS B OF THE LIVER-QI STAGNANCY AND
SPLEEN-DEFICIENCY TYPE]. XU WEI, XU
CHENHUAI, CHEN JINRU, ET AL. chinese journal of
integrated traditional and western medicine on digestion.
2003;11(2):95 (chi*).
3284- gera: 119914/di/ra
[STUDY OF JIANGZHI BAOGAN PILL ON FATTY
LIVER]. MA RONG-HUA, HUANG DE-YOU. modern
journal of integrated traditional chinese and western
medicine . 2003;12(8):791 (chi*).
3285- gera: 119915/di/ra
[RESEARCH OF JIAWEI SINI PULVIS ON
DECREASING LIPID OF FATTY LIVER PATIENT].
PENG HAN-GUANG, WANG PING, AI CHANG-ZHENG,
ET AL. modern journal of integrated traditional chinese
and western medicine . 2003;12(8):793 (chi*).
3286- gera: 119926/di/ra
[CLINICAL EPIDEMIOLOGICAL INVESTIGATION
AND RESEARCH OF SYNDROME DISTRIBUTION
LAW IN CHINESE MEDICINE OF 2060 CASES OF
PRIMARY LIVER CARCINOMA]. LI YONGJIAN ET
AL. china journal of tcm and pharmacy. 2003;18(3):144
(chi).
3287- gera: 119944/di/ra
[EFFECT OF NEW QING GAN DECOCTION ON
LIVER HOMOGENATES NO AND INOS IN RATS
WITH ALCOHOL- INDUCED FATTY LIVER]. HU
GUOJIE, LI SHIFANG, LI DIANGUI, ET AL. zhejiang
journal journal of tcm. 2003;38(3):126 (chi).
3288- gera: 119984/di/ra
[STUDY OF TRADITIONAL CHINESE MEDICINE
COMBINED WITH INTERFERON AND HEPATITIS B
VACCINE ON CHRONIC HEPATITIS B]. ZHANG
LIAN-TAO. modern journal of integrated traditional
chinese and western medicine . 2003;12(9):908 (chi*).
3289- gera: 119985/di/ra
[SURGICAL TREATMENT FOR WILSON'S DISEASE
ACCOMPANIED BY HYPERSPLENIA.]. SHEN YU,
WANG HAN-MING. modern journal of integrated
traditional chinese and western medicine . 2003;12(9):910
(chi*).
3290- gera: 119989/di/ra
[RECENT ACQUAINTANCE WITH SEVERAL BASIC
DRUGS FOR HEPATOPATHY AND ITS
APPROPRIATE APPLICATION]. YE FANG, LU YUE.
modern journal of integrated traditional chinese and
gera 2011

western medicine . 2003;12(9):1001 (chi).
3291- gera: 120012/di/ra
[MULTI-ANALYSIS: CHARACTERISTICS OF
TRADITIONAL CHINESE MEDICAL SYNDROME OF
HEPATOCIRRHOSIS*]. ZHANG QIN, LIU PING, CHEN
HUIFEN, ET AL. chinese journal of integrated traditional
and western medicine on liver diseases. 2003;13(2):69
(chi*).
3292- gera: 120040/di/ra
[EXPERIMENTAL RESEARCHES OF THE EFFECTS
OF SHANXIAN GRANULE ON INVASION OF MOUSE
H22 LIVER CANCER INTO RENAL
CYTOMEMBRANE]. JI RUNLI, GONG YABIN. journal
of shaanxi college of tcm. 2003;26(3):41 (chi*).
3293- gera: 120056/di/ra
[TREATING CHRONIC HEPATITIS B COMBINED
WITH SCHISANDRA, FRUIT AND ASTRAGALUS
ROOT]. YANG JUE-MIN, QIAN YI-SHUN. jiangxi
journal of tcm. 2003;34(5):18 (chi).
3294- gera: 120129/di/ra
[THE CLINICAL OBSERVATION ON TREATMENT
FOR CHRONIC HEPATITIS B WITH THE
COMBINATION OF KURARINONE AND A
PRESCRIBE OF HUOXUE RUANGAN AND ITS
EFFECT FOR SERA OF HA AND TGFB1]. WANG
YUQUN , ET AL. beijing journal of tcm. 2003;22(2):3
(chi).
3295- gera: 120165/di/ra
[CLINICAL STUDY ON GANPISU MIXTURE TO
TREAT CIRRHOSIS .]. CHEN LI-XIA,WANG YU-
KUN,LIU WEI-MING,ET AL. shandong journal of tcm.
2003;22(5):268 (chi).
3296- gera: 120227/di/ra
[CHINESE HERBS IN THE TREATMENT OF 42
PATIENTS WITH ALCOHOLIC HEPATIC DISEASE].
QIAO ZUO-XIAN. henan tcm. 2003;23(3):18 (chi).
3297- gera: 120234/di/ra
[YUEJU PILL AS A CHIEF THERAPY FOR 59
PATIENTS WITH FATTY LIVER]. LEI QI-SHAN.
henan tcm. 2003;23(3):55 (chi).
3298- gera: 120249/di/ra
[CLINICAL STUDY OF INJECTING DEHYDRATED
ALCOHOL BY TRANSCUTANEOUS INTRASPLEEN
IN TREATMENT OF LIVER CIRRHOSIS WITH
HYPERSPLENISM*]. CAI SHANGYUAN, FU MIN,
WANG XINGUO, ET AL. chinese journal of integrated
traditional and western medicine on liver diseases.
2003;13(2):73 (chi*).
3299- gera: 120250/di/ra
[CLINICAL STUDY OF GANTAI PILL ON TREATING
CHRONIC HEPATITIS B*]. GUO XINGLIN, XU JINBO,
YAN ZHANGREN, ET AL. chinese journal of integrated
traditional and western medicine on liver diseases.
2003;13(2):76 (chi*).
3300- gera: 120251/di/ra
[EFFECT OF HAIZHU YIGAN CAPSULE ON SERUM
TNF-A AND SIL-2R OF PATIENTS WITH CHRONIC
HEPATITIS B*]. GONG YUQING, SHENG
GUOGUANG, CHEN YUE. chinese journal of integrated
traditional and western medicine on liver diseases.
201
2003;13(2):79 (chi*).
3301- gera: 120252/di/ra
[CLINICAL STUDY ON TREATMENT OF ACTIVE
LIVER CIRRHOSIS WITH JIANGGANLONG AND
LAMIVUDINE*]. WEN RUI, WANG JIAN, YAN MING.
chinese journal of integrated traditional and western
medicine on liver diseases. 2003;13(2):81 (chi*).
3302- gera: 120253/di/ra
[STUDY ON RISK FACTORS OF NOSOCOMIAL
INFECTION IN PATIENTS WITH CHRONIC
HEPATITIS B*]. GUO JINWEI. chinese journal of
integrated traditional and western medicine on liver
diseases. 2003;13(2):84 (chi*).
3303- gera: 120254/di/ra
[STUDY OF HUMAN SINGLE CHAIN FV ANTIBODY
AGAINST HEPATITIS C VIRUS NS5A ANTIGEN AND
ITS APPLICATION IN INIMUNOHISTOCHEMISTRY
*]. ZHONG YANWEI, CHENG JUN, JIAO CHENGSONG,
ET AL. chinese journal of integrated traditional and
western medicine on liver diseases. 2003;13(2):89 (chi*).
3304- gera: 120255/di/ra
[DEVELOPMENT OF CELLULAR MODEL OF RAT
HSC ACTIVATION STIMULATED BY LPS*]. WANG
JIAN, NIU JIANZHAO, FIE FUJING, ET AL. chinese
journal of integrated traditional and western medicine on
liver diseases. 2003;13(2):92 (chi*).
3305- gera: 120257/di/ra
[EFFECTS OF DRUG SERA FROM LIVER FIBROSIS
RATS ON PROLIFERATION OF HEPATIC
STELLATE CELLS AND ACTIVE TYPE TGFB1
CONTENT*]. WANG HAINAN, LIU PING, WANG
BAOZHEN, ETAL. chinese journal of integrated
traditional and western medicine on liver diseases.
2003;13(2):98 (chi*).
3306- gera: 120259/di/ra
[CORRELATION BETWEEN FIBRINOGEN AND
VARIABLE GENE MARKER OF HCV*]. WU
ZHENJUN, LI BEI, YU QI. chinese journal of integrated
traditional and western medicine on liver diseases.
2003;13(2):104 (chi*).
3307- gera: 120260/di/ra
[CLINICAL SIGNIFICANCE OF GRANULOCYTE -
MACROPHAGE COLONY - STIMULATING FACTOR
IN CHRONIC HEPATITIS B *]. CHEN YAN, JIAO
ZHIYONG, TIAN DEYINH. chinese journal of integrated
traditional and western medicine on liver diseases.
2003;13(2):105 (chi*).
3308- gera: 120288/di/ra
[PROGRESS IN RESEARCH INTO INCREASING THE
LATE RESULT OF CHINESE MEDICINE ON
PRIMARY CARCINOMA OF LIVER]. WEI AILING
TANG JIAN. guangxi journal of tcm. 2003;26(2):10 (chi).
3309- gera: 120305/di/ra
[CLINICAL OBSERVATION ON SEVERE -
HEPATITIS PREPARATION RETAINED INTO
INTESTINE FOR SEVERE HEPATITIS]. ZENG
YUEXIANG, TAN LANXIANG, CHENG XIAOMING, ET
AL. journal of emergency in tcm. 2003;12(2):123 (chi).
3310- gera: 120330/di/ra
[ADVANCEMENT IN RESEARCH ON TREATMENT
gera 2011

OF FATTY LIVER]. CHEN JIA. jiangsu journal of tcm.
2003;24(4):58 (chi).
3311- gera: 120350/di/ra
[HUOZHI TANG ON TREATMENT OF 49 CASES OF
CHRONIC HEPATITIS B WITH STAGNATION OF
THE LIVER-QI AND DEFICIENCY OF THE SPLEEN].
LIN LI, RUAN QING-FA, YE MO-YUAN. fujian journal
of tcm. 2003;34(2):10 (chi).
3312- gera: 120377/di/ra
[SUGGESTIONS ABOUT THE STANDARD-, OF
CHINESE MEDICAL SYNDROME
DIFFERENTIATION FOR PRIMARY LIVER
CANCER]. FANG ZHAO-QIN TANG CHEN-LONG LI
YONG-JIAN,ET AL. shanghai journal of tcm.
2003;37(5):11 (chi*).
3313- gera: 120379/di/ra
[CLINICAL OBSERVATION OF HEPATITIS AND
LIVER CIRRHOSIS TREATED BY HD HEPATIC
EQUIPMENT]. QI PEI-HONG CHI XIAO-LING JIANG
JUN-MIN, ET AL. shanghai journal of tcm. 2003;37(5):17
(chi*).
3314- gera: 120380/di/ra
[CLINICAL STUDY ON CHRONIC HEPATITIS C
TREATED BY " LIVER- CLEARING GRANULE]. SUN
XUE-HUA GAO YUE-QIU WANG LING-TAI, ET AL.
shanghai journal of tcm. 2003;37(5):20 (chi*).
3315- gera: 120381/di/ra
[CLINICAL OBSERVATION OF "LIPID-REDUCING
POWDER" FOR FATTY LIVER IN 56 CASES].
HUANG GUO-YI ZHUO YUN-HUI. shanghai journal of
tcm. 2003;37(5):23 (chi*).
3316- gera: 120382/di/ra
[TREATMENT OF LIVER CIRRHOSIS
COMPLICATED WITH CHRONIC RENAL FAILURE
BY CHINESE MEDICINE: A REPORT OF ONE
CASE]. XU ZHAO-RONG CHEN JUN-HANG YANG
XIAN-HONG. shanghai journal of tcm. 2003;37(5):25
(chi*).
3317- gera: 120521/di/ra
[ADVANCEMENT IN EXPERIMENTAL RESEARCH
ON ANTI - FIBROSIS EFFECT OF CHINESE DRUGS].
YAN JILI, ZHOU MIN. jiangsu journal of tcm.
2003;24(5):58 (chi).
3318- gera: 120535/di/ra
[SUMMARY ON 24 CASES OF VIRUS HEPATITIS
TREATED BY CHIDAN TUIHUANG GRANULAE].
WU YUHUA, ET AL. hunan journal of tcm. 2003;19(3):2
(chi*).
3319- gera: 120540/di/ra
[SUMMARY ON 60 CASES OF FATTY LIVER
TREATED WITH THE THERAPY OF RESOLVING
PHLEGM, SOOTHING THE LIVER AND
PROMOTING BLOOD CIRCULATION]. LIAO HUI.
hunan journal of tcm. 2003;19(3):9 (chi).
3320- gera: 120610/di/ra
[CLINICAL OBSERVATION OF THE HEPATIC
FIBROSIS OF HEPATITIS B TREATED BY
RUANGAN XIAOZHENG CAPSULE]. YANG FUTAI,
ET AL. chinese journal of information on tcm.
2003;10(5):10 (chi*).
202
3321- gera: 120611/di/ra
[THE RELATIONSHIP BETWEEN OXYMATRINE
INJECTION ON CHRONIC HEPATITIS B AND TCM
TYPE OF SYNDROMES]. WANG BANGCAI, ET AL.
chinese journal of information on tcm. 2003;10(5):12
(chi*).
3322- gera: 120617/di/ra
[DEVELOPMENT OBSERVATION OF
JIHUANGTANG ON RATS WITH LABORATORY
ACUTE HEPATIC FAILURE]. ZHANG JIANJUN, ET
AL. chinese journal of information on tcm. 2003;10(5):24
(chi*).
3323- gera: 120638/di/ra
[CLINICAL STUDY ON TREATMENT OF 60 CASES
OF CHRONIC HEPATITIS B BY COMPOUND
HUANGQI GRANULES]. LI JUN, YI MAO, ZHANG
MIN, ET AL. journal of tcm. 2003;44(5):358 (chi).
3324- gera: 120641/di/ra
[STUDY ON CORRELATIVITY OF TCM SYNDROME
TYPES WITH DISTRIBUTION WIDTH AND MEAN
SIZE OF RED BLOOD CELLS IN THE PATIENT OF
CHRONIC HEPATITIS B]. CUI HUAFU, ZHU
MINGJUAN. journal of tcm. 2003;44(5):370 (chi).
3325- gera: 120643/di/ra
[CONTROL STUDY ON PROTECTIVE ACTION OF
YIQI RUANGAN DECOCTION AND HEPATIC
STIMULATING FACTOR ON IMMUNE HEPATIC
FIBROSIS IN RATS]. DUAN ZHIJUN, LI JIYAN, TAN
CHEN, ET AL. journal of tcm. 2003;44(5):374 (chi*).
3326- gera: 120706/di/ra
COMBINACION DE LA TONIFICACION Y LA
DISPERSION EN EL TRATAMIENTO DE¡ HIGADO
GRASO. X. journal of tcm- el puso de la vida. 2003;35:3
(esp*).
3327- gera: 120760/di/ra
[RELATION BETWEEN PATHOGENESIS OF
TRADITIONAL CHINESE MEDICINE AND
HEPATITIS B VIRUS - DNA OR T LYMPHOCYTES
IN CHRONIC HEPATITIS B]. YANG HONG-ZHI, BIAN
ZHUANG, WANG YONG-ZE, ET A. chi j integrated
traditional and western medicine in intensive and critical
care. 2003;10(3):158 (chi*).
3328- gera: 120817/di/ra
[EFFECT OF RUANGAN INFUSION ON P 21MRNA
EXPRESSION OF RAT 18 EXPERIMENTAL
HEPATIC DAMAGE INDUCED BY CC14 . ]. ZHOU
XIAO-ZHOU, ET AL. chinese journal of traditional
medical science and technology. 2003;10(3):138 (chi*).
3329- gera: 120837/di/ra
[EFFECT OF PUERARIA FLAVONE ON LIVER LIPID
METABOLISM IN OVARIECTOMIZED RATS]. JIN
HUAN ET AL. china journal of tcm and pharmacy.
2003;18(4):201 (chi*).
3330- gera: 120843/di/ra
[5 EFFICACIOUS CASES OF SYNDROME
DIFFERENTIATION AND TREATMENT
ACCORDING TO ZANGFU FOR VIRAL HEPATITIS].
TAO XIAPING ET AL. china journal of tcm and
pharmacy. 2003;18(4):222 (chi).
gera 2011

3331- gera: 120891/di/ra
[EFFECT AND MECHANISM OF ARALIA
CHINENSIS L. IN THE TREATMENT OF HEPATIC
FIBROSIS IN RATS]. CUI DAJIANG, NIE DANLI, ZHI
MIN, ET AL. chinese journal of integrated traditional and
western medicine on digestion. 2003;11(3):136 (chi*).
3332- gera: 120892/di/ra
[CHANGES OF G CELLS AND D CELLS IN
PATIENTS WITH CHRONIC GASTROPATHY OF
SPLEEN ASTHENIA TYPE AND ITS SIGNIFICANCE].
SONG YUGANG, YAO YONGLI, LIU LIMIN, ET AL.
chinese journal of integrated traditional and western
medicine on digestion. 2003;11(3):138 (chi*).
3333- gera: 120896/di/ra
[EFFECT OF CHINESE MEDICINE ON HEPATIC
FUNCTIONAL RESERVE AFTER
INTERVENTIONAL THERAPY IN PATIENTS WITH
HEPATIC CANCER]. HUANG GUOXIAN, ZHANG BEI,
ZHANG YAQI, ET AL. chinese journal of integrated
traditional and western medicine on digestion.
2003;11(3):149 (chi*).
3334- gera: 120897/di/ra
[ASSESSMENT OF THERAPEUTIC BENEFIT OF YB-
ZG LIVER DISEASE THERAPY INSTRUMENT IN
THE TREATMENT OF FATTY LIVER]. ZHANG
JUNCHANG, XIA JINYU, CHENG LIANGBING, ET AL.
chinese journal of integrated traditional and western
medicine on digestion. 2003;11(3):151 (chi*).
3335- gera: 120946/di/ra
[ADVANCES OF STUDY ON TCM TREATMENT OF
PRIMARY HEPATIC CARCINOMA]. LI DONGTAO.
journal of tcm. 2003;44(6):470 (chi).
3336- gera: 120964/di/ra
[SERAPHARMACOLOGICAL EFFECT OF
KANGXIAN RUANGAN GRANULE ON THE SELF-
SECRETION AND THE GENE EXPRESSION OF
TRANSFORMING GROWTH FACTOR BETA-1 OF
HEPATIC STELLATE CELLS]. ZHOU ZHENG, LIU
LIPING, ZHANG CHIZHI, ET AL. chinese journal of
integrated traditional and western medicine on digestion.
2003;11(3):157 (chi*).
3337- gera: 121008/di/ra
[THE EFFECT OF PHYLANTHUS EMBLICA ON
ACUTE LIVER INJURY IN MICE CAUSED BY D -
GALACTOSAMINE]. LI PING, ET AL. chinese journal
of ethnomedicine and ethnopharmacy. 2003;6(3):161 (chi).
3338- gera: 121040/di/ra
[EXPLORATION ON THE THINKING OF TCM
TREATMENT FOR CHRONIC HEPATITIS B]. XUE JI,
CAO YI-RONG, LIU LI-MIN. new journal of tcm.
2003;35(6):8 (chi*).
3339- gera: 121048/di/ra
[AN EXPERIMENTAL STUDY OF IN - VIVO EFFECT
OF MATRINE LIPOSOME FOR DUCK HEPATITIS B
VIRUS]. LI CHANG-QING, ZHANG DONG-QING, LL
XIAO-HUI,. new journal of tcm. 2003;35(6):77 (chi).
3340- gera: 121053/di/ra
[SEROPHARMACOLOGICAL EFFECT OF
KANGXIAN RUANGAN GRANULE ON COLLAGEN -
DEGRADATION RELATED GENE EXPRESSION IN
HEPATIC ASTROCYTES]. ZHOU ZHENG, CHEN JIE ,
203
ZHANG CHIZHI , ET AL. traditional chinese drug
research and clinical pharmacology. 2003;14(3):158
(chi*).
3341- gera: 121065/di/ra
[CLINICAL OBSERVATION ON BEIJIA RUANGAN
PILL FOR LIVER FIBROSIS IN HEPATITIS B]. WU
XIUMEI, ZENG CHANGCHUN. traditional chinese drug
research and clinical pharmacology. 2003;14(3):203
(chi*).
3342- gera: 121085/di/ra
[EFFECT OF KINETOGENIC CHINESE HERB ON
ENDOTOXIN TNF-A IN PLASMA OF PATIENTS
WITH CIRRHOSIS]. ZHU JIN-ZHAO, ZHANG JIE,
ZHANG ZHI-JIAN. modern journal of integrated
traditional chinese and western medicine.
2003;12(11):1127 (chi*).
3343- gera: 121103/di/ra
[UNDERSTANDING OF APPLYING LV
CHENGQUAN' S PRESCRIPTION TO TREAT
TYMPANITES CAUSED BY BLOOD - STASIS ].
ZHANG LINQI. china journal of tcm and pharmacy.
2003;18(5):297 (chi).
3344- gera: 121107/di/ra
[DISCUSS ON MEDICINAL FORMULA AND
CLINICAL SIGNIFICANCE OF TREATMENT OF
THE LIVER BY ZHANG ZHONGJING]. HE SAIPING.
china journal of tcm and pharmacy. 2003;18(5):304 (chi).
3345- gera: 121128/di/ra
[PROTECTIVE EFFECT OF YUGAN TABLET-ON
ACUTE AND CHRONIC HEPATIC INJURY IN RATS].
LIU LI-CHANG , ZHANG LEI. chinese journal of basic
medicine in tcm. 2003;9(4):46 (chi).
3346- gera: 121163/di/ra
[THE EXPERIMENTAL RESEARCH ON THE
KUPFFER CELL FUNCTION IN LIVER BY
ACUPUNCTURING "ZUSANLI" AND "GUANYUAN"
OF OLD RATS ...]. ZHU MEI,GAO HONG-QUAN,LIU
RUI-FENG,ET AL. journal of clinical acupuncture and
moxibustion. 2003;19(6):52 (chi*).
3347- gera: 121326/di/ra
[CHINESE-WESTERN-COMBINED THERAPY FOR
46 PATIENTS WITH ASCITES DUE TO CIRRHOSIS].
HOU-SHU-ZHI. henan tcm . 2003;23(5):41 (chi).
3348- gera: 121331/di/ra
[BRIEFING ON THE STUDY OF CHINESE
MEDICINE IN INHIBITING HEPATITIS B VIRUS].
JIANG FENG, GAO SHUI-BO. henan tcm . 2003;23(5):66
(chi*).
3349- gera: 121338/di/ra
[ZHANG ZHENRU EXPERIENCE OF TREATING
LIVER DISEASE .]. ZENG HAO, ET AL. hubei journal
of tcm. 2003;25(5):16 (chi).
3350- gera: 121344/di/ra
[VIRUS HEPATITIS TREATED WITH ANALYSING
AND DIFFERENTIATING THE DEVELOPMENT OF
AN EPIDEMIC FEBRILE BY STUDYING CONDITION
OF THE FOUR SYSTEMS]. YANG YUEYAN. forum on
tcm. 2003;18(3):16 (chi).
3351- gera: 121353/di/ra
gera 2011

[CLINICAL STUDY ON YUYING JIANGMEI
DECOCTION TO TREAT HYPERTHYROID
HEPATIC INJURY]. QIAN QIU-HAI , XIN YAN ,
HUANG DONG-HUI. journal of shandong university of
tcm. 2003;27(3):181 (chi).
3352- gera: 121391/di/ra
[CLINICAL SIGNIFICANCE OF HAPTOGLOBIN
DETERMINED OF PATIENT WITH PRIMARY
HEPATIC CANCER AND HEPATIC CIRRHOSIS]. XIE
YU, ZHANG ZHI-LAN. modern journal of integrated
traditional chinese and western medicine.
2003;12(12):1237 (chi*).
3353- gera: 121393/di/ra
[THERAPEUTIC EFFICACY OF COMBINED
APPLICATION OF LAMIVUDINE AND BUSHEN
RECIPE IN TREATING CHRONIC HEPATITIS B
AND ITS INFLUENCE ON YMDD MOTIF *]. ZHOU
FEI, WANG LING-TAI, CHEN JIAN-JIE, ET AL. chinese
journal of integrated traditional and western medicine.
2003;23(6):417 (chi*).
3354- gera: 121410/di/ra
[STUDY OF XIAOYAO TABLET ON
HEPATOPROTECTIVE ACTION]. HUANG LI JIN
RUO-MIN ET AL. chinese traditional patent medicine.
2003;25(6):473 (chi*).
3355- gera: 121415/di/ra
[EVALUATION ON CLINICAL STAGES OF
WESTERN MEDICINE AND SYNDROME
DIFFERENTIATION OF CHINESE MEDICINE IN
PRIMARY LIVER CANCER]. WANG RONG-PING,
WANG YING. journal of fujian college of tcm.
2003;13(3):1 (chi*).
3356- gera: 121416/di/ra
[CLINICAL STUDY OF DANSHEN INJECTION
COMBINED WITH DAHUANG ZHICHONG PILL
FOR CHRONIC HEPATIC FIBROSIS]. ZHANG SHUI-
YUAN,ZHANG TING-TING. journal of fujian college of
tcm. 2003;13(3):3 (chi*).
3357- gera: 121438/di/ra
[WANG NING EXPERIENCE ON TREATMENT OF
CHRONIC HEPATITIS]. CHENG RONG-SHENG , WU
YUE-PING. shanxi journal of tcm. 2003;19(3):6 (chi*).
3358- gera: 121441/di/ra
[CLINICAL EF F ECT OF GANKANGLING
GRANULE (9F *Y,< ~~ P1 11 ) ON HEPATIC
FIBROSIS]. LUO HONG,NIE QING-HE , GAN XUE-
TING. shanxi journal of tcm. 2003;19(3):20 (chi*).
3359- gera: 121462/di/ra
[CLINICAL OBSERVATION ON CHRONIC VIRUS
HEPATITIS B TREATED BY KURARINONE IN
DIFFERENT SCHEME]. ZHENG WEIDONG, ET AL.
hubei journal of tcm. 2003;25(6):13 (chi).
3360- gera: 121477/di/ra
[MECHANISM AND DEVELOPMENT ON
PATHOGENEISIS OF FATTY LIVER]. RU YONG-XIN,
XU ZONG-PEI. journal of tianjin university of tcm.
2003;22(2):76 (chi).
3361- gera: 121505/di/ra
[SCREENING 20 CHINESE HERBS OFTEN USED
FOR CLEARING HEAT AND DISSIPATING TOXIN
204
WITH NUDE MICE MODEL OF HEPATITIS C VIRAL
INFECTION*]. TANG ZHI-MIN PENG MENG, ZHAN
CHUN-JIAO, ET AL. chinese journal of integrated
traditional and western medicine. 2003;23(6):447 (chi*).
3362- gera: 121569/di/ra
[RELATIONSHIP BETWEEN SYNDROME TYPES OF
TCM AND CD28 EXPRESSED BY T LYMPHOCYTE
IN PATIENTS WITH CHRONIC LIVER DISEASES*].
SHI WEI QUN, YANG JUNCHAO, MIAO XIMIN, ET AL.
chinese journal of integrated traditional and western
medicine on liver diseases. 2003;14(3):132 (chi*).
3363- gera: 121570/di/ra
[EFFECT OF TERLIPRESSIN ON PATIENTS WITH
CHRONIC SEVERE HEPATITIS ACCOMPANIED BY
HEPATORENAL SYNDROME* . ]. XING MINGYOU,
HUANG YUANCHENG, TIAN DEYING. chinese journal
of integrated traditional and western medicine on liver
diseases. 2003;14(3):134 (chi*).
3364- gera: 121571/di/ra
[DETECTION OF LAMIVUDINE-RESISTANT HBV
YMDD MUTANTS AND INVESTIGATION OF
FACTORS RELATED TO DEVELOPMENT OF HBV
YMDD MUTANTS* ]. LI CHUNMING, ZHANG
YUEXIN. chinese journal of integrated traditional and
western medicine on liver diseases. 2003;14(3):137 (chi*).
3365- gera: 121572/di/ra
[CLINICAL STUDY OF COMBINED TREATMENT
WITH KANG'S HEPATITIS B MIXTURE AND
INTERFERON ON CHRONIC HEPATITIS B* ].
ZHENG WEIDONG, MA XIAOJUN, WU JIANHUAN, ET
AL. chinese journal of integrated traditional and western
medicine on liver diseases. 2003;14(3):140 (chi*).
3366- gera: 121573/di/ra
[COMBINATION THERAPY OF ORDINARY
THERAPY AND YB-ZG LIVER DISEASE THERAPY
INSTRUMENT IN PATIENTS WITH LIVER
CIRRHOSIS*]. ZHANG JUNCHANG, XIA JINYU,
CHENG LIANGBING, ETAL. chinese journal of
integrated traditional and western medicine on liver
diseases. 2003;14(3):142 (chi*).
3367- gera: 121574/di/ra
[RELATIONSHIP AMONG SYNDROME TYPES OF
TCM AND SERUM IL-6, TNF-A IN REFRACTORY
CHRONIC HEPATITIS B WITH EXCESS OF
TRANSAMINASE*]. XIONG YIQUN, ZHOU DAQIAO,
LI ZHIQING, ET AL. chinese journal of integrated
traditional and western medicine on liver diseases.
2003;14(3):145 (chi*).
3368- gera: 121575/di/ra
[STUDIES ON DIFFERENTIATION AND APOPTOSIS
OF HUMAN HEPATOCARCINOMA CELLS
INDUCED BY ALL- TRANSRETINOIC ACID, 18B-
GLYCYRRHETINIC ACID AND GLYCYRRHIZIN*].
HUANG WEI, HUANG JIQUN, ZHANG DONGFANG,
ETAL. chinese journal of integrated traditional and
western medicine on liver diseases. 2003;14(3):148 (chi*).
3369- gera: 121576/di/ra
[EFFECTS OF ANTI-FIBROSIS COMPOUND
CONTAINED SERUM ON TYPE I AND IV
PROCOLLAGEN AND MATRIX
METALLOPROTEINASE GENE EXPRESSION OF
HSC-LI 90 CELLS*]. ZHU JUNFENG, ZHAO GANG,
gera 2011

WANG LINGTAI, ETAL. chinese journal of integrated
traditional and western medicine on liver diseases.
2003;14(3):151 (chi*).
3370- gera: 121577/di/ra
[EXPRESSION OF INSULIN-LIKE GROWTH
FACTOR 1 AND ITS INTERVENTION BY
INTERLEUKIN-10 IN EXPERIMENTAL HEPATIC
FIBROSIS* ]. JIANG XIANGRONG, CHEN ZHIXIN,
ZHANG LIJUAN, ET AL. chinese journal of integrated
traditional and western medicine on liver diseases.
2003;14(3):154 (chi*).
3371- gera: 121578/di/ra
[EFFECT OF ARALIA CHINENSIS L. ON
ALDOSTERONE OF RATS WITH HEPATIC
FIBROSIS*]. CUI DAJIANG, WANG ZHIYONG, NIE
DANLI-. chinese journal of integrated traditional and
western medicine on liver diseases. 2003;14(3):157 (chi*).
3372- gera: 121579/di/ra
[EXPERIMENTAL STUDY OF 919 SYRUP ANTI-
HEPATIC FIBROSIS IN RATS*]. HUANG JUN, WU
ZHELI , LIU AIHUA. chinese journal of integrated
traditional and western medicine on liver diseases.
2003;14(3):160 (chi*).
3373- gera: 121580/di/ra
[EFFECT OF KEXIAN CAPSULE ON HEPATOCYTES
APOPTOSIS INDUCED BY HEPATIC INJURY IN
RATS]. REN JIANPING, CHEN LIANG, YAN QIWEI.
chinese journal of integrated traditional and western
medicine on liver diseases. 2003;14(3):163 (chi).
3374- gera: 121721/di/ra
[STATISTICAL ANALYSIS OF EXPERT 'S IDEAS ON
PRIMARY CARCINOMA OF LIVER IN TCM
LITERATURE]. HOU FENG-GANG, LING CHANG-
QUAN. journal of yunnan college of tcm. 2003;26(2):6
(chi*).
3375- gera: 121728/di/ra
[PROFESSOR SU LIAN'S EXPERIENCE OF
TREATING CHRONIC VIRUS B HEPATITIS]. ZHANG
YU-FENG, CHEN TAO. journal of yunnan college of tcm.
2003;26(2):27 (chi).
3376- gera: 121759/di/ra
[CLINICAL STUDY ON CIRROHOSIS OF LIVER IN
DECOMPENSATION PHASE TREATED WITH
RUANGANLISHUI CAPSULE]. WANG CHANGHAI,
JIANG YONGPEI, LI JUNCHANG, ET AL. journal of
emergency in tcm. 2003;12(3):210 (chi*).
3377- gera: 121805/di/ra
[CLINICAL OBSERVATION ON GIANT KNOTWOOD
RHIZOME PIECE TO EARLY HEPATIC FIBROSIS
OF CHRONICITY ACTIVE HEPATITIS B: A REPORT
OF 112 CASES]. CHEN XIAO-LI, CHEN JIAN-ZONG,
ZHOU GUANG-JIN. journal of ch engdu university of
tcm. 2003;26(2):6 (chi).
3378- gera: 121810/di/ra
[CLINICAL OBSERVATION ON CIRRHOSIS
ASCITES TREATED WITH COMBINATION OF TCM
AND WESTERN MEDICINE: A REPORT OF 71
CASES]. SHU XIAO-MEI, QIN ZHI-FENG. journal of ch
engdu university of tcm. 2003;26(2):18 (chi).
3379- gera: 121818/di/ra
205
[LI - ZHONG - YU'S PESTLE - NEEDLE TO
CONTENTS OF GLUTATHIONE IN MICE LIVERS].
LIU YI-MAN, SONG KAI-YUAN. journal of ch engdu
university of tcm. 2003;26(2):34 (chi).
3380- gera: 121826/di/ra
[PROFESSIONAL VIEWPOINT ON
DIFFERENTIATION OF SYMPTOM - COMPLEX OF
PRIMARY CARCINOMA OF LIVER IN
LITERATURE]. HOU FENG-GANG, ZHAO GANG, HE
JIAN. journal of ch engdu university of tcm. 2003;26(2):56
(chi).
3381- gera: 121846/di/ra
[AN ANALYSIS OF LITERATURE ON EXPERTS'
OPINIONS CONCERNING SYNDROME TYPES OF
PRIMARY HEPATIC CARCINOMA]. HOU FENG-
GANG, ZHAO GANG, SHEN XU-BO. journal of nanjing
university of tcm. 2003;19(4):244 (chi*).
3382- gera: 121941/di/ra
[ASCITES DUE TO CIRRHOSIS TREATED WITH
XIAOSHUIDAN]. GENG SHAOMIN, CHEN JIE. shaanxi
journal of tcm. 2003;24(7):579 (chi).
3383- gera: 121942/di/ra
[INTEGRATED TCM AND WM FOR ASCITES DUE
TO CIRRHOSIS]. LIU XUANTING, LI MING. shaanxi
journal of tcm. 2003;24(7):581 (chi).
3384- gera: 121943/di/ra
[TCM PREVENTION AND TREATMENT OF THE
SYNDROME AFTER INDUCED EMBOLISM OF
LIVER CANCER]. LIANG HONGJIANG. shaanxi
journal of tcm. 2003;24(7):585 (chi).
3385- gera: 121944/di/ra
[ADIPOSIS HEPATICA TREATED WITH
GANZHIGANG CAPSULE]. DANG ZHONGQIN.
shaanxi journal of tcm. 2003;24(7):589 (chi).
3386- gera: 121948/di/ra
[CHRONIC HEPATITIS B TREATED WITH
YIGANJIEDU DECOCTION]. BAI WEI. shaanxi journal
of tcm. 2003;24(7):597 (chi).
3387- gera: 121953/di/ra
[CHIEF PHYSICIAN ZHANG HAIFU ' S
EXPERIENCE IN THE TREATMENT OF CHRONIC
HEPATITIS]. ZHANG BO, ZHANG HUAN. shaanxi
journal of tcm. 2003;24(7):633 (chi).
3388- gera: 121956/di/ra
[RECENT SITUATION OF THE RESEARCH ON THE
TCM TREATMENT OF HEPATITIS B]. YAN YANLI,
SONG XIAOYU, SONG GUOYING . shaanxi journal of
tcm. 2003;24(7):667 (chi).
3389- gera: 121999/di/ra
[CLINICAL OBSERVATION ON 30 CASES OF
TREATMENT OVER FEVER CAUSED BY
EXTERNAL FACTORS WITH XIAOQINGLIANGSAN
IN CHRONIC LIVER DISEASE]. WEN WU-BING.
jiangxi journal of tcm. 2003;34(7):16 (chi).
3390- gera: 122001/di/ra
[65 CASES OF TREATMENT OVER TERMINAL
STAGES OF LIVER CANCER COMBINED WITH
TRADITIONAL CHINESE MEDICINE AND
WESTERN MEDICINE]. LONG HAO,CHEN LI-
gera 2011

LI,WANG XIAO. jiangxi journal of tcm. 2003;34(7):29
(chi).
3391- gera: 122140/di/ra
RADIX SOPHORAE FLAVESCENTIS FOR CHRONIC
HEPATITIS B: A SYSTEMATIC REVIEW OF
RANDOMIZED TRIALS. JIANPING LIU ET AL.
american journal of chinese medicine. 2003;31(3):337
(eng*).
3392- gera: 122146/di/ra
EFFECT OF CDA-IL ON CELL VIABILITY, LIPID
PEROXIDATION, GLUTATHIONE
CONCENTRATION AND ITS RELATED ENZYME
ACTIVITIES IN PRIMARY RAT HEPATOCYTES.
WEN-CHUAN LIN ET AL. american journal of chinese
medicine. 2003;31(3):415 (eng*).
3393- gera: 122224/di/ra
[CLINICAL STUDY ON FATTY LIVER TREATED BY
JIANGZHI GRANULE]. XIA GUODONG, ET AL. hubei
journal of tcm. 2003;25(7):12 (chi).
3394- gera: 122227/di/ra
[CLINICAL OBSERVATION ON CHRONIC SEVERE
HEPATITIS TREATED BY CHINESE HERBS AND
KAISHI]. XIE BIHONG. hubei journal of tcm.
2003;25(7):22 (chi).
3395- gera: 122273/di/ra
[CLINICAL EXAMINATION OF ZAOJIA HUAYU
SANJIE TABLETS IN THE TREATMENT OF 45
CASES OF CIRRHOSIS]. LU BAOLEI. journal of henan
university of chinese medicine. 2003;18(106):48 (chi).
3396- gera: 122310/di/ra
[GANLAN JIEJIUYIN'S EFFECT ON LIPID
METABOLISM IN RATS AND MOUSE WITH ACUTE
ALCOHOLIC HEPATIC INJURY]. PENG BO, MIAO
MINGSAN, ZHU PINGSHENG, ET AL. journal of henan
university of chinese medicine. 2003;18(104):16 (chi*).
3397- gera: 122311/di/ra
[COMPARATIVE STUDY OF THE EFFICACY OF
HUATANFANG AND GANPIFANG ON FATTY LIVER
IN RAT MODELS]. ZHAO WENXIA, MIAO MINGSAN,
DUAN RONGZHANG, ET AL. journal of henan
university of chinese medicine. 2003;18(104):18 (chi*).
3398- gera: 122318/di/ra
[CLINICAL STUDY OF CHINESE PLUS WESTERN
MEDICATION IN THE TREATMENT OF
DECOMPENSATED. CIRRHOSIS]. ZHANG HAIJUN,
ZHANG WUSONG. journal of henan university of chinese
medicine. 2003;18(104):36 (chi*).
3399- gera: 122322/di/ra
[OBSERVATION OF THE THERAPEUTIC EFFECT
OF JIANPI LISHUI DECOCTION PLUS WESTERN
MEDICINE IN THE TREATMENT OF OBSTINATE
ASCITES DUE TO CIRRHOSIS]. LU JUNQING. journal
of henan university of chinese medicine. 2003;18(104):44
(chi).
3400- gera: 122335/di/ra
[TIAOZHI XIAOZHANG DECOCTION IN THE
TREATMENT OF 36 CASES OF FATTY LIVER]. GE
AIHUA, ZHANG QIUXIA. journal of henan university of
chinese medicine. 2003;18(104):58 (chi).
206
3401- gera: 122336/di/ra
[TREATMENT OF 156 CASES OF CHRONIC
HEPATITIS B WITH SHENQI YIGAN DECOCTION].
CUI CHUNRONG, DONG BAOZHENG. journal of henan
university of chinese medicine. 2003;18(104):59 (chi).
3402- gera: 122357/di/ra
[RECENT DEVELOPMENT IN THE EXPERIMENTAL
STUDY OF CHINESE MEDICATION FOR LIVER
INJURY]. WANG YULIANG ,WANG YINGFANG.
journal of henan university of chinese medicine.
2003;18(104):33 (chi*).
3403- gera: 122359/di/ra
[RECENT DEVELOPMENT IN THE CLINICAL
STUDY OF CHINESE MEDICATION FOR FATTY
LIVER]. DONG LIU. journal of henan university of
chinese medicine. 2003;18(104):82 (chi*).
3404- gera: 122376/di/ra
[EFFICACY OF LIGANNING ON SERUM PROTEIN
CONTENT OF RATS WITH EXPERIMENTAL
FIBROSIS OF LIVER]. LI XUEBIN. journal of henan
university of chinese medicine. 2003;18(105):34 (chi*).
3405- gera: 122411/di/ra
[RECENT DEVELOPMENT IN THE EXPERIMENTAL
STUDY OF CHINESE MEDICATION FOR FIBROSIS
OF LIVER]. WANG YINGFANG, WANG YULIANG.
journal of henan university of chinese medicine.
2003;18(105):83 (chi*).
3406- gera: 122431/di/ra
[OBSERVATION, ON FATTY LIVER (35 CASES)
TREATED BY MODIFIED POWDER FOR TREATING
COLE LIMBS]. LUO DENGXU. journal of practical tcm.
2003;19(7):342 (chi).
3407- gera: 122483/di/ra
[EFFECT ON LIGANLING ON THE CONTENTS OF
HA, PC III, IV - C, LN IN HEPATIC FIBROSIS RATS].
LI XUEBIN . journal of emergency in tcm. 2003;12(5):453
(chi).
3408- gera: 122497/di/ra
[EFFECT OF COMPOUND PRESCRIPTION BO'AI
PILLS ON PROLIFERATION AND POPTOSIS OF
HUMAN HEPATIC CARCINOMA HEPG2 CELLS].
LIU JIAN, LI HANMIN, YAN XUESHENG . journal of
tcm. 2003;44(10):782 (chi).
3409- gera: 122564/di/ra
[PRESENT CONDITION IN TREATMENT OF
CHRONIC HEPATITIS B WITH INTERFERON AND
CHINESE DRUGS]. RUAN GONGSHI. jiangsu journal of
tcm. 2003;24(7):57 (chi).
3410- gera: 122566/di/ra
SEVENTY-TWO CASES OF ANTIDIABETIC-
INDUCED HEPATOPATHY TREATED BY HUATAN
YIGAN DECOCTION. HU YONGHE, LI JING AND
ZHOU JING. journal of tcm. 2003;23(3):163 (eng*).
3411- gera: 122722/di/ra
STUDY ON HERB-INDUCED LIVER DAMAGE.
CHAU-SHIN HSU, PHD, SHUENN-JYI SHUE PHD, AND
Q. international journal of oriental medicine.
2003;28(2):98 (eng).
3412- gera: 122826/di/ra
gera 2011

[THE APPLICATION OF EBM IN THE MEDICAL
TREATMENT OF PORTAL HYPERTENSION ].
XIANG BAIKANG. journal of zhejiang college of tcm.
2003;27(5): (chi).
3413- gera: 122831/di/ra
[EFFECTS IF GANLIKE ON EXPERIMENTAL LIVER
FIBROSIS IN RATS]. YAN MAOXIANG, CHEN
ZHIYUN XIANG BAIKANG. journal of zhejiang college
of tcm. 2003;27(5):55 (chi*).
3414- gera: 122832/di/ra
[THE INHIBITIVE EFFECT OF MELITTIN GENE
UNDER THE CONTROL OF HUMAN-FETOPROTEIN
GENE PROMOTER FOR HEPATOCARCINOMA
CELLS ]. LI BAI, ZHANG CHEN LI SHAOXIANG, ET
AL. journal of zhejiang college of tcm. 2003;27(5):58
(chi*).
3415- gera: 122892/di/ra
[EFFECT OF SORBARIA SORBIFOLIA
EXTRACTION ON GLUTATHIONE S -
TRANSFERASE AT EARLY STAGE OF RATS'
CHEMICAL HEPATOCARCINOGENESI]. ZHANG
XUE-WU, ET AL. chinese journal of traditional medical
science and technology. 2003;10(6):346 (chi*).
3416- gera: 122893/di/ra
[EXPERIMENTAL STUDY ON THE PROTECTIVE
EFFECT OF RHAMNUS CRENATA EXTRACTION
ON CARBON TETRACHOLORIDE -INDUCED LIVER
DAMAGE IN MICE]. LIANG RONG-GAN , ET AL.
chinese journal of traditional medical science and
technology. 2003;10(6):348 (chi*).
3417- gera: 122914/di/ra
[THERAPEUTIC OBSERVATION ON 35 CASES OF
CHOLESTATIC HEPATITIS TREATED WITH
REMOVING HIGH JAUNDICE TANG]. LI MIN,WANG
LUJUN,ZHU YONGGEN ET AL . forum on tcm.
2003;18(6):19 (chi).
3418- gera: 122933/di/ra
[EFFECT OF DAHUANG ZHECHONG PILL (* SEKK)
ON TRANSFORMING GROWTH FACTOR-1 IN
HEPATIC STELLATE CELLS IN RATS]. LI LAN-
SHENG, XU MAN, LIU ZHI-LONG, ET AL . chinese
journal of integrated traditional and western medicine.
2003;23(10):763 (chi*).
3419- gera: 122934/di/ra
[EXPERIMENTAL STUDY ON ANTAGONIZING
LIVER FIBROSIS OF RADIX PAEONIAE RUBRA]. LI
YAN-CHANG, SUN YU-FENG, FENG ZHI-JIE . chinese
journal of integrated traditional and western medicine.
2003;23(10):767 (chi).
3420- gera: 122958/di/ra
[A SUMMARY ON 62 CASES OF CHRONIC
HEPATITIS B TREATED BY YIGAN AN DECOCTION
]. XU CHAXIANG, YU ZHENGKE, DING FENG. hunan
guiding journal of tcm. 2003;9(10):11 (chi).
3421- gera: 122981/di/ra
[CLINICAL OBSERVATION ON 134 CASES OF
CHRONIC HEPATITIS C TREATED BY SONGZHI
PILLS]. LIU XIUYING, ET AL. hunan journal of tcm.
2003;19(5):10 (chi).
3422- gera: 123103/di/ra
207
[TREATING LIVER CIRRHOSIS WITH ASCITES BY
PROMOTING BLOOD CIRCULATION TO REMOVE
BLOOD STASIS AND REPLENISHING QI AND THE
SPLEEN ]. LONG YU-SHAN, ET AL. chinese journal of
ethnomedicine and ethnopharmacy. 2003;10(5):277 (chi).
3423- gera: 123129/di/ra
[CLINICAL OBSERVATION ON THE EFFECT OF
GANXIAN PRESCRIPTION COMBINED
LAMIVUDINE IN TREATING 31 PATIENTS WITH
CHRONIC HEPATITIS B]. SHEN WEI-SHENG, YANG
HONG-ZHI, HONG QI, ET AL . chinese journal of
integrated traditional and western medicine in intensive
and criti. 2003;10(5):290 (chi*).
3424- gera: 123142/di/ra
[PRIMARY LIVER CANCER TREATED WITH
INTEGRATION OF TRADITIONAL CHINESE AND
WESTERN MEDICINE ]. ZHANG SHU-PIN, WANG YI-
JUN,NIE FU-HU. shandong journal of tcm.
2003;22(10):614 (chi).
3425- gera: 123181/di/ra
[EFFECT OF CHINESE DRUGS IN CAUSING
POSITIVE ASAB AND EMAB TO REVERT TO
NEGATIVE IN 70 CASES]. YU TIAOZHONG. jiangsu
journal of tcm. 2003;24(10):36 (chi).
3426- gera: 123227/di/ra
[CLINICAL OBSERVATION ON 102 CASES OF
ALCOHOLIC FATTY LIVER TREATED WITH JUGE
YIGAN DECOCTION]. JIA JINGPENG, JIANG SEN .
journal of tcm. 2003;44(10):750 (chi).
3427- gera: 123237/di/ra
[RECENT DEVELOPMENT OF TCM RESEARCHES
ON VIRAL HEPATITIS B]. WANG BAOLIN. henan tcm.
2003;23(11):74 (chi*).
3428- gera: 123278/di/ra
[APPLICATION OF DIFFERENTIATION OF
SYNDROMES ACCORDING TO DEFENSIVE, QI,
NUTRIENT AND BLOOD SYSTEM IN TREATMENT
OF VIRAL HEPATITIS ]. FANG YAXIANG, LONG
AIHUA . jiangsu journal of tcm. 2003;24(11):55 (chi).
3429- gera: 123279/di/ra
[RECENT CONDITIONS IN TCM RESEARCH ON
CHRONIC HEPATITIS B]. FAN BOXIAN . jiangsu
journal of tcm. 2003;24(11):58 (chi).
3430- gera: 123293/di/ra
[EXPERIMENTAL STUDY OF THE EFFECT OF
ADRENALIN ON THE MORTALITY OF RATS
INDUCED WITH IMMUNE FIBROSIS OF LIVER]. LI
JIANGUO, GAO AISHE . journal of henan university of
chinese medicine. 2003;18(108):30 (chi*).
3431- gera: 123306/di/ra
[CHINESE-WESTERN-COMBINED THERAPY FOR
55 CASES OF CHRONIC ADVANCED HEPATITIS].
LIU XINGWANG. journal of henan university of chinese
medicine. 2003;18(108):50 (chi).
3432- gera: 123307/di/ra
[CLINICAL EXAMINATION OF QINGKAILING FOR
LIVER INJURY DUE TO VIRAL HEPATITIS]. GU
TIANJIN, ZHANG HONGMEI. journal of henan
university of chinese medicine. 2003;18(108):51 (chi).
gera 2011

3433- gera: 123363/di/ra
[ANTICANCER STUDY OF PS - T ON HEPATIC
CARCINOMA]. CHEN LI, LI DE-SHENG, LU ZHENG-
XIN, ET AL. modern journal of integrated traditional
chinese and western medicine. 2003;12(22):2399 (chi*).
3434- gera: 123410/di/ra
[EFFECT OF LIGUSTRAZIN ON XANTHINE
OXIDASE ACTIVITY DURING HEPATIC
ISCHEMIA/REPERFUSION INJURY]. WANG WAN-
TIE, LIN LI-NA, WANG WEI, ET AL . chinese journal of
integrated traditional and western medicine in intensive
and crit. 2003;10(6):340 (chi*).
3435- gera: 123631/di/ra
[CLINICAL STUDY ON TREATMENT OF LIVER
FIBROSIS DUE TO HEPATITIS B WITH YIGAN
SANHAO AND RADIATION OF NEAR INFRARED
MESSAGE]. TONG GUANG-DONG, ZHOU DA-QIAO,
QI YAN-PING, ET AL. journal of anhui traditional
chinese medical college. 2003;22(5):17 (chi*).
3436- gera: 123634/di/ra
[EFFECTS OF SALVIA MILTIORRHIZA INJECTION
AND ASTRAGALUS MEMBRANACEUS INJECTION
ON DIVER FUNCTION AND SERUM MARKS OF
HEPATIC FIBROSIS IN LIVER CIRRHOSIS
PATIENTS]. CHEN JIAN, CHEN ZHE, HUANG XUE-
QIANG, ET AL. journal of anhui traditional chinese
medical college. 2003;22(5):32 (chi*).
3437- gera: 123651/di/ra
[TREATMENT OF LIVER CANCER BY CHINESE
HERBAL DRUGS COMBINED WITH HEPATIC
ARTERY INTERVENTION CHEMOTHERAPY AND
WHOLE - BODY RADIOTHERAPY: A CLINICAL
OBSERVATION OF 27 CASES]. ZHOU ZHEN-HUA,
LIU LU-MING, HUANG WEN-XIA, E. new journal of
tcm. 2003;35(10):38 (chi*).
3438- gera: 123667/di/ra
[CLINICAL OBSERVATION ON 102 CASES OF
ALCOHOLIC FATTY LIVER TREATED WITH JUGE
YIGAN DECOCTION]. JIA JINGPENG, JIANG SEN .
journal of tcm. 2003;44(10):750 (chi*).
3439- gera: 123676/di/ra
[EFFECT OF COMPOUND PRESCRIPTION BO'AI
PILLS ON PROLIFERATION AND POPTOSIS OF
HUMAN HEPATIC CARCINOMA HEPG2 CELLS].
LIU JIAN, LI HANMIN, YAN XUESHENG . journal of
tcm. 2003;44(10):782 (chi).
3440- gera: 123741/di/ra
[EXPERIMENTAL STUDY ON THE INHIBITIVE
EFFECTS OF YIQIHUOXUE FORMULA ON THE
PROLIFERATION OF RAT HEPATIC STELLATE
CELLS IN VITRO]. YU SHIYING, WANG JIAN, HE
FUJIN, ET AL. journal of beijing university of tcm.
2003;26(6):26 (chi*).
3441- gera: 123767/di/ra
[CLINICAL OBSERVATION ON THE TREATMENT
OF FATTY LIVER WITH LIVER-SOOTHING AND
LIPID-REDUCING DECOCTION ]. CHEN HUA-DONG,
ZHANG YU-LIANG-, WUJUN, ET AL . journal of anhui
traditional chinese medical college. 2003;22(6):13 (chi*).
3442- gera: 123817/di/ra
[DISCUSSION ON TREATMENT OF CHRONIC
208
HEPATITIS B OF TCM ]. HU ZHENBIN, SHENG
GUOGUANG. helongjiang journal of tcm. 2003;6:6 (chi).
3443- gera: 123841/di/ra
[ANALYSIS OF CASES OF CHRONIC HEPATIC
PROBLEMS TREATED BY INVIGORATING THE
SPLEEN]. YANG GUOHONG, HU YANPING. journal of
henan university of chinese medicine. 2003;18(109):37
(chi*).
3444- gera: 123880/di/ra
[EXPERIENCE OF TREATING LIVER CIRRHOSIS
WITH ASCITES WITH MODIFIED XUEFU ZHUYU
DECOCTION]. XIAO HENG. chinese journal of
ethnomedicine and ethnopharmacy. 2003;12(6):340 (chi).
3445- gera: 123938/di/ra
[EFFECT OF JIEDU HUAYU DECOCTION IN
TREATING HYPERBILIRUBINEMIA INDUCED BY
HEPATITIS]. CHEN LANLING, HU JINNAN , ZHAO
GUORONG, ET AL. chinese journal of integrated
traditional and western medicine on liver diseases.
2003;13(5):259 (chi*).
3446- gera: 123939/di/ra
[THERAPEUTIC EFFECT OF JIEDU HUGAN
GRANULE COMBINED WITH INTERFERON
ALPHA-1B ON CHRONIC HEPATITIS C]. REN
XIAOHUA, WEI MEI, LI HUI, ET AL. chinese journal of
integrated traditional and western medicine on liver
diseases. 2003;13(5):261 (chi*).
3447- gera: 123940/di/ra
[STUDY ON RELATIONSHIP AMONG
PATHOLOGICAL AND IMMUNOHISTOCHEMISTRY
CHANGES IN LIVER TISSUES,AND LEVEL OF HBV
DNA IN SERUM OF PATIENTS WITH CHRONIC
HEPATITIS B*]. GUO XIPING, FENG HONGPING, LI
GUOJUN, ET AL. chinese journal of integrated
traditional and western medicine on liver diseases.
2003;13(5):264 (chi*).
3448- gera: 123941/di/ra
[INHIBITORY EFFECTS OF BAICALIN ON HBSAG
AND HBEAG IN VITRO]. ZHANG FENGXUE, WANG
XIAOJUN, LIU NI, ET AL. chinese journal of integrated
traditional and western medicine on liver diseases.
2003;13(5):267 (chi*).
3449- gera: 123942/di/ra
[EFFECTS OF DESMODIUM PULCHELLUM (L .)
BENTH TOTAL ALKALOIDS ON COL- I AND COL-
III GENE EXPRESSION OF HEPATIC FIBROSIS IN
RATS*]. ZHONG MING, YU SHENGMIN, NONG
CHAOZAN, ET AL. chinese journal of integrated
traditional and western medicine on liver diseases.
2003;13(5):272 (chi*).
3450- gera: 123943/di/ra
[EXPERIMENTAL STUDY OF CHITOSAN WITH
TRADITIONAL CHINESE MEDICINE COMPOUND
REDUCING HEPATIC-LIPID IN RATS]. QI
XIAOHONG, ZHANG ZHAOPING, WU CUIZHEN, ET
AL. chinese journal of integrated traditional and western
medicine on liver diseases. 2003;13(5):275 (chi*).
3451- gera: 123944/di/ra
[PREVENTIVE EFFECT OF PRESCRIPTION OF
NOURISHING SHEN ON RAT HEPATOCARCINOMA
INDUCED BY DIETHYLNITROSAMINE ]. ZOU JING,
gera 2011

CHEN JIANJIE. chinese journal of integrated traditional
and western medicine on liver diseases. 2003;13(5):278
(chi*).
3452- gera: 123946/di/ra
[EFFECTS OF KANGXIAN RUANGAN GRANULE ON
MATRIX TRANSITION AND HEPATIC SINUSOID
CAPILLATIZATION IN EXPERIMENTAL RAT
LIVER FIBROSIS* ]. HU TAIHONG, GE YA, ZHANG
CIZHI, ET AL. chinese journal of integrated traditional
and western medicine on liver diseases. 2003;13(5):283
(chi*).
3453- gera: 123947/di/ra
[STUDY ON BRUFEN AGAINST SCHISTOSOMIASIS
WITH HEPATIC FIBROSIS IN RABBITS*]. HUANG
QIAOXIN, TIAN DEYING. chinese journal of integrated
traditional and western medicine on liver diseases.
2003;13(5):286 (chi*).
3454- gera: 123948/di/ra
[EFFECT OF HUOXUE HUAYU AND HUATAN LISHI
ON INSULIN SENSITIVITY INDEX AND TNF OF
FATTY LIVER RATS*]. LI JIN, SHENG GUOGUANG.
chinese journal of integrated traditional and western
medicine on liver diseases. 2003;13(5):289 (chi*).
3455- gera: 123949/di/ra
[48 CHILDREN WITH CHRONIC HEPATITIS B
TREATED BY CHILD HEPATITIS B GRANULE]. YU
PING. chinese journal of integrated traditional and
western medicine on liver diseases. 2003;13(5):297 (chi).
3456- gera: 123971/di/ra
[CLINICAL OBSERVATION OF CHRONIC
CHOLECYSTITIS TREATED WITH AURICULAR - P
LEST ONE CASE OF SYMPTOM SECONDARY TO
CO TOXIC TREATED WITH ACUPUNCTURE]. LI LI-
PING, SUN ZHONG-REN. acta chinese medicine and
pharmacology. 2003;31(3):30 (chi).
3457- gera: 123972/di/ra
[ACUTE PHASE OF CHRONIC CHOLECYSTITIS
TREATED WITH TRADITIONAL CHINESE
MEDICINE AND WESTERN MEDICINE: 104 CASES
REPORTED]. ZHANG DONG-JUN ZHUANG AI-GUO.
acta chinese medicine and pharmacology. 2003;31(3):33
(chi).
3458- gera: 124245/di/ra
[MEDICAL EFFECTIVENESS STUDY OF TIAOZHIJI
SOLUBLE GRANULES ON FATTY DEGENERATION
OF LIVER IN MICE]. PAN ZHIMIN, LI HUA, HUANG
QI, ET AL. journal of zhejiang college of tcm.
2003;27(6):49 (chi*).
3459- gera: 124349/di/ra
[COMPARISON BETWEEN ROUGAN MIXTURE AND
BIEJIAJIAN PILL IN EFFECT OF PREVENTING
HEPATIC FIBROSIS]. ZHU MU, REN GUANG-RONG.
journal of nanjing university of tcm. 2003;19(6):334
(chi*).
3460- gera: 124535/di/ra
[30 PATIENTS WITH BILIARY COLIC TREATED
WITH HYDRO - ACUPUNCTURE THERAPY ].
ZHANG LEI . journal of clinical acupuncture and
moxibustion. 2003;19(11):34 (chi).
3461- gera: 124630/di/ra
209
[54 CASES OF TREATMENT OVER
HEPATOCIRRHOSIS ASCITES COMBINED WITH
TRADITIONAL CHINESE MEDICINE AND FEEDING
BACK OF ULTRAFILTRATING ASCITES]. ZHANG
BI-LUN JIANG YI-PING. jiangxi journal of tcm.
2003;34(12):13 (chi).
3462- gera: 124655/di/ra
[APPLICATION STUDY OF GENECHIP DETECTING
HBV DNA AND LAMIVUDINE RESISTANT
MUTANTS]. LI BING, ZHOU BOPING, WEN BIN,ET AL.
chinese journal of integrated traditional and western
medicine on digestion. 2003;11(6):340 (chi*).
3463- gera: 124656/di/ra
[EFFECT OF HUANGSHEN ELECTUARY ON THE
LIVING QUALITY OF ADVANCED HEPATIC
CANCER PATIENTS]. GAN AIHUA, XU ANGAO, LING
HONG, ET AL. chinese journal of integrated traditional
and western medicine on digestion. 2003;11(6):344 (chi*).
3464- gera: 124658/di/ra
[INFLUENCE OF YIGANSANHAO GRANULE ON
THE CHRONIC HEPATIC DAMAGE INDUCED BY
CCI4]. ZHOU XIAOMEI, ZHOU XIAOZHOU, ZHOU
DAQIAO, ET AL. chinese journal of integrated
traditional and western medicine on digestion.
2003;11(6):349 (chi*).
3465- gera: 124661/di/ra
[EFFECT OF KANGXIAN RUANGAN GRANULE ON
HEPATIC SINUSOID CAPILLATIZATION IN
EXPERIMENTAL RAT LIVER FIBROSIS]. HU
TAIHONG, ZHANG CHIZHI, REN XINGFENG, ET AL.
chinese journal of integrated traditional and western
medicine on digestion. 2003;11(6):356 (chi*).
3466- gera: 124666/di/ra
[REMOTE EFFECT OF OXYMATRINE ON CHRONIC
HEPATITIS B]. XIA TING, SUN HUI. modern journal of
integrated traditional chinese and western medicine.
2003;12(24):2631 (chi*).
3467- gera: 124673/di/ra
[EXPERIMENTAL STUDY ON THE EFFECT OF
GANZHIXIAO DECOCTION ON HEPATIC LIPID
PEROXIDATION AND MEMBRANE FLUIDITY
INJURY OF FATTY LIVER RAT]. MA XIAO-YAN,
WANG PING, ZHONG ZHI-HONG, ET AL. chinese
journal of basic medicine in tcm. 2003;9(10):51 (chi*).
3468- gera: 125105/di/ra
[EFFECT OF ZENGMIANTIAOGANJIEDU
DECOCTION ON PATIENTS WITH
ASYMPTOMATIC HEPATITIS B VIRUS CARRIERS].
JIA QINGYU, YOU WANQING. hebei journal of tcm.
2003;25(12):900 (chi*).
3469- gera: 125226/di/ra
[CLINICAL OBSERVATION ON FUFANG MUJI
CHONGJI IN TREATMENT OF CHRONIC
HEPATITIS B AND CIRRHOSIS ]. WANG LI. liaoning
journal of tcm. 2003;30(12):988 (chi*).
3470- gera: 125252/di/ra
[CHANGES OF NEURAL APOPTOSIS IN RATS
DEALT WITH MSG GAO CHANG ET AL(719)
EFFECTS OF ROUGAN KANGXIAN GRANULE ON
HEPATIC FIBROSIS IN RATS INDUCED BY
COMPOUND FACTORS]. LI XUDONG ET AL. china
gera 2011

journal of tcm and pharmacy. 2003;18(12):721 (chi).
3471- gera: 125274/di/ra
[ZHOU DAIHAN'S CLINICAL EXPERIENCE IN
TREATMENT OF LIVER CANCER]. CHEN
HUALIANG . jtcm. 2003;44(12):894 (chi).
3472- gera: 125312/di/ra
[CLINICAL EVALUATION OF THERAPY EFFECTS
FOR LIVER FIBROSIS AND EARLY LIVER
CIRROSIS BY INTERFERON A AND RUANJIAN
SANJIE FLUID IN THE PATIENTS WITH CHRONIC
HEPATITIS B*]. LIN XIAOTIAN, WANG YU, DAI LIN,
ET AL. chinese journal of integrated traditional and
western medicine on liver diseases. 2003;13(6):327 (chi*).
3473- gera: 125313/di/ra
[A PRELIMINARY STUDY OF TREATING
SUBACUTE GRAVE HEPATITIS WITH SANJUN
TUIHUANG DECOCTION*]. ZHANG XUEHAI, LI
ZHAOZHONG, WANG XIAO. chinese journal of
integrated traditional and western medicine on liver
diseases. 2003;13(6):330 (chi*).
3474- gera: 125314/di/ra
[STUDY ON THE RELATION BETWEEN HBV
GENOTYPE AND THERAPY OF LAMIVADINE ].
ZHOU LANLIANG WU SHIPIN. chinese journal of
integrated traditional and western medicine on liver
diseases. 2003;13(6):332 (chi*).
3475- gera: 125315/di/ra
[CLINICAL EFFECT OF THYMOSIN AL ON
FULMINANT HEPATITIS*]. WU LIANG, WANG
YING, ZHANG ZHENGANG, ET AL. chinese journal of
integrated traditional and western medicine on liver
diseases. 2003;13(6):335 (chi*).
3476- gera: 125316/di/ra
[SCREENING THE PRE-SL PROMOTER OF
HEPATITIS B VIRUS SPECIFIC DNA-BINDING
PROTEINS BY YEAST ONE-HYBRID SYSTEM* ].
HONG YUAN, CHENG JUN . chinese journal of
integrated traditional and western medicine on liver
diseases. 2003;13(6):337 (chi*).
3477- gera: 125317/di/ra
[SCREENING AND IDENTIFICATION OF
HEPATITIS C VIRUS NONSTRUCTURAL PROTEIN
5A-INTERACTING PROTEINS FROM LEUKOCYTE
BY YEAST TWO - HYBRID TECHNIQUE* ]. WANG
LIN, LI KE, CHENG JUN, ET AL. chinese journal of
integrated traditional and western medicine on liver
diseases. 2003;13(6):340 (chi*).
3478- gera: 125318/di/ra
[CLONING AND ANALYSIS OF EXPRESSED GENES
TRANSACTIVATED BY NS5A-TP4 PROTEIN BY
SUPPRESSION SUBTRACTIVE HYBRIDIZATION * ].
YANG QIAN, CHENG JUN, LIU YAN, ET AL. chinese
journal of integrated traditional and western medicine on
liver diseases. 2003;13(6):343 (chi*).
3479- gera: 125320/di/ra
[CLONING AND SEQUENCE ANALYSIS OF A
MONKEY GENE HOMOLOGOUS TO HUMAN
HEPATITIS C VIRUS CORE PROTEIN-BINDING
PROTEIN 6 BY BIOINFORMATICS* ]. CHENG JUN,
LI KE, WANG LIN, ET AL. chinese journal of integrated
traditional and western medicine on liver diseases.
210
2003;13(6):349 (chi*).
3480- gera: 125321/di/ra
[CLONING AND IDENTIFICATION OF GENE NS5A-
TP2 TRANSACTIVATED BY HEPATITIS C VIRUS
NONSTRUCTURAL PROTEIN 5A* ]. YANG QIAN,
CHENG JUN, HONG YUAN, ET AL. chinese journal of
integrated traditional and western medicine on liver
diseases. 2003;13(6):352 (chi*).
3481- gera: 125322/di/ra
[IDENTIFICATION AND EVALUATION PROMOTER
SEQUENCE AND ITS TRANSCRIPTION
ACTIVATION OF THE HCTP4 TRANSACTIVATED
BY CORE PROTEIN OF HEPATITIS C VIRUS* ]. JU
LIZHONG, ZHONG YANWEI, CHENG JUN, ET AL.
chinese journal of integrated traditional and western
medicine on liver diseases. 2003;13(6):354 (chi*).
3482- gera: 125323/di/ra
[IDENTIFICATION AND EVALUATION OF
PROMOTER SEQUENCE AND ILS TRANSCRIPTION
ACTIVATION OF THE HUMAN GENE 9
TRANSACTIVATED BY NONSTRUCTURAL
PROTEIN 5A OF HEPATITIS C VIRUS*]. JU
LIZHONG, ZHONG YANWEI , CHENGJUN, ET AL.
chinese journal of integrated traditional and western
medicine on liver diseases. 2003;13(6):357 (chi*).
3483- gera: 125324/di/ra
[SCREENING OF PROMOTER BINDING PROTEIN
OF HCTP4 TRANSACTIVATED BY HEPATITIS C
VIRUS CORE PROTEIN FROM HUMAN LIVER
CDNA LIBRARY BY PHAGE DISPLAY* ]. JU
LIZHONG, ZHONG YANWEI, CHENG JUN, ET AL.
chinese journal of integrated traditional and western
medicine on liver diseases. 2003;13(6):360 (chi*).
3484- gera: 125325/di/ra
[SCREENING OF PROMOTER DNA-BINDING
PROTEIN OF NS5A-TP9 GENE BY PHAGE DISPLAY
TECHNIQUE FROM HUMAN LIVER CDNA
LIBRARY*]. JU LIZHONG, ZHONG YANWEI, CHENG
JUNH, ET AL. chinese journal of integrated traditional
and western medicine on liver diseases. 2003;13(6):363
(chi*).
3485- gera: 125326/di/ra
[THE EFFECT OF BASIC FIBROBLAST GROWTH
FACTOR MRNA (BFGF MRNA) EXPRESSIONBY
FFXHHG IN THE WOUNDED TISSUE]. LUO
YIWEN,SUN ZHIHAO,TAN XINHUA, ET AL . chinese
journal of traditional medicine traumatology and
orthopedics. 2003;11(6):1 (chi*).
3486- gera: 125392/di/ra
[CLINICAL STUDY ON THE THERAPEUTIC
EFFECTS OF QINGRE JIEDU HUAZHUO TABLETS
ON THE PATIENTS OF CHRONIC VIRAL
HEPATITIS B WITH DIFFERENT PATTERNS .]. XIE
JING, ZHAO GUORONG, XIONG YAN, ET AL. journal
of tcm university of hunan. 2003;23(6):33 (chi*).
3487- gera: 125406/di/ra
[A SIMPLE NEW METHOD TO DETECT THE
RELATIVE LENGTH OF TELOMERE DNA REPEATS
IN RAT LIVER CELLS BY PCR]. ZHANG JIE, LI YUN,
CUI CHENG-DE, ET AL. chinese journal of basic
medicine in tcm. 2003;9(10):31 (chi).
gera 2011

3488- gera: 125435/di/ra
[TREATING 24 CASES OF CIRRHOSIS WITH BU
YANG HUAN WU TANG]. XU XINGGUO. zhejiang
journal of tcm. 2003;38(10):424 (chi).
3489- gera: 125448/di/ra
[EFFECT OF HEGANTANG ON THE IMMUNIZED
MOUSE LIVER DAMAGE]. YAN YAN-LI,WANG XIN-
GUO,SONG XIAO-YU,SONG GUO-YING. chinese
journal of basic medicine in tcm. 2003;9(9):22 (chi*).
3490- gera: 125467/di/ra
[ASCITES DUE TO CIRRHOSIS (68 CASES)
TREATED BY COMBINATION ON TRADITIONAL
CHINESE MEDICINE WITH WESTERN MEDICINE].
WANG ZHONGZHENG. journal of practical tcm.
2003;19(10):528 (chi).
3491- gera: 125479/di/ra
[PROGRESS IN EXPERIMENTAL RESEARCH INTO
ANTI HEPATITIS B VIRUS BY CHINESE HERBAL
MEDICINE]. WANG QIN ,DENG JIAGANG,HUANG
MINGWEN. guangxi journal of tcm. 2003;26(5):1 (chi).
3492- gera: 125488/di/ra
[EFFECTS OF RUANGAN GRANULE ON P21 MRNA
EXPRESSION IN THE EXPERIMENTAL HEPATIC
FIBROSIS INDUCED BY CAR-BON
TETRACHLORIDE IN RATS]. QI YANPING, ZHOU
XIAOZHOU, ZHOU DAQIAO, ET AL. chinese journal of
integrated traditional and western medicine on digestion.
2003;11(5):267 (chi*).
3493- gera: 125492/di/ra
[PROTECTIVE EFFECTS OF K. COCCINICA ON
EXPERIMENTAL HEPATIC IMPAIRMENT IN
RATS]. QU LING, GUO LIANJUN, LU QING, ET AL.
chinese journal of integrated traditional and western
medicine on digestion. 2003;11(5):278 (chi*).
3494- gera: 125493/di/ra
[INHIBITING EFFECT OF FUZHENGHUAYU
CAPSULE ON THE ACTIVATION OF HEPATIC
STELLATE CELLS IN RATS]. JIANG CHUNMENG,
LIU CHENGHAI, LIU CHENG. chinese journal of
integrated traditional and western medicine on digestion.
2003;11(5):280 (chi*).
3495- gera: 125494/di/ra
[HEPATOCYTIC APOPTOSIS INDUCED BY
LIPOPLYSACCHARIDE (LPS) AND INHIBITING
FUNCTION EXERTED FROM THE FORMU-LA
WITH THE FUNCTION OF COOLING BLOOD TO
REMOVE BLOOD STASIS]. CHEN WEIPING, WANG
LUJUN, DING PEI, ET AL. chinese journal of integrated
traditional and western medicine on digestion.
2003;11(5):284 (chi*).
3496- gera: 125496/di/ra
[CLINICAL STUDY OF SHEHUANG PASTE PAVED
ON THE UMBILICUS IN THE TREATMENT OF
REFRACTORY ASCITES DUE TO CIR-RHOSIS].
TONG GUANGDONG , ZHOU DAQIAO, HE JINSONG.
chinese journal of integrated traditional and western
medicine on digestion. 2003;11(5):290 (chi*).
3497- gera: 125500/di/ra
[INFLUENCE ON LIVER FIBROSIS OF CHRONIC
HEPATITIS B TREATED BY COMBINED WITH
GANLIXIN AND DENGZHANHUA INJECTION]. FU
211
PING, PENG LI-LI. jiangxi journal of tcm. 2003;34(10):14
(chi).
3498- gera: 125516/di/ra
[THE SIGNIFICANCE OF WANG TAILIN'S METHOD
OF TREATING HEPATIC DISEASES IN
GYNECOLOGICAL PRACTICES]. PAN TIANXIONG.
henan tcm. 2003;23(10):13 (chi).
3499- gera: 125521/di/ra
[DEVELOPMENT IN CHINESE AND WESTERN
MEDICINE OF STUDIES ON HBV-GN]. GUO
QINGYIN,DING YING. henan tcm. 2003;23(10):81 (chi).
3500- gera: 125569/di/ra
[THE ANTI-HBV ACTIVITY OF HERBAL KIDNEY-
TONIFYING GRANULES IN VITRO ]. ZHANG
YOUXIANG, ET AL. chinese journal of information on
tcm. 2003;10(10):26 (chi*).
3501- gera: 125570/di/ra
[EFFECT OF LIVER-STAGNATION AND SPLEEN-
DEFICIENCY ON THE CELL CYCLE OF H22
ASCITIC FLUID TUMOR IN MICE AND THE
TREATMENT OF SHUGANJIANPIFANG]. WANG JI,
ET AL. chinese journal of information on tcm.
2003;10(10):28 (chi*).
3502- gera: 125580/di/ra
[CHINESE MEDICAL SYNDROMES AND CLINICAL
EFFECTS OF PRIMARY BILIARY CIRRHOSIS].
JIANG JIAN NE MIAO. acta universitatis traditionis
medicalis sinensis pharmacolgiaeque shanghai.
2003;17(3):15 (chi*).
3503- gera: 125586/di/ra
[INFLUENCE OF "HEALTH-SUPPORTING AND
STASIS-RESOLVING DECOCTION" ON
INTERSTITIAL METALLOPROTEINASE ACTIVITY
IN LIVER FIBROSIS RATS]. CUI HONG-YAN LIU
CHENG JIANG ZHE-HAO, ET AL. acta universitatis
traditionis medicalis sinensis pharmacolgiaeque shanghai.
2003;17(3):35 (chi*).
3504- gera: 125595/di/ra
[STUDY OF THE THERAPEUTIC MECHANISM OF
CHRONIC HEPATITIS B UNDER THE GUIDANCE
OF TCM THEORY]. JIA JING-PENG,JIANG SEN. shanxi
journal of tcm. 2003;19(5):1 (chi*).
3505- gera: 125619/di/ra
[CHANGE OF HEPATIC HEMODYNAMICS OF
PATIENTS WITH CIRRHOSIS STIMULATED BY
PULSE CURRENT AT LOCAL POINTS BEFORE AND
AFTER]. ZHANG JUNCHANG, ET AL. hubei journal of
tcm. 2003;25(10):5 (chi).
3506- gera: 125622/di/ra
[CLINICAL OBSERVATION ON FIBROSIS OF LIVER
TREATED BY XIAOCHAIHU DECOCTION
COMBINED A-IF]. XIONG FAN , ET AL. hubei journal
of tcm. 2003;25(10):10 (chi).
3507- gera: 125649/di/ra
[CLINICAL STUDY OF SHENQI TABLET
COMBINED WITH MICROWAVE COAGULATION
FOR PRIMARY LIVER CANCER]. LIN JIAN-JUN,JIN
CHANG-NAN,CHEN XU-LAN,ET AL. fujian journal of
tcm. 2003;34(5):5 (chi).
gera 2011

3508- gera: 126740/di/ra
[RESEARCH THINKING AND METHOD OF
DIFFERENTIATING MOLECULAR SYNDROME FOR
CHRONIC HEPATITIS B]. LI HANMIN. chinese
archives on tcm. 2003;21(12):2008 (chi).
3509- gera: 133515/di/ra
ESTUDIO CLÍNICO SOBRE EL TRATAMIENTO DE
PORTADORES CRÓNICOS DEL VIRUS DE
ANTÍGENO SUPERFICIAL DEL LA HEPATITIS B
CON INYECCIÓN DE TRAGACANTO EN LOS
PUNTOS ACUPUNTURALES. X. medicina energetica.
2003;21:16 (esp).
3510- gera: 133657/di/ra
HEPATOGASTROPATÍAS. X. revista argentina de
acupuntura. 2003;104:2426 (esp).
3511- gera: 134866/di/ra
SESENTA Y DOS CASOS DE HEPATOPATÍA
INDUCIDA POR ANTIDIABÉTICOS TRATADOS CON
LA DECOCCIÓN HUA TAN YI GAN. HU YONG HE, LI
JING, ZHOU JING . el pulso de la vida. 2003;37:5 (esp).
3512- gera: 134898/di/ra
LOS EFECTOS DE LA DECOCCIÓN DA DING FENG
ZHU EN 30 CASOS DE FIBROSIS HEPÁTICA . X. el
pulso de la vida. 2003;38:9 (esp).
3513- gera: 138819/di/ra
LOS EFECTOS DE LA DECOCCIÓN DA DING FENG
ZHU EN 30 CASOS DE FIBROSIS HEPÁTICA]. X. el
pulso de la vida- journal of tcm. 2003;38:9 (esp).
3514- gera: 119831/di/ra
[TREATING CHRONIC HEPATITIS B BY
RELIEVING THE DEPRESSED LIVER AND
REMOVING PATHOGENESES .]. LIANG HEYANG
MIN. journal of henan university of chinese medicine.
2004;19(1):47 (chi*).
3515- gera: 122696/di/ra
[TREATMENT OF FATTY LIVER WITH MODIFIED
MAJOR BUPLEURUM DECOCTION: A REPORT OF
40 CASES]. CHEN DI-PING, CHEN CUI-PING. journal of
anhui traditional chinese medical college. 2004;23(1):22
(chi).
3516- gera: 122703/di/ra
[DUPLICATE THE MODEL OF INTRAHEPATIC
CHOLESTASIS IN PREGNANT MICE]. LONG ZI-
JIANG,HUANG HE-PING, ZHANG WEN JIA, ET AL.
journal of anhui tcm college. 2004;23(1):38 (chi).
3517- gera: 122705/di/ra
[EFFECT OF RUANGAN GRANULE ON THE SERUM
LEVELS OF TGFB1, I - AND III-COLLAGEN IN RATS
WITH LIVER FIBROSIS]. ZHOU DA-QIAO, ZHOU
XIAO-ZHOU, GUO XING-BO, ET AL. journal of anhui
tcm college. 2004;23(1):43 (chi).
3518- gera: 122711/di/ra
[PRESENT SITUATION ON THE TREATMENT OF
CHRONIC VIRAL HEPATITIS B BY THERAPY OF
TRADITIONAL CHINESE MEDICINE]. LIN YI.
journal of anhui tcm college. 2004;23(1):60 (chi).
3519- gera: 123539/di/ra
[DISCUSSION ON PATHOMECHANISM AND
TREATMENT OF FATTY LIVER]. PAN ZHIMIN, LI
212
YUHUA . zhejiang journal of tcm. 2004;39(1):8 (chi).
3520- gera: 124027/di/ra
[STUDY OF FAMCICLOVIR COMBINED WITH
INTERFERON - A ON CHRONIC HEPATITIS B].
KANG DA-QING, ZHOU DA-MING, JU LONG-XIANG,
ET AL. modern journal of integrated traditional chinese
and western medicine. 2004;13(2):155 (chi*).
3521- gera: 124070/di/ra
[TREATMENT OF CHRONIC HEPATITIS B BY
SHENHU TIAOGAN TANG COMBINED WITH
LAMIVUDINE: A CLINICAL OBSERVATION OF 70
CASES ]. LIU TONG-FENG. new journal of tcm.
2004;36(1):40 (chi).
3522- gera: 124080/di/ra
[COMPREHENSIVE THERAPY FOR HEPATITIS B ].
LI LIMIN. shaanxi journal of tcm. 2004;25(1):31 (chi).
3523- gera: 124081/di/ra
[CHRONIC HEPATITIS B TREATED WITH
HUANGQICAIHU DECOCTION ]. WU SHIJIE. shaanxi
journal of tcm. 2004;25(1):39 (chi).
3524- gera: 124082/di/ra
[CHIEF PHYSICIAN CHENG DONGSHENG'S
UNDERSTANDING OF THE MECHANISM OF
CHRONIC LIVER DISEASES]. GAO FENGQIN .
shaanxi journal of tcm. 2004;25(1):50 (chi).
3525- gera: 124088/di/ra
[SEVERAL CENTRAL ASPECTS OF THE CLINICAL
STUDY ON FATTY LIVER ]. YIN CHANG-JIAN.
shandong journal of tcm. 2004;23(1):3 (chi*).
3526- gera: 124135/di/ra
[THE SUMMARY NARRATION OF FIBROSIS OF
LIVER TREATED BY TRADITIONAL CHINESE
HERBS]. QU ZUO FA . gansu journal of tcm.
2004;17(1):40 (chi).
3527- gera: 124143/di/ra
[TREATMENT OF 68 CASES OF ICTERIC VIRAL
HEPATITIS WITH "QINGGANLING" ]. TANG WEI,
ZHU JIANHUA. jiangsu journal of tcm. 2004;25(1):23
(chi).
3528- gera: 124150/di/ra
[EFFECT OF GANLAN JIEJIU DECOCTION ON
FREE RADICAL METABOLISM OF RAT AND MICE
MODELS WITH ACUTE ALCOHOLIC LIVER
DAMAGE ]. PENG BO, MIAO MINGSAN, WANG YING
FANG , ET AL. jiangsu journal of tcm. 2004;25(1):55
(chi).
3529- gera: 124156/di/ra
[APPLICATIONS EXPERIENCES IN TREATMENT
OF LIVER CANCER BY TCM ]. CUI YAN. jilin journal
of tcm. 2004;24(1):18 (chi).
3530- gera: 124266/di/ra
[CLINICAL STUDY ON THE PREVENTION AND
TREATMENT OF STRENGTHENING QI AND
ACTIVATING CIRCULATION HERBS FOR TACE
SYNDROME IN LIVER CANCER]. WANG
BINGSHENG , ET AL. journal of emergency in tcm.
2004;13(1):11 (chi).
3531- gera: 124272/di/ra
gera 2011

[EXPERIMENTAL STUDY ON THE EXPRESSION OF
FADDMRNA IN HEPATIC IMPAIRMENT INDUCED
BY LIPOPLYSYCCHARIDE AND THE EFFECT OF
THE FORMULA REMOVING HEAT FROM THE
BLOOD AND DISSIPATING BLOOD STASIS]. CHEN
WEIPING, ET AL . journal of emergency in tcm.
2004;13(1):39 (chi).
3532- gera: 124288/di/ra
[CLINICAL OBSERVATION ON CHOLESTATIC
HEPATITIS TREATED BY TUIHUANG
DECOCTION]. LI MIN, ET AL. hubei journal of tcm.
2004;26(1):8 (chi).
3533- gera: 124289/di/ra
[INFLUENCE OF POINT APPLICATION COMBINED
WITH ORAL RUANGAN SHUOPI DECOCTION ON
INDEXES OF HEPATIC FIBROSIS OF PATIENTS
WITH ASCITES DUE TO POSTHEPATITIC
CIRRHOSIS]. LUO XULIN , ET AL. hubei journal of
tcm. 2004;26(1):10 (chi).
3534- gera: 124320/di/ra
[CLINICAL OBSERVATION OF LIVER
FIBRINOLYTIC CAPSULE AND GANLIXIN
INJECTION VIRAL HEPATITIS AND LIVER
FIBROSIS ]. CHENG GUANGHUA, LI MIAOZHU, LI
WEI. journal of zhejiang college of tcm. 2004;28(1):36
(chi*).
3535- gera: 124456/di/ra
[A DISCUSSION ON PATHOLOGICAL MECHANISM
OF CHRONIC HEPATITIS WITH A THEORY OF
COLLATERAL DISEASE ]. QI JING. beijing journal of
tcm. 2004;23(1):16 (chi).
3536- gera: 124481/di/ra
[EFFECT OF XIAOCHAIHU DECOCTION ON THE
TH1/TH2 IMMUNE BALANCE OF EXPERIMENTAL
HEPATIC INJURY IN MICE ]. WANG WEN-JIE,WANG
JI. shanxi journal of tcm. 2004;20(1):49 (chi*).
3537- gera: 124570/di/ra
[TREATMENT OF ALCCHOLIC HEPATITIS BY TCM
COMBINED WITH WESTERN MEDICINE:A
CLINICAL OBSERVATION OF 35 CASES ]. FU YU-
JUN, FU YU-XIAO, WANG WEI. new journal of tcm.
2004;36(2):52 (chi*).
3538- gera: 124581/di/ra
[TERMINAL LIVER CANCER (7 CASES) TREATED
BY INJECTION OF KANGLAITE ZHUSHEYE ]. JIAO
WENPING,LIJIANG,WANGFENGDONG. journal of
practical tcm. 2004;20(1):32 (chi).
3539- gera: 124606/di/ra
[WU YOUKE'S ACADEMIC THOUGHTS
ENLIGHTEN THE TREATMENT OF SEVERE
HEPATITIS]. ZHANG LIANGZHI . forum on tcm.
2004;19(1):44 (chi).
3540- gera: 124616/di/ra
[CLINICAL STUDY ON DAHUANG CHISHAO TANG
IN TREATING ENDOTOXEMIA OF LIVER
CIRRHOSIS]. GUO ZHI-ZHONG. chinese journal of
information on tcm. 2004;11(1):24 (chi*).
3541- gera: 124685/di/ra
[INFLUENCE OF COMPOUND FORMULA 991
KANGXIAN FANG ON RAT EXPERIMENTAL
213
HEPATIC FIBROSIS]. TANG XIANG,ET AL. chinese
journal of information on tcm. 2004;11(1):40 (chi*).
3542- gera: 124727/di/ra
[TREATMENT OF CHRONIC HEPATITIS B WITH
KURARINONE: OBSERVATIONS ON ITS ANTI-
FIBROSIS EFFECTS]. PU YUNCHUAN, HU MINTAO,
ZHANG BO. journal of shaanxi college of tcm.
2004;27(1):63 (chi*).
3543- gera: 124761/di/ra
[CLINICAL OBSERVATION OF "LIVER-
DISCHARGING AND BLOOD-ACTIVATING
DECOCTION" IN TREATING FATTY LIVER ]. LI
XIN-HUA. shanghai journal of tcm. 2004;38(2):24 (chi*).
3544- gera: 124804/di/ra
[MORE ATTENTION ON EVIDENCE RESEARCH, TO
ADVANCE INTEGRATIVE CHINESE AND WESTERN
MEDICINE STUDIES IN LIVER DISEASE]. LIU PING.
chinese journal of integrated traditional and western
medicine. 2004;24(1):8 (chi).
3545- gera: 124805/di/ra
[ABOUT NON-ALCOHOLIC LIPOIDAL LIVER
DISEASE]. LI YOU-MING . chinese journal of integrated
traditional and western medicine. 2004;24(1):11 (chi).
3546- gera: 124806/di/ra
[TO STRENGTHEN FURTHER STUDY ON
TREATMENT OF LIPOIDAL LIVER DISEASES BY
TRADITIONAL CHINESE MEDICINE]. HU YI-YANG.
chinese journal of integrated traditional and western
medicine. 2004;24(1):12 (chi).
3547- gera: 124807/di/ra
[CLINICAL STUDY ON TREATMENT OF
ALCOHOLIC LIVER DISEASE BY QINGGAN
HUOXUE RECIPE ]. JI GUANG, WANG YU-QUN, CAO
CHENG-LOU, ET AL. chinese journal of integrated
traditional and western medicine. 2004;24(1):13 (chi*).
3548- gera: 124808/di/ra
[CLINICAL STUDY ON TREATMENT OF LIVER
FIBROSIS BY DIFFERENT DOSAGES OF SALVIA
INJECTION ]. SHE SHI-FENG, HUANG XIAN-ZHANG,
TONG GUANG-DONG . chinese journal of integrated
traditional and western medicine. 2004;24(1):17 (chi*).
3549- gera: 124809/di/ra
[EFFECT OF ANTI-FIBROSIS COMPOUND
CONTAINED SERUM ON PROCOLLAGEN TYPE I
AND IV , MATRIX ETALLOPROTEINASE AND ITS
TISSUE INHIBITOR-1 GENE EXPRESSION IN HSC-
LI90 CELL LINE*]. ZHAO GANG, WANG LING-TAI,
CHEN JIAN-JIE, ET AL. chinese journal of integrated
traditional and western medicine. 2004;24(1):47 (chi*).
3550- gera: 124821/di/ra
[MINUTE OF THE 12TH NATIONAL CONFERENCE
ON INTEGRATIVE CHINESE AND WESTERN
MEDICINE IN LIVER DISEASES]. LIU CHENG-HAI,
HU YI-YANG . chinese journal of integrated traditional
and western medicine. 2004;24(1):91 (chi).
3551- gera: 124833/di/ra
[ANALYSIS ON CHARACTERISTICS OF
SYNDROME IN 2060 CASES OF PRIMARY HEPATIC
CANCER]. FANG ZHAOQIN, LI YONGJIAN, TANG
CHENLONG, ET AL. journal of tcm. 2004;45(1):53 (chi*).
gera 2011

3552- gera: 124949/di/ra
[A SUMMARY ON 30 CASES OF ASCITES DU TO
CIRRHOSIS AFTER HEPATITIS B TREATED. BY
MODIFIED SIJUN WUPI DECOCTION ]. PAN BO,ET
AL. hunan journal of tcm. 2004;20(1):12 (chi).
3553- gera: 125006/di/ra
[CLINICAL STUDY ON TREATING PRIMARY
HEPATIC CARCINOMA WITH GAN' AI
DECOCTION COMBINED WITH ARTERIAL
INFUSION CHEMOTHERAPY AND EMBOLIZATION
]. GAO PING. china journal of tcm and pharmacy.
2004;19(1):28 (chi).
3554- gera: 125022/di/ra
[EFFECT OF BOSCHNIAKIA ROSSICA EXTRACT
ON THE SERUM ANTIOXIDATIVE ACTIVITIES
AND TUMOR NECROSIS FACTOR IN INITIAL
STAGE OF RAT CHEMICAL HEPATO-
CARCINOGENESIS IN RATS]. SHEN MING-HUA,
QUAN JI-SHU, LIU MING-ZHU,ET AL. shandong journal
of tcm. 2004;23(2):99 (chi*).
3555- gera: 125026/di/ra
[OBSERVATION ON HEPATIC INJURY CAUSED BY
ANTITUBERCULOSIS DRUGS (43 CASES) TREATED
BY METHOD OF REINFORCING THE EARTH TO
GENERATE THE METAL ]. ZHANG JUNMIN. journal
of practical tcm. 2004;20(2):62 (chi*).
3556- gera: 125053/di/ra
[EFFECT OF JINSANE ON EXPRESSION OF TGF-B1,
SMAD3, SMAD7 AND CTGF IN EXPERIMENTAL
RATS WITH HEPATIC FIBROSIS]. SONG SHI-LING,
GONG ZUO-JIONG,ZHANG QUAN-RONG, ET . tianjin
journal of tcm. 2004;21(1):62 (chi*).
3557- gera: 125061/di/ra
[EFFECT OF TAURINE ON THE DEVELOPMENT OF
HEPATIC FIBROSIS IN RATS]. WEI XIN, LIANG JIAN,
MAO DEWEN,ET AL. chinese journal of integrated
traditional and western medicine on digestion.
2004;12(1):6 (chi*).
3558- gera: 125065/di/ra
[EFFECT OF GANZHIKANG CAPSULE ON THE
PREVENTION AND TREATMENT OF
NONALCOHOLIC FATTY LIVER IN RATS]. XIA
JINYU, JIA XUEPING, CHENG LIANGBIN, ET AL.
chinese journal of integrated traditional and western
medicine on digestion. 2004;12(1):15 (chi*).
3559- gera: 125070/di/ra
[PROTECTION OF ELIMINATING HEAT AND
REMOVING DAMPNESS AGAINST CARBON
TETRACHLORIDE (CCI, )-INDUCED ACUTE LIVER
INJURY IN MICE]. WEN BIN, HE SONGQI, WU SHIJIU.
chinese journal of integrated traditional and western
medicine on digestion. 2004;12(1):28 (chi*).
3560- gera: 125076/di/ra
[APPLICATION OF RHUBARB TO PREVENTING
ANTI CURING HEPATIC ENCEPHALOPATHY ].
ZHANG CHIZHI . hubei journal of tcm. 2004;26(2):17
(chi).
3561- gera: 125079/di/ra
[TREATMENT OF EARLY CHRONIC SEVERE TYPE
HEPATITIS WITH EXPELLING THE WIND AND
214
RESOLVING PHLEGM]. GUAN HONGFENG. hubei
journal of tcm. 2004;26(2):28 (chi).
3562- gera: 125090/di/ra
[ON LING E ZHU TANG TREATING ON 80 CAMS OF
FATTY LIVER -COMPARED WITH TREATMENT OF
50 CASES WITH WESTERN MEDICINE]. GUO
SHUICHENG . zhejiang journal of tcm. 2004;39(2):66
(chi).
3563- gera: 125180/di/ra
[OBSERVATION OF SERUM MONOAMINE
OXIDASE ACTIVITY IN HEPATOPATHY]. ZHANG
FENG-JU, ZHAI CHUN-XI. modern journal of integrated
traditional chinese and western medicine. 2004;13(4):441
(chi*).
3564- gera: 125190/di/ra
[EXPERIMENTAL STUDY ON LIVER'S FIBROSIS
TREATED WITH BIEJIAKANGXIAN
PRESCRIPTION ]. RANG RUN YING, ET AL. chinese
journal of traditional science and traumatology.
2004;11(1):16 (chi).
3565- gera: 127105/di/ra
[INFLUENCE OF "TUIGAOHUANG DECOCTION"
ON LIVER TISSUE IN RATS OF EXPERIMENTAL
CHOLESTASIS]. WANG LU-JUN LUO LIN DOU ZHI-
HUA, ET AL. journal of henan university of chinese
medicine. 2004;19(110):55 (chi*).
3566- gera: 127106/di/ra
[PROGRESS OF JAPANESE MODEM KAMPO IN
TREATING AND PREVENTING LIVER DISEASES].
JIANG ZHE-HAO . journal of henan university of chinese
medicine. 2004;19(110):58 (chi*).
3567- gera: 129328/di/ra
[ULTRASTRUCTURE STUDY OF JINSANE ON
EXPERIMENTAL HEPATIC FIBROSIS]. SONG SHI-
LING, GONG ZUO-JIONG, ZHANG QUAN-RONG .
modern journal of integrated traditional chinese and
western medicine. 2004;13(11):1429 (chi*).
3568- gera: 129344/di/ra
[STUDY ON SPOROPHONUM PYRAPOLYPORI
POLYSACCHARIDE EFFECTING ANTI - TUMOR
RATE OF HEPA AND NO CONTENT IN SERUM].
GUO LI-XIN, WANG HONG, YI HE, ET AL. information
on tcm. 2004;21(3):64 (chi).
3569- gera: 129431/di/ra
[THE EFFECT OF RADIX SALVIA MITORRHIAC
INJECTION ON THE BLOOD SERUM TNF OF
ALCOHOLIC LIVER INJURY RAT ]. CHEN
XIAONAN, ZHU XI, FANG ZHIMING. journal of
zhejiang college of tcm. 2004;28(3):37 (chi*).
3570- gera: 129433/di/ra
[THE CHANGES OF CYTOKINE : TNF-A, IL-6,
LEPTIN OF FATTY RATS UNDER HIGH FAT DIET ].
SUN LEWES, CHEN ZHIYUN, YAN MAOXIANG, ET AL
. journal of zhejiang college of tcm. 2004;28(3):41' (chi*).
3571- gera: 129448/di/ra
[EFFECT OF JIEDU LIDAN DECOCTION ON SERUM
VIRUS MARKS IN VIRUS B HEPATITIS ]. LIU XUE-
JIAN . journal of anhui traditional chinese medical
college. 2004;23(3):22 (chi).
gera 2011

3572- gera: 129455/di/ra
[EFFECTS OF FIVE TRADITIONAL CHINESE
MEDICINE INJECTIONS ON SHE PROLIFERATION
OF HUMAN LIVER L-02 CELL LINE]. SHEN XU-BO,
LI BAI, YU CHAO-QIN Z. journal of anhui traditional
chinese medical college. 2004;23(3):38 (chi*).
3573- gera: 129456/di/ra
[EFFECT OF LIVER-AID TABLES ON EXPRESSION
OF TRANSFORMING GROWTH FACTOR BETA-1 IN
RAS HEPATIC FIBROSIS]. WU YI-CHUN, WU QIANG,
YANG YAN, ET AL . journal of anhui traditional chinese
medical college. 2004;23(3):40 (chi*).
3574- gera: 129462/di/ra
[COMPARATIVE ANALYSIS ON MANIFESTATIONS
AND PATHOLOGY OF INFANTILE LIVER
FAILURE: A REPORT OF 30 CASES]. ZHU SHI-SHU,
ZHANG HONG-FEI, CHEN JU-MEI, ET AL. journal of
anhui traditional chinese medical college. 2004;23(3):55
(chi).
3575- gera: 129464/di/ra
[CLINICAL AND EXPERIMENTAL STUDIES ON SHE
TREATMENT OF FATTY LIVER WISH
TRADITIONAL CHINESE MEDICINE]. LIU FENG .
journal of anhui traditional chinese medical college.
2004;23(3):59 (chi).
3576- gera: 129499/di/ra
[PROTECTIVE EFFECTS OF THE ETHANOLIC
EXTRACT FROM POTENTILLA CHINENSIS ON
MICE ACUTE HEPATIC INJURY INDUCED BY
CARBON TETRACHLORIDE ]. LI ZHEN, ZHANG TIE-
QUAN, YE LIANG, ET AL . liaoning journal of tcm.
2004;31(5):422 (chi*).
3577- gera: 129522/di/ra
["HUAIER GRANULE" FOR INTERMEDIATE AND
LATE PRIMARY LIVER CANCER IN 98 CASES].
JIANG MEI,ZHOU DAI-HAN. shanghai journal of tcm.
2004;38(6):21 (chi*).
3578- gera: 129523/di/ra
[" HUAZHI FUGAN GRANULE" FOR 124 CASES OF
FATTY LIVER]. ZHANG XIN, ZHAO YU-SHENG, XUE
JING-DONG, ET AL. shanghai journal of tcm.
2004;38(6):23 (chi*).
3579- gera: 129556/di/ra
[PAIN OF LIVER CANCER TREATED BY
APPLICATION WITH SHUANGBAI POWDER]. LI
YONGHAO. journal of external therapy of tcm.
2004;13(3):26 (chi).
3580- gera: 129617/di/ra
[FANG HEQIAN'S EXPERIENCE ON TREATMENT
OF HEPATO - FIBROSIS ]. SUN WEINA. beijing
journal of tcm. 2004;23(3):143 (chi).
3581- gera: 129635/di/ra
[ EFFECT OF XIAOGURUANJIAN PILL ON BLOOD
TNF, IL-P1, IL-6, NO AND ET-1 OF RATS WITH
LIVER CIRRHOSIS]. QI ZHONGXI, ZHANG YIXIN,
LIU XUERONG, ET AL. chinese journal of integrated
traditional and western medicine on digestion.
2004;12(3):133 (chi*).
3582- gera: 129638/di/ra
[INFLUENCE OF THREE CHINESE MEDICAL
215
THERAPIES ON THE PROLIFERATION AND
TELOMERASE ACTIVITY OF HUMAN
HEPATOCARCINOMA CELLS]. DENG XIN, YANG
DAGUO, JIANG XIAOLING, ET AL . chinese journal of
integrated traditional and western medicine on digestion.
2004;12(3):143 (chi*).
3583- gera: 129651/di/ra
CLINICAL INVESTIGATION ON CHINESE HERB
SEQUENTIAL THERAPY FOR 219 CASES OF LIVER
CANCER WITH EMBOLISM OF PERIPHERAL
HEPATIC ARTERY AT CHEMOTHERAPEUTIC
STAGE. SU XIAOKANG, ZHOU WEISHENG, XU
FABIN, ET AL. journal of tcm. 2004;45(6):434 (eng).
3584- gera: 129657/di/ra
EFFECT OF BAOGANNING ON NUCLEAR FACTOR-
KB IN THE COURSE OF ACUTE DAMAGED LIVER
CELLS. ZHAO JINJUN, LU ZHIPING, ZHANG XUFU,
ET AL. journal of tcm. 2004;45(6):457 (eng).
3585- gera: 129708/di/ra
STUDY PROGRESS AND THINKING ABOUT
CHINESE MEDICINE FOR THE TREATMENT OF
FATTY LIVER. FENG MINGHUI,DU FABIN . hunan
guiding journal of tcm. 2004;10(5):61 (chi*).
3586- gera: 129770/di/ra
[EFFECT OF TRADITIONAL HERBS ON LIPID
SECRETION IN PRIMARY CULTURE OF
HEPATOCYTES OF DOG]. MIAO BIN , CUI
NAIQIANG , ZHAO ERPENG , ET AL. chinese journal of
surgery of integrated traditional chinese and western
medicine. 2004;10(3):203 (chi*).
3587- gera: 129789/di/ra
[CLINIC STUDY OF ANTIHEPATITIS B VIRUS ON
HEPATITIS B IMMUNITY RNA , COMBINED WITH
PILL OF DISPERS HEPATITIS ]. SONG WEI HUANG
YANFANG . inner mongol journal of tcm. 2004;24(3):1
(chi).
3588- gera: 129809/di/ra
[CLINICAL OBSERVATION ON FATTY LIVER
TREATED WITH JIANGZHI YIGAN PILL ,A
REPORT OF 62 CASES ]. JI HUI-PENG,PEI HONG-BIN.
shaanxi journal of tcm. 2004;20(3):13 (chi*).
3589- gera: 129823/di/ra
[ACTIVATING EFFECT OF FUGANJIEDU
FORMULA ON PEROXISOME PROLIFERATOR -
ACTIVATED RECEPTOR - 7 IN THE HEPATIC.
TISSUE IN THE RAT WITH ALCOHOLIC LIVER
DISEASE ]. ZHAO CAIYAN, LIANG BAOLI, JIANG
LINGLING, ET AL. journal of beijing university of tcm.
2004;27(3):43 (chi*).
3590- gera: 129928/di/ra
[47 CASES OF ABDOMINAL SWELLING TREATED
ACCORDING TO THE PRINCIPLE OF
INTEGRATING DISEASE AND SYMPTOM ]. SHEN
LONG-ZHU, GAO HONG, WU ZHAO-HONG, ET AL .
liaoning journal of tcm. 2004;31(6):473 (chi).
3591- gera: 129966/di/ra
[ ZHOU ZHONGYING'S EXPERIENCE IN TREATING
CHRONIC HEPATITIS B WITH CLEARING,
RESOLVING AND REGULATING METHODS ]. CHEN
SIQING , TAO XIAPING . jiangsu journal of tcm.
2004;25(6):43 (chi).
gera 2011

3592- gera: 129997/di/ra
[INHIBITING EFFECT OF THE SERUM CONTAINED
WITH GANZHENG PERORAL SOLUTION ON VEGF
EXPRESSION OF THE HUMAN HEPATOCELLULAR
CARCINOMA SMMC-7721 CELLS ]. CUI LIU-FU, YAO
SHU-KUN, SONG HAI-CHENG, ET AL. chinese journal
of basic medicine in tcm. 2004;10(5):50 (chi).
3593- gera: 130005/di/ra
[OBSERVATION 156 CASES TREATED BY ANTI-
HEPATITICS B VIRUS THERAPIES COMBINING
TRADITIONAL CHINESE AND WESTERN
MEDICINE WITH REGULATING IMMUNITY ].
SHUAI ZAI-LIANG, XIAO CHUN. chinese journal of
basic medicine in tcm. 2004;10(5):77 (chi).
3594- gera: 130049/di/ra
[CLINICAL OBSERVATION ON WRIST ANKLE
ACUPUNCTURE FOR TREATMENT OF PAIN OF
MIDDLE-LATE LIVER CANCER]. HU XIA, LINA
CHANG-QUAN, ZHOU QING-HUI . chinese acupuncture
and moxibustion. 2004;24(3):149 (chi*).
Objective To observe therapeutic effect of stone needle
therapy on primary dysmenorrhea. Methods Twenty-one
cases of primary dysmenorrhea were divided into three types,
stagnation of Qi and blood stasis, accumulation of cold and
dampness, deficiency of Qi and blood, and treated by 16
manipulations of stone needle therapy using Bian-stone cone
made by Sibin float-stone. Results Three cases were
markedly effective, 15 cases were effective and 3 cases were
ineffective. Conclusion Stone needle therapy is a safe and
effective for primary dysmenorrhea.
3595- gera: 130113/di/ra
[QUANTIFIED STANDARDS FOR LIVER-
GALLBLADDER DAMPNESS-HEAT SYNDROME OF
PRIMARY LIVER CANCER]. HOU FENG-GANG
ZHAO GANG HE XIAN-MIN,ET AL. acta universitatis
traditionis medicalis sinensis pharmacologiaeque
shanghai. 2004;18(1):31 (chi*).
This article establishes the quantified standards for liver-
gallbladder dampness-heat syndrome of primary liver cancer.
On the basis of epidemiological survey, the factors related to
the syndromes of and of no liver-gallbladder dampness-heat
are quantified and scored, hence to set up the standards.
Results:The diagnostic standard for liver- gallbladder
dampness-heat was 26 points; its retrospective and
prospective sensitivity, specificity and accuracy were over
90% ;positive ratios were 12. 68 and 11. 78 ; grading
standards were 26 - 35 points for mild syndrome, 36 - 45
points for moderate syndrome , and over 46 points for severe
syndrome. It is showed that this standard is of
3596- gera: 130139/di/ra
[A STUDY ON THE EXTRACTING TECHNOLOGY
FOR ZINC-METALLOTHIONEIN IN RABBIT
LIVER]. WU PING PENG XINJUN, HE BIN, ET AL .
journal of tcm university of hunan. 2004;24(3):48 (chi*).
3597- gera: 130172/di/ra
[EFFECTS OF YINSHAOSAN ON IMMUNOLOGIC
FUNCTION OF PATIENTS WITH CHRONIC
HEPATITIS B WITH SYNDROME OF
ACCUMULATION OF DAMP - HEAT IN SPLEEN ].
CHEN JINFANG ET AL . china journal of tcm and
pharmacy. 2004;19(6):352 (chi).
3598- gera: 130248/di/ra
[PROF. ZHOU FU - SHENG' S EXPERIENCE ON THE
216
TREATMENT OF ASCITES DUE TO CIRRHOSIS ].
HU LI-JUAN. new journal of tcm. 2004;36(7):5 (chi*).
Prof. ZHOU put stress on strengthening the spleen for the
treatment of ascites due to cirrhosis. Normal functioning of
stomach - spleen guarantees the transportation of essence and
reduces fluid retention, but tonifying the kidney should not be
ignored. The therapy of activating blood circulation and
removing blood - stasis should be maintained throughout the
whole course of the disease. Since the mass and ascites will
be reduced after blood - stasis is dispersed and the blood
circulates smoothly. The combination of the principle of
elimination and tonification should be followed. For cases
attributive to deficiency of spleen or deficiency of both
spleen and kidney, the therapy of strengthening spleen and
ben-fiting qi, or streng thening spleen and benefiting kidney
should be applied to support the healthy qi; for cases
attributive to qi stagnation, damp retention and accumulation
of damp - heat, the therapy of elimination should be
emphasized, and activating qi, discharging
3599- gera: 130287/di/ra
[TCM RESEARCH OF CHRONIC HEPATITIS B
ASTHENIA AND STHENIA SYNDROMES IN
RELATION TO HEPATIC FIBROSIS]. CHEN YUN, DU
JIAN, WANG YU-HAI. fujian journal of tcm. 2004;35(3):1
(chi ).
3600- gera: 130288/di/ra
[STUDY ON CLINICAL CHARACTERISTIC OF
SYNDROME TYPES OF TCM IN PATIENTS WITH
CHRONIC HEPATITIS B]. WU RUI, JIANG YI-PING, LI
GUO-XIAN. fujian journal of tcm. 2004;35(3):3 (chi).
3601- gera: 130296/di/ra
[TREATMENT PRINCIPLE FOR LIVER FIBROSIS ].
LU LIANGWEI, LOU GUOQIANG. journal of zhejiang
college of tcm. 2004;28(4):1 (chi).
3602- gera: 130329/di/ra
[EFFECTIVE OBSERVATION OF FLAVESCENT
SOPHORA ROOT INJECTION ON CHRONIC
HEPATITIS B]. DENG HAI-PENG TANG TIAN-WU.
journal of laoning college of tcm. 2004;6(4):311 (chi).
3603- gera: 130331/di/ra
[CLINICAL OBSERVATION ON TREATING FATTY
LIVER AFTER HEPATITIS B WITH TCM AND WM
COMBINED]. LU NING . journal of laoning college of
tcm. 2004;6(4):100 (chi).
3604- gera: 130372/di/ra
[STUDY OF LIPO-PROSTAGLANDIN EL ON
SERIOUS CHOLESTASIS OF VIRUS HEPATITIS].
ZHOU HUA-JIAN, LI SHAO-GUANG, YANG XIAO-
YUN, ET AL. modern journal of integrated traditional
chinese and western medicine. 2004;13(13):1704 (chi*).
3605- gera: 130395/di/ra
[EXPERIENCE OF LIU DUZHOU TREATING LIVER
DISEASES ]. JIANG YAN. liaoning journal of tcm.
2004;31(7):533 (chi).
3606- gera: 130417/di/ra
[EFFECT OF PRESCRIPTION FOR SOFTENING
LIVER AND DISPERSING HARD MASSES ON
HEPATIC FIBROSIS OF EXPERIMENTAL RATS].
WANG YAN-PING, GAO ANG, GAO LENG, ET AL.
journal of nanjing university of tcm. 2004;20(4):219 (chi).
3607- gera: 130421/di/ra
gera 2011

[EXPERIMENTAL STUDY ON EFFECT OF HUGAN
YIFEI GRANULE IN PREVENTING LIVER DAMAGE
BY OXOGENIC PARAMISAN SODIUM]. WU QIAN-
HU, MIAO JIA-WEN, SHENG JIAN-HUI. journal of
nanjing university of tcm. 2004;20(4):231 (chi).
3608- gera: 130547/di/ra
[CLINICAL OBSERVATION ON CHRONIC SEVERE
HEPATITIS CAUSED LIVER CIRRHOSIS MAINLY
TREATED BY CONSTITUTION CONSOLIDATION
AND RESOLVING BLOOD STASIS PRINCIPLE].
WANG ZHI-HUA . chinese journal of integrated
traditional and western medicine. 2004;24(7):647 (chi).
3609- gera: 130559/di/ra
[CLINICAL OBSERVATION OF MATRINE
COMBINED WITH DIAMMONIUM
GLYCYRRHIZINATE IN THE TREATMENT OF 32
CHRONIC HEPATITIS B PATIENTS ]. YANG FU-TAI,
ET AL. chinese journal of information on tcm.
2004;11(7):586 (chi*).
3610- gera: 130593/di/ra
[EXPERIMENTAL STUDY ON ANTI - OXIDATION
EFFECT OF KADSURAE COCCINEA ON RATS
WITH EXPERIMENTAL HEPATIC FIBROSIS]. QU
KE-YI, DONG YAN-PING, LI SHOU-HUA , ET AL.
chinese journal of traditional medical science and
technology. 2004;11(4):222 (chi*).
3611- gera: 130598/di/ra
[SOME PROBLEMS OF RESEARCH OF COMBINED
TRADITIONAL CHINESE AND WESTERN
MEDICINE ON HEPATIC DISEASE]. YIN CHANG-
JIAN. journal of shandong university of tcm.
2004;28(4):242 (chi).
3612- gera: 130680/di/ra
[INFLUENCE OF BAIHE GUJIN DECOCTION ON
MEDICAMENTOUS LIVER LESION CAUSED BY
ANTIPHTHISIC MEDICINE]. WANG CHANGMIN, ET
AL . hubei journal of tcm. 2004;26(7):40 (chi).
3613- gera: 130688/di/ra
[EFFECTS OF BIEJIAJIANWAN ON COLLAGEN IN
RAT WITH IMMUNE HEPATIC FIBROSIS AND
EXPRESSION OF ITS RELATED CYTOKINES ]. XIE
SNIPING ET AL. china journal of tcm and pharmacy.
2004;19(7):412 (chi).
3614- gera: 130747/di/ra
[EFFECT OF TRADITIONAL CHINESE MEDICINE
JINSANE ON INTESTINAL PERMEABILITY OF
LIVER FIBROSIS RATS]. RUAN PENG, ZHANG
QUAN-RONG, GONG ZUO-JIONG . modern journal of
integrated traditional chinese and western medicine.
2004;13(14):1838 (chi*).
3615- gera: 130757/di/ra
[A SUMMARY ON 32 CASES OF EARLY CIRRHOSIS
TREATED WITH THE THERAPY OF
REPLENISHING QI TO INVIGORATE THE SPLEEN
AND REMOVING BLOOD STASIS. AND FOOD
STAGNANCY ]. REN ZEJIU, ET AL. hunan journal of
tcm. 2004;20(4):17 (chi).
3616- gera: 130758/di/ra
[A SUMMARY ON 52 CASES OF CHRONIC
HEPATITIS B TREATED WITH COMBINATION OF
CHINESE TRADITIONAL AND WESTERN
217
MEDICINE ]. GUO WEI, ET AL. hunan journal of tcm.
2004;20(4):19 (chi).
3617- gera: 130759/di/ra
[THE TITTLE-TATTLE OF CLINICAL TREATMENT
OVER THE LIVER AND GALLBLADDER DISEASE].
CHEN KUN-SHAN,DAI QI. jiangxi journal of tcm.
2004;35(7):5 (chi).
3618- gera: 130769/di/ra
[EXPERIENCE OF TREATMENT OVER THE
ADVANCED STAGE OF HEPATIC CIRRHOSIS
ASCITES COMBINED WITH TRADITIONAL
CHINESE MEDICINE AND WESTERN MEDICINE].
YU YOU-MING. jiangxi journal of tcm. 2004;35(7):46
(chi).
3619- gera: 130809/di/ra
[CLINICAL SIGNIFICANCE OF HEPATITIS B AND C
VIRUS ANTIGEN EXPRESSION IN GASTRIC
MUCOSA OF PATIENTS WITH CHRONIC LIVER
DISEASE ]. KONG QINGYAN, CHEN NAILING, GE
YANG, ET AL. chinese journal of integrated traditional
and western medicine on liver diseases. 2004;14(3):132
(chi*).
3620- gera: 130810/di/ra
[CLINICAL STUDY OF COMPOUND FORMULA
QINGDUTANG ON INTESTINAL ENDOTOXEMIA IN
PATIENTS WITH LIVER DISEASE]. WANG
RONGBING, LIU JUNMIN, WU YUNZHONG, ET AL.
chinese journal of integrated traditional and western
medicine on liver diseases. 2004;14(3):135 (chi*).
3621- gera: 130811/di/ra
[CLINICAL STUDY OF KANGXIANSAN SOUP TO
PREVENT LIVER FIBROSIS IN PATIENTS WITH
CHRONIC HEPATITIS B]. DING TILONG, MA YONG,
YAN JIACHUN, ET AL. chinese journal of integrated
traditional and western medicine on liver diseases.
2004;14(3):138 (chi*).
3622- gera: 130812/di/ra
[TCM RESEARCH OF CHRONIC HEPATITIS
ASTHENIA AND STHENIA SYNDROMES IN
RELATION TO HEPATIC FIBROSIS]. CHEN YUN,
JIANG HONG, WANG YUHAI. chinese journal of
integrated traditional and western medicine on liver
diseases. 2004;14(3):140 (chi*).
Objective: To study the relationship of TCM syndromesto
hepatic indexes and the pathology grade and stage. Methods:
Hepatic fibrosis indexes were measured with
radioimmunoassay (RIA), in 75 patients with chronic liver
disease from June 2002 to July 2003. Hepatic biopsy was
performed for 20 patients. A normal control group of 15 were
measured at the same time. Results: ( Hepatic fibrosis
indexes were higher in the sthenia syndrome group. The
difference between the two groups were significant. ©2
There was a positive correlation between the pathology grade
and stage with hepatic fibrosis indexes. Conclusion: 1
Hepatia fibrosis indexes provide objective evidence for TCM
syndrome typing (2 )Cases; with damp-heat stagnation
syndrome and blood - stasis blocking collateral syndrome
occur in the active stage of hepatic fibrosis. The therapeutic
principle to prevent hepatic fibrosis were clearing away
dame-heat evil and removing blood stasis to activate the
vessels.
3623- gera: 130813/di/ra
[OBSERVATION ON THE CHANGES OF LIVER
gera 2011

FUNCTION AND FIBROSIS SERUM MARKERS IN
BLOOD STASIS SYNDROME OF CHRONIC
HEPATITIS B ]. CEN YUWEN. chinese journal of
integrated traditional and western medicine on liver
diseases. 2004;14(3):143 (chi*).
Objective: To observe the changes of liver function and
fibrosis serum markers in blood stasis Syndrome of chronic
hepatitis B. Methods: 52 patients with chronic hepatitis B
were divided into group 1 (blood stasis) and group 2
(nonblood stasis) according to clinical symptoms. Serum
ALT, AST, Alb, G1b, A/G, HA, LN, IV -C, PC III were
measured in the above patients. Results: The serum levels of
HA, LN, IV -C were gradually increased in group 1, there
was significant difference between the two groups (P<0.05).
But there were no change in serum ALT, AST, Alb, G1b,
A/G, PC III . Conclusion: In the patients with chronic
hepatitis B, there is a significant correlation between blood
stasis Syndrome and liver fibrosis.
3624- gera: 130814/di/ra
[STUDY ON THE UP-REGULATION EFFECTS OF
HEPATITIS B VIRUS X PROTEIN ON
INTERLEUKIN-18 GENE EXPRESSION]. LIU WEI,
WANG JIANJUN, CHENG JUN, ET AL. chinese journal
of integrated traditional and western medicine on liver
diseases. 2004;14(3):145 (chi*).
3625- gera: 130816/di/ra
[BOAIWAN'S EFFECT ON CELL CYCLE AND
RELATED GENE EXPRESSION OF HUMAN
HEPATOCELLUAR CARCINOMA CELL LINE
HEPG2 ]. LIU JIAN, XIE HONGDONG, LI HANMING,
ET AL. chinese journal of integrated traditional and
western medicine on liver diseases. 2004;14(3):152 (chi*).
3626- gera: 130817/di/ra
[EFFECTS OF XIAOZHIHUGAN DECOCTION ON
LIPID PEROXIDATION OF NONALCOHOLIC
FATTY LIVER OF RAT]. ZHANG ZHUO, GU KEBO, LI
DAOBEN, ET AL. chinese journal of integrated
traditional and western medicine on liver diseases.
2004;14(3):155 (chi*).
3627- gera: 130818/di/ra
[THE SUPPRESSOR EFFECT OF YOGA CAPSULE
ON THE 2.2.15 CELL SECRETING HBSAG AND
HBEAG]. TAN XINHUA, WANG JIAN, WU
MAOSHENG, ET AL. chinese journal of integrated
traditional and western medicine on liver diseases.
2004;14(3):158 (chi*).
3628- gera: 130819/di/ra
[EFFECT OF PHENYLPROPANOLID GLYCOSIDES
OF SCROPHULARIA NINGPOENSIS ON
HEPATOCELLULAR APOPTOSIS IN RATS WITH
ACUTE LIVER INJURY ]. HUANG CAIGUO, LI
YIMING, HE XIANG, ET AL. chinese journal of
integrated traditional and western medicine on liver
diseases. 2004;14(3):160 (chi*).
3629- gera: 130820/di/ra
[STUDY ON THE RELATIONSHIP BETWEEN THE
HBV PRE-C MUTANT AND THE LEVELS OF T
SUBPOPULATION AND SLI-2R]. WAN XUEFA, XIAO
HONG, REN SONG, ET AL. chinese journal of integrated
traditional and western medicine on liver diseases.
2004;14(3):164 (chi*).
3630- gera: 130852/di/ra
[OBSERVATION ON THERAPEUTIC EFFECT OF
218
SANJINPAISHI DRINK IN TREATING VIRD
HEPATITIS COMPLICATED BY CHOLELITH ].
ZHOU HONG, JIN CHUN-YING, LUAN WEI, ET AL. acta
chinese medicine and pharmacology. 2004;32(3):44 (chi*).
3631- gera: 130871/di/ra
[EFFECTS OF GANZHIKANG CAPSULE ON
ULTRASTRUCTURE CHANGES IN NON-
ALCOHOLIC FATTY LIVER RATS]. XIA JINYU, JIA
XUEPING, CHENG LIANGBIN. journal of tcm .
2004;45(3):220 (chi*).
3632- gera: 130878/di/ra
[CLINICAL OBSERVATION ON TREATMENT OF
VIRAL HEPATITIS OF BABY'S GIANT CELL BY
COMBINATION TRADITIONAL CHINESE
MEDICINE AND GENCILOVIR]. ZHEN XIAOFANG,
ET, AL. beijing journal of tcm. 2004;23(2):76 (chi).
3633- gera: 130896/di/ra
[TREATMENT OF SEVERE SUBACUTE HEPATITIS
BY TCM COMBINED WITH WESTERN MEDICINE:
A CLINICAL OBSERVATION OF 23 CASES]. ZHENG
HONG-ZHONG, ZHANG YUAN-HAO, LIN SHAO-H. new
journal of tcm. 2004;36(4):36 (chi*).
3634- gera: 130936/di/ra
[ OBSERVATION ON THERAPEUTIC EFFECT OF
ACUPUNCTURE AND MOXIBUSTION ON FATTY
LIVER ]. LI QI JIAO . chinese acupuncture and
moxibustion. 2004;24(4):(243 (chi*).
Objective To probe methods and therapeutic effects of
treating fatty liver from regulating kidney. Methods The
patients were divided in order of visiting into acupuncture
and moxibustion group (n=46) and control group (n=30).
They were treated for two months and improvement of main
symptoms and objective indexes were compared between the
two groups. Results The total effective rate was 91. 3% in the
treatment group and 73. 3% in the control group with a
significant difference between the two groups (PAO. 05).
Conclusion Treatment of acupuncture and moxibustion from
regulating kidney has a better therapeutic effect on fatty liver.
3635- gera: 130994/di/ra
[CORRELATIVITY BETWEEN HEPATOSPLENIC
ULTRASONIC RESULTS AND LIVER FIBROSIS
INDEXES IN PATIENTS WITH HEPATITIS B ]. HE
ZHENG LI YU-GUO GAO YUE-QIU . acta universitatis
traditionis medicalis sinensis pharmacologiaeque
shanghai. 2004;18(2):26 (chi*).
3636- gera: 131001/di/ra
[EFFECTS OF EXTRACTS OF RHIZOMA
PICRORHIZAE ON RATS' PRIMARY CULTURE
HEPATOCYTES INJURED BY CC14 AND D-GAIN].
ZHANG JIAN-QIANG CHEN MIN LI YI-KUI . acta
universitatis traditionis medicalis sinensis
pharmacologiaeque shanghai. 2004;18(2):42 (chi*).
3637- gera: 131031/di/ra
[CLINICAL STUDY ON KURARINONE INJECTION
IN TREATING CHRONIC HEPATITIS B]. QI
YANPING, ZHENG YINGJUN, XU SHAOMIN, ETC.
henan tcm. 2004;24(6):27 (chi*).
3638- gera: 131038/di/ra
[ DEVELOPMENT OF TCM IN TREATING CHRONIC
HEPATITIS B]. LI YI, CAILIN . henan tcm. 2004;24(6):83
(chi).
gera 2011

3639- gera: 131040/di/ra
[MECHANISM OF ACTION IN TCM TREATMENT
ON PRIMACY CARCINOMA OF LIVER]. LIAO
YUNYUN WANG NAIPING. guanxi journal of tcm.
2004;27(3):4 (chi).
3640- gera: 131050/di/ra
[REPORT OF FATTY LIVER TREATED WITH
COMBINATION OF ERCHEN DECOCTION AND
XIAOYAO SAN ]. CHEN LIQUN, YU HAIFENG, WANG
WEIZHUN. hebei journal of tcm. 2004;26(6):435 (chi*).
3641- gera: 131067/di/ra
[SUPERFICIAL VIEWS ON PREVENTION AND
TREATMENT OF HEPATIC FIBROSIS]. ZHANG
WENYONG, ZHANG MINQING . journal of tcm.
2004;45(7):543 (chi).
3642- gera: 131111/di/ra
[DISCUSSION ON THERAPEUTIC PRINCIPLES OF
TREATING LIVER CANCER WITH TCM ]. XIE
YIZHUANG ET AL . china journal of tcm and pharmacy.
2004;19(3):171 (chi).
3643- gera: 131159/di/ra
[THE DEVELOPMENT OF THE STUDY ON THE
DEATH OF OLD AGE OF LIVER CANCER CELLS
INDUCED BY CHINESE HERBS ]. CHENG WEI-
DONG, ET AL . gansu journal of tcm. 2004;17(4):44 (chi).
3644- gera: 131206/di/ra
[EFFECTS OF KANGXIAN CAPSULE I ON SERUM
TNF-A IN RAT WITH HEPATIC FIBROSIS]. JIANG
MING ET AL. china journal of tcm and pharmacy.
2004;19(5):306 (chi).
3645- gera: 131213/di/ra
[EFFECT OF; SALIDROSIDE ON APOPTOSIS OF
RAT HEPATIC STELLATE CELLS STIMULATED BY
ACETALDEHYDE]. ZHONG XIANFEI, JIANG
MINGDE, MA HONGDE, ET AL. traditional chinese drug
research and clinical pharmacology. 2004;15(3):161
(chi*).
3646- gera: 131263/di/ra
[CLINICAL STUDIES ON TCM SYNDROME
DIFFERENTIATION AND TREATMENT OF
HEPATITIS B ]. LI XIAOYUE. journal of henan
university of chinese medicine. 2004;6(3):32 (chi*).
Objective: To examine the syndrome differentiation and
treatment of hepatitis B. Method: 23 cases of the control
group were given orally Bifendate Tablets , Vitamin C
Tablets, Compound Vitamin B Tablets, Glucuronolactone
and Inosine. 83 cases of the treatment group, according to the
different types of syndromes, were treated respectively with
modification of Yinchenhao Decoction, Xiaoyao Powder,
Chaishao Liujunzi Decoction, Yiguan Decoction. One course
of treatment covered three months. Result: The effective rate
in the treatment group reached 69. 88% while the rate in the
control group amounted to 39. 13% . And there was marked
contrast between the two groups (P<0.01). Conclusion:
Syndrome differentiation of hepatitis B and planing treatment
3647- gera: 131306/di/ra
[THEORETICAL AND RESEARCH BASIS FOR
TREATMENT OF VIRAL HEPATITIS WITH
XIAOCHAIHU DECOCTION ]. YE FANG . jiangsu
journal of tcm. 2004;25(7):9 (chi).
3648- gera: 131347/di/ra
219
[EFFECT OF PS - T AND IL - 2 ON PTEN AND IL - 2R
POSITIVE CELLS IN EXPERIMENTAL HEPATIC
CARCINOMA]. LU PENG CHEN LI, LU ZHENG-XIN .
modern journal of integrated traditional chinese and
western medicine. 2004;13(15):1982 (chi*).
3649- gera: 131349/di/ra
[EXPERIMENTAL STUDY OF JIANGZHIKELI ON
PREVENTION AND TREATMENT OF FATTY
LIVER]. XIA GUO-DONG , XIE CHAO-LIANG , YANG
HUA-XIU, ET A. modern journal of integrated traditional
chinese and western medicine. 2004;13(15):1988 (chi*).
3650- gera: 131428/di/ra
[ TREATMENT BY ST-*ES FOR VIRUS B HEPATIC
DISEASES]. REN ZANYI. henan tcm. 2004;24(7):58 (chi).
3651- gera: 131494/di/ra
USO COMBINATO DI TONIFICAZIONE E
PURGAZIONE NELLA TERAPIA DELLA STENOSI
EPATICA. ZHAN YONGLI. rivista italiana di medicina
tradizionale cinese. 2004;95(1):31 (ita*).
3652- gera: 131512/di/ra
ANALISI PRELIMINARE DEGLI EFFETTI
REGOLATORI DI DIVERSI TRATTAMENTI DI MTC
SULLA TRASCRIZIONE DEI GENI CORRELATI DEL
CANCRO AL FEGATO NEI RATTI. GUANG
DONGYUAN ED ALTRI. rivista italiana di medicina
tradizionale cinese. 2004;95(1):68 (ita*).
3653- gera: 131647/di/ra
[THE STUDY DEVELOPMENT OF HEPATITIS B
TREATED WITH TCM]. LIU SHI-JING, ZHU QIAN.
acta chinese medicine and pharmacology. 2004;32(5):6
(chi).
3654- gera: 131677/di/ra
[PROFESSOR LIU PING'S EXPERIENCE IN
TREATING LIVER CIRRHOSIS]. MU YONG-PING
WANG LEI . acta universitatis traditionis medicalis
sinensis pharmacologiaeque. 2004;18(3):29 (chi*).
This paper introduces professor Liu Ping's experience in the
treatment of liver cirrhosis: focusing on the basic mechanism
in pathogenesis, determining the healthy and pathogenic
factors in treatment and herbal combination
3655- gera: 131765/di/ra
[CLINICAL OBSERVATION ON TREATMENT OF 64
CASES OF FATTY LIVER AFTER VIRAL HEPATITIS
B BY SELF - MADE TIAOGAN JIANGZHI TANG].
LIU LIHUA, LIU XIULIN. beijing journal of tcm.
2004;23(5):276 (chi).
3656- gera: 131772/di/ra
[THE TREATMENT OF CIRRHOSIS AFTER
HEPATITIS BY MEANS OF PATENT
IDENTIFICATION]. SHI HUAIZHI, LI JIANSHENG.
beijing journal of tcm. 2004;23(5):318 (chi).
3657- gera: 131798/di/ra
[EFFECTS OF GANLANJIEJIUYIN ON
PATHOLOGIC PICTURE OF ACUTE ALCOHOLIC
LIVER INJURY IN RAT]. PENG BO ET AL . china
journal of tcm and pharmacy. 2004;19(8):468 (chi).
3658- gera: 131803/di/ra
[CLINICAL OBSERVATION ON TREATING FATTY
LIVER CAUSED BY HYPERLIPEMIA WITH BOTH
TIAOZHIJIAONANG AND GANLIXINJIAONANG].
gera 2011

HUANG BIN. china journal of tcm and pharmacy.
2004;19(8):482 (chi).
3659- gera: 131829/di/ra
[EXPERIMENTAL PHARMACODYNAMIC
RESEARCH OF GANZHIXIAO CAPSULE IN
RESISTING FATTY LIVER IN RAT]. XIE CHUN'E ET
AL. china journal of tcm and pharmacy. 2004;19(9):561
(chi).
3660- gera: 131903/di/ra
[EFFECTS OF DANSHEN INJECTION ON SERUM
ALT AND AST IN ALCOHOLIC HEPATIC INJURY
RATS]. YU LI-PING,CHEN XIAO-NAN,FAND ZHI-
MING. chinese journal of basic medicine in tcm.
2004;10(7):62 (chi*).
3661- gera: 131956/di/ra
[OBSERVATION OF CURATIVE EFFECT ON
TREATING CHRONIC HEPATITIS B WITH
TIBETAN MEDICINE]. HAN XIANG-YING. chinese
journal of ethnomedicine and ethnopharmacy.
2004;8(4):210 (chi).
3662- gera: 131986/di/ra
[CLINICAL SUMMARY OF TREATING 180 CASES
OF CHRONIC HEPATITIS B WITH THE
COMBINATION OF THE TRADITIONAL CHINESE
MEDICINE AND THE WEST MEDICINE .]. LIU XU-
SEN. chinese journal of ethomedicine and
ethnopharmacy. 2004;10(5):272 (chi).
3663- gera: 132010/di/ra
[CLINICAL STUDY OF RUANGAN ZAISHENG
GRANULES FOR ANTIFIBROSIS ON CHRONIC
HEPATITIS B]. WANG LI-DONG. chinese journal of
information on tcm. 2004;11(8):672 (chi*).
3664- gera: 132018/di/ra
[EXPERIMENTAL STUDY OF JIAWEISINISAN ON
RATS LIVER TISSUE PPAR AMRNA OF FATTY
LIVER MODEL RATS]. PENG HAN-GUANG, ET AL .
chinese journal of information on tcm. 2004;11(8):690
(chi*).
3665- gera: 132072/di/ra
[CLINICAL STUDY ON MANIFESTATION OF
HEPATOLENTICULAR DEGENERATION
COMPLICATED WITH EPILEPSY AND
THERAPEUTIC EFFECT OF INTEGRATIVE
CHINESE AND WESTERN MEDICINE
TREATMENT*]. HU JI-YUAN, WANG GONG-QIANG,
CHENG NAN, ET AL . chinese journal of integrated
traditional and western medicine. 2004;24(9):793 (chi*).
3666- gera: 132074/di/ra
[A 16-YEAR CLINICAL OBSERVATION ON 217
CHRONIC HBSAG CARRIERS*]. LI FU-SHAN, CHEN
LONG-HUA , TANG XI-FENG, ET AL . chinese journal of
integrated traditional and western medicine.
2004;24(9):801 (chi*).
3667- gera: 132075/di/ra
[RELATIONSHIP OF PLASMA ENDOTOXIN LEVEL
WITH TCM DEFICIENCY/ EXCESS SYNDROME
AND GRADING/ STAGING OF PATHOLOGIC
CHANGE OF LIVER IN PATIENTS WITH CHRONIC
HEPATITIS*]. CHEN YUN, DU JIAN, WANG YU-HAI .
chinese journal of integrated traditional and western
medicine. 2004;24(9):805 (chi*).
220
3668- gera: 132085/di/ra
[CLINICAL OBSERVATION ON THE TREATMENT
OF MIDDLE-LATE STAGE LIVER CARCINOMA BY
COMBINED THERAPY OF HEPATO-ARTERIAL
CHEMO-EMBOLISING AND CHINESE DRUGS FOR
STRENGTHENING PI AND REGULATING QI]. REN
HUA-PING, CHENG LIN . chinese journal of integrated
traditional and western medicine. 2004;24(9):838 (chi).
3669- gera: 132117/di/ra
[CLINICAL OBSERVATION OF COMBINED
THERAPY OF XINGANBAO AND HEPATOCYTE
GROWTH-PROMOTING FACTOR ON CHRONIC
HEPATITIS B]. XIN YONGNING, SUN YING, SUN
ZHENJUAN, ET AL. chinese journal of integrated
traditional and western medicine on digestion.
2004;12(4):225 (chi*).
3670- gera: 132118/di/ra
[RELATIONSHIP BETWEEN MICROCOSMIC
DISTINGUISH TYPE OF GASTRIC DYSPLASIA AND
THE EXPRESSION OF CDX2 AND ITS
SIGNIFICANCE IN FOLLOW-UP STUDY]. LIN
YIFAN, WANG CHANGHONG, LIU JIE,ET AL. chinese
journal of integrated traditional and western medicine on
digestion. 2004;12(5):257 (chi*).
[ Objective ] To study the relationship between microcosmic
distinguish type of gastric precancerous lesions and the
expression of CdX2 and its significance in follow - up study.
[Methods] One hundred and twenty cases of gastric
precancerous lesions (dysplasia and metaplasia) were
microcosmic divided distinguishally into four types by
endoscopies according to Zang - fu distinguish theory of
traditional Chinese medicine. The expression of CdX2 was
studied by ABC immunohistochemical method. [Results] The
expression of CdX2 in the Type Gastric Net Resort (TGNR)
and Gastric Net Burn (TGNB) ( 37. 5 % , 66. 7 % ) were
higher than that of the groups of Type Gastric Cold (TGC)
and Type Gastric Hot ( TGH ) (6.7 % , 12. 5 %) ( P < 0. 01) .
Sixty-three cases were followed up for 6 to 72 months. There
were 23 cases of TGNR in the 30 cases of cancer formation
group, but 9 in 33 cases of no cancer formation group ( P < 0.
01) . [ Conclusion] The gastric precancerous lesions
(dysplasia and metaplasia ) with TGNR have a close
relationship to cancer formation, and need to pay more
attention in the distinguish treatment.
3671- gera: 132119/di/ra
[EFFECT OF ROUGAN GRANULE ON THE
EXPRESSION OF TRANSFORMING GROWTH
FAC-TOR B1 AND COLLAGEN IN RAT HEPATIC
SATELLITE CELLS]. ZHANG BIN, ZHAO GANG,
WANG LINGTAI,ET AL. chinese journal of integrated
traditional and western medicine on digestion.
2004;12(5):260 (chi*).
3672- gera: 132120/di/ra
[EFFECT OF GANZHIFU DECOCTION ON
EXPERIMENTAL FATTY LIVER RATS INDUCED BY
HIGH FAT FEEDING]. GAO ZHIQIANG, LU
FUER,DONG HUI, ET AL . chinese journal of integrated
traditional and western medicine on digestion.
2004;12(5):263 (chi*).
3673- gera: 132121/di/ra
[EXPERIMENTAL STUDY OF ANTI-LIVER
FIBROSIS OF ZHUANGGAN ZHUYU DECOCTION].
LIN SHOUNING, HUANG GUIHUA, WANG
ZHENCHANG, ET AL. chinese journal of integrated
gera 2011

traditional and western medicine on digestion.
2004;12(5):267 (chi*).
3674- gera: 132127/di/ra
[[]CHANGE OF HEMORHEOLOGY INDEXES IN
NONALCOHOLIC FATTY LIVER PATIENTS OF
BLOOD CONGESTION TYPE]. XIE JIWEN, LI
HONGCHUN, YANG SHENGLAN, ET AL. chinese
journal of integrated traditional and western medicine on
digestion. 2004;12(5):284 (chi*).
3675- gera: 132128/di/ra
[CURATIVE EFFECTS OF LAMIVUDINE AND
YIGANKANG ON THIRTY-TWO CASES OF
CHRONIC HEPATITIS B]. CHEN ZHISHUI, LI
CHUNLEI, WANG KONGJUN . chinese journal of
integrated traditional and western medicine on digestion.
2004;12(5):286 (chi*).
3676- gera: 132129/di/ra
[CLINICAL EFFECT OF YINZHIHUANG INJECTION
AND PROGLUMIDE ON HEPATOGE- NOUS
JAUNDICE]. ZHU JINZHAO, ZHANG ZHONGJIAN .
chinese journal of integrated traditional and western
medicine on digestion. 2004;12(5):289 (chi*).
3677- gera: 132130/di/ra
[STUDY OF DIFFERENT SUBTYPE OF T CELL
AMONG VARIOUS TYPES OF INFECTED PERSON
WITH CHRONIC HBV]. GAO YUEQIU, SUN XUEHUA,
ZHANG XIAOYING, ET AL. chinese journal of
integrated traditional and western medicine on liver
diseases. 2004;14(4):195 (chi*).
3678- gera: 132131/di/ra
[DYNAMIC CHANGES OF HEPATITIS B VIRUS DNA
IN SERUM AND IN PERIPHERAL MONONUCLEAR
CELLS IN THE PATIENTS WITH LAMIVUDINE
THERAPY]. KE CHANGZHENG, CHEN YUE, GONG
ZUOJIONG, ET AL. chinese journal of integrated
traditional and western medicine on liver diseases.
2004;14(4):197 (chi*).
3679- gera: 132132/di/ra
[RELATIONSHIP BETWEEN HISTOLOGY OF LIVER
TISSUE AND EFFECT OF INTERFERON-ALPHA
TREATMENT IN PATIENTS WITH CHRONIC
HEPATITIS B*]. YANG QUN, REN XINGFENG, LI
JING'AN, ET AL. chinese journal of integrated traditional
and western medicine on liver diseases. 2004;14(4):200
(chi*).
3680- gera: 132133/di/ra
[TREATMENT OF CHRONIC HEPATITIS C WITH
KURORINONE INJECTION IN COMBINATION
WITH INTERFERON A*]. YIN MINGSHI, PIAO
HONGXIN, HAN XUEJI, ET AL. chinese journal of
integrated traditional and western medicine on liver
diseases. 2004;14(4):202 (chi*).
3681- gera: 132134/di/ra
[EFFECTS OF ANLUOHUAXIAN CAPSULE ON
HEPATIC FIBROSIS INDEXES IN PATIENTS OF
CHRONIC HEPATITIS*]. HUANG QIWEN. chinese
journal of integrated traditional and western medicine on
liver diseases. 2004;14(4):206 (chi*).
3682- gera: 132135/di/ra
[SCREENING OF BINDING PROTEIN TO THE CORE
PROMOTER DNA OF HEPATITIS B VIRUS BY
221
PHAGE DISPLAY FROM HUMAN LIVER CDNA
LIBRARY]. GAO XUESONG , CHENGJUN, ZHENZHEN,
ET AL. chinese journal of integrated traditional and
western medicine on liver diseases. 2004;14(4):209 (chi*).
3683- gera: 132136/di/ra
[[]CLONING OF HUMAN GENE 2
TRANSACTIVATED BY PRE-SI PROTEIN OF
HEPATITIS B VIRUS*]. GUO JIANG, CHENGJUN, JI
DONG, ET AL. chinese journal of integrated traditional
and western medicine on liver diseases. 2004;14(4):212
(chi*).
3684- gera: 132138/di/ra
[EFFECTS OF GANLIKE ON THE MRNA
EXPRESSION OF INOS IN RATS WITH
EXPERIMENTAL HEPATIC FIBROSIS*]. XIA LIANG,
CHEN ZHIYUN, YAN MAOXIANG, ET AL. chinese
journal of integrated traditional and western medicine on
liver diseases. 2004;14(4):219 (chi*).
3685- gera: 132139/di/ra
[THE EXPERIMENT STUDY OF THE PROTECTIVE
EFFECTS OF ADOGOLD ON HEPATIC TRAUMA*].
CHEN JIGE, SONG XIANZHOU , CHEN LING, ET AL.
chinese journal of integrated traditional and western
medicine on liver diseases. 2004;14(4):222 (chi*).
3686- gera: 132140/di/ra
[COMPARISON BETWEEN CLASSICAL
DIFFERENTIAL DIAGNOSIS OF TRADITIONAL
CHINESE MEDICINE AND CLUSTER ANALYSIS IN
PATIENTS WITH CHRONIC HEPATITIS C]. HUANG
SHENGTENG, XU GUANGHONG, LI YINGXIONG.
chinese journal of integrated traditional and western
medicine on liver diseases. 2004;14(4):246 (chi).
3687- gera: 132172/di/ra
[RELATION BETWEEN MRAN EXPRESSION OF
IFN-Y AND IL-4 OF MONOCYTE IN THE
PERIPHERAL BLOOD OF 108 PATIENTS WITH
CHRONIC HEPATITIS B AND THE SYNDROME
TYPES OF TCM ]. HU SHIPING. chinese journal of
integrated tradtional and western medicine on liver
diseases. 2004;14(5):259 (chi*).
Objective: To evaluate the relation between the clinical
syndrome types of TCM of chronic hepatitis B and mRNA
expression of cytokines. Methods: The mRNA expression of
IFN-'y and IL-4 in the monocytes of peripheral blood of 108
patients with chronic hepatitis B of different syndrome types
of TCM was determinated. Results: It showed that the degree
of IFN-y of these five syndrome types of patients with
chronic hepatitis decreased gradually in the order of damp-
heat blockage, liver stagnation and spleen deficiency,
collateral obstruction by blood stasis, Yin deficiency of liver
and kidney, and Yang deficiency of liver and kidney, while
the degree of IL-4 raised gradually in the same order. The
response of cell immunity declined, and the virus could not
be clear away completely. The disease-process lasted for a
long time, and the disease property changed from excess to
deficiency, the disease trend changed from superficial to
deep. Conclusions: The mRNA expression of cytokines
provides the evidence for
3688- gera: 132173/di/ra
[INFLUENCE OF HBV GENOTYPES ON RESPONSE
TO ANTIVIROTIC THERAPY]. CHU RUIHAI, MA
LIXIAN, WANG GANG, ET AL. chinese journal of
integrated tradtional and western medicine on liver
diseases. 2004;14(5):262 (chi*).
gera 2011

3689- gera: 132174/di/ra
[CLINICAL STUDY ON THE EFFICACY AND
SAFETY OF LAMIVUDINE IN THE TREATMENT OF
CHRONIC SEVERE HEPATITIS B]. WU SHIPIN, LI
WENLI, PENG HONG, ET AL. chinese journal of
integrated tradtional and western medicine on liver
diseases. 2004;14(5):264 (chi*).
3690- gera: 132176/di/ra
[CLINICAL THERAPY EFFECTS OF SHUGAN
JIANPI RUANJIAN MIXTURE ON LIVER FIBROSIS].
REN ZEJIU, KE CHANGZHENG, GONG YUQING, ET
AL. chinese journal of integrated tradtional and western
medicine on liver diseases. 2004;14(5):270 (chi*).
3691- gera: 132177/di/ra
[A CLINICAL OBSERVATION ON NASH BY
TREATMENT BASED ON COMPREHENSIVE
ANALYSING SYMPTOMS AND DISEASES]. LUO
CHUANJIA, HE QIHUI, JIANG DACHUN, ET AL. chinese
journal of integrated tradtional and western medicine on
liver diseases. 2004;14(5):272 (chi*).
3692- gera: 132178/di/ra
[CLONING AND IDENTIFICATION OF HUMAN
GENE OF PROTEIN 1 BINDING WITH NS5A-TP5
PROTEIN]. ZHANG JIAN , LIU YAN , CHENGJUN, ET
AL. chinese journal of integrated tradtional and western
medicine on liver diseases. 2004;14(5):275 (chi*).
3693- gera: 132179/di/ra
[EFFECT OF PRESCRIPTION NO H TO ANTI-
HEPATITIS B FOR METABOLISM OF TXA2 AND
PGI2 IN MICE WITH CHRONIC IMMUNO-HEPATIC
INJURY]. SUN PEIYI, QIAN YALIN, CHEN XIUYUN.
chinese journal of integrated tradtional and western
medicine on liver diseases. 2004;14(5):278 (chi*).
3694- gera: 132180/di/ra
[THE EFFECT OF LIGUSTRAZINE ON
HEPATOCYTE APOPTOSIS]. LIU ZENGQUAN , LI
XIAOSHENG, TAN LIXUE, ET AL. chinese journal of
integrated tradtional and western medicine on liver
diseases. 2004;14(5):281 (chi*).
3695- gera: 132181/di/ra
[STUDY ON MAKING RAT MODELS OF
NONALCOHOLIC FATTY LIVER BY INJECTING
CC14 HYPODERMICALLY IN SMALLER DOSE AND
TAKING FOOD FULL OF FAT ]. GU KEBO, ZHANG
ZHUO, LI DAOBEN, ET AL. chinese journal of integrated
tradtional and western medicine on liver diseases.
2004;14(5):284 (chi*).
3696- gera: 132318/di/ra
[EFFECT OF GANCHANGCHUN ORAL LIQUID ON
LIVER-PROTECTION AND ANTI-FIBROSIS]. PIAO
YUN FENG GAO PU JUN ET AL . chinese traditional
patent medicine. 2004;26(8):657 (chi*).
3697- gera: 132374/di/ra
[CLINICAL OBSERVATION ON INTEGRATED
CHINESE AND WESTERN MEDICINE FOR
CHRONIC HEPATITIS B ]. LIN HUI. fujian journal of
tcm. 2004;35(5):12 (chi).
3698- gera: 132426/di/ra
[OBSERVATION OF CURATIVE EFFECT ON
ASCITES DUE TO CIRRHOSIS BY CENTRAL
222
APPLICATION OF ZHUANG GAN ZHU YU JIAN
DECOCTION]. HUANG GUIHUA LIN SHOUNING WEI
WEI ET, AL. guangxi journal of tcm. 2004;27(4):11 (chi).
3699- gera: 132430/di/ra
[OBSERVATION OF CURATIVE EFFECT ON
SEVERE HEPATITIS WITH JIE DU HUA YU
GRANULE]. MAO DEWEN QIU HUA LI YA ET, AL.
guangxi journal of tcm. 2004;27(4):4 (chi*).
3700- gera: 132431/di/ra
[EFFECTS OF EIGHT DIFFERENT COMPOUND
CHINESE MEDICAL PRESCRIPTIONS ON HBSAG
AND HBEAG EXCRETED BY 2215 CELL]. DENG
JIAGANG ZHENG ZUOWEN WANG QIN ET, AL.
guangxi journal of tcm. 2004;27(4):42 (chi*).
3701- gera: 132432/di/ra
[EXPERIMENTAL STUDY ON REGULATORY
EFFECT OF AI TONG XIAO CAPSULE ON
EXPRESSION OF VEGF IN TRANSPLANTED
HEPATOCARCINOMA 22 TUMOR OF MICE]. WEI
AILING TAN JIAN. guangxi journal of tcm. 2004;27(4):47
(chi*).
3702- gera: 132443/di/ra
[CLINICAL OBSERVATION ON BUYANGHUANWU
DECOCTION IN THE TREATMENT OF HEPATIC
FIBROSIS IN PATIENTS WITH CHRONIC
HEPATITIS B]. SONG JIAJU. hebei journal of tcm.
2004;26(7):523 (chi*).
3703- gera: 132468/di/ra
[[]PROTECTIVE EFFECTS OF DIFFERENT DOSAGE
AND PRESCRIPTION OF UPLEURUM CHINESE
AND SCUTELLARIA BAICALENSIS GEORGI ON
RAT'S ACUTE LIVER DAMAGE CAUSED BY
PARACETAMOL]. WANG XIANLING, LI LIANZHEN,
NIU WAN QIANG . henan tcm. 2004;24(8):15 (chi*).
3704- gera: 132486/di/ra
[[]MICROTHERAPEUTIC STUDY ON JIAQI
GANXIAN GRANULE IN TREATING CHRONIC
HEPATITIS B LIVER FIBROSIS]. GUO ZHENQIU .
henan tcm. 2004;24(9):17 (chi*).
3705- gera: 132488/di/ra
[CLINICAL STUDY ON 120 CASES OF ASCITES DUE
TO CIRRHOSIS TREATED BY JIANPI HUAYU
XIAOSHUI DECOCTION]. GU QUNSHAN . henan tcm.
2004;24(9):22 (chi*).
3706- gera: 132532/di/ra
[CLINICAL STUDY ON SHAODILAN PILLS FOR
THE TREATMENT OF CHRONIC HEPATITIS B].
WEI LINLAN, DU FABIN, SUN XIAOFEN. hunan
guiding journal of tcm. 2004;10(3):9 (chi*).
3707- gera: 132547/di/ra
[A SUMMARY ON 49, CASES OF CHRONIC
HEPATITIS B TREATED WITH COMBINATION OF
CHINESE TRADITIONAL AND WESTERN
MEDICINE]. ZENG SONGLIN, ET AL . hunan journal of
tcm. 2004;20(5):5 (chi).
3708- gera: 132577/di/ra
[36 CASES WITH LCTERUS OF PENTO-HEPATITIS
CURED BY DAN YIN MIXTURE ]. GU BENYU,WANG
JUNXI. inner mongol journal of tcm. 2004;24(5):3 (chi).
gera 2011

3709- gera: 132589/di/ra
[CLINICAL OBSERVATION ON TREATMENT OF 57
CASES OF NON - ALCOHOLIC ADIPOSIS
HEPATICA WITH "WENTONG HUAZHUO
DECOCTION"]. LI ZHANPING. jiangsu journal of tcm.
2004;25(10):36 (chi).
3710- gera: 132598/di/ra
[METHODS OF SYNDROME DIFFERENTIATION
FOR HEPATITIS B]. CHEN SIQING. jiangsu journal of
tcm. 2004;25(10):8 (chi).
3711- gera: 132609/di/ra
[EFFECT OF "QINGGAN HUOXUE PRESCRIPTION"
ON LIVER DAMAGE CAUSED BY LIPID
PEROXIDATION OF RATS WITH ALCOHOLIC
LIVER DISEASE]. ZHENG PEIYONG, JI GUANG, YOU
SHENGFU . jiangsu journal of tcm. 2004;25(8):50 (chi).
3712- gera: 132611/di/ra
[RECENT CONDITION OF TCM TREATMENT OF
HEPATIC FIBROSIS]. YIN GUILAN . jiangsu journal of
tcm. 2004;25(8):58 (chi).
3713- gera: 132634/di/ra
[CLINICAL OBSERVATION OF 45 CASES ABOUT
CHRONIC HEPATITIS B DEFICIENCY OF YIN OF
BOTH LIVER AND KIDNEY TREATED BY
EFFERVESCENT GRANULES HEPATITIS 4]. LI
SHENG-QING,ZHOU JIN-SHENG,YANG SHI-WU,ET
AL. jiangxi journal of tcm. 2004;35(10):27 (chi).
3714- gera: 132637/di/ra
[TREATMENT BASED ON CATEGORICAL
IDENTIFICATION AND CONTRAINDICATION OF
DRUG USE OF CARCINOMA HEPATITIS]. GUO
HONG-FEI,CAL RU-CHUN. jiangxi journal of tcm.
2004;35(10):45 (chi).
3715- gera: 132644/di/ra
[SUMMARY OF SHAO MENG-YANG'S EXPERIENCE
OF DIAGNOSING AND TREATING HEPATOMA].
LIU SHU-JING. jiangxi journal of tcm. 2004;35(8):.8 (chi).
3716- gera: 132649/di/ra
[30 CASES OF TREATING OVER THE HEPATIC
CIRRHOSIS ASCITES COMBINED WITH
TRADITIONAL CHINESE MEDICINE AND
WESTERN MEDICINE]. GAO SHENG , LU DONG-LAN
, LIAO WEI-QUAN . jiangxi journal of tcm. 2004;35(8):41
(chi).
3717- gera: 132657/di/ra
[OBSERVATION ON THERAPEUTIC EFFECTS IN
TREATMENT OF ASCITES DUE TO CIRRHOSIS
WITH JIANPI XINGQI XIAOSHUI TANG IN 52
CASES]. LIU XIAO-LIN. jilin journal of tcm.
2004;24(10):12 (chi).
3718- gera: 132677/di/ra
[ON TREATMENT OF ALCOHOLIC HEPATITIS IN
VIEW OF BLOOD STASIS]. ZHAO YIMEI ET AL. jilin
journal of tcm. 2004;24(9):1 (chi).
3719- gera: 132695/di/ra
[EFFECTS OF ASTRAGALUS ROOT AND ROOT OF
RED-ROOTED SALVIA ON HEMODYNAMICS AND
HEPATIC FIBROSIS'S INDES IN AEGROTUS WITH
HEPATOCIRRHOSIS PORTAL HYPERTENSION].
ZENG FEN . jingxi journal of tcm. 2004;35(9):24 (chi).
223
3720- gera: 132759/di/ra
[TREATMENT OF POSTHEPATITIC CIRRHOSIS
COMPLICATED WITH ASCITES WITH SPLEEN-
INVIGORATING, KIDNEY-REINFORCING AND
DIURESIS-INDUCING DECOCTION COMBINED
WITH WESTERN MEDICINE: A REPORT OF 22
CASES]. ZHU QIN. journal of anhui of traditional
chinese medical college. 2004;23(4):18 (chi).
3721- gera: 132783/di/ra
[CLINICAL OBSERVATION ON THE TREATMENT
OF SEVERE VIRUS HEPATITIS BY THERAPY OF
CHINESE TRADITIONAL AND WESTERN
MEDICINE COMBINED WITH ARTIFICIAL LIVER
SUPPORTING SYSTEM]. LI YONG-SHENG. journal of
anhui traditional chinese medical college. 2004;23(5):13
(chi).
3722- gera: 132787/di/ra
[TREATMENT OF LIVE FIBROSIS DUE TO
HEPATITIS B WITH KANGXIAN RUANGAN
DECOCTION: A REPORT OF 21 CASES]. YANG GUO-
WEN, GE QIANG, JIANG SHEN-YU. journal of anhui
traditional chinese medical college. 2004;23(5):19 (chi).
3723- gera: 132836/di/ra
[EFFECTS OF ZHUANGGANZHUYU DECOCTION
ON THE ACTIVATION OF RAT HEPATIC
STELLATE CELLS]. HUANG GUIHUA, LIN
SHOUNING, WANG ZHENCHANG. journal of beijing
university of tcm. 2004;27(5):36 (chi*).
3724- gera: 132842/di/ra
[EXPERIMENTAL STUDY OF THE EFFECTS
AGAINST HEPATIC FIBROSIS OF
BIEJIAXIAOZHENG PILLS]. HUANG SHENGYING,
WU TIE, LI LIQIANG, ET AL. journal of beijing
university of tcm. 2004;27(5):56 (chi*).
3725- gera: 132852/di/ra
[TWO CASES OF HEPATIC CIRRHOSIS
HYDROPERITONEUM TREATED BY PROFESSOR
CA0 PENG - XIANG THAT DETERMINED THE
TREATMENT BASES IN PATHOGENESIS
OBTAINED THOUGH DIFFERENTIATION OF
SYMPTOMS AND SIGN]. CAO YI-RONG, SUN GUI-
LIANG. journal of chengdu university of tcm.
2004;27(3):(20 (chi).
3726- gera: 132952/di/ra
[CIRRHOSIS ASCITES TREATED BY EXTERNAL
USE WITH ZHUSHUI PASTE]. SONG HUA, ZHANG
LIBIN. journal of external therapy of tcm. 2004;13(5):18
(chi).
3727- gera: 133045/di/ra
[YINHUA CHAIHU DECOCTION IN TREATMENT
OF INFANT HEPATITIS COMPLICATED BY
PROTEIN-BLOODY URINE: A REPORT OF 15
CASES]. LUO YONG. journal of henan university of
chinese medicine. 2004;10(5):56 (chi).
3728- gera: 133116/di/ra
[86 CASES OF ASCITES DUE TO CIRRHOSIS
TREATED BY PRESSING YUXUE COMBINED WITH
HOT MEDICATED COMPRESS OF TCM DRUGS].
MEI YUNWEI. journal of henan university of chinese
medicine. 2004;8(4):69 (chi).
gera 2011

3729- gera: 133118/di/ra
[RESOLVING PHLEGM THERAPY FOR LIVER AND
GALLBLADDER DISEASES]. ZHANG HUILING.
journal of henan university of chinese medicine.
2004;8(4):70 (chi).
3730- gera: 133138/di/ra
[TCM TREATMENT AND RESEARCH CONCLUSION
ABOUT FAT LIVER]. ZHOU FANG-LING . journal of
laoning college of tcm. 2004;6(5):417 (chi).
3731- gera: 133158/di/ra
[PROTECTING EFFECT OF YINCHENHAO
DECOCTION ON ALCOHOLIC LIVER DAMAGE OF
RATS]. HONG MIN, DONG ZI-BO, SUN XIAO-YU, ET
AL. journal of nanjing university of tcm. 2004;20(5):303
(chi).
3732- gera: 133195/di/ra
[]CHRONIC HEPATITIS B (30 CASES) TREATED BY
COMPOUND INJECTION OF SOPHORA
FLAVESCENS AND DIAMMONIUM
GLYCYRRHIZINATE INJECTION].]. CHEN
RUCHENG. journal of practical tcm. 2004;20(9):500 (chi).
3733- gera: 133235/di/ra
[THE THERAPEUTIC EFFECTS OF TENGCHA
FLAVONIDS ON HEPATIC INJURY INDUCED BY
CC14 AMONG MICE]. HE GUIXIA, LI LING, XIAO
JINREN, ET AL. journal of tcm university of hunan.
2004;24(4):7 (chi*).
3734- gera: 133237/di/ra
[DISCUSSION ON THE TREATMENT OF CHRONIC
HEPATITIS B BASED ON THE LIU'S THEORY OF
KIDNEY DEFICIENCY AND INCUBATIVE
PATHOGEN]. TONG GUANGDONG,PENG
SHENGQUAN . journal of tcm university of hunan.
2004;45(10):726 (chi*).
Under the guidance of the Liu's theory of kidney deficiency
and incubative pathogen,the authors point out that for
understanding the incubative pathogen of chronic hepatitis B
(CHB) you should grasp the essence of the pathogenesis,
kidney deficiency. For chronic hepatitis B,it is easier to be
understood and conforms to pathological characteristics of
chronic hepatitis B. The property of the incubative pathogen
can not be restricted to that the incubative cold changes to
warm, it should be understood as epidemic heat and epidemic
toxin. Therefore,the authors first put forward this
hypothesis:the pathogenesis of chronic hepatitis B is kidney
deficiency and damp-heat toxic pathogen incubating in liver
and blood. And based on the hypothesis a comprehensive
therapy including clearing away heat, expelling pathogenic
factors, promoting blood circulation and tonifying the kidney
is
3735- gera: 133240/di/ra
[CLINICAL OBSERVATION ON REMOVING
PATHOGENIC HEAT FROM THE BLOOD AND
TOXIC MATERIAL FROM THE BODY AND
NOURISHING THE KIDNEY AND LIVER METHOD
FOR TREATMENT OF 40 CASES OF FIBROSIS OF
LIVER DUE TO CHR. LIU MIN, LI XIANPING . journal
of tcm university of hunan. 2004;45(10):750 (chi*).
3736- gera: 133242/di/ra
[CLINICAL STUDY ON JIAN PI XIAO JI ORAL
LIQUID FOR IMPROVEMENT OF LIFE QUALITY IN
32 CASES OF LATE LIVER CANCER]. HUANG
ZHIFEN,LI HANZHONG,ZHANG ZUOJUN,ET AL.
224
journal of tcm university of hunan. 2004;45(10):754
(chi*).
3737- gera: 133247/di/ra
[EFFECTS OF GAN LAN JIE JIU YIN ON ALT AND
AST IN R MICE WITH ACUTE ALCOHOLIC
HEPATIC INJURY]. PENG BO . journal of tcm
university of hunan. 2004;45(10):774 (chi*).
3738- gera: 133411/di/ra
[EXPLORATION ON TCM TREATING HEPATITIS-
ASSOCIATED NEPHRITIS]. ZHAO YAN-PING .
liaoning journal of tcm. 2004;31(10):834 (chi).
3739- gera: 133414/di/ra
[PROGRAM FOR DIAGNOSIS AND TREATMENT OF
LIVER CIRRHOSIS WITH INTEGRATIVE CHINESE
AND WESTERN MEDICINE (DRAFT)]. WEI BEI-HAI,
ZHANG WAN-DAI, CHEN ZHI-SHUI, ET AL . liaoning
journal of tcm. 2004;31(10):869 (chi).
3740- gera: 133415/di/ra
[EFFECTS OF SCUTELLARIA BAICALENSIS STEM-
LEAF TOTAL FLAVOURED ON EXPERIMENTAL
LIVER FIBROSIS IN RATS]. LI SU-TING,MEI LI-
XIN,YANG HE-MEI,ET AL. liaoning journal of tcm.
2004;31(10):871 (chi).
3741- gera: 133433/di/ra
[EFFECT OF ARSENIC TRIOXIDE ON ADHESION
AND INVASION OF HUMAN HEPATOCARCINOMA
CELLS IN VITRO]. HUA HAI-QING, QIN SHU-KUI,
WANG JIN-HONG, ET AL . chinese journal of integrated
traditional and western medicine. 2004;24(10):922 (chi).
3742- gera: 133444/di/ra
[CLINICAL EXPERIENCE ON LIU GUO-QIANG
TREATING CHRONIC HEPATITIS B]. YE ZHENG
RONG, XIE LI-FANG, DU WEI-XING. liaoning journal of
tcm. 2004;31(8):627 (chi).
3743- gera: 133448/di/ra
[CLINICAL STUDY ON TREATMENT OF CHRONIC
BETA PARTICLE HEPATITIS WITH TWO KINDS OF
MONGOLIAN MEDICINE]. BA TUDELIGEN BAI
WAN-FU BAI HUHEBALA ET AL. liaoning journal of
tcm. 2004;31(8):650 (chi*).
3744- gera: 133552/di/ra
[CURATIVE EFFECT OBSERVATION OF HAIZHU
YIGAN CAPSULE ON HBV PRI - C GENE
MUTATION PATIENTS]. GONG YU-QING, REN ZE-
JIU, CHEN YUE, ET AL. modern journal of integrated
traditional chinese and western medicine.
2004;13(17):2265 (chi*).
3745- gera: 133572/di/ra
[RELATIONSHIP BETWEEN PLASMA ENDOTOXIN
LEVEL AND HEPATIC FIBROSIS INDEX AND
PATHOLOGY IN PATIENTS WITH CHRONIC
HEPATITIS]. CHEN YUN, JIANG HONG, WANG YU-
HAI . modern journal of integrated traditional chinese
and western medicine. 2004;13(20):2677 (chi*).
3746- gera: 133598/di/ra
[A STUDY ON THE CONTRAST OF DIFFERENT
DOSAGE OF BAIYING TANG FOR THE
TREATMENT OF CHRONIC SEVERE HEPATITIS B].
HE HAO, ZHANG YU-LIANG, YAN YI-ZHONG, ET AL.
new journal of tcm. 2004;36(10):41 (chi).
gera 2011

3747- gera: 133679/di/ra
[RELATIONSHIP BETWEEN TCM SYNDROME
DIFFERENTIATION OF HEPATOCIRRHOSIS AND
THE CHANGES OF SERUM APOLIPOPROTEIN].
ZHU HONG, XIAO WEIMING, LU WEI. shaanxi journal
of tcm. 2004;25(9):771 (chi).
3748- gera: 133681/di/ra
[CLINICAL STUDY OF THE EFFECT OF
XINGANSHU IN PROTECTING THE FUNCTION OF
TRANSPLANTED LIVER]. LIU CHANG, SHI YUAN,
YANG QINLING. shaanxi journal of tcm. 2004;25(9):775
(chi).
3749- gera: 133682/di/ra
[ASCITES DUE TO CIRRHOSIS TREATED BY
SOFTENING HARD MASS AND INDUCING
DIURESIS]. BIAN FANGQIN, GUO YAOLI. shaanxi
journal of tcm. 2004;25(9):777 (chi).
3750- gera: 133683/di/ra
[HEPATIC FATTY INFILTRATION TREATED BY
LIUWEIDIHUANG PILL]. CHEN GUOXIN. shaanxi
journal of tcm. 2004;25(9):778 (chi).
3751- gera: 133684/di/ra
[CHRONIC HEPATITIS B TREATED BY GANSHU
CAPSULE]. AN YUJIN . shaanxi journal of tcm.
2004;25(9):785 (chi).
3752- gera: 133689/di/ra
[CHIEF PHYSICIAN ZENG SHENGHAI'S
EXPERIENCE IN TREATING HEPATIC FATTY
INFILTRATION]. HOU TIEHU. shaanxi journal of tcm.
2004;25(9):821 (chi).
3753- gera: 133690/di/ra
[TCM APPROACH TO THE CAUSES AND
MECHANISM OF HEPATIC FATTY
INFILTRATION]. PAN FENGMAN, YANG QINHE,
SHEN YINGSEN. shaanxi journal of tcm. 2004;25(9):823
(chi).
3754- gera: 133692/di/ra
[INFLUENCE OF MODIFIED SINI POWDER ON
LIVER COLLAGEN I AND II IN RATS WITH LIVER
FIBROSIS]. LI CHANGQIN, HU JIANJUN, ZHENG
XURUI . shaanxi journal of tcm. 2004;25(9):852 (chi).
3755- gera: 133704/di/ra
[DISCUSSION ON METHOD OF TONIFYING THE
KIDNEY AND REMOVING BLOOD STASIS FOR
HEPATOCIRRHOSIS]. SUN JIAN-GUANG. shandong
journal of tcm. 2004;23(8):451 (chi*).
3756- gera: 133752/di/ra
[EFFECTS OF "KE AI TIN" ON P53 AND BCL-2
EXPRESSIONS IN RATS WITH LIVER
CARCINOMA]. WANG YU CHEN GANG XIANG
YONG-CHEN, ET AL . shanghai journal of tcm.
2004;38(10):48 (chi*).
3757- gera: 133757/di/ra
[CLINICAL STUDY ON "GANSHU PLASTER" IN
TREATING HYPOCHONDRIAC PAIN RESULTING
FROM CHRONIC LIVER DISEASES]. CHEN JING
WANG LING-TAI ZHAO GANG. shanghai journal of
tcm. 2004;38(10):6 (chi*).
225
3758- gera: 133760/di/ra
[CLINICAL STUDY ON KURARINONE PLUS RNA
INJECTION FOR HBV]. WEI CHUN-SHENG HE JING-
SONG YUAN BIN, ET AL. shanghai journal of tcm.
2004;38(10):9 (chi).
3759- gera: 133792/di/ra
[CLINICAL OBSERVATION OF COMBINED
CHINESE AND WESTERN MEDICINE IN TREATING
EMBOLIC SYNDROME FOLLOWING LIVER
CANCER INTERVENTION]. YANG JIN-ZU YANG JIN-
KUN ZHENG JIAN, ET AL. shanghai journal of tcm.
2004;38(9):11 (chi*).
3760- gera: 133836/di/ra
[THOUGHT OF TREATMENT OF CHRONIC B
HEPATITIS WITH INTEGRATIVE TCM AND WM].
LUO GUO-JUN . shanxi journal of tcm. 2004;20(5):41
(chi*).
Chronic B hepatitis could be treated with integrative TCM
and WM through the following ways. 1. The advantange of
treatment on the basis of syndrome differentiation in TCM
should be taken fully. And the therapeutic level be enhanced.
Both the principal and the secondary aspects of a disease,
both the disease and the syndromes should be treated at the
same time,so as to enhance the therapeutic level. 2. Anti-
virus therapy and TCM therapy should be complemented
with each other to improve effectiveness and reduce
disadvantages. 3. The healthy energy should be supported
and the body resistance should be strengthened to regulate
the immune function. 4. The method of soothing liver energy
and promoting gallbladder energy should be used to improve
the liver function. 5. The method of promoting the blood
circulation and removing blood stasis should be used to
prevent hepatic fibrosis. The applying of herbs of promoting
the blood circulation to remove blood stasis could prevent the
occurrence of liver cirrhosis and hepatocarcinoma. In a
word,the therapeutic effect on chronic B hepatitis could be
3761- gera: 133837/di/ra
[CLINICAL STUDY ON SERIES OF JIUGAN
DECOCTION IN TREATING CHRONIC B
HEPATITIS]. XU RU-PING,ZHANG LING,ZHANG
WU,ET AL . shanxi journal of tcm. 2004;20(5):44 (chi*).
3762- gera: 133850/di/ra
[EFFECT OF RADIX ACONITI MATCHED WITH
PINELLIA, FRITILLARIA, TRICHOSANTHES,
MAPELOPSIS, BLETALLAE ON THE
CYTOCHROME P450 CONTENT OF LIVER IN
RATS]. XIAO CHENG-RONG, CHEN PENG, WANG YU-
GUANG, ET AL . tianjin journal of tcm. 2004;21(4):311
(chi*).
3763- gera: 133882/di/ra
[EFFECTS OF BIEJIA JIAN IN PREVENTING RAT
HEPATIC FIBROSIS]. KUANG WEIHONG,LL
JIANHUA. traditional chinese drug research and clinical
pharmacology. 2004;15(5):314 (chi*).
3764- gera: 133910/di/ra
[EFFECT OF BUPLEURUM AND SCUTELLARIA ON
ACUTE ALCOHOL INJURY OF LIVER IN RAT].
WANG XIANLING, LIU RENHUI, LIU FANGZHOU, ET
AL . traditional chinese medical research. 2004;17(5):24
(chi).
3765- gera: 133913/di/ra
[60 CASES OF TREATING CHRONIC HEPATITIS B
FIBROSIS BY COMBINING CHINESE MEDICINE
gera 2011

WITH WESTERN MEDICINE]. WU ERGUANG,WU
JIE,ZHANG PINGXIN . traditional chinese medical
research. 2004;17(5):33 (chi).
3766- gera: 133914/di/ra
[CAUSES AND STRATEGY FOR INFLUENCING
CURATIVE EFFECT OF HEPATITIS C]. JIAO
YIMING, YUAN ZHANQUN . traditional chinese medical
research. 2004;17(5):8 (chi).
3767- gera: 134081/di/ra
[CLINICAL STUDY OF CHRONIC VIRAL
HEPATITIS TREATED WITH FUGANNING ]. YAO
SHU - GUI, WANG YI - XIAN, ZHENG JIA - ZHU, ET AL
. acta chinese medicine and pharmacology. 2004;32(4):11
(chi).
3768- gera: 134091/di/ra
[PATHOLOGY STUDY OF ADIPOSIS HEPATICA
TREATED WITH QIANGGAN XIAOZHISAN ]. ZHU
XIAO - DONG. acta chinese medicine and pharmacology.
2004;32(4):52 (chi).
3769- gera: 134107/di/ra
[INFLUENCE OF ELECTROACUPUNCTURE OF
"NEIGUAN" ON NOS EXPRESSION OF LIVER
TISSUES IN ENDOTOXIN-SHOCK RATS]. LI YI-WEI,
LI HUI, DU SHAO-HUI, ET AL . acupuncture research.
2004;29(2):119 (chi*).
3770- gera: 134144/di/ra
THE EFFECT OF GINKGO BILOBA EXTRACT (EGB
761) ON HEPATIC SINUSOIDAL ENDOTHELIAL
CELLS AND HEPATIC MICROCIRCULATION IN
CC14 RATS . CHUNQING ZHANG, JUREN ZU,
HENGMEI SHI, JIYONG LIU AND CHENGYONG QIN.
american journal of chinese medicine. 2004;32(1):21
(eng*).
3771- gera: 134154/di/ra
RADIX BUPLEURI CONTAINING COMPOUND
(KY88 LIVER-LIVO) INDUCES APOPTOSIS AND
PRODUCTION OF INTERLEUKIN-4 AND TUMOR
NECROSIS FACTOR-A IN LIVER CANCER CELLS
IN VITRO . LOUIS WC CHOW, WINGS TY LOO,
JONATHAN S T SHAM AND MARY N B CHEUNG.
american journal of chinese medicine. 2004;32(2):185
(eng*).
3772- gera: 134155/di/ra
SHO-SAIKO-TO PREVENTS LIVER FIBROSIS
INDUCED BY BILE DUCT LIGATION IN RATS .
MING-HO CHEN, JUNG-CHOU CHEN CHIN-CHUAN
TSAI, WEN- CHUANG WANG,DE-CHING CHANG,
CHUN-CHING LIN AND HSIAO- YEN HSIEH. american
journal of chinese medicine. 2004;32(2):195 (eng*).
3773- gera: 134178/di/ra
THE EFFECTIVENESS OF AURICULOACUPOINT
TREATMENT FOR ARTIFICIALLY INDUCED
ACUTE HEPATIC INJURY IN DOGS . SANG-EUN
LEE, KUN-HO SONG, JIANZHU LIU, HYUN-JU KWON,
SANG-BO YOUN, YOUNG-WON LEE, SUNG-HWAN
CHO AND DUCK-HWAN KIM. american journal of
chinese medicine. 2004;32(3):445 (eng*).
This study was to investigate effects of auriculoacupoint
(AAP) treatment on carbon tetrachloride (CC14)-induced
acute hepatic injury in ten dogs (four females and six males).
Dogs have been divided into two groups: the control group
(four dogs), not stimulated after induction of hepatic injury
226
and the experimental group (six dogs), stimulated with AAP
and massaged at the affected liver region of internal ear after
induction of hepatic injury. Serum enzyme activities and
histopathological findings were examined after the
application of AAP Compared to the control group, serum
alanine aminotransferase (ALT) and aspartate
aminotransferase (AST) activities in the experimental group
were significantly decreased at the 4th day (p < 0.05) and at
the 5th day (p < 0.05), respectively. Histopathological
findings of the experimental group showed decrease of
necrotic region and size of lipid droplets compared to the
control group.
3774- gera: 134184/di/ra
MECHANISMS OF HEPATOPROTECTION OF
TERMINALIA CATAPPA L. EXTRACT ON D-
GALACTOSAMINE- INDUCED LIVER DAMAGE .
XIN-HUI TANG, LING GAO, JING GAO, YI-MEI FAN,
LI-ZHI XU, XIAO-NING ZHAO AND QIANG XU.
american journal of chinese medicine. 2004;32(4):509
(eng*).
3775- gera: 134190/di/ra
REGRESSION OF HEPATOCELLULAR
CARCINOMA SPONTANEOUS ORHERBAL
MEDICINE RELATED? . HON MEI CHENG AND
MING CHE TSAI. american journal of chinese medicine.
2004;32(4):579 (eng*).
3776- gera: 134203/di/ra
CHEMOPREVENTION AGAINST
HEPATOCELLULAR CARCINOMA OF CORNUS
OFFICINALIS IN VITRO . JUNG-SAN CHANG, LIEN-
CHAI CHIANG, FEN-FANG HSU AND CHUN-CHING
LIN. american journal of chinese medicine.
2004;32(5):717 (eng*).
3777- gera: 134236/di/ra
[ EFFECTS OF ZIWU LIUZHU NEEDLING METHOD
ON IMMUNOLOGIC FUNCTIONS IN THE PATIENT
OF CHRONIC HEPATITIS B ]. ZHANG JIN-HUA,
SHAO ZHI-LIN, FEI XIN-YING, ET AL. chinese
acupuncture and moxibustion. 2004;24(10):693 (chi*).
3778- gera: 134335/di/ra
[SOME POINTS ON THE CLINICAL STUDY OF NEW
DRUGS FOR ANTAGONIZING LIVER FIBROSIS]. GU
XUE-LAN . chinese journal of integrated traditional and
western medicine. 2004;24(11):1026 (chi).
3779- gera: 134349/di/ra
[CLINICAL OBSERVATION ON EFFECT OF XUEFU
ZHUYU DECOCTION IN TREATING PATIENTS
WITH LIVER FIBROSIS CAUSED BY CHRONIC
HEPATITIS B]. RU QING-JING, TANG ZHI-MIN,
ZHANG ZHEN-E, ET AL . chinese journal of integrated
traditional and western medicine. 2004;24(11):983 (chi*).
3780- gera: 134403/di/ra
[EFFECTS OF GANLIKE ON MRNA EXPRESSION
OF MMP - 2 AND TIMP - 2 IN LIVER TISSUES OF
RATS WITH HEPATIC FIBROSIS]. YAN MAO -
XIANG , CHEN ZHI -YUN , CHEN BAO -ZHEN , ET AL .
chinese journal of traditional medical science and
technology. 2004;11(6):327 (chi*).
3781- gera: 134466/di/ra
[INFLUENCE OF GUIPI GRANULE ON ENZYME
AST,ALT IN LIVER PERFUSION]. WANG XU-PING
ZHENG XIAO-XIANG. chinese traditional patent
gera 2011

medicine. 2004;26(11):916 (chi*).
3782- gera: 134468/di/ra
[PROTECTION OF SANQIBAOGAN CAPSULES
AGAINST THE ACUTE AND CHEMICAL LIVER
INJURY IN MICE ]. WANG CHAO-LIANG KE JIN-HU
ET AL. chinese traditional patent medicine.
2004;26(11):922 (chi*).
3783- gera: 134529/di/ra
[THERAPEUTIC EFFECT OF SOFTING LIVER
FORMULA ON OBSTACLE OF GASTRIC MOTILITY
IN PATIENTS WITH CIRRHOSIS ]. LIU MANJUN,
WANG YUEFEN, CHEN GUOHUI. hebei journal of tcm.
2004;26(8):575 (chi*).
3784- gera: 134540/di/ra
[THERAPEUTIC EFFECT OF OXYMATRINE
INJECTION ON CHRONIC HEPATITIS S B ]. WANG
WEILI, LI XINGMEI. hebei journal of tcm. 2004;26(8):706
(chi*).
3785- gera: 134548/di/ra
[ CLINICAL OBSERVATION ON ZHENGXIAO
CAPSULE IN TREATING 242 CASES OF PRIMARY
CARCINOMA OF LIVER]. SHAO JING' ZHUO
YUYING, ZHOU XIAOJING. henan tcm. 2004;24(11):27
(chi).
3786- gera: 134552/di/ra
[SEVENTY CASES OF INTRACTABLE ASCITIC
FLUID TREATED BY FUSHUI CHAOLU NONGSUO
HUISHUI ALONG WITH CHINESE DRUGS]. LUO
HONGWEI, ZHANG HAO. henan tcm. 2004;24(11):39
(chi).
3787- gera: 134564/di/ra
[EFFECT OF RHUBARB LACTEIN EFFERVESCENT
TABLETS ON GLUTAMINE IN THE BRAIN TISSUE
OF RATS WITH HEPATIC ENCEPHALOPATHY A ].
GHEN JUNMEI , ET AL. hubei journal of tcm.
2004;26(11):3 (chi).
3788- gera: 134565/di/ra
[EFFECT OF HAIZHU YIGAN CAPSULE ON PC III
AND IV - C IN BLOOD SERUM OF THE PATIENTS
WITH CHRONIC VIRUS B HEPATITIS ]. GONG
YUQING, ET AL. hubei journal of tcm. 2004;26(11):31
(chi).
3789- gera: 134578/di/ra
[EXPERIMENTAL STUDY OF IV GANYAN ON
PROTECTION OF EXPERIMENTAL ANIMAL LIVER
INJURY ]. ZHU LIWEI , ET AL. hubei journal of tcm.
2004;26(9):7 (chi).
3790- gera: 134643/di/ra
[HEPATOPATHY TREATMENT AND PROCESS OF
TCM MODERNIZATION ]. XUE BOYU . jiangsu
journal of tcm. 2004;25(11):1 (chi).
3791- gera: 134662/di/ra
[30 CASES OF TREATMENT OVER LIVER HARM
CAUSED BY CHEMOTHERAPY WITH THE
METHOD OF SHUGANJIANPI]. ZHANG JIE. jiangxi
journal of tcm. 2004;35(11):22 (chi).
3792- gera: 134670/di/ra
[WANG SHAO-HE'S EXPERIENCE OF TREATING
CHYLE ASCITES]. WANG ZHAO-JUN,WANG ZHAO-
227
KAI. jiangxi journal of tcm. 2004;35(11):8 (chi).
3793- gera: 134743/di/ra
[EXPERIENCE OF FAMOUS VETERAN DOCTOR
LUO BEN QING ON THE TREATMENT OF ASCITES
DUE TO CIRRHOSIS]. CHEN XINYU . journal of
emergency in tcm. 2004;13(12):822 (chi).
3794- gera: 134746/di/ra
[THE EFFECT OF HUOXUERUANGAN PELLET ON
THE LEVELS OF TNF-OT AND TGF-13, IN RATS
WITH ALCOHOLIC FIBROSIS OF LIVER]. CHEN
KEHE , ET AL . journal of emergency in tcm.
2004;13(12):829 (chi*).
3795- gera: 134760/di/ra
[THE INFLUENCE OF YINSHAO POWDER TO
BLOOD SERUM HA,IV-C LEVEL IN CHRONIC
HEPATITIS B WITH THE SYNDROMES OF DAMP
AND HEAT STAGNATING IN SPLEEN]. CHEN JIN-
FANG,MAO XING-DI,YAO LI-FENG . journal of fujian
college of tcm. 2004;14(6):7 (chi*).
To observe the influence of Yinshao Powder to blood serum
HA,IV-C level in chronic hepatitis B with the syndromes of
damp and heat stagnating in spleen, selecting 64 cases of this
type and dividing them into 2 groups randomly,then
observing the indexes mentioned above 1 month before and
after treatment in each group respectively. It was showed that
the content of blood serum HA,IVC were lowered and the
symptoms were improved obviously in treatment group,the
difference was significant being compared with the control
group (P<O. 05). It can be said that Yinshao powder can
improve blood circulation and has anti-hepatic-fibrosis effect.
3796- gera: 134773/di/ra
[TREATMENT OF CIRRHOSIS
HYDROPERITONEUM IN THE LIGHT OF TRIPLE
WARMER ]. XIAO BIN ET AL . journal of guiyang
college of tcm. 2004;26(4):6 (chi).
3797- gera: 134784/di/ra
[120 CASES OF ACUTE INTEROHEPATITIS
TREATED BY TINYIN SHENHU DECOCTION ].
YANG QIAN-TING. journal of laoning college of tcm.
2004;6(6):470 (chi).
3798- gera: 135159/di/ra
[RESEARCH RECOMMEND OF MOLECULAR
BIOLOGY IN HEPATIC ZANGXIANG SYSTEM].
WANG MI-QU , WU BIN, LIN QIAO, ET AL. modern
journal of integrated traditional chinese and western
medicine. 2004;13(22):2939 (chi).
3799- gera: 135175/di/ra
[TREATMENT OF CHRONIC ASYMPTOMATIC HBV
CARRIER BY JUEYIN SAN CO. : A CLINICAL
OBSERVATION OF 53 CASES]. WANG WEI . new
journal of tcm. 2004;36(11):46 (chi*).
3800- gera: 135301/di/ra
TRATTAMENTO DI 72 CASI DI EPATOPATIA
INDOTTA DA ANTIDIABETICI MEDIANTE IL
DECOTTO HUA TAN YI GAN. HU YONGHE ED
ALTRI. rivista italiana di medicina tradizionale cinese.
2004;97(3):26 (ita*).
3801- gera: 135336/di/ra
EFFICACIA DEL DECOTTO DA DING FENG ZHU IN
30 CASI DI FIBROSI EPATICA. WEILIN ED ALTRI.
rivista italiana di medicina tradizionale cinese.
gera 2011

2004;98(4):30 (ita*).
3802- gera: 135437/di/ra
[TREATMENT OF ONE CASE OF HEPATITIS B
RELEVANT LIVER CARCINOMA BY SINGLE
CHINESE MEDICINE ]. ZHANG JING TU HONG YU
MEI, ET AL . shanghai journal of tcm. 2004;38(11):5
(chi*).
3803- gera: 135451/di/ra
[PROTECTIVE EFFECTS OF ZI QI RUANGAN
GRANULE ON DIMETHYLNITROSAMINE -
INDUCED CHRONIC HEPATIC IN RATS]. ZHOU
LINGLING,FANG TAIHUI,XU LI,ET AL. traditional
chinese drug research and clinical research and clinical
pharmacology. 2004;15(6):392 (chi*).
3804- gera: 136028/di/ra
LOW-FREQUENCY ELECTROMAGNETIC
STIMULATION MAY LEAD TO REGRESSION OF
MORRIS HEPATOMA IN BUFFALO RATS.
FEDOROWSKI A, STECIWKO A, RABCZYNSKI J.
journal of alternative and complementary medicine.
2004;10(2):251-60 (eng).
3805- gera: 136102/di/ra
KOREAN MEDICINAL PLANT EXTRACTS EXHIBIT
ANTIVIRAL POTENCY AGAINST VIRAL
HEPATITIS. JACOB JR, KORBA B,JUNG EUN
YOU,BUD C TENNANT BC,YOUNG-HO KIM. journal of
alternative and complementary medicine.
2004;10(6):1019-26 (eng).
Objectives: Investigation of natural ethnopharmacologic
extracts exhibiting antiviral potential may lead to the
discovery of new therapeutics for the treatment of chronic
viral hepatitis infections. Traditional Korean medicinal herbs
have been identified that exhibit potency against hepatitis B
virus (HBV) and hepatitis C virus (HCV) infections.
Research on the antiviral potential of naturally derived
extracts is facilitated through the use of appropriate animal
and liver cell culture models for these hepatotrophic
pathogens. Objectives of this study were to demonstrate
antiviral activity of an aqueous extract of herbal formulation
KYH-1 in surrogate in vitro assays for HBV and HCV and
identify mechanisms of action.Methods: Antiviral potency of
KYH-1 was measured in tissue culture systems that support
replication of the woodchuck hepatitis virus (WHV), and the
bovine viral diarrhea virus (BVDV). These assays serve as
surrogate models for HBV and HCV, respectively. A
recombinant HBV polymerase gene expression assay was
used to define a molecular target.Results: KYH-1 exhibited
potent antiviral activity against WHV and to a lesser extent
against BVDV. KYH-1 and its constituent components
inhibited HBV polymerase priming in vitro. Additionally,
KYH-1 suppressed HBV replication in a human
hepatoblastoma cell line.Conclusion: Evaluation of naturally
derived products for antiviral activity against HBV and HCV
in standardized surrogate assays provides a scientific basis
for potential use as complementary or alternative medicines.
This study provides significant results justifying preclinical
evaluation of KYH-1 as an antiviral therapy for HBV
infections.
3806- gera: 136307/di/ra
EFFECT OF GANODERMA TSUGAE ON
CHRONICALLY CARBON TETRACHLORIDE-
INTOXICATED RATS. YUEH-WERN WU, KUAN-DEE
CHEN AND WEN-CHUAN LIN. american journal of
chinese medicine. 2004;32(6):841 (eng).
The purpose of this study was to evaluate the
228
hepatoprotective and anti-fibrotic actions of crude extracts of
Ganoderma tsugae (GTE) on chronic liver injury induced by
carbon tetrachloride (CCl4) in rats. CCl4 (20%, 0.5 ml/rat)
was given twice a week for 8 weeks, and animals received
GTE through the whole experimental period. GTE showed
obvious reducing actions on the elevated levels of glutamate-
oxalate-transaminase (GOT) and glutamate-pyruvate-
transaminase (GPT) caused by CCl4 at weeks 3, 6 and 8.
Liver fibrosis in rats induced by CCl4 led to the drop of
serum albumin and hepatic protein concentrations, while
GTE increased serum albumin and hepatic protein
concentrations. The CCl4-induced liver fibrosis may prolong
the prothrombine time and increase albumin/globulin (A/G)
ratio. GTE significantly decreased the prothrombine time and
A/G ratio. Liver fibrosis induced by CCl4 markedly
increased the weight of the spleen, hepatic water and
hydroxyproline contents in rats, while GTE decreased the
rat's spleen weights, hepatic water and hydroxyproline
contents. All these results clearly
3807- gera: 136440/nd/re
ANTI-CANCER AND PRO-APOPTOTIC EFFECTS OF
AN HERBAL MEDICINE AND SACCHAROMYCES
CEREVISIAE PRODUCT (CKBM) ON HUMAN
HEPATOCELLULAR CARCINOMA HEPG2 CELLS
IN VITRO AND IN VIVO. CHAN JY, CHEUNG JY, LUK
SC, WU YJ, PANG SF, FUNG KP. immunopharmacol
immunotoxicol. 2004;26(4):597-609 (eng).
Hepatocellular carcinoma is a major health problem
worldwide. Different treatment strategies have been
developed to cope with this problem. Herbal medicine is now
widely studied in both Eastern and Western countries. In this
study, we used both in vitro and in vivo model to illustrate
the anti-tumor effect of a product, CKBM, consisting of
herbal medicine and specially processed Saccharomyces
cerevisiae. Dose-dependent anti- proliferation effect was
observed on in vitro growth of human hepatoma HepG2 cells
after 48 hours incubation with CKBM. At the 50% inhibitory
concentration (IC50) no significant toxic effect was observed
on normal human fibroblasts Hs68 and human liver WRL-68
cells. The results of morphological changes, detection of
DNA fragmentation, flow cytometric analysis and Western
blot analysis indicated that this anti-tumor effect of CKBM
was mediated via the process of apoptosis. In addition,
HepG2 cells- bearing nude mice model was used for in vivo
anti-tumor study. Our results showed that 14-day treatment
with 0.8 ml daily dosage of CKBM could inhibit 54.1% of
tumor growth. The plasma activities of enzymes specific for
heart and liver, namely creatine kinase, lactate
dehydrogenase, aspartate transaminase and alanine
transaminase, remained at normal levels, indicated that
CKBM did not produce toxicity to the host.
3808- gera: 136443/di/ra
[CLINICAL OBSERVATION OF EFFECT OF XIAO
GU SAN ON CIRRHOSIS ASCITES]. SUN YX, LIU C.
zhongguo zhong yao za zhi. 2004;29(10):993-5 (chi).
OBJECTIVE: To observe the clinical effect of Xiao Gu San
on cirrhosis ascites. METHOD: Groups were randomly
divided into treating group and group of western medicine
comparision. RESULT: 30 cases of the treating group were
observed with the following result: first class curative effect
7; second class 12; the third class 9; effectiveless 2; total
effective rate 93.33%. 30 cases of the Group of Comparison:
first class curative effect 2; second class 6; the third class 15;
effectiveless 7; total effective rate is 76.67%.
CONCLUSION: The curative effect of Xiaogu San combined
with Western medicine on cirrhosis ascites is better than that
of Western medicine alone.
gera 2011

3809- gera: 136641/di/ra
[RECENT CONDITION IN CLINICAL RESEARCH
ON ANTI -FIBROSIS OF LIVER WITH
LIGUSTRAZINE]. CHEN XI -ZHI ET AL. academic
periodical of changchun college of tcm. 2004;20(4):64
(chi).
3810- gera: 136679/di/ra
[CLINICAL APPLICATION IS THE END-RESULT OF
SCIENTIFIC RESEARCH: PROFESSOR WANG
LINGTAI'S ACADEMIC THOUGHTS ( PART TWO)].
ZHAO GANG, GAO YUE-QIU, CHEN JIAN JIE. acta
universitatis traditionis medicalis sinensis
pharmacologiaeque shanghai. 2004;18(4):25 (chi*).
This paper explores professor Wang Lingtai's academic
thoughts in the clinical treatment of liver diseases as
following three aspects:based on clinical practice to seek out
scientific and research projects ; on clinical practice to open
up new fields ; on clinical practice to grasp scientific and
research orientation. Some examples about the syndrome
differentiation standardization of chronic hepatitis C ,
subclinical hepatic encephalopathy and hepatic
3811- gera: 136892/di/ra
[EFFECTS OF ELECTROACUPUNCTURE AT
"ZUSANLI" (ST 36) ON ALCOHOLIC FATTY LIVER
RAT MODEL]. WANG WEI, YU HONG, PIAOSHUN-FU,
ET AL. chinese acupuncture and moxibustion.
2004;24(12):857 (chi*).
Objective To observe preventing and treating effects of
electroacupuncture at "Zusanli" (ST 36) on alcoholic fatty
liver of the rat and study the mechanism. Methods The
alcoholic liver injury rat model was established by
intragastric infusion of 60% alcohol, and changes of serum
total cholesterol (Choi) , triglyceride (TG) and adipohepatic
degrees of the liver were investigated after
electroacupuncture at "Zusanli" (ST 36). Results
Electroaapuncture at "Zusanli" (ST 36) could significantly
reduce fatty degeneration of hepatic cells, and increase serum
:Chol level and decrease serum TG level as compared with
the natural recovery group. Conclusion The mechanism of
electroacupuncture at "Zusanli" (ST 36) for treatment of
alcoholic hepatic injury is possibly relieving fatty
degeneration of hepatic cells and regulating metabolism of
lipids.
3812- gera: 137012/di/ra
[EFFECTS OF YINZHI QINGGAN DECOCTION ON
INTERLEUKIN-16 AND INTERLEUKIN-19 IN ACUTE
LIVER- INJURED RATS]. SONG SHI-LING, HUANG
TUAN-XIN, GONG ZUO-JIONG, ET AL. chinese journal
of basic medicine in tcm. 2004;10(10):12 (chi).
3813- gera: 137264/di/ra
[RELATIVITY ANALYSIS ON RISK FACTORS OF
THE PRECORE 1896 SITE GENE MUTATION AND
ITS RELATION WITH TRADITIONAL CHINESE
MEDICINE SYNDROME IN CHRONIC HEPATITIS B
PATIENTS]. DAI MIN, WANG YONG -ZE, GUAN WEI -
BING, ET AL. chinese journal of integrated traditional
and western medicine in intensive and criti.
2004;11(6):336 (chi*).
Objective: To investigate the relationship of the precore 1896
site gene mutation of hepatitis B virus (HBV) and the
distribution of traditional Chinese medicine syndrome in
chronical hepatitis B (CHB ) patients,and its clinical
significance. Methods: One hundred and forty patients
admitted in the Third Affiliated Hospital of Zhongshan
University from February 1999 to December 2002, whose
HBV precore 1896 site gene mutation was detected, were
229
randomly enrolled. The patients were divided into precore
gene mutation positive and negative groups, and 70 cases in
each group. The marker of HBV, T lymphocytes, the index of
hepatic fibrosis, the serum levels of HBV - DNA were
detected and were compared among the patients with
different traditional Chinese medicine syndromes, in order to
select the beforehand factors of the precore 1896 site gene
mutation in HBV. Results: There were significant differences
of the traditional Chinese medicine syndrome between
precore gene mutation positive and negative group (all P<0.
05). The Logistic analysis showed that the odds ratio (OR) of
CD4+ , type IV collagen( IV . C) and DNA were all more
than 1, CD4+ was negative correlated, and IV .0 and DNA
were positive correlated with precore gene mutation.
Conclusion: The serum level of HBV -DNA, CD4+ and N .0
could be considered as the risk factors of precore 1896 site
gene mutation. The mutative rate would be high in the
patients with syndrome of asthenia of healthy energy as well
as wetness - heat and blood stasis .
3814- gera: 137299/di/ra
[EFFECT OF SPLENECTOMY ON LIVER FIBROSIS
INDUCED BY PORCINE SERUM]. DU GUANGLI, LIU
PING, WANG LEI, ET AL. chinese journal of integrated
traditional and western medicine on digestion.
2004;12(6):339 (chi*).
[ Objective] To investigate the effect of splenectomy on liver
fibrosis induced by porcine serum. [Methods] Wistar rats
were randomly divided into normal control group, model
group, splenectomy group and sham operation group.
Fibrosis model of rats was duplicated by peritoneal injection
of porcine serum. Pathological and collagen stain of the liver
were observed under microscopy. Liver function and
hydroxyproline content in the liver tissue were determined. [
Results] There were thin to thick complete fiber septa in the
model group, splenectomy group and sham operation group
after 12 weeks of injection of porcine serum. Compared with
the normal group, serum ALT activity in rats of the model
group, splenectomy group and sham operation group elevated
significantly [ (46. 79 ± 4.76) , (52. 50 ± 4. 49) , (51. 90 ±
3.47) U/L , P < 0.05 ] ; Alb content decreased markedly [
(28.03 ± 1.41) , (27. 86 ± 1. 66) , (28. 82 ± 1. 37) g/L, P <
0.01, < 0.05 ] ; Hyp content increased significantly [ (303. 77
± 32.59) , (332.62 ± 54.06) , (300. 17 ± 48.05) p g/g wet
liver, P < 0.01 ] ;there were no changes in TP and TBIL
content in each group. Compared with model group, serum
ALT activity in the rats of splenectomy group strengthened
significantly ( P < 0. 05) and Hyp content tended to increase
without statistical significance. [ Conclusion] Splenectomy
can not stop the formation of liver fibrosis of rats induced by
porcine serum.
3815- gera: 137301/di/ra
[EFFECT OF GANLIKE ON THE EXPRESSION OF
TGF-B1, MRNA IN RATS WITH EXPERIMENTAL
LIVER FIBROSIS]. LI BAOLING, YAN MAOXIANG,
CHEN ZHIYUN, ET AL. chinese journal of integrated
traditional and western medicine on digestion.
2004;12(6):344 (chi*).
[ Objective] To study the effect of ganlike, a kind of Chinese
herb compound, on the expression of TGF-B1, mRNA in rats
with experimental liver fibrosis. [ Methods] Rats with
experimental liver fibrosis were induced by injecting 40%
CC14 subcutaneously. After the model was made, rats with
liver fibrosis were given different dosages of ganlike and
colchicines. All the rats were killed at the end of the
eighteenth week. The expression of TGF-B1, mRNA in the
liver tissue was detected by in situ hybridization method. [
Results] The expression of TGF-B1, mRNA in the liver
tissues of the model group was significantly higher than that
gera 2011

of the normal group ( P < 0.01) ; The expression of TGF-B1,
mRNA in rat liver tissues of all the treatment groups was
obviously lower than that of the model group ( P < O. 01 , <
0.05) . There was positive correlation between the expression
of TGF-B1, mRNA and the liver fibrosis scoring in the
model group( r =O. 801 , P < 0.01) . [Conclusion]The
expression of TGF-B1, mRNA in the liver tissue of liver
fibrotic rats increased and closely related with the occurrence
and development of liver fibrosis. Ganlike decreased the
expression of TGF-B1, mRNA , which might be one of its
approaches in resisting
3816- gera: 137321/di/ra
[THERAPEUTIC EFFECTIVENESS OF
THYMOPENTIN COMBINED WITH HEPATITIS B
VACCINE ON CHRONIC ASYMPTOMATIC
CARRIERS WITH LOW TITER OF HBSAG]. HE
XING-E, WANG WENLONG , TIAN YI , ET AL. chinese
journal of integrated traditional and western medicine on
liver diseases. 2004;14(6):325 (chi*).
3817- gera: 137322/di/ra
[STUDY ON LAMIVUDINE WITH YIGAN ZHUANYIN
MIXTURE IN TREATING CHRONIC HEPATITIS B].
SUN YAN, JI GUANGSEN , XU QINGTIAN , ET AL.
chinese journal of integrated traditional and western
medicine on liver diseases. 2004;14(6):328 (chi*).
3818- gera: 137323/di/ra
[A CLINICAL EFFECT OF LAMIVUDINE AND
SHUANG JIA WU LING CAPSULE ON HEPATIC
FIBROSIS]. ZHANG YAN, LI YANHONG , XIE YUMEI ,
ET AL. chinese journal of integrated traditional and
western medicine on liver diseases. 2004;14(6):330 (chi*).
3819- gera: 137324/di/ra
[EFFECTS OF RECOMBINANT HBV VACCINE
COMBINED INTERFERON ON ANTI-HBV AND
HEPATIC FUNCTION OF PATIENTS WITH
CHRONIC HEPATITIS B]. LIU ZHONGJING, LIU
SHENG , YUAN YOUBIN , ET AL. chinese journal of
integrated traditional and western medicine on liver
diseases. 2004;14(6):332 (chi*).
3820- gera: 137326/di/ra
[EXPERIMENTAL STUDY OF THE CURING EFFECT
OF BAOGANJIANGZHIYIN ON
STEATOHEPATITIS]. LI TIANWANG, LI ZHIQING ,
HU KERONG. chinese journal of integrated traditional
and western medicine on liver diseases. 2004;14(6):335
(chi).
3821- gera: 137327/di/ra
[CLINICAL SIGNIFICANCE OF LIVER BIOPSY FOR
CHRONIC HEPATITIS B WITH LOWER DEGREE
RISE IN TRANSAMINASES]. YANG XIAOYUN, LI
SHAOGUANG , WEN FANYUAN , ET AL. chinese
journal of integrated traditional and western medicine on
liver diseases. 2004;14(6):337 (chi*).
3822- gera: 137328/di/ra
[IDENTIFICATION AND CLONING OF HUMAN
GENE DNAPTP4 TRANSACTIVATED BY RNASE H
PROTEIN OF HEPATITIS B VIRUS]. WANG
CHUNHUA, LANG ZHENWEI , CHENG JUN , ET AL.
chinese journal of integrated traditional and western
medicine on liver diseases. 2004;14(6):339 (chi*).
3823- gera: 137329/di/ra
[THE STUDY OF UP-REGULATING EFFECT OF
230
HALR ON THIOREDOXIN REDUCTASE 1 GENE
PROMOTER]. JI DONG, CHENG JUN , GUO JIANG , ET
AL. chinese journal of integrated traditional and western
medicine on liver diseases. 2004;14(6):343 (chi*).
3824- gera: 137330/di/ra
[EFFECTS OF WINED RHUBARB, LACTOHACILLIN
AND RHABARB LACTOHACILLIN SOLUTION ON
THE PREVENTION AND CURE OF ACUTE HEPATIC
ENCEPHALOPATHY]. ZHANG CHIZHI, CHEN
JUNMEI , WEI WEI. chinese journal of integrated
traditional and western medicine on liver diseases.
2004;14(6):347 (chi*).
3825- gera: 137331/di/ra
[EXPERIMENTAL STUDY ON EFFECT OF
ZHIYANXIAO DECOCTION IN PREVENTION AND
TREATMENT OF NONALCOHLIC
STEATOHEPATITIS IN RATS]. WU QIKAI, NIE
GUANG , ZHANG LING , ET AL. chinese journal of
integrated traditional and western medicine on liver
diseases. 2004;14(6):351 (chi*).
3826- gera: 137332/di/ra
[CLINICAL SIGNIFICANT OF 5' NUCLEOTIDASE IN
LIVER FUNCTION]. MA JIANGTAO, JI LING , HE LIN.
chinese journal of integrated traditional and western
medicine on liver diseases. 2004;14(6):360 (chi*).
3827- gera: 137380/di/ra
EFFECT OF DANSHAO HUAXIAN CAPSULE ON
THE EXPRESSION OF COLLAGEN AND CASPASE-3
IN HEPATIC FIBROSIS RATS. GENG XIAO-XIA,
YANG QIN, XIE RU-JIA, ET AL. chinese journal of
integrative medicine. 2004;10(4):289 (eng*).
3828- gera: 137384/di/ra
WANG CHENG-BAI -A PROMINENT
HEPATOLOGIST OF INTEGRATIVE MEDICINE . X.
chinese journal of integrative medicine. 2004;10(4):308
(eng).
3829- gera: 137649/di/ra
[INTEGRATED CHINESE & WESTERN MEDICINE
FOR 46 CASES OF INTRAHEPATIC CHOLESTASIS
OF PREGNANCY]. LAN NING 'CHEN CUI-LING
'WANG YUE-ZHEN. fujian journal of tcm. 2004;35(6):6
(chi).
3830- gera: 137740/di/ra
[CLINICAL RESEARCH ON TREATING THE
FIBROSIS OF LIVER DUE TO CHRONIC VIRUS B
HEPATITIS WITH ZHUANGGAN ZHUYU
GRANULE]. LIN SHOUNING HUANG BIN ZHU
YONGPING. guanxi journal of tcm. 2004;27(6):11 (chi*).
3831- gera: 137743/di/ra
[50 CASES OF ASCITES DUE TO CIRRHOSIS WITH
THE TREATMENT OF INTEGRATED
TRADITIONAL CHINESE MEDICINE AND
WESTERN MEDICINE]. XU JING. guanxi journal of
tcm. 2004;27(6):20 (chi).
3832- gera: 137851/di/ra
[THERAPEUTIC EXPERIENCE OF LIVER FIBROSIS
AFTER HEPATITIS B]. LI XIAN . henan tcm.
2004;24(10):58 (chi).
3833- gera: 137853/di/ra
[RESEARCH DEVELOPMENT OF SYNDROME TYPE
gera 2011

OF CIRRHOSIS]. ZHAO YINGHONG. henan tcm.
2004;24(10):83 (chi).
3834- gera: 137867/di/ra
[TYPING AND DIFFERENTIATION OF SYNDROMES
IN TREATING PRIMARY CARCINOMA OF LIVER:A
REPORT OF 172 CASES]. WANG SHANGJIN . henan
tcm. 2004;24(12):51 (chi).
3835- gera: 137911/di/ra
[OBSERVATION OF CURATIVE EFFECT ON
HYPERBILIRUBINEMIA DUE TO CIRRHOSIS OF
VIRUS HEPATITIS TREATED BY YINZHIHUANG
INJECTION ]. WEN HOUJUN, ET AL. hubei journal of
tcm. 2004;26(12):27 (chi).
3836- gera: 137959/di/ra
[A SUMMARY ON 40 CASES OF HEPATOCIRROSIS
DUE TO CHRONIC HEPATITIS B TREATED WITH
COMBINATION OF CHINESE TRADITIONAL AND
WESTERN MEDICINE]. ZENG SONGLIN, ET AL.
hunan journal of tcm. 2004;20(6):15 (chi).
3837- gera: 137960/di/ra
[A SUMMARY ON 57 CASES OF CHRONIC
HEPATITIS B TREATED WITH COMBINATION OF
CHINESE TRADITIONAL AND WESTERN
MEDICINE]. SHEN SHANGPEI. hunan journal of tcm.
2004;20(6):17 (chi).
3838- gera: 137989/di/ra
[EFFECT OF TUIHUANG SOUP FOR 31 CASES WITH
HEPATITIS TO BILE STASIS]. LIU MEILING . inner
mongol journal of tcm. 2004;23(6):5 (chi).
3839- gera: 138262/di/ra
[INTERFERING EFFECTS OF LIVER-PROTECTIVE
TCM DRUGS ON THE EXPRESSION OF TIMP-1 IN
HSC AND HSC APOPTOSIS]. GUO SHUNGEN, JIANG
TAO , ZHANG WEI , ET AL. journal of beijing university
of tcm. 2004;27(6):23 (chi*).
Objective To observe the effects of liver-protective TCM
drugs on the expression of TIMP-1 in HSC and HSC
apoptosis on the purpose of investigating their target points
for resisting hepatic fibrosis. Method First, the rat HSC was
isolated and cultivated, and then, TIMP-1 expression in HSC
and the interfering effects of the TCM drug- medicated serum
on the TIMP-1 expression were detected by the ABC
immunohistochemical method, the results of which were
analyzed by a quantitative image analytic technique; and the
percentage of HSC apoptosis was calculated by the Giemsa
staining method and TUNEL staining method. Results There
was a significant difference between the absorbency of
TIMP-1 positive reactants in hepatic HSC in the TCM drug-
medicated serum group and that in the control group (P <
0.05) ; and the apoptotic rate was 10.3% in the TCM drug-
medicated serum group. Conclusion The serum mediated
with TCM liver-protective drugs could inhibit the TIMP-1
expression of
3840- gera: 138281/di/ra
[CLINICAL OBSERVATION OF THE EFFECTS OF
LIGANJIANGZHI DECOCTION FOR TREATING
CHRONIC VIRAL HEPATITIS COMPLICATED BY
DISORDER OF LIPID METABOLISM]. LIU MIN, LI
XIANPING. journal of beijing university of tcm.
2004;27(6):83 (chi).
3841- gera: 138447/di/ra
[20 CASES OF PILES HEMORRHAGE CAUSED BY
231
HEPATOCIRRHOSIS TREATED BY HIP BATHING
WITH CHINESE DRUGS]. QIAO JINCHANG. journal of
external therapy of tcm. 2004;13(6):47 (chi).
3842- gera: 138523/di/ra
[EFFECT OF RADIX PAEONIAE RUBRA ON
INSULIN-RESISTANCE AND LEPTIN IN RAT
MODELS WITH FATTY LIVER: EXPERIMENTAL
STUDY]. ZHAO WENXIA, MIAO MINGSAN, LI
JIANGUO, ET AL. journal of henan university of chinese
medicine. 2004;19(6):21 (chi*).
Objective: By studying the effect of Radix Paeoniae Rubra
on Leptin and insulin-resistance in rat models with fatty liver,
the author made a research into this herb's mechanism on
combating fatty liver. Method: Rat models of fatty
degeneration of livers were induced by high-fat food feeding
plus abdominal injection of Tetracycline. After the rats were
divided into a high-dose group of Radix Paeoniae Rubra, a
low-dose group of Radix Paeoniae Rubra and Dongbao
Gantai Group, they were given medicines respectively by
gastric infusion; meanwhile, a model group and a placebo
group were set up for the sake of comparison. 49 days later
their indexes of leptin and insulin- resistance in serum were
measured. Result: In comparison of the model group there
were lower indexes of weight and liver in the high dase group
of Radix Paeoniae Rubra and Dongbai Gantai Group; at the
same time, there appeared marked reduction of the levels of
leptin and insulin-resistance index( P<0.05). The result
suggested Radix Paeoniae Rubra's effect of improving leptin
and insulin-resistance. Conclusion: The therapeutic effect of
Radix Paeoniae Rubrae on fatty liver is probably attributable
to this herb's mechanism of improving insulin and
3843- gera: 138534/di/ra
[COMPOUND RADIX SALVIAE MILTIORRHIZAE
INJECTION PLUS TIOPRONIN IN TREATING
MEDICAMENTOUS LIVER LESION: CLINICAL
OBSERVATION OF 98 CASES]. WU ERGUANG, XU
TINGTING, XU XIANGZHI. journal of henan university
of chinese medicine. 2004;19(6):41 (chi*).
Objective; To observe the clinical effect of Compound Radix
Salviae Miltiorrhizae plus Tiopronin in treating
medicamentous liver lesion. Method: The patients with this
disease were put into two groups: a treatment group of 50
cases, who received compound Radix Salviae Miltiorrhizae
Injection plus Tiopronin, and a control group of 48 cases,
who were treated by HXR Injection plus ASP Kalium
Magnesium Injection. Result: There were 42 cases of marked
effect and 8 of some effect, the effective rate being 100% in
the treatment group. By contrast, there was marked effect in
10 cases, some effect in 16 cases and no effect in 22 cases,
the effective rate being 54.2% in the control group.
Conclusion: Compared with the control group, Compound
Radix Salviae Miltiorrhizae Injection plus Tiopronin is
markedly effective in treating medicamentous liver lesion.
3844- gera: 138544/di/ra
[SHUGAN HUOYU DECOCTION IN THE
TREATMENT OF 30 CASES OF ASCITES DUE TO
HEPATOCIRRHOSIS]. YANG XIANSHENG . journal of
henan university of chinese medicine. 2004;19(6):54 (chi).
3845- gera: 138734/di/ra
[STUDY ON CLINICAL EFFECT OF HEPATIC
FIBROSIS TREATED BY KANG XIAN DECOCTION].
JIANG YIPING, XIONG MINGFANG, ZENG YINGJIAN.
journal of practical tcm. 2004;20(12):676 (chi).
3846- gera: 138841/di/ra
AVANCES EN EL DIAGNÓSTICO Y TRATAMIENTO
gera 2011

DEL HÍGADO GRASO. X. el pulso de la vida- journal of
tcm. 2004;39:37 (esp*).
3847- gera: 138842/di/ra
COMO TRATAR EL DOLOR EN LA REGIÓN
HEPÁTICA ASOCIADO A UNA HEPATITIS
CRÓNICA. X. el pulso de la vida- journal of tcm.
2004;39:45 (esp*).
3848- gera: 138936/di/ra
[ON BASIC PRINCIPLES OF MODERN TCM
TREATMENT OF HEPATITIS B. CHENG LIHUA.
journal of tcm. 2004;45(12):883 (chi*).
In TCM treatment of hepatitis Bone of refractory
diseases,must follow strictly the principles of learning the
past, but not rigidly adhere to it.and opening up and
innovation. The principles of anti-virus,playing attention to
objective detection. clinically re-researching, unifying
disease differentiation and syndrome differentiation,as well
as attaching importance to medicine toxicity and carefully
selecting medicines and so on mentioned in this paper are a
preliminary opinion based on the above view point in
combination with long-term clinical practice and thinking.
3849- gera: 138941/di/ra
[CLINICAL OBSERVATION ON 30 CASES OF
HEPATIC CIRRHOSIS WITH PROTEINURIA
TREATED WITH COMBINATION OF CLEARING,
PURGING, RESOLVING AND TONIFYING
METHOD]. LI YONGWEI, YANG HONGZHI, WANG
YONGZE, ET AL. journal of tcm. 2004;45(12):911 (chi*).
Objective: To observe the clinical effect of modified
combined Qingxia Xiaobu Prescription and Wuzi Yanzong
Decoction on hepatic cirrhosis with proteinuria. Methods:60
cases of hepatic cirrhosis with proteinuria at compensatory
phase were divided into the treatment group (n= 30) treated
with modified Qingxia Xiaobu Prescription and Wuzi
Yanzong Decoction, and the control group treated with
Shenganning Capsules. And the patients of the two groups
were all treated by the same western medicine including
liver-aid,supporting and expectant treatment. The changes of
blood glutamic-pyruvic transminase (ALT) ,total protein (TP)
, albumin (ALB) , total bilirubin (TBIL) , direct bilirubin
(DBIL) , urea nitrogen (BUN) , creatinite (SCr) and 24-h-
urinary protein (24hu-pro) , urinary immunoglobulin G
(IgGu) and albumin (ALBu) levels before and after treatment
were detected. Results:The all indexes in the two groups after
treatment improved significantly (P<0. 05) and the treatment
group had more significant improvement in
TP,ALB,TBIL,DBIL,BUN and 24hu-pro,IgGu and ALBu
levels as compared with the control group (P<0. 05).
Conclusion:The modified combined Qingxia Xiaobu
Description and Wuzi Yanzong Decoction can alleviate
urinary protein and improve renal function in the patient of
hepatic cirrhosis with proteinuria.
3850- gera: 139122/di/ra
[STUDIES ON ESTABLISHING A QUANTIZED
STANDARD OF DEPRESSING SYNDROME OF
LIVER QI OF PRIMARY LIVER CANCER]. HOU
FENG-GANG, LING CHANG-QUAN, ZHAO GANG, ET
AL. journal of yunnan college of tcm. 2004;27(4):14 (chi*).
Objective: To set a quantized standard (including quantized
diagnosis standard and classification standard) on depressing
syndrome of liver qi of primary liver cancer (PLC) . Method :
To identify depressing syndrome of liver qi of PLC according
to relevant referenced standard on the base of survey on
clinical epidemiology and evaluate its correlative factors on
the base of difference of their appearance between depressing
syndrome of liver qi and no depressing syndrome of liver qi,
232
and then set its quantized diagnosis standard and test it; at
last set the classification standard. Results : The diagnosis
standard of depressing syndrome of liver qi of PLC is 20
points; The Sen, Spe and ACC of the prospective and
retrospective examination of it are higher than 85% . + LR of
them are respectively 8.02 and 8.82; 20 26 points is classified
as low grade, 27 34 points is classified as medium grade,
high grade is 35 points. Conclusions: Compared with those
kinds of standards set during studying in the past, the
quantized standard on depressing syndrome of liver qi of
PLC has its characteristics; (1) according with clinical
characteristic of PLC ; (2) rigorous statistical methods; (3)
rationality of evaluation; (4) religious examination; (5)
3851- gera: 139123/di/ra
[EFFECT OF HOVENIA DULCIS THUMB ON
PREVENTIVE HEPATIC FIBROSIS IN RATS]. WEN
WEI, ZHANG HONG, YE LI-PING. journal of yunnan
college of tcm. 2004;27(4):23 (chi).
3852- gera: 139463/di/ra
3-SESIÓN CLÍNICA: HÍGADO GRASO. MOLESTIAS
DIGESTIVAS . X. medicina tradicional. 2004;202:13
(esp).
3853- gera: 139496/di/ra
[EXPERIMENTAL STUDY OF MUSU PILL ON
DIMETHYLNITROSAMINE-INDUCED RAT
HEPATIC FIBROSIS]. GAO FENG, CHENG LIU-FANG,
WANG ZHI-QIANG, ET AL. modern journal of
integrated traditional chinese and western medicine.
2004;13(24):3253 (chi*).
3854- gera: 139590/di/ra
[AN ANALYSIS OF CORRELATION FACTORS IN
TCM SYNDROME PATTERNS OF HEPATIC
FIBROSIS IN CHRONIC HEPATITIS B]. KUANG WEI-
HONG. new journal of tcm. 2004;36(12):30 (chi).
3855- gera: 139593/di/ra
[THE INFLUENCE OF FUZHENG YILIU GRANULE
ON LIVER CANCER CELL H22 APOPTOSIS IN MICE
AND EXPRESSION OF FAS AND FAST]. XU RUI-
FENG, ZHAO JIAN-XIAONG, CHENG WEI-DONG, ET
AL. new journal of tcm. 2004;36(12):65 (chi).
3856- gera: 140059/di/ra
[PROTECTIVE EFFECT OF CLASSIC
PRESCRIPTION SINISAN ON LIVER INJURY AND
THE MECHANISM STUDY]. ZHANG GUO-JUN,
WANG DONG-QIANG, SHI LI-PIN. tianjin journal of
tcm. 2004;21(6):503 (chi).
[Objective] To observe the protective effect of classic
prescription Sinisan and the mechanism on liver injury.
[Methods] Liver injury was induced by oral infusion of
lithocholic acid with gastric tube. Level of serum ALT, AST,
GSH, SOD and MDA was detected and the pathological
observation of liver tissue was made. [Results] Sinisan could
decrease the increased level of serum ALT, AST and MDA,
and could increase the depressed level of serum SOD, GSH
in rats with liver injury. The extent of pathological injury of
liver tissue was alleviated markedly. Sinisan combined with
rice water could decrease the level of AST, MDA apparently
, while Sinisan decoction decreased level of ALT evidently.
[Conclusion] Classic prescription Sinisan has certain
protective effect on liver injurY.
3857- gera: 140151/di/ra
OBSERVATION ON THE EFFECT OF
MOXIBUSTION ON HYPERBILIRUBINEMIA IN
gera 2011

HEPATITIS B TYPE CIRRHOSIS PATIENTS. CHENG
JING JUN, SUN GUO-JIE. world journal of acupuncture-
moxibustion. 2004;14(4):12 (eng*).
Objective: To study the effect of moxibustion on
hyperbilirubinemia in hepatitis B cirrhosis patients. Methods:
56 cases of inpatients with hepatitis B cirrhosis were divided
into treatment group (n = 27) and control group (n = 29)
randomly. All the patients of these two groups were given
with routine expectant treatment including administration of
medicines (Bifendate, Essential, Potenline, etc) for protecting
liver functions, reducing the level of alanine aminotransferase
(ALT) , etc. , and in the meantime, patients of the treatment
group were also treated with moxibustion of Zusanli (ST 36)
, Taichong ( LR 3) and Sanyinjiao (= SP 6) , once daily,
continuously for 4 weeks. Results: After 4 weeks of
treatment, of the 27 and 29 cases of treatment and control
group, 23 and 10 patients had improvement in clinical
symptoms, 4 and 19 failed, with the total effective rates being
85. 18% and 34. 48% respectively. Senn total bilirubin (TBil)
contents of treatment and control groups decreased
significantly, and the level of TBil in the treatment group was
significantly lower than that in the control group (P<0.01).
Conclusion: moxibustion is an effective remedy in relieving
hyperbilirubinemia and improving clinical symptoms in
3858- gera: 140193/di/ra
[STUDY ON CORELATIVITY BETWEEN COLOR
AND OTHER CHARACTERISTICS OF TONGUE
PICTURE IN CHRONIC HEPATITIS B]. LIU
WENLAN, ZHANG YAN, YU MEI, ET AL. zhejiang
journal of tcm. 2004;39(12):516 (chi).
3859- gera: 103179/di/ra
ADVANCES OF STUDIES ON MECHANISMS OF
DRUGS FOR ACTIVATING BLOOD CIRCULATION
AND REMOVING BLOOD STASIS IN TREATMENT
OF PRIMARY LIVER CANCER. REN R, JU L, CHEN Z.
journal of traditional chinese medicine. 2005;25(4):304-9.
(eng).
3860- gera: 123917/di/ra
[PROTECTIVE ACTIONS OF ACUPOINT
MAGNETIC MEDICATED PLASTER THERAPY ON
HEPATIC FUNCTION IN THE PATIENT OF
CIRRHOSIS AFTER HEPATITIS]. HUANG JQ, DENG
JH, ZHENG ZX, XIAO F, ZHANG JJ. chinese acupuncture
and moxibustion. 2005;25(9):613-5. (chi).
OBJECTIVE: To observe the therapeutic effect of acupoint
magnetic medicated plaster therapy on cirrhosis after
hepatitis. METHODS: One hundred and twenty patients with
cirrhosis after hepatitis were randomly divided into 2 groups.
The control group (n=60) were treated by the hepatic
protective therapy (diammonium glyeyrrhiznate, Silymarin,
compound Tanshin, vitamin E), and the treatment group were
treated by the liver-protective therapy and acupoint magnetic
medicated plaster therapy, for 2-6 therapeutic courses.
Clinical symptoms, hepatic function, serum markers of
hepatitis B virus and indexes of hepatic fibrosis were
investigated. RESULTS: The markedly effective rate and the
total effective rate were 65.0% and 95.0% in the treatment
group, and 43.3% and 91.7% in the control group, and the
serum indexes of hepatic fibrosis decreased signficantly, with
significantly diferences (all P < 0.05). CONCLUSION:
Acupoint magnetic medicated plaster therapy can improve
clinical symptoms, rapidly restore hepatic function, decrease
serum indexes of hepatic fibrosis in the patient of cirrhosis
3861- gera: 125997/di/ra
HEPATOPROTECTION OF OLEANOLIC ACID IS
RELATED TO ITS INHIBITION ON
233
MITOCHONDRIAL PERMEABILITY TRANSITION.
TANG XH, GAO J, FANG F, CHEN J, XU LZ, ZHAO XN,
XU Q. american journal of chinese medicine.
2005;33(4):627-37. (eng).
The protective effects of oleanolic acid (OA) on carbon
tetrachloride (CCl4)-induced liver mitochondrial damage and
the possible mechanisms were investigated. Pretreatment
with OA prior to the administration of CCl4 significantly
suppressed the increases of serum aspartate aminotransferase
(AST) and alanine aminotransferase (ALT) (4.2- and 19.9-
fold, respectively) in a dose-dependent manner in mice. The
dissipation of mitochondrial membrane potential (14.8%) and
intra-mitochondrial Ca2+ overload (2.1-fold) in livers of
CCl4-insulted mice were also dose-dependently prevented by
pretreatment with 20, 50 or 100 mg/kg OA. In addition, the
effects of OA on liver mitochondria permeability transition
(MPT) induced by Ca2+ were assessed by measuring the
change in mitochondrial membrane potential, release of
matrix Ca2+ and mitochondrial swelling in vitro. The results
showed that preincubation with 50 or 100 microg/ml OA
obviously inhibited the Ca2+-induced mitochondrial
swelling, mitochondrial membrane depolarization and intra-
mitochondrial Ca2+ release. It could be concluded that OA
has protective effects on liver mitochondria and the
mechanisms underlying its protection may be related to its
3862- gera: 126151/di/ra
A HOSPITAL CLINIC-BASED SURVEY ON
TRADITIONAL CHINESE MEDICINE USAGE
AMONG CHRONIC HEPATITIS B PATIENTS. WONG
VW, LAW MY, HUI AY, LO AO, LI CY, SOO MT,
LEUNG HY, CHAN HL. complementary therapies in
medicine. 2005;13(3):175-82. (eng).
OBJECTIVES: To survey the pattern of traditional Chinese
medicine usage among chronic hepatitis B patients. DESIGN:
Self-administered questionnaire survey. SETTING: Hepatitis
clinic at a university hospital in Hong Kong. MAIN
OUTCOME MEASURES: Proportion of chronic hepatitis B
patients who have ever used traditional Chinese medicine for
the treatment of chronic hepatitis B and factors associated
with the use. RESULTS: Three hundred and sixty-two
patients completed the survey (response rate 93%). One
hundred and sixteen (32%) patients reported history of
traditional Chinese medicine usage. One hundred and five
(91%) patients felt that Chinese medicine had few or no side
effects. Most (81%) patients did not inform their physicians
on Chinese medicine usage. On multivariate analysis, recent
travel to Mainland China, perceived active hepatitis and
family members with chronic hepatitis B were independent
factors associated with the use of Chinese medicine.
CONCLUSIONS: Chronic hepatitis B patients commonly use
traditional Chinese medicine. As patients seldom inform the
physicians about the use of Chinese medicine, doctors should
explicitly enquire about this because of potential therapeutic
3863- gera: 126199/di/ra
THE STATE OF INSULIN RESISTANCE IN
PATIENTS WITH NONALCOHOLIC FATTY LIVER
AND THE INTERVENTION WITH GANKANGYIN.
DENG YQ, FAN XF, LI JP. chinese journal of integrative
medicine. 2005;11(2):117-22. (eng).
OBJECTIVE: To explore the correlation of nonalcoholic
fatty liver (NAFL) with insulin resistance and the
intervention of it by Gankangyin(GKY). METHODS:
Ninety-six patients with NAFL were randomly assigned into
the treated group and the control group. They were treated
with GKY and Silymarin for 3 months respectively. Oral
glucose tolerance test (OGTT) and insulin release test (IRT)
were conducted and insulin sensitivity indexes were
determined before and after treatment. And 32 healthy
gera 2011

nonalcoholic persons were enrolled and used as the healthy
control group. RESULTS: Before treatment, the levels of
blood glucose and insulin at different time points in OGTT
test, and the insulin resistance index (IRI) were significantly
higher (P < 0.05 or P < 0.01) while insulin sensitivity index
(ISI) and insulin active index (IAI) were lower (P < 0.05 or P
< 0.01) in the NAFL patients than those in the healthy
persons. After treatment, the above-mentioned raised criteria
were significantly lowered (P < 0.05, P < 0.01) and the
lowered criteria were significantly increased (P < 0.01) in the
treated group, while in the control group all the criteria were
insignificantly changed (P > 0.05). CONCLUSION: Evident
insulin resistance exists in NAFL patients. GKY could
increase the insulin sensitivity, thus improving the state of
insulin resistance in NAFL patients.
3864- gera: 126243/di/ra
TRAITEMENT DU CANCER DU FOIE EN FONCTION
DES SYMPTOMES : QUATRE CAS CLINIQUES. HU
ANBANG. journal de medecine traditionnelle chinoise.
2005;1(4):37 (fra).
3865- gera: 126266/di/ra
CLINICAL STUDY ON TREATMENT OF PRIMARY
HEPATOCELLULAR CARCINOMA BY SHENQI
MIXTURE COMBINED WITH MICROWAVE
COAGULATION. LIN JJ, JIN CN, ZHENG ML,
OUYANG XN, ZENG JX, DAI XH. chinese journal of
integrative medicine. 2005;11(2):104-10. (eng).
OBJECTIVE: To observe the short-term efficacy and safety
of Shenqi mixture (SQM) combined with microwave
coagulation in treating primary hepatocellular carcinoma
(HCC). METHODS: Seventy-two patients with primary HCC
of stage II-III, Karnofsky scoring > or = 50 scores and
predicted survival period > or = 3 months were selected and
randomly assigned into two groups, the treated group and the
control group, 36 in each. Microwave therapy was applied to
both groups by double leads, 60 W, 800 sec once a week for
two weeks. To the treated group, SQM was given
additionally through oral intake of 20 ml, three times a day
for 1 month. The changes in tumor size, main symptoms,
serum level of alpha-fetoprotein (AFP), immune function and
adverse reaction were observed after treatment and the
immune parameters of the patients were compared with 30
healthy persons in the normal control group. RESULTS: (1)
In the SQM treated group, after treatment 3 patients got
completely remitted (CR), 24 partial remitted (PR), 4
unchanged (NC) and 5 progressively deteriorated (PD), the
effective rate being 75.00%; while in the control group, 1 got
CR, 19 PR, 9 NC and 7 PD, the effective rate being 55.56%.
Comparison of the effective rate between the two groups
showed significant difference (P < 0.05). (2) AFP level
decreased after treatment in both groups, but the decrement in
the treated group was significantly higher than that in the
control group (P < 0.01). (3) After treatment, in the treated
group, CD3(+), CD4(+), CD4(+)/CD8(+) and NK activity
were improved, Karnofsky scores increased and liver
function bettered, with these improvements significantly
superior to those in the control group (P < 0.01). (4) The
improvement in symptoms such as hepatic region pain, fever,
weakness, poor appetite and jaundice in the treated group
after treatment was also superior to that in the control group
(P < 0.01). (5) The 12-month, 18-month and 24-month
survival rates were higher and the recurrence rate was lower
in the treated group than those in the control group, showing
significant difference (P < 0.05). CONCLUSION: Combined
therapy with SQM and microwave coagulation could not only
kill the tumor and residue tumor cells to prevent recurrence,
but also enhance the cellular immunity of organism. It is one
of the effective therapies for patients with middle-advanced
234
hepatocarcinoma, who have lost the chance of surgical
operation. It could improve clinical symptoms, elevate the
quality of life, prolong the survival period of patients, but
shows no
3866- gera: 136277/di/re
TRADITIONAL CHINESE MEDICINE SYNDROMES
OF CHRONIC HEPATITIS B WITH PRECORE
MUTANT. YANG HZ, ZHAO JA, DAI M, LI YW, WANG
YZ, GUAN WB, XIE HP. world j gastroenterol.
2005;11(13):2004-8 (eng).
AIM: This study aims at exploring the distribution of TCM
syndromes in CHB patients with HBV pre-core mutation
(1896) and the relationship between pre-core mutation and T
lymphocytes subgroup, through which to provide objective
data on clinical syndrome differentiation of TCM, and further
to suggest the therapeutic principle and guide clinical
treatment. METHODS: One hundred and forty CHB patients
were evenly divided into two study groups, HBV pre-core
mutant group and HBV pre-core wild-type group. Besides, 30
healthy blood donors were selected as a healthy control
group. HBV-labeled compound, T lymphocytes subgroup,
and HBV-DNA pre-core mutant were tested in the study
groups. T lymphocytes subgroup were also tested in the
control group. All the patients were both diagnosed by
syndrome differentiation of TCM and western medicine.
RESULTS: The most common syndrome in mutant group
was damp-heat combined with blood stasis, and the most
common syndrome in the wild-type group was damp-heat
stasis in the middle-jiao. There were more cases of medium
and severe hepatitis in mutant group than that in wild-type
group. The content of CD4+ lymphocytes and CD4+/CD8+
ratio were decreased gradually (healthy control group>wild-
type group>mutant group). In the wild-type group, severe and
medium CHB patients had considerably lower level of them
than mild CHB patients. However, in the mutant group, the
opposite result appeared. Meanwhile, the content of HBV-
DNA in mutant group was higher than that in wild-type
group. CONCLUSION: Damp, heat, toxin and blood stasis
were the basic pathogens of CHB, whether pre- core mutant
or not. CHB with precore mutant may lead to more severe
hepatitis. The decreased content of CD4+ lymphocytes and
ratio of CD4+/CD8+ may be taken as one of the indices in
confirming the deficiency syndrome of CHB patients with
pre-core mutation.
3867- gera: 136331/di/ra
ANTI-HEPATITIS C VIRUS EFFECT OF CITRUS
UNSHIU PEEL AND ITS ACTIVE INGREDIENT
NOBILETIN. MEGUMI SUZUKI, KENROH SASAKI,
FUMIHIKO YOSHIZAKI, MIN FUJISAWA, KATSUJI
OGUCHI AND JONG-CHOL CYONG. american journal
of chinese medicine. 2005;33(1):87 (eng).
We investigated the effects of water and ethyl acetate extracts
of Citrus unshiu peel (Aurantii Nobilis pericarpium) on
hepatitis C virus (HCV) absorption in MOLT-4 cells (a
human lymphoblastoid leukemia cell line). By reverse
transcription polymerase chain reaction (RT-PCR), we
showed that both the ethyl acetate layer of Citrus unshiu peel
extract and fraction 7 decreased HCV absorption in MOLT-4
cells. Furthermore, we demonstrated that 3′,4′,5,6,7,8-
hexamethoxyflavone (nobiletin) is the active ingredient that
markedly inhibited HCV infection in
3868- gera: 136495/nd/re
EFFECTS OF CHINESE TRADITIONAL
COMPOUND, JINSANE, ON EXPRESSION OF TGF-
BETA1 AND TGF-BETA1 TYPE II RECEPTOR
MRNA, SMAD3 AND SMAD7 ON EXPERIMENTAL
HEPATIC FIBROSIS IN VIVO. SONG SL, GONG ZJ,
gera 2011

ZHANG QR, HUANG TX. world j gastroenterol.
2005;11(15):2269-76 (eng).
AIM: The transforming growth factor-beta (TGF-beta)/Smad
signaling pathway system plays a prominent role in the
control of cell growth and extracellular matrix formation in
the progression of liver fibrogenesis. Smad proteins can
either positively or negatively regulate TGF-beta responses.
In this study, the therapeutic effects of Chinese traditional
compound decoction, JinSanE, and the changes of TGF-
beta/Smad signaling pathway system in carbon tetrachloride
(CCl(4))-induced rat experimental liver fibrosis were
examined. METHODS: Seventy-two healthy Wistar rats
were assigned to groups including normal control group,
CCl(4) model group, JinSanE treatment group I and JinSanE
treatment group II. Each group contained 18 rats. All groups,
except the normal control group, received CCl(4)
subcutaneous injection for 8 wk. Rats in JinSanE groups I
and II were orally treated with JinSanE daily at the 1(st) and
5(th) wk, respectively, after exposure to CCl(4). The
expression of TGF-beta1 and TGF-beta1 type II receptor
(TRII) mRNA in the liver was determined by reverse
transcription polymerase chain reaction, and the expression
of TGF-beta1, Smad3 and Smad7 by immunohistochemistry.
The liver histopathology was also examined by HE staining
and observed under electron microscope. The activities of
several serum fibrosis-associated enzymes, alanine
aminotransferase (ALT), aspartate aminotransferase (AST),
the levels of serum hyaluronic acid (HA) were assayed.
RESULTS: Hepatic fibrosis caused by CCl(4) was
significantly inhibited in the JinSanE-treated groups. The
degrees of necrosis/degeneration and fibrosis scores were
significantly lower in the JinSanE-treated groups than in the
model control group. The expression of TGF-beta1, TRII and
Smad3 was significantly higher in the model group than that
in the JinSanE-treated groups, and the active/total TGF-beta1
ratio in the JinSanE groups was suppressed. Expression of
TRII mRNA and Smad3 proteins showed a distribution
pattern similar to that of TGF-beta1 with a direct correlation
in terms of the degree of hepatic fibrosis. The amount of
positive staining Smad7 cells was significantly less in the
model group than in the JinSanE-treated groups and the
normal group. The contents of ALT, AST and HA were
significantly lower in the JinSanE-treated groups than those
in the model group. CONCLUSION: Traditional Chinese
medicine, JinSanE, prevents the progression of hepatic
damage and fibrosis through the inhibition of TGF-beta1,
TRII and Smad3 signal proteins, and increases expression of
Smad7 signal protein in vivo.
3869- gera: 136507/nd/re
TETRANDRINE INHIBITS ACTIVATION OF RAT
HEPATIC STELLATE CELLS STIMULATED BY
TRANSFORMING GROWTH FACTOR-BETA IN
VITRO VIA UP-REGULATION OF SMAD 7. CHEN
YW, LI DG, WU JX, CHEN YW, LU HM. j
ethnopharmacol. 2005;16 may: (eng).
Tetrandrine is a bisbenzylisoquinoline alkaloid derived from
the root of a Chinese herbal medicine Stephania tetrandra S.
Moore, which has been used traditionally for the treatment of
hepatofibrogenic disease in China for several decades. In the
present study, the inhibitory effects of tetrandrine lower
concentrations (0.25, 0.5, 1, 2mg/L) on culture-activation and
transforming growth factor-beta(1) (TGF-beta(1))-stimulated
activation of quiescent rat hepatic stellate cells (HSCs) in
vitro were assessed, and the possible relations between the
underlying mechanism of these effects and TGF-beta
signaling via its receptors were investigated. As shown by the
examination of alpha- SMA using immunocytochemical
staining or Western blot, tetrandrine inhibited both culture-
activation and TGF- beta(1)-stimulated activation of HSCs.
235
Further investigations revealed that, in this process, TGF-
beta(1) mRNA expression was suppressed significantly in
contrast to an up-regulation of Smad 7, while the expressions
of type I and type II TGF-beta(1) receptors and Smad 3
mRNA were insignificantly changed by tetrandrine. These
results suggest that tetrandrine at lower concentrations has a
significant inhibiting effect on culture-activation and TGF-
beta(1)-stimulated activation of rat HSCs, and that it may be
due to an up-regulation of Smad 7 which in turn blocks TGF-
beta(1) expression and its downstream signaling.
3870- gera: 136510/nd/re
APOPTOTIC EFFECTS OF EXTRACT FROM
ANTRODIA CAMPHORATA FRUITING BODIES IN
HUMAN HEPATOCELLULAR CARCINOMA CELL
LINES. HSU YL, KUO YC, KUO PL, NG LT, KUO YH,
LIN CC. cancer lett. 2005;221(1): (eng).
The fruiting body of Antrodia camphorata is well known in
Taiwan as a traditional medicine for treating cancer and
inflammation. The purpose of this study was to evaluate the
apoptotic effects of ethylacetate extract from A. camphorata
(EAC) fruiting bodies in two human liver cancer cell lines,
Hep G2 and PLC/PRF/5. Treatment with EAC decreased the
cell growth of Hep G2 and PLC/PRF/5 cells in a dose
dependent manner. In Fas/APO-1 positive-Hep G2 cells,
EAC increased the expression level of Fas/APO-1 and its two
forms of ligands, membrane- bound Fas ligand (mFasL) and
soluble Fas ligand (sFasL), in a p53-indenpendent manner. In
addition, EAC also initiated mitochondrial apoptotic pathway
through regulation of Bcl-2 family proteins expression,
release of cytochrome c, and activation of caspase-9 both in
Hep G2 and PLC/PRF/5 cells. Furthermore, EAC also
inhibited the cell survival signaling by enhancing the amount
of IkappaBalpha in cytoplasm and reducing the level and
activity of NF-kappaB in the nucleus, and subsequently
attenuated the expression of Bcl-X(L) in Hep G2 and
PLC/PRF/5 cells. EAC therefore decreased the cell growth
and induced apoptosis both in Hep G2 and PLC/PRF/5
3871- gera: 136528/nd/re
INHIBITION EFFECT OF CHINESE HERBAL
MEDICINE ON TRANSCRIPTION OF HEPATITIS C
VIRUS STRUCTURAL GENE IN VITRO. DOU J, CHEN
Q, WANG J. world j gastroenterol. 2005;11(23):3619-22
(eng).
AIM: To investigate the inhibitory effect of Chinese herbal
medicine on the transcription of hepatitis C virus (HCV)
structural gene in Hela D cells. METHODS: Hela cell line
was transfected with recombinant pBK-CMV-HCV
containing HCV structural gene by Lipofec-tamine. RT-
nested-PCR and Western blot assay were used to testify the
HCV gene expression in Hela cells. The Hela cells
expressing HCV structural protein were named Hela D cells.
Prescriptions of Xiao chaihu Decoction (XCHD), Fufang
Huangqi (FFHQ) and Bingganling (BGL) were respectively
added to Hela D cells in various concentrations. Semi-
quantitative RT-nested-PCR product analysis was performed
according to the fluorescent density between HCV DNA
band and GAPDH DNA band in gel electrophoresis after
screened. RESULTS: Recombinant pBK-CMV-HCV could
correctly express the HCV structural gene in Hela D cells.
After co-culture of Hela D cells with three prescriptional
different concentrations for 48 h respectively, the
transcription of HCV gene decreased with increasing of the
concentration of each prescription. The lightness ratio of
HCV product bands to GAPDH product bands was 0.24, 0.10
and 0.12 in Hela D cells incubated with 0.1 g/mL of XCHD,
FFHQ and BGL respectively and the lightness ratio HCV
product bands to GAPDH product bands was 0.75, 0.67 and
0.61 respectively in the control cells. CONCLUSION: The
gera 2011

prescriptions of XCHD, FFHQ and BGL partly inhibit the
transcription of HCV structural gene in Hela D cells.
3872- gera: 136536/nd/re
EFFICACY OF CHINESE MEDICINE YI-GAN-KANG
GRANULE IN PROPHYLAXIS AND TREATMENT OF
LIVER FIBROSIS IN RATS. YAO XX, JIANG SL,
TANG YW, YAO DM, YAO X. world j gastroenterol.
2005;11(17):2583-90 (eng).
AIM: To investigate the efficacy of a Chinese medicine, Yi-
gan-kang granule (granules for benefiting the liver), in
prophylaxis and treatment of liver fibrosis in rats and its
possible mechanism. METHODS: One hundred and forty
Sprague-Dawley rats were randomly divided into seven
groups (20 each): group 1, blank control group without any
interference during the study; group 2, CCl4-induced liver
fibrosis group; group 3, pig serum-induced liver fibrosis
group; group 4, prophylaxis group of CCl4-induced liver
fibrosis by Yi-gan-kang; group 5, prophylaxis group of pig
serum-induced liver fibrosis by Yi-gan-kang; group 6,
treatment group of CCl4-induced liver fibrosis by Yi-gan-
kang; group 7, treatment group of CCl4-induced liver fibrosis
by Yi-gan-kang. At wk 6, 10, 14 and 20 (baseline for CCl4 or
big serum induction), five rats in each group were
anesthetized and their livers were removed for pathological
studies including immunohistochemical studies for alpha-
SMA, type I collagen and in situ hybridization of tissue
inhibitor of metalloproteinase-1 (TIMP-1) mRNA of hepatic
stellate cells (HSCs). Anti-lipid peroxidation in isolated
mitochondria and 3-(4,5-dimethylthiazol-2-yl)-2,5-diphenyl
tetrazolium bromide (MTT) colorimetric assay for
proliferation and terminal deoxynucleotidyl transferase-
medicated dUTP-biotin nick end-labeling (TUNEL), flow
cytometry and electron microscopy for apoptosis in isolated
HSCs were also studied. RESULTS: The mean number of
pseudolobuli at wk 10, 14 and 20 in the prophylaxis group
was significantly less than that in the control group (P<0.05
or 0.01). The effect of prophylaxis at wk 14 in CCl4 rats and
at wk 10 in pig serum-induced rats was much better than that
of treatment group (P<0.01). The thickness (in microm) of
fibers both in pig serum-induced prophylaxis and in treatment
groups at wk 14 and 20 was significantly less than that in
control group (P<0.05). The number of fibers both in
prophylaxis and in treatment groups from wk 10 or 14 to 20
was significantly less than that in control group (P<0.05 or
P<0.01). The tissue HSC positive rates of type I collagen,
alpha-SMA and TIMP-1 mRNA, which represented the
active phenotype of HSCs in tissues, remained very high
from wk 6 to the end of model making in control group.
While in prophylaxis group, they were at a relatively low
level. In treatment group, there was a gradual decreasing
trend. Time- and dose-dependent effects of anti-lipid
peroxidation on isolated mitochondria, cell proliferation and
apoptosis in cultured HSCs were also observed during the
study. CONCLUSION: Yi-gan-kang can effectively inhibit
or inverse the course of liver fibrogenesis in CCl4- and pig
3873- gera: 136602/nd/ra
EFFECTS OF AMINO ACIDS FROM SELENIUM-
RICH SILKWORM PUPAS ON HUMAN HEPATOMA
CELLS. HU D, LIU Q, CUI H, WANG H, HAN D, XU H.
life sci. 2005;jun 21: (eng).
Selenium (Se) plays an important role in cancer-prevention.
Silkworm pupas have been used as a Chinese traditional
medicine since ancient time. In order to find effective
carcinostatic agents, Se-rich amino acids were extracted from
Ziyang silkworm pupas. The Se content of Ziyang pupas was
measured to be 215 times higher than that of Luoyang normal
ones, and the majority of Se was stored in proteins.
Composition analysis showed that Se- rich amino acids from
236
Ziyang pupas had higher amounts of selenomethionine,
methionine, cystine, and tyrosine than normal amino acids
from Luoyang pupas which were rich in amino acids
containing alkyl side chains. When cultured with human
hepatoma cells SMMC-7721, Se-rich amino acids at
concentrations of 0.5, 1.5, and 2.5 mumol L(-1) Se
significantly and dose-dependently inhibited cell viability,
induced changes in cell morphology and cycle, and caused
cell apoptosis. On the contrary, normal amino acids did not
show any inhibitory effect on SMMC-7721 cells. Sodium
selenite or selenomethionine at the same Se concentrations
only slightly inhibited the hepatoma cells. Mechanism study
showed that selenium-rich amino acids could increase the
generation of intracellular reactive oxygen species (ROS)
concentration-dependently. Antioxidant N-acetylcyteine
partially inhibited the increase of ROS. Those results
suggested that Se-rich amino acids were effective
carcinostatic agents compared with sodium selenite and
selenomethionine. The mechanism for their hepatoma-
inhibitory effects was the induction of cellular apoptosis
through ROS generation.
3874- gera: 136730/di/ra
ANTI-HEPATITIS C VIRUS EFFECT OF CITRUS
UNSHIU PEEL AND ITS ACTIVE INGREDIENT
NOBILETIN . MEGUMI SUZUKI, KENROH SASAKI,
FUMIHIKO YOSHIZAKI, MIN FUJISAWA, KATSUJI
OGUCHI AND JONG-CHOI CYONG. american journal of
chinese medicine. 2005;33(1): (eng*).
3875- gera: 136904/di/ra
[ANALYSIS ON THERAPEUTIC EFFECT OF
ACUPOINT-INJECTION ON CHRONIC HEPATITIS
B]. ZHANG AI-LING, WU YING, JIANG XUE-LIANG.
chinese acupuncture and moxibustion. 2005;25(1):25
(chi*).
Objective To search for an effective method for treatment of
chronic hepatitis B. Methods One hundred and twenty-three
cases were randomly divided into a treatment group (n = 63)
and a control group (n = 60). The treatment group were
treated with injection of Huangqi injection and Danshen
Injection into Ganshu (BL 18) and Zusanli (ST 36), once
every other day; and the control group were treated with oral
administration of Gankangning tablet and fufang yiganling
tablet. The clinical symptoms, hepatic function, hepatitis B e
antigen (HBeAg) , hepatitis B virus-desoxyribose nucleic
acid (HBV-DNA) were compared between the two groups.
Results The total effective rate was 93. 7% in the treatment
group and 76. 7% in the control group with significant
difference between the two groups (P< O. 01) ; and the
treatment group in hepatic function and the effects of turning
negative for HBeAg and HBV-DNA was better than the
control group (P<0. 01). Conclusion Acupoint-injection has
3876- gera: 137076/di/ra
[INFLUENCE OF DRUG SERUM OF ANTI-FIBROSIS
HERBAL COMPOUND ON CALCIUM ION IN
CULTURED HEPATIC STELLLATE CELLS]. XIAO
YONG-HONG, LIU DIAN-WU, LI QING. chinese journal
of basic medicine in tcm. 2005;11(2):118 (chi*).
Objective: To study the molecular mechanism of Anti-
fibrosis herbal compound against liver fibrosis, and to
explore the feasibility of its application in preventing and
treating the portal hypertension. Methods:The serum of rats
containing Anti-fibrosis herbal compound drags was name.
Hepatic stellate cells (HSCs) from rats were treated with
Anti-fibrosis Formula drug serum and carbon tetrachloride(
CCI4) for 24 hours respectively and loaded with Fluo-3/AM .
The intracellular calcium ion ( Ca2+ ) level in each cell was
determined with laser scanning confocal microscopy( LSCM)
gera 2011

. Orthogonal design was used to study the influence on Ca2+
in hepatic stellate cells treated with carbon tetrachloride,
Anti-fibrosisherbal compound serum, carbon tetrachloride
and their order, but their time spans had no influence on
Ca2+ . Carbon tetrachloride caused obvious elevation of
Ca2+ when the dosage of CCI4 from 5mmol/L to 15mmol/L,
5% to 20% Anti-fibrosis Formula serum decreased sharply
the concentration of Ca2+ . Conclusion: The mechanism of
Anti-fibrosis herbal compound against liver fibrosis and
portal hypertension
3877- gera: 137148/di/ra
[EFFECTS OF EMODIN ON HEPATOCELLULER
CANCER CELLS IN GROWTHINHIBITING AND
EXPRESSION OF P53 AND C MYC PROTEIN]. HE
XUE—QIANG, ET AL. chinese journal of information on
tcm. 2005;12(1):21 (chi*).
3878- gera: 137150/di/ra
[INFLUENCE OF RESTRAINT STRESS ON THE
GENE EXPRESSION OF ORNITHINE
DECARBOXYLASE IN RAT WITH CHEMICAL
HEPATOCARCINOMA]. GU LI—GANG, ET AL.
chinese journal of information on tcm. 2005;12(1):35
(chi*).
3879- gera: 137160/di/ra
[CLINICAL RESEARCH OF GANZHIXIAO IN
TREATMENT OF NONALCOHOL FATTY LIVER].
FENG YU, ET AL. chinese journal of information on tcm.
2005;12(2):16 (chi*).
Objective To evaluate the clinical effect of Ganzhixiao on
nonalcohol fatty liver and the accompanying hyperlipemia.
Methods Forty patients with fatty liver of Pixushengshi,
Tanrexueyu and Zuzhimailuo syndrome were selected and
randomly divided into two groups. Group 1 was treated with
Ganzhixiao (n=30), and group 2 was treated with
Dongbaogantaipian (n=10) as control. The changes of clinical
symptoms, blood lipids and liver ultrasonagram were
observed to evaluate therapeutic effect. Results The total
effective rate was 93.3%. Total cholesterol, triglyceride and
low-density lipoprotein were significantly reduced, and
elimination rate of fatty liver with medical imaging was up to
40.0%. All the therapeutic indices were better in Ganzhixiao
group than in the control group. Conclusion Ganzhixiao has
notable and reliable effect on fatty liver and accompanying
3880- gera: 137208/di/ra
[ANALYSIS ON THE PROGNOSTIC FACTORS IN
PATIENTS WITH LARGE HEPATOCARCINOMA
TREATED BY SHENTAO RUANGAN PILL AND
HYDROXYCAMPTOTHECINE "]. LIN LI-ZHU, ZHOU
DAI-HAN, LIU KUN, ET AL. chinese journal of
integrated traditional and western medicine. 2005;25(1):8
(chi*).
Objective To observe the effect of intervention therapy with
Shentao Ruangan pill (SRP) and hydroxycamptothecine
(HCPT) in treating 85 patients with middle-advanced large
hepatocarcinoma, and to analyze the factors that could affect
the prognosis. Methods Eighty-five patients were randomly
divided into the treated group (n = 52) and the control group
(n = 33) . The treated group was treated by oral taking of SRP
combined with local perfusion of HCPT through hepatic
artery catheterization, while to the control group, the
convention-al therapy, transcatheter arterial
chemoembolization (TACE) was conducted for control. The
clinical efficacy of treatment in the two groups was evaluated
by the change of tumor size, the factors related with
prognosis were analyzed using Cox proportional hazards
model and the analysis of survival conducted by Kaplan-
237
Meier method. Results (1) The tumor size reducing rate in the
treated group was 19.2% and the tumor size stabilizing rate
was 82.7% , while those in the control group was 21,2% and
81.8% respectively, comparison of the criteria between the
two groups showed insignificant difference (P > 0.05) ; (2)
The median survival time, 0.5 – year, 1 – year and 2 – year
survival rate in the treated group was 326 days, 80.95% ,
41.39% and 12.42% respectively, those in the control group
was 262 days, 64.29% , 25.00% and 8.33% respectively,
comparison between the two groups showed significant
difference (P <0.05) ; (3) Among the 3 TCM types in
patients, the survival time and rates in patients of Gan-excess
with Pi-deficiency type was similar to those in patients of
Gan- heat with blood stasis type showing insignificant
difference (P >0.05) , but as compared with those in patients
of Gan-Shen Yin-deficiency type, the difference was
significant (P<0.05) ; (4) Beneficial factor to the prognosis
were therapeutic method, that used in the treated group was
superior to that used in the control group. The risk factors to
the prognosis were TCM type, clinical stage and liver
function. Patients of Gan-ex cess with Pi-deficiency type had
the optimal prognosis, those of Gan-heat with blood stasis
type the next and c Gan-Shen Yin-deficiency the worst. The
later the clinical stage and the worse the Child-Pugh grade of
live function was, the worse the prognosis would be.
Conclusion (1) SRP combined with HCPT intervention
treatment is superior to the simple TACE treatment in
elevating patients' survival rate and time; (2) There are some
relations between TCM types and prognosis; (3) Local
Chinese drug therapy combined with systemic therapy could
be one of the effective measures of non-
3881- gera: 137211/di/ra
[CLINICAL STUDY ON TREATMENT OF FATTY
LIVER BY SHENNONG GANZHINING]. LEI LING, AI
SHU-MEI. chinese journal of integrated traditional and
western medicine. 2005;25(1):19 (chi*).
Objective To observe the therapeutic effect and safety of
Shennong Ganzhining (SG) in treating fatty liver. Methods
One hundred and ninety patients with fatty liver were
randomly divided into two groups. The 142 patients in the
treated group received SG and the 48 in the control group
received Zhibituo treatment for 3 months. The
comprehensive therapeutic effect after treatment, symptoms,
signs, liver function, blood lipids and blood viscosity, as well
as iconographic parameters were observed. Results The total
effective rate in the treated group was 80.98% , which was
higher than that in the control group (75.00% ), showing
significant difference statistically (P < 0.05) . Satisfactory
effect was obtained in recovery of liver function,
improvement of blood lipids, blood viscosity and
iconographic parameters, no severe adverse reaction
occurred. Conclusion SG is obviously effective in treating
3882- gera: 137212/di/ra
[RELATIONSHIP BETWEEN PHLEGM-STASIS
SYNDROME AND FIBRINOLYTIC STATUS IN
PATIENTS WITH NON- ALCOHOLIC FATTY
LIVER]. DENG YIN-QUAN, FAN XIAO-FEN, LI JIAN-
PING. chinese journal of integrated traditional and
western medicine. 2005;25(1):22 (chi*).
Objective To explore the relationship between phlegm-stasis
Syndrome (PSS) and the fibrinolytic status in patients with
non-alcoholic fatty liver (NAFL). Methods Seventy patients
with NAFL were divided into the PSS group and non-PSS
group according to TCM Syndrome typing, and a control
group consisted of 28 healthy subjects was set up. Levels of
plasminogen (PLG) , tissue plasminogen activator (t-PA) ,
plasminogen activator inhibitor-1 (PAI-1) and D-dimer were
determined and compared. Results The activity of t-PA in
gera 2011

NAFL patients was significantly lower than that in the
control group (P<0.05), and PLG and PAI-l were
significantly higher than those in the control group (P <
0.05). In respect to the TCM Syndrome typing, in patients of
PSS, t-PA was significantly lower and PLG, PAI-I were
significantly higher than those in patients of non-PSS (P
<0.05 or P < 0.01), while D-dimer was insignificantly
different between patients of the two Syndrome types
(P>0.05). Conclusion NAFL patients of PSS type shows
significant lower of fibrinolytic activity, indicating that there
is certain degree of microcirculatory disturbance and hyper
viscosity state, so the application of dissolving phlegm and
dispelling stasis principle in
3883- gera: 137230/di/ra
[THESIS OF DR. WANG LING-TAI ON
THERAPEUTIC MECHANISM OF NOURISHING
SHEN PRINCIPLE IN TREATING CHRONIC
HEPATITIS B]. ZHAO GANG, CHEN JIAN-JIE. chinese
journal of integrated traditional and western medicine.
2005;25(1):78 (chi).
3884- gera: 137283/di/ra
[INFLUENCE OF ANTI -FIBROSIS
PRESCRIPTION(TNF) ON HEPATIC FIBROSIS IN
PATIENTS WITH CIRRHOSIS]. ZHANG XIAO-ZHAO,
QIAO HAN-CHEN. chinese journal of integrated
traditional and western medicine in intensive and criti.
2005;12(1):23 (chi*).
Objective: To study the curative effects and mechanism of
anti - fibrosis prescription in treatment for hepatic fibrosis in
patients with cirrhosis. Methods: Eighty - six patients with
cirrhosis induced viral hepatitis B were randomly divided
into two groups: the control group (42 cases) was treated with
western medicine, including vitamins, hepatoprotective
medicine, and albumin was administered if necessary; the
treatment group (44 cases) was treated with anti - fibrosis
prescription C main ingredients: salvia miltiorrhiza(),
ligusticum , radix paeoniae rubra , bupleurum Chinese ,
astragalus, codonopsis pilosula , angelica sinensis , carapax
trionycis curcuma zedoaria , poria cocos , atractylodes
macrocephala , polygonum cuspidatum , hedyotis diffusa ,
amomum villosum ,and prepared licorice , The therapeutic
course were 1 year for all the patients, The indexes of
cirrhosis such as hyaluronidase (HA), laminin (LM),
precollagen II (PC II ), collagen VI (VI - C), liver function,
markers of hepatitis B virus were observed before and after
treatment, and biopsy was performed in part of the patients,
Results: As the extension of therapeutic time, the levels of
indexes of hepatic fibrosis were decreased in both groups,
especially in the observation group (all P < 0.05), they were
recovered 4 months after withdrawal all the indexes of
hepatic fibrosis stopping were increased again but were still
lower than those before therapy and there were significantly
different between two groups (all P<0. 05), The rates of ALT
and to bilirubin (TBil) turned to normal (75,4% and 49,6%)
in observation group after therapy were significantly higher
than those (40.7% and 17,5%, all P<0, 05), After 4 months of
withdrawal the rates returned to normal for ALT and TBil
had not markedly different between two groups (all P>0, 05).
The rates returned to negative for HBsAg, HBcAg, and HBV
- DNA and the rates improving clinical symptoms in
observation group were obviously superior to those in control
group (all P<0. 05), meanwhile the changes in tissue
pathology in observation group were a little better than those
in control group but the difference was not significant. No
side effects of medication were found. Conclusion: Anti -
fibrosis prescription has a good curative effect on hepatic
fibrosis in patients with cirrhosis. It is able to improve the
hepatic functions,
238
3885- gera: 137308/di/ra
[PROPHYLACTIC AND THERAPEUTIC EFFECT OF
ACUPOINT INJECTION WITH OXYMATRINE ON
RAT LIVER FIBROSIS]. ZHOU AI-LING, LUO LIN,
MAO JIA-HUI , ET AL. chinese journal of integrated
traditional and western medicine on digestion.
2005;13(1):11 (chi*).
[Objective] To investigate the prophylactic and therapeutic
effects of oxymatrine injection into "Zusanli (ST36)" on
experimental liver fibrosis and reveal its mechanism.
[Methods] Liver fibrosis model in rats was established by
injecting carbon tetrachloride ( CC14 ) intraperitoneally.
Thirty-five SD rats were randomly divided into normal
control group, model control group, control group of
oxymatrine intraperitoneal injection, treatment group of
oxymatrine injection into Zusanli (ST36) and preventive
group of oxymatrine into ST36. At the end of the tenth week,
serum levels of hyaluronic acid (HA),y-glutamyl transferase(
GGT) and con-tents of
hydroxyproline(Hyp),malondialdehyde (MDA) in the liver
tissue were measured. Histopathological changes were
observed by light microscopy. Degree of fibrosis was
assessed with Van Gieson staining. Reverse transcription
polymerase chain reaction (RT-PCR) was used to detect the
expressions of matrix metalloproteinase-2 (MMP-2) mRNA
in liver. MMP-2 protein in liver was determined by gelatin
zymography. [Results] In the treatment and preventive
groups of oxymatrine into ST36, the levels of serum
HA,GGT and the contents of liver tissue Hyp,MDA were
reduced compared with those in the model group( P
<0.05,<0. 01). The pathological improvements were
observed. In the preventive and treatment groups deposition
of collageneous fiber in the liver tissue was markedly
alleviated compared with model group and liver pseudoluboli
reduced. Pathological studies showed that liver fibrosis
degree of the preventive group was lighter than that of the
treatment group. The levels of MMP-2 mRNA and protein in
the liver were significantly reduced in the preventive group
and therapeutic group (P <0. 05, <0. 01). [Conclusion]
Oxymatrine injection into ST36 has obvious prophylactic and
therapeutic effect on CC14 induced liver fibrosis, the
antifibrotic mechanism of which was partly through
protecting hepatocyte from lipoperxidation, down-regulating
expression of MMP-2 mRNA and protein, facilitating
degradation of the
3886- gera: 137312/di/ra
[PROTECTIVE EFFECT OF YINCHEN ZIJIN
DECOCTION ON MICE WITH ACUTE LIVER
INJURY INDUCED BY CARBON TETRACHLORIDE].
HE SONG-QI, LU ZHI-PING , WEN BIN , ET AL. chinese
journal of integrated traditional and western medicine on
digestion. 2005;13(1):26 (chi1).
[Objective] To observe the protective effect of Yinchen Zijin
decoction (YZD) on the acute liver injury induced by CC14
in mice. [Methods] Acute liver injury model was induced by
intraperitoneal injection of 0. 12 % CC14. The levels of ALT
and AST in serum and MDA and SOD in the liver tissue
were measured. Liver index was calculated and pathological
changes of the liver tissue were observed under optic
microscope. [ Results] Both high and medium dose YZD
significantly lowered serum ALT and AST, MDA and SOD
in the liver tissue and the liver index, and markedly
ameliorated the liver damage (P <0.05). [Conclusion] YZD
can protect against acute liver injury induced by CC14, in
mice, the mechanism of which may be related to its
antiperoxidation of lipid.
3887- gera: 137313/di/ra
gera 2011

[PROGNOSTIC ABILITY OF AST/ALT RATIO AND
CHILD PUGH SCORE IN PATIENTS WITH
HEPATITIS B LIVER CIRRHOSIS]. HE YI XIONG
WU-JUN. chinese journal of integrated traditional and
western medicine on digestion. 2005;13(1):28 (chi*).
[Objective]To assess the prognostic ability of the AST/ALT
ratio in patients with hepatitis B liver cirrhosis, and to
evaluate the relationship between the AST/ALT ratio and the
Child Pugh score and to compare their prognostic ability.
[Methods] The AST/ALT ratio and Child Pugh score of 173
patients with hepatitis B liver cirrhosis who had been
followed-up for at least 1 year were retrospectively calculated
and correlated with the patients' 3-month and 1-year
prognosis. Receiver operating characteristic curves were used
to determine the AST/ALT ratio and the Child Pugh score
cut-offs with the best sensitivity (SS) and specificity (SP) in
discriminating between patients who survived and those who
died. [Results] AST/ALT ratios and Child Pugh score
showed significant correlation (r = O. 53, P <0. 01). In all,
17% (30/173) and 28% (50/173) of the patients had died after
3 months and 1 year of follow- up, respectively. AST/ ALT
ratio and Child Pugh score were significantly higher among
the patients who died during both 3-month and 1-yr follow-
up. An AST/ALT ratio cut-off of 1. 6 had 55% SS and 72%
SP, whereas a Child Pugh score cut-off of 10 had 76% SS
and 68% SP in discriminating between patients who survived
and those who died after 1 year. The combined assessment of
the AST/ALT ratio and Child Pugh score had 85% SS and 76
% SP. [Conclusion] In patients with hepatitis B liver
cirrhosis, the AST/ALT ratio has prognostic capability that is
not significantly different from that of Child Pugh score.
Combined assessment of the two parameters increases the
medium-term prognostic accuracy.
3888- gera: 137314/di/ra
[CLINICAL OBSERVATION ON THE EFFECT OF
GANXIAN PRESCRIPTION COMBINED WITH
LAMIVUDINE IN TREATING CHRONIC HEPATITIS
B WITH LIVER FIBROSIS]. HONG QI, SHEN WEI-
SHENG , YANG HONG-ZHI , ET AL. chinese journal of
integrated traditional and western medicine on digestion.
2005;13(1):31 (chi*).
[Objective] To assess the therapeutic effect of Ganxian
prescription combined with lamivudine in treating chronic
hepatitis B with liver fibrosis. [Methods] Seventy-two
patients with chronic hepatitis B in treatment group were
treated with Ganxian prescription and lamivudine, while 86
patients in control group were just received lamivudine. The
therapeutic duration in both groups was two years. [Results]
In the treatment group,the decreased range of liver fibrosis
indexes was much more significant than that of the control
group (P <0. 01 or <0. 05). [Conclusion] Combined medicine
has more advantages for preventing or reversing the
formation and development
3889- gera: 137320/di/ra
[EXPERIMENTAL STUDY OF MODIFIED FUYUAN
HUOXUE DECOCTION (MFHD) IN TREATMENT OF
HEPATIC FIBROSIS IN RATS]. SU QUAN-WU, LI
DAO-BEN, ZHU YOU-MING. chinese journal of
integrated traditional and western medicine on digestion.
2005;13(1):45 (chi*).
[Objective] To explore the effect of modified Fuyuan Huoxue
decoction (MFHD) on experimental hepatic fibrosis and its
possible mechanism. [Methods] The hepatic fibrosis model of
rats was established by carbon tetrachloride. MFHD group
was treated with MFHD by filling into stomach, western
medicine group with colchicine, healthy control group and
model control group with 0. 9% natriichloride of equal
volume. After continuous treatment for eleven weeks, the
239
levels of serum total protein (TP) , albumin ( Alb) , alanine
aminotransferase (ALT) , aspartate aminotransferase( AST)
,serum laminin (LN) , hyaluronic acid( HA) , collagen
peptide type IV (C-IV ) , and HA, LN, CN , procollagen
peptide type III (PC III) in the liver tissue were measured.
Pathological changes of the liver tissue were observed under
microscopy. Expression of LN,C-IV, transfer growth
factor(B-1(TGF-(B1) in the liver tissue was demi-quantified
with immunohistochemistry from paraffin section. [Results]
Compared with western medicine group, the contents of
serum TP, Alb in MFHD group were markedly raised, and
the contents of serum ALT, AST HA, C-IV and HA, LN,
PCIA in the liver tissue were markedly lowered (P <0. 01 or
P <0. 05) ; pathological changes of the liver tissue were
relieved, and the expression of LN, TGF-B1, C IV in the liver
tissue was less than that of the model group and western
medicine group. [Conclusion] MFHD can improve liver
microcirculation, protect hepatocytes, recover liver function,
lower synthesis and sediment of liver collagen, decompose
the collagen.
3890- gera: 137333/di/ra
[EFFECTS OF DIFFERENT SERUM HBEAG
DETECTION METHODS ON THERAPY EFFECT
ASSESSMENT OF ANTI-HBV TREATMENT]. HE
XING-E, LEI JIAN-HUA , YANG XU , ET AL. chinese
journal of integrated traditional and western medicine on
liver diseases. 2005;15(1):3 (chi*).
3891- gera: 137334/di/ra
[DETECTION OF HBV RNA AND HBV DNA IN
PERIPHERAL BLOOD MONONUCLEAR CELLS AND
ITS RELATIONSHIP WITH SERUM HBV DNA IN
CHRONIC HEPATITIS B*]. ZHU XIAO-GANG, LIU
JIAN-JUN , MA JIAN-HUA, ET AL. chinese journal of
integrated traditional and western medicine on liver
diseases. 2005;15(1):5 (chi*).
3892- gera: 137335/di/ra
[QUANTIFICATION OF HEPATITIS B VIRUS IN
PERIPHERAL BLOOD MONONUCLEAR CELLS
(PBMC) FROM CHRONIC INFECTED PATIENTS].
WANG GANG, MA LI-XIAN, MING GUO-HUI , ET AL.
chinese journal of integrated traditional and western
medicine on liver diseases. 2005;15(1):8 (chi*).
3893- gera: 137338/di/ra
[EFFECT OF THE HEPATITIS B VIRUS X GENE
TRANSFECTION ON APOPTOSIS OF HEPG2 AND
ITS MECHANISM*]. LIN NA, CHEN HONG-YING,
ZHANG SHENG-JUN, ET AL. chinese journal of
integrated traditional and western medicine on liver
diseases. 2005;15(1):19 (chi*).
3894- gera: 137342/di/ra
[EXPRESSION OF PANCREATIC ELASTASE IN
DIMETHYLNITROSAMIN-INDUCED LIVER
FIBROSIS IN RATS*]. TAN SHAN-ZHONG, TAN
CHUN-YU, JIANG JIAN , ET AL. chinese journal of
integrated traditional and western medicine on liver
diseases. 2005;15(1):34 (chi*).
3895- gera: 137343/di/ra
[EFFECTS OF DESMODIUM PULCHELLUM (L .)
BENTH TOTAL ALKALOIDS ON TYPE I, III , IV
COLLAGENS AND TGF-B1 IN RATS WITH
IMMUNITY HEPATIC FIBROSIS*]. ZHONG MING,
YU SHENG-MIN, YANG ZENG-YAN, ET AL. chinese
journal of integrated traditional and western medicine on
liver diseases. 2005;15(1):38 (chi*).
gera 2011

3896- gera: 137344/di/ra
[DISTRIBUTION OF HEPATITIS B VIRUS
GENOTYPES OF 1 020 PATIENTS WITH HEPATITIS
B IN WENZHOU AREA*]. XIAO YANG, ZHOU YUE-
JIN, WANG KAI-JIAN , ET AL. chinese journal of
integrated traditional and western medicine on liver
diseases. 2005;15(1):41 (chi*).
3897- gera: 137353/di/ra
[EPIDEMIC SURVEY ON TCM SYNDROME TYPING
AND PRELIMINARY DISCUSSION ON TCM
ETIOLOGY AND PATHOGENESIS OF FATTY LIVER
*]. WANG YAN-XIANG, WANG LING-TAI, GAO YUE-
QIU, ET AL. chinese journal of integrated traditionanl
and western medicine. 2005;25(2):126 (chi*).
Objective To investigate the common TCM syndrome types
of fatty liver by way of epidemic questionnaire, their
occurrence ratio, and the correlation between various
syndrome types and objective indexes. Methods A total of
national wide 503 subjects with fatty liver were enrolled, the
TCM syndromes, body mass index (BMI) , abdominal
perimeter/hip circumference, liver function, blood lipids, B
ultrasonic examination and CT in them were observed and
recorded. Results In the 46 symptoms investigated in total,
the first ten symptoms in order of appearing rate were
lassitude, obese, oral dryness, vertigo, hypochondriac
distending pain, soreness and pain in loin, spiritlessness, oral
bitterness, aching and weakness in knee and abdominal
distention. The mostly appeared tongue figures were pale and
corpulent or pale dim tongue proper, white greasy or yellow
greasy tongue coating, and the mostly appeared pulse figures
were taut, taut-thin and taut slippery. Statistical cluster
analysis showed that syndromes of fatty liver could be typed
into 4 TCM types, the asthenia Pi-Shen with Gan-stagnation
type, the asthenia Pi-Shen type, the asthenia Pi with phlegm-
heat type and the unclassified type. Among them the asthenia
Pi-Shen with Gan-stagnation type was the commonest one,
which accounted to 62 .32 % . Conclusion The mostly
appeared syndrome type of fatty liver was asthenia Pi-Shen
with Gan-stagnation type. The TCM pathogenesis of fatty
liver was deficiency of origin, mainly deficiency of Shen,
involving Pi, with excess superficiality, the turbid- phlegm
and blood stasis.
3898- gera: 137363/di/ra
[EFFECT OF ZILONGJIN ON IMMUNOLOGIC
FUNCTION OF PATIENTS WITH
HEPATOCARCINOMA IN PERIOPERATIVE
STAGE]. LI QIANG, WU QIANG, LI HUI-KAI, ET AL.
chinese journal of integrated traditionanl and western
medicine. 2005;25(2):163 (chi).
3899- gera: 137498/di/ra
[EXPERIMENTAL STUDY ON HEPATOCIRRHOSIS
TREATED WITH LINGDANWANGYANGGAN
CAPSULE]. HUANG YA-PING. chinese journal of
traditional medical science and technology.
2005;12(2):102 (chi).
3900- gera: 137655/di/ra
[CLINICAL OBSERVATION OF CHRONIC
HEPATITIS B TREATED WITH DECOCTION OF
BENEFITING QI, NOURISHING YIN, CLINICAL
OBSERVATION OF CHRONIC HEPATITIS B
TREATED WITH DECOCTION OF BENEFITING QI,
NOURISHING YI CHEN YANG-RONG, HUANG
ZHENG-RONG, JI LI-JIN, ET AL. fujian journal of tcm.
2005;36(1):1 (chi).
240
3901- gera: 137658/di/ra
[88 CASES OF ASCITES DUE TO CIRRHOSIS
TREATED WITH DECOCTION OF REGULATING QI
AND RELAXING LIVER]. XIE CHUAN-CHAO. fujian
journal of tcm. 2005;36(1):5 (chi).
3902- gera: 137714/di/ra
[THE CLINICAL STUDY OF CURING
POSTHEPATITIC CIRRHOSIS IN THE METHOD OF
INTEGRATION OF TRADITIONAL AND WESTERN
MEDICINE]. PAN YI-BIN. guang ming journal of tcm.
2005;20(1): (chi).
3903- gera: 137749/di/ra
[OBSERVATION OF THE SHORT-TERM CURATIVE
EFFECTS ON INTERMEDIATE OR LATE LIVER
CANCER TREATED WITH CRYOCARE TM AR-HE
KNIFE CHINESE HERBS AND CHEMOTHERAPY].
BAI CUANGDE, LIAN ZIQING, LIANG JIAN, ET AL.
guanxi journal of tcm. 2005;28(1):16 (chi).
3904- gera: 137898/di/ra
[SIXTY CASES OF HYPOPROTEINEMIA DUE TO
CIRRHOSIS TREATED BY TRADITIONAL CHINESE
COMBINED WITH WESTERN MEDICINE]. MENG
SHENGXI . henan tcm. 2005;25(2):55 (chi).
3905- gera: 137916/di/ra
[THE RELATIONSHIP BETWEEN TH1,TH2-CELL
FACTORS OF THE PATIENTS WITH CHRONIC
VIRUS B HEPATITIS AND TYPE OF SYNDROME IN
TRADITIONAL CHINESE MEDICINE ]. ZHOU
XIAOJUN, ET AL. hubei journal of tcm. 2005;27(1):17
(chi).
3906- gera: 137917/di/ra
[CLINICAL OBSERVATION ON ANTI-FIBROSIS OF
KANGXIAN CAPSULES]. CHEN MINGMING, ET AL.
hubei journal of tcm. 2005;27(1):18 (chi).
3907- gera: 137931/di/ra
[CLINICAL ELEMENTARY PROBING INTO
HEPATITIS CORRELATIVE ORAL LICHEN PLANUS
TREATED WITH COMBINATION OF TRADITIONAL
CHINESE AND WESTERN MEDICINES]. ZHAO
YAJUN . hubei journal of tcm. 2005;27(2):27 (chi).
3908- gera: 137968/di/ra
[CLINICAL OBSERVATION ON 35 CASES OF
CHRONIC ICTEROHEPATITIS TREATED BY
KUHUANG GRANULE]. DONG JUN, ET AL. hunan
journal of tcm. 2005;21(1):9 (chi).
3909- gera: 137969/di/ra
[A SUMMARY ON 30 CASES OF LIVER FIBROSIS
DUE TO HEPATITIS TREATED BY JINBIE
TABLETS]. WU JIANHUA, ET AL. hunan journal of
tcm. 2005;21(1):11 (chi).
3910- gera: 137973/di/ra
[THE STUDY DEVELOPMENT ON CIRRHOSIS
ASCITES TREATED WITH STANDARD TCM]. CAI
DE-LU. information on tcm. 2005;22(1):16 (chi).
3911- gera: 138035/di/ra
[EFFECT OF GARDENIAE SAPONIN ON BLOOD
RHEOLOGY OF RATS WITH CHRONIC HEPATITIS
DUE TO LIVER DEPRESSION OF SPLEEN
DEFICIENCY]. NA SHA, LONG ZIJIANG, WANG
ZONGDIAN, ET AL. jiangsu journal of tcm. 2005;26(1):52
gera 2011

(chi).
3912- gera: 138059/di/ra
[PROFESSOR PENG BO'S EXPERIENCE IN
TREATING CHRONIC HEPATITIS B BY DEALING
WITH "DEPRESSION"]. GAO SHUIBO. jiangsu journal
of tcm. 2005;26(3):16 (chi).
3913- gera: 138088/di/ra
[APPLICATION OF TRADITIONAL CHINESE
MEDICINE IN AFTER TREATMENT OF PORTAL
VEIN SPONGY DEGENERATION]. ZENG YING—
JIAN, JIANG YI—PING. jiangxi journal of tcm.
2005;36(2):23 (chi).
3914- gera: 138089/di/ra
[84 CASES OF TREATMENT OVER ASCITES
CAUSED BY CIRRHOSIS WITH INTEGRATED
MEDICINE]. ZHAO KE—AN, ZHUO ZHU. jiangxi
journal of tcm. 2005;36(2):38 (chi).
3915- gera: 138143/di/ra
[THERAPEUTIC ANALYSIS ON TREATMENT IF
CHRONIC HEPATITIS B WITH KURARINONE IN 42
CASES]. LI BAOSHU. jilin journal of tcm. 2005;25(2):12
(chi).
3916- gera: 138148/di/ra
[PROBE INTO THE PATHOLOGY OF
NONALCOHOLIC FATTY LIVER DISEASE AND
THE TREATMENT BY COMBINATION OF CHINESE
AND WESTERN MEDICINE FORM THE THEORY OF
DISSIPATIVE STRUCTURE]. YANG YINGXIN ET AL.
jilin journal of tcm. 2005;25(3):1 (chi).
3917- gera: 138151/di/ra
[AFFECT ON THE INDEX OF LIVER FIBROUS OF
HEPATITIS B BY USING THERAPEUTIC
EQUIPMENTS AND FUFANGDANSHEN
INJECTION]. LIN LUPING ET AL. jilin journal of tcm.
2005;25(3):19 (chi).
3918- gera: 138237/di/ra
[EFFECT OF RUANGAN-YIN ON LEVEL OF THE
COLLAGEN METABOLISM IN RATS WITH
IMMUNITY LIVER FIBROSIS]. ZHANG GUO-LIANG,
DAI MIN, XU FAN, ET AL. journal of anhui traditional
chinese medical college. 2005;24(1):17 (chi*).
Objective :The rat model with immunity liver fibrosis was
established to study the effect of composite herbal medicines
of Ruangan-Yin on the levels of serum laminin, hyaluronic,
precollagen type III, and the level of hydroxyproline in liver.
So the mechanism of anti-fibrosis was explored. Method :
The rat models with immunity liver fibrosis were induced by
the human serum albumin, Ruangan-Yin were took by gastric
infusion respectively as little and large dosage group (1 g/kg
and 2 g/kg) in consecutive 8 weeks. Biejia Ruangan Tablet or
colchicines were took as positive contrast drug. The levels of
serum laminin, hyaluronic, precollagen type III were detected
by radioimmunoassay. The level of hydroxyproline in liver
was detected by chemistry method. Result: Ruangan-Yin
could depress the serum levels of laminin, hyaluronic,
precollagen type III in rat models with immunity liver
fibrosis induced by the human serum albumin in two dosage
groups. At the same time, it depressed the level of
hydroxyproline in rat liver. Conclusion : Ruangan-Yin could
affect the collagen metabolism in liver to treat liver
3919- gera: 138253/di/ra
[OBSERVATION ON THE DEPOSIT OF IV-
241
COLLAGEN AND ULTRASTRUCTURE OF LIVER IN
RATS WITH HEPATIC FIBROSIS]. LI QIAO-MEI,
MENG HUI, HUANG ZHEN-YAN, ET AL. journal of
anhui traditional chinese medical college. 2005;24(2):26
(chi*).
Objective: To observe the deposit of IV-collagen and
ultrastructure of liver in rats with hepaticfibrosis in a
dynamic state. Method: The fibrosis liver model was set up
by hypodermic injection of carbon tetrachloride. Result :
Hepaticfibrosis appeared,fat-storing cells( FSCs) actively
proliferated and the deposit of IV-collagen gradually
increased in rat liver. Under electro microscope , A great
quantity collagerous fibers and many FSCs were found out.
Conclusion : Hepaticfibrosis result from CC14 is a gradual
course. The deposit of IV-collagen obviously increases in 6th
week, and gradually extents to liver cells. Hepatic lobules
separated by collagerous fibers in 9th
3920- gera: 138256/di/ra
[STUDIES ON THE DECOMPOSITION AND ITS
EFFECT OF GANXIANKANG-A IN MICE WITH
HEPATIC FIBROSIS]. FENG LIANG-YUAN, YAN
SHUN-QIN, DUAN RUI. journal of anhui traditional
chinese medical college. 2005;24(2):36 (chi*).
Objective : To select best proportion herbs in the
Ganxiankang-A by even-designed method. Method : Eighty-
four mice were divided into 7 groups randomly according to
the even-designed method and the animal model of hepatic
fibrosis was induced by carbon tetrachloride( CC14) . The
best proportion was determined by the levels of Alanine
aminotransferase ( ALT) and Aspartate aminotransferase (
AST) in serum and Hydroxyproline ( Hyp) in liver tissue.
Result: The best proportion of Ganxiankang-A is
Ganxiankang-F (90 : 75 : 24) . Conclusion : Compared with
Ganxiankang-A,Ganxiankang-F treated hepatic fibrosis more
effectively in decreasing the levels of HYP in liver tissue and
ALT in seum. the Ganxiankang-F were optimized.
3921- gera: 138402/di/ra
[EXPERIMENTAL STUDY ON THE EFFECT OF
MANGAN MIXTURE ON PROMOTING LIVER CELL
REGENERATION IN RATS]. JIANG XUELIAN, ET AL.
journal of emergency in tcm. 2005;14(1):64 (chi*).
Objective: To observe the effect of Mangan Mixture on
promoting liver cell regeneration. Methods: The rat model
was duplicated with partial hepatectomy. Rats were treated
with Mangan Mixture, and contrasted with those accepted
hepatic cells generating factor. The hepatic index was
calculated, and the HE of the rats' liver was observed with
optic microscope. The ultrastructure was observed with
electronic microscope. Results: The improvement of the
hepatic index, HE and ultrastructure of Mangan Mixture
group pre-ceded the model obviously. Conclusion: Mangan
Mixture could promote liver cell regeneration.
3922- gera: 138409/di/ra
[CLINICAL OBSERVATION ON MODIFIED
XIAOXIANXIONG DECOCTION FOR
NONALCOHLIC FATTY LIVER DISEASE]. NIE
DANLI ET AL. journal of emergency in tcm.
2005;14(2):116 (chi*).
Objective: To observe the therapeutic effect of Modified
Xiaoxianxiong Decoction( d` 14"t3k ibl it A) for
nonalcoholic laity liver disease ( NAFLD). Methods:57
patients suffering from NAFLD were randomly divided into
the treatment group (30 cases). Patients in which taken
Modified Xiaoxianxiong Decoction, and the controlled group
(27 cases), taken Xuezhikang Capsule( A.hi3k
d.t) . The course of treatment was 90 days. Results: The
hepatic functions and total cholesterol (TC) and triglyceride
gera 2011

(TG) of all patients were relieved in dif¬ferent degree. There
was significantly difference after treatment between
treatment group and the controlled group Modified
Xiaoxianxiong Decoction could improve the image of B –
mode ultrasonography, while the controlled group had no
obvious therapeutic effect on it. Conclusion: Modified
Xiaoxianxiong Decoction has good effect in treating
3923- gera: 138428/di/ra
[THE CLINICAL STUDY ON THE PREVENTION AND
TREATMENT OF SHENQIFUZHENG INJECTION
FOR THE POSTOPERATIVE SYNDROME OF
PRIMARY LIVER CANCER INTERVENTION, AND
THE INFLUENCE ON THE LIVER RESERVE
FUNCTION]. DI LING, , ET AL. journal of emergency in
tcm. 2005;14(3):215 (chi).
3924- gera: 138474/di/ra
[CLINICAL STUDY OF CHINESE HERBS
COMBINED WITH OPERATION ON THE PRIMARY
HEPATOCARCINOMA]. CHEN LI-WU DU JIAN, TAN
JING WANG ET AL. journal of fujian college of tcm.
2005;15(2):6 (chi*).
To investigate the more effective integrated treatment for the
primary hepatocarcinoma (II III ), and detect the synergism
of combining the Chinese herbal treatment in the whole body
with the operation. 60 patients were randomized into two
groups. The group of western medicine combined with
traditional Chinese medicine( 30cases) took the compound
Chinese herbs one week before and after the operation. The
contrast group (30cases) received the treatment of operation
only. Comparing and analyzing the effect, survival rate, side-
effect and complication of the two groups in the study.
Results: The accumulative survival rate at the 6 months, 12
months, 24 months and 36 months was 100.0 % , 93.3 % , 90
% , 66.6 % differently in the group of western medicine
combined with traditional Chinese medicine, however, the
contrast group was 100 %, 93.3 %, 76.6% , 50 % differently.
It showed that the survival rates at the 24 and 36 months were
different distinctly in the two groups( P < 0.05) . Conclusion:
the compound Chinese herbs is effective distinctly applied
before and after the operation for the primary
hepatocarcinoma, and it can promote the effect and the
survival rate accumulatively with less
3925- gera: 138475/di/ra
[CORRELATION DURING TCM SYNDROMES, HP
INFECTION AND PATHOLOGIC CHANGE OF
GASTRIC MUCOSA IN BILE-REGURGITATIONAL
GASTRITIS]. XIAO LI-CHUN, PAN WAN-RUI, CHEN
SHOU-FEI, ET AL. journal of fujian college of tcm.
2005;15(2):9 (chi*).
To observe correlation during TCM syndromes, HP infection
and pathologic change of gastric mucosa, 155 cases with bile-
regurgitational gastritis (BRG) were diagnosed by
gastroscope, and typed by TCM syndrome differentiation.
Conclusion; There are more excess syndrome, and less
deficiency syndrome in BRG. There are more chronic
atrophic gastritis in pathologic change of gastric mucosa( P <
0.01) . HP infection in syndromes of spleen-stomach damp-
heat, and disorder of liver and stomach is higher than that in
deficient cold syndrome of spleen and stomach. Our
detectable rate of HP is higher than other reporter.
3926- gera: 138477/di/ra
[EFFECTS OF CRUDE EXTRACT OF RUBUS
ALCEAEFOLIUS POIR ON TNFA OF
EXPERIMENTAL LIVER INJURY IN RATS]. HONG
ZHEN-FENG, WANG YU-HUA, CHEN YAN-HUA.
journal of fujian college of tcm. 2005;15(2):24 (chi*).
242
To study the prevention and curing effects of crude extract of
Rubus alceaefolius Poir (CERA) on experimental liver injury
and probing its partial mechanism. In haste liver injury
models induced by carbon tetrachloride (CCl4) and interfered
by CERA of three different dose to observe the change of the
serum TNFa, and the change of pathological tissue slices of
liver. Results CERA can significantly decrease the serum of
TNFa abnormal high levels induced by CC14, ameliorate the
pathological injure of liver. Conclusion CERA shows some
degree of treating effects on experimental liver injury in rats.
Decrease the serum of TNFa may be one of its partial
mechanism.
3927- gera: 138513/di/ra
[EFFECTS OF DAN-SHAO-HUA-XIN, A
TRADITIONAL CHINESE MEDICINE
PRESCRIPTION, ON EXPRESSION OF TIMP-1 IN
RAT HEPATIC FIBROSIS]. XIE RUJIA ET AL. journal
of guiyang college of tcm. 2005;27(1):54 (chi).
3928- gera: 138616/di/ra
[DEVELOPMENT OF STUDIES ON PREVENTING
AND CURING PRIMARY CARCINOMA OF LIVER
WITH TCM]. WANG XINJIE, GUO YONGYI. journal of
henan university of chinese medicine. 2005;20(1):84 (chi*).
Summing up achievements in preventing and curing primary
carcinoma of liver from the viewpoints of experimental
studies and clinical application, this paper argues that it is
markedly effective in treating the disease by promoting blood
circulation to remove blood stasis, clearing away heat and
toxic material, reinforcing spleen and regulating qi and
nourishing yin and blood. It is predicated that treatments with
intervention Chinese drugs will be the focus of studies. The
paper also points out the problems in present studies and puts
forward the
3929- gera: 138631/di/ra
[A CLINICAL STUDY ON TREATING FATTY LIVER
WITH JIANGZHI YIGAN POWDER AND DONGBAO
GANTAI PILL]. ZHAO CHANGPU, SUN XIAONA, ' YU
JINZHONG. journal of henan university of chinese
medicine. 2005;20(117):34 (chi*).
Objective: To observe the curative effect of Jiangzhi Yigan
Powder and Dongbao Gantai Pill in treating fatty liver.
Methods: 56 cases of fatty liver were randomly divided into
Dongbao Gantai group (26 cases) and the group of Dongbao
Gantai combined with Jiangzhi Yigan Powder(30 cases).
Results: With treatment, blood fat was obviously lowered in
Dongbao Gantai group without obvious changes of
transaminase. Transaminase was dramatically lowered in the
other group and the effective rate was 90% . Conclusion:
Jiangzhi Yigan Powder combined with Dongbao Gantai Pill
is effective in treating fatty liver.
3930- gera: 138645/di/ra
[56 CASES OF TREATING HEPATITIS B WITH THE
THERAPEUTIC PRINCIPLE REINFORCING THE
SPLEEN TO CONTROL THE LIVER]. LI QUAN .
journal of henan university of chinese medicine.
2005;20(117):54 (chi*).
Injury of the spleen and stomach due to overabundant
pathogens in the liver and gallbladder are the etiology and
pathogenesis of hepatitis B. Reinforcing the spleen to control
the liver should be applied in treatment.
3931- gera: 138670/di/ra
[SOME PROBLEMS SHOULD BE CONCERNED IN
TREATING LIVER CANCER BY TCM]. XU ZHONG-
WEN . journal of liaoning college of tcm. 2005;7(1):41
(chi).
gera 2011

3932- gera: 138679/di/ra
[EXPLANATION ON TCM RESEARCH AND
TREATMENT OF FIBROUS LIVER]. XIA HONG-TAO
. journal of liaoning journal of tcm. 2005;7(2):135 (chi).
3933- gera: 138750/di/ra
[HEPATOCIRRHOSIS (23 CASES) TREATED BY
RELISHING SPLEEN AND SOFTENING LIVER
DECOCTION]. WANG XINGIANG . journal of practical
tcm. 2005;21(1):16 (chi).
3934- gera: 138769/di/ra
[CHRONIC MAJOR HEPATITIS (22 CASES)
TREATED BY QUICK ACTING XIAOHUANG
DRINK]. YANG DEQUAN, YANG QIN. journal of
practical tcm. 2005;21(3):149 (chi).
3935- gera: 138802/di/ra
[LIU XIAN-LIN ' S EXPERIENCES IN TREATING
ASCITES DUE TO CIRRHOSIS OF LIVER]. ZHANG
SU-YING. journal of shandong university of tcm.
2005;29(1):28 (chi).
3936- gera: 138814/di/ra
[EXPERIMENTAL STUDY OF POLYPEPTIDE
EXTRACT FROM SCORPION VENOM ON S1
SARCOMA AND H22 HEPATOMA IN MICE]. ZHANG
WEI-DONG, CUI YA-ZHOU, JIA QING , ET AL. journal
of shandong university of tcm. 2005;29(2):152 (chi*).
Objective: the study was designed to evaluate the anti-
angiogenic activity and anti-tumor activity in vivo of PESV,
a peptide extract from scorpion venom. Methods: PESV was
isolated by Sephadex G50 gel filtration with Sepharose FF
ion-exchange chromatography. Chicken embryo
chorioallantoic membrane (CAM) assay was used to
determine the effect of PESV on neovascularization in vivo.
The mice with S180 sarcoma or H,2 hepatoma were injected
with PESV at 3 mg/kg, angiogenesis in vivo and tumor
growth were observed. Results: PESV demonstrated
suppression of neovascularization in the CAM assay. In vivo,
systemic administration of PESV suppressed tumor growth of
implanted S180 sarcoma or H22 hepatoma in mice.
Immunohistochemical examination showed a significant
decrease in the number of blood vessel and reduced
expression of VEGF and bFGF by PESV. Conclusions:
PESV is of potent anti-angiogenic activity in vivo. PESV
could be regarded as a candidate for tumor angiogenesis
inhibitor (TAI) and a potent chemotherapeutic agent of
malignant tumors, and
3937- gera: 138950/di/ra
[CLINICAL OBSERVATION ON JIANPI LIQI
RECIPE FOR TREATMENT OF 25 CASES OF
DISTAL METASTASIS OF LIVER CANCER]. LIN
JUNHUA, GUO WEIJIAN. journal of tcm. 2005;46(1):26
(chi*).
Objective:To observe interfering action of Chinese drugs for
strengthening spleen and regulating Qi on promoting
metastasis of transcatheter arterial chemoemboization
(TACE) of liver cancer. Methods:50 cases of primary cancer
of liver were randomly divided into TACE group and TACE
plus Jianpi Liqi Recipe group,and serum vascular endothelial
growth factor (VEGF) level before and after TACE was
determined and the survival rate and the distal metastasis rate
were observed. Results:There was no significant differences
before and after TACE,and between the two groups (P>0.
05). The survival rates of 1 and 2 years were 76% and 40% in
TACE group,and 72% and 64% in TACE plus Jianpi Liqi
Recipe group,respectively. There was a significant difference
243
between the two groups in the survival rate of 2 years (P<0.
01). The distal metastasis rates of 1 and 2 years were
28%,52% ,and 8% '24% in the two groups with a significant
difference in the distal metastasis of 2 years between the two
groups (P <0. 05). Conclusion:The drug for strengthening
spleen and regulating Qi has a certain blocking action on
TACE promoting metastasis of liver cancer,but TACE does
not obviously inhibit depression of VEGF within a sort term.
3938- gera: 138956/di/ra
[RELATION OF TCM SYNDROME TYPES OF THE
PATIENT OF LIVER CANCER WITH SENSITIVITY
OF LIVER CANCER CELLS TO
CHEMOTHERAPEUTIC DRUGS IN VITRO].
HUANGFU CHAOSHEN, LIU BIN, LI LUJUAN, ET A L.
journal of tcm. 2005;46(1):50 (chi*).
Objective: To observe sensitivity of liver cancer cells of the
patient of liver cancer with different TCM syndromes to
chemotherapeutic drugs in vitro. Methods:60 specimens from
removed liver cancer were taken and the sensitivity of the
hepatic cells from patients of live cancer with different TCM
syndromes to 6 commonly-used chemotherapeutic drugs in
vitro were determined by MTT method. Results:The
sensitivity to the drugs in the deficiency of the spleen Qi-
deficiency group,the liver-Qi stagnation group and the group
of obstruction of blood stasis in collaterals had the tendency
to gradually decrease with no statistically significant
difference; the sensitivity to various drugs in the groups of
stasis of blood in the liver, deficiency of the spleen and
obstruction in collateral decreased significantly.
Conclusion:The patients of liver cancer with different TCM
syndromes have a certain difference in the sensitivity to
chemotherapeutic drugs,so treatment of liver cancer should
be based on the patients' sensitivity to therapeutic
3939- gera: 138964/di/ra
[CLINICAL OBSERVATION ON WEICHANGSHU
FOR TREATMENT OF 30 CASES OF ABNORMAL
GASTROINTESTINAL MOTOR DUE TO
HEPATOCIRRHOSIS AFTER HEPATITIS]. ZHONG
YI, ZHOU HONG, ZHONG LING. journal of tcm.
2005;46(2):110 (chi*).
Objective: To investigate changes of gastrointestinal motor
and effects of hepatic function on gastrointestinal motor and
therapeutic action of Weichangshu in the patient of
hepatocirrhosis after hepatitis. Methods: 90 cases of
hepatocirrhosis after hepatitis were randomly divided into 3
groups. Group I was treated by basic treatment for protecting
liver, group II by basic treatment plus oral administration of
Weichangshu ,and group II by basic treatment plus
Motolium,for 4 weeks. Antroduodenal migrating motor
complex (MMC) at interdigestive period before and after
treatment were detected with 20 healthy volunteers used as
controls. Results: The phase I time of MMC in the patient of
hepatocirrhosis after hepatitis prolonged and the phase
shortened 'and the amplitude of contraction wave
significantly decreased as compared with controls (P<0. 05).
The lasting time of phase II and the amplitude of contraction
wave in the patients with grades A,B,C of hepatic functions
were positively correlated with degrees of hepatic injury
(P<0. 05). After basic treatment plus Weichangshu or plus
Motolium,lasting time of phase II prolonged significantly and
the amplitude of contraction wave significantly increased as
compared with those before treatment (P< 0. 05) ,but the
lasting time and the amplitude in the basic treatment group
did not significantly change after treatment. Clinical
observation found that gastrointestinal symptoms in the
patients who took Weichangshu improved to varying degrees.
Conclusion: The patient of hepatocirrhosis after hepatitis has
obvious gastric motility disorder,which aggravates along with
gera 2011

exacerbation of hepatic function; Weichangshu has a better
therapeutic action on gastric motility disorder in the patient
of hepatocirrhosis after hepatitis.
3940- gera: 139038/di/ra
[EXPERIMENTAL MODEL OF ACUTE FATTY
LIVER IN MICE AND THE EFFECT OF CHINESE
HERBS ZHI GAN QING ON THE MODEL]. LI YU-
HONG, ZHANG ZHEN-ZHI, DUAN WEI-HUA, ET AL.
journal of tianjin university of tcm. 2005;24(1):13 (chi*).
[Objective]Acute fatty liver with hyperlipidemia animal
model in mice was produced. To observe the effect of
Chinese herbs Zhi Gan Qing on the animal model. [Methods]
Acute fatty liver mice model was produced by injecting
Dexamethasone Sodium Phosphate injection in the animals'
abdomen and feeding mice high fat diet at one time. Then the
models were prevented with high dosage, medium dosage
and low dosage of Zhi Gan Qing Chinese herbs respectively
contrasting with traditional Chinese medicine Zhi Bi Tuo and
Western medicine Simvastatin tablets. The index of blood
sugar, blood serum grease, liver grease, liver pathology was
observed and compared between each group. [Results] The
method was adapted to produce acute fatty liver with
hyperlipidemia animal mice. Zhi Gan Qing Chinese drugs
lowered index of acute liver fatty in mice, triglyceride and
total cholesterin in blood and liver, improved pathologic
changes in live. [Conclusion] Here we afford a method of
producing acute fatty liver with hyperlipidemia animal model
in mice. Zhi Gan Qing Chinese herbs might be
3941- gera: 139162/di/ra
[54 CASES OF LIVER FIBROSIS OF CHRONIC
HEPATITIS II TREATED WITH XIAOZHENG
KANGXIAN DECOCTION]. SHEN GUOLIANG. journal
of zhejiang college of tcm. 2005;29(1):19 (chi*).
Objective:Observe the effect of Xiaozheng Kangxian
(remove stasis and anti-fibrosis) Decoction (XZKXD) on the
liver fibrosis of patients with chronic hepatitic (CH) II .
Method: Choose 120 cases of patients with CH II ,whom
were divided into 2 groups; for the treatment group,and
XZKXD while treating with basic liver protection,1 dose
daily,take in 2 times;for the control group,and bill of Rhubarb
and Corydiidae,6 for one time, 2 times daily, the treating
course was 3 months for both groups. Then observe the
changes of clinical symptoms,liver function and the index of
liver fibrosis before and after treatment. Result: After
treatment,the clinical symptoms, liver function and index of
liver fibrosis were markedly improved in both groups,
however the improvement of the treatment group was better
than that of control group, their difference was obvious (P>0.
05) by statistical calculation.
3942- gera: 139163/di/ra
[THE LATE EFFECT OF A INTERFERON ON THE
LIVER FIBROSIS INDEX OF SERUM OF CHRONIC
VIRAL HEPATITIS]. ZHANG YUANHAI, ZHOU
QINGRONG, ZHONG YUEPING, ET AL. journal of
zhejiang college of tcm. 2005;29(1):21 (chi).
3943- gera: 139169/di/ra
[ANALGESIC ACTION OF WRISTANKLE
ACUPUNCTURE ON THE PAIN OF MEDIATE AND
SEVERE LIVER CANCER.]. ZHOU QINGHUI, HU XIA,
CU WEI, ET AL. journal of zhejiang college of tcm.
2005;29(1):53 (chi*).
Objective: To assess the analgesic efficacy of wrist-ankle
acupuncture (WAA) in relieving moderate and severe pain of
patients with primary liver cancer,and to observe its analgesic
characteristics and side effects. Methods:Ninety- four
patients with primary liver cancer were observed. Forty
244
patients with moderate cancer pain were divided into 2
groups,including WAA-treated group and codine-treated
group,with 20 patients in each group. Fifty-four patients with
severe cancer pain were divided into 3 groups,including 16
patients treated with WAA, 20 patients treated with MS
contin, and 18 patients treated with WAA and MS contin.
Results:The pain relief rates of the two moderate pain groups
(WAA-treated and contin treated) were 85.0 % and 65. 0%
respectively. The pain relief rates of the three severe pain
groups (WAA-treated,MS contin-treated,WAA and MS
contin-treated) were 63. 0% 85. 0% and 83. 3% respectively.
WAA had shorter start time and longer effective period than
the drug therapy,and had no statistic difference in optimal
relief time as compared with the drug therapy.
Conclusion:The present study confirms the analgesic efficacy
of WAA therapy for cancer pain caused by
heptocarcinoma,especially
3944- gera: 139177/di/ra
[TREAT LIVER CANCER FROM DEFICIENCY]. WU
YITING. journal of zhejiang college of tcm. 2005;29(2):3
(chi*).
The experience of treating liver cancer from deficiency is
expounded from light and heavy diseases, as well as organ
types according to the pathogenesis, the relation between
local lesion and the wholeness, and the individual differences
of the liver cancer. It puts forward that to treat liver cancer
should pay attention to TCM features, abide by the whole
concept and the differentiation of symptoms and signs.
Meanwhile, under the characteristics of cancer, warm-
tonification,can, not warm-tonification,can be applied for
treatment; "to tonify deficiency without forgetting excess,to
purge excess while remembering the deficiency"means we
should a-void only removing the pathogen, and harming the
vital qi, causing the pathogenic factors linger and crisis.
3945- gera: 139182/di/ra
[PORTAL THROMBUS FORMATION AFTER
PORTAAZYGOUS DEVASCULARIZATION IN
EARLY STAG 'TREATED WITH COMBINATION OF
TCM AND WESTERN MEDICINE]. LIU LIWEI, YE
GUOCHAO. journal of zhejiang college of tcm.
2005;29(2):19 (chi*).
Objective:To explore the therapeutic effect of the early
combination of Chinese and western medicine in treating the
portal thrombosis after portalazygous disconnection.
Methods:The patients with portal hyper-tension were early
treated with salivia miltiorrhia, low molecular dextran and
oral administration of dipyridamole,however,no hemostatic
drugs were used. The change of platelet count, prothrombin
time (PT) and the recover time of portal thrombosis were
studied. Results: The incidence of portal thrombosis was de-
creased markedly in therapeutic group. Conclusion: The early
use of salivia miltiorrhia, low molecular dextrar and
dipyridamole can effectively prevent and treat the portal
thrombosis after portalazygous disconnection.
3946- gera: 139185/di/ra
[HYPERBILINIBINEMIA FROM VIRAL HEPATITIS
TREATED WITH-DECOCTION OF EXTRAVASATED
BLOOD BY CATHARSIS]. FA YUEJUAN, GUO
JIANCHUN. journal of zhejiang college of tcm.
2005;29(2):27 (chi).
3947- gera: 139270/di/ra
[60 CASES OF HUANGQI DANSHEN INJECTION
AGAINST LIVE FIBER]. LI QIONG. liaoning journal of
tcm. 2005;32(2):128 (chi).
3948- gera: 139507/di/ra
gera 2011

[CLINICAL OBSERVATION OF INTEGRATED
TRADITIONAL CHINESE AND WESTERN
MEDICINE THERAPY ON 46 PATIENTS WITH
FATTY LIVER]. LIN XIONG. modern journal of
integrated traditional chinese and western medicine.
2005;14(1):29 (chi).
3949- gera: 139531/di/ra
[INVESTIGATIVE PROGRESSION OF MECHANISM
OF ACTION OF MECHANISM OF ACTION ON ANTI
HEPATIC FIBROSIS]. GAO FENG, CHENG LIU-FANG.
modern journal of integrated traditional chinese and
western medicine. 2005;14(3):395 (chi).
3950- gera: 139540/di/ra
[THE EFFECT OF JIANPIHUOXUE RECIPE ON
LACTOGEN AND ESTRADIOL IN PATIENTS WITH
LIVER CIRRHOSIS]. PAN FENG ZHANG YONG HUA,
XU JIAN-JUN. modern journal of integrated traditional
chinese and western medicine. 2005;14(4):439 (chi*).
3951- gera: 139561/di/ra
[THE STUDY OF ASCITES DIALYZING
CONCENTRATION RETRANSFUSION THERAPY ON
INTRACTABLE ASCITES OF CIRRHOSIS]. GAO YU-
JIN, YANG YOU-GUO. modern journal of integrated
traditional chinese and western medicine. 2005;14(6):712
(chi*).
Objective It is to observe the curative effect and untoward
reaction of ascites dialyzing concentration re-transfusion
therapy on intractable ascites of cirrhosis. Methods The left-
inferior abdomen was punctured to elicit ascites out, and the
right abdomen was regarded as ascites re-transport end. The
two puncture points were linked with dialyzing machine, and
then the ascites was dialyzed, concentrated and re-transported
to abdominal cavity. Results The total effective rate of 60
patients with 106 time treatments was 73 % . The urine
volume increased and some patients' renal functions
improved. There were untoward reactions including fever,
low blood pressure, and hepatic encephalopathy and so on,
and the rate was 22 % . Conclusion Ascites dialyzing
concentration re- transfusion therapy is an effective method
to treat intractable ascites of cirrhosis, but there are some
untoward
3952- gera: 139568/di/ra
[LATEST STUDY PROGRESSION OF
NONALCOHOLIC FATTY LIVER DISEASE]. LIU
SHENG. modern journal of integrated traditional chinese
and western medicine. 2005;14(6):831 (chi).
3953- gera: 139600/di/ra
[A CLINICAL STUDY OF FUFANG SHUANGCAO
MIXTURE FOR HEPATIC FIBROSIS IN CHRONIC
HEPATITIS B]. LIAN YUE -XIANG, WU WAN -FEN,
LIN LU -PIN, ET AL. new journal of tcm. 2005;37(1):44
(chi).
3954- gera: 139601/di/ra
[TREATMENT OF CHRONIC HEPATITIS C BY
JIANPI HUOXUE FANG: A CLINICAL
OBSERVATION OF 32 CASES]. XIAO HUI -QUAN,
LUO RI -YONG, WU WAN -FEN. new journal of tcm.
2005;37(1):46 (chi).
3955- gera: 139619/di/ra
[PROF. LIAN JIAN -WEI' S EXPERIENCE ON THE
TREATMENT OF VIRAL HEPATITIS]. MAO JUN -
MIN, LI RU -HUI. new journal of tcm. 2005;37(3):11
(chi*).
245
prof. LIAN considered that viral hepatitis is classified to A,
B. C. D and E types, although the difference of pathogens but
the manifestations of active stage of acute and chronic stages
are similar, the therapeutical principle of clearing heat, re-
moving toxic substance, activating blood circulation and
eliminating dampness is applied for the treatment of acute
enteric hepatitis and active stage of chronic hepatitis, the
principle of warming middle jiao, resolving dampness for yin
type jaundice; the principle of strengthening spleen
benefiting kidney, nourishing liver and eliminating
pathogenic factor for persisting stage of chronic hepatitis; the
principle of supporting healthy qi, removing toxic substance
and promoting diuresis, etc. for ascitic stage of cirrhosis. By
the syndrome differentiation and treatment to enhance the
healthy qi. eliminate pathogenic factor, the disease tends
3956- gera: 139620/di/ra
[PROF. QIAN YING'S EXPERIENCE ON THE
TREATMENT OF CHRONIC SEVERE VIRAL
HEPATITIS]. ZHANG QIU -YUN, LI XIU -HUI. new
journal of tcm. 2005;37(3):14 (chi*).
Prof QIAN according to the theory of "structure of liver
belongs with yin and its function with yang" and the clinical
characteristics of chronic severse hepatitis, he considered that
the damage of yin and yang simultaneously is the key
pathogenesis of the disease. He put forward a thinking of
syndrome differentiation by application of tonifying the
substance base for liver yin and liver blood to enhance the
function of liver yang and liver qi, and put stress on
benefiting and tonifying the liver, dispersing stagnated liver
qi to protect the liver, treating the secondary and primary
aspects simultaneously, and emphasizes the therapy of TCM
combined with western medicine ( WM) . So that a markedly
curative effect is obtained.
3957- gera: 139621/di/ra
[TREATMENT OF III STAGE LIVER CANCER BY
FUZHENG JIEDU CAPSULE: A CLINICAL
OBSERVATION OF 25 CASES]. CHEN MENG -XI,
ZHANG HONG, HE YING -HONG, ET AL. new journal of
tcm. 2005;37(3):25 (chi*).
ObjeCtive: To observe the curative effect of Fuzheng Jiedu
Capsule (FJC) for III stage liver cancer (LC) . Methods: 50
cases of III stage LC were allocated to 2 groups randomly.
The treatment group (25 cases) was treated by FJC
(composed of Radix Astragali, Rhizoma Atractylodis
Macrocephalae, Caulis et Folium Clerodendri Bungei,
Rhizoma Paridis, Alumen and Radix Glycyrrhizae), the
control group (25 cases) by Dahuang Zhechong Wan. The
changes of tumor volume and the life quality and the
improvement of clinical symptoms of both groups were
observed before and after treatment. Results: The stable rate
of tumor volume in clinical treatment group was 60% , and
52% in control group ( P > 0.05). The increase stable rate of
life quality and the effective rate on the improvement of
clinical symptoms was 72% and 80% in treatment group and
56% and 52% in control group respectively( P < O. 05).
Conclusion: The FJC possesses a definite curative effect for
Ill stage LC.
3958- gera: 139628/di/ra
[TREATMENT OF LIVER CANCER BY
INTERVENTIONAL THERAPY COMBINED WITH
XIAOZHENG FUZHENG TANG: A CLINICAL
OBSERVATION OF 24 CASES]. YUAN JING -BO, SU
CHUN -ZHI, WANG WEN -ZHI, ET AL. new journal of
tcm. 2005;37(3):63 (chi*).
Objective: To observe the curative effect of interventional
therapy (IT) combined with Xiaozheng Fuzheng Tang (XFT)
for liver cancer (LC). Methods: 45 cases of LC were
gera 2011

allocated to 2 groups randomly. The treatment group (24
cases) was treated by IT combined with XFT (composed of
Radix Astragali, Rhizoma Atractylodis Macrocephalae,
Poria, Herba Solani Nigri. Radix Angelicae Sinensis , Radix
Rehmanniae, Faeces Trogopterori, Fructus Lycii, Radix
Paeoniae Alba, Rhizoma Chuanxiong, Rhizoma Cyperi and
Cortex Moutan. etc. ) for oral use; the control group (21
cases) by IT alone. Results: In treatment group, the total
effective rate was 79. 2% , and 47. 6% in control group (P <
0. 05) , after treatment, the WBC count showed no significant
difference in compared with before treatment( P > O. 05), but
markedly decreased in control group compared with before
treatment (P < 0. 05) . After treatment, the comparison
between treatment group and control group. the decrease of
WBC showed markedly significant difference (P < 0. 05) .
The comparison between before and after treatment. the
serum AFP of both groups were markedly decreased ( P <
0.05, P < O. 01); the comparison between before and after
treat-ment of both groups showed markedly significant
difference ( P < 0.05). The comparison of Car' s soring
between both groups showed marked significant difference (
P < O. 05), and the treatment group is superior than that of
control group. Conclusion: combined with XHF can increase
the curative effect of LC and markedly improve the life
quality.
3959- gera: 139746/di/ra
PROGRESSI NELLA DIAGNOSI E NEL
TRATTAMENTO DELLA STEATOSI EPATICA.
ZHAO XIAOWEI. rivista italiana di medicina tradizionale
cinese. 2005;99(1):69 (ita*).
3960- gera: 139747/di/ra
COME TRATTARE IL DOLORE IPOCONDRIACO
CAUSATO DA UN' EPATITE CRONICA?. LIN
ZONGGUANG. rivista italiana di medicina tradizionale
cinese. 2005;99(1):73 (ita*).
Chronic viral hepatitis type B and C both have the symptoms
of pain in the hepatic region, asthenia, poor appetite,
abdominal fullness, among which pain in the hepatic region
is the most commonly seen. According to the author's clinical
experience, treatment based on accurate TCM differentiation
can not only eliminate pain in the hepatic region but also
restore the hepatic function at the same time. Differentiation
includes analysis of the nature of the hepatic pain and the
accompanying symptoms, and the treatment is aimed at the
differentiated symptoms. The following are methods of
treatment.
3961- gera: 139763/di/ra
[COMPARISON OF BIOCHEMICAL DIFFERENCES
BETWEEN DIFFERENT TCM SYNDROME
PATTERNS OF CHRONIC HEPATITIS B]. YU MEI,
LIU WENLAN, ZHANG YAN, ET AL. shaanxi journal of
tcm. 2005;26(1):3 (chi).
3962- gera: 139765/di/ra
[CIRRHOTIC ASCITES TREATED BY SELF
FORMULATED GUZHANGLING]. SHI ZHIHONG.
shaanxi journal of tcm. 2005;26(1):11 (chi).
3963- gera: 139766/di/ra
[STIGMA CROCI SATIVI POWDER FOR
HEPATOCIRRHOSIS]. ZHENG WEIMIN, LI JINAGBIN.
shaanxi journal of tcm. 2005;26(1):12 (chi).
3964- gera: 139772/di/ra
[TCM SYNDROME PATTERNS OF CHRONIC
HEPATITIS B AND LEVEL OF PSYCHOLOGICAL
HEALTH]. LIU WENLAN, YU MEI, ZHANG YAN, ET
246
AL. shaanxi journal of tcm. 2005;26(1):41 (chi).
3965- gera: 139774/di/ra
[JI AIYING'S EXPERIENCE IN THE TREATMENT
OF HEPATITIS AND HEPATOCIRRHOSIS]. ZHAO
HONG YING. shaanxi journal of tcm. 2005;26(1):50 (chi).
3966- gera: 139775/di/ra
[PROF. LIU DUZHOU'S EXPERIENCE IN
SYNDROME DIFFERENTIATION AND TREATMENT
OF LIVER JIANG YAN. shaanxi journal of tcm.
2005;26(1):52 (chi).
3967- gera: 139792/di/ra
[INFLUENCE OF HEGAN DECOCTION ON
CHEMICAL LIVER INJURY IN MICE]. YAN YANLI,
WANG XINGUO, SONG XIAOQU, ET AL. shaanxi
journal of tcm. 2005;26(2):182 (chi).
3968- gera: 139926/di/ra
[YIQI HUOXUE LISHUI DECOCTION" PLUS
ASCITES HYPERINSPISSATION REFUSION FOR
HEPATOCIRRHOSIS ASCITES IN 37 CASES]. ZHU
CHU-LIANG XIE SHENG. shanghai journal of tcm.
2005;39(1):21 (chi*).
Thirty-seven cases of hepatocirrhosis ascites were treated by
" Yiqi Huoxue Lishui Decoction" plus ascites
hyperinspissation refusion. Result showed marked
effectiveness in 4 cases, improvement in 28 cases and failure
in 5 cases, with the total effective rate of 86. 5%.
3969- gera: 139927/di/ra
[PROFESSOR JIN HONGYUAN'S EXPERIENCE IN
TREATING CHRONIC HEPATITIS B ON
SYNDROME DIFFERENTIATION]. WANG CHUN-
FANG . shanghai journal of tcm. 2005;39(1):22 (chi*).
Professor Jin Hongyuan laid stress on macro-syndrome
differentiation and micro-syndrome differentiation in the
treatment of chronic hepatitis B , and advocated its treatment
by stage with nourishing liver yin, activating blood and
resolving blood-stasis, and invigorating spleen throughout the
whole treatment, as well as his herbal
3970- gera: 139939/di/ra
[EFFECTS OF "FUZHENG HUAYU DECOCTION"
ON HEPATOCELLULAR APOPTOSIS IN RATS
WITH DMN LIVER FIBROSIS]. TAN CHUN-YU TAN
SHAN-ZHONG JIANG JIAN, ET AL. shanghai journal of
tcm. 2005;39(1):47 (chi*).
To study the effects of " Fuzheng Huayu Decoction" on
hepatocellular apoptosis in rats with DMN liver fibrosis,
fifty- two rats were modeled to be liver fibrosis by O. 5%
DMN and then randomized into group A, group B and group
C and respectively given tap water, 3. 69g. 100ml-1 "
Fuzheng Huayu Decoction" and O. 1% colchicines, for 6
times in four weeks. Group D with 8 rats was given normal
saline in the former 4 weeks and tap water in the latter 4
weeks. Eight weeks later, the rats were sacrificed and some
investigations were made. Results: In group B, the death of
rats and occurrence of ascites were lower and the liver
functions improved; liver Hyp content, collagen staging and
fibrosis reduced; a-SMA expression de-creased obviously,
HSC apoptosis increased, while hepatocellular apoptosis
decreased, with significant differences in comparison with
group A. It is proved that the Decoction probably functions to
quicken HSC apoptosis and inhibit hepatocellular apoptosis
to treat liver fibrosis.
3971- gera: 139954/di/ra
[STUDY ON CLINICAL DISTRIBUTION OF BASIC
gera 2011

SYNDROME OF TRADITIONAL CHINESE
MEDICINE OF PRIMARY LIVER CANCER]. HOU
FENG-GANG LING CHANG-QUAN ZHAO GANG, ET
AL. shanghai journal of tcm. 2005;39(2):22 (chi*).
To investigate the intrinsic laws of the major syndrome
distribution of primary liver cancer, 267 subjects were
surveyed and analyzed. Results: The first stage was
characterized by blood-stasis and spleen-qi deficiency
syndromes; the second stage by blood-stasis, spleen-qi
deficiency, liver-bladder dampness-heat, and liver-qi
stagnation syndromes; the third stage by blood-stasis, spleen-
qi deficiency, liver-bladder dampness-heat, dampness
retention, liver-qi stagnation, liver-yin defi-ciency and
kidney-yin deficiency syndromes. Conclusions: The six
syndromes in third stage are the major syndromes of primary
liver cancer.
3972- gera: 139979/di/ra
[CLINICAL STUDY IN RELATIONSHIP BETWEEN
SYNDROME DIFFERENTIATION AND QUANTITY
REPLICATION OF VIRUS IN HEPATITIS B]. LIU
GUANG-WEI GAO YUE-QIU MA RUN-LIN. shanghai
journal of tcm. 2005;39(3):20 (chi*).
To study the relationship between Chinese syndrome
differentiation and the quantity and replication of virus in
hepatitis B, 275 cases were studied on their syndromes,
quantity and replication of hepatitis B virus in blood. The
results showed that the quality of virus in sthenia syndromes
were higher than the asthenia syndromes, which demonstrates
the quantity of virus may relate to different syndromes; there
was positive relation-ship between asthenia syndrome and the
degree of virus replication, indicating that there was immue-
tolerance in asthenia
3973- gera: 140007/di/ra
[TREATMENT OF FATTY LIVER BY " SHUGAN
QUZHI CAPSULE" IN 42 CASES]. QI QING-QUAN
WANG FU-MEI . shanghai journal of tcm. 2005;39(4):17
(chi*).
To observe the clinical efficacy of " Shugan Quzhi Capsule"
in the treatment of fatty liver, 72 subjects were randomized
into two groups: treatment group in which 42 cases were
treated with "Shugan Quzhi Capsule" and control group in
which 30 cases were treated with " Xuezhikang Capsule".
The clinical symptoms, liver function, blood lipid and B-
ultrasonic outcomes were detected respectively after six and
twelve weeks. Results: The effective rate was 85. 7% in
treatment group and 60% in control group; TG, TC, ALT and
B-ultrasonic out-comes improved much significantly in
treatment group than in control group (P < O. 05) . It is
showed that this Capsule is quite
3974- gera: 140041/di/ra
[THE TREATMENT OF HEPATITIS B OF
ADOLESCENT WITH QINGGAN JIEDU
DECOCTION, A REPORT OF 120 CASES]. HAN
ZHONG-CHENG HAN WEN-BIAO. shanxi journal of
tcm. 2005;21(1):15 (chi*).
Objective:To observe the therapeutic effect of QJI) in treating
hepatitis B of adolescent. Method: 120 adolescent patients
with hepatitis B were treated with QJD for 30 days. Result:
15 patients were cured, 101 patients turned better, 4 patients
ineffective, the total effective rate was 96. 7%. Conclusion:
The method of clearing away heat and toxic material,
promoting blood circulation and removing dampness could
significantly improve the symptoms and liver function of
hepatitis B in strong patients,and decrease the serum level of
hepatitis B virus.
3975- gera: 140129/di/ra
247
[INFLUENCE OF INTERFERON-A2B AND LIPID
GANODERMA SPORE OIL ON THE DNA OF
HEPATITIS B VIRUS]. QIAN XIAOQI, CHEN HONG ,
JIN ZEQIU , ET AL. traditional chinese medicinal
research. 2005;18(1):29 (chi).
3976- gera: 140202/di/ra
[EXPERIENCE ON TREATMENT OF FATTY LIVER
WITH COURSE THE LIVER, WARM THE KIDNEY
AND QUICKEN THE BLOOD]. LI HONG . zhejiang
journal of tcm. 2005;40(1):12 (chi).
3977- gera: 140389/nd/re
[ANALYSIS OF LITERATURE ON THERAPEUTIC
METHODS AND MEDICINES OF TRADITIONAL
CHINESE MEDICINE FOR PRIMARY LIVER
CANCER.]. LIU Q, ZHANG YB, MA CH, YUE XQ, LING
CQ. zhong xi yi jie he xue bao. 2005;3(4):260-2 (chi).
Objective: To find out the rules of therapeutic methods,
formulas and medicines of traditional Chinese medicine
(TCM) for primary liver cancer (PLC). Methods: The
frequencies of treatments and medicines of TCM in 978
pieces of documents concerning PLC were analyzed. Results:
Among the 165 therapeutic methods, 277 formulas and 459
kinds of herbs, the methods for activating blood circulation,
the formulas for regulating qi-flowing and the herbs for
invigorating qi are the most commonly used. Conclusion:
Therapeutic methods such as invigorating qi, regulating qi-
flowing and activating blood circulation are the main choices
for PLC, and the methods such as clearing heat, removing
dampness and nourishing yin are used as supplements.
3978- gera: 140401//ra
EFFECT OF THE HERBAL MEDICINE DAI-
KENCHU-TO FOR SERUM AMMONIA IN
HEPATECTOMIZED PATIENTS. KAIHO T, TANAKA
T, TSUCHIYA S, YANAGISAWA S, TAKEUCHI O,
MIURA M, SAIGUSA N, MIYAZAKI M.
hepatogastroenterology. 2005;52(61):161-5 (eng).
BACKGROUND/AIMS: Prolonged paralytic ileus occurring
in hepatectomized patients may induce hyperammonemia or
bacterial translocation, which injures the remnant liver
function and sometimes causes post- resection liver failure.
We examined the effectiveness of the herbal medicine, Dai-
kenchu-to (DKT), on postoperative serum ammonia levels in
patients with liver resection and compared it with lactulose.
METHODOLOGY: Patients with liver resection were
divided into three groups. Lactulose group (n=31), 16g of
lactulose was administered orally three times a day from the
first postoperative day. DKT group (n=27), 5g of DKT was
administered in the same fashion. Control group (n=26),
neither lactulose nor DKT was administered. In all three
groups, 16g of lactulose was administered three times a day
for three days preoperatively. RESULTS: There was no
significant difference among the groups in age, gender and
preoperative hepatic functional values, such as ICG-R15 or
galactose tolerance test. There was also no difference in
parenchymal hepatic resection rate, operative time and
amount of intraoperative bleeding volume. Postoperative
serum ammonia levels were significantly lower in the DKT
group than control and lactulose groups. Instances of delayed
flatulence and occurrence of diarrhea were also fewer in the
DKT group. CONCLUSIONS: DKT may become a more
effective and safe agent than lactulose in postoperative
management of liver resection.
3979- gera: 140409//ra
PROTECTIVE EFFECT OF BAICALIN ON TERT-
BUTYL HYDROPEROXIDE-INDUCED RAT
HEPATOTOXICITY. HWANG JM, WANG CJ, CHOU
gera 2011

FP, TSENG TH, HSIEH YS, HSU JD, CHU CY. arch
toxicol. 2005;79(2):102-9 (eng).
Baicalin (BA) is a flavonoid compound purified from
Scutellaria baicalensis Georgi that is used as a traditional
Chinese herbal medicine. Baicalin was studied for the
mechanism of its inhibitory effects on the tert-butyl
hydroperoxide (t-BHP)-induced cytotoxicity and lipid
peroxidation in rat liver system. Baicalin expressed an
antioxidant property by its capacity for quenching the free
radicals of 1,1-diphenyl-2-picrylhydrazyl (DPPH). Further
investigations using the t-BHP-induced cytotoxicity in rat
primary hepatocytes demonstrated that baicalin, at the
concentrations of 2-220 microM, significantly decreased the
leakages of lactate dehydrogenase (LDH) and alanine
aminotransferase (ALT), and the formation of
malondialdehyde (MDA) induced by 30 min treatment of t-
BHP(1.5 mM). Baicalin also attenuated the t-BHP-induced
depletion of glutathione (GSH) and high level of DNA
repaired synthesis. An in vivo study in rats showed that
pretreatment with baicalin (i.p.) at concentrations of 0.5 and 5
mg/kg for 5 days before a single i.p. dose of t-BHP (0.1
mmol/kg) significantly lowered the serum levels of hepatic
enzyme markers (ALT and AST) and reduced oxidative
stress in the liver. Histopathological evaluation of the rat
livers revealed that baicalin reduced the incidence of liver
lesions induced by t-BHP including hepatocyte swelling,
leukocyte infiltration, and necrosis. Based on the results
described above, we speculate that baicalin may play a
chemopreventive role via reducing oxidative stress in living
systems.
3980- gera: 140475/di/ra
[SUMMARY OF STUDY ON HEPATITIS B TREATED
WITH ACUPUNCTURE.]. JIANG YING-HENG, ZHOU
EN-HUA. journal of clinical acupuncture and
moxibustion. 2005;21(3):64 (chi).
3981- gera: 140599/di/ra
[INFLUENCE OF ELECTROACUPUNCTURE ON
GLUTATHIONE AND THE MORPHOLOGY OF
ENTERIC MUCOSA IN HEPATOCIRRHOSIS RATS.].
ZHUO LS, YIN HF , HE DS , ET AL. shanghai journal of
acupuncture and moxibustion. 2005;24(6):38 (chi*).
Objective To investigate the mechanism by which
acupuncture treats hepatocirrhosis. Methods A model of
hepatocirrhosis was made with CCL4. The models were
divided into model and electroacupuncture groups and a
normal group was established as a control to observe hepatic
, serous and intestinal glutathione ( GSH) contents and to
quantitatively analyze-the state of enteric mucosa. Results
and Conclusion The above indices were significantly higher
in the electroacupuncture group than in the model group( P <
0.01) , showing that acupuncture can raise GSH in
experimental hepatocirrhosis rats and abate intestinal blood
stagnancy in gastrointestinal mucosa disease due to portal
hypertension so as to treat hepatocirrhosis. The indices were
significantly lower in the electroacupuncture group than in
the control group( P < 0.01) and therefore the course of
acupuncture treatment should be prolonged and point
compatibility adjusted for further investigation.
3982- gera: 140760/nd/re
THE INHIBITORY EFFECT OF A KOREAN HERBAL
MEDICINE, ZEDOARIAE RHIZOMA, ON GROWTH
OF CULTURED HUMAN HEPATIC
MYOFIBROBLAST CELLS. KIM DI, LEE TK, JANG
TH, KIM CH. life sci. 2005;77(8):890-906 (eng*).
The aim of this study was to assess the effect of ZR on the
growth of cultured human hepatic myofibroblast cells (hMF).
The zedoary (Zedoariae Rhizoma) made from the dried
248
rhizome of Curcuma zedoaria Roscoe is an herbal drug used
as an aromatic stomachic. The plant is a perennial herb which
is natively distributed throughout Korea and is a traditional
Korean herbal medicine. Zedoariae rhizoma is a bioactive
traditional medicine with anti- tumor, anti-atherosclerosis,
anti-inflammation, and growth-regulating properties. During
the course of liver fibrogenesis, hMF, mostly derived from
hepatic stellate cells, proliferate and synthesize excessive
amounts of extracellular matrix components. To evaluate the
antiproliferative effect of a traditional herbal medicine,
Zedoariae rhizoma water extracts (ZR) was examined on the
growth inhibition of hMF since proliferation of hMF is
known to be central for the development of fibrosis during
liver injury, and factors that may limit their growth are
potential antifibrotic agents. The aim of this study was to test
the effects of ZR on the proliferation in cultured hMF. hMF
were obtained by outgrowth from human liver explants. ZR
markedly reduced serum driven cell proliferation, as assessed
by nuclear autoradiography experiments and measurement of
actual cell growth. Growth inhibition was totally reversed
after removal of the ZR. ZR potently inhibited hMF growth
(IC50 = 8.5 microg/ml), in a pertussis toxin-insensitive
manner. Analysis of the mechanisms involved in growth
inhibition revealed that ZR rapidly increased prostaglandin
E2 production and in turn cAMP, which inhibited hMF
proliferation, did not affect cAMP levels. Production of
cAMP by ZR was abolished by NS-398, a selective inhibitor
of cycloxygenase (COX)-2. Also, ZR potently induced COX-
2 protein expression. Blocking COX-2 by NS-398 blunted
the antiproliferative effect of ZR. We conclude that ZR
inhibits proliferation of hMF, probably via an intracellular
mechanism, through early COX-2-dependent release of
prostaglandin E2 and cAMP, and delayed COX-2 induction.
Our results indicated a novel role for ZR as a growth
inhibitory mediator and pointed out its potential involvement
in the negative regulation of liver fibrogenesis. The results
that ZR exhibits potent antiproliferative and antifibrogenic
effects toward hMF, indicated that ZR might have therapeutic
implications in chronic liver disease.
3983- gera: 140765/nd/re
COMMENTS ON THE PAPER 'THE EFFECT OF A
HERBAL MEDICINE (MAO-TO) FOR THE
PREVENTION OF INTERFERON-INDUCED
PSYCHIATRIC COMPLICATIONS IN CHRONIC
HEPATITIS C: A PILOT STUDY'. LOFTIS JM,
HAUSER P. hum psychopharmacol. 2005;20(3):211-2
(eng).
.
3984- gera: 140768/nd/re
THE HERBAL MEDICINE SHO-SAIKO-TO
SELECTIVELY INHIBITS CD8+ T-CELL
PROLIFERATION. OHTAKE N, YAMAMOTO M,
TAKEDA S, ABURADA M, ISHIGE A, WATANABE K,
INOUE M. eur j pharmacol. 2005;507(1-3):301-10 (eng*).
Sho-saiko-to (SST), a Chinese/Japanese traditional herbal
medicine, has been widely used to treat chronic hepatitis in
Japan, and the immunomodulatory properties of SST are
likely to mediate its beneficial effect. In the present study, we
examined the effects of SST and its various ingredients on
the count and proliferation of T-cell subsets in cultured
splenocytes and hepatic mononuclear cells. SST, wogonin-7-
O-glucuronoside (a major SST ingredient), and wogonin (an
intestinal metabolite of wogonin-7-O-glucuronoside)
increased CD4/CD8 ratio via a decrease of CD8+ T-cell
counts with no effect on CD4+ T-cell counts. Flow
cytometric analyses of viability, proliferation, and cell cycle
revealed that wogonin suppressed CD8+ T-cell proliferation
without inducing cell death. SST and wogonin administered
gera 2011

to mice increased the CD4/CD8 ratio in hepatic mononuclear
cells but not in splenocytes. These findings suggest that SST
may modulate the CD4/CD8 ratio via the selective inhibition
of CD8+ T-cell proliferation by the SST ingredient wogonin-
7-O-glucuronoside or its metabolite wogonin.
3985- gera: 140896/di/ra
SYNERGISTIC EFFECT OF ACUPUNCTURE ON
ACANTHOPANAX BARK AND PUERARIA ROOT
DRINK AGAINST RAT ALCOHOLIC LIVER INJURY.
JIAO CHENG-YUAN ,CHENG ZE-DONG ,CHEN MING-
MING ,CHEN YI-GUO. shanghai journal of acupuncture
and moxibustion. 2005;24(7):41 (chi*).
Objective To investigate the curative effects of acupuncture
and compound acanthopanax bark and pueraria root drink on
rat early alcoholic liver injury and the mechanism of the
synergistic action of acupuncture and herbs. Methods A rat
model of early alcoholic liver disease (ALD) was made by
white spirit lavage and high fat diet. The influences of simple
herbs ,simple acupuncture and combined acupuncture and
herbs were observed on serum alanine transaminase (ALT)
,aspartate transaminase (AST) ,triglyceride and total
cholesterol ,and hepatic ultrastructure in the rats. Results The
combined use of acupuncture and acanthopanax bark and
pueraria root drink was better than simple herbs and simple
acupuncture in inhibiting hepatocellular fatty degeneration,
reducing hepatocellular fat deposit and restoring liver
function. Conclusion The mechanism of the synergistic
action of acupuncture and herbs may be related to that
acupuncture increases the concentration of the herbal
effective components into the target organ ,and the chance of
contact and an affinity between the herbal medicine and the
3986- gera: 141991/di/ra
ANALYSIS OF CHARACTERISTICS FOR
SYNDROMES IN 2060 PATIENTS WITH PRIMARY
LIVER CANCER. FANG ZHAOQINLI, YONGJIAN,
TANG CHENLONG, MA JUN, GUAI, DONGYUAN,
CHEN DESU. european journal of integrated eastern and
western medicine. 2005;3(2):41 (eng).
Objective: To observe the evolution characteristics of
syndromes and the concurrency of syndromes in patients with
liver cancer. Method: A large-sample clinical
epidemiological survey was carried out to investigate
changes of syndromes in 2060 patients with primary liver
cancer. Result: The pathogenesis of primary liver cancer is
found with constant changes with the development of the
disease. Syndromes at stage 1-111 are mainly characterized
by stagnation of the liver-qi and deficiency of the spleen-qi;
syndromes at stage II, by obstruction of the blood in the liver,
qi stagnation, qi deficiency and damp-heat, and syndromes at
stage III, by qi deficiency, yin deficiency, blood stasis, qi
stagnation and water retention in the body. Qi stagnation,
blood stasis, qi deficiency and yin deficiency stand at the first
four places in the incidence of syndromes at various stages. It
was also found that liver cancer patients with no
differentiable syndrome account for only 1.07% while the
combination of 3, 4 and 5 syndromes occupies 23.06%,
24.37% and 18.11% respectively, 3.75 syndromes on average
for each patient, 2.03, 3.47 and 4.99 syndromes on average at
stagel, II and Ill respectively. Conclusion: With the
development of the disease, the concurrence of syndromes
becomes more significant and their pathogenesis more
complicated. Qi stagnation and blood stasis as well as
deficiency of both qi and yin are the fundamental
pathogeneses throughout the disease.
3987- gera: 145284/di/ra
ANALYSIS OF CHARACTERISTICS FOR
SYNDROMES IN 2060 PATIENTS WITH PRIMARY
249
LIVER CANCER. FANG ZHAOQINLI, YONGJIAN,
TANG CHENLONG,MA JUN, GUAN DONGYUAN,
CHEN DESN. european journal of integrated eastern and
western medicine. 2005;2(3): (eng).
Objective: To observe the evolution characteristics of
syndromes and the concurrency of syndromes in patients with
liver cancer. Method: A large-sample clinical
epidemiological survey was carried out to investigate
changes of syndromes in 2060 patients with primary liver
cancer. Result: The pathogenesis of primary liver cancer is
found with constant changes with the development of the
disease. Syndromes at stage I-Ill are mainly characterized by
stagnation of the liver-qi and deficiency of the spleen-qi;
syndromes at stage II, by obstruction of the blood in the liver,
qi stagnation, qi deficiency and damp-heat, and syndromes at
stage Ill, by qi deficiency, yin deficiency, blood stasis, qi
stagnation and water retention in the body. Qi stagnation,
blood stasis, qi deficiency and yin deficiency stand at the first
four places in the incidence of syndromes at various stages. It
was also found that liver cancer patients with no
differentiable syndrome account for only 1.07% while the
combination of 3, 4 and 5 syndromes occupies 23.06%,
24.37% and 18.11% respectively, 3.75 syndromes on average
for each patient, 2.03, 3.47 and 4.99 syndromes on average at
stagel, II and Ill respectively. Conclusion: With the
development of the disease, the concurrence of syndromes
becomes more significant and their pathogenesis more
complicated. Qi stagnation and blood stasis as well as
deficiency of both qi and yin are the fundamental
pathogeneses throughout the disease.
3988- gera: 145684/di/cg
STUDY AND EVALUATION OF TREATMENT OF
HEPATIC FIBROSIS BY TRADITIONAL
PHARMACOTHERAPY. HU JIANHUA, LI XIUHUI,
GOU CHUNYAN, LI JINGYING, MI JUN, ZHENG
JINHUI. 2eme congres national de medecine chinoise,
paris. 2005;:269 (eng).
Now we are lack of good evaluation standard for Chinese
herbal medicine in anti-liver fibrosis, and the establishment
of the normal, objective, scientific standard is urgent matter.
In the long-term of clinical research, we have a set of integral
evaluation standard, integrating Bien zheng Inn zhi with
modern medical examination means, referring to the
professional standard of chronic hepatitis. There are three
main parts in the standard, such as: First, the integral
evaluation standard for TCM symptoms (good validity,
validity, invalid).Second, the integral evaluation standard for
the serum and special check (good validity, validity,
invalid).Three, the synthetical integral evaluation standard for
TCM symptoms, serum and special check. In conclusion, the
standard is comprehensive, objective, compact, scientific,
practicable, and with good clinic and scientific research
value.
3989- gera: 146733/nd/ra
[EFFECTS OF STRENGTHENING AND
REGULATING SPLEEN-QI RECIPE ON NUDE MICE
WITH METASTATIC HUMAN HEPATOCELLULAR
CARCINOMA]. CHENG WW, SONG MZ, XUE Q, SHEN
YH. zhonghua gan zang bing za zhi. 2005;13(6):460-1
(chi).
3990- gera: 125972/di/ra
[EFFECTS OF ACUPOINT-INJECTION OF KAIXILAI
ON TG, TC, MDA, SOD, AST AND ALT IN THE
PATIENT OF NON-ALCOHOLIC FATTY LIVER]. JIN
JJ, XU YL, ZHENG Y. chinese acupuncture and
moxibustion. 2006;26(2):100-2 (chi).
OBJECTIVE: To observe therapeutic effect of acupoint-
gera 2011

injection of Kaixilai on non-alcoholic fatty liver.
METHODS: One hundred cases of non-alcoholic fatty liver
were randomly divided into a test group and a control group,
50 cases in each group. The test group were treated with
injection of 2 mL Kaixilai injection into Zusanli (ST 36),
thrice each week, for 3 months; and the control group were
treated with intravenous drip of 200 mL Kaixilai injection,
once each day, for 3 months. Changes of triglyceride (TG),
total cholesterol (TC), malondialhyde (MDA), superoxide
dismutase (SOD), glutamic-oxaloacetic transaminase (AST),
glutamic-pyruvic transaminase (ALT), and clinical symptoms
were observed in the two groups. RESULTS: There were
significant differences before and after treatment in the
symptoms, TG, TC, MDA, SOD, AST and ALT in the two
groups (P<0.05), with no significant difference between the
two groups (P>0.05). CONCLUSION: Acupoint-injection of
Kaixilai is an effective therapy for non-alcoholic fatty liver,
with convenience, economic and no adverse effect.
3991- gera: 125974/di/ra
[OBSERVATION ON THERAPEUTIC EFFECT OF
TCM IONTOPHORESIS ON CHRONIC HEPATITIS
WITH SPLENOMEGALY]. HOU Y, LI L, YANG ZY.
chinese acupuncture and moxibustion. 2006;26(2):94-6.
(chi).
OBJECTIVE: To search for an effective therapy for chronic
hepatitis with splenomegaly. METHODS: Five hundred and
seventy eight cases of chronic hepatitis with splenomegaly
were randomly divided into a treatment group (n=292) and a
control group (n=286). The two groups were treated with
intravenous drip of hepatocyte growth- promoting factors and
Danshen Injectio, with TCM iontophoresis added to the
treatment group, once daily, 20 sessions constituting one
course. After one course, their therapeutic effects were
observed. RESULTS: Both the cured rate and the effective
rate on splenomegaly were 66.1% and 98.6% in the treatment
group, which were higher than 18.2% and 76.2% in the
control group. The treatment group in the therapeutic effect
in improvement of liver function and attenuation of the
spleen and remission of hyperfunction of the spleen was
better than the control group (P < 0.05). CONCLUSION:
TCM iontophoresis has obvious therapeutic effect on chronic
hepatitis with
3992- gera: 126047/di/ra
ANTIPROLIFERATIVE AND APOPTOTIC EFFECTS
OF TETRANDRINE ON DIFFERENT HUMAN
HEPATOMA CELL LINES. NG LT, CHIANG LC, LIN
YT, LIN CC. american journal of chinese medicine.
2006;34(1):125-35. (eng).
Tetrandrine (TET), a bis-benzylisoquinoline alkaloid isolated
from the dried root of Hang-Fang-Chi (Stephania tetrandra S.
Moore), is well known to possess activities including
antioxidant, anti-inflammation, anti-fibrotic and anticancer. It
is used clinically to treat hypertension and silicosis. In the
present study, the anti-proliferative and apoptotic effects of
TET were evaluated on three different hepatoma cell lines,
namely Hep G2, PLC/PRF/5 and Hep 3B. Using XTT assay,
results showed that the IC50 values of TET were 4.35
microM for Hep G2, 9.44 microM for PLC/PRF/5 and 10.41
microM for Hep 3B cells. The CC50 of TET against BNL-
CL.2 mouse normal liver cells was 31.12 microM.
Interestingly, TET exhibited a lower IC50 value and better
selectivity against Hep G2 and PLC/PRF/5 cells than
cisplatin. Microscopic observation study, DNA fragmentation
assay and flow cytometric analysis further supported
apoptotic effect of TET on both PLC/PRF/5 and Hep 3B
cells. The cell cycle of PLC/PRF/5 treated with TET
appeared to arrest at G2/M phase in a dose-dependent
manner, whereas no effect was noted on the cell cycle of Hep
250
3B cells. The present study concludes that TET exhibited
anti-proliferative effect on Hep G2, PLC/PRF/5 and Hep 3B
cells in a dose-dependent manner. TET also possesses a
lower IC50 and better SI value than cisplatin against Hep G2
and PLC/PRF/5 cells. The effect of TET on cell cycle
progression was found to vary with the type of hepatoma
cells, suggesting the genetic make-up of the cells play an
important role in the response to drug treatment.
3993- gera: 126050/di/ra
THERAPEUTIC EFFECTS AND MOLECULAR
MECHANISMS OF GINKGO BILOBA EXTRACT ON
LIVER FIBROSIS IN RATS. LIU SQ, YU JP, CHEN HL,
LUO HS, CHEN SM, YU HG. american journal of chinese
medicine. 2006;34(1):99-114. (eng).
Oxidative stress can be implicated as a cause of liver fibrosis.
In this sense, Ginkgo Biloba Extract (EGB), an antioxidant,
may be beneficial in restraining liver fibrosis. The aim of this
study was to evaluate the effects of EGB on experimental
liver fibrosis. Rat liver fibrosis was induced by
intraperitoneal injection of carbon tetrachloride (CCl4) twice
a week for 8 weeks. Three groups of rats received EGB (0.25,
0.5 and 1.0 g/kg, respectively) by stomach everyday. CCl4
administration induced liver fibrosis, which was inhibited by
EGB in a dose-dependent manner. The histopathologic score
of fibrosis, liver function and the levels of plasma hyaluronic
acid (HA) and laminin (LN) were significantly improved in
rats treated with CCl4 + EGB, compared with those treated
with CCl4 only (p < 0.01 or p < 0.05). The activities of
superoxide dismutase (SOD) and glutathione peroxidase
(GSH-Px) were notably elevated, while malondialdehyde
(MDA) content was significantly decreased in the rats treated
with CCl4 + EGB (p < 0.01 or p < 0.05). Inhibition of hepatic
stellate cell (HSC) activation and nuclear factor kappaBP65
(NF-kappaBP65) expression was demonstrated in the livers
of EGB-treated rats. The activation of NF- kappaB was
significantly suppressed in EGB-treated rats determined by
electrophoretic mobility shift assay (EMSA). Furthermore,
EGB reduced expressions of transforming growth factor-
beta1 (TGF-beta1) and collagen I mRNA. In conclusion,
EGB is able to ameliorate liver injury and prevent rats from
CCl4-induced liver fibrosis by suppressing oxidative stress.
This process may be related to inhibiting the induction of NF-
kappaB on HSC activation and the expression of TGF-beta1.
3994- gera: 126066/di/ra
ANTI-HEPATITIS ACTIVITIES IN THE BROTH OF
GANODERMA LUCIDUM SUPPLEMENTED WITH A
CHINESE HERBAL MEDICINE. LI Y, YANG Y, FANG
L, ZHANG Z, JIN J, ZHANG K. american journal of
chinese medicine. 2006;34(2):341-9 (eng).
The anti-hepatitis B virus activity and hepatoprotective
activity of a liquid fermentation broth of Ganoderma lucidum
were investigated. The cultured broth was supplemented with
aqueous extract of Radix Sophorae flavescentis, a kind of
Chinese herbal medicine. Our results indicated that the
cultured broth had effects of anti- hepatitis B virus activity in
vitro and protected mice from liver damage in vivo. Our
results also indicated that the co-fermentation broth of
Ganoderma lucidum in the presence of aqueous extract of
Radix Sophorae flavescentis has better medicinal effects than
simply mixing these two ingredients together, suggesting a
potential novel way to
3995- gera: 126091/di/ra
HEPATOPROTECTIVE EFFECT OF PHYLLANTHUS
IN TAIWAN ON ACUTE LIVER DAMAGE INDUCED
BY CARBON TETRACHLORIDE. LEE CY, PENG WH,
CHENG HY, CHEN FN, LAI MT, CHIU TH. american
journal of chinese medicine. 2006;34(3):471-82. (eng).
gera 2011

The effect of oral administration of Phyllanthus methanolic
extracts (PME) (i.e. P. acidus, P. emblica, P. myrtifolius, P.
multiflorus, P. amarus, P. debilis, P. embergeri, P. hookeri, P.
tenellus, P. urinaria L.s. nudicarpus, P. urinaria L.s. urinaria)
or gallic acid (GA) on the progression of acute liver damage
induced by CCl(4) in rats was examined by morphological
and biochemical methods. P. acidus, P. urinaria L.s. urinaria,
GA at a dose of 0.5 g/kg, and P. emblica, P. urinaria L.s.
nudicarpus at a dose of 1.0 g/kg attenuated CCl(4)-induced
increase in serum glutamate-oxalate-transaminase (GOT). P.
acidus, P. urinaria L.s. nudicarpus, P. urinaria L.s. urinaria,
GA at a dose of 0.5 g/kg, and P. emblica, P. amarus, P.
hookeri, P. tenellus at a dose of 1.0 g/kg attenuated CCl(4)-
induced increase in serum glutamate-pyruvate-transaminase
(GPT). Concurrently, P. acidus, P. multiflorus, P. embergeri,
P. hookeri, P. tenellus and P. urinaria L.s. urinaria elevated
the activity of liver reduced glutathione peroxidase (GSH-
Px). Since the protective effects of P. acidus, P. emblica, P.
myrtifolius, P. embergeri, P. urinaria L.s. nudicarpus, P.
urinaria L.s. urinaria and GA correlate with a reduction in
liver infiltration and focal necrosis observed using
histological methods, these data demonstrate that P. acidus
and P. urinaria L.s. urinaria are hepatoprotective and
antioxidant agents.
3996- gera: 126334/di/ra
CAS CLINIQUES ET PROPOS MEDICAUX
DIAGNOSTIC ET TRAITEMENT DE L'HEPATITE
CHRONIQUE. CHEN JIMING. journal de medecine
traditionnelle chinoise. 2006;2(2):22 (fra).
3997- gera: 133484/di/ra
CLINICAL STUDY ON GANBI DECOCTION IN
TREATING ANTITUBERCULOTIC AGENT-CAUSED
LIVER INJURY. XIAN YS, WANG ZR, GONG XF,
HUANG BZ. chinese journal of integrative medicine.
2006;12(2):107-11. (eng*).
OBJECTIVE: To study the effect and mechanism of Ganbi
decoction (GBD) in treating patients with antituberculotic
agent caused liver injury (ATB-LI). METHODS: One
hundred and twenty-eight patients with ATB-LI were
randomly assigned to the treated group (n = 66) and the
control group (n = 62) with the envelop method. Meanwhile,
60 healthy persons were selected as the healthy control
group. The treated group was treated by GBD one dose every
day with the constituents modified depending on patients'
symptoms, and the control group was treated with
glucuronolactone tablets and inosine injection. One week was
taken as one treatment course. The changes of clinical
syndromes, physical signs, T-lymphycyte sub-groups and
serum level of nitric oxide (NO) were observed before and
after treatment and the recovery time of liver function was
recorded. The outcome was compared with that in the healthy
control group. RESULTS: In the treated group, 28 patients
(42.4%) were cured, 30 (45.5%) improved and 8 (12.1%)
ineffectively cured, the total effective rate being 87.9%
(58/66). In the control group, 17 patients (27.4%) were cured,
24 (38.7%) improved, and 21 (33.9%) ineffectively cured, the
total effective rate being 66.1% (41/62). The total effective
rate in the treated group was significantly higher than that in
the control group (P < 0.05). Liver function was improved in
both groups, recovery time in the treated group was 12.0 +/-
7.0 days, which was significantly shorter than that in the
control group (16.0 +/- 8.0 days), showing significant
difference between the two groups (P < 0.05). The levels of
CD3, CD4 and CD8 were significantly higher and level of
NO significantly lower in the two groups of patients than
those in the healthy control group (P < 0.05), but these
parameters were improved more significantly in the treated
group after treatment, when compared with those before
251
treatment or with those in the control group, all showing
significant difference (P < 0.05). CONCLUSION: GBD
could prevent ATB-LI, and its mechanism could be by way
of reducing NO production induced by endotoxin of
macrophage and stimulating the proliferation of T-
lymphycyte to elevate immunity.
3998- gera: 141202/di/re
HEPATOPROTECTIVE EFFECT OF MANUAL
ACUPUNCTURE AT ACUPOINT GB34 AGAINST
CCL(4)-INDUCED CHRONIC LIVER DAMAGE IN
RATS. YIM YK, LEE H, HONG KE, KIM YI, LEE BR,
KIM TH, YI JY. world j gastroenterol. 2006;12(14):2245-9
(eng).
AIM: To investigate the hepatoprotective effect of manual
acupuncture at Yanglingquan (GB34) on CCl(4)- induced
chronic liver damage in rats. METHODS: Rats were injected
intraperitoneally with CCl(4) (1 mL/kg) and treated with
manual acupuncture using reinforcing manipulation
techniques at left GB34 (Yanglingquan) 3 times a week for
10 wk. A non-acupoint in left gluteal area was selected as a
sham point. To estimate the hepatoprotective effect of
manual acupuncture at GB34, measurement of liver index,
biochemical assays including serum ALT, AST, ALP and
total cholesterol, histological analysis and blood cell counts
were conducted.RESULTS: Manual acupuncture at GB34
reduced the liver index, serum ALT, AST, ALP and total
cholesterol levels as compared with the control group and the
sham acupuncture group. It also increased and normalized the
populations of WBC and lymphocytes. CONCLUSION:
Manual acupuncture with reinforcing manipulation
techniques at left GB34 reduces liver toxicity, protects liver
function and liver tissue, and normalizes
3999- gera: 141785/di/ra
STUDY ON EFFECTS OF EXTRACTS FROM SALVIA
MILTIORRHIZA AND CURCUMA LONGA IN
INHIBITING PHOSPHORYLATED
EXTRACELLULAR SIGNAL REGULATED KINASE
EXPRESSION IN RAT'S HEPATIC STELLATE
CELLS. CHENG Y, PING J, LIU C, TAN YZ, CHEN GF.
chinese journal of integrative medecine. 2006;12(3):207
(eng).
4000- gera: 142103/nd/re
LAY BELIEFS ABOUT HEPATITIS AMONG NORTH
AMERICAN CHINESE: IMPLICATIONS FOR
HEPATITIS PREVENTION. CHEN H, TU SP, TEH CZ,
YIP MP, CHOE JH, HISLOP TG, TAYLOR VM,
THOMPSON B. j community health. 2006;31(2): (eng).
The objective was to learn about the hepatitis prevention
behavior of relatively unacculturated North American
Chinese adults, along with their knowledge, beliefs, and
perceptions with regard to hepatitis, screening, and
vaccination. Forty Chinese men and women, aged 18-64,
were recruited from immigrant communities in Seattle,
Washington, and Vancouver, British Columbia. Semi-
structured interviews (Cantonese or Mandarin) were
audiotaped, translated, transcribed verbatim, and coded. Open
coding, axial coding, constant comparison methods, and QSR
NUD*IST 5 software was used for analysis. Findings were
validated using eight focus groups. Findings indicated that
many interviewees lack accurate knowledge with regard to
hepatitis, often confusing the different types. Perceived
causes of hepatitis included potentially harmful food (e.g.,
fried foods or potentially contaminated foods), alcohol,
contact with infected individuals, stress, and inadequate rest.
Preventive strategies associated with Chinese health beliefs
included the use of Chinese herbal medicine, maintaining a
stress-free mind, strengthening the body's natural defenses,
gera 2011

and getting enough sleep. Other preventive strategies were
the practice of good hygiene, vaccination, and the avoidance
of contact with infected persons. Vaccination was not seen as
primary, as 65% of those who had heard of hepatitis
vaccination did not cite it as a means for hepatitis prevention
until asked. Also, participants lacked information about the
types and purposes of hepatitis vaccination and were worried
about side effects. In conclusion, any attempt to promote
hepatitis testing and vaccination among the North American
Chinese should take traditional beliefs and practices into
consideration.
4001- gera: 142105/nd/re
HEPATOPROTECTIVE AND ANTIOXIDANT
EFFECTS OF CUSCUTA CHINENSIS AGAINST
ACETAMINOPHEN- INDUCED HEPATOTOXICITY
IN RATS. YEN FL, WU TH, LIN LT, LIN CC. j
ethnopharmacol. 2006;nov.-11: (eng).
Tu-Si-Zi, the seeds of Cuscuta chinensis Lam.
(Convolvulaceae), is a traditional Chinese medicine that is
commonly used to nourish and improve the liver and kidney
conditions in China and other Asian countries. As oxidative
stress promotes the development of acetaminophen (APAP)-
induced hepatotoxicity, the aim of the present study was to
evaluate and compare the hepatoprotective effect and
antioxidant activities of the aqueous and ethanolic extracts of
C chinensis on APAP-induced hepatotoxicity in rats. The C
chinensis ethanolic extract at an oral dose of both 125 and
250mg/kg showed a significant hepatoprotective effect
relatively to the same extent (P<0.05) by reducing levels of
glutamate oxaloacetate transaminase (GOT), glutamate
pyruvate transaminase (GPT), and alkaline phosphatase
(ALP). In addition, the same ethanolic extract prevented the
hepatotoxicity induced by APAP-intoxicated treatment as
observed when assessing the liver histopathology. Regarding
the antioxidant activity, C chinensis ethanolic extract
exhibited a significant effect (P<0.05) by increasing levels of
superoxide dismutase (SOD), catalase (CAT), and
glutathione peroxidase (GPx), and by reducing
malondialdehyde (MDA) levels. In contrast, the same doses
of the aqueous extract of C chinensis did not present any
hepatoprotective effect as seen in the ethanolic extract, and
resulted in further liver deterioration. In conclusion, these
data suggest that the ethanolic extract of Cuscuta chinensis
can prevent hepatic injuries from APAP-induced
hepatotoxicity in rats and this is likely mediated through its
antioxidant activities.
4002- gera: 142109/nd/re
INHIBITORY EFFECTS OF LIGUSTICUM
CHUANXIONG ON THE PROLIFERATION OF RAT
HEPATIC STELLATE CELLS. LIN YL, LEE TF,
HUANG YJ, HUANG YT. j gastroenterol hepatol.
2006;21(8): (eng).
BACKGROUND AND AIMS: Platelet-derived growth factor
(PDGF) is a very potent mitogen for hepatic stellate cells
(HSC) in hepatic fibrogenesis. Ligusticum chuanxiong Hort.
(LC), a traditional Chinese herb used for cerebrovascular
diseases, has been shown to exert anti-inflammatory and free
radical scavenging effects. The aims of the present study
were to investigate the effects of LC extract on the
proliferation-related biomarkers in a rat HSC cell line (HSC-
T6) stimulated with PDGF. METHODS: DNA synthesis via
bromodeoxyuridine (BrdU) incorporation, cell cycle related
proteins and apoptosis markers were determined to evaluate
the inhibitory effects of LC. RESULTS: The results revealed
that LC extract (25-100 microg/mL) concentration-
dependently decreased the PDGF-induced cell proliferation
as well as alpha-smooth muscle actin expression in HSC. The
inhibitory activity of LC on HSC was associated with: (i)
252
inhibition of BrdU incorporation; (ii) induction of apoptosis
with the activation of caspase-3, up-regulation of cell cycle
inhibitory proteins p21 and p27, and down-regulation of cell
cycle stimulatory proteins cyclins D1 and D2; and (iii)
increased phosphorylation of mitogen-activated protein
kinases (JNK). LC at the studied concentrations showed no
direct cytotoxicity on primary hepatocytes. CONCLUSION:
The results suggest that LC significantly inhibited PDGF-
activated HSC proliferation, possibly through apoptotic
mechanisms and the potential of LC as an antifibrotic agent
warrants further investigation.
4003- gera: 142110/nd/re
EFFECT OF SEASONAL VARIATION ON THE
CLINICAL COURSE OF CHRONIC HEPATITIS B.
ZHANG SJ, CHEN ZX, JIAN G KP, WU WK, ZHANG CY,
GU YL. j gastroenterol. 2006;41(11): (eng).
BACKGROUND: Seasonal variation in immunity has been
found in healthy individuals and in association with some
diseases. It is still unknown whether seasonal variation
affects the clinical course of chronic hepatitis B. Our aim in
this study was to explore the effect of seasonal variation on
the clinical course of chronic hepatitis B. METHODS: The
flare and remission time of chronic hepatitis B were observed
in patients with hepatitis B virus (HBV) infection. All
patients enrolled were followed up at least every 3 months for
a mean follow-up time of 24.0 (range, 12-60) months.
Seasonal decomposition was employed to analyze the
relationship between seasonal variation and flares, remission,
and hepatitis B e antigen (HBeAg) seroconversion in chronic
hepatitis B patients during follow-up. RESULTS: A total of
2238 patients were observed in our study. Flare and HBeAg
seroconversion were seldom seen in 1076 patients (48.08%)
with alanine aminotransferase (ALT) levels of less than 2.0 x
upper limit of normal (ULN) during follow-up (mean, 36
months). The remaining 1162 patients (51.92%) (766,
HBeAg positive; 387 anti-HBeAg positive; 9 negative for
both HBeAg and anti-HBeAg) with ALT levels >/=2.0 x
ULN were followed longitudinally for 12 months to judge
flare, remission, and HBeAg seroconversion. Flare,
remission, and HBeAg seroconversion in patients with ALT
levels >/=2.0 x ULN showed clear seasonal patterns (P <
0.001), with high peaks during spring, summer, and summer,
respectively. An autocorrelation correlogram showed that
flares, remission, and HBeAg seroconversion occurred with
distinct periodicity in winter, spring, summer, and autumn.
CONCLUSIONS: Seasonal variation might affect the clinical
course of chronic hepatitis B. The role of seasonal triggering
factors should be further investigated.
4004- gera: 142355/di/ra
QUANTITATIVE ANALYSIS ON CHANGES OF
HEPATIC HEMODYNAMICS AFTER
TRANSCUTANEOUS ELECTRIC PULSE
STIMULATION OF LOCAL POINTS BY USING
COLOR DOPPLER ULTRASOUND DIAGNOSTIC
APPARATUS. ZHANG JUN-CHANG, WANG LING, LI
HONG, AL. world journal of acupuncture-moxibustion.
2006;16(3):3 (eng).
Objective: To evaluate the effect of transcutaneous electric
pulse stimulation (TEPS) on hepatic ) lood flow and
parenchymal microcirculation in patients with fatty liver.
Methods: A total of 31 fatty liver vol-inteer patients were
observed in this study. Changes of color Doppler energy
(ODE) images before and after TEPS of local points nearby
the liver were recorded by using color Doppler ultrasound
diagnostic apparatus : ACUSON 128XP/10C). Sum of color
pixel area (SCPA), average of color value (ACV) and SCPA
ACV integral) of the hepatic flow images were analyzed by
an image processing system, single blind method and ) aired
gera 2011

t-test. Programmed TEPS (0.5— 150 Hz/2 000 Hz, 10-25 V)
was applied to the right Qimen_R 14)-Jingmen GB 25) , Fuai
SP 16)-Ganshu BL 18) respectively for 15 min. Results:
Dompared with basic values of pretreatment, SCPA, ACV
and SCPA X ACV increased significantly ( t =2.71, °<0 . 02;
t =3.42, P<0.01; and t =8.15, P<0.001) after TEPS, meaning
improvement of hepatic blood low supply. Conclusion: TEPS
of acupoints near the liver can improve hepatic
4005- gera: 142883/nd/re
YISHENG INJECTION DECREASES THE
EXPRESSION OF H60 AND RAE-1 GENES IN
ISCHEMIC MICE LIVER. CHENG F, FENG L, LI S,
TAN J, CAO L, HE Y, YE Z, LI Y. transplant proc.
2006;38(7): (eng).
OBJECTIVE: Major histocompatability complex class I
chain-related antigen A, B (MICA, B) functions as ligands
for human NKG2D receptors, which may play a role in graft
rejection and cellular stress. In this study we explored the
effect of ischemia/reperfusion injury (IRI) on the expression
of H60 and RAE-1 (MICA, B homologues) in mice to study
the protective effect of Yisheng injection (YS), an herbal
preparation developed from traditional Chinese medicine.
METHODS: Male BALB/c mice were divided into sham,
ischemic, and YS-treated groups using 90 minutes of left
liver lobe ischemia. Sham control mice underwent the same
operation, but without vascular occlusion. In the treated
group, YS (20 mg/kg) was given before ischemia and after
reperfusion for 7 days. Liver samples collected at 7 days
postoperation were used for real-time quantitative
polymerase chain reaction analysis, Western blotting, and
immunohistochemical assays. RESULTS: Compared with the
sham group, H60 and RAE-1 mRNA levels were increased
by sevenfold and 4.5-fold in the ischemic group, respectively.
After YS treatment, they were reduced by 76% and 70%,
respectively. Western blotting and immunohistochemical
assays showed that there was absent or faint H60 and RAE-1
expression in sham liver, but they were apparently increased
in ischemic liver; however, the expressions were significantly
decreased in the presence of YS. CONCLUSIONS: Hepatic
IRI significantly increased H60 and RAE-1 expression in
mouse liver. YS treatment effectively reduced this increase,
seeming to attenuate NKG2D-ligand-mediated immune
responses caused by IRI. This may suggest a new concept to
prevent IRI and graft rejection.
4006- gera: 143249/di/ra
STUDY ON EFFECTS OF EXTRACTS FROM SALVIA
MILTIORRHIZA AND CURCUMA LONGA IN
INHIBITING PHOSPHORYLATED
EXTRACELLULAR SIGNAL REGULATED KINASE
EXPRESSION IN RAT'S HEPATIC STELLATE
CELLS. CHENG YANG, PING JIAN, LIU CHENG, ET
AL. chinese journal of integrative medicine.
2006;12(3):207 (eng).
Objective: To study the effect of salvianolic acid B (SAB)
and curcumin, the extracts of Sal-via Miltiorrhiza and
Curcuma Longa, on the proliferation and activation of
hepatic stellate cell ( HSC) , and the extracellular signal
regulated kinase (ERK) expression in it. Methods: Rat' s
HSC-T6 were cultured and treated by SAB or curcumin. The
inhibitory effect on cell proliferation was determined by 3-(4,
5-dimthyl-2- 2thiazoly)-2,5-dipheny1-2H- tetrazolium
bromide (MTT) colorimetry, and the expression levels of a
smooth actin (a-SMA) , collagen type I , and ERK were
determined by Western blot. Results: SAB and curcumin
in-hibited the proliferation and activation of rat' s HSC-T6 in
dose-dependent fashion and significantly reduced the
expression level of a-SMA ( P<0.01). Curcumin significantly
reduced the expression of collagen type I ( P<0.05). Both
253
SAB and curcumin showed insignificant effect on the ERK
expression level, but they could significantly reduce the level
of phosphorylated- ERK expression, showing significant
difference as compared with that in the control group ( P<0.
01 and P<0. 05 respectively). Conclusion : SAB and
curcumin could significantly inhibit the proliferation,
activation of HSC, and the production of type I collagen in
HSC, the mechanism may be associated with their inhibition
on ERK phosphorylation.
4007- gera: 143408/nd/re
COMPARISON OF THERAPEUTIC EFFECTIVENESS
OF COMBINED INTERVENTIONAL THERAPY FOR
1126 CASES OF PRIMARY LIVER CANCER. LIU YM,
QIN H, WANG C B, FANG XH, MA QY. world j
gastroenterol. 2006;12(31): (eng).
AIM: To verify the effect of combined interventional therapy
for hepatocellular carcinoma (HCC). METHODS: The
clinical data of 1126 HCC patients who received combined
interventional therapy for transcatheter arterial
chemoembolization (TACE) before or after hepatectomy,
TACE and radio-frequency ablation (RFA), Chinese
medicine treatment and biotherapy after TACE or
transcatheter arterial infusion (TAI), were reviewed
according to the results of their liver function, alpha-
fetoprotein, image data, color-ultrasonography finding and
survival rate. RESULTS: A total of 874 patients were
followed up for a period of 2 to 63 mo. The overall 1-, 3- and
5- year survival rates were 67.8%, 28.7% and 18.8%
respectively. The 1- 3- and 5- year survival rates of patients
who received TACE were 74.7%, 41.4%, 36.9% before
hepatectomy and 78.9%, 40.4%, 37.5% after hepatectomy.
The effective rate (PR + NC) after TACE and RFA was
93.4%, the 1- and 3- year survival rates were 74.5% and
36.8% after TACE and RFA. The effective rate of PR + NC
after TACE was 83.2%. The 1-, 3- and 5- year survival rates
were 69.3%, 21.7%, 8.4% after TACE. The effective rate of
PR + NC after TAI was 27.5%, the 1- and 2- year survival
rates were 11.6% and 0% after TAI. The liver function,
color-ultrasonography finding and alpha-fetoprotein after
TACE + RFA, TACE and TAI were compared. There was no
significant difference in each index between TACE and RFA
or TACE as well as in liver function between TACE and
RFA or between TACE and TAI. CONCLUSION: The
therapeutic effectiveness of TACE before or after
hepatectomy is most significant, while the effect of TACE
and RFA is better than that of TACE, and the effect of TAI is
minimal.
4008- gera: 143506/di/ra
QUANTITATIVE ANALYSIS ON CHANGES OF
HEPATIC HEMODYNAMICS AFTER
TRANSCUTANEOUS ELECTRIC PULSE
STIMULATION OF LOCAL POINTS BY USING
COLOR DOPPLER ULTRASOUND DIAGNOSTIC
APPARATUS. ZHANG JUN-CHANG, WANG LING, LI
HONG, ET AL. world journal of acupuncture-
moxibution. 2006;16(3):3 (eng).
Objective: To evaluate the effect of transcutaneous electric
pulse stimulation (TEPS) on hepatic blood flow and
parenchymal microcirculation in patients with fatty liver.
Methods: A total of 31 fatty liver vol-unteer patients were
observed in this study. Changes of color Doppler energy
(CDE) images before and after TEPS of local points nearby
the liver were recorded by using color Doppler ultrasound
diagnostic apparatus (ACUSON 128XP/10C). Sum of color
pixel area (SCPA) , average of color value (ACV) and SCPA
ACV ( integral) of the hepatic flow images were analyzed by
an image processing system, single blind method and paired
t-test. Programmed TEPS (0.5— 150 Hz/2 000 Hz, 10-25 V)
gera 2011

was applied to the right Qimen (MN LR 14)-Jingmen (Trm
GB 25) , Fuai (Am SP 16)-Ganshu (AT* BL 18) respectively
for 15 min. Results: Compared with basic values of
pretreatment, SCPA, ACV and SCPA X ACV increased
significantly ( t= 2.71, P<0.02; t = 3.42, P<0.01; and t =8. 15,
P < 0 .001) after TEPS, meaning improvement of hepatic
blood flow supply. Conclusion: TEPS of acupoints near the
liver can improve hepatic blood flow and hepatic
parenchymal microcirculation in patients with fatty liver.
4009- gera: 143628/di/ra
JINSANE DECOCTION, A CHINESE HERBAL
MEDICINE, INHIBITS EXPRESSION OF TGF-
BETA1/SMADS IN EXPERIMENTAL HEPATIC
FIBROSIS IN RATS. SONG SL, GONG ZJ, HUANG YQ,
ZHANG QR, HUANG TX. american journal of chinese
medicine. 2006;34(6):1047-61. (eng).
The study is to investigate the effects of a Chinese herbal
medicine, JinSanE decoction, on the TGF-beta1/Smads signal
transduction pathway in a carbon tetrachloride (CCl(4))-
induced hepatic fibrosis model in rats. Rats were randomly
divided into 4 study groups: namely, a normal control group,
a hepatic fibrosis model group, and 2 treatment groups with
different doses of JinSanE (6 and 12 g/kg). Ten rats in each
group were sacrificed at 4 and 8 weeks after exposure to
CCl(4) respectively. The levels of TGF-beta1 and TRII
mRNA in liver tissue were analyzed by RT-PCR. The
expressions of TGF-beta1, Smad3 and Smad7 in liver tissues
were evaluated by immunohistochemistry. The liver
histopathology was examined by hematoxylin and eosin (HE)
staining and electron microscopy respectively. The liver
hydroxyproline (HYP), liver function and hyaluronic acid
(HA) were examined by biochemistry and radioimmunoassay
(RIA) respectively. Compared with the hepatic fibrosis model
group, the levels of TGF-beta1, TRII mRNA and Smad3
expression significantly decreased in the 2 treatment groups.
The expression of Smad7 was significantly increased in the
liver of the rats treated with JinSanE (p < 0.05 or p < 0.01).
The histological changes of fibrotic liver were obviously
improved in the treatment rats. The levels of liver HYP,
serum liver function and HA were also remarkably improved
in the treatment rats. Moreover, the effects of JinSanE
occurred in a dose- and time-dependent manner in the
process of the protection of liver injury and fibrosis. JinSanE
decoction had a protective effect on liver injury and could
ameliorate hepatic fibrosis in rats. The mechanisms might be
associated with their effects of down-regulating TGF-beta1,
TRII mRNA and Smad3, and up-
4010- gera: 144566/nd/ra
INTERVENTION EFFECTS OF JIANPI LIQI
HUOXUE DECOCTION ON LIPID PEROXIDATIVE
LIVER INJURY INDUCED BY ALCOHOL. CUI JW,
HU YY, FANG ZH, WANG XN, CHENG Y, JING-HUA P,
FENG Q, HUI Z. chin j integr med. 2006;12(4):281 (eng).
OBJECTIVE: To study the intervention effects of Jianpi Liqi
Huoxue Decoction ( JLHD) on lipid peroxidative liver injury
induced by alcohol. METHODS: The rat alcoholic model of
liver disease (ALD) induced by Lieber-DeCarli liquid diet
was established. Thirty-two male SD rats were randomly
divided into 4 groups: the normal group (n =5), the control
group (n =9), the model group (n =9) and the JLHD group (n
=9). From the 4th week after modeling, the rats were given
JLHD or distilled water by gastrogavage respectively, and the
samples of blood and liver tissues were taken out from the
rats for determination by the end of the 8th week. The hepatic
pathological changes were observed with HE staining; the
liver injury related indices, including activity of alanine
aminotransferase (ALT) and aspartate aminotransferase
(AST) in serum, Y-glutamyl transpeptidase (Y-GT) activity
254
and triglyceride (TG) content in liver tissues, as well as the
lipid peroxidation related indices, including malonaldehyde
(MDA) content and nitric oxide synthase (NOS) activity in
liver tissue, serum Fe2+ level, and the anti-peroxidation
capacity related indices, including superoxide dismutase
(SOD) activity, glutathion (GSH) content and reactive
oxygen species (anti-ROS) activity in liver tissues were
determined. RESULTS: (1) There were obvious figures of
fatty degeneration and inflammatory infiltration in liver
tissues of the model group. As compared with the control
group, in the model group, the activity of ALT and AST, and
Fe2+ content in serum, Y-GT and NOS activity, TG and
MDA content in liver tissues were significantly higher (P<0.
01), while the activity of SOD, GSH and anti-ROS in liver
tissues were significantly lower (P<0.01). (2) The fatty
degeneration and inflammatory infiltration of liver tissues in
the JLHD group were significantly lessen as compared with
those in the model group; and the abnormalities of all the
indexes revealed in the model rats were restored to certain
extent in the JLHD group, and especially significant were the
levels of ALT activity, MDA content and Fe2+ , which were
nearly normal. CONCLUSION: JLHD has significant effects
against alcoholic liver injury, the acting mechanism of which
is likely to be related with its anti-
4011- gera: 144571/nd/ra
EFFECTS OF SHEHUANG PASTE ON
HEMODYNAMICS, ENDOTOXIN, NITRIC OXIDE
AND ENDOTHELIN-1 IN PATIENTS WITH
REFRACTORY CIRRHOTIC ASCITES. TONG GD,
ZHOU DQ, HE JS, LI SL, PENG LS. chin j integr med.
2006;12(4):255 (eng).
OBJECTIVE: To explore the influence of Shehuang Paste
(SHP) to the hemodynamics, endotoxin, nitric oxide (NO),
and endothelin-1 (ET-1) in patients with refractory cirrhotic
ascites. METHODS: Fifty-nine cases of refractory cirrhotic
ascites were randomly assigned to two groups, 32 cases in the
treatment group and 27 cases in the control group. The basic
treatment was the same for both groups, including liver
protecting medicines, diuretics and supportive drugs, but
SHP navel sticking was applied for the treatment group
additionally once a day. A course of one month of treatment
was applied and the general efficacy on ascites was observed
by the end of the therapeutic course. Before and after the
treatment, examinations by limulus lysate chromogenic test
was conducted to measure plasma endotoxin content;
colorimetry to measure plasma content of NO indirectly,
radioimmunoassay to measure plasma ET-1 content; and
color Doppler ultrasonography to measure the blood flow of
portal vein and splenic vein. The relationship between the
blood flow of portal vein and splenic vein and endotoxin, NO
and ET-1 in the treatment group was analyzed as well.
RESULTS: The total effective rate on ascites was 84.4% in
the treatment group, and 48. 1% in the control group, with
significant difference shown between them (P<0.01). In the
treatment group the blood flow of portal vein and splenic
vein, contents of endotoxin, NO and ET-1 all got
significantly reduced after treatment ( P<0.05 or P<0.01);
while these indexes in the control group were not
significantly changed ( P 0.05). Moreover, it was found that
in the treatment group, the blood flow of portal vein and
splenic vein had a positive correlation to the levels of NO,
ET-1, and endotoxin, either before or after treatment.
CONCLUSION: Application of SHP navel sticking could
clearly reduce the blood flow of portal vein and splenic vein,
and lower the content of endotoxin, NO and ET-1. The blood
flow of portal vein and splenic vein in the treatment group
showed a positive correlation with the contents of endotoxin,
NO and ET-1. liver cirrhosis, refractory ascites, vasoactive
substance, hemodynamics
gera 2011

4012- gera: 144660/di/ra
TRADITIONAL CHINESE MEDICINE CAUSING
HEPATOTOXICITY IN PATIENTS WITH CHRONIC
HEPATITIS B INFECTION: A 1-YEAR
PROSPECTIVE STUDY. YUEN MF, T AM S, FUNG J,
WONG DK, WONG BC, LAI CL. aliment pharmacol ther.
2006;24(8):1179-86 (eng).
BACKGROUND: Safety of traditional Chinese medicine in
patients with chronic hepatitis B is unknown. AIM: To study
the clinical outcome of traditional Chinese medicine-induced
hepatotoxicity in chronic hepatitis B patients. PATIENTS
AND METHODS: All chronic hepatitis B patients in 2004
with liver dysfunction requiring hospitalization were
screened prospectively for traditional Chinese medicine
intake. The hepatotoxicity of individual traditional Chinese
medicine elements was determined by extensive search of
both English and Chinese publications. RESULTS: Of 45
chronic hepatitis B patients, the liver dysfunction in seven
(15.6%) was attributable to traditional Chinese medicine. All
had liver dysfunction pattern resembling those of acute
exacerbation of chronic hepatitis B. Three patients had
adverse outcomes (two deaths, one liver transplantation). One
patient had accelerated course of cirrhosis now awaiting liver
transplantation. The identified hepatotoxic components were
Polygonum multiflorum Thunb, Cassia obtusifolia L, Melia
toosendan Sieb., Rheum palmatum L., Scolopendra
subspinipes mutilans L, Alisma orientale Juzepe, Glycyrrhiza
uralensis Fisch. and Mentha haplocalyx Briq. One traditional
Chinese medicine formula was adulterated with a highly
hepatotoxic agent, N-nitrosofenfluramine. CONCLUSIONS:
Traditional Chinese medicine-related hepatotoxicity resulted
in high mortality in chronic hepatitis B patients. Prospective
randomized-controlled trials with the same stringent criteria
as western medicine clinical trials are required for Chinese
medicines, to document their efficacies and safety before
they can be advocated for the treatment of patients.
4013- gera: 144830/ra/di
[EFFECTS OF RESOLVING PHLEGM METHOD ON
FIBRINOLYTIC STATUS IN NON-ALCOHOLIC
STEATOHEPATITIS PATIENTS OF PHLEGM AND
BLOOD-STASIS SYNDROME]. CHEN L, JIANG YK,
CAI YB. chinese journal of integrated traditional and
western medicine. 2006;26(12):1090 (eng).
OBJECTIVE: To observe the effect of resolving phlegm
method (RPM) on fibrinolytic status in non-alcoholic
steatohepatitis (NASH) patients of phlegm blood-stasis (PBS)
syndrome type. METHODS: Sixty-two patients were
randomly assigned to 2 groups, namely the treated group (n =
34) treated with Chinese herbs for resolving phlegm and
dampness, smoothing liver and gallbladder, promoting blood
circulation and removing blood stasis (composition: Indigo
Naturalis 10 g, Alumen 3 g, Semen Cassiae 15 g, Fructus
Crataegi 15 g, vinegar prepared Radix Bupleuri 10 g, Radix
Curcumae 10 g, Radix Salviae Miltiorrhizae 12 g, Herba
Lycopi 12 g, talc 12 g and Radix Glycyrrhizae 2 g), one dose
twice per day orally, and the control group (n = 28) with
ursodeoxycholic acid tablet (UAT) 150 mg three times per
day. The treatment course for both groups was 12 weeks.
Liver function (ALT, AST, ALP), insulin resistance (IR)
index represented by homeostasis model-IR (HOMA-IR) and
insulin (Ins), levels of tissue plasminogen activator (t-PA)
and plasminogen activator inhibitor-1 (PAI-1), as well as
main symptoms and physical signs were assessed before and
after treatment. RESULTS: (1) Compared with those before
treatment, levels of ALT, AST, HOMA-IR, t-PA, PAl-1 and
main symptoms were all improved in the treated group (P <
0.05 or P < 0.01); (2) There was significant difference in
ALP, HOMA-IR, t-PA and PAI-1 between the treated group
255
and the control group (P < 0.05 or P < 0.01); (3) The
improvement in liver function related indexes in the control
group was mainly the level of ALT, t-PA (P < 0.01), and also
shown on HOMA-IR, Ins and PAI-1. CONCLUSION: RPM
could effectively improve liver function and fibrinolytic
status. Its effect was better than that of UAT.
4014- gera: 144833/ra/di
[EFFECT OF CHINESE MEDICINE FOR RESOLVING
DAMPNESS ON ACTIVATED AND FUNCTIONAL T
LYMPHOCYTE SUBSETS IN CHRONIC HEPATITIS
B PATIENTS WITH DAMPNESS SYNDROME].
ZHANG SJ, CHEN ZX, LIN YW. chinese journal of
integrated traditional and western medicine.
2006;26(12):1078 (eng).
OBJECTIVE: To explore the relation between the effect of
Huashi Decoction (HD) and levels of activated and functional
T lymphocyte subsets in chronic hepatitis B (CHB) patients
of dampness syndrome (DS). METHODS: Seventy CHB
patients were nonrandomly assigned to two groups, the
treated group (n = 45) treated by HD and the control group (n
= 30) by nucleotide analogies. The clinical efficay was
observed and levels of activated and functional T lymphocyte
subsets were detected before and after treatment. RESULTS:
The peripheral blood levels of CD8+ CD28+ and CD4+
CD28+ T cells were significantly lower in CHB patients than
those in the healthy subjects (P < 0.01), which were higher in
the treated group after treatment compared with those before
treatment (P < 0.05), while the CD8+ CD38+ T cell level was
significantly higher in CHB patients than in the healthy
subjects (P < 0.05), which was lower in the treated and the
control groups after treatment than those before treatment
respectively (P < 0.05). No significant difference was found
in the markedly effective rate and total effective rate between
the two groups (P > 0.05). The levels of CD8+ CD28+ and
CD4+ CD28+ T cells increased and the CD8+ CD3+ and
CD4+ CD25+ T cell level decreased obviously after
treatment in those who acquired marked effectiveness (P <
0.05), while they changed insignificantly in those who did
not acquire marked effectiveness (P > 0.05). CONCLUSION:
HD is effective in regulating activated and functional T
lymphocyte subsets in CHB patients with DS, which might
be its mechanism of inhibiting virus replication and
eliminating virus.
4015- gera: 144838/ra/di
[GUIDELINE FOR THE DIAGNOSIS AND
TREATMENT OF LIVER FIBROSIS WITH
INTEGRATIVE MEDICINE]. LIVER DISEASE
COMMITTEE CHINESE ASSOCIATION OF
INTEGRATIVE MEDICINE. chinese journal of integrated
traditional and western medicine. 2006;26(12): (eng).
4016- gera: 144851/ra/di
[RELATIONSHIP BETWEEN ALCOHOLIC LIVER
INJURY AND ENDOTOXIN LEAKAGE FROM GUT
AND INTERVENTION EFFECT OF JIANPI LIQI
HUOXUE DECOCTION]. FANG ZH, HU YY, CUI JW.
chinese journal of integrated traditional and western
medicine. 2006;26(9):813 (eng).
OBJECTIVE: To study the effects and mechanisms of Jianpi
Liqi Huoxue Decoction (JLHD) in anti-alcoholic liver injury
(ALI) through the pathological relation of ALI with changes
of intestinal permeability and endotoxin leakage.
METHODS: The liver injury model induced by Lieber-
DeCarli alcoholic forage was established. Altogether 42 male
SD rats were randomly divided into 4 groups, the normal
group (n=6), the control group fed with non-alcohol diet
(n=12), the model group fed with alcoholic diet (n=12) and
the treated group fed with alcoholic diet and treated with
gera 2011

JLHD (n=12). The medicine or distilled water was
administered by gavage from the 3rd week to the end of the
6th week. Then after fasting for 5 h all the rats except those
in the normal group were given lipopolysaccharide (LPS) 10
mg/kg by gavage, and the blood plasma from portal vein,
serum from inferior cava vein as well as tissues of liver and
intestine were prepared for detection of plasma LPS level in
the portal vein to observe the change of intestinal
permeability through LPS content in portal vein blood
plasma, the pathological and ultrastructural changes of the
small intestine by HE staining, the pathological change of
liver and triglyceride (TG) content and gamma glutamyl
transpeptidase (GGT) activity in liver, the changes of serum
alanine aminotransferase (ALT) and aspartate
aminotransferase (AST) activity, and plasma tumor necrosis
factor-alpha (TNF-alpha) level. RESULTS: In rats after
modeling, there were obvious fatty degeneration, significant
increase of hepatic TG content and GGT activity, serum ALT
and AST activity, as well as plasma TNF-alpha level, with
high plasma LPS level indicating increased intestinal
permeability, and seriously injured mucosa microvilla of
small intestine. However, all the above abnormal changes
were milder in the treated group than those in the model
group. Meanwhile, the TNF-alpha content, endotoxin level
and ALT activity were found to be positively correlated.
CONCLUSION: JLHD could alleviate liver injury through
inhibiting the alcohol induced increased intestinal
4017- gera: 144857/ra/di
[CLINICAL STUDY ON EFFECT OF GANNENG
DRIPPING PILL IN TREATING CHRONIC
HEPATITIS B]. LI L, YUAN HL, WU Q. chinese journal
of integrated traditional and western medicine.
2006;26(9):788 (eng).
OBJECTIVE: To observe the antiviral efficacy of Ganneng
Dripping Pill (GDP) in treating patients with chronic hepatitis
B. METHODS: Eighty-four patients of chronic hepatitis B
with positive HBV-DNA, HBsAg, and HBeAg were
randomly assigned to 2 groups, the treated group (56
patients) treated with GDP and the control group (28
patients) treated with lamivudine. The therapeutic course for
both groups was 6 months. The negative conversion rate of
HBeAg and HBV-DNA, changes of liver function, symptoms
and physical signs in patients were observed before and after
treatment. RESULTS: In the treated group, the negative
conversion rate of HBV-DNA and HBeAg was 54.0%
(27/50) and 30.0% (15/50) respectively, and the ALT
normalizing rate was 80.0% (40/50), while those were
67.86% (19/28), 21.8% (6/28) and 75.0% (21/28)
respectively in the control group, showing no significant
difference between the two groups (all P > 0.05). However,
the AST normalizing rate was 97.96% (48/49) in the treated
group, higher than that in the control group (48.0%, 12/25, P
< 0.01); and the clinical symptoms, especially the poor
appetite, lassitude, gastric distention and yellow urine, were
improved more significantly in the treated group than those
in the control group (P <0.05 or P < 0.01). CONCLUSION:
GDP has a favorable short-term effect on chronic hepatitis B,
it could effectively inhibit HBV replication and improve the
liver function, symptoms and signs in patients
4018- gera: 144870/ra/di
STUDY ON EFFECTS OF EXTRACTS FROM SALVIA
MILTIORRHIZA AND CURCUMA LONGA IN
INHIBITING PHOSPHORYLATED
EXTRACELLULAR SIGNAL REGULATED KINASE
EXPRESSION IN RAT'S HEPATIC STELLATE
CELLS. CHENG Y, PING J, LIU C, TAN YZ, CHEN GF.
chinese journal of integrative medicine. 2006;12(3):207
(eng).
256
OBJECTIVE: To study the effect of salvianolic acid B (SAB)
and curcumin, the extracts of Salvia Miltiorrhiza and
Curcuma Longa, on the proliferation and activation of
hepatic stellate cell (HSC), and the extracellular signal
regulated kinase (ERK) expression in it. METHODS: Rat's
HSC-T6 were cultured and treated by SAB or curcumin. The
inhibitory effect on cell proliferation was determined by 3-(4,
5-dimthyl-2-2thiazoly)-2, 5-diphenyl-2H- tetrazolium
bromide (MTT) colorimetry, and the expression levels of
alpha smooth actin (alpha-SMA), collagen type I, and ERK
were determined by Western blot. RESULTS: SAB and
curcumin inhibited the proliferation and activation of rat's
HSC-T6 in dose-dependent fashion and significantly reduced
the expression level of alpha-SMA (P < 0.01). Curcumin
significantly reduced the expression of collagen type I (P <
0.05). Both SAB and curcumin showed insignificant effect on
the ERK expression level, but they could significantly reduce
the level of phosphorylated-ERK expression, showing
significant difference as compared with that in the control
group (P < 0.01 and P < 0.05 respectively). CONCLUSION:
SAB and curcumin could significantly inhibit the
proliferation, activation of HSC, and the production of type I
collagen in HSC, the mechanism may be associated with their
inhibition on ERK phosphorylation.
4019- gera: 144989/ra/di
MECHANISM OF MOXIBUSTION REGULATION ON
CELLULAR APOPTOSIS IN RAT'S PRECANCEROUS
LESION OF PRIMARY HEPATOCELLULAR
CARCINOMA. GUO ZI-YI, RONG HAI-BO, DIAO CAN-
YANG, AL. journal acupuncture and tuina science.
2006;4(6):328 (eng).
Objective: To investigate the mechanism of moxibustion in
regulating cellular apoptosis in rat's precancerous lesion of
primary hepatocellular carcinoma (HCC). Methods: Seventy-
four rats were randomly allocated to normal group, model
group and moxibustion group, and the diethylic nitrosamine
(DEN) was used to establish HCC model. Moxibustion with
moxa cone which is as big as a grain of wheat was performed
on acupoint Zusanli (ST 36), 3 cones for each acupoint and
0.5 mg for each cone, the treatment was given once a day,
totally 16 weeks. Then the changes in the body weight, liver
weight and thymus weight, a morphological change in the
liver tissue and changes in y-GT and GST were observed;
Immunohistochemical staining method was adopted to
observe the tendency of changes in relevant apoptosis genes
such as C-myc, N-ras and mutant type P53, and the influence
of moxibustion on cell cycle modulation genes such as
cyclinD 1, CDK4 and p 16. Results: Moxibustion could
reduce the activities of y-GT and GST in the_ blood,
obviously decrease the protein expression of relevant
apoptosis genes such as C-myc, N-ras and mutant type P53
and markedly inhibit the over-expression of relevant cell
cycle modulation genes such as cyclinD1 and CDK4 and the
mutation of cell cycle modulation gene p16. Conclusion:
Moxibustion might play a certain role in relieving HCC
precancerous lesion and its action mechanism might be
related to the regulation on partial apoptosis genes.
4020- gera: 145029/di/ra
A RETROSPECTIVE CONTROLLED ANALYSIS OF
OUTCOMES OF USING INTEGRATED THERAPY OF
TRADITIONAL CHINESE AND MODERN
MEDICINES FOR PRIMARY LIVER CANCER OF
MIDDLE AND LATE STAGES. CHEN Z, LI B, YUE X,
ZHU D, YU C, WU M, LING C. journal of alternative and
complementary medicine. 2006;12(10):941 (eng).
4021- gera: 145531/nd/ra
EFFECTS OF GEKKO SULFATED
gera 2011

POLYSACCHARIDE ON THE PROLIFERATION AND
DIFFERENTIATION OF HEPATIC CANCER CELL
LINE. WU X, CHEN D, XIE GR. cell biol int.
2006;30(8):659-64 (eng).
Gekko swinhonis Guenther has been used as an anti-cancer
drug in traditional Chinese medicine. Gekko sulfated
polysaccharide (Gepsin) was investigated for its activity in
hepatocellular carcinoma. Hepatocarcinoma cell line (Bel-
7402) and liver cell line (L-02) were exposed to Gepsin (100
microg/ml and 10 microg/ml). Gepsin did not suppress the
proliferation and viability of normal liver L-02 cells, but
strongly inhibited the proliferation of hepatocarcinoma Bel-
7402 cells. Gepsin did not induce the apoptosis of Bel-7402
cells, but blocked cells in G2/M phase. Treated with Gepsin,
Bel-7402 cells showed ultrastructural features of
differentiation. AFP secretion decreased while ALB secretion
increased markedly on Gepsin-treated cells. The data show
that Gepsin suppressed the proliferation and induced
differentiation of hepatocarcinoma, but the toxicity to normal
liver cells was
4022- gera: 145799/di/ra
A CASE OF ELEVATED LIVER ENZYMES.
KIRSCHBAUM B. lantern. 2006;3(3): (eng).
4023- gera: 145919/di/ra
PROGRESSI NELLO STUDIO DEL MECCANISMO
D'AZIONE DEI FARMACI PER LA
MOBILIZZAZIONE DEL SANGUE NEL
TRATTAMENTO DEL CANCRO EPATICO
PRIMITIVO. JU LIXIA ED ALTRI. rivista italiana di
medicina tradizionale cinese. 2006;106(4):72 (ita).
Primary liver cancer is mainly characterized by the mass in
hypochondriac region, stabbing pain at a fixative region,
tenderness, dim complexion, vascular spider, vein exposure,
livid tongue, etch}gnosis, taut and uneven pulse and other
symptoms of blood stasis. Experimental studies have found
that the patient with liver cancer is often accompanied with
disturbance of microcirculation, increase of blood viscosity
and high blood agglutinative state. Therefore, activating
blood circulation to remove blood stasis is clinically an
important therapy for primary liver cancer. A great number of
studies on the mechanisms have been carried out in China
and other countries.
4024- gera: 148359/di/ra
[GUIDELINE FOR THE DIAGNOSIS AND
TREATMENT OF LIVER FIBROSIS WITH
INTEGRATIVE MEDICINE]. CHINESE ASSOCIATION
OF INTEGRATIVE MEDICINE, LIVER DISEASE
COMMITTEE. zhong xi yi jie he xue bao. 2006;4(6):551-5
(chi).
4025- gera: 148365/di/ra
[CURATIVE EFFECTS OF FUZHENG HUAYU
CAPSULES ON HEPATIC FIBROSIS AND THE
FUNCTIONAL MECHANISMS: A REVIEW]. ZHAO
CQ, WU YQ, XU LM. zhong xi yi jie he xue bao.
2006;4(5):467-72 (chi).
Deficiency of Qi (healthy energy) and blood stasis are the
basic pathological changes of hepatic fibrosis according to
the theories of traditional Chinese medicine. Fuzheng Huayu
Capsule, a compound Chinese herbal medicine for hepatic
fibrosis, is produced in the light of this pathological
mechanism. More than a decade of clinical studies and
experimental researches show that this medicine has effects
of protecting hepatic cells, relieving liver injury, and
controlling the development of hepatic fibrosis. It has definite
functional mechanisms on anti-hepatic fibrosis. It is a safe
and effective medicine for hepatic fibrosis, and deserves to be
257
well introduced to clinic.
4026- gera: 148377/di/ra
ANTIOXIDANT AND HEPATOPROTECTIVE
ACTIVITIES OF CIRSIUM SETIDENS NAKAI
AGAINST CCL(4)-INDUCED LIVER DAMAGE. LEE
SH, HEO SI, LI L, LEE MJ, WANG MH. the american
journal of chinese medicine. 2006;36(1):107 (eng).
The antioxidant activity and hepatoprotective potential of
Cirsium setidens Nakai, a widely used medicinal plant, were
investigated. The n-butanol (n-BuOH) fraction of leaves and
roots of C. setidens had a higher 1,1-diphenyl-2-
picrylhydrazyl (DPPH) radical scavenging activity than the
other soluble fractions. The n-BuOH fraction of roots of C.
setidens had a significant hepatoprotective activity at a dose
of 500 mg/kg compared to that of a standard agent. The
biochemical results were confirmed by histological
observations indicating that C. setidens extract decreased
ballooning degeneration in response to CCl(4) treatment. The
n-BuOH fraction reduced CCl(4)-induced liver injury in rats,
and transcript levels of genes encoding antioxidant enzymes
such as glutathione peroxidase 1 (GPO1), glutathione
peroxidase 3 (GPO3) and superoxide dismutase (SOD1) were
elevated in the livers of rats treated with this fraction (500
mg/kg). Based on these results, we suggest that the C.
setidens extract has
4027- gera: 144288/di/re
ACUPUNCTURE STIMULATION OF ST36 (ZUSANLI)
ATTENUATES ACUTE RENAL BUT NOT HEPATIC
INJURY IN LIPOPOLYSACCHARIDE-STIMULATED
RATS. HUANG CL, TSAI PS, WANG TY, YAN LP, XU
HZ, HUANG CJ HUANG CL, TSAI PS, WANG TY, YAN
LP, XU HZ, HUANG CJ. anesth analg. 2007;104(3):646-54
(eng).
BACKGROUND: We sought to determine the effects of
ST36 acupuncture on sepsis-induced kidney and liver
injuries. METHODS: A total of 120 rats were randomized
into 10 groups: 1) lipopolysaccharide (LPS), 2) normal saline
(N/S), 3) LPS + ST36, 4) ST36, 5) LPS + P-ST36, 6) P-
ST36, 7) LPS + Sham, 8) Sham, 9) LPS + P-Sham, and 10)
P-Sham groups. Rats in the LPS + ST36, ST36, LPS +Sham,
and Sham groups received ST36 (designated as "ST36") or a
nonacupoint (designated as "Sham") acupuncture for 30 min
followed by LPS or N/S injection. Rats in the LPS + P-ST36,
P-ST36, LPS + P-Sham, and P-Sham groups received LPS or
N/S injection for 3 h followed by a 30 min of ST36 or a
"nonacupoint" acupuncture. Rats were killed at 6 h after LPS
injection. RESULTS: LPS caused prominent kidney and liver
injuries. The renal and hepatic nitric oxide (NO)
concentrations and inducible NO synthase (iNOS) expression
were also increased by LPS. ST36 acupuncture pretreatment
significantly attenuated the LPS-induced kidney injury and
the increases in renal NO concentration and iNOS
expression. However, ST36 acupuncture pretreatment did not
affect the LPS-induced liver injury and increases in hepatic
NO concentration or iNOS expression. Furthermore, ST36
acupuncture performed after LPS did not affect the LPS-
induced organ injuries or increases in NO concentration and
iNOS expression. CONCLUSIONS: ST36 acupuncture
pretreatment significantly attenuated sepsis-induced kidney,
but not liver, injury in rats, whereas ST36 acupuncture
performed after sepsis induction had no protective effects
against sepsis-induced organ injuries.
4028- gera: 144532/di/ra
HEPATITIS B AND LIVER CANCER BELIEFS
AMONG KOREAN IMMIGRANTS IN WESTERN
WASHINGTON: REPORT OF A QUALITATIVE
STUDY. CHOE JH, CHAN N, DO HH, WOODALL E, LIM
gera 2011

E, TAYLOR VM. cancer. 2007;MARCH 7:x (eng).
Hepatocellular cancer occurs more frequently among
Koreans, Vietnamese, and Chinese than other racial/ethnic
groups in the U.S. This excess risk can be attributed to high
rates of chronic hepatitis B viral (HBV) infection and low
rates of HBV vaccination among Asian immigrants.
However, there is little available information regarding the
hepatitis B knowledge, beliefs, and practices among Koreans,
the fifth-largest Asian population in the U.S. This brief report
summarizes results from 30 qualitative interviews and two
focus groups investigating hepatitis and liver cancer
prevention, behavior, and beliefs among first-generation
Korean immigrant adults ages 18–64 years residing in the
Seattle–Tacoma metropolitan area of Washington State. The
report concludes with suggestions for future investigations to
address the high rates of chronic HBV infection and
hepatocellular cancer in this vulnerable
4029- gera: 144580/di/ra
[YIQI HUOXUE RECIPE COMBINED WITH
POLYENE PHOSPHATIDYCHOLINE CAPSULE IN
TREATING 50 PATIENTS WITH NON-ALCOHOLIC
FATTY HEPATITIS]. WANG YL. chinese journal of
integrated traditional and western medicine.
2007;27(2):162 (eng).
OBJECTIVE: To observe the clinical effect of Yiqi Huoxue
Recipe (YHR) combined with polyene phosphatidycholine
capsule (PPC) in treating non-alcoholic fatty hepatitis (NFH).
METHODS: Eighty NFH patients were randomly assigned to
two groups according to the sequence of their visiting, the 30
in the control group were treated with PPC alone and the 50
in the treated group were given YHR and PPC in
combination. The therapeutic course for both groups was 3
months. RESULTS: The improvement of syndrome, liver
function, blood lipid and B ultrasonic figure in the treated
group was superior to that in the control group, and the
clinical efficacies between the two groups were significantly
different (P < 0.01). CONCLUSION: YHR combined with
PPC has a good effect in
4030- gera: 144605/di/ra
[EFFECT OF ACUPOINT-INJECTION OF
OXYMATRINE ON EXPERIMENTAL HEPATIC
CARCINOMA AND STUDY ON THE MECHANISM].
ZHOU AL, ZHU YJ, HU YE, MAO JH, JIANG DR. chinese
acupuncture and moxibustion. 2007;27(1):48 (eng).
OBJECTIVE: To investigate the effect of acupoint injection
of oxymatrine (OM) on experimental hepatocellular
carcinoma and the mechanism. METHODS: The rats of
hepatocellular carcinoma induced by 2- acetoaminoflurence
(2-AAF) were randomly divided into a normal control group
(group N), a model group (group M), a control group of
oxymatrine intraperitoneal injection (OM ip group) and a
treatment group of small dose oxymatrine injection into
Zusanli (OM ZSL group). At the end of 12h week, the serum
levels of alanine aminotransferase (ALT), aspartate
aminotransferase (AST) and gamma-glutamyl transferase
(gamma-GT) were determined. Reverse transcription
polymerase chain reaction (RT-PCR) was used to detect the
expressions of cyclin D1 and cyclin-dependent kinase 4
(CDK4) mRNA in hepatocellular carcinoma tissues.
RESULTS :The number of cancer nodes on the surface of
liver in th Om ip group and the Om ZSL group was lower
than in the group M, with the serum ALT, AST, and gamma-
GT levels significantly decreased (P<0. 01), and significantly
inhibited expressions of cyclin D1, CDK4 mRNA (P<0. 01).
CONCLUSION: OM ip and small dose oxymatrine injection
into ZSL can treat or delay hepatocarcinogenisis of
hepatocellular carcinoma induced by 2-AAF. Partial
mechanism of this anti-carcinoma is protecting hepatocytes
258
possibly through improving hepatic functions, and inhibiting
excessive proliferation of liver cancer cells via inhibiting the
expressions of cyclin Dl, CDK4 mRNA.
4031- gera: 145391/di/ra
THE EFFECT OF OCULO-ACUPUNCTURE ON
ACUTE HEPATIC INJURY INDUCED BY CARBON
TETRACHLORIDE IN DOGS. LIU J, CHO SN, SONG
KH, KIM DH, KIM MC, CHO SW. american journal of
chinese medicine. 2007;35(1):53-61 (eng).
We investigated the therapeutic effect of oculo-acupuncture
on dogs induced with acute hepatic injury. Hepatic injury was
induced by intraperitoneal injection with carbon tetrachloride
(CCl(4)) in 8 mongrel dogs (4 females and 4 males, aged 2 to
4 years). The dogs were divided into the control group (4
dogs) and the experimental group (4 dogs). The experimental
group was treated with oculo-acupuncture at the
liver/gallbladder regions plus the zhong jiao region of the eye
after the induction of hepatic injury. Serum aspartate
aminotransferase (AST), alanine aminotransferase (ALT),
and gamma glutamyl transpeptidase (GGT) activities were
measured in both control and experimental groups. The
serum AST, ALT, and GGT activities in the experimental
group were decreased as compared to those in the control
group. The significant differences were detected on the third
day (AST, p < 0.05), second day (ALT, p < 0.05) and third
day (GGT, p < 0.05) in the experimental group, respectively.
Oculo- acupuncture alleviated acute liver damage induced by
carbon tetrachloride in dogs was also confirmed by
histopathological examination. We concluded that oculo-
acupuncture at the liver/gallbladder regions plus the
4032- gera: 145412/di/ra
HERB MEDICINE YIN-CHEN-HAO-TANG
AMELIORATES HEPATIC FIBROSIS IN BILE DUCT
LIGATION RATS. LEE TY, CHANG HH, CHEN JH,
HSUEH ML, KUO JJ. j ethnopharmacol. 2007;109(2):318-
24 (eng).
The accumulation of hydrophilic bile acids in the liver is
considered to play a pivotal role in the induction of hepatic
injury. Yin-Chen-Hao-Tang (YCHT) decoction is an aqueous
extract from three different herbs: Artemisia capillaries
Thunb (Compositae), Gardenia jasminoides Ellis
(Rubiaceae), Rheum officinale Baill (Polygonaceae), which
has been recognized as a hepatoprotective agent for various
types of liver diseases. Therefore, we used an experimental of
biliary atresia model to test that YCHT plays a regulatory
role in the pathogenesis of hepatic fibrosis. Hepatic damage
with fibrosis was produced by common bile duct ligation
(BDL) for 27 days in experimental cholestasis animal model.
After surgery, YCHT (250 and 500mg/kg BW) oral
administration once a day continued for 27 days. BDL caused
a prominent liver collagen deposition that was supported by
the increased alpha-SMA protein and mRNA expression of
procollagen I. YCHT significantly decreased hepatic alpha-
SMA protein levels and decreased in hydroxyproline and
thiobarbituric acid reactive substances (TBARS) levels of
BDL rats. On the other hand, the normalizing effect of YCHT
(250mg/kg) on the TGF-beta1mRNA expression was
independent on the dose of YCHT, 500mg/kg was not
effectively changed the quantitative composition of mRNA
levels. The study shows that hepatic hydroxyproline
accumulation caused by hydrophilic bile acids accompanied
by elevated hepatic lipid peroxidation, and hepatic collagen
levels can be decreased in the presence of YCHT. In
conclusion, long-term administration of YCHT in rats
ameliorated the hydropholic bile acids induced hepatic injury
that probably related to a reduced oxidant stress and degree
of hepatic fibrosis.
gera 2011

4033- gera: 145547/nd/ra
A SURVEY OF CHINESE HERBAL INGREDIENTS
WITH LIVER PROTECTION ACTIVITIES. WANG R,
KONG J, WANG D, LIEN L, LIEN E. chin med.
2007;2(1):5 (eng).
ABSTRACT: A literature survey was conducted on herbs,
their prepa rations and ingredients with reported liver
protection activities, in which a total of 274 different species
and hundreds of active ingredients have been examined.
These ingredients can be roughly classified into two
categories according to their activities: (1) the main
ingredients, such as silybin, osthole, coumarin, glycyrrhizin,
saikosaponin A, schisandrin A, flavonoids; and (2)
supporting substances, such as sugars, amino acids, resins,
tannins and volatile oil. Among them, some active
ingredients have hepatoprotective activities (e.g. anti-
inflammatory, anticancer, antioxidant, immunomodulating
and liver cirrhosis-regulating effects). Calculation of
physicochemical parameters indicates that the main
ingredients with negative and positive Elumo values possibly
display their hepatoprotective effects through different
mechanisms, such as antioxidative, anti-inflammatory and
immunomodulating effects. As the combination of herbs may
achieve some treatment effects synergistically and/or
additively, it is common in Chinese medicine to use mixtures
of various medicinal herbs with pharmacologically active
compounds to have synergistic and/or additive effects, or to
reduce harmful effects of some pharmacologically active
compounds. In particular, the active compounds with Clog P
around 2 are suitable for passive transport across membranes
and accessible to the target sites. Thus, Elumo and Clog P
values are good indicators among the calculated parameters.
Seven different physicochemical parameters (MW, Clog P,
CMR, u, Ehomo, Elumo and Hf) and four major biological
activities (antioxidant, anti-inflammatory, antiviral/antitumor
and immunomodulating) are discussed in this review. It is
hoped that the discussion may provide some leads in the
development of new
4034- gera: 145549/nd/ra
ZHI-FUZI, A CARDIOTONIC CHINESE HERB, A
NEW MEDICAL TREATMENT CHOICE FOR
PORTAL HYPERTENSION?. LIN JS, CHAN CY, YANG
C, WANG YH, CHIOU HY, SU YC. exp biol med
(maywood). 2007;232(4):557-64 (eng).
Zhi-Fuzi (Radix Aconiti lateralis preparata) is prescribed
fairly frequently in Chinese medicine clinical practice for
treating the complications of cirrhosis. However, scientific
evidence regarding its efficacy and safety has not been
available until now; in addition, its treatment efficacy has not
yet been evaluated in well-designed clinical trials. Hence, we
investigated the hemodynamic effects of Zhi-Fuzi in
conscious rats with portal vein ligation (PVL) and the safety
in normal rats. Our study included 3 parts: (i) early
administration during which the hemodynamic effects of low
and high doses of Zhi-Fuzi (0.4 and 0.8 g/kg twice daily) and
propranolol (15 and 30 mg/kg twice daily) administered for
14 days after PVL on male Sprague-Dawley rats were
evaluated; (ii) late administration during which the other
group of PVL rats received 2.4 g/kg of Zhi-Fuzi twice daily
from the 15th to 28th postoperative day; hemodynamic
effects were measured when the Zhi-Fuzi treatment was
finished; and (iii) safety evaluation during which 2 groups of
normal rats were administered Zhi-Fuzi (0.4 and 0.8 g/kg
twice daily) for 14 days; biochemical and histopathologic
studies were completed after hemodynamic measurement. In
early administration the portal pressures in rats receiving low
and high doses of Zhi-Fuzi, low and high doses of
propranolol, and distilled water were 13.81 +/- 0.11, 11.59
+/- 0.07, 17.09 +/- 0.06, 14.52 +/- 0.29, and 20.11 +/- 0.22
259
mm Hg, respectively. The high dose of Zhi-Fuzi exerted
more portal hypotensive effects than propranolol and
simultaneously ameliorated the systemic arterial hypotension
in PVL rats. The late administration of Zhi-Fuzi also
significantly reduced the elevated portal pressure (14.56 +/-
0.19 vs. 19.50 +/- 0.31 mm Hg in control, P < 0.05). There
were no adverse effects seen in normal rats receiving Zhi-
Fuzi. The results suggest that Zhi-Fuzi is a potential drug for
the prophylaxis and treatment of portal hypertension.
4035- gera: 145566/nd/ra
COMPLEMENTARY AND ALTERNATIVE
MEDICINE IN HEPATOLOGY: REVIEW OF THE
EVIDENCE OF EFFICACY. VERMA S, THULUVATH
PJ. clin gastroenterol hepatol. 2007;5(4):408-16 (eng).
There is an increase in the use of complementary and
alternative medicine (CAM), especially herbal therapy,
among patients with liver disease. The most commonly used
herbal agent is silymarin. In animal models, many of the
commonly used agents have shown anti-inflammatory and
antifibrotic effects. Although many human studies have
shown improvements in subjective symptoms (well being)
and liver biochemistry, there are no convincing data to
suggest a definite histologic and/or virologic improvement
with most of these agents. Poorly designed studies,
heterogeneous patient populations, lack of standardized
preparations, and poorly defined nonobjective end points may
partly explain the conflicting reports in the literature.
Hepatotoxicity and drug interactions are common with many
herbal medications, and therefore physicians need to be
cognizant of known or occult use of CAM by their patients.
Only well-designed, randomized, controlled trials will be
able to ascertain whether CAM has any role in the
management of patients with acute or chronic liver diseases.
Until such time, the use of CAM
4036- gera: 146218/di/ra
[RELATIONSHIP BETWEEN HBV-DNA IN
PERIPHERAL BLOOD MONONUCLEAR CELLS AND
SYNDROME TYPES OF TCM IN CHRONIC
HEPATITIS B PATIENTS]. MIYU-QIANG, ZHENG
SHU-WEN, ZHANG HONG, ET AL. chinese journal of
integrated traditional and western medicine.
2007;27(4):296 (chi).
Objective To study the relationship between TCM syndrome
type and HBV-DNA in serum and peripheral blood
mononuclear cells (PBMCs) in chronic hepatitis B (CHB)
patients. Methods The serum HBV markers,HBV-DNA
levels in serum and PBMCs, were quantitatively detected in
220 CHB patients by PCR method , and TCM syndrome type
of 205 patients were differentiated. Results Arranged from
low to high, the percentages of CHB patients with the serum
HBV-DNA X1.0 x 105copy/mL (high viral loading) in the
five syndrome types were as follows: damp-heat retention in
middle-jiao syndrome (DHRS, 55.2 %) , blood stasis
blocking collateral syndrome (BSBC) , Gan-Shen yin
deficiency syndrome (GSYS) , Pi-Shen yang deficiency
syndrome (PSDS) and Gan stagnation with Pi deficiency
syndrome (GSPS, 82.5% ) , the difference was signifi-cant
between DHRS and GSPS; those with HBV-DNA in PBMCs
infection were: GSYS (27.3% ) , DHRS (34.3% ) , BSBC
(53.1% ) and GSPS (77.2% ) . The percentage in GSPS was
the highest, which was signifi-candy different to that in other
syndromes. Conclusion Amount of serum HBV-DNA and
PBMCs HBV-DNA infection has certain correlation with the
TCM syndrome type of CHB. The highest percentage of
patients with HBV-DNA---1.0 x 105copy/mL and PBMCs
HBV- DNA infection presented in CHB patients of GSPS
type. We should pay more attention to strengthen genuine qi
to eliminate pathogenic factors in treatment of CHB.
gera 2011

4037- gera: 146219/di/ra
[EFFECT OF SPLEEN-INVIGORATING
PRESCRIPTION ON DENDRITIC CELL FUNCTION
IN PATIENTS WITH CHRONIC HEPATITIS B OF
TCIVI PI-DEFICIENCY SYNDROME TYPE]. GAO
YUE-QIU, ZI-IENG YA-JIANG, AND WANG LING-TAI.
chinese journal of integrated traditional and western
medicine. 2007;27(4):300 (chi).
Objective To observe the effect of Spleen-invigorating
Prescription ( SIP ) on dendritic cell function in patients with
chronic hepatitis B. Methods A total of 60 patients with
chronic HBV of Pi-deficiency syndrome type were enrolled
and randomized to 2 groups, 30 in each group. Patients in the
control group were given intramuscular injection with human
interferon alb, 3 times a week, while those in the treated
group were given orally with SIP twice a day, the therapy
lasted for 6 months. Dendritic cells (DCs) were isolated from
pe-ripheral blood and cultured, then the expression of surface
markers, HLA-DR ,CD86 , CD80 , CD40 , CD14 and CD11c
were detected before and after treatment by flow cytometry,
and the function of DCs was also evaluated by mixed
lymphocyte reaction ( MLR) determination once before
treatment and once after treatment. Results The expressions
of DCs' surface CD86, CD80 , CD40 and CD11c in the
treated group were higher ( P <0.05 , P <0.01) and the
changes of stimulating index , IFN-y and IL-12 were superior
in the treated group to those in the control group (P< 0.05) .
Conclusions SIP can significantly improve DC' s function, so,
one of mechanisms of SIP in improving clinical
4038- gera: 146226/di/ra
[HOW TO SIMPLIFY AND SHORTEN THE ENGLISH
TRANSLATION OF TRADITIONAL CHINESE
MEDICINE]. SHI XIN-MIN. chinese journal of integrated
traditional and western medicine. 2007;27(4):370 (chi).
4039- gera: 146227/di/ra
[STRENGTHENING RESEARCH OF TRADITIONAL
CHINESE MEDICINE ON FATTY LIVER]. HUYI-
YANG. chinese journal of integrated traditional and
western medicine. 2007;27(4):293 (chi).
4040- gera: 146228/di/ra
[PREVENTION AND TREATMENT OF FATTY
LIVER BY INTEGRATIVE MEDICINE]. FAN JIAN
GAO . chinese journal of integrated traditional and
western medicine. 2007;27(4):294 (chi).
4041- gera: 146229/di/ra
[FATTY LIVER A DISEASE SHOULDN'T BE
IGNORED]. ZHAOWEN-XIA. chinese journal of
integrated traditional and western medicine.
2007;27(4):295 (chi).
4042- gera: 146230/di/ra
[CLINICAL OBSERVATION ON AUXILIARY
TREATMENT WITH SUANZAOREN DECOCTION
FOR CHRONIC SEVERE HEPATITIS]. ZHUHAI-
PENG, GAO ZHI-HANG, TAN DE-MING, ET AL. chinese
journal of integrated traditional and western medicine.
2007;27(4):300 (chi).
4043- gera: 146238/di/ra
[EFFECT OF FUZHENG YILIU GRANULE
CONTAINED-SERUM FROM TUMOR BEARING
MICE ON APOPTOTIC RATE, FREE RADICALS
CONTENT AND MITOCHONDRIAL MEMBRANE
POTENTIAL OF HEPATOMA CELL LINES H„ IN
VITRO]. WANG NUE-XI, ZHAO JIAN-XIONG, CIIEN
260
RU, ET AL. chinese journal of integrated traditional and
western medicine. 2007;27(4):343 (chi).
4044- gera: 146308/nd/ra
YIN-CHEN-HAO-TANG AMELIORATES
OBSTRUCTION-INDUCED HEPATIC APOPTOSIS IN
RATS. LEE TY, CHANG HH, WU MY, LIN HC. j pharm
pharmacol. 2007;59(4):583-90 (eng).
The accumulation of hydrophobic bile acids in the liver is
considered to play a pivotal role in the induction of apoptosis
of hepatocytes during cholestasis\. Thus, factors that affect
apoptosis may be used to modulate liver fibrosis\. Yin-Chen-
Hao-Tang (YCHT) decoctions have been recognised as a
hepatoprotective agent for jaundice and various types of liver
diseases\. We used an experimental rat model of bile-duct
ligation (BDL) to test whether YCHT plays a regulatory role
in the pathogenesis of hepatic apoptosis\. BDL-plus-YCHT
groups received 250 or 500 mg kg (-1) YCHT by gavage
once daily for 27 days\. YCHT significantly ameliorated the
portal hypertensive state and serum TNF-alpha compared
with the vehicle-treated control group\. In BDL-plus-YCHT-
treated rats, hepatic glutathione contents were significantly
higher than than in BDL-only rats\. BDL caused a prominent
liver apoptosis that was supported by an increase in Bax and
cytochrome c protein and increased expression of Bax and
Bcl-2 messenger RNA\. The normalising effect of YCHT on
expression of Bax and Bcl-2 mRNA was dependent on the
dose of YCHT, 500 mg kg (-1) having the greater effect on
both Bax and Bcl-2 of mRNA levels\. Additionally, YCHT
treatment down-regulated both hepatic caspase-3 and -8
activities of BDL rats\. This study demonstrates the anti-
apoptotic properties of YCHT and suggests a potential
application of YCHT in the clinical management of hepatic
disease resulting from biliary obstruction.
4045- gera: 146310/di/re
TRADITIONAL CHINESE MEDICINE KANG XIAN
FU FANG I IS EFFECTIVE FOR PROPHYLAXIS AND
TREATMENT OF ALCOHOLIC LIVER DISEASE IN
RATS. LV XH, ZHOU LP, LIU DP, WANG Y, WANG BY,
FU BY, SONG M, LIU CR. hepatobiliary pancreat dis int.
2007;6(2):182-7 (eng).
BACKGROUND: Reversal of liver fibrosis is one of the key
steps in the prevention and treatment of alcoholic liver
disease (ALD), but the mechanism is unknown\. This study
was to investigate the effects of the Chinese medicine Kang
Xian Fu Fang I (KXI) on prophylaxis and treatment of ALD
in rats and its possible mechanism of action\. METHODS:
Eighty male Wistar rats were randomly divided into four
groups: normal control; ALD model; treatment of ALD with
KXI; and prophylaxis of ALD by KXI\. At the end of 4, 8, 12
and 16 weeks, five rats from each group were anesthetized
and their livers were removed for pathological studies using
hematoxylin-eosin and Masson stain, immunohistochemical
studies, and flow cytometry for matrix metalloproteinase-2
(MMP-2) and matrix metalloproteinase-9 (MMP-9)\. Blood
samples were taken for hyaluronic acid (HA) assay\.
RESULTS: Serum HA level and liver collagen content were
lower in the groups given KXI for prophylaxis and treatment
than in ALD model group (P<0.05)\. The levels of MMP-2
and MMP-9 were also decreased in the prophylaxis and
treatment groups (P<0.05)\. Immunohistochemistry showed
immunoreactive MMP-2 in endothelial cells of the hepatic
artery and portal vein, sinusoidal endothelial cells, and
sinusoidal cells\. Immunoreactive MMP-9 occurred in the
hepatic cells around the veins and sinusoidal cells\.
CONCLUSIONS: KXI can effectively inhibit or reverse the
course of ALD\. This may be attributable to its capacity to
inhibit the expression of MMP-2 and MMP-9.
gera 2011

4046- gera: 146341/nd/ra
HERBAL MEDICINE IN THE TREATMENT OF
LIVER DISEASES. STICKEL F, SCHUPPAN D. dig liver
dis. 2007;39(4):293-304 (eng).
Herbal drugs have become increasingly popular and their use
is widespread\. Licensing regulations and pharmacovigilance
regarding herbal products are still incomplete and clearcut
proof of their efficacy in liver diseases is sparse\.
Nevertheless, a number of herbals show promising activity
including silymarin for antifibrotic treatment, phyllantus
amarus in chronic hepatitis B, glycyrrhizin to treat chronic
viral hepatitis, and a number of herbal combinations from
China and Japan that deserve testing in appropriate studies\.
Apart from therapeutic properties, reports are accumulating
about liver injury after the intake of herbals, including those
advertised for liver diseases\. Acute and/or chronic liver
damage occurred after ingestion of some Chinese herbs,
herbals that contain pyrrolizidine alkaloids, germander,
greater celandine, kava, atractylis gummifera, callilepsis
laureola, senna alkaloids, chaparral and many others\. Since
the evidence supporting the use of botanicals to treat chronic
liver diseases is insufficient and only few of them are well
standardised and free of potential serious side effects, most of
these medications are not recommended outside clinical
trials\. Particularly with regard to the latter, adequately
powered randomised-controlled clinical trials with well-
selected end points are needed to assess the role of herbal
therapy for liver diseases.
4047- gera: 146633/nd/ra
[LIVER INJURY AND INTERVENTION OF
COMPOUND 912 LIQUID ON IT IN RATS WITH
ENDOTOXEMIA]. HU L, ZHANG SW, YIN CH.
zhongguo zhong xi yi jie he za zhi. 2007;27(6):523-6 (chi).
OBJECTIVE: To investigate the liver injury in model rats
with endotoxemia and to observe the protective effect of
Compound 912 Liquid on it. METHODS: Rats were
randomly divided into three groups, the endotoxemia model
group (EMG, injected by lipoplysaccharides (LPS)
peritoneally), the intervention group (IG, treated with
Compound 912 Liquid via gastrogavage 1 h before model
establishing) and the normal control group (NCG). Blood
samples of rats were taken at the time points of the 2nd, 4th,
8th, 12th, 48th, 72nd hour and the 7th day after modeling for
measuring liver function, levels of plasmatic endotoxin,
tumor necrosis factor alpha (TNF-alpha), interleukin-10 (IL-
10). The pathological change of liver was observed using
light microscope and electro-transmission microscope.
RESULTS: The peak concentration of endotoxin detected at
2 hour after modeling in the IG was significantly lower than
that in the EMG (0.358 +/- 0.056 vs 0.685 +/- 0.030), but
insignificant difference (P > 0.05) was shown between them
in TNF-alpha level. The level of IL-10 continuously rose in
IG after treatment, it was still higher than normal level until
day 7 (49.096 +/- 4.076 vs 43.454 +/- 5.928, P < 0.05).
CONCLUSION: LPS can induce the increase of serum
inflammatory cytokines and anti-inflammatory cytokines in
rats to injure liver. Therefore, the inflammatory reaction
indicated by LPS may be one of the mechanisms for liver
injury. Preventive medication with Compound 912 Liquid
showed a significant liver protective effect.
4048- gera: 146747/nd/ra
TREATMENT OF CHRONIC LIVER INJURIES IN
MICE BY ORAL ADMINISTRATION OF
ETHANOLIC EXTRACT OF THE FRUIT OF
HOVENIA DULCIS. FANG HL, LIN HY, CHAN MC, LIN
WL, LIN WC. am j chin med. 2007;35(4):693 (eng).
The present study examined the effects of an ethanolic
extract of the fruit of Hovenia dulcis (EHD) on chronic
261
hepatitis induced by carbon tetrachloride (CCl(4)) in mice.
CCl(4) (5%; 0.1 ml/10 g body weight) was given twice a
week for 9 weeks, and mice received EHD throughout the
entire experimental period. Plasma activities of GPT and
GOT, and hepatic levels of malondialdehyde were
significantly lowered in mice treated with EHD as compared
to mice treated with CCl(4) only. Histological evaluation
showed that EHD could attenuate the liver fibrosis and
necrosis caused by CCl(4). RT-qPCR analysis also showed
that EHD treatment decreased hepatic collagen (alpha1)(I)
and collagen (alpha1)(III) mRNA expressions. Chronic
CCl(4) treatment caused liver injuries in mice, characterized
by an increase in hepatic methionine adenosyltransferase
(MAT) 2A gene expression, and decreased MAT1A gene
expression. EHD significantly reduced the changes in MAT
gene expression due to the chronic CCl(4) treatment. These
results clearly demonstrate that the EHD can reduce hepatic
injuries in mice induced by
4049- gera: 146796/di/ra
CLINICAL EXPERIENCE IN TCM DIFFERENTIAL
TREATMENT OF FATTY LIVER. CAI M, YANG Y.
journal of traditional chinese medicine. 2007;27(2):115-16
(eng).
4050- gera: 146799/di/ra
CLINICAL OBSERVATION ON
ELECTROACUPUNCTURE TREATMENT OF 30
CASES OF CHRONIC HEPATITIS B. QIU W, CHANG
J, SHEN SE, SHI B, PAN X. journal of traditional chinese
medicine. 2007;27(2):108-10 (eng).
OBJECTIVE: To probe into the methods and therapeutic
effects of electroacupuncture (EA) on hepatitis B.
METHODS: 60 hospitalized cases of mild or moderate
hepatitis B were randomly divided into a treatment group (30
cases) and a control group (30 cases). EA was applied at the
points selected according to the differentiation of symptoms
and signs. The treatment was given once daily for 30
minutes, and 2 weeks of treatments constituted a therapeutic
course, with 2-3 courses on average in the treatment group.
Conventional treatment for liver protection was given in the
control group. RESULTS: As compared with the control
group, the duration of the treatment for recovery of the
hepatic functions was significantly shorter, and the IL-8 level
significantly lower in the treatment group. CONCLUSION:
In treating hepatitis B, EA is effective in improving
symptoms, recovering hepatic functions,
4051- gera: 147024/nd/ra
DIAMMONIUM GLYCYRRHIZINATE, A
COMPONENT OF TRADITIONAL CHINESE
MEDICINE GAN-CAO, PREVENTS MURINE T-
CELL-MEDIATED FULMINANT HEPATITIS IN IL-
10- AND IL-6-DEPENDENT MANNERS. FENG C,
WANG H, YAO C, ZHANG J, TIAN Z. int
immunopharmacol. 2007;7(10):1292-8 (eng).
Diammonium glycyrrhizinate (DG), a traditional Chinese
medicine (TCM), is extracted and purified from liquorices
(Radix glycyrrhizae). The liquorices exert an important
function in the treatment of hepatitis because of its anti-
inflammatory effects based upon the clinical practice, but the
underlying mechanism is unclear. In this study, we
investigated the mechanisms of DG in protecting mice from
ConA-induced hepatitis. The results showed that
intraperitoneal administration of DG protected mice against
ConA-induced elevation of serum ALT levels and apoptosis
of hepatocytes; at the same time, the absolute amount of
hepatic NKT cells and T cells was significantly decreased,
indicating that DG can inhibit the recruitment of lymphocytes
into the liver. In addition, the production of IL-6 and IL-10
gera 2011

was improved by DG pretreatment, suggesting that DG may
possibly protect the liver from injury via two pathways:
direct protection of hepatocytes from apoptosis through an
IL-6-dependent way and indirect
4052- gera: 147103/di/ra
EFFECT OF QI-PROTECTING POWDER (HUQI SAN)
ON EXPRESSION OF C-JUN, C-FOS AND C-MYC IN
DIETHYLNITROSAMINE-MEDIATED
HEPATOCARCINOGENESIS. LI X, SHI ZM, FENG P,
WEN ZY, WANG XJ. world j gastroenterol.
2007;13(31):4192-8 (eng).
AIM: To study the inhibitory effect of Huqi San (Qi-
protecting powder) on rat prehepatocarcinoma induced by
diethylinitrosamine (DEN) by analyzing the mutational
activation of c-fos proto-oncogene and over-expression of c-
jun and c-myc oncogenes. METHODS: A Solt-Farber two-
step test model of prehepatocarcinoma was induced in rats by
DEN and 2-acetylaminofluorene (AAF) to investigate the
modifying effects of Huqi San on the expression of c-jun, c-
fos and c-myc in DEN-mediated hepatocarcinogenesis. Huqi
San was made of eight medicinal herbs containing
glycoprival granules, in which each milliliter contains 0.38 g
crude drugs. gamma-glutamy- transpeptidase-isoenzyme
(gamma-GTase) was determined with histochemical
methods. Level of 8- hydroxydeoxyguanosine (OHdG)
formed in liver and c-jun, c-fos and c-myc proto-oncogenes
were detected by immunohistochemical methods. RESULTS:
The level of 8-OHdG, a mark of oxidative DNA damage, was
significantly decreased in the liver of rats with
prehepatocarcinoma induced by DEN who received 8 g/kg
body weight or 4 g/kg body weight Huqi San before (1 wk)
and after DEN exposure (4 wk). Huqi San-treated rats
showed a significant decrease in number of gamma-GT
positive foci (P < 0.001, prevention group: 4.96 +/- 0.72 vs
29.46 +/- 2.17; large dose therapeutic group: 7.53 +/- 0.88 vs
29.46 +/- 2.17). On the other hand, significant changes in
expression of c-jun, c-fos and c-myc were found in Huqi San-
treated rats. CONCLUSION: Activation of c-jun, c-fos and c-
myc plays a crucial role in the pathogenesis of liver cancer.
Huqi San can inhibit the over-expression of c- jun, c-fos and
c-myc oncogenes and liver preneolastic lesions induced by
DEN.
4053- gera: 147170/di/ra
HEPATOPROTECTIVE AND ANTIOXIDANT
EFFECTS OF ETHANOL EXTRACT FROM
PHELLINUS MERRILLII ON CARBON
TETRACHLORIDE-INDUCED LIVER DAMAGE.
HENG-YUAN CHANG; WEN-HUANG PENG; MING-JYH
SHEU; GUAN-JHONG HUANG;. the american journal of
chinese medicine. 2007;35(5):793 (eng).
In the present study, we investigated the hepatoprotective and
antioxidant capacities of ethanol extract of Phellinus merrillii
(PM) on carbon tetrachloride-induced hepatotoxicity. In
high-performance liquid chromatography (HPLC) analysis,
the finger print chromatogram of PM was established. Both
hispolon and PM showed a similar peak at the retention time
of 6 min. This implied that PM did contain the active
ingredient of hispolon. Treatment with PM (0.5, 1 and 2
g/kg) prior to the administration of carbon tetrachloride (1.5
ml/kg in olive oil, 20%) significantly prevented the increased
serum alanine aminotransferase (s-GOT) and serum aspartate
aminotransferase (s-GPT) in a dose-dependent manner. We
also found that the incidences of ballooning degeneration,
necrosis and portal triaditis were lowered in the group
pretreated with PM. Carbon tetrachloride induces up-
regulation of antioxidant enzymes, including superoxide
dismutase (SOD) (86.6%), catalase (58.8%) and glutathione
peroxidase (GPx)(64.7%) in the liver. Pretreatment with PM
262
significantly reduced the all these antioxidant enzyme
activities. Therefore, we verified that ethanol extract of PM
has the hepatoprotective and
4054- gera: 147380/di/ra
BIOACTIVE CONSTITUENTS FROM CHINESE
NATURAL MEDICINES. XXVI. CHEMICAL
STRUCTURES AND HEPATOPROTECTIVE
EFFECTS OF CONSTITUENTS FROM ROOTS OF
RHODIOLA SACHALINENSIS. NAKAMURA S, LI X,
MATSUDA H, NINOMIYA K, MORIKAWA T,
YAMAGUTI K, YOSHIKAWA M. chem pharm bull
(tokyo). 2007;55(10):1505-11 (eng).
The methanolic extract from the roots of Rhodiola
sachalinensis was found to show a protective effect on D-
galactosamine-induced cytotoxicity in primary cultured
mouse hepatocytes. From the methanolic extract, five new
glycosides, two monoterpene glycosides, two flavonol
bisdesmosides, and a cyanogenic glycoside, were isolated
together with 34 known compounds. The structures of new
constituents were elucidated on the basis of chemical and
physicochemical evidence. In addition, the principal
constituents, sachalosides III and IV, rhodiosin, and trans-
caffeic acid, displayed hepatoprotective effects.
4055- gera: 147625/di/ra
PROTECTIVE EFFECTS OF GINKGO BILOBA,
PANAX GINSENG, AND SCHIZANDRA CHINENSIS
EXTRACT ON LIVER INJURY IN RATS. CHANG HF,
LIN YH, CHU CC, WU SJ, TSAI YH, CHAO JC. the
american journal of chinese medicine. 2007;35(6):995
(eng).
This study investigated the effects of the combined extracts
of Ginkgo biloba, Panax ginseng, and Schizandra chinensis at
different doses on hepatic antioxidant status and fibrosis in
rats with carbon tetrachloride (CCl(4))- induced liver injury.
Male Sprague-Dawley rats (n = 8-12 per group) were divided
into the control, CCl(4), CCl(4) + silymarin (0.35%), CCl(4)
+ low-dose herbal extract (0.24% of Ginkgo biloba, Panax
ginseng, and Schizandra chinensis extract at 1:1:1; LE), and
CCl(4) + high-dose herbal extract (1.20% of the same herbal
extract; HE) groups. Silymarin or herbal extract was orally
given to rats a week before chronic intraperitoneal injection
with CCl(4) for 6 weeks. The pathological results showed
that herbal extract suppressed hepatic bile duct proliferation,
and low-dose herbal extract inhibited liver fibrosis. Hepatic
superoxide dismutase (SOD) activity was lower in the CCl(4)
group, but there was no difference in the silymarin or herbal
extract treated groups compared to the control group. Hepatic
catalase activity and the ratio of reduced to oxidized
glutathione were significantly higher (p < 0.05) in the HE
group than those in the CCl(4) group. Silymarin and herbal
extract reversed the impaired hepatic total antioxidant status
(p < 0.05). Herbal extract partially reduced the elevated
hepatic lipid peroxides. Hepatic transforming growth factor-
beta1 (TGF-beta1) level decreased significantly (p < 0.05) in
the LE group. Therefore, high-dose herbal extract improved
hepatic antioxidant capacity through enhancing catalase
activity and glutathione redox status, whereas low-dose
herbal extract inhibited liver fibrosis through decreasing
hepatic TGF- beta1 level in rats with CCl(4)-induced liver
injury.
4056- gera: 147643/nd/ra
EFFECT OF TIAOZHI YANGGAN DECOCTION IN
TREATING PATIENTS WITH NON-ALCOHOLIC
FATTY LIVER. GU CL, ZHANG YK, FU YX, YANG SF,
LI XQ. chinese journal of integrative medicine.
2007;13(4):275 (eng).
OBJECTIVE: To observe the clinical efficacy and safety of
gera 2011

Tiaozhi Yanggan Decoction (TZYGD) in treating non-
alcoholic fatty liver. METHODS: One hundred and thirty-
eight patients were enrolled and randomized into two groups
according to the random number table in a ratio of 3:1, with 8
cases eventually dropping out. The symptoms, signs, liver
function markers, blood lipids, iconographic indices and
clinical comprehensive efficacy after a 12-week treatment
course were assessed in 101 patients treated with TZYGD in
the treated group and 29 patients treated with Thiola in the
control group. RESULTS: The total effective rate in the
treated group and the control group was 81.19% and 68.97%,
respectively, showing a significant difference between the
two groups with the former being significantly higher than
the latter (P<0.05). Moreover, the improvements in the
symptoms, signs, liver function, blood lipids and
iconographic indices in the treated group were favorable with
no serious adverse reactions. CONCLUSION: TZYGD is
effective and highly safe in treating non-alcoholic fatty liver.
4057- gera: 147787/di/ra
TREATING CARCINOID HEPATIC METASTASES
WITH ACUPUNCTURE AND HERBS. JIANGUO XU.
international journal of clinical medicine. 2007;16(3):213
(eng).
4058- gera: 148191/di/ra
[CONSTRUCTION OF A THERAPEUTIC EFFECT
EVALUATION SYSTEM FOR PATIENTS WITH
PRIMARY LIVER CANCER BASED ON SYNDROME
DIFFERENTIATION IN TRADITIONAL CHINESE
MEDICINE]. LI DT, LING CQ, LANG QB, ZHU DZ, YU
CQ, CHEN Z, ZHAI XF, SHEN J, ZHANG JF, ZHANG BH.
zhong xi yi jie he xue bao. 2007;5(1):15-22 (chi).
OBJECTIVE: To construct a system of therapeutic effect
evaluation for patients with primary liver cancer according to
the theory of syndrome differentiation in traditional Chinese
medicine (TCM), and to examine its reliability. METHODS:
Analytic hierarchy process and 100 mm surveyor's rod
method were applied to obtain bottom layer and top level
syndromes, which were used to construct the method of
therapeutic effect evaluation, and its reliability was verified
in clinical practice by comparing with some evaluation
criteria in Western medicine, such as cancer severity scale;
Karnofsky performance scale; Child-Pugh classification,
cancer staging classification, and quality of life scale, etc.
RESULTS: A system of therapeutic effect evaluation was
constructed, and it could reflect the progress of tumor,
changes of hepatic function and constitution. The evaluation
scores acquired from the system were highly associated with
the quality of life of the patients. CONCLUSION: The
system of therapeutic effect evaluation can reflect the
severity of disease and the characteristics of TCM treatment.
4059- gera: 148344/di/ra
[CORRELATION BETWEEN SYNDROMES OF
POSTHEPATITIC CIRRHOSIS AND BIOLOGICAL
PARAMETERS: A REPORT OF 355 CASES]. ZHANG
Q, QIU H, WANG L, DU GL, LIU P. zhong xi yi jie he xue
bao. 2007;5(2):130-3 (chi).
OBJECTIVE: To investigate the pathological factors of
syndrome pathomechanism through studying the correlation
between syndromes of posthepatitic cirrhosis and biological
parameters. METHODS: Clinical information of three
hundred and fifty-five patients with posthepatitic cirrhosis
was collected and the database was established. Parameters
with statistical significance were analyzed with multi-factor
regression analysis to investigate the main influencing factors
of the syndromes of posthepatitic cirrhosis. RESULTS:
Formulae of six syndromes, including syndrome of yin
deficiency of liver and kidney, syndrome of damp heat,
263
syndrome of stagnated heat smoldering, syndrome of yang
deficiency of spleen and kidney, syndrome of stagnation of
liver qi and spleen deficiency and syndrome of blood stasis
due to qi deficiency, were established with stepwise
regression analysis. CONCLUSIONS: One of the
pathophysiological bases of syndrome of blood stasis due to
qi deficiency in cirrhosis is synthetic dysfunction of
hepatocytes. The pathophysiological basis of syndrome of
damp heat is inflammatory injury, which is also syndrome of
stagnated heat smoldering in cirrhosis patients. The
relationship between syndrome of yin deficiency of liver and
kidney and stasis and damp heat may be the
pathophysiological basis of the posthepatitic cirrhosis..
4060- gera: 148345/di/ra
[CORRELATION BETWEEN SYNDROME
DIFFERENTIATION AND CT QUANTITATIVE
DIAGNOSIS OF FATTY LIVER]. WANG S, LI Q,
WANG XF, JI G. zhong xi yi jie he xue bao. 2007;5(2):126-
9 (chi).
OBJECTIVE: To explore the correlation between syndrome
differentiation and CT quantitative diagnosis of fatty liver.
METHODS: One hundred and thirteen cases of fatty liver
verified clinically accepted plain CT scan after syndrome
differentiation (syndrome of stagnation of liver qi and spleen
deficiency, syndrome of intermingled phlegm and blood
stasis, syndrome of phlegm-dampness blocking internally,
syndrome of deficiency of liver and kidney, syndrome of
interior dampness-heat), and then the CT values of the liver
and the spleen were measured respectively. RESULTS: It
was shown that there was a correlation between the syndrome
differentiation and the fatty infiltration in the liver.
Significant differences of the distribution of fat and the ratio
of liver-spleen were found among the five different
syndromes (P<0.05). Diffused, mild fatty liver mainly
displayed syndrome of stagnation of liver qi and spleen
deficiency. CONCLUSION: Syndrome differentiation of
fatty liver is correlated with CT quantitative diagnosis, which
can be discriminated by the ratio of liver-spleen.
4061- gera: 148570/di/ra
PROTECTIVE EFFECTS OF MEDICAL OZONE
COMBINED WITH TRADITIONAL CHINESE
MEDICINE AGAINST CHEMICALLY-INDUCED
HEPATIC INJURY IN DOGS. LI LJ, YANG YG,
ZHANG ZL, NIE SF, LI Z, LI F, HUA HY, HU YJ, ZHANG
HS, GUO YB LI LJ, YANG YG, ZHANG ZL, NIE SF, LI Z,
LI F, HUA HY, HU YJ, ZHANG HS, GUO YB. world j
gastroenterol. 2007;13545°:5989-94 (eng).
AIM: To investigate the protective effect of medical ozone
(O(3)) combined with Traditional Chinese Medicine (TCM)
Yigan Fuzheng Paidu Capsules (YC) against carbon
tetrachloride (CCl(4))-induced hepatic injury in dogs.
METHODS: Thirty healthy dogs were divided randomly into
five groups (n = 6 in each group), namely control, oleanolic
acid tablet (OAT), O(3), YC and O(3) + YC, given either no
particular pre-treatment, oral OAT, medical ozone rectal
insulfflation every other day, oral YC, or oral YC plus
medical ozone rectal insulfflation every other day,
respectively, for 30 consecutive days. After pre-treatment,
acute hepatic injury was induced in all dogs with a single-
dose intraperitoneal injection of CCl(4). General condition
and survival time were recorded. The biochemical and
hematological indexes of alanine aminotransferase (ALT),
aspartate aminotransferase/alanine aminotransferase
(AST/ALT), serum total bilirubin (TBIL), prothrombin time
(PT), blood ammonia (AMMO), and blood urea nitrogen
(BUN) were measured after CCl(4) injection. Hepatic
pathological changes were also observed. RESULTS:
Compared to the other four groups, the changes of group
gera 2011

O(3) + YC dogs' general conditions (motoricity, mental state,
eating, urination and defecation) could be better controlled.
In group O(3) + YC the survival rates were higher (P < 0.05
vs group control). AST/ALT values were kept within a
normal level in group O(3) + YC. Hepatic histopathology
showed that hepatic injury in group O(3) + YC was less
serious than those in the other four groups. CONCLUSION:
Medical ozone combined with TCM YC could exert a
protective effect on acute liver injury induced by CCl(4).
4062- gera: 148128/di/ra
EFFECTS OF YINCHENHAO TANG AND RELATED
DECOCTIONS ON DMN-INDUCED
CIRRHOSIS/FIBROSIS IN RATS. LIU C, SUN M,
WANG L, WANG G, CHEN G, LIU C, LIU P. chin med.
2008;3(1):1 (eng).
ABSTRACT: BACKGROUND: Chinese medicine
decoctions such as Yinchenhao Tang (YCHT), Xiayuxue
Tang (XYXT), Huangqi Tang (HQT), Yiguan Jian (YGJ) and
Xiaochaihu Tang (XCHT)) were used to treat liver cirrhosis.
The present study evaluates the effects of these decoctions on
fibrosis in rats induced by dimethylnitrosamine (DMN).
METHODS: DMN solution (0.5%) was injected to rats for
three consecutive days per week for four weeks. At the
beginning of week 3, rats were randomly divided into 4-week
DMN control group, YCHT, XYXT, HQT, YGJ, XCHT and
vehicle groups. Each group was orally administered with
specific decoctions daily for two weeks. Rats in the vehicle
group were orally administered with only water. RESULTS:
Liver fibrosis and cirrhosis were observed in weeks 2 and 4
in DMN-intoxicated rats. Compared with normal rats, alanine
transaminase (ALT), aspartate transaminase (AST), alkaline
phosphatase (ALP) activities and level of total bilirubin acid
(TBA) in serum and content of Hydroxyproline (Hyp) in liver
tissue of model group rats rose significantly. However, the
albumin (Alb) level in serum decreased significantly.
Compared with the 4-week DMN group, the pathological
conditions and functions of the liver in the YCHT group
improved significantly, and the content of Hyp decreased
remarkably: only one rat in this group developed liver
cirrhosis and the ratio of cirrhosis was only 8.3%. On the
other hand, the other decoctions did not show remarkable
effects. YCHT inhibited alpha-SMA activation, including its
gene expression into mRNA and protein. CONCLUSION:
Among the five Chinese medicine decoctions, YCHT exerted
the most significant therapeutic effects on DMN-induced
cirrhosis/fibrosis in rats.
4063- gera: 148206/nd/ra
TREATMENT OF CHRONIC HEPATITIS B WITH
INTEGRATIVE MEDICINE. YE YONG-AN. chinese
journal of integrated and western medicine on digestion.
2008;28(1):8 (chi).
4064- gera: 148207/nd/ra
PAYING ATTENTION TO TCM AND INTEGRATIVE
MEDICINE IN TREATING YMDD MUTATION OF
CHRONIC HEPATITIS B. LI JUN. chinese journal of
integrated and western medicine on digestion.
2008;28(1):9 (chi).
4065- gera: 148208/nd/ra
SITUATION AND PROSPECT OF TCM TREATMENT
OF CHRONIC HEPATITIS C. WANG LING-TAI.
chinese journal of integrated and western medicine on
digestion. 2008;28(1):11 (chi).
4066- gera: 148209/nd/ra
CLINICAL STUDY ON TREATMENT OF SEVERE
HEPATITIS WITH REMOVING DAMPNESS AND
264
PURGATIVE METHOD. ZHANG JIAN-JUN AND
HUANG JIA-QUAN. chinese journal of integrated and
western medicine on digestion. 2008;28(1):13 (chi).
To evaluate the clinical effect of removing dampness and
purgative ( RDP) method in treating acute , subacute and
chronic severe hepatitis. Methods One hundred and twenty
cases of severe hepatitis were randomly assigned to 2 groups,
60 patients in the control group were treated with routine
Western medicine, 60 patients in the treatment group were
treated with the same Western medicine plus Chinese
medicine prescribed based on RDP principle orally and/or via
enema. Fourteen days of treatment constituted one
therapeutic course , and patients were treated for 3 courses.
Changes of clinical symptoms and signs , complication
occurrence , liver function, serum markers of hepatitis B
virus, and some biological indexes were observed and
compared. The case fatality rate was compared after a 6-
month follow-up. Results The total effective rate and marked
improving rate in the treatment group was 71. 7% (43/60
cases) and 48. 3% (29/60 cases) respectively, while those in
the control group, 51. 7% (31/60 cases) and 20. 0% (12/60
cases) respectively, showing significant difference between
the two groups (P < 0. 05) . After treatment , the clinical
symptoms and signs were relieved and complications were
reduced in the treatment group , showing marked
improvement as compared with that in the control group (P <
0.05). ALT, AST, TBi1, quantitative titer of HBV-DNA and
HBeAg decreased markedly, and ALB, prothrombase activity
( PTA) and total cholesterol (TC) increased significantly in
both groups after treatment (P <0. 01) . Significant difference
was found in AST, TBi1, PTA and quantitative titer of HBV-
DNA between the two groups (P < 0. 05 , P < 0. 01) . In the
6-month follow-up , the case fatality rate was 23. 3% (14/60
cases) in the treatment group , significantly lower than that in
the control group (P <0. 05) , which was 41. 6% (25/60 case)
Conclusion RDP treatment is helpful to improve the
prognosis of patients with severe hepatitis , it is one of the
effective measures for enhancing the efficacy of
comprehensive treatment.
4067- gera: 148210/nd/ra
EFFECTS OF OXYMATRINE ON SERUM
CYTOKINES AND HEPATIC FIBROTIC INDEXES IN
PATIENTS WITH CHRONIC HEPATITIS B. SHEN
BAO-SHENG AND SONG XIN-WEN. chinese journal of
integrated and western medicine on digestion.
2008;28(1):17 (chi).
Objective To study the effect of oxymatrine on serum
cytokines and hepatic fibrotic indexes in patients with
chronic hepatitis B ( CHB) . Methods Eighty-two CHB
patients were randomly assigned to the control group treated
with Western routine therapy and the treated group treated by
Western routine therapy plus oxymatrine. The treatment
course was 24 weeks. Another group with 20 healthy subjects
was set as the normal control group. The serum levels of
transforming growth factor-f3, ( TGF-(3, ) , interleukin-6 (IL-
6) , hyaline acid (HA) , collagen type IV( C-N) and laminin
(LN) were measured by ELISA and RIA before and after
treatment. Results The serum levels of TGF-(3, , IL-6 , HA ,
C-1V and LN in CHB patients were significantly higher than
those in the normal control group (P <0. 01) . After 24-week
treatment with oxymatrine , these abnormal indexes in the
treated group were significantly lowered , as compared with
those before treatment and in the control group , the
differences were significant ( all P <0. 01) . Conclusion
Oxymatrine could lower the levels of cytokines, in eluding
TGF-(3, , IL-6 , etc. in patients with CHB , which might be
one of the mechanisms of its action in reversing liver fibrosis.
4068- gera: 148211/nd/ra
gera 2011

STUDY ON TCM SYNDROME TYPING OF CHRONIC
HEPATITIS B. ZHU LEI-LEI, MENG HONG, JIANG
JIAN, ET AL. chinese journal of integrated and western
medicine on digestion. 2008;28(1):20 (chi).
Objective To explore the method for TCM syndrome typing
of chronic hepatitis B ( CHB) . Methods Clinical
questionnaire of epidemiological investigation was
established , by which the relative information from 871
patients with CHB was collected on the spot to conduct
multi-analysis , including factor analysis , cluster analysis ,
correspondence analysis , etc. Then the population basic
TCM syndrome types and the individual TCM syndrome type
of patients were obtained adopting the new combination of
factor analysis and variable cluster, and the corresponding
relation between TCM syndrome type and the figures of
tongue and pulse was analyzed as well. Results Analysis on
distribution of TCM syndrome type in patients showed that
single syndrome type presented in 380 cases (43. 6% ) ,
including Gan-Shen yin deficiency type in 126 (14. 5% ) ,
Gan-Dan dampness-heat type in 126 (14. 5% ) , Gan-
depression and Pi-deficiency type in 128 (14.7% ) ;
compound syndrome type presented in 301 (34. 6% ) ; the
other 190 patients (14. 5% ) without any symptom was
regarded as no syndrome type. Multiple correspondence
analysis showed that Gan-Shen yin deficiency type is related
to red tongue, thin yellowish fur, and taut pulse; Gan-Dan
dampness-heat type is related to yellowish greasy fur and
slippery pulse; Gan-depression with Pi-deficiency type is
related to thin whitish fur and taut thready pulse. Conclusion
The above-mentioned typing of TCM syndrome well
coincided with the clinical practice, and the correspondence
between single syndrome type and the manifestation of
tongue and pulse is obvious.
4069- gera: 148212/nd/ra
APPLYING FUZHENG HUAYU GANTANG
COMPREHENSIVE THERAPEUTIC PROGRAM FOR
TREATMENT OF POST-HEPATITIS B LIVER
CIRRHOSIS ASSOCIATED WITH GLYCO-
METABOLIC ABNORMALITY. ZHAO CHANG-QING,
GU HONG-TU, CHENG YANG, ET AL. chinese journal of
integrated and western medicine on digestion.
2008;28(1):24 (chi).
Objective To study the clinical effects of Fuzheng Huayu
Gantang comprehensive therapeutic program ( FHGP) on
post-hepatitis B liver cirrhosis associated with glyco-
metabolic abnormality (LCGA) . Methods The patients with
LCGA enrolled in the randomized controlled clinical trial
were assigned to 2 groups, the treated group (68 cases) and
the control group (74 cases) , they were treated respectively
by FHGP and conventional TCM and Western medicine
therapeutic program for 3 months. Indexes including fasting
plasma glucose (FPG) , 2 h postprandial plasma glucose (2 h
PG) , fasting insulin (FINS) were detected, homeostasis
model assessment insulin resistance (HOMA-IR) was
calculated, and the score of syndrome was recorded before
and after treatment. Then the effects on syndrome and glyco-
metabolic abnormality were evaluated through statistical
analysis. Results Level of 2 h PG after treatment was lowered
in both groups (P < 0. 01) , but significant difference was
found in the pre-treatment to post-treatment decrement of
FPG and HOMA-IR between the two groups (P < 0. 05 ) .
The syndrome improving rate and the total effective rate on
glyco-metabolic abnormality in the treated group were
significantly better than those in the control group
respectively (85. 3% vs 64. 9% , P < 0. 01 ; 80. 9% vs 62. 2%
, P <0. 05) . Conclusion FHGP has the capability to improve
the syndrome and glyco-metabolic abnormality of patients
with LCGA.
265
4070- gera: 148216/nd/ra
EFFECTS OF DANGGUI BUXUE DECOCTION (
J.31111 ) ON LIVER FIBROSIS AND HEPATIC LIPID
PEROXIDATION IN RATS. CHEN YUAN, TAO YAN-
YAN, LI FENG-HUA, ET AL. chinese journal of
integrated and western medicine on digestion.
2008;28(1):39 (chi).
Objective To observe the effects of Danggui Buxue
Decoction ( DBD) on liver fibrosis and to explore its
mechanism related to hepatic lipid peroxidation in rats.
Methods Liver fibrosis model was established in 28 rats by
the combination of injecting carbon tetrachloride (CC1a)
subcutaneously and feeding high lipid and low protein diet.
The model rats were randomly divided into 2 groups , the
model group (n =14) and the treated group (n =14) . Besides ,
a normal group was set up with 10 normal rats. For the
treated group , rats were administered with DBD at a dosage
of 6 g/kg body weight once a day by gastrogavage starting
from the day of modeling for 6 successive weeks and to the
control group , equal volume of normal saline was
administered instead. The inflammation and fatty
degeneration in rat liver tissues were examined with HE
staining; the collagen deposition observed with sirius red; the
liver function including serum level of alanine transaminase (
ALT) , aspartate aminotransferase ( AST) , albumin ( Alb)
and total bilirubin (TBi1) were determined using
corresponding test kits ; the hepatic lipid peroxidation
indexes , including triglyceride (TG) , superoxide dismutase (
SOD) and malondialdehyde ( MDA ) were measured by
biochemical methods; the hepatic hydroxyproline (Hyp)
content was detected with Jamall's method and the expression
;f collagen type I was analyzed by Western blotting. Results
Compared with those in the normal rats , serum ALT , AST ,
TBil level , TG and MDA content remarkablely increased ,
level of Alb and SOD activity decreased , and hepatic fatty
degeneration and collagen pathological deposition in liver
was more obvious inthe model rats ( all P < 0. 05) . While in
the DBD group , the hepatic fatty degeneration and collagen
deposition were significantly improved, changes of all the
above-mentioned indexes were significantly reversed (P < 0.
05 ) . Conclusion DBD has a good antagonist effect against
experimental liver fibrosis, and its mechanism may be related
to the anti-lipid peroxidation injury effect.
4071- gera: 148229/nd/ra
EXPERIMENTAL ADVANCE OF APPLYING
EMODIN FOR PREVENTION AND TREATMENT OF
LIVER DISEASES. XU XIAN-CHOU AND LIN SHENG-
ZHANG. chinese journal of integrated and western
medicine on digestion. 2008;28(1):91 (chi).
The experimental researches of applying emodin for
prevention and treatment of liver diseases in recent years
were reviewed. Emodin can inhibit the growth of liver tumor
cells in vitro and in vivo , inducing cell apoptosis is one of its
mechanisms. Emodin also has the effects of liver protection ,
anti-liver fibrosis , and so on , the mechanisms for those
effects still need more studies.
4072- gera: 148231/nd/ra
MINUTE OF THE 16TH NATIONAL ACADEMIC
CONFERENCE OF INTEGRATIVE MEDICINE ON
HEPATIC DISEASES. LIU CHENG-HAI AND HU YI-
YANG. chinese journal of integrated and western
medicine on digestion. 2008;28(1):95 (chi).
4073- gera: 148714/di/ra
[REGULATORY EFFECT OF GINSENOSIDE ON
GLUCOCORTICOID RECEPTOR IN MICE WITH
ISCHEMIC LIWER DAMAGE]. FENG YING-LU,
CHENG BIN-BIN, AND LING CHANG-QUAN. chinese
gera 2011

journal of integrated traditional and western medicine.
2008;28(3):252 (chi).
Objective To study whether ginsenoside (GS) can regulate
the glucocorticoid receptor (GR) in mice with ischemic liver
damage, and to preliminarily observe its dose-effect
relationship for providing an experimental bases in seeking a
new way to relieve the damage from view of GR. Methods
Adult male SD mouse was used to establish liver ischemia
model , and different doses (100 , 50 , and 25 mg/kg) of GS
was given via gastric infusion before modeling. The maximal
GR binding capacity (Bmax) of liver and the level of GR
mRNA expression in liver were dynamically determined at
various time points (2 h , 6 h , 12 h and 24 h) after modeling.
Results Compared with the normal control group , GR Bmax
and GR mRNA expression in model rats were lower
obviously (P <0. 01) . As compared with the control group ,
GR Bmax and GR mRNA expression in model rats treated
with 50 mg/kg GS significantly raised at 2 h , 6 h , 12 h (P <
0. 01) , while the changes in modeling rats treated with other
two doses of GS were of no statistical significance.
Conclusion GS in dose of 50 mg/kg can elevate the GR
Bmax of liver and
4074- gera: 148779/nd/ra
EVIDENCE-BASED EFFICACY OF KAMPO
FORMULAS IN A MODEL OF NON ALCOHOLIC
FATTY LIVER. FUJIMOTO M, TSUNEYAMA K,
KAINUMA M, SEKIYA N, GOTO H, TAKANO Y,
TERASAWA K, SELMI C, GERSHWIN ME, SHIMADA
exp biol med (maywood). 2008;233(3):328-37 (eng).
Data on the efficacy of herbal compounds are often burdened
by the lack of appropriate controls or a limited statistical
power. Treatments to prevent the progression of non
alcoholic fatty liver disease (NAFLD) to steatohepatitis
(NASH) remain unsatisfactory. A total of 56 rabbits were
arrayed into 7 groups fed with standard rabbit chow (SRC),
SRC with 1% cholesterol, or each of the five experimental
treatments (Kampo formulas 1% keishibukuryogan [KBG],
1% orengedokuto [OGT], and 1% shosaikoto [SST]; vitamin
E [VE]; or pioglitazone [PG]) in a 1% cholesterol SRC. We
analyzed changes after 12 weeks in plasma and liver lipid
profiles, glucose metabolism, adipocytokines, oxidative
stress, and liver fibrosis. Data demonstrated that all five
treatments were associated with significant amelioration of
lipid profiles, oxidative stress, and liver fibrosis compared to
no supplementation. KBG was superior to VE and PG in the
reduction of liver total cholesterol (P < 0.01) and lipid
peroxidase levels (P < 0.05), urinary 8-hydroxy-2'-
deoxyguanosine (P < 0.05), hepatic alpha-smooth muscle
actin positive areas (P < 0.01) and activated stellate cells (P <
0.01). In conclusion, there was a statistically significant
benefit of Kampo formulas (KBG in particular) on a dietary
model of NAFLD/NASH. Future studies need to be directed
at the mechanisms in the treatment of NASH.
4075- gera: 148904/di/ra
ANTICANCER ACTIVITIES AND MECHANISMS OF
BLUMEA BALSAMIFERA EXTRACT IN
HEPATOCELLULAR CARCINOMA CELLS.
NORIKURA T, KOJIMA-YUASA A, SHIMIZU M,
HUANG X, XU S, KAMETANI S, RHO SN, KENNEDY
DO, MATSUI-YUASA I. the american journal of chinese
medicine. 2008;36(2):411 (eng).
Blumea balsamifera (also known as sambong), a medicinal
plant, is known to improve physiological disorders such as
rheumatism and hypertension. However, its anticancer
activity has not been well elucidated. In this study, we found
that Blumea balsamifera MeOH extract (BME) induced
growth inhibitory activity in rat and human hepatocellular
carcinoma cells (McA-RH7777, HepG2, respectively)
266
without cytotoxicity as in with rat hepatocytes used as a
normal cell model. BME induced cell cycle arrest at G1
phase via decreases in expression of cyclin-E and
phosphorylation of retinoblastoma (Rb) protein in both dose-
and time-dependent manners. Furthermore, BME reduced the
level of a proliferation related ligand (APRIL) which
stimulates tumor cell growth. The anti- proliferative effect of
BME was improved slightly but significantly by the
treatment with recombinant human APRIL. These findings
suggest that BME may have a possible therapeutic potential
in hepatoma cancer patients and the depletion of cellular
APRIL may be one of the important mechanisms on the
growth inhibitory effect of
4076- gera: 149064/di/ra
STUDY ON PROTECTIVE ACTION OF
ELECTROACUPUNCTURE ON ENDOTOXIN-
INDUCED HEPATIC INJURY IN RATS. SHI XIA ,
SONG QI , HU SEN , LI ZE-FENG , LIUQIAN , WANG
LEI , GUAN LING. chinese acupuncture and moxibustion.
2008;28(4):290 (chi).
Objective to observe whether electroacupuncture (EA) at
Zusanli (ST 36) reduces endotoxininduced hepatic injury in
rats and to explore the mechanism. Methods Forty male SD
rats were randomly divided into 4 groups, a endotoxin group,
an EA group, a normal group and a non-acupoint group.
Hepatic injury rat model_ was prepared by injection of
endotoxin (5 mg/kg) into the caudal vein, the normal group
received the injection of the equal amount of saline; for the
EA group, EA (2-100 Hz, 2 mA, 1. 5 h) was given at
"Zusanli" (ST 36) half an hour after modeling, and for the
non-acupoint group, acupuncture was given at the point 5
mm lateral to and 5 mm below "Zusanli" (ST 36) , and other
treatments were as same as those in the EA group. Results
Injection of endotoxin into the caudal vein could significantly
increase TNF-a content in the liver and plasma ALT activity
(P<0. 01) , which were decreased by EA (P<0. 01) and were
not significantly changed in the non-acupoint group (P>0.
05). Conclusion The abnormal increases of TNF-a content in
the liver and plasma ALT activity induced by endotoxin can
be decreased by EA at "Zusanli" (ST 36), protecting the
organ, and the mechanism is possibly related with the
4077- gera: 149073/nd/ra
MELITTIN PREVENTS LIVER CANCER CELL
METASTASIS THROUGH INHIBITION OF THE
RAC1-DEPENDENT PATHWAY. LIU S, YU M, HE Y,
XIAO L, WANG F, SONG C, SUN S, LING C, XU Z.
hepatology. 2008;47(6):1964-73 (eng).
Melittin, a water-soluble toxic peptide derived from bee
venom of Apis mellifera was reported to have inhibitory
effects on hepatocellular carcinoma (HCC). However, its role
in antimetastasis and the underlying mechanism remains
elusive. By utilizing both HCC cell lines and an animal
model based assay system, we found that Rac1, which has
been shown to be involved in cancer cell metastasis, is highly
expressed in aggressive HCC cell lines and its activity
correlated with cell motility and cytoskeleton polymerization.
In addition, Rac1-dependent activity and metastatic potential
of aggressive HCC cells are remarkably high in both cellular
and nude mouse models. We provide evidence here that
melittin inhibits the viability and motility of HCC cells in
vitro, which correlates with its suppression of Rac1-
dependent activity, cell motility, and microfilament
depolymerization. Furthermore, melittin suppresses both
HCC metastasis and Rac1-dependent activity in nude mouse
models. The specificity of the effect of melittin on Rac1 was
confirmed in HCC cells both in vitro and in vivo.
Conclusion: Melittin inhibits tumor cell metastasis by
reducing cell motility and migration via the suppression of
gera 2011

Rac1-dependent pathway, suggesting that melittin is a
potential therapeutic agent for HCC. (HEPATOLOGY
2008;47:1964-1973.).
4078- gera: 149091/nd/ra
EFFECTS OF TRADITIONAL CHINESE MEDICINE
ON ENDOTOXIN AND ITS RECEPTORS IN RATS
WITH NON- ALCOHOLIC STEATOHEPATITIS. GAO
Y, SONG LX, JIANG MN, GE GY, JIA YJ. inflammation.
2008;31(2):121-32 (eng).
AIMS: The aim of this research is to study the effects of
traditional Chinese medicine on endotoxin and its receptors
in rats with nonalcoholic steatohepatitis (NASH).
METHODS: Fifty-six SD rats were divided into seven
groups. All the animals were fed high fatty diet for 12 weeks.
Rats with non-alcoholic steatohepatitis (NASH) were treated
with traditional Chinese medicine according to low-dose,
middle-dose, high-dose and Lipitor from fifth week. All rats
were killed at the end of 12th week. The liver pathology
changes were observed under light microscope. The levels of
serum lipoid, alanine aminotransferase (ALT), endotoxin
(ET), tumor necrosis factor- alpha (TNF-alpha) and
interleukine-1beta (IL-1beta) were determined. The
expressions of CD14 and nuclear transcriptional factor
kappaB (NF-kappaB) were observed by
immunohistochemistry. The expressions of
lipopolysaccharide binding protein (LBP), toll-like receptor-4
(TLR-4), myeloid differentiation-2 (MD-2) and induced
nitric oxide synthase (iNOS) mRNA were detected by the
reverse transcription polymerase chain reaction (RT- PCR).
RESULTS: The levels of serum endotoxin in the middle dose
group (0.0225 +/- 0.0112 EU/l) were lower than those in high
fatty diet model group (0.2249 +/- 0.0982 EU/l) at 12th week,
the difference was significant (P < 0.01). In the middle dose
group, mean values of serum TNF-alpha and IL-1beta levels
decreased dramatically (1.604 +/- 0.302 ng/ml and 0.052 +/-
0.024 ng/ml) compared with those in the high fatty diet
model group (4.029 +/- 1.180 ng/ml and 14.944 +/- 0.491
ng/ml; P < 0.01 and P < 0.01). The expressions of CD14 and
NF-kappaB in the middle dose group decreased compared
with those in the high fatty diet model group. The
expressions of LBP mRNA (0.284 +/- 0.105) and TLR-4
mRNA (0.290 +/- 0.123) in the middle dose group down
regulated compared with those in the high fatty diet model
group (1.060 +/- 0.158 and 1.261 +/- 0.368; P < 0.01 and P <
0.01). In the middle dose group MD-2 and iNOS gene
expressions were 0.132 +/- 0.058 and 0.164 +/- 0.061,
respectively, which were significantly lower compared with
the high fatty diet model group (0.795 +/- 0.294 and 1.029 +/-
0.388; P < 0.01 and P < 0.01). CONCLUSIONS: The
mechanism of non-alcoholic steatohepatitis (NASH) maybe
related to increasing the levels of serum endotoxin,
upregulating endotoxin receptors of hepatic tissue and
enhancing liver inflammatory injury. Traditional Chinese
medicine is a good treatment for non-alcoholic steatohepatitis
(NASH). It can produce a marked effect via relieving LPS-
induced liver injury.
4079- gera: 149303/di/ra
RELATIONSHIP BETWEEN ABNORMAL
CHARACTERISTICS OF SUBLINGUAL
COLLATERAL AND PORTAL VEIN
HEMODYNAMIC CHANGES IN PATIENTS WITH
PRIMARY HEPATIC CARCINOMA. DENG WZ, LANG
QB, LING CQ. chin j integr med. 2008;14(1):28 (eng).
OBJECTIVE: To investigate the relationship between the
abnormal characteristics of sublingual collateral (SC) and
portal vein hemodynamic changes in patients with primary
hepatic carcinoma (PHC). METHODS: A total of 123
patients of PHC with abnormal SC were enrolled. The SC
267
characteristics were classified and evaluated. The principal
components (PC) of SC extracted from them by principal
component analysis and the relationship between PC and the
dynamic changes of portal vein flow were analyzed by
correlation analysis. RESULTS: Three groups of PC were
extracted, namely PC-1 (length, width, presentation type of
visualization), PC-2 (circuitous, vesicular change), and PC-3
(color, collateral hemostasis, petechiae, ecchymosis). Their
total accumulative contribution degree reached 56.803%.
Correlation analysis shows that PC-1 was significantly
positively correlated with the hemodynamic parameters of
the portal vein (P<0.01), while PC-2 and PC-3 were not
(P>0.05). CONCLUSION: Length, width and presentation
type of SC could be used for predicting the changes of portal
4080- gera: 149375/nd/ra
FREQUENCY AND PATTERN OF CHINESE HERBAL
MEDICINE PRESCRIPTIONS FOR CHRONIC
HEPATITIS IN TAIWAN. CHEN FP, KUNG YY, CHEN
YC, JONG MS, CHEN TJ, CHEN FJ, HWANG SJ. j
ethnopharmacol. 2008;117(1):84-91 (eng).
ETHNOPHARMACOLOGICAL RELEVANCE: Chinese
herbal medicine (CHM) has been commonly used in treating
liver diseases in Asian countries. AIM OF STUDY: To
conduct a large-scale pharmacoepidemiological study and
evaluate the frequency and pattern of CHM prescriptions in
treating chronic hepatitis. MATERIALS AND METHODS:
We obtained the database of traditional Chinese medicine
outpatient claims from the national health insurance in
Taiwan for the whole 2002. Patients with chronic hepatitis
were identified by the corresponding diagnosis of
International Classification of Disease among claimed
visiting files. Corresponding prescription files were analyzed,
and association rule were applied to evaluate the co-
prescription of CHM in treating chronic hepatitis. RESULTS:
Among the 91,080 subjects treated by CHM for chronic
hepatitis, the peak age was in the 40 s, followed by 30 s and
50 s. Male/female ratio was 2.07:1. Long-dan-xie-gan-tang
and Saliva miltiorrhiza (Dan- shen) were the most commonly
prescribed Chinese herbal formula and single herbal drug,
respectively. The most common two-drug prescription was
Jia-wei-xia-yao-san plus Saliva miltiorrhiza, and the most
common three-drug prescription was Jia-wei-xia-yao-san
plus Saliva miltiorrhiza and Artemisia capillaries (Yin-chen-
hao). CONCLUSIONS: This study showed the utilization
pattern of Chinese herbal drugs or formulae in treating
chronic hepatitis. Further researches and clinical trials are
needed to evaluate the efficacy of these Chinese herbs or its
ingredients in treating chronic hepatitis.
4081- gera: 149497/nd/ra
PROTECTION OF A POLYSACCHARIDE FROM
SALVIA MILTIORRHIZA, A CHINESE MEDICINAL
HERB, AGAINST IMMUNOLOGICAL LIVER
INJURY IN MICE. SONG YH, LIU Q, LV ZP, CHEN YY,
ZHOU YC, SUN XG. int j biol macromol. 2008;may 13:x
(eng).
This study was designed to evaluate the hepatoprotective
effects of S. miltiorrhiza polysaccharides (SMPS) in
immunological liver injury induced by Bacille-Calmette-
Guerin (BCG) and lipopolysaccharide (LPS) in mice. SMPS
effectively improved the liver index, spleen index and
thymus index, reduced the serum levels of alanine
aminotransferase, aspartate aminotransferase and nitric oxide,
and restored liver homogenate contents of tumor necrosis
factor-alpha and interleukin-1beta. The histopathological
analysis suggested that SMPS reduced the degree of liver
injury. The results suggest that SMPS play a protective role
against immunological liver injury, which may have
important implications for our understanding on the
gera 2011

immunoregulatory mechanisms of
4082- gera: 149504/nd/ra
PROTECTIVE EFFECTS OF TOTAL FLAVONOIDS
OF BIDENS PILOSA L. (TFB) ON ANIMAL LIVER
INJURY AND LIVER FIBROSIS. YUAN LP, CHEN FH,
LING L, DOU PF, BO H, ZHONG MM, XIA LJ. j
ethnopharmacol. 2008;116(3):539-46 (eng).
The hepatoprotective effects of total flavonoids of Bidens
pilosa L. (TFB), a traditional Chinese medicine were
evaluated in carbon tetrachloride (CCl(4))-induced liver
injury in mice and rats. Total flavonoids of Bidens pilosa L.
(25, 50 and 100mg/kg) were administered via gavage daily
for 10 days to CCl(4)-treated mice as well as TFB (30, 60
and 90mg/kg) administered for 6 weeks to CCl(4)-treated
rats. Liver index (liver weight/body weight), serum levels of
transaminases (alanine aminotransferase, ALT and aspartate
aminotransferase, AST), hepatic malondialdehyde (MDA)
content, superoxide dismutase (SOD) and glutathione
peroxidase (GSH-Px) activities were evaluated following the
10 days treatment in mice. In addition histopathologic
changes and nuclear factor- kappaB (NF-kappaB) expression
of the liver were detected with hematoxylin-eosin (HE) and
immunohistochemistry methods, respectively. The results
showed that TFB (50 and 100mg/kg) effectively reduced the
CCl(4)-induced elevated liver index, serum ALT, AST levels,
hepatic MDA content, and restored hepatic SOD, GSH-Px
activities in acute liver injury mice. TFB (60 and 90mg/kg)
treatment significantly inhibited NF-kappaB activation in
liver fibrosis of rats. The histopathological analysis suggested
that TFB reduced the degree of liver injury in mice and
severity of liver fibrosis in rats. These results suggested that
TFB had a protective and therapeutic effect on animal liver
injury, which might be associated with its antioxidant
properties and inhibition of NF-kappaB activation.
4083- gera: 149526/di/ra
EFFECT OF ACUPUNCTURE FOR GENERAL
SYMPTOMS ACCOMPANIED WITH
HEPATOCELLULAR CARCINOMA: A CASE
REPORT. YAMAZAKI TASUKU, FUKUDA FUMIHIKO,
TAKEDA TAROU, ISHIZAKI NAOTO, YAMAMURA
YOSHIHARU. journal of the japan society of acupuncture
and moxibustion. 2008;58(2):61 (jap).
INTRODUCTION: Acupuncture has been reported to be
useful for both physical and psychological symptoms. Here
we report a case who complained of various physical
symptoms due to advanced hepatocellular carcinoma
effectively cared for with acupuncture.Case: A 64-year-old
female complained of general fatigue, constipation, and pain
in the lower back and leg during her hospitalization for leg
edema due to advanced hepatocellular carcinoma. Although
the leg edema was improved by the administration of
albumin, physical symptoms such as pain in the lower back
and leg, constipation, or general fatigue remained. We
applied acupuncture with aiming at relaxing muscles (erector
spinae, rectus femoris, right adductor) by, a local needling
approach, and to improve incomplete defecation by applying
moxibustion at the acupoint on, the abdomen.METHOD:
Faces Scale was used to evaluate general condition.
Evaluation of the pain in the lower back and lower
extremities were made with a Numerical Scale where 10
indicates the most painful, while 0 indicates no
pain.RESULT: Both general fatigue and pain in the lower
extremities were relieved after acupuncture treatments (FS
for general condition improved from 3 to 1, NS for pain
decreased from 7 to 4). Also, the feeling of incomplete
defecation disappeared.
4084- gera: 149638/nd/ra
268
PHENOLS FROM THE ROOTS OF RHEUM
PALMATUM ATTENUATE CHEMOTAXIS IN RAT
HEPATIC STELLATE CELLS. LIN YL, WU CF,
HUANG YT. planta med. 2008;jul 8:x (eng).
In liver injury, hepatic stellate cells (HSCs) acquire an
activated phenotype, migrate to the injured region in response
to chemotactic factors and produce extracellular matrix
(ECM) proteins including alpha-smooth muscle actin (alpha-
SMA) and collagen in order to repair the damage. HSC-T6, a
cell line of rat HSCs, was used in IN VITRO experiments.
TGF-beta1 was used as a chemoattractant. The expression of
alpha-SMA was used as a marker of activated hepatic stellate
cells and cell migration was assayed with the Transwell
method to investigate the active principles of the roots of
RHEUM PALMATUM L. (Dahuang), a well-known
traditional Chinese herb used for treating liver diseases.
Under cell activation and chemotaxis-directed fractionation
and purification, four anthraquinones, rhein ( 1), emodin ( 2),
chrysophanol ( 3) and physcion ( 4), and four
phenylbutanoids, lindleyin ( 5), isolindleyin ( 7), 4-(4'-
hydroxyphenyl)-2-butanone 4'- O-beta- D-glucopyranoside (
8), and 4-(4'-hydroxyphenyl)-2- butanone ( 9), and a stilbene,
3,5,4'-trihydroxystilbene 4'- O-beta- D-glucopyranoside 6'-
O-gallate ( 6) were isolated from the active fractions. Among
them, compounds 1 and 2 inhibited alpha-SMA expression.
However, compounds 3, 4, 6 and 8 attenuated chemotactic
migration, but not alpha-SMA expression. alpha-SMA:alpha-
smooth muscle actin CI:chemotaxis index ECM:extracellular
matrix HSCs:hepatic stellate cells Rh:ethanolic extract of the
roots of RHEUM PALMATUMTGF:transforming growth
factor.
4085- gera: 149644/nd/ra
ORIDONIN-LOADED POLY(EPSILON-
CAPROLACTONE)-POLY(ETHYLENE OXIDE)-
POLY(EPSILON- CAPROLACTONE) COPOLYMER
NANOPARTICLES:. FENG N, WU P, LI Q, MEI Y, SHI
S, YU J, XU J, LIU Y, WANG Y. j drug target.
2008;16(6):479-85 (eng).
The aim of the present study was to develop a polymeric
delivery system for water-insoluble drug oridonin.
Amphiphilic block copolymers, poly(epsilon-caprolactone)-
poly(ethylene glycol)-poly (epsilon-caprolactone) (PCL-
PEO-PCL), were synthesized by ring-opening polymerization
of caprolactone initiated by the hydroxyl groups of
poly(ethylene glycol)6000 (PEG-6000) with stannous octoate
as catalyzer. Oridonin-loaded PCL-PEO-PCL copolymer
nanoparticles (ORI-PCL-PEO-PCL-NPs) were prepared by
the interfacial deposition method. The mean particle size of
the drug-loaded nanoparticles was 97.5 nm and the zeta
potential was - 25 mV. The entrapment efficiency and actual
drug loading of the nanoparticles were 87.52% +/- 1.86% and
8.63% +/- 0.49%, respectively. The antitumor activity of
ORI-PCL-PEO-PCL-NPs was evaluated by measuring
changes in tumor volumes, tumor weights, and survival rates
of mice with grafted hepatoma (H22). The results indicated
that ORI-PCL-PEO-PCL-NPs prolonged the survival time of
mice and exhibited higher therapeutic efficacy compared with
free oridonin. Thus, ORI-PCL-PEO-PCL-NPs may be used
as a promising delivery system for liver cancer treatment.
4086- gera: 149718/di/ra
INFLUENCE OF ELECTROACUPUNCTURE ON
INSULIN-RESISTANCE IN NONALCOHOLIC FATTY
LIVER RATS. FENG WEN-0 , ZENG ZHI-HUA , ZHUO
LIAN-SHI. acupuncture research. 2008;33(2):111 (chi).
Objective To investigate the mechanism of
electroacupuncture (EA) in treating nonalcoholic fatty liver
disease (NAFLD) in rats. Methods Thirty male SD rats were
randomized into normal control, NAFLD model and EA
gera 2011

groups, with 10 cases in each. NAFLD model was
established by feeding the rats with high-fat food for 8
weeks. EA (2 Hz, 4 mA) was applied to "Zusanli" (ST 36),
"Fenglong" (ST 40) , "Sanyinjiao" (SP 6), and "Taichong"
(LR 3) for 15 min, once daily for 4 weeks. Fasting blood
sugar (FBG) and serum free fatty acids (FFA) were detected
with chromatometry; serum insulin (INS) was determined
with radioimmunoassay; homeostasis model assessment
insulin resistance (HOMA-IR) and liver index (LI) were
calculated. Liver tissue was cut into sections for detecting
pathological changes. Results Compared with normal control
group, FBG, INS, FFA, HOMA-IR and LI of model group
increased significantly (P<0. 05), and hepatic diffuse
steatosis with cellular necrosis and inflammatory cell
infiltration was obvious. In comparison with model group, all
the 5 indexes in EA group decreased significantly (P<0. 05),
and pathological changes as hepatic steatosis, etc. were
significantly reduced. Conclusion EA may be
4087- gera: 149926/di/ra
[STUDY OF MODIFIED BIEJIAJIAN PILL ON
PATHOLOGICAL IMMUNE HEPATIC FIBROSIS
MODEL INDUCED BY ALBUMIN IN RATS]. SUN HY,
REN Y, YIN JX, ET AL. chinese journal of integrated
traditional and western medicine. 2008;28(6):526 (chi).
OBJECTIVE: To quantitatively analyze the effect of
modified Biejiajian Pill (BJJP) on the pathological change
and degree of albumin induced immune hepatic fibrosis in
rats. METHODS: Rats were immunized by multiple
subcutaneous injections of human serum albumin (8 g/L) ,
and were medicated in groups respectively after antibody
producing, BJJP high-dose (13 g/kg) group, medium-dose
(6.5 g/kg) group, low-dose (3.25 g/kg) group, the model
group, colchicines (1.0 mg/kg) group, and Ganpikang (22.23
mg/kg) group. Then, caudal vein injection of albumin was
given 40 min after medication to induce liver fibrosis.
Animals were sacrificed finally to observe the pathological
change, and the distribution and content of collagen and
plastin were determined quantitatively with HE and Masson
stain. RESULTS: BJJP high-, medium-, and low-dose groups
could obviously improve the pathological change of the
hepatic fibrosis rats (decreasing rate of the total score was
62.50%, 40.75%, and 8.33%, respectively), and the content
of collagen reduced markedly (P<0.05, P<0.01).
CONCLUSION: BJJP can effectively prevent and reduce the
pathological change of albumin induced immune hepatic
fibrosis in rats.
4088- gera: 149974/di/ra
RHEIN INDUCES APOPTOSIS AND CELL CYCLE
ARREST IN HUMAN HEPATOCELLULAR
CARCINOMA BEL- 7402 CELLS. SHI P, HUANG Z,
CHEN G. the american journal of chinese medicine.
2008;36(4):805 (eng).
Rhein, an anthraquinone derivative of rhubarb, inhibits the
proliferation of various human cancer cells. In this paper, we
focused on studying the effects of rhein on human
hepatocelluar carcinoma BEL-7402 cells and further
understanding the underlying molecular mechanism in an
effort to make the potential development of rhein in the
treatment of cancers. Using MTT assay and flow cytometry,
we demonstrate a critical role of rhein in the suppression of
BEL-7402 cell proliferation in a concentration- and time-
dependent manner. The increase of apoptosis rate was
observed after incubation of BEL-7402 cells with rhein at 50-
200 muM for 48 hours, and the cells exhibit typical apoptotic
features including cellular morphological change and
chromatin condensation. Moreover, rhein-induced cell cycle
S-phase arrest. Additionally, after rhein treatment, expression
levels of c-Myc gene were decreased, while those of caspase-
269
3 gene were increased in a dose-dependent manner by using
real- time PCR assay. The results demonstrate for the first
time that cell cycle S-phase arrest is one of the mechanisms
of rhein in inhibition of BEL-7402 cells. Rhein plays its role
by inducing cell cycle arrest via downregulation of oncogene
c-Myc and apoptosis through the caspase-dependent
pathway. It is expected that rhein will be effective and useful
as a new agent in hepatocelluar carcinoma treatment in the
future.
4089- gera: 150022/nd/ra
ANTIPROLIFERATIVE AND APOPTOTIC EFFECTS
OF PAEONOL ON HUMAN HEPATOCELLULAR
CARCINOMA CELLS. CHUNHU Z, SUIYU H, MEIQUN
C, GUILIN X, YUNHUI L. anticancer drugs.
2008;19(4):401-9 (eng).
Paeonol, a major phenolic component of Moutan Cortex, is
known to have antitumor effects through an unknown
mechanism. In this study, we tried to elucidate the anticancer
effects of paeonol on human hepatocellular carcinoma (HCC)
cell lines BEL-7404, SMMC-7721, and MHCC97-H in vitro.
Using the 3-[4,5-dimethylthiazol-2-yl]- 2,5-
diphenyltetrazolium bromide assay, we compared the
cytotoxicity of paeonol with the cytotoxicity of 5-
fluorouracil (5-FU) in these three HCC cell lines. In addition,
we examined the combined effect of paeonol and 5- FU over
time, and found that the two compounds inhibited the
proliferation of all three human HCC cell lines in a dose-
dependent manner. The concentrations that inhibited the
proliferation by 50% ranged from 11.39 to 56.23 mg/l for
paeonol, and 6.47 to 37.87 mg/l for 5-FU. We determined
that exposure to these compounds led to an upregulation of
the anti-oncogene PTEN, and the downregulation of the
oncogene AKT in the cell lines tested as determined by real-
time quantitative reverse transcription-PCR and western blot.
In addition, paeonol induced DNA fragmentation in the HCC
cell line BEL-7404. These observations suggest that paeonol
has the potential to
4090- gera: 150030/di/ra
EFFECT OF JIANPI HUOXUE DECOCTION ON
INFLAMMATORY CYTOKINE SECRETION
PATHWAY IN RAT LIVER WITH
LIPOPOLYSACCHARIDE CHALLENGE. PENG JH,
HU YY, CHENG Y, HAN C, XU LL, FENG Q, CHEN SD,
TAO Q, LI HS, LI XM. world j gastroenterol.
2008;14(12):1851-7 (eng).
AIM: To evaluate the effect of Chinese traditional medicinal
prescription, JIANPI HUOXUE decoction (JHD) on cytokine
secretion pathway in rat liver induced by lipopolysaccharide
(LPS). METHODS: Twenty-four male SD rats were divided
into normal group (n = 4), model group (n = 10) and JHD
group (n = 10) randomly. Rats in model group and JHD
group were administrated with normal saline or JHD via
gastrogavage respectively twice a day for 3 d. One hour after
the last administration, rats were injected with LPS via tail
vein, 50 mug/kg. Simultaneously, rats in normal group were
injected with equivalent normal saline. After LPS stimulation
for 1.5 h, serum and liver tissue were collected. Pathological
change of liver tissues was observed through hematoxylin-
eosin (H.E.) staining. Tumor necrosis factor alpha (TNF-
alpha) in serum were assayed by enzyme linked
immunosorbent assay (ELISA). The protein expression of
TNF-alpha, phosphorylated inhibit-kappaB (p-IkappaB) and
CD68 in liver were assayed by Western blot. The distribution
of CD68 protein in liver was observed through
immunohistochemical staining. The mRNA expression of
TNF-alpha, interleukin-6 (IL-6), CD14, toll-like receptor 2
(TLR2) and TLR4 in liver were assayed by real-time RT-
PCR. RESULTS: Predominant microvesicular change,
gera 2011

hepatocyte tumefaction and cytoplasm dilution were
observed in liver tissues after LPS administration as well as
obvious CD68 positive staining in hepatic sinusoidal. After
LPS stimulation, serum TNF-alpha (31.35 +/- 6.06 vs
12225.40 +/- 9007.03, P < 0.05), protein expression of CD68
(1.13 +/- 0.49 vs 3.36 +/- 1.69, P < 0.05), p-IkappaB (0.01 +/-
0.01 vs 2.07 +/- 0.83, P < 0.01) and TNF-alpha (0.27 +/- 0.13
vs 1.29 +/- 0.37, P < 0.01) in liver and mRNA expression of
TNF-alpha (1.96 +/- 2.23 vs 21.45 +/- 6.00, P < 0.01), IL-6
(4.80 +/- 6.42 vs 193.50 +/- 36.36, P < 0.01) and TLR2 (1.44
+/- 0.62 vs 4.16 +/- 0.08, P < 0.01) in liver were also
increased significantly. These pathological changes were all
improved in JHD group. On the other hand, TLR4 mRNA
(1.22 +/- 0.30 vs 0.50 +/- 0.15, P < 0.05) was down-regulated
and CD14 mRNA increased but not significantly after LPS
stimulation. CONCLUSION: JHD can inhibit cytokine
secretion pathway induced by LPS in rat liver, which is
probably associated with its regulation on CD68, p-IkappaB
and
4091- gera: 150095/nd/ra
ANTIOXIDATIVE AND HEPATOPROTECTIVE
EFFECT OF CGX, AN HERBAL MEDICINE,
AGAINST TOXIC ACUTE INJURY IN MICE. HU XP,
SHIN JW, WANG JH, CHO JH, SON JY, CHO CK, SON
CG. j ethnopharmacol. 2008;aug 7:x (eng).
AIM: CGX, a modified traditional Chinese herbal drug
whose name means "liver cleaning," is used to treat various
liver disorders. This study investigated the protective effects
of CGX and its mechanisms. MATERIAL AND METHODS:
After pretreating ICR mice twice daily with CGX (po, 50 or
100mg/kg) or distilled water for three consecutive days, acute
liver injury was induced by a single injection of CCl(4) (ip,
10mg/kg of 0.2% in olive oil) (n=10 per group). RESULTS:
Pretreatment with CGX significantly attenuated the elevation
in biochemical parameters, such as alanine transaminase
(ALT), aspartate transaminase (AST), and lactate
dehydrogenase (LDH) in serum, and the malondialdehyde
concentrations in liver tissue. Pretreatment with CGX
significantly restored the reduction of catalase activity and
glutathione (GSH) content, but not superoxide dismutase
(SOD) activity, and it inhibited the CCl(4)-induced high
expression of iNOS and TNF-alpha in hepatic tissue.
CONCLUSION: This study showed that CGX has
hepatoprotective effects against free radical-induced acute
injury via primarily antioxidative
4092- gera: 150129/nd/ra
EFFECTS OF DAN-SHAO-HUA-XIAN ON
EXPRESSION OF PPAR-GAMMA AND NF-KAPPA B
IN RAT LIVER FIBROSIS. WANG HY, CHENG ML.
hepatobiliary pancreat dis int. 2008;74(5):179-84 (eng).
BACKGROUND: Peroxisome proliferator-activated receptor
gamma (PPAR-gamma) and nuclear factor kappa B (NF-
kappaB) play important roles in liver fibrosis. This study
aimed to investigate the effects of Dan-shao-hua-xian, a
preparation of traditional Chinese medicine, on the
expression of PPAR-gamma and NF-kappaB in the fibrotic
livers of rats. METHODS: Seventy Wistar rats were
randomly divided into 4 groups: treatment (model, 8
weeks+treatment, 8 weeks; group A), natural recovery (
model, 8 weeks+saline, 8 weeks; group B), model (model
only, 8 weeks; group C), and control (normal, untreated, 16
weeks; group D). Each group consisted of 20 rats (except for
group D, which had 10). Fibrotic liver models were induced
in rats by subcutaneous injection of CCl4, oral administration
of alcohol and a high-lipid/low-protein diet for 8 weeks.
After the models were established, the rats in group A were
orally given Dan-shao-hua-xian capsules daily for another 8
weeks. Then, the liver indices serum hyaluronic acid (HA),
270
tumor necrosis factor-alpha (TNF-alpha) and alanine
aminotransferase (ALT) were measured. The degree of
hepatic fibrosis was evaluated by optical microscopy.
Hydroxyproline (Hyp) in the liver tissue was determined. The
expression of PPAR-gamma was detected by
immunohistochemical techniques. The protein levels of
PPAR-gamma and NF-kappaB were determined by Western
blotting. RESULTS: The concentrations of serum HA, TNF-
alpha and Hyp in group C increased compared with group D
(P<0.05), and they decreased in group A compared with
group C (P<0.05). The expression of PPAR-gamma in group
C decreased compared with group D (P<0.05), and it
increased in group A compared with groups B and C
(P<0.05). Similarly, Western blotting showed that the
expression of PPAR-gamma in group C decreased compared
with group D, and it increased in group A compared with
group C. The expression of NF-kappaB increased in group C
compared with group D (P<0.05), and it decreased in group
A compared with group C (P<0.05). CONCLUSION: Dan-
shao-hua-xian capsules enhance the expression of PPAR-
gamma but decrease that of TNF-alpha and NF-kappaB in the
liver tissues of CCl4-induced hepatic fibrotic rats. These
effects may play a role in its activity in treating hepatic
fibrosis.
4093- gera: 150251/di/ra
THE EFFECT OF QUYUHUATANTONGLUO
DECOCTION ON THE NON-ALCOHOLIC
STEATOHEPATITIS. ZHANG SJ, CHEN ZX, JIANG KP,
CHENG YH, GU YL. complementary therapies in
medicine. 2008;16(4):206 (eng).
Non-alcoholic steatohepatitis (NASH) is the most common
cause of cryptogenic cirrhosis, is becoming more prevalent in
China. However, there is as yet no clearly established therapy
for reversing fatty liver. Our aim is to explore the effect of
traditional Chinese herbs QuYuHuaTanTongLuo Decoction
(QYHTTLD) on non-alcoholic steatohepatitis. Sixty-nine
non-alcoholic steatohepatitis patients were randomly divided
into two groups. One group of 35 patients were treated by
QYHTTLD, another group of 34 patients were treated by
Ursodeoxycholic acid (UDCA). The TNF-alpha, IL-8, MDA
level, SOD activity and liver function, as well as B ultrasonic
image were detected before and after being treated. The
results showed: after 6 months treatment, MBI of the
treatment group was obviously decreased (p<0.05). The
levels of TC, TG and LDL-C were significantly decreased
whereas the level of HDL-C increased (p<0.01, p<0.05,
p<0.05, and p<0.05, respectively) in the treatment group, the
levels of TC, TG, LDL-C and HDL-C had no significant
difference in the control group (p>0.05). The levels of TNF-
alpha, IL-8 and MDA were significantly decreased whereas
SOD activity was significantly increased (p<0.01, p<0.05,
p<0.01, and p<0.01, respectively) in the treatment group, the
level of MDA was significantly decreased in the control
group (p<0.05). B ultrasonic images were ameliorated in
different degree (p<0.01 and p<0.01, respectively). Both
QYHTTLD and UDCA had the effect in improving the
scores of symptoms and signs of patients, however, the
difference value of the scores in treatment group were
significantly higher than that in control group after being
treated for 6 months (p<0.05). Conclusion: QYHTTLD is
effective for treating non-alcoholic steatohepatitis, and its
effect seems to relate with the ways of QYHTTL down-
regulating inflammation cytokine IL-8 level and relieving
lipid peroxidation of liver.
4094- gera: 150391/di/ra
EFFECTS OF ELECTRO-ACUPUNCTURE ON
EXPRESSIONS OF COLLAGEN TYPE I AND TYPE
III INRNA HI RATS OF HEPATIC FIBROSIS. MIN
gera 2011

YOU JIANG, MA XIAO-PENG , ZHAO TIAN-PING , WU
HUAN- GAN , SHI ZHENG , YANG SHAN , TAN LIN-
YING , ZHAO CUI-YING. shanghai journal of
acupuncture and moxibustion. 2008;27(8):43 (chi).
Objective To investigate the effects of electro-acupuncture(
EA) on expressions of collagen type I and type III mRNA in
rats of hepatic fibrosis. Methods Wistar rats were randomly
divided into EA-treated group ,medicine- treated group
,model group and normal group. Rat models of hepatic
fibrosis were made by carbon tetrachloride. EA-treated group
was punctured at Zusanli ( ST36) and Ganshu( BL18) with
EA , medicine-treated group was treated with colchicine. The
collagen fiber proliferation were observed under light
microscope with Masson staining, the expressions of collagen
type I and type III mRNA were detected by real-time
fluorescence quantitative polymerase chain reaction( FQ-
PCR). Results Compared with normal group, the collagen
hyperplasy and expressions of collagen type I and type III
mRNA increased significantly in the model group (P < 0.01).
Compared with model group, collagen hyperplasy and the
expressions of collagen type I and type III mRNA decreased
significantly in the EA-treated group( P <0.01 ). Conclusion
Puncturing Zusanli( ST36) and Ganshu( BL18) with EA
could down-regulate the expressions of collagen type I and
type III mRNA, which maybe the important molecular
4095- gera: 150394/di/ra
REGULATORY EFFECT OF BUSHEN JIANPI
RECIPE ( WATITO-) ON CELLULAR IMMUNITY OF
PATIENTS WITH PRIMARY LIVER CANCER AFTER
INTERVENTION THERAPY. WANG WEN-HAI, ZHOU
RONG-YAO, YAN ZHI-PING, ET AL. chinese journal of
integrated traditional and western medicine.
2008;28(7):583 (chi).
Objective To observe the regulatory effect of Bushen Jianpi
Recipe ( BSJPR) on cellular immunity the of primary liver
cancer patients of Gan-Shen yin-deficiency and Pi qi-
deficiency syndrome type after intervention therapy. Methods
According to the multi-center randomized controlled
principle , 117 patients after trailscatheter arterial
chemoembolization ( TACE) were assigned to two groups ,
60 in the treated group and 57 in the control group , who
were treated respectively with BSJPR and liver protecting
remedy ( silymarin and vitamin c) for 12 weeks. Changes in
TCM syndrome , quality of life ( QOL) , immediate effect on
tumor size and survival time were observed. Meantime , the
cellular immune function was also observed, including the T
lymphocyte response determined by 3H-TdR, expression of
MHC class I / II and B7 molecule detected by FACS , and
interleukin 10 and 12 ( IL-10 , IL-12) , interferon-y ( IFN-y)
tested by ELISA. Results In the treated group after treatment
, the efficacy for improving TCM syndrome reached 73. 33%
(44/60 cases) , their half-year survival rate being 83. 33%
(50/60 cases) ; while those in the control group were 52. 63%
(30/57 cases) and 70. 18% (40/57 cases) respectively,
significant difference was shown between the two groups (P
<0. 05) . The patients' QOL was improved in the treated
group after treatment, with no obvious adverse reaction.
However, the clinical benefit rate in the control group (92.
7% , 51/55 cases) was higher than that in the treated group
(78. 0% , 46/59 cases , P =0. 035 ). Laboratory examination
showed increases of MHC class II (CD14 +/HLA-DR)
expression on monocyte surface as well as IFN-y and IL-12
production in the treated group. Conclusion Using BSJPR
together with TACE could enhance patients' cellular immune
function to elevate the clinical curative effect on primary
liver cancer.
4096- gera: 150395/di/ra
QUALITY ASSESSMENT OF THE REPORT OF
271
RANDOMIZED CONTROLLED TRIALS ON
TREATMENT OF LIVER CARCINOMA WITH
TRADITIONAL CHINESE MEDICINE. ZHANG YING,
ZHANG RUI-MING, CHANG JING, ET AL. chinese
journal of integrated traditional and western medicine.
2008;28(7):588 (chi).
Objective To investigate the published randomized controlled
trials ( RCTs ) concerning the treatment of liver carcinoma
with TCM, and to assess their methodologic quality and
quality of report. Methods Related RCT reports published
from Jan. 2004 to June 2006 were retrieved by computerized
and manual search , and the criteria of CONSORT statement
( revised edition) were applied to assess the articles searched.
Results Forty-six articles up to the RCTs inclusion standard
were searched, among them, the method for randomized
distribution sequence producing was described in 9 articles
(19. 57% ) , none mentioned randomization concealment and
the estimation of the sample size. The blinded method was
adopted in 3 articles ( 6. 52% ) , the inclusion and exclusion
criteria were reported in 18 ( 39. 13% ) and 1 ( 2. 17% ) ,
respectively. Participant flow was reported in 3 (6. 52% ) ,
but flow chart was not described in any article. Patients'
compliance was reported in 5 ( 10. 87% ) , and the concrete P
value was reported in 6 (13. 04% ) , but with no report
involving the confidence interval. Adverse events were
described in 15 (32. 61% ) . Only 5 articles ( 10. 87% )
discussed the limitations of the present study in their section
of discussion. Conclusion The quality of RCTs reports on
treatment of liver carcinoma with TCM are still in low
quality, not meeting the CONSORT statement.
4097- gera: 150402/di/ra
SYNERGISTIC EFFECT OF EMODIN AND
CYCLOSPORINE A ON REJECTIVE REACTION
AGAINST LIVER GRAFT IN RATS. JING HE, LIN
SHENG-ZHANG, YANG XIAO, ET AL. chinese journal of
integrated traditional and western medicine.
2008;28(7):614 (chi).
Objective To evaluate the effect of emodin in combination
with cyclosporine A ( CsA) on rejective reaction against liver
graft in rats. Methods The LEW-BN orthotopic liver
transplantation rat model was used in the study. A total of 48
rats were divided into 4 groups randomly and equally, after
operation they were intraperitoneally injected respectively
with normal saline ( 0. 5 mL d -1, group A) ; CsA (10. 0 mg
kg -1 (1-' , group B) ; emodin (50. 0 mg kg V' , group C) ;
and CsA plus emodin ( group D , at the same dose as in B
and C). Six rats taken from each group were sacrificed on the
8th day after operation to calculate the rejection active index
( RAI) and hepatocyte apoptosis index ( AI) . The remainder
were stopped medication and used for observing the survival
time. Results The inter-group comparisons in mean survival
time, RAI and AI showed significant difference in comparing
group A with group B , C and D (P <0. 01) , and those in
group D were more obvious than in group B and C (P < 0.
05) , but showed no significant difference between group B
and group C ( P > 0. 05 ). Conclusion Administering of
emodin combined with CsA after liver transplantation shows
a synergistic effect for suppressing acute rejective
4098- gera: 150403/di/ra
INTERVENING AND THERAPEUTIC EFFECT OF
CORDYCEPS MYCELIA EXTRACT ON LIVER
CIRRHOSIS INDUCED BY
DIMETHYLNITROSAMINE IN RATS. WANG XIAN-
BO, LIU PING, TANG ZHI-PENG, ET AL. chinese journal
of integrated traditional and western medicine.
2008;28(7):617 (chi).
Objective To explore the intervening and therapeutic effect of
Cordyceps mycelia extract ( CME) on liver cirrhosis induced
gera 2011

by dimethylnitrosamine ( DMN) in rats. Methods Rat liver
cirrhosis model was established by peritoneal injection of
DMN at a dose of 10 Kg/kg, once daily in the first 3 days of
every week for 4 successive weeks. Experimental study on
CME-intervention was conducted from the beginning of
modeling to the end of the 4th week, while the CME-
treatment experiment was carried out from the 4th week of
modeling, when terminating the modeling factor, to the end
of the 8th week , by administering CME at a dose of 0. 74 g/
( kg d) once a day. Animals were killed in batches on the 3rd
day, the 2nd ( T1) , 4th ( T2) , 6th ( T3 ) and 8th ( T4) week
after modeling, to observe the histopathologic change in liver
and the immunohistochemical staining of alpha-smooth
muscle actin ( a-SMA) and collagen type I ( Col I) ,
determine the content of hydroxyproline ( Hyp ) in liver , and
the liver function was tested as well. Results CME-
intervention experiment showed that as compared to those in
the modeled rats at corresponding time points , in rats at T1
and 12 , serum alanine aminotransferase ( ALT) , aspartate
aminotransferase ( AST) activity and total bilirubin ( TBIL)
content were significantly lower, and albumin ( Alb)
obviously higher; while at T2 , Hyp content, a-SMA and Col
I positive expression were significantly lower ( P <0. 05) , the
proliferation of collagen fibre attenuated. CME-treatment
experiment showed that as compared to those in the modeled
rats at corresponding time points, lower serum ALT, AST
activity and TBIL content, and higher serum level of Alb
were shown in rats at T, ; and lower Hyp content, liver
collagen fibre, and cc-SMA positive expression were shown
at T, and T, ; while less Col I positive expression at T, was
also shown in them ( all P < 0. 05 ). Conclusion CME could
not only prevent the development of liver cirrhosis induced
by DMN in rats, but also effectively promote the reversion of
already formed liver cirrhosis , having a favourable prospect
of clinical
4099- gera: 150408/di/ra
EFFECT OF SODIUM FERULATE ON
HEMODYNAMICS IN HEPATIC CIRRHOSIS
PATIENTS WITH PORTAL HYPERTENSION.
HUANG ZHONG, WEI WEI , AND ZHONG QIANG.
chinese journal of integrated traditional and western
medicine. 2008;28(7):640 (chi).
Objective To observe the effect of sodium ferulate on the
hemodynamics of hepatic cirrhosis patients. Methods Eighty-
two hepatic cirrhosis patients were randomly assigned to two
groups, the 27 patients in the control group were treated by
conventional liver protecting therapy, and the 55 patients in
the treated group were treated with sodium ferulate besides
the conventional therapy. The therapeutic course for both
groups was two weeks. The following indexes were
measured before treatment and two weeks after treatment
respectively; inner diameter of portal vein ( PV) , inner
diameter of splenic vein ( SPV) , maximum portal vein flow
rate ( PVX) , maximum splenic vein flow rate ( SPVX) ,
portal vein blood flow ( QPV) and endothelin-1 ( ET-1 )
concentration. The adverse effect was observed meanwhile.
Results In the treated group after treatment , levels of PV ,
SPV and ET-1 decreased (P < 0. 01) , PVX and SPVX
increased significantly (P <0. 01) , but QPV was unchanged ;
while no significant change of all the indexes was found in
the control group ( P > 0. 05) . Further analysis showed that
in the treated group , PV , SPV and ET-1 decreased
significantly in patients of Child grade A and B ( P < 0. 01) ,
but QPV changed insignificantly (P > 0. 05) , and all indexes
were unchanged in patients of Child grade C ( P > 0. 05) .
Conclusion Sodium ferulate can effectively lower the
pressure of portal vein in hepatic cirrhosis patients without
any influence on the blood flow of portal vein, the effect is
more significant on patients of Child grade A and B.
272
4100- gera: 150409/di/ra
EFFECT OF UMBILICAL STICKING THERAPY
WITH QITOU XIAOGU PLASTER ( GIFF IGISM-*) IN
TREATING LIVER CIRRHOSIS PATIENTS WITH
PORTAL HYPERTENSION. SHI WEI-QUN , RU QING-
JING , CAI GUO-YING , ET AL. chinese journal of
integrated traditional and western medicine.
2008;28(7):642 (chi).
Objective To observe the effect of umbilical sticking therapy
( UST) with Qitou Xiaogu Plaster ( QXP) on hemodynamics
of portal system in patients with liver cirrhosis. Methods One
hundred and twenty patients of liver cirrhosis with portal
hypertension were assigned to two groups. On the basis of
conventional therapy , UST was applied in the 66 patients in
treated group , which was exchanged once every 3 days with
an interval of 1-day rest. The 54 patients in the control group
were orally administered with propanolol. The therapeutic
course for both groups was 1 month. Before and after
treatment, the hemodynamic changes in portal or splenic
veins were observed by color Doppler ultrasonograph , and
the changes of liver function , blood coagulation and patients'
subjective symptoms were observed as well. Results After
treatment , portal vein diameter and splenic vein diameter
significantly decreased (P <0. 05) , portal venous flow
velocity and splenic venous flow velocity apparently
increased (P <0. 05) , and portal venous flow apparently
decreased in both groups (P <0. 05) , while no significant
change was found in the splenic venous flow (P > 0. 05) .
The liver function and blood coagulation indexes in both
groups were improved. The improvement of clinical
symptoms in the treated group was superior to that in the
control group. Conclusion UST with QXP could decrease the
portal vein pressure in a short time, with the therapeutic
effect comparable to propanolol, and with no adverse
reaction.
4101- gera: 150428/nd/ra
PROTECTIVE EFFECTS OF TOTAL FLAVONOIDS
OF BIDENS BIPINNATA L. AGAINST CARBON
TETRACHLORIDE-INDUCED LIVER FIBROSIS IN
RATS. YUAN LP, CHEN FH, LING L, BO H, CHEN ZW,
LI F, ZHONG MM, XIA LJ. j pharm pharmacol.
2008;60(10):1393-402 (eng).
Bidens bipinnata L. is well known in China as a traditional
Chinese medicine and has been used to treat hepatitis in
clinics for many years. In a previous study we found that total
flavonoids of Bidens bipinnata L. (TFB) had a protective
effect against carbon tetrachloride (CCl4)-induced acute liver
injury in mice. Now this study was designed to investigate its
therapeutic effect against CCl4-induced liver fibrosis in rats
and to determine, in part, its mechanism of action. The liver
fibrosis model was established by subcutaneous injection of
50% CCl4 twice a week for 18 weeks. TFB (40, 80 and 160
mg kg(-1)) was administered by gastrogavage daily from the
9th week. The results showed that TFB (80 and 160 mg kg(-
1)) treatment for 10 weeks significantly reduced the elevated
liver index (liver weight/body weight) and spleen index
(spleen weight/body weight), elevated levels of serum
transaminases (alanine aminotransferase and aspartate
aminotransferase), hyaluronic acid, type III procollagen and
hepatic hydroxyproline. In addition, TFB markedly inhibited
CCl4-induced lipid peroxidation and enhanced the activity of
the antioxidant enzymes superoxide dismutase and
glutathione peroxidase. Moreover, TFB (80 and 160 mg kg(-
1)) treatment improved the morphologic changes of hepatic
fibrosis induced by CCl4 and suppressed nuclear factor (NF)-
kappaB, alpha-smooth muscle actin (SMA) protein
expression and transforming growth factor (TGF)-beta1 gene
expression in the liver of liver fibrosis of rats. In conclusion,
gera 2011

TFB was able to ameliorate liver injury and protect rats from
CCl4-induced liver fibrosis by suppressing oxidative stress.
This process may be related to inhibiting the induction of NF-
kappaB on hepatic stellate cell activation and the expression
of TGF-beta1.
4102- gera: 150447/nd/ra
ORIDONIN-LOADED POLY(EPSILON-
CAPROLACTONE)-POLY(ETHYLENE OXIDE)-
POLY(EPSILON- CAPROLACTONE) COPOLYMER
NANOPARTICLES. FENG N, WU P, LI Q, MEI Y, SHI S,
YU J, XU J, LIU Y, WANG Y. j drug target.
2008;16(6):479-85 (eng).
The aim of the present study was to develop a polymeric
delivery system for water-insoluble drug oridonin.
Amphiphilic block copolymers, poly(epsilon-caprolactone)-
poly(ethylene glycol)-poly (epsilon-caprolactone) (PCL-
PEO-PCL), were synthesized by ring-opening polymerization
of caprolactone initiated by the hydroxyl groups of
poly(ethylene glycol)6000 (PEG-6000) with stannous octoate
as catalyzer. Oridonin-loaded PCL-PEO-PCL copolymer
nanoparticles (ORI-PCL-PEO-PCL-NPs) were prepared by
the interfacial deposition method. The mean particle size of
the drug-loaded nanoparticles was 97.5 nm and the zeta
potential was - 25 mV. The entrapment efficiency and actual
drug loading of the nanoparticles were 87.52% +/- 1.86% and
8.63% +/- 0.49%, respectively. The antitumor activity of
ORI-PCL-PEO-PCL-NPs was evaluated by measuring
changes in tumor volumes, tumor weights, and survival rates
of mice with grafted hepatoma (H22). The results indicated
that ORI-PCL-PEO-PCL-NPs prolonged the survival time of
mice and exhibited higher therapeutic efficacy compared with
free oridonin. Thus, ORI-PCL-PEO-PCL-NPs may be used
as a promising delivery system for liver cancer treatment.
4103- gera: 150860/di/ra
APPLICATION OF KUSHENIN ON PATIENTS WITH
CHRONIC HEPATITIS C AFTER RENAL
TRANSPLANTATION. LI YANG, XUE WU-JUN, FAN
PING, ET AL. chinese journal of integrative medicine.
2008;14(3):167 (eng).
ABSTRACT Objective: To evaluate the efficacy of kushenin
in treating patients with chronic hepatitis C after renal
transplantation. Methods: Fifty-five patients were randomly
assigned by lottery to the treatment group (29 cases) and
control group (26 cases). The same immunosuppression
therapy was given to all patients in both groups. Patients in
the treatment group were treated with kushenin 0.6 g once a
day, while those in the control group were treated with
conventional liver protective agents such as vitamins. The
treatment duration of both groups was 3 months. The
incidences of serious hepatitis and acute rejection reaction,
serum biochemistry parameters including indicators of liver
and kidney functions, hepatic fibrosis index, and serum
HCV-RNA were compared between the two groups. Results:
(1) The incidence of serious hepatitis in the treatment group
and the control group was 3.45% (1/29 cases) and 11.54%
(3/26 cases), respectively, which was insignificantly different
between the two groups (P=0.335). (2) The incidence of
acute rejection in the treatment group was 6.90% (2/29 cases)
and that in the control group was 7.69% (2/26 cases),
showing insignificant difference (P=0.335). (3) The
differences in serum alanine aminotransferase (ALT), direct
bilirubin (DBIL), hyaluronic acid (HA), propeptide collagen
type III (PC III), laminin (LN), collagen type N (Col N)
levels between the two groups were insignificant before
transplantation (P>0.05), while the above-mentioned
parameters in the treatment group were significantly lower
than those in the control group after transplantation (P<0.05).
The difference in serum creatinine (SCr) and endogenous
273
creatinine clearance rate (CCr) between the two groups was
insignificant before and after transplantation (P>0.05). (4)
The negative conversion rate of HCV-RNA in the treatment
group was 31.03% (9/29 cases), significantly higher than the
value of 11.54% (3/26 cases) in the control group after
transplantation (P<0.05). (5) The levels of serum ALT and
DBIL in patients with HCV-RNA converted to negative were
significantly lower than those with still-positive HCV- RNA
(P<0.05). Conclusions: Kushenin has a certain effect on
inhibiting the proliferation of HCV, protecting liver cells, and
anti-liver fibrosis. On the other hand, it has no obvious
influence on Penal allograft function. Thus, the drug is
clinically safe and effective for use in treating patients with
chronic hepatitis C after renal transplantation.
4104- gera: 150901/di/ra
THIRTY CASES OF CHRONIC CHOLECYSTITIS
TREATED BY ACUPUNCTURE AND ORAL
ADIMINISTRATION OF DA CHAI HU TANG. ZHOU
SHENGHONG. journal of traditional chinese medicine.
2008;28(3):173 (eng).
4105- gera: 150910/di/ra
THE EFFECT-ENHANCING AND TOXICITY-
REDUCING ACTION OF THE EXTRACT OF HERBA
SCUTELLARIAE BARBATAE FOR
CHEMOTHERAPY IN HEPATOMA H22 TUMOR-
BEARING MICE. DAI ZHIJUN, LIU XIAOXU, JI
ZONGZHENG, ET AL. journal of traditional chinese
medicine. 2008;28(3):205 (eng).
Objective: To investigate the effect-enchancing and toxicity-
reducing action of the extract of Ban Zhi Lian Herba
Scutellariae Barbatae, EHSB) for chemotherapy in hepatoma
H22 tumor-bearing mice. Methods: The tumor- bearing mice
were divided into 6 groups randomly: a model group, a high
dose EHSB group, a low dose EHSB group, a 5-fluorouracil
(5-FU) group, a 5-FU+high dose EHSB group and a 5-
FU+low dose EHSB group, and with `a normal group set as
the controls. All the groups were treated for 10 days. The life
prolongation rate, toxic reactions of chemotherapy, WBC
count, the body weight, tumor weight, thymus index and
spleen index, and phagocytic function of intra-abdominal
macrophages were investigated in the I-122 tumor-bearing
mice. Results: The increase of the body weight in both the 5-
FU+EHSB groups was significantly higher than that in the 5-
FU group, with the toxic reactions such as anorexia,
abdominal distension and emaciation significantly alleviated.
Growth of the tumor was significantly inhibited in the high
dose EHSB group, the 5-FU group, the 5-FU+high dose
EHSB group, and the 5-FU+low dose EHSB group. The
survival time in the 5-FU+high dose EHSB group and the 5-
FU+low dose EHSB group was significantly prolonged as
compared with that of the 5-FU group. The life prolongation
rate was 98.72% in the 5-FU+high dose EHSB group and
52.11% in the 5-FU+low dose EHSB group. Growth of the
transplanted tumor was significantly inhibited in the high
dose EHSB group, the 5-FU group, the 5-FU+high dose
EHSB group, the 5-FU+low dose EHSB group. The tumor
inhibition rate in the high dose EHSB group, the 5-FU group,
the 5-FU+high dose EHSB group and the 5-FU+low dose
EHSB group was 36.98%, 42.26%, 65.28% and 52.45%,
respectively. 5-FU combined with a high-dose EHSB could
significantly enhance the tumor inhibition rate (P<0.05). The
thymus index and the spleen index significantly increased in
the high dose EHSB group, and atrophy of the
immunological organs induced by chemotherapy was
improved in the 5-FU+high dose EHSB group and in the 5-
FU+low dose EHSB group. The WBC count decreased
significantly in the 5-FU group, but increased in both the 5-
FU+EHSB groups. The phagocytic function of infra-
gera 2011

abdominal macrophages was increased in both the 5-
FU+EHSB groups, with the phagocytic rate and the
phagocytic index increased by 78.55% and 81.63% in the 5-
FU+high dose EHSB group and by 43.97% and 44.90% in
the 5-FU+low dose EHSB group. Conclusions: EHSB can
significantly enhance the tumor inhibition rate of 5-FU,
reduce the toxic effects, prolong the survival time, and
improve immune function in the H22 tumor-bearing mice.
4106- gera: 150927/nd/ra
ARSENIC TRIOXIDE-INDUCED GROWTH ARREST
OF HUMAN HEPATOCELLULAR CARCINOMA
CELLS INVOLVING FOXO3A EXPRESSION AND
LOCALIZATION. FEI M, LU M, WANG Y, ZHAO Y, HE
S, GAO S, KE Q, LIU Y, LI P, CUI X, SHEN A, CHENG C.
med oncol. 2008;oct 21:x (eng).
Human hepatocellular carcinoma (HCC) remains incurable
with current therapies, and novel biologically based therapies
are urgently needed. Arsenic agents have long been used as
anticancer agents in traditional Chinese medicine. In this
study, to evaluate the effect of As(2)O(3) on HCC cells, we
investigate cell growth inhibition, cell cycle arrest, and the
molecular mechanism after As(2)O(3) treatment in human
HCC cells in vitro. We detected the proliferation of HCC
cells by the Cell Counting Kit and FACS/Calibur Flow
Cytometer and analyzed the expression and localization of
FOXO3a by Western blotting Analysis and Cell
Fractionation. Furthermore, we study the Akt activation after
As(2)O(3) treatment and the HCC cells proliferation after
combination of As(2)O(3) with PI3K inhibitor Wortmannin.
As(2)O(3) significantly inhibited the proliferation of all the
three HCC cell lines (SMMC7721, HepG2, Hep3B) tested in
this study in a dose-dependent manner. Western blotting
revealed that treatment HCC cells HepG2 with As(2)O(3)
resulted in the increasing of FOXO3a expression and
triggered phosphorylation of FOXO3a at the Thr(32) residue
decrease. This FOXO3a accumulation correlated well with
the As(2)O(3)-induced reduction of active Akt. Nuclear and
cytoplasmic protein extracts isolated from the HCC cell line
HepG2 revealed that the amount of nuclear FOXO3a was
increased by treatment with As(2)O(3), whereas the amount
of cytoplasmic FOXO3a was decreased. Both As(2)O(3) and
PI3K/Akt inhibitor Wortmannin induced cell cycle arrest.
However, compared with As(2)O(3) alone, PI3K inhibitor
Wortmannin combined with As(2)O(3) enhanced the
antitumor effect of As(2)O(3) through induction of apoptosis.
These findings suggest that As(2)O(3) at a clinically safe
concentration may be an effective chemotherapeutic agent,
and that As(2)O(3) and PI3K/Akt inhibitor Wortmannin may
synergize for HCC cells. Taken together, the present study
may suggest a specific molecular mechanism by which HCC
cell lines are susceptible to the As(2)O(3) therapy through
FOXO3a expression and localization.
4107- gera: 150930/di/ra
THERAPEUTIC EFFECT OF TRADITIONAL
CHINESE MEDICINE ON COAGULATION
DISORDER AND ACCOMPANYING INTRACTABLE
JAUNDICE IN HEPATITIS B VIRUS-RELATED
LIVER CIRRHOSIS PATIENTS. LI YM, YANG HZ,
GUAN WB, KE QS, DAI M, XIE HP, ZHANG SJ. world j
gastroenterol. 2008;14(39):6060-4 (eng).
AIM: To observe the therapeutic effects of new traditional
Chinese medicine (TCM) therapy on coagulation disorder
and accompanying intractable jaundice in HBV-related liver
cirrhosis patients. METHODS: Using stratified random
sampling according to fibrinogen (Fib) levels, 145 liver
cirrhosis patients due to hepatitis B complicated by
coagulation disorder were treated. Of them, 70 in research
group were treated with TCM by "nourishing yin, cooling
274
blood and invigorating blood circulation" and Western
medicine, 75 in control group were treated with conventional
Western medicine. The indexes of liver function, coagulation
function and bleeding events were observed and compared.
RESULTS: The prothrombin time (PT) was shorter and the
fibrinogen (Fib) level was higher in the research group than
in the control group (Fib = 1.6-2.0 g/L, 1.1-1.5 g/L, and <=
1.0 g/L). The total bilirubin (TBIL) level was significantly
lower in the research group than in the control group, except
for the subgroup of FIB <= 1.0 g/L. CONCLUSION: TCM
therapy can improve coagulation fuction and decrease TBIL.
4108- gera: 150990/nd/ra
EVALUATION OF PROTECTIVE EFFECTS OF CHI-
ZHI-HUANG DECOCTION ON PHASE I DRUG
METABOLISM OF LIVER INJURED RATS BY
COCKTAIL PROBE DRUGS. TANG H, MIN G, GE B, LI
Y, LIU X, JIANG S. j ethnopharmacol. 2008;117(3):420-6
(eng).
AIM OF THE STUDY: Chi-Zhi-Huang decoction (PGR) is
one of the traditional Chinese medicine (TCM) preparations
with unique effect on withdrawing jaundice and has been
used to treat icteric patients in China for many years. In this
research, we aim at to evaluate the potential activity of PGR
in restoring hepatic drug metabolism in a damaged liver.
MATERIALS AND METHODS: A cocktail approach with
caffeine (10mg/kg), dapsone (10mg/kg) and chlorzoxazone
(20mg/kg) respectively as probe drug of cytochrome P450
(CYP) isoform of CYP 1A2, 3A4 and 2E1 was used to
evaluate its possible effects on Phase I oxidative metabolism.
Pretreated with three dosages of PGR water extract (0.75, 1.5
and 3g/kg, po) for 5 days, male Wistar rats (220-240 g) were
intoxicated by phenylisothiocyanate (PITC, 100mg/kg, po)
24h before probes intravenous injection. The
pharmacokinetics of the probes in the blood was determined
simultaneously by HPLC, and their non- compartmental
parameters were used to evaluate the metabolic difference
among the groups. Moreover, the levels of liver enzymes
(ALT, AST, ALP) and bilirubins were also measured for
insight of liver function. RESULTS: The findings in this
study suggest that PGR induces CYP 3A4, does not have
much effect on CYP 2E1, and inhibits CYP 1A2 at high
dosage. CONCLUSION: The current pharmacokinetic
approach allowed the protective effects of PGR on oxidative
drug metabolism in damaged liver to be systemically
examined and will certainly help in the explanation of
synergistic effect of the composites formula.
4109- gera: 151077/di/ra
[REGULATIVE EFFECTS OF CHINESE HERBS FOR
NOURISHING YIN AND REMOVING FIRE ON GENE
EXPRESSIONS OF ESTROGEN RECEPTOR ALPHA,
INSULIN-LIKE GROWTH FACTOR-1 RECEPTOR.
LU JP, CAI DP. chinese journal of integrated traditional
and western medicine. 2008;28(8):721 (chi).
OBJECTIVE: To investigate the effect of Chinese herbs for
nourishing yin and removing fire (NYRF) on gene
expressions of estrogen receptor alpha (ER alpha), insulin-
like growth factor-1 receptor (IGF-1R) and epithelial growth
factor receptor (EGFR) in the epiphyseal growth plate of the
female pubertal rats. METHODS: The rats were randomly
divided into the control group and the intervened group.
Immunohistochemistry and realtime-PCR methods were used
to measure the gene expression of ER alpha, IGF-1R and
EGFR and their protein synthesis in epiphyseal growth plate.
RESULTS: After being intervened with NYRF, the gene
expressions of ER alpha and IGF- 1R were down-regulated
and their protein synthesis markedly reduced, while those of
EGFR were unchanged. CONCLUSION: NYRF can
modulate the development and maturation of bone by
gera 2011

regulating the expressions of ER
4110- gera: 151078/di/ra
[EFFECTS OF HUANGLIAN JIEDU DECOCTION ON
THE OXIDATIVE STRESS OF LIVER
MITOCHONDRIA IN INSULIN RESISTANT RATS].
HUANG L, LU FE, YANG XY. chinese journal of
integrated traditional and western medicine.
2008;28(8):725 (chi).
OBJECTIVE: To study the protective effects of Huanglian
Jiedu Decoction (HLJD) on the oxidative damage of liver
mitochondria in insulin resistant rats and to explore its
possible mechanism. METHODS: Male Wistar rats were fed
with high-fat diet to set up an insulin resistant model, and
randomly divided into four groups, the control group and
three test groups intervened respectively with HLJD,
berberine, and thioctic acid for 6 weeks. The liver
mitochondrial function and energy metabolic capability were
assayed by measuring the activities of ATPase, succinic
dehydrogenase (SDH), cytochrome oxidase (CCO) and the
content of ATP in liver tissue. The anti- oxidation capability
of liver mitochondria was determined by measuring the
activities of superoxide dismutase (SOD), glutathione
peroxidase (GSH-Px) and the content of malondialdehyde
(MDA). RESULTS: HLJD showed the effect in improving
the activities of GSH-Px, SOD and ATPase, inhibiting the
production of MDA, promoting the energy metabolism and
strengthening the activities of SDH and CCO in liver tissue
of insulin resistant rats. CONCLUSION: HLJD could
improve the liver mitochondria function and energy
metabolism, strengthen the mitochondrial anti-oxidation
capacity, and showed evidently protective effect on liver
mitochondrial damage in insulin resistant rats. The
mechanism might be correlated with its scavenging action on
oxygen radicals and inhibition on lipid-peroxidation.
4111- gera: 151089/di/ra
[COMPREHENSIVE THERAPY OF CHRONIC
HEPATITIS B INDUCED LIVER FIBROSIS]. HU YY,
CHENG Y. chinese journal of integrated traditional and
western medicine. 2008;28(8):765 (chi).
4112- gera: 151176/di/ra
ASSESSMENT OF PRESCRIBED HERBAL
MEDICINE ON LIVER FUNCTION IN KOREA: A
PROSPECTIVE OBSERVATIONAL STUDY. YUN YJ,
NAH SS, PARK JH, JUNG SK, PAECK EK, PARK JH,
LEE EJ, KIM SH, PARK HM, LEE SD, KIM JY, HONG SJ,
CHOE BK, CHUNG JH. journal of alternative and
complementary medicine. 2008;14(9):1131-6 (eng).
OBJECTIVE: The aim of this study was to investigate the
influence of herbal medicine (HM) prescribed by doctors of
Korean medicine (KMD) on liver function in Korea.
DESIGN AND INTERVENTIONS: For this multicenter,
prospective, observational study, we enrolled patients who
wished to take HM prescribed by KMD for various medical
purposes in Korea. One hundred and twenty-two (122)
patients took HM for an average of 20.6 +/- 8.4 (mean +/-
standard deviation) days, and completed questionnaires.
OUTCOME MEASURES: Liver function tests (LFTs) were
performed before (first test) and after each HM treatment
(second test). For LFT, aspartate aminotransferase, alanine
aminotransferase, total bilirubin (t-Bil), direct bilirubin,
alkaline phosphatase, and gamma-glutamyl transferase were
measured. RESULTS: There were no significant changes in
LFT data between the first and second tests, except in the t-
Bil level. However, all data of total bilirubin level in second
test were within normal range, except only one patient.
Multivariate analysis did not identify any herb that
significantly increased t-Bil; hence no hepatotoxic herb was
275
found. Twenty-one (21) of the 122 patients were abnormal on
first testing, and 10 at the second testing. Of the patients
taking herbs, 4 changed from normal to abnormal and 15
from abnormal to normal (p = 0.019). CONCLUSION: The
current study showed that ingestion of HM prescribed by
KMD did not increase the frequency of abnormal LFTs, at
least in the short term.
4113- gera: 151182/di/ra
TRADITIONAL CHINESE MEDICINE PLUS
TRANSCATHETER ARTERIAL
CHEMOEMBOLIZATION FOR UNRESECTABLE
HEPATOCELLULAR CARCINOMA. MENG MB, CUI
YL, GUAN YS, YING Z, ZHENG MH, YUAN CK,
ZHANG RM. journal of alternative and complementary
medicine. 2008;14(8):1027-42 (eng).
OBJECTIVES: To compare the efficacy and safety of
Traditional Chinese Medicine (TCM) plus transcatheter
arterial chemoembolization (TACE) with that of TACE alone
(therapy I versus therapy II, respectively) in treating
unresectable hepatocellular carcinoma (UHCC) through a
meta-analysis of all available randomized controlled trials.
METHODS: Literature retrieval was conducted using the
Cochrane Library, MEDLINE, EMBASE, CBMdisk, and
CNKI in any language. Meta-analysis was performed on the
results of homogeneous studies. Analyses subdivided by
TACE frequency (subgroup A, <3 times; subgroup B, > or =3
times) were also performed, but were not done for both
therapy I and therapy II. RESULTS: Based on our search
criteria, we found 37 trials involving 2653 patients. Our
results showed that therapy I, compared with therapy II,
improved patient survival, quality of life, alleviation of
symptoms, and tumor response, and was thus more
therapeutically beneficial. Further analysis showed that
subgroup A proved to be better for patients' survival and
alleviation of symptoms, while the two subgroups were
similar in improved tumor response. No serious adverse
events were reported. CONCLUSIONS: Therapy I benefited
patients with UHCC. Subgroup A improved the survival of
patients and the amelioration of symptoms more than
subgroup B. As in some trials, there were flaws in the
methodological quality, and the data therefore have a risk of
bias and of being insufficient for determining the effects of
therapy I and subgroup A. Hence, further large-scale trials are
warranted.
4114- gera: 152334/di/ra
[ANALYSIS ON ASSOCIATED RISK FACTORS AND
SYNDROME TYPES IN DIABETES MELLITUS TYPE
2 PATIENTS COMPLICATED WITH NON-
ALCOHOLIC FATTY LIVER]. CHEN ZH, XIA CD,
HUAN JN.. chinese journal of integrated traditional and
western medicine. 2008;28(10):879-81 (chi).
OBJECTIVE: To explore the risk factors and the main TCM
syndrome types associated with the diabetes mellitus type 2
(DM2) patients complicated with non-alcoholic fatty liver
(FL). METHODS: Adopted controlled trial method, the age,
stature, body weight, and body mass index (BMI) of 180
DM2 patients were compared with those complicated with or
without FL. And some related laboratory indexes, including
the age, stature, body weight, BMI, fasting blood glucose
(FBG), C-peptide (CP), glycosylated hemoglobin (HbA1c),
triglyceride (TG), total cholesterol (TC), high and low
density lipoprotein cholesterol (HDL-C and LDL-C), and 2 h
post-prandial CP (2 h CP), were compared as well. Moreover,
patients' TCM syndrome types were classified. RESULTS:
No significant differences were found between DM2 patients
complicated with or without FL in aspects of FBG, HbA1c,
TC, LDL-C and age, stature (P > 0.05), but significant
difference did show between them in aspects of CP (4.09 +/-
gera 2011

2.40 microg/L vs 2.47 +/- 1.74 microg/L), 2h CP (6.38 +/-
5.46 microg/L vs 4.35 +/- 2.92 microg/L), TG (2.81 +/- 2.33
mmol/L vs 1.93 +/- 1.92 mmol/L), HDL-C (1.07 +/- 0.06
mmol/L vs 1.19 +/- 0.32 mmol/L) as well as in body weight
(73.4 +/- 11.7 kg vs 61.4 +/- 10.1 kg) and BMI (26.0 +/- 3.67
vs 22.8 +/- 3.23), respectively (P < 0.05 or P < 0.01).
Moreover, phlegm-dampness type was more liable to appear
in DM2 patients complicated FL. CONCLUSIONS: Obesity,
insulin resistance and lipid metabolism disorder are the chief
risk factors in DM2 patients complicated with FL and
phlegm-dampness is the chief pathogenesis.
4115- gera: 152345/di/ra
[EFFECT OF RONGGAN MIXTURE ON CELL
APOPTOSIS IN RATS WITH CHRONIC IMMUNE
LIVER INJURY INDUCED BY CONCANAVALIN A].
WANG FY, TANG XD, XU YG. chinese journal of
integrated traditional and western medicine.
2008;28(9):835-8 (chi).
OBJECTIVE: To explore the effects of Ronggan Mixture
(RGM) on cell apoptosis by observing the expressions of
apoptosis-related genes (Fasl and Bcl-2) in transgenic mice
with chronic liver immune injury induced by concanavalin A
(ConA). METHODS: Seventy-four transgenic mice were
divided into 6 groups, the model group, the normal group,
and the treated groups treated respectively with
biphenyldicarboxylate (DDB), oriental wormwood (OWW),
Yinchenhao Decoction (YCHD) and RGM. Pathologic
changes of liver tissue were observed by light microscopy,
number of apoptotic cells were determined by TUNEL
method, and expressions of apoptosis- related genes, Fasl and
Bcl-2, in hepatic T lymphocyte were detected by flow
cytometer. RESULTS: Evident pathological changes of liver
appeared in the model mice, showed severely destroyed
structure of hepatic lobules. As compared with the model
group, the changes of liver fibrosis and cell necrosis were
much lessened in the RGM group and the YCHD group (P <
0.05). The protein expression of apoptotic gene Fasl and the
apoptotic index in the model group were higher than those in
the normal group (P < 0.05), but that of the apoptotic
inhibiting gene, Bcl-2, in model mice was similar to that in
normal mice. As compared with the model group, apoptosis
index decreased (P < 0.01), levels of Fasl expression was
lower and Bcl-2 expression was higher in the RGM group
and the YCHD group (P < 0.05, P < 0.01), and the effect of
the two was similar, but significantly superior to that of
OWW and DDB (P < 0.05 or P < 0.01). CONCLUSION: The
Chinese compound, RGM and YCHD can not only relieve
the hepatic pathological injury, but also reduce the cell
apoptosis in chronic liver immune injury mice through
regulating the expressions of Fasl and Bcl-2.
4116- gera: 152356/di/ra
[COMBINED THERAPY OF SHEHUANG PASTE AND
COLONIC DIALYSIS WITH CHINESE MEDICINES
FOR TREATMENT OF REFRACTORY CIRRHOTIC
ASCITES COMPLICATED WITH AZOTEMIA]. TONG
GD, ZHOU DQ, HE JS. chinese journal of integrated
traditional and western medicine. 2008;28(9):788-92 (chi).
OBJECTIVE: To observe the clinical efficacy of combined
therapy of Shehuang Paste (SHP) with colonic dialysis in
treating patients with refractory cirrhotic ascites complicated
with azotemia. METHODS: Adopting a multi- centered,
randomized, double blinded and 1:1 parallel controlled trial,
120 patients were equally randomized into 2 groups, the
control group was treated by conventional basic therapy
(umbilical application of placebo paste and colonic dialysis
with normal saline), and the treatment group by, besides the
same basic therapy, umbilical application of SHP once a day
and colonic dialysis with herbal medicine once every other
276
day. The course was 1 month for both groups. Changes of
ascites volume, renal function, serum and urinary levels of
Na+ and K+, blood vasoactive substance, and portal
dynamics in patients before and after treatment were
observed. RESULTS: The total effective rate for ascites was
71.7% (43/60 cases) in the treatment group and 18.3% (11/60
cases) in the control group, showing significant difference
between groups (P < 0.01). Significant difference of blood
creatinine, urea nitrogen, serum Na+ levels, and urinary
Na+/K+ ratio were shown in the treatment group (P < 0.01)
before and after treatment, and between groups after
treatment (P < 0.05, P < 0.01). Portal vein blood flow was
significantly lowered in the treatment group after treatment
(P < 0.01), which showed significant difference as compared
with that in the control group (P < 0.01). Besides, levels of
atrial natriuretic peptide, renin, angiotensin, nitric oxide, and
aldosterone decreased and endotoxemia improved
remarkably in the treatment group (P < 0.01). One-year
follow- up showed that the ascites eliminating rate and the
incidence of hepato-renal syndrome in the treatment group
was 38.3% (23/60 cases) and 23.3% (14/60 cases)
respectively, while in the control group 0 and 41.7% (25/60
cases) respectively, all showed statistical difference between
groups (all P < 0.05). CONCLUSION: Combined therapy of
SHP and colonic dialysis with herbal medicine could
effectively eliminate the ascites, improve the hemodynamic
condition of portal and splenic veins, reduce the content of
vasoactive substance and noxious substances like ammonia
and endotoxin in blood, and lower the incidence of hepato-
renal syndrome.
4117- gera: 152357/di/ra
[PROTECTIVE EFFECT OF COMPOUND TONGFU
GRANULE ON INTESTINAL MUCOSAL BARRIER IN
PATIENTS WITH CIRRHOSIS OF
DECOMPENSATION STAGE]. JIANG CY, WANG BE,
CHEN D. chinese journal of integrated traditional and
western medicine. 2008;28(9):784-7 (chi).
OBJECTIVE: To explore the intestinal mucosal barrier
protective effect of herbal medicine Compound Tongfu
Granule (CTG) in patients with liver cirrhosis of
decompensation stage. METHODS: Fifty patients enrolled
were randomly assigned to the control group (26 cases) and
the CTG group (24 cases), and 30 healthy adults were set up
as normal control. After 2-week treatment, the intestinal
permeability (IP, represented by urinary lactulose/mannitol
excretion rate), plasma endotoxin (EDT) level, and change of
enteric bacteria (EB) in patients were observed before and
after treatment, and compared with those in the normal
control. RESULTS: Before treatment, cirrhotic patients
showed significantly higher levels of IP, EDT, and intestinal
bacilli, but a lower amount of enteric bifidobacteria as
compared with those the normal control. After 2-week
treatment, levels of EDT and urinary excretion rate of
lactulose in the CTG group were lowered more significantly
than those in the control group (P < 0.05), while the amount
of bifidobacteria in the CTG group increased accompanied
with intestinal bacilli significantly lowered to near the levels
in the normal control (P < 0.05, P < 0.01). CONCLUSION:
CTG can improve the intestinal barrier function, correct the
intestinal bacteria disturbance, and significantly reduce the
entero-derived endotoxemia in cirrhotic patients of
decompensation stage.
4118- gera: 153554/nd/ra
ROLE OF GRAPE SEED EXTRACT ON
METHOTREXATE INDUCED OXIDATIVE STRESS
IN RAT LIVER. CETIN A, KAYNAR L, KOCYIGIT I,
HACIOGLU SK, SARAYMEN R, OZTURK A, SARI I,
SAGDIC O. am j chin med. 2008;36(5):861-72 (eng).
gera 2011

The efficacy of methotrexate (MTX), a widely used cytotoxic
chemotherapeutic agent, is often limited by its severe
hepatotoxicity. Regarding the mechanisms of these adverse
effects, several hypotheses have been put forward, among
which oxidative stress is noticeable. The present study was
undertaken to determine whether grape seed extract (GSE), a
new natural free radical scavenger, could ameliorate the
MTX-induced oxidative injury in the rat liver. The animals
were divided into 3 groups. Each group consisted of 12
animals. MTX-GSE group: rats were given GSE (100mg/kg
body weight) orally for 15 days, and a single dose of MTX
(20 mg/kg, intraperitoneally) was added on the 10th day.
MTX group: these received placebo distilled water (orally)
instead of GSE for 15 days and the same MTX protocol
applied to this group on the 10th day. Control group: rats
were given distilled water (orally) through 15 days and
physiological saline (intraperitoneally) instead of MTX was
administered on the 10th day in a similar manner. On the
16th day, liver tissue samples were obtained under deep
anaesthesia. The level of malondialdehyde (MDA), an end
product of lipid peroxidation, and the activities of süperoxide
dismutase (SOD) and catalase (CAT), two important
endogenous antioxidants, were evaluated in the tissue
homogenates. MTX administration increased the MDA level
and decreased the SOD and CAT activities in the liver
homogenates (p < 0.001), while these alterations were
significantly reversed by GSE treatment (p < 0.001). MTX
led to significantly reduced whole blood count parameters (p
< 0.05). When GSE was supplemented, no significant
changes in blood count parameters were noted. It appears that
GSE protects the rat liver and inhibits methotrexate-induced
oxidative stress. These data indicate that GSE may be of
therapeutic benefit when used with MTX.
4119- gera: 152429/di/ra
INFLUENCE OF TCM THERAPY FOR
SUPPLEMENTING PI () AND NOURISHING SHEN ()
ON DENDRITIC CELL FUNCTION IN PATIENTS
WITH CHRONIC HEPATITIS B TREATED BY
LAMIVUDINE. ZHANG YH, LIU YH. chinese journal of
integrative medicine. 2009;15(1):60-2 (eng).
OBJECTIVE: To observe the influence of traditional Chinese
medicine (TCM) therapy for supplementing Pi () and
nourishing Shen (, SPNS) on dendritic cell function in
patients with chronic hepatitis B (CHB) treated by
lamivudine. METHODS: Sixty CHB patients with positive
HBeAg were equally randomized by digital table into two
groups: the observation group and the control group. Patients
in the control group were treated with lamivudine only, while
patients in the observation group were treated with
lamivudine combined with SPNS fomula, for 12 weeks. The
phenotype and function of dendritic cell, as well as its
secretion factor interleukin 12 (IL-12) in all patients were
determined after termination of therapy and the impacts on
alanine transaminase (ALT) and HBVDNA were observed.
RESULTS: The phenotypes of dendritic cells such as CD1a,
CD80, CD86, human leukocyte antigen (HLA-DR) and
intercellular adhesion molecule-1, as well as the levels of
stimulation index (SI) and IL-12 were higher in the
observation group than those in the control group (P<0.05 or
P<0.01). Meanwhile, signififi cant difference between the
two groups was also shown in the normalizing rates of ALT
and HBV-DNA (P<0.05). CONCLUSION: TCM therapy for
SPNS can signifificantly improve the function of dendritic
cells in patients with CHB treated by lamivudine and enhance
the early stage response of patients to the treatment.
4120- gera: 152434/di/ra
EVALUATION ON QUALITY OF LIFE AND
ANALYSIS ON ITS CORRELATION WITH TCM
277
SYNDROMES IN PATIENTS OF CHRONIC
HEPATITIS B. ZHANG W, WANG LQ, LIU YB. chinese
journal of integrative medicine. 2009;15(1):30-3 (eng).
OBJECTIVE: To evaluate the quality of life (QOL) in
patients with chronic hepatitis B (CHB) and analyze its
correlation with traditional Chinese medicine (TCM)
syndrome types. METHODS: With cross-sectional
investigation adopted, the QOL of 335 CHB patients was
studied by the World Health Organization Quality of Life
BREF Questionnaire (WHOQOL-BREF) and the chronic
liver disease questionnaire (CLDQ). The results was
compared with that of 30 healthy persons. RESULTS: The
QOL of the patients with chronic hepatitis B was lower than
the healthy persons with signififi cant difference between
them (P<0.01). Also it was different in patients of different
TCM syndrome types (P<0.05 or P<0.01). The lowest QOL
was shown in patients of the blood-stasis blocking vessel
type and Gan ()-stagnation with Pi ()-defificiency type
(P<0.01). CONCLUSION: The QOL of CHB patients is
lower than of healthy persons and closely correlated with
TCM syndrome types.
4121- gera: 152589/di/ra
ANTIOXIDANT AND PREVENTIVE EFFECTS OF
EXTRACT FROM NYMPHAEA CANDIDA FLOWER
ON IN VITRO IMMUNOLOGICAL LIVER INJURY
OF RAT PRIMARY HEPATOCYTE CULTURES.
ZHAO J, LIU T, MA L, YAN M, GU Z, HUANG Y, XU F,
ZHAO Y. evid based complement alternat med. 2009;FEB
5: (eng).
Nymphaea candida is traditional Uighur medicine that is
commonly used to treat head pains, cough, hepatitis and
hypertension in Xinjiang of China. In this article, the extract
of N. candida was measured for antioxidant activity, using
1,1-diphenyl-2-picrylhydrazyl (DPPH) radicals scavenging
assay and reducing power determination, and compared with
those of the positive controls of butylated hydroxytoluene
(BHT) and gallic acid (GA). The active extract was further
purified by liquid-liquid partition to afford four fractions, of
which the ethyl acetate-soluble (EA) fraction (NCE)
exhibited the strongest antioxidant capacity with IC(50) value
of 12.6 microg/ml for DPPH.. Thirteen phenolic compounds
were isolated from this fraction, and they all showed
significant antioxidant activities in DPPH model system.
Furthermore, NCE showed potent antioxidant capacity with
IC(50) value of 59.32 microg/ml, 24.48 microg/ml and 86.85
microg/ml, for O(2)(-),.OH and H(2)O(2) radicals,
respectively. Moreover, NCE on BCG plus LPS-induced
immunological liver injury was evaluated using primary
cultured rat hepatocytes. NCE produced significant
hepatoprotective effects as evidenced by decreased
supernatant enzyme activities (AST-aspartate transaminase, P
< 0.01; ALT-alanine transferase, P < 0.01) and nitric oxide
(NO, P < 0.01) production. These results revealed the in vitro
antioxidant and hepatoprotective activities of NCE against
immunological liver injury. Further investigations are
necessary to verify these activities in vivo.
4122- gera: 152804/di/ra
THERAPEUTIC EFFECT OF PUERARIN ON NON-
ALCOHOLIC RAT FATTY LIVER BY IMPROVING
LEPTIN SIGNAL TRANSDUCTION THROUGH
JAK2/STAT3 PATHWAYS. ZHENG P, JI G, MA Z, LIU
T, XIN L, WU H, LIANG X, LIU J.. am j chin med.
2009;37(1):63-83 (eng).
In order to investigate the mechanism of the therapeutic
effect of puerarin on non-alcoholic fatty liver disease, a non-
alcoholic fatty disease male rat model was induced by a high
fat diet, all rats were randomly divided into a blank group,
model group, simavastatin group and puerarin group. After 4
gera 2011

weeks of drug treatment, the liver was slided to investigate
pathological morphology. Elisa was used to measure the total
cholesterol (TC), triglyeride (TG) in liver, and leptin content
in serum. RT-PCR and Western blotting were employed to
detect liver leptin mRNA receptor expression and P-JAK2, P-
STAT3 expression levels in the liver respectively. The results
showed that puerarin significantly decreased the TG, TC
content in liver of the non-alcoholic fatty disease rats,
ameliorated steatosis in liver, lowered liver inflammatory
reaction, decreased leptin level in serum, and enhanced the
expression of leptin receptor mRNA and P-JAK2/P-STAT3
level. All the results demonstrated that puerarin can exhibit
therapeutic effect on non-alcoholic fatty liver disease by
improving leptin signal transduction through
4123- gera: 152808/di/ra
HEPATOPROTECTIVE EFFECTS OF MARINE AND
KUHUANG IN LIVER TRANSPLANT RECIPIENTS.
XU X, LING Q, GAO F, HE ZL, XIE HY, ZHENG SS.. am
j chin med. 2009;37(1):27-34 (eng).
We aimed to assess the effects of traditional Chinese
medicine; marine (MT) and kuhuang (KH), either alone or in
combination, on the early graft function of the recipients and
overall patient survival rate after liver transplantation (LT) by
using diammonium glycyrrhizinate (DG) as a positive
control. A total of 151 subjects undergoing LT were included
in this prospective study. According to the different regimens
given in the first two post-transplant weeks, they were
divided into DG group (n = 49), DG + KH group (n = 36),
MT group (n = 42) and MT + KH group (n = 24). The graft
function in the early post-transplant period and patient
survival rate were examined. During the first two post-
transplant weeks, there was no significant difference in total
bilirubin, alanine transaminase, aspartate transaminase, serum
creatinine, and prothrombin time between MT group and DG
group. Patient survivals in these two groups were also
similar. Compared to DG group, DG + KH group showed a
significantly lower total bilirubin value on post-transplant
day 5 (3.2 +/- 2.1 mg/dL vs. 5.7 +/- 5.6 mg/dL, p < 0.01) and
day 7 (2.8 +/- 1.8 mg/dL vs. 5.8 +/- 6.1 mg/dL, p < 0.01), and
higher patient survival. There was no significant difference
between DG + KH group and MT + KH group. In
conclusion, MT provides an alternative to DG after LT. The
combination of MT and KH is highly effective in decreasing
the total blirubin in the early post-transplant period and
improving patient survival.
4124- gera: 152981/nd/re
CHANGES OF HEPATIC PROTEOME IN BILE DUCT
LIGATED RATS WITH HEPATIC FIBROSIS
FOLLOWING TREATMENT WITH YIN-CHEN-HAO-
TANG. LEE TY, CHANG HH, KUO JJ, SHEN JJ. int j mol
med. 2009;23(4):477-84 (eng).
Yin-Chen-Hao-Tang (YCHT) is recognized as a
hepatoprotective agent for various types of liver diseases.
Proteomics approaches were used to study hepatic and serum
protein expression changes in bile duct ligated (BDL) rats
following YCHT treatment for 27 days. Two-dimensional gel
electrophoresis was used to analyze proteome changes. Of
the proteins that exhibited changes, 17 were identified by
means of matrix-assisted laser desorption/ionization-time-of-
flight (MALDI-TOF) mass spectrometry. The major effect of
YCHT was evident in cytoskeleton related protein, plectin-1.
In addition, proteins involved in metabolism of lipids were
also shown to be affected, including low-density lipoprotein
receptor-related protein 2 precursor (glycoprotein 330) and
apolipoprotein A-I precursor (ApoA-I). Significant up-
regulation of keratin 8 and 19 was found in liver tissue of
BDL rats. Supplementation with YCHT also triggered
alterations in the above proteins. Interestingly, YCHT
278
treatment caused a statistically significant down-regulation in
the secretion of monocyte chemoattractant protein-1 (MCP-1)
and tissue inhibitor of metalloproteinase-1 (TIMP-1) in BDL
rats with fibrosis. Our results suggested that YCHT may be
useful for treatment of liver fibrosis because of its possible
antiapoptotic properties, and the therapeutic effects of YCHT
on liver diseases might be associated with its lipid
biosynthesis regulation.
4125- gera: 153086/di/ra
[EFFECTS OF 18BETA-GLYCYRRHIZIC ACID AND
18ALPHA-GLYCYRRHIZIC ACID ON MRNA AND
PROTEIN EXPRESSION OF CYTOCHROME P450 3A
IN CULTURED RAT PRIMARY HEPATOCYTE].
WANG Y, YANG M, MA Z, LIANG Q, TAN H, XIAO C,
GAO Y. zhongguo zhong yao za zhi. 2009;34(3):307-11
(chi).
To study the effects of 18beta-glycyrrhizic acid and 18alpha-
glycyrrhizic acid on mRNA and protein expression of
cytochrome P450 3A in cultured rat primary hepatocyte.
METHOD: Rat heaptocyte were isolated by two-step in situ
collagenase perfusion method; the hepatocytes were seeded
in dishes coated with type I rat tail collagen, culture medium
was added and changed daily after gelation, the effect of
18beta-glycyrrhizic acid and 18alpha- glycyrrhizic acid on
the expression of CYP3A was determined by reverse
transcriptase-polymerase chain reaction (RT-PCR) and
western blot respectively. RESULT: Treatment with 18beta-
glycyrrhizic acid of primary rat hepatocytes resulted in
marked up-regulation of CYP3A1 expression at both mRNA
and protein levels in a concentration dependent manner,
while exposure to 18alpha-glycyrrhizic acid of primary rat
hepatocytes resulted in marked down-regulation of CYP3A1
expression at both mRNA and protein levels in a
concentration dependent manmer. CONCLUSION: 18beta-
glycyrrhizic acid and 18alpha-glycyrrhizic acid up-regulate
and down-regulate
4126- gera: 153272/di/ra
IN-CHERN-HAU-TANG AND GENIPIN REDUCES
ACUTE URINARY BLADDER DISTENSION EVOKED
SYMPATHETIC ACTIVATION-INDUCED HEPATIC
DYSFUNCTION IN RATS. YEN YH, CHEN WC,
HAYAKAWA S, CHIEN CT. am j chin med.
2009;37(2):339-49 (eng).
Increased norepinephrine production by acute urine retention
(AUR) induced sympathetic activation may contribute to
acute liver injury (ALI) via the action of hepatic
vasoconstriction and increased reactive oxygen species
(ROS) production. We evaluated whether In-Chern-Hau-
Tang, a hepatoprotective herb medicine, and its major
ingredient genipin, may ameliorate norepinephrine-induced
liver injury in the rat. We determined the effects of In-Chern-
Hau-Tang and genipin on norepinephrine-induced oxidative
stress in the Kupffer and endothelial cells and AUR-induced
ALI in the rat via a chemiluminescence analyzer, physiologic
and biochemical determination and western blot. The results
of in vitro study showed that genipin with efficient H(2)O(2)
and HOCl scavenging activities decreased norepinephrine-
enhanced ROS production in the Kupffer cell and endothelial
cell cultures. AUR activated hepatic sympathetic nervous
activity lead to a hepatic hypoxia/hypoperfusion, and a
reduction in bile flow. AUR increased intercellular adhesion
molecular 1 (ICAM-1) protein expression, and hepatic ROS
production from the activated leukocyte NADPH oxidase
activity subsequently leading to plasma aspartate
aminotransferase (AST) elevation. Hepatic sympathetic
denervation, or oral pretreatment of In-Chern-Hau-Tang or
genipin for 1 week ameliorated the level in AUR-induced
hepatic hypoxia/hypoperfusion, and bile stasis. Hepatic
gera 2011

denervation, In-Chern-Hau-Yang and genipin inhibited AUR-
enhanced hepatic ICAM-1 expression, hepatic ROS
production, leukocyte NADPH oxidase activity and plasma
AST activity. In conclusion, In-Chern-Hau-Tang along with
its active component, genipin, can ameliorate AUR-induced
ALI via the alleviation of oxidative stress possibly by the
inhibition of sympathetic induced hypoxia/hypoperfusion and
leukocyte NADPH oxidase activity.
4127- gera: 153273/di/ra
STUDY ON PRETREATMENT OF FPS-1 IN RATS
WITH HEPATIC ISCHEMIA-REPERFUSION
INJURY. LIN S, LIU K, WU W, CHEN C, WANG Z,
ZHANG X. am j chin med. 2009;37(2):323-37 (eng).
This study was designed to determine whether FPS-1, the
water-soluble polysaccharide isolated from fuzi, protected
against hepatic damage in hepatic ischemia-reperfusion
injury in rats, and its mechanism. SD rats were subjected to
60 min of hepatic ischemia, followed by 120 min reperfusion.
FPS-1 (160 mg/kg/day) was administered orally for 5 days
before ischemia-reperfusion injury in treatment group. Serum
aspartate aminotransferase (AST), alanine aminotransferase
(ALT) and albumin (ALB) were assayed to evaluate liver
functions. Liver samples were taken for histological
examination and determination of malondialdehyde (MDA),
superoxide dismutase (SOD), that catalase (CAT) in liver.
Na(+)-K(+)-ATPase and Ca(2+)-ATPase in mitochondria
were measured with colorimetry method. Morphological
changes were also investigated by using both light
microscopy and electron microscopy (EM). In addition,
apoptosis and oncosis were detected by Annexin V-FITC/PI
immunofluorescent flow cytometry analysis. Serum AST and
ALT levels were elevated in groups exposed to ischemia-
reperfusion (p < 0.05). Ischemia-reperfusion caused a marked
increase in MDA level, and significant decreases in hepatic
SOD and CAT (p < 0.05). Na(+)-K(+)-ATPase and Ca(2+)-
ATPase were reduced in ischemia- reperfusion groups
compared to the sham group (p < 0.05). Oncosis and
apoptosis were also observed in ischemia- reperfusion
groups. Pretreatment with FPS-1 reversed all these
biochemical parameters as well as histological alterations,
evidently by increased SOD, CAT, reduced MDA and
histological scores compared to the model group (p < 0.05).
FPS-1 could attenuate the necrotic states by the detection of
immunofluorescent flow cytometry analysis. Pretreatment
with FPS-1 reduced hepatic ischemia-reperfusion injury
through its potent antioxidative effects and attenuation of
necrotic states.
4128- gera: 153347/di/ra
[EFFECT OF GANJI RECIPE COMBINED WITH
FRUCTUS BRUCEAE OIL EMULSION
INTERVENTION ON QUALITY OF LIFE IN
PATIENTS WITH ADVANCED PRIMARY HEPATIC
CANCER]. WANG B, TIAN HQ, LIANG GW. chinese
journal of integrated traditional and western medicine.
2009;29(3):257-60 (chi).
To observe and compare the quality of life (QOL) and
survival time in patients with advanced primary hepatic
cancer (PHC) after they have been treated by the combination
of ganji recipe and interventional therapy with Fructus
Bruceae Oil Emulsion (FBE) or by the trans-hepatic arterial
chemical embolization (TACE) adopting Seldinger's
technique. METHODS: Seventy-seven patients with
advanced PHC were randomly assigned to two groups, 37
patients in the control group treated with TACE alone, and 40
in the treatment group with the combined therapy. One
therapeutic course was 4 weeks, and the intervention therapy
was repeated generally after an interval of 4-6 weeks
according to patients'condition ,the average intervention
279
frequency was 2.3 for one case. The QOL and the survival
time in patients were evaluated after treatment. RESULTS:
Significant difference was shown in the changes of the
Karnofsky score between the two groups (P < 0.05). The
scores suggested that the improvements in the treatment
group, including patients'physical energy enhancing,
symptoms alleviating and overall QOL improving, were
superior to those in the control group (P < 0.05). No
significant difference of the 3- month survival rate between
the two groups was found (P > 0.05), but the 0.5- and 1-year
survival rate were significantly superior in the treatment
group to those in the control group (67.6% vs. 42.4% and
38.2% vs. 16.1%, respectively). The median survival time in
the two groups was 8.9 and 5.3 months respectively.
CONCLUSION: Combination of ganji recipe and
interventional therapy with FBE in treating PHC could
improve patients' QOL, raise the 0.5- and 1-year survival
rate, and prolong the survival time, suggesting TCM
treatment has an affirmative significance for enhancing the
therapeutic efficacy and improving the prognosis in patients.
4129- gera: 153350/di/ra
[SYNDROME IDENTIFICATION OF CCL4 INDUCED
LIVER FIBROSIS MODEL RATS BASED ON
SYNDROME DETECTING FROM RECIPE USED].
TAO Q, SUN MY, FENG Q. chinese journal of integrated
traditional and western medicine. 2009;29(3):246-50 (chi).
To further demonstrate the cognition upon the prominent
effect of Yiguanjian and Xiayuxue Decoction on the CCI4
induced rat model of chronic liver fibrosis which have been
verified in the previous studies. From the viewpoint of
detecting TCM syndrome by recipe used, through this
cognition the pathological features of the liver injury model
manifesting a syndrome of "Gan-yin deficiency with blood
stasis obstructing collaterals" were further explored.
METHODS: Wistar rats were randomly divided into the
normal group, the model group, and the three medicated
groups. All rats, except those in the normal group, were made
into chronic liver injury model by subcutaneously injecting
CCI4 for 12 weeks. Medication for the three medicated
groups began from the 9th week after modeling, with oral
administering of Yiguanjian (YGJ, a recipe has been verified
to be effective for liver injury and fibrosis), Liuwei Dihuang
Decoction (LWDH, a recipe with effects similar to YGJ) and
Yinchenhao Decoction (YCHD, a recipe functioned
differently) respectively for four weeks. Rats were sacrificed
at the end of the experiment, changes of hepatic function,
liver pathology and hydroxyproline (Hyp) content in the liver
tissue were detected, and contents of Afamin and mRNA
expression of alpha-smooth muscle actin (alpha-SMA) in the
liver tissue were assayed as well with Real-time PCR.
RESULTS: As compared with the normal group, the
pathological figures of the chronic liver injury and fibrosis
and hepatic function deterioration obviously appeared in the
model rats, with the liver content of Hyp and alpha-SMA
mRNA expression increased, and Afamin mRNA expression
decreased significantly. In the YGJ treated group, the hepatic
collagen hyperplasia and deteriorated hepatic function
alleviated significantly after treatment, with content of Hyp
significantly lowered, and mRNA expressions of alpha-SMA
and Afamin restored to some extent (P < 0.05); the same
effects on mRNA expressions of alpha-SMA and Afamin
were shown in the LWDH treated group, also a decreasing
trend of Hyp content (0.05 < P < 0.1), and a significant
decreasing of alanine transaminase (ALT) activity was found;
while in the YCHD treated group these pharmacological
effects mentioned above were not observed at all.
CONCLUSION: The pharmacological effects of LWDH and
YGJ were similar to some degree, which gives support to the
cognition that the feature of chronic liver
gera 2011

4130- gera: 153355/di/ra
[PRIMARY HEPATOCARCINOMA TREATED BY
TRADITIONAL CHINESE MEDICINE COMBINED
WITH TRANSCATHETER ARTERIAL
CHEMOEMBOLIZATION]. HOU EC, LU YX. chinese
journal of integrated traditional and western medicine.
2009;29(3):225-7 (chi).
To observe the effect of traditional Chinese medicine (TCM)
combining transcatheter arterial chemoembolization (TACE)
in patients with primary hepatocarcinoma (PHC), and its
influence on patients' immunity, quality of life and adverse
reaction. METHODS: Sixty-seven patients with mid-
advanced stage PHC were assignd to two groups: the 35
patients in Group 1 treated with TCM combined TACE and
the 32 in Group 2 treated with TACE alone. TACE with
Gemzar (GEM) and Cisplatinum (DDP) were applied once in
both groups, and followed by conventional post- operational
management as hydration. The TCM used was prescribed
according to syndrome differentiation. Peripheral blood T-
lymphocyte subsets and natural killer (NK) cells of patients
were measured before treatment (as the base line) and at the
end of the 1st and 4th week after treatment (W1, W4),
patients' quality of life (QOL) was estimated at the sametime
by Karnofsky sore (KPS). Moreover, CT or MRI examination
was performed at end of the 4th week to evaluate the short-
term efficacy of treatment. RESULTS: Short-term efficacy
analyses showed that the effective rate was 51.4% (18/35) in
Group 1 and 37.5% (12/32) in Group 2, showing insignificant
difference between them (P > 0.05). The levels of CD3+,
CD4+, CD4+/CD8+, NK cells actionties and KPS score
reduced slightly in both groups at W1, with no significant
intergroup difference; but at W4, they did show significant
differences between groups, and all indices in both groups
were significantly different to those of the baseline and at W1
(P < 0.05 or P < 0.01). Aduerse reaction occurred were
mainly fever, digestive reaction and lowering of peripheral
white blood cell counting, platelet counting, etc. and the
incidence of fever in Group 1 was lower than in Group 2.
CONCLUSION: TCM treatment combined with TACE can
enhance the immunity and QOL of PHC patients, and
alleviate the adverse reaction of chemotherapeutic agents.
4131- gera: 153432/di/ra
[PRIMARY HEPATOCARCINOMA TREATED BY
TRADITIONAL CHINESE MEDICINE COMBINED
WITH TRANSCATHETER ARTERIAL
CHEMOEMBOLIZATION]. HOU EN-CUN, LU YUN-
XIN,. chinese journal of integrated traditional and
western medicine. 2009;29(3):225 (chi).
To observe the effect of traditional Chinese medicine (TCM)
combining transcatheter arterial chemoembolization (TACE)
in patients with primary hepatocarcinoma ( PHC) , and its
influence on patients' immunity, quality of life and adverse
reaction. Methods Sixty-seven patients with mid-advanced
stage PHC were assignd to two groups: the 35 patients in
Group 1 treated with TCM combined TACE and the 32 in
Group 2 treated with TACE alone. TACE with Gemzar (
GEM) and Cisplatinum ( DDP) were applied once in both
groups, and followed by conventional post- operational
management as hydration. The TCM used was prescribed
according to syndrome differentiation. Peripheral blood T-
lymphocyte subsets and natural killer ( NK) cells of patients
were measured before treatment (as the base line) and at the
end of the l st and 4th week after treatment (W1 , W4) ,
patients' quality of life (QOL) was estimated at the sametime
by Karnofsky sore ( KPS). Moreover, CT or MRI
examination was performed at end of the 4th week to
evaluate the short-term efficacy of treatment. Results Short-
term efficacy analyses showed that the effective rate was 51.
280
4% (18/35) in Group 1 and 37. 5% (12/32) in Group 2,
showing insignificant difference between them ( P > 0. 05).
The levels of CD,' , CD: , CD:/CD,' , NK cells actionties and
KPS score reduced slightly in both groups at W1 , with no
significant intergroup difference; but at W4, they did show
significant differences between groups, and all indices in
both groups were significantly different to those of the
baseline and at W1 ( P <0. 05 or P <O. 01 ) . Aduerse
reaction occurred were mainly fever, digestive reaction and
lowering of peripheral white blood cell counting, platelet
counting, etc. and the incidence of fever in Group 1 was
lower than in Group 2. Conclusion TCM treatment combined
with TACE can enhance the immunity and QOL of PHC
patients, and alleviate the adverse reaction of
chemotherapeutic agents.
4132- gera: 153437/di/ra
[SYNDROME IDENTIFICATION OF CCI, INDUCED
LIVER FIBROSIS MODEL RATS BASED ON
SYNDROME DETECTING FROM RECIPE USED].
TAO QING, SUN MING-YU, FENG QIN,. chinese journal
of integrated traditional and western medicine.
2009;29(3):246 (chi).
To further demonstrate the cognition upon the prominent
effect of Yiguanjian and Xiayuxue Decoction on the CCI,
induced rat model of chronic liver fibrosis which have been
verified in the previous studies. From the viewpoint of
detecting TCM syndrome by recipe used, through this
cognition the pathological features of the liver injury model
manifesting a syndrome of " Gan-yin deficiency with blood
stasis obstructing collaterals" were further explored. Methods
Wistar rats were randomly divided into the normal group, the
model group, and the three medicated groups. All rats, except
those in the normal group, were made into chronic liver
injury model by subcutaneously injecting CCI, for 12 weeks.
Medication for the three medicated groups began from the
9th week after modeling, with oral administering of
Yiguanjian (YGJ, a recipe has been verified to be effective
for liver injury and fibrosis) , Liuwei Dihuang Decoction (
LWDH, a recipe with effects similar to YGJ) and
Yinchenhao Decoction (YCHD, a recipe functioned
differently) respectively for four weeks. Rats were sacrificed
at the end of the experiment, changes of hepatic function,
liver pathology and hydroxyproline ( Hyp) content in the
liver tissue were detected, and contents of Afamin and
mRNA expression of a-smooth muscle actin ( a-SMA) in the
liver tissue were assayed as well with Real-time PCR. Results
As compared with the normal group, the pathological figures
of the chronic liver injury and fibrosis and hepatic function
deterioration obviously appeared in the model rats, with the
liver content of Hyp and a-SMA mRNA expression
increased, and Afamin mRNA expression decreased
significantly. In the YGJ treated group, the hepatic collagen
hyperplasia and deteriorated hepatic function alleviated
significantly after treatment, with content of Hyp
significantly lowered, and mRNA expressions of a-SMA and
Afamin restored to some extent ( P <0.05) ; the same effects
on mRNA expressions of a- SMA and Afamin were shown in
the LWDH treated group, also a decreasing trend of Hyp
content (0. 05 < P<0. 1 ) , and a significant decreasing of
alanine transaminase ( ALT) activity was found; while in the
YCHD treated group these pharmacological effects
mentioned above were not observed at all. Conclusion The
pharmacological effects of LWDH and YGJ were similar to
some degree, which gives support to the cognition that the
feature of chronic liver
4133- gera: 153440/di/ra
[EFFECT OF GANJI RECIPE COMBINED WITH
FRUCTUS BRUCEAE OIL EMULSION
gera 2011

INTERVENTION ON QUALITY OF LIFE IN
PATIENTS WITH ADVANCED PRIMARY HEPATIC
CANCER]. WANG BIN, TIAN HUA-QIN, LIANG GUI-
WEN,. chinese journal of integrated traditional and
western medicine. 2009;29(3):257 (chi).
To observe and compare the quality of life ( QOL) and
survival time in patients with advanced primary hepatic
cancer ( PHC) after they have been treated by the
combination of Ganji Recipe and interventional therapy with
Fructus Bruceae Oil Emulsion ( FBE) or by the trans-hepatic
arterial chemical embolization (TACE) adopting Seldinger's
technique. Methods Seventy-seven patients with advanced
PHC were randomly assigned to two groups, 37 patients in
the control group treated with TACE alone, and 40 in the
treatment group with the combined therapy. One therapeutic
course was 4 weeks, and the intervention therapy was
repeated generally after an interval of 4-6 weeks according to
patients'condition, the average intervention frequency was 2.
3 for one case. The QOL and the survival time in patients
were evaluated after treatment. Results Significant difference
was shown in the changes of the Karnofsky score between
the two groups ( P <0.05). The scores suggested that the
improvements in the treatment group, including patients '
physical energy enhancing, symptoms alleviating and overall
QOL improving, were superior to those in the control group (
P <0. 05). No significant difference of the 3-month survival
rate between the two groups was found (P>O. 05) , but the 0.
5- and 1 -year survival rate were significantly superior in the
treatment group to those in the control group (67. 6% vs 42.
4% and 38. 2% vs 16. 1 % , respectively). The median
survival time in the two groups was 8. 9 and 5. 3 months
respectively. Conclusion Combination of Ganji Recipe and
interventional therapy with FBE in treating PHC could
improve patients' QOL, raise the 0. 5- and 1-year survival
rate, and prolong the survival time, suggesting TCM
treatment has an affirmative significance for enhancing the
therapeutic efficacy and improving the prognosis in patients.
4134- gera: 153618/di/ra
[PROGRESS ON PREVENTION AND TREATMENT
OF CHINESE MEDICINE TO MOLECULAR
MECHANISM OF LIVER CANCER]. JIANG Z, HUA H.
china journal of chinese materia medica.
2009;34(10):1310-3 (chi).
The occurrence of liver cancer is a multi-phase and multi-
factor process, while Chinese medicine used for antitumor is
all-round with multiple approaches. This summary is a
literature review which elaborates the prevention and
treatment of Chinese medicine to the molecular mechanism
of liver cancer in eight aspects, such as inhibiting the
proliferation of hepatoma cell, inducing their differentiation,
affecting the activity of telomerase, resisting the invasion and
metastasis of hepatoma cell, inhibiting the formation of
tumor vessel, adjusting the immunity function, and reversing
the multidrug resistance, etc.
4135- gera: 153702/di/ra
THE AUGMENTED ANTI-TUMOR EFFECTS OF
ANTRODIA CAMPHORATA CO-FERMENTED WITH
CHINESE MEDICINAL HERB IN HUMAN
HEPATOMA CELLS. LI SL, HUANG ZN, HSIEH HH,
YU WC, TZENG WY, LEE GY, CHEN YP, CHANG CY,
CHUU JJ. am j chin med. 2009;37(4):771-83 (eng).
Antrodia camphorata, unique fungal specie, has been used as
a folk medicine in Taiwan for many years. The purpose of
this study was to compare the extracts from the solid-state
culture of A. camphorata co-fermented with Chinese
medicinal herb (AC-CF) with two other extracts from fruiting
bodies (AC-FB) or solid-state culture (AC-SS), for their anti-
tumor effects in human hepatoma HepG2 cells. We measured
281
in vitro cell proliferation, percentage of apoptosis, population
distribution of cell cycles, Western blot analysis of multiple
drugs resistance-1 (MDR-1), and apoptosis-related proteins
in HepG2 cells treated with three different preparations of A.
camphorate extracts. Our results showed that AC-CF had
better anti-proliferation effect on human hepatoma HepG2
cells than AC-FB or AC- SS dose-dependently. In addition,
AC-CF in combination with anti-tumor agents (mitomycin C
or methotrexate) showed better adjuvant anti-tumor effects
than AC-FB or AC-SS. We further demonstrated the
augmented adjuvant anti-tumor effects of AC-CF not only
through down regulation of MDR-1 expression but also
through a COX-2 dependent apoptosis pathway, involving
down-regulation of COX-2 and p-AKT and up-regulation of
PARP-1. In conclusion, in this study, we have demonstrated a
novel strategy of fermenting A. camphorata with Chinese
medicinal herb (AC-CF), which augmented their anti-tumor
effects in human hepatoma HepG2 cells as compared to the
traditional ones (AC-FB or AC-SS).
4136- gera: 153739/di/ra
COMPARATIVE STUDY ON THE PROTECTIVE
EFFECTS OF YINCHENHAO DECOCTION ()
AGAINST LIVER INJURY INDUCED BY ALPHA-
NAPHTHYLISOTHIOCYANATE AND CARBON
TETRACHLORIDE. HONG-XIN C, HUI S, XIN-GANG J,
HAI-TAO L, GUANG-MEI Z, XI- JUN W, WEN-JUN S,
ZE-MING W, PING W, LIAN L, JUE Z. chin j integr med.
2009;15(3):204-9 (eng).
To optimize the animal model of liver injury that can
properly represent the pathological characteristics of
dampness-heat jaundice syndrome of traditional Chinese
medicine. METHODS: The liver injury in the model rat was
induced by alpha-naphthylisothiocyanate (ANIT) and carbon
tetrachloride (CCl(4) ) respectively, and the effects of
Yinchenhao Decoction (, YCHD), a proved effective Chinese
medical formula for treating the dampness- heat jaundice
syndrome in clinic, on the two liver injury models were
evaluated by analyzing the serum level of alanine
aminotransferase (ALT), asparate aminotransferase (AST),
alkaline phosphatase (ALP), malondialchehyche (MDA),
total bilirubin (T-BIL), superoxide dismutase (SOD),
glutathione peroxidase (GSH-PX) as well as the ratio of liver
weight to body weight. The experimental data were analyzed
by principal component analytical method of pattern
recognition. RESULTS: The ratio of liver weight to body
weight was significantly elevated in the ANIT and CCl(4)
groups when compared with that in the normal control
(P<0.01). The contents of ALT and T-BIL were significantly
higher in the ANIT group than in the normal control
(P<0.05,P<0.01), and the levels of AST, ALT and ALP were
significantly elevated in CCl(4) group relative to those in the
normal control P<0.01). In the YCHD group, the increase in
AST, ALT and ALP levels was significantly reduced
(P<0.05, P<0.01), but with no significant increase in serum
T-BIL. In the CCl(4) intoxicated group, the MDA content
was significantly increased and SOD, GSH-PX activities
decreased significantly compared with those in the normal
control group, respectively (P<0.01). The increase in MDA
induced by CCl(4) was significantly reduced by YCHD
P<0.05). CONCLUSION: YCHD showed significant effects
on preventing liver injury progression induced by CCl(4),
and the closest or most suitable animal model for damp-heat
jaundice syndrome may be the one induced by CCl(4).
4137- gera: 154622/di/ra
[OBSERVATION ON THERAPEUTIC EFFECT OF
ACUPUNCTURE COMBINED WITH CHINESE
HERBAL DECOCTION ON COMPENSATED LIVER
CIRRHOSIS]. HAN J, GU YJ.. chinese acupuncture and
gera 2011

moxibustion. 2009;29(12):970-2 (chi).
OBJECTIVE: To compare the clinical effect difference
between acupuncture combined with Chinese herb plus
western medicine and simple western medicine in the
treatment of compensated liver cirrhosis. METHODS: Eighty
cases were divided into a high viral load group and a low
viral load group according to HBV- DNA test. The patients
in two groups were randomly divided into a Chinese
medicine plus western medicine treatment group (group A,
group C) and a western medicine treatment group (Group
B,group D), respectively, 20 cases in each group. The group
A was treated with acupuncture at Ganshu (BL 18), Qimen
(LR 14), Sanyinjiao (SP 6), etc. and oral administration of
Chinese herbal decoction combined with Heptodin tablets;
the group B with oral administration of Glucurolactone
tablets combined with Heptodin tablets; the group C was
treated with acupuncture at Ganshu (BL 18), Qimen (LR 14),
Taixi (KI 3), etc. and oral administration of Chinese herbal
decoction; the group D with oral administration of
Glucurolactone tablets alone. After they were treated for 30
days, their therapeutic effects and the negative conversion
rate of HBV-DNA were observed.RESULTS: The total
effective rate of 95.0% in the group A was better than 70.0%
in the group B, and the total effective rate of 95.0% in the
group C was better than 65.0% in the group D (both P <
0.05). There was no significant difference in the negative
conversion rate of HBV-DNA between group A and group B
or between group C and group D (both P >
0.05).CONCLUSION: Acupuncture combined with Chinese
herb plus western medicine treatment can more significantly
improve clinical symptoms of the patients with compensated
liver cirrhosis than simple western medicine therapy.
4138- gera: 154669/di/ra
[OBSERVATION ON THERAPEUTIC EFFECT OF
ACUPUNCTURE FOR TREATMENT OF PATIENTS
WITH NONALCOHOLIC STEATOHEPATITIS]. Meng
SX.. chinese acupuncture and moxibustion.
2009;29(8):616-8 (chi).
OBJECTIVE: To observe the therapeutic effect of
acupuncture for treatment of patients with nonalcoholic
steatohepatitis.METHODS: Ninety-eight cases were
randomly divided into an acupuncture group (n= 50) and a
medicine group (n=48). The acupuncture group was treated
with acupuncture at Shenshu (BL 23), Guanyuan (CV 4),
Taixi (KI 3), Sanyinjiao (SP 6), etc.; the medicine group was
treated with oral administration of Polyene
Phosphatidylcholine Capsules. They were treated for 12
weeks. The changes of clinical symptoms, serum enzyme,
blood fat and abdominal CT performance were compared
between the two groups before and after
treatment.RESULTS: After treatment, alanine
aminotransferase (ALT), aspartate aminotransferase (AST),
galactosylhydroxylysyl glucosyltransferase (GGT),
triglyeride (TG) and total cholesterol (TC) significantly
decreased in the acupuncture group (all P<0.01); ALT, AST
and GGT significantly decreased in the medicine group (all
P<0.01), and there were no significant differences in changes
of TG and TC in the medicine group (both P>0.05). After
treatment, CT image showed there was significant
improvement of liver injury in both groups (both P<0.01),
and the improvement of liver injury in the acupuncture group
was superior to that in the medicine group
(P<0.01).CONCLUSION: Acupuncture has a significant
therapeutic effect on nonalcoholic steatohepatitis.
4139- gera: 154777/di/ra
[RETROSPECTIVE ANALYSIS OF MR. XIE
XILIANG'S MEDICAL RECORDS ACCUMULATED
IN 30 YEARS ON DIRECT MOXIBUSTION FOR
282
TREATING HEPATITIS B]. GUAN L, XIANG HC, ZOU
Y.. chinese acupuncture and moxibustion. 2009;29(6:487-
90 (chi).
To analyze retrospectively Mr. Xie Xiliang's medical records
accumulated in 30 years on direct moxibustion for treating
hepatitis B, in which 86 cases were included. Before
accepting direct moxibustion, 80.23% of the cases had been
treated by conventional Chinese and western medicine, but
no satisfactory therapeutic effects were obtained. Direct
moxibustion was applied for 7-9 cones at each point selected.
Point selection was related to ages. Usually, only a few points
were used, and Ganshu (BL 18) and Pishu (BL 20) were used
as main points. Shenzhu (GV 12) was added for children, and
Zusanli (ST 36) added for adults. The improvement rate in
clinical symptoms and physical signs were 100%. In the
cases with hepatauxe, splenauxe, liver cirrhosis, and
abdominal dropsy diagnozed by the B-ultrasonic
examination, the improvement was obvious. Of the total, the
rates turning to be negative in HBsAg, HBeAg and HBcAb
were 28.85%, 38.46%, and 36.54%, respectively. It took
some 10 days to 1 month to begin to show improvement in
physical signs and hepetic functions, and about 3-6 months
for their restoration. For the five items tested in type B
hepatitis, it took 5 months to 1 year, even several years, to
show their improvement. It is indicated that direct
moxibustion is definitely effective in treating type B
hepatitis. It is easy to handle and worth popularizing.
4140- gera: 154898/di/ra
[RETROSPECTIVE ANALYSIS OF MR. XIE
XILIANG'S MEDICAL RECORDS ACCUMULATED
IN 30 YEARS ON DIRECT MOXIBUSTION FOR
TREATING HEPATITIS B]. GUAN L, XIANG HC, ZOU
Y.. chinese acupuncture and moxibustion. 2009;29(6):487-
90 (chi).
To analyze retrospectively Mr. Xie Xiliang's medical records
accumulated in 30 years on direct moxibustion for treating
hepatitis B, in which 86 cases were included. Before
accepting direct moxibustion, 80.23% of the cases had been
treated by conventional Chinese and western medicine, but
no satisfactory therapeutic effects were obtained. Direct
moxibustion was applied for 7-9 cones at each point selected.
Point selection was related to ages. Usually, only a few points
were used, and Ganshu (BL 18) and Pishu (BL 20) were used
as main points. Shenzhu (GV 12) was added for children, and
Zusanli (ST 36) added for adults. The improvement rate in
clinical symptoms and physical signs were 100%. In the
cases with hepatauxe, splenauxe, liver cirrhosis, and
abdominal dropsy diagnozed by the B-ultrasonic
examination, the improvement was obvious. Of the total, the
rates turning to be negative in HBsAg, HBeAg and HBcAb
were 28.85%, 38.46%, and 36.54%, respectively. It took
some 10 days to 1 month to begin to show improvement in
physical signs and hepetic functions, and about 3-6 months
for their restoration. For the five items tested in type B
hepatitis, it took 5 months to 1 year, even several years, to
show their improvement. It is indicated that direct
moxibustion is definitely effective in treating type B
hepatitis. It is easy to handle and worth popularizing.
4141- gera: 154531/di/ra
[CLINICAL ANALYSIS OF CASES WITH DRUG-
INDUCED LIVER INJURY FOR KAMPO MEDICINE].
YUKARI GONO, HIROSHI ODAGUCHI,. kampo
medicine. 2010;61(6):828-833 (jap).
We analyzed the clinical features of 21 cases with drug-
induced liver injury due to Kampo medicines between the
years 2000 and 2009 in our institute. The mean age in these
cases was 55.2 ± 13.4 years. Five of the cases were men, and
16 were women. In 17 of the 21 cases, drug-induced liver
gera 2011

injury had occurred within 3 months after beginning Kampo
medicines. There were no subjective symptoms in 11 cases.
Nine cases of both hepatocellular injury, and of mixed-type
injury were seen. Causative Kampo medicines included an
Ogon (Scutellariae Radix) component in 19 cases. A drug-
induced lymphocyte stimulation test (DLST) was performed
in 5 cases. The test was positive for Kampo medicines in only
one of the 5 cases. Liver injury improved or normalized in 18
cases (85.7%) after discontinuing causative Kampo
medicines. In another 2 cases, liver injury normalized after
changing a Kampo medicine to the same prescription without
Ogon. These results suggest that even if patients complain of
no symptoms we must perform blood tests to check liver
function within 3 months of prescribing Kampo medicines,
especially those including Ogon, to facilitate early diagnosis
of drug-induced liver injury.
4142- gera: 154584/di/ra
[JUZENTAIHOTO (TJ-48) MAY BE AN IMPORTANT
AND EFFECTIVE ANTI-INFLAMMATORY AGENT
FOR INTRACTABLE CASES OF PATIENTS WITH
HCV-ASSOCIATED CHRONIC LIVER DISEASES].
Kazuo TARAO, Yasunari SAKAMOTO, Kazuo TARAO,
Yasunari SAKAMOTO, Kazuo TARAO, Yasunari
SAKAMOTO, KAZUO TARAO, YASUNARI
SAKAMOTO,. kampo medicine. 2010;61(1):1-8 (jap).
Although glycyrrhizin (SNMC), and ursodeoxycholic acid
(UDCA), alone or in combination have been administered in
patients with active HCV-associated chronic hepatitis (HCV-
CH) or liver cirrhosis (HCV-LC), there are many patients
who do not respond well to these anti-inflammatory
treatments. In this study, we examined retrospectively the
possibility for juzentaihoto to alleviate inflammation in such
patients. We calculated average ALT levels every 6 months
for all 67 patients. If we assume an improvement in average
serum ALT levels of more than 25% after juzentaihoto
administration to be significantly effective, as compared with
average ALT levels before juzentaihoto administration, 23
out of 40 patients (57.5%) showed significant improvement
within one year. In the 32 patients with HCV-associated liver
disease who were treated with combination SNMC and
UDCA therapy, and whose average ALT levels did not
decline to less than 80 IU/L, 18 (56.3%) showed significant
improvement when juzentaihoto was added. Juzentaihoto was
effective in 62.5% of patients with CH, and 54.2% of those
with LC. Moreover, juzentaihoto was effective in 41.2% of
male, and 69.6% of female patients. And in about 40% of
283
patients, average ALT levels lowered increasingly over time,
out to 2 years. Juzentaihoto may be an effective anti-
inflammatory agent for intractable cases of active HCV-CH,
or HCV-LC.
4143- gera: 155102/di/ra
[CLINICAL OBSERVATION ON ACUPOINT
CATGUT EMBEDDING FOR TREATMENT OF NON-
ALCOHOLIC STEATOHEPATITIS]. LIU XD, WANG
M, LI YZ.. chinese acupuncture and moxibustion.
2010;30(8):637-41 (chi).
OBJECTIVE: To compare the effect of acupoint catgut
embedding and western medication for treatment of non-
alcoholic steatohepatitis (NASH). METHODS: Sixty cases
were randomly divided into a catgut embedding group and a
western medicine group, 30 cases in each group. The catgut
embedding group was treated with acupoint catgut
embedding at Geshu (BL 17), Ganshu (BL 18), Zhongwan
(CV 12), Qihai (CV 6), Zusanli (ST 36), Yanglingquan (GB
34), Fenglong (ST 40); the western medicine group was
treated with oral administration of Tiopronin till the patients
recovered normal liver function, then changed to take
Xuezhikang capsule. Four weeks for a course of treatment,
two groups were treated with two courses continuously. Then
clinical symptoms, and levels of body mass index (BMI),
obesity degree, alanine aminotransferase (ALT), aspartate
aminotransferase (AST), gamma-glutamyl transpeptidase
(gamma-GT), total cholesterol (TC), triglyceride (TG) and
CT ratio of liver and spleen before and after treatment were
compared between two groups. RESULTS: BMI, obesity
degree and the levels of ALT, AST, gamma-GT, TC, TG in
the serum decreased more significantly in two groups after
treatment (all P<0.05), and there were significant differences
between two groups (all P<0.05), the catgut embedding group
decreased more significantly. CT ratio of liver and spleen
was improved after treatment compared with that before
treatment in two groups (both P<0.05), and the improvement
of CT ratio of liver and spleen in the catgut embedding group
was greater than that in the western medicine group (P<0.05).
The total effective rate of 90.0% (27/30) in the catgut
embedding group was superior to that of 76.7% (23/30) in the
western medicine group, and the total efficiency of catgut
embedding group was more effective than that in the western
medicine group (P<0.05).CONCLUSION: Acupoint catgut
embedding is an effective method for the treatment of non-
alcoholic steatohepatitis and this therapy is superior to oral
administration of Tiopronin and Xuezhikang capsule.
gera 2011
 284

CAI YUWEN ET AL¤ 1813 ,

Index des auteurs CAI ZIHONG, ET AL¤ 2827 ,
CAO CHANG'EN, ET AL¤ 2409 ,
AHN YK ET AL¤ 1124
CAO FU-QUAN¤ 1600 ,
AI SHAO BO¤ 451 ,
CAO HUIBO ET AL¤ 1507 ,
AI SHAO-ZUO¤ 2846 ,
CAO JIANMEI, HU YIYANG¤ 3248 ,
AKIHARU WATANABE ET AL¤ 599 ,
CAO LIANG LIU KANG-YONG ZHAO LEI-LEI¤ 3232 ,
AL-FHAFAJI MAZIN¤ 1901 ,
CAO LI-QIN¤ 2839 , 2841 ,
AN YUJIN ¤ 3751 ,
CAO SHAO-TING¤ 2903 ,
ARICHI ET AL¤ 19 , 22 , 27 ,
CAO SHU-HE ET AL¤ 809 ,
ARICHI S¤ 23 , 26 , 30 ,
CAO SHU-HUA, GAO HONG-MEI, WANG YONG-
ARICHI SHIGERU ET AL¤ 129 ,
QIANG¤ 2843 ,
ASSOCIATON OF TCM AND PHARMACY¤ 1303 ,
CAO SHUNMING¤ 1264 ,
AUTEROCHE B ET AL¤ 357 ,
CAO WEIZU ET AL¤ 1573 ,
BA TUDELIGEN BAI WAN-FU BAI HUHEBALA ET
CAO XIAJU¤ 1960 ,
AL¤ 3743 ,
CAO XIANYING ET AL¤ 1686 ,
BAI CUANGDE, LIAN ZIQING, LIANG JIAN, ET AL¤
CAO XIAOJU ET AL¤ 1836 ,
3903 ,
CAO YANG¤ 1989 ,
BAI DONGMEI, ET AL¤ 2886 ,
CAO YI ET AL¤ 2619 ,
BAI HU ET AL¤ 1844 ,
CAO YI-RONG, SUN GUI-LIANG¤ 3725 ,
BAI JINWEN ET AL¤ 1811 , 1945 ,
CAO YONGKANG¤ 295 ,
BAI JUN¤ 2253 ,
CEN YUWEN¤ 3623 ,
BAI JUNFENG¤ 1022 ,
CETIN A, KAYNAR L, KOCYIGIT I, HACIOGLU SK,
BAI LIN ET AL¤ 992 , 2427 ,
SARAYMEN R, OZTURK A, 4118 ,
BAI SHU XUN ET AL¤ 187 ,
CHA LIANGYI ET AL¤ 268 ,
BAI WEI¤ 3386 ,
CHAI JICAI ET AL¤ 577 ,
BAI YANLONG¤ 574 ,
CHAI XIA¤ 2974 ,
BAI YINGCAI ET AL¤ 1869 ,
CHAKRABARTI AK ET AL¤ 127 ,
BAIND JUAN ET AL¤ 1961 ,
CHAN JY, CHEUNG JY, LUK SC, WU YJ, PANG SF,
BANOS A¤ 960 ,
FUNG KP¤ 3807 ,
BAO XUN¤ 57 ,
CHANG CHUNTAO¤ 859 ,
BASMAN A¤ 6 ,
CHANG HF, LIN YH, CHU CC, WU SJ, TSAI YH, CHAO
BATEY RG ET AL¤ 1720 ,
JC¤ 4055 ,
BEI RUNPU¤ 86 ,
CHANG HM ET AL¤ 178 ,
BEIJING HOSPITAL OF TRADITIONAL CHINESE¤ 729 ,
CHANG IM ET AL¤ 182 ,
BEN CHANGEN¤ 1555 ,
CHANG JIE¤ 1178 ,
BI DE-ZHONG ET AL¤ 2151 ,
CHANG JIE ET AL¤ 1806 , 1952 ,
BI QING ET AL¤ 2043 ,
CHANG YU YING ET AL¤ 251 ,
BI SHIMIN ET AL¤ 1495 ,
CHANG YUXUAN ET AL¤ 45 ,
BI YONGSHENG ET AL¤ 828 ,
CHANG YUYING ET AL¤ 237 ,
BIAN FANGQIN, GUO YAOLI¤ 3749 ,
CHANGJIAN Y¤ 1310 ,
BIAN HUIQIN¤ 1160 ,
CHAOLIANG Z ET AL¤ 1318 ,
BING HENG LEE¤ 191 ,
CHAU-SHIN HSU, PHD, SHUENN-JYI SHUE PHD, AND
BINGGONG L ET AL¤ 631 ,
Q¤ 3411 ,
BINGYIN L ET AL¤ 634 ,
CHE NIANCONG¤ 2279 ,
BO LIMIN¤ 1470 , 1471 ,
CHE NIANCONG ET AL¤ 1094 , 1278 , 1464 ,
BORIS D ET AL¤ 1771 ,
CHEH JIANJIE ET AL¤ 1415 ,
BO-TANG L¤ 647 ,
CHEN AIPING ET AL¤ 790 ,
BOUVILLE L ET AL¤ 194 ,
CHEN BAOMING¤ 656 ,
BU-REN-DA-LAI, ET AL¤ 3069 , 3184 ,
CHEN BIN, ET , AL¤ 2360 ,
BYUNG WOON KIM¤ 362 ,
CHEN BIN, SUN KE-WEI LIU MING-DE, ET AL¤ 3048 ,
CAI CHUNJIANG ET AL ¤ 2602 ,
3163 ,
CAI DE-LU¤ 3910 ,
CHEN BIN, SUN KEWEI, XIE FENGYING, ET AL¤ 2960 ,
CAI HONG¤ 3228 ,
3039 , 3154 ,
CAI JINWEI¤ 1327 , 2430 , 2496 , 2535 ,
CHEN CHANGHUAI ET AL¤ 1588 ,
CAI LINGUANG¤ 1239 ,
CHEN CHAOJUN,ET AL¤ 3050 , 3165 ,
CAI M, YANG Y¤ 4049 ,
CHEN CHUN-YONG, XU KAI, ZHU DI-YING, ET AL¤
CAI SHANGYUAN, FU MIN, WANG XINGUO, ET AL¤
3012 , 3127 ,
3298 ,
CHEN DAOSHENG¤ 2220 ,
CAI XIONGMAO, CHEN XINCHUN, ZHOU BOPING, ET
CHEN DAXUN¤ 165 ,
AL¤ 2753 ,
CHEN DE-CHANG ET AL¤ 2581 ,
CAI YALI ET AL¤ 2304 ,
CHEN DE-SU, FANG ZHAO-QIN¤ 2631 ,
CAI YI ET AL¤ 1473 ,
CHEN DI-PING, CHEN CUI-PING¤ 3515 ,
CAI YIMEI ET AL¤ 1273 ,
CHEN FANG¤ 1493 ,
CAI YOE, GAO KARMEN, QIU MEIHONG EL AL¤ 2560
CHEN FANHAI ET AL¤ 2054 ,
, CHEN FP, KUNG YY, CHEN YC, JONG MS, CHEN TJ,
CAI YONG-LIANG ET AL¤ 1596 ,
CHEN FJ, HWANG SJ¤ 4080 ,
CAI YONG-LIANG, YANG REN-MIN, XU SHENG-
CHEN FULAI ET AL¤ 505 ,
HONG, ET¤ 1673 ,
CHEN GUO LIN ET AL¤ 526 ,

gera 2011
 285
CHEN GUOXIN¤ 3750 , CHEN LIULIN¤ 232 ,
CHEN H, TU SP, TEH CZ, YIP MP, CHOE JH, HISLOP CHEN LI-WU DU JIAN, TAN JING WANG ET AL¤ 3924 ,
TG, TAYLOR VM, 4000 , CHEN LI-XIA, ET AL¤ 2688 , 3063 , 3178 ,
CHEN HAIYING ET AL¤ 1778 , 3018 , 3133 , CHEN LI-XIA,WANG YU-KUN,LIU WEI-MING,ET AL¤
CHEN HANCHENG ET AL¤ 1923 , 3295 ,
CHEN HAN-CHENG, WENG LUN-HUA¤ 2569 , CHEN LIXIN¤ 1997 ,
CHEN HAO¤ 1591 , CHEN LUHUA ET AL¤ 1904 ,
CHEN HC ET AL¤ 1396 , CHEN MENG -XI, ZHANG HONG, HE YING -HONG, ET
CHEN HONGBIN, ZHANG YADONG, LI JIANJUN, ET AL¤ 3957 ,
AL¤ 2447 , CHEN MINGMING, ET AL¤ 3906 ,
CHEN HONGCI ET AL¤ 1885 , CHEN MUTAO¤ 1106 ,
CHEN HONG-LUE ET AL¤ 2096 , CHEN NINGSHENG¤ 98 , 724 , 977 ,
CHEN HONG-SHENG¤ 1012 , CHEN NINGSHENG ET AL¤ 416 , 1715 , 2197 , 2260 ,
CHEN HONGXUN ET AL¤ 85 , CHEN PEIFENG¤ 741 ,
CHEN HUA, YANG SHOUFENG, YANG XUEQIN¤ 2856 CHEN QI¤ 2806 ,
, CHEN QIAN, DOU JUN¤ 3209 ,
CHEN HUA-DONG HE HAO ZHANG YU-LIANG¤ 2933 , CHEN QIAOYUAN¤ 1237 ,
CHEN HUA-DONG, ZHANG YU-LIANG-, WUJUN, ET CHEN QINGCHUAN ET AL¤ 1460 ,
AL ¤ 3441 , CHEN QINGQUAN ET AL¤ 477 ,
CHEN HUALIANG ¤ 3471 , CHEN QINGSHAN¤ 2925 ,
CHEN HUAXIE ET AL¤ 660 , CHEN QUAN-SHOU ET AL¤ 1440 ,
CHEN HUIJING ET AL¤ 2723 , CHEN RONGXIAN¤ 39 ,
CHEN JIA¤ 3310 , CHEN RUCHENG¤ 3732 ,
CHEN JIAFU ET AL¤ 1776 , 2092 , CHEN RUI-CHUN¤ 2050 ,
CHEN JIAN ET AL¤ 1852 , 1888 , CHEN RUILIE ET AL¤ 2592 ,
CHEN JIAN, CHEN ZHE, HUANG XUE-QIANG, ET AL¤ CHEN RUOPING ET AL¤ 1199 ,
3436 , CHEN SANCAI¤ 1807 ,
CHEN JIANGIE, WANG LINGTAI, REN JINYU, ET AL¤ CHEN SHAO-XIAN ET AL¤ 1635 ,
2444 , CHEN SHENGDUO, LUO JUNHUA, I YANG PEIMING,
CHEN JIANJIE ET AL¤ 109 , 779 , ET AL¤ 3214 ,
CHEN JIANNING¤ 860 , CHEN SHIJUN ET AL¤ 1503 ,
CHEN JIAN-PING YUAN QI-XIA¤ 2916 , CHEN SHI-WEI, WANG XIN ¤ 2563 ,
CHEN JIGE, SONG XIANZHOU , CHEN LING, ET AL¤ CHEN SHIZHUANG ET AL¤ 1972 ,
3685 , CHEN SHOU-SHAN¤ 1441 ,
CHEN JIMING¤ 70 , 290 , 3996 , CHEN SHUAI¤ 3250 ,
CHEN JIMING ET AL¤ 96 , CHEN SHUFAN¤ 1845 ,
CHEN JIN FANG ET AL¤ 1991 , CHEN SHUYUAN ET AL¤ 120 ,
CHEN JINFANG ET AL ¤ 3597 , CHEN SIQING¤ 3710 ,
CHEN JIN-FANG, WU CHENG, LIU LI-JUAN¤ 3023 , CHEN SIQING , TAO XIAPING ¤ 3591 ,
3138 , CHEN TS ET AL¤ 1678 ,
CHEN JIN-FANG,MAO XING-DI,YAO LI-FENG ¤ 3795 , CHEN WEI PING ET AL¤ 198 ,
CHEN JIN-FANG,XIE RONG,ZHOU XIAO-LING,ET AL¤ CHEN WEIMING ET AL¤ 1492 ,
3206 , CHEN WEIPING¤ 3271 ,
CHEN JING¤ 1877 , 2284 , CHEN WEI-PING¤ 2958 ,
CHEN JING WANG LING-TAI ZHAO GANG¤ 3757 , CHEN WEIPING, ET AL ¤ 3531 ,
CHEN JING-JIAN ET AL¤ 1603 , CHEN WEIPING, WANG LUJUN, DING PEI, ET AL¤
CHEN JINHONG¤ 2989 , 3097 , 3495 ,
CHEN JUNXIONG, REN DONGLIN , FAN XIAOHUA , CHEN WEIQIANG, CHEN YANGSHU¤ 1731 ,
ET AL¤ 2334 , CHEN WEN-HUI ET AL¤ 2212 ,
CHEN KAIHONG ET AL¤ 1346 , CHEN WEN-HUI, ZHANG CHAO, LIN QING, ET AL¤
CHEN KEHE , ET AL ¤ 3794 , 2830 ,
CHEN KEJI¤ 1779 , CHEN WUI-MING¤ 2166 ,
CHEN KEN ET AL¤ 2139 , CHEN XI -ZHI ET AL¤ 3809 ,
CHEN KEQIN ET AL¤ 136 , CHEN XIANG-QING, WANG QIN-MAO, FANG-HUA-
CHEN KUN-SHAN,DAI QI¤ 3617 , WU, ET AL¤ 2675 ,
CHEN L, JIANG YK, CAI YB¤ 4013 , CHEN XIANGRONG¤ 1329 ,
CHEN LAN¤ 3027 , 3142 , CHEN XIAO-LI, CHEN JIAN-ZONG, ZHOU GUANG-
CHEN LANLING¤ 2258 , 2606 , JIN¤ 3377 ,
CHEN LANLING, HU JINNAN , ZHAO GUORONG, ET CHEN XIAONAN, ZHU XI 9 HE JIAGAN, ET AL¤ 3081 ,
AL¤ 3445 , 3196 ,
CHEN LI, LI DE-SHENG, LU ZHENG-XIN, ET AL¤ 3433 , CHEN XIAONAN, ZHU XI, FANG ZHIMING¤ 3569 ,
CHEN LIAN-QI ET AL¤ 323 , CHEN XINYU ¤ 3793 ,
CHEN LIHUA¤ 113 , 364 , 576 , 758 , 923 , 1063 , 1300 , CHEN YAN¤ 3255 ,
CHEN LI-HUA¤ 87 , CHEN YAN ET AL¤ 1974 ,
CHEN LIHUA ET AL¤ 206 , 265 , 400 , 411 , CHEN YAN, JIAO ZHIYONG, TIAN DEYINH¤ 3307 ,
CHEN LINGCAI¤ 148 , CHEN YANG-RONG, HUANG ZHENG-RONG, JI LI-JIN,
CHEN LIPING FAN XIANGHONG ET AL¤ 1201 , ET AL¤ 3900 ,
CHEN LI-QUN, WANG WEI-CHUN¤ 2460 , CHEN YANLING, YU FEIFEI, HUANG JIANFU, ET AL¤
CHEN LIQUN, YU HAIFENG, WANG WEIZHUN¤ 3640 , 2417 ,
CHEN LIRONG ET AL¤ 985 , CHEN YANNAN ET AL¤ 1590 , 1703 , 1754 ,

gera 2011
 286
CHEN YAN-NAN, ZHANG WEN-CHAO, DONG CHENG TIJUAN ET AL¤ 730 , 1242 ,
CHANG-SONG,¤ 2809 , CHENG TI-JUAN ET AL¤ 1241 ,
CHEN YAN-XI, MAO BAI-YUAN, JIANG JIAN-HUA, ET CHENG WEI-DONG, ET AL ¤ 3643 ,
AL¤ 2678 , CHENG WENQIAN¤ 991 ,
CHEN YA-XI ET AL¤ 1390 , CHENG WW, SONG MZ, XUE Q, SHEN YH¤ 3989 ,
CHEN YAXI, QI ZHENYUAN, GUO SHUHUA, ET AL¤ CHENG XINNONG¤ 381 ,
2471 , CHENG Y, PING J, LIU C, TAN YZ, CHEN GF¤ 3999 ,
CHEN YI ET AL¤ 1400 , 4018 ,
CHEN YI, CAI YANMEI, WU BIN, ET AL¤ 3034 , 3149 , CHENG YANG, PING JIAN, LIU CHENG, ET AL¤ 4006 ,
CHEN YONG ET AL¤ 208 , CHENG YANG, ZHANG MIN, LIU CHAZHEN, ET AL¤
CHEN YONG XIANG ET AL¤ 214 , 2451 ,
CHEN YONG-KANG ET AL¤ 1109 , CHENG YU-LIN¤ 1105 ,
CHEN YONG-PING, GAO TAO¤ 3220 , CHENG ZAI-ZHI¤ 1444 ,
CHEN YUAN, TAO YAN-YAN, LI FENG-HUA, ET AL¤ CHENG ZHI QING¤ 1336 ,
4070 , CHENG ZHIQING¤ 1458 ,
CHEN YUANFENG ET AL¤ 378 , CHENGBO W¤ 1407 ,
CHEN YUEFEI GAO TIANSHU¤ 2854 , CHENG-XIU LI ET AL¤ 1689 ,
CHEN YUFEN¤ 837 , CHEUNG CS¤ 952 , 965 ,
CHEN YUN, DU JIAN, WANG YU-HAI¤ 3599 , 3667 , CHIN HW ET AL¤ 1542 ,
CHEN YUN, JIANG HONG, WANG YUHAI¤ 3622 , CHIN-CHUAN TSAI ET AL¤ 1621 ,
CHEN YUN, JIANG HONG, WANG YU-HAI ¤ 3745 , CHINESE ASSOCIATION OF INTEGRATIVE
CHEN YUNXIN, WANG XIAOZHONG, WENG MEDICINE, LIVER DISEASE 4024 ,
SHANGENG, ET A¤ 2948 , CHIU H ET AL¤ 604 ,
CHEN YW, LI DG, WU JX, CHEN YW, LU HM¤ 3869 , CHIU JEN-HWEY ET AL¤ 1677 ,
CHEN Z, LI B, YUE X, ZHU D, YU C, WU M, LING C¤ CHIZHI Z¤ 1373 ,
4020 , CHOE JH, CHAN N, DO HH, WOODALL E, LIM E,
CHEN ZELIN ET AL¤ 73 , 77 , TAYLOR VM¤ 4028 ,
CHEN ZEMI¤ 324 , CHOU YUFENG ET AL¤ 954 ,
CHEN ZENGTAN ET AL¤ 397 , 751 , CHU RUIHAI, MA LIXIAN, WANG GANG, ET AL¤ 3688
CHEN ZENTAN ET AL¤ 225 , ,
CHEN ZEQI ET AL¤ 759 , CHU YUYI¤ 1756 ,
CHEN ZEXIONG ET AL¤ 1539 , CHU ZHENG YUN ET AL¤ 679 , 684 ,
CHEN ZH, XIA CD, HUAN JN.¤ 4114 , CHUN CHING LIN ET AL¤ 827 ,
CHEN ZHAOYANG¤ 693 , CHUN-CHING LIN ET AL¤ 957 , 958 , 961 , 1118 , 1620 ,
CHEN ZHE ET AL¤ 2114 , CHUN-CHING-LIN ET AL¤ 1751 ,
CHEN ZHENGTAN¤ 161 , CHUNHU Z, SUIYU H, MEIQUN C, GUILIN X, YUNHUI
CHEN ZHENGTU ET AL¤ 2142 , L¤ 4089 ,
CHEN ZHISHUI ET AL¤ 309 , CHUNQING ZHANG, JUREN ZU, HENGMEI SHI,
CHEN ZHISHUI, LI CHUNLEI, WANG KONGJUN ¤ 3675 JIYONG LIU AND CHENGYONG 3770 ,
, COLLEGE DE MTC DE HUBEI¤ 33 ,
CHEN ZHI-XIANG¤ 1521 , COMPILED BY WEI LIFU¤ 155 ,
CHEN ZHIXIN, ZHANG LIJUAN, CHEN YUNXIN, ET CONFORTI M ET AL¤ 190 ,
AL¤ 2702 , COOPERATIVE GROUP OF FUZHOU¤ 288 ,
CHEN ZHONGYI¤ 1830 , CUAN JIKE¤ 1041 ,
CHENG BIN ET AL¤ 1149 , CUI CHUNRONG, DONG BAOZHENG¤ 3401 ,
CHENG DONGSHENG ET AL¤ 1038 , CUI DAJIANG ET AL¤ 3266 ,
CHENG F, FENG L, LI S, TAN J, CAO L, HE Y, YE Z, LI CUI DAJIANG, NIE DANLI, ZHI MIN, ET AL¤ 3331 ,
Y¤ 4005 , CUI DAJIANG, WANG ZHIYONG, NIE DANLI-¤ 3371 ,
CHENG GUANGHUA, LI MIAOZHU, LI WEI¤ 3534 , CUI GUI-XIANG ET AL¤ 2290 ,
CHENG GUANG-LI¤ 993 , CUI HONG-YAN LIU CHENG JIANG ZHE-HAO, ET AL¤
CHENG HUIHUA, ZHENG LISHENG, CHEN 3503 ,
ZHANGSHU, ET A¤ 1730 , CUI HUAFU¤ 2448 ,
CHENG JIANHUA AND LIU XINHONG¤ 1727 , CUI HUAFU ET AL¤ 2924 ,
CHENG JIAN-HUA ET AL¤ 1631 , 2277 , CUI HUAFU, ZHU MINGJUAN¤ 3324 ,
CHENG JIAN-HUA, CHANG GANG, WU WAN-YIN, ET CUI JW, HU YY, FANG ZH, WANG XN, CHENG Y,
AL¤ 2571 , JING-HUA P, FENG Q, HUI Z¤ 4010 ,
CHENG JING HUA ET AL¤ 683 , CUI KOUSHI¤ 876 ,
CHENG JING JUN, SUN GUO-JIE¤ 3857 , CUI LIAN¤ 1419 ,
CHENG JINGGUO¤ 1043 , CUI LI-AN ZHANG JUN-FU¤ 2914 ,
CHENG JINGHUA ET AL¤ 694 , CUI LIU-FU, YAO SHU-KUN, SONG HAI-CHENG, ET
CHENG JUN, LI KE, WANG LIN, ET AL¤ 3479 , AL¤ 3592 ,
CHENG LIHUA¤ 3848 , CUI MINLU¤ 1693 , 1874 , 2286 ,
CHENG MINGLIANG ET AL¤ 1643 , 1662 , 1665 , CUI SHILIN¤ 1056 ,
CHENG MING-LIANG ET AL¤ 1637 , CUI SUNAN, WANG ZHAOHONG, LI XINLI, ET AL¤
CHENG MING-LIANG, LU YIN-YING, WU JUN, ET AL¤ 2794 ,
2568 , CUI YAN¤ 3529 ,
CHENG PENG ET AL¤ 2223 , CUI YONGAN¤ 3241 ,
CHENG RONG-SHENG , WU YUE-PING¤ 3357 , CUI YUNHUA, WANG XIAOLING, YAN ZHENGUO, ET
CHENG TIANMING, GAO FANG, ZHOU HUA, ET AL¤ AL¤ 3210 ,
2358 , CUO PINGQING¤ 701 ,

gera 2011
 287
DAI CHUANGUI ET AL¤ 1790 , DONG LIU¤ 3403 ,
DAI FUHAI ET AL¤ 1511 , DONG MINGQIANG¤ 1093 ,
DAI GUAN RONG ET AL¤ 1519 , DONG QUANSHENG ET AL¤ 2230 ,
DAI JING ET AL¤ 720 , DONG XIU-LI CHANG-HUA, LI WEI¤ 2347 ,
DAI KEMIN¤ 2109 , DONG XJ ET AL¤ 966 ,
DAI MIN, LIU QINGYUAN, ZI XIAOMEI, ET AL¤ 2457 , DONG YONG-SUI ET AL¤ 979 ,
DAI MIN, WANG YONG -ZE, GUAN WEI -BING, ET DONG YONG-SUI, HUANG ZHI-HUA, WU LAN-FEN,
AL¤ 3813 , ET AL¤ 1523 ,
DAI NING ET AL¤ 1957 , DONG ZHENXIANG ET AL¤ 553 , 718 , 739 ,
DAI YU, DAI DAJIANG, HE FUJIN, ET AL¤ 2922 , DONG ZHI-BO, ET AL¤ 2691 ,
DAI YUN ET AL¤ 725 , DONG ZI-QIANG ¤ 2731 ,
DAI ZHIJUN, LIU XIAOXU, JI ZONGZHENG, ET AL¤ DONG ZIQIANG,ZHAO YONGJUN,SHI YUXIA¤ 3059 ,
4105 , 3174 ,
DAN KAIRONG¤ 1570 , DONG-DU H¤ 650 ,
DAN LIANKAI ET AL¤ 475 , DONGHAI L ET AL¤ 1321 ,
DANG ZHONGQIN¤ 1738 , 3385 , DOU DING GUO¤ 195 ,
DARTIGUES J-P,¤ 1367 , DOU J, CHEN Q, WANG J¤ 3871 ,
DE TYMOWSKI¤ 4 , DOU MONG HAU ET AL¤ 824 ,
DE-MING Y¤ 648 , DOU-MONG HAU ET AL¤ 1120 ,
DENG BIN, LIU AIQIONG, YAN SHAOLAN¤ 2947 , DU BIN¤ 1800 , 1850 ,
DENG CHU-SHU, LUO LI, ZHU CHENG-QUAN, ET AL¤ DU BIN ET AL¤ 2289 , 2964 ,
3260 , DU BIN PAN XUEFEI, ZHANG CHANGFA¤ 2911 ,
DENG DUZHONG ET AL¤ 564 , DU FA-BIN ET AL¤ 1153 ,
DENG HAI-PENG TANG TIAN-WU¤ 3602 , DU FB ET AL¤ 1127 ,
DENG HAIPENG, TANG JIANWU¤ 2993 , 3106 , DU GUANGLI, LIU PING, WANG LEI, ET AL¤ 3814 ,
DENG HEJUN ET AL¤ 1000 , DU GUANGMING¤ 42 ,
DENG JIAGANG ZHENG ZUOWEN WANG QIN ET, AL¤ DU JIAWEN, HUANG LINPING, ZHOU LEI, ET AL¤
3700 , 3277 ,
DENG QIYUAN¤ 697 , DU JIZENG ET AL¤ 105 ,
DENG WZ, LANG QB, LING CQ¤ 4079 , DU LIN, ET AL¤ 2441 ,
DENG XIN, YANG DAGUO, JIANG XIAOLING, ET AL ¤ DU TINGGUI¤ 1498 ,
3582 , DU TONG FANG¤ 545 ,
DENG YILING¤ 199 , DU XINPING¤ 1306 ,
DENG YINQUAN¤ 1565 , DU YING-HAN¤ 3217 ,
DENG YINQUAN ET AL¤ 1141 , 1429 , DUAN LIAN YOU ET AL¤ 2029 ,
DENG YIN-QUAN, FAN XIAO-FEN¤ 2325 , DUAN LIFENG¤ 3071 , 3186 ,
DENG YIN-QUAN, FAN XIAO-FEN, LI JIAN-PING¤ 3882 DUAN QINGYIN¤ 2912 ,
, DUAN RONGZHANG ET AL¤ 1714 ,
DENG YQ, FAN XF, LI JP¤ 3863 , DUAN ZHENGFU ET AL¤ 2511 , 2549 ,
DENG ZE MING ET AL¤ 846 , DUAN ZHI-JUN, LI JI-YAN, CONG ZHEN-RI, ET AL¤
DENG ZHENG PU¤ 1337 , 2891 ,
DENG ZHENMING¤ 871 , DUAN ZHIJUN, LI JIYAN, TAN CHEN, ET AL¤ 3325 ,
DENG ZHONG YAN ET AL¤ 254 , DUBOIS JC¤ 20 ,
DENG ZHONGYAN ET AL¤ 72 , EYBL V ET AL¤ 973 ,
DEWEN W ET AL¤ 356 , FA YUEJUAN, GUO JIANCHUN¤ 3946 ,
DI CAIYUN¤ 1831 , FAN BOXIAN ¤ 3429 ,
DI LING, , ET AL¤ 3923 , FAN CANGZHEN ET AL¤ 303 ,
DI STANISLAO C¤ 1782 , FAN D¤ 617 ,
DIAO SHIQUAN ET AL¤ 1973 , FAN JIAHUA ET AL¤ 118 ,
DIEHL DL¤ 1775 , FAN JIAN GAO ¤ 4040 ,
DING ANWEI ET AL¤ 1050 , FAN YAN LEI ET AL¤ 2112 ,
DING GUO-FENG, CHENG ZHEN-IAN, LIU MING¤ 3076 FAN YIJUN ET AL¤ 685 ,
, 3191 , FAN ZONG PANG ET AL¤ 678 , 682 ,
DING GUO-FENG, WU JIN-LIAN¤ 2888 , FANG BU-WU ET AL¤ 1070 , 2158 ,
DING HONG AND HUANG JIE-AN¤ 2896 , FANG BW ET AL¤ 1079 ,
DING HONGFANG, TIAN DEYING, HUANG FANG HL, LIN HY, CHAN MC, LIN WL, LIN WC¤ 4048 ,
YUANCHENG, ET AL¤ 2413 , FANG JIE¤ 687 ,
DING HUI-GUO, WANG BAO-EN, SHANG HONG-WEI, FANG L¤ 614 ,
ET AL¤ 2679 , FANG TAI-HUI, ET AL¤ 2077 ,
DING QINGXUE¤ 1994 , FANG YAXIANG, LONG AIHUA ¤ 3428 ,
DING TILONG, MA YONG, YAN JIACHUN, ET AL¤ FANG YUAN¤ 2483 , 2522 ,
3621 , FANG ZH, HU YY, CUI JW¤ 4016 ,
DING XIA ET AL¤ 1721 , 1917 , FANG ZHAO-QIN TANG CHEN-LONG LI YONG-
DING XUAN-SHENG ET AL¤ 2580 , JIAN,ET AL¤ 3312 ,
DINGMING H ET AL¤ 1226 , FANG ZHAO-QIN, GUAN DONG-YUAN, LIANG
DOGLIA FIORELLO¤ 1781 , SHANG-HUA, ET¤ 2666 ,
DONG CHANGJIANG, CHEN XIANGRONG¤ 2341 , FANG ZHAOQIN, LI YONGJIAN, TANG CHENLONG,
DONG HAITAO¤ 1048 , ET AL¤ 3551 ,
DONG JUN, ET AL¤ 3908 , FANG ZHAOQINLI, YONGJIAN, TANG CHENLONG,
DONG LIN ET AL¤ 2764 , MA JUN, GUAI, 3986 ,

gera 2011
 288
FANG ZHAOQINLI, YONGJIAN, TANG GAO HAN¤ 1457 ,
CHENLONG,MA JUN, GUAN 3987 , GAO HONG¤ 1651 ,
FEDOROWSKI A, STECIWKO A, RABCZYNSKI J¤ 3804 GAO HUI ET AL¤ 2058 ,
, GAO HUI ZHOU DAQIAO XIONG YIQUN, ET AL¤ 2783
FEI M, LU M, WANG Y, ZHAO Y, HE S, GAO S, KE Q, ,
LIU Y, LI P, CUI X, SHEN 4106 , GAO HUI, ZHOU DAQIAO, XIONG YIQUN, ET AL¤
FENG C, WANG H, YAO C, ZHANG J, TIAN Z¤ 4051 , 2412 , 3033 , 3148 ,
FENG CHONGHUAN¤ 874 , GAO HUI, ZHOU DA-QIAO, XIONG YI-QUN, ET AL¤
FENG CHONGLIAN¤ 2970 , 3123 , 3261 ,
FENG CHONG-LIAN¤ 2352 , GAO JILIANG, SHEN ZHUANGHONG¤ 2640 ,
FENG G ET AL¤ 1564 , GAO LIANYIN, ET AL¤ 2431 ,
FENG GUANGYU ET AL¤ 1245 , GAO PING¤ 3553 ,
FENG HUIMING ET AL¤ 2257 , GAO QING ET AL¤ 1587 ,
FENG JINGKE ET AL¤ 2036 , GAO RONGHUI¤ 738 ,
FENG LAN ET AL¤ 1953 , GAO SHAOQIU¤ 1889 ,
FENG LIANG-YUAN, YAN SHUN-QIN, DUAN RUI¤ GAO SHENG , LU DONG-LAN , LIAO WEI-QUAN ¤
3920 , 3716 ,
FENG MINGHUI,DU FABIN ¤ 3585 , GAO SHI MEI ET AL¤ 1361 ,
FENG N, WU P, LI Q, MEI Y, SHI S, YU J, XU J, LIU Y, GAO SHU-HUA, ZHANG TING-WEI, MA YONG-LIN¤
WANG Y¤ 4085 , 4102 , 2621 ,
FENG PING, FU CANYUN, XIANG YUANGENG¤ 2742 , GAO SHUIBO¤ 3912 ,
FENG SHILUN¤ 282 , GAO XUESONG , CHENGJUN, ZHENZHEN, ET AL¤
FENG WEN-0 , ZENG ZHI-HUA , ZHUO LIAN-SHI¤ 4086 3682 ,
, GAO Y, SONG LX, JIANG MN, GE GY, JIA YJ¤ 4078 ,
FENG XIAOLING ET AL¤ 856 , GAO YANJING ET AL¤ 1551 ,
FENG XS ET AL¤ 1384 , GAO YAOHUA¤ 1995 ,
FENG YING-LU, CHENG BIN-BIN, AND LING CHANG- GAO YUEQIU, SUN XUEHUA, ZHANG XIAOYING, ET
QUAN¤ 4073 , AL¤ 3677 ,
FENG YU, ET AL¤ 3879 , GAO YUE-QIU, ZI-IENG YA-JIANG, AND WANG LING-
FENG ZHIJIE, YAO XIXIAN¤ 2331 , TAI¤ 4037 ,
FENG ZHIJIE, ZHAI JUNXIA,SUN YUFENG, ET AL¤ GAO YU-JIN, YANG YOU-GUO¤ 3951 ,
3281 , GAO YUNYAN ET AL¤ 696 ,
FENG ZHI-PENG¤ 2393 , GAO ZHIQIANG, LU FUER,DONG HUI, ET AL ¤ 3672 ,
FENG-LIN HSU ET AL¤ 1119 , GAO ZHONGSHAN ET AL¤ 422 ,
FENGQIANG Z¤ 1448 , GAOYA¤ 698 ,
FENMING Y¤ 611 , GASSIES P¤ 272 ,
FIRST HOSPITAL FOR INFECTIONS DISEASES¤ 17 , GE AIHUA, ZHANG QIUXIA¤ 3400 ,
FLAMENT M¤ 3 , GE MAN-TIAN¤ 1256 ,
FU CHA NGGE ET AL¤ 2979 , 3087 , GE WEN-JING, LI GUO-HONG¤ 2741 ,
FU DAIMING¤ 65 , GE YA, HU TAIHONG, FONG LI, ET AL¤ 2748 ,
FU I-LI ET AL¤ 1006 , GENG LANSHU ET AL¤ 2185 ,
FU LANGLIN¤ 2515 , GENG LUFANG ET AL¤ 2264 ,
FU LANG-LIN¤ 1280 , GENG SHAOMIN, CHEN JIE¤ 3382 ,
FU LIQI¤ 2319 , GENG XIAO-XIA, YANG QIN, XIE RU-JIA, ET AL¤ 3827
FU LU¤ 2422 , ,
FU MEIQING¤ 1332 , 1350 , GENG YUN ET AL¤ 877 ,
FU NAI-WU ET AL¤ 1062 , GENG ZIXUAN, QI ZHONGXI¤ 2362 ,
FU PING, PENG LI-LI¤ 3497 , GENG-XIAN Q¤ 649 ,
FU T ET AL¤ 970 , GERA¤ 1224 , 1225 ,
FU XINSHUN¤ 2122 , GERNIERS W¤ 1 ,
FU XUMEI¤ 1466 , GHEN JUNMEI , ET AL¤ 3787 ,
FU YUANZHONG ET AL¤ 1884 , GILANI AH ET AL¤ 1230 ,
FU YU-JUN, FU YU-XIAO, WANG WEI¤ 3537 , GONG HUIMIN¤ 1209 ,
FUJIMOTO M, TSUNEYAMA K, KAINUMA M, SEKIYA GONG NIANQIAO, GUO HUI, YE QIFA¤ 2946 ,
N, GOTO H, TAKANO Y, 4074 , GONG QI-MING ET AL¤ 3046 , 3161 ,
FUJIWARA K ET AL¤ 1389 , GONG TAO ET AL¤ 1634 ,
GAI BAIRONG¤ 104 , GONG WEIXING¤ 405 ,
GAN AIHUA, XU ANGAO, LING HONG, ET AL¤ 3463 , GONG WEIXING ET AL¤ 342 ,
GAN JING-ZHOU ET AL¤ 2152 , GONG XIANFENG ET AL¤ 2020 ,
GAN XUE-TING, BAI XIAN-GUANG¤ 3054 , 3169 , GONG YUQING, ET AL¤ 3788 ,
GAO BIN, YUAN GUIYU, LIANG SHUREN, ET AL¤ GONG YU-QING, REN ZE-JIU, CHEN YUE, ET AL¤ 3744
2376 , ,
GAO BINGE ET AL¤ 806 , GONG YUQING, SHENG GUOGUANG, CHEN YUE¤
GAO FENG, CHENG LIU-FANG¤ 3949 , 3300 ,
GAO FENG, CHENG LIU-FANG, WANG ZHI-QIANG, ET GOU SHENGLIANG ET AL¤ 1383 ,
AL¤ 3853 , GU BENYU,WANG JUNXI¤ 3708 ,
GAO FENGQIN ¤ 3524 , GU CL, ZHANG YK, FU YX, YANG SF, LI XQ¤ 4056 ,
GAO FENG-QIN¤ 1180 , 1259 , GU ERLI¤ 2049 ,
GAO GUIYING ET AL¤ 1113 , GU HUIMIN¤ 409 ,
GAO GUOXUN ET AL¤ 90 , GU HUIMIN ET AL¤ 163 ,

gera 2011
 289
GU HUIMING ET AL¤ 247 , GUO YONG¤ 1935 ,
GU KEBO, ZHANG ZHUO, LI DAOBEN, ET AL¤ 3695 , GUO YONGLE¤ 568 ,
GU LI—GANG, ET AL¤ 3878 , GUO ZHENQIU ¤ 3704 ,
GU QUNSHAN ¤ 3705 , GUO ZHENQIU ET AL¤ 1432 , 1909 , 2082 ,
GU RONGFANG¤ 1072 , GUO ZHI-ZHONG¤ 3540 ,
GU TIANJIN, ZHANG HONGMEI¤ 3432 , GUO ZI-YI, RONG HAI-BO, DIAO CAN-YANG, AL¤
GU WEIXIU ET AL¤ 489 , 4019 ,
GU XIAOXIA¤ 1827 , GUOJI H¤ 1451 ,
GU XUE-LAN ¤ 3778 , GUOKE Y ET AL¤ 1378 ,
GUAN CHUNSHOU, YI PING, LIN YANJUAN, ET AL¤ GUOQIANG H ET AL¤ 1227 ,
2482 , 2521 , HA LI-YANG,LIU YU-IING¤ 3252 ,
GUAN DONGYUAN ET AL¤ 1896 , HAI CHONGXI¤ 313 ,
GUAN DONGYUAN, FANG ZHAOQIN, LU HENGXIN HAI RIHAN ET AL¤ 2173 ,
ET AL¤ 3010 , 3125 , HAIRONG K¤ 622 ,
GUAN HONGFENG¤ 3561 , HAN DE WU ET AL¤ 179 , 587 ,
GUAN L, XIANG HC, ZOU Y.¤ 4139 , 4140 , HAN DEWU ET AL¤ 68 , 243 ,
GUAN MAOHUI¤ 170 , HAN GUOZHU ET AL¤ 686 ,
GUAN YOUBO ET AL¤ 217 , HAN J, GU YJ.¤ 4137 ,
GUANG DONGYUAN ED ALTRI¤ 3652 , HAN JINGHUAN¤ 368 ,
GUANGRONG L¤ 1582 , HAN JINGHUAN ET AL¤ 280 ,
GUI JIN-SHUI ET AL¤ 590 , HAN JINGLAN ET AL¤ 2555 ,
GUI MEI-HUA¤ 2196 , HAN JUN-QING ET AL¤ 1640 ,
GUI XIANGPING CHEN YOUKUN¤ 2693 , HAN KANGLING¤ 123 ,
GUI XIUXIONG¤ 512 , HAN KEQI, LING CHANGQUAN, HUANG CHUANJI, ET
GUIDO M, RUGGE M, COLOMBARI R, CECCHETTO A, AL¤ 3212 ,
SCARPA A, CADROBBI 1732 , HAN KEQI, ZHOU LITANG, HUANG CHUANJI¤ 2455 ,
GUIFANG C ET AL¤ 637 , HAN QI-XUN¤ 386 ,
GUIMAN L¤ 639 , HAN SHENYING¤ 896 ,
GUIMIAN W ET AL¤ 1368 , HAN WEIFENG ET AL¤ 1886 ,
GUO BA¤ 1905 , HAN XANGLING ET AL¤ 58 ,
GUO FANG-QIN¤ 1168 , HAN XIANG-YING¤ 3661 ,
GUO HAI-TAO¤ 2732 , HAN XUE HUA ET AL¤ 450 ,
GUO HAI-TAO, WANG GUAN-MIN, HAO XIAO-JUN, HAN YALAN ET AL¤ 2174 ,
ET AL¤ 2658 , HAN YIN FANG ET AL¤ 1204 ,
GUO HONG-FEI,CAL RU-CHUN¤ 3714 , HAN YONGZHU ET AL¤ 1777 ,
GUO HUI¤ 1258 , HAN YU-XIA PING YU-HUA¤ 2566 ,
GUO JIA¤ 760 , HAN ZHONG-CHENG HAN WEN-BIAO¤ 3974 ,
GUO JIA ET AL¤ 905 , HAO JIANMEI, GAO HONGMEI¤ 2994 , 3107 ,
GUO JIANCHUN ET AL¤ 1902 , 2618 , HAO PO¤ 509 ,
GUO JIANG, CHENGJUN, JI DONG, ET AL¤ 3683 , HAO PU¤ 59 , 569 ,
GUO JIAQIANG¤ 1833 , HAO PU ET AL¤ 1840 ,
GUO JINWEI¤ 3302 , HAO SHUWEN¤ 816 ,
GUO JU-TAO ET AL¤ 1030 , HAO ZHONGPIN¤ 2009 ,
GUO LAI¤ 1736 , HASE K ET AL¤ 1606 , 1611 ,
GUO LI-XIN, WANG HONG, YI HE, ET AL¤ 3568 , HE BINGFU¤ 2225 ,
GUO LIZHU¤ 2389 , HE CHENGJIAN ET AL¤ 41 ,
GUO MEIZI ET AL¤ 2616 , HE DONGYI ET AL¤ 1968 , 2224 , 2302 ,
GUO PENG¤ 595 , HE DONG-YI ET AL¤ 2211 ,
GUO PENG ET AL¤ 1654 , HE FUJIN ET AL¤ 1646 ,
GUO QINGJIE ET AL¤ 2132 , HE GUIXIA, LI LING, XIAO JINREN, ET AL¤ 3733 ,
GUO QINGYIN,DING YING¤ 3499 , HE HAO, ZHANG YULIANG, YAN YIZHONG¤ 2962 ,
GUO SHUICHEN ET AL¤ 1345 , HE HAO, ZHANG YU-LIANG, YAN YI-ZHONG¤ 2990 ,
GUO SHUICHENG ¤ 3562 , 3100 ,
GUO SHUNGEN, JIANG TAO , ZHANG WEI , ET AL¤ HE HAO, ZHANG YU-LIANG, YAN YI-ZHONG, ET AL¤
3839 , 3746 ,
GUO SHUNGEN, ZHANG WEI, JIANG TAO, ET AL¤ HE JIANCHENG ET AL¤ 1567 ,
3004 , 3118 , HE JIANGPING AND WANG CHENGBO¤ 1728 ,
GUO TAOMEI ET AL¤ 1469 , HE JIANGPING ET AL¤ 478 , 752 , 849 , 1547 , 1659 ,
GUO TIE SHENG ET AL¤ 1453 , HE JIANG-PING ET AL¤ 1636 ,
GUO WEI, ET AL¤ 3616 , HE JIANJUN ET AL¤ 975 ,
GUO WEI, TAO XINXUE, DING HONGFANG, ET AL¤ HE JIE ET AL¤ 1456 ,
2789 , HE JINYANG ET AL¤ 2744 ,
GUO WEIZHENG ET AL¤ 890 , HE LIXUAN¤ 575 ,
GUO XIANGYUN ET AL¤ 395 , HE QINGSI ET AL¤ 2268 ,
GUO XIN ET AL¤ 1335 , HE REN¤ 3224 ,
GUO XINGLIN, XU JINBO, YAN ZHANGREN, ET AL¤ HE RONGHUA¤ 2203 ,
3299 , HE RUIXING ET AL¤ 1964 ,
GUO XIPING, FENG HONGPING, LI GUOJUN, ET AL¤ HE SAIPING¤ 3344 ,
3447 , HE SONG-QI¤ 3052 , 3167 ,
GUO YIMIN¤ 2188 , HE SONG-QI, LU ZHI-PING , WEN BIN , ET AL¤ 3886 ,

gera 2011
 290
HE SONG-QI, WEN BIN, ZHENG HANG¤ 3264 , HU BING ET AL¤ 1913 ,
HE XIANGYU¤ 3075 , 3190 , HU CONG, ET AL¤ 2351 ,
HE XING-E, LEI JIAN-HUA , YANG XU , ET AL¤ 3890 , HU D, LIU Q, CUI H, WANG H, HAN D, XU H¤ 3873 ,
HE XING-E, WANG WENLONG , TIAN YI , ET AL¤ 3816 HU DA-QING ET AL¤ 2227 ,
, HU DING BANG¤ 1223 ,
HE XUE—QIANG, ET AL¤ 3877 , HU FANGLIN¤ 2387 ,
HE YANZHUAN, HUANG ZHONGMIN, QIN HOUJI¤ HU GUOJIE, LI SHIFANG, LI DIANGUI, ET AL¤ 3287 ,
3001 , 3115 , HU JIAN HUA¤ 66 ,
HE YAORONG¤ 900 , HU JIANHUA, LI XIUHUI, GOU CHUNYAN, LI
HE YI XIONG WU-JUN¤ 3887 , JINGYING, MI JUN, ZHENG 3988 ,
HE YONG-HE, FANG JI-LIANG¤ 1675 , HU JIAN-WEN, WU WEN-BIAO¤ 2941 ,
HE YUN, YUAN FENG--YI WANG JIAN BIN, ET AL¤ HU JINMAN¤ 1499 ,
2893 , HU JINQUAN¤ 312 ,
HE YUN, YUAN HONGBO, YUAN FENGYI, ET AL¤ HU JI-YUAN, WANG GONG-QIANG, CHENG NAN, ET
2462 , AL ¤ 3665 ,
HE YU-YING ET AL¤ 925 , HU L, ZHANG SW, YIN CH¤ 4047 ,
HE ZHENG LI YU-GUO GAO YUE-QIU ¤ 3635 , HU LI-JUAN¤ 3598 ,
HE ZHIQIANG,TANG YANENG¤ 3074 , 3189 , HU LINHUA¤ 1328 ,
HE ZHONGHUA¤ 1163 , HU LINHUA ET AL¤ 269 ,
HEINDRYCKX J ET AL¤ 603 , HU PING ET AL¤ 1984 ,
HENGXIN ET AL¤ 2285 , HU SHIPING¤ 3065 , 3180 , 3687 ,
HENG-YUAN CHANG; WEN-HUANG PENG; MING-JYH HU SHI-SHAO ET AL¤ 1035 ,
SHEU; GUAN-JHONG 4053 , HU TAIHONG, GE YA, ZHANG CIZHI, ET AL¤ 3452 ,
HIKINO H¤ 263 , HU TAIHONG, ZHANG CHIZHI, REN XINGFENG, ET
HIRAYAMA C ET AL¤ 710 , AL¤ 3465 ,
HIROSHI HIKINO¤ 177 , HU WENBIN ET AL¤ 1656 , 1688 ,
HIROSHI SAKAGUSHI ET AL¤ 46 , HU WEN-BIN, YANG REN-MIN¤ 2369 ,
HO LK ET AL¤ 1534 , HU WEN-BIN, YANG REN-MIN, REN MING-SHAN ET
HON MEI CHENG AND MING CHE TSAI¤ 3775 , AL¤ 2707 ,
HONG FANLI ET AL¤ 1816 , HU WEN-HAO¤ 1819 ,
HONG HUIWEN¤ 1297 , HU XIA, LINA CHANG-QUAN, ZHOU QING-HUI ¤ 3594
HONG HUIWEN ET AL¤ 1624 , ,
HONG MIN, DONG ZI-BO, SUN XIAO-YU, ET AL¤ 3731 HU XIA-MIN ET AL¤ 2256 ,
, HU XIAOYU ET AL¤ 2100 ,
HONG MINGFAN ET AL¤ 2071 , 2272 , HU XIAO-YU ET AL¤ 1931 ,
HONG QI, SHEN WEI-SHENG , YANG HONG-ZHI , ET HU XILIU, LI JIQIANG , CHANG XIUFENG¤ 2340 ,
AL¤ 3888 , HU XIYING¤ 121 ,
HONG WEN¤ 2705 , HU XP, SHIN JW, WANG JH, CHO JH, SON JY, CHO CK,
HONG YUAN, CHENG JUN ¤ 3476 , SON CG¤ 4091 ,
HONG ZHEN-FENG, WANG YU-HUA, CHEN YAN- HU YAO-HUA ET AL¤ 1574 ,
HUA¤ 3926 , HU YIQIAO ET AL¤ 1866 ,
HONGWEI L ET AL¤ 1371 , HU YI-YANG¤ 3546 ,
HONG-XIN C, HUI S, XIN-GANG J, HAI-TAO L, HU YIYANG ET AL¤ 1054 , 1073 ,
GUANG-MEI Z, XI-JUN W, WEN- 4136 , HU YI-YANG ET AL¤ 861 , 1785 ,
HONG-YEN HSU¤ 25 , 28 , HU YONG¤ 498 ,
HORI S¤ 1669 , HU YONG HE, LI JING, ZHOU JING ¤ 3511 ,
HORI S ET AL¤ 1083 , HU YONGHE ED ALTRI¤ 3800 ,
HOSONO HACHIRO¤ 132 , HU YONGHE, LI JING AND ZHOU JING¤ 3410 ,
HOSPITAL OF THE CHINESE TRADITIONAL MEDI¤ HU YONGZHEN¤ 581 ,
560 , HU YY, CHENG Y¤ 4111 ,
HOU EC, LU YX¤ 4130 , HU ZHENBIN, SHENG GUOGUANG¤ 3442 ,
HOU EN-CUN, LU YUN-XIN,¤ 4131 , HU ZHIJIAN¤ 248 ,
HOU FENG-GANG LING CHANG-QUAN ZHAO GANG, HUA BI-CHUN ET AL¤ 1873 ,
ET AL¤ 3971 , HUA GENCAI ET AL¤ 1446 ,
HOU FENG-GANG ZHAO GANG HE XIAN-MIN,ET AL¤ HUA GENMU ET AL¤ 1428 ,
3595 , HUA HAI-QING¤ 2439 ,
HOU FENG-GANG, LING CHANG-QUAN¤ 3374 , HUA HAIQING ET AL¤ 1848 ,
HOU FENG-GANG, LING CHANG-QUAN, ZHAO HUA HAI-QING, QIN SHU-KUI, WANG JIN-HONG, ET
GANG, ET AL¤ 3850 , AL ¤ 3741 ,
HOU FENG-GANG, ZHAO GANG, HE JIAN¤ 3380 , HUA YUYING ET AL¤ 987 ,
HOU FENG-GANG, ZHAO GANG, SHEN XU-BO¤ 3381 , HUAIZI ET AL¤ 1317 ,
HOU LIUIA ET AL¤ 858 , HUAN LIJUAN¤ 432 ,
HOU SHIRONG ET AL¤ 2181 , HUANG AIHUA¤ 353 ,
HOU TIEHU¤ 3752 , HUANG ANAN ET AL¤ 1177 ,
HOU Y, LI L, YANG ZY¤ 3991 , HUANG BIN¤ 3658 ,
HOU-SHU-ZHI¤ 3347 , HUANG BIN WEI AILING¤ 2769 , 2865 ,
HSIEH MING TSUEN ET AL¤ 550 , HUANG CAIGUO, LI YIMING, HE XIANG, ET AL¤ 3628
HSU YL, KUO YC, KUO PL, NG LT, KUO YH, LIN CC¤ ,
3870 , HUANG CHANGRONG¤ 1482 ,
HU ANBANG¤ 3864 , HUANG CHAO¤ 3230 ,

gera 2011

HUANG CHAOYANG, ET AL¤ 3267 ,
HUANG CL, TSAI PS, WANG TY, YAN LP, XU HZ,
HUANG CJ 4027 ,
HUANG CUANGRONG ET AL¤ 1342 ,
HUANG CUN-YUAN¤ 515 ,
HUANG DABIN¤ 1009 ,
HUANG DAO FU ET AL¤ 677 ,
HUANG DONG-DU¤ 668 , 669 ,
HUANG GUIHUA LIN SHOUNING WEI WEI ET, AL¤
3698 ,
HUANG GUIHUA, LIN SHOUNING, WANG
ZHENCHANG¤ 3723 ,
HUANG GUOJIAN ET AL¤ 1926 ,
HUANG GUOXIAN, ZHANG BEI, ZHANG YAQI, ET
AL¤ 3333 ,
HUANG GUO-YI ZHUO YUN-HUI¤ 3315 ,
HUANG HAIXIAO¤ 497 ,
HUANG HANMING ET AL¤ 537 ,
HUANG HUI¤ 1047 ,
HUANG JIAQUAN, WANG JUN GUO WEI, ET AL¤ 2377
, 3938 ,
HUANG JINGFENG ET AL¤ 885 ,
HUANG JQ, DENG JH, ZHENG ZX, XIAO F, ZHANG JJ¤
3860 ,
HUANG JUN¤ 542 , 1020 , 1758 , 1864 ,
HUANG JUN ET AL¤ 2596 ,
HUANG JUN, WU ZHELI , LIU AIHUA¤ 3372 ,
HUANG L, LU FE, YANG XY¤ 4110 ,
HUANG LI JIN RUO-MIN ET AL¤ 3354 ,
HUANG LI-MING ET AL¤ 1170 ,
HUANG MIN, BI JIN, FAN HONG, ET AL¤ 3213 ,
HUANG MINGQING ET AL¤ 2062 ,
HUANG QIAOXIN, TIAN DEYING¤ 3453 ,
HUANG QIN FENG ET AL¤ 771 ,
HUANG QINGYUN ET AL¤ 813 ,
HUANG QIWEN¤ 3681 ,
HUANG RAY LING ET AL¤ 325 ,
HUANG RUIJIE¤ 1459 ,
HUANG SHENGTENG, XU GUANGHONG, LI
YINGXIONG¤ 3686 ,
HUANG SHENGTENG, XU KUANGHUNG¤ 2945 ,
HUANG SHENGYING, WU TIE, LI LIQIANG, ET AL¤
3724 ,
HUANG SHUIYUAN¤ 1061 ,
HUANG TING ET AL¤ 799 ,
HUANG WAN YUN ET AL¤ 671 ,
HUANG WEI, ET AL¤ 2692 ,
HUANG WEI, HUANG JIQUN, ZHANG DONGFANG,
ETAL¤ 3368 ,
HUANG XIANZHANG, SHE SHIFENG, WANG
GUOBIN¤ 2450 ,
HUANG XIAO-YU ET AL¤ 1037 ,
HUANG XING KAI¤ 532 , 562 ,
HUANG XUEZHONG ET AL¤ 1222 ,
HUANG YA-PING¤ 3899 ,
HUANG YAPING ET AL¤ 1663 , 2512 , 2550 ,
HUANG YAPING, RU QINGJING, CHEN XIUGUI, ET
AL¤ 2469 ,
HUANG YI QI ET AL¤ 1999 ,
HUANG YIQI YANG HUI NIE MING ET AL¤ 2874 ,
HUANG YT ET AL¤ 1398 ,
HUANG YUANCHENG, ZHANG ZHIAN, SHI SHUXIAN,
ET AL¤ 3259 ,
HUANG YUANYUAN¤ 3247 ,
HUANG YUE, CHEN HONGBIN, HUANG ZHONGWEN,
ET AL¤ 2792 ,
HUANG YUEHUA, ZHU KELUN, GAO ZHILIANG¤ 2466
, JIANG CHENG-HUI ET AL¤ 1098 ,
HUANG YUHONG, ET AL¤ 2654 ,
HUANG YUHUA, SHENG GUOGUANG, ZHANG
291
JIANJUN¤ 2415 , 2791 ,
HUANG ZHAOQIAN ET AL¤ 1949 ,
HUANG ZHAOSHENG ET AL¤ 1956 ,
HUANG ZHENG MING ET AL¤ 673 , 733 ,
HUANG ZHENQIAO¤ 782 ,
HUANG ZHIFEN ET AL¤ 2236 ,
HUANG ZHI-FEN, LL HAN-ZHONG, SHI ZHI-YAN, ET
AL¤ 3066 , 3181 ,
HUANG ZHIFEN,LI HANZHONG,ZHANG ZUOJUN,ET
AL¤ 3736 ,
HUANG ZHI-HUA ET AL¤ 1639 ,
HUANG ZHIHUA, YE SIYING, DONG YONGSUI, ET
AL¤ 1729 ,
HUANG ZHONG, WEI WEI , AND ZHONG QIANG¤ 4099
,
HUANG ZHUO WEI ET AL¤ 470 ,
HUANG ZIPING¤ 230 ,
HUANG ZIXIA, ZHENG CHINUO, QIU CAIXIN¤ 2785 ,
HUANG ZP ET AL¤ 1289 ,
HUANGFU CHAOSHEN, LIU BIN, LI LUJUAN, ET A L¤
HUBEI COLLEGE OF TCM¤ 36 ,
HUI XIULI¤ 1465 ,
HUI-FEN CHIU ET AL¤ 964 ,
HUI-FEN CHUI ET AL¤ 493 ,
HUIJUN Z¤ 1375 ,
HUO QINGPING ET AL¤ 1857 , 1936 ,
HUYI-YANG¤ 4039 ,
HWANG JM, WANG CJ, CHOU FP, TSENG TH, HSIEH
YS, HSU JD, CHU CY¤ 3979 ,
HYUNG-SUP BAE, YOUNG-SUK KIM, KI-HO CHO,
KYUNG-SUP¤ 3031 , 3146 ,
IGARI ET AL¤ 76 ,
INSTITUT DE MTC DE TIANJIN¤ 594 ,
IP SP ET AL¤ 1397 ,
ISHIZUKA O ET AL¤ 968 ,
ISRAPIL, ET AL ¤ 2585 ,
ITO M ET AL¤ 716 ,
JACOB JR, KORBA B,JUNG EUN YOU,BUD C
TENNANT BC,YOUNG-HO KIM¤ 3805 ,
JANG SHAO LING ET AL¤ 1514 ,
JEONG SANG KIM ET AL¤ 2072 ,
JI CHANGXIAN¤ 1483 ,
JI DONG, CHENG JUN , GUO JIANG , ET AL¤ 3823 ,
JI GUANG ET AL¤ 1220 , 2164 , 2222 , 2228 , 2597 ,
JI GUANG, CAO CHENGLOU, ZHANG WEI, ET AL¤
2752 ,
JI GUANG, WANG YU-QUN, CAO CHENG-LOU, ET
AL¤ 3547 ,
JI HUI-PENG,PEI HONG-BIN¤ 3588 ,
JI KUN6MING ET AL¤ 2307 ,
JI QING ET AL¤ 1045 ,
JI RUNLI, GONG YABIN¤ 3292 ,
JI XINLIANG¤ 722 ,
JI YANG, ET AL¤ 2392 ,
JIA DE-XING, XU LEI, SU FEN, ET AL¤ 2368 ,
JIA GUI-ZHI ET AL¤ 2297 ,
JIA JIANWEI ET AL¤ 2273 ,
JIA JIANWEI, YANG JIMING, YUAN GUIYU¤ 2407 ,
JIA JINGPENG, JIANG SEN ¤ 3426 , 3438 ,
JIA JING-PENG,JIANG SEN¤ 3504 ,
JIA JIN-PENG ET AL¤ 2269 ,
JIA KUAN ET AL¤ 672 ,
JIA QINGYU, YOU WANQING¤ 3468 ,
JIA XIN QIU¤ 712 ,
JIAN SEN¤ 1029 ,
JIANG BENYOU¤ 737 ,
JIANG CHUNHUA¤ 169 ,
JIANG CHUN-MEN, LIU CHENG¤ 2788 ,
gera 2011
 292
JIANG CHUNMENG ET AL¤ 2143 , JIN SHI ET AL¤ 1001 , 1296 , 1692 ,
JIANG CHUNMENG, LIU CHENGHAI, LIU CHENG¤ JIN SHUGEN ET AL¤ 1281 ,
3494 , JIN WENJUN, YE XIAOGUANG TANG ZHENGYUN ET
JIANG CHUNSHUI ET AL¤ 2513 , 2551 , AL¤ 2871 ,
JIANG CIPENG ET AL¤ 52 , JIN YI¤ 538 ,
JIANG CP ET AL¤ 1288 , JING BINRONG ET AL¤ 1096 ,
JIANG CY, WANG BE, CHEN D¤ 4117 , JING HE, LIN SHENG-ZHANG, YANG XIAO, ET AL¤
JIANG DEYOU ET AL¤ 1982 , 4097 ,
JIANG FENG, GAO SHUI-BO¤ 3348 , JING YU-ZHEN ET AL¤ 436 ,
JIANG HAIHUA¤ 2106 , JINGHUA C ET AL¤ 643 ,
JIANG HUANPING, ET AL¤ 2426 , JINGXIANG W ET AL¤ 638 ,
JIANG JIAN¤ 1090 , JINGZHEN S¤ 615 ,
JIANG JIAN ET AL¤ 218 , JONG-CHOL CYONG ET AL¤ 2073 ,
JIANG JIAN GAO YUE-QIU WU XIAO, ET AL¤ 2717 , JU CHANGRUI ET AL¤ 1597 ,
JIANG JIAN NE MIAO¤ 3502 , JU LIJUN, MENG XINAGHUA, WANG MENG¤ 2745 ,
JIANG JILIN¤ 1348 , JU LIXIA ED ALTRI¤ 4023 ,
JIANG KAIPING¤ 1701 , JU LIZHONG, ZHONG YANWEI , CHENGJUN, ET AL¤
JIANG LELONG ET AL¤ 1344 , 3482 ,
JIANG LI ET AL¤ 2243 , 2244 , JU LIZHONG, ZHONG YANWEI, CHENG JUN, ET AL¤
JIANG LIANZHANG ET AL¤ 2267 , 3481 , 3483 ,
JIANG MEI¤ 2024 , JU LIZHONG, ZHONG YANWEI, CHENG JUNH, ET AL¤
JIANG MEI,ZHOU DAI-HAN¤ 3577 , 3484 ,
JIANG MING ET AL¤ 3644 , JUN H ET AL¤ 1376 ,
JIANG SEN¤ 108 , 238 , 260 , 578 , 707 , 1535 , 2079 , 2271 JUNG-SAN CHANG, LIEN-CHAI CHIANG, FEN-FANG
, HSU AND CHUN-CHING LIN¤ 3776 ,
JIANG SEN ET AL¤ 994 , 1023 , 1416 , 1749 , JUNSHENG W¤ 1313 ,
JIANG SEN, JIA JING-PENG, JIANG FANG-LI¤ 2714 , JUNYU W ET AL¤ 1450 ,
JIANG SHENG¤ 913 , JUR-MIN LIN ET AL¤ 1121 ,
JIANG SHUTAN¤ 201 , JUSAN G¤ 623 ,
JIANG TAO, GUO SHUNGEN, MENG YICHUN¤ 2375 , KAIHO T, TANAKA T, TSUCHIYA S, YANAGISAWA S,
JIANG XIANGRONG, CHEN ZHIXIN, ZHANG LIJUAN, TAKEUCHI O, MIURA M, 3978 ,
ET AL¤ 3370 , KANE JA ET AL¤ 1381 ,
JIANG XIANGRONG, WANG XIAOZHONG, CHEN KANG DA-QING, ZHOU DA-MING, JU LONG-XIANG,
XIAOCHUN, ET¤ 2694 , ET AL¤ 3520 ,
JIANG XINGLIANG¤ 691 , KANG DIAN HONG¤ 761 ,
JIANG XINJUN¤ 2399 , KANG JJ ET AL¤ 1558 ,
JIANG XUELIAN ET AL¤ 1808 , 1809 , KANG JUN-JIE, KANG SU-QIONG¤ 2313 ,
JIANG XUELIAN, ET AL¤ 3921 , KANG LIANG-SHI ET AL¤ 404 ,
JIANG XUE-LIAN, JIN YAN-HUA, BEN CHANG-EN¤ KAPIL A ET AL¤ 1137 ,
2930 , KARINO Y ET AL¤ 1084 ,
JIANG YAN¤ 3605 , 3966 , Kazuo TARAO, Yasunari SAKAMOTO, 4142 ,
JIANG YING-HENG, ZHOU EN-HUA¤ 3980 , KAZUO YANAGI¤ 1770 ,
JIANG YIPING, XIONG MINGFANG, ZENG YINGJIAN¤ KE CHANGZHENG, CHEN YUE, GONG ZUOJIONG, ET
3845 , AL¤ 3678 ,
JIANG YOU-LIN¤ 2885 , KE GAN¤ 445 ,
JIANG Z, HUA H¤ 4134 , KE JUN ET AL¤ 461 ,
JIANG ZHE-HAO ¤ 3566 , KEZHUANG L¤ 633 ,
JIANGUO XU¤ 4057 , KIKUTANI TOYOHIKO¤ 173 , 205 ,
JIANPING LIU ET AL¤ 3391 , KIM DI, LEE TK, JANG TH, KIM CH¤ 3982 ,
JIANYING Y ET AL¤ 605 , KIM YM¤ 47 ,
JIAO CHENG-YUAN ,CHENG ZE-DONG ,CHEN MING- KIM YONG-HYUN,ZHANG HAO,TIAN DE-LU¤ 3240 ,
MING ,CHEN YI-GUO¤ 3985 , KIM YS ET AL¤ 1610 ,
JIAO DONG HAI ET AL¤ 732 , KIRSCHBAUM B¤ 4022 ,
JIAO DONGHAI ET AL¤ 359 , 756 , KITAJIMA S ET AL¤ 1282 ,
JIAO HE-LING ET AL¤ 2189 , KO KM ET AL¤ 1382 ,
JIAO SHUANLIN ET AL¤ 1485 , 1787 , KOIZUMI K ET AL¤ 1285 ,
JIAO SHUDE¤ 144 , KONG QINGFU ET AL¤ 2147 ,
JIAO WENPING,LIJIANG,WANGFENGDONG¤ 3538 , KONG QINGYAN, CHEN NAILING, GE YANG, ET AL¤
JIAO XIAOLAN ET AL¤ 1746 , 3619 ,
JIAO YIMING ET AL¤ 1649 , KONG YAN-MEI¤ 3244 ,
JIAO YIMING, YUAN ZHANQUN ¤ 3766 , KONG YC ET AL¤ 9 ,
JIEMIN G¤ 1449 , KRAVCHENKO L¤ 2576 , 2577 ,
JIN GUILAN, ET AL¤ 3078 , 3193 , KUANG CUIZHANG¤ 1538 , 1593 ,
JIN HONG-DE¤ 1821 , KUANG WEI-HONG¤ 3854 ,
JIN HONGSHU ET AL¤ 2484 , 2523 , KUANG WEI-HONG, YANG XIAO-JUN¤ 3223 ,
JIN HUAN ET AL¤ 3329 , KUANG WEIHONG,LL JIANHUA¤ 3763 ,
JIN JJ, XU YL, ZHENG Y¤ 3990 , KUANG ZAO-YUAN ET AL¤ 1912 ,
JIN PU-FANG¤ 1442 , KUBO S ET AL¤ 971 ,
JIN QINGFENG¤ 933 , KUO-LIANG LU ET AL¤ 2074 ,
JIN QINGMING¤ 2226 , LAI YI-QIN, JIN YUAN, HUANG PING, ET AL¤ 2370 ,

gera 2011
 293
LAI YUNGCHUNG ET AL¤ 63 , ,
LAN NING 'CHEN CUI-LING 'WANG YUE-ZHEN¤ 3829 , LI HAILIANG ET AL¤ 2283 ,
LE ENSHI ET AL¤ 2967 , 3105 , LI HAI-YAN ET AL¤ 1928 ,
LE MIN¤ 2773 , LI HANLIN, ET AL¤ 2611 ,
LEE CY, PENG WH, CHENG HY, CHEN FN, LAI MT, LI HANMIN¤ 3508 ,
CHIU TH¤ 3995 , LI HAN-ZHONG ET AL¤ 2213 ,
LEE DIXING¤ 773 , LI HONG¤ 2209 , 3976 ,
LEE KY ET AL¤ 1532 , LI HONG-HAO, LIANG JUN-XIONG, CHEN JI-SHENG¤
LEE SH, HEO SI, LI L, LEE MJ, WANG MH¤ 4026 , 2405 ,
LEE TY, CHANG HH, CHEN JH, HSUEH ML, KUO JJ¤ LI HUA , ZHANG WEI, ZENG BIN-FANG¤ 2318 ,
4032 , LI HUA SHAN ET AL¤ 2013 ,
LEE TY, CHANG HH, KUO JJ, SHEN JJ¤ 4124 , LI HUAMIN¤ 798 ,
LEE TY, CHANG HH, WU MY, LIN HC¤ 4044 , LI HUIGANG ET AL¤ 980 , 1546 ,
LEE-YAN SHEEN ET AL¤ 1764 , LI J ET AL¤ 1316 ,
LEI CHENGDUO¤ 2172 , LI JI ET AL¤ 2424 ,
LEI CHUNLIANG, FAN HUIMIN, YANG ZHANG, ET LI JIABIN¤ 427 ,
AL¤ 2445 , LI JIA-FU, ZHANG HUI-QIN, SHI PENG-HUI, ET AL¤
LEI LING, AI SHU-MEI¤ 3881 , 2648 ,
LEI QISHAN¤ 3233 , LI JIANGUO ET AL¤ 1962 ,
LEI QI-SHAN¤ 3297 , LI JIANGUO, GAO AISHE ¤ 3430 ,
LEI YONGZHENG ET AL¤ 69 , LI JIANRONG ET AL¤ 2140 ,
LEI YONGZHONG ET AL¤ 778 , LI JIAN-SHENG, LL JIAN-GUO, GAO AI-SHE, ET AL¤
LEI YOUNZHONG ET AL¤ 373 , 2342 ,
LI AIFANG ET AL¤ 1275 , 1553 , LI JIANXL, ZHANG SHIZHEN, YANG ZHIQIANG ET
LI BAI, ET AL¤ 3055 , 3170 , AL¤ 2655 ,
LI BAI, ZHANG CHEN LI SHAOXIANG, ET AL¤ 3414 , LI JICHENG ET AL¤ 1955 ,
LI BAOLING, YAN MAOXIANG, CHEN ZHIYUN, ET LI JI-CHENG, YUAN SHU-HUI, ZHAO JIAN-PEI, ET AL¤
AL¤ 3815 , 2573 ,
LI BAOSHU¤ 3915 , LI JIN, SHENG GUOGUANG¤ 3454 ,
LI BING, ZHOU BOPING, WEN BIN,ET AL¤ 3462 , LI JINGPING, SU NANXIANG¤ 2381 ,
LI BO-TANG¤ 666 , LI JIQIANG ET AL¤ 1676 ,
LI CAIDONG ET AL¤ 2144 , LI JISHENG¤ 2390 ,
LI CAI-XIA,FENG YI-NONG,BI YONG¤ 3251 , LI JUN¤ 1343 , 4064 ,
LI CHANG-QIN ET AL¤ 3254 , LI JUN ET AL¤ 1863 ,
LI CHANGQIN, HU JIANJUN, ZHENG XURUI ¤ 3754 , LI JUN YU ET AL¤ 458 ,
LI CHANG-QING, ZHANG DONG-QING, LL XIAO- LI JUN, LIU SHIJING, WANG XIAOMING, ET AL¤ 2475
HUI,¤ 3339 , ,
LI CHAO¤ 2883 , 2982 , 3090 , LI JUN, YI MAO, ZHANG MIN, ET AL¤ 3323 ,
LI CHONG-AN¤ 2739 , LI L, YUAN HL, WU Q¤ 4017 ,
LI CHUN-HUA ET AL¤ 1351 , LI LAN-SHENG, XU MAN, LIU ZHI-LONG, ET AL ¤
LI CHUNMING, ZHANG YUEXIN¤ 3364 , 3418 ,
LI DA BIN¤ 770 , LI LI-JUAN ET AL¤ 2120 ,
LI DAN, WANG XIAOZHONG, CHEN ZHIXIN, ET AL¤ LI LIMIN¤ 3522 ,
2869 , LI LIN ET AL¤ 1463 , 2774 ,
LI DEMING¤ 1883 , LI LIN, ET AL¤ 2881 ,
LI DI XIN¤ 525 , LI LI-PING, SUN ZHONG-REN¤ 3456 ,
LI DI-XIN¤ 664 , LI LJ, YANG YG, ZHANG ZL, NIE SF, LI Z, LI F, HUA
LI DONG ET AL¤ 2179 , HY, HU YJ, ZHANG HS, 4061 ,
LI DONG LIANG ET AL¤ 1940 , LI MIN, ET AL¤ 3532 ,
LI DONGTAO¤ 3335 , LI MIN,WANG LUJUN,ZHU YONGGEN ET AL ¤ 3417 ,
LI DONG-TAO SHOU GUI-ZHI YU ZHI-KUI¤ 2931 , LI MING, WANG AI ZHEN, YANG QI-YING, ET AL¤
LI DONGTAO, ET AL¤ 2510 , 2548 , 2833 ,
LI DT, LING CQ, LANG QB, ZHU DZ, YU CQ, CHEN Z, LI MINGZHAO, ZHAO LIFU¤ 3056 , 3171 ,
ZHAI XF, SHEN J, ZHANG 4058 , LI MINJIE¤ 202 ,
LI FANGYU¤ 1512 , LI NAI MIN ET AL¤ 847 ,
LI FU ET AL¤ 1454 , LI NAIMIN¤ 270 ,
LI FU SHAN ET AL¤ 466 , LI PEIWEN ET AL¤ 1959 ,
LI FUSHAN ET AL¤ 848 , LI PING¤ 2023 , 2252 ,
LI FU-SHAN, CHEN LONG-HUA , TANG XI-FENG, ET LI PING, ET AL¤ 3337 ,
AL ¤ 3666 , LI QI JIAO ¤ 3634 ,
LI FUSHENG ET AL¤ 1476 , LI QIANG, WU QIANG, LI HUI-KAI, ET AL¤ 3898 ,
LI GANG¤ 2669 , LI QIANGOU¤ 2509 , 2547 ,
LI GANG ET AL¤ 2503 , LI QIAO-MEI, MENG HUI, HUANG ZHEN-YAN, ET AL¤
LI GENGHE¤ 43 , 3919
LI GUANGHUI¤ 3201 , LI QIMING ET AL¤ 1491 ,
LI GUANHUO¤ 1825 , 1867 , LI QIONG¤ 3947 ,
LI GUI ET AL¤ 872 , LI QI-SONG ET AL¤ 1283 ,
LI GUO YONG¤ 258 , LI QIUGUI ET AL¤ 797 ,
LI GUO-AN ET AL¤ 2170 , LI QUAN ¤ 3930 ,
LI GUOQIN, YE BAOCHUN, GAO BIHUA, ET AL¤ 2870 LI SAIGENG¤ 768 ,

gera 2011
 294
LI SAIMEI¤ 555 , 922 , LI YIFANG¤ 300 ,
LI SAIMEI ET AL¤ 727 , LI YING ET AL¤ 2193 ,
LI SHAOSONG,ZHANG YINGLI¤ 3080 , 3195 , LI YINGSONG ET AL¤ 1879 ,
LI SHENGCAI¤ 1735 , LI YI-WEI, LI HUI, DU SHAO-HUI, ET AL ¤ 3769 ,
LI SHENG-QING,ZHOU JIN-SHENG,YANG SHI-WU,ET LI YM, YANG HZ, GUAN WB, KE QS, DAI M, XIE HP,
AL¤ 3713 , ZHANG SJ¤ 4107 ,
LI SHENQING ET AL¤ 1184 , LI YONG ET AL¤ 2125 ,
LI SHONGHUA¤ 870 , LI YONG HONG ET AL¤ 2107 ,
LI SHU-FEN ET AL¤ 2584 , LI YONG, NIE LIANBO, ZHANG XUEMING, ET AL¤
LI SHUIQING, LIU YANJU¤ 2384 , 2668 ,
LI SHULI ET AL¤ 2063 , LI YONGHAO¤ 3579 ,
LI SHULIANG¤ 736 , LI YONGJIAN ET AL¤ 3286 ,
LI SHUPING LI QIANG¤ 3237 , LI YONG-JIAN ET AL¤ 2574 , 3098 ,
LI SHU-QING ET AL¤ 2078 , LI YONGJIAN, SANG JIUHUA, DI RUOHONG, ET AL¤
LI SHU-WEN¤ 433 , 2343
LI SL, HUANG ZN, HSIEH HH, YU WC, TZENG WY, LI YONG-SHENG¤ 3721 ,
LEE GY, CHEN YP, CHANG 4135 , LI YONGWEI, YANG HONGZHI, WANG YONGZE, ET
LI SU¤ 1842 , AL¤ 3849 ,
LI SU JUAN ET AL¤ 681 , LI YOU ZHANG¤ 1515 ,
LI SU-TING,MEI LI-XIN,YANG HE-MEI,ET AL¤ 3740 , LI YOU-MING ¤ 3545 ,
LI TIAN-ER¤ 320 , LI YUEHENG¤ 387 ,
LI TIANWANG, LI ZHIQING , HU KERONG¤ 3820 , LI YUHAO ET AL¤ 1243 ,
LI TONG ET AL¤ 1814 , LI YU-HONG ZHANG BO-LI XU ZONG-PEI, ET AL¤
LI WEI ET AL¤ 1404 , 1698 , 2909 ,
LI WEI, ET AL¤ 2432 , LI YU-HONG, ZHANG ZHEN-ZHI, DUAN WEI-HUA, ET
LI WEIDONG¤ 2187 , AL¤ 3940 ,
LI WEI-LIN¤ 2820 , LI YUN¤ 1208 ,
LI WEILIN, WANG CAIDANG, ZHANG JUNLI¤ 2816 , LI YUYIN¤ 83 , 103 , 172 ,
LI WEILIN, ZHAO XIANMING, XIANG YIQUN, ET AL¤ LI ZHANGLIN ET AL¤ 986 ,
2697 , LI ZHANPING¤ 3709 ,
LI WEI-QING, ZHOU DA-QIAO, PENG LI-SHENG, ET LI ZHAOJIAN¤ 1425 ,
AL¤ 2344 , LI ZHAO-JIAN ET AL¤ 2089 ,
LI WEIXING, TAN DAQI, LI QIUHUA, ET AL¤ 2704 , LI ZHEN, ZHANG TIE-QUAN, YE LIANG, ET AL ¤ 3576
LI WENBIAO, WANG YIREN¤ 2470 , ,
LI WEN-LIANG, LI QIANG, YAO NAI-LI, ET AL¤ 2889 , LI ZHENG ET AL¤ 932 ,
LI WENXUE¤ 1028 , LI ZHENG YU¤ 1682 , 1685 , 1717 ,
LI X ET AL¤ 841 , LI ZHI XIONG ET AL¤ 1360 ,
LI X, SHI ZM, FENG P, WEN ZY, WANG XJ¤ 4052 , LI ZHIFANG¤ 149 ,
LI XIAN ¤ 3832 , LI ZHI-HONG¤ 956 ,
LI XIAO HUA ET AL¤ 452 , LI ZHILONG¤ 940 ,
LI XIAOBIN ET AL¤ 1965 , LI ZHIQING, YANG WANGANG, XIONG YIQUN¤ 2421 ,
LI XIAOOU, GUO JIANCHUN¤ 2790 , LI ZHONGNAN¤ 501 ,
LI XIAOYAN ET AL¤ 1862 , LI ZINGZYNG ET AL¤ 44 ,
LI XIAOYUE¤ 3646 , LI ZUOQING¤ 1081 , 1594 ,
LI XINGGUO ET AL¤ 800 , LI, P RYAN AND R G BATEY¤ 3032 , 3147 ,
LI XIN-HUA¤ 3543 , LIAN WEIZHEN¤ 757 ,
LI XINMEI ET AL¤ 2262 , LIAN WEIZHEN ET AL¤ 740 ,
LI XIUHUI¤ 812 , 2365 , LIAN YUE -XIANG, WU WAN -FEN, LIN LU -PIN, ET
LI XIUHUI ET AL¤ 2083 , AL¤ 3953 ,
LI XIU-RONG, ZHANG DAN, QI YUAN-FU, ET AL¤ LIAN YUEXIANG ET AL¤ 1958 , 2097 ,
2327 , LIAN YUE-XIANG, LONG XIAO-YING, WU WAN-FEN,
LI XIUYU ET AL¤ 996 , ET AL¤ 2324 ,
LI XUDONG¤ 2247 , LIAN ZHICHENG ET AL¤ 2553 ,
LI XUDONG ET AL¤ 3470 , LIANG FENGMING¤ 572 ,
LI XU-DONG WANG SHU-HUAI ET AL¤ 2564 , LIANG GUOCHUAN¤ 1854 ,
LI XUEBIN¤ 3404 , 3407 , LIANG HEYANG MIN¤ 3514 ,
LI Y ET AL¤ 1077 , LIANG HONGJIANG¤ 3384 ,
LI Y, YANG Y, FANG L, ZHANG Z, JIN J, ZHANG K¤ LIANG HUILANG ET AL¤ 101 ,
3994 , LIANG JUNXIONG ET AL¤ 2095 ,
LI YAMIN ET AL¤ 2316 , LIANG LIN ET AL¤ 1323 ,
LI YAN ET AL¤ 2229 , LIANG LIYUN ET AL¤ 1461 ,
LI YAN-CHANG, SUN YU-FENG, FENG ZHI-JIE ¤ 3419 , LIANG MAN-HUA¤ 1355 ,
LI YANG, XUE WU-JUN, FAN PING, ET AL¤ 4103 , LIANG QIMING¤ 1349 ,
LI YANHEN ET AL¤ 608 , LIANG RONG-GAN , ET AL¤ 3416 ,
LI YE, WANG XINHUA, LU MEISHENG, ET AL¤ 3258 , LIANG SHANG-HUA, FANG ZHAO-QIN, SHI XIAO-IAN
LI YI FANG¤ 329 , ET AL¤ 3238 ,
LI YI FANG ET AL¤ 330 , LIANG TIE-JUN, ZHANG WEI, ZHANG CAI-QING ET
LI YI, CAILIN ¤ 3638 , AL¤ 2677 ,
LI YI, GUI XIEN, ZHANG YONGXI, ET AL¤ 2750 , LIANG XUIZHI ET AL¤ 2263 ,
LI YICHANG ET AL¤ 314 , LIANG YU-GUO, CHU XIU-JU¤ 2680 ,

gera 2011
 295
LIANG ZHILONG, ZHAO GUOREN¤ 2642 , LING YI HE ET AL¤ 331 ,
LIAO HUI¤ 3319 , LING ZHENGQIANG¤ 1058 ,
LIAO KONG YU ET AL¤ 467 , LINSHENG K¤ 612 ,
LIAO SHUQI, ET AL¤ 2737 , LIU AIPING, PANG XIAOYING GU YINAN, ET AL¤
LIAO YUNYUN WANG NAIPING¤ 3639 , 2378 ,
LIAO YY ET AL¤ 38 , LIU BIANLIN¤ 1832 ,
LIAO ZHEN-QIU¤ 322 , LIU BING¤ 2656 ,
LIBOTTE R¤ 192 , LIU C, SUN M, WANG L, WANG G, CHEN G, LIU C, LIU
LIHUA C¤ 1380 , P¤ 4062 ,
LIN CC ET AL¤ 1133 , 1385 , 1672 , LIU CHANG SHI ET AL¤ 131 ,
LIN DEXIN¤ 1155 , LIU CHANG, SHI YUAN, YANG QINLING¤ 3748 ,
LIN HANCHENG ET AL¤ 867 , LIU CHANGKAI ET AL¤ 1203 ,
LIN HEHE¤ 71 , LIU CHANGSHI¤ 655 , 1861 ,
LIN HE-HUO¤ 513 , LIU CHENG¤ 431 ,
LIN HONG ET AL¤ 853 , LIU CHENG ET AL¤ 310 , 857 , 1299 , 2221 ,
LIN HUI¤ 3697 , LIU CHENG, XU GUANGFU, LU XIONG, ET AL¤ 2858 ,
LIN JG ET AL¤ 1394 , LIU CHENG-HAI AND HU YI-YANG¤ 4072 ,
LIN JH ET AL¤ 1393 , LIU CHENGHAI ET AL¤ 1487 , 1747 , 2154 ,
LIN JIAN-HUI¤ 2458 , LIU CHENG-HAI, HU YI-YANG ¤ 3550 ,
LIN JIAN-JUN,JIN CHANG-NAN,CHEN XU-LAN,ET LIU CHENG-HAI, HU YI-YANG, LIU PING¤ 2651 ,
AL¤ 3507 , LIU CHENG-HAI, WANG XIAO-LING, TAN YIN-ZI, ET
LIN JINGHUA¤ 504 , AL¤ 2367 ,
LIN JJ, JIN CN, ZHENG ML, OUYANG XN, ZENG JX, LIU CHENG-HAI, XU LIE-MING, LIU PING¤ 3025 , 3140
DAI XH¤ 3865 , ,
LIN JM ET AL¤ 1132 , LIU CHENGJI ET AL¤ 1059 ,
LIN JS, CHAN CY, YANG C, WANG YH, CHIOU HY, SU LIU DAO-XI¤ 2607 ,
YC¤ 4034 , LIU DERONG¤ 1100 , 1198 ,
LIN JUNHUA¤ 1207 , LIU DIJIA¤ 1881 ,
LIN JUNHUA ET AL¤ 1269 , 1293 , 1422 , LIU DONGSHENG¤ 301 ,
LIN JUNHUA, GUO WEIJIAN¤ 3937 , LIU FANG¤ 823 , 836 , 838 ,
LIN LI ET AL¤ 2291 , LIU FENG ¤ 3575 ,
LIN LI, RUAN QING-FA, YE MO-YUAN¤ 3311 , LIU FENG ET AL¤ 2232 ,
LIN LIZHU¤ 2852 , LIU FENGJUN¤ 2957 ,
LIN LIZHU, LAN SHAOQING¤ 2321 , LIU GENG TAO ET AL¤ 454 ,
LIN LI-ZHU, ZHOU DAI-HAN, LIU KUN, ET AL¤ 3880 , LIU GENGTAO¤ 946 ,
LIN LUPING ET AL¤ 3917 , LIU GENGTAO ET AL¤ 97 ,
LIN NA, CHEN HONG-YING, ZHANG SHENG-JUN, ET LIU GT¤ 181 ,
AL¤ 3893 , LIU GUANG HONG¤ 531 , 561 ,
LIN QING, ET AL¤ 2635 , 2636 , LIU GUANGHAN¤ 307 , 819 , 1341 ,
LIN S, LIU K, WU W, CHEN C, WANG Z, ZHANG X¤ LIU GUANG-WEI GAO YUE-QIU MA RUN-LIN¤ 3972 ,
4127 , LIU GUANGZE ET AL¤ 2064 ,
LIN SC ET AL¤ 1231 , 1252 , 1287 , 1401 , 1543 , LIU GUIYING¤ 1271 ,
LIN SHOU QUAN ET AL¤ 334 , LIU GUOYING ZHANG JINYING¤ 3019 , 3134 ,
LIN SHOUNING ET AL¤ 2968 , 3112 , LIU HANCHENG ET AL¤ 352 ,
LIN SHOUNING HUANG BIN ZHU YONGPING¤ 3830 , LIU HECHEN ¤ 2674 ,
LIN SHOUNING, HUANG GUIHUA, WANG LIU HONG, YANG DAGUO, WANG DONG, ET AL¤
ZHENCHANG, ET AL¤ 3673 , 2696 ,
LIN SHOUQUAN¤ 284 , 285 , LIU HUI ET AL¤ 1706 ,
LIN SHU-HUA WANG YU-QUN, ZHANG WEI ET AL¤ LIU HUILAN ET AL¤ 156 ,
2907 , LIU J ET AL¤ 1388 ,
LIN SHU-HUA ZHANG WEI WANG YU-QUN, ET AL¤ LIU J, CHO SN, SONG KH, KIM DH, KIM MC, CHO SW¤
2718 , 4031 ,
LIN SONG-CHOW ET AL¤ 1562 , LIU JIA-LEI¤ 902 ,
LIN T ET AL¤ 967 , LIU JIALEI ET AL¤ 1235 ,
LIN WENBO, GUO SUICHENG¤ 2643 , LIU JIA-LEI ET AL¤ 1366 ,
LIN XIAOTIAN ET AL¤ 1976 , LIU JIAN¤ 907 ,
LIN XIAOTIAN, HOU JINLIN, CAI LILI, ET AL¤ 2380 , LIU JIAN SHENG ET AL¤ 530 ,
LIN XIAOTIAN, WANG YU, DAI LIN, ET AL¤ 3472 , LIU JIAN, LI HANMIN, YAN XUESHENG ¤ 3408 , 3439 ,
LIN XIONG¤ 3948 , LIU JIAN, XIE HONGDONG, LI HANMING, ET AL¤
LIN YI¤ 3518 , 3625 ,
LIN YIFAN, WANG CHANGHONG, LIU JIE,ET AL¤ LIU JIANGUO¤ 2068 ,
3670 , LIU JIANJUN¤ 3202 ,
LIN YL, LEE TF, HUANG YJ, HUANG YT¤ 4002 , LIU JIAN-SHENG ET AL¤ 1004 ,
LIN YL, WU CF, HUANG YT¤ 4084 , LIU JIE ET AL¤ 1820 ,
LIN YUN FANG ET AL¤ 465 , LIU JIN-SHU¤ 1091 , 1217 ,
LIN ZHI BIN ET AL¤ 460 , LIU KEZHOU ET AL¤ 747 ,
LIN ZONGGUANG¤ 135 , 1301 , 2103 , 2408 , 3960 , LIU KE-ZHOU ET AL¤ 978 , 1576 ,
LING CHANG-QUAN, CHEN ZHE, ZHU DE-ZENG, ET LIU KE-ZHOU, TONG ZHONG-HANG, ZHANG MING-
AL¤ 2570 , TAI, E¤ 1522 ,
LING HONGYING ET AL¤ 597 , LIU L ET AL¤ 2902 ,

gera 2011
 296
LIU LI CANG¤ 744 , LIU XINGWANG¤ 3431 ,
LIU LIANGWEI ET AL¤ 1748 , LIU XINMENG ET AL¤ 1612 ,
LIU LICANG ET AL¤ 1018 , LIU XIN-MENG, XIAO WEI¤ 2429 ,
LIU LI-CHANG , ZHANG LEI¤ 3345 , LIU XINWU¤ 1027 ,
LIU LIHUA, LIU XIULIN¤ 3655 , LIU XIUYING, ET AL¤ 3421 ,
LIU LIJUN ET AL¤ 2614 , LIU XIUZHEN¤ 2762 ,
LIU LIWEI, YE GUOCHAO¤ 3945 , LIU XUANTING, LI MING¤ 3383 ,
LIU LM ¤ 1135 , LIU XUEHUA ET AL¤ 1954 ,
LIU LU MING¤ 558 , LIU XUE-JIAN ¤ 3571 ,
LIU LUMING¤ 593 , 772 , LIU XU-SEN¤ 3662 ,
LIU LUMING ET AL¤ 708 , 754 , 951 , LIU YA PING ET AL¤ 462 ,
LIU MANJUN, WANG YUEFEN, CHEN GUOHUI¤ 3783 , LIU YAMING ET AL ¤ 2712 ,
LIU MEILING ¤ 3838 , LIU YAN¤ 1880 , 2850 ,
LIU MIN ET AL¤ 1798 , LIU YAN ZHANG ET AL¤ 2306 ,
LIU MIN, LI XIANPING ¤ 3735 , 3840 , LIU YANHUA¤ 1556 ,
LIU MING ET AL¤ 2116 , LIU YANLING ET AL¤ 1481 ,
LIU MINGXU ET AL¤ 2057 , LIU YAN-LING, CHEN LI-HUA¤ 3024 , 3139 ,
LIU P ET AL¤ 1126 , 2578 , LIU YANRONG¤ 1279 ,
LIU PENG, ET AL¤ 2605 , LIU YANZHONG, ET AL¤ 2904 ,
LIU PING¤ 3544 , LIU YICHUN¤ 417 ,
LIU PING ET AL¤ 1154 , 1577 , 1578 , 1990 , LIU YI-FAN, SHI XUE-MIN, HAN JING-XIAN, ETAL¤
LIU PING, WU DING-ZHONG, LIU CHENG-HAI, ET AL¤ 2394 ,
2665 , LIU YIJIN¤ 1733 ,
LIU PING, YASUHIRO MIZOGUZHI AND SEIJI LIU YI-MAN, SONG KAI-YUAN¤ 3379 ,
MORISAWA¤ 1527 , LIU YINGKE, ZHANG YIPING, XU ZHIDE, ET AL¤ 2729
LIU PING, ZENG MIN-DE, WANG JI-YAO, ET AL¤ 2676 ,
, LIU YM, QIN H, WANG C B, FANG XH, MA QY¤ 4007 ,
LIU Q, ZHANG YB, MA CH, YUE XQ, LING CQ¤ 3977 , LIU YONG-GANG CHEN HOU-CHANG ET AL¤ 3044 ,
LIU QIN, CUIJIANG JUN, WANG SONG, ET AL¤ 2333 , 3159
LIU QING, YUE XIAO-QIANG, HOU FENG-GANG, ET LIU YONG-HONG ET AL¤ 1516 ,
AL¤ 3083 , 3198 , LIU YU, WANG GUO-SHUN, TIAN LAN-JUN, ET AL¤
LIU QING-CHI ET AL¤ 1391 , 2844 ,
LIU QINGRONG¤ 821 , 982 , LIU YU, WANG GUO-SHUN, TIAN LAN-JUN, ET AL
LIU RONGXI¤ 2644 , AL¤ 2810 ,
LIU RUI HUA ET AL¤ 2000 , LIU YUE, WANG SONG, ZHOU TAOYOU, ET AL¤ 2857
LIU RUIXIN, LI FENGLAN, BA CUIZHEN, ET AL¤ 2673 ,
, LIU YUNMEI ET AL¤ 1838 ,
LIU S, YU M, HE Y, XIAO L, WANG F, SONG C, SUN S, LIU YUNXIA, GAO HAISHENG, TIAN JIANHUI, ET AL¤
LING C, XU Z¤ 4077 , 2433
LIU SHAO NENG ET AL¤ 2017 , LIU Z ET AL¤ 1403 ,
LIU SHAOHUI¤ 437 , LIU ZENGQUAN , LI XIAOSHENG, TAN LIXUE, ET
LIU SHAONENEG¤ 2554 , AL¤ 3694 ,
LIU SHAONENG, YAO NAILI, YIN HAIBO, ET AL¤ LIU ZHAN-HAI, ZHANG XIAO-SHUANG, SHAO
2740 , XIANG-WEN¤ 3022 , 3137 ,
LIU SHENG¤ 3952 , LIU ZHAO JUN ET AL¤ 1364 ,
LIU SHIJING ET AL¤ 1695 , 2722 , LIU ZHENG GUANG ET AL¤ 518 ,
LIU SHI-JING, ZHU QIAN¤ 3653 , LIU ZHIYONG ET AL¤ 1655 ,
LIU SHUCHANG ET AL¤ 1894 , LIU ZHONG, SHEN ZHONGYI, GUAN FENGLIN, ET
LIU SHU-JIA ET AL¤ 1363 , AL¤ 2428 ,
LIU SHU-JING¤ 3715 , LIU ZHONGJING ET AL¤ 2149 ,
LIU SHULUAN ET AL¤ 1586 , LIU ZHONGJING, LIU SHENG , YUAN YOUBIN , ET
LIU SHU-XIAN ET AL¤ 995 , AL¤ 3819 ,
LIU SQ, YU JP, CHEN HL, LUO HS, CHEN SM, YU HG¤ LIU ZHONG-JING, XIONG MANG-QI, LI SAI-MEI, ET
3993 , AL¤ 2354 ,
LIU TAO-SHI ET AL¤ 2091 , LIU ZHUANG ET AL¤ 1580 ,
LIU TIANMING¤ 3026 , 3141 , LIU ZHUOYOU¤ 188 ,
LIU TIE JUN ET AL¤ 1998 , LIVER DISEASE COMMITTEE CHINESE
LIU TIEXIN ET AL¤ 1431 , ASSOCIATION OF INTEGRATIVE 4015 ,
LIU TONG-FENG¤ 3521 , LIXIU-HUI, ZHAO CHUN-HUI, JIN RONG-HUA ET AL¤
LIU WEI ET AL¤ 1966 , 2137 , 2894 ,
LIU WEI, WANG JIANJUN, CHENG JUN, ET AL¤ 3624 , LIYING Z ET AL¤ 632 ,
LIU WEIMIN¤ 3029 , 3144 , LOFTIS JM, HAUSER P¤ 3983 ,
LIU WEIMIN, YAO NAILI¤ 3057 , 3172 , LONG AIHUA ET AL¤ 2594 ,
LIU WENLAN, YU MEI, ZHANG YAN, ET AL¤ 3964 , LONG HAO,CHEN LI-LI,WANG XIAO¤ 3390 ,
LIU WENLAN, ZHANG YAN, YU MEI, ET AL¤ 3858 , LONG QINGHUA, YU XIAO-FENG, QU-YANG HONG¤
LIU XD, WANG M, LI YZ.¤ 4143 , 2459 ,
LIU XIAO-LIN¤ 3717 , LONG YU-SHAN, ET AL¤ 3422 ,
LIU XIAO-PENG¤ 898 , LONG ZHIPING ET AL¤ 1424 ,
LIU XIN ET AL¤ 2145 , LONG ZI JIANG ET AL¤ 1941 ,
LIU XING ET AL¤ 2030 , LONG ZI-JIANG,HUANG HE-PING, ZHANG WEN JIA,

gera 2011
 297
ET AL¤ 3516 , LUO XINLA ZHU QINGJING LU DINGBO¤ 2784 ,
LOU GUO-QIANG¤ 2308 , LUO XIU FU¤ 457 ,
LOU XIAOWEI¤ 1664 , LUO XULIN , ET AL¤ 3533 ,
LOUIS WC CHOW, WINGS TY LOO, JONATHAN S T LUO YIWEN,SUN ZHIHAO,TAN XINHUA, ET AL ¤ 3485
SHAM AND MARY N B 3771 , ,
LU BAOLEI¤ 3395 , LUO YONG¤ 3727 ,
LU DONGDONG ET AL¤ 2588 , LUO YUANCHAO¤ 911 ,
LU FU-XING ET AL¤ 1261 , LUO ZEMIN ET AL¤ 1985 , 2059 ,
LÜ GUIZHI ET AL¤ 340 , LUO ZHIQIANG ET AL¤ 750 ,
LU HUIHUI¤ 3204 , LUO ZHONG-MIN¤ 2770 ,
LU JI¤ 1417 , LUO ZIYI, CHEN QUDING, GUAN LIJUAN, ET AL¤
LU JIANPING ET AL¤ 831 , 2357 ,
LU JINGJANG ET AL¤ 117 , LV XH, ZHOU LP, LIU DP, WANG Y, WANG BY, FU
LU JINGYUN¤ 916 , BY, SONG M, LIU CR¤ 4045 ,
LU JP, CAI DP¤ 4109 , MA ANLIN ET AL¤ 2067 ,
LU JUN¤ 2309 , MA CUIYU ET AL¤ 591 ,
LU JUNQING¤ 3399 , MA FENGYOU¤ 936 ,
LU JUNQING ET AL¤ 2038 , MA FUXING ET AL¤ 1092 ,
LÜ LANKAI ET AL¤ 998 , MA FUZHONG¤ 2201 ,
LU LANXUN¤ 423 , MA GUOQING ET AL¤ 2035 ,
LU LIANGEWI¤ 1700 , MA HANQIAN ET AL¤ 2076 ,
LU LIANGWEI¤ 974 , 1622 , 2391 , 2440 , MA HANQIAN, ZHOU LIPING¤ 2559 ,
LU LIANGWEI, CAI WEIMIN, ZHANG YONGSHENG, MA HONG-WEI, ET AL¤ 2690 ,
ET AL¤ 2701 , MA HUEHUI ET AL¤ 95 ,
LU LIANGWEI, CHEN QUNWEI, CHAI WEIMIN ET AL¤ MA JI ET AL¤ 2500 , 2539 ,
3072 , 3187 , MA JIANGTAO, JI LING , HE LIN¤ 3826 ,
LU LIANGWEI, LOU GUOQIANG¤ 3601 , MA JIN-LONG¤ 2647 ,
LU MIN¤ 1104 , MA JUN, LI YONGJIAN¤ 2434 ,
LU MING¤ 2612 , MA LIEQING¤ 1589 , 2880 ,
LU NING ¤ 3603 , MA LINGYUN¤ 1550 ,
LU PENG CHEN LI, LU ZHENG-XIN ¤ 3648 , MA MENGCHANG¤ 1741 ,
LU QING-TAO ET AL¤ 2113 , MA PING ET AL¤ 1837 ,
LU QIYUN¤ 2996 , 3109 , MA RONG-HUA, HUANG DE-YOU¤ 3284 ,
LU SHAONENG ET AL¤ 2823 , MA SUEHUI ET AL¤ 482 ,
LU SHAOWU¤ 2726 , MA WEI-RONG¤ 2910 ,
LU SHEN ET AL¤ 2403 , MA WUKAI¤ 2233 ,
LU WA ET AL¤ 1561 , MA XIAN ZAO¤ 255 ,
LU WEIMIN ET AL¤ 3013 , 3128 , MA XIAOYAN, JI YALING, YANG YANG, ET AL¤ 2860
LU WENLIN ET AL¤ 814 , ,
LU XIN SHENG ET AL¤ 453 , MA XIAO-YAN, WANG PING, ZHONG ZHI-HONG, ET
LU XINWEI¤ 2031 , AL¤ 3467 ,
LU XUE YA ET AL¤ 449 , MA XUE HUI ET AL¤ 792 ,
LU XUNCONG, ET AL¤ 2402 , MA XUE-HUI ET AL¤ 999 ,
LU YAN ET AL¤ 3205 , MA XUEYU ¤ 2599 ,
LU YIZHU, FAN YINGCHANG, LI GUANGBIN¤ 2681 , MA YONGYUAN ET AL¤ 1410 ,
LU YUE-QING ET AL¤ 2502 , 2541 , MA ZHAOYU¤ 1044 ,
LU YUNZHAO ET AL¤ 567 , MA ZHENLI ET AL¤ 377 ,
LU ZAISHENG¤ 293 , MA ZHENYA, ET AL¤ 2659 ,
LU ZHILIAN ET AL¤ 2045 , 2099 , MA ZUO-FENG, JIANG RUI-XUE¤ 2632 ,
LU ZHIPING, YU FANGTING, YU SHOUYI, ET AL¤ MAIHEFURETI, ET AL¤ 2927 ,
2443 , MAM NAIJUE¤ 297 ,
LULIANG WEI ET AL¤ 2818 , MANABE N ET AL¤ 1559 ,
LUO CHUANJIA, HE QIHUI, JIANG DACHUN, ET AL¤ MANG SHI-JUN, CHEN ZE-XIONG, LAO SHAO-XIAN,
3691 , ET A¤ 2898 ,
LUO DENGXU¤ 3406 , MAO DECHENG ET AL¤ 1331 ,
LUO FEI¤ 903 , MAO DEWEN QIU HUA LI YA ET, AL¤ 3699 ,
LUO GUANG-JING¤ 2984 , 3092 , MAO DEWEN,LI XINGGANG¤ 3011 , 3126 ,
LUO GUO JUN¤ 403 , MAO GUORONG¤ 2105 ,
LUO GUO JUN ET AL¤ 805 , MAO JUN -MIN, LI RU -HUI¤ 3955 ,
LUO GUOJUN¤ 383 , 1246 , MAO XIAO-LING, ET AL¤ 3062 , 3177 ,
LUO GUO-JUN¤ 1065 , 3760 , MARTIN RW¤ 193 ,
LUO GUOJUN ET AL¤ 789 , MATSUDA H ET AL¤ 972 ,
LUO GUO-JUN ET AL¤ 1186 , 1216 , MATSUYAMA Y ET AL¤ 62 ,
LUO HONG,NIE QING-HE , GAN XUE-TING¤ 3358 , MAYANAGI M ET AL¤ 1082 ,
LUO HONGWEI, ZHANG HAO¤ 3786 , MAYUPING PENG JIE ZHAO LING¤ 2800 ,
LUO LI-JUAN¤ 2156 , ME FENGYING, LI XIAOLIANG, SUN KEWEI ET AL¤
LUO QIANG ET AL¤ 2305 , 2575 , 3099 ,
LUO QUN ET AL¤ 1595 , MEGUMI SUZUKI, KENROH SASAKI, FUMIHIKO
LUO RISHENG¤ 1039 , YOSHIZAKI, MIN FUJISAWA, 3874 ,
LUO XINLA ET AL¤ 1804 , MEGUMI SUZUKI, KENROH SASAKI, FUMIHIKO

gera 2011
 298
YOSHIZAKI, MIN FUJISAWA, 3867 , HUANG X, XU S, KAMETANI S, 4075 ,
MEI CUN-JIN ET AL¤ 1876 , OBNISHI T ET AL¤ 1533 ,
MEI YUNWEI¤ 3728 , OCHI H¤ 1085 ,
MEN XIANYI¤ 60 , OHTA S ET AL¤ 969 , 1129 ,
MENG DINGSHUI ET AL¤ 728 , OHTA Y ET AL¤ 1386 , 1615 , 1619 ,
MENG JIAN ET AL¤ 844 , OHTAKE N, YAMAMOTO M, TAKEDA S, ABURADA
MENG LINSHENG¤ 294 , M, ISHIGE A, WATANABE 3984 ,
MENG MB, CUI YL, GUAN YS, YING Z, ZHENG MH, OHTAKI Y ET AL¤ 1248 ,
YUAN CK, ZHANG RM¤ 4113 , OKA H ET AL¤ 1402 ,
MENG SHENGXI ¤ 3904 , OKITA K ET AL¤ 1131 ,
Meng SX.¤ 4138 , OU WEIPING ET AL¤ 1897 ,
MENG ZHI-QIANG ET AL¤ 1927 , OU ZHONGBO¤ 2295 ,
MENG ZHONGJI, ZHANG QUANRONG, YANG LIHUA, PACKER M ET AL¤ 494 ,
ET AL¤ 2754 , PAN BO,ET AL¤ 3552 ,
MI JUN¤ 1205 , PAN CHENG-LIAN¤ 1010 ,
MI LIEHAN¤ 426 , PAN CHEN-LIAN¤ 901 ,
MI S ¤ 1076 , PAN CHEN-LIAN ET AL¤ 317 ,
MIAO BIN , CUI NAIQIANG , ZHAO ERPENG , ET AL¤ PAN FENG ZHANG YONG HUA, XU JIAN-JUN¤ 3950 ,
3586 , PAN FENGMAN, YANG QINHE, SHEN YINGSEN¤ 3753
MIAO WEIFENG ET AL¤ 2301 , ,
MIAO WENHONG¤ 1478 , PAN HONGYING SHI JUNPING FU XIAOQIN ET AL¤
MIAO XIANG-DONG¤ 2986 , 3094 , 2819 ,
MIAO ZHENGQIU¤ 480 , PAN HONGYING, YU XIULI, LOU GUOQIANG, ET AL¤
MIN XIAN ET AL¤ 1843 , 3256
MIN YOU JIANG, MA XIAO-PENG , ZHAO TIAN-PING , PAN MIN QIU ET AL¤ 261 , 459 ,
WU HUAN-GAN , SHI 4094 , PAN MINGJI ET AL¤ 1712 ,
MING ANPING, YAN XUESHENG, ZHU QINGJING, ET PAN MINGQIU, ET AL¤ 2736 ,
AL¤ 2454 , PAN MINQIU ET AL¤ 236 , 1099 ,
MING-HO CHEN, JUNG-CHOU CHEN CHIN-CHUAN PAN MINQUI ET AL¤ 372 ,
TSAI, WEN-CHUANG 3772 , PAN QIMING, LI XINGQUN ET AL¤ 224 ,
MING-HUI S¤ 646 , PAN TAICHUAN¤ 3082 , 3197 ,
MINGWU ZHANG ET AL¤ 355 , PAN TAILONG, LI YINGXIONG¤ 3043 , 3158 ,
MIYU-QIANG, ZHENG SHU-WEN, ZHANG HONG, ET PAN TIANXIONG¤ 3498 ,
AL¤ 4036 , PAN XINGNAN ET AL¤ 1969 ,
MO JINMING¤ 934 , PAN XUDONG ¤ 2639 ,
MONFARDINI A¤ 16 , PAN XUE FEI ET AL¤ 2016 ,
MOTOO Y ET AL¤ 1616 , 1617 , PAN XUEFEI, ZHANG CHANGFA, LIU YINGNA, ET
MU KEHONG ET AL¤ 1583 , AL¤ 2557 ,
MU QI-JIN ET AL¤ 2275 , PAN YI-BIN¤ 3902 ,
MU RONG, ZHENG QUBIN¤ 2828 , PAN YONGHUA ET AL¤ 2210 ,
MU YONG-PING WANG LEI ¤ 3654 , PAN YUREN¤ 162 ,
NA SHA, LONG ZIJIANG, WANG ZONGDIAN, ET AL¤ PAN ZHIHENG ET AL¤ 1795 ,
3911 , PAN ZHIHENG, CHENG MUHUA, LI LIN, ET AL¤ 3235 ,
NAGAYAMA K¤ 7 , PAN ZHIMIN¤ 1859 ,
NAKAI SACHIKO ET AL¤ 2194 , PAN ZHIMIN, LI HUA, HUANG QI, ET AL¤ 3458 ,
NAKAJIMA O ET AL¤ 134 , PAN ZHIMIN, LI YUHUA ¤ 3519 ,
NAKAMURA S, LI X, MATSUDA H, NINOMIYA K, PAN ZIHAN¤ 503 ,
MORIKAWA T, YAMAGUTI K, 4054 , PANG JUNQUN¤ 584 ,
NAKATA K ET AL¤ 24 , PAUWELS A ET AL¤ 1125 ,
NAKATA KEIGO ET AL¤ 128 , PEI DAO-LING TANG SHENG-LONG¤ 3231 ,
NAKAYAMA S ET AL¤ 1134 , PEI DAO-LING, ZHOU YU-QIN, ZHANG-XIAN¤ 2364 ,
NANJING COLLEGE OF TCM¤ 588 , PEI JUNQING ET AL¤ 2219 ,
NG LT, CHIANG LC, LIN YT, LIN CC¤ 3992 , PEI LEI, REN YING¤ 2627 ,
NI HONG-MEI¤ 2613 , PEI YUE PING ET AL¤ 1359 ,
NI JUXIOU¤ 1412 , PEI ZHENGXUE ET AL¤ 596 ,
NI KEZHONG ET AL¤ 1427 , PENG BO¤ 1648 , 3737 ,
NI WUFENG¤ 1963 , PENG BO ET AL¤ 1497 , 1918 , 2048 , 2162 , 2218 , 2231 ,
NIANCONG C¤ 1379 , 3657 ,
NIE DANLI ET AL¤ 3922 , PENG BO, MIAO MINGSAN, WANG YING FANG , ET
NIE DANLI, ZHI MIN, CUI DAJIANG¤ 2660 , AL¤ 3528 ,
NIE GUANG¤ 1274 , 1506 , 2622 , 2899 , PENG BO, MIAO MINGSAN, ZHU PINGSHENG, ET AL¤
NIE GUANG ET AL¤ 2069 , 3396 ,
NIE KAN ET AL¤ 1340 , PENG DA-WEI ET AL¤ 1036 ,
NING Z¤ 1314 , PENG FANG LIU XIAOBAO, FANG CHUNSHENG¤ 2934
NING ZEPO¤ 784 , ,
NIU JIANZHAO¤ 147 , PENG FANG,FANG CHUNSHENG,LIU XIAOBO, ET
NIU JIANZHAO ET AL¤ 167 , 496 , AL¤ 3269 ,
NIU YAOLI ET AL¤ 1892 , PENG GUIYING, GU LIGANG, WANG QINGGUO, ET
NOMURA M ET AL¤ 1228 , 1284 , AL¤ 2921 ,
NORIKURA T, KOJIMA-YUASA A, SHIMIZU M, PENG HANGUANG¤ 919 ,

gera 2011
 299
PENG HANGUANG ET AL¤ 906 , 1805 , QIAO FUQU¤ 425 ,
PENG HAN-GUANG, ET AL ¤ 3664 , QIAO GUO-MIN, CHEN CHUAN-MING¤ 2837 ,
PENG HAN-GUANG, WANG PING, AI CHANG-ZHENG, QIAO JINCHANG¤ 3841 ,
ET AL¤ 3285 , QIAO ZUO-XIAN¤ 3296 ,
PENG HUILI, GU SHIMIN, JIANG WEILUN, ET AL¤ QIN CHUANGUANG ET AL¤ 2303 ,
2465 , QIN CHUNHONG ET AL¤ 1505 ,
PENG JH, HU YY, CHENG Y, HAN C, XU LL, FENG Q, QIN DANPING, ET AL¤ 3079 , 3194 ,
CHEN SD, TAO Q, LI HS, 4090 , QIN HUATAI¤ 2436 ,
PENG SHENGQUAN ET AL¤ 769 , QIN QIU-HAO ET AL¤ 2168 ,
PENG WENJUAN ET AL¤ 1851 , QIN SIMING ET AL¤ 2270 ,
PENG YAN, ET AL¤ 2401 , QIN YI-ZHONG ET AL¤ 1191 ,
PENG YINGCAI¤ 289 , QIN YOUJUAN¤ 1970 ,
PENG YUNSHENG, DONG LINJIANG, ZHOU LIHONG, QING GUI-LUN ET AL¤ 1604 ,
ET AL¤ 2449 , QING-BO ZHANG ET AL¤ 183 ,
PENG ZHENG-SHUN ET AL¤ 1152 , QINGJUN Z ET AL¤ 610 ,
PENG ZHENG-SHUN, RAO RONG-SHENG, NI YONG- QIU JIAXIN ET AL¤ 338 , 592 ,
WEN, E¤ 1525 , QIU LIN'AN ET AL¤ 1824 ,
PENG ZS ET AL¤ 1128 , QIU MAOLIANG ET AL¤ 99 , 154 , 175 ,
PIAO YUN FENG GAO PU JUN ET AL ¤ 3696 , QIU MEI ET AL ¤ 2600 ,
PILLANS PI ET AL¤ 1249 , QIU MEI, ZHOU DA-QIAO, ZHOU XIAO-ZHOU, ET AL¤
PING QUAN-YI ET AL¤ 1182 , 3021 , 3136 ,
PO H ET AL¤ 616 , QIU PEILUN ET AL¤ 491 ,
PU JIANGYINA¤ 2804 , QIU QIN CUI ZHAO-JIE ET AL¤ 2565 ,
PU JIANYING¤ 2623 , QIU SU LAN ET AL¤ 523 ,
PU YAOKUN¤ 510 , QIU W, CHANG J, SHEN SE, SHI B, PAN X¤ 4050 ,
PU YONG-RI ET AL¤ 1046 , QIU ZHIJI ET AL¤ 1666 ,
PU YUNCHUAN, HU MINTAO, ZHANG BO¤ 3542 , QU BAO XI ET AL¤ 551 ,
PUQUAN Q¤ 644 , QU KEYI ET AL¤ 2281 ,
QAN YING ET AL¤ 988 , QU KE-YI, DONG YAN-PING, LI SHOU-HUA , ET AL¤
QI JIANSHENG ET AL¤ 1760 , 3610 ,
QI JING¤ 3535 , QU LIANGYI ET AL¤ 2198 ,
QI LA-MEI, ZHU QING-FENG¤ 3263 , QU LING, GUO LIANJUN, LU QING, ET AL¤ 3493 ,
QI PEI-HONG CHI XIAO-LING JIANG JUN-MIN, ET AL¤ QU LISHA ET AL¤ 3058 , 3173 ,
3313 , QU PUQUAN¤ 388 , 695 ,
QI PEIHONG ET AL¤ 2146 , QU YAO,ET AL¤ 266 ,
QI QING-QUAN WANG FU-MEI ¤ 3973 , QU ZUO FA ¤ 3526 ,
QI WEN XUAN ET AL¤ 448 , RAND J¤ 1652 ,
QI XIAO-HONG, JIANG LI, LI XIAO-YU ET AL¤ 2721 , RANG RUN YING, ET AL¤ 3564 ,
QI XIAOHONG, ZHANG ZHAOPING, WU CUIZHEN, ET RAO HAN-XIONG¤ 688 ,
AL¤ 3450 , RAO WANGFU¤ 692 ,
QI XIN GUAN ET AL¤ 845 , RAO XIANYI¤ 227 ,
QI XIN GUANG¤ 766 , RAO XIANYI ET AL¤ 152 ,
QI XIN-GUANG AND YUTAKA INAGAKI¤ 1526 , RAT P¤ 8 ,
QI YANPING, ZHENG YINGJUN, XU SHAOMIN, ETC¤ REN AIDONG ET AL¤ 2175 ,
3637 REN CHANGQING ET AL¤ 818 ,
QI YANPING, ZHOU XIAOZHOU, ZHOU DAQIAO, ET REN GUANG-RONG¤ 1053 ,
AL¤ 3492 , REN HUA-PING ET AL¤ 1875 ,
QI YINGJE¤ 79 , REN HUA-PING, CHENG LIN ¤ 3668 ,
QI ZHIJIA ET AL¤ 126 , REN JIAN ET AL¤ 1829 ,
QI ZHONGXI¤ 1788 , REN JIANPING, CHEN LIANG, YAN QIWEI¤ 3373 ,
QI ZHONGXI, ZHANG YIXIN, LIU XUERONG, ET AL¤ REN JINYU, ET AL¤ 2478 , 2517 ,
3581 REN JIN-YU, WANG LING-TAI, LEI CHENG-DUO, ET
QIAN BOWEN¤ 429 , AL¤ 2323 ,
QIAN BOWEN ET AL¤ 246 , REN MINGSHAN ET AL¤ 1725 ,
QIAN CUNZE ET AL¤ 379 , REN MING-SHAN ET AL¤ 1629 ,
QIAN HAIQING¤ 1742 , 2085 , REN QIUGUI ET AL¤ 1980 ,
QIAN HAIQING ET AL¤ 1887 , REN R, JU L, CHEN Z¤ 3859 ,
QIAN JUN-DA ET AL¤ 811 , REN XIAOHUA, WEI MEI, LI HUI, ET AL¤ 3446 ,
QIAN QIU-HAI , XIN YAN , HUANG DONG-HUI¤ 3351 , REN XIAO-QIAO, CHEN YONG-XU¤ 2363 ,
QIAN XIAOQI, CHEN HONG , JIN ZEQIU , ET AL¤ 3975 REN XIAOQIAO, LU YUEQING, CHEN YONGXU ET
, AL¤ 2374 ,
QIAN YALIN ET AL¤ 2492 , 2531 , REN YINGQUAN¤ 1834 ,
QIAN YALIN, CHEN WEIMIN, SUN PEIYI¤ 2446 , REN YUAN ET AL¤ 2081 ,
QIAN YALIN, ET AL¤ 2396 , REN ZANYI¤ 3650 ,
QIAN YALIN, SUN PEIYI, SUN YUN, ET AL¤ 2383 , REN ZEJIU, ET AL¤ 3615 ,
QIAN YAN, FIN YAN, LI YUAN, ET AL¤ 3073 , 3188 , REN ZEJIU, KE CHANGZHENG, GONG YUQING, ET
QIAN YAN, LING CHANG-QUAN, JIN YAN¤ 2730 , AL¤ 3690 ,
QIAN YING¤ 440 , REN ZHOUXIN ET AL¤ 1938 ,
QIAN YUSHOU ET AL¤ 511 , REQUENA Y¤ 18 , 29 , 337 , 602 ,
QIANG YONG ET AL¤ 1992 , RIDGWAY KJ¤ 1087 ,

gera 2011

ROCH FX¤ 82 ,
RONGCHUN L ET AL¤ 1309 ,
ROSENHOLZ U¤ 133 ,
RU QING-JING, TANG ZHI-MIN, ZHANG ZHEN-E, ET
AL ¤ 3779 ,
RU YONG-XIN, XU ZONG-PEI¤ 3360 ,
RUAN GONGSHI¤ 3409 ,
RUAN GONGSHI ET AL¤ 3200 ,
RUAN PENG, ZHANG QUAN-RONG, GONG ZUO-
JIONG ¤ 3614 ,
RUAN QINGFA¤ 2558 ,
RUFFING E¤ 2 ,
RURIKO HARANAKA ET AL¤ 245 ,
SAI XIYA¤ 2021 ,
SAINOKAMI S ET AL¤ 1251 ,
SANG FENG-MEI, SUN LIU-HE¤ 2706 ,
SANG-EUN LEE, KUN-HO SONG, JIANZHU LIU,
HYUN-JU KWON, SANG-BO 3773 ,
SATO N ET AL¤ 1387 ,
SCHULLER B ET AL¤ 1117 ,
SCUTARI R ET AL¤ 274 ,
SEIKOEN HOSONO CLINIC ET AL¤ 80 ,
SEO YOUNG CHOI¤ 363 ,
SEREBRINA LA ET AL¤ 944 ,
SHA YANRONG ET AL¤ 304 ,
SHAN SHOU XIAN ET AL¤ 742 ,
SHANG JIANZHONG ET AL¤ 2251 ,
SHANG JIAN-ZHONG, MA LONG-FEI, YAO XIN, ET
AL¤ 2836 ,
SHANG QINGHUA ET AL¤ 2148 ,
SHANG XIANMIN ET AL¤ 714 ,
SHAO JING' ZHUO YUYING, ZHOU XIAOJING¤ 3785 ,
SHAO NIAN-FANG¤ 715 ,
SHAO RONGSHI¤ 895 ,
SHAO RONGSHI,GU QINGHUA,JI YANHAO ET AL¤
3007 , 3121 ,
SHAO XIAOMING¤ 81 ,
SHAO ZHONG-XING ET AL¤ 2278 ,
SHE SHI-FENG, HUANG XIAN-ZHANG, TONG
GUANG-DONG ¤ 3548 ,
SHE WANXIAN ET AL¤ 1159 ,
SHEN BAO-SHENG AND SONG XIN-WEN¤ 4067 ,
SHEN GUOLIANG¤ 3941 ,
SHEN HONGXUN¤ 119 ,
SHEN JIANJUN¤ 1841 ,
SHEN JIXUAN ET AL¤ 1996 ,
SHEN JIYUN ET AL¤ 1650 , 1849 ,
SHEN LONGZHU ET AL¤ 1057 ,
SHEN LONG-ZHU, GAO HONG, WU ZHAO-HONG, ET
AL ¤ 3590 ,
SHEN MINGHE ET AL¤ 908 ,
SHEN MING-HUA, QUAN JI-SHU, LIU MING-ZHU,ET
AL¤ 3554 ,
SHEN NINGSHENG¤ 283 ,
SHEN PENG ET AL¤ 1034 ,
SHEN PENG, MA XIAO YING¤ 2882 ,
SHEN QIANG¤ 1502 ,
SHEN QIMING ET AL¤ 1174 ,
SHEN QINGLIANG ET AL¤ 878 ,
SHEN SHANGPEI¤ 3837 ,
SHEN SHUWEN¤ 158 ,
SHEN WEI-SHENG, YANG HONG-ZHI, HONG QI, ET
AL ¤ 3423 ,
SHEN XIANG¤ 1486 ,
SHEN XU-BO, LI BAI, YU CHAO-QIN Z¤ 3572 ,
SHEN YING ET AL¤ 1602 ,
SHEN YU, WANG HAN-MING¤ 3289 ,
SHEN ZHONGHOU¤ 767 ,
SHEN ZHONGLIANG, ET AL¤ 2757 ,
SHEN ZHONGYUAN¤ 875 , 1138 , 2171 ,
300
SHENG GUO-GUANG¤ 2586 ,
SHENG GUOGUANG, LI HANMIN, RAN RUIQIONG, ET
AL¤ 2452 ,
SHENGLI Z¤ 517 ,
SHENGRONG Y ET AL¤ 1377 ,
SHI BINGPEI ET AL¤ 209 ,
SHI BOAN ET AL¤ 2037 ,
SHI CHUN-LEI ET AL¤ 2086 ,
SHI DINGWEN ET AL¤ 899 ,
SHI GANG SHI WENBIN, MA BAOLIN¤ 2805 ,
SHI GANG, ET AL¤ 2410 ,
SHI HUAIZHI, LI JIANSHENG¤ 3656 ,
SHI JINGLI ET AL¤ 1699 ,
SHI JIZHAO¤ 112 ,
SHI JUN ET AL¤ 2590 ,
SHI JUNPING, W17NG XINGUANG, LOU GUOQIANG
ET AL¤ 3225 ,
SHI JUNPING, WU JUYING, PAN HONGYING ET AL¤
2797 ,
SHI JZ ET AL¤ 1392 ,
SHI MIN ET AL¤ 1179 ,
SHI P, HUANG Z, CHEN G¤ 4088 ,
SHI QIAOLING¤ 2808 ,
SHI SHIDE ET AL¤ 2242 ,
SHI SHIDE, LI RENXIAN, ZHOU DAIHAN¤ 2437 ,
SHI WEI QUN, YANG JUNCHAO, MIAO XIMIN, ET AL¤
3362 ,
SHI WEI-QUN , RU QING-JING , CAI GUO-YING , ET
AL¤ 4100 ,
SHI WEN-FENG¤ 514 ,
SHI XIA , SONG QI , HU SEN , LI ZE-FENG , LIUQIAN ,
WANG LEI , GUAN LING¤ 4076 ,
SHI XIN-MIN¤ 4038 ,
SHI XUEPING¤ 1993 ,
SHI YAXIANG¤ 2310 ,
SHI YOUXIN ET AL¤ 279 ,
SHI YOUXING ET AL¤ 360 ,
SHI YUHUA ET AL¤ 375 ,
SHI YUMIN ET AL¤ 100 , 556 , 709 ,
SHI YU'MIN ET AL¤ 780 ,
SHI YUMIN,DUAN SHUCHENG ET AL¤ 267 ,
SHI ZHIHONG¤ 3962 ,
SHI ZHIYAN LUO YONG MENG JIAHUI¤ 2561 ,
SHI ZHONGSHUN¤ 1161 , 2320 ,
SHI ZHONGSHUN ET AL¤ 802 ,
SHIGERU ARICHI¤ 474 ,
SHIGEYUKI KANAI ET AL¤ 1690 ,
SHIYI L ET AL¤ 484 ,
SHU CHANGJIE¤ 124 ,
SHU PENG¤ 2056 ,
SHU SHIJIAN¤ 240 ,
SHU SHI-JIAN¤ 249 , 321 ,
SHU XIANGDE, ET AL¤ 2425 ,
SHU XIAO-MEI, QIN ZHI-FENG¤ 3378 ,
SHU ZHI JUN ET AL¤ 521 ,
SHU ZHIJUN ET AL¤ 490 ,
SHUAI ZAI-LIANG, XIAO CHUN¤ 3593 ,
SHUANGYIN W ET AL¤ 1372 ,
SHUN DE RONG ET AL¤ 1518 ,
SHUN WEIFENG ET AL¤ 1823 ,
SHUYUAN Z ET AL¤ 621 ,
SINGERU HORI¤ 376 ,
SONG DONG-JUAN¤ 2276 ,
SONG FUYIN¤ 938 ,
SONG HUA, ZHANG LIBIN¤ 3726 ,
SONG HUAIYU ET AL¤ 1977 ,
SONG HUAI-YU ET AL¤ 2161 ,
SONG JIAJU¤ 3702 ,
SONG JIAN, ZHONG HUIMIN, YAO PING¤ 2859 ,
SONG JIANXIN, WANG JUN, LU DINGBO, ET AL¤ 2699

gera 2011
 301
, SUN JUN¤ 2628 ,
SONG JIE ET AL¤ 2255 , SUN LEWES, CHEN ZHIYUN, YAN MAOXIANG, ET AL
SONG JIN-DUO ET AL¤ 2121 , ¤ 3570 ,
SONG JING-GUI, XIAO ZHENG-MING, LI SHI-PENG, SUN LIN ET AL¤ 1872 ,
ET AL¤ 2348 , SUN LING JUAN ET AL¤ 2002 ,
SONG JU ET AL¤ 1146 , SUN LIXIA¤ 2388 ,
SONG KAIYUAN ET AL¤ 347 , SUN MEIQIN, ZHAO LIANSAN, WANG SONG, ET AL¤
SONG MING-YUAN¤ 2629 , 3000 , 3114 ,
SONG QIAN¤ 2995 , 3108 , SUN MING-HUI¤ 665 , 1443 ,
SONG SAIFEN¤ 1891 , SUN PEIYI, QIAN YALIN, CHEN XIUYUN¤ 3693 ,
SONG SHI-LING, GONG ZUO-JIONG, ZHANG QUAN- SUN PENG-QIANG ET AL¤ 2131 ,
RONG ¤ 3567 , SUN RONG, ZHAO ZHIYUAN, WANG PING, ET AL¤
SONG SHI-LING, GONG ZUO-JIONG,ZHANG QUAN- 3270 ,
RONG, ET ¤ 3556 , SUN SHOU-CAI¤ 2487 , 2526 ,
SONG SHI-LING, HUANG TUAN-XIN, GONG ZUO- SUN SHOU-CAI ET AL¤ 2261 ,
JIONG, ET AL¤ 3812 , SUN SHOU-CAI LIU GUANG-WEI, CENG FU-HAI ET
SONG SL, GONG ZJ, HUANG YQ, ZHANG QR, HUANG AL¤ 2928 ,
TX¤ 4009 , SUN SHOUCAI, LI XIAOMIAO, ET AL¤ 2684 ,
SONG SL, GONG ZJ, ZHANG QR, HUANG TX¤ 3868 , SUN SU¤ 2491 , 2530 ,
SONG SONG-WEN ET AL¤ 1253 , SUN WEI ET AL¤ 469 ,
SONG SU-HUA ET AL¤ 2609 , SUN WEINA¤ 3580 ,
SONG WEI HUANG YANFANG ¤ 3587 , SUN XIAOLONG¤ 1846 ,
SONG XIN-WEI, LUO YONG-ZHONG¤ 2650 , SUN XINMIN ET AL¤ 1474 ,
SONG YH, LIU Q, LV ZP, CHEN YY, ZHOU YC, SUN SUN XUAN ET AL¤ 2208 ,
XG¤ 4081 , SUN XUEHUA , ET AL¤ 2977 ,
SONG YUGANG, YAO YONGLI, LIU LIMIN, ET AL¤ SUN XUE-HUA GAO YUE-QIU WANG LING-TAI, ET
3332 , AL¤ 3314 ,
SONG YUMEI ET AL¤ 1791 , SUN XUEHUA, ET AL¤ 2709 , 3085 ,
SONG ZHENG ET AL¤ 775 , 850 , SUN XUE-QUAN¤ 348 , 349 ,
SONG-CHOW LIN ET AL¤ 1618 , 1763 , SUN YALIN ET AL¤ 1951 ,
SOTTE L ET AL¤ 948 , SUN YAN, JI GUANGSEN , XU QINGTIAN , ET AL¤
STEVINSON C¤ 1802 , 3817 ,
STICKEL F, SCHUPPAN D¤ 4046 , SUN YIE-NONG¤ 1169 ,
SU HEPING¤ 984 , SUN YU¤ 2747 ,
SU LIWEN ET AL¤ 2589 , SUN YUANQIN¤ 566 ,
SU QUAN-WU, LI DAO-BEN, ZHU YOU-MING¤ 3889 , SUN YUFENG, YAO XIXIAN, CUI DONGLAI¤ 2672 ,
SU XIANSHI ET AL¤ 67 , 176 , 2938 ,
SU XIAOKANG, ZHOU WEISHENG, XU FABIN, ET AL¤ SUN YX, LIU C¤ 3808 ,
3583 , SURESH G ET AL¤ 1627 ,
SU XUN-BO¤ 2371 , TAI HUILING¤ 1930 ,
SU YONGQING¤ 801 , TAJIRI H ET AL¤ 950 ,
SU YUNFANG ET AL¤ 204 , TAN CHUN-YU TAN SHAN-ZHONG JIANG JIAN, ET
SUI DAO-JING ET AL¤ 2608 , AL¤ 3970 ,
SUI JIDONG¤ 1510 , TAN FAJIN, YU RONG, WEI YON¤ 3226 ,
SUI YANHUA ET AL¤ 1718 , TAN HUANGYING¤ 1614 ,
SUI YAN-QING ET AL¤ 1353 , TAN KAIJI ET AL¤ 1855 ,
SUN BAIJUN, CUI NAIQIANG¤ 2356 , TAN MIN BIN XIAONONG WU WANYIN, ET AL¤ 2877 ,
SUN BINJIE ET AL¤ 1944 , TAN QIWEN ET AL¤ 2042 ,
SUN CHUANG-BIN, YU ZE-PU, LIN QING ET AL¤ 2831 TAN SHAN-ZHONG, TAN CHUN-YU, JIANG JIAN , ET
, AL¤ 3894 ,
SUN DI¤ 2926 , TAN XINGHUA, TAN JUN, YIN CHIBIAO, ET AL¤ 2386
SUN DIANXING ET AL¤ 1761 , ,
SUN FANJUN¤ 746 , TAN XINHUA, WANG JIAN, WU MAOSHENG, ET AL¤
SUN FEI LIN ET AL¤ 711 , 3627 ,
SUN GANG ET AL¤ 2493 , 2532 , TAN YING ET AL¤ 2495 , 2534 ,
SUN HUA ET AL¤ 1007 , TAN YOU-WEN YIN YU-MEI, YU XUE-JUN, ET AL¤
SUN HY, REN Y, YIN JX, ET AL¤ 4087 , 2562 ,
SUN JIAN¤ 2150 , TANG BS ¤ 1291 ,
SUN JIANG QIAO ET AL¤ 2015 , TANG GUANGYU¤ 1238 ,
SUN JIAN-GUAN¤ 2866 , TANG H, MIN G, GE B, LI Y, LIU X, JIANG S¤ 4108 ,
SUN JIAN-GUANG¤ 3755 , TANG JIANWU ET AL¤ 2202 ,
SUN JINFANG, YIN ZHONGDONG¤ 2855 , TANG JINMO, CHEN GUOLIANG¤ 3245 ,
SUN JING ZHEN ET AL¤ 257 , TANG MENGGUANG¤ 777 ,
SUN JINGINGET AL¤ 1784 , TANG MING-ZHENG, ET AL¤ 3273 ,
SUN JINHUI ET AL¤ 2817 , TANG NONG ET AL¤ 2186 ,
SUN JIUGUANG ET AL¤ 2007 , 2104 , TANG QING MING ET AL¤ 548 ,
SUN JIUGUANG XU HONGWEI¤ 2339 , TANG QIQIANG ET AL¤ 1925 ,
SUN JIUGUANG, WU JIANFANG, YANG JU, ET AL¤ TANG RONGZHEN¤ 2456 ,
3199 , TANG SHANLING¤ 921 ,
SUN JUE ET AL¤ 2159 , TANG SHILI LIU QIZHENG WANG YANNI¤ 2803 ,

gera 2011

TANG TIAN¤ 1257 ,
TANG TIECHENG¤ 904 ,
TANG WEI, ZHU JIANHUA¤ 3527 ,
TANG WENCHAN ET AL¤ 1858 ,
TANG XH, GAO J, FANG F, CHEN J, XU LZ, ZHAO XN,
XU Q¤ 3861 ,
TANG XIANG,ET AL¤ 3541 ,
TANG XIHUA¤ 408 ,
TANG XIN MIN ET AL¤ 262 ,
TANG XINMIN¤ 241 ,
TANG YI ET AL¤ 1702 ,
TANG YOUWEI, YAO XIXIAN, YAO HONGSEN¤ 2671 ,
TANG YUNLONG¤ 84 ,
TANG ZHIMIN ET AL¤ 1981 ,
TANG ZHI-MIN ET AL¤ 1575 ,
TANG ZHI-MIN PENG MENG, ZHAN CHUN-JIAO, ET
AL¤ 3361 ,
TANG ZHIMIN, ZHAN CHUNJIAO, JIN WENYIN, ET
AL¤ 2873 ,
TAO CUILING, LI YAN, ZHAO YANBO¤ 3246 ,
TAO JIHONG ET AL¤ 2743 ,
TAO MINGZHONG ET AL¤ 351 , 483 , 492 , 554 ,
TAO Q, SUN MY, FENG Q¤ 4129 ,
TAO QIMIN ET AL¤ 1780 ,
TAO QING, SUN MING-YU, FENG QIN,¤ 4132 ,
TAO SHOU PENG¤ 547 ,
TAO XIAOCHEN ET AL¤ 488 ,
TAO XIAPING ET AL¤ 3330 ,
TAO YUFENG¤ 92 ,
TATSUTA MASAHARU ET AL¤ 1229 ,
TENG LI-MING¤ 2985 , 3093 ,
TENNEKOON KH ET AL¤ 1286 ,
THAMLIKIKUL V ET AL¤ 941 ,
TI GUIXIANG, ET AL¤ 2583 ,
TIAN CUISHI, BO AIHUA, LI ZHONGPING, ET AL¤
3211 ,
TIAN DELU ET AL¤ 1197 ,
TIAN GUIZHEN¤ 2936 ,
TIAN HAIHE¤ 1014 ,
TIAN HUANGAN, LIANG GUI-WEN, TAO YIN, ET AL¤
2556 ,
TIAN HUA-QIN, LIANG GUI-WEN, TAO YIN, ET AL¤
2435 ,
TIAN JIANHUI ET AL¤ 2274 ,
TIAN JIAN-HUI ET AL¤ 2615 ,
TIAN JIANHUI, LIU YUNXIA, AU BAOGANG, ET AL¤
2829 ,
TIAN N ET AL¤ 706 ,
TIAN NAIGENG¤ 64 ,
TIAN WEIJUN , WANG PENGZHI, ZHU LIWEI, ET AL¤
2335 ,
TONG FU FUYI, BAI JINGYU TANG YONGHUANG, ET
AL¤ 2868 ,
TONG GD, ZHOU DQ, HE JS¤ 4116 ,
TONG GD, ZHOU DQ, HE JS, LI SL, PENG LS¤ 4011 ,
TONG GUANGDONG , ZHOU DAQIAO, HE JINSONG¤
3496 ,
TONG GUANG-DONG, ET AL¤ 3272 ,
TONG GUANG-DONG, ZHOU DA-QIAO, QI YAN-PING,
ET AL¤ 3435 ,
TONG GUANGDONG,PENG SHENGQUAN ¤ 3734 ,
TONG QIAOXIA, CAI SUQING¤ 3037 , 3152 ,
TONG YINGJIE¤ 419 ,
TORRACCA F¤ 2195 ,
TSAI CC ET AL¤ 1607 , 1671 ,
TSAY CHING HUNG¤ 130 ,
TSENG TH ET AL¤ 1531 ,
TSUNEO KINOSHITA¤ 945 ,
TU HUA CHENG ET AL¤ 705 ,
TU SHENG-HAO ET AL¤ 1005 ,
302
TUNG-YUAN LAI ET AL¤ 1691 , 1752 , 1762 ,
VERMA S, THULUVATH PJ¤ 4035 ,
WAGNER M¤ 180 ,
WAN CHUANGUI ET AL¤ 1641 ,
WAN MING TANG RONG¤ 1206 ,
WAN SHEN ET AL¤ 278 ,
WAN XUEFA, XIAO HONG, REN SONG, ET AL¤ 3629 ,
WAN XUYING ET AL¤ 2661 , 2953 ,
WANG AIMIN¤ 1326 ,
WANG B, TIAN HQ, LIANG GW¤ 4128 ,
WANG BANGCAI, ET AL¤ 3321 ,
WANG BAO EN ET AL¤ 734 ,
WANG BAOEN¤ 164 ,
WANG BAOLIN¤ 3427 ,
WANG BAOYI ET AL¤ 495 , 1049 , 1195 ,
WANG BAO-ZHEN¤ 2499 , 2538 ,
WANG BAO-ZHEN, ET AL¤ 3060 , 3175 ,
WANG BENXIANG ET AL¤ 122 ,
WANG BIN, TIAN HUA-QIN, LIANG GUI-WEN,¤ 4133 ,
WANG BING ET AL¤ 2123 ,
WANG BINGLI ET AL¤ 1882 ,
WANG BINGSHENG , ET AL¤ 3530 ,
WANG BOXIANG¤ 2206 ,
WANG CANG-JUN ET AL¤ 1906 ,
WANG CHANGHAI, JIANG YONGPEI, LI JUNCHANG,
ET AL¤ 3376 ,
WANG CHANGJUN ET AL¤ 1794 , 2044 , 2237 ,
WANG CHANGJUN, LIAO ZIJUN, CHEN QINGQIANG,
ET A¤ 2728 ,
WANG CHANGMIN, ET AL ¤ 3612 ,
WANG CHANGMING , SHI YONGFEN , WANG
DANHUA¤ 3280 ,
WANG CHAO-LIANG KE JIN-HU ET AL¤ 3782 ,
WANG CHENBAI ET AL¤ 749 ,
WANG CHEN-BAI ET AL¤ 1002 ,
WANG CHENBO¤ 234 ,
WANG CHENGBAI ET AL¤ 345 , 1537 ,
WANG CHENGBO¤ 75 , 145 , 291 ,
WANG CHENGBO ET AL¤ 102 , 221 , 399 , 552 ,
WANG CHUIJIE ET AL¤ 880 ,
WANG CHUN SHENG¤ 653 ,
WANG CHUNFANG¤ 2041 ,
WANG CHUN-FANG ¤ 3969 ,
WANG CHUNHUA, LANG ZHENWEI , CHENG JUN , ET
AL¤ 3822 ,
WANG CHUNLI, YU JINDONG, GAO TAO, ET AL¤ 2416
,
WANG DE LONG¤ 808 ,
WANG DE-JING¤ 3015 , 3130 ,
WANG DONGQING, WU BUTAO, XIANG XIANG¤ 2474
,
WANG FANG ET AL¤ 1333 ,
WANG FANG LU XINLIE¤ 2777 ,
WANG FANG, ET AL¤ 2711 ,
WANG FAZHI¤ 1750 ,
WANG FENG ET AL¤ 2200 ,
WANG FU ET AL¤ 2094 ,
WANG FY, TANG XD, XU YG¤ 4115 ,
WANG GANG, MA LI-XIAN, MING GUO-HUI , ET AL¤
3892 ,
WANG GENGXIN ET AL¤ 481 ,
WANG GS AND HAN ZW¤ 1200 ,
WANG GUANTING ET AL¤ 138 , 402 ,
WANG GUI ZHEN ET AL¤ 256 ,
WANG GUIMIAN ET AL¤ 1250 , 1305 ,
WANG GUIRONG, ZHANG HONGXIA, ZHANG
RUILING¤ 2330 ,
WANG GUO SHEN ET AL¤ 680 ,
WANG GUOBIN¤ 1719 , 1722 ,
WANG GUOPING¤ 783 ,
gera 2011
 303
WANG GUOSHEN ET AL¤ 203 , 222 , WANG MI-QU , WU BIN, LIN QIAO, ET AL¤ 3798 ,
WANG GUOSHENG¤ 141 , WANG MONGSHI ET AL¤ 211 ,
WANG GUOSHENG ET AL¤ 786 , WANG NING¤ 1247 ,
WANG GUOWEI, ET AL¤ 2776 , WANG NUE-XI, ZHAO JIAN-XIONG, CIIEN RU, ET AL¤
WANG HAINAN, LIU PING, WANG BAOZHEN, ETAL¤ 4043 ,
3305 , WANG P,WU YL, ZHANG YQ¤ 3008 , 3122 ,
WANG HONG ¤ 2604 , WANG PING, LIU LING, QIU XINGFAN, ET AL¤ 2453 ,
WANG HONG-CHAO, ZHANG HUA, ZHOU TONG- WANG QI ET AL¤ 1697 ,
LIANG, ET AL¤ 2649 , WANG QIANSHAN¤ 1489 ,
WANG HONGYE ET AL¤ 485 , WANG QIAOCHU¤ 540 ,
WANG HUAIZHANG¤ 1726 , WANG QICHI¤ 2084 ,
WANG HUAMENG¤ 2217 , WANG QIN ,DENG JIAGANG,HUANG MINGWEN¤
WANG HUA-NING FENG NI¤ 2983 , 3091 , 3491 ,
WANG HUI JI¤ 794 , WANG QINGMIN ET AL¤ 1681 , 2027 ,
WANG HY, CHENG ML¤ 4092 , WANG QING-MIN ET AL¤ 713 ,
WANG JI , ET AL¤ 2978 , WANG QIN-MIN ET AL¤ 1031 ,
WANG JI FENG ET AL¤ 326 , WANG QUANCHU, SHEN DELIN, ZHANG
WANG JI, ET AL¤ 3086 , 3501 , CHENGDAO, ET AL¤ 2467 ,
WANG JIAJUN¤ 565 , WANG R, KONG J, WANG D, LIEN L, LIEN E¤ 4033 ,
WANG JIAN ZHONG¤ 259 , WANG RONG GUO¤ 327 ,
WANG JIAN, HE FUJING, NIU JIANZHAO, ET AL¤ 2700 WANG RONG PING¤ 546 ,
, WANG RONGBING, LIU JUNMIN, WU YUNZHONG, ET
WANG JIAN, NIU JIANZHAO, FIE FUJING, ET AL¤ 3304 AL¤ 3620 ,
, WANG RONGBING, SUN FENGXIA, JIANG YUYONG,
WANG JIANGZHONG¤ 2887 , ET AL¤ 3036 , 3151 ,
WANG JIANLING ET AL¤ 55 , WANG RONGGUO¤ 286 ,
WANG JIANYI ET AL¤ 1890 , WANG RONGGUO,LIN RUIJING¤ 3047 , 3162 ,
WANG JIEFEI ET AL¤ 2061 , WANG RONGPING¤ 343 ,
WANG JIFENG, DAI SHUJING, NIU JIANZHAO, ET AL¤ WANG RONGPING ET AL¤ 1744 ,
2359 , WANG RONG-PING ET AL¤ 2293 ,
WANG JINGJIANG¤ 1334 , WANG RONG-PING, WANG YING¤ 3355 ,
WANG JINGQI, ET AL¤ 2775 , WANG RU-GAO ET AL¤ 2504 , 2542 ,
WANG JING-QUAN, CUI SHI-CHANG, WANG HAI- WANG RUI-PING, YANG CHEN¤ 2932 ,
YAN,¤ 3265 , WANG S, LI Q, WANG XF, JI G¤ 4060 ,
WANG JUE¤ 2759 , 3017 , 3132 , WANG SAN-HONG¤ 1254 ,
WANG JUN ET AL ¤ 2687 , WANG SHANGJIN¤ 2686 , 3834 ,
WANG JUNHUA¤ 1445 , WANG SHAOHUA¤ 851 ,
WANG JUNQUI¤ 1213 , WANG SHAO-HUA¤ 88 ,
WANG JUNXIA¤ 1308 , WANG SHENG-CHUN ZHAO HUI-PING ET AL¤ 2646 ,
WANG JUNYI¤ 439 , WANG SHOUFENG ET AL¤ 2182 ,
WANG JY ET AL¤ 1136 , WANG SHOUPENG ¤ 2610 ,
WANG KAI FAN XIAO-PENG LIN YA-JIE¤ 2772 , WANG SHUYING ET AL¤ 1008 ,
WANG KE-XIAN ET AL¤ 2234 , WANG SONG ET AL¤ 2098 ,
WANG LI¤ 3469 , WANG TAOHUA LIU YUCHEN, WANG HANDONG ET
WANG LI ZHEN¤ 1946 , AL¤ 2657 ,
WANG LIANJIANG, FENG BINGAN, CHEN JIANING, WANG TIANCAI ET AL ¤ 2598 ,
ET AL¤ 2355 , WANG TIAN-RAN, ZENG XIANG-YUAN, MA BU-REN¤
WANG LICHUN ET AL¤ 1767 , 2438 , 2771 ,
WANG LI-DONG¤ 3663 , WANG TIEJUN ET AL¤ 34 , 37 ,
WANG LILI ET AL¤ 1942 , WANG TING ET AL¤ 1268 ,
WANG LILING ET AL¤ 690 , WANG WAN-TIE XU ZHENG-JIE LIN LI-NA ET AL¤
WANG LIN, LI KE, CHENG JUN, ET AL¤ 3477 , 2765 ,
WANG LING ET AL¤ 151 , WANG WAN-TIE, LIN LI-NA, WANG WEI, ET AL ¤
WANG LING, LI HONG, LI JUN, ET AL¤ 2695 , 3434 ,
WANG LING-TAI¤ 4065 , WANG WEI ¤ 3799 ,
WANG LING-TAI CHEN JIAN-JIE ZHANG BIN, ET AL¤ WANG WEI KUNG ET AL¤ 1563 ,
2337 , WANG WEI, YU HONG, PIAOSHUN-FU, ET AL¤ 3811 ,
WANG LINGTAI ET AL¤ 196 , 1042 , WANG WEI, ZHOU XUEWEN, ZHUANG YAN, ET AL¤
WANG LIN-TAI CHEN JIAN-JIE ZHANG BIN ET AL¤ 3002 , 3116 ,
2969 , 2971 , WANG WEILI, LI XINGMEI¤ 3784 ,
WANG LU-JUN LUO LIN DOU ZHI-HUA, ET AL¤ 3565 , WANG WEIPING ET AL¤ 2266 ,
WANG LUJUN, ZHU YONGGEN, LI MIN, ET AL¤ 3242 , WANG WEN-HAI, ZHOU RONG-YAO, YAN ZHI-PING,
WANG M ET AL¤ 1395 , ET AL¤ 4095 ,
WANG MAOSHAN ET AL¤ 472 , WANG WEN-JIE,WANG JI¤ 3253 , 3536 ,
WANG MEI NA ET AL¤ 704 , WANG WEN-RONG, CUI SHENG-DA, ZENG LI-MING¤
WANG MEI XIA ET AL¤ 702 , 3020 , 3135 ,
WANG MEIXIA ET AL¤ 1292 , WANG WENZHENG ET AL¤ 1013 ,
WANG MENG ET AL¤ 1920 , WANG WENZHING¤ 244 ,
WANG MIN CHONG¤ 533 , 563 , WANG WU HUA¤ 2053 ,
WANG MINCONG¤ 843 , 939 , WANG WUREN¤ 216 ,

gera 2011
 304
WANG XI, LIU QING, YUE XIAOQIANG, ET AL¤ 3227 , WANG YU QUN ET AL¤ 2011 ,
WANG XIANBO ET AL¤ 1592 , WANG YU ZHI¤ 2039 ,
WANG XIANBO, ET AL¤ 2397 , WANG YU-FANG¤ 2160 ,
WANG XIAN-BO, LIU PING, TANG ZHI-PENG, ET AL¤ WANG YULIANG ,WANG YINGFANG¤ 3402 ,
4098 , WANG YUMEI ET AL¤ 311 ,
WANG XIANGLIN¤ 410 , WANG YUNONG ET AL¤ 1418 ,
WANG XIANLING, LI LIANZHEN, NIU WAN QIANG ¤ WANG YUQIANG ET AL¤ 2591 ,
3703 , WANG YUQUN , ET AL¤ 3294 ,
WANG XIANLING, LIU RENHUI, LIU FANGZHOU, ET WANG YUQUN ET AL¤ 787 , 1262 , 2587 ,
AL ¤ 3764 , WANG YUQUN, ET AL¤ 2758 ,
WANG XIAO ET AL¤ 1033 , WANG YURUN¤ 358 ,
WANG XIAOFENG ET AL¤ 1803 , WANG ZHAOHUI, ZHANG XIANKANG, MIAO
WANG XIAO-HONG, AND LIU YU-MAO¤ 2572 , MINGYONG, ET¤ 2951 ,
WANG XIAO-JUN¤ 2981 , 3089 , WANG ZHAO-JUN,WANG ZHAO-KAI¤ 3792 ,
WANG XIAOJUN,ZHANG XIAOGANG,ZHANG WANG ZHAO-LIN¤ 1828 ,
XUEWEN,ET AL¤ 3278 , WANG ZHAOTENG ET AL¤ 774 ,
WANG XIAOLI ET AL¤ 1405 , WANG ZHAO-XIANG ET AL¤ 2488 , 2527 ,
WANG XIAOLING ET AL¤ 2046 , WANG ZHEN BIAO ET AL¤ 1362 ,
WANG XIAOMING¤ 2040 , WANG ZHEN YUE ET AL¤ 455 ,
WANG XIAO-SU LI YONG¤ 3070 , 3185 , WANG ZHENG-LIN ET AL¤ 1032 ,
WANG XIAOXIAN¤ 1210 , WANG ZHENLING ET AL¤ 54 ,
WANG XIMING¤ 380 , 882 , WANG ZHENQUAN¤ 1145 ,
WANG XING YUE ET AL¤ 1988 , WANG ZHI-HUA ¤ 3608 ,
WANG XINGIANG ¤ 3933 , WANG ZHONGZHENG¤ 3490 ,
WANG XINGTIAN, WANG ZONGYING¤ 3219 , WANG ZONGZHAN ET AL¤ 1480 ,
WANG XINGWEN ET AL¤ 1572 , WANG LI-LIN ET AL¤ 2248 ,
WANG XINJIE, GUO YONGYI¤ 3928 , WATARI N¤ 74 ,
WANG XINMING ET AL¤ 776 , WEI AILING¤ 1705 ,
WANG XINXIANG¤ 428 , WEI AI-LING¤ 2767 ,
WANG XINYAO¤ 570 , WEI AILING TAN JIAN¤ 3701 ,
WANG XIN-YAO¤ 1406 , WEI AILING TANG JIAN¤ 3308 ,
WANG XINYAO ET AL¤ 953 , 1739 , WEI BEIHAI¤ 160 ,
WANG XINYUE¤ 1219 , WEI BEIHAI ET AL¤ 424 , 1108 ,
WANG XINYUE ET AL¤ 2080 , WEI BEI-HAI, ZHANG WAN-DAI, CHEN ZHI-SHUI, ET
WANG XI-PEI¤ 1066 , AL ¤ 3739 ,
WANG XIWEN¤ 788 , WEI BEI-HUAN ET AL¤ 319 ,
WANG XIYAO ET AL¤ 1910 , WEI CHANG-CHEN¤ 316 ,
WANG XIZHOU¤ 420 , WEI CHUN-SHENG HE JING-SONG YUAN BIN, ET AL¤
WANG XP ¤ 1544 , 3758 ,
WANG XUEJIANG, ET AL¤ 2366 , WEI DAOWU ET AL¤ 2180 ,
WANG XUEMEI ET AL¤ 765 , WEI GUOLUAN, LIU XINSHENG, SHAO ZUYAN, ET
WANG XUEZHI, YANG ZHIQIANG, MA WEI ET AL¤ AL¤ 2920 ,
2667 , WEI HUA-FENG, JI GUANG XING LIAN-JUN¤ 2908 ,
WANG XU-PING ZHENG XIAO-XIANG¤ 3781 , WEI JIAQING, ET AL¤ 2724 ,
WANG XU-ZHAI¤ 385 , WEI JINRONG¤ 937 ,
WANG Y, YANG M, MA Z, LIANG Q, TAN H, XIAO C, WEI JUN¤ 1187 ,
GAO Y¤ 4125 , WEI JUXIAN¤ 507 ,
WANG YA-FAN , LI PING , LI QI-FEN , ET AL¤ 2980 , WEI LIN YANG CHENGUANG¤ 2802 ,
WANG YA-FAN, LI PING, LI QI-FEN, ET AL¤ 3088 , WEI LINLAN, DU FABIN, SUN XIAOFEN¤ 3706 ,
WANG YANHENG ET AL¤ 544 , WEI MEI, YANG HUAXIU, LIU PENG, ET AL¤ 2746 ,
WANG YAN-PING, GAO ANG, GAO LENG, ET AL¤ WEI XIN, LIANG JIAN, MAO DEWEN,ET AL¤ 3557 ,
3606 , WEI XUE-QIN ET AL¤ 2088 ,
WANG YAN-XIANG, WANG LING-TAI, GAO YUE-QIU, WEILIN ED ALTRI¤ 3801 ,
ET AL¤ 3897 , WELLMANN KF ET AL¤ 40 ,
WANG YAOCHU ET AL¤ 689 , WEN BIN, HE SONGQI, WU SHIJIU¤ 3559 ,
WANG YAOJUN ET AL¤ 2101 , WEN HOUJUN, ET AL¤ 3835 ,
WANG YAOPING¤ 539 , WEN JIANCHUN ET AL¤ 2507 , 2545 ,
WANG YI LI ET AL¤ 524 , WEN LIU-RUI, LI QING-JIE, FAN TONG-XIN¤ 2734 ,
WANG YI ZHANG WEI XING LIAN-JUN, ET AL¤ 2917 , WEN QIZHEN ET AL¤ 335 ,
WANG YIN TANG ET AL¤ 519 , WEN RUFENG¤ 2124 ,
WANG YING-FANG ET AL¤ 2489 , 2528 , WEN RUI, WANG JIAN, YAN MING¤ 3301 ,
WANG YINGFANG, WANG YULIANG¤ 3405 , WEN SHEN ET AL¤ 276 , 277 ,
WANG YIQIN ET AL¤ 1769 , WEN WEI, ZHANG HONG, YE LI-PING¤ 3851 ,
WANG YL¤ 4029 , WEN WEI-BO, ET AL¤ 2738 ,
WANG YONG KUA¤ 1541 , 1560 , WEN WU-BING¤ 3389 ,
WANG YONG WANG RONG-PING¤ 2798 , WEN ZHI JIAN ET AL¤ 463 ,
WANG YU CHEN GANG XIANG YONG-CHEN, ET AL ¤ WEN-CHUAN LIN ET AL¤ 3392 ,
3756 , WENG FULU ET AL¤ 1267 ,
WANG YU JING¤ 143 , WENG WEI-DONG¤ 3016 , 3131 ,
WANG YU MEI ET AL¤ 743 , WEN-TSAN HUANG¤ 949 ,

gera 2011
 305
WILLIAMS J¤ 962 , WU YITING¤ 3944 ,
WILLIAMS JE¤ 1218 , 1716 , WU YU¤ 726 ,
WO WINGDE ET AL¤ 1737 , WU YU, LL JI-CHENG, MAO LIAN-GEN, ET AL¤ 2326 ,
WONG VW, LAW MY, HUI AY, LO AO, LI CY, SOO MT, WU YUHUA, ET AL¤ 3318 ,
LEUNG HY, CHAN HL¤ 3862 , WU YUSHENG¤ 892 ,
WU BICHENG ET AL¤ 392 , 1214 , WU ZHENJUN, LI BEI, YU QI¤ 3306 ,
WU CHAO ET AL¤ 1584 , WU ZHESHENG ET AL¤ 2192 ,
WU CHENG¤ 2296 , WU ZHICHENG ET AL¤ 1107 , 1488 ,
WU CHUNRONG ET AL¤ 473 , WU ZONGLIN ET AL¤ 764 ,
WU DAN-HONG, CHEN YUN-YING¤ 2472 , X¤ 5 , 10 , 11 , 12 , 13 , 14 , 15 , 21 , 48 , 49 , 50 , 142 , 157 ,
WU DEFU¤ 721 , 336 , 825 , 826 , 839 , 840 , 955 , 959 , 1086 , 1369 , 1413 ,
WU DE-PING¤ 2404 , 1765 , 2824 , 2825 , 2826 , 2954 , 2955 , 2963 , 3326 , 3509 ,
WU DINGLIAN¤ 915 , 3510 , 3512 , 3513 , 3828 , 3846 , 3847 , 3852 ,
WU ERGUANG, XU TINGTING, XU XIANGZHI¤ 3843 , XI CALKUN¤ 78 ,
WU ERGUANG,WU JIE,ZHANG PINGXIN ¤ 3765 , XI JIA¤ 1490 ,
WU GANTONG ET AL¤ 1455 , XI ZHUTING ET AL¤ 2336 ,
WU GUOCHUN¤ 2315 , XI ZHU-TING LUAN XI-YING LI KE-KE ET AL¤ 2929 ,
WU GUODONG, LUO DUANDE¤ 2756 , XIA BAOWEI¤ 2710 ,
WU GUO-FAN¤ 2506 , 2544 , XIA DECHENG¤ 125 ,
WU GUO-LI¤ 3067 , 3182 , XIA DEQING¤ 146 ,
WU HAN-BING¤ 976 , XIA DEXIN ET AL¤ 197 ,
WU HANMIN¤ 658 , 3218 , XIA DEXING ET AL¤ 93 ,
WU HANMIN ET AL¤ 1937 , XIA DEYING ET AL¤ 1115 ,
WU JIAGENG ET AL¤ 1295 , 1783 , XIA GUO-DONG , XIE CHAO-LIANG , YANG HUA-XIU,
WU JIANHUA, ET AL¤ 3909 , ET A¤ 3649 ,
WU JIYONG¤ 2176 , XIA GUODONG, ET AL¤ 3393 ,
WU JUNYU ET AL¤ 1095 , XIA HONG-TAO ¤ 3932 ,
WU LIANG, WANG YING, ZHANG ZHENGANG, ET XIA JINYU, JIA XUEPING, CHENG LIANGBIN¤ 3631 ,
AL¤ 3475 , XIA JINYU, JIA XUEPING, CHENG LIANGBIN, ET AL¤
WU LI-MAO, ZHAO YI, WANG QIN, ET AL¤ 2821 , 3558 ,
WU MEIQIAN¤ 2292 , XIA JINYU, LI TIANWANG, ZHU XIAOHONG, ET AL¤
WU PEITIAN¤ 2663 , 2683 , 3009 , 3124 , 2332 ,
WU PING PENG XINJUN, HE BIN, ET AL ¤ 3596 , XIA JUNHONG¤ 888 ,
WU QIAN-HU, MIAO JIA-WEN, SHENG JIAN-HUI¤ 3607 XIA JUNQUAN¤ 1408 ,
, XIA LIANG, CHEN ZHIYUN, YAN MAOXIANG, ET AL¤
WU QIKAI ET AL¤ 2034 , 2240 , 3684 ,
WU QIKAI, NIE GUANG , ZHANG LING , ET AL¤ 3825 , XIA QIN ET AL¤ 2141 ,
WU QI-KAI, YANG DA-GUO, TAO YAN-YAN, ET AL¤ XIA TING, SUN HUI¤ 3466 ,
2956 , XIA WEI JIANG ET AL¤ 579 ,
WU QINSHUN¤ 1947 , XIA WEI-JIANG ET AL¤ 589 ,
WU RUI, JIANG YI-PING, LI GUO-XIAN¤ 3600 , XIA XIANG ET AL¤ 580 ,
WU SHANMING ET AL¤ 107 , 2136 , XIA YI-GUO¤ 1745 ,
WU SHANMING JIANG JIA¤ 1265 , XIA YONG-LIANG¤ 3229 ,
WU SHENGCHANG¤ 983 , XIA YONG-LIANG ET AL¤ 2287 ,
WU SHIJIE¤ 3523 , XIAN YS, WANG ZR, GONG XF, HUANG BZ¤ 3997 ,
WU SHIPIN, LI WENLI, PENG HONG, ET AL¤ 3689 , XIANFU J ET AL¤ 609 ,
WU SHU GUANG ET AL¤ 332 , XIANG BAIKANG¤ 2617 , 3412 ,
WU SHUISHENG ET AL¤ 2988 , 3096 , XIANG JUZHENG ET AL¤ 271 , 273 ,
WU SHU-KUN ET AL¤ 1934 , XIANG MEI ET AL¤ 1979 ,
WU SHUZHONG¤ 391 , XIANG NAN¤ 2314 ,
WU TIANCAI¤ 1475 , XIANG X¤ 635 ,
WU W ET AL¤ 1290 , XIANG YANG ET AL¤ 1817 ,
WU WANFEN ET AL¤ 223 , 886 , XIANG-LAN ZHAO ET AL¤ 339 ,
WU WANYIN ET AL¤ 1660 , XIANYI M¤ 641 ,
WU WEN-SHE ET AL¤ 1520 , XIAO BIN ET AL ¤ 3796 ,
WU X, CHEN D, XIE GR¤ 4021 , XIAO CAISONG ET AL¤ 1166 ,
WU XIAO-CHUN, XIN HUA-WEN, LI QING ET AL¤ XIAO CHENG-RONG, CHEN PENG, WANG YU-
2768 , GUANG, ET AL ¤ 3762 ,
WU XIAODONG JIN XUEJUN LIU SHUMEI, ET AL¤ XIAO HENG¤ 3444 ,
3006 , 3120 , XIAO HUI -QUAN, LUO RI -YONG, WU WAN -FEN¤
WU XIAOING¤ 1740 , 3954 ,
WU XIUJIN¤ 31 , XIAO HUIQUAN ET AL¤ 1766 , 1922 ,
WU XIUJIN ET AL¤ 35 , XIAO JIANZHEN ET AL¤ 1796 ,
WU XIUMEI, ZENG CHANGCHUN¤ 3341 , XIAO LI-CHUN, PAN WAN-RUI, CHEN SHOU-FEI, ET
WU YABIN, GONG ZUOJIONG, YANG LIHUA¤ 3042 , AL¤ 3925 ,
3157 , XIAO TIANXIANG¤ 3051 , 3166 ,
WU YANGFEI, SUN JIANMIN¤ 2624 , XIAO XINHUA¤ 111 ,
WU YAOSHENG¤ 585 , XIAO YANG, ZHOU YUE-JIN, WANG KAI-JIAN , ET
WU YI-CHUN, WU QIANG, YANG YAN, ET AL ¤ 3573 , AL¤ 3896 ,
WU YINWEI ET AL¤ 1975 , XIAO YONG-HONG, LIU DIAN-WU, LI QING¤ 3876 ,

gera 2011
 306
XIAO ZHENG-MING ET AL¤ 1871 , XU CHENRU¤ 106 ,
XIE BIHONG¤ 3394 , XU CHI-HUA ET AL¤ 215 ,
XIE BI-HONG¤ 3221 , XU CIANG-TIAN ET AL¤ 1148 ,
XIE CHAO-LIANG, SHAO ZE-YONG¤ 2813 , XU CUI HUA ET AL¤ 522 , 528 ,
XIE CHUAN-CHAO¤ 3901 , XU CUIHUA ET AL¤ 374 , 795 ,
XIE CHUN'E ET AL¤ 3659 , XU CUI-HUA ET AL¤ 434 ,
XIE FENGYING ED ALTRI¤ 2901 , XU DIHUA¤ 438 ,
XIE FENGYING ET AL¤ 1799 , XU DONG, TIAN DEYING, GUO WEI, ET AL¤ 3257 ,
XIE HUAI-PING, ET AL¤ 2353 , XU FEI¤ 185 ,
XIE HUANRONG¤ 1304 , XU FEI ET AL¤ 137 ,
XIE JIANGUO ET AL¤ 1479 , XU GUANGFU¤ 1704 ,
XIE JING, ZHAO GUORONG, XIONG YAN, ET AL¤ XU GUOGUANG, LUO CHENGYU, WU SHANGMING,
3486 , ET AL¤ 2414 ,
XIE JIWEN, LI HONGCHUN, YANG SHENGLAN, ET XU HAIQING ET AL¤ 2127 ,
AL¤ 3674 , XU HUI BO ET AL¤ 2012 ,
XIE RUJIA ET AL¤ 3927 , XU HUIXIANG¤ 1743 ,
XIE SHIDA¤ 1494 , XU HUIYUAN ET AL¤ 1661 ,
XIE SHIFANG ET AL¤ 1111 , XU JIAN ET AL¤ 2498 , 2537 ,
XIE SNIPING ET AL¤ 3613 , XU JIANZHONG ET AL¤ 1414 ,
XIE XUE-JUN¤ 1437 , XU JIAPING BAI XIANGUANG¤ 2782 ,
XIE XUSHAN¤ 1484 , XU JIA-XIN¤ 443 ,
XIE YIZHUANG ET AL ¤ 3642 , XU JINBO , ZHOU YONGFANG¤ 2997 ,
XIE YU, ZHANG ZHI-LAN¤ 3352 , XU JINBO, ZHOU YONGFANG¤ 3110 ,
XIE YUANMING¤ 763 , XU JING¤ 3831 ,
XIE ZHAOFENG¤ 855 , XU JING SHI ET AL¤ 2199 ,
XIE ZHENQIANG¤ 389 , XU JIPING ET AL¤ 1172 ,
XIE ZHIFU¤ 446 , XU JIQUN ET AL¤ 110 , 396 ,
XIE ZHON-JIAN ET AL¤ 989 , XU JI-WEN¤ 2259 ,
XIMING W¤ 1312 , XU KAI ET AL¤ 1895 ,
XIN YONGNING, SUN YING, SUN ZHENJUAN, ET AL¤ XU KUI, YAN ZHAO-HONG, WANG HUI, ET AL¤ 2653 ,
3669 , XU LIEMING ET AL¤ 1302 ,
XING CUI ET AL¤ 1753 , XU LIMING¤ 2117 ,
XING JIAN-KE¤ 1192 , XU LIN-BEN ET AL¤ 2183 ,
XING LIANJUN ET AL¤ 1069 , 1294 , XU LM ET AL¤ 1244 ,
XING LIAN-JUN ET AL¤ 2501 , 2540 , XU MING¤ 369 ,
XING LIAN-JUN JI GUANG ZHANG WEI, ET AL¤ 2338 , XU QIAN ET AL¤ 506 , 2005 ,
XING LIAN-JUN, JI GUANG, CHENG-LOU, ET AL¤ 2787 XU QUAN ET AL¤ 654 ,
, XU RUI-FENG, ZHAO JIAN-XIAONG, CHENG WEI-
XING MINGYOU, HUANG YUANCHENG, TIAN DONG, ET AL¤ 3855 ,
DEYING¤ 3363 , XU RUIPING ET AL¤ 1911 ,
XIN-HUI TANG, LING GAO, JING GAO, YI-MEI FAN, XU RUIPING, ET AL¤ 2940 ,
LI-ZHI XU, XIAO-NING 3774 , XU RU-PING,ZHANG LING,ZHANG WU,ET AL ¤ 3761 ,
XINLA L ET AL¤ 613 , XU SB ET AL¤ 1123 ,
XIONG FAN , ET AL¤ 3506 , XU SHENG-HONG ET AL¤ 1632 ,
XIONG LIJUAN, ZHU JIANFANG, LUO DUANDE, ET XU SHOUCHANG ET AL¤ 1710 ,
AL¤ 2796 , XU TIANXIONG ET AL¤ 1263 ,
XIONG LI-LAN ET AL¤ 1139 , XU WEI, XU CHENHUAI, CHEN JINRU, ET AL¤ 3283 ,
XIONG LI-LAN, ZHU SHI-CAI, CAO GUO-MING¤ 1605 , XU WEIDAN , ET AL¤ 3028 ,
XIONG MONIAN¤ 1768 , XU WEIDAN, ET AL¤ 3143 ,
XIONG YIFEI¤ 1687 , XU WEN-GANG ET AL¤ 2126 ,
XIONG YING, ET AL¤ 2349 , XU WENZHONG¤ 997 ,
XIONG YIQUN, ZHOU DAQIAO, LI ZHIQING, ET AL¤ XU WENZHONG ET AL¤ 868 , 879 ,
3367 , XU X, LING Q, GAO F, HE ZL, XIE HY, ZHENG SS.¤
XIONG YIQUN, ZHU HUIMIN, ZHANG CHIZHI, ET AL¤ 4123 ,
2468 , XU XIAN-CHOU AND LIN SHENG-ZHANG¤ 4071 ,
XIU JIANGDONG¤ 1724 , XU XIAOMEI ET AL¤ 2494 , 2533 ,
XIUWEN F¤ 1452 , XU XINGGUO¤ 1324 , 3488 ,
XIZHOU W¤ 625 , XU XING-GUO ET AL¤ 1181 ,
XU AIHUA, JA XIAOQIN, CHEN HUASHENG, ET AL¤ XU XUEJUN¤ 2766 ,
2398 , XU XUEQIN¤ 3216 ,
XU BING DONG ET AL¤ 674 , XU YIBIN, JI GUANG¤ 3243 ,
XU BING-QUAN, ET AL¤ 2350 , XU YIYU¤ 1581 ,
XU BO-LENG¤ 1255 , XU YIYU ET AL¤ 1196 , 1270 ,
XU BO-PING, ZHANG YA-QI, LL SHENG-PING, ET AL¤ XU YOU-QI¤ 1102 ,
2406 , XU YUFANG ET AL¤ 1983 ,
XU BOZHONG¤ 1157 , XU ZHAO-RONG CHEN JUN-HANG YANG XIAN-
XU CHAXIANG, YU ZHENGKE, DING FENG¤ 3420 , HONG¤ 3316 ,
XU CHENG, LIU ZHONGRONG, WANG SONG, ET AL¤ XU ZHENGANG ET AL¤ 930 ,
3234 , XU ZHENGHAI¤ 1847 ,
XU CHENGHE¤ 1496 , XU ZHIWEI¤ 2976 , 3084 ,

gera 2011
 307
XU ZHI-WEI, CHEN QUN, LIU YA-MEI, ET AL¤ 2312 , YANG FUTAI, ET AL¤ 3320 ,
XU ZHONGHONG¤ 1509 , YANG FU-TAI, ET AL¤ 3609 ,
XU ZHONG-WEN ¤ 3931 , YANG GONGYOU YING HUIYU¤ 1212 ,
XUAN EN-YU ET AL¤ 2129 , YANG GUOHAN, DAI YUGUANG, ZHONG YU¤ 3005 ,
XUAN WEIJUN¤ 2485 , 2524 , 3119 ,
XUDONG L¤ 618 , YANG GUOHONG, HU YANPING¤ 3443 ,
XUE BOYU ¤ 2725 , 3790 , YANG GUO-WEN, GE QIANG, JIANG SHEN-YU¤ 3722 ,
XUE BO-YU ET AL¤ 2245 , YANG HONG, HOU JIAYU, TIAN DELU, ET AL¤ 3279 ,
XUE BOYU, ZHOU MIN, ZHOU ZHONGYING, ET AL¤ YANG HONG, ZHANG JIN, CUI DAN, ET AL¤ 3215 ,
2795 , YANG HONGZHI ET AL¤ 1680 , 1914 , 2026 ,
XUE HUANDE ET AL¤ 1694 , YANG HONG-ZHI, BIAN ZHUANG, WANG YONG-ZE,
XUE JI, CAO YI-RONG, LIU LI-MIN¤ 3338 , ET A¤ 3327 ,
XUE JING DONG¤ 2025 , YANG HONG-ZHI,WANG YONG-ZE,DAI MIN,ET AL¤
XUE LEBIN¤ 1272 , 3068 , 3183 ,
XUE QINGPEI ET AL¤ 1185 , YANG HUAN¤ 920 ,
XUE TAO¤ 305 , YANG HUIMIN¤ 1144 ,
XUE YUNFENG¤ 1055 , YANG HZ, ZHAO JA, DAI M, LI YW, WANG YZ, GUAN
XUE YUN-FENG¤ 435 , WB, XIE HP¤ 3866 ,
XUEYIN Z¤ 619 , YANG JIAN HUI¤ 2001 ,
XUSHAN X ET AL¤ 630 , YANG JIAN-HU¤ 2373 ,
YAMADA S ET AL¤ 1122 , YANG JIANYING ET AL¤ 281 , 600 ,
YAMAMOTO K ET AL¤ 1399 , YANG JIEBIN¤ 606 ,
YAMAMOTO M¤ 365 , YANG JINHONG ET AL¤ 1165 ,
YAMAMOTO M ET AL¤ 1528 , YANG JIN-XIANG¤ 928 ,
YAMASHIKI M ET AL¤ 1075 , 1530 , YANG JINXIANG ET AL¤ 807 , 1647 ,
YAMAZAKI TASUKU, FUKUDA FUMIHIKO, TAKEDA YANG JIN-ZU YANG JIN-KUN ZHENG JIAN, ET AL¤
TAROU, 4083 , 3759 ,
YAN HANG¤ 2923 , YANG JUE-MIN, QIAN YI-SHUN¤ 3293 ,
YAN HUIPING ET AL¤ 2134 , YANG JUEMING,ET AL¤ 3203 ,
YAN JILI, ZHOU MIN¤ 3317 , YANG LI¤ 1734 ,
YAN JUN ET AL ¤ 2713 , YANG LIN¤ 1060 ,
YAN JUN, WANG XU¤ 2361 , YANG LIN GUAN ET AL¤ 793 ,
YAN L¤ 627 , YANG LING¤ 929 , 1626 ,
YAN MAO -XIANG , CHEN ZHI -YUN , CHEN BAO - YANG LING ET AL¤ 2593 ,
ZHEN , ET AL ¤ 3780 , YANG LING, ZHANG CHIZHI, ZHU QINGJING, ET AL¤
YAN MAOXIANG, CHEN ZHIYUN XIANG BAIKANG¤ 2918 ,
3413 , YANG LING, ZHU QINGJING, LL HANMIN, ET AL¤
YAN MUXIN ET AL¤ 2055 , 2461 ,
YAN NANYING, SUN QIYAN¤ 2379 , YANG LING, ZHU QING-JING, ZHANG CHI-ZHI¤ 2311 ,
YAN QIN ¤ 2761 , YANG LIU-MING ZHAO-YAN LONG WU ZHI-RONG
YAN RONG ET AL¤ 456 , ET AL¤ 2892 ,
YAN RUNMIN ET AL¤ 887 , YANG MUXIANG ET AL¤ 1932 ,
YAN SHUCHANG ET AL¤ 476 , YANG MU-XIANG ET AL¤ 2214 ,
YAN WANGGUI¤ 394 , YANG MU-XIANG WANG YI-XIN WANG ZHAN-BO,
YAN XIAO-YAN¤ 2163 , ET AL¤ 2867 ,
YAN XIN¤ 1723 , YANG MUXIANG, ZHANG YIXIN , LI PINGSHAN, ET
YAN XUESHEN, LI HANMIN, PENG YAQIN, ET AL¤ AL¤ 2937 ,
2420 , YANG QIAN, CHENG JUN, HONG YUAN, ET AL¤ 3480 ,
YAN YANLI, SONG XIAOYU, SONG GUOYING ¤ 3388 , YANG QIAN, CHENG JUN, LIU YAN, ET AL¤ 3478 ,
YAN YANLI, WANG XINGUO, SONG XIAOQU, ET AL¤ YANG QIAN-TING¤ 3797 ,
3967 , YANG QING¤ 1948 , 2028 ,
YAN YAN-LI,WANG XIN-GUO,SONG XIAO-YU,SONG YANG QING, ZI-IAO BING, YAN YINGCHUN¤ 2480 ,
GUO-YING¤ 3489 , 2519 ,
YAN YI JIAN ET AL¤ 2019 , YANG QIWEI¤ 116 ,
YAN ZHEN-DONG¤ 1352 , YANG QUN, REN XINGFENG, LI JING'AN, ET AL¤ 3679
YAN ZHIYONG ET AL¤ 1921 , ,
YAN ZHONG-SHENG ET AL¤ 1579 , YANG RENMIN¤ 891 ,
YAN ZHONGSHENG, SHEN JIYUN, ZHAO SHUYUAN¤ YANG RENMIN ET AL¤ 166 , 748 ,
2878 , YANG REN-MIN, CHENG NAN¤ 2832 ,
YANG BIN¤ 2799 , YANG SHANDONG¤ 571 ,
YANG BIN, HU JI-YUAN, HONG MING-FAN, ET AL¤ YANG SHANMAI, LIU SHUITENG, LI LIXIONG¤ 3208 ,
2620 , YANG SHI-ZHONG¤ 3222 ,
YANG BO¤ 1625 , YANG SHIZHONG ET AL¤ 842 ,
YANG DA-GUO ET AL¤ 1240 , YANG SHI-ZHONG ET AL¤ 2807 , 2972 ,
YANG DAOFENG TIAN DEYING SHEN HANXIN¤ 2872 YANG SHUN-MIN, ZHANG LIANG, ZHOU LING-LING,
, ET¤ 2884 ,
YANG DE-MING¤ 667 , YANG TONGLI¤ 1545 ,
YANG DEQUAN¤ 1903 , YANG WEI¤ 909 ,
YANG DEQUAN, YANG QIN¤ 3934 , YANG WEIFENG, CHEN HOUCHANG, JIANG YIPING¤
YANG FENMING¤ 296 , 3207 ,

gera 2011
 308
YANG WEIPENG¤ 1878 , YE ZAI-SHI¤ 200 ,
YANG WEN-BIN, CHAI QIU-YAN, LI BAI-QIANG, ET YE ZHENG RONG, XIE LI-FANG, DU WEI-XING¤ 3742 ,
AL¤ 2715 , YEN FL, WU TH, LIN LT, LIN CC¤ 4001 ,
YANG WENHUI ET AL¤ 229 , YEN MN ET AL¤ 942 ,
YANG WENYI ET AL¤ 1548 , YEN YH, CHEN WC, HAYAKAWA S, CHIEN CT¤ 4126 ,
YANG XIANGSHENG¤ 1330 , YI FA-YIN HU FANG-LIN¤ 2998 , 3111 ,
YANG XIANG-SHENG ET AL¤ 1150 , YI HUANG-SHAN ET AL¤ 651 ,
YANG XIANSHENG ¤ 3844 , YI LU-QIAN WANG XIAO-WANG¤ 2815 ,
YANG XIAOYUN, LI SHAOGUANG , WEN FANYUAN , YIAN GUOREI¤ 150 ,
ET AL¤ 3821 , YIAN Z¤ 1315 ,
YANG XINGCHI¤ 1500 , YIE LONG-YU ET AL¤ 1097 ,
YANG XING-ZHONG ET AL¤ 912 , YIE YONGAN ET AL¤ 1623 ,
YANG XW ET AL¤ 943 , YIM YK, LEE H, HONG KE, KIM YI, LEE BR, KIM TH,
YANG YANFANG ET AL¤ 1971 , YI JY¤ 3998 ,
YANG YANFANG WANG MIANZHI WANG XU ET AL¤ YIN CHANGJIAN¤ 852 , 1683 ,
2630 , YIN CHANG-JIAN¤ 3525 , 3611 ,
YANG YI, YANG JIN¤ 2862 , YIN CHANGJIAN ET AL¤ 1175 , 1549 ,
YANG YINGJIE,ZHENG YONGZHI, HU WEI¤ 2641 , YIN CHANG-JIAN ET AL¤ 2128 ,
YANG YINGXIN ET AL¤ 3916 , YIN CHANG-JIAN, SUN JIAN-GUANG, SHAN CHUN-
YANG YUAN-JING ET AL¤ 441 , MEI¤ 2346 ,
YANG YUEYAN¤ 3350 , YIN CHENGHONG ET AL¤ 1870 ,
YANG YUNKUAN, DIAO CANYANG, HU YOUPING, YIN CHENGHONG MA HONG MA XUEMEI, ET AL¤
ET AL¤ 2822 , 2876 ,
YANG ZHEN¤ 1236 , YIN DESUI¤ 140 ,
YANG ZHEN ET AL¤ 414 , YIN FEI', YAO SHUKUN, GAO HONGSHENG¤ 2477 ,
YANG ZHENGWU¤ 2603 , 2516 ,
YANG ZHIJUN¤ 2490 , 2529 , YIN GUILAN ¤ 3712 ,
YANG ZONGYAN ET AL¤ 1658 , 1772 , 2093 , YIN J ET AL¤ 1221 ,
YAO CHANGHUI¤ 1757 , YIN JIDONG, TIAN DEYING, HUANG QIAOXIN¤ 2751 ,
YAO DINGKANG, XIE WEIFEN, CHEN WEIZHONG, ET 2919 ,
AL¤ 2943 , YIN JIE ET AL¤ 2579 ,
YAO GENGMING ET AL¤ 159 , YIN MINGSHI, PIAO HONGXIN, HAN XUEJI, ET AL¤
YAO GONG-SHU¤ 318 , 442 , 3680 ,
YAO SHIAN¤ 926 , YIN XIN ET AL¤ 2118 ,
YAO SHU - GUI, WANG YI - XIAN, ZHENG JIA - ZHU, YIN YICAI ET AL¤ 573 ,
ET AL ¤ 3767 , YIN YUSHENGYU CHUANSU¤ 1202 ,
YAO SHUKUN ET AL¤ 2102 , YIN ZONGFU, HE QINGYU, LIU LIANG, ET AL¤ 2779 ,
YAO WEI ET AL¤ 927 , YING T ET AL¤ 636 ,
YAO XIN, YAO XIXIAN, FENG LIYING, ET AL¤ 2949 , YONGLUO Z ET AL¤ 1374 ,
YAO XI-XIAN CUI DONG-LAI SUN YU-FENG, ET AL¤ YOSHIKAWA M ET AL¤ 1608 ,
2895 , YOSHIKUBO S ET AL¤ 1670 ,
YAO XX, JIANG SL, TANG YW, YAO DM, YAO X¤ 3872 YOTSUMOTO H ET AL¤ 1609 ,
, YOU HONG ET AL¤ 2066 ,
YAO YUKBN¤ 1156 , YOU JIANLIANG ET AL¤ 2514 , 2552 ,
YAO ZHANGWEI¤ 1426 , YOU JIANLIANG, ET AL¤ 2400 ,
YAO ZHENMIN¤ 1919 , YOU JS ET AL¤ 1232 ,
YAO ZHENMIN ET AL¤ 1667 , YOU KAIHONG¤ 398 ,
YAOYONG¤ 186 , YOU KAIHONG ET AL¤ 370 , 869 ,
YAPING Y¤ 628 , YOU SONGXIN ET AL¤ 1540 , 1696 ,
YA-XIN WANG¤ 2708 , YU BAOFENG¤ 1893 ,
YD ZHANG ET AL¤ 1021 , YU CHANG-YUAN,CHEN ZHEN-GUI,TIAN YONG-
YE ANNA ET AL¤ 1797 , LI,ET AL¤ 2965 , 3103 ,
YE BAIKUAN¤ 1552 , YU CHAO-QIN ET AL¤ 2205 ,
YE FANG ¤ 3647 , YU CHMEN ET AL¤ 2300 ,
YE FANG, LU YUE¤ 3290 , YU DI-XIA ET AL¤ 865 ,
YE HAILING ET AL¤ 2022 , YU ER-XIN¤ 1674 ,
YE JIAN, XU XIKUN, ZHOU JIANWEI, ET AL¤ 2670 , YU ERXIN ET AL¤ 371 , 401 ,
YE JIAN-HUA¤ 2165 , YU ERXING¤ 51 ,
YE JIN ET AL¤ 2135 , YU FENG-CHUN ET AL¤ 2130 ,
YE LIYAN¤ 1822 , YU GUANGSHEN ET AL¤ 367 ,
YE REN¤ 1865 , YU GUANGSHENG ET AL¤ 292 ,
YE SHENG LONG ET AL¤ 527 , YU GUAN-YA¤ 1024 , 2051 ,
YE XIAOHAN¤ 1853 , YU GURAN ET AL¤ 981 ,
YE XINMIAO¤ 407 , YU HUIMIN¤ 719 ,
YE YONG-AN¤ 4063 , YU HUIQIN ET AL¤ 53 , 94 , 189 ,
YE YONG'AN ET AL¤ 1645 , 1810 , YU JIAN ET AL¤ 1112 , 1420 ,
YE YONG-AN, TIAN DE-LU, LI XIAO-LIN, ET AL¤ 2890 YU JIAN SHI YUMIN¤ 1266 ,
, YU JIAN-PING¤ 2778 ,
YE YONG-AN,TIAN DE-LU,ZHU LING-QUN ET AL¤ YU JING ET AL¤ 1986 ,
3239 , YU KEYONG¤ 415 ,

gera 2011
 309
YU LI-PING,CHEN XIAO-NAN,FAND ZHI-MING¤ 3660 , ZENG WENTING ET AL¤ 2239 ,
YU LU-PING¤ 661 , ZENG WENTING, TANG WUBING, NI HONG, ET AL ¤
YU MEI, LIU WENLAN, ZHANG YAN, ET AL¤ 3961 , 3038 , 3153 ,
YU MING¤ 817 , ZENG YING—JIAN, JIANG YI—PING¤ 3913 ,
YU MINGYAN ET AL¤ 884 , ZENG YUANHUA ET AL¤ 1067 ,
YU PING¤ 2385 , 3455 , ZENG YUEXIANG, TAN LANXIANG, CHENG
YU RENZE ET AL¤ 1234 , XIAOMING, ET AL¤ 3309 ,
YU RONGQING¤ 700 , ZENG ZHENDONG WEI JINYU LI YAN¤ 2322 ,
YU RONG-QING ET AL¤ 1630 , ZENGJIE Z¤ 516 ,
YU SENSHAN¤ 207 , 717 , 1462 , ZHAI LI ET AL¤ 822 ,
YU SHEN CHU¤ 174 , ZHAI WEILI¤ 873 ,
YU SHENSHAN ET AL¤ 1171 , ZHAN NINGSHENG ET AL¤ 1015 ,
YU SHENSLAN ET AL¤ 1298 , ZHAN YONGLI¤ 3651 ,
YU SHIYING ET AL¤ 1644 , ZHAN YUTAO ET AL¤ 1924 ,
YU SHIYING, WANG JIAN, HE FUJIN, ET AL¤ 3440 , ZHAN YU-TAO ET AL¤ 1907 ,
YU SHOUSHAN ET AL¤ 804 , ZHANG AI-LING, WU YING, JIANG XUE-LIANG¤ 3875
YU SHUILUO ET AL¤ 1158 , ,
YU TIAOZHONG¤ 3425 , ZHANG BAOLIANG ET AL¤ 1176 ,
YU WENJUN¤ 2411 , ZHANG BEIPING ET AL¤ 1967 ,
YU WENJUN, GENG CHANGE¤ 2991 , 3101 , ZHANG BI-LUN JIANG YI-PING¤ 3461 ,
YU XIAO¤ 670 , ZHANG BIN, WANG LINGTAI, CHEN JIANJIE, ET AL¤
YU XINZHONG¤ 1908 , 2479 , 2518 ,
YU YAOCAI ET AL¤ 835 , ZHANG BIN, ZHAO GANG, WANG LINGTAI,ET AL¤
YU YI-QUAN¤ 1356 , 3671 ,
YU YOU-MING¤ 3618 , ZHANG BI-ZI ET AL¤ 1190 ,
YU YUN¤ 931 , ZHANG BO¤ 662 ,
YU Z ET AL¤ 1320 , ZHANG BO ET AL¤ 2003 , 2010 ,
YU ZEPU ET AL¤ 1064 , ZHANG BO, ZHANG HUAN¤ 3387 ,
YU ZHE FENG ET AL¤ 1939 , ZHANG BOYING¤ 583 ,
YU ZHI-JIAN ET AL¤ 1151 , ZHANG BUO ET AL¤ 1409 ,
YU ZHI-JIAN MENG XIAN-YONG, XU KE-CHENG, ET ZHANG BZ ET AL¤ 1130 ,
AL¤ 1524 , ZHANG CAI-QING, LIANG TIE-JUN, HUANG CHEN,ET
YU ZHONGQING, HU LIHUA, RAO SHENZONG¤ 2382 , AL¤ 2652 ,
YU ZHU YUAN ET AL¤ 703 , ZHANG CHANGFA ET AL¤ 1140 ,
YU ZP ET AL¤ 1080 , ZHANG CHAOXI¤ 1508 ,
YUAN CAI ET AL¤ 447 , ZHANG CHEN, WAN XU-YING, LI BAI, ET AL¤ 3262 ,
YUAN CHANGJIN¤ 2111 , ZHANG CHIZHI¤ 1504 , 3560 ,
YUAN DEXIA ET AL¤ 354 , ZHANG CHIZHI ET AL¤ 2280 ,
YUAN JING -BO, SU CHUN -ZHI, WANG WEN -ZHI, ET ZHANG CHIZHI, CHEN JUNMEI , WEI WEI¤ 3824 ,
AL¤ 3958 , ZHANG CHUNGYUU¤ 91 ,
YUAN LP, CHEN FH, LING L, BO H, CHEN ZW, LI F, ZHANG CHUNQING, ZHU JUREN, SHI HENGMEI, ET
ZHONG MM, XIA LJ¤ 4101 , AL¤ 2419 ,
YUAN LP, CHEN FH, LING L, DOU PF, BO H, ZHONG ZHANG CHUNTAO ET AL¤ 1052 ,
MM, XIA LJ¤ 4082 , ZHANG CUNYI ET AL¤ 1421 ,
YUAN MAOYUN¤ 543 , ZHANG CUN-YI ET AL¤ 2157 ,
YUAN YI-HONG¤ 2838 , 2840 , ZHANG DAN ET AL¤ 2090 ,
YUAN ZHAOKAI¤ 1325 , ZHANG DECHAO¤ 299 ,
YUAN ZHENJIA¤ 935 , ZHANG DING GUO¤ 2004 ,
YUE ZHEMIN¤ 115 , ZHANG DING-FENG¤ 1193 ,
YUEH-WERN WU, KUAN-DEE CHEN AND WEN- ZHANG DONG-JUN ZHUANG AI-GUO¤ 3457 ,
CHUAN LIN¤ 3806 , ZHANG ENQIN ET AL¤ 832 , 833 ,
YUEN MF, T AM S, FUNG J, WONG DK, WONG BC, LAI ZHANG FAN-DING¤ 1439 ,
CL¤ 4012 , ZHANG FENG-JU, ZHAI CHUN-XI¤ 3563 ,
YUKARI GONO, HIROSHI ODAGUCHI,¤ 4141 , ZHANG FENGXUE, WANG XIAOJUN, LIU NI, ET AL¤
YUN YJ, NAH SS, PARK JH, JUNG SK, PAECK EK, 3448 ,
PARK JH, LEE EJ, KIM SH, 4112 , ZHANG FUNAN¤ 1898 ,
YUNDONG L¤ 1311 , ZHANG FUXIU ET AL¤ 854 ,
YUNYAN G ET AL¤ 645 , ZHANG GE¤ 557 ,
YUNZHAO L ET AL¤ 624 , ZHANG GONG-XIANG¤ 2915 ,
ZANG QINGYUN ET AL¤ 1792 , ZHANG GUANG-YE¤ 2999 , 3113 ,
ZANG YONG FENG ET AL¤ 1435 , ZHANG GUIMING¤ 1339 ,
ZAO JIMIN¤ 947 , ZHANG GUO-JUN, WANG DONG-QIANG, SHI LI-PIN¤
ZEN YAQING¤ 897 , 3856 ,
ZENG FEN ¤ 3719 , ZHANG GUO-LIANG¤ 2900 ,
ZENG HAO, ET AL¤ 3349 , ZHANG GUO-LIANG, DAI MIN, XU FAN, ET AL¤ 3918 ,
ZENG QINGHUA¤ 486 , ZHANG GUOTAI ¤ 2760 ,
ZENG QING-PEI¤ 1011 , ZHANG GUO-XI ¤ 2625 ,
ZENG SONGLIN, ET AL ¤ 3707 , 3836 , ZHANG GUOXI ET AL¤ 341 ,
ZENG WEIZHENG, WU XIAOLING, JIANG MINGDE, ZHANG HAI-BO ZHOU RONG-YAO¤ 3236 ,
ET AL¤ 2780 , ZHANG HAIJUN, ZHANG WUSONG¤ 3398 ,

gera 2011

ZHANG HONGYU ET AL¤ 2238 ,
ZHANG HUILING¤ 3729 ,
ZHANG HUI-YUN ET AL¤ 2204 ,
ZHANG HUI-YUN REN QUAN-ZHONG ZHU XU-ZHI¤
2975 ,
ZHANG HUI-YUN, LI ZENG-KUI, SONG XIU-GUANG,
ET AL¤ 2682 ,
ZHANG JIAJUN ET AL¤ 487 ,
ZHANG JIAN , LIU YAN , CHENGJUN, ET AL¤ 3692 ,
ZHANG JIAN JUN ET AL¤ 1338 ,
ZHANG JIAN, LL NING, XING YONGNING, ET AL¤
2481 , 2520 ,
ZHANG JIANGMING ET AL¤ 1943 ,
ZHANG JIAN-GUO¤ 2115 ,
ZHANG JIANHUA ET AL¤ 2138 ,
ZHANG JIAN-JUN AND HUANG JIA-QUAN¤ 4066 ,
ZHANG JIANJUN, ET AL¤ 3322 ,
ZHANG JIAN-JUN, ET AL¤ 2848 ,
ZHANG JIANJUN, SHENG GUOGUANG, ZHANG
CHIZHI, ET A¤ 2944 ,
ZHANG JIAN-QIANG CHEN MIN LI YI-KUI ¤ 3636 ,
ZHANG JIA-XING¤ 1517 ,
ZHANG JIDONG ET AL¤ 1142 ,
ZHANG JIE¤ 3791 ,
ZHANG JIE ET AL¤ 675 ,
ZHANG JIE, LI YUN, CUI CHENG-DE, ET AL¤ 3487 ,
ZHANG JING CHENG WEI-ZHONG LU MIN ET AL¤
2973 ,
ZHANG JING ET AL¤ 1173 ,
ZHANG JING TU HONG YU MEI, ET AL ¤ 3802 ,
ZHANG JING-YU ET AL¤ 2299 ,
ZHANG JIN-HUA, SHAO ZHI-LIN, FEI XIN-YING, ET
AL¤ 3777 ,
ZHANG JINNAN¤ 1812 ,
ZHANG JIN-YUN¤ 2847 ,
ZHANG JUFU, WANG YUEFEN, WU FAN ET AL¤ 2634 ,
ZHANG JUN¤ 1536 , 1759 , 1786 ,
ZHANG JUN FU ET AL¤ 1233 ,
ZHANG JUNCHANG, ET AL¤ 3505 ,
ZHANG JUN-CHANG, WANG LING, LI HONG, AL¤
4004 ,
ZHANG JUN-CHANG, WANG LING, LI HONG, ET AL¤
4008 ,
ZHANG JUNCHANG, XIA JINYU, CHENG LIANGBING,
ET AL¤ 3334 ,
ZHANG JUNCHANG, XIA JINYU, CHENG LIANGBING,
ETAL¤ 3366 ,
ZHANG JUN-FU¤ 1436 ,
ZHANG JUNFU ET AL¤ 361 , 659 , 1194 , 1571 ,
ZHANG JUN-FU ET AL¤ 866 , 1260 ,
ZHANG JUNMIN¤ 3555 ,
ZHANG KE PING¤ 328 ,
ZHANG KELI¤ 1167 ,
ZHANG KEPING¤ 287 ,
ZHANG LEI ¤ 3460 ,
ZHANG LI BIN ET AL¤ 520 ,
ZHANG LIANGMAO¤ 1566 ,
ZHANG LIANGZHI ¤ 3539 ,
ZHANG LIAN-TAO¤ 3288 ,
ZHANG LIJUAN ET AL¤ 2060 ,
ZHANG LINQI¤ 3343 ,
ZHANG LUGAO¤ 2786 ,
ZHANG M ET AL¤ 1529 ,
ZHANG MENGREN ET AL¤ 1088 ,
ZHANG MING-CHANG¤ 444 ,
ZHANG MINGCHANG ET AL¤ 418 ,
ZHANG MINGHUA¤ 1899 ,
ZHANG MINGXUE¤ 1598 ,
ZHANG PEIFENG¤ 1423 ,
ZHANG PEI-QIN, ET AL¤ 3061 , 3176 ,
310
ZHANG Q, QIU H, WANG L, DU GL, LIU P¤ 4059 ,
ZHANG QI¤ 139 , 1933 , 2861 ,
ZHANG QIANDE¤ 1839 ,
ZHANG QILAN¤ 1189 ,
ZHANG QIN, LIU PING¤ 2464 ,
ZHANG QIN, LIU PING, CHEN HUIFEN, ET AL¤ 3291 ,
ZHANG QING ET AL¤ 541 , 582 ,
ZHANG QINGBO ET AL¤ 231 , 242 , 264 ,
ZHANG QING-BO ET AL¤ 275 ,
ZHANG QINRONG ET AL¤ 785 ,
ZHANG QIU -YUN, LI XIU -HUI¤ 3956 ,
ZHANG RONGBI¤ 406 ,
ZHANG RUIXIA ET AL¤ 762 ,
ZHANG RUKUN ET AL¤ 2849 ,
ZHANG RUNLING, CHAO DONGMEI, ET AL¤ 2863 ,
ZHANG SHANCHUAN ET AL¤ 663 ,
ZHANG SHAOJIAN¤ 2155 ,
ZHANG SHAO-PING ET AL¤ 2246 ,
ZHANG SHENGLI¤ 535 ,
ZHANG SHI JIE ET AL¤ 735 ,
ZHANG SHI-JIE ET AL¤ 1071 ,
ZHANG SHIJUN CHEN ZEXIONG HUANG BIJUN, ET
AL¤ 2781 ,
ZHANG SHIJUN ET AL¤ 2282 ,
ZHANG SHIJUN, CHEN ZEXIONG, HUANG BIJUN¤
2879 ,
ZHANG SHI-JUN, CHEN ZE-XIONG, HUANG BI-JUN,
ET¤ 2812 ,
ZHANG SHUANGBIN¤ 820 ,
ZHANG SHUI-YUAN,ZHANG TING-TING¤ 3356 ,
ZHANG SHU-PIN, WANG YI-JUN,NIE FU-HU¤ 3424 ,
ZHANG SHU-PING¤ 2087 ,
ZHANG SHUWEN ET AL¤ 2241 ,
ZHANG SJ ¤ 1078 ,
ZHANG SJ, CHEN ZX, JIAN G KP, WU WK, ZHANG CY,
GU YL¤ 4003 ,
ZHANG SJ, CHEN ZX, JIANG KP, CHENG YH, GU YL¤
4093 ,
ZHANG SJ, CHEN ZX, LIN YW¤ 4014 ,
ZHANG SU-YING¤ 3935 ,
ZHANG W, WANG LQ, LIU YB¤ 4120 ,
ZHANG WAN-GUO HU JIN-HONG ET AL ¤ 2645 ,
ZHANG WANGUO, HU JINHONG, CAI QIN¤ 2959 ,
ZHANG WANGUO, HU JINHONG, HUANG JIN¤ 2950 ,
ZHANG WEI ET AL¤ 1613 , 1929 , 2133 ,
ZHANG WEI JI GUANG WANG YU-QUN, ET AL¤ 2851 ,
ZHANG WEI, WANG YU-QUN, JI GUANG, ET AL¤ 2626
,
ZHANG WEI-DONG, CUI YA-ZHOU, JIA QING , ET AL¤
3936 ,
ZHANG WEIJIE¤ 153 ,
ZHANG WEIMING ET AL¤ 1434 ,
ZHANG WENCAI ET AL¤ 3049 , 3164 ,
ZHANG WENJIN¤ 1472 ,
ZHANG WENYONG, ZHANG MINQING ¤ 3641 ,
ZHANG WU, XU RU-PING, ZHANG LING ET AL¤ 2633 ,
ZHANG WUYI¤ 412 ,
ZHANG XIANYAO¤ 2178 ,
ZHANG XIAO PING ET AL¤ 333 ,
ZHANG XIAOBIN ET AL¤ 346 , 350 ,
ZHANG XIAO-HONG, YANG SHAO-JI, MEI YONG-YU,
ET¤ 2835 ,
ZHANG XIAO-IAN¤ 2638 ,
ZHANG XIAOPING¤ 430 ,
ZHANG XIAOPING, CHEN JIANMING, QIANG
SHIPING¤ 3276 ,
ZHANG XIAO-PING, CHEN JIAN-MING, QIANG SHI-
PING¤ 2811 ,
ZHANG XIAORONG ET AL¤ 384 ,
ZHANG XIAOSHAN ET AL¤ 2075 ,
gera 2011
 311
ZHANG XIAOXIA ET AL¤ 1755 , 3929 ,
ZHANG XIAO-ZHAO, QIAO HAN-CHEN¤ 3884 , ZHAO CHANG-QING, GU HONG-TU, CHENG YANG,
ZHANG XIKUI¤ 862 , ET AL¤ 4069 ,
ZHANG XIN, ZHAO YU-SHENG, XUE JING-DONG, ET ZHAO CHENG MEI ET AL¤ 2018 ,
AL¤ 3578 , ZHAO CHENGME¤ 2716 ,
ZHANG XUDONG¤ 803 , ZHAO CHIN JIUN¤ 559 ,
ZHANG XUEHAI, LI ZHAOZHONG, WANG XIAO¤ 3473 ZHAO CHONGXUE¤ 601 ,
, ZHAO CQ, WU YQ, XU LM¤ 4025 ,
ZHANG XUELAN ET AL¤ 1585 , ZHAO DONG-QIANG, JIANG HUI-QLNG, XIU HE-
ZHANG XUE-WU ET AL¤ 2486 , 2525 , MING ET¤ 2897 ,
ZHANG XUE-WU, ET AL¤ 3415 , ZHAO FENGDA ET AL¤ 1183 ,
ZHANG XUEWU, ZHOU MIN, HU GUOQI¤ 2793 , 3035 , ZHAO FUJIN¤ 1835 ,
3150 , ZHAO FUSHENG¤ 1477 ,
ZHANG YABING ET AL¤ 2047 , 2110 , ZHAO GANG, CHEN JIAN-JIE¤ 3883 ,
ZHANG YAN, LI YANHONG , XIE YUMEI , ET AL¤ ZHAO GANG, GAO YUE-QIU, CHEN JIAN JIE¤ 3810 ,
3818 , ZHAO GANG, WANG LING-TAI, CHEN JIAN-JIE, ET
ZHANG YASHENG¤ 1411 , 1773 , AL¤ 3549 ,
ZHANG YH, LIU YH¤ 4119 , ZHAO GANG, ZHANG BIN, CHEN JIAN-JIE, ET AL¤
ZHANG YI-FA, WANG LIN-LUN,YIN WEI-HUA¤ 2814 , 2834 ,
ZHANG YING ET AL¤ 382 , 1110 , ZHAO GEN¤ 2190 ,
ZHANG YING, ZHANG RUI-MING, CHANG JING, ET ZHAO GUORONG ET AL¤ 1950 ,
AL¤ 4096 , ZHAO HENG¤ 810 ,
ZHANG YINGHUA CHEN XING ET AL¤ 235 , ZHAO HONG YING¤ 3965 ,
ZHANG YING-HUA ET AL¤ 864 , ZHAO HONGTAO ET AL¤ 2288 ,
ZHANG YIQUN¤ 1707 , ZHAO HONGXIN ET AL¤ 1987 ,
ZHANG YIXIN, YANG MUXIANG¤ 3275 , ZHAO J, LIU T, MA L, YAN M, GU Z, HUANG Y, XU F,
ZHANG YI-XIN, YANG MU-XIANG¤ 3077 , 3192 , ZHAO Y¤ 4121 ,
ZHANG YI-XIN,YANG MU-XIANG,WANG ZHAN-BO, ZHAO JIANQIN ET AL¤ 2595 ,
ET AL¤ 2966 , 3104 , ZHAO JIANQIN, LIU LI, LEI XUEZHONG, ET AL¤ 2698 ,
ZHANG YONG ET AL¤ 1599 , 1684 , ZHAO JIMIN¤ 89 , 220 , 586 ,
ZHANG YONGDONG 9 XIONG JIADE, HOU ZHAO JINJUN, LU ZHIPING, ZHANG XUFU, ET AL¤
GANZENG¤ 3003 , 3117 , 3584 ,
ZHANG YONG-HUA ET AL¤ 1019 , ZHAO KE—AN, ZHUO ZHU¤ 3914 ,
ZHANG YONGSHENG, LU LIANGWEI¤ 2662 , ZHAO LIANG ET AL¤ 2119 ,
ZHANG YOUAN¤ 1433 , ZHAO LICHEN¤ 56 ,
ZHANG YOUXIANG, ET AL¤ 3500 , ZHAO LICHEN ET AL¤ 184 ,
ZHANG YOU-XIANG, ZHANG JIA-FA¤ 2664 , ZHAO LING HUANG XIAOZHENG SUN FANGXIA¤
ZHANG YUANHAI, ZHOU QINGRONG, ZHONG 2801 ,
YUEPING, ET AL¤ 3942 , ZHAO LIYUN ET AL¤ 1916 ,
ZHANG YUANZHI¤ 781 , ZHAO NAI XIN¤ 252 ,
ZHANG YUBO, WANG MIN, HU ZHENGXUE¤ 2328 , ZHAO QI ET AL¤ 1709 ,
ZHANG YUELIN ET AL¤ 302 , ZHAO QIN ET AL¤ 1051 ,
ZHANG YUE-YING ET AL¤ 2497 , 2536 , ZHAO QINGJUN¤ 499 ,
ZHANG YUFANG¤ 306 , ZHAO SENG-LI, TAN REN-BIN, ET AL¤ 2735 ,
ZHANG YU-FENG, CHEN TAO¤ 3375 , ZHAO SHOU YE ET AL¤ 2108 ,
ZHANG YUNHAN ET AL¤ 791 , ZHAO TIAN-MIN¤ 1467 ,
ZHANG YUNPENG ET AL¤ 699 , ZHAO TIANPING ET AL¤ 1915 , 2191 ,
ZHANG YUXUAN¤ 344 , ZHAO WEI¤ 1438 , 1774 ,
ZHANG YUXUAN ET AL¤ 753 , ZHAO WEIQIANG¤ 298 ,
ZHANG ZENGJIE¤ 534 , ZHAO WEN-XIA ET AL¤ 1638 ,
ZHANG ZHAN-MIN ET AL¤ 1025 , ZHAO WENXIA, MIAO MINGSAN, DUAN
ZHANG ZHAOQI ET AL¤ 2006 , 2235 , RONGZHANG, ET AL¤ 3397 ,
ZHANG ZHENG ET AL¤ 529 , ZHAO WENXIA, MIAO MINGSAN, LI JIANGUO, ET
ZHANG ZHENGANG ET AL¤ 1978 , AL¤ 3842 ,
ZHANG ZHENGCHEN ET AL¤ 536 , ZHAO XIAOWEI¤ 2939 , 3959 ,
ZHANG ZHENGHUA ET AL¤ 479 , ZHAO XILIAN ET AL¤ 2254 ,
ZHANG ZHENGLI¤ 1711 , 1713 , ZHAO XINMIN¤ 508 ,
ZHANG ZHENRU¤ 228 , ZHAO XINXIU ET AL¤ 1162 ,
ZHANG ZHENXING¤ 308 , ZHAO XUEYIN¤ 1017 ,
ZHANG ZHI'AN ET AL¤ 1793 , ZHAO YAJUN ¤ 3907 ,
ZHANG ZHIYIN¤ 1818 , ZHAO YAN-PING ¤ 3738 ,
ZHANG ZHI-YIN¤ 2329 , ZHAO YIMEI ET AL¤ 3718 ,
ZHANG ZHIZHEN ET AL¤ 1276 , ZHAO YINGHONG¤ 3833 ,
ZHANG ZHUO, GU KEBO, LI DAOBEN, ET AL¤ 3626 , ZHAO YU-ZHEN ET AL¤ 1900 ,
ZHANGZHONG Z¤ 640 , ZHAO ZHENG ET AL¤ 61 ,
ZHANJIE C¤ 629 , ZHAOWEN-XIA¤ 4041 ,
ZHAO CAIYAN, LIANG BAOLI, JIANG LINGLING, ET ZHAOYANG C¤ 642 ,
AL¤ 3589 , ZHAO-ZHONG ET AL¤ 2508 , 2546 ,
ZHAO CANXIN¤ 910 , ZHEN JIU XUE¤ 32 ,
ZHAO CHANGPU, SUN XIAONA, ' YU JINZHONG¤ ZHEN XIAOFANG, ET, AL¤ 3632 ,

gera 2011
 312
ZHENFENG Z¤ 626 , ZHOU CHUN-XIANG XU QIANG CAO JIN-SONG, ET
ZHENG DONG-ZHEN ET AL¤ 1633 , AL¤ 2719 ,
ZHENG GUOQING¤ 1815 , ZHOU DAI HAN ET AL¤ 253 ,
ZHENG HONG-ZHONG, ZHANG YUAN-HAO, LIN ZHOU DAIHAN ET AL¤ 226 ,
SHAO-H¤ 3633 , ZHOU DANHAN¤ 168 ,
ZHENG JIANPING ET AL¤ 239 , ZHOU DAOHONG¤ 1501 , 2317 ,
ZHENG LI-HUANG ET AL¤ 2216 , ZHOU DAOHONG ET AL¤ 1860 , 2207 ,
ZHENG LIMING ET AL¤ 1826 , ZHOU DAOZHONG¤ 315 ,
ZHENG LINING, QIU JING¤ 2685 , ZHOU DA-QIAO, ZHOU XIAO-ZHOU, GUO XING-BO,
ZHENG MIN SHI ET AL¤ 755 , ET AL¤ 3517 ,
ZHENG MINSHI¤ 963 , ZHOU FANG-LING ¤ 3730 ,
ZHENG MINSHI ET AL¤ 468 , 471 , 657 , 881 , 1116 , 1557 ZHOU FAYANG¤ 2153 ,
, ZHOU FEI, WANG LING-TAI, CHEN JIAN-JIE, ET AL¤
ZHENG P, JI G, MA Z, LIU T, XIN L, WU H, LIANG X, 3353 ,
LIU J.¤ 4122 , ZHOU FEI, ZHANG BIN, WANG LING-TAI, ET AL¤
ZHENG PEIYONG, JI GUANG, YOU SHENGFU ¤ 3711 , 2473 ,
ZHENG PING¤ 745 , ZHOU HAIWANG ET AL¤ 2250 ,
ZHENG RU QI ET AL¤ 464 , ZHOU HONG¤ 889 ,
ZHENG SHU-GUO YAN SHUN-QIN, FENG LIANG- ZHOU HONG ET AL¤ 3014 , 3129 ,
YUAN¤ 2845 , ZHOU HONG, JIN CHUN-YING, LUAN WEI, ET AL¤
ZHENG SONGMING¤ 2177 , 3630 ,
ZHENG WEI-DA ZHENG DONG-HAI ZHENG WEI- ZHOU HUA-JIAN, LI SHAO-GUANG, YANG XIAO-
HONG¤ 2952 , YUN, ET AL¤ 3604 ,
ZHENG WEIDONG, ET AL¤ 3359 , ZHOU HUI PING ET AL¤ 676 ,
ZHENG WEIDONG, MA XIAOJUN, WU JIANHUAN, ET ZHOU HUIDING¤ 421 ,
AL¤ 3365 , ZHOU JIANFENG ET AL¤ 2184 ,
ZHENG WEIMIN, LI JINAGBIN¤ 3963 , ZHOU JIAN-FENG ET AL¤ 2249 ,
ZHENG WENGAO ET AL¤ 829 , 830 , ZHOU JIAN-HUA ET AL¤ 1103 ,
ZHENG XHONGXING¤ 210 , ZHOU JINCHENG ET AL¤ 990 ,
ZHENG XIANG ET AL¤ 1211 , ZHOU JING¤ 3053 , 3168 ,
ZHENG XIANMING¤ 213 , ZHOU JIN-GANG¤ 2298 ,
ZHENG XIAOYING ET AL¤ 1868 , ZHOU JINGCHENG ET AL¤ 1068 ,
ZHENG XINYU ¤ 2727 , ZHOU JIN-SHENG¤ 2505 , 2543 ,
ZHENG XIOUYIN ET AL¤ 1215 , ZHOU JU-YING ET AL¤ 1143 ,
ZHENG YONG-PING YANG BI-HUI LIN YI-FEN,¤ 2935 , ZHOU LANLIANG WU SHIPIN¤ 3474 ,
ZHENG YU¤ 2842 , ZHOU LIANGMEI ET AL¤ 731 ,
ZHENG YU, MA HONGBIN, YANG SHAOJUN, ET AL¤ ZHOU LINGLING, ET AL¤ 2395 ,
3274 , ZHOU LINGLING,FANG TAIHUI,XU LI,ET AL¤ 3803 ,
ZHENG YULING¤ 1188 , ZHOU MIN, XUE BO-YU, LL CHUN-TING, ET AL¤ 2372
ZHENG ZHARONG¤ 1668 , ,
ZHENG ZHIMING ET AL¤ 390 , ZHOU QINGHUI, HU XIA, CU WEI, ET AL¤ 3943 ,
ZHENG ZUOSHEN ET AL¤ 1708 , ZHOU QINHUA¤ 914 ,
ZHENGYE M ET AL¤ 1447 , ZHOU QIN-HUA ET AL¤ 1468 ,
ZHE-SHEN W¤ 620 , ZHOU SHENGHONG¤ 4104 ,
ZHI JUNHON ET AL¤ 413 , ZHOU SHIMING¤ 917 ,
ZHIJI Q¤ 1370 , ZHOU SHIWENG ET AL¤ 1513 ,
ZHIZHI L ET AL¤ 1319 , ZHOU XIAOJUN, ET AL¤ 3905 ,
ZHONG JANPING¤ 883 , ZHOU XIAOMEI, ZHOU XIAOZHOU, ZHOU DAQIAO,
ZHONG LEI¤ 500 , ET AL¤ 3464 ,
ZHONG MING¤ 2567 , ZHOU XIAOPING, LI XIANGXIA, LI AIYUE, ET AL¤
ZHONG MING, YU SHENGMIN, HUANG LINYUN, ET 2418 ,
AL¤ 2755 , ZHOU XIAOZHOU, CIIEN JINGJUN, ZHOU DAQIAO,
ZHONG MING, YU SHENGMIN, NONG CHAOZAN, ET ET AL¤ 3041 , 3156 ,
AL¤ 3449 , ZHOU XIAO-ZHOU, ET AL¤ 3328 ,
ZHONG MING, YU SHENG-MIN, YANG ZENG-YAN, ET ZHOU XIAO-ZHOU, GUO ZHEN-QIU, YANG ZHENG-
AL¤ 3895 , WANG, ET¤ 2345 ,
ZHONG SHENQING¤ 1114 , ZHOU XIAOZHOU, HE JINSONG, XU WENJUN, ET AL¤
ZHONG SONGCAI¤ 1089 , 3282 ,
ZHONG XIANFEI, JIANG MINGDE, MA HONGDE, ET ZHOU XIAOZHOU, ZHOU DAQIAO, QI YANPING, ET
AL¤ 3645 , AL¤ 2961 ,
ZHONG YANWEI, CHENG JUN, JIAO CHENGSONG, ET ZHOU XIAQIU ET AL¤ 1568 ,
AL¤ 3303 , ZHOU XIU-TONG ¤ 2720 ,
ZHONG YI, ZHOU HONG, CHEN CHUN-YONG¤ 2733 , ZHOU XUEYI, WU XIONG ZUO XIANG ET AL¤ 2906 ,
ZHONG YI, ZHOU HONG, ZHONG LING¤ 3939 , ZHOU YIHUA ET AL¤ 1856 ,
ZHONG YU-MING ET AL¤ 893 , ZHOU YIQIANG ET AL¤ 1657 ,
ZHONG ZHENG-XIAN, ET AL¤ 2637 , ZHOU YUQIN¤ 2008 ,
ZHONQ JIAXI ET AL¤ 1016 , ZHOU YU-QIN¤ 2052 ,
ZHOU AILING ET AL¤ 1801 , ZHOU ZHENG ET AL¤ 2913 ,
ZHOU AI-LING, LUO LIN, MAO JIA-HUI , ET AL¤ 3885 , ZHOU ZHENG, CHEN JIE , ZHANG CHIZHI , ET AL¤
ZHOU AL, ZHU YJ, HU YE, MAO JH, JIANG DR¤ 4030 , 3340 ,

gera 2011
 313
ZHOU ZHENG, ET AL¤ 3268 , ZHU MEI-JU, ZHANG HONG, GAO SHUN-SHENG, ET
ZHOU ZHENG, LIU LIPING, ZHANG CHIZHI, ET AL¤ AL¤ 3249 ,
3336 , ZHU MEI-LUN ET AL¤ 1147 ,
ZHOU ZHENHUA ET AL¤ 2070 , ZHU MINGLIE¤ 502 ,
ZHOU ZHEN-HUA, LIU LU-MING, HUANG WEN-XIA, ZHU MU, REN GUANG-RONG¤ 3459 ,
E¤ 3437 , ZHU QIGUI, HUANG QIAN, ZHU JIANHONG¤ 3040 ,
ZHOU ZHONGYING¤ 2582 , 3155 ,
ZHU AIJUN ET AL¤ 2294 , ZHU QIN¤ 3720 ,
ZHU BEN-ZHONG ET AL¤ 1357 , ZHU QINGJING ET AL¤ 1789 , 2065 ,
ZHU BIANZHU¤ 171 , ZHU QING-JING, ET AL¤ 2689 ,
ZHU BINBIN¤ 219 , ZHU SHENGHUA ET AL¤ 1653 ,
ZHU BING, LIU DIAN-WU, FANG WEN-LIANG, ET AL¤ ZHU SHIFU¤ 1322 ,
2992 , 3102 , ZHU SHI-SHU, ZHANG HONG-FEI, CHEN JU-MEI, ET
ZHU BING,LIU DIAN-WU,CUI JUN-SHENG,ET AL¤ AL¤ 3574 ,
3045 , 3160 , ZHU TIANZHONG ET AL¤ 114 ,
ZHU BINGBING ET AL¤ 212 , 366 , ZHU XIAN BAO ET AL¤ 250 ,
ZHU BOXING ET AL¤ 1347 , ZHU XIAO - DONG¤ 3768 ,
ZHU CHENGLAN ET AL¤ 1101 , ZHU XIAO-GANG, LIU JIAN-JUN , MA JIAN-HUA, ET
ZHU CHU-LIANG XIE SHENG¤ 3968 , AL¤ 3891 ,
ZHU CHUNHUA ET AL¤ 2601 , ZHU XUDONG¤ 894 ,
ZHU DAN, CHI MING-YU, JIANG DIAN-XUN, ET AL¤ ZHU YAN-ZHEN¤ 1601 ,
2942 , ZHU YAOQUN, CHEN JUNXIAN, LIN ZUHUI¤ 2476 ,
ZHU FANG SHI¤ 1026 , ZHU YAO-QUN, ET AL¤ 3064 , 3179 ,
ZHU FANGSHI¤ 1040 , ZHU YING, YUAN WEIJIAN, YAO HONGYAN¤ 3030 ,
ZHU FANGSHI ET AL¤ 1277 , 1307 , 1430 , 1628 , 1642 , 3145 ,
ZHU FANG-SHI ET AL¤ 2169 , ZHU YINGLAI ET AL¤ 2215 ,
ZHU GUANG-ZE ET AL¤ 2905 , ZHU YIUCAI ET AL¤ 924 ,
ZHU HONG, XIAO WEIMING, LU WEI¤ 3747 , ZHU YOUCAI ET AL¤ 796 ,
ZHU HONGMING ET AL¤ 1074 , ZHU YU ET AL¤ 549 ,
ZHU JIANHUA¤ 863 , ZHU YUE, SUO AISHENG¤ 2749 ,
ZHU JIAN-LIANG ET AL¤ 1003 , ZHU YUEWEI¤ 598 ,
ZHU JIANMING , WANG BI, XU GUIYING, ET AL¤ 2987 ZHU YUN¤ 918 ,
, ZHU YUWEI ET AL¤ 607 , 834 ,
ZHU JIANMING, WANG BI, XU GUIYING, ET AL¤ 3095 ZHU ZHI-JUN¤ 2763 ,
, ZHUANG JINFU¤ 393 ,
ZHU JIANMING, XU GUIYING PAN XIAOHONG ET ZHUHAI-PENG, GAO ZHI-HANG, TAN DE-MING, ET
AL¤ 2864 , AL¤ 4042 ,
ZHU JIN-ZHAO, ZHANG JIE, ZHANG ZHI-JIAN¤ 3342 , ZHUO HUANCI, WANG BAOEN ET AL¤ 233 ,
ZHU JINZHAO, ZHANG ZHONGJIAN ¤ 3676 , ZHUO LS, YIN HF , HE DS , ET AL¤ 3981 ,
ZHU JIUZI¤ 815 , ZHUO YUN-HUI, CHEN JIAN-JIE, WANG LING-TAI¤
ZHU JUNFENG, ZHAO GANG, WANG LINGTAI, ETAL¤ 2853 ,
3369 , ZI-IAO ZHIYOU, YAO ZHENMIN, ZHONG QINGPING,
ZHU LEI-LEI, MENG HONG, JIANG JIAN, ET AL¤ 4068 , ET AL¤ 2463 ,
ZHU LI LI YUEHUA LL XIAOYU, ET AL¤ 2875 , ZONGGUANG L¤ 1679 ,
ZHU LIN¤ 1354 , ZOU JING ET AL¤ 2167 ,
ZHU LINGQUN ET AL¤ 1554 , ZOU JING, CHEN JIANJIE¤ 3451 ,
ZHU LIWEI , ET AL¤ 3789 , ZOU KUICHANG ET AL¤ 1164 , 1569 ,
ZHU LI-ZHUAN ET AL¤ 1358 , ZOU LIYI, WU TIE, CUI LIAO¤ 2703 ,
ZHU MEI JU ET AL¤ 2014 , ZU WU¤ 2442 ,
ZHU MEI,GAO HONG-QUAN,LIU RUI-FENG,ET AL¤ ZU YAN-ZHEN ET AL¤ 1365 ,
3346 , ZUO JUNLING¤ 2032 , 2033 ,
ZHU MEIJU ET AL¤ 2265 , ZUO SHU YAN¤ 652 ,
ZHU MEI-JU, GUO ZHEN-QIU¤ 2423 , ZUO SHUYAN¤ 723 ,

gera 2011
 314

index des sujets/ subject index 2,05 -¤ meridians/ méridiens

(non exhaustif) dermatoses méridiennes¤ 44 ,
-¤ /
¤ 52 , 53 , 62 , 188 , 190 , 202 , 273 , 390 , 548 , 549 , 550 , 2,06 -¤ points/ points
551 , 702 , 703 , 704 , 705 , 766 , 847 , 906 , 962 , 964 , 1045 E36¤ 38 , 127 , 1109 , 1776 , 1801 , 2828 , 3811 , 3875 ,
, 1059 , 1062 , 1209 , 1390 , 1656 , 1678 , 1762 , 1795 , 1958 4027 ,
, 1963 , 1965 , 1991 , 2011 , 2069 , 2219 , 3994 , F3¤ 156 ,
huatuojiaji¤ 2042 ,
1,01 -¤ GENERAL ASPECTS AND HISTORY/ localistaion¤ 1085 ,
ASPECTS GENERAUX ET HISTOIRE MC6¤ 1801 , 2828 , 3769 ,
armée¤ 8 , MU¤ 353 ,
combinaison médecine occidentale- mtc¤ 52 , 273 , 1341 , points nouveaux¤ 21 , 47 ,
1355 , 1356 , 1359 , 1366 , 1480 , 1483 , 1491 , 1517 , 1521 , RN1¤ 1738 ,
1600 , 1603 , 1659 , 1682 , 1685 , 1725 , 1942 , 1964 , 2005 , RN7¤ 1801 ,
2031 , 2034 , 2036 , 2038 , 2054 , 2059 , 2087 , 2111 , 2114 , RTE6¤ 1801 ,
2122 , 2123 , 2171 , 2254 , 2267 , 2283 , 2290 , 2533 , 2734 , shu¤ 188 ,
2762 , 3593 , 3611 , 3616 , 3618 , 3633 , 3662 , 3697 , 3739 , shu du dos¤ 353 ,
3759 , 3760 , 3765 , 3831 , 3837 , 3902 , 3904 , 3907 , 3914 , spécificité¤ 1801 ,
3916 , 3945 , 3948 , 3956 , V18¤ 156 , 3875 ,
congrès¤ 794 , V23¤ 127 ,
hôpital¤ 8 , V25¤ 127 ,
informatique¤ 208 , 1004 , VG14¤ 586 ,
VG26¤ 277 , 278 , 822 , 1738 ,
1,02 -¤ history/ histoire
*¤ 719 , 1227 , 3828 , 3,01 -¤ chronobiology/ chronobiologie
*¤ 347 , 754 , 1599 , 1749 , 2079 , 2245 , 3777 ,
1,03 -¤ medical classics/ classiques médicaux chronopuncture¤ 754 , 3777 ,
fu qing zhu nu ke¤ 1053 , jour¤ 136 ,
shang han lun¤ 513 , 656 ,
3,02 -¤ pathogeny. causes of diseases/ pathogénie
1,04 -¤ asian medicines/ médecines asiatiques *¤ 2439 ,
*¤ 105 , chaleur¤ 73 , 77 , 212 , 221 , 291 , 305 , 345 , 399 , 419 , 478
tibet¤ 105 , , 569 , 741 ,
feu¤ 159 ,
2,01 -¤ ANATOMY- PHYSIOLOGY/ ANATOMIE- humidite¤ 77 , 232 , 247 , 305 ,
PHYSIOLOGIE humidite-chaleur¤ 1213 , 1773 , 1950 , 2128 , 2245 ,
*¤ 2057 , stress¤ 38 , 685 , 686 ,
mort¤ 136 , vent¤ 313 , 750 , 1815 ,
ongle¤ 264 ,
4,02 -¤ tongue diagnosis/ glossoscopie
2,02 -¤ yin-yang. five elements/ yin-yang. cinq éléments *¤ 145 , 264 , 270 , 488 , 706 , 856 , 1008 , 1181 , 1358 ,
5 mouvements¤ 191 , 1595 , 1814 , 1816 , 3858 ,
bois¤ 4 , 782 , veines sublinguales¤ 137 , 367 ,
feu¤ 159 ,
4,03 -¤ pulse diagnosis/ pulsologie
2,03 -¤ qi, blood, body fluids/ energie, sang et liquides *¤ 488 , 1008 , 1324 , 1561 ,
organiques
énergie mentale¤ 78 , 4,04 -¤ face and ear diagnosis/ examen auriculaire et
liquide¤ 140 , facial
sang¤ 30 , 30 , 107 , 107 , 170 , 170 , 221 , 221 , 227 , 227 , *¤ 188 , 1814 ,
291 , 291 , 345 , 345 , 399 , 399 , 478 , 478 , 573 , 573 , 611 , iridologie¤ 16 , 192 , 1814 ,
611 , 727 , 727 , 769 , 769 , lésion cutanée ponctuelle¤ 35 , 41 , 188 , 1051 ,

2,04 -¤ organs and functions/ organes et fonctions 4,05 -¤ point diagnosis/ examen des points somatiques
*¤ 186 , 337 , *¤ 21 , 47 , 156 , 188 ,
coeur¤ 78 ,
estomac¤ 51 , 4,07 -¤ syndromes/ syndromes
foie¤ 20 , 72 , 73 , 112 , 159 , 186 , 191 , 224 , 337 , 431 , *¤ 57 , 73 , 77 , 112 , 191 , 224 , 310 , 380 , 431 , 473 , 477 ,
726 , 737 , 782 , 799 , 894 , 1678 , 591 , 713 , 750 , 887 , 912 , 978 , 1277 ,
intestin grele¤ 1776 , chaleur¤ 73 , 77 , 212 , 221 , 291 , 305 , 345 , 399 , 419 , 478
poumons¤ 736 , , 569 , 741 ,
rate¤ 51 , 72 , 112 , 149 , 224 , 232 , 247 , 371 , 401 , 502 , chaleur du sang¤ 1953 ,
613 , 628 , 705 , 726 , 763 , 785 , 798 , 814 , 894 , 940 , 1313 differenciation des syndromes¤ 65 , 264 , 1343 , 1484 , 1492
, , 1519 , 1654 , 1745 , 1773 , 1774 , 1783 , 1786 , 1795 , 1896
reins¤ 73 , 196 , 517 , 535 , 682 , 698 , 814 , 929 , 940 , , 1935 , 1952 , 2103 , 2108 , 2115 , 2127 , 2150 , 2155 , 2169
respiration¤ 20 , , 2200 , 2217 , 2245 , 2260 , 2271 , 2275 , 2293 , 2312 , 2321
triple rechauffeur¤ 158 , 650 , 669 , 1654 , , 2325 , 2485 , 2520 , 3551 , 3595 , 3599 , 3600 , 3622 , 3646
vésicule biliaire¤ 337 , , 3670 , 3687 , 3747 , 3795 , 3813 , 3833 , 3834 , 3854 , 3866

gera 2011
 315
, 3882 , 3897 , 3905 , 3925 , 3938 , 3956 , 3961 , 3964 , 3971
, 3972 , 3986 , 5,11 -¤ nose, face, eye, hand and foot acupuncture/
glaire¤ 73 , 232 , 842 , 887 , 2245 , 2442 , rhinofacio, manopodo, craniopuncture
humidité-chaleur¤ 3595 , manopuncture¤ 3594 ,
humidité-chaleur de l'estomac¤ 3597 , podopuncture¤ 3594 ,
humidité-glaires¤ 2128 , 3795 ,
paraclinique¤ 57 , 5,12 -¤ electro-acupuncture/ electro-acupuncture
plénitude¤ 866 , *¤ 127 , 1776 , 3769 , 3981 ,
plénitude chaleur¤ 2312 ,
qi¤ 371 , 705 , 737 , 5,13 -¤ magnetic acupuncture/ magnétothérapie
sang¤ 30 , 107 , 170 , 221 , 227 , 291 , 345 , 399 , 478 , 573 , *¤ 3804 ,
611 , 727 , 769 ,
stase¤ 30 , 107 , 112 , 170 , 227 , 305 , 405 , 573 , 611 , 727 , 5,14 -¤ laser acupuncture/ laser
737 , 769 , 887 , *¤ 2008 ,
stase de glaires¤ 2177 , 2325 , 3882 ,
stase de qi¤ 1783 , 2169 , 2177 , 2664 , 5,15 -¤ drug acupuncture/ chimiothérapie
stase de qi du foie¤ 1781 , 1783 , 2169 , 2245 , 2534 , 3501 , *¤ 352 , 593 , 643 , 757 , 772 , 773 , 837 , 850 , 867 , 885 ,
3850 , 3911 , 1273 , 1687 , 1739 , 1750 , 1801 , 2250 , 2615 , 3133 , 3509 ,
stase du sang¤ 782 , 847 , 858 , 1004 , 1008 , 1179 , 1575 ,
1744 , 1783 , 1991 , 2169 , 2196 , 2345 , 2664 , 2665 , 3623 , 5,16 -¤ qi gong. massages/ qi gong. massages
3718 , *¤ 55 , 85 , 119 , 378 , 379 , 602 , 661 , 670 , 828 ,
vide¤ 73 , 112 , 149 , 196 , 224 , 228 , 232 , 247 , 265 , 310 , acupression¤ 485 , 637 , 867 , 1449 ,
364 , 394 , 400 , 401 , 431 , 506 , 535 , 682 , 705 , 741 , 785 , qi gong¤ 55 , 83 , 84 , 85 , 103 , 120 , 172 , 185 , 355 , 378 ,
866 , 3944 , 379 , 441 , 602 , 661 , 670 , 770 , 793 , 828 , 898 , 931 , 1147
vide de qi¤ 1935 , 2249 , 2345 , , 1741 , 2112 ,
vide de qi de rate¤ 1660 , 2103 , 2115 , 2169 , tai ji¤ 84 , 119 ,
vide de rate¤ 868 , 879 , 997 , 1037 , 1783 , 1992 , 2024 ,
2179 , 2347 , 2534 , 3501 , 3911 , 5,17 -¤ dietetics/ diététique
vide de sang¤ 858 , *¤ 56 , 184 , 504 , 829 , 830 ,
vide de sang du foie¤ 2287 ,
vide de yang de rate¤ 883 , 5,19 -¤ adverse effects/ accidents thérapeutiques
vide de yang de rate et des reins¤ 2169 , *¤ 1741 ,
vide de yang des reins¤ 1163 , fievre¤ 606 , 1743 , 2312 ,
vide de yin¤ 1935 , 1990 , 2312 , hépatite¤ 1 , 8 , 42 , 53 , 56 , 89 , 126 , 272 , 273 , 275 , 282 ,
vide de yin des reins¤ 2103 , 284 , 285 , 286 , 311 , 312 , 313 , 314 , 316 , 317 , 318 , 319 ,
vide de yin des reins et de rate¤ 2115 , 2169 , 322 , 323 , 324 , 342 , 344 , 351 , 352 , 353 , 357 , 360 , 361 ,
vide de yin du foie¤ 1664 , 2103 , 2296 , 3713 , 379 , 383 , 385 , 389 , 391 , 392 , 406 , 407 , 435 , 437 , 440 ,
vide des reins¤ 3734 , 3755 , 443 , 445 , 476 , 477 , 478 , 479 , 480 , 483 , 490 , 500 , 503 ,
yang¤ 265 , 364 , 400 , 506 , 504 , 505 , 506 , 507 , 508 , 509 , 513 , 514 , 515 , 595 , 626 ,
yin¤ 73 , 228 , 312 , 394 , 682 , 741 , 627 , 699 , 700 ,

5,02 -¤ principles of treatment/ principes thérapeutiques 5,20 -¤ tcm and alternative medicine/ mtc et médecines
*¤ 53 , 78 , 110 , 618 , 695 , 774 , 894 , 974 , 1680 , douces
activation de la circulation et levée de stase.¤ 26 , 54 , 95 , homeopathie¤ 193 ,
116 , 152 , 212 , 287 , 291 , 298 , 405 , 508 , 571 , 611 , 655 , oligo-élements¤ 310 , 323 , 402 , 526 , 548 , 1656 , 1925 ,
699 , 746 , 888 , 952 , 1033 , 1045 , 1069 , 1070 , 1081 , 1250
, 1258 , 1281 , 1299 , 1354 , 1661 , 1686 , 1799 , 1911 , 1929 6,01 -¤ algology/ algologie
, 1943 , 2128 , 2179 , 2787 , 3608 , 3615 , 3755 , *¤ 1188 , 1250 , 1368 , 3594 ,
dispersion¤ 2160 , 2260 , psychisme¤ 925 , 3964 ,
purgation¤ 370 ,
tonification¤ 613 , 698 , 7,02 -¤ heart failure/ insuffisance cardiaque
*¤ 136 , 436 ,
5,03 -¤ acupuncture/ acupuncture myocardite¤ 436 ,
*¤ 606 , 835 , 1007 ,
association ou interaction médicamenteuse¤ 7 , 474 , 7,03 -¤ coronary diseases/ coronaropathies
choix des points¤ 606 , *¤ 136 , 384 , 847 , 1779 ,
deqi¤ 586 ,
tonification-dispersion¤ 835 , 1007 , 7,07 -¤ peripheral circulation/ circulation périphérique
microcirculation¤ 183 , 231 , 264 , 275 , 432 ,
5,06 -¤ intradermal needle. embedding sutures/ aiguille à
demeure. catgut 7,08 -¤ arteries/ artères
*¤ 353 , 4143 , angiome¤ 539 , 799 ,

5,09 -¤ moxibustion/ moxibustion 8,11 -¤ ulcer. wound/ ulcères. plaies

*¤ 62 , 76 , 351 , 379 , 579 , 953 , 1085 , 1109 , 2194 , 3857 , *¤ 606 ,

5,10 -¤ ear acupuncture. auricular medicine/ 9,01 -¤ ENDOCRINOLOGY- NUTRITION/

auriculopuncture. auriculomédecine ENDOCRINOLOGIE- NUTRITION
*¤ 485 , 598 , 607 , 637 , 834 , 867 , 1283 , 1375 , 1449 , *¤ 1681 , 2027 ,
1449 , 3456 , 3456 , 3773 ,

gera 2011
 316
9,02 -¤ thyroid gland/ thyroïde 627 , 699 , 700 ,
*¤ 866 , 1047 , parasitose¤ 72 ,

9,03 -¤ diabetes mellitus/ diabète 10,11 -¤ bile ducts/ voies biliaires

*¤ 658 , 2194 , 3511 , 3800 , *¤ 16 , 55 , 102 , 337 , 359 , 759 , 1211 , 1234 , 1304 , 1521 ,
1771 , 1775 , 1815 , 2028 , 2038 ,
9,04 -¤ hypoglycemia/ hypoglycémie
*¤ 38 , 325 , 10,12 -¤ pancreas/ pancréas
*¤ 359 , 1084 , 2503 ,
9,05 -¤ adrenal glands/ surrénales
*¤ 377 , 10,15 -¤ gastrointestinal hemorrhage/ hémorragies
digestives
9,07 -¤ hyperlipidemia/ hyperlipidémie *¤ 728 ,
*¤ 365 , 1243 , 1753 , 2040 ,
11,01 -¤ GYNECOLOGY- OBSTETRICS/
9,08 -¤ obesity/ obésité GYNECOLOGIE- OBSTETRIQUE
*¤ 496 , 707 , *¤ 320 ,

9,10 -¤ sexual hormones/ hormones sexuelles 11,07 -¤ breast/ sein

testostérone¤ 866 , *¤ 2027 ,

10,01 -¤ GASTROENTEROLOGY/ GASTRO- 11,09 -¤ infertility. contraception. abortion/ stérilité.

ENTEROLOGIE contraception. ivg
peristaltisme¤ 1801 , 3783 , *¤ 965 ,

10,02 -¤ hiccup/ hoquet 11,10 -¤ obstetrics/ obstétrique

*¤ 606 , *¤ 514 , 1361 , 1954 , 2839 , 3829 ,

10,03 -¤ dyspepsia. nausea. vomiting/ dyspepsie. nausées. 12,01 -¤ HEMATOLOGY/ HEMATOLOGIE

vomissements lymphocyte¤ 1776 , 2321 ,
*¤ 606 ,
12,02 -¤ anemia. cytopenia/ anémie. cytopénie
10,04 -¤ oesophagus/ oesophage *¤ 382 , 992 , 1344 ,
*¤ 137 ,
12,05 -¤ thrombosis/ thromboses
10,05 -¤ stomach. duodenum/ estomac. duodénum *¤ 363 , 1753 ,
*¤ 31 , 35 , 82 , 137 , 185 , 602 , 1796 , 1979 ,
gastrine¤ 866 , 1289 , 13,01 -¤ INFECTIOUS DISEASES/ MALADIES
INFECTIEUSES
10,06 -¤ intestines/ intestins *¤ 190 , 213 , 216 , 292 , 446 , 502 ,
*¤ 82 , fievre¤ 606 , 1743 , 2312 ,
parasitose¤ 72 ,
13,02 -¤ influenza/ grippe
10,07 -¤ diarrhea/ diarrhées *¤ 1279 ,
*¤ 190 , 359 , 2370 ,
13,05 -¤ tetanus. diphtheria. typhoid/ tétanos. diphtérie.
10,10 -¤ liver/ foie thyphoïde
*¤ 1 , 7 , 16 , 20 , 31 , 35 , 41 , 44 , 55 , 82 , 83 , 84 , 136 , *¤ 190 ,
137 , 186 , 188 , 190 , 191 , 192 , 193 , 242 , 245 , 264 , 274 ,
276 , 277 , 278 , 314 , 338 , 343 , 350 , 357 , 359 , 367 , 378 , 13,06 -¤ mycoses and parasitic diseases/ parasitoses et
383 , 384 , 422 , 448 , 514 , 531 , 593 , 602 , 606 , 608 , 703 , mycoses
705 , 735 , 750 , 754 , 782 , 800 , 822 , 824 , 835 , 847 , 864 , *¤ 190 ,
874 , 880 , 907 , 926 , 957 , 960 , 990 , 1003 , 1007 , 1050 ,
1051 , 1059 , 1073 , 1084 , 1085 , 1087 , 1125 , 1132 , 1228 , 13,07 -¤ malaria/ paludisme
1234 , 1248 , 1249 , 1279 , 1371 , 1375 , 1381 , 1391 , 1558 , *¤ 52 , 1779 ,
1563 , 1678 , 1679 , 1737 , 1738 , 1741 , 1746 , 1775 , 1779 ,
1782 , 1801 , 1873 , 1932 , 1935 , 2205 , 2668 , 3783 , 3943 , 14,03 -¤ coma. brain injury/ coma. traumatisme crânien
4027 , *¤ 49 , 199 , 928 , 1279 ,
abcès¤ 442 ,
ascite¤ 283 , 366 , 367 , 368 , 386 , 393 , 439 , 501 , 567 , 571 14,07 -¤ cerebrovascular diseases. hemiplegia/ accidents
, 582 , 601 , 736 , vasculaires cérébraux. *¤ 1779 ,
cirrhose¤ 7 , 43 , 53 , 73 , 185 , 249 , 283 , 358 , 386 , 393 ,
395 , 433 , 439 , 444 , 446 , 469 , 482 , 489 , 501 , 502 , 508 , 14,10 -¤ neuromuscular diseases. poliomyelitis/ pathologie
567 , 571 , 621 , 622 , 623 , 624 , 745 , 771 , 774 , 857 , neuro-musculaire. poliomyélite
hepatite¤ 1 , 8 , 42 , 53 , 56 , 89 , 126 , 272 , 273 , 275 , 282 , *¤ 959 ,
284 , 285 , 286 , 311 , 312 , 313 , 314 , 316 , 317 , 318 , 319 ,
322 , 323 , 324 , 342 , 344 , 351 , 352 , 353 , 357 , 360 , 361 , 14,12 -¤ spasm and tic/ spasmes et tics
379 , 383 , 385 , 389 , 391 , 392 , 406 , 407 , 435 , 437 , 440 , *¤ 1652 ,
443 , 445 , 476 , 477 , 478 , 479 , 480 , 483 , 490 , 500 , 503 ,
504 , 505 , 506 , 507 , 508 , 509 , 513 , 514 , 515 , 595 , 626 , 14,14 -¤ psychiatry/ psychiatrie

gera 2011
 317
*¤ 764 , , 2161 , 2162 , 2293 , 2615 , 3777 ,
psychisme¤ 925 , 3964 , greffe¤ 1298 , 2195 , 3748 ,
psychotherapie¤ 1998 , lymphocyte¤ 1776 , 2321 ,

15,02 -¤ conjunctiva/ conjonctive 23,04 -¤ oncology/ cancérologie

*¤ 606 , *¤ 40 , 41 , 51 , 63 , 112 , 135 , 137 , 168 , 187 , 226 , 235 ,
236 , 241 , 270 , 270 , 287 , 288 , 295 , 328 , 331 , 338 , 340 ,
16,04 -¤ nose. sinus/ nez. sinus 343 , 371 , 372 , 373 , 387 , 394 , 401 , 450 , 459 , 464 , 488 ,
*¤ 269 , 527 , 546 , 592 , 593 , 597 , 602 , 608 , 614 , 617 , 632 , 651 ,
674 , 708 , 712 , 741 , 754 , 763 , 772 , 778 , 784 , 785 , 788 ,
16,05 -¤ pharynx. larynx/ pharynx. larynx 823 , 836 , 837 , 838 , 841 , 847 , 876 , 882 , 892 , 908 , 951 ,
*¤ 314 , 972 , 980 , 1016 , 1033 , 1036 , 1048 , 1081 , 1131 , 1143 ,
1151 , 1152 , 1164 , 1170 , 1196 , 1207 , 1210 , 1248 , 1250 ,
17,04 -¤ asthma/ asthme 1268 , 1269 , 1270 , 1283 , 1284 , 1293 , 1301 , 1305 , 1312 ,
*¤ 606 , 1373 , 1450 , 1530 , 1541 , 1545 , 1546 , 1550 , 1560 , 1588 ,
1594 , 1658 , 1677 , 1772 , 1784 , 1794 , 1811 , 1813 , 1814 ,
17,05 -¤ lung neoplasms/ tumeurs broncho-pulmonaires 1895 , 1896 , 1906 , 1916 , 1927 , 1928 , 1945 , 1969 , 1977 ,
*¤ 1007 , 1980 , 1985 , 1989 , 1990 , 1992 , 2014 , 2059 , 2082 , 2095 ,
2107 , 2112 , 2114 , 2157 , 2159 , 2161 , 2167 , 2182 , 2198 ,
17,06 -¤ pulmonary tuberculosis/ tuberculose pulmonaire 2215 , 2248 , 2249 , 2255 , 2266 , 2268 , 2276 , 2277 , 2278 ,
*¤ 835 , 1019 , 2283 , 2288 , 2293 , 2327 , 2347 , 2370 , 2434 , 2435 , 2483 ,
2493 , 2532 , 2666 , 2670 , 2736 , 3501 , 3583 , 3594 , 3595 ,
17,07 -¤ acute bronchopneumonia/ 3648 , 3668 , 3714 , 3715 , 3736 , 3756 , 3759 , 3771 , 3775 ,
bronchopneumopathies aigües 3776 , 3785 , 3804 , 3807 , 3834 , 3850 , 3855 , 3865 , 3870 ,
*¤ 1935 , 3873 , 3877 , 3878 , 3880 , 3903 , 3923 , 3928 , 3931 , 3936 ,
3937 , 3938 , 3943 , 3944 , 3957 , 3992 , 4142 ,
17,08 -¤ hemoptysis/ hémoptysies chimiotherapie¤ 387 , 1143 , 2432 , 3791 ,
*¤ 359 , radiotherapie¤ 387 ,

20,01 -¤ poisoning/ intoxications 23,07 -¤ gerontology/ gérontologie

*¤ 74 , 116 , 126 , 214 , 347 , 475 , 490 , 521 , 550 , 868 , 949 *¤ 341 , 599 , 1065 ,
, 997 , 1241 , 1282 , 1405 ,
benzène¤ 1228 , 1248 , 1284 , 23,08 -¤ inflammation/ inflammation
CCl4¤ 74 , 126 , 521 , 868 , 949 , 1132 , 1241 , 1282 , 1405 , *¤ 1751 ,
1684 , 1718 , 1746 , 1748 , 1751 , 1752 , 1785 , 1801 , 1907 ,
1918 , 1984 , 2143 , 2211 , 2438 , 2884 , 23,09 -¤ preventive medicine. hygiene/ médecine
préventive. hygiène
20,03 -¤ substance abuse/ toxicomanies *¤ 696 , 788 ,
*¤ 2230 , 3660 ,
23,11 -¤ pediatrics/ pédiatrie
20,04 -¤ alcoholism/ alcoolisme *¤ 39 , 61 , 100 , 101 , 165 , 209 , 267 , 298 , 304 , 408 , 420 ,
*¤ 818 , 1144 , 1197 , 1721 , 1763 , 1810 , 1874 , 1917 , 1988 436 , 503 , 524 , 556 , 578 , 709 , 780 , 806 , 810 , 860 , 871 ,
, 2214 , 2286 , 3764 , 3794 , 3794 , 3811 , 872 , 884 , 979 , 1022 , 1048 , 1112 , 1146 , 1187 , 1192 ,
1266 , 1315 , 1548 , 1627 , 1724 , 1986 ,
21,01 -¤ EMERGENCIES- RESUSCITATION/
URGENCES- REANIMATION 23,12 -¤ oedema/ oedèmes
*¤ 44 , 449 , 606 , *¤ 1072 ,

21,02 -¤ fainting. shock/ syncopes. choc 24,07 -¤ / animaux de laboratoire

*¤ 549 , chien¤ 3773 , 4031 ,
lapin¤ 214 , 276 , 277 , 278 , 822 , 2919 ,
22,01 -¤ UROLOGY- NEPHROLOGY/ URO- modèle animal¤ 997 , 2069 , 3911 , 4132 ,
NEPHROLOGIE rat¤ 62 , 105 , 127 , 147 , 341 , 356 , 362 , 382 , 395 , 487 ,
*¤ 441 , 1737 , 490 , 550 , 592 , 685 , 686 , 765 , 766 , 785 , 791 , 800 , 997 ,
1228 , 1282 , 1284 , 1558 , 1686 , 1718 , 1747 , 1752 , 1753 ,
22,02 -¤ kidney diseases. kidney failure/ néphropathies. 1785 , 1810 , 1811 , 1813 , 1907 , 1916 , 1918 , 1940 , 1945 ,
insuffisance rénale 1956 , 1957 , 1972 , 1982 , 1984 , 2011 , 2012 , 2015 , 2016 ,
*¤ 1085 , 1520 , 3738 , 2055 , 2082 , 2089 , 2102 , 2162 , 2194 , 2205 , 2208 , 2211 ,
2212 , 2214 , 2228 , 2231 , 2281 , 2302 , 2331 , 2355 , 2356 ,
22,07 -¤ urologic and male genital diseases/ appareil 2503 , 2519 , 2578 , 2670 , 2795 , 2884 , 2920 , 3614 , 3631 ,
génital masculin 3731 , 3754 , 3763 , 3764 , 3769 , 3770 , 3772 , 3780 , 3803 ,
testostérone¤ 866 , 3804 , 3806 , 3811 , 3812 , 3815 , 3825 , 3827 , 3842 , 3851 ,
3853 , 3869 , 3872 , 3885 , 3886 , 3889 , 3894 , 3895 , 3911 ,
23,01 -¤ INTERNAL MEDICINE. MISCELLANEOUS/ 3918 , 3919 , 3921 , 3926 , 3927 , 3970 , 3979 , 3981 , 3985 ,
MEDECINE INTERNE. DIVERS 3993 , 3998 , 4027 ,
*¤ 950 , souris¤ 74 , 126 , 167 , 339 , 340 , 347 , 369 , 375 , 475 ,
1559 , 1604 , 1746 , 1801 , 1955 , 1983 , 2080 , 2099 , 2280 ,
23,02 -¤ allergology. immunology/ allergologie. 2312 , 2433 , 2437 , 2438 , 2615 , 2666 , 2811 , 3782 , 3855 ,
immunologie. 3920 , 3940 , 3967 ,
*¤ 57 , 89 , 220 , 363 , 776 , 1374 , 1447 , 1776 , 2024 , 2092

gera 2011

25,02 -¤ afferent pathways/ voies afférentes
*¤ 276 ,
26,01 -¤ HERBAL MEDICINE/ PHYTOTHERAPIE
*¤ 80 , 80 , 244 , 244 , 284 , 373 , 375 , 375 , 572 , 572 , 600 ,
600 , 604 , 604 , 625 , 625 , 657 , 657 , 709 , 709 ,
26,02 -¤ prescriptions/ prescriptions
*¤ 27 , 43 , 58 , 106 , 108 , 123 , 124 , 128 , 129 , 132 , 134 ,
151 , 159 , 167 , 189 , 200 , 202 , 223 , 226 , 228 , 233 , 235 ,
268 , 279 , 280 , 281 , 288 , 301 , 304 , 306 , 309 , 311 , 336 ,
340 , 341 , 360 , 361 , 362 , 363 , 364 , 365 , 369 , 370 , 372 ,
395 , 398 , 403 , 404 , 407 , 408 , 410 , 412 , 414 , 415 , 420 ,
428 , 430 , 433 , 443 , 469 , 475 , 478 , 484 , 487 , 490 , 491 ,
495 , 500 , 503 , 505 , 506 , 509 , 514 , 516 , 521 , 534 , 550 ,
551 , 556 , 565 , 566 , 574 , 575 , 577 , 578 , 592 , 609 , 610 ,
612 , 616 , 619 , 622 , 629 , 631 , 634 , 642 , 646 , 647 , 648 ,
653 , 662 , 664 , 665 , 666 , 667 , 684 , 688 , 689 , 690 , 691 ,
693 , 697 , 718 , 734 , 738 , 751 , 756 , 761 , 776 , 777 , 779 ,
781 , 797 , 808 , 809 , 810 , 815 , 816 , 818 , 820 , 821 , 844 ,
849 , 868 , 879 , 880 , 890 , 902 , 903 , 911 , 913 , 916 , 917 ,
918 , 919 , 920 , 924 , 930 , 932 , 935 , 936 , 937 , 941 , 976 ,
979 , 988 , 989 , 994 , 997 , 1001 , 1005 , 1006 , 1011 , 1012 ,
1017 , 1020 , 1022 , 1024 , 1025 , 1039 , 1048 , 1054 , 1241 ,
1684 , 1742 , 1743 , 1746 , 1747 , 1748 ,
da huang zhe chong wan¤ 870 ,
dang gui bu xue tang¤ 147 ,
er zhi wan¤ 1050 ,
gui pi tang¤ 3781 ,
gui zhi fu ling wan¤ 945 ,
huang qin tang¤ 791 ,
wei ling tang¤ 1735 ,
wu ji bai feng wan¤ 861 ,
wu ling san¤ 245 ,
xiao chai hu tang¤ 942 , 950 , 973 ,
xiao yao san¤ 792 ,
yi gan san¤ 998 ,
26,03 -¤ plants/ plantes
*¤ 9 , 42 , 45 , 67 , 68 , 94 , 95 , 102 , 105 , 107 , 122 , 126 ,
142 , 144 , 147 , 158 , 162 , 166 , 176 , 179 , 180 , 181 , 182 ,
187 , 201 , 214 , 215 , 220 , 237 , 242 , 243 , 269 , 292 , 344 ,
358 , 359 , 374 , 377 , 390 , 392 , 399 , 434 , 435 , 470 , 472 ,
476 , 479 , 480 , 481 , 482 , 493 , 494 , 496 , 605 , 638 , 643 ,
645 , 683 , 685 , 686 , 694 , 696 , 707 , 716 , 722 , 725 , 729 ,
730 , 731 , 732 , 733 , 747 , 766 , 780 , 824 , 869 , 878 , 941 ,
943 , 943 , 957 , 969 , 999 , 1011 , 1082 , 1082 , 1751 ,
angelica¤ 865 ,
artemisia annua l.¤ 864 ,
astragalus¤ 1021 ,
bupleurum¤ 942 , 1019 ,
cordyceps¤ 857 , 1003 ,
cordyceps sinensis (berk.) sacc.¤ 1677 ,
desmodium styracifolium (osb.) merr.¤ 968 ,
forsythia¤ 968 ,
ganoderma lucidum (leyss. ex fr.) karst.¤ 1121 , 1132 ,
glycyrrhiza¤ 841 , 949 ,
paeonia lactiflora¤ 845 ,
panax¤ 972 , 995 ,
panax ginseng c.a. meyer¤ 1753 ,
polygonatum¤ 968 ,
rheum¤ 886 , 910 , 987 ,
salvia miltiorrhiza bunge¤ 845 , 1000 , 1009 , 1045 ,
schisandra¤ 946 , 967 , 1228 ,
schisandra chinensis (turcz.) baill.¤ 971 ,
scutellaria¤ 964 ,
sophora¤ 850 ,
strychnos¤ 893 ,
uncaria hirsuta havil.¤ 961 ,
uncaria rhynchophylla (miq.) jackson¤ 961 ,
318
26,04 -¤ animal products/ produits animaux
*¤ 27 , 126 , 396 , 809 , 853 , 854 , 1282 , 1752 ,
26,05 -¤ mineral products/ produits minéraux
*¤ 345 ,
26,07 -¤ toxicology/ toxicité
*¤ 730 ,
26,08 -¤ classification and therapeutic actions/ classes
thérapeutiques
*¤ 54 , 285 , 785 ,
26,09 -¤ pharmacognosy/ pharmacognosie
*¤ 347 ,
27,01 -¤ methods/ méthodes
cas clinique¤ 1773 , 1782 , 2195 ,
comparaison de 2 techniques de la MTC¤ 947 ,
double aveugle¤ 392 , 702 , 729 ,
essai clinique non randomisé¤ 220 , 593 , 867 , 1586 , 1910 ,
3133 ,
essai comparatif éventuellement randomisé¤ 1449 , 1590 ,
1739 , 2828 , 2850 , 3258 ,
essai contrôlé randomisé¤ 598 , 1109 , 1219 , 1280 , 1283 ,
1703 , 1750 , 1754 , 2250 , 2515 , 2663 , 3594 , 3634 , 3777 ,
3860 , 3875 , 3943 , 3990 , 3991 , 4037 , 4050 , 4104 , 4137 ,
4138 ,
essai ouvert (acupuncture)¤ 31 , 41 , 42 , 44 , 52 , 53 , 112 ,
168 , 264 ,
étude controlée (acupuncture)¤ 8 , 352 , 1280 , 1776 ,
étude controlée (phytotérapie)¤ 387 , 392 , 702 , 729 , 751 ,
941 , 979 , 1081 , 1665 , 1676 , 1777 , 1797 , 1817 , 1895 ,
2009 , 2020 , 2029 , 2071 , 2217 , 2220 , 2235 , 2277 ,
étude experimentale humaine¤ 54 ,
experimentation animale¤ 38 , 62 , 105 , 126 , 127 , 147 , 167
, 276 , 277 , 278 , 339 , 340 , 341 , 347 , 356 , 362 , 369 , 375
, 377 , 382 , 395 , 469 , 475 , 481 , 482 , 487 , 490 , 550 , 592
, 685 , 686 , 735 , 765 , 766 , 785 , 791 , 800 , 822 , 905 ,
expérimentation animale (acupuncture)¤ 74 , 214 , 1748 ,
1801 , 2194 , 2615 , 3769 , 3773 , 3804 , 3811 , 3885 , 3981 ,
3998 , 4027 , 4031 ,
expérimentation animale (acupuncture)/ lapin¤ 1051 ,
expérimentation animale (acupuncture)/ rat¤ 354 , 1165 ,
expérimentation animale (acupuncture)/ souris¤ 949 , 1084 ,
expérimentation animale (phytothérapie)¤ 245 , 818 , 997 ,
999 , 1189 , 1228 , 1241 , 1282 , 1284 , 1558 , 1559 , 1604 ,
1684 , 1686 , 1718 , 1736 , 1746 , 1747 , 1752 , 1753 , 1785 ,
1810 , 1811 , 1813 , 1906 , 1907 , 1916 , 1918 , 1940 , 1941 ,
1945 , 1955 , 1956 , 1957 , 1958 , 1972 , 1982 , 1983 , 1984 ,
2012 , 2015 , 2016 , 2055 , 2080 , 2082 , 2089 , 2099 , 2102 ,
2162 , 2175 , 2205 , 2208 , 2211 , 2212 , 2214 , 2228 , 2231 ,
2280 , 2281 , 2302 , 2331 , 2355 , 2356 , 2433 , 2437 , 2438 ,
2503 , 2519 , 2578 , 2666 , 2670 , 2795 , 2811 , 2818 , 2884 ,
2919 , 2920 , 3614 , 3631 , 3731 , 3754 , 3763 , 3764 , 3770 ,
3772 , 3780 , 3782 , 3803 , 3806 , 3812 , 3815 , 3825 , 3827 ,
3842 , 3851 , 3853 , 3855 , 3868 , 3869 , 3872 , 3886 , 3889 ,
3895 , 3918 , 3919 , 3920 , 3921 , 3926 , 3927 , 3940 , 3967 ,
3970 , 3979 , 3985 , 3993 , 3995 ,
expérimentation animale (phytothérapie) / lapin¤ 846 , 1005 ,
expérimentation animale (phytothérapie) / rat¤ 841 , 868 ,
942 , 958 , 967 , 968 , 969 , 970 , 972 , 1000 , 1064 , 1070 ,
1082 , 1121 , 1122 , 1164 , 1242 , 1243 , 1248 , 1252 , 1285 ,
1286 , 1290 , 1299 , 1382 , 1389 ,
expérimentation animale (phytothérapie) / souris¤ 864 , 943 ,
1021 , 1059 , 1062 , 1200 , 1242 , 1275 , 1281 , 1287 , 1392 ,
1447 ,
placebo¤ 8 ,
revue générale¤ 272 , 740 , 891 , 909 , 956 , 1031 , 1071 ,
gera 2011
 319
1112 , 1188 , 1278 , 1303 , 1551 , 1552 , 1687 , 1736 , 1775 , interleukine¤ 750 , 1406 , 2355 , 2356 , 2437 , 2493 , 2532 ,
1800 , 1933 , 1960 , 2206 , 2248 , 2289 , 2310 , 2483 , 2555 , prostaglandine¤ 887 ,
2736 , 3977 , testostérone¤ 866 ,
revue générale (phytothérapie)¤ 2567 ,
27,04 -¤ pharmaceutical products/ produits
27,02 -¤ / techniques d'exploration pharmaceutiques
radiologie¤ 188 , corticoide¤ 7 , 147 , 167 , 369 , 375 , 377 , 382 , 474 ,
rhéologie¤ 107 , 343 , 858 , 1514 , 1744 , paracetamol¤ 1392 ,
temperature¤ 156 ,
27,06 -¤ geographical terms/ termes géographiques
27,03 -¤ biological l products/ produits biologiques mongolie¤ 1197 ,
gastrine¤ 866 , 1289 , taiwan¤ 493 , 827 , 957 ,
interféron¤ 1406 , 2057 , 2493 , 2532 , thailande¤ 941 ,

gera 2011
 320
academic periodical of changchun college of t c m¤ 2297 ,
Index des sources 2298 , 2299 ,
academic periodical of changchun college of tcm¤ 2972 ,
1 - congrès 3222 , 3809 ,
2eme congres mondial d'acupuncture et moxibustion, paris¤
academic periodical of changchun college of traditional
834 , 835 ,
chinese medicine¤ 2427 , 2609 , 2807 ,
2eme congres national de medecine chinoise, paris¤ 3988 ,
acpunctuur¤ 1717 ,
advances in acupuncture and acupuncture
acta chinese medicine and pharmacology¤ 842 , 1008 , 1009 ,
anaesthesia,beijing¤ 35 , 36 , 37 ,
1338 , 1339 , 1465 , 1878 , 1879 , 1880 , 2035 , 2084 , 2085 ,
colloque international d'acupuncture nguyen van nghi,
2229 , 2230 , 2303 , 2409 , 2410 , 2627 , 2743 , 2744 , 2817 ,
marseille¤ 2195 ,
2882 , 2959 , 3057 , 3172 , 3456 , 3457 , 3630 , 3653 , 3767 ,
conferences d'acupuncture,gera,toulon¤ 18 ,
3768 ,
in compilation of the abstracts of acupuncture and
acta medica sinica¤ 382 , 383 , 384 , 484 , 492 , 495 , 496 ,
moxibustion papers, beijing¤ 346 , 347 ,
497 , 596 , 601 , 699 , 879 , 880 , 881 , 882 , 1054 , 1211 ,
in selections from article abstracts on acupuncture and
acta pharmaceutica sinica¤ 105 , 122 , 1021 , 1200 , 1392 ,
moxiibustion, beijing¤ 350 , 351 , 352 , 353 ,
acta pharmacologica sinica¤ 1077 , 1123 ,
international symposium on diagnosis and treatment with
acta universitatis traditionis medicalis sinensis
auricular points, beijing¤ 607 , 608 ,
pharmacolgiaeque shanghai¤ 3502 , 3503 ,
proceedings of the fifth international congress of chinese
acta universitatis traditionis medicalis sinensis
medicine,berkeley¤ 712 ,
pharmacologiaeque¤ 3654 ,
second national symposium on acupuncture and
acta universitatis traditionis medicalis sinensis
moxibustion,beijing¤ 136 , 154 , 155 , 156 ,
pharmacologiaeque shanghai¤ 2664 , 2665 , 2666 , 2787 ,
third world conference on acupuncture¤ 1083 , 1084 , 1085 ,
2788 , 2853 , 2969 , 2971 , 3595 , 3635 , 3636 , 3810 ,
2- extraits de traités actes du iième congres d'acupuncture afera, nimes¤ 357 ,
chinese qigong, publishing house of shanghai college of tcm,
acupuncture¤ 337 , 602 ,
shanghai¤ 828 ,
acupuncture and electrotherapeutics research¤ 127 ,
essentials of contemporary chinese acupuncturists' clinical
acupuncture and electro-therapeutics research¤ 1770 ,
experiences, foreign lang¤ 606 ,
acupuncture research¤ 276 , 277 , 278 , 354 , 1612 , 3769 ,
in a research into acupuncture and its clinical
4086 ,
practice,commercial press,hong kong¤ 15 ,
acupuncture research quarterly¤ 46 , 47 , 130 ,
in acupuncture treatment of common diseases based upon
acupunctuur¤ 1682 , 1685 ,
differentiation of syndrome¤ 588 ,
akupunktur theorie und praxis¤ 1117 ,
in barefoot doctor's manual¤ 10 , 11 , 12 , 13 ,
aliment pharmacol ther¤ 4012 ,
in chinese acupuncture and moxibustion, foreign languages
am j chin med¤ 4048 , 4118 , 4122 , 4123 , 4126 , 4127 ,
press, *¤ 381 ,
4135 ,
in chinese acupuncture and moxibustion, publishing house of
american journal of acupuncture¤ 837 , 962 , 1716 ,
shanghai college of tcm,¤ 831 ,
american journal of chinese medicine¤ 19 , 38 , 40 , 339 , 493
in chinese medicated diet, publishing house of shanghai
, 604 , 827 , 949 , 950 , 957 , 958 , 961 , 964 , 1118 , 1119 ,
college of tcm, shanghai¤ 829 , 830 ,
1120 , 1121 , 1132 , 1133 , 1231 , 1232 , 1252 , 1287 , 1385 ,
in clinical experiences, new world press, beijing¤ 714 ,
1386 , 1393 , 1394 , 1401 , 1533 , 1542 , 1543 , 1558 , 1561 ,
in doctor's manual of chinese medical diet¤ 48 , 49 , 50 ,
1562 , 1563 , 1615 , 1616 , 1617 , 1618 , 1619 , 1620 , 1621 ,
in methode therapeutique par qi gong chinois,edition
1677 , 1689 , 1690 , 1691 , 1751 , 1752 , 1753 , 1762 , 1763 ,
scientifique du shandong,jinan¤ 355 ,
1764 , 2072 , 2073 , 2074 , 2902 , 3031 , 3032 , 3146 , 3147 ,
in patent medicine,harmonious sunshine cultural center,san
3391 , 3392 , 3770 , 3771 , 3772 , 3773 , 3774 , 3775 , 3776 ,
francisco¤ 336 ,
3806 , 3861 , 3867 , 3874 , 3992 , 3993 , 3994 , 3995 , 4009 ,
in recueil d'experiences clinques en acupuncture-moxa¤ 348 ,
4031 ,
349 ,
annales de la societe d'acupuncture d'aquitaine¤ 960 ,
in roustan,traite d'acupuncture,masson,paris¤ 157 ,
anticancer drugs¤ 4089 ,
in seca et al, acupuncture en medecine clinique, decarie,
arch toxicol¤ 3979 ,
montreal¤ 594 ,
beijing journal of tcm¤ 1313 , 1314 , 1315 , 1316 , 1450 ,
in the manual of china's current acupuncture
1451 , 1452 , 1462 , 1463 , 1464 , 1850 , 1930 , 2083 , 2880 ,
therapy,medecine and health publishing¤ 5 ,
2881 , 2940 , 3205 , 3294 , 3535 , 3580 , 3632 , 3655 , 3656 ,
in treatment of 100 common diseases by new acupuncture¤
beijing journal of traditional chinese medicine¤ 282 , 283 ,
14 ,
385 , 386 , 387 , 388 , 389 , 459 , 642 , 643 , 644 , 645 , 693 ,
recent advances in chinese herbal drugs,science
694 , 695 , 696 , 728 , 729 , 801 , 802 , 803 , 804 , 933 , 934 ,
press,beijing¤ 946 ,
988 , 1093 , 1094 , 1095 , 1096 , 2365 , 2366 , 2430 , 2431 ,
selections from shanghai journal of acupuncture and
2507 , 2545 , 2614 , 2758 , 2774 , 2775 , 2776 ,
moxibustion 1982-84¤ 175 ,
breath exercice (an exercice for health and longevity)¤ 441 ,
the treatment of knotty diseases, shandong science and
bulletin de la societe d'acupuncture¤ 1 ,
technology press¤ 715 ,
bulletin of chinese materia medica¤ 214 , 215 , 469 , 470 ,
536 ,
3 - mémoires bulletin of the oriental healing arts institute¤ 22 , 23 , 24 , 25 ,
memoire d'acupuncture,afa¤ 6 ,
26 , 27 , 28 , 30 , 80 , 128 , 129 , 132 , 173 , 205 ,
memoire d'acupuncture,bordeaux 2¤ 272 ,
cahiers de biotherapie¤ 2 , 3 , 4 ,
cancer¤ 4028 ,
4 - revues d'acupuncture et MTC cell biol int¤ 4021 ,
abstract and review of clinical tcm¤ 1086 ,
chem pharm bull (tokyo)¤ 4054 ,
abstract and review of clinical traditional chinese medicine¤
chi j integrated traditional and western medicine in intensive
952 , 965 ,
and critical care¤ 3068 , 3183 , 3327 ,
abstracts of chinese medicine¤ 587 ,
chin j integr med¤ 4010 , 4011 , 4079 , 4136 ,

gera 2011

chin med¤ 4033 , 4062 ,
china journal of basic medicine in tcm¤ 2367 ,
china journal of chinese materia medica¤ 683 , 685 , 686 ,
730 , 731 , 795 , 878 , 1000 , 1050 , 1059 , 1064 , 1080 , 1242
, 1243 , 1244 , 1292 , 1400 , 1405 , 4134 ,
china journal of tcm and pharmacy¤ 1141 , 1538 , 1539 ,
1545 , 1582 , 1593 , 2628 , 2924 , 2970 , 3013 , 3014 , 3058 ,
3123 , 3128 , 3129 , 3173 , 3271 , 3286 , 3329 , 3330 , 3343 ,
3344 , 3470 , 3553 , 3597 , 3613 , 3642 , 3644 , 3657 , 3658 ,
3659 ,
china journal of traditional chinese medicine and pharmacy¤
977 , 1073 , 1111 , 1275 , 1276 , 1277 , 1278 , 1279 , 1281 ,
1376 , 1377 , 1378 , 1379 , 1622 , 1623 , 1643 , 1665 , 1699 ,
1700 , 1701 , 1702 , 1714 , 1721 , 1722 , 1807 , 2440 , 2441 ,
2509 , 2547 , 2712 , 2713 , 2818 ,
chinese acupuncture and moxibustion¤ 44 , 89 , 90 , 220 ,
483 , 485 , 593 , 598 , 740 , 867 , 1007 , 1109 , 1165 , 1280 ,
1375 , 1586 , 1590 , 1591 , 1687 , 1703 , 1704 , 1738 , 1739 ,
1750 , 1754 , 1778 , 1902 , 1903 , 1915 , 1951 , 2021 , 2042 ,
2663 , 2822 , 2828 , 2829 , 2850 , 3594 , 3634 , 3777 , 3811 ,
3860 , 3875 , 3990 , 3991 , 4030 , 4076 , 4137 , 4138 , 4139 ,
4140 , 4143 ,
chinese archives of tcm¤ 2976 , 2977 , 3055 , 3084 , 3085 ,
3170 ,
chinese archives on tcm¤ 3508 ,
chinese j basic med tcm¤ 2574 , 3098 ,
chinese journal of acupuncture and moxibustion¤ 586 , 947 ,
chinese journal of basic medicine in tcm¤ 1927 , 1928 , 1934
, 1935 , 1988 , 1989 , 1990 , 2214 , 2228 , 2354 , 2889 , 2890
, 2891 , 2928 , 2929 , 2930 , 2931 , 2965 , 2966 , 2992 , 3102
, 3103 , 3104 , 3238 , 3239 , 3240 , 3345 , 3467 , 3487 , 3489
, 3592 , 3593 , 3660 , 3812 , 3876 ,
chinese journal of basic medicine in traditional chinese
medicine¤ 2311 , 2312 , 2313 , 2345 , 2498 , 2537 , 2719 ,
2820 , 2821 ,
chinese journal of ethnomedicine and ethnopharmacy¤ 1904 ,
1905 , 1947 , 1948 , 1949 , 2175 , 2209 , 2210 , 2352 , 2353 ,
2638 , 2709 , 2710 , 2711 , 2724 , 2738 , 2739 , 2846 , 2847 ,
2927 , 2984 , 2985 , 3069 , 3092 , 3093 , 3184 , 3337 , 3422 ,
3444 , 3661 ,
chinese journal of ethomedicine and ethnopharmacy¤ 3662 ,
chinese journal of infectious diseases¤ 231 ,
chinese journal of information on tcm¤ 1870 , 1961 , 1962 ,
2247 , 2265 , 2936 , 2978 , 3078 , 3079 , 3086 , 3193 , 3194 ,
3267 , 3268 , 3320 , 3321 , 3322 , 3500 , 3501 , 3540 , 3541 ,
3609 , 3663 , 3664 , 3877 , 3878 , 3879 ,
chinese journal of information on traditional chinese
medicine¤ 2389 , 2432 , 2492 , 2510 , 2511 , 2531 , 2548 ,
2549 , 2583 , 2635 ,
chinese journal of information on traditional chinese
medicine(ii)¤ 2395 , 2396 , 2397 ,
chinese journal of integrated and western medicine¤ 1747 ,
2216 ,
chinese journal of integrated and western medicine on
digestion¤ 4063 , 4064 , 4065 , 4066 , 4067 , 4068 , 4069 ,
4070 , 4071 , 4072 ,
chinese journal of integrated and western medicine on gastro-
spleen¤ 1921 , 1922 ,
chinese journal of integrated traditional and western
medicine¤ 3778 , 3779 ,
chinese journal of integrated traditional and western
medicine¤ 94 , 95 , 97 , 124 , 137 , 164 , 166 , 167 , 221 , 222
, 223 , 224 , 225 , 230 , 233 , 235 , 266 , 267 , 268 , 269 , 270
, 271 , 273 , 279 , 280 , 281 , 338 , 340 , 341 , 342 , 343 , 476
, 477 , 478 , 479 , 480 , 481 , 482 , 487 , 488 , 489 , 490 , 491
, 521 , 591 , 592 , 597 , 600 , 605 , 747 , 748 , 749 , 750 , 751
, 752 , 753 , 754 , 755 , 794 , 808 , 845 , 846 , 847 , 864 , 865
, 866 , 978 , 979 , 1002 , 1003 , 1004 , 1005 , 1006 , 1030 ,
1031 , 1032 , 1070 , 1071 , 1078 , 1079 , 1126 , 1127 , 1128 ,
1130 , 1139 , 1148 , 1149 , 1150 , 1151 , 1152 , 1153 , 1154 ,
321
1190 , 1240 , 1241 , 1390 , 1391 , 1404 , 1574 , 1575 , 1576 ,
1577 , 1578 , 1579 , 1580 , 1596 , 1629 , 1630 , 1631 , 1632 ,
1633 , 1634 , 1635 , 1636 , 1637 , 1638 , 1639 , 1640 , 1676 ,
1688 , 1725 , 1726 , 1727 , 1728 , 1729 , 1730 , 1731 , 1777 ,
1783 , 1784 , 1817 , 1923 , 1924 , 1925 , 1926 , 1955 , 1956 ,
1957 , 1958 , 2071 , 2149 , 2277 , 2278 , 2323 , 2324 , 2325 ,
2326 , 2327 , 2368 , 2369 , 2405 , 2406 , 2562 , 2573 , 2585 ,
2586 , 2620 , 2621 , 2622 , 2648 , 2649 , 2650 , 2651 , 2676 ,
2677 , 2678 , 2679 , 2680 , 2812 , 2813 , 2814 , 2815 , 2832 ,
2833 , 2834 , 2835 , 2836 , 2837 , 2892 , 2893 , 2894 , 2895 ,
2896 , 2897 , 2898 , 2899 , 2900 , 2956 , 3020 , 3021 , 3022 ,
3023 , 3024 , 3025 , 3066 , 3135 , 3136 , 3137 , 3138 , 3139 ,
3140 , 3181 , 3353 , 3361 , 3418 , 3419 , 3544 , 3545 , 3546 ,
3547 , 3548 , 3549 , 3550 , 3608 , 3665 , 3666 , 3667 , 3668 ,
3741 , 3880 , 3881 , 3882 , 3883 , 4029 , 4036 , 4037 , 4038 ,
4039 , 4040 , 4041 , 4042 , 4043 , 4073 , 4087 , 4095 , 4096 ,
4097 , 4098 , 4099 , 4100 , 4109 , 4110 , 4111 , 4114 , 4115 ,
4116 , 4117 , 4128 , 4129 , 4130 , 4131 , 4132 , 4133 ,
chinese journal of integrated traditional and western medicine
(english edition)¤ 1522 , 1523 , 1524 , 1525 , 1526 , 1527 ,
1605 , 1673 , 1674 , 1675 , 2568 , 2569 , 2570 , 2571 , 2572 ,
2707 ,
chinese journal of integrated traditional and western medicine
in intensive and crit¤ 3434 ,
chinese journal of integrated traditional and western medicine
in intensive and criti¤ 2581 , 2765 , 2843 , 2844 , 2935 , 3423
, 3813 , 3884 ,
chinese journal of integrated traditional and western medicine
on digestion¤ 2221 , 2222 , 2223 , 2224 , 2225 , 2280 , 2281 ,
2282 , 2283 , 2302 , 2330 , 2331 , 2332 , 2333 , 2357 , 2358 ,
2477 , 2478 , 2479 , 2480 , 2481 , 2482 , 2516 , 2517 , 2518 ,
2519 , 2520 , 2521 , 2597 , 2598 , 2599 , 2600 , 2601 , 2670 ,
2671 , 2672 , 2673 , 2728 , 2729 , 2780 , 2781 , 2782 , 2783 ,
2784 , 2857 , 2858 , 2859 , 2860 , 2918 , 2919 , 2920 , 3000 ,
3001 , 3002 , 3003 , 3114 , 3115 , 3116 , 3117 , 3234 , 3235 ,
3278 , 3279 , 3280 , 3281 , 3282 , 3283 , 3331 , 3332 , 3333 ,
3334 , 3336 , 3462 , 3463 , 3464 , 3465 , 3492 , 3493 , 3494 ,
3495 , 3496 , 3557 , 3558 , 3559 , 3581 , 3582 , 3669 , 3670 ,
3671 , 3672 , 3673 , 3674 , 3675 , 3676 , 3814 , 3815 , 3885 ,
3886 , 3887 , 3888 , 3889 ,
chinese journal of integrated traditional and western medicine
on gastro-spleen¤ 2069 , 2070 , 2097 , 2098 , 2099 , 2100 ,
2101 , 2102 , 2103 ,
chinese journal of integrated traditional and western medicine
on liver diseases¤ 1966 , 1967 , 1968 , 1969 , 1970 , 1971 ,
1972 , 1973 , 1974 , 1975 , 1976 , 1977 , 1978 , 1979 , 1980 ,
1981 , 1982 , 1983 , 1984 , 1985 , 1986 , 1987 , 2043 , 2044 ,
2045 , 2046 , 2047 , 2057 , 2058 , 2059 , 2060 , 2061 , 2062 ,
2063 , 2064 , 2065 , 2066 , 2067 , 2068 , 2133 , 2134 , 2135 ,
2136 , 2137 , 2138 , 2139 , 2140 , 2141 , 2142 , 2143 , 2144 ,
2145 , 2146 , 2147 , 2148 , 2236 , 2237 , 2238 , 2239 , 2240 ,
2241 , 2242 , 2243 , 2376 , 2377 , 2378 , 2379 , 2380 , 2381 ,
2382 , 2383 , 2384 , 2385 , 2386 , 2412 , 2413 , 2414 , 2415 ,
2416 , 2417 , 2418 , 2419 , 2420 , 2421 , 2444 , 2445 , 2446 ,
2447 , 2448 , 2449 , 2450 , 2451 , 2452 , 2453 , 2454 , 2455 ,
2456 , 2461 , 2462 , 2463 , 2464 , 2465 , 2466 , 2467 , 2468 ,
2469 , 2470 , 2471 , 2588 , 2589 , 2590 , 2591 , 2592 , 2593 ,
2594 , 2595 , 2596 , 2694 , 2695 , 2696 , 2697 , 2698 , 2699 ,
2700 , 2701 , 2702 , 2703 , 2704 , 2745 , 2746 , 2747 , 2748 ,
2749 , 2750 , 2751 , 2752 , 2753 , 2754 , 2755 , 2756 , 2789 ,
2790 , 2791 , 2792 , 2793 , 2794 , 2795 , 2796 , 2868 , 2869 ,
2870 , 2871 , 2872 , 2873 , 2874 , 2875 , 2876 , 2877 , 2943 ,
2944 , 2945 , 2946 , 2947 , 2948 , 2949 , 2950 , 2951 , 3033 ,
3034 , 3035 , 3036 , 3037 , 3038 , 3039 , 3040 , 3041 , 3042 ,
3043 , 3148 , 3149 , 3150 , 3151 , 3152 , 3153 , 3154 , 3155 ,
3156 , 3157 , 3158 , 3208 , 3209 , 3210 , 3211 , 3212 , 3213 ,
3214 , 3215 , 3216 , 3256 , 3257 , 3258 , 3259 , 3291 , 3298 ,
3299 , 3300 , 3301 , 3302 , 3303 , 3304 , 3305 , 3306 , 3307 ,
3362 , 3363 , 3364 , 3365 , 3366 , 3367 , 3368 , 3369 , 3370 ,
3371 , 3372 , 3373 , 3445 , 3446 , 3447 , 3448 , 3449 , 3450 ,
gera 2011

3451 , 3452 , 3453 , 3454 , 3455 , 3472 , 3473 , 3474 , 3475 ,
3476 , 3477 , 3478 , 3479 , 3480 , 3481 , 3482 , 3483 , 3484 ,
3619 , 3620 , 3621 , 3622 , 3623 , 3624 , 3625 , 3626 , 3627 ,
3628 , 3629 , 3677 , 3678 , 3679 , 3680 , 3681 , 3682 , 3683 ,
3684 , 3685 , 3686 , 3816 , 3817 , 3818 , 3819 , 3820 , 3821 ,
3822 , 3823 , 3824 , 3825 , 3826 , 3890 , 3891 , 3892 , 3893 ,
3894 , 3895 , 3896 ,
chinese journal of integrated traditional ional and western
medicine¤ 2799 ,
chinese journal of integrated traditionanl and western
medicine¤ 3897 , 3898 ,
chinese journal of integrated tradtional and western medicine
on liver diseases¤ 3687 , 3688 , 3689 , 3690 , 3691 , 3692 ,
3693 , 3694 , 3695 ,
chinese journal of integrative medicine¤ 3863 , 3865 ,
chinese journal of integrative medecine¤ 3999 ,
chinese journal of integrative medicine¤ 3827 , 3828 , 3997 ,
4006 , 4056 , 4103 , 4119 , 4120 ,
chinese journal of marine drugs¤ 2244 , 2721 ,
chinese journal of medical history¤ 1227 ,
chinese journal of modern developments in traditional
medicine¤ 45 , 75 ,
chinese journal of surgery of integrated traditional and
western medicine¤ 2268 ,
chinese journal of surgery of integrated traditional chinese
and western medicine¤ 2334 , 2335 , 2355 , 2356 , 2428 ,
2503 , 2668 , 2779 , 3277 , 3586 ,
chinese journal of traditional medical science and
technology¤ 1906 , 1907 , 1939 , 1940 , 1941 , 2011 , 2012 ,
2013 , 2014 , 2015 , 2016 , 2017 , 2018 , 2211 , 2212 , 2249 ,
2392 , 2486 , 2525 , 2636 , 2637 , 2688 , 2689 , 2690 , 2691 ,
2692 , 2763 , 2848 , 3060 , 3061 , 3062 , 3063 , 3064 , 3175 ,
3176 , 3177 , 3178 , 3179 , 3272 , 3273 , 3328 , 3415 , 3416 ,
3610 , 3780 , 3899 ,
chinese journal of traditional medical science and technology
(¤ 2349 , 2350 , 2351 ,
chinese journal of traditional medicine traumatology and
orthopedics¤ 3485 ,
chinese journal of traditional science and traumatology¤ 3564
, 2435 , 2474 ,
chinese medical journal¤ 17 , 112 , 264 , 275 , 713 , 956 ,
1283 , 1779 , 1780 ,
chinese medical sciences journal¤ 1290 ,
chinese pharmaceutical bulletin¤ 142 ,
chinese pharmaceutical journal¤ 1803 ,
chinese traditional and herbal drugs¤ 123 , 165 , 335 , 468 ,
471 , 472 , 537 , 734 , 735 , 792 , 999 , 1062 , 1189 , 1340 ,
1852 , 1865 , 1866 , 2193 , 2218 , 2423 , 2768 ,
chinese traditional patent medicine¤ 720 , 732 , 733 , 886 ,
1110 , 1201 , 1202 , 1222 , 1308 , 1455 , 1456 , 1583 , 1584 ,
1585 , 1746 , 1820 , 1876 , 1900 , 2039 , 2090 , 2091 , 2113 ,
2152 , 2213 , 2284 , 2564 , 2565 , 2566 , 2645 , 2646 , 2647 ,
3044 , 3159 , 3354 , 3696 , 3781 , 3782 ,
chinesische medizin¤ 1773 , 1774 ,
clin gastroenterol hepatol¤ 4035 ,
comparative medicine east and west¤ 9 ,
complementary therapies in medicine¤ 3862 ,
complementary therapies in medicine¤ 4093 ,
deutsche zeitschrift fur akupunktur¤ 2576 , 2577 ,
dig liver dis¤ 4046 ,
el pulso de la vida¤ 1223 , 1541 , 3511 , 3512 ,
el pulso de la vida- journal of tcm¤ 3513 , 3846 , 3847 ,
enerqi¤ 1910 ,
european journal of integrated eastern and western medicine¤
3986 , 3987 ,
evid based complement alternat med¤ 4121 ,
exp biol med (maywood)¤ 4034 , 4074 ,
focus on alternative and complementary therapies¤ 1652 ,
1802 ,
folia sinotherapeutica¤ 603 , 711 ,
322
forum on tcm¤ 2036 , 2190 , 2191 , 2199 , 2911 , 2912 , 3059
, 3174 , 3350 , 3417 , 3539 ,
forum on traditional chinese medicine¤ 2422 , 2634 , 2643 ,
fujian journal of tcm¤ 1226 , 1317 , 1318 , 1319 , 1744 , 1822
, 1823 , 1824 , 1999 , 2000 , 2078 , 2096 , 2293 , 3228 , 3311
, 3507 , 3599 , 3600 , 3697 , 3829 , 3900 , 3901 ,
fujian journal of traditional chinese medicine¤ 91 , 106 , 118 ,
174 , 284 , 285 , 286 , 287 , 288 , 327 , 328 , 334 , 390 , 391 ,
392 , 393 , 394 , 432 , 697 , 701 , 727 , 869 , 897 , 900 , 1061
, 1198 , 1199 , 1214 , 1410 , 2370 , 2371 , 2472 , 2584 , 2658
, 2798 , 2811 ,
gansu journal of tcm¤ 2904 , 3526 , 3643 ,
gansu journal of traditional chinese medicine¤ 2764 ,
guang ¤ 2777 ,
guang ming journal of tcm¤ 3902 ,
guang ming journal tcm¤ 1898 ,
guang ming journal traditional chinese medicine¤ 2436 ,
2808 , 2957 ,
guang xi journal of traditional chinese medicine¤ 1081 ,
guangming journal tcm¤ 1993 , 1994 , 2232 , 2233 ,
guangxi journal of tcm¤ 1933 , 2186 , 2187 , 2270 , 2968 ,
3112 , 3237 , 3308 , 3491 , 3698 , 3699 , 3700 , 3701 ,
guangxi journal of traditional chinese medicine¤ 2567 , 2769
,
guanxi journal of tcm¤ 3639 , 3830 , 3831 , 3903 ,
hebei journa of tcm¤ 2641 ,
hebei journal of tcm¤ 1872 , 1932 , 2006 , 2007 , 2008 , 2009
, 2010 , 2054 , 2055 , 2104 , 2219 , 2220 , 2235 , 2266 , 2267
, 2300 , 2937 , 2938 , 2991 , 3065 , 3071 , 3101 , 3180 , 3186
, 3199 , 3468 , 3640 , 3702 , 3783 , 3784 ,
hebei journal of traditional chinese medicine¤ 2339 , 2411 ,
2558 , 2559 , 2560 , 2561 , 2623 , 2766 ,
heilongjiang journal of tcm¤ 2263 ,
helongjiang journal of tcm¤ 3080 , 3195 , 3442 ,
henan journal of tcm and phamacy¤ 2903 ,
henan journal of tcm and pharmacy¤ 1946 ,
henan journal of traditional chinese medicine and pharmacy¤
2556 ,
henan journal of traditional chinese medicine and phrmacy¤
henan tcm¤ 2983 , 3053 , 3091 , 3168 , 3296 , 3297 , 3347 ,
3348 , 3427 , 3498 , 3499 , 3637 , 3638 , 3650 , 3703 , 3704 ,
3705 , 3785 , 3786 , 3832 , 3833 , 3834 , 3904 ,
henan traditional chinese medicine¤ 395 , 698 , 899 , 932 ,
1142 , 1167 , 1320 , 1321 , 1496 , 1497 , 1498 , 1812 , 1918 ,
2112 , 2189 , 2342 , 2363 , 2364 , 2488 , 2489 , 2527 , 2528 ,
2706 , 2731 , 2732 , 2733 ,
hepatobiliary pancreat dis int¤ 4092 ,
hepatogastroenterology¤ 3978 ,
hepatology¤ 4077 ,
hubei journal of tcm¤ 3393 , 3394 ,
hubei journal of tcm¤ 1322 , 1323 , 1324 , 1325 , 1466 , 1804
, 1805 , 1851 , 1868 , 1877 , 1883 , 1884 , 1885 , 2031 , 2032
, 2033 , 2034 , 2110 , 2111 , 2226 , 2252 , 2654 , 2886 , 2887
, 2913 , 2925 , 2979 , 3026 , 3027 , 3028 , 3049 , 3050 , 3051
, 3087 , 3141 , 3142 , 3143 , 3164 , 3165 , 3166 , 3349 , 3359
, 3505 , 3506 , 3532 , 3533 , 3560 , 3561 , 3612 , 3787 , 3788
, 3789 , 3835 , 3905 , 3906 , 3907 ,
hubei journal of traditional chinese medicine¤ 252 , 324 , 446
, 473 , 499 , 500 , 501 , 502 , 503 , 504 , 610 , 611 , 612 , 613
, 719 , 726 , 875 , 907 , 915 , 1044 , 1179 , 1210 , 2360 , 2400
, 2401 , 2402 , 2605 , 2610 , 2611 , 2656 ,
hubei- journal of traditional chinese medicine¤ 2757 ,
hubei journal of traditional medicine¤ 1106 ,
hunan guiding journal of tcm¤ 3585 ,
hunan guiding journal of tcm¤ 3420 , 3706 ,
hunan guiding journal of tcmp¤ 2824 , 2954 , 2955 , 2963 ,
3011 , 3126 ,
hunan guiding journal of tgmp¤ 2825 , 2826 ,
hunan journal of tcm¤ 1432 , 1889 , 2030 , 2056 , 2257 ,
gera 2011

2258 , 2923 , 2988 , 3074 , 3075 , 3096 , 3189 , 3190 , 3202 ,
3203 , 3204 , 3318 , 3319 , 3421 , 3552 , 3615 , 3616 , 3707 ,
3836 , 3837 , 3908 , 3909 ,
hunan journal of traditional chinese medicine¤ 1733 , 2295 ,
2425 , 2426 , 2495 , 2534 , 2606 , 2736 , 2737 ,
in clinic of tcm (1), publishing house of shanghai college of
tcm, shanghai¤ 832 , 833 ,
inflammation¤ 4078 ,
information on tcm¤ 1942 , 1943 , 1944 , 2184 , 2185 , 2554 ,
2555 , 3568 , 3910 ,
information on traditional chinese medicine¤ 2424 , 2722 ,
2723 , 2823 ,
inner mongol journal of tcm¤ 2182 , 3017 , 3132 , 3587 ,
3708 , 3838 ,
inner mongol journal of traditional chinese medicine¤ 2322 ,
2512 , 2513 , 2514 , 2550 , 2551 , 2552 , 2804 , 2805 ,
inner mongolia journal of tcm¤ 2038 ,
int immunopharmacol¤ 4051 ,
int j biol macromol¤ 4081 ,
international conference on tcm and pharmacology,shanghai¤
358 , 359 , 360 , 361 , 362 , 363 , 364 , 365 , 366 , 367 , 368 ,
369 , 370 , 371 , 372 , 373 , 374 , 375 , 377 , 378 , 379 , 380 ,
international journal of chinese medicine¤ 177 , 178 , 179 ,
180 , 181 , 182 , 183 , 193 ,
international journal of clinical acupuncture¤ 953 , 954 ,
1219 , 1406 , 2515 ,
international journal of clinical medicine¤ 4057 ,
international journal of oriental medicine¤ 599 , 824 , 945 ,
2708 , 3411 ,
international journal of veterinary acupuncture¤ 1087 ,
ital j gastroenterol hepatol¤ 1732 ,
j drug target¤ 4085 , 4102 ,
j ethnopharmacol¤ 4032 , 4080 , 4082 , 4091 , 4108 ,
j pharm pharmacol¤ 4044 , 4101 ,
japan society of acupuncture journal¤ 74 ,
jiangsu journal of tcm¤ 505 , 506 , 507 , 508 , 509 , 510 , 511
, 512 , 1326 , 1327 , 1328 , 1329 , 1486 , 1487 , 1488 , 1489 ,
1490 , 1491 , 1492 , 1493 , 1494 , 1495 , 1806 , 1839 , 1840 ,
1841 , 1842 , 1843 , 1844 , 1845 , 1846 , 1847 , 1848 , 1890 ,
1891 , 1899 , 1936 , 1937 , 1938 , 1952 , 1953 , 1954 , 2116 ,
2117 , 2285 , 2309 , 2310 , 2906 , 2987 , 3056 , 3095 , 3171 ,
3218 , 3219 , 3241 , 3242 , 3243 , 3310 , 3409 , 3425 , 3428 ,
3429 , 3527 , 3528 , 3591 , 3647 , 3709 , 3710 , 3711 , 3712 ,
3790 , 3911 , 3912 ,
jiangsu journal of tcm¤ 3317 ,
jiangsu journal of traditional chinese medicine¤ 256 , 257 ,
663 , 721 , 722 , 723 , 724 , 725 , 798 , 799 , 855 , 856 , 894 ,
909 , 1001 , 1055 , 1145 , 1155 , 1178 , 1185 , 1212 , 2387 ,
2388 , 2390 , 2490 , 2491 , 2529 , 2530 , 2644 , 2725 , 2726 ,
2806 ,
jiangxi journal of tcm¤ 513 , 514 , 515 , 1330 , 1331 , 1332 ,
1433 , 1434 , 1435 , 1740 , 1827 , 1828 , 1829 , 2001 , 2002 ,
2003 , 2050 , 2051 , 2188 , 2885 , 3067 , 3182 , 3293 , 3389 ,
3390 , 3461 , 3497 , 3617 , 3618 , 3713 , 3714 , 3715 , 3716 ,
3791 , 3792 , 3913 , 3914 ,
jiangxi journal of traditional chinese medicine¤ 620 , 687 ,
688 , 745 , 877 , 893 , 986 , 1029 , 1072 , 1089 , 1183 , 1184 ,
1215 , 2373 , 2458 , 2459 , 2460 , 2505 , 2506 , 2543 , 2544 ,
2607 , 2608 , 2759 , 2778 ,
jiangxi journal of traditional chinese medicine and
pharmacology¤ 451 ,
jiansu journal of traditional chinese medicine¤ 615 , 616 ,
jilin journal of tcm¤ 3529 , 3717 , 3718 , 3915 , 3916 , 3917 ,
jingxi journal of tcm¤ 3719 ,
journal de medecine traditionnelle chinoise¤ 3864 , 3996 ,
journal de mtc and chinese materia medica of jilin¤ 2291 ,
journal journal of anhui traditional chinese medical college¤
2675 ,
journal of alternative and complementary medicine¤ 1775 ,
3804 , 3805 , 4020 , 4112 , 4113 ,
323
journal of anhui of traditional chinese medical college¤ 3720
,
journal of anhui tcm college¤ 3516 , 3517 , 3518 ,
journal of anhui traditional chinese medical college¤ 1888 ,
2022 , 2114 , 2205 , 2653 , 2730 , 2845 , 2932 , 2933 , 3260 ,
3261 , 3262 , 3263 , 3435 , 3436 , 3441 , 3515 , 3571 , 3572 ,
3573 , 3574 , 3575 , 3721 , 3722 , 3918 , 3919 , 3920 ,
journal of beijing college of traditional chinese medicine¤
807 , 863 , 868 , 996 , 997 , 1033 , 1144 , 1197 ,
journal of beijing tcm college¤ 440 ,
journal of beijing university of tcm¤ 1309 , 1447 , 1448 ,
1552 , 1554 , 1555 , 1556 , 1592 , 1808 , 1809 , 1810 , 1811 ,
1916 , 1917 , 1945 , 2094 , 2095 , 2208 , 2921 , 2922 , 3118 ,
3119 , 3120 , 3440 , 3589 , 3723 , 3724 , 3839 , 3840 ,
journal of beijing university of traditional chinese medicine¤
1644 , 1645 , 1646 , 1647 , 1648 , 1686 , 1706 , 2359 , 2374 ,
2375 , 2630 , 2681 , 3207 ,
journal of beijing university oftcm¤ 3004 , 3005 , 3006 ,
journal of ch engdu university of tcm¤ 3377 , 3378 , 3379 ,
3380 ,
journal of chang chun college of tcm¤ 1998 ,
journal of chengdu university of tcm¤ 1913 , 1931 , 2088 ,
2089 , 3725 ,
journal of chengdu university of traditional chinese
medicine¤ 2399 , 2438 , 2770 , 2771 ,
journal of chinese medicine¤ 158 , 1218 , 1901 ,
journal of clinical acupuncture and moxibustion¤ 2173 , 2174
, 2705 , 3346 , 3460 , 3980 ,
journal of emergency in tcm¤ 2856 , 3309 , 3376 , 3407 ,
3530 , 3531 , 3793 , 3794 , 3921 , 3922 , 3923 ,
journal of emergency in traditional chinese medicine¤ 2742 ,
journal of external therapy of tcm¤ 1997 , 2274 , 3019 , 3134
, 3250 , 3579 , 3726 , 3841 ,
journal of external therapy of traditional chinese medicine¤
2508 , 2546 ,
journal of fujian college of tcm¤ 1873 , 1991 , 3206 , 3355 ,
3356 , 3795 , 3924 , 3925 , 3926 ,
journal of fujian college of traditional chinese medicine¤
2497 , 2536 ,
journal of gansu college of tcm¤ 2081 , 2180 ,
journal of gansu college of traditional chinese medicine¤
2842 ,
journal of guiyang college of tcm¤ 2926 , 3266 , 3796 , 3927
,
journal of guiyang college of traditional chinese medicine¤
2314 , 2315 , 2316 , 2317 , 2687 , 2849 ,
journal of henan college of tcm¤ 2107 , 2108 ,
journal of henan university of chinese medicine¤ 3233 , 3395
, 3396 , 3397 , 3398 , 3399 , 3400 , 3401 , 3402 , 3403 , 3404
, 3405 , 3430 , 3431 , 3432 , 3443 , 3514 , 3565 , 3566 , 3646
, 3727 , 3728 , 3729 , 3842 , 3843 , 3844 , 3928 , 3929 , 3930
,
journal of hunan college of tcm¤ 1950 , 2082 , 2960 , 2961 ,
2962 ,
journal of laoning college of tcm¤ 2958 , 3249 , 3602 , 3603 ,
3730 , 3797 ,
journal of laoning college of traditional chinese medicine¤
2248 ,
journal of liaoning college of tcm¤ 1912 , 2053 , 3931 ,
journal of liaoning journal of tcm¤ 3932 ,
journal of nanjing university 0 traditional chinese medicine
(natural science)¤ 2439 ,
journal of nanjing university of tcm¤ 3381 , 3459 , 3606 ,
3607 , 3731 ,
journal of nanjing university of tcm (natural science)¤ 2884 ,
journal of nanjing university of traditional chinese
medicine(natural science)¤ 2372 ,
journal of nanjing university tcm¤ 1992 , 2077 , 2245 , 2246 ,
2579 , 2580 ,
journal of new chinese medicine¤ 39 , 56 , 64 , 65 , 98 , 101 ,
gera 2011

104 , 108 , 121 , 125 , 139 , 146 , 153 , 159 , 210 , 226 , 229 ,
239 , 312 , 313 , 314 , 437 , 438 , 439 , 498 ,
journal of new tcm¤ 79 ,
journal of practical tcm¤ 1908 , 1995 , 1996 , 2048 , 2049 ,
2215 , 2301 , 2639 , 2640 , 2996 , 2997 , 3007 , 3047 , 3109 ,
3110 , 3121 , 3162 , 3406 , 3490 , 3538 , 3555 , 3732 , 3845 ,
3933 , 3934 ,
journal of practical traditional chinese medicine¤ 2494 , 2533
, 2762 , 2785 , 2786 ,
journal of practice tcm¤ 2864 ,
journal of pratical traditional chinese medicine¤ 2294 ,
journal of qigong and science¤ 83 , 84 , 85 , 103 , 119 , 120 ,
journal of shaanxi college of tcm¤ 2118 , 2119 , 2120 , 2261 ,
3292 , 3542 ,
journal of shaanxi college of traditional chinese medicine¤
2429 , 2487 , 2526 , 2684 , 2861 , 2862 , 2863 ,
journal of shandong college of tcm¤ 244 , 1310 , 1311 , 1312
, 1549 , 1550 , 1551 , 1553 ,
journal of shandong college of traditional chinese medicine¤
746 , 1013 , 1074 , 1114 ,
journal of shandong tcm college¤ 595 ,
journal of shandong university of tcm¤ 1653 , 1654 , 1655 ,
1718 , 1768 , 1787 , 1788 , 1871 , 2160 , 2161 , 2162 , 2163 ,
3083 , 3198 , 3351 , 3611 , 3935 , 3936 ,
journal of shandong university of traditional chinese
medicine¤ 1683 , 1684 , 1755 , 2348 , 2393 , 2394 , 2809 ,
journal of tcm¤ 189 , 243 , 246 , 265 , 289 , 290 , 291 , 292 ,
293 , 344 , 1370 , 1371 , 1372 , 1373 , 1374 , 1535 , 1536 ,
1537 , 1540 , 1546 , 1547 , 1548 , 1587 , 1588 , 1589 , 1594 ,
1613 , 1614 , 1656 , 1657 , 1658 , 1659 , 1660 , 1661 , 1662 ,
1749 , 1766 , 1767 , 1772 , 1776 , 1794 , 1795 , 1796 , 1797 ,
1798 , 1799 , 1800 , 1874 , 1894 , 1911 , 1959 , 1960 , 2020 ,
2026 , 2027 , 2079 , 2080 , 2153 , 2154 , 2155 , 2217 , 2251 ,
2271 , 2272 , 2279 , 2288 , 2289 , 2553 , 2575 , 2939 , 2964 ,
3009 , 3010 , 3029 , 3030 , 3082 , 3099 , 3124 , 3125 , 3144 ,
3145 , 3197 , 3245 , 3246 , 3274 , 3275 , 3276 , 3323 , 3324 ,
3325 , 3335 , 3408 , 3410 , 3426 , 3438 , 3439 , 3551 , 3583 ,
3584 , 3631 , 3641 , 3848 , 3849 , 3937 , 3938 , 3939 ,
journal of tcm and chinese materia medica of jilin¤ 311 , 433
, 434 , 435 , 436 , 1335 , 1336 , 1337 , 1453 , 1454 , 1821 ,
2004 , 2005 , 2150 , 2151 , 2905 , 3015 , 3130 , 3200 , 3201 ,
journal of tcm- el puso de la vida¤ 3326 ,
journal of tcm university of hunan¤ 3048 , 3163 , 3486 , 3596
, 3733 , 3734 , 3735 , 3736 , 3737 ,
journal of the american college of traditional chinese
medicine¤ 131 , 184 ,
journal of the japan society of acupuncture¤ 76 , 376 , 825 ,
826 , 839 , 840 , 955 , 959 , 1369 , 1669 ,
journal of the japan society of acupuncture and moxibustion¤
2194 , 4083 ,
journal of the kyoto pain control institute¤ 7 ,
journal of tian in university of tianjin traditional chinese
medicine¤ 2716 ,
journal of tianjin college of tcm¤ 2087 ,
journal of tianjin university of tcm¤ 3244 , 3360 , 3940 ,
journal of tmc¤ 345 ,
journal of tongji medical university¤ 841 , 1384 , 1564 ,
journal of traditional chinese medicinal literature¤ 2165 ,
2166 , 2727 ,
journal of traditional chinese medicine¤ 52 , 53 , 54 , 57 , 58 ,
59 , 61 , 66 , 67 , 68 , 70 , 71 , 72 , 73 , 77 , 86 , 96 , 102 , 109
, 110 , 111 , 126 , 140 , 144 , 145 , 147 , 160 , 161 , 169 , 170
, 176 , 196 , 206 , 207 , 211 , 217 , 218 , 228 , 234 , 238 , 245
, 259 , 260 , 294 , 295 , 296 , 356 , 396 , 397 , 398 , 399 , 400
, 401 , 402 , 403 , 404 , 475 , 486 , 552 , 553 , 554 , 555 , 556
, 614 , 657 , 658 , 659 , 660 , 700 , 707 , 708 , 709 , 717 , 718
, 736 , 737 , 738 , 739 , 756 , 757 , 758 , 796 , 797 , 822 , 823
, 848 , 849 , 851 , 852 , 853 , 854 , 857 , 871 , 872 , 884 , 895
, 910 , 911 , 922 , 923 , 929 , 963 , 980 , 991 , 1047 , 1048 ,
1049 , 1063 , 1088 , 1099 , 1107 , 1108 , 1140 , 1166 , 1171 ,
324
1172 , 1173 , 1174 , 1175 , 1194 , 1203 , 1208 , 1209 , 1237 ,
1250 , 1293 , 1294 , 1295 , 1296 , 1297 , 1298 , 1299 , 1300 ,
1301 , 1302 , 1303 , 1380 , 1383 , 1407 , 1624 , 1641 , 1680 ,
1681 , 1692 , 1693 , 1694 , 1695 , 1696 , 1707 , 1708 , 1709 ,
1710 , 1711 , 1712 , 1715 , 1756 , 1757 , 1758 , 1895 , 1896 ,
1914 , 2320 , 2321 , 2328 , 2407 , 2408 , 2442 , 2443 , 2484 ,
2485 , 2523 , 2524 , 2557 , 2587 , 2683 , 2693 , 2816 , 2878 ,
2879 , 3859 , 4049 , 4050 , 4104 , 4105 ,
journal of traditional chinese medicine and chinese materia
medica of jilin¤ 661 , 662 , 742 , 743 , 744 , 925 , 926 , 976 ,
992 , 993 , 994 , 995 , 1018 , 1195 , 2403 , 2404 , 2629 , 2838
, 2839 , 2840 , 2841 , 3254 , 3255 ,
journal of traditional chinese medicine hubei¤ 2827 ,
journal of traditional chinese medicine university of hunan¤
3226 , 3227 ,
journal of traditional chinese veterinary medicine¤ 2655 ,
2667 ,
journal of yunnan college of tcm¤ 2830 , 2831 , 3374 , 3375 ,
3850 , 3851 ,
journal of zhejiang college of tcm¤ 1333 , 1334 , 1457 , 1458
, 1595 , 1663 , 1664 , 1667 , 1668 , 1737 , 1748 , 1919 , 2040
, 2953 , 3018 , 3072 , 3073 , 3133 , 3187 , 3188 , 3224 , 3225
, 3412 , 3413 , 3414 , 3458 , 3534 , 3569 , 3570 , 3601 , 3941
, 3942 , 3943 , 3944 , 3945 , 3946 ,
journal of zhejiang college of traditional chinese medicine¤
741 , 908 , 974 , 975 , 2391 , 2617 , 2618 , 2619 , 2797 ,
journal of zhejiang college traditional chinese medicine¤
2819 ,
journal of zhejiang tcm college¤ 406 , 407 ,
journal of zhejiang traditional chinese medical college¤ 557 ,
journal of zhejiang traditional chinese medicine¤ 251 ,
journal of zhejiang traditional chinese medicine college¤ 237
,
jtcm¤ 3471 ,
kampo medicine¤ 4141 , 4142 ,
lantern¤ 4022 ,
liaoning journal of tcm¤ 429 , 430 , 431 , 1666 , 1723 , 1724 ,
1813 , 1814 , 1815 , 1816 , 1849 , 2028 , 2029 , 2052 , 2164 ,
2167 , 2168 , 2169 , 2170 , 2227 , 2287 , 2907 , 2908 , 2909 ,
2910 , 2941 , 2942 , 2986 , 3094 , 3469 , 3576 , 3590 , 3605 ,
3738 , 3739 , 3740 , 3742 , 3743 , 3947 ,
liaoning journal of traditional chinese medicine¤ 208 , 209 ,
309 , 310 , 531 , 532 , 533 , 558 , 559 , 560 , 561 , 562 , 563 ,
652 , 653 , 774 , 873 , 883 , 906 , 990 , 1026 , 1100 , 1146 ,
1306 , 1307 , 1408 , 1409 , 1430 , 1431 , 1565 , 1597 , 1598 ,
1628 , 1649 , 1650 , 1651 , 1697 , 1705 , 2473 , 2500 , 2501 ,
2502 , 2539 , 2540 , 2541 , 2615 , 2625 , 2626 , 2631 , 2720 ,
2741 , 2767 ,
life sci¤ 3873 ,
med oncol¤ 4106 ,
medicina energetica¤ 3509 ,
medicina holistica¤ 1224 , 1225 ,
medicina tradicional¤ 3852 ,
mensuel du medecin acupuncteur¤ 29 , 31 , 32 , 33 , 34 ,
modern journal of integrated traditional chinese and western
medicine¤ 2980 , 2990 , 2999 , 3054 , 3088 , 3100 , 3113 ,
3169 , 3220 , 3284 , 3285 , 3288 , 3289 , 3290 , 3342 , 3352 ,
3433 , 3466 , 3520 , 3563 , 3567 , 3604 , 3614 , 3648 , 3649 ,
3744 , 3745 , 3798 , 3853 , 3948 , 3949 , 3950 , 3951 , 3952 ,
mtc et acupuncture¤ 188 ,
nei mongol journal of tcm¤ 1892 , 1893 ,
new jounal of traditional chinese medicine¤ 862 ,
new journal of tcm¤ 1341 , 1342 , 1343 , 1344 , 1345 , 1346 ,
1347 , 1348 , 1349 , 1350 , 1499 , 1500 , 1501 , 1502 , 1503 ,
1504 , 1505 , 1506 , 1507 , 1508 , 1509 , 1510 , 1511 , 1512 ,
1743 , 1853 , 1854 , 1855 , 1856 , 1857 , 1858 , 1859 , 1860 ,
1861 , 1862 , 1863 , 1864 , 1897 , 2023 , 2024 , 2075 , 2076 ,
2176 , 2177 , 2178 , 2179 , 2192 , 2197 , 2198 , 2254 , 2255 ,
2260 , 2343 , 2852 , 2981 , 2982 , 3012 , 3076 , 3077 , 3089 ,
3090 , 3127 , 3191 , 3192 , 3223 , 3264 , 3265 , 3338 , 3339 ,
gera 2011

3437 , 3521 , 3537 , 3598 , 3633 , 3746 , 3799 , 3854 , 3855 ,
3953 , 3954 , 3955 , 3956 , 3957 , 3958 ,
new journal of traditional chinese medicine¤ 654 , 655 , 656 ,
759 , 767 , 768 , 769 , 870 , 892 , 896 , 1014 , 1015 , 1016 ,
1017 , 1020 , 1022 , 1027 , 1028 , 1058 , 1101 , 1138 , 1176 ,
1177 , 1213 , 1238 , 1239 , 1759 , 1760 , 2206 , 2207 , 2362 ,
2475 , 2476 , 2582 , 2865 ,
new journal of traditionnal chinese medicine¤ 2171 , 2172 ,
officiel des medecines naturelles¤ 192 , 194 ,
oriental healing arts international bulletin¤ 474 , 494 ,
pacific journal of oriental medicine¤ 191 ,
planta med¤ 4084 ,
practical journal of integrating chinese with modern
medicine¤ 887 , 888 , 889 , 890 , 891 , 924 , 1034 , 1035 ,
1036 , 1037 , 1045 , 1046 , 1097 , 1098 , 1102 , 1103 , 1104 ,
1105 , 1147 , 1168 , 1169 , 1170 , 1191 , 1192 , 1193 , 1351 ,
1352 , 1353 , 1354 , 1355 , 1356 , 1357 , 1358 , 1359 , 1360 ,
1361 , 1362 , 1363 , 1364 , 1365 , 1366 , 1513 , 1514 , 1515 ,
1516 , 1517 , 1518 , 1519 , 1520 , 1521 , 1600 , 1601 , 1602 ,
1603 , 1604 ,
primary journal of chinese materia medica¤ 2262 , 2457 ,
pulso de la vida¤ 1560 ,
qi gong¤ 770 , 793 ,
qigong¤ 185 , 898 , 931 ,
qi-gong (an exercice for health and longevity)¤ 670 ,
qigong and physical training¤ 1741 ,
qigong and science¤ 171 , 172 ,
research of tcm¤ 2264 , 2336 ,
research of traditional chinese¤ 2616 ,
research of traditional chinese medicine¤ 2624 ,
revista argentina de acupuntura¤ 3510 ,
revista de la medicina tradicional china¤ 838 , 951 , 1305 ,
revista uruguaya de acupuntura¤ 62 ,
revue de mtc du yunnan¤ 42 , 63 , 152 , 162 , 187 , 213 , 227
, sociedad espanola de medicos acupuntores sema¤ 21 ,
rivista italiana di agopuntura¤ 16 , 133 , 274 , 1781 , 1782 ,
rivista italiana di medicina tradizionale cinese¤ 836 , 948 ,
1116 , 1368 , 1679 , 2092 , 2093 , 2286 , 2901 , 3651 , 3652 ,
3800 , 3801 , 3959 , 3960 , 4023 ,
shaanxi journal of tcm¤ 299 , 300 , 301 , 302 , 303 , 304 , 305
, 306 , 307 , 308 , 413 , 414 , 415 , 416 , 417 , 418 , 419 , 420
, 421 , 422 , 423 , 424 , 425 , 426 , 427 , 428 , 2993 , 2994 ,
3106 , 3107 , 3382 , 3383 , 3384 , 3385 , 3386 , 3387 , 3388 ,
3522 , 3523 , 3524 , 3588 , 3747 , 3748 , 3749 , 3750 , 3751 ,
3752 , 3753 , 3754 , 3961 , 3962 , 3963 , 3964 , 3965 , 3966 ,
3967 ,
shaanxi journal of traditional chinese medicine¤ 1271 , 1272 ,
1304 , 1445 , 1446 , 1469 , 1470 , 1471 , 1472 , 1473 , 1474 ,
1475 , 1476 , 1477 , 1478 , 1479 , 1830 , 1831 , 1832 , 1833 ,
1834 , 1835 , 1836 , 1881 , 1882 , 2025 , 2200 , 2201 , 2202 ,
2203 , 2304 , 2305 , 2660 , 2800 , 2801 , 2802 , 2803 ,
shaanxi traditional chinese medicine¤ 329 , 516 , 517 , 534 ,
535 , 564 , 565 , 566 , 567 , 568 , 569 , 570 , 571 , 572 , 573 ,
574 , 575 , 621 , 622 , 623 , 624 , 625 , 626 , 627 , 628 , 629 ,
762 , 763 , 812 , 813 , 814 , 815 , 816 , 817 , 818 , 819 , 820 ,
821 , 876 , 916 , 917 , 918 , 919 , 920 , 921 , 935 , 936 , 937 ,
938 , 939 , 940 , 981 , 982 , 983 , 984 , 1038 , 1039 , 1040 ,
1041 , 1158 , 1159 , 1160 , 1161 , 1162 , 1163 , 1187 , 1235 ,
1236 ,
shandong journal of tcm¤ 1480 , 1481 , 1482 , 1483 , 1484 ,
1485 , 1599 , 1790 , 1791 , 1792 , 1793 , 1920 , 2086 , 2121 ,
2125 , 2126 , 2128 , 2129 , 2130 , 2131 , 2204 , 2234 , 2259 ,
2290 , 2866 , 2867 , 3045 , 3052 , 3160 , 3167 , 3217 , 3295 ,
3424 , 3525 , 3554 , 3755 ,
shandong journal of traditional chinese medicine¤ 405 , 576 ,
577 , 775 , 850 , 987 , 998 , 2346 , 2347 , 2493 , 2532 , 2563 ,
2652 , 2682 , 2810 ,
shanghai j0urnal 0f tradtional chinese medicine¤ 2499 , 2538
, yunnan journal of traditional chinese medicine¤ 692 , 790 ,
shanghai journal of acupuncture and moxibustion¤ 99 , 579 ,
325
589 , 590 , 771 , 772 , 773 , 1206 , 1273 , 1449 , 1801 , 3008 ,
3046 , 3122 , 3161 , 3981 , 3985 , 4094 ,
shanghai journal of tcm¤ 78 , 186 , 247 , 248 , 297 , 298 , 408
, 409 , 410 , 411 , 412 , 1745 , 1769 , 1785 , 1786 , 1818 ,
1819 , 1875 , 1929 , 2019 , 2115 , 2156 , 2157 , 2158 , 2159 ,
2196 , 2275 , 2276 , 2306 , 2307 , 2308 , 2669 , 2851 , 2914 ,
2915 , 2916 , 2917 , 2952 , 2973 , 2974 , 2975 , 2998 , 3016 ,
3070 , 3111 , 3131 , 3185 , 3229 , 3230 , 3231 , 3232 , 3236 ,
3312 , 3313 , 3314 , 3315 , 3316 , 3543 , 3577 , 3578 , 3756 ,
3757 , 3758 , 3759 , 3802 , 3968 , 3969 , 3970 , 3971 , 3972 ,
3973 ,
shanghai journal of traditional chinese medicine¤ 41 , 43 , 51
, 55 , 60 , 69 , 81 , 92 , 93 , 100 , 107 , 113 , 135 , 138 , 141 ,
163 , 197 , 203 , 204 , 212 , 216 , 219 , 232 , 236 , 241 , 242 ,
261 , 262 , 538 , 539 , 540 , 541 , 542 , 543 , 580 , 581 , 582 ,
583 , 584 , 585 , 689 , 690 , 691 , 760 , 776 , 777 , 778 , 779 ,
780 , 781 , 782 , 783 , 784 , 785 , 786 , 787 , 788 , 859 , 860 ,
874 , 885 , 904 , 905 , 914 , 985 , 1042 , 1043 , 1052 , 1056 ,
1057 , 1068 , 1069 , 1092 , 1112 , 1113 , 1115 , 1156 , 1157 ,
1164 , 1196 , 1207 , 1234 , 1262 , 1263 , 1264 , 1265 , 1266 ,
1267 , 1268 , 1269 , 1270 , 1411 , 1412 , 1413 , 1414 , 1415 ,
1416 , 1417 , 1418 , 1419 , 1420 , 1421 , 1422 , 1423 , 1424 ,
1425 , 1426 , 1427 , 1428 , 1429 , 1566 , 1567 , 1568 , 1569 ,
1570 , 1571 , 1572 , 1573 , 1581 , 1761 , 2329 , 2337 , 2338 ,
2717 , 2718 , 2772 , 2773 ,
shanxi journal of tcm¤ 1459 , 1460 , 1461 , 1837 , 1838 ,
1909 , 2109 , 2122 , 2123 , 2124 , 2269 , 2888 , 3251 , 3252 ,
3253 , 3357 , 3358 , 3504 , 3536 , 3760 , 3761 , 3974 ,
shanxi journal of traditional chinese medicine¤ 578 , 664 ,
761 , 789 , 805 , 806 , 912 , 913 , 989 , 1023 , 1024 , 1053 ,
1065 , 1066 , 1143 , 1182 , 1186 , 1216 , 1245 , 1246 , 1247 ,
2344 , 2504 , 2542 , 2613 , 2632 , 2633 , 2714 , 2715 , 2734 ,
2735 ,
shanxi medical journal¤ 522 ,
study journal of tcm¤ 2253 ,
study journal of traditional chinese medicine¤ 2296 , 2361 ,
the american journal of chinese medicine¤ 4026 , 4053 , 4055
, 4075 , 4088 ,
the practical journal of integrating chinese with modern
medicine¤ 843 , 844 , 1025 , 1204 , 1205 ,
tianjin journal of tcm¤ 1436 , 2037 , 2132 , 2273 , 2967 ,
3105 , 3221 , 3556 , 3762 , 3856 ,
tianjin journal of traditional chinese medicine¤ 544 , 764 ,
765 , 930 , 1180 , 1181 , 1233 , 1259 , 1260 , 1261 , 2496 ,
2535 ,
traditional chinese drug research and clinical pharmacology¤
2181 , 2183 , 2256 , 2398 , 2437 , 2740 , 2934 , 3269 , 3270 ,
3340 , 3341 , 3645 , 3763 ,
traditional chinese drug research and clinical research and
clinical pharmacology¤ 3803 ,
traditional chinese medical research¤ 3764 , 3765 , 3766 ,
traditional chinese medicinal research¤ 791 , 858 , 1067 ,
1188 , 1274 , 1557 , 1625 , 1626 , 1642 , 1698 , 1713 , 1719 ,
1789 , 2127 , 2433 , 2434 , 2657 , 2685 , 2686 , 2854 , 2855 ,
3975 ,
traditional chinese medicine¤ 2661 , 2662 ,
word journal of acupuncture-moxibustion¤ 1771 ,
world j gastroenterol¤ 4052 , 4061 , 4090 , 4107 ,
world journal of acupuncture-moxibustion¤ 2659 , 3857 ,
4004 ,
world journal of acupuncture-moxibution¤ 4008 ,
xinjiang journal of tcm¤ 1869 , 2041 , 2250 ,
xinjiang journal of traditional chinese medicine¤ 2318 , 2612
,
yunnan journal of tcm¤ 315 ,
yunnan journal of tcm and materia medica¤ 1467 , 1468 ,
2231 ,
800 , 1051 , 1258 ,
gera 2011
 326
zhejiang journal journal of tcm¤ 3287 , int j mol med¤ 4124 ,
zhejiang journal of tcm¤ 646 , 647 , 648 , 649 , 650 , 651 , j clin lab immunol¤ 1075 ,
1437 , 1438 , 1439 , 1440 , 1441 , 1442 , 1443 , 1444 , 1734 , j community health¤ 4000 ,
1735 , 1736 , 1742 , 1825 , 1826 , 1867 , 1886 , 1887 , 1963 , j ethnopharmacol¤ 1286 , 1389 , 1399 , 1607 , 3869 , 4001 ,
1964 , 1965 , 2105 , 2106 , 2292 , 2883 , 2995 , 3081 , 3097 , j gastroenterol¤ 4003 ,
3108 , 3196 , 3247 , 3248 , 3488 , 3519 , 3562 , 3858 , 3976 , j gastroenterol hepatol¤ 1530 , 1678 , 1720 , 4002 ,
zhéjiâng journal of tcm¤ 2989 , j lab clin med¤ 1395 ,
zhejiang journal of traditional chinese medicine¤ 87 , 88 , j med assoc thai¤ 941 ,
114 , 115 , 116 , 117 , 143 , 148 , 149 , 150 , 151 , 168 , 195 , j med pharm sci¤ 134 ,
198 , 199 , 200 , 201 , 202 , 240 , 249 , 258 , 316 , 317 , 318 , j nat prod¤ 1534 ,
319 , 320 , 321 , 322 , 323 , 442 , 443 , 444 , 445 , 545 , 546 , j toxicol sci¤ 1124 ,
547 , 665 , 666 , 667 , 668 , 669 , 809 , 810 , 811 , 861 , 901 , jiangsu journal of tcm¤ 617 , 618 , 619 ,
902 , 903 , 927 , 928 , 1010 , 1011 , 1012 , 1019 , 1060 , 1090 jiangsu medical journal¤ 674 , 678 , 682 ,
, 1091 , 1217 , 1220 , 1253 , 1254 , 1255 , 1256 , 1257 , 2319 jiangxi zhongyiyao¤ 250 ,
, 2483 , 2522 , 2602 , 2603 , 2604 , 2642 , 2674 , 2760 , 2761 journal of beijing medical university¤ 460 , 529 ,
, journal of capital institute of medicine¤ 447 , 452 ,
zhejiang journal of traditional chinese medicine , (monthly)¤ journal of china pharmaceutical university¤ 676 ,
2340 , 2341 , journal of ethnopharmacology¤ 942 ,
zhong xi yi jie he xue bao¤ 4024 , 4025 , 4058 , 4059 , 4060 , journal of gastroenterology and hepatology¤ 706 ,
zhongguo zhong xi yi jie he za zhi¤ 4047 , journal of henan medical university¤ 461 , 702 ,
zhongguo zhong yao za zhi¤ 3808 , 4125 , journal of lanzhou medical college¤ 448 , 519 ,
zhonghua gan zang bing za zhi¤ 3989 , journal of new chinese medicine¤ 253 , 254 , 255 ,
journal of northeast normal university¤ 333 ,
5 - revues extérieures journal of shanxi medical college¤ 518 ,
acta neurol scand¤ 1544 , journal of shenyang college of pharmacy¤ 679 , 684 ,
acta pharmaceutica sinica¤ 326 , 449 , 454 , 675 , journal of the fourth military medical college¤ 456 ,
acta pharmacol sin¤ 2578 , journal of the taiwan pharmaceutical association¤ 325 , 550 ,
acta pharmacologica sinica¤ 331 , 332 , 671 , journal of xi'an medical university¤ 330 , 704 ,
american journal of chinese medicine¤ 1671 , 1672 , jpma j pak med assoc¤ 1230 ,
anesth analg¤ 4027 , jpn j pharmacol¤ 1559 ,
anticancer res¤ 1284 , korean j intern med¤ 1610 ,
antiviral res¤ 1396 , life sci¤ 1398 , 3982 ,
biochem mol biol int¤ 1532 , lyon mediterranee medical¤ 190 ,
biochem pharmacol¤ 1122 , 1137 , national medical journal of china¤ 549 , 1076 ,
biol pharm bull¤ 1248 , 1611 , new drugs and clinical remedies¤ 465 ,
biomed environ sci¤ 967 , 970 , new zealand medical journal¤ 1249 ,
bulletin of chinese materia medica¤ 528 , nippon naika gakkai zasshi¤ 1251 ,
cancer¤ 1402 , nippon shokakibyo gakkai zasshi¤ 1670 ,
cancer lett¤ 1228 , 3870 , nippon yakurigaku zasshi¤ 1082 , 1134 , 1285 ,
cesk farm¤ 973 , pediatrics¤ 1627 ,
chem biol interact¤ 1531 , pharmacology and clinics of chiense materia medica¤ 466 ,
chem pharm bull¤ 716 , pharmacology and clinics of chinese materia medica¤ 462 ,
chinese journal of cancer¤ 450 , 463 ,
chinese journal of clinical oncology¤ 551 , planta med¤ 943 , 971 , 1382 , 1397 , 1606 , 1609 ,
chinese journal of experimental surgery¤ 453 , poult sci¤ 1136 ,
chinese journal of immunology¤ 672 , res commun chem pathol pharmacol¤ 1282 ,
chinese pharmaceutical bulletin¤ 263 , shandong journal of tcm¤ 630 , 631 ,
chinese pharmaceutical journal¤ 673 , 766 , shanghai journal of tcm¤ 632 , 633 , 634 , 635 , 636 , 637 ,
chung hua chung liu tsa chih¤ 1135 , 638 , 639 , 640 , 641 ,
chung hua i hsueh tsa chih¤ 1403 , shanghai medical journal¤ 680 , 681 ,
chung hua nei ko tsa chih¤ 966 , 1288 , 1289 , sichuanzhongyi¤ 467 , 523 , 525 ,
chung hua wai ko tsa chih¤ 1291 , toxicol appl pharmacol¤ 1388 ,
dev pharmacol ther¤ 1221 , trace elements¤ 526 , 548 ,
eur j cancer prev¤ 1131 , transplant proc¤ 4005 ,
eur j pharmacol¤ 3984 , tumor¤ 527 , 703 , 705 ,
european journal of cancer¤ 1229 , voprosy kurortologii¤ 944 ,
fujian journal of tcm¤ 609 , world j gastroenterol¤ 3866 , 3868 , 3871 , 3872 , 3998 ,
fujian medical journal¤ 530 , 4007 ,
gastroent japonica¤ 710 , xinjiang zhongyiyao¤ 677 ,
gastroenterol clin biol¤ 1125 , yakugaku zasshi¤ 968 , 969 , 972 , 1129 , 1387 , 1608 ,
gastroenterology¤ 1529 , zhong xi yi jie he xue bao¤ 3977 ,
guangdong medical journal¤ 524 , zhongchengyao yanjiu¤ 455 , 458 ,
guangzhou medical journal¤ 464 ,
guizhou medical journal¤ 520 , 6 - thèses
gut¤ 1381 , these medecine,besancon¤ 20 ,
hepatobiliary pancreat dis int¤ 4045 , these medecine,bordeaux 2¤ 82 ,
hepatology¤ 1528 , these medecine,marseille¤ 8 ,
hum psychopharmacol¤ 3983 ,
hunan zhongyizazhi¤ 457 ,
immunopharmacol immunotoxicol¤ 3807 ,

gera 2011